Citrus Sinensis ID: 024027
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 273 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGP4 | 1010 | Probable LRR receptor-lik | yes | no | 0.941 | 0.254 | 0.451 | 2e-63 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.948 | 0.252 | 0.428 | 1e-57 | |
| C0LGT6 | 1031 | LRR receptor-like serine/ | no | no | 0.886 | 0.234 | 0.435 | 9e-53 | |
| Q9ZUI0 | 980 | Putative leucine-rich rep | no | no | 0.937 | 0.261 | 0.357 | 2e-45 | |
| Q9FL28 | 1173 | LRR receptor-like serine/ | no | no | 0.912 | 0.212 | 0.363 | 2e-39 | |
| C0LGR6 | 913 | Probable LRR receptor-lik | no | no | 0.838 | 0.250 | 0.382 | 5e-38 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.871 | 0.190 | 0.346 | 6e-38 | |
| Q9FN94 | 868 | Receptor-like protein kin | no | no | 0.890 | 0.279 | 0.332 | 1e-37 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.897 | 0.196 | 0.347 | 4e-37 | |
| O49564 | 642 | Cysteine-rich receptor-li | no | no | 0.886 | 0.376 | 0.346 | 6e-37 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 242 bits (618), Expect = 2e-63, Method: Compositional matrix adjust.
Identities = 125/277 (45%), Positives = 174/277 (62%), Gaps = 20/277 (7%)
Query: 3 VAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSN-----EEFKALVLEYMPHG 57
VAVKV N+Q A KSF ECE +K IRHRNL+K++++CS+ EF+AL+ E+MP+G
Sbjct: 728 VAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNG 787
Query: 58 SLEKYLYSSNC--------ILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLL 109
SL+ +L+ L + +RLNI IDVAS L+YLH C P+ HCDLKP NVLL
Sbjct: 788 SLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLL 847
Query: 110 DDNLVAYLSDFGIAKLLIGEDQ-----SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSF 164
DD+L A++SDFG+A+LL+ D+ ++ TIGY APEYG G+ S NGDVYSF
Sbjct: 848 DDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSF 907
Query: 165 GIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLS-QEDIHFVAKEQCV 223
GI+L+E FTGK+PT E F G TL + LP +++VD ++L + F E C+
Sbjct: 908 GILLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESILHIGLRVGFPVVE-CL 966
Query: 224 SFVFNLAMACTVESPEQRINAKEIVTKLLKIRDSLLR 260
+ VF + + C ESP R+ +V +L+ IR+ +
Sbjct: 967 TMVFEVGLRCCEESPMNRLATSIVVKELISIRERFFK 1003
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 223 bits (568), Expect = 1e-57, Method: Compositional matrix adjust.
Identities = 119/278 (42%), Positives = 168/278 (60%), Gaps = 19/278 (6%)
Query: 3 VAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEF-----KALVLEYMPHG 57
VA+KV NL A KSF ECE + IRHRNL+K+++ CS+ +F +ALV E+MP+G
Sbjct: 745 VAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNG 804
Query: 58 SLEKYLYSSNC--------ILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLL 109
+L+ +L+ L +F RLNI IDVASAL YLH C P+ HCD+KP N+LL
Sbjct: 805 NLDMWLHPDEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILL 864
Query: 110 DDNLVAYLSDFGIAKLLIGEDQSMTQTQ-----TLATIGYMAPEYGREGRVSTNGDVYSF 164
D +L A++SDFG+A+LL+ D+ Q TIGY APEYG G S GDVYSF
Sbjct: 865 DKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSF 924
Query: 165 GIMLMETFTGKKPTYEFFNGEMTLKHWVNDWL-PISTMEVVDANLLSQEDIHFVAKEQCV 223
GI+L+E FTGK+PT + F +TL + L +++ D +L +C+
Sbjct: 925 GIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETILRGAYAQHFNMVECL 984
Query: 224 SFVFNLAMACTVESPEQRINAKEIVTKLLKIRDSLLRN 261
+ VF + ++C+ ESP RI+ E ++KL+ IR+S R+
Sbjct: 985 TLVFRVGVSCSEESPVNRISMAEAISKLVSIRESFFRD 1022
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 207 bits (526), Expect = 9e-53, Method: Compositional matrix adjust.
Identities = 118/271 (43%), Positives = 154/271 (56%), Gaps = 29/271 (10%)
Query: 3 VAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSN-----EEFKALVLEYMPHG 57
VAVKV NL A KSF ECE K IRHRNL+K+I+ CS+ +F+ALV E+MP G
Sbjct: 738 VAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKG 797
Query: 58 SLEKYLYSSNC--------ILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLL 109
SL+ +L + L ++LNI IDVASALEYLH C PV HCD+KP N+LL
Sbjct: 798 SLDMWLQLEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILL 857
Query: 110 DDNLVAYLSDFGIAKLLIGEDQ-----SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSF 164
DD+L A++SDFG+A+LL D+ + TIGY APEYG G+ S GDVYSF
Sbjct: 858 DDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSF 917
Query: 165 GIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVS 224
GI+L+E F+GKKPT E F G+ L + L T A ++ +
Sbjct: 918 GILLLEMFSGKKPTDESFAGDYNLHSYTKSILSGCTSSGGSN-----------AIDEGLR 966
Query: 225 FVFNLAMACTVESPEQRINAKEIVTKLLKIR 255
V + + C+ E P R+ E V +L+ IR
Sbjct: 967 LVLQVGIKCSEEYPRDRMRTDEAVRELISIR 997
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 182 bits (463), Expect = 2e-45, Method: Compositional matrix adjust.
Identities = 99/277 (35%), Positives = 163/277 (58%), Gaps = 21/277 (7%)
Query: 2 EVAVKVFNLQCGRAFK-SFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 60
+VAVKV + + F SF EC+++K RHRNLI++I++CS F ALVL MP+GSLE
Sbjct: 685 KVAVKVLDPKTALEFSGSFKRECQILKRTRHRNLIRIITTCSKPGFNALVLPLMPNGSLE 744
Query: 61 KYLYS---SNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYL 117
++LY S+ LD+ Q +NI DVA + YLH V+HCDLKP N+LLDD + A +
Sbjct: 745 RHLYPGEYSSKNLDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALV 804
Query: 118 SDFGIAKLLIGEDQSMTQTQTLA----------TIGYMAPEYGREGRVSTNGDVYSFGIM 167
+DFGI++L+ G +++++ +++ ++GY+APEYG R ST+GDVYSFG++
Sbjct: 805 TDFGISRLVQGVEETVSTDDSVSFGSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVL 864
Query: 168 LMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLL------SQEDIHFVAKEQ 221
L+E +G++PT N +L ++ P S +++ L E + +E
Sbjct: 865 LLEIVSGRRPTDVLVNEGSSLHEFMKSHYPDSLEGIIEQALSRWKPQGKPEKCEKLWREV 924
Query: 222 CVSFVFNLAMACTVESPEQRINAKEIVTKLLKIRDSL 258
+ + L + CT +P R + ++ ++ ++++ L
Sbjct: 925 ILEMI-ELGLVCTQYNPSTRPDMLDVAHEMGRLKEYL 960
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 162 bits (411), Expect = 2e-39, Method: Compositional matrix adjust.
Identities = 97/267 (36%), Positives = 158/267 (59%), Gaps = 18/267 (6%)
Query: 3 VAVKVFNLQ--CGRAFKSFDVECEMMKSIRHRNLIKVIS-SCSNEEFKALVLEYMPHGSL 59
+AVKV NL+ + K F E + + ++HRNL+K++ + + + KALVL +M +G+L
Sbjct: 895 IAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKILGFAWESGKTKALVLPFMENGNL 954
Query: 60 EKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLS 118
E ++ S I + +++++ + +AS ++YLH G P++HCDLKP N+LLD + VA++S
Sbjct: 955 EDTIHGSAAPIGSLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVS 1014
Query: 119 DFGIAKLL-IGEDQSMTQTQTL--ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGK 175
DFG A++L ED S T + + TIGY+APE+ +V+T DV+SFGI++ME T +
Sbjct: 1015 DFGTARILGFREDGSTTASTSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQ 1074
Query: 176 KPTYEFFNGE----MTLKHWVNDWLP---ISTMEVVDANLLSQEDIHFVAKEQCVSFVFN 228
+PT N E MTL+ V + + V+D L + I + +E+ +
Sbjct: 1075 RPTS--LNDEDSQDMTLRQLVEKSIGNGRKGMVRVLDMEL--GDSIVSLKQEEAIEDFLK 1130
Query: 229 LAMACTVESPEQRINAKEIVTKLLKIR 255
L + CT PE R + EI+T L+K+R
Sbjct: 1131 LCLFCTSSRPEDRPDMNEILTHLMKLR 1157
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGR6|Y4291_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g29180 OS=Arabidopsis thaliana GN=At4g29180 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 158 bits (399), Expect = 5e-38, Method: Compositional matrix adjust.
Identities = 91/238 (38%), Positives = 136/238 (57%), Gaps = 9/238 (3%)
Query: 17 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNC-ILDIFQR 75
K F VE E++ ++ HRNL + C + AL+ EYM +G+L+ YL S N L +R
Sbjct: 619 KEFQVEAELLLTVHHRNLASFVGYCDDGRSMALIYEYMANGNLQDYLSSENAEDLSWEKR 678
Query: 76 LNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQ 135
L+I ID A LEYLH GC P++H D+K N+LL+DNL A ++DFG++K+ +D S
Sbjct: 679 LHIAIDSAQGLEYLHHGCRPPIVHRDVKTANILLNDNLEAKIADFGLSKVFPEDDLSHVV 738
Query: 136 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGE-MTLKHWVND 194
T + T GY+ PEY +++ DVYSFGI+L+E TGK+ + +GE M + H+V
Sbjct: 739 TAVMGTPGYVDPEYYNTFKLNEKSDVYSFGIVLLELITGKRSIMKTDDGEKMNVVHYVEP 798
Query: 195 WLPISTME-VVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKL 251
+L + ++ VVD L + FV +AM+C + R N +IV+ L
Sbjct: 799 FLKMGDIDGVVDPRLHGD-----FSSNSAWKFV-EVAMSCVRDRGTNRPNTNQIVSDL 850
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 157 bits (398), Expect = 6e-38, Method: Compositional matrix adjust.
Identities = 86/248 (34%), Positives = 140/248 (56%), Gaps = 10/248 (4%)
Query: 17 KSFDVECEMMKSIRHRNLIKVISSCSNEE--FKALVLEYMPHGSLEKYLYSSNC-----I 69
KSF+ E + + +IRHR+L+K++ CS++ L+ EYM +GS+ +L+++ +
Sbjct: 988 KSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKKEV 1047
Query: 70 LDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 129
L RL I + +A +EYLH+ C P++H D+K NVLLD N+ A+L DFG+AK+L G
Sbjct: 1048 LGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGN 1107
Query: 130 DQSMTQTQTL--ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMT 187
+ T++ T+ + GY+APEY + + DVYS GI+LME TGK PT F+ E
Sbjct: 1108 YDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAMFDEETD 1167
Query: 188 LKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSF-VFNLAMACTVESPEQRINAKE 246
+ WV L L+ E + E+ ++ V +A+ CT P++R ++++
Sbjct: 1168 MVRWVETVLDTPPGSEAREKLIDSELKSLLPCEEEAAYQVLEIALQCTKSYPQERPSSRQ 1227
Query: 247 IVTKLLKI 254
LL +
Sbjct: 1228 ASEYLLNV 1235
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FN94|RLK7_ARATH Receptor-like protein kinase At5g59670 OS=Arabidopsis thaliana GN=At5g59670 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 157 bits (396), Expect = 1e-37, Method: Compositional matrix adjust.
Identities = 84/253 (33%), Positives = 140/253 (55%), Gaps = 10/253 (3%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 61
+VAVKV + + K F E +++ + H NL+ ++ C ++ ALV E++P+G L++
Sbjct: 588 QVAVKVLSQSSTQGSKEFKAEVDLLLRVHHTNLVSLVGYCCEGDYLALVYEFLPNGDLKQ 647
Query: 62 YLYS--SNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSD 119
+L N I++ RL I ++ A LEYLH GC+ P++H D+K N+LLD+N A L+D
Sbjct: 648 HLSGKGGNSIINWSIRLRIALEAALGLEYLHIGCTPPMVHRDVKTANILLDENFKAKLAD 707
Query: 120 FGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTY 179
FG+++ GE +S T T+GY+ PE GR+ DVYSFGI+L+E T +P
Sbjct: 708 FGLSRSFQGEGESQESTTIAGTLGYLDPECYHSGRLGEKSDVYSFGIVLLEMIT-NQPVI 766
Query: 180 EFFNGEMTLKHWVNDWLPIS-TMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238
+G+ + WV + +E++D NL +I+ + LAM+C S
Sbjct: 767 NQTSGDSHITQWVGFQMNRGDILEIMDPNLRKDYNINSAWR------ALELAMSCAYPSS 820
Query: 239 EQRINAKEIVTKL 251
+R + +++ +L
Sbjct: 821 SKRPSMSQVIHEL 833
|
Probable receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 155 bits (391), Expect = 4e-37, Method: Compositional matrix adjust.
Identities = 92/265 (34%), Positives = 144/265 (54%), Gaps = 20/265 (7%)
Query: 17 KSFDVECEMMKSIRHRNLIKVISSCSN--EEFKALVLEYMPHGSLEKYLYSSNCIL---- 70
KSF E + + IRHR+L+K++ CS+ E L+ EYM +GS+ +L+ +L
Sbjct: 991 KSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKK 1050
Query: 71 ---DIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI 127
D RL I + +A +EYLH C P++H D+K NVLLD N+ A+L DFG+AK+L
Sbjct: 1051 KLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLT 1110
Query: 128 GEDQSMTQTQTL--ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGE 185
+ T + T + GY+APEY + + DVYS GI+LME TGK PT F E
Sbjct: 1111 ENCDTNTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAE 1170
Query: 186 MTLKHWVNDWLPISTM---EVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRI 242
M + WV L ++ +++D L + + F C V +A+ CT SP++R
Sbjct: 1171 MDMVRWVETHLEVAGSARDKLIDPKL--KPLLPFEEDAACQ--VLEIALQCTKTSPQERP 1226
Query: 243 NAKEIVTKLLKIRDSLLRNVGGRRI 267
++++ LL + ++ R G +++
Sbjct: 1227 SSRQACDSLLHVYNN--RTAGYKKL 1249
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49564|CRK27_ARATH Cysteine-rich receptor-like protein kinase 27 OS=Arabidopsis thaliana GN=CRK27 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 154 bits (390), Expect = 6e-37, Method: Compositional matrix adjust.
Identities = 89/257 (34%), Positives = 142/257 (55%), Gaps = 15/257 (5%)
Query: 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 60
+E+AVK ++ G+ F E +M ++H+NL+K+ E + LV E++P+ SL+
Sbjct: 356 LEIAVKRLSIHSGQGNAEFKTEVLLMTKLQHKNLVKLFGFSIKESERLLVYEFIPNTSLD 415
Query: 61 KYLYSS--NCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLS 118
++L+ LD +R NI++ V+ L YLH G P+IH DLK NVLLD+ ++ +S
Sbjct: 416 RFLFDPIKQKQLDWEKRYNIIVGVSRGLLYLHEGSEFPIIHRDLKSSNVLLDEQMLPKIS 475
Query: 119 DFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPT 178
DFG+A+ ++ + + T GYMAPEY GR S DVYSFG++++E TGK+ +
Sbjct: 476 DFGMARQFDFDNTQAVTRRVVGTYGYMAPEYAMHGRFSVKTDVYSFGVLVLEIITGKRNS 535
Query: 179 YEFFNGEMTLK--HWVNDWLPISTMEVVDANLLSQEDIHFVAKE--QCVSFVFNLAMACT 234
L W N W+ ++ME++D LL D KE QC+ +A++C
Sbjct: 536 GLGLGEGTDLPTFAWQN-WIEGTSMELIDPVLLQTHD----KKESMQCL----EIALSCV 586
Query: 235 VESPEQRINAKEIVTKL 251
E+P +R +V+ L
Sbjct: 587 QENPTKRPTMDSVVSML 603
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 273 | ||||||
| 224139658 | 1019 | predicted protein [Populus trichocarpa] | 0.970 | 0.260 | 0.620 | 1e-90 | |
| 359483198 | 1087 | PREDICTED: probable LRR receptor-like se | 0.923 | 0.231 | 0.639 | 1e-90 | |
| 359485451 | 1454 | PREDICTED: LRR receptor-like serine/thre | 0.941 | 0.176 | 0.637 | 3e-90 | |
| 302143440 | 929 | unnamed protein product [Vitis vinifera] | 0.941 | 0.276 | 0.637 | 3e-90 | |
| 359485176 | 1160 | PREDICTED: probable LRR receptor-like se | 0.934 | 0.219 | 0.655 | 4e-89 | |
| 359485453 | 1202 | PREDICTED: probable LRR receptor-like se | 0.930 | 0.211 | 0.640 | 7e-89 | |
| 224116832 | 1061 | predicted protein [Populus trichocarpa] | 0.919 | 0.236 | 0.612 | 1e-87 | |
| 359483683 | 1228 | PREDICTED: LRR receptor-like serine/thre | 0.941 | 0.209 | 0.621 | 2e-86 | |
| 359483677 | 1229 | PREDICTED: LRR receptor-like serine/thre | 0.941 | 0.209 | 0.610 | 3e-86 | |
| 147853795 | 1420 | hypothetical protein VITISV_005816 [Viti | 0.934 | 0.179 | 0.630 | 6e-86 |
| >gi|224139658|ref|XP_002323215.1| predicted protein [Populus trichocarpa] gi|222867845|gb|EEF04976.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 338 bits (867), Expect = 1e-90, Method: Compositional matrix adjust.
Identities = 165/266 (62%), Positives = 207/266 (77%), Gaps = 1/266 (0%)
Query: 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 60
+ VAVK+FNLQ RAF+SFD ECE+M++IRHRNL+K+I SCSN +FKALVLEYMP GSLE
Sbjct: 754 LNVAVKIFNLQLQRAFRSFDTECEIMRNIRHRNLVKIICSCSNLDFKALVLEYMPKGSLE 813
Query: 61 KYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDF 120
K+LYS N LDI QR+NIMIDVASALEYLH G +PV+HCDLKP NVLLD+++VA++ DF
Sbjct: 814 KWLYSHNYCLDIIQRVNIMIDVASALEYLHHGYPSPVVHCDLKPSNVLLDEDMVAHVCDF 873
Query: 121 GIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYE 180
GIAKLL GE++S QT+TLATIGYMAPEYG +G VST DVYSFGIMLME T K+PT E
Sbjct: 874 GIAKLL-GENESFAQTRTLATIGYMAPEYGLDGLVSTKIDVYSFGIMLMEMLTRKRPTDE 932
Query: 181 FFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQ 240
F GEM+LK V + LP S +++VD+N+L++ D + V KE CV+ + LA+ C ESP +
Sbjct: 933 MFEGEMSLKRLVKESLPDSVIDIVDSNMLNRGDGYSVKKEHCVTSIMELALQCVNESPGE 992
Query: 241 RINAKEIVTKLLKIRDSLLRNVGGRR 266
R+ EI+ +L I+ LR+ RR
Sbjct: 993 RMAMVEILARLKNIKAEFLRDSERRR 1018
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483198|ref|XP_002271405.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 338 bits (867), Expect = 1e-90, Method: Compositional matrix adjust.
Identities = 163/255 (63%), Positives = 203/255 (79%), Gaps = 3/255 (1%)
Query: 3 VAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNE--EFKALVLEYMPHGSLE 60
A+KVFNLQ AFKSFD ECE+M IRHRNLIK++SSCSN +FKALVLEY+P+GSLE
Sbjct: 829 AAIKVFNLQEEAAFKSFDAECEVMHHIRHRNLIKIVSSCSNSYIDFKALVLEYVPNGSLE 888
Query: 61 KYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDF 120
++LYS N LDI QRLNIMIDVA A+EYLH GCS PV+HCDLKP N+LLD++ ++ DF
Sbjct: 889 RWLYSHNYCLDILQRLNIMIDVALAMEYLHHGCSTPVVHCDLKPSNILLDEDFGGHVGDF 948
Query: 121 GIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYE 180
GIAKLL E++S+ +TQTLATIGYMAP+Y G V+T+GDVYS+GI+LMETFT ++PT E
Sbjct: 949 GIAKLL-REEESIRETQTLATIGYMAPKYVSNGIVTTSGDVYSYGIVLMETFTRRRPTDE 1007
Query: 181 FFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQ 240
F+ EM++K+WV DWL S EVVDANLL ED F+AK+QC+S + LAM C +SPE+
Sbjct: 1008 IFSEEMSMKNWVWDWLCGSITEVVDANLLRGEDEQFMAKKQCISLILGLAMDCVADSPEE 1067
Query: 241 RINAKEIVTKLLKIR 255
RI K++VT L KI+
Sbjct: 1068 RIKMKDVVTTLKKIK 1082
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485451|ref|XP_002276944.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 337 bits (865), Expect = 3e-90, Method: Compositional matrix adjust.
Identities = 165/259 (63%), Positives = 205/259 (79%), Gaps = 2/259 (0%)
Query: 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 60
+ VAVKVFNL+ AF+SFD ECE+M+SIRHRNL+K+I+ CSN +FKALVLEYMP GSL+
Sbjct: 1197 LTVAVKVFNLEFQGAFRSFDSECEVMQSIRHRNLVKIITCCSNLDFKALVLEYMPKGSLD 1256
Query: 61 KYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDF 120
K+LYS N LD+ QRLNIMIDVASALEYLH C + V+HCDLKP+N+LLDD++VA++ DF
Sbjct: 1257 KWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCPSLVVHCDLKPNNILLDDDMVAHVGDF 1316
Query: 121 GIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYE 180
GIA+LL E +SM QT+TL TIGYMAPEYG +G VST GDV+S+GIMLME F KKP E
Sbjct: 1317 GIARLLT-ETESMQQTKTLGTIGYMAPEYGSDGIVSTKGDVFSYGIMLMEVFARKKPMDE 1375
Query: 181 FFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQ 240
FNG++TLK WV + L S +EVVDANLL +ED F K C+S + LA+ACT +SPE+
Sbjct: 1376 MFNGDLTLKSWV-ESLADSMIEVVDANLLRREDEDFATKLSCLSSIMALALACTTDSPEE 1434
Query: 241 RINAKEIVTKLLKIRDSLL 259
RI+ K++V L KI+ LL
Sbjct: 1435 RIDMKDVVVGLKKIKIELL 1453
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302143440|emb|CBI22001.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 337 bits (865), Expect = 3e-90, Method: Compositional matrix adjust.
Identities = 165/259 (63%), Positives = 205/259 (79%), Gaps = 2/259 (0%)
Query: 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 60
+ VAVKVFNL+ AF+SFD ECE+M+SIRHRNL+K+I+ CSN +FKALVLEYMP GSL+
Sbjct: 672 LTVAVKVFNLEFQGAFRSFDSECEVMQSIRHRNLVKIITCCSNLDFKALVLEYMPKGSLD 731
Query: 61 KYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDF 120
K+LYS N LD+ QRLNIMIDVASALEYLH C + V+HCDLKP+N+LLDD++VA++ DF
Sbjct: 732 KWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCPSLVVHCDLKPNNILLDDDMVAHVGDF 791
Query: 121 GIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYE 180
GIA+LL E +SM QT+TL TIGYMAPEYG +G VST GDV+S+GIMLME F KKP E
Sbjct: 792 GIARLLT-ETESMQQTKTLGTIGYMAPEYGSDGIVSTKGDVFSYGIMLMEVFARKKPMDE 850
Query: 181 FFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQ 240
FNG++TLK WV + L S +EVVDANLL +ED F K C+S + LA+ACT +SPE+
Sbjct: 851 MFNGDLTLKSWV-ESLADSMIEVVDANLLRREDEDFATKLSCLSSIMALALACTTDSPEE 909
Query: 241 RINAKEIVTKLLKIRDSLL 259
RI+ K++V L KI+ LL
Sbjct: 910 RIDMKDVVVGLKKIKIELL 928
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485176|ref|XP_002280075.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 333 bits (855), Expect = 4e-89, Method: Compositional matrix adjust.
Identities = 169/258 (65%), Positives = 200/258 (77%), Gaps = 3/258 (1%)
Query: 3 VAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKY 62
VAVKVFNL+ AFKSFD ECE+M++I+HRNL+K+ISSCS FKALVLEYMP+GSLEK+
Sbjct: 903 VAVKVFNLEFQGAFKSFDAECEIMRNIQHRNLVKIISSCSILNFKALVLEYMPNGSLEKW 962
Query: 63 LYSSNCILDIFQRLNIMIDVASALEYLHFGCSA-PVIHCDLKPDNVLLDDNLVAYLSDFG 121
LYS N L++ QRLNIMIDVASALEYLH S PV+HCDLKP+NVLLD+ +VA L DFG
Sbjct: 963 LYSHNYCLNLVQRLNIMIDVASALEYLHHDFSVNPVVHCDLKPNNVLLDEEMVARLGDFG 1022
Query: 122 IAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEF 181
I+KLL E +SM QT+TL TIGYMAPEYG EG VST GDVYS+GIM+METF KKPT E
Sbjct: 1023 ISKLLT-ETESMEQTRTLGTIGYMAPEYGSEGIVSTRGDVYSYGIMMMETFARKKPTDEM 1081
Query: 182 FNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQR 241
F GE+TL+ WV + L MEVVD NL+ +ED HF KE C+ + LA+ CT ESP R
Sbjct: 1082 FGGEVTLRSWV-ESLAGRVMEVVDGNLVRREDQHFGIKESCLRSIMALALECTTESPRDR 1140
Query: 242 INAKEIVTKLLKIRDSLL 259
I+ KE+V +L KIR LL
Sbjct: 1141 IDMKEVVVRLKKIRIKLL 1158
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485453|ref|XP_003633276.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 333 bits (853), Expect = 7e-89, Method: Compositional matrix adjust.
Identities = 164/256 (64%), Positives = 200/256 (78%), Gaps = 2/256 (0%)
Query: 3 VAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKY 62
VAVKVFNL+ AFKSF+VECE+M++IRHRNL K+ISSCSN +FKALVLEYMP+GSLEK+
Sbjct: 943 VAVKVFNLELQGAFKSFEVECEVMRNIRHRNLAKIISSCSNLDFKALVLEYMPNGSLEKW 1002
Query: 63 LYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGI 122
LYS N LD QRL IMIDVAS LEYLH S PV+HCDLKP NVLLDD++VA++SDFGI
Sbjct: 1003 LYSHNYYLDFVQRLKIMIDVASGLEYLHHYYSNPVVHCDLKPSNVLLDDDMVAHISDFGI 1062
Query: 123 AKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFF 182
AKLL+G + M +T+TL T+GYMAPEYG EG VST GD+YS+GI+LMETF KKPT E F
Sbjct: 1063 AKLLMG-SEFMKRTKTLGTVGYMAPEYGSEGIVSTKGDIYSYGILLMETFVRKKPTDEMF 1121
Query: 183 NGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRI 242
E+TLK WV + MEV+DANLL++ED F K C S + LA+ CTVE PE+RI
Sbjct: 1122 VEELTLKSWVESSTN-NIMEVIDANLLTEEDESFALKRACFSSIMTLALDCTVEPPEKRI 1180
Query: 243 NAKEIVTKLLKIRDSL 258
N K++V +L K+ + +
Sbjct: 1181 NTKDVVVRLKKLLNQI 1196
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224116832|ref|XP_002317405.1| predicted protein [Populus trichocarpa] gi|222860470|gb|EEE98017.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 329 bits (843), Expect = 1e-87, Method: Compositional matrix adjust.
Identities = 155/253 (61%), Positives = 202/253 (79%), Gaps = 2/253 (0%)
Query: 3 VAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKY 62
+AVKVF+LQ FD ECE+++ +RHRNL+K+ISSC N +FKAL+LE++PHGSLEK+
Sbjct: 796 IAVKVFHLQLEGELMRFDSECEVLRMLRHRNLVKIISSCCNLDFKALILEFIPHGSLEKW 855
Query: 63 LYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGI 122
LYS N LDI QRLNIMIDVASALEYLH GC+ PV+HCDLKP NVL+++++VA++SDFGI
Sbjct: 856 LYSHNYYLDILQRLNIMIDVASALEYLHHGCTRPVVHCDLKPSNVLINEDMVAHVSDFGI 915
Query: 123 AKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFF 182
++LL GE ++TQT TLATIGYMAPEYG EG VS GDVYS+GI LMETFT KKPT + F
Sbjct: 916 SRLL-GEGDAVTQTLTLATIGYMAPEYGLEGIVSVKGDVYSYGIFLMETFTRKKPTDDMF 974
Query: 183 NGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRI 242
GEM+LK+WV LP + EV+DANLL +E+ HFVAK+ C++ + NLA+ C+ + P +RI
Sbjct: 975 GGEMSLKNWVKQSLPKAITEVIDANLLIEEE-HFVAKKDCITSILNLALECSADLPGERI 1033
Query: 243 NAKEIVTKLLKIR 255
++++ L KI+
Sbjct: 1034 CMRDVLPALEKIK 1046
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483683|ref|XP_003633001.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 324 bits (831), Expect = 2e-86, Method: Compositional matrix adjust.
Identities = 161/259 (62%), Positives = 202/259 (77%), Gaps = 2/259 (0%)
Query: 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 60
+ VA+KVFNL+ A +SFD ECE+M+ I HRNLI++I+ CSN +FKALVLEYMP GSL+
Sbjct: 971 LTVAIKVFNLEFQGALRSFDSECEVMQGICHRNLIRIITCCSNLDFKALVLEYMPKGSLD 1030
Query: 61 KYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDF 120
K+LYS N LD+FQRLNIMIDVASALEYLH CS+ V+HCDLKP NVLLD+N+VA+++DF
Sbjct: 1031 KWLYSHNYFLDLFQRLNIMIDVASALEYLHHDCSSLVVHCDLKPSNVLLDNNMVAHVADF 1090
Query: 121 GIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYE 180
GIA+LL E +SM QT+TL TIGYMAPEYG +G VST GDVYS+GI+LME F KKP E
Sbjct: 1091 GIARLLT-ETESMQQTKTLGTIGYMAPEYGSDGIVSTKGDVYSYGILLMEVFARKKPMDE 1149
Query: 181 FFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQ 240
F G++TLK WV + L S +EVVDANLL ++D K +S + LA+ACT +SPE+
Sbjct: 1150 MFTGDVTLKTWV-ESLSSSVIEVVDANLLRRDDEDLATKLSYLSSLMALALACTADSPEE 1208
Query: 241 RINAKEIVTKLLKIRDSLL 259
RIN K++V +L KI+ LL
Sbjct: 1209 RINMKDVVVELKKIKIKLL 1227
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483677|ref|XP_003633000.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 324 bits (830), Expect = 3e-86, Method: Compositional matrix adjust.
Identities = 158/259 (61%), Positives = 202/259 (77%), Gaps = 2/259 (0%)
Query: 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 60
+ VA+KVFNL+ A +SFD ECE+M+ IRHRNL+++I+ CSN +FKALVLEYMP+GSLE
Sbjct: 972 LTVAIKVFNLEFQGALRSFDSECEVMQGIRHRNLVRIITCCSNLDFKALVLEYMPNGSLE 1031
Query: 61 KYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDF 120
K+LYS N LD+ QRLNIMIDVASALEYLH CS+ V+HCDLKP+NVLLDD++VA+++DF
Sbjct: 1032 KWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCSSLVVHCDLKPNNVLLDDDMVAHVADF 1091
Query: 121 GIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYE 180
GI KLL + +SM QT+TL TIGYMAPE+G +G VST DVYS+GI+LME F+ KKP E
Sbjct: 1092 GITKLLT-KTESMQQTKTLGTIGYMAPEHGSDGIVSTKSDVYSYGILLMEVFSRKKPMDE 1150
Query: 181 FFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQ 240
F G++TLK WV + L S ++VVDANLL +ED K C+S + LA+ACT +SPE+
Sbjct: 1151 MFTGDLTLKTWV-ESLSNSVIQVVDANLLRREDEDLATKLSCLSSIMALALACTTDSPEE 1209
Query: 241 RINAKEIVTKLLKIRDSLL 259
R+N K+ V +L K R LL
Sbjct: 1210 RLNMKDAVVELKKSRMKLL 1228
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147853795|emb|CAN81714.1| hypothetical protein VITISV_005816 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 323 bits (827), Expect = 6e-86, Method: Compositional matrix adjust.
Identities = 162/257 (63%), Positives = 198/257 (77%), Gaps = 2/257 (0%)
Query: 3 VAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKY 62
VAVKVFNL+ AFKSF+VECE+M++IRHRNL K+ISSCSN +FKALVLEYMP+ SLEK+
Sbjct: 944 VAVKVFNLELHGAFKSFEVECEVMRNIRHRNLAKIISSCSNLDFKALVLEYMPNESLEKW 1003
Query: 63 LYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGI 122
LYS N LD QRL IMIDVAS LEYLH S PV+HCDLKP NVLLDD++VA++SDFGI
Sbjct: 1004 LYSHNYCLDFIQRLKIMIDVASGLEYLHHDYSNPVVHCDLKPSNVLLDDDMVAHISDFGI 1063
Query: 123 AKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFF 182
AKLL+G + M +T+TL TIGYMAPEYG EG VST D YS+GI+LME F KKPT E F
Sbjct: 1064 AKLLMGS-EFMKRTKTLGTIGYMAPEYGSEGIVSTKCDTYSYGIILMEIFVRKKPTDEMF 1122
Query: 183 NGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRI 242
E+TLK WV + MEV+DANLL++ED F K+ C S + LA+ CT+E PE+RI
Sbjct: 1123 VEELTLKSWVESSAN-NIMEVIDANLLTEEDESFALKQACFSSIMTLALDCTIEPPEKRI 1181
Query: 243 NAKEIVTKLLKIRDSLL 259
N K++V +L KI + ++
Sbjct: 1182 NMKDVVARLKKILNQIV 1198
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 273 | ||||||
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.941 | 0.254 | 0.451 | 4e-57 | |
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.941 | 0.254 | 0.433 | 1e-55 | |
| TAIR|locus:2079157 | 1011 | AT3G47580 [Arabidopsis thalian | 0.941 | 0.254 | 0.425 | 1.2e-53 | |
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 0.945 | 0.251 | 0.433 | 5.3e-52 | |
| TAIR|locus:2175703 | 502 | AT5G39390 [Arabidopsis thalian | 0.886 | 0.482 | 0.442 | 2.3e-46 | |
| TAIR|locus:2149922 | 1031 | EFR "EF-TU receptor" [Arabidop | 0.886 | 0.234 | 0.439 | 5.9e-46 | |
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.934 | 0.248 | 0.375 | 5.4e-45 | |
| TAIR|locus:2047525 | 980 | AT2G24130 [Arabidopsis thalian | 0.937 | 0.261 | 0.357 | 7.5e-41 | |
| TAIR|locus:2126540 | 876 | AT4G29990 [Arabidopsis thalian | 0.934 | 0.291 | 0.345 | 3.5e-38 | |
| TAIR|locus:2170483 | 1173 | FLS2 "FLAGELLIN-SENSITIVE 2" [ | 0.919 | 0.213 | 0.358 | 1.4e-37 |
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 595 (214.5 bits), Expect = 4.0e-57, P = 4.0e-57
Identities = 125/277 (45%), Positives = 174/277 (62%)
Query: 3 VAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSN-----EEFKALVLEYMPHG 57
VAVKV N+Q A KSF ECE +K IRHRNL+K++++CS+ EF+AL+ E+MP+G
Sbjct: 728 VAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNG 787
Query: 58 SLEKYLYSSNC--------ILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLL 109
SL+ +L+ L + +RLNI IDVAS L+YLH C P+ HCDLKP NVLL
Sbjct: 788 SLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLL 847
Query: 110 DDNLVAYLSDFGIAKLLIGEDQS-----MTQTQTLATIGYMAPEYGREGRVSTNGDVYSF 164
DD+L A++SDFG+A+LL+ D+ ++ TIGY APEYG G+ S NGDVYSF
Sbjct: 848 DDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSF 907
Query: 165 GIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQE-DIHFVAKEQCV 223
GI+L+E FTGK+PT E F G TL + LP +++VD ++L + F E C+
Sbjct: 908 GILLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESILHIGLRVGFPVVE-CL 966
Query: 224 SFVFNLAMACTVESPEQRINAKEIVTKLLKIRDSLLR 260
+ VF + + C ESP R+ +V +L+ IR+ +
Sbjct: 967 TMVFEVGLRCCEESPMNRLATSIVVKELISIRERFFK 1003
|
|
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 582 (209.9 bits), Expect = 1.0e-55, P = 1.0e-55
Identities = 120/277 (43%), Positives = 173/277 (62%)
Query: 3 VAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSN-----EEFKALVLEYMPHG 57
VAVKV N+Q A KSF ECE +K IRHRNL+K++++C++ EF+AL+ E+MP+G
Sbjct: 727 VAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACASIDFQGNEFRALIYEFMPNG 786
Query: 58 SLEKYLYSSNC--------ILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLL 109
SL+K+L+ L + +RLNI IDVAS L+YLH C P+ HCDLKP N+LL
Sbjct: 787 SLDKWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNILL 846
Query: 110 DDNLVAYLSDFGIAKLLIGEDQS-----MTQTQTLATIGYMAPEYGREGRVSTNGDVYSF 164
DD+L A++SDFG+A+LL+ DQ ++ TIGY APEYG G+ S +GDVYSF
Sbjct: 847 DDDLTAHVSDFGLARLLLKFDQESFFNQLSSAGVRGTIGYAAPEYGMGGQPSIHGDVYSF 906
Query: 165 GIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLL-SQEDIHFVAKEQCV 223
G++++E FTGK+PT E F G TL + LP +++ D ++L S + F E C+
Sbjct: 907 GVLVLEMFTGKRPTNELFGGNFTLNSYTKAALPERVLDIADKSILHSGLRVGFPVLE-CL 965
Query: 224 SFVFNLAMACTVESPEQRINAKEIVTKLLKIRDSLLR 260
+ ++ + C ESP R+ E +L+ IR+ +
Sbjct: 966 KGILDVGLRCCEESPLNRLATSEAAKELISIRERFFK 1002
|
|
| TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 563 (203.2 bits), Expect = 1.2e-53, P = 1.2e-53
Identities = 118/277 (42%), Positives = 171/277 (61%)
Query: 3 VAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSN-----EEFKALVLEYMPHG 57
VAVKV N+Q A KSF ECE +K RHRNL+K++++C++ EF+AL+ EY+P+G
Sbjct: 729 VAVKVLNMQRRGAMKSFMAECESLKDTRHRNLVKLLTACASTDFQGNEFRALIYEYLPNG 788
Query: 58 SLEKYLYSSNC--------ILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLL 109
S++ +L+ L + +RLNI+IDVAS L+YLH C P+ HCDLKP NVLL
Sbjct: 789 SVDMWLHPEEVEEIRRPPRTLTLLERLNIVIDVASVLDYLHVHCHEPIAHCDLKPSNVLL 848
Query: 110 DDNLVAYLSDFGIAKLLIGEDQS--MTQTQTLA---TIGYMAPEYGREGRVSTNGDVYSF 164
+D+L A++SDFG+A+LL+ D+ + Q + TIGY APEYG G+ S +GDVYSF
Sbjct: 849 EDDLTAHVSDFGLARLLLKFDKESFLNQLSSAGVRGTIGYAAPEYGMGGQPSIHGDVYSF 908
Query: 165 GIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQE-DIHFVAKEQCV 223
G++L+E FTGK+PT E F G +TL + LP E+ D +L + F E C+
Sbjct: 909 GVLLLEMFTGKRPTDELFGGNLTLHSYTKLALPEKVFEIADKAILHIGLRVGFRTAE-CL 967
Query: 224 SFVFNLAMACTVESPEQRINAKEIVTKLLKIRDSLLR 260
+ V + + C E P R+ E+ +L+ IR+ +
Sbjct: 968 TLVLEVGLRCCEEYPTNRLATSEVAKELISIRERFFK 1004
|
|
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 548 (198.0 bits), Expect = 5.3e-52, P = 5.3e-52
Identities = 121/279 (43%), Positives = 170/279 (60%)
Query: 3 VAVKVFNLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCSNEEF-----KALVLEYMPH 56
VA+KV NL C R A KSF ECE + IRHRNL+K+++ CS+ +F +ALV E+MP+
Sbjct: 745 VAIKVLNL-CKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPN 803
Query: 57 GSLEKYLYSSNC--------ILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVL 108
G+L+ +L+ L +F RLNI IDVASAL YLH C P+ HCD+KP N+L
Sbjct: 804 GNLDMWLHPDEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNIL 863
Query: 109 LDDNLVAYLSDFGIAKLLIGEDQSMTQTQ-----TLATIGYMAPEYGREGRVSTNGDVYS 163
LD +L A++SDFG+A+LL+ D+ Q TIGY APEYG G S GDVYS
Sbjct: 864 LDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYS 923
Query: 164 FGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPI-STMEVVDANLLSQEDIHFVAKEQC 222
FGI+L+E FTGK+PT + F +TL + L +++ D +L +C
Sbjct: 924 FGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETILRGAYAQHFNMVEC 983
Query: 223 VSFVFNLAMACTVESPEQRINAKEIVTKLLKIRDSLLRN 261
++ VF + ++C+ ESP RI+ E ++KL+ IR+S R+
Sbjct: 984 LTLVFRVGVSCSEESPVNRISMAEAISKLVSIRESFFRD 1022
|
|
| TAIR|locus:2175703 AT5G39390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 486 (176.1 bits), Expect = 2.3e-46, P = 2.3e-46
Identities = 120/271 (44%), Positives = 155/271 (57%)
Query: 3 VAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSN-----EEFKALVLEYMPHG 57
VAVKV NL A KSF ECE K IRHRNL K+I+ CS+ +F+ALV E+MP G
Sbjct: 235 VAVKVLNLLKHGATKSFIAECESFKGIRHRNLAKLITVCSSLDSQGNDFRALVYEFMPKG 294
Query: 58 SLEKYLY-----SSNC---ILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLL 109
SL+ +L S+N L +++NI IDVASALEYLH C PV HCD+KP NVLL
Sbjct: 295 SLDMWLQPEDLESANNHSRSLTFAEKVNIAIDVASALEYLHVYCHDPVAHCDIKPSNVLL 354
Query: 110 DDNLVAYLSDFGIAKLLIGEDQSMTQTQ-----TLATIGYMAPEYGREGRVSTNGDVYSF 164
DD+L A++SDFG+A+LL D+ Q TIGY APEYG + S GDVYSF
Sbjct: 355 DDDLTAHVSDFGLARLLYNFDEKTFLNQFSSAGVRGTIGYAAPEYGMGSKPSIQGDVYSF 414
Query: 165 GIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVS 224
G++L+E FTGKKPT F G L + L ST S+ V ++ +
Sbjct: 415 GVLLLEMFTGKKPTDNSFGGGYNLHGYTKSVLSCST---------SRGGRTMV--DEWLR 463
Query: 225 FVFNLAMACTVESPEQRINAKEIVTKLLKIR 255
V + + C+ E P R+ E V +L+ I+
Sbjct: 464 LVLEVGIKCSEEYPRDRMGMAEAVRELVSIK 494
|
|
| TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 492 (178.3 bits), Expect = 5.9e-46, P = 5.9e-46
Identities = 119/271 (43%), Positives = 156/271 (57%)
Query: 3 VAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSN-----EEFKALVLEYMPHG 57
VAVKV NL A KSF ECE K IRHRNL+K+I+ CS+ +F+ALV E+MP G
Sbjct: 738 VAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKG 797
Query: 58 SLEKYLYSSNC--------ILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLL 109
SL+ +L + L ++LNI IDVASALEYLH C PV HCD+KP N+LL
Sbjct: 798 SLDMWLQLEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILL 857
Query: 110 DDNLVAYLSDFGIAKLLIGEDQSMTQTQ-----TLATIGYMAPEYGREGRVSTNGDVYSF 164
DD+L A++SDFG+A+LL D+ Q TIGY APEYG G+ S GDVYSF
Sbjct: 858 DDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSF 917
Query: 165 GIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVS 224
GI+L+E F+GKKPT E F G+ L + L T +N + ++ +
Sbjct: 918 GILLLEMFSGKKPTDESFAGDYNLHSYTKSILSGCTSSG-GSNAI----------DEGLR 966
Query: 225 FVFNLAMACTVESPEQRINAKEIVTKLLKIR 255
V + + C+ E P R+ E V +L+ IR
Sbjct: 967 LVLQVGIKCSEEYPRDRMRTDEAVRELISIR 997
|
|
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 483 (175.1 bits), Expect = 5.4e-45, P = 5.4e-45
Identities = 105/280 (37%), Positives = 173/280 (61%)
Query: 3 VAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSN-----EEFKALVLEYMPHG 57
VAVKV L+ +A KSF ECE ++++RHRNL+K+++ CS+ +FKA+V ++MP+G
Sbjct: 733 VAVKVLKLENPKALKSFTAECEALRNMRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNG 792
Query: 58 SLEKYLY------SSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDD 111
SLE +++ + L++ +R+ I++DVA AL+YLH PV+HCD+K NVLLD
Sbjct: 793 SLEDWIHPETNDQADQRHLNLHRRVTILLDVACALDYLHRHGPEPVVHCDIKSSNVLLDS 852
Query: 112 NLVAYLSDFGIAKLLIGEDQSMTQTQT-----LATIGYMAPEYGREGRVSTNGDVYSFGI 166
++VA++ DFG+A++L+ + S+ Q T + TIGY APEYG ST+GD+YS+GI
Sbjct: 853 DMVAHVGDFGLARILV-DGTSLIQQSTSSMGFIGTIGYAAPEYGVGLIASTHGDIYSYGI 911
Query: 167 MLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLL--SQEDIHFVAKE---- 220
+++E TGK+PT F ++ L+ +V L +VVD L+ S+ ++
Sbjct: 912 LVLEIVTGKRPTDSTFRPDLGLRQYVELGLHGRVTDVVDTKLILDSENWLNSTNNSPCRR 971
Query: 221 --QCVSFVFNLAMACTVESPEQRINAKEIVTKLLKIRDSL 258
+C+ ++ L ++C+ E P R +I+ +L I+ +L
Sbjct: 972 ITECIVWLLRLGLSCSQELPSSRTPTGDIIDELNAIKQNL 1011
|
|
| TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 444 (161.4 bits), Expect = 7.5e-41, P = 7.5e-41
Identities = 99/277 (35%), Positives = 163/277 (58%)
Query: 2 EVAVKVFNLQCGRAFK-SFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 60
+VAVKV + + F SF EC+++K RHRNLI++I++CS F ALVL MP+GSLE
Sbjct: 685 KVAVKVLDPKTALEFSGSFKRECQILKRTRHRNLIRIITTCSKPGFNALVLPLMPNGSLE 744
Query: 61 KYLYS---SNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYL 117
++LY S+ LD+ Q +NI DVA + YLH V+HCDLKP N+LLDD + A +
Sbjct: 745 RHLYPGEYSSKNLDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALV 804
Query: 118 SDFGIAKLLIGEDQSMTQTQTLA----------TIGYMAPEYGREGRVSTNGDVYSFGIM 167
+DFGI++L+ G +++++ +++ ++GY+APEYG R ST+GDVYSFG++
Sbjct: 805 TDFGISRLVQGVEETVSTDDSVSFGSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVL 864
Query: 168 LMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLL------SQEDIHFVAKEQ 221
L+E +G++PT N +L ++ P S +++ L E + +E
Sbjct: 865 LLEIVSGRRPTDVLVNEGSSLHEFMKSHYPDSLEGIIEQALSRWKPQGKPEKCEKLWREV 924
Query: 222 CVSFVFNLAMACTVESPEQRINAKEIVTKLLKIRDSL 258
+ + L + CT +P R + ++ ++ ++++ L
Sbjct: 925 ILEMI-ELGLVCTQYNPSTRPDMLDVAHEMGRLKEYL 960
|
|
| TAIR|locus:2126540 AT4G29990 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 418 (152.2 bits), Expect = 3.5e-38, P = 3.5e-38
Identities = 92/266 (34%), Positives = 146/266 (54%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 61
+VAVK+ + + + +K F E E++ + H NL +I C+ + AL+ EYM +G+L
Sbjct: 597 QVAVKILSEESTQGYKEFRAEVELLMRVHHTNLTSLIGYCNEDNHMALIYEYMANGNLGD 656
Query: 62 YLYS-SNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDF 120
YL S+ IL +RL I +D A LEYLH+GC P++H D+KP N+LL++NL A ++DF
Sbjct: 657 YLSGKSSLILSWEERLQISLDAAQGLEYLHYGCKPPIVHRDVKPANILLNENLQAKIADF 716
Query: 121 GIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYE 180
G+++ E S T TIGY+ PEY +++ DVYSFG++L+E TGK +
Sbjct: 717 GLSRSFPVEGSSQVSTVVAGTIGYLDPEYYATRQMNEKSDVYSFGVVLLEVITGKPAIWH 776
Query: 181 FFNGEMTLKHWVNDWLPISTME-VVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239
+ L V L ++ +VD L + ++ K + LA+AC ES E
Sbjct: 777 SRTESVHLSDQVGSMLANGDIKGIVDQRLGDRFEVGSAWK------ITELALACASESSE 830
Query: 240 QRINAKEIVTKLLKIRDSLLRNVGGR 265
QR ++V ++++ S+ V R
Sbjct: 831 QRPTMSQVV---MELKQSIFGRVNNR 853
|
|
| TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 415 (151.1 bits), Expect = 1.4e-37, P = 1.4e-37
Identities = 95/265 (35%), Positives = 159/265 (60%)
Query: 3 VAVKVFNLQ--CGRAFKSFDVECEMMKSIRHRNLIKVIS-SCSNEEFKALVLEYMPHGSL 59
+AVKV NL+ + K F E + + ++HRNL+K++ + + + KALVL +M +G+L
Sbjct: 895 IAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKILGFAWESGKTKALVLPFMENGNL 954
Query: 60 EKYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLS 118
E ++ S I + +++++ + +AS ++YLH G P++HCDLKP N+LLD + VA++S
Sbjct: 955 EDTIHGSAAPIGSLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVS 1014
Query: 119 DFGIAKLL-IGEDQSMTQTQTL--ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGK 175
DFG A++L ED S T + + TIGY+APE+ +V+T DV+SFGI++ME T +
Sbjct: 1015 DFGTARILGFREDGSTTASTSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQ 1074
Query: 176 KPTY--EFFNGEMTLKHWVNDWLPIST---MEVVDANLLSQEDIHFVAKEQCVSFVFNLA 230
+PT + + +MTL+ V + + V+D L + I + +E+ + L
Sbjct: 1075 RPTSLNDEDSQDMTLRQLVEKSIGNGRKGMVRVLDMEL--GDSIVSLKQEEAIEDFLKLC 1132
Query: 231 MACTVESPEQRINAKEIVTKLLKIR 255
+ CT PE R + EI+T L+K+R
Sbjct: 1133 LFCTSSRPEDRPDMNEILTHLMKLR 1157
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 273 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-45 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-44 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-42 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-41 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-41 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-41 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-38 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-35 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-34 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-29 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-28 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-27 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-27 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-26 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-25 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-25 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-25 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 9e-25 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-24 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-24 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-23 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-23 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-23 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-22 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-22 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-22 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-22 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-22 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-21 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-21 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-21 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-20 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-20 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-19 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-19 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-18 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-18 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-17 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-17 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-17 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-17 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-17 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 7e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-17 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-16 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-16 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-16 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-16 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-16 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-16 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-16 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-16 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-16 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-15 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-15 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-15 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-15 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-15 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 8e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-14 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-14 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-14 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-14 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-14 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 9e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-13 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-13 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-13 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-13 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 8e-13 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-12 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-12 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-12 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-12 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-12 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-12 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 8e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 8e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 9e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 9e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-11 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-11 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-11 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-11 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-11 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 8e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 9e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 9e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 9e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-10 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-10 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-10 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 7e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-10 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 9e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-09 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-09 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-09 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-09 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-09 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 8e-09 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 8e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 9e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-08 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-08 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-08 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-08 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-08 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-08 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-08 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 7e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 8e-08 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-07 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 2e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-07 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-07 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-07 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-07 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-07 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-07 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-07 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-07 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-07 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-07 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 9e-07 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 9e-07 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-06 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-06 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 9e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-05 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-05 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-05 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-04 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-04 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 6e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 7e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 8e-04 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 0.001 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.002 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 0.002 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.002 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.002 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 3e-45
Identities = 59/172 (34%), Positives = 90/172 (52%), Gaps = 8/172 (4%)
Query: 2 EVAVKVFNLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 60
+VA+K+ + + E E++K + H N++K+ +E LV+EY GSL+
Sbjct: 20 KVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79
Query: 61 KYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLD-DNLVAYLSD 119
L + L + L I++ + LEYLH S +IH DLKP+N+LLD DN L+D
Sbjct: 80 DLLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLAD 136
Query: 120 FGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR-EGRVSTNGDVYSFGIMLME 170
FG++KLL + T YMAPE +G S D++S G++L E
Sbjct: 137 FGLSKLL--TSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 2e-44
Identities = 75/253 (29%), Positives = 122/253 (48%), Gaps = 26/253 (10%)
Query: 1 MEVAVKVFNLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
+EVAVK + F E +M+ + H N++K++ C+ EE +V+EYM G L
Sbjct: 29 VEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDL 88
Query: 60 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSD 119
YL + L + L+ + +A +EYL S IH DL N L+ +NLV +SD
Sbjct: 89 LSYLRKNRPKLSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISD 145
Query: 120 FGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPT 178
FG+++ + +D + I +MAPE +EG+ ++ DV+SFG++L E FT G++P
Sbjct: 146 FGLSR-DLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQP- 203
Query: 179 YEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238
Y M+ + + + + L Q C +++L + C E P
Sbjct: 204 YP----GMSNEEVLEY--------LKNGYRLPQP-------PNCPPELYDLMLQCWAEDP 244
Query: 239 EQRINAKEIVTKL 251
E R E+V L
Sbjct: 245 EDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 5e-42
Identities = 75/254 (29%), Positives = 120/254 (47%), Gaps = 27/254 (10%)
Query: 1 MEVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
+EVAVK + + F E +M+ + H N++K++ C+ EE +V+EYMP G L
Sbjct: 29 VEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDL 88
Query: 60 EKYL-YSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLS 118
YL + L + L+ + +A +EYL S IH DL N L+ +NLV +S
Sbjct: 89 LDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKIS 145
Query: 119 DFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 177
DFG+++ + +D I +MAPE +EG+ ++ DV+SFG++L E FT G++P
Sbjct: 146 DFGLSR-DLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEP 204
Query: 178 TYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237
Y M+ + + L + C ++ L + C E
Sbjct: 205 -YP----GMSNAEVLEY--------LKKGYRLPKP-------PNCPPELYKLMLQCWAED 244
Query: 238 PEQRINAKEIVTKL 251
PE R E+V L
Sbjct: 245 PEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 1e-41
Identities = 74/252 (29%), Positives = 115/252 (45%), Gaps = 27/252 (10%)
Query: 2 EVAVKVFNLQCGRAFKSFDV----ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHG 57
VAVK+ + D E +++ + H N++++I + +++ LV+EY G
Sbjct: 26 IVAVKILKKR--SEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGG 83
Query: 58 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYL 117
L YL S L + I + + LEYLH S +IH DLKP+N+LLD+N V +
Sbjct: 84 DLFDYL-SRGGPLSEDEAKKIALQILRGLEYLH---SNGIIHRDLKPENILLDENGVVKI 139
Query: 118 SDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGR-VSTNGDVYSFGIMLMETFTGKK 176
+DFG+AK L+ S+T T T YMAPE G DV+S G++L E TGK
Sbjct: 140 ADFGLAKKLLKSSSSLT-TFV-GTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKP 197
Query: 177 PTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236
P F + + + ++ L E E+ + C +
Sbjct: 198 P---FSGENILDQLQLIR-------RILGPPLEFDEPKWSSGSEEAKDLIKK----CLNK 243
Query: 237 SPEQRINAKEIV 248
P +R A+EI+
Sbjct: 244 DPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 3e-41
Identities = 67/247 (27%), Positives = 109/247 (44%), Gaps = 25/247 (10%)
Query: 2 EVAVKVFNLQCGRAF-KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 60
VA+KV + + + E +++K ++H N++++ +E+ LV+EY G L
Sbjct: 26 LVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLF 85
Query: 61 KYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDF 120
L L + + + SALEYLH S ++H DLKP+N+LLD++ L+DF
Sbjct: 86 DLL-KKRGRLSEDEARFYLRQILSALEYLH---SKGIVHRDLKPENILLDEDGHVKLADF 141
Query: 121 GIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYE 180
G+A+ L ++ T T YMAPE D++S G++L E TGK P
Sbjct: 142 GLARQLDPGEKLTTFVGTPE---YMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPP--- 195
Query: 181 FFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQ 240
F G+ L +S E + + V + PE+
Sbjct: 196 -FPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLI--RKL--LVKD---------PEK 241
Query: 241 RINAKEI 247
R+ A+E
Sbjct: 242 RLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 141 bits (359), Expect = 4e-41
Identities = 70/260 (26%), Positives = 115/260 (44%), Gaps = 39/260 (15%)
Query: 1 MEVAVKVFNLQCG-RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
+VAVK + F E +MK + H N+++++ C+ E +V EYMP G L
Sbjct: 29 TKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDL 88
Query: 60 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSD 119
+L L + L + + +A +EYL S +H DL N L+ +NLV +SD
Sbjct: 89 LDFLRKHGEKLTLKDLLQMALQIAKGMEYLE---SKNFVHRDLAARNCLVTENLVVKISD 145
Query: 120 FGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPT 178
FG+++ + +D + I +MAPE ++G+ ++ DV+SFG++L E FT G++P
Sbjct: 146 FGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPY 205
Query: 179 YEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAK-------EQCVSFVFNLAM 231
+S EV + + E C ++ L +
Sbjct: 206 PG-----------------MSNEEV----------LELLEDGYRLPRPENCPDELYELML 238
Query: 232 ACTVESPEQRINAKEIVTKL 251
C PE R E+V L
Sbjct: 239 QCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (341), Expect = 2e-38
Identities = 77/261 (29%), Positives = 120/261 (45%), Gaps = 33/261 (12%)
Query: 1 MEVAVKVFNLQCGRAFKS-FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
EVAVK + F E +MK + H N+++++ C+ EE LVLEYM G L
Sbjct: 24 TEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDL 83
Query: 60 EKYLYSSNC--------ILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDD 111
YL S L + L+ I +A +EYL S +H DL N L+ +
Sbjct: 84 LDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGE 140
Query: 112 NLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMET 171
+LV +SDFG+++ + +D +T I +MAPE ++G ++ DV+SFG++L E
Sbjct: 141 DLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEI 200
Query: 172 FT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLA 230
FT G P N E+ L++ + L + E C ++ L
Sbjct: 201 FTLGATPYPGLSNEEV-LEY------------LRKGYRLPK-------PEYCPDELYELM 240
Query: 231 MACTVESPEQRINAKEIVTKL 251
++C PE R E+V +L
Sbjct: 241 LSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 5e-35
Identities = 71/265 (26%), Positives = 110/265 (41%), Gaps = 48/265 (18%)
Query: 2 EVAVKVFNLQCGRA--FKSFDVECEMMKSIRHRNLIKVISSCSNEEFKAL--VLEYMPHG 57
+AVK L ++ + E ++ S++H N+++ S +EE L LEY+ G
Sbjct: 27 LMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGG 86
Query: 58 SLEKYLYSSNCILDIFQRLNI------MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDD 111
SL L F +L + L YLH S ++H D+K N+L+D
Sbjct: 87 SLSSLLKK-------FGKLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDS 136
Query: 112 NLVAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAPEYGREGRVSTNGDVYSFGIMLME 170
+ V L+DFG AK +G+ ++ T ++ T +MAPE R D++S G ++E
Sbjct: 137 DGVVKLADFGCAK-RLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIE 195
Query: 171 TFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDA--NLLSQEDIHFVAKEQCVSFVFN 228
TGK P E N L I + LS+E F+ K
Sbjct: 196 MATGKPPWSELGNPMAALYK-------IGSSGEPPEIPEHLSEEAKDFLRK--------- 239
Query: 229 LAMACTVESPEQRINAKEIVTKLLK 253
C P++R A E LL+
Sbjct: 240 ----CLRRDPKKRPTADE----LLQ 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 8e-34
Identities = 82/271 (30%), Positives = 123/271 (45%), Gaps = 44/271 (16%)
Query: 1 MEVAVKVFNLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
VAVK A K F+ E E++ + +H N++K C+ + +V EYM HG L
Sbjct: 36 ELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDL 95
Query: 60 EKYLYS------------SNCI-LDIFQRLNIMIDVASALEYL---HFGCSAPVIHCDLK 103
K+L S S L + Q L I + +AS + YL HF +H DL
Sbjct: 96 NKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHF------VHRDLA 149
Query: 104 PDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYS 163
N L+ +LV + DFG+++ + D T+ I +M PE + +T DV+S
Sbjct: 150 TRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWS 209
Query: 164 FGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQC 222
FG++L E FT GK+P Y N E+ +E + L Q C
Sbjct: 210 FGVVLWEIFTYGKQPWYGLSNEEV--------------IECITQGRLLQR------PRTC 249
Query: 223 VSFVFNLAMACTVESPEQRINAKEIVTKLLK 253
S V+++ + C P+QRIN K+I +L K
Sbjct: 250 PSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 1e-29
Identities = 77/278 (27%), Positives = 119/278 (42%), Gaps = 31/278 (11%)
Query: 1 MEVAVKVFNLQ---CGRAFKSFDVECEMMKSIRH-RNLIKVISSCSNEEFKALVLEYMPH 56
VA+KV + + + F E +++ S+ H N++K+ +E LV+EY+
Sbjct: 23 KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDG 82
Query: 57 GSLEKYL--YSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNL- 113
GSLE L L + L I+ + SALEYLH S +IH D+KP+N+LLD +
Sbjct: 83 GSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGR 139
Query: 114 VAYLSDFGIAKLLIGEDQSMTQTQTLA----TIGYMAPEY---GREGRVSTNGDVYSFGI 166
V L DFG+AKLL + + + T GYMAPE S++ D++S GI
Sbjct: 140 VVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGI 199
Query: 167 MLMETFTGKKP---TYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCV 223
L E TG P TLK + P + +N E
Sbjct: 200 TLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSN-----------PELIS 248
Query: 224 SFVFNLAMACTVESPEQRINAKEIVTKLLKIRDSLLRN 261
+L + P+ R+++ ++ L L +
Sbjct: 249 KAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKES 286
|
Length = 384 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-28
Identities = 78/252 (30%), Positives = 120/252 (47%), Gaps = 33/252 (13%)
Query: 3 VAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 61
VAVK L+ A ++F E +M ++RH NL++++ +V EYM GSL
Sbjct: 32 VAVK--CLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVD 89
Query: 62 YLYS-SNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDF 120
YL S ++ + Q+L +DV +EYL +H DL NVL+ ++LVA +SDF
Sbjct: 90 YLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDF 146
Query: 121 GIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTY 179
G+AK + S Q + + APE RE + ST DV+SFGI+L E ++ G+ P Y
Sbjct: 147 GLAK-----EASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP-Y 200
Query: 180 EFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239
+ LK +VV ++ A E C V+ + C P
Sbjct: 201 P----RIPLK------------DVVPH---VEKGYRMEAPEGCPPEVYKVMKDCWELDPA 241
Query: 240 QRINAKEIVTKL 251
+R K++ +L
Sbjct: 242 KRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-27
Identities = 66/182 (36%), Positives = 99/182 (54%), Gaps = 15/182 (8%)
Query: 2 EVAVKVFNLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 60
+VAVK L+ G + ++F E ++MK +RH L+++ + CS EE +V EYM GSL
Sbjct: 32 KVAVKT--LKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLL 89
Query: 61 KYLYSSNCILDIFQRLNIMID----VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAY 116
+L S RL ++D +A + YL S IH DL N+L+ +NLV
Sbjct: 90 DFLKSGE---GKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCK 143
Query: 117 LSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GK 175
++DFG+A+ LI +D+ + I + APE GR + DV+SFGI+L E T G+
Sbjct: 144 IADFGLAR-LIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGR 202
Query: 176 KP 177
P
Sbjct: 203 VP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-27
Identities = 75/263 (28%), Positives = 121/263 (46%), Gaps = 39/263 (14%)
Query: 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 60
M VAVK A K F E E++ +++H +++K C + + +V EYM HG L
Sbjct: 36 MLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLN 95
Query: 61 KYLYS---------------SNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPD 105
K+L + + L + Q L+I +AS + YL S +H DL
Sbjct: 96 KFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATR 152
Query: 106 NVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFG 165
N L+ NL+ + DFG+++ + D T+ I +M PE + +T DV+SFG
Sbjct: 153 NCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFG 212
Query: 166 IMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVS 224
++L E FT GK+P W +S EV++ ++Q + C
Sbjct: 213 VILWEIFTYGKQP-----------------WFQLSNTEVIEC--ITQGRV-LERPRVCPK 252
Query: 225 FVFNLAMACTVESPEQRINAKEI 247
V+++ + C P+QR+N KEI
Sbjct: 253 EVYDIMLGCWQREPQQRLNIKEI 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 4e-26
Identities = 68/249 (27%), Positives = 120/249 (48%), Gaps = 39/249 (15%)
Query: 19 FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN----------- 67
F E E+M ++H N++ ++ C+ E+ ++ EY+ HG L ++L ++
Sbjct: 55 FRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGD 114
Query: 68 ----CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 123
LD L+I I +A+ +EYL S +H DL N L+ + L +SDFG++
Sbjct: 115 ETVKSSLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLS 171
Query: 124 KLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTYEFF 182
+ + D Q+++L + +M PE G+ +T D++SFG++L E F+ G +P Y F
Sbjct: 172 RDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS 231
Query: 183 NGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRI 242
N E+ +E++ + E C + V+ L + C E P +R
Sbjct: 232 NQEV--------------IEMI------RSRQLLPCPEDCPARVYALMIECWNEIPARRP 271
Query: 243 NAKEIVTKL 251
K+I T+L
Sbjct: 272 RFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 7e-26
Identities = 66/251 (26%), Positives = 111/251 (44%), Gaps = 27/251 (10%)
Query: 3 VAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKY 62
VA+K+ + F E + +K +RH++LI + + CS E ++ E M GSL +
Sbjct: 33 VAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAF 92
Query: 63 LYSSNC-ILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFG 121
L S +L + +++ VA + YL IH DL N+L+ ++LV ++DFG
Sbjct: 93 LRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFG 149
Query: 122 IAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTYE 180
+A+L+ ++ + + APE G ST DV+SFGI+L E FT G+ P
Sbjct: 150 LARLI--KEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPG 207
Query: 181 FFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQ 240
N E + + A +C ++ + + C PE
Sbjct: 208 MNNHE--------------VYDQITAGY------RMPCPAKCPQEIYKIMLECWAAEPED 247
Query: 241 RINAKEIVTKL 251
R + K + +L
Sbjct: 248 RPSFKALREEL 258
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-25
Identities = 67/268 (25%), Positives = 119/268 (44%), Gaps = 32/268 (11%)
Query: 2 EVAVKVFNLQCGRAFKS-FDVECEMMKSIRHRNLIKVISSCSNEEFKA--LVLEYMPHGS 58
+VAVK N +S F+ E E+++++ H N++K C ++ L++EY+P GS
Sbjct: 35 QVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGS 94
Query: 59 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLS 118
L YL +++ + L + ++YL S IH DL N+L++ + +S
Sbjct: 95 LRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKIS 151
Query: 119 DFGIAKLL-IGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 177
DFG+AK+L +D + + I + APE R + S+ DV+SFG+ L E FT P
Sbjct: 152 DFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDP 211
Query: 178 TYE----------FFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVF 227
+ G+M + + L +E C V+
Sbjct: 212 SQSPPAEFLRMIGIAQGQMIVTRLLE---------------LLKEGERLPRPPSCPDEVY 256
Query: 228 NLAMACTVESPEQRINAKEIVTKLLKIR 255
+L C P+ R + +++ + ++R
Sbjct: 257 DLMKLCWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 1e-25
Identities = 68/249 (27%), Positives = 109/249 (43%), Gaps = 24/249 (9%)
Query: 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 60
EVA+K L+ + E +MK +H N++ S + +V+EYM GSL
Sbjct: 45 KEVAIKKMRLRKQNK-ELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLT 103
Query: 61 KYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDF 120
+ + ++ Q + +V LEYLH S VIH D+K DN+LL + L+DF
Sbjct: 104 DIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADF 160
Query: 121 GIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYE 180
G A L +++S + + T +MAPE + D++S GIM +E G+ P
Sbjct: 161 GFAAQL-TKEKSKRNSV-VGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLR 218
Query: 181 FFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQ 240
L +P + + S E F+ K C V+ PE+
Sbjct: 219 -EPPLRALFLITTKGIP----PLKNPEKWSPEFKDFLNK-------------CLVKDPEK 260
Query: 241 RINAKEIVT 249
R +A+E++
Sbjct: 261 RPSAEELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 3e-25
Identities = 55/180 (30%), Positives = 85/180 (47%), Gaps = 6/180 (3%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 61
EVA+KV L+ + E +++K +H N++K S ++ +V+E+ GSL+
Sbjct: 27 EVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKD 86
Query: 62 YLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFG 121
L S+N L Q + ++ LEYLH S +IH D+K N+LL + L DFG
Sbjct: 87 LLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFG 143
Query: 122 IAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEF 181
++ L T + T +MAPE D++S GI +E GK P E
Sbjct: 144 LSAQLSDTKARNT---MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL 200
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 9e-25
Identities = 72/271 (26%), Positives = 117/271 (43%), Gaps = 44/271 (16%)
Query: 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 60
M VAVK A + F E E++ ++H+++++ C+ +V EYM HG L
Sbjct: 36 MLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLN 95
Query: 61 KYLYSSNC---ILD-----------IFQRLNIMIDVASALEYL---HFGCSAPVIHCDLK 103
++L S IL + Q L I +AS + YL HF +H DL
Sbjct: 96 RFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHF------VHRDLA 149
Query: 104 PDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYS 163
N L+ LV + DFG+++ + D +T+ I +M PE + +T D++S
Sbjct: 150 TRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWS 209
Query: 164 FGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQC 222
FG++L E FT GK+P W +S E ++ +E C
Sbjct: 210 FGVVLWEIFTYGKQP-----------------WYQLSNTEAIECITQGRE---LERPRTC 249
Query: 223 VSFVFNLAMACTVESPEQRINAKEIVTKLLK 253
V+ + C P+QR+ K+I ++L
Sbjct: 250 PPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 2e-24
Identities = 65/179 (36%), Positives = 95/179 (53%), Gaps = 9/179 (5%)
Query: 2 EVAVKVFNLQCGRA-FKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 60
VAVK L+ G K F E ++MK +RH LI++ + C+ EE +V E M +GSL
Sbjct: 32 PVAVK--TLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLL 89
Query: 61 KYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSD 119
+YL L + Q +++ VAS + YL + IH DL NVL+ +N + ++D
Sbjct: 90 EYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVAD 146
Query: 120 FGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 177
FG+A+ +I ED + I + APE R S DV+SFGI+L E T G+ P
Sbjct: 147 FGLAR-VIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.2 bits (243), Expect = 4e-24
Identities = 56/156 (35%), Positives = 78/156 (50%), Gaps = 8/156 (5%)
Query: 25 MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 84
++ I H ++K+ + EE LVLEY P G L +L + R ++
Sbjct: 46 ILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF-YAAEIVL 104
Query: 85 ALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLA-TIG 143
ALEYLH S +I+ DLKP+N+LLD + L+DFG+AK L E +T T T
Sbjct: 105 ALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS---RTNTFCGTPE 158
Query: 144 YMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTY 179
Y+APE D +S G++L E TGK P Y
Sbjct: 159 YLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFY 194
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 2e-23
Identities = 63/220 (28%), Positives = 101/220 (45%), Gaps = 23/220 (10%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81
E ++M + H NL+++ C+ + +V EYM +G L YL L L++ D
Sbjct: 49 EAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSD 108
Query: 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLAT 141
V A+EYL S IH DL N L+ ++ V +SDFG+A+ ++ +DQ + T
Sbjct: 109 VCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVL-DDQYTSSQGTKFP 164
Query: 142 IGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTM 201
+ + PE R S+ DV+SFG+++ E F+ K YE F S
Sbjct: 165 VKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERF----------------SNS 208
Query: 202 EVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQR 241
EVV++ + + V+ + +C E PE R
Sbjct: 209 EVVES---VSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDR 245
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-23
Identities = 72/252 (28%), Positives = 115/252 (45%), Gaps = 23/252 (9%)
Query: 1 MEVAVKVFNLQCGRAFK-SFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
EVAVK K F E E++K H N++K+I C ++ +V+E +P GSL
Sbjct: 20 TEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79
Query: 60 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSD 119
+L L + + L + +D A+ +EYL S IH DL N L+ +N V +SD
Sbjct: 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISD 136
Query: 120 FGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTY 179
FG+++ G +++ I + APE GR ++ DV+S+GI+L ETF+
Sbjct: 137 FGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSL----- 191
Query: 180 EFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239
G+ N T E +++ A + C ++ L + C PE
Sbjct: 192 ----GDTPYPGMSNQ----QTRERIESGY------RMPAPQLCPEEIYRLMLQCWAYDPE 237
Query: 240 QRINAKEIVTKL 251
R + EI +L
Sbjct: 238 NRPSFSEIYNEL 249
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 3e-23
Identities = 68/253 (26%), Positives = 126/253 (49%), Gaps = 31/253 (12%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 61
+VAVK N++C ++F E +M + H+NL++++ + +V+E M G+L
Sbjct: 31 KVAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNGLY-IVMELMSKGNLVN 87
Query: 62 YLYS-SNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDF 120
+L + ++ + Q L +DVA +EYL S ++H DL N+L+ ++ VA +SDF
Sbjct: 88 FLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDF 144
Query: 121 GIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYE 180
G+A++ SM + + + APE + + S+ DV+S+G++L E F+ + Y
Sbjct: 145 GLARV-----GSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYP 199
Query: 181 FFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQ 240
+M+LK EV + ++ E C + V+ L +C P++
Sbjct: 200 ----KMSLK------------EVKEC---VEKGYRMEPPEGCPADVYVLMTSCWETEPKK 240
Query: 241 RINAKEIVTKLLK 253
R + ++ KL K
Sbjct: 241 RPSFHKLREKLEK 253
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 5e-23
Identities = 73/262 (27%), Positives = 116/262 (44%), Gaps = 36/262 (13%)
Query: 3 VAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKY 62
VAVK A K F E E++ +++H +++K C + +V EYM HG L K+
Sbjct: 38 VAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKF 97
Query: 63 LYSSN------------CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLD 110
L + L Q L+I +A+ + YL S +H DL N L+
Sbjct: 98 LRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVG 154
Query: 111 DNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLME 170
+NL+ + DFG+++ + D T+ I +M PE + +T DV+S G++L E
Sbjct: 155 ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWE 214
Query: 171 TFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNL 229
FT GK+P Y+ N E+ +E + + Q C V++L
Sbjct: 215 IFTYGKQPWYQLSNNEV--------------IECITQGRVLQR------PRTCPKEVYDL 254
Query: 230 AMACTVESPEQRINAKEIVTKL 251
+ C P R+N KEI + L
Sbjct: 255 MLGCWQREPHMRLNIKEIHSLL 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 1e-22
Identities = 68/259 (26%), Positives = 107/259 (41%), Gaps = 50/259 (19%)
Query: 3 VAVKVFNLQCGRAFKSFDVECEMMKSIRH--RNLIKVIS----SCSNEEFK----ALVLE 52
A+K + D + E K + + L S C +K ++VLE
Sbjct: 29 YALKKIH---------VDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79
Query: 53 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDN 112
YM GSL L I + I + L+YLH +IH D+KP N+L++
Sbjct: 80 YMDGGSLADLLKKVGKIPEPVLAY-IARQILKGLDYLHT--KRHIIHRDIKPSNLLINSK 136
Query: 113 LVAYLSDFGIAKLLIGEDQSMTQTQT-LATIGYMAPEYGREGRVSTNGDVYSFGIMLMET 171
++DFGI+K+L + ++ Q T + T+ YM+PE + S D++S G+ L+E
Sbjct: 137 GEVKIADFGISKVL---ENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLEC 193
Query: 172 FTGKKPTYEFFNGE----MTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVF 227
GK P F L + D P S + A S E F++
Sbjct: 194 ALGKFP---FLPPGQPSFFELMQAICDGPPPS----LPAEEFSPEFRDFIS--------- 237
Query: 228 NLAMACTVESPEQRINAKE 246
AC + P++R +A E
Sbjct: 238 ----ACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (233), Expect = 1e-22
Identities = 51/167 (30%), Positives = 82/167 (49%), Gaps = 12/167 (7%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF---QRLNI 78
E +++K + H N+IK S + +V+EY G L + + F Q L+
Sbjct: 49 EVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW 108
Query: 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQT 138
+ + AL+YLH S ++H D+KP N+ L N + L DFGI+K+L + +T
Sbjct: 109 FVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLS-STVDLAKTV- 163
Query: 139 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGE 185
+ T Y++PE + + D++S G +L E T K P F GE
Sbjct: 164 VGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP----FEGE 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 1e-22
Identities = 71/280 (25%), Positives = 113/280 (40%), Gaps = 75/280 (26%)
Query: 2 EVAVKVFN-LQCGRAFKSFDVECE---MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHG 57
E A+K+ + Q + K V+ E + + H +IK+ + +EE VLEY P+G
Sbjct: 28 EYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNG 87
Query: 58 SLEKYL--YSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVA 115
L +Y+ Y S LD ++ ALEYLH S +IH DLKP+N+LLD ++
Sbjct: 88 ELLQYIRKYGS---LDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHI 141
Query: 116 YLSDFGIAKLLIGEDQSMTQTQTLATIG-------------------YMAPEYGREGRVS 156
++DFG AK+L + S + AT Y++PE E
Sbjct: 142 KITDFGTAKVL-DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAG 200
Query: 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHF 216
+ D+++ G ++ + TGK P F G N++L
Sbjct: 201 KSSDLWALGCIIYQMLTGKPP----FRG-------SNEYL-------------------- 229
Query: 217 VAKEQCVSFVFNLAMACTVESPEQRIN--AKEIVTKLLKI 254
F + P AK+++ KLL +
Sbjct: 230 ---------TFQKILKLEYSFPP-NFPPDAKDLIEKLLVL 259
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 3e-22
Identities = 70/269 (26%), Positives = 123/269 (45%), Gaps = 45/269 (16%)
Query: 3 VAVKVF-NLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 61
VA+K ++ + + F E +M + H N++ ++ + E+ ++ EY+ G L +
Sbjct: 37 VAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHE 96
Query: 62 YLY----------------SSNCILDIFQRLNIMIDVASALEYL--HFGCSAPVIHCDLK 103
+L + LD L+I I +A+ +EYL HF +H DL
Sbjct: 97 FLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF-----FVHKDLA 151
Query: 104 PDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYS 163
N+L+ + L +SD G+++ + D Q ++L I +M PE G+ S++ D++S
Sbjct: 152 ARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWS 211
Query: 164 FGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQC 222
FG++L E F+ G +P Y F N E+ +E+V L E C
Sbjct: 212 FGVVLWEIFSFGLQPYYGFSNQEV--------------IEMVRKRQL------LPCSEDC 251
Query: 223 VSFVFNLAMACTVESPEQRINAKEIVTKL 251
+++L C E P +R K+I T+L
Sbjct: 252 PPRMYSLMTECWQEGPSRRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 7e-22
Identities = 70/260 (26%), Positives = 109/260 (41%), Gaps = 46/260 (17%)
Query: 3 VAVKVFNLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 60
VA+K +L+ A KS E +++K+++H N++K I S + ++LEY +GSL
Sbjct: 28 VAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLR 87
Query: 61 KYLYSSN------CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLV 114
+ + + ++Q V L YLH VIH D+K N+L + V
Sbjct: 88 QIIKKFGPFPESLVAVYVYQ-------VLQGLAYLH---EQGVIHRDIKAANILTTKDGV 137
Query: 115 AYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTG 174
L+DFG+A L + + T +MAPE ST D++S G ++E TG
Sbjct: 138 VKLADFGVATKLNDVSK--DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTG 195
Query: 175 KKPTYEFFNGEMTLKHWV-NDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMAC 233
P Y+ N L V +D P+ + F+ M C
Sbjct: 196 NPPYYD-LNPMAALFRIVQDDHPPLPEG----------------ISPELKDFL----MQC 234
Query: 234 TVESPEQRINAKEIVTKLLK 253
+ P R AK+ LLK
Sbjct: 235 FQKDPNLRPTAKQ----LLK 250
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 9e-22
Identities = 59/164 (35%), Positives = 88/164 (53%), Gaps = 11/164 (6%)
Query: 17 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKA-LVLEYMPHGSLEKYLYS-SNCILDIFQ 74
++F E +M +RH NL++++ E+ +V EYM GSL YL S +L
Sbjct: 44 QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDC 103
Query: 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMT 134
L +DV A+EYL + +H DL NVL+ ++ VA +SDFG+ K + S T
Sbjct: 104 LLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASST 155
Query: 135 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 177
Q + + APE RE + ST DV+SFGI+L E ++ G+ P
Sbjct: 156 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 1e-21
Identities = 68/260 (26%), Positives = 110/260 (42%), Gaps = 30/260 (11%)
Query: 1 MEVAVKVFNL-QCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
+VA+K +L +C + E + M H N++K +S + LV+ Y+ GSL
Sbjct: 27 EKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSL 86
Query: 60 E---KYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAY 116
K Y LD ++ +V LEYLH S IH D+K N+LL ++
Sbjct: 87 LDIMKSSYPRG-GLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVK 142
Query: 117 LSDFGIAKLLI--GEDQSMTQTQTLATIGYMAPEYGREGRVSTNG-DVYSFGIMLMETFT 173
++DFG++ L G+ + + T +MAPE + D++SFGI +E T
Sbjct: 143 IADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELAT 202
Query: 174 GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMAC 233
G P ++ ++ + ND P S D S+ ++ C
Sbjct: 203 GAAPYSKYPPMKVLMLTLQND--PPSLETGADYKKYSKSFRKMISL-------------C 247
Query: 234 TVESPEQRINAKEIVTKLLK 253
+ P +R A+E LLK
Sbjct: 248 LQKDPSKRPTAEE----LLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 2e-21
Identities = 56/186 (30%), Positives = 94/186 (50%), Gaps = 6/186 (3%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 61
+VA+K + + + F E ++M + H L+++ C+ LV E+M HG L
Sbjct: 30 KVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSD 88
Query: 62 YLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFG 121
YL + L + +DV + YL S+ VIH DL N L+ +N V +SDFG
Sbjct: 89 YLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFG 145
Query: 122 IAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTYE 180
+ + ++ +DQ + T T + + +PE + S+ DV+SFG+++ E F+ GK P
Sbjct: 146 MTRFVL-DDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN 204
Query: 181 FFNGEM 186
N E+
Sbjct: 205 RSNSEV 210
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 7e-21
Identities = 48/172 (27%), Positives = 84/172 (48%), Gaps = 4/172 (2%)
Query: 19 FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78
F E ++M + H L+++ C+ + +V EYM +G L YL Q L +
Sbjct: 46 FIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEM 105
Query: 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQT 138
DV + YL S IH DL N L+DD +SDFG+++ ++ +D+ + +
Sbjct: 106 CKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVL-DDEYTSSVGS 161
Query: 139 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKH 190
+ + PE + S+ DV++FG+++ E ++ K YE FN T++
Sbjct: 162 KFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEK 213
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 1e-20
Identities = 50/182 (27%), Positives = 86/182 (47%), Gaps = 7/182 (3%)
Query: 1 MEVAVKVFNLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
+ VA+KV + A K E +M S+ H ++++++ C + + L+ + MP G L
Sbjct: 37 IPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQV-QLITQLMPLGCL 95
Query: 60 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSD 119
Y+ + + LN + +A + YL ++H DL NVL+ ++D
Sbjct: 96 LDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITD 152
Query: 120 FGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPT 178
FG+AKLL +++ I +MA E + DV+S+G+ + E T G KP
Sbjct: 153 FGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKP- 211
Query: 179 YE 180
YE
Sbjct: 212 YE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 3e-20
Identities = 59/173 (34%), Positives = 93/173 (53%), Gaps = 9/173 (5%)
Query: 17 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY-SSNCILDIFQR 75
++F E ++MK +RH L+++ + S EE +V EYM GSL +L L + Q
Sbjct: 46 EAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQL 104
Query: 76 LNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQ 135
+++ +AS + Y+ +H DL+ N+L+ +NLV ++DFG+A+L+ ED T
Sbjct: 105 VDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTA 159
Query: 136 TQTLA-TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEM 186
Q I + APE GR + DV+SFGI+L E T G+ P N E+
Sbjct: 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV 212
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 4e-20
Identities = 58/175 (33%), Positives = 90/175 (51%), Gaps = 9/175 (5%)
Query: 3 VAVKVFNLQCGRAFKS-FDVECEMMKSIRHRNLIKVISSCSNEEFKA--LVLEYMPHGSL 59
VAVK +CG+ S + E ++K++ H N++K CS + K L++EY+P GSL
Sbjct: 36 VAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSL 95
Query: 60 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSD 119
YL L++ Q L + + YLH S IH DL NVLLD++ + + D
Sbjct: 96 RDYLPKHK--LNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGD 150
Query: 120 FGIAKLL-IGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 173
FG+AK + G + + + + + A E +E + S DV+SFG+ L E T
Sbjct: 151 FGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 4e-20
Identities = 67/259 (25%), Positives = 123/259 (47%), Gaps = 30/259 (11%)
Query: 2 EVAVKVFNLQCGRAFKS---FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGS 58
EVAV + L+ G K F E +M H N+I++ + + ++ EYM +G+
Sbjct: 33 EVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGA 92
Query: 59 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLS 118
L+KYL + +Q + ++ +A+ ++YL +H DL N+L++ NL +S
Sbjct: 93 LDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVS 149
Query: 119 DFGIAKLLIGEDQSMTQTQTLATIG--YMAPEYGREGRVSTNGDVYSFGIMLMETFT-GK 175
DFG++++L +D T T + I + APE + ++ DV+SFGI++ E + G+
Sbjct: 150 DFGLSRVL-EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGE 208
Query: 176 KPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTV 235
+P ++ N E+ M+ ++ + A C S V+ L + C
Sbjct: 209 RPYWDMSNHEV--------------MKAIN------DGFRLPAPMDCPSAVYQLMLQCWQ 248
Query: 236 ESPEQRINAKEIVTKLLKI 254
+ +R +IV L K+
Sbjct: 249 QDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 6e-20
Identities = 52/172 (30%), Positives = 87/172 (50%), Gaps = 6/172 (3%)
Query: 3 VAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKY 62
VAVK + + F E +MK I+H NL++++ C+ E ++ E+M +G+L Y
Sbjct: 34 VAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 92
Query: 63 LYSSN-CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFG 121
L N ++ L + ++SA+EYL IH DL N L+ +N + ++DFG
Sbjct: 93 LRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFG 149
Query: 122 IAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 173
+++L+ G D I + APE + S DV++FG++L E T
Sbjct: 150 LSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 3e-19
Identities = 58/176 (32%), Positives = 89/176 (50%), Gaps = 8/176 (4%)
Query: 17 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNC-ILDIFQR 75
+SF E ++MK +RH L+++ + S E +V EYM GSL +L L +
Sbjct: 46 ESFLEEAQIMKKLRHDKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKDGEGRALKLPNL 104
Query: 76 LNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQ 135
+++ VA+ + Y+ IH DL+ N+L+ D LV ++DFG+A+L+ ED T
Sbjct: 105 VDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLI--EDNEYTA 159
Query: 136 TQTLA-TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKH 190
Q I + APE GR + DV+SFGI+L E T + Y N L+
Sbjct: 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQ 215
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 3e-19
Identities = 52/156 (33%), Positives = 79/156 (50%), Gaps = 7/156 (4%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81
E +++ + H L+ + S +EE LV++ + G L +Y S Q + +
Sbjct: 50 ERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDL-RYHLSQKVKFSEEQVKFWICE 108
Query: 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLAT 141
+ ALEYLH S +IH D+KPDN+LLD+ +++DF IA + ++T T T T
Sbjct: 109 IVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKV--TPDTLT-TSTSGT 162
Query: 142 IGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 177
GYMAPE S D +S G+ E GK+P
Sbjct: 163 PGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 4e-19
Identities = 74/273 (27%), Positives = 118/273 (43%), Gaps = 43/273 (15%)
Query: 1 MEVAVKVFNLQCG-RAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGS 58
VAVK+ + E EMMK I +H+N+I ++ C+ E +V+EY HG+
Sbjct: 43 STVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGN 102
Query: 59 LEKYL---------YSSNCILDIFQRL------NIMIDVASALEYLHFGCSAPVIHCDLK 103
L +L S + + L + VA +E+L S IH DL
Sbjct: 103 LRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFL---ASKKCIHRDLA 159
Query: 104 PDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYS 163
NVL+ ++ V ++DFG+A+ + D T + +MAPE + + DV+S
Sbjct: 160 ARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 219
Query: 164 FGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQ- 221
FG++L E FT G P + I E+ LL + + + K Q
Sbjct: 220 FGVLLWEIFTLGGSP-----------------YPGIPVEELFK--LLKEG--YRMEKPQN 258
Query: 222 CVSFVFNLAMACTVESPEQRINAKEIVTKLLKI 254
C +++L C E P QR K++V L ++
Sbjct: 259 CTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 6e-19
Identities = 62/235 (26%), Positives = 105/235 (44%), Gaps = 32/235 (13%)
Query: 26 MKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASA 85
M ++H N++K+I C +E+ L+ EY+ +L + L + L +R I I +A A
Sbjct: 737 MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKA 792
Query: 86 LEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYM 145
L +LH CS V+ +L P+ +++D +L + LL T T+ + Y+
Sbjct: 793 LRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC------TDTKCFISSAYV 845
Query: 146 APEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHW---------VNDWL 196
APE ++ D+Y FG++L+E TGK P F ++ W ++ W
Sbjct: 846 APETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMW- 904
Query: 197 PISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKL 251
I D ++ E + V NLA+ CT P R A +++ L
Sbjct: 905 -IDPSIRGDVSVNQNEIVE----------VMNLALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 6e-19
Identities = 62/189 (32%), Positives = 94/189 (49%), Gaps = 15/189 (7%)
Query: 4 AVKVFNLQCGR--AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 61
AVK +Q K E ++++ ++H NL+K + E + +EY G+LE+
Sbjct: 29 AVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEE 88
Query: 62 YLYSSNCILD--IFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSD 119
L ILD + + + + L YLH S ++H D+KP N+ LD N V L D
Sbjct: 89 LLEHGR-ILDEHVIRVYTLQL--LEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGD 142
Query: 120 FGIAKLLIGEDQSM-TQTQTLA-TIGYMAPEYGREGRVSTNG---DVYSFGIMLMETFTG 174
FG A L +M + Q+LA T YMAPE G+ +G D++S G +++E TG
Sbjct: 143 FGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATG 202
Query: 175 KKPTYEFFN 183
K+P E N
Sbjct: 203 KRPWSELDN 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 1e-18
Identities = 56/174 (32%), Positives = 86/174 (49%), Gaps = 9/174 (5%)
Query: 3 VAVKVFNLQCGRAFK-SFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 61
VAVK + K F E ++K H N++K+I C+ + +V+E +P G
Sbjct: 22 VAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81
Query: 62 YLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFG 121
+L L Q + +D A+ + YL S IH DL N L+ +N V +SDFG
Sbjct: 82 FLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFG 138
Query: 122 IAKLLIGEDQSMTQTQTLAT--IGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 173
+++ ED + + L I + APE GR S+ DV+S+GI+L ETF+
Sbjct: 139 MSR---QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-18
Identities = 59/173 (34%), Positives = 92/173 (53%), Gaps = 9/173 (5%)
Query: 17 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNC-ILDIFQR 75
++F E ++MK +RH L+ + + S EE +V E+M GSL +L + L + Q
Sbjct: 46 EAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQL 104
Query: 76 LNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQ 135
+++ +A + Y+ IH DL+ N+L+ DNLV ++DFG+A+L+ ED T
Sbjct: 105 VDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLI--EDNEYTA 159
Query: 136 TQTLA-TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEM 186
Q I + APE GR + DV+SFGI+L E T G+ P N E+
Sbjct: 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV 212
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 3e-18
Identities = 59/228 (25%), Positives = 100/228 (43%), Gaps = 28/228 (12%)
Query: 19 FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78
F E ++K H N++++I C+ ++ +V+E + G +L + L + + + +
Sbjct: 40 FLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQM 99
Query: 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQT 138
+ + A+ +EYL IH DL N L+ + V +SDFG+++ ED T
Sbjct: 100 VENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSRE--EEDGVYASTGG 154
Query: 139 LATI--GYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDW 195
+ I + APE GR S+ DV+SFGI+L E F+ G P N +
Sbjct: 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ---------- 204
Query: 196 LPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRIN 243
T E + ++ + E C V+ L C P QR +
Sbjct: 205 ----TREAI------EQGVRLPCPELCPDAVYRLMERCWEYDPGQRPS 242
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 3e-18
Identities = 64/206 (31%), Positives = 103/206 (50%), Gaps = 27/206 (13%)
Query: 3 VAVKVFNLQCG---RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
VAVK L+ G + K F E +M + H N++K++ C E + +++E M G L
Sbjct: 29 VAVK--TLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDL 86
Query: 60 EKYLYSSNC------ILDIFQRLNIMIDVASALEYL---HFGCSAPVIHCDLKPDNVLL- 109
YL + +L + + L+I +DVA YL HF IH DL N L+
Sbjct: 87 LSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHF------IHRDLAARNCLVS 140
Query: 110 ----DDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFG 165
D + V + DFG+A+ + D + + L + +MAPE +G+ +T DV+SFG
Sbjct: 141 EKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFG 200
Query: 166 IMLMETFT-GKKPTYEFFNGEMTLKH 190
+++ E T G++P Y N + L+H
Sbjct: 201 VLMWEILTLGQQP-YPALNNQEVLQH 225
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 4e-18
Identities = 56/193 (29%), Positives = 86/193 (44%), Gaps = 19/193 (9%)
Query: 3 VAVKVFN---LQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
A+KV + E +++ + ++K+ S ++ LV+EY+P G L
Sbjct: 21 YAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80
Query: 60 EKYLYSSNCILDIFQRLNIMIDVASALEYLH-FGCSAPVIHCDLKPDNVLLDDNLVAYLS 118
L + LD + ++ ALEYLH G IH DLKPDN+L+D N L+
Sbjct: 81 ASLLENVGS-LDEDVARIYIAEIVLALEYLHSNGI----IHRDLKPDNILIDSNGHLKLT 135
Query: 119 DFGIAKLLIGEDQSMTQ------TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETF 172
DFG++K+ + Q + + T Y+APE S D +S G +L E
Sbjct: 136 DFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFL 195
Query: 173 TGKKPTYEFFNGE 185
G P F+GE
Sbjct: 196 VGIPP----FHGE 204
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 7e-18
Identities = 65/271 (23%), Positives = 113/271 (41%), Gaps = 52/271 (19%)
Query: 3 VAVKVFNLQCGRAFKS-FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 61
VAVK+ + ++ F E +M H N++K++ C+ + L+ EYM +G L +
Sbjct: 38 VAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNE 97
Query: 62 YLYSSN---------------------CILDIFQRLNIMIDVASALEYL---HFGCSAPV 97
+L + L ++L I VA+ + YL F
Sbjct: 98 FLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKF------ 151
Query: 98 IHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVST 157
+H DL N L+ +N+V ++DFG+++ + D I +M PE R +T
Sbjct: 152 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTT 211
Query: 158 NGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHF 216
DV+++G++L E F+ G +P Y + E + + V D N+LS
Sbjct: 212 ESDVWAYGVVLWEIFSYGMQPYYGMAH-EEVIYY------------VRDGNVLS------ 252
Query: 217 VAKEQCVSFVFNLAMACTVESPEQRINAKEI 247
+ C ++NL C + P R + I
Sbjct: 253 -CPDNCPLELYNLMRLCWSKLPSDRPSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 2e-17
Identities = 45/156 (28%), Positives = 73/156 (46%), Gaps = 6/156 (3%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81
E +++ ++ + N ++ +EYM GSL+K L + I +
Sbjct: 49 ELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVA 108
Query: 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLAT 141
V L YLH +IH D+KP N+L++ L DFG++ L+ S+ +T T
Sbjct: 109 VLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLV---NSLAKTFV-GT 162
Query: 142 IGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 177
YMAPE + S D++S G+ L+E TG+ P
Sbjct: 163 SSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 2e-17
Identities = 65/273 (23%), Positives = 114/273 (41%), Gaps = 49/273 (17%)
Query: 3 VAVKVFNLQCG---RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
VAVKV L+ A + F E +++ + N+ +++ C+ + +++EYM +G L
Sbjct: 49 VAVKV--LRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106
Query: 60 EKYLY----------------SSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLK 103
++L S + + L + +AS + YL S +H DL
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTL------LYMATQIASGMRYLE---SLNFVHRDLA 157
Query: 104 PDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYS 163
N L+ N ++DFG+++ L D Q + I +MA E G+ +T DV++
Sbjct: 158 TRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWA 217
Query: 164 FGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQED---IHFVAK 219
FG+ L E T ++ YE +T V +E +A ++D I+
Sbjct: 218 FGVTLWEILTLCREQPYE----HLT-DQQV--------IE--NAGHFFRDDGRQIYLPRP 262
Query: 220 EQCVSFVFNLAMACTVESPEQRINAKEIVTKLL 252
C ++ L + C E R +EI L
Sbjct: 263 PNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-17
Identities = 72/268 (26%), Positives = 116/268 (43%), Gaps = 34/268 (12%)
Query: 3 VAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIK---VISSCSNEEFKALVLEYMPHGSL 59
VAVK + F+ E E++KS++H N++K V S + LV+EY+P+GSL
Sbjct: 36 VAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR-LVMEYLPYGSL 94
Query: 60 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSD 119
YL LD + L + +EYL S +H DL N+L++ + D
Sbjct: 95 RDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGD 151
Query: 120 FGIAKLL-IGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT----G 174
FG+ K+L ++ + + I + APE E + S DV+SFG++L E FT
Sbjct: 152 FGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKS 211
Query: 175 KKPTYEFF-------NGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVF 227
P EF G+M + H + L + + A C + ++
Sbjct: 212 CSPPAEFMRMMGNDKQGQMIVYHLIE---------------LLKNNGRLPAPPGCPAEIY 256
Query: 228 NLAMACTVESPEQRINAKEIVTKLLKIR 255
+ C P QR + E+ ++ IR
Sbjct: 257 AIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-17
Identities = 63/242 (26%), Positives = 113/242 (46%), Gaps = 28/242 (11%)
Query: 2 EVAVKVFNLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 60
+VA+K +L+ G + ++F E +MK ++H L+++ + + E ++ EYM +GSL
Sbjct: 32 KVAIK--SLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQEPI-YIITEYMENGSLV 88
Query: 61 KYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSD 119
+L + I L I + +++ +A + ++ IH DL+ N+L+ + L ++D
Sbjct: 89 DFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIAD 145
Query: 120 FGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTY 179
FG+A+ LI +++ + I + APE G + DV+SFGI+L E T + Y
Sbjct: 146 FGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPY 204
Query: 180 EFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239
P T V NL + + C ++ L C E PE
Sbjct: 205 -----------------PGMTNPEVIQNL--ERGYRMPRPDNCPEELYELMRLCWKEKPE 245
Query: 240 QR 241
+R
Sbjct: 246 ER 247
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 3e-17
Identities = 45/166 (27%), Positives = 74/166 (44%), Gaps = 15/166 (9%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKAL--VLEYMPHGSLEKYLYSSNCILDIFQRL--- 76
E +++ ++H N+++ + + L V+EY G L + + C + + +
Sbjct: 49 EVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLI--QKCKKE-RKYIEEE 105
Query: 77 ---NIMIDVASALEYLHFGCSAP--VIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQ 131
I+ + AL H V+H DLKP N+ LD N L DFG+AK+L G D
Sbjct: 106 FIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL-GHDS 164
Query: 132 SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 177
S +T + T YM+PE D++S G ++ E P
Sbjct: 165 SFAKT-YVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 4e-17
Identities = 51/187 (27%), Positives = 97/187 (51%), Gaps = 8/187 (4%)
Query: 2 EVAVKVFNLQCG---RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGS 58
E+ V + L+ G + + F E +M H N+I + + + +V EYM +GS
Sbjct: 32 EIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGS 91
Query: 59 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLS 118
L+ +L + + Q + ++ +AS ++YL +H DL N+L++ NLV +S
Sbjct: 92 LDAFLRKHDGQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVS 148
Query: 119 DFGIAKLLIGE-DQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKK 176
DFG++++L + + + T I + APE + ++ DV+S+GI++ E + G++
Sbjct: 149 DFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER 208
Query: 177 PTYEFFN 183
P +E N
Sbjct: 209 PYWEMSN 215
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 4e-17
Identities = 64/251 (25%), Positives = 115/251 (45%), Gaps = 26/251 (10%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 61
+VA+K N + + + F E ++M + H L+++ C+ ++ +V E+M +G L
Sbjct: 30 KVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLN 88
Query: 62 YLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFG 121
YL L L++ DV +EYL IH DL N L+ V +SDFG
Sbjct: 89 YLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFG 145
Query: 122 IAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTYE 180
+ + ++ +D+ + + + + PE + S+ DV+SFG+++ E FT GK P
Sbjct: 146 MTRYVL-DDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMP--- 201
Query: 181 FFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQ 240
F + S EVV+ +S+ + K ++ V+ + +C E PE
Sbjct: 202 -FEKK-------------SNYEVVEM--ISRGFRLYRPKLASMT-VYEVMYSCWHEKPEG 244
Query: 241 RINAKEIVTKL 251
R E++ +
Sbjct: 245 RPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 7e-17
Identities = 48/177 (27%), Positives = 86/177 (48%), Gaps = 6/177 (3%)
Query: 3 VAVKVFNLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 61
VA+K + GR F+ M S+ H +++++ C + LV + P GSL
Sbjct: 39 VAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQ-LVTQLSPLGSLLD 97
Query: 62 YLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFG 121
++ LD + LN + +A + YL ++H +L N+LL + + ++DFG
Sbjct: 98 HVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFG 154
Query: 122 IAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 177
+A LL +D+ ++ I +MA E GR + DV+S+G+ + E + G +P
Sbjct: 155 VADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEP 211
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 7e-17
Identities = 46/160 (28%), Positives = 83/160 (51%), Gaps = 8/160 (5%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81
E ++K ++H N+++ + S + + + LEY+P GS+ L + + R N +
Sbjct: 56 EIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-NFVRQ 114
Query: 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMT---QTQT 138
+ L YLH + +IH D+K N+L+D+ +SDFGI+K L S +
Sbjct: 115 ILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS 171
Query: 139 L-ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 177
L ++ +MAPE ++ + D++S G +++E TGK P
Sbjct: 172 LQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 1e-16
Identities = 65/263 (24%), Positives = 110/263 (41%), Gaps = 34/263 (12%)
Query: 1 MEVAVK-VFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
VA+K V R F E +MK ++++++ S + +V+E M G L
Sbjct: 37 TRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDL 96
Query: 60 EKYLYS------SNCILDIFQRLNIM---IDVASALEYLHFGCSAPVIHCDLKPDNVLLD 110
+ YL S +N L + ++A + YL + +H DL N ++
Sbjct: 97 KSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVA 153
Query: 111 DNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLME 170
++L + DFG+ + + D + L + +MAPE ++G +T DV+SFG++L E
Sbjct: 154 EDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWE 213
Query: 171 TFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNL 229
T ++P Y+ + E LK V+D L E C + L
Sbjct: 214 MATLAEQP-YQGLSNEEVLKF------------VIDGGHLDL-------PENCPDKLLEL 253
Query: 230 AMACTVESPEQRINAKEIVTKLL 252
C +P+ R EIV+ L
Sbjct: 254 MRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 2e-16
Identities = 54/188 (28%), Positives = 88/188 (46%), Gaps = 30/188 (15%)
Query: 3 VAVKVFNLQCGRAFKSFDV----ECEMMKSIRHRNLIK----VISSCSNEEFKALVLEYM 54
VA+K ++ + + F + E ++++ +RH N+++ V S + +V EYM
Sbjct: 27 VALKKIRMENEK--EGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIY--MVFEYM 82
Query: 55 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLV 114
H L L S Q M + L+YLH S ++H D+K N+L++++ V
Sbjct: 83 DH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGV 138
Query: 115 AYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPE-------YGREGRVSTNGDVYSFGIM 167
L+DFG+A+ S T + T+ Y PE YG E V D++S G +
Sbjct: 139 LKLADFGLARPYTKR-NSADYTNRVITLWYRPPELLLGATRYGPE--V----DMWSVGCI 191
Query: 168 LMETFTGK 175
L E F GK
Sbjct: 192 LAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-16
Identities = 50/172 (29%), Positives = 74/172 (43%), Gaps = 24/172 (13%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEF-----KALVLEYMPHGSLEKYLYSSNCILDIFQR- 75
E ++ S+ H N+I E F +V+EY P G L K + +
Sbjct: 49 EIRILASVNHPNII-----SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQ 103
Query: 76 --LNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSM 133
I I + L+ LH ++H DLK N+LL N + + D GI+K+L ++M
Sbjct: 104 EIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVL---KKNM 157
Query: 134 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGE 185
+TQ T YMAPE + S D++S G +L E T P F
Sbjct: 158 AKTQI-GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP----FEAR 204
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 2e-16
Identities = 65/194 (33%), Positives = 91/194 (46%), Gaps = 23/194 (11%)
Query: 2 EVAVKVFNLQCGRAFKS-FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 60
EVAVK + A K F E +M + H ++++I C E LV+E P G L
Sbjct: 25 EVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPL-MLVMELAPLGPLL 83
Query: 61 KYL--YSSNCILDIFQRLNIMIDVASALEYL---HFGCSAPVIHCDLKPDNVLLDDNLVA 115
KYL + D+ + VA + YL HF +H DL NVLL + A
Sbjct: 84 KYLKKRREIPVSDL---KELAHQVAMGMAYLESKHF------VHRDLAARNVLLVNRHQA 134
Query: 116 YLSDFGIAKLL-IGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT- 173
+SDFG+++ L G D T + + APE G+ S+ DV+S+G+ L E F+
Sbjct: 135 KISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSY 194
Query: 174 GKKPTYEFFNGEMT 187
G KP Y GEM
Sbjct: 195 GAKP-Y----GEMK 203
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 3e-16
Identities = 46/169 (27%), Positives = 84/169 (49%), Gaps = 10/169 (5%)
Query: 14 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDI- 72
+ ++ E +++KS++H N+++ + +C ++ ++ +E++P GS+ L + +
Sbjct: 44 KEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPV 103
Query: 73 FQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQS 132
F + I + YLH C V+H D+K +NV+L N + L DFG A+ L
Sbjct: 104 FCKYTKQI--LDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH 158
Query: 133 MTQTQTLATIG----YMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 177
T + L ++ +MAPE E D++S G + E TGK P
Sbjct: 159 GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-16
Identities = 50/170 (29%), Positives = 84/170 (49%), Gaps = 22/170 (12%)
Query: 17 KSFDVECEMM-KSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI------ 69
+ F E E++ K H N+I ++ +C N + + +EY P+G+L +L S +
Sbjct: 47 RDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAF 106
Query: 70 ---------LDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDF 120
L Q L DVA+ ++YL IH DL NVL+ +NL + ++DF
Sbjct: 107 AKEHGTASTLTSQQLLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADF 163
Query: 121 GIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLME 170
G+++ GE+ + +T + +MA E +T DV+SFG++L E
Sbjct: 164 GLSR---GEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWE 210
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 4e-16
Identities = 56/185 (30%), Positives = 88/185 (47%), Gaps = 22/185 (11%)
Query: 3 VAVKVFNLQCGRAFKSFDV-----ECEMMKSIRH---RNLIKVISSCSNEEFKALVLEYM 54
VA+K+ NL DV E ++ +R N+ K S +++EY
Sbjct: 29 VALKIINLDT----PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYA 84
Query: 55 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLV 114
GS+ + L + I + + + I+ +V AL+Y+H VIH D+K N+L+ +
Sbjct: 85 EGGSV-RTLMKAGPIAEKYISV-IIREVLVALKYIH---KVGVIHRDIKAANILVTNTGN 139
Query: 115 AYLSDFGIAKLLIGEDQSMTQTQTLATIGY-MAPEYGREGRV-STNGDVYSFGIMLMETF 172
L DFG+A LL +Q+ ++ T Y MAPE EG+ T D++S GI + E
Sbjct: 140 VKLCDFGVAALL---NQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMA 196
Query: 173 TGKKP 177
TG P
Sbjct: 197 TGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 4e-16
Identities = 50/185 (27%), Positives = 94/185 (50%), Gaps = 5/185 (2%)
Query: 3 VAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 61
VA+K + F E +M H N+I++ + ++ EYM +GSL+K
Sbjct: 35 VAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDK 94
Query: 62 YLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFG 121
+L ++ + Q + ++ +AS ++YL +H DL N+L++ NLV +SDFG
Sbjct: 95 FLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY---VHRDLAARNILVNSNLVCKVSDFG 151
Query: 122 IAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTYE 180
+++ L + + T I + APE + ++ DV+SFGI++ E + G++P ++
Sbjct: 152 LSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWD 211
Query: 181 FFNGE 185
N +
Sbjct: 212 MSNQD 216
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 4e-16
Identities = 54/166 (32%), Positives = 84/166 (50%), Gaps = 14/166 (8%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI- 80
E + ++HRN+++ + S S F + +E +P GSL L S L + +I
Sbjct: 55 EIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNE--QTIIF 112
Query: 81 ---DVASALEYLHFGCSAPVIHCDLKPDNVLLDD-NLVAYLSDFGIAKLLIGEDQSMTQT 136
+ L+YLH ++H D+K DNVL++ + V +SDFG +K L G + T+T
Sbjct: 113 YTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN-PCTET 168
Query: 137 QTLATIGYMAPEYGREGR--VSTNGDVYSFGIMLMETFTGKKPTYE 180
T T+ YMAPE +G D++S G ++E TGK P E
Sbjct: 169 FT-GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIE 213
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 4e-16
Identities = 53/174 (30%), Positives = 89/174 (51%), Gaps = 28/174 (16%)
Query: 17 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGS----LEKYLYSSNCILDI 72
K+ E E +K + H N+++ + + EE+ ++ LEY+P GS L Y ++
Sbjct: 53 KALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRF 112
Query: 73 FQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL---LIGE 129
F V L YLH S ++H DLK DN+L+D + + +SDFGI+K +
Sbjct: 113 FTE-----QVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDN 164
Query: 130 DQSMTQTQTLATIGYMAPE------YGREGRVSTNGDVYSFGIMLMETFTGKKP 177
DQ+M+ ++ +MAPE G +V D++S G +++E F G++P
Sbjct: 165 DQNMSMQ---GSVFWMAPEVIHSYSQGYSAKV----DIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 4e-16
Identities = 63/242 (26%), Positives = 110/242 (45%), Gaps = 27/242 (11%)
Query: 2 EVAVKVFNLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 60
+VAVK L+ G + ++F E +MK+++H L+++ + + EE ++ EYM GSL
Sbjct: 32 KVAVK--TLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLL 89
Query: 61 KYLYSSNCILDIFQRL-NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSD 119
+L S + +L + +A + Y+ IH DL+ NVL+ ++L+ ++D
Sbjct: 90 DFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIAD 146
Query: 120 FGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTY 179
FG+A+ +I +++ + I + APE G + DV+SFGI+L E T K
Sbjct: 147 FGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGK--- 202
Query: 180 EFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239
+P M D Q E C ++++ C E E
Sbjct: 203 ----------------IPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTCWKEKAE 246
Query: 240 QR 241
+R
Sbjct: 247 ER 248
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 6e-16
Identities = 51/194 (26%), Positives = 91/194 (46%), Gaps = 26/194 (13%)
Query: 2 EVAVKVFNL-----QCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPH 56
E+AVK + + + + E +++K+++H +++ ++E ++ +EYMP
Sbjct: 29 ELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPG 88
Query: 57 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAY 116
GS++ L + + + R + +EYLH S ++H D+K N+L D
Sbjct: 89 GSVKDQLKAYGALTETVTR-KYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVK 144
Query: 117 LSDFGIAKLLIGEDQSMTQTQTLATIG---YMAPE------YGREGRVSTNGDVYSFGIM 167
L DFG +K L + + T + G +M+PE YGR+ DV+S G
Sbjct: 145 LGDFGASKRL--QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRK------ADVWSVGCT 196
Query: 168 LMETFTGKKPTYEF 181
++E T K P EF
Sbjct: 197 VVEMLTEKPPWAEF 210
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 7e-16
Identities = 66/266 (24%), Positives = 111/266 (41%), Gaps = 37/266 (13%)
Query: 3 VAVKVFNLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSC----SNEEFKA--LVLEYM 54
VAVK L + F E MK H N++K+I C S ++ ++L +M
Sbjct: 30 VAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFM 89
Query: 55 PHGSLEKYLYSSNC-----ILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLL 109
HG L +L S L + L M+D+A +EYL + IH DL N +L
Sbjct: 90 KHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYL---SNRNFIHRDLAARNCML 146
Query: 110 DDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLM 169
+++ ++DFG++K + D + ++A E + ++ DV++FG+ +
Sbjct: 147 REDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMW 206
Query: 170 ETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFN 228
E T G+ P N E+ D+L N L Q E C+ +++
Sbjct: 207 EIATRGQTPYPGVENHEIY------DYL-------RHGNRLKQ-------PEDCLDELYD 246
Query: 229 LAMACTVESPEQRINAKEIVTKLLKI 254
L +C P+ R ++ L I
Sbjct: 247 LMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 8e-16
Identities = 59/260 (22%), Positives = 121/260 (46%), Gaps = 30/260 (11%)
Query: 2 EVAVKVFNLQCG---RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGS 58
E+ V + L+ G + + F E +M H N+I + + ++ E+M +G+
Sbjct: 32 EIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGA 91
Query: 59 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLS 118
L+ +L ++ + Q + ++ +A+ ++YL +H DL N+L++ NLV +S
Sbjct: 92 LDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVS 148
Query: 119 DFGIAKLLIGEDQSMTQTQTLA---TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-G 174
DFG+++ L + T T +L I + APE + ++ DV+S+GI++ E + G
Sbjct: 149 DFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYG 208
Query: 175 KKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACT 234
++P ++ +S +V++A ++D C + + L + C
Sbjct: 209 ERPYWD-----------------MSNQDVINA---IEQDYRLPPPMDCPTALHQLMLDCW 248
Query: 235 VESPEQRINAKEIVTKLLKI 254
+ R +IV+ L K+
Sbjct: 249 QKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-15
Identities = 62/266 (23%), Positives = 118/266 (44%), Gaps = 40/266 (15%)
Query: 3 VAVKVFNLQCGRAFKS-FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 61
VA+K + + F E M ++H N++ ++ + E+ +++ Y H L +
Sbjct: 38 VAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHE 97
Query: 62 YLY---------------SSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDN 106
+L + L+ ++I+ +A+ +E+L S V+H DL N
Sbjct: 98 FLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRN 154
Query: 107 VLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGI 166
VL+ D L +SD G+ + + D +L I +M+PE G+ S + D++S+G+
Sbjct: 155 VLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGV 214
Query: 167 MLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSF 225
+L E F+ G +P + N ++ I +V L +D C ++
Sbjct: 215 VLWEVFSYGLQPYCGYSNQDVIEM--------IRNRQV----LPCPDD--------CPAW 254
Query: 226 VFNLAMACTVESPEQRINAKEIVTKL 251
V+ L + C E P +R K+I ++L
Sbjct: 255 VYTLMLECWNEFPSRRPRFKDIHSRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-15
Identities = 63/259 (24%), Positives = 107/259 (41%), Gaps = 29/259 (11%)
Query: 1 MEVAVKVFNLQCGRAFKS-FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
+ VAVK + + F E +M+ H +++K+I + E +V+E P G L
Sbjct: 35 IAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVIT-ENPVWIVMELAPLGEL 93
Query: 60 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSD 119
YL + LD+ + +++AL YL S +H D+ NVL+ L D
Sbjct: 94 RSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGD 150
Query: 120 FGIAKLLIGEDQSM-TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 177
FG+++ L ED+S ++ I +MAPE R ++ DV+ FG+ + E G KP
Sbjct: 151 FGLSRYL--EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKP 208
Query: 178 TYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237
N ++ + + LP+ C +++L C
Sbjct: 209 FQGVKNNDVIGRIENGERLPMP--------------------PNCPPTLYSLMTKCWAYD 248
Query: 238 PEQRINAKEIVTKLLKIRD 256
P +R E+ +L I
Sbjct: 249 PSKRPRFTELKAQLSDILQ 267
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-15
Identities = 53/173 (30%), Positives = 86/173 (49%), Gaps = 20/173 (11%)
Query: 22 ECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-----------YSSNCI 69
E EMMK I +H+N+I ++ +C+ + +++EY G+L +YL Y+ +
Sbjct: 73 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQV 132
Query: 70 ----LDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL 125
L ++ VA +EYL S IH DL NVL+ ++ V ++DFG+A+
Sbjct: 133 PEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 189
Query: 126 LIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 177
+ D T + +MAPE + + DV+SFG++L E FT G P
Sbjct: 190 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 242
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 1e-15
Identities = 64/255 (25%), Positives = 99/255 (38%), Gaps = 27/255 (10%)
Query: 3 VAVKVF-NLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 61
VAVK + + F E +M S+ H NLI++ +V E P GSL
Sbjct: 26 VAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLM-MVTELAPLGSLLD 84
Query: 62 YLYSSNC-ILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDF 120
L I + + +A+ + YL S IH DL N+LL + + DF
Sbjct: 85 RLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDF 141
Query: 121 GIAK-LLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPT 178
G+ + L ED + + + APE R S DV+ FG+ L E FT G++P
Sbjct: 142 GLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEP- 200
Query: 179 YEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238
+ +G LK +D E + E C ++N+ + C +P
Sbjct: 201 WAGLSGSQILKK-------------IDKEG---ERLE--RPEACPQDIYNVMLQCWAHNP 242
Query: 239 EQRINAKEIVTKLLK 253
R + L +
Sbjct: 243 ADRPTFAALREFLPE 257
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-15
Identities = 53/177 (29%), Positives = 84/177 (47%), Gaps = 7/177 (3%)
Query: 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 60
EVA+K NLQ + E +M+ +H N++ + S + +V+EY+ GSL
Sbjct: 45 QEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLT 104
Query: 61 KYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDF 120
+ + +D Q + + ALE+LH S VIH D+K DN+LL + L+DF
Sbjct: 105 DVV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDF 159
Query: 121 GIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 177
G + E ++ + T +MAPE D++S GIM +E G+ P
Sbjct: 160 GFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 2e-15
Identities = 66/247 (26%), Positives = 111/247 (44%), Gaps = 48/247 (19%)
Query: 3 VAVKVFNLQCGRAFKS-FDV-----ECEMMKSIRHRNLIK---VISSCSNEEFKAL--VL 51
VA+K + F D E ++++ +RH N+I ++ S E+F + V
Sbjct: 28 VAIK----KISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVT 83
Query: 52 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDD 111
E M L K + S + D + + + L+YLH SA VIH DLKP N+L++
Sbjct: 84 ELMET-DLHKVIKSPQPLTDDHIQY-FLYQILRGLKYLH---SANVIHRDLKPSNILVNS 138
Query: 112 NLVAYLSDFGIAKLLIGEDQSMTQTQT--LATIGYMAPE-------YGREGRVSTNGDVY 162
N + DFG+A+ + D+ T + T Y APE Y + D++
Sbjct: 139 NCDLKICDFGLAR-GVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRY------TKAIDIW 191
Query: 163 SFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQC 222
S G + E T KP F G + +++ I +EV+ S+ED+ F+ E+
Sbjct: 192 SVGCIFAELLTR-KP---LFPG----RDYIDQLNLI--VEVLGT--PSEEDLKFITSEKA 239
Query: 223 VSFVFNL 229
+++ +L
Sbjct: 240 RNYLKSL 246
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-15
Identities = 55/240 (22%), Positives = 104/240 (43%), Gaps = 31/240 (12%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79
E E+++++ H N++K C+ + L++E++P GSL++YL + +++ Q+L
Sbjct: 56 EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYA 115
Query: 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTL 139
+ + ++YL S +H DL NVL++ + DFG+ K + + + T L
Sbjct: 116 VQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDL 172
Query: 140 -ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT----GKKPTYEFF------NGEMTL 188
+ + + APE + + DV+SFG+ L E T P F +G+MT+
Sbjct: 173 DSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTV 232
Query: 189 KHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIV 248
V + +E C V+ L C P +R + ++
Sbjct: 233 TRLVR---------------VLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-15
Identities = 65/244 (26%), Positives = 114/244 (46%), Gaps = 28/244 (11%)
Query: 3 VAVKVFNLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 61
VAVK+ + A F E ++M +++ N+I+++ C +++ ++ EYM +G L +
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106
Query: 62 YL-----YS----SNCI--LDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLD 110
+L S +N I + I L + + +AS ++YL S +H DL N L+
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVG 163
Query: 111 DNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLME 170
++ ++DFG+++ L D Q + + I +MA E G+ +T DV++FG+ L E
Sbjct: 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWE 223
Query: 171 TFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNL 229
FT K+ Y + E ++ +T E I+ C S VF L
Sbjct: 224 MFTLCKEQPYSLLSDEQVIE---------NTGEFFRNQ---GRQIYLSQTPLCPSPVFKL 271
Query: 230 AMAC 233
M C
Sbjct: 272 MMRC 275
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-15
Identities = 54/188 (28%), Positives = 87/188 (46%), Gaps = 19/188 (10%)
Query: 4 AVKVFNL----QCGR-AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGS 58
AVK +L Q G+ A K + E ++ ++H N+++ + + E+ + LE +P GS
Sbjct: 29 AVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGS 88
Query: 59 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLS 118
L K L + LEYLH +H D+K N+L+D N V L+
Sbjct: 89 LAK-LLKKYGSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLA 144
Query: 119 DFGIAKLLIGEDQSMTQTQTLATIG---YMAPEY-GREGRVSTNGDVYSFGIMLMETFTG 174
DFG+AK Q + + + G +MAPE ++G D++S G ++E TG
Sbjct: 145 DFGMAK------QVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATG 198
Query: 175 KKPTYEFF 182
K P +
Sbjct: 199 KPPWSQLE 206
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-15
Identities = 55/173 (31%), Positives = 87/173 (50%), Gaps = 20/173 (11%)
Query: 22 ECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-----------YSSNCI 69
E EMMK I +H+N+I ++ +C+ + +++EY G+L +YL Y +
Sbjct: 70 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARV 129
Query: 70 LD---IFQRL-NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL 125
D F+ L + VA +EYL S IH DL NVL+ +N V ++DFG+A+
Sbjct: 130 PDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARD 186
Query: 126 LIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 177
+ D T + +MAPE + + DV+SFG+++ E FT G P
Sbjct: 187 VNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-15
Identities = 46/155 (29%), Positives = 78/155 (50%), Gaps = 21/155 (13%)
Query: 31 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI---------------LDIFQR 75
H N+I ++ +C + + L +EY PHG+L +L S + L Q
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 76 LNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQ 135
L+ DVA ++YL IH DL N+L+ +N VA ++DFG+++ G++ + +
Sbjct: 127 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 180
Query: 136 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLME 170
T + +MA E +TN DV+S+G++L E
Sbjct: 181 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWE 215
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 4e-15
Identities = 67/259 (25%), Positives = 103/259 (39%), Gaps = 55/259 (21%)
Query: 3 VAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKY 62
VA+KV + + E ++K ++K S +V+EY GS
Sbjct: 31 VAIKVVPV--EEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGS---- 84
Query: 63 LYSSNCILDIFQRLN----------IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDN 112
+ DI + N I+ LEYLH S IH D+K N+LL++
Sbjct: 85 ------VSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEE 135
Query: 113 LVAYLSDFGIAKLLIGEDQSMTQTQTLATIG---YMAPEYGREGRVSTNGDVYSFGIMLM 169
A L+DFG++ L +M + T+ IG +MAPE +E + D++S GI +
Sbjct: 136 GQAKLADFGVSGQLTD---TMAKRNTV--IGTPFWMAPEVIQEIGYNNKADIWSLGITAI 190
Query: 170 ETFTGKKPTYEF--FNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVF 227
E GK P + + + P T+ D S E FV K
Sbjct: 191 EMAEGKPPYSDIHPMRAIFMIPNK-----PPPTLS--DPEKWSPEFNDFVKK-------- 235
Query: 228 NLAMACTVESPEQRINAKE 246
C V+ PE+R +A +
Sbjct: 236 -----CLVKDPEERPSAIQ 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-15
Identities = 58/257 (22%), Positives = 111/257 (43%), Gaps = 47/257 (18%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI------------ 69
E ++K + H ++IK+ +CS + L++EY +GSL +L S +
Sbjct: 53 EFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRN 112
Query: 70 -----------LDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLS 118
L + ++ ++ ++YL ++H DL NVL+ + +S
Sbjct: 113 SSYLDNPDERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKIS 169
Query: 119 DFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 177
DFG+++ + ED + +++ + +MA E + +T DV+SFG++L E T G P
Sbjct: 170 DFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 229
Query: 178 TYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237
+ G + + NLL + E C ++NL + C +
Sbjct: 230 ----YPGIAPERLF---------------NLL-KTGYRMERPENCSEEMYNLMLTCWKQE 269
Query: 238 PEQRINAKEIVTKLLKI 254
P++R +I +L K+
Sbjct: 270 PDKRPTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 8e-15
Identities = 57/173 (32%), Positives = 88/173 (50%), Gaps = 20/173 (11%)
Query: 22 ECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL---------YS-SNCIL 70
E EMMK I +H+N+I ++ +C+ + +++EY G+L +YL YS C L
Sbjct: 67 EMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKL 126
Query: 71 D----IFQRL-NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL 125
F+ L + VA +EYL S IH DL NVL+ ++ V ++DFG+A+
Sbjct: 127 PEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARD 183
Query: 126 LIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 177
+ D T + +MAPE + + DV+SFG++L E FT G P
Sbjct: 184 VHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-14
Identities = 69/268 (25%), Positives = 120/268 (44%), Gaps = 37/268 (13%)
Query: 1 MEVAVKVFNLQ-CGRA-FKSFDVECEMMKSIRHRNLIKVISSC----SNEEFKA--LVLE 52
++VAVK + C R+ + F E MK H N++++I C +E + + ++L
Sbjct: 27 LKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILP 86
Query: 53 YMPHGSLEKYLYSSNC-----ILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNV 107
+M HG L +L S L + M D+AS +EYL S IH DL N
Sbjct: 87 FMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYL---SSKSFIHRDLAARNC 143
Query: 108 LLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIM 167
+L++N+ ++DFG++K + D + ++A E + +T DV+SFG+
Sbjct: 144 MLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVT 203
Query: 168 LMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFV 226
+ E T G+ P N E + D+L N L Q C+ +
Sbjct: 204 MWEIATRGQTPYPGVENSE------IYDYLR-------QGNRLKQ-------PPDCLDGL 243
Query: 227 FNLAMACTVESPEQRINAKEIVTKLLKI 254
++L +C + +P+ R + + + +L K
Sbjct: 244 YSLMSSCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 1e-14
Identities = 52/194 (26%), Positives = 86/194 (44%), Gaps = 34/194 (17%)
Query: 3 VAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKY 62
VA+KV L+ G F+ E M+K RH N++ S + +V+EY GSL+
Sbjct: 31 VAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQ-- 88
Query: 63 LYSSNCILDIFQRLN----------IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDN 112
DI+Q + + L YLH IH D+K N+LL ++
Sbjct: 89 --------DIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTED 137
Query: 113 LVAYLSDFGIAKLLIGEDQSMTQTQTLATIG---YMAPEYG---REGRVSTNGDVYSFGI 166
L+DFG++ L ++ + ++ IG +MAPE R+G D+++ GI
Sbjct: 138 GDVKLADFGVSAQL---TATIAKRKSF--IGTPYWMAPEVAAVERKGGYDGKCDIWALGI 192
Query: 167 MLMETFTGKKPTYE 180
+E + P ++
Sbjct: 193 TAIELAELQPPMFD 206
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-14
Identities = 49/172 (28%), Positives = 87/172 (50%), Gaps = 37/172 (21%)
Query: 22 ECEMMKSIRHRNLIKVISSC-----SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 76
E E+++ + H N++K C N E + L LE+M GSLE I D
Sbjct: 122 EIEILRDVNHPNVVK----CHDMFDHNGEIQVL-LEFMDGGSLE-----GTHIADEQFLA 171
Query: 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQ- 135
++ + S + YLH ++H D+KP N+L++ ++DFG++++L Q+M
Sbjct: 172 DVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL---AQTMDPC 225
Query: 136 TQTLATIGYMAPEYGREGRVSTN----------GDVYSFGIMLMETFTGKKP 177
++ TI YM+PE R++T+ GD++S G+ ++E + G+ P
Sbjct: 226 NSSVGTIAYMSPE-----RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-14
Identities = 52/179 (29%), Positives = 89/179 (49%), Gaps = 6/179 (3%)
Query: 1 MEVAVKVFNLQCG-RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
+ VA+K+ N G +A F E +M S+ H +L++++ C + + LV + MPHG L
Sbjct: 37 IPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCL 95
Query: 60 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSD 119
Y++ + LN + +A + YL ++H DL NVL+ ++D
Sbjct: 96 LDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITD 152
Query: 120 FGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 177
FG+A+LL G+++ I +MA E + + DV+S+G+ + E T G KP
Sbjct: 153 FGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 2e-14
Identities = 56/202 (27%), Positives = 89/202 (44%), Gaps = 36/202 (17%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81
E E+++ H ++K+ + ++++ +++EY G L L + D + +
Sbjct: 43 EKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRG-LFDEYTARFYIAC 101
Query: 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTL-A 140
V A EYLH + +I+ DLKP+N+LLD N L DFG AK L +S +T T
Sbjct: 102 VVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL----KSGQKTWTFCG 154
Query: 141 TIGYMAPE------YGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVND 194
T Y+APE Y + D +S GI+L E TG+ P F + D
Sbjct: 155 TPEYVAPEIILNKGYDF------SVDYWSLGILLYELLTGRPP----FGED--------D 196
Query: 195 WLPISTMEVVDANLLSQEDIHF 216
P+ + L + F
Sbjct: 197 EDPMEIYNDI---LKGNGKLEF 215
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-14
Identities = 52/186 (27%), Positives = 86/186 (46%), Gaps = 16/186 (8%)
Query: 2 EVAVKVFNLQCG---RAFKSFDVECEMMKSIRHRNLIKVISSCSNEE-FKALVLEYMPHG 57
EVA+K+ F E + + H N++ ++ S V EY+P
Sbjct: 5 EVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGR 64
Query: 58 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLL---DDNLV 114
+L + L +++ L + +M+ V AL H + ++H DLKP N+++
Sbjct: 65 TLREVL-AADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTGVRPH 120
Query: 115 AYLSDFGIAKLLIGEDQSMTQTQTLAT--IG---YMAPEYGREGRVSTNGDVYSFGIMLM 169
A + DFGI LL G + T T T +G Y APE R V+ N D+Y++G++ +
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFL 180
Query: 170 ETFTGK 175
E TG+
Sbjct: 181 ECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (176), Expect = 2e-14
Identities = 55/171 (32%), Positives = 83/171 (48%), Gaps = 35/171 (20%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI- 80
E +++SIRH L+ + S ++ LV+EY+P G L +L S R +
Sbjct: 51 EKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSG-------RFPEPVA 103
Query: 81 -----DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQ 135
V ALEYLH S +++ DLKP+N+LLD + ++DFG AK + G +
Sbjct: 104 RFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG------R 154
Query: 136 TQTL-ATIGYMAPE------YGREGRVSTNGDVYSFGIMLMETFTGKKPTY 179
T TL T Y+APE YG+ D ++ GI++ E G P +
Sbjct: 155 TYTLCGTPEYLAPEIILSKGYGKA------VDWWALGILIYEMLAGYPPFF 199
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-14
Identities = 50/163 (30%), Positives = 77/163 (47%), Gaps = 25/163 (15%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPH---GSLEKYLYSSNCILDIFQRLNI 78
E M+K +RH NL+ +I ++ LV E++ H LEKY LD +
Sbjct: 50 EIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG----LDESRVRKY 105
Query: 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQT 138
+ + +E+ H S +IH D+KP+N+L+ + V L DFG A+ L + T
Sbjct: 106 LFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--TDY 160
Query: 139 LATIGYMAPE-------YGREGRVSTNGDVYSFGIMLMETFTG 174
+AT Y APE YGR D+++ G ++ E TG
Sbjct: 161 VATRWYRAPELLVGDTKYGRA------VDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-14
Identities = 54/189 (28%), Positives = 88/189 (46%), Gaps = 25/189 (13%)
Query: 1 MEVAVKVFNLQCGRAFKS-FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
++VAVK C +S F +E +M H+N++++I + ++LE M G L
Sbjct: 37 LQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDL 96
Query: 60 EKYLY---------SSNCILDIFQRLNIMIDVASALEYL---HFGCSAPVIHCDLKPDNV 107
+ +L SS + D+ L DVA +YL HF IH D+ N
Sbjct: 97 KSFLRENRPRPERPSSLTMKDL---LFCARDVAKGCKYLEENHF------IHRDIAARNC 147
Query: 108 LLDD---NLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSF 164
LL VA ++DFG+A+ + + + I +M PE +G ++ DV+SF
Sbjct: 148 LLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSF 207
Query: 165 GIMLMETFT 173
G++L E F+
Sbjct: 208 GVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-14
Identities = 49/161 (30%), Positives = 72/161 (44%), Gaps = 12/161 (7%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFK--ALVLEYMPHGSLE---KYLYSSNCILDIFQRL 76
E E+ KS + ++K + +E + +EY GSL+ K + +
Sbjct: 49 ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG 108
Query: 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQT 136
I V L YLH S +IH D+KP N+LL L DFG++ L+ S+ T
Sbjct: 109 KIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV---NSLAGT 162
Query: 137 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 177
T T YMAPE + S DV+S G+ L+E + P
Sbjct: 163 FT-GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 3e-14
Identities = 50/170 (29%), Positives = 85/170 (50%), Gaps = 22/170 (12%)
Query: 17 KSFDVECEMM-KSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI------ 69
+ F E E++ K H N+I ++ +C + + L +EY PHG+L +L S +
Sbjct: 40 RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF 99
Query: 70 ---------LDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDF 120
L Q L+ DVA ++YL IH DL N+L+ +N VA ++DF
Sbjct: 100 AIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADF 156
Query: 121 GIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLME 170
G+++ G++ + +T + +MA E +TN DV+S+G++L E
Sbjct: 157 GLSR---GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWE 203
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 4e-14
Identities = 44/151 (29%), Positives = 84/151 (55%), Gaps = 8/151 (5%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMI 80
EC+++K + H N+I+ + ++ +V+EY P G+L +Y+ N +LD L+ +
Sbjct: 49 ECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFV 108
Query: 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDN-LVAYLSDFGIAKLLIGEDQSMTQTQTL 139
+ AL ++H + ++H DLK N+LLD + +V + DFGI+K+L + ++ T +
Sbjct: 109 QILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT---VV 162
Query: 140 ATIGYMAPEYGREGRVSTNGDVYSFGIMLME 170
T Y++PE + D+++ G +L E
Sbjct: 163 GTPCYISPELCEGKPYNQKSDIWALGCVLYE 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-14
Identities = 50/161 (31%), Positives = 83/161 (51%), Gaps = 13/161 (8%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81
E ++K + H +I++ + ++ F +++EY+P G L YL +S + +
Sbjct: 51 EKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF-YASE 109
Query: 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTL-A 140
+ ALEYLH S +++ DLKP+N+LLD L+DFG AK L +T TL
Sbjct: 110 IVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR------DRTWTLCG 160
Query: 141 TIGYMAPE-YGREGRVSTNGDVYSFGIMLMETFTGKKPTYE 180
T Y+APE +G + D ++ GI++ E G P ++
Sbjct: 161 TPEYLAPEVIQSKGH-NKAVDWWALGILIYEMLVGYPPFFD 200
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-14
Identities = 59/262 (22%), Positives = 111/262 (42%), Gaps = 39/262 (14%)
Query: 3 VAVKVFNL----QCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGS 58
V VK F+ E +M + + H+N+++++ C E ++LEY G
Sbjct: 38 VLVKALQKTKDENLQSEFRR---ELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGD 94
Query: 59 LEKYLYSSNCI--------LDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLD 110
L+++L ++ L Q++ + +A +++L +A +H DL N L+
Sbjct: 95 LKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVS 151
Query: 111 DNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLME 170
+S ++K + + + L + ++APE +E ST DV+SFG+++ E
Sbjct: 152 SQREVKVSLLSLSKDVYNSEYYKLR-NALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWE 210
Query: 171 TFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNL 229
FT G+ P Y + E+ N L + E C S ++ L
Sbjct: 211 VFTQGELPFYGLSDEEVL-------------------NRLQAGKLELPVPEGCPSRLYKL 251
Query: 230 AMACTVESPEQRINAKEIVTKL 251
C +P+ R + E+V+ L
Sbjct: 252 MTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 7e-14
Identities = 57/259 (22%), Positives = 112/259 (43%), Gaps = 32/259 (12%)
Query: 3 VAVKVFNLQCG-RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 61
VA+K N R F E +MK ++++++ S + +++E M G L+
Sbjct: 39 VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 98
Query: 62 YLYS---------SNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDN 112
YL S + + + + ++A + YL+ + +H DL N ++ ++
Sbjct: 99 YLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAED 155
Query: 113 LVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETF 172
+ DFG+ + + D + L + +M+PE ++G +T DV+SFG++L E
Sbjct: 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 215
Query: 173 TGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMA 232
T + Y+ + E L+ V++ LL + D C +F L
Sbjct: 216 TLAEQPYQGMSNEQVLRF------------VMEGGLLDKPD-------NCPDMLFELMRM 256
Query: 233 CTVESPEQRINAKEIVTKL 251
C +P+ R + EI++ +
Sbjct: 257 CWQYNPKMRPSFLEIISSI 275
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 7e-14
Identities = 68/268 (25%), Positives = 115/268 (42%), Gaps = 37/268 (13%)
Query: 2 EVAVKVF--NLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKA------LVLEY 53
+VAVK+ ++ + F E MK H N+IK+I K ++L +
Sbjct: 29 KVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPF 88
Query: 54 MPHGSLEKYLYSSNC-----ILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVL 108
M HG L +L S L + + MID+AS +EYL S IH DL N +
Sbjct: 89 MKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCM 145
Query: 109 LDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIML 168
L++N+ ++DFG++K + D + + ++A E + +T+ DV++FG+ +
Sbjct: 146 LNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTM 205
Query: 169 METFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVF 227
E T G+ P N E + ++L + N L Q C+ V+
Sbjct: 206 WEIMTRGQTPYAGVENSE------IYNYL-------IKGNRLKQ-------PPDCLEDVY 245
Query: 228 NLAMACTVESPEQRINAKEIVTKLLKIR 255
L C P+ R + + + +L I
Sbjct: 246 ELMCQCWSPEPKCRPSFQHLRDQLELIW 273
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 7e-14
Identities = 46/156 (29%), Positives = 78/156 (50%), Gaps = 19/156 (12%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81
E ++++ ++H N+I ++ ++ LV E+M LEK + + +L + M+
Sbjct: 52 EIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLM 110
Query: 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLAT 141
LEYLH S ++H DLKP+N+L+ + V L+DFG+A+ ++ MT Q + T
Sbjct: 111 TLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMT-HQ-VVT 165
Query: 142 IGYMAPE-------YGREGRVSTNGDVYSFGIMLME 170
Y APE YG D++S G + E
Sbjct: 166 RWYRAPELLFGARHYG------VGVDMWSVGCIFAE 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 9e-14
Identities = 51/183 (27%), Positives = 93/183 (50%), Gaps = 12/183 (6%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 61
+VAVK +L+ + + E +M+ +H N++++ SS + +V+E++ G+L
Sbjct: 46 QVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD 105
Query: 62 YLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFG 121
+ + ++ Q + + V AL +LH + VIH D+K D++LL + LSDFG
Sbjct: 106 IVTHTR--MNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFG 160
Query: 122 IAKLLIGEDQSMTQTQTLATIGY-MAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYE 180
+ + + + ++L Y MAPE T D++S GIM++E G+ P
Sbjct: 161 FCAQV---SKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP--- 214
Query: 181 FFN 183
+FN
Sbjct: 215 YFN 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-13
Identities = 51/155 (32%), Positives = 76/155 (49%), Gaps = 6/155 (3%)
Query: 25 MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 84
++K+++H L+ + S E VL+Y+ G L +L C L+ R +VAS
Sbjct: 49 LLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVAS 107
Query: 85 ALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGY 144
A+ YLH S +I+ DLKP+N+LLD L+DFG+ K G + T + T Y
Sbjct: 108 AIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKE--GVEPEETTSTFCGTPEY 162
Query: 145 MAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTY 179
+APE R+ D + G +L E G P Y
Sbjct: 163 LAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFY 197
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-13
Identities = 43/156 (27%), Positives = 74/156 (47%), Gaps = 9/156 (5%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81
E +++K + H N+IK++ ++ LV E+M L K + L + +
Sbjct: 48 EIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQ 106
Query: 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLAT 141
+ L + H S ++H DLKP+N+L++ V L+DFG+A+ T + T
Sbjct: 107 LLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGS--PVRPYTHYVVT 161
Query: 142 IGYMAPE--YGREGRVSTNGDVYSFGIMLMETFTGK 175
Y APE G +G ST D++S G + E + +
Sbjct: 162 RWYRAPELLLGDKG-YSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-13
Identities = 66/259 (25%), Positives = 110/259 (42%), Gaps = 32/259 (12%)
Query: 3 VAVKVFNLQCG-RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 61
VAVK N R F E +MK ++++++ S + +V+E M HG L+
Sbjct: 39 VAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKS 98
Query: 62 YLYS-----SNCILDIFQRLNIMI----DVASALEYLHFGCSAPVIHCDLKPDNVLLDDN 112
YL S N L MI ++A + YL+ + +H DL N ++ +
Sbjct: 99 YLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHD 155
Query: 113 LVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETF 172
+ DFG+ + + D + L + +MAPE ++G +T+ D++SFG++L E
Sbjct: 156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEIT 215
Query: 173 TGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMA 232
+ + Y+ + E LK V+D L Q + C V +L
Sbjct: 216 SLAEQPYQGLSNEQVLKF------------VMDGGYLDQ-------PDNCPERVTDLMRM 256
Query: 233 CTVESPEQRINAKEIVTKL 251
C +P+ R EIV L
Sbjct: 257 CWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-13
Identities = 48/163 (29%), Positives = 76/163 (46%), Gaps = 15/163 (9%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGS----LEKYLYSSNCILDIFQRLN 77
E +M + H ++I+++ + + L +E+M GS L KY ++ +N
Sbjct: 53 EIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-----IN 107
Query: 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDN-LVAYLSDFGIAKLLI--GEDQSMT 134
+ L YLH +IH D+K N+L+D ++DFG A L G
Sbjct: 108 YTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEF 164
Query: 135 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 177
Q Q L TI +MAPE R + + DV+S G +++E T K P
Sbjct: 165 QGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-13
Identities = 52/181 (28%), Positives = 92/181 (50%), Gaps = 9/181 (4%)
Query: 1 MEVAVKVFNLQCGRAFK-SFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
++VA+KV + ++ + E E+M + + ++++I C E LV+E G L
Sbjct: 23 IDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEAL-MLVMEMASGGPL 81
Query: 60 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSD 119
K+L + + + +M V+ ++YL +H DL NVLL + A +SD
Sbjct: 82 NKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISD 138
Query: 120 FGIAKLLIGEDQSMTQTQTLAT--IGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKK 176
FG++K L G D S + ++ + + APE + S+ DV+S+GI + E F+ G+K
Sbjct: 139 FGLSKAL-GADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQK 197
Query: 177 P 177
P
Sbjct: 198 P 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-13
Identities = 45/182 (24%), Positives = 82/182 (45%), Gaps = 10/182 (5%)
Query: 4 AVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL 63
A K+ ++ + F VE +++ +H N++ + + E +++E+ G+L+ +
Sbjct: 34 AAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIM 93
Query: 64 YSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 123
L Q + + AL +LH S VIH DLK N+LL + L+DFG++
Sbjct: 94 LELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVS 150
Query: 124 KLLIGEDQSMTQTQTLATIGYMAPEY-----GREGRVSTNGDVYSFGIMLMETFTGKKPT 178
Q + + T +MAPE ++ D++S GI L+E + P
Sbjct: 151 AKNKSTLQK--RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPH 208
Query: 179 YE 180
+E
Sbjct: 209 HE 210
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-13
Identities = 45/176 (25%), Positives = 83/176 (47%), Gaps = 6/176 (3%)
Query: 1 MEVAVKVFNLQCGRAFK-SFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGS 58
M+VAVK+ + + + E ++M + H N++ ++ +C+ ++ EY +G
Sbjct: 66 MKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGD 125
Query: 59 LEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYL 117
L +L L + L+ VA + +L S IH DL NVLL + +
Sbjct: 126 LLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKI 182
Query: 118 SDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 173
DFG+A+ ++ + + + + +MAPE + DV+S+GI+L E F+
Sbjct: 183 CDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-13
Identities = 47/158 (29%), Positives = 77/158 (48%), Gaps = 6/158 (3%)
Query: 25 MMKSIRHRNLIKVISSCSNEEFKALV-LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVA 83
+MK H N++ ++ C E LV L YM HG L ++ S + + + VA
Sbjct: 49 IMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVA 108
Query: 84 SALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLAT-- 141
+EYL S +H DL N +LD++ ++DFG+A+ + ++ T A
Sbjct: 109 KGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP 165
Query: 142 IGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTY 179
+ +MA E + + +T DV+SFG++L E T P Y
Sbjct: 166 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 203
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-13
Identities = 53/173 (30%), Positives = 87/173 (50%), Gaps = 20/173 (11%)
Query: 22 ECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-----NCILDI--- 72
E E+MK I +H+N+I ++ C+ E +++EY G+L ++L + + DI
Sbjct: 67 EMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKV 126
Query: 73 ------FQRL-NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL 125
F+ L + VA +EYL S IH DL NVL+ ++ V ++DFG+A+
Sbjct: 127 PEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARG 183
Query: 126 LIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 177
+ D + + +MAPE + + DV+SFGI++ E FT G P
Sbjct: 184 VHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 6e-13
Identities = 42/163 (25%), Positives = 72/163 (44%), Gaps = 18/163 (11%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS-------SNCILDIFQ 74
E ++ + +I+ S ++ +V+EY +G L K L + + F
Sbjct: 49 EARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFF- 107
Query: 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMT 134
I + L +LH S ++H D+K N+ LD + D G+AKLL D +
Sbjct: 108 -----IQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL--SDNTNF 157
Query: 135 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 177
+ T Y++PE + + DV++ G++L E TGK P
Sbjct: 158 ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 8e-13
Identities = 40/104 (38%), Positives = 54/104 (51%), Gaps = 9/104 (8%)
Query: 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQ 137
I + + ALEYLH S VIH D+KP NVL++ N L DFGI+ L+ S+ +T
Sbjct: 108 IAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLV---DSVAKTI 162
Query: 138 TLATIGYMAPEY----GREGRVSTNGDVYSFGIMLMETFTGKKP 177
YMAPE + DV+S GI ++E TG+ P
Sbjct: 163 DAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 8e-13
Identities = 59/178 (33%), Positives = 89/178 (50%), Gaps = 11/178 (6%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISS--CSNEEFKALVLEYMPHGSL 59
EVA+K NLQ + E +MK +++ N++ + S +E F +V+EY+ GSL
Sbjct: 46 EVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELF--VVMEYLAGGSL 103
Query: 60 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSD 119
+ + C +D Q + + ALE+LH + VIH D+K DNVLL + L+D
Sbjct: 104 TDVV-TETC-MDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTD 158
Query: 120 FGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 177
FG + E QS T + T +MAPE D++S GIM +E G+ P
Sbjct: 159 FGFCAQITPE-QSKRSTM-VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 8e-13
Identities = 52/162 (32%), Positives = 77/162 (47%), Gaps = 6/162 (3%)
Query: 25 MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 84
++K+++H L+ + S + VL+Y+ G L +L C L+ R ++AS
Sbjct: 49 LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIAS 107
Query: 85 ALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGY 144
AL YLH S +++ DLKP+N+LLD L+DFG+ K I E T T T Y
Sbjct: 108 ALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI-EHNGTTST-FCGTPEY 162
Query: 145 MAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEM 186
+APE + D + G +L E G P Y EM
Sbjct: 163 LAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-12
Identities = 51/162 (31%), Positives = 77/162 (47%), Gaps = 6/162 (3%)
Query: 25 MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 84
++K+++H L+ + S + VL+Y+ G L +L + R ++AS
Sbjct: 49 LLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIAS 107
Query: 85 ALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGY 144
AL YLH S +I+ DLKP+N+LLD L+DFG+ K G + S T + T Y
Sbjct: 108 ALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKE--GIEHSKTTSTFCGTPEY 162
Query: 145 MAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEM 186
+APE R+ D + G +L E G P Y EM
Sbjct: 163 LAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (162), Expect = 1e-12
Identities = 39/123 (31%), Positives = 62/123 (50%), Gaps = 6/123 (4%)
Query: 26 MKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASA 85
+K ++H N++K++ E LV EY L+KYL L +IM +
Sbjct: 52 LKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRG 110
Query: 86 LEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYM 145
L Y H S ++H DLKP N+L++ + V L+DFG+A+ ++ T + T+ Y
Sbjct: 111 LAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY--THEVVTLWYR 165
Query: 146 APE 148
APE
Sbjct: 166 APE 168
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-12
Identities = 48/184 (26%), Positives = 89/184 (48%), Gaps = 14/184 (7%)
Query: 1 MEVAVKVFNLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
+ VAVK+ + A F E ++M ++ N+I++++ C + ++ EYM +G L
Sbjct: 47 VLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL 106
Query: 60 EKYL---------YSSNCILDIFQRLNIM-IDVASALEYLHFGCSAPVIHCDLKPDNVLL 109
++L ++ + + L M +AS ++YL S +H DL N L+
Sbjct: 107 NQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLV 163
Query: 110 DDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLM 169
N ++DFG+++ L D Q + + I +M+ E G+ +T DV++FG+ L
Sbjct: 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLW 223
Query: 170 ETFT 173
E T
Sbjct: 224 EILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-12
Identities = 52/169 (30%), Positives = 88/169 (52%), Gaps = 15/169 (8%)
Query: 15 AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQ 74
+ ++F E +MK+++H L+K+ + + E ++ E+M GSL +L S Q
Sbjct: 44 SVEAFLAEANVMKTLQHDKLVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDE---GSKQ 99
Query: 75 RLNIMID----VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 130
L +ID +A + ++ IH DL+ N+L+ +LV ++DFG+A+++ ED
Sbjct: 100 PLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVI--ED 154
Query: 131 QSMTQTQTLA-TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 177
T + I + APE G + DV+SFGI+LME T G+ P
Sbjct: 155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-12
Identities = 42/114 (36%), Positives = 55/114 (48%), Gaps = 19/114 (16%)
Query: 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQ 137
I + AL YL +IH D+KP N+LLD N L DFGI+ L+ S+ +T+
Sbjct: 112 IAVATVKALNYLK--EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV---DSIAKTR 166
Query: 138 TLATIGYMAPEYGREGRVSTNG--------DVYSFGIMLMETFTGKKPTYEFFN 183
YMAPE R+ + DV+S GI L E TGK P Y +N
Sbjct: 167 DAGCRPYMAPE-----RIDPSARDGYDVRSDVWSLGITLYEVATGKFP-YPKWN 214
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-12
Identities = 45/186 (24%), Positives = 86/186 (46%), Gaps = 12/186 (6%)
Query: 3 VAVKVFNLQCG-RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 61
VA+ C + + F E + H N++++ + +V EYM +G+L+
Sbjct: 36 VAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDS 95
Query: 62 YLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFG 121
+L L Q + ++ +AS ++YL +H L VL++ +LV +S F
Sbjct: 96 FLRKHEGQLVAGQLMGMLPGLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFR 152
Query: 122 IAKLLIGEDQSMTQTQTL---ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 177
+ ED+S T+ + + + APE + S+ DV+SFGI++ E + G++P
Sbjct: 153 RLQ----EDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
Query: 178 TYEFFN 183
++
Sbjct: 209 YWDMSG 214
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-12
Identities = 47/187 (25%), Positives = 84/187 (44%), Gaps = 11/187 (5%)
Query: 5 VKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE---K 61
V++F + +A + E +++K + H N+IK ++S +VLE G L K
Sbjct: 35 VQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIK 94
Query: 62 YLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFG 121
+ ++ + + SALE++H S ++H D+KP NV + V L D G
Sbjct: 95 HFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLG 151
Query: 122 IAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEF 181
+ + ++ + T YM+PE E + D++S G +L E + P F
Sbjct: 152 LGRFF--SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP---F 206
Query: 182 FNGEMTL 188
+ +M L
Sbjct: 207 YGDKMNL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-12
Identities = 52/190 (27%), Positives = 86/190 (45%), Gaps = 20/190 (10%)
Query: 19 FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN------CILDI 72
F E + +S++H NL++ + C+ LV+E+ P G L+ YL S
Sbjct: 42 FLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTT 101
Query: 73 FQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQS 132
QR+ ++A L +LH IH DL N LL +L + D+G++ ED
Sbjct: 102 LQRM--ACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156
Query: 133 MTQTQTLATIGYMAPEYGRE--GRV-----STNGDVYSFGIMLMETFT-GKKPTYEFFNG 184
+T Q + ++APE E G + + +V+S G+ + E F G +P Y +
Sbjct: 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP-YRHLSD 215
Query: 185 EMTLKHWVND 194
E L + V +
Sbjct: 216 EQVLTYTVRE 225
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 3e-12
Identities = 46/160 (28%), Positives = 76/160 (47%), Gaps = 18/160 (11%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81
E ++++ +RH N++ + + + LV EY+ LE L +S L + +
Sbjct: 50 EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLE-LLEASPGGLPPDAVRSYIWQ 108
Query: 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLAT 141
+ A+ Y H S +IH D+KP+N+L+ ++ V L DFG A+ L S T +AT
Sbjct: 109 LLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS-PLTDYVAT 164
Query: 142 IGYMAPE-------YGREGRVSTNGDVYSFGIMLMETFTG 174
Y APE YG+ DV++ G ++ E G
Sbjct: 165 RWYRAPELLVGDTNYGKP------VDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 3e-12
Identities = 41/122 (33%), Positives = 57/122 (46%), Gaps = 26/122 (21%)
Query: 78 IMIDVASALEYL---HFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMT 134
+ + + AL YL H VIH D+KP N+LLD + L DFGI+ L+ S
Sbjct: 119 MTVAIVKALHYLKEKH-----GVIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKA 170
Query: 135 QTQTLATIGYMAPEYGREGRVSTN---------GDVYSFGIMLMETFTGKKPTYEFFNGE 185
+T++ YMAPE R+ DV+S GI L+E TG+ P Y+ E
Sbjct: 171 KTRSAGCAAYMAPE-----RIDPPDPNPKYDIRADVWSLGISLVELATGQFP-YKNCKTE 224
Query: 186 MT 187
Sbjct: 225 FE 226
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-12
Identities = 51/187 (27%), Positives = 94/187 (50%), Gaps = 22/187 (11%)
Query: 3 VAVKVFNLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 61
VAVK+ + A F E +++ ++ N+I+++ C +E+ ++ EYM +G L +
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 62 YLYS----------------SNCILDIFQR--LNIMIDVASALEYLHFGCSAPVIHCDLK 103
+L S ++C+ I L++ + +AS ++YL S +H DL
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLA 165
Query: 104 PDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYS 163
N L+ +NL ++DFG+++ L D Q + + I +MA E G+ +T DV++
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWA 225
Query: 164 FGIMLME 170
FG+ L E
Sbjct: 226 FGVTLWE 232
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-12
Identities = 39/130 (30%), Positives = 60/130 (46%), Gaps = 7/130 (5%)
Query: 49 LVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNV 107
LV+ M G L+ ++Y+ + + + LE+LH +++ DLKP+NV
Sbjct: 70 LVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENV 126
Query: 108 LLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIM 167
LLDD+ +SD G+A L G T GYMAPE + + D ++ G
Sbjct: 127 LLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCT 183
Query: 168 LMETFTGKKP 177
L E G+ P
Sbjct: 184 LYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-12
Identities = 43/120 (35%), Positives = 65/120 (54%), Gaps = 19/120 (15%)
Query: 71 DIFQRLN--IMI----------DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLS 118
D+F RL+ +M ++A AL++LH S +I+ DLKP+N+LLD+ L+
Sbjct: 84 DLFTRLSKEVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLT 140
Query: 119 DFGIAKLLIGEDQSMTQTQTLATIGYMAPE-YGREGRVSTNGDVYSFGIMLMETFTGKKP 177
DFG++K I D T+ YMAPE R G + + D +SFG+++ E TG P
Sbjct: 141 DFGLSKESI--DHEKKAYSFCGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 4e-12
Identities = 42/131 (32%), Positives = 68/131 (51%), Gaps = 7/131 (5%)
Query: 49 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVL 108
L+L+Y+ G L +LY + R+ I ++ AL++LH +I+ D+K +N+L
Sbjct: 82 LILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDHLH---QLGIIYRDIKLENIL 137
Query: 109 LDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG--DVYSFGI 166
LD L+DFG++K + E++ + TI YMAPE R G + D +S G+
Sbjct: 138 LDSEGHVVLTDFGLSKEFLAEEEERAYS-FCGTIEYMAPEVIRGGSGGHDKAVDWWSLGV 196
Query: 167 MLMETFTGKKP 177
+ E TG P
Sbjct: 197 LTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-12
Identities = 52/176 (29%), Positives = 85/176 (48%), Gaps = 7/176 (3%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 61
EVA++ NLQ + E +M+ ++ N++ + S + +V+EY+ GSL
Sbjct: 47 EVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD 106
Query: 62 YLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFG 121
+ + C +D Q + + ALE+LH S VIH D+K DN+LL + L+DFG
Sbjct: 107 VV-TETC-MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFG 161
Query: 122 IAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 177
+ E ++ + T +MAPE D++S GIM +E G+ P
Sbjct: 162 FCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 4e-12
Identities = 51/189 (26%), Positives = 84/189 (44%), Gaps = 18/189 (9%)
Query: 19 FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCIL------DI 72
F E + + + H N+++ + C LVLE+ P G L+ YL S+ ++ D+
Sbjct: 42 FLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDV 101
Query: 73 FQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQS 132
QR+ +VAS L +LH A IH DL N L +L + D+G+A ED
Sbjct: 102 LQRM--ACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156
Query: 133 MTQTQTLATIGYMAPEYGRE-------GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGE 185
+T+ + ++APE + +++S G+ + E FT Y + E
Sbjct: 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE 216
Query: 186 MTLKHWVND 194
LK V +
Sbjct: 217 QVLKQVVRE 225
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 5e-12
Identities = 64/265 (24%), Positives = 110/265 (41%), Gaps = 53/265 (20%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 61
V +KV R +F +M + H++L+K+ C +E +V EY+ G L+
Sbjct: 32 SVVLKVLG-SDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDEN-IMVEEYVKFGPLDV 89
Query: 62 YLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLL---DDN----LV 114
+L+ + + +L++ +ASAL YL ++H ++ N+L+ N
Sbjct: 90 FLHREKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPF 146
Query: 115 AYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTN--GDVYSFGIMLMETF 172
LSD GI + +++ + + I ++APE R G+ S D +SFG L+E
Sbjct: 147 IKLSDPGIPITV------LSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEI- 199
Query: 173 TGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCV------SFV 226
NGE P+ST L S E F ++Q + +
Sbjct: 200 --------CSNGE----------EPLST-------LSSSEKERFY-QDQHRLPMPDCAEL 233
Query: 227 FNLAMACTVESPEQRINAKEIVTKL 251
NL C P +R + + I+ L
Sbjct: 234 ANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 6e-12
Identities = 52/179 (29%), Positives = 91/179 (50%), Gaps = 9/179 (5%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 61
+VAVK+ +L+ + + E +M+ +H+N++++ S E +++E++ G+L
Sbjct: 48 QVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTD 107
Query: 62 YLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFG 121
+ S L+ Q + V AL YLH S VIH D+K D++LL + LSDFG
Sbjct: 108 IV--SQTRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFG 162
Query: 122 IAKLLIGEDQSMTQTQTLATIGY-MAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTY 179
+ + + + ++L Y MAPE T D++S GIM++E G+ P +
Sbjct: 163 FCAQI---SKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYF 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 7e-12
Identities = 49/172 (28%), Positives = 80/172 (46%), Gaps = 35/172 (20%)
Query: 22 ECEMMKSIRHRNLIK---VISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILD----- 71
E ++++ +H N+I +I S E F +V E M L K + + + D
Sbjct: 53 EIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIKTQHLSNDHIQYF 111
Query: 72 IFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI-GED 130
++Q L L+Y+H SA V+H DLKP N+LL+ N + DFG+A++ D
Sbjct: 112 LYQILR-------GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD 161
Query: 131 QSMTQTQTLATIGYMAPE-------YGREGRVSTNGDVYSFGIMLMETFTGK 175
+ T+ +AT Y APE Y + D++S G +L E + +
Sbjct: 162 HTGFLTEYVATRWYRAPEIMLNSKGY------TKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 8e-12
Identities = 52/162 (32%), Positives = 77/162 (47%), Gaps = 6/162 (3%)
Query: 25 MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 84
++K+++H L+ + S E VL+++ G L +L + R ++AS
Sbjct: 49 LLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIAS 107
Query: 85 ALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGY 144
AL YLH S +++ DLKP+N+LLD L+DFG+ K G QS T T T Y
Sbjct: 108 ALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKE--GIAQSDTTTTFCGTPEY 162
Query: 145 MAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEM 186
+APE R+ D + G +L E G P Y EM
Sbjct: 163 LAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 8e-12
Identities = 43/133 (32%), Positives = 69/133 (51%), Gaps = 12/133 (9%)
Query: 49 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI---DVASALEYLHFGCSAPVIHCDLKPD 105
L+L+Y+ G + +LY D F + ++ ALE+LH +++ D+K +
Sbjct: 82 LILDYVSGGEMFTHLYQR----DNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLE 134
Query: 106 NVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR-EGRVSTNGDVYSF 164
N+LLD L+DFG++K + E++ T + TI YMAPE R +G D +S
Sbjct: 135 NILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGTIEYMAPEIIRGKGGHGKAVDWWSL 193
Query: 165 GIMLMETFTGKKP 177
GI++ E TG P
Sbjct: 194 GILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 9e-12
Identities = 42/134 (31%), Positives = 67/134 (50%), Gaps = 7/134 (5%)
Query: 49 LVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNV 107
LV+ M G L+ ++Y+ L++ + ++ + + +LH S +++ D+KP+NV
Sbjct: 70 LVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENV 126
Query: 108 LLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIM 167
LLDD LSD G+A L T TQ T GYMAPE +E S D ++ G
Sbjct: 127 LLDDQGNCRLSDLGLAVELKD---GKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCS 183
Query: 168 LMETFTGKKPTYEF 181
+ E G+ P +
Sbjct: 184 IYEMVAGRTPFKDH 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 9e-12
Identities = 42/157 (26%), Positives = 82/157 (52%), Gaps = 7/157 (4%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMI 80
E ++++ + R ++ + + ++ LVL M G L+ ++Y + + +
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAA 109
Query: 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLA 140
++ LE LH +++ DLKP+N+LLDD+ +SD G+A + + E Q++ +
Sbjct: 110 EICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTIKGR--VG 163
Query: 141 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 177
T+GYMAPE + R + + D ++ G +L E G+ P
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-11
Identities = 65/248 (26%), Positives = 114/248 (45%), Gaps = 27/248 (10%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 61
+VAVK +L+ + + E +M+ H N++ + +S + +V+E++ G+L
Sbjct: 49 QVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTD 108
Query: 62 YLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFG 121
+ + ++ Q + + V AL YLH + VIH D+K D++LL + LSDFG
Sbjct: 109 IVTHTR--MNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFG 163
Query: 122 IAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEF 181
+ E + + T +MAPE T D++S GIM++E G+ P +
Sbjct: 164 FCAQVSKEVPK--RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP---Y 218
Query: 182 FNGEMTLKHWVNDWLPISTMEVVDANLLSQ-EDIHFVAKEQCVSFVFNLAMACTVESPEQ 240
FN P+ M + NL + +D H V+ + +L + V P Q
Sbjct: 219 FNEP-----------PLQAMRRIRDNLPPRVKDSHKVS--SVLRGFLDLML---VREPSQ 262
Query: 241 RINAKEIV 248
R A+E++
Sbjct: 263 RATAQELL 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 1e-11
Identities = 55/176 (31%), Positives = 86/176 (48%), Gaps = 7/176 (3%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 61
EVA+K NLQ + E +M+ ++ N++ + S + +V+EY+ GSL
Sbjct: 46 EVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD 105
Query: 62 YLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFG 121
+ + C +D Q + + AL++LH S VIH D+K DN+LL + L+DFG
Sbjct: 106 VV-TETC-MDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFG 160
Query: 122 IAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 177
+ E QS T + T +MAPE D++S GIM +E G+ P
Sbjct: 161 FCAQITPE-QSKRSTM-VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-11
Identities = 50/177 (28%), Positives = 85/177 (48%), Gaps = 10/177 (5%)
Query: 3 VAVKVFNLQCGRAFKSFDV-ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 61
VA+K +L S + E +MK ++H N++++ E LV EYM L+K
Sbjct: 28 VALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM-DKDLKK 86
Query: 62 YL--YSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSD 119
Y+ + LD + + + + H V+H DLKP N+L++ L+D
Sbjct: 87 YMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLAD 143
Query: 120 FGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTGK 175
FG+A+ G + T + + T+ Y AP+ R ST+ D++S G ++ E TG+
Sbjct: 144 FGLAR-AFGIPVN-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-11
Identities = 42/156 (26%), Positives = 80/156 (51%), Gaps = 6/156 (3%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL-EKYLYSSNCILDIFQRLNIMI 80
E ++ ++H N+I + ++ + +EY G+L +K + + + L +
Sbjct: 49 EIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLF 108
Query: 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLA 140
+ SA+ Y+H A ++H D+K N+ L + L DFGI+K+L G + SM +T +
Sbjct: 109 QIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKIL-GSEYSMAET-VVG 163
Query: 141 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKK 176
T YM+PE + + + D+++ G +L E T K+
Sbjct: 164 TPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-11
Identities = 47/178 (26%), Positives = 80/178 (44%), Gaps = 8/178 (4%)
Query: 5 VKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE---K 61
V++F+L +A E +++K + H N+IK +S + +VLE G L K
Sbjct: 35 VQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIK 94
Query: 62 YLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFG 121
+ ++ + + SALE++H S V+H D+KP NV + V L D G
Sbjct: 95 HFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLG 151
Query: 122 IAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTY 179
+ + ++ + T YM+PE E + D++S G +L E + P Y
Sbjct: 152 LGRFF--SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-11
Identities = 52/147 (35%), Positives = 69/147 (46%), Gaps = 30/147 (20%)
Query: 49 LVLEYMPHGSLEKYLYSSNCILDIFQRLNI-MIDVAS--------ALEYLHFGCSAPVIH 99
L+LEY+ G L +L +R I M D A ALE+LH +I+
Sbjct: 77 LILEYLSGGELFMHL----------EREGIFMEDTACFYLSEISLALEHLH---QQGIIY 123
Query: 100 CDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPE-YGREGRVSTN 158
DLKP+N+LLD L+DFG+ K I E ++T T TI YMAPE R G
Sbjct: 124 RDLKPENILLDAQGHVKLTDFGLCKESIHEG-TVTHT-FCGTIEYMAPEILMRSGH-GKA 180
Query: 159 GDVYSFGIMLMETFTGKKPTYEFFNGE 185
D +S G ++ + TG P F E
Sbjct: 181 VDWWSLGALMYDMLTGAPP----FTAE 203
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-11
Identities = 43/136 (31%), Positives = 70/136 (51%), Gaps = 9/136 (6%)
Query: 43 NEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGCSAPVIHCD 101
NE + +E+M GSL++ I ++I + I + V L YL+ ++H D
Sbjct: 74 NENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK--IAVAVVEGLTYLYN--VHRIMHRD 129
Query: 102 LKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 161
+KP N+L++ L DFG++ LI S+ T + T YM+PE + G+ + DV
Sbjct: 130 IKPSNILVNSRGQIKLCDFGVSGELI---NSIADT-FVGTSTYMSPERIQGGKYTVKSDV 185
Query: 162 YSFGIMLMETFTGKKP 177
+S GI ++E GK P
Sbjct: 186 WSLGISIIELALGKFP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-11
Identities = 48/169 (28%), Positives = 86/169 (50%), Gaps = 9/169 (5%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81
E +M+ + + ++++I C E + LV+E G L K+L + + + ++
Sbjct: 46 EANVMQQLDNPYIVRMIGICEAESW-MLVMELAELGPLNKFLQKNKHVTE-KNITELVHQ 103
Query: 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLAT 141
V+ ++YL +H DL NVLL A +SDFG++K L G D++ + +T
Sbjct: 104 VSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKAL-GADENYYKAKTHGK 159
Query: 142 --IGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMT 187
+ + APE + S+ DV+SFG+++ E F+ G+KP E+T
Sbjct: 160 WPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT 208
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 5e-11
Identities = 47/172 (27%), Positives = 81/172 (47%), Gaps = 24/172 (13%)
Query: 22 ECEMMKSIRHRNLIKVI------SSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQR 75
E + +++ +H ++K++ S LV+EYMP L + L L Q
Sbjct: 49 EIKALQACQHPYVVKLLDVFPHGSGFV------LVMEYMPS-DLSEVLRDEERPLPEAQV 101
Query: 76 LNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQ 135
+ M + + Y+H + ++H DLKP N+L+ + V ++DFG+A+L E++
Sbjct: 102 KSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLF-SEEEPRLY 157
Query: 136 TQTLATIGYMAPE--YGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGE 185
+ +AT Y APE YG + D+++ G + E G P F GE
Sbjct: 158 SHQVATRWYRAPELLYGAR-KYDPGVDLWAVGCIFAELLNG-SP---LFPGE 204
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-11
Identities = 51/184 (27%), Positives = 84/184 (45%), Gaps = 15/184 (8%)
Query: 4 AVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL 63
A+KV L+ G F E MMK +H N++ S + + +E+ GSL+ +
Sbjct: 38 AIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQD-I 96
Query: 64 YSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 123
Y L Q + + L YLH S +H D+K N+LL DN L+DFG++
Sbjct: 97 YHVTGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVS 153
Query: 124 KLLIGEDQSMTQTQTLATIG---YMAPEYG---REGRVSTNGDVYSFGIMLMETFTGKKP 177
+ + T + + IG +MAPE R+G + D+++ GI +E + P
Sbjct: 154 AQI-----TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPP 208
Query: 178 TYEF 181
++
Sbjct: 209 MFDL 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 6e-11
Identities = 47/180 (26%), Positives = 83/180 (46%), Gaps = 19/180 (10%)
Query: 11 QCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALV--LEYMPHGSLEKYLYSSNC 68
+ + + + E +++K+++H +++ + K L +EYMP GS++ L +
Sbjct: 43 ETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA 102
Query: 69 ILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG 128
+ + R + + YLH S ++H D+K N+L D L DFG +K L
Sbjct: 103 LTESVTR-KYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158
Query: 129 EDQSMTQTQTLATIGY-MAPE------YGREGRVSTNGDVYSFGIMLMETFTGKKPTYEF 181
S T +++ Y M+PE YGR+ DV+S G ++E T K P E+
Sbjct: 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRK------ADVWSLGCTVVEMLTEKPPWAEY 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 6e-11
Identities = 39/131 (29%), Positives = 60/131 (45%), Gaps = 13/131 (9%)
Query: 50 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLL 109
++EY GS L LD I+ +V LEYLH IH D+K N+LL
Sbjct: 77 IMEYCGGGSCLDLLKP--GKLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILL 131
Query: 110 DDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIG---YMAPEYGREGRVSTNGDVYSFGI 166
+ L+DFG++ L + T ++ +G +MAPE ++ D++S GI
Sbjct: 132 SEEGDVKLADFGVSGQL-----TSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGI 186
Query: 167 MLMETFTGKKP 177
+E G+ P
Sbjct: 187 TAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 7e-11
Identities = 55/176 (31%), Positives = 82/176 (46%), Gaps = 29/176 (16%)
Query: 22 ECEMMKSIRHRNLIK----VISSCSNEEFKA------LVLEYMPH---GSLEKYL--YSS 66
E ++++ + HRN++ V +FK LV EYM H G LE L +S
Sbjct: 56 EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSE 115
Query: 67 NCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 126
+ I ++L L Y H +H D+K N+LL++ L+DFG+A+L
Sbjct: 116 DHIKSFMKQL------LEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLY 166
Query: 127 IGEDQSMTQTQTLATIGYMAPE--YGREGRVSTNGDVYSFGIMLMETFTGKKPTYE 180
E+ T + T+ Y PE G E R DV+S G +L E FT KKP ++
Sbjct: 167 NSEESRP-YTNKVITLWYRPPELLLGEE-RYGPAIDVWSCGCILGELFT-KKPIFQ 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-11
Identities = 40/129 (31%), Positives = 65/129 (50%), Gaps = 7/129 (5%)
Query: 49 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVL 108
+++EY+ GS L + D FQ ++ ++ L+YLH S IH D+K NVL
Sbjct: 79 IIMEYLGGGSALDLLRAGP--FDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVL 133
Query: 109 LDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIML 168
L + L+DFG+A L D + + + T +MAPE ++ + D++S GI
Sbjct: 134 LSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITA 191
Query: 169 METFTGKKP 177
+E G+ P
Sbjct: 192 IELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-11
Identities = 61/247 (24%), Positives = 114/247 (46%), Gaps = 25/247 (10%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMI 80
E ++++ + + ++ + + ++ LVL M G L+ ++Y+ N + + L
Sbjct: 50 EKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAA 109
Query: 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLA 140
++ LE LH ++ DLKP+N+LLDD +SD G+A + I E +S+ +
Sbjct: 110 EILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLA-VKIPEGESIRGR--VG 163
Query: 141 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPIST 200
T+GYMAPE R + + D + G ++ E G+ P F G K V
Sbjct: 164 TVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP----FRGR---KEKVK------- 209
Query: 201 MEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLLKIRDSLLR 260
E VD +L E+++ + + + + + P+QR+ +E +K R R
Sbjct: 210 REEVDRRVLETEEVYSAKFSEEAKSICKMLLT---KDPKQRLGCQEEGAGEVK-RHPFFR 265
Query: 261 NVGGRRI 267
N+ +R+
Sbjct: 266 NMNFKRL 272
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 8e-11
Identities = 49/168 (29%), Positives = 69/168 (41%), Gaps = 35/168 (20%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKA-----LVLEYMPH---GSLEKYLYSSNCILDIF 73
E M+K ++H NL+ +I E F+ LV EY H LEK +
Sbjct: 50 EIRMLKQLKHPNLVNLI-----EVFRRKRKLHLVFEYCDHTVLNELEKNPRG----VPEH 100
Query: 74 QRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSM 133
I+ A+ + H IH D+KP+N+L+ L DFG A++L G
Sbjct: 101 LIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY 157
Query: 134 TQTQTLATIGYMAPE-------YGREGRVSTNGDVYSFGIMLMETFTG 174
T +AT Y APE YG DV++ G + E TG
Sbjct: 158 --TDYVATRWYRAPELLVGDTQYG------PPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 9e-11
Identities = 49/180 (27%), Positives = 82/180 (45%), Gaps = 29/180 (16%)
Query: 52 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDD 111
E+M GSL+ Y +L I + V L YL S ++H D+KP N+L++
Sbjct: 79 EFMDGGSLDVYRKIPEHVLG-----RIAVAVVKGLTYL---WSLKILHRDVKPSNMLVNT 130
Query: 112 NLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMET 171
L DFG++ L+ S+ +T + T YMAPE + + DV+S GI ME
Sbjct: 131 RGQVKLCDFGVSTQLV---NSIAKTY-VGTNAYMAPERISGEQYGIHSDVWSLGISFMEL 186
Query: 172 FTGKKPTYEFFNGEMTLKHWVNDWLPISTME--------VVDANLLSQEDIHFVAKEQCV 223
G+ P + + +L +P+ ++ V+ S++ +HF+ QC+
Sbjct: 187 ALGRFPYPQIQKNQGSL-------MPLQLLQCIVDEDPPVLPVGQFSEKFVHFIT--QCM 237
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 9e-11
Identities = 42/133 (31%), Positives = 66/133 (49%), Gaps = 7/133 (5%)
Query: 49 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVL 108
+++EY+ GS L LD Q I+ ++ L+YLH S IH D+K NVL
Sbjct: 79 IIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH---SEKKIHRDIKAANVL 133
Query: 109 LDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIML 168
L ++ L+DFG+A L D + + + T +MAPE ++ + D++S GI
Sbjct: 134 LSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITA 191
Query: 169 METFTGKKPTYEF 181
+E G+ P E
Sbjct: 192 IELAKGEPPHSEL 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 9e-11
Identities = 48/187 (25%), Positives = 84/187 (44%), Gaps = 11/187 (5%)
Query: 5 VKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE---K 61
V++F + +A + E +++K + H N+IK + S + +VLE G L K
Sbjct: 35 VQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIK 94
Query: 62 YLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFG 121
Y ++ + + SA+E++H S V+H D+KP NV + V L D G
Sbjct: 95 YFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLG 151
Query: 122 IAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEF 181
+ + ++ + T YM+PE E + D++S G +L E + P F
Sbjct: 152 LGRFF--SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP---F 206
Query: 182 FNGEMTL 188
+ +M L
Sbjct: 207 YGDKMNL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-10
Identities = 50/173 (28%), Positives = 84/173 (48%), Gaps = 18/173 (10%)
Query: 20 DVECEMMK------SIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 73
DVEC M++ + H L + + +E V+EY+ G L ++ SS D
Sbjct: 38 DVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSG-RFDEA 96
Query: 74 QRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSM 133
+ ++ L++LH +I+ DLK DNVLLD + ++DFG+ K + +
Sbjct: 97 RARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--- 150
Query: 134 TQTQTL-ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGE 185
+ T T Y+APE + + + + D +SFG++L E G+ P F+GE
Sbjct: 151 GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP----FHGE 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-10
Identities = 44/166 (26%), Positives = 80/166 (48%), Gaps = 26/166 (15%)
Query: 26 MKSIRHRNLIKVISSC----SNEEFK-ALVLEYMPHGSLEKYL-------YSSNCILDIF 73
+++ H N+++++ C ++ E K LV E++ L YL + I D+
Sbjct: 56 LEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLM 114
Query: 74 QRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSM 133
++ L++LH C ++H DLKP+N+L+ L+DFG+A++ M
Sbjct: 115 RQF------LRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY---SCQM 162
Query: 134 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTY 179
T + T+ Y APE + +T D++S G + E F +KP +
Sbjct: 163 ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLF 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 2e-10
Identities = 54/159 (33%), Positives = 78/159 (49%), Gaps = 28/159 (17%)
Query: 31 HRNLIKVISSCSNEEFKA-------LVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMI 80
H N++K+++ KA LV EYM H + N + D+ +R IM
Sbjct: 66 HPNIVKLLNV-----IKAENDKDIYLVFEYMETDLHAVIRA-----NILEDVHKRY-IMY 114
Query: 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL--IGEDQSM-TQTQ 137
+ AL+Y+H S VIH DLKP N+LL+ + L+DFG+A+ L + E+ T
Sbjct: 115 QLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTD 171
Query: 138 TLATIGYMAPEYGREGRVSTNG-DVYSFGIMLMETFTGK 175
+AT Y APE T G D++S G +L E GK
Sbjct: 172 YVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-10
Identities = 63/247 (25%), Positives = 114/247 (46%), Gaps = 27/247 (10%)
Query: 3 VAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKY 62
VAVK +L+ + + E +M+ +H N++++ +S + +V+E++ G+L
Sbjct: 48 VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDI 107
Query: 63 LYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGI 122
+ + ++ Q + + V AL LH + VIH D+K D++LL + LSDFG
Sbjct: 108 VTHTR--MNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGF 162
Query: 123 AKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFF 182
+ E + + T +MAPE D++S GIM++E G+ P +F
Sbjct: 163 CAQVSKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP---YF 217
Query: 183 NGEMTLKHWVNDWLPISTMEVVDANLLSQ-EDIHFVAKEQCVSFVFNLAMACTVESPEQR 241
N P+ M+++ NL + +++H V+ F+ L V P QR
Sbjct: 218 NEP-----------PLKAMKMIRDNLPPKLKNLHKVSP-SLKGFLDRL----LVRDPAQR 261
Query: 242 INAKEIV 248
A E++
Sbjct: 262 ATAAELL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 2e-10
Identities = 39/153 (25%), Positives = 73/153 (47%), Gaps = 11/153 (7%)
Query: 21 VECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI--LDIFQRLNI 78
+E +++++ H ++I++ + + +VL PH S + Y Y + L I Q L I
Sbjct: 106 IEAMLLQNVNHPSVIRMKDTLVSGAITCMVL---PHYSSDLYTYLTKRSRPLPIDQALII 162
Query: 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQT 138
+ L YLH + +IH D+K +N+ ++D + D G A+ + + T
Sbjct: 163 EKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGT 219
Query: 139 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMET 171
+ T APE + ++ D++S GI+L E
Sbjct: 220 VET---NAPEVLARDKYNSKADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 63/226 (27%), Positives = 103/226 (45%), Gaps = 49/226 (21%)
Query: 22 ECEMMKSIRHRNLIK---VISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILD----- 71
E ++++ + H N+I ++ E F +V E M L + + SS + D
Sbjct: 54 EIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQY 112
Query: 72 -IFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED 130
++Q L L+Y+H SA V+H DLKP N+LL+ N + DFG+A+ +
Sbjct: 113 FLYQLLR-------GLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG 162
Query: 131 QSMTQTQTLATIGYMAPE-------YGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFN 183
M T+ + T Y APE Y T DV+S G + E G+KP F
Sbjct: 163 DFM--TEYVVTRWYRAPELLLNCSEYT------TAIDVWSVGCIFAELL-GRKP---LFP 210
Query: 184 GEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNL 229
G K +V+ I E++ + S+ED+ F+ E+ ++ +L
Sbjct: 211 G----KDYVHQLKLI--TELLGSP--SEEDLGFIRNEKARRYIRSL 248
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 2e-10
Identities = 44/159 (27%), Positives = 72/159 (45%), Gaps = 13/159 (8%)
Query: 22 ECEMMKSIRHRNLIK----VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77
E ++ ++RH N+++ V+ + F LV+EY L L + Q
Sbjct: 56 EITLLLNLRHPNIVELKEVVVGKHLDSIF--LVMEYCEQ-DLASLLDNMPTPFSESQVKC 112
Query: 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQ 137
+M+ + L+YLH +IH DLK N+LL D ++DFG+A+ + M T
Sbjct: 113 LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM--TP 167
Query: 138 TLATIGYMAPEYGREGRVSTNG-DVYSFGIMLMETFTGK 175
+ T+ Y APE T D+++ G +L E K
Sbjct: 168 KVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-10
Identities = 45/179 (25%), Positives = 77/179 (43%), Gaps = 21/179 (11%)
Query: 11 QCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCIL 70
CG F + E ++M I+H N++ ++ +F LV++ M L+K + L
Sbjct: 60 MCGIHFTTLR-ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDRKIRL 116
Query: 71 DIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK-----L 125
Q I++ + + L LH +H DL P N+ ++ + ++DFG+A+
Sbjct: 117 TESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPP 173
Query: 126 LIGE--DQSMTQ-----TQTLATIGYMAPE--YGREGRVSTNGDVYSFGIMLMETFTGK 175
Q T + T+ Y APE G E + D++S G + E TGK
Sbjct: 174 YSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAE-KYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-10
Identities = 51/181 (28%), Positives = 86/181 (47%), Gaps = 10/181 (5%)
Query: 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKA-LVLEYMPHGSL 59
M+V K +Q + + E ++++ IR + + + K L+L+Y+ G L
Sbjct: 33 MKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGEL 92
Query: 60 EKYLYSSNCILDIFQRLNIMI-DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLS 118
+L + Q + I ++ ALE+LH +I+ D+K +N+LLD N L+
Sbjct: 93 FTHLSQRERFKE--QEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLT 147
Query: 119 DFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG--DVYSFGIMLMETFTGKK 176
DFG++K ED+ TI YMAP+ R G + D +S G+++ E TG
Sbjct: 148 DFGLSKEFH-EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGAS 206
Query: 177 P 177
P
Sbjct: 207 P 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-10
Identities = 52/185 (28%), Positives = 85/185 (45%), Gaps = 17/185 (9%)
Query: 4 AVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL 63
AVK+ L+ G F E M+K +H N++ S + E + +EY GSL+ +
Sbjct: 38 AVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQD-I 96
Query: 64 YSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 123
Y L Q + + L YLH S +H D+K N+LL DN L+DFG+A
Sbjct: 97 YHVTGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVA 153
Query: 124 KLLIGEDQSMTQTQT-LATIGYMAPEYGREGRVSTNG------DVYSFGIMLMETFTGKK 176
+ ++ + ++ + T +MAPE V NG D+++ GI +E +
Sbjct: 154 AKITA---TIAKRKSFIGTPYWMAPEV---AAVEKNGGYNQLCDIWAVGITAIELAELQP 207
Query: 177 PTYEF 181
P ++
Sbjct: 208 PMFDL 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-10
Identities = 55/194 (28%), Positives = 90/194 (46%), Gaps = 24/194 (12%)
Query: 2 EVAVKV--FNLQCGRAFKSFD-VECE--MMKSIRHRNLIKVISSCSNEEFKALVL--EYM 54
E+AVK F+ K + +ECE ++K++RH +++ + E K L + EYM
Sbjct: 29 ELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYM 88
Query: 55 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLV 114
P GS++ L + + + R + + YLH S ++H D+K N+L D
Sbjct: 89 PGGSIKDQLKAYGALTENVTR-RYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGN 144
Query: 115 AYLSDFGIAKLLIGEDQSMTQTQTLATIGY-MAPE------YGREGRVSTNGDVYSFGIM 167
L DFG +K + S T +++ Y M+PE YGR+ DV+S
Sbjct: 145 VKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRK------ADVWSVACT 198
Query: 168 LMETFTGKKPTYEF 181
++E T K P E+
Sbjct: 199 VVEMLTEKPPWAEY 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 4e-10
Identities = 49/190 (25%), Positives = 75/190 (39%), Gaps = 33/190 (17%)
Query: 19 FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78
E +++ ++K+ S +EE LV+EYMP G L L + + R I
Sbjct: 48 VRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYI 107
Query: 79 MIDVASALEYLH-FGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQ 137
++ AL+ +H G IH D+KPDN+L+D + L+DFG+ K +
Sbjct: 108 A-ELVLALDSVHKLGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLN 162
Query: 138 ---------------------------TLATIGYMAPEYGREGRVSTNGDVYSFGIMLME 170
T+ T Y+APE R D +S G++L E
Sbjct: 163 DSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222
Query: 171 TFTGKKPTYE 180
G P Y
Sbjct: 223 MLYGFPPFYS 232
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 5e-10
Identities = 47/165 (28%), Positives = 78/165 (47%), Gaps = 21/165 (12%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK-------YLYSSNCILDIFQ 74
E ++ ++H N++ +S +V+EY G L K L+S + IL F
Sbjct: 49 EVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF- 107
Query: 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDN-LVAYLSDFGIAKLLIGEDQSM 133
+ ++ L+++H ++H D+K N+ L N +VA L DFGIA+ L + SM
Sbjct: 108 -----VQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL---NDSM 156
Query: 134 TQTQTLA-TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 177
T T Y++PE + + D++S G +L E T K P
Sbjct: 157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 5e-10
Identities = 49/178 (27%), Positives = 83/178 (46%), Gaps = 23/178 (12%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI--M 79
E +++ + + L+K++ + ++E+ L +EY+P G L + + + R + M
Sbjct: 51 ERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEM 110
Query: 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTL 139
+ AL L + IH DLKP+N L+D + L+DFG++K ++ S+ +
Sbjct: 111 FEAVDALHELGY------IHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV-----V 159
Query: 140 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGE------MTLKHW 191
+ YMAPE R D +S G ML E G P F+G LK+W
Sbjct: 160 GSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP----FSGSTPNETWENLKYW 213
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 6e-10
Identities = 38/133 (28%), Positives = 68/133 (51%), Gaps = 11/133 (8%)
Query: 22 ECEMMKSIRHRNL--IKVISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRLN 77
E ++++ +H N+ I+ I +FK +V++ M L ++S + + R
Sbjct: 54 ELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRY- 111
Query: 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG--EDQSMTQ 135
+ + L+Y+H SA VIH DLKP N+L++++ + DFG+A+ L +
Sbjct: 112 FLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFM 168
Query: 136 TQTLATIGYMAPE 148
T+ +AT Y APE
Sbjct: 169 TEYVATRWYRAPE 181
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 7e-10
Identities = 47/164 (28%), Positives = 74/164 (45%), Gaps = 12/164 (7%)
Query: 20 DVECEMMK------SIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 73
DV+C M + + +H L + ++ V+EY+ G L + S +
Sbjct: 38 DVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPR 97
Query: 74 QRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSM 133
R +V AL +LH VI+ DLK DN+LLD L+DFG+ K I +
Sbjct: 98 SRF-YAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--V 151
Query: 134 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 177
T T T Y+APE +E + D ++ G+++ E G+ P
Sbjct: 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 7e-10
Identities = 43/156 (27%), Positives = 76/156 (48%), Gaps = 8/156 (5%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMI 80
E ++K + H N++K++ E LV E++ H L+K++ +S + + + +
Sbjct: 49 EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLF 107
Query: 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLA 140
+ L + H S V+H DLKP N+L++ L+DFG+A+ T T +
Sbjct: 108 QLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVV 162
Query: 141 TIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTGK 175
T+ Y APE + ST D++S G + E T +
Sbjct: 163 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 7e-10
Identities = 42/130 (32%), Positives = 69/130 (53%), Gaps = 7/130 (5%)
Query: 49 LVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNV 107
LVL M G L+ ++Y+ N D + + ++ LE LH +++ DLKP+N+
Sbjct: 77 LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENI 133
Query: 108 LLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIM 167
LLDD +SD G+A + I E +++ + T+GYMAPE + R + + D + G +
Sbjct: 134 LLDDYGHIRISDLGLA-VEIPEGETIRGR--VGTVGYMAPEVVKNERYTFSPDWWGLGCL 190
Query: 168 LMETFTGKKP 177
+ E GK P
Sbjct: 191 IYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 8e-10
Identities = 47/165 (28%), Positives = 85/165 (51%), Gaps = 14/165 (8%)
Query: 20 DVECEMMK------SIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 73
DVEC M++ + H L + + +E V+EY+ G L ++ S + D+
Sbjct: 38 DVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCH-KFDLP 96
Query: 74 QRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL-LIGEDQS 132
+ ++ L++LH S +++ DLK DN+LLD + ++DFG+ K ++G+ ++
Sbjct: 97 RATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT 153
Query: 133 MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 177
T T Y+APE + +T+ D +SFG++L E G+ P
Sbjct: 154 CT---FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 8e-10
Identities = 51/228 (22%), Positives = 95/228 (41%), Gaps = 45/228 (19%)
Query: 25 MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 84
MM + K+ S ++++ LV+EY+ G + + + + + + + +V
Sbjct: 50 MMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK-QYIAEVVL 108
Query: 85 ALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGY 144
+E LH +IH D+KP+N+L+D L+DFG+++ G + + T Y
Sbjct: 109 GVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSR--NGL----ENKKFVGTPDY 159
Query: 145 MAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVV 204
+APE D +S G ++ E G P F+ E T + V
Sbjct: 160 LAPETILGVGDDKMSDWWSLGCVIFEFLFGYPP----FHAE--------------TPDAV 201
Query: 205 DANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLL 252
N+LS+ I++ + + SPE A +++ +LL
Sbjct: 202 FDNILSR-RINWPEEVK------------EFCSPE----AVDLINRLL 232
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 9e-10
Identities = 48/172 (27%), Positives = 76/172 (44%), Gaps = 16/172 (9%)
Query: 20 DVECEMM-KSI-----RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 73
DVEC M K + +H L ++ S ++ V+EY+ G L ++ S D
Sbjct: 38 DVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG-RFDEP 96
Query: 74 QRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSM 133
+ ++ L++LH +I+ DLK DNVLLD ++DFG+ K I
Sbjct: 97 RARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-- 151
Query: 134 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGE 185
T + T Y+APE D ++ G++L E G+ P F G+
Sbjct: 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSP----FEGD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-09
Identities = 47/173 (27%), Positives = 89/173 (51%), Gaps = 18/173 (10%)
Query: 20 DVECEMMK----SIRHRN--LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 73
DVEC M++ ++ N L + + +E V+E++ G L ++ D++
Sbjct: 38 DVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKG-RFDLY 96
Query: 74 QRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL-LIGEDQS 132
+ ++ L++LH S +I+ DLK DNV+LD + ++DFG+ K + G++++
Sbjct: 97 RATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA 153
Query: 133 MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGE 185
T T Y+APE + + + + D +SFG++L E G+ P F+G+
Sbjct: 154 ST---FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP----FHGD 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-09
Identities = 43/158 (27%), Positives = 74/158 (46%), Gaps = 6/158 (3%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81
E ++K+ RH L + S ++ V+EY+ G L +L + R +
Sbjct: 45 ESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF-YGAE 103
Query: 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLAT 141
+ SAL+YLH S +++ DLK +N++LD + ++DFG+ K G + T T
Sbjct: 104 IVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKE--GITDAATMKTFCGT 158
Query: 142 IGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTY 179
Y+APE + D + G+++ E G+ P Y
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-09
Identities = 60/259 (23%), Positives = 106/259 (40%), Gaps = 31/259 (11%)
Query: 3 VAVKVFNLQCG-RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 61
VA+K +A K E +M S+ + ++ +++ C + L+ + MP G L
Sbjct: 39 VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLD 97
Query: 62 YLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFG 121
Y+ + LN + +A + YL ++H DL NVL+ ++DFG
Sbjct: 98 YVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFG 154
Query: 122 IAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTYE 180
+AKLL +++ I +MA E + DV+S+G+ + E T G KP
Sbjct: 155 LAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY-- 212
Query: 181 FFNGEMTLKHWVNDWLPISTMEVV--DANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238
D +P S + + L Q I C V+ + + C +
Sbjct: 213 -------------DGIPASEISSILEKGERLPQPPI-------CTIDVYMIMVKCWMIDA 252
Query: 239 EQRINAKEIVTKLLKI-RD 256
+ R +E++ + K+ RD
Sbjct: 253 DSRPKFRELIIEFSKMARD 271
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-09
Identities = 39/127 (30%), Positives = 63/127 (49%), Gaps = 7/127 (5%)
Query: 51 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLD 110
+E+M GSL++ L + I + I I V L YL ++H D+KP N+L++
Sbjct: 78 MEHMDGGSLDQVLKKAGRIPENILG-KISIAVLRGLTYLREKHK--IMHRDVKPSNILVN 134
Query: 111 DNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLME 170
L DFG++ LI SM + + T YM+PE + + D++S G+ L+E
Sbjct: 135 SRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVE 190
Query: 171 TFTGKKP 177
G+ P
Sbjct: 191 MAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-09
Identities = 45/175 (25%), Positives = 78/175 (44%), Gaps = 12/175 (6%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLE-YMPHGSLEKYLYSSNCI-------LDIF 73
E ++ + H+N++ ++ C + VL YM G+L+ +L L
Sbjct: 58 ESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQ 117
Query: 74 QRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSM 133
Q +++ I +A + YLH VIH D+ N ++D+ L ++D +++ L D
Sbjct: 118 QLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHC 174
Query: 134 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMT 187
+ +MA E S+ DV+SFG++L E T G+ P E EM
Sbjct: 175 LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA 229
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-09
Identities = 32/104 (30%), Positives = 54/104 (51%), Gaps = 3/104 (2%)
Query: 70 LDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 129
L L+ VA +E+L S +H DL NVLL + + DFG+A+ ++ +
Sbjct: 234 LTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHD 290
Query: 130 DQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 173
+++ T + +MAPE + +T DV+S+GI+L E F+
Sbjct: 291 SNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-09
Identities = 44/151 (29%), Positives = 78/151 (51%), Gaps = 12/151 (7%)
Query: 34 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGC 93
++++ + ++++ +V+EYMP G L L S+ + + + + +V AL+ +H
Sbjct: 105 VVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKF-YTAEVVLALDAIH--- 159
Query: 94 SAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQT-LATIGYMAPEY--- 149
S +IH D+KPDN+LLD + L+DFG + ++ M + T + T Y++PE
Sbjct: 160 SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM--DETGMVRCDTAVGTPDYISPEVLKS 217
Query: 150 -GREGRVSTNGDVYSFGIMLMETFTGKKPTY 179
G +G D +S G+ L E G P Y
Sbjct: 218 QGGDGYYGRECDWWSVGVFLFEMLVGDTPFY 248
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 3e-09
Identities = 47/181 (25%), Positives = 82/181 (45%), Gaps = 22/181 (12%)
Query: 5 VKVFN--LQCGRAFKSFDVECEMMKSIRHRNLIKVIS-------SCSNEEFKALVLEYMP 55
VF + C R F+ E +M+ +H N++ + E + V+ +
Sbjct: 34 PNVFQNLVSCKRVFR----ELKMLCFFKHDNVLSALDILQPPHIDPFEEIY---VVTELM 86
Query: 56 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVA 115
L K + S + ++ + + L+YLH SA ++H D+KP N+L++ N V
Sbjct: 87 QSDLHKIIVSPQPLSSDHVKV-FLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVL 142
Query: 116 YLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG-DVYSFGIMLMETFTG 174
+ DFG+A++ D+S TQ + T Y APE R T+ D++S G + E
Sbjct: 143 KICDFGLARVE-EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGR 201
Query: 175 K 175
+
Sbjct: 202 R 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 3e-09
Identities = 46/141 (32%), Positives = 67/141 (47%), Gaps = 22/141 (15%)
Query: 49 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVL 108
+V+EYMP G L L S+ I + + R +V AL+ +H S IH D+KPDN+L
Sbjct: 120 MVMEYMPGGDLVN-LMSNYDIPEKWARFYTA-EVVLALDAIH---SMGFIHRDVKPDNML 174
Query: 109 LDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPE----------YGREGRVSTN 158
LD + L+DFG + + + + + T Y++PE YGRE
Sbjct: 175 LDKSGHLKLADFGTC-MKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRE------ 227
Query: 159 GDVYSFGIMLMETFTGKKPTY 179
D +S G+ L E G P Y
Sbjct: 228 CDWWSVGVFLYEMLVGDTPFY 248
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 4e-09
Identities = 47/144 (32%), Positives = 70/144 (48%), Gaps = 16/144 (11%)
Query: 48 ALVLEYMPHGSLEKYLYSSNCILDIFQRLN---IMIDVASALEYLHFGCSAPVIHCDLKP 104
ALVL+Y G L + + S F+ + I V A+ ++H S +IH D+K
Sbjct: 115 ALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKS 171
Query: 105 DNVLLDDNLVAYLSDFGIAKLL---IGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 161
N+LL N + L DFG +K+ + +D T T Y+APE R S D+
Sbjct: 172 ANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT---FCGTPYYVAPEIWRRKPYSKKADM 228
Query: 162 YSFGIMLMETFTGKKPTYEFFNGE 185
+S G++L E T K+P F+GE
Sbjct: 229 FSLGVLLYELLTLKRP----FDGE 248
|
Length = 496 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 4e-09
Identities = 64/248 (25%), Positives = 101/248 (40%), Gaps = 52/248 (20%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKA-LVLEYMPHGSLEKYLYSSNCILDIFQR----- 75
E ++ +RH N I+ C E A LV+EY L S++ IL++ ++
Sbjct: 65 EVRFLQQLRHPNTIE-YKGCYLREHTAWLVMEYC--------LGSASDILEVHKKPLQEV 115
Query: 76 --LNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSM 133
I L YLH S IH D+K N+LL + L+DFG A L +
Sbjct: 116 EIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASL-------V 165
Query: 134 TQTQT-LATIGYMAPEY---GREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLK 189
+ + + T +MAPE EG+ DV+S GI +E +KP N L
Sbjct: 166 SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPLFNMNAMSALY 224
Query: 190 HWV-NDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIV 248
H ND +S+ + S +FV C + P+ R +++E++
Sbjct: 225 HIAQNDSPTLSSND------WSDYFRNFVDS-------------CLQKIPQDRPSSEELL 265
Query: 249 TKLLKIRD 256
+R+
Sbjct: 266 KHRFVLRE 273
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 5e-09
Identities = 41/132 (31%), Positives = 64/132 (48%), Gaps = 8/132 (6%)
Query: 49 LVLEYMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPD 105
LV+ M G L ++Y+ N + + S LE+LH +I+ DLKP+
Sbjct: 70 LVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPE 126
Query: 106 NVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFG 165
NVLLD++ +SD G+A L + QS T+ T G+MAPE + + D ++ G
Sbjct: 127 NVLLDNDGNVRISDLGLAVELK-DGQSKTKGYA-GTPGFMAPELLQGEEYDFSVDYFALG 184
Query: 166 IMLMETFTGKKP 177
+ L E + P
Sbjct: 185 VTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 5e-09
Identities = 43/150 (28%), Positives = 75/150 (50%), Gaps = 10/150 (6%)
Query: 34 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGC 93
++++ + ++ + +V+EYMP G L L S+ + + + R +V AL+ +H
Sbjct: 105 VVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARF-YTAEVVLALDAIH--- 159
Query: 94 SAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEY---- 149
S IH D+KPDN+LLD + L+DFG + + ++ + + T Y++PE
Sbjct: 160 SMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDTAVGTPDYISPEVLKSQ 218
Query: 150 GREGRVSTNGDVYSFGIMLMETFTGKKPTY 179
G +G D +S G+ L E G P Y
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 5e-09
Identities = 53/173 (30%), Positives = 81/173 (46%), Gaps = 25/173 (14%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81
E ++K ++H N++ + E L+ E++ L+KYL S +D
Sbjct: 49 EISLLKELQHPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSL--------PKGQYMD 99
Query: 82 VASALEYLH-------FGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMT 134
YL+ F S V+H DLKP N+L+D+ V L+DFG+A+ G +
Sbjct: 100 AELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLAR-AFGIPVRV- 157
Query: 135 QTQTLATIGYMAPE--YGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGE 185
T + T+ Y APE G R ST D++S G + E T KKP F+G+
Sbjct: 158 YTHEVVTLWYRAPEVLLGSP-RYSTPVDIWSIGTIFAEMAT-KKP---LFHGD 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 6e-09
Identities = 36/109 (33%), Positives = 57/109 (52%), Gaps = 4/109 (3%)
Query: 70 LDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 129
LD+ L VA +++L S IH D+ NVLL D VA + DFG+A+ ++ +
Sbjct: 209 LDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265
Query: 130 DQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 177
+ + + +MAPE + + DV+S+GI+L E F+ GK P
Sbjct: 266 SNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-09
Identities = 50/194 (25%), Positives = 88/194 (45%), Gaps = 24/194 (12%)
Query: 2 EVAVKVFNL-----QCGRAFKSFDVECEMMKSIRHRNLIKVISSCSN--EEFKALVLEYM 54
E+AVK + + + + E +++K++ H +++ + E ++ +E+M
Sbjct: 29 ELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHM 88
Query: 55 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLV 114
P GS++ L S + + R + + YLH S ++H D+K N+L D
Sbjct: 89 PGGSIKDQLKSYGALTENVTR-KYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGN 144
Query: 115 AYLSDFGIAKLLIGEDQSMTQTQTLATIGY-MAPE------YGREGRVSTNGDVYSFGIM 167
L DFG +K L S T +++ Y M+PE YGR+ D++S G
Sbjct: 145 VKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRK------ADIWSVGCT 198
Query: 168 LMETFTGKKPTYEF 181
++E T K P EF
Sbjct: 199 VVEMLTEKPPWAEF 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 6e-09
Identities = 37/105 (35%), Positives = 55/105 (52%), Gaps = 12/105 (11%)
Query: 85 ALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQ---TQTLAT 141
L+Y+H SA V+H DLKP N+L++ + + DFG+A+ E+ T+ +AT
Sbjct: 117 GLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLAR-GFSENPGENAGFMTEYVAT 172
Query: 142 IGYMAPEYGREGRVSTNG-DVYSFGIMLMETFTGKKPTYEFFNGE 185
Y APE + T DV+S G +L E G+KP F G+
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAE-LLGRKP---VFKGK 213
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 7e-09
Identities = 33/97 (34%), Positives = 52/97 (53%), Gaps = 4/97 (4%)
Query: 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLAT 141
VA +E+L S IH DL N+LL +N V + DFG+A+ + + + +
Sbjct: 182 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 142 IGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 177
+ +MAPE + +T DV+SFG++L E F+ G P
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 275
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 8e-09
Identities = 34/119 (28%), Positives = 59/119 (49%), Gaps = 3/119 (2%)
Query: 55 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLV 114
P + L + + L + VA+ +E+L S +H DL NVL+ + +
Sbjct: 221 PERTRRDTLINESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKL 277
Query: 115 AYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 173
+ DFG+A+ ++ + +++ T + +MAPE +T DV+SFGI+L E FT
Sbjct: 278 VKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 8e-09
Identities = 53/258 (20%), Positives = 98/258 (37%), Gaps = 45/258 (17%)
Query: 6 KVFNLQCGRAFKSFDVECEMMKSIRHRNLIKV----ISSCSNEEFKALVLEYMPHGSLEK 61
K F+ + E + ++ I N++K+ I + +L+LEY G L +
Sbjct: 52 KKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLRE 111
Query: 62 YLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFG 121
L L +L++ ID L L+ + P + +L + L+ +N
Sbjct: 112 VLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTEN--------Y 160
Query: 122 IAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTN--------GDVYSFGIMLMETFT 173
K++ + + + + +M Y ++ + D+YS G++L E FT
Sbjct: 161 KLKIICHGLEKILSSPPFKNVNFMV--Y-FSYKMLNDIFSEYTIKDDIYSLGVVLWEIFT 217
Query: 174 GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMAC 233
GK P F ++T E+ D L+ ++ C + + AC
Sbjct: 218 GKIP----FEN-------------LTTKEIYD--LIINKNNSLKLPLDCPLEIKCIVEAC 258
Query: 234 TVESPEQRINAKEIVTKL 251
T +R N KEI+ L
Sbjct: 259 TSHDSIKRPNIKEILYNL 276
|
Length = 283 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 9e-09
Identities = 50/189 (26%), Positives = 84/189 (44%), Gaps = 36/189 (19%)
Query: 3 VAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 60
VA+KV +++ G F + E ++K ++H N++ + +E V EYM H L
Sbjct: 33 VALKVISMKTEEGVPFTAIR-EASLLKGLKHANIVLLHDIIHTKETLTFVFEYM-HTDLA 90
Query: 61 KY-------LYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNL 113
+Y L+ N L +FQ L L Y+H ++H DLKP N+L+
Sbjct: 91 QYMIQHPGGLHPYNVRLFMFQLLR-------GLAYIH---GQHILHRDLKPQNLLISYLG 140
Query: 114 VAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP-------EYGREGRVSTNGDVYSFGI 166
L+DFG+A+ S T + + T+ Y P +Y S+ D++ G
Sbjct: 141 ELKLADFGLAR--AKSIPSQTYSSEVVTLWYRPPDVLLGATDY------SSALDIWGAGC 192
Query: 167 MLMETFTGK 175
+ +E G+
Sbjct: 193 IFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-08
Identities = 47/142 (33%), Positives = 68/142 (47%), Gaps = 8/142 (5%)
Query: 49 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVL 108
LVL ++ G L +L D+ + ++ ALE LH VI+ DLKP+N+L
Sbjct: 70 LVLAFINGGELFHHLQREGR-FDLSRARFYTAELLCALENLH---KFNVIYRDLKPENIL 125
Query: 109 LDDNLVAYLSDFGIAKLLIGEDQSMTQTQTL-ATIGYMAPEYGREGRVSTNGDVYSFGIM 167
LD L DFG+ KL + +D +T T T Y+APE + D ++ G++
Sbjct: 126 LDYQGHIALCDFGLCKLNMKDDD---KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVL 182
Query: 168 LMETFTGKKPTYEFFNGEMTLK 189
L E TG P Y+ EM K
Sbjct: 183 LYEMLTGLPPFYDENVNEMYRK 204
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-08
Identities = 53/182 (29%), Positives = 83/182 (45%), Gaps = 24/182 (13%)
Query: 3 VAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 60
VA+KV LQ G F + E ++K ++H N++ + +E LV EY+ H L
Sbjct: 33 VALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLHDIIHTKETLTLVFEYV-HTDLC 90
Query: 61 KY-------LYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNL 113
+Y L+ N L +FQ L L Y+H ++H DLKP N+L+ D
Sbjct: 91 QYMDKHPGGLHPENVKLFLFQLLR-------GLSYIH---QRYILHRDLKPQNLLISDTG 140
Query: 114 VAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPE-YGREGRVSTNGDVYSFGIMLMETF 172
L+DFG+A+ S T + + T+ Y P+ ST D++ G + +E
Sbjct: 141 ELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMI 198
Query: 173 TG 174
G
Sbjct: 199 QG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-08
Identities = 40/131 (30%), Positives = 68/131 (51%), Gaps = 9/131 (6%)
Query: 48 ALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDN 106
++ +E+M GSL++ L + I +I +++I V L YL ++H D+KP N
Sbjct: 79 SICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA--VLRGLAYLRE--KHQIMHRDVKPSN 134
Query: 107 VLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGI 166
+L++ L DFG++ LI SM + + T YM+PE + S D++S G+
Sbjct: 135 ILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQGTHYSVQSDIWSMGL 190
Query: 167 MLMETFTGKKP 177
L+E G+ P
Sbjct: 191 SLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-08
Identities = 33/97 (34%), Positives = 52/97 (53%), Gaps = 4/97 (4%)
Query: 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLAT 141
VA +E+L S IH DL N+LL +N V + DFG+A+ + + + +
Sbjct: 183 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 142 IGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 177
+ +MAPE + +T DV+SFG++L E F+ G P
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-08
Identities = 47/183 (25%), Positives = 86/183 (46%), Gaps = 10/183 (5%)
Query: 4 AVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL 63
A KV + + + VE E++ + H ++K++ + + +++E+ P G+++ +
Sbjct: 41 AAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIM 100
Query: 64 YSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 123
+ L Q I + AL+YLH S +IH DLK NVLL + L+DFG++
Sbjct: 101 LELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVS 157
Query: 124 KLLIGEDQSMTQTQTLATIGYMAPEY-----GREGRVSTNGDVYSFGIMLMETFTGKKPT 178
+ Q + + T +MAPE ++ D++S GI L+E + P
Sbjct: 158 AKNVKTLQR--RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH 215
Query: 179 YEF 181
+E
Sbjct: 216 HEL 218
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-08
Identities = 41/157 (26%), Positives = 79/157 (50%), Gaps = 7/157 (4%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMI 80
E +++ + R ++ + + ++ LVL M G L+ ++Y+ N D + +
Sbjct: 50 EKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAA 109
Query: 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLA 140
++ LE L +++ DLKP+N+LLDD +SD G+A + I E +++ +
Sbjct: 110 ELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLA-VQIPEGETV--RGRVG 163
Query: 141 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 177
T+GYMAPE + + + D + G ++ E G+ P
Sbjct: 164 TVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-08
Identities = 32/97 (32%), Positives = 51/97 (52%), Gaps = 4/97 (4%)
Query: 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLAT 141
VA +E+L S IH DL N+LL +N V + DFG+A+ + + + +
Sbjct: 188 VAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 142 IGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 177
+ +MAPE + + DV+SFG++L E F+ G P
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-08
Identities = 55/197 (27%), Positives = 89/197 (45%), Gaps = 37/197 (18%)
Query: 3 VAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVI------SSCSNEEFKAL------- 49
VAVK L ++ K E ++++ + H N++KV S E+ +L
Sbjct: 33 VAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVY 92
Query: 50 -VLEYMP---HGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKP 104
V EYM LE+ S L ++Q L L+Y+H SA V+H DLKP
Sbjct: 93 IVQEYMETDLANVLEQGPLSEEHARLFMYQLLR-------GLKYIH---SANVLHRDLKP 142
Query: 105 DNVLLD-DNLVAYLSDFGIAKLLIGEDQSMTQ----TQTLATIGYMAPEYGREGRVSTNG 159
NV ++ ++LV + DFG+A+++ D + ++ L T Y +P T
Sbjct: 143 ANVFINTEDLVLKIGDFGLARIV---DPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKA 199
Query: 160 -DVYSFGIMLMETFTGK 175
D+++ G + E TGK
Sbjct: 200 IDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 2e-08
Identities = 33/137 (24%), Positives = 65/137 (47%), Gaps = 14/137 (10%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNE-----EFKA---LVLEYMPHGSLEKYLYSSNCILDIF 73
E ++++ ++H N++ +I C + +K LV E+ H L L + N +
Sbjct: 61 EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLS 119
Query: 74 QRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK--LLIGEDQ 131
+ +M + + L Y+H ++H D+K N+L+ + + L+DFG+A+ L +
Sbjct: 120 EIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSK 176
Query: 132 SMTQTQTLATIGYMAPE 148
T + T+ Y PE
Sbjct: 177 PNRYTNRVVTLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 36/118 (30%), Positives = 55/118 (46%), Gaps = 19/118 (16%)
Query: 76 LNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQ---- 131
L+I + + +EY+H S V+H DLKPDN+LL + D+G A E++
Sbjct: 116 LSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172
Query: 132 -----------SMTQT-QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 177
SMT + + T YMAPE S + D+Y+ G++L + T P
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 2e-08
Identities = 43/155 (27%), Positives = 77/155 (49%), Gaps = 17/155 (10%)
Query: 26 MKSIRHRNLIKVISSC----SNEEFK-ALVLEYMPHGSLEKYLYSSNCI---LDIFQRLN 77
++S H N+++++ C ++ E K LV E++ L YL S C L +
Sbjct: 55 LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYL--SKCPKPGLPPETIKD 111
Query: 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQ 137
+M + +++LH S ++H DLKP N+L+ + ++DFG+A++ M T
Sbjct: 112 LMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIY---SFEMALTS 165
Query: 138 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETF 172
+ T+ Y APE + +T D++S G + E F
Sbjct: 166 VVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELF 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-08
Identities = 48/162 (29%), Positives = 78/162 (48%), Gaps = 25/162 (15%)
Query: 22 ECEMMKSIRHRNLIKVISS-CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80
E +++K +RH N+I + S E V E + G+ L +S + F + +
Sbjct: 59 ELKLLKHLRHENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQY-FLY 115
Query: 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLA 140
+ L+Y+H SA V+H DLKP N+L+++N + DFG+A++ +D M T ++
Sbjct: 116 QILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI---QDPQM--TGYVS 167
Query: 141 TIGYMAPE-------YGREGRVSTNGDVYSFGIMLMETFTGK 175
T Y APE Y E D++S G + E GK
Sbjct: 168 TRYYRAPEIMLTWQKYDVE------VDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-08
Identities = 46/166 (27%), Positives = 79/166 (47%), Gaps = 26/166 (15%)
Query: 26 MKSIRHRNLIKVISSCS----NEEFK-ALVLEYMPHGSLEKYL-------YSSNCILDIF 73
+++ H N++++ C+ + E K LV E++ L YL + I D+
Sbjct: 58 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDM- 115
Query: 74 QRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSM 133
M + L++LH S V+H DLKP N+L+ + L+DFG+A++ M
Sbjct: 116 -----MFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQM 164
Query: 134 TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTY 179
T + T+ Y APE + +T D++S G + E F +KP +
Sbjct: 165 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLF 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-08
Identities = 32/103 (31%), Positives = 53/103 (51%), Gaps = 5/103 (4%)
Query: 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQT 136
NI + + AL YLH ++H DL P+N++L ++ ++DFG+AK + + T
Sbjct: 117 NIFVQMVLALRYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQK-QPESKL--T 171
Query: 137 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTY 179
+ TI Y PE + DV++FG +L + T + P Y
Sbjct: 172 SVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFY 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-08
Identities = 33/100 (33%), Positives = 51/100 (51%), Gaps = 5/100 (5%)
Query: 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQ 137
I+ ++ L+YLH S IH D+K NVLL + L+DFG+A L D + +
Sbjct: 106 ILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNT 160
Query: 138 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 177
+ T +MAPE ++ D++S GI +E G+ P
Sbjct: 161 FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-08
Identities = 40/131 (30%), Positives = 68/131 (51%), Gaps = 9/131 (6%)
Query: 48 ALVLEYMPHGSLEKYLYSSNCILD-IFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDN 106
++ +E+M GSL++ L + I + I +++I V L YL ++H D+KP N
Sbjct: 79 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLRE--KHKIMHRDVKPSN 134
Query: 107 VLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGI 166
+L++ L DFG++ LI SM + + T YM+PE + S D++S G+
Sbjct: 135 ILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQGTHYSVQSDIWSMGL 190
Query: 167 MLMETFTGKKP 177
L+E G+ P
Sbjct: 191 SLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 3e-08
Identities = 44/132 (33%), Positives = 64/132 (48%), Gaps = 13/132 (9%)
Query: 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLA 140
++ SAL +LH +I+ DLK DNVLLD L+DFG+ K I T +
Sbjct: 104 EITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKTTSTFCG 158
Query: 141 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPIST 200
T Y+APE +E + D ++ G++L E G P +E N + + +ND
Sbjct: 159 TPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAP-FEAENEDDLFEAILND------ 211
Query: 201 MEVVDANLLSQE 212
EVV LSQ+
Sbjct: 212 -EVVYPTWLSQD 222
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-08
Identities = 47/175 (26%), Positives = 81/175 (46%), Gaps = 9/175 (5%)
Query: 5 VKVFNLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEE-FKALVLEYMPHGSLEK 61
+K NL+ R K+ + E +++ ++H N++ S E+ +V+ + G L
Sbjct: 30 IKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYH 89
Query: 62 YLYSSNC-ILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDF 120
L +L Q + + +A AL+YLH ++H DLK NV L + + D
Sbjct: 90 KLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDL 146
Query: 121 GIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGK 175
GIA++L E+Q + + T YM+PE + DV++ G + E T K
Sbjct: 147 GIARVL--ENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 4e-08
Identities = 48/186 (25%), Positives = 83/186 (44%), Gaps = 28/186 (15%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS----NCILDIFQRLN 77
E ++ + H ++ ++ S +E +LE++ G L +L + N + +
Sbjct: 68 EKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYH--- 124
Query: 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQ 137
++ A EYLH S +I+ DLKP+N+LLD+ ++DFG AK + +T
Sbjct: 125 --AELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAK------KVPDRTF 173
Query: 138 TL-ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP--------TYE-FFNGEMT 187
TL T Y+APE + D ++ G++L E G P YE G +
Sbjct: 174 TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLK 233
Query: 188 LKHWVN 193
+W +
Sbjct: 234 FPNWFD 239
|
Length = 329 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 4e-08
Identities = 43/178 (24%), Positives = 73/178 (41%), Gaps = 17/178 (9%)
Query: 29 IRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-----NCILDIFQRLNIMIDVA 83
++H N+++ + C LV EY G L+ YL N L + QR+ ++A
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRM--ACEIA 109
Query: 84 SALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIG 143
+ + ++H +H DL N L +L + D+GI ED T+ +
Sbjct: 110 AGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR 166
Query: 144 YMAPEY--GREGRVSTN-----GDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVND 194
++APE G + T +V++ G+ L E F Y + L H + D
Sbjct: 167 WLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKD 224
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 5e-08
Identities = 46/167 (27%), Positives = 77/167 (46%), Gaps = 30/167 (17%)
Query: 22 ECEMMKSIRHRNLIKVIS----SCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQR 75
E ++K + H N+I ++ + S E+F+ LV M L + Q+
Sbjct: 64 ELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC--------QK 114
Query: 76 LN------IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 129
L+ ++ + L+Y+H SA +IH DLKP N+ ++++ + DFG+A+
Sbjct: 115 LSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHT--- 168
Query: 130 DQSMTQTQTLATIGYMAPEYGREGRVSTNG-DVYSFGIMLMETFTGK 175
D M T +AT Y APE D++S G ++ E TGK
Sbjct: 169 DDEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 5e-08
Identities = 42/158 (26%), Positives = 73/158 (46%), Gaps = 6/158 (3%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81
E ++++ RH L + + + V+EY G L +L + R +
Sbjct: 45 ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAE 103
Query: 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLAT 141
+ SALEYLH S V++ D+K +N++LD + ++DFG+ K I + +M T
Sbjct: 104 IVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGT 158
Query: 142 IGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTY 179
Y+APE + D + G+++ E G+ P Y
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 6e-08
Identities = 47/177 (26%), Positives = 79/177 (44%), Gaps = 6/177 (3%)
Query: 3 VAVKVFNLQCG-RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 61
VA+KV +A K E +M + + +++ C + LV + MP+G L
Sbjct: 39 VAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQ-LVTQLMPYGCLLD 97
Query: 62 YLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFG 121
Y+ + + LN + +A + YL ++H DL NVL+ ++DFG
Sbjct: 98 YVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFG 154
Query: 122 IAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 177
+A+LL ++ I +MA E R + DV+S+G+ + E T G KP
Sbjct: 155 LARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 7e-08
Identities = 42/161 (26%), Positives = 75/161 (46%), Gaps = 19/161 (11%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81
E ++K+++H N++ + E LV EY+ L++YL + ++ + M
Sbjct: 53 EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQ 111
Query: 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLAT 141
+ L Y H ++H DLKP N+L+++ L+DFG+A+ + T + + T
Sbjct: 112 LLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLAR--AKSVPTKTYSNEVVT 166
Query: 142 IGYMAP-------EYGREGRVSTNGDVYSFGIMLMETFTGK 175
+ Y P EY ST D++ G +L E TG+
Sbjct: 167 LWYRPPDVLLGSTEY------STPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 7e-08
Identities = 49/183 (26%), Positives = 82/183 (44%), Gaps = 18/183 (9%)
Query: 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 60
EV +KV + +SF MM + H++L+ C + +V EY+ GSL+
Sbjct: 28 TEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLD 87
Query: 61 KYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLL----DDNL--- 113
YL + +++I +L + +A AL +L + H ++ NVLL D
Sbjct: 88 TYLKKNKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNP 144
Query: 114 -VAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGR-VSTNGDVYSFGIMLMET 171
LSD GI+ ++ ++ L I ++ PE + +S D +SFG L E
Sbjct: 145 PFIKLSDPGISITVLPKE------ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEI 198
Query: 172 FTG 174
F+G
Sbjct: 199 FSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 8e-08
Identities = 54/184 (29%), Positives = 90/184 (48%), Gaps = 24/184 (13%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKA--------LVLEYMPHGSLEKYL--YS-SNCIL 70
E +MK++ H N+I + E FK +V+E++P ++ KY+ Y+ +N L
Sbjct: 109 ELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHAL 167
Query: 71 DIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNL-VAYLSDFGIAKLLIGE 129
+F + AL Y+H S + H DLKP N+L+D N L DFG AK L+
Sbjct: 168 PLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG 224
Query: 130 DQSMTQTQTLATIGYMAPEYGR-EGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTL 188
+S++ + + Y APE +T+ D++S G ++ E G Y F+G+ ++
Sbjct: 225 QRSVSY---ICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG----YPIFSGQSSV 277
Query: 189 KHWV 192
V
Sbjct: 278 DQLV 281
|
Length = 440 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 1e-07
Identities = 42/173 (24%), Positives = 75/173 (43%), Gaps = 24/173 (13%)
Query: 22 ECEMMKSIRHRNLIK----VISSCSNEEFKA----LVLEYMPHGSLEKYLYSSNCILDIF 73
E +++K ++H N++ + + K +V YM H L L + + L
Sbjct: 57 EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTES 115
Query: 74 QRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSM 133
Q M+ + + YLH ++H D+K N+L+D+ + ++DFG+A+ G +
Sbjct: 116 QIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNP 172
Query: 134 TQ---------TQTLATIGYMAPEY--GREGRVSTNGDVYSFGIMLMETFTGK 175
T + T Y PE G E R +T D++ G + E FT +
Sbjct: 173 KGGGGGGTRKYTNLVVTRWYRPPELLLG-ERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-07
Identities = 47/160 (29%), Positives = 77/160 (48%), Gaps = 15/160 (9%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI--- 78
E ++K ++H N++++ +E+ LV EY+ L+K++ SS D + +
Sbjct: 51 EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSP---DFAKNPRLIKT 106
Query: 79 -MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAY-LSDFGIAKLLIGEDQSMTQT 136
+ + + Y H S V+H DLKP N+L+D A L+DFG+A+ T T
Sbjct: 107 YLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF--GIPVRTFT 161
Query: 137 QTLATIGYMAPEYGREGR-VSTNGDVYSFGIMLMETFTGK 175
+ T+ Y APE R ST D++S G + E K
Sbjct: 162 HEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-07
Identities = 31/106 (29%), Positives = 55/106 (51%), Gaps = 12/106 (11%)
Query: 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQT 138
M+ ++ LH+ +H D+KPDN+L+D N L+DFG + L + ED ++ +
Sbjct: 111 MVIAIDSVHQLHY------VHRDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVA 163
Query: 139 LATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMETFTGKKPTY 179
+ T Y++PE + +G+ D +S G+ + E G+ P Y
Sbjct: 164 VGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY 209
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-07
Identities = 48/176 (27%), Positives = 73/176 (41%), Gaps = 31/176 (17%)
Query: 17 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY-------SSNCI 69
K+ E +++K+I HR +I +I + K+ V MP + + Y
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRW---KSTVCMVMPKYKCDLFTYVDRSGPLPLEQA 187
Query: 70 LDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 129
+ I +RL AL YLH +IH D+K +N+ LD+ A L DFG A L
Sbjct: 188 ITIQRRL------LEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKL--- 235
Query: 130 DQSMTQTQTLATIGYM---APEYGREGRVSTNGDVYSFGIMLME------TFTGKK 176
D Q G + +PE D++S G++L E T GK+
Sbjct: 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291
|
Length = 392 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 2e-07
Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 10/99 (10%)
Query: 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQ-TL 139
++ LE++H + V++ DLKP N+LLD++ +SD G+A D S + ++
Sbjct: 105 EIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLAC-----DFSKKKPHASV 156
Query: 140 ATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTGKKP 177
T GYMAPE ++G ++ D +S G ML + G P
Sbjct: 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 39/155 (25%), Positives = 72/155 (46%), Gaps = 7/155 (4%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81
E ++K ++H N++ + E+ LV EY+ L++YL +++ +
Sbjct: 54 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQ 112
Query: 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLAT 141
+ L Y H V+H DLKP N+L+++ L+DFG+A+ + T + + T
Sbjct: 113 LLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYSNEVVT 167
Query: 142 IGYMAPE-YGREGRVSTNGDVYSFGIMLMETFTGK 175
+ Y P+ ST D++ G + E TG+
Sbjct: 168 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-07
Identities = 32/103 (31%), Positives = 56/103 (54%), Gaps = 4/103 (3%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81
E ++K ++H+N++++ +++ LV EY L+KY S N +D + M
Sbjct: 49 EICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQ 107
Query: 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 124
+ L + H S V+H DLKP N+L++ N L+DFG+A+
Sbjct: 108 LLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-07
Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 17/162 (10%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI---LDIFQRLNI 78
E +++ I H + + S +E + LVLE++ G +L + + F I
Sbjct: 81 ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQI 140
Query: 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQT 138
++ EYL S +++ DLKP+N+LLD + ++DFG AK++ T+T T
Sbjct: 141 VL----IFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV------DTRTYT 187
Query: 139 L-ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTY 179
L T Y+APE D ++ GI + E G P Y
Sbjct: 188 LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFY 229
|
Length = 340 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 2e-07
Identities = 41/146 (28%), Positives = 71/146 (48%), Gaps = 21/146 (14%)
Query: 59 LEKYLYSSNCILDIFQRL---------NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLL 109
LEK + ++ +IF+R+ NIM D+ + LEY+H + H D+KP+N+++
Sbjct: 106 LEKLVENTK---EIFKRIKCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMV 159
Query: 110 DDNLVAYLSDFGIAKLLI--GEDQSMTQTQT---LATIGYMAPEYGREGRVSTNGDVYSF 164
D N Y+ D+GIA I G+ ++ Q T+ Y + V+ GD+ S
Sbjct: 160 DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESL 219
Query: 165 GIMLMETFTGKKPTYEFFNGEMTLKH 190
G +++ + G K ++ F L H
Sbjct: 220 GYCMLK-WAGIKLPWKGFGHNGNLIH 244
|
Length = 294 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-07
Identities = 30/87 (34%), Positives = 46/87 (52%), Gaps = 6/87 (6%)
Query: 98 IHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR-----E 152
+H D+KPDNVLLD N L+DFG + L + D ++ + T Y++PE + +
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGK 182
Query: 153 GRVSTNGDVYSFGIMLMETFTGKKPTY 179
GR D +S G+ + E G+ P Y
Sbjct: 183 GRYGPECDWWSLGVCMYEMLYGETPFY 209
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.6 bits (122), Expect = 2e-07
Identities = 52/190 (27%), Positives = 87/190 (45%), Gaps = 37/190 (19%)
Query: 3 VAVKVFNLQCGRAFKSFDVECEMM---KSIR----HRNLIK---VISSCSNEEFKALVLE 52
VA+K + F S++ EC + KS+R H N++K V N+E V E
Sbjct: 27 VAIKKMK----KKFYSWE-ECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELY-FVFE 78
Query: 53 YMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLH----FGCSAPVIHCDLKPDNV 107
YM G+L + + +I+ + L ++H F H DLKP+N+
Sbjct: 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFF-------HRDLKPENL 130
Query: 108 LLDDNLVAYLSDFGIAKLLIGEDQSM-TQTQTLATIGYMAPE-YGREGRVSTNGDVYSFG 165
L+ V ++DFG+A+ E +S T ++T Y APE R S+ D+++ G
Sbjct: 131 LVSGPEVVKIADFGLAR----EIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALG 186
Query: 166 IMLMETFTGK 175
++ E +T +
Sbjct: 187 CIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-07
Identities = 40/141 (28%), Positives = 67/141 (47%), Gaps = 7/141 (4%)
Query: 38 ISSCSNEEFKA-LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAP 96
+ SC + LV+EY+ G L ++ + + R ++ AL +LH
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARF-YAAEICIALNFLH---ERG 116
Query: 97 VIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVS 156
+I+ DLK DNVLLD + L+D+G+ K +G T + T Y+APE R
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TTSTFCGTPNYIAPEILRGEEYG 174
Query: 157 TNGDVYSFGIMLMETFTGKKP 177
+ D ++ G+++ E G+ P
Sbjct: 175 FSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-07
Identities = 39/131 (29%), Positives = 64/131 (48%), Gaps = 11/131 (8%)
Query: 49 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVL 108
+L+ M G L +L + R ++ LE++H + V++ DLKP N+L
Sbjct: 74 FILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIILGLEHMH---NRFVVYRDLKPANIL 129
Query: 109 LDDNLVAYLSDFGIAKLLIGEDQSMTQTQ-TLATIGYMAPEYGREGRV-STNGDVYSFGI 166
LD++ +SD G+A D S + ++ T GYMAPE ++G ++ D +S G
Sbjct: 130 LDEHGHVRISDLGLAC-----DFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGC 184
Query: 167 MLMETFTGKKP 177
ML + G P
Sbjct: 185 MLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 2e-07
Identities = 42/134 (31%), Positives = 67/134 (50%), Gaps = 11/134 (8%)
Query: 49 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI-DVASALEYLHFGCSAPVIHCDLKPDNV 107
LV +YM G L +L + R I ++ ALE+LH +++ DLKP+N+
Sbjct: 73 LVTDYMSGGELFWHLQKEGRFSE--DRAKFYIAELVLALEHLH---KYDIVYRDLKPENI 127
Query: 108 LLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTL-ATIGYMAPEYGREGRVSTNG-DVYSFG 165
LLD L DFG++K + ++++ T T T Y+APE + + T D +S G
Sbjct: 128 LLDATGHIALCDFGLSKANLTDNKT---TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLG 184
Query: 166 IMLMETFTGKKPTY 179
+++ E G P Y
Sbjct: 185 VLVFEMCCGWSPFY 198
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (121), Expect = 3e-07
Identities = 47/172 (27%), Positives = 75/172 (43%), Gaps = 25/172 (14%)
Query: 25 MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL------EKYLYSSNCILDIFQRLNI 78
+MK + N IK+ S + + L+++Y+ G L E L + I Q
Sbjct: 64 LMKD--NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQ---- 117
Query: 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLV-AYLSDFGIAKLLIGEDQSMTQTQ 137
+ AL LH +IH D+K +NVL D YL D+G+ K +IG
Sbjct: 118 ---LVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK-IIGTPSCYD--- 167
Query: 138 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLK 189
T+ Y +PE + + D ++ G++ E TGK P E + E+ L+
Sbjct: 168 --GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLE 217
|
Length = 267 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 3e-07
Identities = 38/112 (33%), Positives = 59/112 (52%), Gaps = 23/112 (20%)
Query: 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTL- 139
++A L +LH S +I+ DLK DNV+LD ++DFG+ K I ++ T+T
Sbjct: 109 EIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRTFC 162
Query: 140 ATIGYMAPE------YGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGE 185
T Y+APE YG+ + D ++FG++L E G+ P F+GE
Sbjct: 163 GTPDYIAPEIIAYQPYGK------SVDWWAFGVLLYEMLAGQPP----FDGE 204
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-07
Identities = 47/190 (24%), Positives = 82/190 (43%), Gaps = 24/190 (12%)
Query: 4 AVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL 63
A KV + + + + VE +++ S H N++K++ + E +++E+ G+++ +
Sbjct: 34 AAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVM 93
Query: 64 YSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 123
L Q + AL YLH +IH DLK N+L + L+DFG+
Sbjct: 94 LELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGV- 149
Query: 124 KLLIGEDQSMTQTQTL-------ATIGYMAPEY-----GREGRVSTNGDVYSFGIMLMET 171
S T+T+ T +MAPE ++ DV+S GI L+E
Sbjct: 150 --------SAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201
Query: 172 FTGKKPTYEF 181
+ P +E
Sbjct: 202 AQIEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 3e-07
Identities = 46/168 (27%), Positives = 82/168 (48%), Gaps = 15/168 (8%)
Query: 22 ECEMMKSIRHRNLIKV--ISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79
E ++ ++H N++ V + SN + +V+EY+ H L+ + + + +M
Sbjct: 54 EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLM 112
Query: 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTL 139
+ + S + +LH ++H DLK N+LL++ + + DFG+A+ + TQ +
Sbjct: 113 LQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY--TQLV 167
Query: 140 ATIGYMAPE--YGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGE 185
T+ Y APE G ST D++S G + E T KKP F G+
Sbjct: 168 VTLWYRAPELLLG-AKEYSTAIDMWSVGCIFAELLT-KKP---LFPGK 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 4e-07
Identities = 32/109 (29%), Positives = 51/109 (46%), Gaps = 4/109 (3%)
Query: 70 LDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE 129
LD L+ VA + +L S IH DL N+LL + + DFG+A+ + +
Sbjct: 211 LDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267
Query: 130 DQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 177
+ + + +MAPE + DV+S+GI+L E F+ G P
Sbjct: 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 4e-07
Identities = 37/155 (23%), Positives = 72/155 (46%), Gaps = 7/155 (4%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81
E ++K ++H N++ + ++ LV EY+ L++Y+ I+ + +
Sbjct: 54 EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQ 112
Query: 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLAT 141
+ L Y H V+H DLKP N+L+++ L+DFG+A+ + T + + T
Sbjct: 113 ILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLAR--AKSVPTKTYSNEVVT 167
Query: 142 IGYMAPEYGR-EGRVSTNGDVYSFGIMLMETFTGK 175
+ Y P+ ST D++ G + E +G+
Sbjct: 168 LWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 4e-07
Identities = 42/147 (28%), Positives = 67/147 (45%), Gaps = 6/147 (4%)
Query: 31 HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 90
H L+ + S E V+EY+ G L ++ + + R +++ AL YLH
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH 113
Query: 91 FGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYG 150
+I+ DLK DNVLLD L+D+G+ K G T + T Y+APE
Sbjct: 114 ---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSTFCGTPNYIAPEIL 168
Query: 151 REGRVSTNGDVYSFGIMLMETFTGKKP 177
R + D ++ G+++ E G+ P
Sbjct: 169 RGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 4e-07
Identities = 48/180 (26%), Positives = 76/180 (42%), Gaps = 44/180 (24%)
Query: 14 RAFKSFDVECEMMKSIRHRNLIKVIS----SCSNEEFKA--LVLEYMP------------ 55
RA++ +MK + H+N+I +++ S EEF+ LV+E M
Sbjct: 61 RAYREL----VLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLD 116
Query: 56 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVA 115
H + LY C +++LH SA +IH DLKP N+++ +
Sbjct: 117 HERMSYLLYQMLC----------------GIKHLH---SAGIIHRDLKPSNIVVKSDCTL 157
Query: 116 YLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGK 175
+ DFG+A+ G M T + T Y APE N D++S G ++ E G
Sbjct: 158 KILDFGLAR-TAGTSFMM--TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 5e-07
Identities = 45/139 (32%), Positives = 67/139 (48%), Gaps = 22/139 (15%)
Query: 51 LEYMPHGSLEKYLY---SSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNV 107
+EYM GSL+K LY + + I V L++L +IH D+KP NV
Sbjct: 78 MEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNV 134
Query: 108 LLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIG---YMAPEYGREGRVSTNG----- 159
L++ N L DFG++ L+ S+ +T IG YMAPE + G + N
Sbjct: 135 LVNGNGQVKLCDFGVSGNLV---ASLAKTN----IGCQSYMAPERIKSGGPNQNPTYTVQ 187
Query: 160 -DVYSFGIMLMETFTGKKP 177
DV+S G+ ++E G+ P
Sbjct: 188 SDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 5e-07
Identities = 50/198 (25%), Positives = 94/198 (47%), Gaps = 19/198 (9%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM-- 79
E ++ +++H N+++ S +V++Y G L K + + +L F I+
Sbjct: 49 EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVL--FPEDQILDW 106
Query: 80 -IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQT 138
+ + AL+++H ++H D+K N+ L + L DFGIA++L + ++ +T
Sbjct: 107 FVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL---NSTVELART 160
Query: 139 -LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEM---TLKHWVND 194
+ T Y++PE + D+++ G +L E T K + F G M LK
Sbjct: 161 CIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLK---HAFEAGNMKNLVLKIIRGS 217
Query: 195 WLPISTMEVVD-ANLLSQ 211
+ P+S+ D NL+SQ
Sbjct: 218 YPPVSSHYSYDLRNLVSQ 235
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 5e-07
Identities = 45/166 (27%), Positives = 75/166 (45%), Gaps = 19/166 (11%)
Query: 24 EMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVA 83
E S RH L+ + + E+ V+EY G L ++++ D+F + A
Sbjct: 54 ETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-----DVFSEPRAVFYAA 108
Query: 84 S---ALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTL- 139
L+YLH +++ DLK DN+LLD ++DFG+ K +G +T T
Sbjct: 109 CVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD---RTSTFC 162
Query: 140 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGE 185
T ++APE E + D + G+++ E G+ P F G+
Sbjct: 163 GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP----FPGD 204
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 5e-07
Identities = 42/158 (26%), Positives = 72/158 (45%), Gaps = 5/158 (3%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81
E ++++ RH L + S + V+EY G L +L + R +
Sbjct: 45 ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAE 103
Query: 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLAT 141
+ SAL+YLH V++ DLK +N++LD + ++DFG+ K I + +M T
Sbjct: 104 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM--KTFCGT 159
Query: 142 IGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTY 179
Y+APE + D + G+++ E G+ P Y
Sbjct: 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 6e-07
Identities = 46/163 (28%), Positives = 77/163 (47%), Gaps = 19/163 (11%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMI 80
E ++K + H N+++++ +E LV E++ L+KY+ S LD + +
Sbjct: 48 EISLLKELNHPNIVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLY 106
Query: 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK-----LLIGEDQSMTQ 135
+ + Y H S V+H DLKP N+L+D L+DFG+A+ + T
Sbjct: 107 QLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-------RTY 156
Query: 136 TQTLATIGYMAPEYGREGR-VSTNGDVYSFGIMLMETFTGKKP 177
T + T+ Y APE R ST D++S G + E ++P
Sbjct: 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN-RRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 8e-07
Identities = 56/245 (22%), Positives = 102/245 (41%), Gaps = 46/245 (18%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81
E + ++ I+H N I+ E LV+EY L S++ +L++ ++ ++
Sbjct: 75 EVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC--------LGSASDLLEVHKKPLQEVE 126
Query: 82 VAS-------ALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMT 134
+A+ L YLH S +IH D+K N+LL + L+DFG A + +
Sbjct: 127 IAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASI------ASP 177
Query: 135 QTQTLATIGYMAPEY---GREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHW 191
+ T +MAPE EG+ DV+S GI +E K P + N L H
Sbjct: 178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-MNAMSALYH- 235
Query: 192 VNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKL 251
++Q + + + + N +C + P+ R ++E++ +
Sbjct: 236 -----------------IAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278
Query: 252 LKIRD 256
+R+
Sbjct: 279 FVLRE 283
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 9e-07
Identities = 48/184 (26%), Positives = 86/184 (46%), Gaps = 24/184 (13%)
Query: 14 RAFKSFDVECEMMKSIRHRNLIKVIS----SCSNEEFKA--LVLEYMPHGSLEKYLYSSN 67
RA++ E ++K + H+N+I +++ S EEF+ LV+E M +L + ++
Sbjct: 66 RAYR----ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHME- 119
Query: 68 CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI 127
LD + ++ + +++LH SA +IH DLKP N+++ + + DFG+A+
Sbjct: 120 --LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART-- 172
Query: 128 GEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMT 187
+ T + T Y APE N D++S G ++ E G F G
Sbjct: 173 -ACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSV----IFQGTDH 227
Query: 188 LKHW 191
+ W
Sbjct: 228 IDQW 231
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 9e-07
Identities = 46/146 (31%), Positives = 61/146 (41%), Gaps = 31/146 (21%)
Query: 49 LVLEYMPHGS---LEKYLYSSNCILDIFQRLN------IMIDVASALEYLHFGCSAPVIH 99
LV+E GS L K L +RL I+ + L YLH VIH
Sbjct: 86 LVMELCGGGSVTDLVKGLRKKG------KRLKEEWIAYILRETLRGLAYLH---ENKVIH 136
Query: 100 CDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIG---YMAPE-----YGR 151
D+K N+LL N L DFG++ L D ++ + T IG +MAPE
Sbjct: 137 RDIKGQNILLTKNAEVKLVDFGVSAQL---DSTLGRRNT--FIGTPYWMAPEVIACDEQP 191
Query: 152 EGRVSTNGDVYSFGIMLMETFTGKKP 177
+ DV+S GI +E GK P
Sbjct: 192 DASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-06
Identities = 50/184 (27%), Positives = 77/184 (41%), Gaps = 22/184 (11%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDI----FQRLN 77
E ++ +RH N I+ E LV+EY L S++ +L++ Q +
Sbjct: 65 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC--------LGSASDLLEVHKKPLQEVE 116
Query: 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQ 137
I AL+ L + S +IH D+K N+LL + + L DFG A ++
Sbjct: 117 IAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANX 170
Query: 138 TLATIGYMAPEY---GREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVND 194
+ T +MAPE EG+ DV+S GI +E K P + N L H +
Sbjct: 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-MNAMSALYHIAQN 229
Query: 195 WLPI 198
P
Sbjct: 230 ESPA 233
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-06
Identities = 44/166 (26%), Positives = 77/166 (46%), Gaps = 28/166 (16%)
Query: 22 ECEMMKSIRHRNLIKVIS----SCSNEEFKALVL-EYMPHGSLEKYLYSSNCILDIFQRL 76
E ++K ++H N+I ++ + S EEF + L ++ L + D Q L
Sbjct: 66 ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 125
Query: 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQT 136
+ + L+Y+H SA +IH DLKP N+ ++++ + DFG+A+ D MT
Sbjct: 126 --IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMT-- 175
Query: 137 QTLATIGYMAPEYGREGRVSTNG-------DVYSFGIMLMETFTGK 175
GY+A + R + N D++S G ++ E TG+
Sbjct: 176 ------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 1e-06
Identities = 40/155 (25%), Positives = 74/155 (47%), Gaps = 11/155 (7%)
Query: 20 DVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE---KYLYSSNCILDIFQRL 76
+ E +++ + H ++K +S + ++ EY L+ + L + L Q
Sbjct: 50 NQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVC 109
Query: 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGE-DQSMTQ 135
I + + Y+H ++H DLK N+ L +NL+ + DFG+++LL+G D + T
Sbjct: 110 EWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKNNLLK-IGDFGVSRLLMGSCDLATTF 165
Query: 136 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLME 170
T T YM+PE + + D++S G +L E
Sbjct: 166 T---GTPYYMSPEALKHQGYDSKSDIWSLGCILYE 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 1e-06
Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 85 ALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMT-QTQTLATIG 143
AL+Y+H +A V H DLKP N+L + + + DFG+A++ + + T +AT
Sbjct: 115 ALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171
Query: 144 YMAPEYGRE--GRVSTNGDVYSFGIMLMETFTGK 175
Y APE + + D++S G + E TGK
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-06
Identities = 40/138 (28%), Positives = 60/138 (43%), Gaps = 10/138 (7%)
Query: 49 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVL 108
LV+EY P G L L N D F +A + +H +H D+KP+NVL
Sbjct: 78 LVMEYQPGGDLLSLL---NRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVL 134
Query: 109 LDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEY------GREGRVSTNGDVY 162
+D L+DFG A L ++ + + T Y+APE +G D +
Sbjct: 135 IDRTGHIKLADFGSAARL-TANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWW 193
Query: 163 SFGIMLMETFTGKKPTYE 180
S G++ E G+ P +E
Sbjct: 194 SLGVIAYEMIYGRSPFHE 211
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 29/87 (33%), Positives = 47/87 (54%), Gaps = 6/87 (6%)
Query: 98 IHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE----- 152
+H D+KPDNVLLD N L+DFG + L + +D ++ + + T Y++PE +
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGM 182
Query: 153 GRVSTNGDVYSFGIMLMETFTGKKPTY 179
G+ D +S G+ + E G+ P Y
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETPFY 209
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 34/105 (32%), Positives = 53/105 (50%), Gaps = 9/105 (8%)
Query: 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLA 140
++A L +LH S +I+ DLK DNV+LD ++DFG+ K + + +T
Sbjct: 109 EIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD--GVTTKTFCG 163
Query: 141 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGE 185
T Y+APE + D ++FG++L E G+ P F GE
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP----FEGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-06
Identities = 47/167 (28%), Positives = 74/167 (44%), Gaps = 24/167 (14%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM-I 80
E ++++ RH L + S + V+EY G L + + S + R
Sbjct: 45 ESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGA 102
Query: 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTL- 139
++ SAL YLH S V++ DLK +N++LD + ++DFG+ K E S T
Sbjct: 103 EIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTF 155
Query: 140 -ATIGYMAPE------YGREGRVSTNGDVYSFGIMLMETFTGKKPTY 179
T Y+APE YGR D + G+++ E G+ P Y
Sbjct: 156 CGTPEYLAPEVLEDNDYGRA------VDWWGLGVVMYEMMCGRLPFY 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 45/171 (26%), Positives = 78/171 (45%), Gaps = 38/171 (22%)
Query: 22 ECEMMKSIRHRNLIKVIS----SCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77
E ++K ++H N+I ++ + S E F + L G+ N I+ Q+L+
Sbjct: 64 ELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGA------DLNNIVK-CQKLS 116
Query: 78 ------IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQ 131
++ + L+Y+H SA +IH DLKP NV ++++ + DFG+A+ D
Sbjct: 117 DEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADD 170
Query: 132 SMTQTQTLATIGYMAPEYGREGRVSTNG-------DVYSFGIMLMETFTGK 175
MT GY+A + R + N D++S G ++ E GK
Sbjct: 171 EMT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-06
Identities = 49/184 (26%), Positives = 85/184 (46%), Gaps = 24/184 (13%)
Query: 14 RAFKSFDVECEMMKSIRHRNLIKVIS----SCSNEEFKAL--VLEYMPHGSLEKYLYSSN 67
RA++ E +MK + H+N+I +++ S EEF+ + V+E M +L + +
Sbjct: 69 RAYR----ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME- 122
Query: 68 CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI 127
LD + ++ + +++LH SA +IH DLKP N+++ + + DFG+A+
Sbjct: 123 --LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART-- 175
Query: 128 GEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMT 187
S T + T Y APE N D++S G ++ E G F G
Sbjct: 176 -AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV----LFPGTDH 230
Query: 188 LKHW 191
+ W
Sbjct: 231 IDQW 234
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-06
Identities = 37/118 (31%), Positives = 60/118 (50%), Gaps = 15/118 (12%)
Query: 49 LVLEYMPHGSLEKYLYSSNCILDIFQR---LNIMIDVASALEYLHFGCSAPVIHCDLKPD 105
LV+EY+ G ++ L+ I F + + +VA AL+YLH +IH DLKPD
Sbjct: 81 LVMEYLIGGDVKSLLH----IYGYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPD 133
Query: 106 NVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYS 163
N+L+ + L+DFG++K+ + + +M T ++ +Y R T G V S
Sbjct: 134 NMLISNEGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKPKNDYSR-----TPGQVLS 186
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 50/188 (26%), Positives = 81/188 (43%), Gaps = 36/188 (19%)
Query: 3 VAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 60
VA+K L+ G F + E ++K ++H N++ + ++ LV EY+ L+
Sbjct: 33 VALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL-DTDLK 90
Query: 61 KYLYSSNCILD-------IFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNL 113
+Y+ L +FQ L L Y H V+H DLKP N+L+ +
Sbjct: 91 QYMDDCGGGLSMHNVRLFLFQLLR-------GLAYCH---QRRVLHRDLKPQNLLISERG 140
Query: 114 VAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP-------EYGREGRVSTNGDVYSFGI 166
L+DFG+A+ S T + + T+ Y P EY ST+ D++ G
Sbjct: 141 ELKLADFGLAR--AKSVPSKTYSNEVVTLWYRPPDVLLGSTEY------STSLDMWGVGC 192
Query: 167 MLMETFTG 174
+ E TG
Sbjct: 193 IFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 43/175 (24%), Positives = 71/175 (40%), Gaps = 26/175 (14%)
Query: 15 AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQ 74
A+ ++ C + + H ++K +++ L++EY G L K I Q
Sbjct: 110 AYARSELHC--LAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNK---------QIKQ 158
Query: 75 RLN------------IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGI 122
RL + + AL+ +H S ++H DLK N+ L + L DFG
Sbjct: 159 RLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGF 215
Query: 123 AKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 177
+K + T Y+APE R S D++S G++L E T +P
Sbjct: 216 SKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 3e-06
Identities = 36/129 (27%), Positives = 61/129 (47%), Gaps = 6/129 (4%)
Query: 49 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVL 108
V+E++ G L ++ + + R +++ AL +LH +I+ DLK DNVL
Sbjct: 73 FVIEFVSGGDLMFHMQRQRKLPEEHARF-YSAEISLALNFLH---ERGIIYRDLKLDNVL 128
Query: 109 LDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIML 168
LD L+D+G+ K I T + T Y+APE R + D ++ G+++
Sbjct: 129 LDAEGHIKLTDYGMCKEGIRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLM 186
Query: 169 METFTGKKP 177
E G+ P
Sbjct: 187 FEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 3e-06
Identities = 51/184 (27%), Positives = 84/184 (45%), Gaps = 53/184 (28%)
Query: 14 RAFKSFDVECEMMKSIRHRNLIKVI----SSCSNEEFKA--LVLEYM---------PHGS 58
RA++ E ++K ++H N+I ++ S+ S +EF+ LV+ YM S
Sbjct: 60 RAYR----ELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLS 115
Query: 59 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLS 118
+K Y ++Q L L+Y+H SA +IH DLKP N+ ++++ +
Sbjct: 116 EDKVQYL------VYQML-------CGLKYIH---SAGIIHRDLKPGNLAVNEDCELKIL 159
Query: 119 DFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG-------DVYSFGIMLMET 171
DFG+A+ D MT GY+ + R V N D++S G ++ E
Sbjct: 160 DFGLAR---HADAEMT--------GYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEM 208
Query: 172 FTGK 175
TGK
Sbjct: 209 LTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-06
Identities = 43/164 (26%), Positives = 76/164 (46%), Gaps = 9/164 (5%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81
E +M+++++ N++++ + LV EY+ LE N + R + +
Sbjct: 50 ELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVR-SYIYQ 108
Query: 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLAT 141
+ A+ + H ++H D+KP+N+L+ N V L DFG A+ L E + T+ +AT
Sbjct: 109 LIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNL-SEGSNANYTEYVAT 164
Query: 142 IGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGE 185
Y +PE D++S G +L E G+ F GE
Sbjct: 165 RWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQP----LFPGE 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 4e-06
Identities = 28/131 (21%), Positives = 59/131 (45%), Gaps = 22/131 (16%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECE--MMKSIRHRNLI--KVISSCSNEEFKALVLEYMPHG 57
+ +K+ K D E E +++ + + L KV++S ++ + L++E++
Sbjct: 23 DYVLKINP----SREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78
Query: 58 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAP---VIHCDLKPDNVLLDDNLV 114
+L++ + ++ +I +A L LH P + H DL P N+L+DD +
Sbjct: 79 TLDE--------VSEEEKEDIAEQLAELLAKLH---QLPLLVLCHGDLHPGNILVDDGKI 127
Query: 115 AYLSDFGIAKL 125
+ D+ A
Sbjct: 128 LGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 4e-06
Identities = 43/162 (26%), Positives = 75/162 (46%), Gaps = 12/162 (7%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY-SSNCILDIFQRLNIMI 80
E ++++I H ++I++ + + +F L+L P + Y Y ++ + I L I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLIL---PRYKTDLYCYLAAKRNIAICDILAIER 189
Query: 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIA--KLLIGEDQSMTQTQT 138
V A++YLH +IH D+K +N+ ++ L DFG A + I ++ T
Sbjct: 190 SVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGT 246
Query: 139 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYE 180
+AT APE D++S GI+L E T +E
Sbjct: 247 IAT---NAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285
|
Length = 391 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 4e-06
Identities = 36/114 (31%), Positives = 54/114 (47%), Gaps = 28/114 (24%)
Query: 85 ALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI---------GEDQSMTQ 135
ALEYLH + ++H DLKPDN+L+ L+DFG++K+ + G + T+
Sbjct: 113 ALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169
Query: 136 ----TQTLATIGYMAPE------YGREGRVSTNGDVYSFGIMLMETFTGKKPTY 179
Q T Y+APE YG+ D ++ GI+L E G P +
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKP------VDWWAMGIILYEFLVGCVPFF 217
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 5e-06
Identities = 49/184 (26%), Positives = 85/184 (46%), Gaps = 24/184 (13%)
Query: 14 RAFKSFDVECEMMKSIRHRNLIKVISSCSN----EEFKA--LVLEYMPHGSLEKYLYSSN 67
RA++ E +MK + H+N+I +++ + EEF+ LV+E M +L + +
Sbjct: 62 RAYR----ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQME- 115
Query: 68 CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI 127
LD + ++ + +++LH SA +IH DLKP N+++ + + DFG+A+
Sbjct: 116 --LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART-- 168
Query: 128 GEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMT 187
S T + T Y APE N D++S G ++ E K F G
Sbjct: 169 -AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDY 223
Query: 188 LKHW 191
+ W
Sbjct: 224 IDQW 227
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 9e-06
Identities = 48/179 (26%), Positives = 77/179 (43%), Gaps = 28/179 (15%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81
E + ++ ++H N I+ E LV+EY L S++ +L++ ++ ++
Sbjct: 71 EVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYC--------LGSASDLLEVHKKPLQEVE 122
Query: 82 VAS-------ALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMT 134
+A+ L YLH +IH D+K N+LL + L+DFG A S
Sbjct: 123 IAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASK------SSP 173
Query: 135 QTQTLATIGYMAPEY---GREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKH 190
+ T +MAPE EG+ DV+S GI +E K P + N L H
Sbjct: 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-MNAMSALYH 231
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 9e-06
Identities = 40/173 (23%), Positives = 79/173 (45%), Gaps = 26/173 (15%)
Query: 25 MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 84
MM+ + H++++ + C + +V E++ G L+ +++ + +L + + +AS
Sbjct: 57 MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLAS 116
Query: 85 ALEYLHFGCSAPVIHCDLKPDNVLL-------DDNLVAYLSDFGIAKLLIGEDQSMTQTQ 137
AL YL ++H ++ N+LL + LSD GI + +++ +
Sbjct: 117 ALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITV------LSRQE 167
Query: 138 TLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLK 189
+ I ++APE + + S D +SFG L E +NGE+ LK
Sbjct: 168 CVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI---------CYNGEIPLK 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 1e-05
Identities = 42/165 (25%), Positives = 76/165 (46%), Gaps = 18/165 (10%)
Query: 25 MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 84
+M + H +L V C +V E++ HG L+ L + + ++ + +AS
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLAS 128
Query: 85 ALEYLHFGCSAPVIHCDLKPDNVL-----LDDNLVAY--LSDFGIAKLLIGEDQSMTQTQ 137
AL YL ++H ++ N+L L + + LSD G++ ++++ +
Sbjct: 129 ALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSF------TALSREE 179
Query: 138 TLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMET-FTGKKPTYE 180
+ I ++APE G +ST D +SFG L+E F G+ P E
Sbjct: 180 RVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKE 224
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 45/187 (24%), Positives = 77/187 (41%), Gaps = 17/187 (9%)
Query: 3 VAVKVFNL--QCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 60
VAVK NL K E + ++H N++ ++S + +V M +GS E
Sbjct: 28 VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE 87
Query: 61 KYLYSSNCILDIFQRL---NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYL 117
L + + L I+ DV +AL+Y+H S IH +K ++LL + L
Sbjct: 88 DLLKTHFP--EGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVL 142
Query: 118 SDFGIAKLLIGEDQSMTQ-----TQTLATIGYMAPEYGREGRVSTN--GDVYSFGIMLME 170
S + +I + ++ + +++PE ++ N D+YS GI E
Sbjct: 143 SGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACE 202
Query: 171 TFTGKKP 177
G P
Sbjct: 203 LANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-05
Identities = 41/164 (25%), Positives = 69/164 (42%), Gaps = 20/164 (12%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK-------YLYSSNCILDIFQ 74
E ++ ++H N++ S + +V+EY G L + L+ + IL F
Sbjct: 48 EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWF- 106
Query: 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMT 134
+ + ++++H V+H D+K N+ L N L DFG A+LL
Sbjct: 107 -----VQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL---TSPGA 155
Query: 135 QTQT-LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 177
T + T Y+ PE + D++S G +L E T K P
Sbjct: 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 2e-05
Identities = 49/197 (24%), Positives = 89/197 (45%), Gaps = 43/197 (21%)
Query: 21 VECEMMKSIRHRNLIKVISSCSNEEFKAL--VLEYMPHGSLEKYL---------YSSNCI 69
+E +M+ ++H+N+++ I N+ + L ++E+ G L + + + I
Sbjct: 61 IEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAI 120
Query: 70 LDIFQRLNIMIDVASALEYLHFGCSAP----VIHCDLKPDNVLLD-------------DN 112
+DI ++L AL Y H P V+H DLKP N+ L +N
Sbjct: 121 VDITRQL------LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANN 174
Query: 113 L----VAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTN--GDVYSFGI 166
L +A + DFG++K + E SM + + T Y +PE S + D+++ G
Sbjct: 175 LNGRPIAKIGDFGLSKNIGIE--SMAHS-CVGTPYYWSPELLLHETKSYDDKSDMWALGC 231
Query: 167 MLMETFTGKKPTYEFFN 183
++ E +GK P ++ N
Sbjct: 232 IIYELCSGKTPFHKANN 248
|
Length = 1021 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 3e-05
Identities = 49/189 (25%), Positives = 86/189 (45%), Gaps = 23/189 (12%)
Query: 4 AVKVFNLQCGRAFKSFDVECEMMKSI-RHRNLIKVI------SSCSNEEFKALVLEYMPH 56
A+KV ++ + +E M+K HRN+ S +++ LV+E+
Sbjct: 45 AIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGA 103
Query: 57 GSLEKYLYSS--NCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLV 114
GS+ + ++ N + + + I ++ L +LH + VIH D+K NVLL +N
Sbjct: 104 GSVTDLVKNTKGNALKEDWIAY-ICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAE 159
Query: 115 AYLSDFGIAKLLIGEDQSMTQTQT-LATIGYMAPEY-----GREGRVSTNGDVYSFGIML 168
L DFG++ L D+++ + T + T +MAPE + D++S GI
Sbjct: 160 VKLVDFGVSAQL---DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITA 216
Query: 169 METFTGKKP 177
+E G P
Sbjct: 217 IEMAEGAPP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 4e-05
Identities = 47/169 (27%), Positives = 80/169 (47%), Gaps = 22/169 (13%)
Query: 14 RAFKSFDVECEMMKSIRHRNLIKVI----SSCSNEEFKA--LVLEYMPHGSLEKYLYSSN 67
RA++ E ++K ++H N+I ++ S + F LV+ +M L K +
Sbjct: 60 RAYR----ELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEK 114
Query: 68 CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI 127
D Q L + + L+Y+H +A +IH DLKP N+ ++++ + DFG+A+
Sbjct: 115 LSEDRIQFL--VYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR--- 166
Query: 128 GEDQSMTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGK 175
D M T + T Y APE + D++S G ++ E TGK
Sbjct: 167 QTDSEM--TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 5e-05
Identities = 33/111 (29%), Positives = 56/111 (50%), Gaps = 21/111 (18%)
Query: 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLA 140
+++ L +LH +I+ DLK DNV+LD ++DFG+ K + + +T
Sbjct: 109 EISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD--GVTTRTFCG 163
Query: 141 TIGYMAPE------YGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGE 185
T Y+APE YG+ + D +++G++L E G+ P F+GE
Sbjct: 164 TPDYIAPEIIAYQPYGK------SVDWWAYGVLLYEMLAGQPP----FDGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 5e-05
Identities = 49/190 (25%), Positives = 79/190 (41%), Gaps = 43/190 (22%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL--YSSNCILDIFQRLNIM 79
E E++ ++ H L + +S E + LV++Y P G L + L C+ + R
Sbjct: 51 EQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA 110
Query: 80 IDVASALEYLH-FGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL------------ 126
+V ALEYLH G +++ DLKP+N+LL ++ LSDF ++K
Sbjct: 111 -EVLLALEYLHLLG----IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALR 165
Query: 127 ---IGEDQSMTQTQTLATIG------------YMAPE----YGREGRVSTNGDVYSFGIM 167
+ ++T + Y+APE G V D ++ GI+
Sbjct: 166 KGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV----DWWTLGIL 221
Query: 168 LMETFTGKKP 177
L E G P
Sbjct: 222 LYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 1e-04
Identities = 32/103 (31%), Positives = 49/103 (47%), Gaps = 12/103 (11%)
Query: 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQT-L 139
++ L +LH VIH D+K NVLL +N L DFG++ L D+++ + T +
Sbjct: 119 EILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFI 172
Query: 140 ATIGYMAPEY-----GREGRVSTNGDVYSFGIMLMETFTGKKP 177
T +MAPE + D++S GI +E G P
Sbjct: 173 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 3e-04
Identities = 52/234 (22%), Positives = 90/234 (38%), Gaps = 53/234 (22%)
Query: 34 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGC 93
++K+ S +++ V++Y+P G + L ++ R I ++ A+E +H
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA-ELTLAIESVH--- 118
Query: 94 SAPVIHCDLKPDNVLLDDNLVAYLSDFGIA------------------------------ 123
IH D+KPDN+L+D + L+DFG+
Sbjct: 119 KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD 178
Query: 124 ---------KLLIGEDQSMTQTQT------LATIGYMAPEYGREGRVSTNGDVYSFGIML 168
+L E ++ Q Q + T Y+APE + D +S G++L
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238
Query: 169 METFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQC 222
E G+ P E LK V +W +T+ + LS E + + K C
Sbjct: 239 FEMLVGQPPFLAPTPTETQLK--VINWE--NTLHIPPQVKLSPEAVDLITKLCC 288
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 4e-04
Identities = 41/147 (27%), Positives = 66/147 (44%), Gaps = 27/147 (18%)
Query: 49 LVLEYMPHGSLEKYLYSSNCILDIFQRLN------IMIDVASALEYLHFGCSAPVIHCDL 102
LVLE GS+ + + +L QRL+ I+ L++LH + +IH D+
Sbjct: 101 LVLELCNGGSVTELVKG---LLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDV 154
Query: 103 KPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPE---------YGREG 153
K +N+LL L DFG++ L + + ++ T +MAPE Y +
Sbjct: 155 KGNNILLTTEGGVKLVDFGVSAQLT--STRLRRNTSVGTPFWMAPEVIACEQQYDYSYDA 212
Query: 154 RVSTNGDVYSFGIMLMETFTGKKPTYE 180
R DV+S GI +E G P ++
Sbjct: 213 RC----DVWSLGITAIELGDGDPPLFD 235
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 4e-04
Identities = 23/73 (31%), Positives = 38/73 (52%), Gaps = 4/73 (5%)
Query: 50 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLL 109
V++Y+P G + L + R I ++ A+E +H IH D+KPDN+L+
Sbjct: 79 VMDYIPGGDMMSLLIRLGIFEEDLARFYIA-ELTCAIESVH---KMGFIHRDIKPDNILI 134
Query: 110 DDNLVAYLSDFGI 122
D + L+DFG+
Sbjct: 135 DRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 4e-04
Identities = 32/143 (22%), Positives = 58/143 (40%), Gaps = 27/143 (18%)
Query: 24 EMM--KSIRHRNLIKVISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRL--- 76
E+ + ++H N++ ++ K+ L+ +Y H + +
Sbjct: 52 EIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVK 111
Query: 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLL----DDNLVAYLSDFGIA-------KL 125
+++ + + + YLH S V+H DLKP N+L+ + V + D G+A K
Sbjct: 112 SLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP 168
Query: 126 LIGEDQSMTQTQTLATIGYMAPE 148
L D + TI Y APE
Sbjct: 169 LADLD------PVVVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 6e-04
Identities = 30/116 (25%), Positives = 51/116 (43%), Gaps = 3/116 (2%)
Query: 56 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVA 115
L YL + L + Q + + SA++Y+H +IH D+K +NVL++
Sbjct: 243 RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDI 299
Query: 116 YLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMET 171
L DFG A G + T+ APE + + D++S G+++ E
Sbjct: 300 CLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEA 355
|
Length = 461 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 7e-04
Identities = 28/90 (31%), Positives = 45/90 (50%), Gaps = 4/90 (4%)
Query: 35 IKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCS 94
+K+ S +E + L++EY+P G + L + + R I + A++ +H
Sbjct: 64 VKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIA-ETILAIDSIH---K 119
Query: 95 APVIHCDLKPDNVLLDDNLVAYLSDFGIAK 124
IH D+KPDN+LLD LSDFG+
Sbjct: 120 LGYIHRDIKPDNLLLDAKGHIKLSDFGLCT 149
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 8e-04
Identities = 41/177 (23%), Positives = 73/177 (41%), Gaps = 37/177 (20%)
Query: 34 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGC 93
++K+ S ++ L++E++P G + L + + + + I + A++ +H
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLAIDSIH--- 118
Query: 94 SAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL---------------IGED---QSMTQ 135
IH D+KPDN+LLD LSDFG+ L + D Q+M
Sbjct: 119 QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNS 178
Query: 136 TQ---------------TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 177
+ T+ T Y+APE + + D +S G+++ E G P
Sbjct: 179 KRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.001
Identities = 42/177 (23%), Positives = 67/177 (37%), Gaps = 41/177 (23%)
Query: 97 VIHCDLKPDNVLLDDNL-VAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGR- 154
V+H DLKP N+L+D + ++D G+ + +S T + T+ Y APE
Sbjct: 131 VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY--THEIVTLWYRAPEVLLGSTH 188
Query: 155 VSTNGDVYSFGIMLMETFTGK--------------------KPTYEFFNGEMTLKHW--V 192
ST D++S G + E + PT + + G L+ W
Sbjct: 189 YSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEF 248
Query: 193 NDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVT 249
W P V LS E + + K ++ P +RI+AK +T
Sbjct: 249 PQWKPQDLSRAVPD--LSPEGLDLLQK----MLRYD---------PAKRISAKAALT 290
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.002
Identities = 26/90 (28%), Positives = 46/90 (51%), Gaps = 4/90 (4%)
Query: 34 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGC 93
++ + S + ++ L++E++P G L L + + R M + A+E +H
Sbjct: 63 VVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRF-YMAECVLAIEAVH--- 118
Query: 94 SAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 123
IH D+KPDN+L+D LSDFG++
Sbjct: 119 KLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 38.8 bits (91), Expect = 0.002
Identities = 21/72 (29%), Positives = 40/72 (55%), Gaps = 7/72 (9%)
Query: 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQT 136
+ M + +L+++H + H D+KP+N+L+ D+++ L+DFG + G T
Sbjct: 104 SYMYQLLKSLDHMH---RNGIFHRDIKPENILIKDDILK-LADFGSCR---GIYSKPPYT 156
Query: 137 QTLATIGYMAPE 148
+ ++T Y APE
Sbjct: 157 EYISTRWYRAPE 168
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.002
Identities = 40/177 (22%), Positives = 71/177 (40%), Gaps = 37/177 (20%)
Query: 34 LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGC 93
++K+ S ++ L++E++P G + L + + + + I + A++ +H
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-ETVLAIDAIH--- 118
Query: 94 SAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED------------------QSMTQ 135
IH D+KPDN+LLD LSDFG+ L Q+M
Sbjct: 119 QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178
Query: 136 TQ---------------TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 177
+ T+ T Y+APE + + D +S G+++ E G P
Sbjct: 179 KRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.002
Identities = 40/176 (22%), Positives = 71/176 (40%), Gaps = 39/176 (22%)
Query: 14 RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILD-- 71
RA + E + + H N++K+ +E ++ + L ++Y D
Sbjct: 205 RAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF-DLYSFMYDEA--FDWK 261
Query: 72 ----IFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLI 127
+ Q IM + A+EY+H +IH D+K +N+ L+ + L DFG A
Sbjct: 262 DRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFE 318
Query: 128 GEDQSMTQTQTLATIGYMAPEYGREGRVSTNG-------------DVYSFGIMLME 170
E + A +YG G V+TN D++S G++L++
Sbjct: 319 KERE--------------AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLD 360
|
Length = 501 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 273 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.98 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.93 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.92 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.9 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.86 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.82 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.79 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.76 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.75 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.73 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.7 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.67 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.66 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.65 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.65 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.63 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.62 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.6 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.57 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.56 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.55 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.45 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.43 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.34 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.31 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.3 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.3 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.24 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.23 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.17 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.13 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.1 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.07 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.07 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.06 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.04 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.0 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.93 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.8 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.61 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.56 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.5 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.36 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.36 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.35 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.3 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.2 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.1 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.05 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.99 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.94 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.88 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.8 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.69 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.66 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.62 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 97.59 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.56 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.52 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.34 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.31 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.27 | |
| PLN02236 | 344 | choline kinase | 97.21 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.2 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.02 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.98 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.96 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.84 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 96.79 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.48 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.93 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.44 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 95.39 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 95.34 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.14 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.04 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 94.99 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 94.76 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 94.32 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 94.31 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.28 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 94.05 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 93.69 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 93.49 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 92.58 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 92.55 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-51 Score=331.54 Aligned_cols=230 Identities=23% Similarity=0.329 Sum_probs=191.1
Q ss_pred CeEEEEEeecccCh-------hhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHH
Q 024027 1 MEVAVKVFNLQCGR-------AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 73 (273)
Q Consensus 1 ~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 73 (273)
+.||||+++..... .....++|+++|++++|||||+++++|+.+...||||||++||+|.+++-.++ .+.++
T Consensus 198 k~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk-~l~ed 276 (475)
T KOG0615|consen 198 KQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANK-YLRED 276 (475)
T ss_pred cEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhcc-ccccc
Confidence 57999999765211 12335799999999999999999999999999999999999999999996654 68888
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCC---CceEEeecccccccccCCCcceeecccccCCCCCCccc
Q 024027 74 QRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDN---LVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYG 150 (273)
Q Consensus 74 ~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~---~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 150 (273)
....++.|++.|+.||| +.||+||||||+|||++.+ ..+||+|||++.... ........|||+.|.|||++
T Consensus 277 ~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g---~~sfm~TlCGTpsYvAPEVl 350 (475)
T KOG0615|consen 277 LGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSG---EGSFMKTLCGTPSYVAPEVL 350 (475)
T ss_pred hhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccchhhccc---cceehhhhcCCccccChhhe
Confidence 88999999999999999 9999999999999999765 789999999998753 34456678999999999999
Q ss_pred CCCC---cCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHH
Q 024027 151 REGR---VSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVF 227 (273)
Q Consensus 151 ~~~~---~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 227 (273)
.+.. +..+.||||+||++|-+++|.+||.+.........++.. ....+.......++++..
T Consensus 351 ~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~----------------G~y~f~p~~w~~Iseea~ 414 (475)
T KOG0615|consen 351 ASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILK----------------GRYAFGPLQWDRISEEAL 414 (475)
T ss_pred ecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhc----------------CcccccChhhhhhhHHHH
Confidence 8765 345789999999999999999999875444322222211 122233344678899999
Q ss_pred HHHhhcCCCCccCCCCHHHHHHHHHH
Q 024027 228 NLAMACTVESPEQRINAKEIVTKLLK 253 (273)
Q Consensus 228 ~li~~~l~~dp~~Rps~~~~l~~l~~ 253 (273)
+||.+||..||++|||++|+|+|=|-
T Consensus 415 dlI~~mL~VdP~~R~s~~eaL~hpW~ 440 (475)
T KOG0615|consen 415 DLINWMLVVDPENRPSADEALNHPWF 440 (475)
T ss_pred HHHHHhhEeCcccCcCHHHHhcChhh
Confidence 99999999999999999999999873
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-50 Score=319.18 Aligned_cols=229 Identities=22% Similarity=0.289 Sum_probs=192.4
Q ss_pred eEEEEEeecc-cChhhhhHHHHHHHHhcCCCccceeeeeeeecCCc-eeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 2 EVAVKVFNLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEF-KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 2 ~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
-+|+|++... ++...+++.+|+++++..+||+||++||.|..++. ++|+||||++|+|.+++... +.+++....+++
T Consensus 106 i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia 184 (364)
T KOG0581|consen 106 IYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRV-GRIPEPVLGKIA 184 (364)
T ss_pred EEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHH
Confidence 5899999644 35667889999999999999999999999999995 99999999999999999765 469999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 159 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 159 (273)
.+++.||.|||+ +.+|+||||||+|+|++..|.|||+|||.+..+.+. .....+||..|||||.+.+..|+.++
T Consensus 185 ~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~s 258 (364)
T KOG0581|consen 185 RAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----IANTFVGTSAYMSPERISGESYSVKS 258 (364)
T ss_pred HHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----hcccccccccccChhhhcCCcCCccc
Confidence 999999999994 499999999999999999999999999999877443 44667899999999999999999999
Q ss_pred hhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhh-hhHHHHHHHHhhcCCCCc
Q 024027 160 DVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKE-QCVSFVFNLAMACTVESP 238 (273)
Q Consensus 160 DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~dp 238 (273)
||||||+.++|+..|+.||................... ..++ ..|. .+++++++|+..||.+||
T Consensus 259 DIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~------------~ppP---~lP~~~fS~ef~~FV~~CL~Kdp 323 (364)
T KOG0581|consen 259 DIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD------------EPPP---RLPEGEFSPEFRSFVSCCLRKDP 323 (364)
T ss_pred ceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc------------CCCC---CCCcccCCHHHHHHHHHHhcCCc
Confidence 99999999999999999987642222222222221111 0111 0133 488999999999999999
Q ss_pred cCCCCHHHHHHHHH
Q 024027 239 EQRINAKEIVTKLL 252 (273)
Q Consensus 239 ~~Rps~~~~l~~l~ 252 (273)
.+|||++++++|=.
T Consensus 324 ~~R~s~~qLl~Hpf 337 (364)
T KOG0581|consen 324 SERPSAKQLLQHPF 337 (364)
T ss_pred ccCCCHHHHhcCHH
Confidence 99999999999866
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-49 Score=331.44 Aligned_cols=224 Identities=24% Similarity=0.283 Sum_probs=194.1
Q ss_pred eEEEEEeecc---cChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 2 EVAVKVFNLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 2 ~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
.||+|++... .....+...+|++|-+.++|||||+++++|++..+.|||.|.|..++|..+++ .++.+++.+++.+
T Consensus 45 ~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~K-rrk~ltEpEary~ 123 (592)
T KOG0575|consen 45 VVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLK-RRKPLTEPEARYF 123 (592)
T ss_pred EEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHH-hcCCCCcHHHHHH
Confidence 6999999764 35677889999999999999999999999999999999999999999999986 5568999999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCc
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTN 158 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 158 (273)
+.||+.||.||| +.+|+|||||..|++++.+..|||+|||++..+...+ ......||||-|.|||++....++..
T Consensus 124 l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~--Erk~TlCGTPNYIAPEVl~k~gHsfE 198 (592)
T KOG0575|consen 124 LRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG--ERKKTLCGTPNYIAPEVLNKSGHSFE 198 (592)
T ss_pred HHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCcc--cccceecCCCcccChhHhccCCCCCc
Confidence 999999999999 9999999999999999999999999999999874332 33456799999999999999999999
Q ss_pred chhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc
Q 024027 159 GDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238 (273)
Q Consensus 159 ~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 238 (273)
+||||+||++|.||.|++||....-.++... + .......|...+.++.+||.+||..||
T Consensus 199 vDiWSlGcvmYtLL~G~PPFetk~vkety~~-I--------------------k~~~Y~~P~~ls~~A~dLI~~lL~~~P 257 (592)
T KOG0575|consen 199 VDIWSLGCVMYTLLVGRPPFETKTVKETYNK-I--------------------KLNEYSMPSHLSAEAKDLIRKLLRPNP 257 (592)
T ss_pred hhhhhhhhHHHhhhhCCCCcccchHHHHHHH-H--------------------HhcCcccccccCHHHHHHHHHHhcCCc
Confidence 9999999999999999999987433322211 1 111222356788889999999999999
Q ss_pred cCCCCHHHHHHHHH
Q 024027 239 EQRINAKEIVTKLL 252 (273)
Q Consensus 239 ~~Rps~~~~l~~l~ 252 (273)
.+|||+++|+.|=-
T Consensus 258 ~~Rpsl~~vL~h~F 271 (592)
T KOG0575|consen 258 SERPSLDEVLDHPF 271 (592)
T ss_pred ccCCCHHHHhcCHh
Confidence 99999999998743
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=313.28 Aligned_cols=235 Identities=31% Similarity=0.470 Sum_probs=196.4
Q ss_pred EEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCC-ceeEEEeccCCCCHHHhhhc-CCCCCCHHHHHHH
Q 024027 3 VAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEE-FKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNI 78 (273)
Q Consensus 3 vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~ 78 (273)
||||++...+ ....+.|.+|+.+|++++||||++++|+|.++. .+++||||+++|+|.+++.. .+..+++..+..+
T Consensus 68 vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~ 147 (362)
T KOG0192|consen 68 VAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRI 147 (362)
T ss_pred EEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHH
Confidence 9999998653 233669999999999999999999999999987 79999999999999999987 4668999999999
Q ss_pred HHHHHHHHHHHhcCCCCC-eEeccCCCCceeeCCCC-ceEEeecccccccccCCCcceeecccccCCCCCCcccC--CCC
Q 024027 79 MIDVASALEYLHFGCSAP-VIHCDLKPDNVLLDDNL-VAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR--EGR 154 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~-i~h~di~p~nil~~~~~-~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~ 154 (273)
+.||+.|+.||| +.+ |+|+||||+|+|++.++ ++||+|||+++...... .......||+.|+|||++. ...
T Consensus 148 aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~ 222 (362)
T KOG0192|consen 148 ALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSP 222 (362)
T ss_pred HHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc--ccccCCCCCccccChhhhcCCCCc
Confidence 999999999999 888 99999999999999997 99999999998763321 2223367999999999999 558
Q ss_pred cCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcC
Q 024027 155 VSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACT 234 (273)
Q Consensus 155 ~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 234 (273)
++.++||||||+++|||++|..||........... ... .......+..++..+..|+.+||
T Consensus 223 ~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~-v~~------------------~~~Rp~~p~~~~~~l~~l~~~CW 283 (362)
T KOG0192|consen 223 YTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASA-VVV------------------GGLRPPIPKECPPHLSSLMERCW 283 (362)
T ss_pred CCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHH-HHh------------------cCCCCCCCccCCHHHHHHHHHhC
Confidence 99999999999999999999999987655221111 110 11111123447788999999999
Q ss_pred CCCccCCCCHHHHHHHHHHHHHhhhhh
Q 024027 235 VESPEQRINAKEIVTKLLKIRDSLLRN 261 (273)
Q Consensus 235 ~~dp~~Rps~~~~l~~l~~~~~~~~~~ 261 (273)
..||..||++.+++..|+.+.......
T Consensus 284 ~~dp~~RP~f~ei~~~l~~~~~~~~~~ 310 (362)
T KOG0192|consen 284 LVDPSRRPSFLEIVSRLESIMSHISSA 310 (362)
T ss_pred CCCCCcCCCHHHHHHHHHHHHHhhccc
Confidence 999999999999999999998876543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=318.10 Aligned_cols=231 Identities=34% Similarity=0.536 Sum_probs=198.2
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhc-CCCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~ 80 (273)
+||+|.++.. ....++|.+|+++|++|+|++||+++++|..++.++|||||++.|+|.+||+. .+..++....+.++.
T Consensus 232 ~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~ 310 (468)
T KOG0197|consen 232 KVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAA 310 (468)
T ss_pred cccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHH
Confidence 7999999876 34557899999999999999999999999998899999999999999999986 566799999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
|||+|++||+ +++++||||...|||++.+..+||+|||+++.. ..+.........-+..|.|||.+....++.+||
T Consensus 311 qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~-~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSD 386 (468)
T KOG0197|consen 311 QIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLI-GDDEYTASEGGKFPIKWTAPEALNYGKFSSKSD 386 (468)
T ss_pred HHHHHHHHHH---hCCccchhhhhhheeeccCceEEEccccccccc-CCCceeecCCCCCCceecCHHHHhhCCcccccc
Confidence 9999999999 999999999999999999999999999999933 223222223333466799999999999999999
Q ss_pred hHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCcc
Q 024027 161 VYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239 (273)
Q Consensus 161 iwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 239 (273)
|||||++|||++| |+.||....+.+... . .....+.+.|..||+++.+++..||..+|+
T Consensus 387 VWSFGVlL~E~fT~G~~py~~msn~ev~~--------------~------le~GyRlp~P~~CP~~vY~lM~~CW~~~P~ 446 (468)
T KOG0197|consen 387 VWSFGVLLWELFTYGRVPYPGMSNEEVLE--------------L------LERGYRLPRPEGCPDEVYELMKSCWHEDPE 446 (468)
T ss_pred eeehhhhHHHHhccCCCCCCCCCHHHHHH--------------H------HhccCcCCCCCCCCHHHHHHHHHHhhCCcc
Confidence 9999999999999 888987755443211 1 133445666899999999999999999999
Q ss_pred CCCCHHHHHHHHHHHHHh
Q 024027 240 QRINAKEIVTKLLKIRDS 257 (273)
Q Consensus 240 ~Rps~~~~l~~l~~~~~~ 257 (273)
+|||++.+...++++...
T Consensus 447 ~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 447 DRPTFETLREVLEDFFTS 464 (468)
T ss_pred cCCCHHHHHHHHHHhhhc
Confidence 999999999999887653
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-47 Score=293.18 Aligned_cols=230 Identities=23% Similarity=0.328 Sum_probs=184.7
Q ss_pred eEEEEEeecc--cChhhhhHHHHHHHHhcCCCccceeeee-eeecCCc-eeEEEeccCCCCHHHhhh---cCCCCCCHHH
Q 024027 2 EVAVKVFNLQ--CGRAFKSFDVECEMMKSIRHRNLIKVIS-SCSNEEF-KALVLEYMPHGSLEKYLY---SSNCILDIFQ 74 (273)
Q Consensus 2 ~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~-~~~~~~~-~~lv~e~~~~~~L~~~l~---~~~~~~~~~~ 74 (273)
.||.|.++.+ +..+++....|+.+|++|+||||+++++ .|.++.. ++||||+|.+|+|.++++ +.+..+++..
T Consensus 46 l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~ 125 (375)
T KOG0591|consen 46 LVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKT 125 (375)
T ss_pred hhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHH
Confidence 5788888755 3556788999999999999999999999 5655554 899999999999999985 4456799999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCC-eEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCC
Q 024027 75 RLNIMIDVASALEYLHFGCSAP-VIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG 153 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~~-i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 153 (273)
+|+++.|++.||.++|+++.+| +.||||||.||+++.+|.+||+|||++..+. .........+|||.|++||.+.+.
T Consensus 126 Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~--s~~tfA~S~VGTPyYMSPE~i~~~ 203 (375)
T KOG0591|consen 126 VWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS--SKTTFAHSLVGTPYYMSPERIHES 203 (375)
T ss_pred HHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc--chhHHHHhhcCCCcccCHHHHhcC
Confidence 9999999999999999544443 8899999999999999999999999999873 334456678999999999999999
Q ss_pred CcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhc
Q 024027 154 RVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMAC 233 (273)
Q Consensus 154 ~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 233 (273)
+|+.+|||||+||++|||..-++||.+. .+..... .+... ..........+.++..|+..|
T Consensus 204 ~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L~~---------KI~qg-----d~~~~p~~~YS~~l~~li~~c 264 (375)
T KOG0591|consen 204 GYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSLCK---------KIEQG-----DYPPLPDEHYSTDLRELINMC 264 (375)
T ss_pred CCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHHHH---------HHHcC-----CCCCCcHHHhhhHHHHHHHHH
Confidence 9999999999999999999999999874 1111111 11111 111011256778899999999
Q ss_pred CCCCccCCCCHHHHHHHHH
Q 024027 234 TVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 234 l~~dp~~Rps~~~~l~~l~ 252 (273)
+.+||..||+.-.++..+.
T Consensus 265 i~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 265 IAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred ccCCcccCCCcchHHHHHH
Confidence 9999999998655544443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=302.06 Aligned_cols=225 Identities=27% Similarity=0.413 Sum_probs=184.3
Q ss_pred CeEEEEEeecc--cChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 1 MEVAVKVFNLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 1 ~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
..||||.+... .....+.+..|+++|+.++|||||++++++.+++.+++|||||+||+|.+|+++.+ .+++..++.+
T Consensus 36 ~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~-~l~e~t~r~F 114 (429)
T KOG0595|consen 36 TEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRRG-RLPEATARHF 114 (429)
T ss_pred ceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHcC-CCCHHHHHHH
Confidence 37999999876 45567778999999999999999999999999999999999999999999997665 7999999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCC------CceEEeecccccccccCCCcceeecccccCCCCCCcccCC
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDN------LVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE 152 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~------~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 152 (273)
+.||+.||++|| +++|+||||||.|||++.. ..+||+|||+++.+. ........+|++.|||||++..
T Consensus 115 m~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~---~~~~a~tlcGSplYMAPEV~~~ 188 (429)
T KOG0595|consen 115 MQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ---PGSMAETLCGSPLYMAPEVIMS 188 (429)
T ss_pred HHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC---chhHHHHhhCCccccCHHHHHh
Confidence 999999999999 9999999999999999764 468999999999874 2334566899999999999999
Q ss_pred CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhh
Q 024027 153 GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMA 232 (273)
Q Consensus 153 ~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 232 (273)
..|+.|+|+||+|+++|++++|+.||......+-.. .+.. ........+..++...++|+..
T Consensus 189 ~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~-~~~k-----------------~~~~~~~~~~~~s~~~~~Ll~~ 250 (429)
T KOG0595|consen 189 QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLL-YIKK-----------------GNEIVPVLPAELSNPLRELLIS 250 (429)
T ss_pred ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHH-HHhc-----------------cccccCchhhhccCchhhhhhH
Confidence 999999999999999999999999998644433222 1110 0111111234445556778888
Q ss_pred cCCCCccCCCCHHHHHHH
Q 024027 233 CTVESPEQRINAKEIVTK 250 (273)
Q Consensus 233 ~l~~dp~~Rps~~~~l~~ 250 (273)
.+..+|.+|.+..+-+.+
T Consensus 251 ll~~~~~~~~~~~~~~~~ 268 (429)
T KOG0595|consen 251 LLQRNPKDRISFEDFFDH 268 (429)
T ss_pred HHhcCccccCchHHhhhh
Confidence 888888888877766554
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=291.07 Aligned_cols=243 Identities=22% Similarity=0.243 Sum_probs=192.1
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
+-||||+|..+. +.-.+-..+|+++|++++|+|+|.++.+|...+.+++|||||+. ++.+-+.......+...+.++
T Consensus 28 qIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-TvL~eLe~~p~G~~~~~vk~~ 106 (396)
T KOG0593|consen 28 QIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-TVLHELERYPNGVPSELVKKY 106 (396)
T ss_pred cEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch-HHHHHHHhccCCCCHHHHHHH
Confidence 469999997553 33456678999999999999999999999999999999999987 787888887778999999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC-CCcCC
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE-GRVST 157 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~ 157 (273)
++|++.|+.|+| +++++||||||+||+++.+|.+||+|||+++.+.. .....+..+.|.||+|||++.+ ..|+.
T Consensus 107 l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pgd~YTDYVATRWYRaPELLvGDtqYG~ 181 (396)
T KOG0593|consen 107 LYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA--PGDNYTDYVATRWYRAPELLVGDTQYGK 181 (396)
T ss_pred HHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcC--CcchhhhhhhhhhccChhhhcccCcCCC
Confidence 999999999999 99999999999999999999999999999998743 3334566788999999999998 57999
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhcc--Cccchhhhhhhc------cc---cchhhhhhhhhhHHHH
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWL--PISTMEVVDANL------LS---QEDIHFVAKEQCVSFV 226 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~------~~---~~~~~~~~~~~~~~~l 226 (273)
..||||+||++.||++|.+.|.+...- +.+..+..... .+........+. .+ ...-.....+..+.-+
T Consensus 182 pVDiWAiGCv~aEl~~G~pL~PG~SDi-DQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ 260 (396)
T KOG0593|consen 182 PVDIWAIGCVFAELLTGEPLWPGRSDI-DQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVL 260 (396)
T ss_pred cccchhhhHHHHHHhcCCcCCCCcchH-HHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHH
Confidence 999999999999999999998764332 22222222211 111111111111 00 0111112234566679
Q ss_pred HHHHhhcCCCCccCCCCHHHHHHH
Q 024027 227 FNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 227 ~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
.+|+.+||..||.+|+|.++++.|
T Consensus 261 ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 261 LDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred HHHHHHHhcCCccccccHHHHhcC
Confidence 999999999999999999999976
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=281.46 Aligned_cols=244 Identities=22% Similarity=0.279 Sum_probs=196.1
Q ss_pred CeEEEEEeecccCh--hhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 1 MEVAVKVFNLQCGR--AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 1 ~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
+.||||+++.+... .-....+|++.|+.++|+||+.++++|...+.+.+|+||++. +|+..++.....++...+..|
T Consensus 28 ~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t-dLe~vIkd~~i~l~pa~iK~y 106 (318)
T KOG0659|consen 28 KRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT-DLEVVIKDKNIILSPADIKSY 106 (318)
T ss_pred cEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc-cHHHHhcccccccCHHHHHHH
Confidence 47999999877433 245677999999999999999999999999999999999987 999999988888999999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCC-cCC
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGR-VST 157 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~ 157 (273)
+.+++.|++||| .+.|.||||||.|+|++.+|.+|++|||+++.+...+.. ....+.|.+|+|||++.|.. |+.
T Consensus 107 ~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~--~~~~V~TRWYRAPELLfGsr~Yg~ 181 (318)
T KOG0659|consen 107 MLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI--QTHQVVTRWYRAPELLFGSRQYGT 181 (318)
T ss_pred HHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc--cccceeeeeccChHHhccchhcCC
Confidence 999999999999 999999999999999999999999999999988544432 33348899999999998865 999
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhh---------hhccccchhhhhhhhhhHHHHHH
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVD---------ANLLSQEDIHFVAKEQCVSFVFN 228 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~l~~ 228 (273)
..||||.||++.||+.|.+-|.+ .++-.++..+......+...++.+ ........... .-..++.++.|
T Consensus 182 ~VDmWavGCI~AELllr~P~fpG-~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~-lf~aas~d~ld 259 (318)
T KOG0659|consen 182 GVDMWAVGCIFAELLLRVPFFPG-DSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNN-LFPAASSDALD 259 (318)
T ss_pred cchhhhHHHHHHHHHccCCCCCC-CchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCcccc-ccccccHHHHH
Confidence 99999999999999998877655 333344444444333322222211 11122222222 23456777899
Q ss_pred HHhhcCCCCccCCCCHHHHHHHHH
Q 024027 229 LAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 229 li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
|+.+||.+||.+|+|++++++|=.
T Consensus 260 Ll~~m~~ynP~~Rita~qaL~~~y 283 (318)
T KOG0659|consen 260 LLSKMLTYNPKKRITASQALKHPY 283 (318)
T ss_pred HHHhhhccCchhcccHHHHhcchh
Confidence 999999999999999999998743
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-45 Score=301.57 Aligned_cols=244 Identities=24% Similarity=0.235 Sum_probs=194.0
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecC--CceeEEEeccCCCCHHHhhhcCCCCCCHHHHH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNE--EFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (273)
+-||+|+++.+. +....-..+|+.||++|.||||+++.+...+. +.+|||||||+. +|..++...+-.+++.++.
T Consensus 143 kivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIK 221 (560)
T KOG0600|consen 143 KIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIK 221 (560)
T ss_pred cEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhcCCCcccChHHHH
Confidence 369999998775 44455567899999999999999999988776 789999999988 9999998877789999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCC-Cc
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG-RV 155 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~ 155 (273)
.++.||+.||.||| .+|+.|||||.+|||++.+|.+||+|||+++++...... ..+..+.|.||+|||++.|. .|
T Consensus 222 c~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~-~~T~rVvTLWYRpPELLLG~t~Y 297 (560)
T KOG0600|consen 222 CYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSA-PYTSRVVTLWYRPPELLLGATSY 297 (560)
T ss_pred HHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCCCCc-ccccceEEeeccChHHhcCCccc
Confidence 99999999999999 999999999999999999999999999999987554432 35677899999999999886 49
Q ss_pred CCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhh--ccCccchhhhh-------hhccccchhhhhhhhhhHHHH
Q 024027 156 STNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVND--WLPISTMEVVD-------ANLLSQEDIHFVAKEQCVSFV 226 (273)
Q Consensus 156 ~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~l 226 (273)
+.+.|+||.|||+.||+.|++.|.+..+-+ ++..+... .+....+...+ ................++...
T Consensus 298 g~aVDlWS~GCIl~El~~gkPI~~G~tEve-Ql~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~ 376 (560)
T KOG0600|consen 298 GTAVDLWSVGCILAELFLGKPILQGRTEVE-QLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASA 376 (560)
T ss_pred ccceeehhhhHHHHHHHcCCCCcCCccHHH-HHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHH
Confidence 999999999999999999999987744332 22222222 22222222000 000111112222245567789
Q ss_pred HHHHhhcCCCCccCCCCHHHHHHH
Q 024027 227 FNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 227 ~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
.+|+..||..||.+|.|+.++|.+
T Consensus 377 l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 377 LDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred HHHHHHHhccCccccccHHHHhcC
Confidence 999999999999999999999864
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=306.54 Aligned_cols=226 Identities=26% Similarity=0.394 Sum_probs=190.6
Q ss_pred CeEEEEEeecc---cChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHH
Q 024027 1 MEVAVKVFNLQ---CGRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (273)
+.+|||++... .......+..|=++|.+| .||.|++++-.|+|+..+|+|+||+++|+|.++|++.+ .+++..++
T Consensus 99 keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~G-sfde~caR 177 (604)
T KOG0592|consen 99 KEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKYG-SFDETCAR 177 (604)
T ss_pred ceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHhC-cchHHHHH
Confidence 46899998644 233345677888999999 89999999999999999999999999999999998775 79999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCc---------cee--ecccccCCCC
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQS---------MTQ--TQTLATIGYM 145 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~---------~~~--~~~~~~~~~~ 145 (273)
.++.+|+.||.||| ++||+||||||+|||++.++.++|+|||.+..+...... ... ...+||..|.
T Consensus 178 ~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYV 254 (604)
T KOG0592|consen 178 FYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYV 254 (604)
T ss_pred HHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeeccc
Confidence 99999999999999 999999999999999999999999999999888644332 111 3478999999
Q ss_pred CCcccCCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHH
Q 024027 146 APEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSF 225 (273)
Q Consensus 146 aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (273)
+||++.....+.++|+|+|||++|+|+.|.+||....+- -.+.. ...+....+.++++.
T Consensus 255 SPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney-liFqk--------------------I~~l~y~fp~~fp~~ 313 (604)
T KOG0592|consen 255 SPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY-LIFQK--------------------IQALDYEFPEGFPED 313 (604)
T ss_pred CHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH-HHHHH--------------------HHHhcccCCCCCCHH
Confidence 999999999999999999999999999999999874321 11111 112233346778888
Q ss_pred HHHHHhhcCCCCccCCCCHHHHHHHH
Q 024027 226 VFNLAMACTVESPEQRINAKEIVTKL 251 (273)
Q Consensus 226 l~~li~~~l~~dp~~Rps~~~~l~~l 251 (273)
+.+|+.++|..||.+|+|+++|-+|-
T Consensus 314 a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 314 ARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred HHHHHHHHHccCccccccHHHHhhCc
Confidence 99999999999999999999888774
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=303.82 Aligned_cols=225 Identities=24% Similarity=0.327 Sum_probs=187.5
Q ss_pred CeEEEEEeecc----cC-hhhhhHHHHHHHHhcCC-CccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHH
Q 024027 1 MEVAVKVFNLQ----CG-RAFKSFDVECEMMKSIR-HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQ 74 (273)
Q Consensus 1 ~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (273)
+.||||++... .. ...+.+.+|+.+++.++ ||||+++++++.....+++||||+.||+|.+++.. .+++.+..
T Consensus 43 ~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ 121 (370)
T KOG0583|consen 43 EKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVN-KGRLKEDE 121 (370)
T ss_pred CeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHH-cCCCChHH
Confidence 37999987653 11 23456778999999998 99999999999999999999999999999999987 66799999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCC-CceEEeecccccccccCCCcceeecccccCCCCCCcccCCC
Q 024027 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDN-LVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG 153 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~-~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 153 (273)
+..+|+|+++|++||| +.||+||||||+|++++.+ +.+||+|||++.... .........+|++.|+|||++.+.
T Consensus 122 ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~ 196 (370)
T KOG0583|consen 122 ARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGK 196 (370)
T ss_pred HHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCC
Confidence 9999999999999999 9999999999999999999 999999999998763 223345667899999999999987
Q ss_pred C-cC-CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhh-HHHHHHHH
Q 024027 154 R-VS-TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQC-VSFVFNLA 230 (273)
Q Consensus 154 ~-~~-~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li 230 (273)
. |+ .++||||+|+++|.|++|..||.+...... +..+. ......|..+ +.++.+|+
T Consensus 197 ~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l-~~ki~--------------------~~~~~~p~~~~S~~~~~Li 255 (370)
T KOG0583|consen 197 GTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNL-YRKIR--------------------KGEFKIPSYLLSPEARSLI 255 (370)
T ss_pred CCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHH-HHHHh--------------------cCCccCCCCcCCHHHHHHH
Confidence 7 75 789999999999999999999987222211 11111 1111224445 78899999
Q ss_pred hhcCCCCccCCCCHHHHHHHHH
Q 024027 231 MACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 231 ~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
.+||..||.+|+|+.+++.|=|
T Consensus 256 ~~mL~~~P~~R~t~~~i~~h~w 277 (370)
T KOG0583|consen 256 EKMLVPDPSTRITLLEILEHPW 277 (370)
T ss_pred HHHcCCCcccCCCHHHHhhChh
Confidence 9999999999999999997666
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-45 Score=305.08 Aligned_cols=225 Identities=25% Similarity=0.339 Sum_probs=191.7
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
+.||||.+........+-+.+|+.+|+..+|+|||.+++.|.....+++||||++||+|.+.+.... +++.+|..++.
T Consensus 299 ~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~~~--~~E~qIA~Icr 376 (550)
T KOG0578|consen 299 QEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTKTR--MTEGQIAAICR 376 (550)
T ss_pred ceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhccc--ccHHHHHHHHH
Confidence 3699999987765566778999999999999999999999998899999999999999999986554 99999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
.+++||+||| .+||+|+|||.+|||++.+|.+||+|||+|..+..... ....-+||++|+|||+.....|+.+.|
T Consensus 377 e~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVD 451 (550)
T KOG0578|consen 377 EILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVD 451 (550)
T ss_pred HHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC--ccccccCCCCccchhhhhhcccCcccc
Confidence 9999999999 99999999999999999999999999999987744332 345678999999999999999999999
Q ss_pred hHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccC
Q 024027 161 VYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQ 240 (273)
Q Consensus 161 iwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 240 (273)
|||||++..||+-|++||-.... ....+.- -..+......+..++.++++|+.+||+.|+.+
T Consensus 452 IWSLGIMaIEMveGEPPYlnE~P---lrAlyLI---------------a~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~ 513 (550)
T KOG0578|consen 452 IWSLGIMAIEMVEGEPPYLNENP---LRALYLI---------------ATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQ 513 (550)
T ss_pred chhhhhHHHHHhcCCCCccCCCh---HHHHHHH---------------hhcCCCCcCCccccCHHHHHHHHHHhhcchhc
Confidence 99999999999999999865211 1111110 01122223336778999999999999999999
Q ss_pred CCCHHHHHHH
Q 024027 241 RINAKEIVTK 250 (273)
Q Consensus 241 Rps~~~~l~~ 250 (273)
|+|+.|+|+|
T Consensus 514 RasA~eLL~H 523 (550)
T KOG0578|consen 514 RASAKELLEH 523 (550)
T ss_pred CCCHHHHhcC
Confidence 9999999987
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=309.92 Aligned_cols=225 Identities=26% Similarity=0.334 Sum_probs=191.8
Q ss_pred CeEEEEEeecc---cChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
|.+|||++... .......+.+|+-+|+.+.|||++++|++|++..++|+|.||++||.|++++-+.+ ++.+.++++
T Consensus 38 qlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG-~l~e~eaa~ 116 (786)
T KOG0588|consen 38 QLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKG-PLPEREAAH 116 (786)
T ss_pred ceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhhC-CCCCHHHHH
Confidence 46899999654 23456779999999999999999999999999999999999999999999997665 689999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCc-C
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRV-S 156 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~ 156 (273)
+++||+.|+.||| ..+|||+|+||+|+|++..+.+||+|||++..- ....-....||++.|.|||++.|..| +
T Consensus 117 ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe---~~gklLeTSCGSPHYA~PEIV~G~pYdG 190 (786)
T KOG0588|consen 117 FFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLE---VPGKLLETSCGSPHYAAPEIVSGRPYDG 190 (786)
T ss_pred HHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecc---cCCccccccCCCcccCCchhhcCCCCCC
Confidence 9999999999999 999999999999999999999999999999753 22223456799999999999999887 6
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++||||-|+|+|.||+|..||.+..-. ..+ .+.....+..|..++.++.+||.+||+.
T Consensus 191 ~~sDVWSCGVILfALLtG~LPFdDdNir-~LL--------------------lKV~~G~f~MPs~Is~eaQdLLr~ml~V 249 (786)
T KOG0588|consen 191 RPSDVWSCGVILFALLTGKLPFDDDNIR-VLL--------------------LKVQRGVFEMPSNISSEAQDLLRRMLDV 249 (786)
T ss_pred CccccchhHHHHHHHHhCCCCCCCccHH-HHH--------------------HHHHcCcccCCCcCCHHHHHHHHHHhcc
Confidence 7899999999999999999999752111 111 1122223344788899999999999999
Q ss_pred CccCCCCHHHHHHHHHH
Q 024027 237 SPEQRINAKEIVTKLLK 253 (273)
Q Consensus 237 dp~~Rps~~~~l~~l~~ 253 (273)
||++|+|.++|++|-+-
T Consensus 250 Dp~~RiT~~eI~kHP~l 266 (786)
T KOG0588|consen 250 DPSTRITTEEILKHPFL 266 (786)
T ss_pred CccccccHHHHhhCchh
Confidence 99999999999999763
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-45 Score=294.88 Aligned_cols=233 Identities=29% Similarity=0.401 Sum_probs=187.8
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCC--ceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEE--FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
.+|||.+...+....+.+.+|+.+|++++|||||+++|...... .++++|||+++|+|.+++.+.+..+++..+..+.
T Consensus 44 ~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~yt 123 (313)
T KOG0198|consen 44 LMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYT 123 (313)
T ss_pred ceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHH
Confidence 47899887654444677999999999999999999999754444 6899999999999999998877689999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCC-CCceEEeecccccccccC-CCcceeecccccCCCCCCcccCCC-CcC
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDD-NLVAYLSDFGIAKLLIGE-DQSMTQTQTLATIGYMAPEYGREG-RVS 156 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~-~~~~kl~Df~~~~~~~~~-~~~~~~~~~~~~~~~~aPE~~~~~-~~~ 156 (273)
.|++.||.||| ++|++|+||||+|||++. ++.+||+|||.+...... ..........||+.|+|||++.+. ...
T Consensus 124 r~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~ 200 (313)
T KOG0198|consen 124 RQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVAR 200 (313)
T ss_pred HHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCC
Confidence 99999999999 999999999999999999 799999999998876431 112233456799999999999853 334
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccc-cccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEF-FNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTV 235 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 235 (273)
.++|||||||++.||++|.+||... ...+..+...... .....|..++.++.+|+.+|+.
T Consensus 201 ~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~-------------------~~P~ip~~ls~~a~~Fl~~C~~ 261 (313)
T KOG0198|consen 201 RESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED-------------------SLPEIPDSLSDEAKDFLRKCFK 261 (313)
T ss_pred ccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC-------------------CCCCCCcccCHHHHHHHHHHhh
Confidence 5999999999999999999999874 1111111100000 0113366688889999999999
Q ss_pred CCccCCCCHHHHHHHHHHHHH
Q 024027 236 ESPEQRINAKEIVTKLLKIRD 256 (273)
Q Consensus 236 ~dp~~Rps~~~~l~~l~~~~~ 256 (273)
.||++|||++++|+|.-...+
T Consensus 262 ~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 262 RDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred cCcccCcCHHHHhhChhhhcc
Confidence 999999999999999875443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=301.50 Aligned_cols=241 Identities=19% Similarity=0.209 Sum_probs=192.2
Q ss_pred eEEEEEeecccCh-hhhhHHHHHHHHhcCC-CccceeeeeeeecCC-ceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 2 EVAVKVFNLQCGR-AFKSFDVECEMMKSIR-HRNLIKVISSCSNEE-FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 2 ~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
-||||.+|..... +.-.-.+|++.|++++ ||||+++.+++.+.. .+++|||||+. +|+++++..+..+++..+..|
T Consensus 37 ~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irni 115 (538)
T KOG0661|consen 37 LVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNI 115 (538)
T ss_pred eeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHH
Confidence 4899999876432 2223458999999998 999999999998877 99999999977 999999988889999999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCC-CcCC
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG-RVST 157 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~ 157 (273)
+.||++||+|+| .+|+.|||+||+|||+..+..+||+|||+++.+.... ..+..+.|.||+|||++... .|+.
T Consensus 116 m~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~ 189 (538)
T KOG0661|consen 116 MYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKP---PYTEYVSTRWYRAPEVLLRSGYYSS 189 (538)
T ss_pred HHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccccCC---CcchhhhcccccchHHhhhccccCC
Confidence 999999999999 9999999999999999999999999999999774433 35667899999999988765 5899
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhh-----hhc------cccchhhhhhhhhhHHHH
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVD-----ANL------LSQEDIHFVAKEQCVSFV 226 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~------~~~~~~~~~~~~~~~~~l 226 (273)
+.||||+||+++|+.+-++.|.+..+ .+....+.+....+....+.. ..+ .....+....+ .++.++
T Consensus 190 pvD~wA~GcI~aEl~sLrPLFPG~sE-~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p-~~s~~~ 267 (538)
T KOG0661|consen 190 PVDMWAVGCIMAELYSLRPLFPGASE-IDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLP-NASSEA 267 (538)
T ss_pred chHHHHHHHHHHHHHHhcccCCCCcH-HHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCc-ccCHHH
Confidence 99999999999999999999877433 333444444333332222221 111 01112222333 388899
Q ss_pred HHHHhhcCCCCccCCCCHHHHHHHH
Q 024027 227 FNLAMACTVESPEQRINAKEIVTKL 251 (273)
Q Consensus 227 ~~li~~~l~~dp~~Rps~~~~l~~l 251 (273)
.++|.+|+.+||.+|||++++++|-
T Consensus 268 ~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 268 ASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHHHHHHhcCCCccCccHHHHhcCc
Confidence 9999999999999999999999874
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=291.59 Aligned_cols=237 Identities=25% Similarity=0.357 Sum_probs=195.4
Q ss_pred eEEEEEeecc-cChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcC-CCCCCHHHHHHHH
Q 024027 2 EVAVKVFNLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIM 79 (273)
Q Consensus 2 ~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ 79 (273)
.||||++.-. +..+...+.+|++.++.++||||++.+.+|..+..+++||.||.+|++.+.++.. ...+++..|..++
T Consensus 53 ~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iL 132 (516)
T KOG0582|consen 53 VVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATIL 132 (516)
T ss_pred EEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHH
Confidence 5999999855 4556889999999999999999999999999999999999999999999999643 3359999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCC-ccee-ecccccCCCCCCcccCC--CCc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQ-SMTQ-TQTLATIGYMAPEYGRE--GRV 155 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~-~~~~-~~~~~~~~~~aPE~~~~--~~~ 155 (273)
.+++.||.||| ++|.+|||||+.|||++.+|.|+|+|||..-.+...+. .... ...+|++.|+|||++.. ..|
T Consensus 133 re~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GY 209 (516)
T KOG0582|consen 133 REVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGY 209 (516)
T ss_pred HHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCc
Confidence 99999999999 99999999999999999999999999998765543322 1112 45689999999999654 469
Q ss_pred CCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCC
Q 024027 156 STNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTV 235 (273)
Q Consensus 156 ~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 235 (273)
+.|+||||||++..|+.+|..||.....-...+..+....+... . ...+.......+..++.++..||+
T Consensus 210 dfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~-t----------~~~~~d~~k~~~ksf~e~i~~CL~ 278 (516)
T KOG0582|consen 210 DFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL-T----------SGLDKDEDKKFSKSFREMIALCLV 278 (516)
T ss_pred cchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc-c----------ccCChHHhhhhcHHHHHHHHHHhh
Confidence 99999999999999999999999987766665555544433222 1 111222234455679999999999
Q ss_pred CCccCCCCHHHHHHHHH
Q 024027 236 ESPEQRINAKEIVTKLL 252 (273)
Q Consensus 236 ~dp~~Rps~~~~l~~l~ 252 (273)
.||.+|||++++++|=.
T Consensus 279 kDP~kRptAskLlkh~F 295 (516)
T KOG0582|consen 279 KDPSKRPTASKLLKHAF 295 (516)
T ss_pred cCcccCCCHHHHhccHH
Confidence 99999999999998743
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=316.57 Aligned_cols=235 Identities=32% Similarity=0.529 Sum_probs=202.7
Q ss_pred CeEEEEEeecccCh-hhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC------------
Q 024027 1 MEVAVKVFNLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN------------ 67 (273)
Q Consensus 1 ~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------ 67 (273)
+-||||.+|...+. ..++|++|++++..++|||||+++|+|..++.+++|||||..|||.+||....
T Consensus 517 ~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~ 596 (774)
T KOG1026|consen 517 QLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDT 596 (774)
T ss_pred eehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCC
Confidence 35999999987655 78999999999999999999999999999999999999999999999995332
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCC
Q 024027 68 -CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMA 146 (273)
Q Consensus 68 -~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~a 146 (273)
.+++..+.+.++.||+.|+.||. ++.++||||..+|+||.++..|||+|||+++..-+.+-........-+.+|||
T Consensus 597 ~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMp 673 (774)
T KOG1026|consen 597 PPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMP 673 (774)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCC
Confidence 23788899999999999999999 99999999999999999999999999999987654443333334456788999
Q ss_pred CcccCCCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHH
Q 024027 147 PEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSF 225 (273)
Q Consensus 147 PE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (273)
||.+...+++.+|||||+||++||+++ |..||.+..+.+.-.. + ... ...+.|++||.+
T Consensus 674 pEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~--------------i-----~~g-~lL~~Pe~CP~~ 733 (774)
T KOG1026|consen 674 PESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC--------------I-----RAG-QLLSCPENCPTE 733 (774)
T ss_pred HHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHH--------------H-----HcC-CcccCCCCCCHH
Confidence 999999999999999999999999998 9999988766543211 1 112 226669999999
Q ss_pred HHHHHhhcCCCCccCCCCHHHHHHHHHHHHHhh
Q 024027 226 VFNLAMACTVESPEQRINAKEIVTKLLKIRDSL 258 (273)
Q Consensus 226 l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 258 (273)
+++||..||..+|++|||++||-..|++..+.-
T Consensus 734 vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 734 VYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred HHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 999999999999999999999999999887653
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=287.61 Aligned_cols=223 Identities=29% Similarity=0.323 Sum_probs=184.4
Q ss_pred eEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 2 EVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 2 ~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
-+|+|+++... ....+...+|..+|..++||.|++++..|++.+.+|+|+||+.||.|...|++.+ .+++..+.-+
T Consensus 52 iYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg-~F~E~~arfY 130 (357)
T KOG0598|consen 52 IYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQREG-RFSEDRARFY 130 (357)
T ss_pred eeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhcC-CcchhHHHHH
Confidence 47899997652 3356778899999999999999999999999999999999999999999997665 6999999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCc
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTN 158 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 158 (273)
+..|+.||.||| +.||+|||+||+|||++.+|.++|+|||++.... .........+||+.|+|||++.+..|+..
T Consensus 131 laEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~--~~~~~t~tfcGT~eYmAPEil~~~gy~~~ 205 (357)
T KOG0598|consen 131 LAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL--KDGDATRTFCGTPEYMAPEILLGKGYDKA 205 (357)
T ss_pred HHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcc--cCCCccccccCCccccChHHHhcCCCCcc
Confidence 999999999999 9999999999999999999999999999998542 22233455799999999999999999999
Q ss_pred chhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc
Q 024027 159 GDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238 (273)
Q Consensus 159 ~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 238 (273)
+|.||||+++|+|++|.+||.........-...... ....+...+.+.+++++++|..||
T Consensus 206 vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k--------------------~~~~p~~ls~~ardll~~LL~rdp 265 (357)
T KOG0598|consen 206 VDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK--------------------LPLPPGYLSEEARDLLKKLLKRDP 265 (357)
T ss_pred cchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc--------------------CCCCCccCCHHHHHHHHHHhccCH
Confidence 999999999999999999998744332211110000 011133377889999999999999
Q ss_pred cCCC----CHHHHHHH
Q 024027 239 EQRI----NAKEIVTK 250 (273)
Q Consensus 239 ~~Rp----s~~~~l~~ 250 (273)
++|. ++.++-+|
T Consensus 266 ~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 266 RQRLGGPGDAEEIKRH 281 (357)
T ss_pred HHhcCCCCChHHhhcC
Confidence 9996 45554333
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=289.04 Aligned_cols=223 Identities=23% Similarity=0.317 Sum_probs=189.4
Q ss_pred CeEEEEEeecc---cChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
|.||||.++.+ +..+.-.+.+|++|++.|+||||+.++.+|+..+.+.|||||..+|.|++|+...+ .+++.+++.
T Consensus 79 R~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer~-~LsErEaRh 157 (668)
T KOG0611|consen 79 REVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISERG-SLSEREARH 157 (668)
T ss_pred cEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHhc-cccHHHHHH
Confidence 57999999866 45667778999999999999999999999999999999999999999999996544 699999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCc-C
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRV-S 156 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~ 156 (273)
+|.||++|+.||| +++++|+|||.+|||+|.++++||+|||+++.+.. .......||++-|.+||+..|..| +
T Consensus 158 fFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~---~kfLqTFCGSPLYASPEIvNG~PY~G 231 (668)
T KOG0611|consen 158 FFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD---KKFLQTFCGSPLYASPEIVNGTPYKG 231 (668)
T ss_pred HHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhcc---ccHHHHhcCCcccCCccccCCCCCCC
Confidence 9999999999999 99999999999999999999999999999987732 334567899999999999999887 6
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
+..|.||||+++|.+..|..||.+.+-.... .++. .+.. ..+.-+..+..||++||..
T Consensus 232 PEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lv-rQIs------------------~GaY---rEP~~PSdA~gLIRwmLmV 289 (668)
T KOG0611|consen 232 PEVDSWSLGVLLYTLVYGTMPFDGRDHKRLV-RQIS------------------RGAY---REPETPSDASGLIRWMLMV 289 (668)
T ss_pred CccchhhHHHHHHHHhhcccccCCchHHHHH-HHhh------------------cccc---cCCCCCchHHHHHHHHHhc
Confidence 7899999999999999999999875332111 1100 0110 0222344578899999999
Q ss_pred CccCCCCHHHHHHHHH
Q 024027 237 SPEQRINAKEIVTKLL 252 (273)
Q Consensus 237 dp~~Rps~~~~l~~l~ 252 (273)
||.+|.|+.++.+|.|
T Consensus 290 NP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 290 NPERRATIEDIASHWW 305 (668)
T ss_pred CcccchhHHHHhhhhe
Confidence 9999999999999987
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=291.29 Aligned_cols=250 Identities=38% Similarity=0.608 Sum_probs=195.3
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCC-ceeEEEeccCCCCHHHhhhcCCC-CCCHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEE-FKALVLEYMPHGSLEKYLYSSNC-ILDIFQRLNI 78 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~ 78 (273)
+.||||.+........++|..|+.++.+++|||+++++|||.+.+ ..++|+||+++|+|.+++..... .++|..+.+|
T Consensus 100 ~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kI 179 (361)
T KOG1187|consen 100 TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKI 179 (361)
T ss_pred CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHH
Confidence 469999887654321466999999999999999999999999988 59999999999999999987665 8999999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecc-cccCCCCCCcccCCCCcCC
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQT-LATIGYMAPEYGREGRVST 157 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~-~~~~~~~aPE~~~~~~~~~ 157 (273)
+.+++.||+|||+.+...|+||||||+|||+|.+...||+|||++...... ....... .||.+|+|||.......+.
T Consensus 180 a~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~ 257 (361)
T KOG1187|consen 180 ALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTE 257 (361)
T ss_pred HHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCc
Confidence 999999999999755557999999999999999999999999999543221 1112222 7999999999998888999
Q ss_pred cchhHHHHHHHHHHHhCCCCCcccc-ccccchhhhhhh-ccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFF-NGEMTLKHWVND-WLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTV 235 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 235 (273)
++||||||+++.|+++|+.|..... .++..+..|... .......+.++..+..... . ....-..+..+..+|+.
T Consensus 258 KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~-~---~~~~~~~~~~~a~~C~~ 333 (361)
T KOG1187|consen 258 KSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEY-P---DEKEVKKLAELALRCLR 333 (361)
T ss_pred ccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCC-C---hHHHHHHHHHHHHHHcC
Confidence 9999999999999999998876533 223334444322 2222455555554432110 0 00334448899999999
Q ss_pred CCccCCCCHHHHHHHHHHHHH
Q 024027 236 ESPEQRINAKEIVTKLLKIRD 256 (273)
Q Consensus 236 ~dp~~Rps~~~~l~~l~~~~~ 256 (273)
.+|.+||++.+|++.|..+..
T Consensus 334 ~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 334 PDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred cCCCcCcCHHHHHHHHHhhcc
Confidence 999999999999988855443
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=288.74 Aligned_cols=228 Identities=22% Similarity=0.275 Sum_probs=183.8
Q ss_pred CeEEEEEeecccCh---hhhhHHHHHHHHhcCCCccceeeeeeeec----CCceeEEEeccCCCCHHHhhhcCCCCCCHH
Q 024027 1 MEVAVKVFNLQCGR---AFKSFDVECEMMKSIRHRNLIKVISSCSN----EEFKALVLEYMPHGSLEKYLYSSNCILDIF 73 (273)
Q Consensus 1 ~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 73 (273)
++||||+++..... ..+.+.+|+.+|++++||||+++++++.+ ....++||||+++|+|.+++... ..+++.
T Consensus 44 ~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-~~~~~~ 122 (283)
T PHA02988 44 KEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE-KDLSFK 122 (283)
T ss_pred EEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhC-CCCChh
Confidence 37999999765322 25678899999999999999999999876 35788999999999999999654 368899
Q ss_pred HHHHHHHHHHHHHHHHhcCCC-CCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC
Q 024027 74 QRLNIMIDVASALEYLHFGCS-APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE 152 (273)
Q Consensus 74 ~~~~~~~ql~~~l~~lh~~~~-~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 152 (273)
....++.|++.|+.||| + .+++|+||||+||+++.++.+||+|||++..+... .....++..|+|||.+.+
T Consensus 123 ~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~ 194 (283)
T PHA02988 123 TKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP-----PFKNVNFMVYFSYKMLND 194 (283)
T ss_pred HHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc-----cccccCcccccCHHHhhh
Confidence 99999999999999999 7 48999999999999999999999999998765221 123457888999999876
Q ss_pred --CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHH
Q 024027 153 --GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLA 230 (273)
Q Consensus 153 --~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 230 (273)
..++.++|||||||++|+|++|..||......+. ........ .....+..++.++.+|+
T Consensus 195 ~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~-~~~i~~~~------------------~~~~~~~~~~~~l~~li 255 (283)
T PHA02988 195 IFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI-YDLIINKN------------------NSLKLPLDCPLEIKCIV 255 (283)
T ss_pred ccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHhcC------------------CCCCCCCcCcHHHHHHH
Confidence 6789999999999999999999999976432211 11110000 00111335677899999
Q ss_pred hhcCCCCccCCCCHHHHHHHHHHHHH
Q 024027 231 MACTVESPEQRINAKEIVTKLLKIRD 256 (273)
Q Consensus 231 ~~~l~~dp~~Rps~~~~l~~l~~~~~ 256 (273)
.+||+.||.+|||++++++.|+.++.
T Consensus 256 ~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 256 EACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred HHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 99999999999999999999998764
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=282.24 Aligned_cols=245 Identities=24% Similarity=0.226 Sum_probs=190.1
Q ss_pred CeEEEEEee--cccChhhhhHHHHHHHHhcCCCccceeeeeeeec-----CCceeEEEeccCCCCHHHhhhcCCCCCCHH
Q 024027 1 MEVAVKVFN--LQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSN-----EEFKALVLEYMPHGSLEKYLYSSNCILDIF 73 (273)
Q Consensus 1 ~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 73 (273)
+.||||++. ..+....+...+|+++|++++|+||+.+++++.. -...|+|+|+|+. +|...++.+ ..++..
T Consensus 48 ~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elMet-DL~~iik~~-~~L~d~ 125 (359)
T KOG0660|consen 48 EKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELMET-DLHQIIKSQ-QDLTDD 125 (359)
T ss_pred CEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHHhh-HHHHHHHcC-ccccHH
Confidence 379999997 4456677889999999999999999999999866 2468999999955 999999654 359999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC-
Q 024027 74 QRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE- 152 (273)
Q Consensus 74 ~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~- 152 (273)
.+..+++|++.||+|+| +.+++|||+||+|++++.++.+|++|||+++...........+..+.|.+|+|||++..
T Consensus 126 H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~ 202 (359)
T KOG0660|consen 126 HAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNS 202 (359)
T ss_pred HHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhcc
Confidence 99999999999999999 99999999999999999999999999999997754433344567788999999998765
Q ss_pred CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccc-----------hhhhhhhccccchhhhhhhhh
Q 024027 153 GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPIST-----------MEVVDANLLSQEDIHFVAKEQ 221 (273)
Q Consensus 153 ~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~ 221 (273)
..|+.+.||||+||++.||++|++-|.+...- .++..+.+....+.. ...+.........-....-+.
T Consensus 203 ~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v-~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~ 281 (359)
T KOG0660|consen 203 SEYTKAIDIWSVGCILAEMLTGKPLFPGKDYV-HQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPN 281 (359)
T ss_pred ccccchhhhhhhhHHHHHHHcCCCCCCCCchH-HHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCC
Confidence 56999999999999999999999988763321 122222222222211 111111111111111222346
Q ss_pred hHHHHHHHHhhcCCCCccCCCCHHHHHHHH
Q 024027 222 CVSFVFNLAMACTVESPEQRINAKEIVTKL 251 (273)
Q Consensus 222 ~~~~l~~li~~~l~~dp~~Rps~~~~l~~l 251 (273)
+++.+.+|+.+||..||.+|+|++|+|.|-
T Consensus 282 a~p~AidLlekmL~fdP~kRita~eAL~hP 311 (359)
T KOG0660|consen 282 ANPLAIDLLEKMLVFDPKKRITAEEALAHP 311 (359)
T ss_pred CCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence 788899999999999999999999999874
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=292.38 Aligned_cols=234 Identities=24% Similarity=0.399 Sum_probs=184.1
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcC-CCccceeeeeeeecC-CceeEEEeccCCCCHHHhhhcCC-----------
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSI-RHRNLIKVISSCSNE-EFKALVLEYMPHGSLEKYLYSSN----------- 67 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~----------- 67 (273)
.||||+++... ......+..|+.+++.+ +||||++++++|... +.++++|||+++|+|.+++....
T Consensus 39 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~ 118 (338)
T cd05102 39 TVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSP 118 (338)
T ss_pred hhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccch
Confidence 58999997543 33456788999999999 899999999988764 45789999999999999986431
Q ss_pred --------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 024027 68 --------------------------------------------------CILDIFQRLNIMIDVASALEYLHFGCSAPV 97 (273)
Q Consensus 68 --------------------------------------------------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i 97 (273)
..+++..+..++.|++.||.||| +.|+
T Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~i 195 (338)
T cd05102 119 KQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLA---SRKC 195 (338)
T ss_pred hhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHH---HCCE
Confidence 23677888999999999999999 9999
Q ss_pred EeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcchhHHHHHHHHHHHh-CCC
Q 024027 98 IHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKK 176 (273)
Q Consensus 98 ~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~ 176 (273)
+|+||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..
T Consensus 196 vHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~ 275 (338)
T cd05102 196 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGAS 275 (338)
T ss_pred ECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999876532222222223345678999999988889999999999999999997 999
Q ss_pred CCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHHHHHH
Q 024027 177 PTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLLKIRD 256 (273)
Q Consensus 177 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 256 (273)
||......+......... .....+..++.++.+|+.+||..||.+|||+.++++.|+++.+
T Consensus 276 pf~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 276 PYPGVQINEEFCQRLKDG-------------------TRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred CCCCCCccHHHHHHHhcC-------------------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 987643222111110000 0001134566779999999999999999999999999998876
Q ss_pred h
Q 024027 257 S 257 (273)
Q Consensus 257 ~ 257 (273)
+
T Consensus 337 ~ 337 (338)
T cd05102 337 E 337 (338)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=289.85 Aligned_cols=223 Identities=23% Similarity=0.298 Sum_probs=182.5
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||||+++... ......+..|+.+++.++||||+++++++..+...++||||+++++|.+++...+ .+++..+..
T Consensus 21 ~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~ 99 (323)
T cd05571 21 KYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARF 99 (323)
T ss_pred CEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHH
Confidence 469999997542 3345667889999999999999999999999999999999999999999986543 689999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
++.|++.||.||| +.|++||||||+||+++.++.+||+|||++...... .......+|++.|+|||++.+..++.
T Consensus 100 ~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~ 174 (323)
T cd05571 100 YGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLEDNDYGR 174 (323)
T ss_pred HHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCcccceecCccccChhhhcCCCCCc
Confidence 9999999999999 999999999999999999999999999998653211 11223456899999999999889999
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
++||||+||++|+|++|..||........ ...... . ....+..++.++.+|+.+||..|
T Consensus 175 ~~DiwSlG~il~elltg~~Pf~~~~~~~~-~~~~~~----------------~----~~~~p~~~~~~~~~li~~~L~~d 233 (323)
T cd05571 175 AVDWWGLGVVMYEMMCGRLPFYNQDHEKL-FELILM----------------E----EIRFPRTLSPEAKSLLAGLLKKD 233 (323)
T ss_pred cccCcccchhhhhhhcCCCCCCCCCHHHH-HHHHHc----------------C----CCCCCCCCCHHHHHHHHHHccCC
Confidence 99999999999999999999865322111 000000 0 00113456778999999999999
Q ss_pred ccCCC-----CHHHHHHH
Q 024027 238 PEQRI-----NAKEIVTK 250 (273)
Q Consensus 238 p~~Rp-----s~~~~l~~ 250 (273)
|++|| ++.++++|
T Consensus 234 P~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 234 PKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred HHHcCCCCCCCHHHHHcC
Confidence 99999 89999887
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=293.33 Aligned_cols=237 Identities=26% Similarity=0.404 Sum_probs=198.4
Q ss_pred eEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 2 EVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 2 ~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
+||||+++... ++..+.|+.|+.+|++-+|.||+-+.|+|..++. .||+.||+|-+|+.+++-....++....+.|+
T Consensus 416 dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIA 494 (678)
T KOG0193|consen 416 DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIA 494 (678)
T ss_pred ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHH
Confidence 79999999774 5578899999999999999999999999998887 99999999999999998888889999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCC---CcC
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG---RVS 156 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~ 156 (273)
+|+++|+.||| .++|+|+|||..||++..+++|||+|||++.......+........+...|+|||++... .|+
T Consensus 495 qQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS 571 (678)
T KOG0193|consen 495 QQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFS 571 (678)
T ss_pred HHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCC
Confidence 99999999999 999999999999999999999999999999876555444555566788889999998644 489
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
..+||||||+++|||++|..||.....+...+ ..=.+...++ .......|+.++.+|+..||.+
T Consensus 572 ~qSDVYaFGiV~YELltg~lPysi~~~dqIif-mVGrG~l~pd---------------~s~~~s~~pk~mk~Ll~~C~~~ 635 (678)
T KOG0193|consen 572 FQSDVYAFGIVWYELLTGELPYSIQNRDQIIF-MVGRGYLMPD---------------LSKIRSNCPKAMKRLLSDCWKF 635 (678)
T ss_pred cccchhhhhHHHHHHHhCcCCcCCCChhheEE-EecccccCcc---------------chhhhccCHHHHHHHHHHHHhc
Confidence 99999999999999999999998322221111 0000011111 1111356888899999999999
Q ss_pred CccCCCCHHHHHHHHHHHHHhh
Q 024027 237 SPEQRINAKEIVTKLLKIRDSL 258 (273)
Q Consensus 237 dp~~Rps~~~~l~~l~~~~~~~ 258 (273)
++++||++.+|+..|+++..++
T Consensus 636 ~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 636 DREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred CcccCccHHHHHHHHHHhhhcc
Confidence 9999999999999999998864
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=281.12 Aligned_cols=243 Identities=22% Similarity=0.251 Sum_probs=182.6
Q ss_pred CeEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 1 MEVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 1 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
+.||+|+++... ......+.+|+.+++.++||||+++++++.++...++||||+++ +|.+++...+..+++..+..++
T Consensus 31 ~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~ 109 (288)
T cd07871 31 NLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFM 109 (288)
T ss_pred CEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHH
Confidence 369999997543 23345678999999999999999999999999999999999976 9999987666668999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC-CCcCCc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE-GRVSTN 158 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~ 158 (273)
.|++.||.||| +.|++|+||||+||+++.++.+||+|||++....... .......+++.|+|||.+.+ ..++.+
T Consensus 110 ~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~ 184 (288)
T cd07871 110 FQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT--KTYSNEVVTLWYRPPDVLLGSTEYSTP 184 (288)
T ss_pred HHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC--ccccCceecccccChHHhcCCcccCcH
Confidence 99999999999 9999999999999999999999999999987542221 12233467889999998865 458999
Q ss_pred chhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCc--cchhhh------hhhcccc--chhhhhhhhhhHHHHHH
Q 024027 159 GDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPI--STMEVV------DANLLSQ--EDIHFVAKEQCVSFVFN 228 (273)
Q Consensus 159 ~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~------~~~~~~~--~~~~~~~~~~~~~~l~~ 228 (273)
+||||+||++|+|++|..||......+.. .........+ ...... ....... ..........++.++.+
T Consensus 185 ~DiwslG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 263 (288)
T cd07871 185 IDMWGVGCILYEMATGRPMFPGSTVKEEL-HLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGID 263 (288)
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHH
Confidence 99999999999999999999764332221 1111111100 000000 0000000 00001112346778999
Q ss_pred HHhhcCCCCccCCCCHHHHHHH
Q 024027 229 LAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 229 li~~~l~~dp~~Rps~~~~l~~ 250 (273)
|+.+||.+||.+|||++++++|
T Consensus 264 ll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 264 LLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred HHHHhcCcCcccCCCHHHHhcC
Confidence 9999999999999999999976
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=281.72 Aligned_cols=246 Identities=22% Similarity=0.243 Sum_probs=181.8
Q ss_pred CeEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 1 MEVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 1 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
+.||||+++... ......+.+|+.+++.++||||+++++++.++...++||||++ ++|.+++......+++..+..++
T Consensus 31 ~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~ 109 (303)
T cd07869 31 KLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFL 109 (303)
T ss_pred CEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHH
Confidence 369999997553 2334467789999999999999999999999999999999996 48988887766678999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC-CCcCCc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE-GRVSTN 158 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~ 158 (273)
.|++.||.||| +.|++|+||||+||+++.++.+||+|||++...... ........+++.|+|||++.+ ..++.+
T Consensus 110 ~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 184 (303)
T cd07869 110 FQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP--SHTYSNEVVTLWYRPPDVLLGSTEYSTC 184 (303)
T ss_pred HHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC--CccCCCCcccCCCCChHHHcCCCCCCcH
Confidence 99999999999 999999999999999999999999999998654221 112234567899999998865 457889
Q ss_pred chhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhh--h------h-hhc--cccchh-hhhhhhhhHHHH
Q 024027 159 GDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEV--V------D-ANL--LSQEDI-HFVAKEQCVSFV 226 (273)
Q Consensus 159 ~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~------~-~~~--~~~~~~-~~~~~~~~~~~l 226 (273)
+||||+||++|+|++|..||......................... . . ... ...... ........+..+
T Consensus 185 ~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (303)
T cd07869 185 LDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHA 264 (303)
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHH
Confidence 999999999999999999997643322222222111111000000 0 0 000 000000 000111234668
Q ss_pred HHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 227 FNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 227 ~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
.+|+.+||+.||++|||+.++++|=.
T Consensus 265 ~dli~~mL~~dp~~R~s~~~~l~h~~ 290 (303)
T cd07869 265 EDLASKLLQCFPKNRLSAQAALSHEY 290 (303)
T ss_pred HHHHHHHhccCchhccCHHHHhcCcc
Confidence 99999999999999999999998643
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=283.70 Aligned_cols=222 Identities=24% Similarity=0.336 Sum_probs=182.2
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||||++.... ......+.+|+++++.++||||+++++++.+....++||||+++++|.+++...+ .+++..+..
T Consensus 27 ~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~ 105 (291)
T cd05612 27 HYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG-RFSNSTGLF 105 (291)
T ss_pred CEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHcC-CCCHHHHHH
Confidence 469999997542 2345668899999999999999999999999999999999999999999996544 689999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
++.|++.||+||| +.|++|+||||+||+++.++.++|+|||++..... ......|++.|+|||.+.+..++.
T Consensus 106 ~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ 177 (291)
T cd05612 106 YASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-----RTWTLCGTPEYLAPEVIQSKGHNK 177 (291)
T ss_pred HHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccC-----CcccccCChhhcCHHHHcCCCCCc
Confidence 9999999999999 99999999999999999999999999999876522 112346889999999998888999
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
++|||||||++|+|++|..||........ ....... ....+...+..+.+|+.+||+.|
T Consensus 178 ~~DiwSlG~il~~l~~g~~pf~~~~~~~~-~~~i~~~--------------------~~~~~~~~~~~~~~li~~~l~~d 236 (291)
T cd05612 178 AVDWWALGILIYEMLVGYPPFFDDNPFGI-YEKILAG--------------------KLEFPRHLDLYAKDLIKKLLVVD 236 (291)
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhC--------------------CcCCCccCCHHHHHHHHHHcCCC
Confidence 99999999999999999999865322111 1111000 00112334667999999999999
Q ss_pred ccCCCC-----HHHHHHHHH
Q 024027 238 PEQRIN-----AKEIVTKLL 252 (273)
Q Consensus 238 p~~Rps-----~~~~l~~l~ 252 (273)
|.+||+ ++++++|-+
T Consensus 237 p~~R~~~~~~~~~~~l~h~~ 256 (291)
T cd05612 237 RTRRLGNMKNGADDVKNHRW 256 (291)
T ss_pred HHHccCCccCCHHHHhcCcc
Confidence 999995 999999865
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=289.83 Aligned_cols=221 Identities=27% Similarity=0.395 Sum_probs=187.4
Q ss_pred eEEEEEeecc--cChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 2 EVAVKVFNLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 2 ~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
-||+|.+.+. .+.+.+.+.+|+++++.++||||+.++++|+...++++|.||+.| +|..++... +.++++.+..++
T Consensus 29 ~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~d-~~lpEe~v~~~a 106 (808)
T KOG0597|consen 29 VVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQD-GKLPEEQVRAIA 106 (808)
T ss_pred EEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHhc-cCCCHHHHHHHH
Confidence 5899999644 345678899999999999999999999999999999999999977 999999654 479999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 159 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 159 (273)
.|++.||.||| +.+|.|+|+||.||++..++.+|++|||+++.+.. .........|||.|+|||+..+..|+..+
T Consensus 107 ~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t~vltsikGtPlYmAPElv~e~pyd~~s 181 (808)
T KOG0597|consen 107 YDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NTSVLTSIKGTPLYMAPELVEEQPYDHTS 181 (808)
T ss_pred HHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhccc--CceeeeeccCcccccCHHHHcCCCccchh
Confidence 99999999999 99999999999999999999999999999987632 33445667899999999999999999999
Q ss_pred hhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCcc
Q 024027 160 DVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239 (273)
Q Consensus 160 DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 239 (273)
|+||+||++||++.|++||.... ..+..+.....+. ..|...+..+.+|+..+|.+||.
T Consensus 182 DlWslGcilYE~~~G~PPF~a~s-----i~~Lv~~I~~d~v----------------~~p~~~S~~f~nfl~gLL~kdP~ 240 (808)
T KOG0597|consen 182 DLWSLGCILYELYVGQPPFYARS-----ITQLVKSILKDPV----------------KPPSTASSSFVNFLQGLLIKDPA 240 (808)
T ss_pred hHHHHHHHHHHHhcCCCCchHHH-----HHHHHHHHhcCCC----------------CCcccccHHHHHHHHHHhhcChh
Confidence 99999999999999999986521 1111111100000 01446778899999999999999
Q ss_pred CCCCHHHHHHH
Q 024027 240 QRINAKEIVTK 250 (273)
Q Consensus 240 ~Rps~~~~l~~ 250 (273)
+|.|+.+++.|
T Consensus 241 ~RltW~~Ll~H 251 (808)
T KOG0597|consen 241 QRLTWTDLLGH 251 (808)
T ss_pred hcccHHHHhcC
Confidence 99999999977
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=285.47 Aligned_cols=224 Identities=22% Similarity=0.297 Sum_probs=182.3
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||+|+++... ......+..|+++++.++||||++++++|..+...++||||+++|+|..++...+ .+++..++.
T Consensus 21 ~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~-~~~~~~~~~ 99 (323)
T cd05595 21 RYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARF 99 (323)
T ss_pred CEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHH
Confidence 369999997542 3345567789999999999999999999999999999999999999999886544 689999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++...... ........|++.|+|||.+.+..++.
T Consensus 100 ~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~ 174 (323)
T cd05595 100 YGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLEDNDYGR 174 (323)
T ss_pred HHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC--CCccccccCCcCcCCcccccCCCCCc
Confidence 9999999999999 999999999999999999999999999988643211 11223456899999999998888999
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
++|+|||||++|+|++|..||........ ....... ....+..++.++.+|+.+||..|
T Consensus 175 ~~DiwSlGvil~ell~g~~Pf~~~~~~~~-~~~~~~~--------------------~~~~p~~~~~~~~~li~~~L~~d 233 (323)
T cd05595 175 AVDWWGLGVVMYEMMCGRLPFYNQDHERL-FELILME--------------------EIRFPRTLSPEAKSLLAGLLKKD 233 (323)
T ss_pred hhchhhhHHHHHHHHhCCCCCCCCCHHHH-HHHHhcC--------------------CCCCCCCCCHHHHHHHHHHccCC
Confidence 99999999999999999999865322211 1100000 00113456778999999999999
Q ss_pred ccCCC-----CHHHHHHHH
Q 024027 238 PEQRI-----NAKEIVTKL 251 (273)
Q Consensus 238 p~~Rp-----s~~~~l~~l 251 (273)
|.+|| ++.++++|-
T Consensus 234 P~~R~~~~~~~~~~~l~h~ 252 (323)
T cd05595 234 PKQRLGGGPSDAKEVMEHR 252 (323)
T ss_pred HHHhCCCCCCCHHHHHcCC
Confidence 99998 899998873
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=284.84 Aligned_cols=223 Identities=24% Similarity=0.281 Sum_probs=181.5
Q ss_pred CeEEEEEeecc---cChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||+|+++.. .......+..|+.+++.++||||+++++++..+...++||||+++|+|.+++...+ .+++..+..
T Consensus 19 ~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~ 97 (312)
T cd05585 19 RIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREG-RFDLSRARF 97 (312)
T ss_pred CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhcC-CCCHHHHHH
Confidence 36999999753 23445678889999999999999999999999999999999999999999996543 689999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
++.|++.||.||| +.|++||||||+||+++.++.++|+|||++...... ........|++.|+|||.+.+..++.
T Consensus 98 ~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~ 172 (312)
T cd05585 98 YTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD--DDKTNTFCGTPEYLAPELLLGHGYTK 172 (312)
T ss_pred HHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccC--CCccccccCCcccCCHHHHcCCCCCC
Confidence 9999999999999 999999999999999999999999999998753221 12233456899999999999888999
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
++||||+||++|+|++|..||........ ...... . ....+..++.++.+|+.+||..|
T Consensus 173 ~~DvwslGvil~el~tg~~pf~~~~~~~~-~~~~~~----------------~----~~~~~~~~~~~~~~li~~~L~~d 231 (312)
T cd05585 173 AVDWWTLGVLLYEMLTGLPPFYDENVNEM-YRKILQ----------------E----PLRFPDGFDRDAKDLLIGLLSRD 231 (312)
T ss_pred ccceechhHHHHHHHhCCCCcCCCCHHHH-HHHHHc----------------C----CCCCCCcCCHHHHHHHHHHcCCC
Confidence 99999999999999999999975322111 000000 0 01113456677999999999999
Q ss_pred ccCCC---CHHHHHHH
Q 024027 238 PEQRI---NAKEIVTK 250 (273)
Q Consensus 238 p~~Rp---s~~~~l~~ 250 (273)
|.+|| ++.++++|
T Consensus 232 p~~R~~~~~~~e~l~h 247 (312)
T cd05585 232 PTRRLGYNGAQEIKNH 247 (312)
T ss_pred HHHcCCCCCHHHHHcC
Confidence 99997 46788876
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=298.68 Aligned_cols=226 Identities=21% Similarity=0.242 Sum_probs=183.6
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhc---CCCCCCHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS---SNCILDIFQRLNI 78 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~ 78 (273)
.||+|.+..........+..|+.+++.++||||++++++|..++..++||||+++|+|.+++.. ...++++..+..+
T Consensus 95 ~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i 174 (478)
T PTZ00267 95 KVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLL 174 (478)
T ss_pred EEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHH
Confidence 5888887665555566788999999999999999999999999999999999999999988753 2346889999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCc
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTN 158 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 158 (273)
+.|++.||.||| +.|++||||||+||+++.++.+||+|||++..+............+|++.|+|||++.+..++.+
T Consensus 175 ~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 251 (478)
T PTZ00267 175 FYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKK 251 (478)
T ss_pred HHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcH
Confidence 999999999999 99999999999999999999999999999986643222222344568999999999998889999
Q ss_pred chhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc
Q 024027 159 GDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238 (273)
Q Consensus 159 ~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 238 (273)
+|||||||++|+|++|..||......+.. ...... . ....+..++.++.+++.+||..||
T Consensus 252 ~Dv~slG~~l~el~tg~~Pf~~~~~~~~~-~~~~~~----------------~---~~~~~~~~s~~~~~li~~~L~~dP 311 (478)
T PTZ00267 252 ADMWSLGVILYELLTLHRPFKGPSQREIM-QQVLYG----------------K---YDPFPCPVSSGMKALLDPLLSKNP 311 (478)
T ss_pred HhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhC----------------C---CCCCCccCCHHHHHHHHHHhccCh
Confidence 99999999999999999998653221110 000000 0 001133466779999999999999
Q ss_pred cCCCCHHHHHHH
Q 024027 239 EQRINAKEIVTK 250 (273)
Q Consensus 239 ~~Rps~~~~l~~ 250 (273)
++|||+.+++.+
T Consensus 312 ~~Rps~~~~l~~ 323 (478)
T PTZ00267 312 ALRPTTQQLLHT 323 (478)
T ss_pred hhCcCHHHHHhC
Confidence 999999999865
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=286.39 Aligned_cols=224 Identities=25% Similarity=0.312 Sum_probs=194.2
Q ss_pred eEEEEEeecc--cChhhhhHHHHHHHHhcCCCccceeeeeeeecCCc-eeEEEeccCCCCHHHhhhcCC-CCCCHHHHHH
Q 024027 2 EVAVKVFNLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEF-KALVLEYMPHGSLEKYLYSSN-CILDIFQRLN 77 (273)
Q Consensus 2 ~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~ 77 (273)
.||+|.+... +...++....|..++++++||||+.+.+.|..++. .+|||+||+||++.+.+.+.+ ..+++..+..
T Consensus 31 ~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~ 110 (426)
T KOG0589|consen 31 LYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILK 110 (426)
T ss_pred eEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHH
Confidence 6899999755 35566788999999999999999999999999888 999999999999999998766 5699999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
|+.|++.|+.||| ++.|+|||||+.||++++++.|+|+|||++..++... ......+||+.|++||++.+.+|..
T Consensus 111 ~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~ 185 (426)
T KOG0589|consen 111 WFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED--SLASTVVGTPYYMCPEILSDIPYNE 185 (426)
T ss_pred HHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCch--hhhheecCCCcccCHHHhCCCCCCc
Confidence 9999999999999 9999999999999999999999999999999875543 2455678999999999999999999
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
++|||||||++|||++-+++|...+...-...... ....+.+...+.++..++..||..+
T Consensus 186 KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~--------------------~~~~Plp~~ys~el~~lv~~~l~~~ 245 (426)
T KOG0589|consen 186 KSDIWSLGCCLYEMCTLKPAFKASNMSELILKINR--------------------GLYSPLPSMYSSELRSLVKSMLRKN 245 (426)
T ss_pred cCcchhhcchHHHHHhcccccCccchHHHHHHHhh--------------------ccCCCCCccccHHHHHHHHHHhhcC
Confidence 99999999999999999999987544332221111 1122336677888999999999999
Q ss_pred ccCCCCHHHHHHH
Q 024027 238 PEQRINAKEIVTK 250 (273)
Q Consensus 238 p~~Rps~~~~l~~ 250 (273)
|..||++.++|.+
T Consensus 246 P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 246 PEHRPSALELLRR 258 (426)
T ss_pred CccCCCHHHHhhC
Confidence 9999999999987
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=269.51 Aligned_cols=245 Identities=20% Similarity=0.181 Sum_probs=189.8
Q ss_pred eEEEEEeecccChh--hhhHHHHHHHHhcCCCccceeeeeeeec--CCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 2 EVAVKVFNLQCGRA--FKSFDVECEMMKSIRHRNLIKVISSCSN--EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 2 ~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
-||+|.++.+.+.. .-...+|+.+|.+.+|||||.+-.+..- -..+|||||||+. +|..++...+.++...++..
T Consensus 103 IVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~ 181 (419)
T KOG0663|consen 103 IVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKT 181 (419)
T ss_pred eEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHHhccCCCchHHHHH
Confidence 59999999775333 3346789999999999999999887643 3568999999987 99999988888899999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCC-cC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGR-VS 156 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~ 156 (273)
++.|++.|++||| .+.|+|||||++|+|++..|.+|++|||+++.+... ....+..+-|.||+|||++.+.. |+
T Consensus 182 L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp--~k~~T~lVVTLWYRaPELLLG~~tys 256 (419)
T KOG0663|consen 182 LMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP--LKPYTPLVVTLWYRAPELLLGAKTYS 256 (419)
T ss_pred HHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhcCC--cccCcceEEEeeecCHHHhcCCcccC
Confidence 9999999999999 999999999999999999999999999999987433 33455678899999999998865 99
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhh-hccCccchhhhhhhcc------cc---chhhhhhhhh-hHHH
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVN-DWLPISTMEVVDANLL------SQ---EDIHFVAKEQ-CVSF 225 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~------~~---~~~~~~~~~~-~~~~ 225 (273)
.+.|+||+|||+.+++++.+-|.+...-+.....+.. +.+....++....... .. ..+....+.. .++.
T Consensus 257 t~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~ 336 (419)
T KOG0663|consen 257 TAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQ 336 (419)
T ss_pred cchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchh
Confidence 9999999999999999999998775443322222221 1222222222211110 01 1111111111 5678
Q ss_pred HHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 226 VFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 226 l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
-.+|+..+|.+||++|.|+++.|+|=+
T Consensus 337 g~~Lln~llt~dP~kR~tA~~~L~h~~ 363 (419)
T KOG0663|consen 337 GFDLLNKLLTYDPGKRITAEDGLKHEY 363 (419)
T ss_pred HHHHHHHHhccCccccccHHHhhcccc
Confidence 999999999999999999999998743
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=278.18 Aligned_cols=233 Identities=30% Similarity=0.510 Sum_probs=188.4
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC------------CC
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN------------CI 69 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------~~ 69 (273)
.||+|.++..+......+.+|+++++.++||||+++++++......+++|||+++++|.+++...+ ..
T Consensus 37 ~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~ 116 (288)
T cd05093 37 LVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAE 116 (288)
T ss_pred EEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCC
Confidence 488999876655667789999999999999999999999999999999999999999999986433 24
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcc
Q 024027 70 LDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEY 149 (273)
Q Consensus 70 ~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~ 149 (273)
+++..++.++.|++.||+||| +.|++|+||||+||+++.++.++|+|||++................++..|+|||.
T Consensus 117 l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 193 (288)
T cd05093 117 LTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPES 193 (288)
T ss_pred CCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHH
Confidence 899999999999999999999 99999999999999999999999999999875532222112223345678999999
Q ss_pred cCCCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHH
Q 024027 150 GREGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFN 228 (273)
Q Consensus 150 ~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 228 (273)
+.+..++.++|+||||+++++|++ |..||........ ........ ....+..++.++.+
T Consensus 194 ~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~-~~~i~~~~-------------------~~~~~~~~~~~l~~ 253 (288)
T cd05093 194 IMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV-IECITQGR-------------------VLQRPRTCPKEVYD 253 (288)
T ss_pred hccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHcCC-------------------cCCCCCCCCHHHHH
Confidence 988889999999999999999998 8999865432211 11111100 00112345667999
Q ss_pred HHhhcCCCCccCCCCHHHHHHHHHHHHHh
Q 024027 229 LAMACTVESPEQRINAKEIVTKLLKIRDS 257 (273)
Q Consensus 229 li~~~l~~dp~~Rps~~~~l~~l~~~~~~ 257 (273)
|+.+||..||.+|||+.++++.|+++.++
T Consensus 254 li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 254 LMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 99999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=265.34 Aligned_cols=229 Identities=22% Similarity=0.335 Sum_probs=186.8
Q ss_pred EEEEEeecc--cChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 3 VAVKVFNLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 3 vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
+|+|+++.. +..+.+++.+|+.|-+.++||||+++.+.+...+..|+|||++.|++|..-|-.. ..+++..+..+.+
T Consensus 39 fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~r 117 (355)
T KOG0033|consen 39 FAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQ 117 (355)
T ss_pred HHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHH-HHHHHHHHHHHHH
Confidence 345555432 2446789999999999999999999999999999999999999999996655332 3588888999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeC---CCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCC
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLD---DNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~---~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
||+.||.|+| .+||+|||+||.|+++. ...-+||+|||++..++ ........+|+|+|+|||+....+|+.
T Consensus 118 QiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~---~g~~~~G~~GtP~fmaPEvvrkdpy~k 191 (355)
T KOG0033|consen 118 QILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN---DGEAWHGFAGTPGYLSPEVLKKDPYSK 191 (355)
T ss_pred HHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeC---CccccccccCCCcccCHHHhhcCCCCC
Confidence 9999999999 99999999999999994 45579999999999875 334566788999999999999999999
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
.+|||+-|+++|-++.|++||.+..... .+..+..+ .........+.+++++++|+++||..|
T Consensus 192 pvDiW~cGViLfiLL~G~~PF~~~~~~r-lye~I~~g----------------~yd~~~~~w~~is~~Ak~LvrrML~~d 254 (355)
T KOG0033|consen 192 PVDIWACGVILYILLVGYPPFWDEDQHR-LYEQIKAG----------------AYDYPSPEWDTVTPEAKSLIRRMLTVN 254 (355)
T ss_pred cchhhhhhHHHHHHHhCCCCCCCccHHH-HHHHHhcc----------------ccCCCCcccCcCCHHHHHHHHHHhccC
Confidence 9999999999999999999997743321 22222211 111222225678889999999999999
Q ss_pred ccCCCCHHHHHHHHHHHH
Q 024027 238 PEQRINAKEIVTKLLKIR 255 (273)
Q Consensus 238 p~~Rps~~~~l~~l~~~~ 255 (273)
|++|+|+.|+|+|-|-..
T Consensus 255 P~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 255 PKKRITADEALKHPWICN 272 (355)
T ss_pred hhhhccHHHHhCCchhcc
Confidence 999999999999877443
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=277.92 Aligned_cols=229 Identities=31% Similarity=0.566 Sum_probs=185.6
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC-------------
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN------------- 67 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------- 67 (273)
.||+|.++... ......+.+|+.+++.++||||+++++++.+....+++|||+++++|.+++....
T Consensus 37 ~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 116 (283)
T cd05048 37 SVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDET 116 (283)
T ss_pred eEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCccccccccccc
Confidence 58999997543 3445678999999999999999999999999999999999999999999996532
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCC
Q 024027 68 --CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYM 145 (273)
Q Consensus 68 --~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (273)
..+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++................+++.|+
T Consensus 117 ~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 193 (283)
T cd05048 117 VKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWM 193 (283)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCccccccc
Confidence 35788899999999999999999 9999999999999999999999999999987543222222223345678899
Q ss_pred CCcccCCCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHH
Q 024027 146 APEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVS 224 (273)
Q Consensus 146 aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (273)
|||.+.+..++.++|+|||||++|+|++ |..||......+.. .. +... .....+..++.
T Consensus 194 aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~-~~-------------i~~~------~~~~~~~~~~~ 253 (283)
T cd05048 194 PPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI-EM-------------IRSR------QLLPCPEDCPA 253 (283)
T ss_pred CHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HH-------------HHcC------CcCCCcccCCH
Confidence 9999988889999999999999999998 99998764332110 00 0000 01112456788
Q ss_pred HHHHHHhhcCCCCccCCCCHHHHHHHHHH
Q 024027 225 FVFNLAMACTVESPEQRINAKEIVTKLLK 253 (273)
Q Consensus 225 ~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 253 (273)
++.+|+.+||..||.+||++++++++|++
T Consensus 254 ~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 254 RVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 89999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=285.00 Aligned_cols=224 Identities=23% Similarity=0.299 Sum_probs=182.8
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||||+++... ......+.+|+.+++.++||||+++++++..+...++||||+++|+|.+++... ..+++..+..
T Consensus 21 ~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-~~l~~~~~~~ 99 (328)
T cd05593 21 KYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRE-RVFSEDRTRF 99 (328)
T ss_pred CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHH
Confidence 479999997542 344567888999999999999999999999999999999999999999998654 3689999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
++.|++.||.||| +.|++|+||||+||+++.++.+||+|||++...... ........|++.|+|||.+.+..++.
T Consensus 100 ~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~ 174 (328)
T cd05593 100 YGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATMKTFCGTPEYLAPEVLEDNDYGR 174 (328)
T ss_pred HHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc--ccccccccCCcCccChhhhcCCCCCc
Confidence 9999999999999 999999999999999999999999999998653211 11223456899999999998888999
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
++|||||||++|+|++|..||........ ...... .....+..++.++.+|+.+||..|
T Consensus 175 ~~DiwslGvil~elltG~~Pf~~~~~~~~-----~~~~~~----------------~~~~~p~~~~~~~~~li~~~L~~d 233 (328)
T cd05593 175 AVDWWGLGVVMYEMMCGRLPFYNQDHEKL-----FELILM----------------EDIKFPRTLSADAKSLLSGLLIKD 233 (328)
T ss_pred cCCccccchHHHHHhhCCCCCCCCCHHHH-----HHHhcc----------------CCccCCCCCCHHHHHHHHHHcCCC
Confidence 99999999999999999999965322111 000000 000113456777999999999999
Q ss_pred ccCCC-----CHHHHHHHH
Q 024027 238 PEQRI-----NAKEIVTKL 251 (273)
Q Consensus 238 p~~Rp-----s~~~~l~~l 251 (273)
|++|| ++.++++|-
T Consensus 234 P~~R~~~~~~~~~~il~h~ 252 (328)
T cd05593 234 PNKRLGGGPDDAKEIMRHS 252 (328)
T ss_pred HHHcCCCCCCCHHHHhcCC
Confidence 99997 899999883
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=286.44 Aligned_cols=222 Identities=20% Similarity=0.244 Sum_probs=181.8
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||||+++... ......+.+|+++++.++||||+++++++.+++..++||||+++++|.+++...+ .+++..+..
T Consensus 44 ~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~ 122 (329)
T PTZ00263 44 EYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAG-RFPNDVAKF 122 (329)
T ss_pred CEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHcC-CCCHHHHHH
Confidence 469999997542 2345678899999999999999999999999999999999999999999996543 688999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
++.|++.||.||| +.|++|+||||+||+++.++.+||+|||++...... .....|++.|+|||.+.+..++.
T Consensus 123 ~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~ 194 (329)
T PTZ00263 123 YHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-----TFTLCGTPEYLAPEVIQSKGHGK 194 (329)
T ss_pred HHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-----cceecCChhhcCHHHHcCCCCCC
Confidence 9999999999999 999999999999999999999999999998765221 12346899999999999888999
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
++|+|||||++|+|++|..||....... ........ ....+..++..+.+|+.+||..|
T Consensus 195 ~~DiwslG~il~elltg~~pf~~~~~~~-~~~~i~~~--------------------~~~~p~~~~~~~~~li~~~L~~d 253 (329)
T PTZ00263 195 AVDWWTMGVLLYEFIAGYPPFFDDTPFR-IYEKILAG--------------------RLKFPNWFDGRARDLVKGLLQTD 253 (329)
T ss_pred cceeechHHHHHHHHcCCCCCCCCCHHH-HHHHHhcC--------------------CcCCCCCCCHHHHHHHHHHhhcC
Confidence 9999999999999999999986532211 01110000 00112335667899999999999
Q ss_pred ccCCCC-----HHHHHHHHH
Q 024027 238 PEQRIN-----AKEIVTKLL 252 (273)
Q Consensus 238 p~~Rps-----~~~~l~~l~ 252 (273)
|.+||+ ++++++|-+
T Consensus 254 P~~R~~~~~~~~~~ll~hp~ 273 (329)
T PTZ00263 254 HTKRLGTLKGGVADVKNHPY 273 (329)
T ss_pred HHHcCCCCCCCHHHHhcCCc
Confidence 999997 799998843
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=278.36 Aligned_cols=227 Identities=34% Similarity=0.578 Sum_probs=179.0
Q ss_pred eEEEEEeecccC-hhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcC-CCCCCHHHHHHHH
Q 024027 2 EVAVKVFNLQCG-RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIM 79 (273)
Q Consensus 2 ~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ 79 (273)
+|+||+++.... +....+.+|++.+++++||||++++|++...+..++|+||+++|+|.+++... ...+++..++.++
T Consensus 30 ~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~ 109 (259)
T PF07714_consen 30 PVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIA 109 (259)
T ss_dssp EEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHH
T ss_pred EEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 799999976533 35788999999999999999999999999888899999999999999999876 5679999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 159 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 159 (273)
.|++.||.||| +.+++|++|+++||+++.++.+||+|||+.....................|+|||.+....++.++
T Consensus 110 ~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ks 186 (259)
T PF07714_consen 110 IQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKS 186 (259)
T ss_dssp HHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHH
T ss_pred ccccccccccc---cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999 999999999999999999999999999999776332222233344567789999999888899999
Q ss_pred hhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc
Q 024027 160 DVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238 (273)
Q Consensus 160 DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 238 (273)
||||||+++|++++ |..||......+. ...... ......+..++..+.+++.+||..||
T Consensus 187 DVysfG~~l~ei~~~~~~p~~~~~~~~~-~~~~~~-------------------~~~~~~~~~~~~~~~~li~~C~~~~p 246 (259)
T PF07714_consen 187 DVYSFGMLLYEILTLGKFPFSDYDNEEI-IEKLKQ-------------------GQRLPIPDNCPKDIYSLIQQCWSHDP 246 (259)
T ss_dssp HHHHHHHHHHHHHTTSSGTTTTSCHHHH-HHHHHT-------------------TEETTSBTTSBHHHHHHHHHHT-SSG
T ss_pred cccccccccccccccccccccccccccc-cccccc-------------------cccceeccchhHHHHHHHHHHcCCCh
Confidence 99999999999999 7788766422211 111100 00111244567779999999999999
Q ss_pred cCCCCHHHHHHHH
Q 024027 239 EQRINAKEIVTKL 251 (273)
Q Consensus 239 ~~Rps~~~~l~~l 251 (273)
.+|||+.++++.|
T Consensus 247 ~~RPs~~~i~~~L 259 (259)
T PF07714_consen 247 EKRPSFQEILQEL 259 (259)
T ss_dssp GGS--HHHHHHHH
T ss_pred hhCcCHHHHHhcC
Confidence 9999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=276.66 Aligned_cols=244 Identities=19% Similarity=0.203 Sum_probs=182.1
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
+.||||+++... ....+.+.+|+++++.++||||+++++++..++..++||||++++.+..+. .....+++..++.+
T Consensus 27 ~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~ 105 (287)
T cd07848 27 EIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLE-EMPNGVPPEKVRSY 105 (287)
T ss_pred cEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHH-hcCCCCCHHHHHHH
Confidence 368999997542 334567889999999999999999999999999999999999986665444 44456899999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCc
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTN 158 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 158 (273)
+.|++.||.||| +.|++|+||||+||+++.++.++|+|||++........ .......+++.|+|||.+.+..++.+
T Consensus 106 ~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~ 181 (287)
T cd07848 106 IYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-ANYTEYVATRWYRSPELLLGAPYGKA 181 (287)
T ss_pred HHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc-ccccccccccccCCcHHHcCCCCCCc
Confidence 999999999999 99999999999999999999999999999876532211 11223468899999999988889999
Q ss_pred chhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccc--hhhh----------hhhccccchhhhhhhhhhHHHH
Q 024027 159 GDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPIST--MEVV----------DANLLSQEDIHFVAKEQCVSFV 226 (273)
Q Consensus 159 ~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~----------~~~~~~~~~~~~~~~~~~~~~l 226 (273)
+|+||+||++|+|++|+.||......+. .........+... .... .................++.++
T Consensus 182 ~DiwslGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 260 (287)
T cd07848 182 VDMWSVGCILGELSDGQPLFPGESEIDQ-LFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVL 260 (287)
T ss_pred hhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHH
Confidence 9999999999999999999976433221 1111110000000 0000 0000000001111123467789
Q ss_pred HHHHhhcCCCCccCCCCHHHHHHH
Q 024027 227 FNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 227 ~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
.+|+.+||++||++|||++++++|
T Consensus 261 ~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 261 LDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred HHHHHHHccCCcccCCCHHHHhcC
Confidence 999999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=287.55 Aligned_cols=232 Identities=24% Similarity=0.388 Sum_probs=184.1
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC------------
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN------------ 67 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------ 67 (273)
.||||+++... ......+.+|+.+++.+ +|+||++++++|......++||||+++|+|.+++....
T Consensus 70 ~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~ 149 (374)
T cd05106 70 RVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPE 149 (374)
T ss_pred eeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccc
Confidence 69999997543 33456788999999999 89999999999999999999999999999999985321
Q ss_pred ---------------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHh
Q 024027 68 ---------------------------------------------------------CILDIFQRLNIMIDVASALEYLH 90 (273)
Q Consensus 68 ---------------------------------------------------------~~~~~~~~~~~~~ql~~~l~~lh 90 (273)
.++++..++.++.|++.||.|||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH 229 (374)
T cd05106 150 ISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA 229 (374)
T ss_pred cccccccccccchhcccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH
Confidence 23678889999999999999999
Q ss_pred cCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcchhHHHHHHHHH
Q 024027 91 FGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLME 170 (273)
Q Consensus 91 ~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ 170 (273)
+.|++||||||+||+++.++.++|+|||++................++..|+|||++.+..++.++|||||||++|+
T Consensus 230 ---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~e 306 (374)
T cd05106 230 ---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWE 306 (374)
T ss_pred ---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHH
Confidence 99999999999999999999999999999876533222112222335567999999988889999999999999999
Q ss_pred HHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHH
Q 024027 171 TFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVT 249 (273)
Q Consensus 171 ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~ 249 (273)
|++ |..||............ .... .....+...+.++.+++.+||..||.+|||+.++++
T Consensus 307 llt~G~~Pf~~~~~~~~~~~~-~~~~------------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 307 IFSLGKSPYPGILVNSKFYKM-VKRG------------------YQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHhCCCCCCccccccHHHHHH-HHcc------------------cCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 997 99998764332211111 1000 000112334677999999999999999999999999
Q ss_pred HHHHHH
Q 024027 250 KLLKIR 255 (273)
Q Consensus 250 ~l~~~~ 255 (273)
.|+++.
T Consensus 368 ~l~~~~ 373 (374)
T cd05106 368 LIQRQL 373 (374)
T ss_pred HHHHHh
Confidence 998764
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=289.74 Aligned_cols=221 Identities=25% Similarity=0.394 Sum_probs=187.5
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~q 81 (273)
.||||+++ +.-..+++-|++|+||||+.+.|+|.....+|||||||..|-|...|+.. ..+.......|..+
T Consensus 149 tVAVKKV~-------elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~-~~itp~llv~Wsk~ 220 (904)
T KOG4721|consen 149 TVAVKKVR-------ELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAG-RPITPSLLVDWSKG 220 (904)
T ss_pred eehhHHHh-------hhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhcc-CccCHHHHHHHHHH
Confidence 68999885 33345888999999999999999999999999999999999999999554 47888889999999
Q ss_pred HHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcchh
Q 024027 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 161 (273)
Q Consensus 82 l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di 161 (273)
|+.|+.||| .+.|+|||||.-|||++.+..|||+|||.+..+... ...-.++||..|||||++.+...+.+.||
T Consensus 221 IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDI 294 (904)
T KOG4721|consen 221 IAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDI 294 (904)
T ss_pred hhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccce
Confidence 999999999 999999999999999999999999999999866332 22334679999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccCC
Q 024027 162 YSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQR 241 (273)
Q Consensus 162 wslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 241 (273)
|||||+|||||||..||.+.+....-+- .....+..+.|..|++.+.-|+++||...|..|
T Consensus 295 wSfGVVLWEmLT~EiPYkdVdssAIIwG-------------------VGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNR 355 (904)
T KOG4721|consen 295 WSFGVVLWEMLTGEIPYKDVDSSAIIWG-------------------VGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNR 355 (904)
T ss_pred ehhHHHHHHHHhcCCCccccchheeEEe-------------------ccCCcccccCcccCchHHHHHHHHHHhcCCCCC
Confidence 9999999999999999876433221110 111223445578899999999999999999999
Q ss_pred CCHHHHHHHHHHHH
Q 024027 242 INAKEIVTKLLKIR 255 (273)
Q Consensus 242 ps~~~~l~~l~~~~ 255 (273)
||+.+++.||+=..
T Consensus 356 PSFrqil~HldIa~ 369 (904)
T KOG4721|consen 356 PSFRQILLHLDIAS 369 (904)
T ss_pred ccHHHHHHHHhhcC
Confidence 99999999997443
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=279.53 Aligned_cols=235 Identities=24% Similarity=0.420 Sum_probs=181.2
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC-------------
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN------------- 67 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------- 67 (273)
+||||+++... ......+.+|++++..++||||+++++++.+....++||||+++++|.+++....
T Consensus 48 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 127 (304)
T cd05096 48 LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVP 127 (304)
T ss_pred EEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccc
Confidence 59999997653 3345679999999999999999999999999999999999999999999985431
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccC
Q 024027 68 -----CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATI 142 (273)
Q Consensus 68 -----~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~ 142 (273)
..+++..++.++.|++.||.||| +.|++|+||||+||+++.++.+||+|||++..+.............++.
T Consensus 128 ~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~ 204 (304)
T cd05096 128 PAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPI 204 (304)
T ss_pred cccccccccHHHHHHHHHHHHHHHHHHH---HCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCc
Confidence 23677889999999999999999 9999999999999999999999999999987653222212222334577
Q ss_pred CCCCCcccCCCCcCCcchhHHHHHHHHHHHh--CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhh
Q 024027 143 GYMAPEYGREGRVSTNGDVYSFGIMLMETFT--GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKE 220 (273)
Q Consensus 143 ~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (273)
.|+|||.+.+..++.++||||||+++|+|++ +..||........ ...... ..... ........+.
T Consensus 205 ~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~-~~~~~~---------~~~~~---~~~~~~~~~~ 271 (304)
T cd05096 205 RWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQV-IENAGE---------FFRDQ---GRQVYLFRPP 271 (304)
T ss_pred cccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHH-HHHHHH---------Hhhhc---cccccccCCC
Confidence 8999999988889999999999999999987 5567765332211 100000 00000 0000011134
Q ss_pred hhHHHHHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 221 QCVSFVFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 221 ~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
.++..+.+|+.+||..||.+|||+.++.+.|+
T Consensus 272 ~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 272 PCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 56778999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=276.58 Aligned_cols=233 Identities=31% Similarity=0.509 Sum_probs=188.3
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC--------------
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-------------- 67 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------- 67 (273)
.||+|.++.........+.+|+++++.++|+||+++++++......++||||+++++|.+++....
T Consensus 37 ~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~ 116 (291)
T cd05094 37 LVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQA 116 (291)
T ss_pred eeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccC
Confidence 488899876655566789999999999999999999999999999999999999999999996532
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCC
Q 024027 68 -CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMA 146 (273)
Q Consensus 68 -~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~a 146 (273)
..+++..++.++.|++.|++||| ++|++|+||+|+||+++.++.++|+|||++................++..|+|
T Consensus 117 ~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~a 193 (291)
T cd05094 117 KGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMP 193 (291)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecC
Confidence 23788999999999999999999 99999999999999999999999999999875432221122233446778999
Q ss_pred CcccCCCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHH
Q 024027 147 PEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSF 225 (273)
Q Consensus 147 PE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (273)
||.+.+..++.++||||||+++|+|++ |..||......+. ........ ....+..++..
T Consensus 194 PE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-~~~~~~~~-------------------~~~~~~~~~~~ 253 (291)
T cd05094 194 PESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV-IECITQGR-------------------VLERPRVCPKE 253 (291)
T ss_pred hHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHhCCC-------------------CCCCCccCCHH
Confidence 999988889999999999999999998 9999865433211 10000000 00012335667
Q ss_pred HHHHHhhcCCCCccCCCCHHHHHHHHHHHHHh
Q 024027 226 VFNLAMACTVESPEQRINAKEIVTKLLKIRDS 257 (273)
Q Consensus 226 l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~ 257 (273)
+.+++.+||..||.+|||+.++++.|.++.+.
T Consensus 254 ~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 254 VYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 99999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=265.05 Aligned_cols=210 Identities=26% Similarity=0.319 Sum_probs=180.5
Q ss_pred EEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 3 VAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 3 vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
+|+|+++.+. ....+....|-.+|+.+.||.++++++.|.+.++++|||||++||.|..++++.+ ++++..++-++
T Consensus 72 YAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~-rF~e~~arFYA 150 (355)
T KOG0616|consen 72 YAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSG-RFSEPHARFYA 150 (355)
T ss_pred eehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcC-CCCchhHHHHH
Confidence 6899997663 3345667789999999999999999999999999999999999999999996654 79999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 159 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 159 (273)
.||+.||+||| +.++++||+||+|||+|.+|.+|++|||++..+ .......||||.|+|||++....++.++
T Consensus 151 AeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v-----~~rT~TlCGTPeYLAPEii~sk~ynkav 222 (355)
T KOG0616|consen 151 AEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRV-----SGRTWTLCGTPEYLAPEIIQSKGYNKAV 222 (355)
T ss_pred HHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEe-----cCcEEEecCCccccChHHhhcCCCCcch
Confidence 99999999999 999999999999999999999999999999876 2234567999999999999999999999
Q ss_pred hhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCcc
Q 024027 160 DVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239 (273)
Q Consensus 160 DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 239 (273)
|-||||+++|||+.|.+||..... ...+..+.+. ....|..++.++.+|+.++|+.|-.
T Consensus 223 DWWalGVLIYEMlaG~pPF~~~~~-~~iY~KI~~~--------------------~v~fP~~fs~~~kdLl~~LL~vD~t 281 (355)
T KOG0616|consen 223 DWWALGVLIYEMLAGYPPFYDDNP-IQIYEKILEG--------------------KVKFPSYFSSDAKDLLKKLLQVDLT 281 (355)
T ss_pred hHHHHHHHHHHHHcCCCCCcCCCh-HHHHHHHHhC--------------------cccCCcccCHHHHHHHHHHHhhhhH
Confidence 999999999999999999987544 2222222211 1112666788899999999999999
Q ss_pred CCC
Q 024027 240 QRI 242 (273)
Q Consensus 240 ~Rp 242 (273)
+|.
T Consensus 282 ~R~ 284 (355)
T KOG0616|consen 282 KRF 284 (355)
T ss_pred hhh
Confidence 993
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=285.64 Aligned_cols=231 Identities=23% Similarity=0.358 Sum_probs=183.2
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC------------
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN------------ 67 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------ 67 (273)
.||||+++... ....+.+.+|+.+++.+ +||||++++++|.+.+..++||||+++|+|.+++....
T Consensus 67 ~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~ 146 (375)
T cd05104 67 TVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHA 146 (375)
T ss_pred eEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchh
Confidence 69999997543 34456788999999999 89999999999999999999999999999999986422
Q ss_pred --------------------------------------------------------------CCCCHHHHHHHHHHHHHH
Q 024027 68 --------------------------------------------------------------CILDIFQRLNIMIDVASA 85 (273)
Q Consensus 68 --------------------------------------------------------------~~~~~~~~~~~~~ql~~~ 85 (273)
..+++..+..++.|++.|
T Consensus 147 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~ 226 (375)
T cd05104 147 EAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKG 226 (375)
T ss_pred hhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHH
Confidence 136788899999999999
Q ss_pred HHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcchhHHHH
Q 024027 86 LEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFG 165 (273)
Q Consensus 86 l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG 165 (273)
|.||| +.|++|+||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++||||||
T Consensus 227 l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG 303 (375)
T cd05104 227 MSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYG 303 (375)
T ss_pred HHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHH
Confidence 99999 999999999999999999999999999998765332222222223346679999999988999999999999
Q ss_pred HHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccCCCCH
Q 024027 166 IMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINA 244 (273)
Q Consensus 166 ~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 244 (273)
|++|+|++ |..||................. ....+...+.++.+|+.+||..||++|||+
T Consensus 304 ~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 364 (375)
T cd05104 304 ILLWEIFSLGSSPYPGMPVDSKFYKMIKEGY-------------------RMLSPECAPSEMYDIMKSCWDADPLKRPTF 364 (375)
T ss_pred HHHHHHHhcCCCCCCCCCchHHHHHHHHhCc-------------------cCCCCCCCCHHHHHHHHHHccCChhHCcCH
Confidence 99999998 8888865432221111111000 001123345679999999999999999999
Q ss_pred HHHHHHHHHH
Q 024027 245 KEIVTKLLKI 254 (273)
Q Consensus 245 ~~~l~~l~~~ 254 (273)
.++++.|++.
T Consensus 365 ~eil~~l~~~ 374 (375)
T cd05104 365 KQIVQLIEQQ 374 (375)
T ss_pred HHHHHHHHhh
Confidence 9999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=276.03 Aligned_cols=229 Identities=20% Similarity=0.249 Sum_probs=182.1
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcC-CCCCCHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~ 76 (273)
+.||||++.... ......+.+|+.+++.++|++|+++++++.+++..++|+||+++|+|.+++... ...+++..+.
T Consensus 26 ~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~ 105 (285)
T cd05631 26 KMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAI 105 (285)
T ss_pred ceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHH
Confidence 469999986442 223345778999999999999999999999999999999999999999887543 3358999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcC
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVS 156 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 156 (273)
.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++...... .......|+..|+|||.+.+..++
T Consensus 106 ~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~ 179 (285)
T cd05631 106 FYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG---ETVRGRVGTVGYMAPEVINNEKYT 179 (285)
T ss_pred HHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC---CeecCCCCCCCccCHhhhcCCCCC
Confidence 99999999999999 999999999999999999999999999998764221 122345689999999999988999
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++|||||||++|+|++|..||......... ...... .. ......+..++.++.+|+.+||..
T Consensus 180 ~~~DvwslGvil~el~~g~~pf~~~~~~~~~-~~~~~~-------------~~---~~~~~~~~~~s~~~~~li~~~l~~ 242 (285)
T cd05631 180 FSPDWWGLGCLIYEMIQGQSPFRKRKERVKR-EEVDRR-------------VK---EDQEEYSEKFSEDAKSICRMLLTK 242 (285)
T ss_pred cccCchhHHHHHHHHHhCCCCCCCCCcchhH-HHHHHH-------------hh---cccccCCccCCHHHHHHHHHHhhc
Confidence 9999999999999999999999764322110 000000 00 000111344677899999999999
Q ss_pred CccCCCC-----HHHHHHHHH
Q 024027 237 SPEQRIN-----AKEIVTKLL 252 (273)
Q Consensus 237 dp~~Rps-----~~~~l~~l~ 252 (273)
||.+||+ ++++++|-+
T Consensus 243 ~P~~R~~~~~~~~~~~~~h~~ 263 (285)
T cd05631 243 NPKERLGCRGNGAAGVKQHPI 263 (285)
T ss_pred CHHHhcCCCCCCHHHHhcCHh
Confidence 9999997 899998743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=282.47 Aligned_cols=224 Identities=26% Similarity=0.363 Sum_probs=189.6
Q ss_pred CeEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 1 MEVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 1 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
+.||+|++.... ..+.+++++|+.+|.+++++||.+.|+.|..+..+.++||||.||++.+.++.. ..+.+..+.-++
T Consensus 39 k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~-~~~~E~~i~~il 117 (467)
T KOG0201|consen 39 KVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSG-NILDEFEIAVIL 117 (467)
T ss_pred ceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccC-CCCccceeeeeh
Confidence 469999998653 556889999999999999999999999999999999999999999999999544 456889999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 159 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 159 (273)
.+++.|+.||| ..+.+|+|||+.||++..+|.+|++|||.+-.+...... ....+||+.|||||++.+..|+.++
T Consensus 118 re~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r--r~tfvGTPfwMAPEVI~~~~Y~~KA 192 (467)
T KOG0201|consen 118 REVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR--RKTFVGTPFWMAPEVIKQSGYDTKA 192 (467)
T ss_pred HHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhhc--cccccccccccchhhhccccccchh
Confidence 99999999999 999999999999999999999999999999877544332 3678999999999999988999999
Q ss_pred hhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCcc
Q 024027 160 DVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239 (273)
Q Consensus 160 DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 239 (273)
||||||++.+||++|.+|+.+...... ...+.+...+.. ...++..+++|+..||++||+
T Consensus 193 DIWSLGITaiEla~GePP~s~~hPmrv--------------lflIpk~~PP~L------~~~~S~~~kEFV~~CL~k~P~ 252 (467)
T KOG0201|consen 193 DIWSLGITAIELAKGEPPHSKLHPMRV--------------LFLIPKSAPPRL------DGDFSPPFKEFVEACLDKNPE 252 (467)
T ss_pred hhhhhhHHHHHHhcCCCCCcccCcceE--------------EEeccCCCCCcc------ccccCHHHHHHHHHHhhcCcc
Confidence 999999999999999999877544211 111111111110 224666699999999999999
Q ss_pred CCCCHHHHHHH
Q 024027 240 QRINAKEIVTK 250 (273)
Q Consensus 240 ~Rps~~~~l~~ 250 (273)
.|||+.++++|
T Consensus 253 ~RpsA~~LLKh 263 (467)
T KOG0201|consen 253 FRPSAKELLKH 263 (467)
T ss_pred cCcCHHHHhhh
Confidence 99999999986
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=282.65 Aligned_cols=224 Identities=24% Similarity=0.291 Sum_probs=181.6
Q ss_pred CeEEEEEeeccc----ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHH
Q 024027 1 MEVAVKVFNLQC----GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (273)
+.||||+++... ......+..|+.+++.++||||+++++++..++..++||||+++++|.+++...+ .+.+..+.
T Consensus 25 ~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~ 103 (323)
T cd05584 25 KIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREG-IFMEDTAC 103 (323)
T ss_pred CEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHcC-CCCHHHHH
Confidence 369999997532 2334567889999999999999999999999999999999999999999996554 57888999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcC
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVS 156 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 156 (273)
.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++....... .......|++.|+|||.+.+..++
T Consensus 104 ~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~ 178 (323)
T cd05584 104 FYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG--TVTHTFCGTIEYMAPEILMRSGHG 178 (323)
T ss_pred HHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC--CcccccCCCccccChhhccCCCCC
Confidence 99999999999999 9999999999999999999999999999986432211 122335689999999999888899
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++|||||||++|+|++|..||....... ....... .....+..++.++.+|+.+||..
T Consensus 179 ~~~DiwslG~il~ell~G~~pf~~~~~~~-~~~~~~~--------------------~~~~~~~~~~~~~~~li~~~l~~ 237 (323)
T cd05584 179 KAVDWWSLGALMYDMLTGAPPFTAENRKK-TIDKILK--------------------GKLNLPPYLTPEARDLLKKLLKR 237 (323)
T ss_pred CcceecccHHHHHHHhcCCCCCCCCCHHH-HHHHHHc--------------------CCCCCCCCCCHHHHHHHHHHccc
Confidence 99999999999999999999986532211 0100000 00112344667799999999999
Q ss_pred CccCCC-----CHHHHHHHH
Q 024027 237 SPEQRI-----NAKEIVTKL 251 (273)
Q Consensus 237 dp~~Rp-----s~~~~l~~l 251 (273)
||++|| ++.++++|-
T Consensus 238 ~p~~R~~~~~~~~~~l~~h~ 257 (323)
T cd05584 238 NPSSRLGAGPGDAAEVQSHP 257 (323)
T ss_pred CHhHcCCCCCCCHHHHhcCC
Confidence 999999 899998874
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=280.25 Aligned_cols=224 Identities=24% Similarity=0.331 Sum_probs=192.7
Q ss_pred eEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 2 EVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 2 ~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
+||||++.... .-....+..|++.++.++|||||++|.+...+..+|+|+|.-++|+|.+||-++...+++..+.++|
T Consensus 45 kVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF 124 (864)
T KOG4717|consen 45 KVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYF 124 (864)
T ss_pred eeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHH
Confidence 69999997653 4456678899999999999999999999999999999999999999999998888889999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceee-CCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcC-C
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLL-DDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVS-T 157 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~-~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~ 157 (273)
.||+.|+.||| +..++||||||+|+.+ .+-|-|||.|||++..+.... .....+|+.-|-|||++.|..|. +
T Consensus 125 ~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~---kL~TsCGSLAYSAPEILLGDsYDAP 198 (864)
T KOG4717|consen 125 AQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK---KLTTSCGSLAYSAPEILLGDSYDAP 198 (864)
T ss_pred HHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc---hhhcccchhhccCchhhhcCccCCc
Confidence 99999999999 9999999999999887 477899999999998874433 34567899999999999999885 6
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
+.||||||+|+|.+..|++||......+. +..++. . ....|..++.+.++||.+||..|
T Consensus 199 AVDiWSLGVILyMLVCGq~PFqeANDSET-LTmImD------------C--------KYtvPshvS~eCrdLI~sMLvRd 257 (864)
T KOG4717|consen 199 AVDIWSLGVILYMLVCGQPPFQEANDSET-LTMIMD------------C--------KYTVPSHVSKECRDLIQSMLVRD 257 (864)
T ss_pred chhhhHHHHHHHHHHhCCCccccccchhh-hhhhhc------------c--------cccCchhhhHHHHHHHHHHHhcC
Confidence 79999999999999999999987544332 222211 1 12337778999999999999999
Q ss_pred ccCCCCHHHHHHHHH
Q 024027 238 PEQRINAKEIVTKLL 252 (273)
Q Consensus 238 p~~Rps~~~~l~~l~ 252 (273)
|++|.|.++|..+-|
T Consensus 258 PkkRAslEeI~s~~W 272 (864)
T KOG4717|consen 258 PKKRASLEEIVSTSW 272 (864)
T ss_pred chhhccHHHHhcccc
Confidence 999999999988754
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=274.87 Aligned_cols=228 Identities=33% Similarity=0.544 Sum_probs=184.0
Q ss_pred eEEEEEeecccCh-hhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC-------------
Q 024027 2 EVAVKVFNLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN------------- 67 (273)
Q Consensus 2 ~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------- 67 (273)
+||||+++..... ....+.+|+++++.++|+||+++++++......+++|||+++++|.+++...+
T Consensus 37 ~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~ 116 (280)
T cd05049 37 LVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPM 116 (280)
T ss_pred eEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhccccccc
Confidence 6899999865443 56789999999999999999999999999999999999999999999996542
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCC
Q 024027 68 CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 147 (273)
Q Consensus 68 ~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aP 147 (273)
..+++..+..++.|++.|+.+|| +.|++|+||+|+||+++.++.++|+|||++................+++.|+||
T Consensus 117 ~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aP 193 (280)
T cd05049 117 GELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPP 193 (280)
T ss_pred ccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecCh
Confidence 34788899999999999999999 999999999999999999999999999998754222211122233456789999
Q ss_pred cccCCCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHH
Q 024027 148 EYGREGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFV 226 (273)
Q Consensus 148 E~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 226 (273)
|.+.+..++.++||||||+++|+|++ |..||......+. ..... ... ....+..++..+
T Consensus 194 E~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~-~~~~~-------------~~~------~~~~~~~~~~~~ 253 (280)
T cd05049 194 ESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV-IECIT-------------QGR------LLQRPRTCPSEV 253 (280)
T ss_pred hhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH-HHHHH-------------cCC------cCCCCCCCCHHH
Confidence 99998889999999999999999998 9999865332211 11000 000 001123466779
Q ss_pred HHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 227 FNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 227 ~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
.+++.+||..||.+|||+.|+++.|.
T Consensus 254 ~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 254 YDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 99999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=284.91 Aligned_cols=220 Identities=21% Similarity=0.252 Sum_probs=181.3
Q ss_pred eEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 2 EVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 2 ~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
.||+|++.... ......+.+|+.+++.++||||+++++++.++...++||||+++|+|.+++.... .+++..+..+
T Consensus 58 ~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~-~~~~~~~~~~ 136 (340)
T PTZ00426 58 PVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNK-RFPNDVGCFY 136 (340)
T ss_pred EEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHH
Confidence 69999986442 3345678899999999999999999999999999999999999999999996554 6899999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCc
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTN 158 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 158 (273)
+.|++.||.||| +.|++||||||+||+++.++.++|+|||++..... ......|++.|+|||++.+..++.+
T Consensus 137 ~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~ 208 (340)
T PTZ00426 137 AAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-----RTYTLCGTPEYIAPEILLNVGHGKA 208 (340)
T ss_pred HHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC-----CcceecCChhhcCHHHHhCCCCCcc
Confidence 999999999999 99999999999999999999999999999876522 1234568999999999988889999
Q ss_pred chhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc
Q 024027 159 GDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238 (273)
Q Consensus 159 ~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 238 (273)
+|+||+||++|+|++|..||....... ........ . ...+..++..+.+++.+||..||
T Consensus 209 ~DiwSlGvil~ell~G~~Pf~~~~~~~-~~~~i~~~----------------~----~~~p~~~~~~~~~li~~~l~~dp 267 (340)
T PTZ00426 209 ADWWTLGIFIYEILVGCPPFYANEPLL-IYQKILEG----------------I----IYFPKFLDNNCKHLMKKLLSHDL 267 (340)
T ss_pred ccccchhhHHHHHhcCCCCCCCCCHHH-HHHHHhcC----------------C----CCCCCCCCHHHHHHHHHHcccCH
Confidence 999999999999999999997532211 11111100 0 01133456678999999999999
Q ss_pred cCCC-----CHHHHHHHH
Q 024027 239 EQRI-----NAKEIVTKL 251 (273)
Q Consensus 239 ~~Rp-----s~~~~l~~l 251 (273)
++|+ |++++++|-
T Consensus 268 ~~R~~~~~~~~~~~~~hp 285 (340)
T PTZ00426 268 TKRYGNLKKGAQNVKEHP 285 (340)
T ss_pred HHcCCCCCCCHHHHHcCC
Confidence 9995 899999884
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=262.24 Aligned_cols=230 Identities=27% Similarity=0.403 Sum_probs=187.4
Q ss_pred eEEEEEeeccc----C----hhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCH
Q 024027 2 EVAVKVFNLQC----G----RAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDI 72 (273)
Q Consensus 2 ~vavK~~~~~~----~----~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 72 (273)
..|+|++.... . +-.++-.+|+.+|+++ .||+|+++.++|+.+...++|+|.|+.|.|+|++... -.+++
T Consensus 44 e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~-VtlSE 122 (411)
T KOG0599|consen 44 EFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSK-VTLSE 122 (411)
T ss_pred ceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhh-eeecH
Confidence 57888885432 1 1244556799999999 6999999999999999999999999999999999544 46999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccC-
Q 024027 73 FQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR- 151 (273)
Q Consensus 73 ~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~- 151 (273)
...++++.|+..|+.||| .++|+|+|+||+||+++++-+++|+|||+++.+.. .......||||+|+|||.+.
T Consensus 123 K~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~---GekLrelCGTPgYLAPEtikC 196 (411)
T KOG0599|consen 123 KETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGFACQLEP---GEKLRELCGTPGYLAPETIKC 196 (411)
T ss_pred HHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEeccceeeccCC---chhHHHhcCCCcccChhheee
Confidence 999999999999999999 99999999999999999999999999999998633 33345689999999999875
Q ss_pred -----CCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHH
Q 024027 152 -----EGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFV 226 (273)
Q Consensus 152 -----~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 226 (273)
.+.|+...|+|+.|+++|.++.|.+||....+- .-+..+ +.....+..+...+.+...
T Consensus 197 ~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm-lMLR~I----------------meGkyqF~speWadis~~~ 259 (411)
T KOG0599|consen 197 SMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM-LMLRMI----------------MEGKYQFRSPEWADISATV 259 (411)
T ss_pred ecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH-HHHHHH----------------HhcccccCCcchhhccccH
Confidence 345889999999999999999999998652111 001111 1122233344467788889
Q ss_pred HHHHhhcCCCCccCCCCHHHHHHHHHHHH
Q 024027 227 FNLAMACTVESPEQRINAKEIVTKLLKIR 255 (273)
Q Consensus 227 ~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 255 (273)
.+||.+||+.||.+|.|++|+|.|-.-..
T Consensus 260 KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 260 KDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred HHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 99999999999999999999999866433
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=267.50 Aligned_cols=243 Identities=24% Similarity=0.205 Sum_probs=187.5
Q ss_pred CeEEEEEeecccC--hhhhhHHHHHHHHhcCCCcc-ceeeeeeeecCC------ceeEEEeccCCCCHHHhhhcCC---C
Q 024027 1 MEVAVKVFNLQCG--RAFKSFDVECEMMKSIRHRN-LIKVISSCSNEE------FKALVLEYMPHGSLEKYLYSSN---C 68 (273)
Q Consensus 1 ~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~-i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~---~ 68 (273)
+.||+|+++.... .......+|+.+|+.++|+| |+++++++.... .+++||||++. +|..++.... .
T Consensus 37 ~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~ 115 (323)
T KOG0594|consen 37 KFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQ 115 (323)
T ss_pred CEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEeecc-cHHHHHHhcccccc
Confidence 4699999987643 25566889999999999999 999999998776 88999999977 9999997655 3
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCc
Q 024027 69 ILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPE 148 (273)
Q Consensus 69 ~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE 148 (273)
.++...+..++.||+.||+||| +++|+||||||.||+++++|.+||+|||++..+.- ........++|.+|+|||
T Consensus 116 g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~i--p~~~yt~evvTlWYRaPE 190 (323)
T KOG0594|consen 116 GLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGLARAFSI--PMRTYTPEVVTLWYRAPE 190 (323)
T ss_pred CCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccchHHHhcC--CcccccccEEEeeccCHH
Confidence 5777899999999999999999 99999999999999999999999999999986532 223345667899999999
Q ss_pred ccCCC-CcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhh--ccCccchhhhhhhcccc-chhhh-------h
Q 024027 149 YGREG-RVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVND--WLPISTMEVVDANLLSQ-EDIHF-------V 217 (273)
Q Consensus 149 ~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~-~~~~~-------~ 217 (273)
++.+. .|+...||||+||++.||+++++.|.+...- .++..+... .+....++......... ..... .
T Consensus 191 vLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~-~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~ 269 (323)
T KOG0594|consen 191 VLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI-DQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSS 269 (323)
T ss_pred HhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH-HHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHH
Confidence 99887 6999999999999999999999998875542 223232222 11112222111110000 00001 1
Q ss_pred hhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHH
Q 024027 218 AKEQCVSFVFNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 218 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
..+.......+++.+||..+|++|.|++.+++|
T Consensus 270 ~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 270 ILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred hccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 112223479999999999999999999999998
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=257.52 Aligned_cols=234 Identities=23% Similarity=0.267 Sum_probs=187.9
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCC-----ceeEEEeccCCCCHHHhhhcC---CCCCCHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEE-----FKALVLEYMPHGSLEKYLYSS---NCILDIF 73 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~---~~~~~~~ 73 (273)
-+|+|++..++.++.+...+|++..++++|||+++++++...+. ..|++++|+..|+|.+.++.. +..+++.
T Consensus 48 ~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~ 127 (302)
T KOG2345|consen 48 LYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEA 127 (302)
T ss_pred chhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHH
Confidence 47999999888888999999999999999999999999875543 489999999999999998643 4469999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCC--eEeccCCCCceeeCCCCceEEeecccccccccCCCcc-------eeecccccCCC
Q 024027 74 QRLNIMIDVASALEYLHFGCSAP--VIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSM-------TQTQTLATIGY 144 (273)
Q Consensus 74 ~~~~~~~ql~~~l~~lh~~~~~~--i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~-------~~~~~~~~~~~ 144 (273)
+++.|+.+++.||.+|| +.. ++|+||||.||+++..+.+++.|||.++...-.-... ......+|..|
T Consensus 128 ~iL~if~gic~gL~~lH---~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~py 204 (302)
T KOG2345|consen 128 QILWIFLGICRGLEALH---EKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPY 204 (302)
T ss_pred HHHHHHHHHHHHHHHHh---ccCCcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcc
Confidence 99999999999999999 887 9999999999999999999999999987653221111 11234588999
Q ss_pred CCCcccCCC---CcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhh
Q 024027 145 MAPEYGREG---RVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQ 221 (273)
Q Consensus 145 ~aPE~~~~~---~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (273)
+|||++.-. ..+.++|||||||++|.|++|..||............-. ......++....
T Consensus 205 RAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv-----------------~n~q~s~P~~~~ 267 (302)
T KOG2345|consen 205 RAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAV-----------------QNAQISIPNSSR 267 (302)
T ss_pred cCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEee-----------------eccccccCCCCC
Confidence 999998643 478999999999999999999999975433222111100 011112222334
Q ss_pred hHHHHHHHHhhcCCCCccCCCCHHHHHHHHHHHH
Q 024027 222 CVSFVFNLAMACTVESPEQRINAKEIVTKLLKIR 255 (273)
Q Consensus 222 ~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 255 (273)
.+..+..++++||..||.+||++.+++.+++++.
T Consensus 268 yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 268 YSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 7788999999999999999999999999998764
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=269.17 Aligned_cols=229 Identities=26% Similarity=0.398 Sum_probs=181.3
Q ss_pred CeEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 1 MEVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 1 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
+.||+|.+.... ......+.+|+++++.++||||+++++++......++||||+++++|.+++......+++..++.++
T Consensus 21 ~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ 100 (252)
T cd05084 21 TPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMV 100 (252)
T ss_pred ceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHH
Confidence 368999886443 3345679999999999999999999999999999999999999999999997666668999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 159 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 159 (273)
.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++.................+..|+|||.+.+..++.++
T Consensus 101 ~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 177 (252)
T cd05084 101 ENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSES 177 (252)
T ss_pred HHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHH
Confidence 99999999999 999999999999999999999999999998754221111111111234569999999888899999
Q ss_pred hhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc
Q 024027 160 DVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238 (273)
Q Consensus 160 DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 238 (273)
|+||||+++|++++ |..||........ ... .. .. .....+..++..+.+|+.+||..||
T Consensus 178 Dv~slG~il~e~~~~~~~p~~~~~~~~~-~~~-~~------------~~------~~~~~~~~~~~~~~~li~~~l~~~p 237 (252)
T cd05084 178 DVWSFGILLWEAFSLGAVPYANLSNQQT-REA-IE------------QG------VRLPCPELCPDAVYRLMERCWEYDP 237 (252)
T ss_pred HHHHHHHHHHHHHhCCCCCccccCHHHH-HHH-HH------------cC------CCCCCcccCCHHHHHHHHHHcCCCh
Confidence 99999999999997 8888865322110 000 00 00 0011133456779999999999999
Q ss_pred cCCCCHHHHHHHHH
Q 024027 239 EQRINAKEIVTKLL 252 (273)
Q Consensus 239 ~~Rps~~~~l~~l~ 252 (273)
++|||++++++.|.
T Consensus 238 ~~Rps~~~~~~~l~ 251 (252)
T cd05084 238 GQRPSFSTVHQELQ 251 (252)
T ss_pred hhCcCHHHHHHHHh
Confidence 99999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=273.78 Aligned_cols=244 Identities=24% Similarity=0.311 Sum_probs=185.6
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecC--C---ceeEEEeccCCCCHHHhhhc---CCCCCCH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNE--E---FKALVLEYMPHGSLEKYLYS---SNCILDI 72 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~---~~~lv~e~~~~~~L~~~l~~---~~~~~~~ 72 (273)
.+||||+.-.+. +.-.+|+++|+.++||||+++.-+|... + ...+||||++. +|.++++. .+..++.
T Consensus 50 ~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~ 124 (364)
T KOG0658|consen 50 EEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPL 124 (364)
T ss_pred ceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCce
Confidence 379999986442 4556899999999999999999988543 2 45699999998 99999963 3456888
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCC-CceEEeecccccccccCCCcceeecccccCCCCCCcccC
Q 024027 73 FQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDN-LVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR 151 (273)
Q Consensus 73 ~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~-~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 151 (273)
-.++-+.+||..||+||| ..|||||||||.|+|+|.+ |.+||+|||.+..+..... .....++..|+|||++.
T Consensus 125 ~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep---niSYicSRyYRaPELif 198 (364)
T KOG0658|consen 125 LEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP---NISYICSRYYRAPELIF 198 (364)
T ss_pred eeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCC---ceeEEEeccccCHHHHc
Confidence 889999999999999999 9999999999999999965 8999999999988743332 24456889999999988
Q ss_pred CC-CcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhcc---------ccchhhhhhhhh
Q 024027 152 EG-RVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLL---------SQEDIHFVAKEQ 221 (273)
Q Consensus 152 ~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~ 221 (273)
+. .|+.+.||||.||++.||+.|++-|.+ ......+..+..-...+...+....+.. ............
T Consensus 199 ga~~Yt~~IDiWSaGCV~aELl~g~plFpG-~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~ 277 (364)
T KOG0658|consen 199 GATEYTTSIDIWSAGCVMAELLKGQPLFPG-DSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKR 277 (364)
T ss_pred CccccCceeEEhhhhHHHHHHhcCCcccCC-CCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccC
Confidence 86 599999999999999999999999987 3334444444443333222222111110 001101112345
Q ss_pred hHHHHHHHHhhcCCCCccCCCCHHHHHHH--HHHHHH
Q 024027 222 CVSFVFNLAMACTVESPEQRINAKEIVTK--LLKIRD 256 (273)
Q Consensus 222 ~~~~l~~li~~~l~~dp~~Rps~~~~l~~--l~~~~~ 256 (273)
.++++.+|+.++|.++|.+|.++.+++.| +.++++
T Consensus 278 ~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 278 LPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred CCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 67889999999999999999999999975 444443
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=271.63 Aligned_cols=229 Identities=23% Similarity=0.386 Sum_probs=184.0
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
+||+|.++... ......+.+|+.+++.++||||+++++++..+...++||||+++++|.+++......+++..++.++.
T Consensus 35 ~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~ 114 (266)
T cd05064 35 PVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLP 114 (266)
T ss_pred eEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHH
Confidence 68999998653 23456788999999999999999999999999999999999999999999977666789999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
|++.||+||| +.|++|+||+|+||+++.++.++++|||.......... .......++..|+|||.+.+..++.++|
T Consensus 115 ~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~D 190 (266)
T cd05064 115 GLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASD 190 (266)
T ss_pred HHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccccccccch-hcccCCCCceeecCHHHHhhCCccchhH
Confidence 9999999999 99999999999999999999999999998764321111 1111223456799999998888999999
Q ss_pred hHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCcc
Q 024027 161 VYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239 (273)
Q Consensus 161 iwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 239 (273)
||||||++|++++ |..||......+. .... . .. ...+.+..++..+.+++.+||..+|.
T Consensus 191 i~slG~~l~ell~~g~~p~~~~~~~~~-~~~~-~------------~~------~~~~~~~~~~~~~~~li~~c~~~~p~ 250 (266)
T cd05064 191 VWSFGIVMWEVMSYGERPYWDMSGQDV-IKAV-E------------DG------FRLPAPRNCPNLLHQLMLDCWQKERG 250 (266)
T ss_pred HHHHHHHHHHHhcCCCCCcCcCCHHHH-HHHH-H------------CC------CCCCCCCCCCHHHHHHHHHHcCCCch
Confidence 9999999999775 9999865422211 1100 0 00 00112445677799999999999999
Q ss_pred CCCCHHHHHHHHHHH
Q 024027 240 QRINAKEIVTKLLKI 254 (273)
Q Consensus 240 ~Rps~~~~l~~l~~~ 254 (273)
+|||++++++.|.++
T Consensus 251 ~RP~~~~i~~~l~~~ 265 (266)
T cd05064 251 ERPRFSQIHSILSKM 265 (266)
T ss_pred hCCCHHHHHHHHHhh
Confidence 999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=269.92 Aligned_cols=230 Identities=26% Similarity=0.474 Sum_probs=186.8
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
.||||+++... ......+..|+.+++.++||||+++++++...+..+++|||+++++|.+++......+++..++.++.
T Consensus 34 ~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ 113 (266)
T cd05033 34 DVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLR 113 (266)
T ss_pred eEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHH
Confidence 58999987553 34456788999999999999999999999999999999999999999999977666789999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
|++.|+.||| +.+++|+||+|+||+++.++.++|+|||++..+.............++..|+|||.+.+..++.++|
T Consensus 114 ~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~D 190 (266)
T cd05033 114 GIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASD 190 (266)
T ss_pred HHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccc
Confidence 9999999999 9999999999999999999999999999998764222222222233467899999998888999999
Q ss_pred hHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCcc
Q 024027 161 VYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239 (273)
Q Consensus 161 iwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 239 (273)
+||||+++|++++ |..||........ ........ ....+..++..+.+++.+||..+|+
T Consensus 191 v~slG~~l~~l~~~g~~p~~~~~~~~~-~~~~~~~~-------------------~~~~~~~~~~~l~~li~~cl~~~p~ 250 (266)
T cd05033 191 VWSFGIVMWEVMSYGERPYWDMSNQDV-IKAVEDGY-------------------RLPPPMDCPSALYQLMLDCWQKDRN 250 (266)
T ss_pred hHHHHHHHHHHHccCCCCCCCCCHHHH-HHHHHcCC-------------------CCCCCCCCCHHHHHHHHHHcCCCcc
Confidence 9999999999997 9999865332211 01000000 0011234567799999999999999
Q ss_pred CCCCHHHHHHHHHHH
Q 024027 240 QRINAKEIVTKLLKI 254 (273)
Q Consensus 240 ~Rps~~~~l~~l~~~ 254 (273)
+||++.+++++|.++
T Consensus 251 ~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 251 ERPTFSQIVSTLDKM 265 (266)
T ss_pred cCcCHHHHHHHHHhh
Confidence 999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=277.80 Aligned_cols=232 Identities=25% Similarity=0.361 Sum_probs=180.5
Q ss_pred CeEEEEEeeccc---------C-----hhhhhHHHHHHHHhcCCCccceeeeeeeecC--CceeEEEeccCCCCHHHhhh
Q 024027 1 MEVAVKVFNLQC---------G-----RAFKSFDVECEMMKSIRHRNLIKVISSCSNE--EFKALVLEYMPHGSLEKYLY 64 (273)
Q Consensus 1 ~~vavK~~~~~~---------~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~ 64 (273)
+-||||++.... . ...+...+|+.+|++++|||||+++.+..++ ..+|||+|||..|.+..- -
T Consensus 123 ~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~-p 201 (576)
T KOG0585|consen 123 KLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWC-P 201 (576)
T ss_pred cEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccC-C
Confidence 358999996431 0 1235788999999999999999999999775 578999999998887432 2
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCC---Ccceeeccccc
Q 024027 65 SSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED---QSMTQTQTLAT 141 (273)
Q Consensus 65 ~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~---~~~~~~~~~~~ 141 (273)
..+.-+.+.+++.++.+++.||.||| .+||+||||||+|+|++.+|.+||+|||.+..+.... ........+||
T Consensus 202 ~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGT 278 (576)
T KOG0585|consen 202 PDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGT 278 (576)
T ss_pred CCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCC
Confidence 22323899999999999999999999 9999999999999999999999999999998763221 11122346899
Q ss_pred CCCCCCcccCCCC----cCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhh
Q 024027 142 IGYMAPEYGREGR----VSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFV 217 (273)
Q Consensus 142 ~~~~aPE~~~~~~----~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (273)
+-|+|||...+.. .+.+.||||+|+++|.++.|+.||.+... +..+.. +...++.++
T Consensus 279 PAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~----~~l~~K---------------Ivn~pL~fP 339 (576)
T KOG0585|consen 279 PAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE----LELFDK---------------IVNDPLEFP 339 (576)
T ss_pred ccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH----HHHHHH---------------HhcCcccCC
Confidence 9999999877632 46789999999999999999999865222 111111 112222333
Q ss_pred hhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHHHHH
Q 024027 218 AKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLLKIR 255 (273)
Q Consensus 218 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 255 (273)
..+.....+.+||.+||++||+.|+++.+|..|.+-..
T Consensus 340 ~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 340 ENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR 377 (576)
T ss_pred CcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence 33456777999999999999999999999999988443
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=278.07 Aligned_cols=239 Identities=21% Similarity=0.274 Sum_probs=183.2
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
.||+|+++... ......+.+|+++++.++||||+++++++.+++..++||||+++++|.+++.... .+++..+..++.
T Consensus 32 ~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ 110 (331)
T cd06649 32 IMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK-RIPEEILGKVSI 110 (331)
T ss_pred EEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHcC-CCCHHHHHHHHH
Confidence 58999987653 3345679999999999999999999999999999999999999999999996544 588999999999
Q ss_pred HHHHHHHHHhcCCCC-CeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcc
Q 024027 81 DVASALEYLHFGCSA-PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 159 (273)
Q Consensus 81 ql~~~l~~lh~~~~~-~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 159 (273)
|++.||.||| +. +++|+||||+||+++.++.++|+|||++...... ......++..|+|||.+.+..++.++
T Consensus 111 ~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~ 183 (331)
T cd06649 111 AVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQS 183 (331)
T ss_pred HHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc----ccccCCCCcCcCCHhHhcCCCCCchH
Confidence 9999999999 75 6999999999999999999999999998754221 12334688999999999988899999
Q ss_pred hhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCc-------------------------------cchhhhhhhc
Q 024027 160 DVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPI-------------------------------STMEVVDANL 208 (273)
Q Consensus 160 DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~ 208 (273)
|||||||++|+|++|+.||......+ +.......... .........
T Consensus 184 DiwslG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 260 (331)
T cd06649 184 DIWSMGLSLVELAIGRYPIPPPDAKE--LEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYI- 260 (331)
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHH-
Confidence 99999999999999999996432211 11110000000 000000000
Q ss_pred cccchhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 209 LSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 209 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
............++.++.+|+.+||..||++|||++++++|-+
T Consensus 261 -~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~ 303 (331)
T cd06649 261 -VNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF 303 (331)
T ss_pred -HhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence 0000000001235678999999999999999999999999976
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=283.09 Aligned_cols=224 Identities=23% Similarity=0.292 Sum_probs=181.5
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||+|+++... ......+..|+++++.++||||+++++++..+..+++||||+++|+|..++.... .+++..+..
T Consensus 21 ~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~-~l~~~~~~~ 99 (325)
T cd05594 21 RYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARF 99 (325)
T ss_pred CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHH
Confidence 369999997542 3345667889999999999999999999999999999999999999999886543 689999999
Q ss_pred HHHHHHHHHHHHhcCCC-CCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcC
Q 024027 78 IMIDVASALEYLHFGCS-APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVS 156 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~-~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 156 (273)
++.|++.||.||| + .|++|+||||+||+++.++.++|+|||++....... .......|++.|+|||++.+..++
T Consensus 100 ~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~ 174 (325)
T cd05594 100 YGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYG 174 (325)
T ss_pred HHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cccccccCCcccCCHHHHccCCCC
Confidence 9999999999999 7 799999999999999999999999999986532211 122335689999999999888899
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++|||||||++|+|++|..||........ ....... ....+..++.++.+|+.+||..
T Consensus 175 ~~~DiwslG~il~el~tG~~Pf~~~~~~~~-~~~i~~~--------------------~~~~p~~~~~~~~~li~~~L~~ 233 (325)
T cd05594 175 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-FELILME--------------------EIRFPRTLSPEAKSLLSGLLKK 233 (325)
T ss_pred CccccccccceeeeeccCCCCCCCCCHHHH-HHHHhcC--------------------CCCCCCCCCHHHHHHHHHHhhc
Confidence 999999999999999999999865322111 0000000 0011334667799999999999
Q ss_pred CccCCC-----CHHHHHHHH
Q 024027 237 SPEQRI-----NAKEIVTKL 251 (273)
Q Consensus 237 dp~~Rp-----s~~~~l~~l 251 (273)
||++|+ ++.++++|-
T Consensus 234 dP~~R~~~~~~~~~~il~h~ 253 (325)
T cd05594 234 DPKQRLGGGPDDAKEIMQHK 253 (325)
T ss_pred CHHHhCCCCCCCHHHHhcCC
Confidence 999997 899999884
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=281.70 Aligned_cols=229 Identities=21% Similarity=0.265 Sum_probs=183.6
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||||+++... ......+..|++++..++||||+++++++.+....++||||+++++|.+++...+ .+++..+..
T Consensus 27 ~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~ 105 (333)
T cd05600 27 EIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLG-VLSEDHARF 105 (333)
T ss_pred CEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHcC-CCCHHHHHH
Confidence 479999997542 2345678899999999999999999999999999999999999999999996543 688999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
++.|++.||.||| +.|++||||||+||+++.++.+||+|||++..... ......|++.|+|||.+.+..++.
T Consensus 106 ~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ 177 (333)
T cd05600 106 YMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDF 177 (333)
T ss_pred HHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----ccCCcccCccccChhHhcCCCCCC
Confidence 9999999999999 99999999999999999999999999999875422 233456899999999999889999
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
++|||||||++|+|++|..||......+. ....... .. ... .+........++.++.+|+.+||..+
T Consensus 178 ~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~-~~-----~~~------~~~~~~~~~~~s~~~~~li~~~l~~~ 244 (333)
T cd05600 178 TVDYWSLGCMLYEFLCGFPPFSGSTPNET-WENLKYW-KE-----TLQ------RPVYDDPRFNLSDEAWDLITKLINDP 244 (333)
T ss_pred ccceecchHHHhhhhhCCCCCCCCCHHHH-HHHHHhc-cc-----ccc------CCCCCccccccCHHHHHHHHHHhhCh
Confidence 99999999999999999999875332211 1111000 00 000 00000001245778999999999999
Q ss_pred ccCCCCHHHHHHHH
Q 024027 238 PEQRINAKEIVTKL 251 (273)
Q Consensus 238 p~~Rps~~~~l~~l 251 (273)
|.+|||+.++++|-
T Consensus 245 ~~rr~s~~~ll~h~ 258 (333)
T cd05600 245 SRRFGSLEDIKNHP 258 (333)
T ss_pred hhhcCCHHHHHhCc
Confidence 99999999999884
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=279.79 Aligned_cols=223 Identities=24% Similarity=0.282 Sum_probs=180.0
Q ss_pred CeEEEEEeecc---cChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHH
Q 024027 1 MEVAVKVFNLQ---CGRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (273)
+.||||+++.. .....+.+..|..++..+ +||||+++++++.....+++||||+++|+|.+++.... .+++..+.
T Consensus 21 ~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~~-~l~~~~~~ 99 (320)
T cd05590 21 RLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSR-RFDEARAR 99 (320)
T ss_pred CEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHcC-CCCHHHHH
Confidence 36999999754 234456677898898877 79999999999999999999999999999999986554 68999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcC
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVS 156 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 156 (273)
.++.|++.||.||| +.|++||||||+||+++.++.++|+|||++....... .......|++.|+|||.+.+..++
T Consensus 100 ~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~ 174 (320)
T cd05590 100 FYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTSTFCGTPDYIAPEILQEMLYG 174 (320)
T ss_pred HHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--CcccccccCccccCHHHHcCCCCC
Confidence 99999999999999 9999999999999999999999999999986532211 122345689999999999888899
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++|+|||||++|+|++|..||........ ....... ....+..++.++.+++.+||..
T Consensus 175 ~~~DiwslG~il~el~~g~~Pf~~~~~~~~-~~~i~~~--------------------~~~~~~~~~~~~~~li~~~L~~ 233 (320)
T cd05590 175 PSVDWWAMGVLLYEMLCGHAPFEAENEDDL-FEAILND--------------------EVVYPTWLSQDAVDILKAFMTK 233 (320)
T ss_pred CccchhhhHHHHHHHhhCCCCCCCCCHHHH-HHHHhcC--------------------CCCCCCCCCHHHHHHHHHHccc
Confidence 999999999999999999999975332211 1111000 0011334567799999999999
Q ss_pred CccCCCCH------HHHHHH
Q 024027 237 SPEQRINA------KEIVTK 250 (273)
Q Consensus 237 dp~~Rps~------~~~l~~ 250 (273)
||.+||++ +++++|
T Consensus 234 dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 234 NPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred CHHHCCCCCCCCCHHHHHcC
Confidence 99999998 777776
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=272.08 Aligned_cols=229 Identities=23% Similarity=0.267 Sum_probs=181.5
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhc---CCCCCCHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS---SNCILDIFQ 74 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~ 74 (273)
+.||+|++.... ....+.+..|+++++.++|+||+++.+++..+...++||||+++|+|.+++.. ....+++..
T Consensus 19 ~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~ 98 (280)
T cd05608 19 KLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPR 98 (280)
T ss_pred cEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHH
Confidence 369999997542 22345678899999999999999999999999999999999999999888742 334689999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCC
Q 024027 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGR 154 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 154 (273)
+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++..+.... .......+++.|+|||.+.+..
T Consensus 99 ~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~ 173 (280)
T cd05608 99 ACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTKGYAGTPGFMAPELLQGEE 173 (280)
T ss_pred HHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC--ccccccCCCcCccCHHHhcCCC
Confidence 9999999999999999 9999999999999999999999999999987653221 1123346889999999999889
Q ss_pred cCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcC
Q 024027 155 VSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACT 234 (273)
Q Consensus 155 ~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 234 (273)
++.++|+||+|+++|+|++|+.||......... ......... . ....+..++.++.+++.+||
T Consensus 174 ~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~-------------~---~~~~~~~~~~~~~~li~~~l 236 (280)
T cd05608 174 YDFSVDYFALGVTLYEMIAARGPFRARGEKVEN-KELKQRILN-------------D---SVTYPDKFSPASKSFCEALL 236 (280)
T ss_pred CCccccHHHHHHHHHHHHhCCCCCCCCCcchhH-HHHHHhhcc-------------c---CCCCcccCCHHHHHHHHHHh
Confidence 999999999999999999999999753322111 000000000 0 00113456777999999999
Q ss_pred CCCccCCC-----CHHHHHHHH
Q 024027 235 VESPEQRI-----NAKEIVTKL 251 (273)
Q Consensus 235 ~~dp~~Rp-----s~~~~l~~l 251 (273)
..||++|| +++++++|-
T Consensus 237 ~~~P~~R~~~~~~~~~~~l~h~ 258 (280)
T cd05608 237 AKDPEKRLGFRDGNCDGLRTHP 258 (280)
T ss_pred cCCHHHhcCCCCCCHHHHhcCh
Confidence 99999999 778888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=279.83 Aligned_cols=224 Identities=23% Similarity=0.274 Sum_probs=181.2
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (273)
+.||||+++... ......+..|.+++..+ +||||+++++++.+++.+++||||+++++|..++...+ .+++..+.
T Consensus 21 ~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~-~~~~~~~~ 99 (321)
T cd05591 21 EVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSR-KFDEPRSR 99 (321)
T ss_pred CEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHcC-CCCHHHHH
Confidence 369999997542 33455677899999876 89999999999999999999999999999999986543 68999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcC
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVS 156 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 156 (273)
.++.|++.||.||| +.|++||||||+||+++.++.++|+|||++....... .......|++.|+|||.+.+..++
T Consensus 100 ~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~ 174 (321)
T cd05591 100 FYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTTTFCGTPDYIAPEILQELEYG 174 (321)
T ss_pred HHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCC--ccccccccCccccCHHHHcCCCCC
Confidence 99999999999999 9999999999999999999999999999987532211 122345689999999999888899
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++|+|||||++|+|++|..||........ ....... ....+..++.++.+++.+||..
T Consensus 175 ~~~DvwslG~il~el~tg~~Pf~~~~~~~~-~~~i~~~--------------------~~~~p~~~~~~~~~ll~~~L~~ 233 (321)
T cd05591 175 PSVDWWALGVLMYEMMAGQPPFEADNEDDL-FESILHD--------------------DVLYPVWLSKEAVSILKAFMTK 233 (321)
T ss_pred CccceechhHHHHHHhcCCCCCCCCCHHHH-HHHHHcC--------------------CCCCCCCCCHHHHHHHHHHhcc
Confidence 999999999999999999999975432211 1111100 0011234567799999999999
Q ss_pred CccCCC-------CHHHHHHHH
Q 024027 237 SPEQRI-------NAKEIVTKL 251 (273)
Q Consensus 237 dp~~Rp-------s~~~~l~~l 251 (273)
||.+|| +++++++|-
T Consensus 234 dp~~R~~~~~~~~~~~~~~~hp 255 (321)
T cd05591 234 NPNKRLGCVASQGGEDAIKQHP 255 (321)
T ss_pred CHHHcCCCCCCCCCHHHHhcCC
Confidence 999999 889998874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=279.25 Aligned_cols=227 Identities=24% Similarity=0.323 Sum_probs=184.3
Q ss_pred eEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 2 EVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 2 ~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
-+|+|+++.+. ....+.+..|=.+|....+|.||+++..|++..++||||||++||++..+|.+.+ .++++.+.-+
T Consensus 168 iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~-~L~e~~arfY 246 (550)
T KOG0605|consen 168 IYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKD-TLTEDWARFY 246 (550)
T ss_pred EEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhcC-cCchHHHHHH
Confidence 47999998764 3456778889999999999999999999999999999999999999999997665 7999999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCC---------------------Ccc----
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED---------------------QSM---- 133 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~---------------------~~~---- 133 (273)
+.+++.|+..+| +.|++|+||||+|+|+|..|.+||+|||++..+.... ...
T Consensus 247 iaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (550)
T KOG0605|consen 247 IAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNT 323 (550)
T ss_pred HHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCcccccccc
Confidence 999999999999 9999999999999999999999999999985442100 000
Q ss_pred --------------------eeecccccCCCCCCcccCCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhh
Q 024027 134 --------------------TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVN 193 (273)
Q Consensus 134 --------------------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~ 193 (273)
.....+|||.|+|||++.+..|+...|.||||||+||||.|.+||......++ ...+..
T Consensus 324 ~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T-~rkI~n 402 (550)
T KOG0605|consen 324 PRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQET-YRKIVN 402 (550)
T ss_pred ccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHH
Confidence 00134799999999999999999999999999999999999999987544432 222221
Q ss_pred hccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccCCCC---HHHHHHH
Q 024027 194 DWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRIN---AKEIVTK 250 (273)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~~l~~ 250 (273)
......++....++.+++|||.+||. ||+.|.. ++||-+|
T Consensus 403 ----------------wr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 403 ----------------WRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKH 445 (550)
T ss_pred ----------------HhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcC
Confidence 11122222244566889999999999 9999986 5555444
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=272.13 Aligned_cols=228 Identities=30% Similarity=0.491 Sum_probs=183.6
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC--------------
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-------------- 67 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------- 67 (273)
.||+|.++.........+.+|+++++.++|+||+++++++.+....+++|||+++++|.+++....
T Consensus 37 ~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~ 116 (280)
T cd05092 37 LVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAP 116 (280)
T ss_pred EEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCc
Confidence 578898876656667789999999999999999999999999999999999999999999986543
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCC
Q 024027 68 CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 147 (273)
Q Consensus 68 ~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aP 147 (273)
..+++..++.++.|++.|++||| +.|++|+||+|+||+++.++.++|+|||++................+++.|+||
T Consensus 117 ~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 193 (280)
T cd05092 117 GQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPP 193 (280)
T ss_pred cccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCH
Confidence 24788999999999999999999 999999999999999999999999999998754322211112223346789999
Q ss_pred cccCCCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHH
Q 024027 148 EYGREGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFV 226 (273)
Q Consensus 148 E~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 226 (273)
|.+.+..++.++|+|||||++|++++ |.+||......+... ..... .....+..++..+
T Consensus 194 E~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~-~~~~~-------------------~~~~~~~~~~~~~ 253 (280)
T cd05092 194 ESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE-CITQG-------------------RELERPRTCPPEV 253 (280)
T ss_pred HHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHH-HHHcC-------------------ccCCCCCCCCHHH
Confidence 99988889999999999999999998 899986533221110 00000 0011133466779
Q ss_pred HHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 227 FNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 227 ~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
.+|+.+||..||.+||+++++++.|+
T Consensus 254 ~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 254 YAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHHHHccCChhhCCCHHHHHHHHh
Confidence 99999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=283.28 Aligned_cols=233 Identities=23% Similarity=0.391 Sum_probs=186.0
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCC-CccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC------------
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIR-HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN------------ 67 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------ 67 (273)
.||||+++... ....+.+.+|+++++++. ||||++++++|.+....++||||+++|+|.+++....
T Consensus 69 ~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~ 148 (400)
T cd05105 69 KVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPK 148 (400)
T ss_pred EEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhcccccccc
Confidence 58999997543 344567899999999995 9999999999999999999999999999999885421
Q ss_pred --------------------------------------------------------------------------------
Q 024027 68 -------------------------------------------------------------------------------- 67 (273)
Q Consensus 68 -------------------------------------------------------------------------------- 67 (273)
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 228 (400)
T cd05105 149 KDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSD 228 (400)
T ss_pred ccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHh
Confidence
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCC
Q 024027 68 ---CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGY 144 (273)
Q Consensus 68 ---~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~ 144 (273)
..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++................++..|
T Consensus 229 ~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y 305 (400)
T cd05105 229 DGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKW 305 (400)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcce
Confidence 23677888999999999999999 999999999999999999999999999998765333222222334567789
Q ss_pred CCCcccCCCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhH
Q 024027 145 MAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCV 223 (273)
Q Consensus 145 ~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (273)
+|||.+.+..++.++||||||+++|+|++ |..||................ .....+..++
T Consensus 306 ~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~ 366 (400)
T cd05105 306 MAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSG-------------------YRMAKPDHAT 366 (400)
T ss_pred EChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcC-------------------CCCCCCccCC
Confidence 99999988889999999999999999997 999987543322211111100 0011134567
Q ss_pred HHHHHHHhhcCCCCccCCCCHHHHHHHHHHHHH
Q 024027 224 SFVFNLAMACTVESPEQRINAKEIVTKLLKIRD 256 (273)
Q Consensus 224 ~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 256 (273)
.++.+++.+||..||++|||+.++.+.|+++.+
T Consensus 367 ~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 367 QEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 789999999999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=280.25 Aligned_cols=232 Identities=21% Similarity=0.241 Sum_probs=181.2
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (273)
+.||||+++... ......+..|..++..+ +||||+++++++.++..+++||||+++|+|.+++... ..+++..++
T Consensus 21 ~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~-~~l~~~~~~ 99 (329)
T cd05588 21 RIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQ-RKLPEEHAR 99 (329)
T ss_pred CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHc-CCCCHHHHH
Confidence 369999998542 33456688999999998 7999999999999999999999999999999988654 369999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcC
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVS 156 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 156 (273)
.++.|++.||.||| +.|++||||||+||+++.++.++|+|||++...... ........|++.|+|||++.+..++
T Consensus 100 ~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~ 174 (329)
T cd05588 100 FYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDTTSTFCGTPNYIAPEILRGEDYG 174 (329)
T ss_pred HHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccC--CCccccccCCccccCHHHHcCCCCC
Confidence 99999999999999 999999999999999999999999999998642111 1122345689999999999988899
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++|+|||||++|+|++|..||............ .......... ......+..++.++.+++.+||..
T Consensus 175 ~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~---------~~~~~~~~~~---~~~~~~p~~~~~~~~~li~~~L~~ 242 (329)
T cd05588 175 FSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN---------TEDYLFQVIL---EKQIRIPRSLSVKASSVLKGFLNK 242 (329)
T ss_pred CccceechHHHHHHHHHCCCCccccccccccccc---------chHHHHHHHH---cCCCCCCCCCCHHHHHHHHHHhcc
Confidence 9999999999999999999999643221100000 0000000000 000112345677799999999999
Q ss_pred CccCCCC------HHHHHHH
Q 024027 237 SPEQRIN------AKEIVTK 250 (273)
Q Consensus 237 dp~~Rps------~~~~l~~ 250 (273)
||.+||| +.++++|
T Consensus 243 dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 243 DPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CHHHcCCCCCCCCHHHHhcC
Confidence 9999997 6788876
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=268.02 Aligned_cols=229 Identities=27% Similarity=0.424 Sum_probs=183.6
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcC-CCCCCHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIM 79 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ 79 (273)
+.||+|+++.. ......+.+|+++++.++|+||+++++++..+...+++|||+++++|.+++... ...+++..++.++
T Consensus 32 ~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~ 110 (263)
T cd05052 32 LTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMA 110 (263)
T ss_pred ceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHH
Confidence 36899998754 344577899999999999999999999999999999999999999999999654 3458899999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 159 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 159 (273)
.|++.||+||| +.|++|+||+|+||+++.++.++|+|||++........ ........+..|+|||.+.+..++.++
T Consensus 111 ~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~ 186 (263)
T cd05052 111 TQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKS 186 (263)
T ss_pred HHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCcccccccccee-eccCCCCCccccCCHHHhccCCCCchh
Confidence 99999999999 99999999999999999999999999999876532211 111122235679999999888899999
Q ss_pred hhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc
Q 024027 160 DVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238 (273)
Q Consensus 160 DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 238 (273)
|||||||++|+|++ |..||......+ ........ .....+..++.++.+++.+||..||
T Consensus 187 Dv~slG~il~el~t~g~~p~~~~~~~~-~~~~~~~~-------------------~~~~~~~~~~~~~~~li~~cl~~~p 246 (263)
T cd05052 187 DVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEKG-------------------YRMERPEGCPPKVYELMRACWQWNP 246 (263)
T ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHHCC-------------------CCCCCCCCCCHHHHHHHHHHccCCc
Confidence 99999999999998 899986532211 11111000 0011134567789999999999999
Q ss_pred cCCCCHHHHHHHHHHH
Q 024027 239 EQRINAKEIVTKLLKI 254 (273)
Q Consensus 239 ~~Rps~~~~l~~l~~~ 254 (273)
++|||+.++++.|+.+
T Consensus 247 ~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 247 SDRPSFAEIHQAFETM 262 (263)
T ss_pred ccCCCHHHHHHHHHhh
Confidence 9999999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=255.89 Aligned_cols=223 Identities=24% Similarity=0.300 Sum_probs=191.4
Q ss_pred eEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC-CCCCHHHHHH
Q 024027 2 EVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLN 77 (273)
Q Consensus 2 ~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~ 77 (273)
-||+|++..+. ......+.+|+++.++|+||||+++|++|-+....|+++||.++|.+...++... ..+++..++.
T Consensus 49 IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~ 128 (281)
T KOG0580|consen 49 IVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAAT 128 (281)
T ss_pred EEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhH
Confidence 48999996542 3345778999999999999999999999999999999999999999999997443 3599999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
+..|++.|+.|+| ..+++||||||.|+|++..+.+|++|||-+..-. .......+||..|.+||...+..++.
T Consensus 129 Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p----~~kR~tlcgt~dyl~pEmv~~~~hd~ 201 (281)
T KOG0580|consen 129 YIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SNKRKTLCGTLDYLPPEMVEGRGHDK 201 (281)
T ss_pred HHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecC----CCCceeeecccccCCHhhcCCCCccc
Confidence 9999999999999 9999999999999999999999999999987532 23345678999999999999999999
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
..|+|++|++.|+++.|.+||..... ...+..+.. .+...|..++.++.|+|.+|+..+
T Consensus 202 ~Vd~w~lgvl~yeflvg~ppFes~~~-~etYkrI~k--------------------~~~~~p~~is~~a~dlI~~ll~~~ 260 (281)
T KOG0580|consen 202 FVDLWSLGVLCYEFLVGLPPFESQSH-SETYKRIRK--------------------VDLKFPSTISGGAADLISRLLVKN 260 (281)
T ss_pred hhhHHHHHHHHHHHHhcCCchhhhhh-HHHHHHHHH--------------------ccccCCcccChhHHHHHHHHhccC
Confidence 99999999999999999999988663 333332221 111225678888999999999999
Q ss_pred ccCCCCHHHHHHHHH
Q 024027 238 PEQRINAKEIVTKLL 252 (273)
Q Consensus 238 p~~Rps~~~~l~~l~ 252 (273)
|.+|.+..+++.|-+
T Consensus 261 p~~r~~l~~v~~hpw 275 (281)
T KOG0580|consen 261 PIERLALTEVMDHPW 275 (281)
T ss_pred ccccccHHHHhhhHH
Confidence 999999999999976
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=302.29 Aligned_cols=235 Identities=29% Similarity=0.469 Sum_probs=199.5
Q ss_pred eEEEEEeecc-cChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcC------CCCCCHHH
Q 024027 2 EVAVKVFNLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS------NCILDIFQ 74 (273)
Q Consensus 2 ~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~ 74 (273)
.||||.++.. +.....+|.+|..+|+.++||||++++|++.+.+..+|++|||.||+|..||++. ...+....
T Consensus 724 ~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~d 803 (1025)
T KOG1095|consen 724 QVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRD 803 (1025)
T ss_pred EEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHH
Confidence 5999999866 4567888999999999999999999999999999999999999999999999877 45688889
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCC
Q 024027 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGR 154 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 154 (273)
.+.++.|++.|+.||+ +++++||||..+|+|++....+||+|||+++.....+-........-+..|||||.+....
T Consensus 804 Ll~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~i 880 (1025)
T KOG1095|consen 804 LLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGI 880 (1025)
T ss_pred HHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcc
Confidence 9999999999999999 9999999999999999999999999999999553332222222223456899999999999
Q ss_pred cCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhc
Q 024027 155 VSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMAC 233 (273)
Q Consensus 155 ~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 233 (273)
++.++|||||||++||+++ |..||....+.+....- . ...+...|..|+..++++|..|
T Consensus 881 FtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~-~-------------------~ggRL~~P~~CP~~ly~lM~~C 940 (1025)
T KOG1095|consen 881 FTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDV-L-------------------EGGRLDPPSYCPEKLYQLMLQC 940 (1025)
T ss_pred cccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHH-H-------------------hCCccCCCCCCChHHHHHHHHH
Confidence 9999999999999999999 99998876554332211 0 1113444788999999999999
Q ss_pred CCCCccCCCCHHHHHHHHHHHHHhhh
Q 024027 234 TVESPEQRINAKEIVTKLLKIRDSLL 259 (273)
Q Consensus 234 l~~dp~~Rps~~~~l~~l~~~~~~~~ 259 (273)
|..+|++||++..+++.+.++.+...
T Consensus 941 W~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 941 WKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred ccCChhhCccHHHHHhhhhhhhhhhc
Confidence 99999999999999999999988744
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=279.00 Aligned_cols=246 Identities=21% Similarity=0.222 Sum_probs=178.3
Q ss_pred CeEEEEEeecc--cChhhhhHHHHHHHHhcCCCccceeeeeeeecC-----CceeEEEeccCCCCHHHhhhcCCCCCCHH
Q 024027 1 MEVAVKVFNLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNE-----EFKALVLEYMPHGSLEKYLYSSNCILDIF 73 (273)
Q Consensus 1 ~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 73 (273)
+.||||+++.. .......+.+|+++++.++||||+++++++... ...++||||++ ++|.+++.... .+++.
T Consensus 26 ~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~ 103 (338)
T cd07859 26 EKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKAND-DLTPE 103 (338)
T ss_pred CEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHHHHHHhcc-cCCHH
Confidence 47999998743 223445688999999999999999999987543 34799999995 59999986543 58999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCc-ceeecccccCCCCCCcccCC
Q 024027 74 QRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQS-MTQTQTLATIGYMAPEYGRE 152 (273)
Q Consensus 74 ~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~ 152 (273)
.+..++.|++.||.||| +.|++|+||||+||+++.++.+||+|||++......... .......+++.|+|||++.+
T Consensus 104 ~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 180 (338)
T cd07859 104 HHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 180 (338)
T ss_pred HHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhc
Confidence 99999999999999999 999999999999999999999999999998754322211 12234568999999998865
Q ss_pred --CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCcc-----------chhhhhhhccccchhhhhhh
Q 024027 153 --GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPIS-----------TMEVVDANLLSQEDIHFVAK 219 (273)
Q Consensus 153 --~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~ 219 (273)
..++.++|||||||++|+|++|+.||........ ............ ....................
T Consensus 181 ~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 259 (338)
T cd07859 181 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ-LDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKF 259 (338)
T ss_pred cccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHH-HHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhc
Confidence 5689999999999999999999999965332110 000000000000 00000000000000001111
Q ss_pred hhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 220 EQCVSFVFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 220 ~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
..++.++.+++.+||..||++|||++++++|=+
T Consensus 260 ~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~ 292 (338)
T cd07859 260 PNADPLALRLLERLLAFDPKDRPTAEEALADPY 292 (338)
T ss_pred CCCChHHHHHHHHHcCcCcccCCCHHHHhcCch
Confidence 245667899999999999999999999998843
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=267.58 Aligned_cols=228 Identities=33% Similarity=0.544 Sum_probs=188.0
Q ss_pred eEEEEEeecccCh-hhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcC--------CCCCCH
Q 024027 2 EVAVKVFNLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS--------NCILDI 72 (273)
Q Consensus 2 ~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~ 72 (273)
+||+|+++..... ....+.+|+++++.++|+|++++++++......+++|||+++++|.+++... ...+++
T Consensus 25 ~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 104 (262)
T cd00192 25 EVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSL 104 (262)
T ss_pred eEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCH
Confidence 6899999866433 3678999999999999999999999999999999999999999999999765 467999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC
Q 024027 73 FQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE 152 (273)
Q Consensus 73 ~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 152 (273)
..++.++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||.+................++..|+|||.+.+
T Consensus 105 ~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 181 (262)
T cd00192 105 KDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKD 181 (262)
T ss_pred HHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhcc
Confidence 999999999999999999 99999999999999999999999999999987644332222334557788999999988
Q ss_pred CCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHh
Q 024027 153 GRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAM 231 (273)
Q Consensus 153 ~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 231 (273)
..++.++|+||+|++++++++ |..||....... ....... ......+..++.++.+++.
T Consensus 182 ~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~~------------------~~~~~~~~~~~~~~~~li~ 241 (262)
T cd00192 182 GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE--VLEYLRK------------------GYRLPKPEYCPDELYELML 241 (262)
T ss_pred CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHHc------------------CCCCCCCccCChHHHHHHH
Confidence 889999999999999999999 699987642211 1000000 0111124455778999999
Q ss_pred hcCCCCccCCCCHHHHHHHHH
Q 024027 232 ACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 232 ~~l~~dp~~Rps~~~~l~~l~ 252 (273)
+||..||.+|||+.+++++|+
T Consensus 242 ~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 242 SCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHccCCcccCcCHHHHHHhhC
Confidence 999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=267.10 Aligned_cols=233 Identities=22% Similarity=0.307 Sum_probs=184.7
Q ss_pred CeEEEEEeecc---cChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhc---CCCCCCHHH
Q 024027 1 MEVAVKVFNLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS---SNCILDIFQ 74 (273)
Q Consensus 1 ~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~ 74 (273)
+.||||.++.. .......+.+|+++++.++||||+++++++.+.+..++++||+++++|.+++.. ....+++..
T Consensus 28 ~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~ 107 (267)
T cd08228 28 KPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERT 107 (267)
T ss_pred CEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHH
Confidence 47899988642 234456688999999999999999999999999999999999999999988853 234578899
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCC
Q 024027 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGR 154 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 154 (273)
+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||.+..+.... .......++..|+|||.+.+..
T Consensus 108 ~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~ 182 (267)
T cd08228 108 VWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENG 182 (267)
T ss_pred HHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh--HHHhcCCCCccccChhhhccCC
Confidence 9999999999999999 9999999999999999999999999999987653221 1122345788899999998888
Q ss_pred cCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcC
Q 024027 155 VSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACT 234 (273)
Q Consensus 155 ~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 234 (273)
++.++|+||+|+++|++++|..||.................. .........+..+.+++.+||
T Consensus 183 ~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~li~~cl 245 (267)
T cd08228 183 YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD-----------------YPPLPTEHYSEKLRELVSMCI 245 (267)
T ss_pred CCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCC-----------------CCCCChhhcCHHHHHHHHHHC
Confidence 999999999999999999999998653322111111111000 000012345567999999999
Q ss_pred CCCccCCCCHHHHHHHHHHHH
Q 024027 235 VESPEQRINAKEIVTKLLKIR 255 (273)
Q Consensus 235 ~~dp~~Rps~~~~l~~l~~~~ 255 (273)
..+|.+|||+.++++.++.++
T Consensus 246 ~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 246 YPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CCCcccCcCHHHHHHHHHHhc
Confidence 999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=279.36 Aligned_cols=225 Identities=22% Similarity=0.327 Sum_probs=175.6
Q ss_pred CeEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 1 MEVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 1 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
+.||||++.... ......+.+|+++++.++|+||+++++++...+.+++||||+++++|.+.. ..++..+..++
T Consensus 100 ~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~-----~~~~~~~~~i~ 174 (353)
T PLN00034 100 RLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTH-----IADEQFLADVA 174 (353)
T ss_pred CEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCcccccc-----cCCHHHHHHHH
Confidence 479999997543 334567899999999999999999999999999999999999999986542 35677888999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC-----CC
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE-----GR 154 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~ 154 (273)
.|++.||.||| +.|++|+||||+||+++.++.+||+|||++..+.... .......|+..|+|||.+.. ..
T Consensus 175 ~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~ 249 (353)
T PLN00034 175 RQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--DPCNSSVGTIAYMSPERINTDLNHGAY 249 (353)
T ss_pred HHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc--ccccccccCccccCccccccccccCcC
Confidence 99999999999 9999999999999999999999999999987653211 11233568999999998743 22
Q ss_pred cCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcC
Q 024027 155 VSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACT 234 (273)
Q Consensus 155 ~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 234 (273)
.+.++|||||||++|+|++|+.||......+ ......... .......+..++.++.+|+.+||
T Consensus 250 ~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~~~~~~~~---------------~~~~~~~~~~~~~~l~~li~~~l 312 (353)
T PLN00034 250 DGYAGDIWSLGVSILEFYLGRFPFGVGRQGD--WASLMCAIC---------------MSQPPEAPATASREFRHFISCCL 312 (353)
T ss_pred CCcchhHHHHHHHHHHHHhCCCCCCCCCCcc--HHHHHHHHh---------------ccCCCCCCCccCHHHHHHHHHHc
Confidence 4568999999999999999999997322211 111100000 00001113456677999999999
Q ss_pred CCCccCCCCHHHHHHHHH
Q 024027 235 VESPEQRINAKEIVTKLL 252 (273)
Q Consensus 235 ~~dp~~Rps~~~~l~~l~ 252 (273)
..||++|||+.++++|-+
T Consensus 313 ~~~P~~Rpt~~ell~hp~ 330 (353)
T PLN00034 313 QREPAKRWSAMQLLQHPF 330 (353)
T ss_pred cCChhhCcCHHHHhcCcc
Confidence 999999999999999855
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=269.02 Aligned_cols=243 Identities=26% Similarity=0.401 Sum_probs=184.1
Q ss_pred eEEEEEeecccC-hhhhhHHHHHHHHhcCCCccceeeeeeeecC--CceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 2 EVAVKVFNLQCG-RAFKSFDVECEMMKSIRHRNLIKVISSCSNE--EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 2 ~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
.||+|+++.... .....+.+|+++++.++||||+++++++... ...+++|||+++++|.+++... .+++..++.+
T Consensus 35 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i 112 (283)
T cd05080 35 MVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH--KLNLAQLLLF 112 (283)
T ss_pred eEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHc--CCCHHHHHHH
Confidence 689999976532 3456788999999999999999999987653 4578999999999999999654 4899999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcc-eeecccccCCCCCCcccCCCCcCC
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSM-TQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
+.|++.||.||| +.|++|+||||+||+++.++.++|+|||++.......... ......++..|+|||.+.+..++.
T Consensus 113 ~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~ 189 (283)
T cd05080 113 AQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSY 189 (283)
T ss_pred HHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCc
Confidence 999999999999 9999999999999999999999999999987653322111 112223556799999998888999
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhh-hccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVN-DWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
++||||||+++++|++|..||............... .............. .....+..++.++.+++.+||..
T Consensus 190 ~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~cl~~ 263 (283)
T cd05080 190 ASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG------MRLPCPKNCPQEVYILMKNCWET 263 (283)
T ss_pred ccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC------CCCCCCCCCCHHHHHHHHHHhcc
Confidence 999999999999999999997653221111110000 00000000001000 11112445678899999999999
Q ss_pred CccCCCCHHHHHHHHHHHH
Q 024027 237 SPEQRINAKEIVTKLLKIR 255 (273)
Q Consensus 237 dp~~Rps~~~~l~~l~~~~ 255 (273)
||++|||++++++.|+++.
T Consensus 264 ~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 264 EAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred ChhhCCCHHHHHHHHHHhh
Confidence 9999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=277.37 Aligned_cols=223 Identities=22% Similarity=0.300 Sum_probs=177.2
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHH---hcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMM---KSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQ 74 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (273)
+.||||+++... ....+.+..|.+++ +.++||||+++++++.+....++||||+++++|..++... .+++..
T Consensus 25 ~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~--~l~~~~ 102 (324)
T cd05589 25 ELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTD--VFSEPR 102 (324)
T ss_pred CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhcC--CCCHHH
Confidence 469999997542 23345666776665 4668999999999999999999999999999999888543 589999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCC
Q 024027 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGR 154 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 154 (273)
+..++.|++.||.||| +.|++|+||||+||+++.++.+||+|||++....... .......|++.|+|||.+.+..
T Consensus 103 ~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~ 177 (324)
T cd05589 103 AVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG--DRTSTFCGTPEFLAPEVLTETS 177 (324)
T ss_pred HHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC--CcccccccCccccCHhHhcCCC
Confidence 9999999999999999 9999999999999999999999999999886432211 1223456899999999999888
Q ss_pred cCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcC
Q 024027 155 VSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACT 234 (273)
Q Consensus 155 ~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 234 (273)
++.++|+|||||++|+|++|..||......+. ....... ....+..++.++.+++.+||
T Consensus 178 ~~~~~DiwslG~il~el~~G~~pf~~~~~~~~-~~~i~~~--------------------~~~~p~~~~~~~~~li~~~L 236 (324)
T cd05589 178 YTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV-FDSIVND--------------------EVRYPRFLSREAISIMRRLL 236 (324)
T ss_pred CCcccchhhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhC--------------------CCCCCCCCCHHHHHHHHHHh
Confidence 99999999999999999999999865322111 0000000 00113446777999999999
Q ss_pred CCCccCCC-----CHHHHHHHH
Q 024027 235 VESPEQRI-----NAKEIVTKL 251 (273)
Q Consensus 235 ~~dp~~Rp-----s~~~~l~~l 251 (273)
..||.+|| ++.++++|-
T Consensus 237 ~~dP~~R~~~~~~~~~~l~~~~ 258 (324)
T cd05589 237 RRNPERRLGSGEKDAEDVKKQP 258 (324)
T ss_pred hcCHhHcCCCCCCCHHHHhhCC
Confidence 99999999 688888764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=265.64 Aligned_cols=229 Identities=24% Similarity=0.348 Sum_probs=184.9
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
+.||+|++..........+..|+++++.++||||+++++++.+...++++|||+++++|.+++......+++..+..++.
T Consensus 29 ~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ 108 (262)
T cd06613 29 ELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCR 108 (262)
T ss_pred CEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHH
Confidence 36899999876555678899999999999999999999999999999999999999999999977656799999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCC---CcCC
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG---RVST 157 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~ 157 (273)
|++.|+.||| +.|++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||.+.+. .++.
T Consensus 109 ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~~ 183 (262)
T cd06613 109 ETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--AKRKSFIGTPYWMAPEVAAVERKGGYDG 183 (262)
T ss_pred HHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhh--hccccccCCccccCchhhcccccCCcCc
Confidence 9999999999 9999999999999999999999999999987653221 122334578889999998776 7889
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
++|+||+|+++++|++|..||................. ...........+.++.+++.+||..|
T Consensus 184 ~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~li~~~l~~~ 247 (262)
T cd06613 184 KCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNF----------------PPPKLKDKEKWSPVFHDFIKKCLTKD 247 (262)
T ss_pred hhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC----------------CCccccchhhhhHHHHHHHHHHcCCC
Confidence 99999999999999999999865332211110000000 00000113345667999999999999
Q ss_pred ccCCCCHHHHHHH
Q 024027 238 PEQRINAKEIVTK 250 (273)
Q Consensus 238 p~~Rps~~~~l~~ 250 (273)
|.+|||+++++.|
T Consensus 248 p~~Rpt~~~il~~ 260 (262)
T cd06613 248 PKKRPTATKLLQH 260 (262)
T ss_pred hhhCCCHHHHhcC
Confidence 9999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=279.15 Aligned_cols=232 Identities=22% Similarity=0.243 Sum_probs=180.4
Q ss_pred CeEEEEEeecc---cChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHH
Q 024027 1 MEVAVKVFNLQ---CGRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (273)
+.||+|+++.. .......+..|+.++..+ +||||+++++++..+...++||||+++++|..++...+ .+++..++
T Consensus 21 ~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~-~l~~~~~~ 99 (329)
T cd05618 21 RIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHAR 99 (329)
T ss_pred CEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHcC-CCCHHHHH
Confidence 36999999854 234456678899998877 89999999999999999999999999999998886543 68999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcC
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVS 156 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 156 (273)
.++.|++.||.||| +.|++||||||+||+++.++.++|+|||++...... ........|++.|+|||.+.+..++
T Consensus 100 ~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~ 174 (329)
T cd05618 100 FYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTTSTFCGTPNYIAPEILRGEDYG 174 (329)
T ss_pred HHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC--CCccccccCCccccCHHHHcCCCCC
Confidence 99999999999999 999999999999999999999999999998643211 1122345689999999999998999
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++|+|||||++|+|++|..||............ .......... ......+..++.++.+++.+||..
T Consensus 175 ~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~---------~~~~~~~~i~---~~~~~~p~~~~~~~~~ll~~~L~~ 242 (329)
T cd05618 175 FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN---------TEDYLFQVIL---EKQIRIPRSLSVKAASVLKSFLNK 242 (329)
T ss_pred CccceecccHHHHHHhhCCCCCccCCCcCCcccc---------cHHHHHHHHh---cCCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999999999999999999999642221110000 0000000000 000112445677799999999999
Q ss_pred CccCCCC------HHHHHHH
Q 024027 237 SPEQRIN------AKEIVTK 250 (273)
Q Consensus 237 dp~~Rps------~~~~l~~ 250 (273)
||++||+ +.++++|
T Consensus 243 dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 243 DPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CHHHcCCCCCCCCHHHHhcC
Confidence 9999998 4688777
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=274.21 Aligned_cols=233 Identities=23% Similarity=0.348 Sum_probs=186.8
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
+||||+++... ....+.+..|+.+++.++||||+++++++... ..++++||+++|+|.+++......+++..++.++.
T Consensus 38 ~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~ 116 (316)
T cd05108 38 PVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 116 (316)
T ss_pred eEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHH
Confidence 48999997543 34567789999999999999999999998765 56799999999999999987666788999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
|++.||+||| +.|++|+||||+||+++.++.++|+|||++..+..............+..|+|||.+.+..++.++|
T Consensus 117 qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~D 193 (316)
T cd05108 117 QIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSD 193 (316)
T ss_pred HHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhh
Confidence 9999999999 9999999999999999999999999999998764333222222233456799999998888999999
Q ss_pred hHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCcc
Q 024027 161 VYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239 (273)
Q Consensus 161 iwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 239 (273)
|||||+++|++++ |..||......+ ....... ......+..++.++.+++.+||..||.
T Consensus 194 i~slGv~l~el~t~g~~p~~~~~~~~--~~~~~~~------------------~~~~~~~~~~~~~~~~li~~cl~~~p~ 253 (316)
T cd05108 194 VWSYGVTVWELMTFGSKPYDGIPASE--ISSILEK------------------GERLPQPPICTIDVYMIMVKCWMIDAD 253 (316)
T ss_pred hHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHhC------------------CCCCCCCCCCCHHHHHHHHHHccCChh
Confidence 9999999999997 999986532211 1111100 001111334566799999999999999
Q ss_pred CCCCHHHHHHHHHHHHHhh
Q 024027 240 QRINAKEIVTKLLKIRDSL 258 (273)
Q Consensus 240 ~Rps~~~~l~~l~~~~~~~ 258 (273)
+|||+.+++.++..+.++-
T Consensus 254 ~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 254 SRPKFRELIIEFSKMARDP 272 (316)
T ss_pred hCcCHHHHHHHHHHHHcCC
Confidence 9999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=276.70 Aligned_cols=223 Identities=23% Similarity=0.267 Sum_probs=180.4
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (273)
+.||||+++... ......+..|..+++.+ +||||+++++++.+...+++||||+++++|.+++...+ .+++..+.
T Consensus 21 ~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~ 99 (318)
T cd05570 21 ELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG-RFDEPRAR 99 (318)
T ss_pred CEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcC-CCCHHHHH
Confidence 369999998542 33456677899999888 79999999999999999999999999999999986553 68999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcC
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVS 156 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 156 (273)
.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++...... .......++++.|+|||.+.+..++
T Consensus 100 ~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~ 174 (318)
T cd05570 100 FYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--GVTTSTFCGTPDYIAPEILSYQPYG 174 (318)
T ss_pred HHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcC--CCcccceecCccccCHHHhcCCCCC
Confidence 99999999999999 999999999999999999999999999988643111 1122334688999999999988999
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++|+|||||++|+|++|..||........ ....... ....+..++.++.+|+.+||..
T Consensus 175 ~~~DiwslGvil~~l~~G~~pf~~~~~~~~-~~~i~~~--------------------~~~~~~~~~~~~~~li~~~l~~ 233 (318)
T cd05570 175 PAVDWWALGVLLYEMLAGQSPFEGDDEDEL-FQSILED--------------------EVRYPRWLSKEAKSILKSFLTK 233 (318)
T ss_pred cchhhhhHHHHHHHHhhCCCCCCCCCHHHH-HHHHHcC--------------------CCCCCCcCCHHHHHHHHHHccC
Confidence 999999999999999999999965322111 0000000 0011334567799999999999
Q ss_pred CccCCCCH-----HHHHHH
Q 024027 237 SPEQRINA-----KEIVTK 250 (273)
Q Consensus 237 dp~~Rps~-----~~~l~~ 250 (273)
||.+|||+ .++++|
T Consensus 234 dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 234 NPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CHHHcCCCCCCCHHHHhcC
Confidence 99999999 888876
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=267.67 Aligned_cols=229 Identities=29% Similarity=0.486 Sum_probs=186.6
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcC-CCCCCHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIM 79 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ 79 (273)
+.||+|+++.........+..|+.+++.++|+||+++++++.+....++||||+++++|.+++... +..+++..+..++
T Consensus 31 ~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ 110 (261)
T cd05148 31 VRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMA 110 (261)
T ss_pred CcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHH
Confidence 368999998776556778999999999999999999999999999999999999999999999753 3458999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 159 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 159 (273)
.|++.|+.||| +.|++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++
T Consensus 111 ~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~ 185 (261)
T cd05148 111 CQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV--YLSSDKKIPYKWTAPEAASHGTFSTKS 185 (261)
T ss_pred HHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCcc--ccccCCCCceEecCHHHHccCCCCchh
Confidence 99999999999 9999999999999999999999999999987652211 111233456679999999888899999
Q ss_pred hhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc
Q 024027 160 DVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238 (273)
Q Consensus 160 DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 238 (273)
|+||||++++++++ |..||......+ ....... ......+..++..+.+++.+||..||
T Consensus 186 DiwslG~~l~~l~~~g~~p~~~~~~~~-~~~~~~~-------------------~~~~~~~~~~~~~~~~~i~~~l~~~p 245 (261)
T cd05148 186 DVWSFGILLYEMFTYGQVPYPGMNNHE-VYDQITA-------------------GYRMPCPAKCPQEIYKIMLECWAAEP 245 (261)
T ss_pred hHHHHHHHHHHHHcCCCCCCCcCCHHH-HHHHHHh-------------------CCcCCCCCCCCHHHHHHHHHHcCCCc
Confidence 99999999999998 899986533211 1111100 00111234566779999999999999
Q ss_pred cCCCCHHHHHHHHHHH
Q 024027 239 EQRINAKEIVTKLLKI 254 (273)
Q Consensus 239 ~~Rps~~~~l~~l~~~ 254 (273)
.+|||++++++.|+++
T Consensus 246 ~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 246 EDRPSFKALREELDNI 261 (261)
T ss_pred hhCcCHHHHHHHHhcC
Confidence 9999999999999853
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=276.23 Aligned_cols=227 Identities=23% Similarity=0.284 Sum_probs=193.3
Q ss_pred CeEEEEEeecccC---hhhhhHHHHHHHHhcCC-CccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHH
Q 024027 1 MEVAVKVFNLQCG---RAFKSFDVECEMMKSIR-HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (273)
+++|+|+++.... .+...+.+|+++|+++. ||||+.+.+.|++....++|||+|.||.|.+.+... . +++..+.
T Consensus 61 ~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~-~-~sE~da~ 138 (382)
T KOG0032|consen 61 KEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK-H-YSERDAA 138 (382)
T ss_pred ceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc-c-CCHHHHH
Confidence 4799999976643 35678999999999998 999999999999999999999999999999999766 3 9999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCC----CCceEEeecccccccccCCCcceeecccccCCCCCCcccCC
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDD----NLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE 152 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~----~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 152 (273)
.++.|++.++.||| ..|++|+|+||+|+++.. ++.++++|||++..... .......+||+.|+|||++..
T Consensus 139 ~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~ 212 (382)
T KOG0032|consen 139 GIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGG 212 (382)
T ss_pred HHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC---CceEeeecCCccccCchhhcC
Confidence 99999999999999 999999999999999963 24799999999987643 344567899999999999999
Q ss_pred CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhh
Q 024027 153 GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMA 232 (273)
Q Consensus 153 ~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 232 (273)
..|+..+||||+|+++|.|+.|.+||...........- .. ....+.....+.++..+.+++++
T Consensus 213 ~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i-~~----------------~~~~f~~~~w~~is~~akd~i~~ 275 (382)
T KOG0032|consen 213 RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAI-LR----------------GDFDFTSEPWDDISESAKDFIRK 275 (382)
T ss_pred CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHH-Hc----------------CCCCCCCCCccccCHHHHHHHHH
Confidence 99999999999999999999999999875544433311 11 11122333356778889999999
Q ss_pred cCCCCccCCCCHHHHHHHHH
Q 024027 233 CTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 233 ~l~~dp~~Rps~~~~l~~l~ 252 (273)
||..||.+|+|+.++|+|-|
T Consensus 276 ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 276 LLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred hcccCcccCCCHHHHhcCcc
Confidence 99999999999999999955
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=275.16 Aligned_cols=239 Identities=20% Similarity=0.276 Sum_probs=181.3
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
.||+|+++... ......+.+|+++++.++|+||++++++|.+++..++||||+++++|.+++...+ .+++..+..++.
T Consensus 32 ~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ 110 (333)
T cd06650 32 IMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSI 110 (333)
T ss_pred EEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHH
Confidence 58899887542 3345678999999999999999999999999999999999999999999996544 588999999999
Q ss_pred HHHHHHHHHhcCCCC-CeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcc
Q 024027 81 DVASALEYLHFGCSA-PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 159 (273)
Q Consensus 81 ql~~~l~~lh~~~~~-~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 159 (273)
|++.||.||| +. +++|+||||+||+++.++.++|+|||++..+... ......++..|+|||.+.+..++.++
T Consensus 111 ~l~~~l~~lH---~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~ 183 (333)
T cd06650 111 AVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQS 183 (333)
T ss_pred HHHHHHHHHH---hcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh----ccccCCCCccccCHHHhcCCCCCcHH
Confidence 9999999999 64 7999999999999999999999999998754221 12234688899999999988899999
Q ss_pred hhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccc-----------------------------hhhhhhhccc
Q 024027 160 DVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPIST-----------------------------MEVVDANLLS 210 (273)
Q Consensus 160 DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~ 210 (273)
|+|||||++|++++|..||......... ........... ........
T Consensus 184 DvwslG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 259 (333)
T cd06650 184 DIWSMGLSLVEMAIGRYPIPPPDAKELE--LMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIV-- 259 (333)
T ss_pred HHHHHHHHHHHHHHCCCCCCCcchhHHH--HHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHh--
Confidence 9999999999999999998653321110 00000000000 00000000
Q ss_pred cchhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 211 QEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 211 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
............+.++.+|+.+||..||++|||+.+++.|-.
T Consensus 260 ~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~ 301 (333)
T cd06650 260 NEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAF 301 (333)
T ss_pred cCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHH
Confidence 000000001124677999999999999999999999998855
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=273.86 Aligned_cols=234 Identities=26% Similarity=0.422 Sum_probs=183.9
Q ss_pred CeEEEEEeeccc-ChhhhhHHHHHHHHhcC-CCccceeeeeeeec-CCceeEEEeccCCCCHHHhhhcCC----------
Q 024027 1 MEVAVKVFNLQC-GRAFKSFDVECEMMKSI-RHRNLIKVISSCSN-EEFKALVLEYMPHGSLEKYLYSSN---------- 67 (273)
Q Consensus 1 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~---------- 67 (273)
+.||+|+++... ......+..|+++++++ +|+||++++++|.. +...++++||+++++|.+++....
T Consensus 38 ~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~ 117 (337)
T cd05054 38 RTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKS 117 (337)
T ss_pred ceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhcccccccccccc
Confidence 369999997543 23345678899999999 89999999998765 456889999999999999985321
Q ss_pred --------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 024027 68 --------------------------------------------------CILDIFQRLNIMIDVASALEYLHFGCSAPV 97 (273)
Q Consensus 68 --------------------------------------------------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i 97 (273)
..+++..+..++.|++.||.||| +.|+
T Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~i 194 (337)
T cd05054 118 TRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLA---SRKC 194 (337)
T ss_pred ccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCe
Confidence 25788899999999999999999 9999
Q ss_pred EeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcchhHHHHHHHHHHHh-CCC
Q 024027 98 IHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKK 176 (273)
Q Consensus 98 ~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~ 176 (273)
+|+||||+||+++.++.++|+|||++..+.............++..|+|||.+.+..++.++|||||||+++++++ |..
T Consensus 195 vHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~ 274 (337)
T cd05054 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGAS 274 (337)
T ss_pred ecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCC
Confidence 9999999999999999999999999987633322222233445678999999998899999999999999999998 999
Q ss_pred CCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHHHHHH
Q 024027 177 PTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLLKIRD 256 (273)
Q Consensus 177 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 256 (273)
||......+. ......... ....+...+.++.+++.+||..+|++||++.+++++|.++.+
T Consensus 275 p~~~~~~~~~-~~~~~~~~~------------------~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 275 PYPGVQIDEE-FCRRLKEGT------------------RMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred CCCCCCccHH-HHHHHhccC------------------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9865322221 111100000 001133456679999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=271.49 Aligned_cols=231 Identities=30% Similarity=0.458 Sum_probs=183.6
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcC-------------
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS------------- 66 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------------- 66 (273)
.||+|.++... ......+.+|+++++.+ +|+||+++++++..++.++++|||+++++|..++...
T Consensus 44 ~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 123 (293)
T cd05053 44 TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPR 123 (293)
T ss_pred eEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCcccccccccc
Confidence 58999987542 34456788999999999 8999999999999999999999999999999998532
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCC
Q 024027 67 --NCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGY 144 (273)
Q Consensus 67 --~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~ 144 (273)
...+++..++.++.|++.||+||| +.|++|+||+|+||+++.++.++|+|||++..+.............++..|
T Consensus 124 ~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y 200 (293)
T cd05053 124 PPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKW 200 (293)
T ss_pred ccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccc
Confidence 345888999999999999999999 999999999999999999999999999999765332211111222345679
Q ss_pred CCCcccCCCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhH
Q 024027 145 MAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCV 223 (273)
Q Consensus 145 ~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (273)
+|||.+.+..++.++|||||||++|++++ |..||......+. ..... .. .....+..++
T Consensus 201 ~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-~~~~~-------------~~------~~~~~~~~~~ 260 (293)
T cd05053 201 MAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL-FKLLK-------------EG------YRMEKPQNCT 260 (293)
T ss_pred cCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH-HHHHH-------------cC------CcCCCCCCCC
Confidence 99999988889999999999999999997 8899865322111 00000 00 0001133456
Q ss_pred HHHHHHHhhcCCCCccCCCCHHHHHHHHHHHH
Q 024027 224 SFVFNLAMACTVESPEQRINAKEIVTKLLKIR 255 (273)
Q Consensus 224 ~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 255 (273)
..+.+|+.+||..||++|||+.++++.|+++.
T Consensus 261 ~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 261 QELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 77999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=280.51 Aligned_cols=223 Identities=25% Similarity=0.313 Sum_probs=180.0
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
+.||+|+++... ......+..|++++++++||||+++++++.+++.+++||||+++++|.+++.+. ..+++..+..+
T Consensus 25 ~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~ 103 (318)
T cd05582 25 QLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE-VMFTEEDVKFY 103 (318)
T ss_pred CEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHH
Confidence 368999997542 234456778999999999999999999999999999999999999999999654 36899999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCc
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTN 158 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 158 (273)
+.|++.||.||| +.|++|+||||+||+++.++.++|+|||++....... .......|++.|+|||.+.+..++.+
T Consensus 104 ~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~ 178 (318)
T cd05582 104 LAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQS 178 (318)
T ss_pred HHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--CceecccCChhhcCHHHHcCCCCCCc
Confidence 999999999999 9999999999999999999999999999987542221 12234568899999999988889999
Q ss_pred chhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc
Q 024027 159 GDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238 (273)
Q Consensus 159 ~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 238 (273)
+|||||||++|+|++|..||........ ....... ....+..++.++.+|+.+||..||
T Consensus 179 ~DiwslG~il~el~tg~~p~~~~~~~~~-~~~i~~~--------------------~~~~p~~~~~~~~~li~~~l~~~P 237 (318)
T cd05582 179 ADWWSFGVLMFEMLTGSLPFQGKDRKET-MTMILKA--------------------KLGMPQFLSPEAQSLLRALFKRNP 237 (318)
T ss_pred cceeccceEeeeeccCCCCCCCCCHHHH-HHHHHcC--------------------CCCCCCCCCHHHHHHHHHHhhcCH
Confidence 9999999999999999999865322111 1110000 001133466779999999999999
Q ss_pred cCCCC-----HHHHHHH
Q 024027 239 EQRIN-----AKEIVTK 250 (273)
Q Consensus 239 ~~Rps-----~~~~l~~ 250 (273)
.+||| +.++++|
T Consensus 238 ~~R~~a~~~~~~~~~~~ 254 (318)
T cd05582 238 ANRLGAGPDGVEEIKRH 254 (318)
T ss_pred hHcCCCCCCCHHHHhCC
Confidence 99999 5667665
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=275.48 Aligned_cols=223 Identities=23% Similarity=0.284 Sum_probs=177.5
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (273)
+.||||+++... ....+.+..|..++... +||||+++++++..+...++||||++||+|.+++.... .+++..+.
T Consensus 21 ~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~-~~~~~~~~ 99 (316)
T cd05592 21 EFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSG-RFDEARAR 99 (316)
T ss_pred CEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHcC-CCCHHHHH
Confidence 369999997542 23445566677777655 89999999999999999999999999999999986544 68999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcC
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVS 156 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 156 (273)
.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++....... .......|++.|+|||.+.+..++
T Consensus 100 ~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~ 174 (316)
T cd05592 100 FYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKASTFCGTPDYIAPEILKGQKYN 174 (316)
T ss_pred HHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--CccccccCCccccCHHHHcCCCCC
Confidence 99999999999999 9999999999999999999999999999987542222 223345689999999999988899
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++|+|||||++|+|++|..||........ ....... ....+..++.++.+|+.+||..
T Consensus 175 ~~~DvwslG~il~ell~G~~Pf~~~~~~~~-~~~i~~~--------------------~~~~~~~~~~~~~~ll~~~l~~ 233 (316)
T cd05592 175 ESVDWWSFGVLLYEMLIGQSPFHGEDEDEL-FDSILND--------------------RPHFPRWISKEAKDCLSKLFER 233 (316)
T ss_pred CcccchhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHcC--------------------CCCCCCCCCHHHHHHHHHHccC
Confidence 999999999999999999999975332111 1000000 0011344667789999999999
Q ss_pred CccCCCCHH-HHHHH
Q 024027 237 SPEQRINAK-EIVTK 250 (273)
Q Consensus 237 dp~~Rps~~-~~l~~ 250 (273)
||.+||++. ++++|
T Consensus 234 ~P~~R~~~~~~l~~h 248 (316)
T cd05592 234 DPTKRLGVDGDIRQH 248 (316)
T ss_pred CHHHcCCChHHHHcC
Confidence 999999875 66665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=264.86 Aligned_cols=225 Identities=26% Similarity=0.420 Sum_probs=180.0
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~q 81 (273)
.||+|.++.. ......+..|+++++.++||||+++++++......+++|||+++|+|.+++......+++..+..++.|
T Consensus 30 ~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ 108 (256)
T cd05114 30 KVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQD 108 (256)
T ss_pred eEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHH
Confidence 6899988644 333467889999999999999999999999999999999999999999999765556899999999999
Q ss_pred HHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcchh
Q 024027 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 161 (273)
Q Consensus 82 l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di 161 (273)
++.||.||| +.|++|+||+|+||+++.++.++++|||.+........ .......++..|+|||.+.+..++.++|+
T Consensus 109 i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 184 (256)
T cd05114 109 VCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TSSSGAKFPVKWSPPEVFNFSKYSSKSDV 184 (256)
T ss_pred HHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-eccCCCCCchhhCChhhcccCccchhhhh
Confidence 999999999 99999999999999999999999999998875422111 11112234567999999988889999999
Q ss_pred HHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccC
Q 024027 162 YSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQ 240 (273)
Q Consensus 162 wslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 240 (273)
||+|+++|++++ |..||......+. ........ ....+...+.++.+++.+||..||.+
T Consensus 185 ~s~G~~l~el~~~g~~p~~~~~~~~~-~~~i~~~~-------------------~~~~~~~~~~~~~~li~~c~~~~p~~ 244 (256)
T cd05114 185 WSFGVLMWEVFTEGKMPFEKKSNYEV-VEMISRGF-------------------RLYRPKLASMTVYEVMYSCWHEKPEG 244 (256)
T ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHCCC-------------------CCCCCCCCCHHHHHHHHHHccCCccc
Confidence 999999999999 8999865332211 11111100 00012234556899999999999999
Q ss_pred CCCHHHHHHHH
Q 024027 241 RINAKEIVTKL 251 (273)
Q Consensus 241 Rps~~~~l~~l 251 (273)
|||++++++.|
T Consensus 245 Rps~~~l~~~l 255 (256)
T cd05114 245 RPTFAELLRAI 255 (256)
T ss_pred CcCHHHHHHhh
Confidence 99999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=275.47 Aligned_cols=223 Identities=21% Similarity=0.237 Sum_probs=177.7
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (273)
+.||||+++... ......+..|..++... +||||+++++++.+.+..++||||+++++|.+++... ..+++..+.
T Consensus 21 ~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~-~~~~~~~~~ 99 (316)
T cd05620 21 EYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDK-GRFDLYRAT 99 (316)
T ss_pred CEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHc-CCCCHHHHH
Confidence 369999997542 23455677788888765 8999999999999999999999999999999998654 368999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcC
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVS 156 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 156 (273)
.++.|++.||.||| +.|++||||||+||+++.++.++|+|||++..... .........|++.|+|||.+.+..++
T Consensus 100 ~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~ 174 (316)
T cd05620 100 FYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF--GDNRASTFCGTPDYIAPEILQGLKYT 174 (316)
T ss_pred HHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc--CCCceeccCCCcCccCHHHHcCCCCC
Confidence 99999999999999 99999999999999999999999999999864311 11223345689999999999988999
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++||||+||++|+|++|..||....... ....... .. ...+..++.++.+++.+||..
T Consensus 175 ~~~DiwslGvil~el~~g~~Pf~~~~~~~-~~~~~~~----------------~~----~~~~~~~~~~~~~li~~~l~~ 233 (316)
T cd05620 175 FSVDWWSFGVLLYEMLIGQSPFHGDDEDE-LFESIRV----------------DT----PHYPRWITKESKDILEKLFER 233 (316)
T ss_pred cccchhhhHHHHHHHHhCCCCCCCCCHHH-HHHHHHh----------------CC----CCCCCCCCHHHHHHHHHHccC
Confidence 99999999999999999999996532211 0100000 00 011234567799999999999
Q ss_pred CccCCCCH-HHHHHH
Q 024027 237 SPEQRINA-KEIVTK 250 (273)
Q Consensus 237 dp~~Rps~-~~~l~~ 250 (273)
||.+||++ +++++|
T Consensus 234 dP~~R~~~~~~~~~h 248 (316)
T cd05620 234 DPTRRLGVVGNIRGH 248 (316)
T ss_pred CHHHcCCChHHHHcC
Confidence 99999998 466654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=269.19 Aligned_cols=228 Identities=24% Similarity=0.416 Sum_probs=179.5
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC---------CCCC
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN---------CILD 71 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~ 71 (273)
.||||+++... ......+.+|+.+++.++||||+++++++......++||||+++++|.+++.... ..++
T Consensus 38 ~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ 117 (277)
T cd05062 38 RVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPS 117 (277)
T ss_pred EEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCC
Confidence 58999986432 2345568899999999999999999999999999999999999999999986432 2356
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccC
Q 024027 72 IFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR 151 (273)
Q Consensus 72 ~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 151 (273)
+..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++................++..|+|||.+.
T Consensus 118 ~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 194 (277)
T cd05062 118 LKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK 194 (277)
T ss_pred HHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhh
Confidence 7888999999999999999 9999999999999999999999999999987543222211112234567899999998
Q ss_pred CCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHH
Q 024027 152 EGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLA 230 (273)
Q Consensus 152 ~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 230 (273)
+..++.++|+||||+++|++++ |..||....... .......... ...+..++..+.+++
T Consensus 195 ~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~-~~~~~~~~~~-------------------~~~~~~~~~~~~~li 254 (277)
T cd05062 195 DGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ-VLRFVMEGGL-------------------LDKPDNCPDMLFELM 254 (277)
T ss_pred cCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHHcCCc-------------------CCCCCCCCHHHHHHH
Confidence 8889999999999999999998 788886532211 1111000000 011334567799999
Q ss_pred hhcCCCCccCCCCHHHHHHHHH
Q 024027 231 MACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 231 ~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
.+||..||++|||+.++++.|+
T Consensus 255 ~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 255 RMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHcCCChhhCcCHHHHHHHhh
Confidence 9999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=264.64 Aligned_cols=229 Identities=25% Similarity=0.417 Sum_probs=182.4
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
.||+|+++... ....+.+.+|+.+++.++|+||+++++++.. ...++||||+++++|.+++......+++..++.++.
T Consensus 24 ~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 102 (257)
T cd05115 24 DVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMH 102 (257)
T ss_pred eEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHH
Confidence 48999997553 3345678999999999999999999998864 468899999999999999976666799999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcce-eecccccCCCCCCcccCCCCcCCcc
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMT-QTQTLATIGYMAPEYGREGRVSTNG 159 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~ 159 (273)
|++.||.||| +.|++|+||||+||+++.++.++|+|||.+........... .....++..|+|||.+.+..++.++
T Consensus 103 ~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 179 (257)
T cd05115 103 QVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRS 179 (257)
T ss_pred HHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchh
Confidence 9999999999 99999999999999999999999999999875432222111 1112235679999999888899999
Q ss_pred hhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc
Q 024027 160 DVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238 (273)
Q Consensus 160 DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 238 (273)
|+||||+++|++++ |..||......+. ... ... . .....+..++.++.+++.+||..||
T Consensus 180 Di~slG~~l~el~~~g~~p~~~~~~~~~-~~~-~~~------------~------~~~~~~~~~~~~l~~li~~c~~~~~ 239 (257)
T cd05115 180 DVWSYGITMWEAFSYGQKPYKKMKGPEV-MSF-IEQ------------G------KRLDCPAECPPEMYALMKDCWIYKW 239 (257)
T ss_pred hHHHHHHHHHHHhcCCCCCcCcCCHHHH-HHH-HHC------------C------CCCCCCCCCCHHHHHHHHHHcCCCh
Confidence 99999999999996 9999876432211 000 000 0 0011234567889999999999999
Q ss_pred cCCCCHHHHHHHHHHH
Q 024027 239 EQRINAKEIVTKLLKI 254 (273)
Q Consensus 239 ~~Rps~~~~l~~l~~~ 254 (273)
++||++.++.+.|+.+
T Consensus 240 ~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 240 EDRPNFAKVEERMRTY 255 (257)
T ss_pred hhCcCHHHHHHHHhhh
Confidence 9999999999998865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=265.28 Aligned_cols=225 Identities=29% Similarity=0.471 Sum_probs=180.3
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~q 81 (273)
.+|+|+++... .....+.+|+++++.++|+||+++++++...+..++||||+++++|.+++......+++..+..++.|
T Consensus 30 ~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~q 108 (256)
T cd05059 30 DVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSD 108 (256)
T ss_pred cEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHH
Confidence 58999986542 23456888999999999999999999999999999999999999999999766557899999999999
Q ss_pred HHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcchh
Q 024027 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 161 (273)
Q Consensus 82 l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di 161 (273)
++.|++||| +.|++|+||+|+||+++.++.++|+|||.+....... ........++..|+|||.+.+..++.++|+
T Consensus 109 i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di 184 (256)
T cd05059 109 VCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ-YTSSQGTKFPVKWAPPEVFDYSRFSSKSDV 184 (256)
T ss_pred HHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceeccccc-ccccCCCCCCccccCHHHhccCCCCchhhH
Confidence 999999999 9999999999999999999999999999987552211 111111223457999999988889999999
Q ss_pred HHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccC
Q 024027 162 YSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQ 240 (273)
Q Consensus 162 wslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 240 (273)
||||+++|++++ |..||......+. ....... .....+..++.++.+++.+||..+|++
T Consensus 185 ~slG~il~~l~~~g~~p~~~~~~~~~-~~~~~~~-------------------~~~~~~~~~~~~~~~li~~cl~~~p~~ 244 (256)
T cd05059 185 WSFGVLMWEVFSEGKMPYERFSNSEV-VESVSAG-------------------YRLYRPKLAPTEVYTIMYSCWHEKPED 244 (256)
T ss_pred HHHHHHHHHHhccCCCCCCCCCHHHH-HHHHHcC-------------------CcCCCCCCCCHHHHHHHHHHhcCChhh
Confidence 999999999998 8999865332211 1110000 001113346778999999999999999
Q ss_pred CCCHHHHHHHH
Q 024027 241 RINAKEIVTKL 251 (273)
Q Consensus 241 Rps~~~~l~~l 251 (273)
|||+.++++.|
T Consensus 245 Rpt~~~~l~~l 255 (256)
T cd05059 245 RPAFKKLLSQL 255 (256)
T ss_pred CcCHHHHHHHh
Confidence 99999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=265.16 Aligned_cols=229 Identities=31% Similarity=0.457 Sum_probs=183.1
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC-CCCCHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIM 79 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ 79 (273)
+.||||.++... ...+.+.+|+++++.++|+||+++++++...+..+++|||+++++|.+++.... ..+++..+..++
T Consensus 31 ~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ 109 (261)
T cd05068 31 TPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMA 109 (261)
T ss_pred eEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHH
Confidence 368999997553 345678999999999999999999999999999999999999999999996543 468999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 159 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 159 (273)
.|++.|+.+|| +.|++|+||+|+||+++.++.++|+|||++....... .........+..|+|||.+.+..++.++
T Consensus 110 ~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 185 (261)
T cd05068 110 AQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI-YEAREGAKFPIKWTAPEAALYNRFSIKS 185 (261)
T ss_pred HHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc-ccccCCCcCceeccCccccccCCCCchh
Confidence 99999999999 9999999999999999999999999999987663211 1111112234579999999888899999
Q ss_pred hhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc
Q 024027 160 DVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238 (273)
Q Consensus 160 DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 238 (273)
|+||||++++++++ |..||....... ......... ....+..++..+.+++.+||..+|
T Consensus 186 Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~~~~~~-------------------~~~~~~~~~~~~~~li~~~l~~~P 245 (261)
T cd05068 186 DVWSFGILLTEIVTYGRMPYPGMTNAE-VLQQVDQGY-------------------RMPCPPGCPKELYDIMLDCWKEDP 245 (261)
T ss_pred hHHHHHHHHHHHHhcCCCCCCCCCHHH-HHHHHHcCC-------------------CCCCCCcCCHHHHHHHHHHhhcCc
Confidence 99999999999999 999986532211 111100000 001123456679999999999999
Q ss_pred cCCCCHHHHHHHHHHH
Q 024027 239 EQRINAKEIVTKLLKI 254 (273)
Q Consensus 239 ~~Rps~~~~l~~l~~~ 254 (273)
.+||+++++++.|+++
T Consensus 246 ~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 246 DDRPTFETLQWKLEDF 261 (261)
T ss_pred ccCCCHHHHHHHHhcC
Confidence 9999999999998753
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=269.06 Aligned_cols=231 Identities=24% Similarity=0.378 Sum_probs=184.5
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC-CCCCHHHHHHH
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNI 78 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~ 78 (273)
.||||+++... ....+.+.+|+.+++++ +|+||+++++++...+..+++|||+++++|.+++.... ..+++..+..+
T Consensus 67 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i 146 (302)
T cd05055 67 KVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSF 146 (302)
T ss_pred EEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHH
Confidence 68999987553 33456789999999999 79999999999999999999999999999999996543 34899999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCc
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTN 158 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 158 (273)
+.|++.||.||| +.+++|+||+|+||+++.++.++++|||++................++..|+|||.+.+..++.+
T Consensus 147 ~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 223 (302)
T cd05055 147 SYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFE 223 (302)
T ss_pred HHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcH
Confidence 999999999999 99999999999999999999999999999876533222112222345678999999988889999
Q ss_pred chhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 159 GDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 159 ~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
+||||+|+++|++++ |..||......+......... . ....+...+.++.+++.+||..+
T Consensus 224 ~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~-------------~------~~~~~~~~~~~~~~li~~cl~~~ 284 (302)
T cd05055 224 SDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEG-------------Y------RMAQPEHAPAEIYDIMKTCWDAD 284 (302)
T ss_pred hHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcC-------------C------cCCCCCCCCHHHHHHHHHHcCCC
Confidence 999999999999998 999986543322111110000 0 00012234567999999999999
Q ss_pred ccCCCCHHHHHHHHHHH
Q 024027 238 PEQRINAKEIVTKLLKI 254 (273)
Q Consensus 238 p~~Rps~~~~l~~l~~~ 254 (273)
|++|||+.++++.|.++
T Consensus 285 p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 285 PLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred chhCcCHHHHHHHHHhh
Confidence 99999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=280.15 Aligned_cols=229 Identities=22% Similarity=0.286 Sum_probs=183.2
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||||+++... ......+.+|+.+++.++|+||+++++++.+....++||||+++++|.+++......+++..+..
T Consensus 27 ~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~ 106 (330)
T cd05601 27 DIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQF 106 (330)
T ss_pred CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHH
Confidence 369999998542 23556788999999999999999999999999999999999999999999987756799999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccC------
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR------ 151 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~------ 151 (273)
++.|++.||.||| +.|++||||||+||+++.++.++|+|||++..+..... .......+++.|+|||++.
T Consensus 107 ~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ 182 (330)
T cd05601 107 YLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-VNSKLPVGTPDYIAPEVLTTMNGDG 182 (330)
T ss_pred HHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc-eeeecccCCccccCHHHhccccccc
Confidence 9999999999999 99999999999999999999999999999976532222 1223346899999999886
Q ss_pred CCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHh
Q 024027 152 EGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAM 231 (273)
Q Consensus 152 ~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 231 (273)
...++.++|||||||++|+|++|..||....... ........ ......+....++.++.+|+.
T Consensus 183 ~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-~~~~i~~~----------------~~~~~~~~~~~~~~~~~~li~ 245 (330)
T cd05601 183 KGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK-TYNNIMNF----------------QRFLKFPEDPKVSSDFLDLIQ 245 (330)
T ss_pred cCCCCCcceeecccceeeeeccCCCCCCCCCHHH-HHHHHHcC----------------CCccCCCCCCCCCHHHHHHHH
Confidence 3457889999999999999999999986532211 11111100 000011112346677999999
Q ss_pred hcCCCCccCCCCHHHHHHHH
Q 024027 232 ACTVESPEQRINAKEIVTKL 251 (273)
Q Consensus 232 ~~l~~dp~~Rps~~~~l~~l 251 (273)
+||. +|.+|||++++++|-
T Consensus 246 ~ll~-~p~~R~t~~~l~~h~ 264 (330)
T cd05601 246 SLLC-GQKERLGYEGLCCHP 264 (330)
T ss_pred HHcc-ChhhCCCHHHHhCCC
Confidence 9998 999999999999873
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=268.46 Aligned_cols=229 Identities=29% Similarity=0.514 Sum_probs=182.1
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcC--------------
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-------------- 66 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------------- 66 (273)
.||+|.++... ......+.+|+.+++.++||||+++++++..+...+++|||+++++|.+++...
T Consensus 36 ~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 115 (283)
T cd05090 36 LVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDG 115 (283)
T ss_pred eEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCcccccccccc
Confidence 68999997543 334567889999999999999999999999999999999999999999998532
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCC
Q 024027 67 --NCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGY 144 (273)
Q Consensus 67 --~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~ 144 (273)
...+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++................++..|
T Consensus 116 ~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 192 (283)
T cd05090 116 TVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRW 192 (283)
T ss_pred ccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCcccee
Confidence 124778889999999999999999 999999999999999999999999999999765333222222333456679
Q ss_pred CCCcccCCCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhH
Q 024027 145 MAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCV 223 (273)
Q Consensus 145 ~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (273)
+|||.+.+..++.++|+||||+++|+|++ |..||........ .. .... .. ....+..++
T Consensus 193 ~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~-~~-~~~~------------~~------~~~~~~~~~ 252 (283)
T cd05090 193 MPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV-IE-MVRK------------RQ------LLPCSEDCP 252 (283)
T ss_pred cChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-HH-HHHc------------CC------cCCCCCCCC
Confidence 99999988889999999999999999998 8889865322110 11 0000 00 001133466
Q ss_pred HHHHHHHhhcCCCCccCCCCHHHHHHHHHH
Q 024027 224 SFVFNLAMACTVESPEQRINAKEIVTKLLK 253 (273)
Q Consensus 224 ~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 253 (273)
..+.+++.+||..||++||++.+++++|.+
T Consensus 253 ~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 253 PRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 779999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=264.70 Aligned_cols=226 Identities=24% Similarity=0.429 Sum_probs=180.8
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~q 81 (273)
.||||.++... .....+.+|+.+++.++||||+++++++......+++|||+++++|.+++......+++..++.++.|
T Consensus 30 ~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~ 108 (256)
T cd05113 30 DVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKD 108 (256)
T ss_pred cEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHH
Confidence 58999987542 33467899999999999999999999999999999999999999999999765557899999999999
Q ss_pred HHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcchh
Q 024027 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 161 (273)
Q Consensus 82 l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di 161 (273)
++.||.||| +.|++|+||+|+||+++.++.++|+|||.+....... ........++..|+|||.+.+..++.++|+
T Consensus 109 i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~-~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di 184 (256)
T cd05113 109 VCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLLYSKFSSKSDV 184 (256)
T ss_pred HHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCc-eeecCCCccChhhCCHHHHhcCcccchhHH
Confidence 999999999 9999999999999999999999999999987542211 111122234567999999988889999999
Q ss_pred HHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccC
Q 024027 162 YSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQ 240 (273)
Q Consensus 162 wslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 240 (273)
||||+++|+|++ |..||........ ........ ....+...+..+.+++.+||..||.+
T Consensus 185 ~slG~~l~~l~~~g~~p~~~~~~~~~-~~~~~~~~-------------------~~~~~~~~~~~~~~li~~cl~~~p~~ 244 (256)
T cd05113 185 WAFGVLMWEVYSLGKMPYERFNNSET-VEKVSQGL-------------------RLYRPHLASEKVYAIMYSCWHEKAEE 244 (256)
T ss_pred HHHHHHHHHHhcCCCCCcCcCCHHHH-HHHHhcCC-------------------CCCCCCCCCHHHHHHHHHHcCCCccc
Confidence 999999999998 9999865332211 11110000 00012234567999999999999999
Q ss_pred CCCHHHHHHHHH
Q 024027 241 RINAKEIVTKLL 252 (273)
Q Consensus 241 Rps~~~~l~~l~ 252 (273)
|||+.++++.|+
T Consensus 245 Rp~~~~ll~~~~ 256 (256)
T cd05113 245 RPTFQQLLSSIE 256 (256)
T ss_pred CCCHHHHHHhhC
Confidence 999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=273.43 Aligned_cols=223 Identities=23% Similarity=0.291 Sum_probs=177.4
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (273)
+.||||+++... ......+..|..+++.. +||||+++++++.+...+++||||+++|+|.+++... ..+++..+.
T Consensus 21 ~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~ 99 (316)
T cd05619 21 QFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSC-HKFDLPRAT 99 (316)
T ss_pred CEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHH
Confidence 369999997542 23445567788888764 8999999999999999999999999999999999654 468899999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcC
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVS 156 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 156 (273)
.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++...... ........|++.|+|||.+.+..++
T Consensus 100 ~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~ 174 (316)
T cd05619 100 FYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--DAKTCTFCGTPDYIAPEILLGQKYN 174 (316)
T ss_pred HHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC--CCceeeecCCccccCHHHHcCCCCC
Confidence 99999999999999 999999999999999999999999999998643111 1122345689999999999988899
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++|+||+||++|+|++|..||......+. .... . . .. ...+..++.++.+++.+||..
T Consensus 175 ~~~DvwslG~il~el~~G~~pf~~~~~~~~-~~~i-~------------~---~~----~~~~~~~~~~~~~li~~~l~~ 233 (316)
T cd05619 175 TSVDWWSFGVLLYEMLIGQSPFHGHDEEEL-FQSI-R------------M---DN----PCYPRWLTREAKDILVKLFVR 233 (316)
T ss_pred chhhhhhHHHHHHHHHhCCCCCCCCCHHHH-HHHH-H------------h---CC----CCCCccCCHHHHHHHHHHhcc
Confidence 999999999999999999999975332111 0000 0 0 00 001234566789999999999
Q ss_pred CccCCCCHH-HHHHH
Q 024027 237 SPEQRINAK-EIVTK 250 (273)
Q Consensus 237 dp~~Rps~~-~~l~~ 250 (273)
||++||++. +++.|
T Consensus 234 ~P~~R~~~~~~l~~h 248 (316)
T cd05619 234 EPERRLGVKGDIRQH 248 (316)
T ss_pred CHhhcCCChHHHHcC
Confidence 999999997 66654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=281.95 Aligned_cols=234 Identities=29% Similarity=0.385 Sum_probs=196.0
Q ss_pred EEEEEeecc---cChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 3 VAVKVFNLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 3 vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
||||..+.. ....+.++.+|++++++++||||+++||+..++..+++|||+|+||+|.++|++.+..++..+...++
T Consensus 189 VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~ 268 (474)
T KOG0194|consen 189 VAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFC 268 (474)
T ss_pred eEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHH
Confidence 899999863 35678899999999999999999999999999999999999999999999998887779999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 159 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 159 (273)
.+.+.||+||| +.+++||||-.+|+|++.++.+||+|||++..-. ..........-+..|+|||.+....++.++
T Consensus 269 ~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kT 343 (474)
T KOG0194|consen 269 YDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKT 343 (474)
T ss_pred HHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccccCCc--ceeeccccccCcceecChhhhccCcccccc
Confidence 99999999999 9999999999999999999999999999987531 111111122356789999999999999999
Q ss_pred hhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc
Q 024027 160 DVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238 (273)
Q Consensus 160 DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 238 (273)
|||||||++||+++ |..||......+.... +.........+...+.++..++.+|+..||
T Consensus 344 DV~sfGV~~~Eif~~g~~Py~g~~~~~v~~k-------------------I~~~~~r~~~~~~~p~~~~~~~~~c~~~~p 404 (474)
T KOG0194|consen 344 DVWSFGVLLWEIFENGAEPYPGMKNYEVKAK-------------------IVKNGYRMPIPSKTPKELAKVMKQCWKKDP 404 (474)
T ss_pred chhheeeeEEeeeccCCCCCCCCCHHHHHHH-------------------HHhcCccCCCCCCCHHHHHHHHHHhccCCh
Confidence 99999999999999 8889877544321110 001122233355677889999999999999
Q ss_pred cCCCCHHHHHHHHHHHHHhhhh
Q 024027 239 EQRINAKEIVTKLLKIRDSLLR 260 (273)
Q Consensus 239 ~~Rps~~~~l~~l~~~~~~~~~ 260 (273)
++|||+.++.+.++.+.+....
T Consensus 405 ~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 405 EDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred hhccCHHHHHHHHHHHHhcccc
Confidence 9999999999999999987654
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=266.69 Aligned_cols=233 Identities=24% Similarity=0.343 Sum_probs=184.8
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
+||+|+++... ......+..|+.+++.++|+||+++++++... ..++++||+++|+|.+++......+++..++.++.
T Consensus 38 ~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~ 116 (279)
T cd05109 38 PVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCV 116 (279)
T ss_pred EEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHH
Confidence 58999997543 34567788999999999999999999998754 56799999999999999977666789999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
|++.||.||| +.|++|+||||+||+++.++.++|+|||++..+.............++..|+|||...+..++.++|
T Consensus 117 qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~D 193 (279)
T cd05109 117 QIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSD 193 (279)
T ss_pred HHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhH
Confidence 9999999999 9999999999999999999999999999987664322221222233466799999998888999999
Q ss_pred hHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCcc
Q 024027 161 VYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239 (273)
Q Consensus 161 iwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 239 (273)
||||||++|++++ |..||....... ........ . ....+..++.++.+++.+||..||+
T Consensus 194 i~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~------------~------~~~~~~~~~~~~~~li~~~l~~dp~ 253 (279)
T cd05109 194 VWSYGVTVWELMTFGAKPYDGIPARE--IPDLLEKG------------E------RLPQPPICTIDVYMIMVKCWMIDSE 253 (279)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHCC------------C------cCCCCccCCHHHHHHHHHHcCCChh
Confidence 9999999999998 889986532211 11111100 0 0011234566799999999999999
Q ss_pred CCCCHHHHHHHHHHHHHhh
Q 024027 240 QRINAKEIVTKLLKIRDSL 258 (273)
Q Consensus 240 ~Rps~~~~l~~l~~~~~~~ 258 (273)
+||++.++++.|.++..+.
T Consensus 254 ~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 254 CRPRFRELVDEFSRMARDP 272 (279)
T ss_pred hCcCHHHHHHHHHHhhcCC
Confidence 9999999999988776543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=264.58 Aligned_cols=227 Identities=26% Similarity=0.326 Sum_probs=186.6
Q ss_pred eEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC-CCCCHHHHHH
Q 024027 2 EVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLN 77 (273)
Q Consensus 2 ~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~ 77 (273)
..|+|++.... ......++.|-+||+.++||.+..+|+.|+.+...|++||||+||+|..+++++. ..+++..++-
T Consensus 104 ~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRF 183 (459)
T KOG0610|consen 104 LFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARF 183 (459)
T ss_pred eEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHH
Confidence 57999997663 3345667789999999999999999999999999999999999999999997664 4599999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCC---------------------------
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED--------------------------- 130 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~--------------------------- 130 (273)
++..++.||+||| ..||++|||||+|||+-.+|.|-|+||.++.......
T Consensus 184 YaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~ 260 (459)
T KOG0610|consen 184 YAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSP 260 (459)
T ss_pred HHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCccccccccccccc
Confidence 9999999999999 9999999999999999999999999999874431100
Q ss_pred ------Cc---------------------ceeecccccCCCCCCcccCCCCcCCcchhHHHHHHHHHHHhCCCCCccccc
Q 024027 131 ------QS---------------------MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFN 183 (273)
Q Consensus 131 ------~~---------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 183 (273)
.. ......+||-.|+|||++.|...+.+.|.|+||+++|||++|.-||.+..+
T Consensus 261 r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~ 340 (459)
T KOG0610|consen 261 RCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNN 340 (459)
T ss_pred chhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCc
Confidence 00 011234688899999999999999999999999999999999999998766
Q ss_pred cccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccCCCC----HHHHHHH
Q 024027 184 GEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRIN----AKEIVTK 250 (273)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~~~l~~ 250 (273)
.++...-.. .+..++..+.++..++|||+++|++||++|.. +.||-+|
T Consensus 341 ~~Tl~NIv~-------------------~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 341 KETLRNIVG-------------------QPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred hhhHHHHhc-------------------CCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcC
Confidence 654433211 11222223467778999999999999999998 7777655
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=264.98 Aligned_cols=231 Identities=26% Similarity=0.374 Sum_probs=185.8
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
.||||...... ....+.+.+|+.+++.++||||+++++++.++ ..++||||+++++|.+++......+++..+..++.
T Consensus 36 ~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 114 (270)
T cd05056 36 AVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSY 114 (270)
T ss_pred ceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHH
Confidence 58999987654 34567899999999999999999999998764 56799999999999999976655689999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
|++.||.||| +.|++|+||+|+||+++.++.++|+|||++........ .......++..|+|||.+.+..++.++|
T Consensus 115 ~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~D 190 (270)
T cd05056 115 QLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY-YKASKGKLPIKWMAPESINFRRFTSASD 190 (270)
T ss_pred HHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeecccccc-eecCCCCccccccChhhhccCCCCchhh
Confidence 9999999999 99999999999999999999999999999876533211 1112223456799999988888999999
Q ss_pred hHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCcc
Q 024027 161 VYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239 (273)
Q Consensus 161 iwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 239 (273)
+||||++++++++ |..||......+... ..... .....+..++.++.+++.+|+..+|.
T Consensus 191 i~slG~il~el~~~g~~pf~~~~~~~~~~-~~~~~-------------------~~~~~~~~~~~~~~~li~~~l~~~P~ 250 (270)
T cd05056 191 VWMFGVCMWEILMLGVKPFQGVKNNDVIG-RIENG-------------------ERLPMPPNCPPTLYSLMTKCWAYDPS 250 (270)
T ss_pred hHHHHHHHHHHHHcCCCCCCCCCHHHHHH-HHHcC-------------------CcCCCCCCCCHHHHHHHHHHcCCChh
Confidence 9999999999996 999987643322111 10000 00011345677899999999999999
Q ss_pred CCCCHHHHHHHHHHHHHh
Q 024027 240 QRINAKEIVTKLLKIRDS 257 (273)
Q Consensus 240 ~Rps~~~~l~~l~~~~~~ 257 (273)
+|||+.++++.|.++.++
T Consensus 251 ~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 251 KRPRFTELKAQLSDILQE 268 (270)
T ss_pred hCcCHHHHHHHHHHHHhc
Confidence 999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=275.08 Aligned_cols=230 Identities=23% Similarity=0.258 Sum_probs=181.0
Q ss_pred CeEEEEEeeccc----ChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHH
Q 024027 1 MEVAVKVFNLQC----GRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQR 75 (273)
Q Consensus 1 ~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (273)
+.||+|+++... ....+.+..|+++++.+ +|++|+++++++..+..+++||||+++|+|.+++.... .+++..+
T Consensus 29 ~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~ 107 (332)
T cd05614 29 KLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRD-NFSEDEV 107 (332)
T ss_pred CEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHH
Confidence 368999997432 23455688899999999 59999999999999999999999999999999986543 5899999
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCC-C
Q 024027 76 LNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG-R 154 (273)
Q Consensus 76 ~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~ 154 (273)
..++.|++.||.||| +.|++||||||+||+++.++.++|+|||++..+..... .......|+..|+|||.+.+. .
T Consensus 108 ~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~ 183 (332)
T cd05614 108 RFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK-ERTYSFCGTIEYMAPEIIRGKGG 183 (332)
T ss_pred HHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC-CccccccCCccccCHHHhcCCCC
Confidence 999999999999999 99999999999999999999999999999876532221 122345689999999998765 4
Q ss_pred cCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcC
Q 024027 155 VSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACT 234 (273)
Q Consensus 155 ~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 234 (273)
++.++|||||||++|+|++|..||......... ..+.... .. .....+..++..+.+++.+||
T Consensus 184 ~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-~~~~~~~------------~~----~~~~~~~~~~~~~~~li~~~l 246 (332)
T cd05614 184 HGKAVDWWSLGILIFELLTGASPFTLEGERNTQ-SEVSRRI------------LK----CDPPFPSFIGPEAQDLLHKLL 246 (332)
T ss_pred CCCccccccchhhhhhhhcCCCCCCCCCCCCCH-HHHHHHH------------hc----CCCCCCCCCCHHHHHHHHHHc
Confidence 788999999999999999999999643222111 1110000 00 001113346677999999999
Q ss_pred CCCccCCC-----CHHHHHHHHH
Q 024027 235 VESPEQRI-----NAKEIVTKLL 252 (273)
Q Consensus 235 ~~dp~~Rp-----s~~~~l~~l~ 252 (273)
..||++|| +++++++|-+
T Consensus 247 ~~dp~~R~~~~~~~~~~~l~h~~ 269 (332)
T cd05614 247 RKDPKKRLGAGPQGASEIKEHPF 269 (332)
T ss_pred CCCHHHcCCCCCCCHHHHHcCCC
Confidence 99999999 8889998743
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=264.78 Aligned_cols=219 Identities=22% Similarity=0.359 Sum_probs=175.4
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~q 81 (273)
+||+|++..........+.+|+.+++.++||||+++++++..+...+++|||+++++|..++......+++..++.++.|
T Consensus 34 ~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~q 113 (262)
T cd05077 34 KVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQ 113 (262)
T ss_pred eEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHH
Confidence 58999987655555667889999999999999999999999999999999999999999998766667999999999999
Q ss_pred HHHHHHHHhcCCCCCeEeccCCCCceeeCCCCc-------eEEeecccccccccCCCcceeecccccCCCCCCcccC-CC
Q 024027 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLV-------AYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR-EG 153 (273)
Q Consensus 82 l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~-------~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~ 153 (273)
++.||.||| +.|++|+||+|+||+++.++. ++++|||++..... .....++..|+|||.+. +.
T Consensus 114 i~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~ 184 (262)
T cd05077 114 LASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLS------RQECVERIPWIAPECVEDSK 184 (262)
T ss_pred HHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccC------cccccccccccChhhhcCCC
Confidence 999999999 999999999999999986654 89999998865421 12234677899999886 45
Q ss_pred CcCCcchhHHHHHHHHHHH-hCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhh
Q 024027 154 RVSTNGDVYSFGIMLMETF-TGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMA 232 (273)
Q Consensus 154 ~~~~~~DiwslG~~l~~ll-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 232 (273)
.++.++|||||||++|+|+ .|..||......+. ..+... . .......+.++.+|+.+
T Consensus 185 ~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~~~~~~------------~--------~~~~~~~~~~~~~li~~ 242 (262)
T cd05077 185 NLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK--ERFYEG------------Q--------CMLVTPSCKELADLMTH 242 (262)
T ss_pred CCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH--HHHHhc------------C--------ccCCCCChHHHHHHHHH
Confidence 6899999999999999998 48888754221110 000000 0 00012234568999999
Q ss_pred cCCCCccCCCCHHHHHHHH
Q 024027 233 CTVESPEQRINAKEIVTKL 251 (273)
Q Consensus 233 ~l~~dp~~Rps~~~~l~~l 251 (273)
||..||.+||++.++++++
T Consensus 243 cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 243 CMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred HcCCChhhCcCHHHHHHhc
Confidence 9999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=263.89 Aligned_cols=232 Identities=23% Similarity=0.321 Sum_probs=184.8
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhc---CCCCCCHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS---SNCILDIFQ 74 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~ 74 (273)
++||||.+.... ......+.+|+.+++.++|+||+++++++..++..+++|||+++++|.+++.. ....+++..
T Consensus 28 ~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~ 107 (267)
T cd08229 28 VPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKT 107 (267)
T ss_pred ceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHH
Confidence 378999886432 33456788999999999999999999999999999999999999999998853 234589999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCC
Q 024027 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGR 154 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 154 (273)
++.++.|++.|+.||| +.|++|+||+|+||+++.++.++++|||++........ ......++..|+|||.+.+..
T Consensus 108 ~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~ 182 (267)
T cd08229 108 VWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENG 182 (267)
T ss_pred HHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc--ccccccCCcCccCHHHhcCCC
Confidence 9999999999999999 99999999999999999999999999999876532221 122345788999999998888
Q ss_pred cCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcC
Q 024027 155 VSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACT 234 (273)
Q Consensus 155 ~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 234 (273)
++.++|+||+|+++|+|++|..||................. ......+..++.++.+++.+||
T Consensus 183 ~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~li~~~l 245 (267)
T cd08229 183 YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC-----------------DYPPLPSDHYSEELRQLVNMCI 245 (267)
T ss_pred ccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC-----------------CCCCCCcccccHHHHHHHHHhc
Confidence 99999999999999999999999864322211111100000 0000012346677999999999
Q ss_pred CCCccCCCCHHHHHHHHHHH
Q 024027 235 VESPEQRINAKEIVTKLLKI 254 (273)
Q Consensus 235 ~~dp~~Rps~~~~l~~l~~~ 254 (273)
..||.+|||+.+|++.+.++
T Consensus 246 ~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 246 NPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CCCcccCCCHHHHHHHHhhh
Confidence 99999999999999988875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=265.97 Aligned_cols=228 Identities=23% Similarity=0.290 Sum_probs=177.4
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC-CCCCHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~ 76 (273)
+.||+|++.... ......+..|+++++.++||||+++++++..+...++||||++|++|.+++.... ..+++..+.
T Consensus 19 ~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~ 98 (277)
T cd05607 19 KMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVI 98 (277)
T ss_pred cEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHH
Confidence 368999986432 1223456679999999999999999999999999999999999999998885433 358889999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcC
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVS 156 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 156 (273)
.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++...... .......++..|+|||.+.+..++
T Consensus 99 ~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~ 172 (277)
T cd05607 99 HYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTITQRAGTNGYMAPEILKEEPYS 172 (277)
T ss_pred HHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC---ceeeccCCCCCccCHHHHccCCCC
Confidence 99999999999999 999999999999999999999999999998765321 122334688899999999888899
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++|+||+||++|+|++|..||......... ...... ....... .....++.++.+|+.+||..
T Consensus 173 ~~~DvwslGv~l~el~~g~~p~~~~~~~~~~-~~~~~~------------~~~~~~~---~~~~~~~~~~~~li~~~L~~ 236 (277)
T cd05607 173 YPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK-EELKRR------------TLEDEVK---FEHQNFTEESKDICRLFLAK 236 (277)
T ss_pred CchhHHHHHHHHHHHHhCCCCCCCCcchhhH-HHHHHH------------hhccccc---cccccCCHHHHHHHHHHhcc
Confidence 9999999999999999999998753322110 000000 0000000 00124567799999999999
Q ss_pred CccCCCCHHHHHHH
Q 024027 237 SPEQRINAKEIVTK 250 (273)
Q Consensus 237 dp~~Rps~~~~l~~ 250 (273)
||.+||++.++++.
T Consensus 237 ~P~~R~~~~~~~~~ 250 (277)
T cd05607 237 KPEDRLGSREKNDD 250 (277)
T ss_pred CHhhCCCCccchhh
Confidence 99999999665533
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=280.50 Aligned_cols=229 Identities=22% Similarity=0.304 Sum_probs=181.1
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||||+++... ......+.+|+.+++.++||||+++++++.++...++||||+++|+|.+++...+ .+++..+..
T Consensus 27 ~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~l~~~~~~~ 105 (364)
T cd05599 27 HIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKD-TFTEEETRF 105 (364)
T ss_pred CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHcC-CCCHHHHHH
Confidence 469999997542 3345668889999999999999999999999999999999999999999996544 689999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcc------------------------
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSM------------------------ 133 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~------------------------ 133 (273)
++.|++.||.||| +.|++||||||+||+++.++.++|+|||++..+.......
T Consensus 106 ~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (364)
T cd05599 106 YIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182 (364)
T ss_pred HHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccccccccccccccccccccccccc
Confidence 9999999999999 9999999999999999999999999999986542211100
Q ss_pred ------------eeecccccCCCCCCcccCCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccch
Q 024027 134 ------------TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTM 201 (273)
Q Consensus 134 ------------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 201 (273)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||........ .......
T Consensus 183 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~-~~~i~~~------- 254 (364)
T cd05599 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQET-YRKIINW------- 254 (364)
T ss_pred ccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHH-HHHHHcC-------
Confidence 01123589999999999888899999999999999999999999975432211 1111000
Q ss_pred hhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccCCCC---HHHHHHHH
Q 024027 202 EVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRIN---AKEIVTKL 251 (273)
Q Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~~l~~l 251 (273)
...........++.++.+|+.+|+. +|.+|++ +.++++|-
T Consensus 255 ---------~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~ 297 (364)
T cd05599 255 ---------KETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHP 297 (364)
T ss_pred ---------CCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCC
Confidence 0000001112356779999999997 9999998 99999874
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=266.01 Aligned_cols=229 Identities=25% Similarity=0.343 Sum_probs=180.3
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
+.||+|+++.........+.+|+.+++.++||||+++++++..+...++|+||+++++|.+++... ..+++..+..++.
T Consensus 35 ~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ 113 (267)
T cd06646 35 ELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVT-GPLSELQIAYVCR 113 (267)
T ss_pred eEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHH
Confidence 368999997665555667889999999999999999999999999999999999999999998654 3689999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccC---CCCcCC
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR---EGRVST 157 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~ 157 (273)
|++.|+.||| +.|++|+|++|+||+++.++.++|+|||++..+.... .......++..|+|||.+. ...++.
T Consensus 114 qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~ 188 (267)
T cd06646 114 ETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI--AKRKSFIGTPYWMAPEVAAVEKNGGYNQ 188 (267)
T ss_pred HHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeecccc--cccCccccCccccCHhHcccccCCCCcc
Confidence 9999999999 9999999999999999999999999999987653211 1122345788899999874 344788
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
++|+||+|+++++|++|..||................... . ........+..+.+++.+||..|
T Consensus 189 ~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------------~--~~~~~~~~~~~~~~li~~~l~~~ 252 (267)
T cd06646 189 LCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQP--------------P--KLKDKTKWSSTFHNFVKISLTKN 252 (267)
T ss_pred hhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCC--------------C--CCccccccCHHHHHHHHHHhhCC
Confidence 9999999999999999999986432221110000000000 0 00002234567999999999999
Q ss_pred ccCCCCHHHHHHHH
Q 024027 238 PEQRINAKEIVTKL 251 (273)
Q Consensus 238 p~~Rps~~~~l~~l 251 (273)
|++|||++++++++
T Consensus 253 P~~Rp~~~~il~~l 266 (267)
T cd06646 253 PKKRPTAERLLTHL 266 (267)
T ss_pred hhhCcCHHHHhcCC
Confidence 99999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=280.06 Aligned_cols=230 Identities=26% Similarity=0.355 Sum_probs=184.8
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||||+++... ......+..|++++..++|+||+++++++.++...++||||+++++|.+++... ..+++..++.
T Consensus 27 ~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~ 105 (350)
T cd05573 27 QVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK-DVFPEETARF 105 (350)
T ss_pred CEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHH
Confidence 479999997542 245567889999999999999999999999999999999999999999999765 4689999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCC---------------------------
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED--------------------------- 130 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~--------------------------- 130 (273)
++.|++.||.||| +.|++||||||+||+++.++.++|+|||++.......
T Consensus 106 i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (350)
T cd05573 106 YIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQ 182 (350)
T ss_pred HHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccccccccccccccccccccccccc
Confidence 9999999999999 9999999999999999999999999999987653322
Q ss_pred CcceeecccccCCCCCCcccCCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccc
Q 024027 131 QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLS 210 (273)
Q Consensus 131 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (273)
.........|++.|+|||.+.+..++.++|||||||++|+|++|..||........ .......
T Consensus 183 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~-~~~i~~~---------------- 245 (350)
T cd05573 183 RRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET-YNKIINW---------------- 245 (350)
T ss_pred ccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHH-HHHHhcc----------------
Confidence 00112344689999999999998999999999999999999999999976432211 1111000
Q ss_pred cchhhhhhhhhhHHHHHHHHhhcCCCCccCCCC-HHHHHHHHH
Q 024027 211 QEDIHFVAKEQCVSFVFNLAMACTVESPEQRIN-AKEIVTKLL 252 (273)
Q Consensus 211 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~~~l~~l~ 252 (273)
......+....++.++.+|+.+||. ||.+||+ ++++++|-.
T Consensus 246 ~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~ 287 (350)
T cd05573 246 KESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPF 287 (350)
T ss_pred CCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCC
Confidence 0000111112257779999999997 9999999 999999843
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=270.06 Aligned_cols=239 Identities=28% Similarity=0.407 Sum_probs=187.1
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC------------
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN------------ 67 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------ 67 (273)
.||+|+++... ......+..|+++++.+ +||||+++++++.+.+..+++|||+++|+|.+++....
T Consensus 46 ~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~ 125 (314)
T cd05099 46 TVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITK 125 (314)
T ss_pred EEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccC
Confidence 48999987542 34566788999999999 69999999999999999999999999999999996532
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCC
Q 024027 68 ---CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGY 144 (273)
Q Consensus 68 ---~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~ 144 (273)
..+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||.+................++..|
T Consensus 126 ~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y 202 (314)
T cd05099 126 VPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKW 202 (314)
T ss_pred CcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccc
Confidence 34788899999999999999999 999999999999999999999999999999755322111111122234579
Q ss_pred CCCcccCCCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhH
Q 024027 145 MAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCV 223 (273)
Q Consensus 145 ~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (273)
+|||.+.+..++.++|+||||+++|++++ |..||......+ ....... . .....+..++
T Consensus 203 ~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~-~~~~~~~-------------~------~~~~~~~~~~ 262 (314)
T cd05099 203 MAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE-LFKLLRE-------------G------HRMDKPSNCT 262 (314)
T ss_pred cCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHc-------------C------CCCCCCCCCC
Confidence 99999988889999999999999999998 888885432111 1111000 0 0001134556
Q ss_pred HHHHHHHhhcCCCCccCCCCHHHHHHHHHHHHHhhhhhcc
Q 024027 224 SFVFNLAMACTVESPEQRINAKEIVTKLLKIRDSLLRNVG 263 (273)
Q Consensus 224 ~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~~~ 263 (273)
.++.+++.+||..||++|||+.++++.|+++......+..
T Consensus 263 ~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~~~~ 302 (314)
T cd05099 263 HELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEEYL 302 (314)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcCCce
Confidence 7799999999999999999999999999999876554443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=270.84 Aligned_cols=245 Identities=20% Similarity=0.242 Sum_probs=183.1
Q ss_pred CeEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 1 MEVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 1 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
+.||||.++... ......+.+|+++++.++||||+++++++..+...++||||+++ +|.+++...+..+++..+..++
T Consensus 32 ~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~ 110 (309)
T cd07872 32 NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFL 110 (309)
T ss_pred CeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHH
Confidence 369999997543 23345677899999999999999999999999999999999976 9999887666678999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC-CCcCCc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE-GRVSTN 158 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~ 158 (273)
.|++.||.||| +.|++||||||+||+++.++.++|+|||++....... .......+++.|+|||.+.+ ..++.+
T Consensus 111 ~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~ 185 (309)
T cd07872 111 YQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT--KTYSNEVVTLWYRPPDVLLGSSEYSTQ 185 (309)
T ss_pred HHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCc--cccccccccccccCCHHHhCCCCCCcH
Confidence 99999999999 9999999999999999999999999999987542221 11223457889999998765 458899
Q ss_pred chhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCc--cchhhhh-------hhcccc-chhhhhhhhhhHHHHHH
Q 024027 159 GDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPI--STMEVVD-------ANLLSQ-EDIHFVAKEQCVSFVFN 228 (273)
Q Consensus 159 ~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~-------~~~~~~-~~~~~~~~~~~~~~l~~ 228 (273)
+||||+||++|+|++|..||......+. ........... ....... ...... ..........++.++.+
T Consensus 186 ~DiwslG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (309)
T cd07872 186 IDMWGVGCIFFEMASGRPLFPGSTVEDE-LHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIE 264 (309)
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHH
Confidence 9999999999999999999976443222 11111111000 0000000 000000 00001112346778999
Q ss_pred HHhhcCCCCccCCCCHHHHHHHHH
Q 024027 229 LAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 229 li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
|+.+||..||.+|||+.++++|-+
T Consensus 265 li~~~L~~dp~~R~t~~e~l~h~~ 288 (309)
T cd07872 265 LLTKFLQYESKKRISAEEAMKHAY 288 (309)
T ss_pred HHHHhccCChhhCCCHHHHhcChh
Confidence 999999999999999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=263.24 Aligned_cols=228 Identities=24% Similarity=0.372 Sum_probs=181.4
Q ss_pred eEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 2 EVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 2 ~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
.||+|+++... ....+.+..|+.+++.++||||+++++++.. ...++||||+++++|.+++.... .+++..+..++
T Consensus 24 ~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~ 101 (257)
T cd05116 24 TVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELGPLNKFLQKNK-HVTEKNITELV 101 (257)
T ss_pred EEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHH
Confidence 68999987553 2345678999999999999999999998864 46789999999999999996543 68999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcce-eecccccCCCCCCcccCCCCcCCc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMT-QTQTLATIGYMAPEYGREGRVSTN 158 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~ 158 (273)
.|++.|+.+|| +.|++|+||+|+||+++.++.++|+|||.+..+........ .....++..|+|||.+....++.+
T Consensus 102 ~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 178 (257)
T cd05116 102 HQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSK 178 (257)
T ss_pred HHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCch
Confidence 99999999999 99999999999999999999999999999876543322111 112233568999999988889999
Q ss_pred chhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 159 GDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 159 ~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
+|+||||+++|++++ |..||....... ..... .. .. ....+..++.++.+++.+||..|
T Consensus 179 ~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~i-~~------------~~------~~~~~~~~~~~l~~li~~~~~~~ 238 (257)
T cd05116 179 SDVWSFGVLMWEAFSYGQKPYKGMKGNE-VTQMI-ES------------GE------RMECPQRCPPEMYDLMKLCWTYG 238 (257)
T ss_pred hHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHH-HC------------CC------CCCCCCCCCHHHHHHHHHHhccC
Confidence 999999999999998 999987543221 11111 00 00 01123456778999999999999
Q ss_pred ccCCCCHHHHHHHHHHH
Q 024027 238 PEQRINAKEIVTKLLKI 254 (273)
Q Consensus 238 p~~Rps~~~~l~~l~~~ 254 (273)
|++||++++|.+.|+++
T Consensus 239 p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 239 VDERPGFAVVELRLRNY 255 (257)
T ss_pred chhCcCHHHHHHHHhcc
Confidence 99999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=273.27 Aligned_cols=223 Identities=21% Similarity=0.248 Sum_probs=178.4
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCC-ccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRH-RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (273)
+.||||+++... ....+.+..|.+++..+.| ++|+++++++.....+++||||+++|+|.+++.... .+++..+.
T Consensus 26 ~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~-~~~~~~~~ 104 (324)
T cd05587 26 ELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-KFKEPHAV 104 (324)
T ss_pred CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC-CCCHHHHH
Confidence 369999997542 3455678889999999965 568889999999999999999999999999986543 58899999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcC
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVS 156 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 156 (273)
.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++....... .......|++.|+|||++.+..++
T Consensus 105 ~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~ 179 (324)
T cd05587 105 FYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG--KTTRTFCGTPDYIAPEIIAYQPYG 179 (324)
T ss_pred HHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC--CceeeecCCccccChhhhcCCCCC
Confidence 99999999999999 9999999999999999999999999999986432111 123345689999999999988899
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++|+||+||++|+|++|+.||......+. ....... ....+..++.++.+++.+||..
T Consensus 180 ~~~DiwslGvil~elltG~~pf~~~~~~~~-~~~i~~~--------------------~~~~~~~~~~~~~~li~~~l~~ 238 (324)
T cd05587 180 KSVDWWAFGVLLYEMLAGQPPFDGEDEDEL-FQSIMEH--------------------NVSYPKSLSKEAVSICKGLLTK 238 (324)
T ss_pred cccchhhhHHHHHHHHhCCCCCCCCCHHHH-HHHHHcC--------------------CCCCCCCCCHHHHHHHHHHhhc
Confidence 999999999999999999999965332111 1110000 0011334567799999999999
Q ss_pred CccCCCCH-----HHHHHH
Q 024027 237 SPEQRINA-----KEIVTK 250 (273)
Q Consensus 237 dp~~Rps~-----~~~l~~ 250 (273)
||.+|++. +++++|
T Consensus 239 ~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 239 HPAKRLGCGPTGERDIREH 257 (324)
T ss_pred CHHHcCCCCCCCHHHHhcC
Confidence 99999986 677776
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=267.52 Aligned_cols=241 Identities=23% Similarity=0.277 Sum_probs=176.6
Q ss_pred eEEEEEeeccc--ChhhhhHHHHHHHHhcC---CCccceeeeeeee-----cCCceeEEEeccCCCCHHHhhhcC-CCCC
Q 024027 2 EVAVKVFNLQC--GRAFKSFDVECEMMKSI---RHRNLIKVISSCS-----NEEFKALVLEYMPHGSLEKYLYSS-NCIL 70 (273)
Q Consensus 2 ~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~-~~~~ 70 (273)
.||||+++... ......+.+|+.+++.+ +||||+++++++. ....+++||||+++ +|.+++... ...+
T Consensus 29 ~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~ 107 (290)
T cd07862 29 FVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGV 107 (290)
T ss_pred EEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCCC-CHHHHHHhCCCCCC
Confidence 58999987543 22234566788777766 6999999999875 34568999999975 999998653 3458
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCccc
Q 024027 71 DIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYG 150 (273)
Q Consensus 71 ~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 150 (273)
++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++...... .......+++.|+|||.+
T Consensus 108 ~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~ 181 (290)
T cd07862 108 PTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVL 181 (290)
T ss_pred CHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccceEeccCC---cccccccccccccChHHH
Confidence 99999999999999999999 999999999999999999999999999998765322 122345688999999999
Q ss_pred CCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhh------hhccc-cchhhhhhhhhhH
Q 024027 151 REGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVD------ANLLS-QEDIHFVAKEQCV 223 (273)
Q Consensus 151 ~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~-~~~~~~~~~~~~~ 223 (273)
.+..++.++|||||||++|+|++|.+||......+ ................... ..... .........+.++
T Consensus 182 ~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (290)
T cd07862 182 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDID 260 (290)
T ss_pred hCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCC
Confidence 88889999999999999999999999997643322 1222221111000000000 00000 0000111123467
Q ss_pred HHHHHHHhhcCCCCccCCCCHHHHHHH
Q 024027 224 SFVFNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 224 ~~l~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
..+.+|+.+||..||++|||+.++++|
T Consensus 261 ~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 261 ELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred HHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 778999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=268.49 Aligned_cols=229 Identities=25% Similarity=0.451 Sum_probs=182.0
Q ss_pred eEEEEEeecccC-hhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcC--------------
Q 024027 2 EVAVKVFNLQCG-RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-------------- 66 (273)
Q Consensus 2 ~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------------- 66 (273)
+||||+++.... ...+.+.+|+.+++.++||||+++++++......++++||+++++|.+++...
T Consensus 37 ~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~ 116 (283)
T cd05091 37 AVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKT 116 (283)
T ss_pred EEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccc
Confidence 699999975533 23466889999999999999999999999999999999999999999998421
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCC
Q 024027 67 -NCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYM 145 (273)
Q Consensus 67 -~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (273)
...+++..+..++.|++.||.||| +.|++|+||||+||+++.++.+||+|||++................+++.|+
T Consensus 117 ~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~ 193 (283)
T cd05091 117 VKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWM 193 (283)
T ss_pred cccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCceEecccccccccccchheeeccCccCCcccc
Confidence 124788889999999999999999 9999999999999999999999999999987553222212222334567899
Q ss_pred CCcccCCCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHH
Q 024027 146 APEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVS 224 (273)
Q Consensus 146 aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (273)
|||.+.+..++.++|+|||||++|+|++ |..||......+. ..... ... ....+..++.
T Consensus 194 aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-~~~i~----~~~---------------~~~~~~~~~~ 253 (283)
T cd05091 194 SPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV-IEMIR----NRQ---------------VLPCPDDCPA 253 (283)
T ss_pred CHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHH----cCC---------------cCCCCCCCCH
Confidence 9999988889999999999999999998 8888765322111 11000 000 0111445778
Q ss_pred HHHHHHhhcCCCCccCCCCHHHHHHHHHH
Q 024027 225 FVFNLAMACTVESPEQRINAKEIVTKLLK 253 (273)
Q Consensus 225 ~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 253 (273)
++.+|+.+||+.+|.+||++++++..|+.
T Consensus 254 ~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 254 WVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 89999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=264.40 Aligned_cols=228 Identities=26% Similarity=0.435 Sum_probs=183.1
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcC-CCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~ 80 (273)
.||+|.++.. ....+.+.+|+.+++.++|+||+++++++.+....++++||+++++|.+++... ...+++..+..++.
T Consensus 32 ~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 110 (261)
T cd05072 32 KVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA 110 (261)
T ss_pred eEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHH
Confidence 6899988654 334578899999999999999999999999999999999999999999999653 34588899999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
|++.||+||| +.+++|+||+|+||+++.++.++|+|||++........ .......++..|+|||.+.+..++.++|
T Consensus 111 ~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~D 186 (261)
T cd05072 111 QIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSD 186 (261)
T ss_pred HHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCce-eccCCCccceecCCHHHhccCCCChhhh
Confidence 9999999999 99999999999999999999999999999976532211 1112233566799999998888999999
Q ss_pred hHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCcc
Q 024027 161 VYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239 (273)
Q Consensus 161 iwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 239 (273)
+||||+++|+|++ |..||........ ....... ...+....++.++.+++.+||..+|+
T Consensus 187 i~slG~~l~~l~t~g~~p~~~~~~~~~-~~~~~~~-------------------~~~~~~~~~~~~~~~li~~~l~~~p~ 246 (261)
T cd05072 187 VWSFGILLYEIVTYGKIPYPGMSNSDV-MSALQRG-------------------YRMPRMENCPDELYDIMKTCWKEKAE 246 (261)
T ss_pred hhhhHHHHHHHHccCCCCCCCCCHHHH-HHHHHcC-------------------CCCCCCCCCCHHHHHHHHHHccCCcc
Confidence 9999999999998 9999865332211 1111000 00111234567799999999999999
Q ss_pred CCCCHHHHHHHHHHH
Q 024027 240 QRINAKEIVTKLLKI 254 (273)
Q Consensus 240 ~Rps~~~~l~~l~~~ 254 (273)
+|||++++.+.|+++
T Consensus 247 ~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 247 ERPTFDYLQSVLDDF 261 (261)
T ss_pred cCcCHHHHHHHHhcC
Confidence 999999999998753
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=266.52 Aligned_cols=245 Identities=26% Similarity=0.378 Sum_probs=183.4
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeec--CCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSN--EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
.||||+++.......+.+.+|+++++.++||||+++++++.. ....++|+||+++++|.+++......+++..++.++
T Consensus 35 ~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~ 114 (284)
T cd05081 35 VVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYA 114 (284)
T ss_pred EEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHH
Confidence 689999987666667789999999999999999999998643 346889999999999999997666678999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCccee-ecccccCCCCCCcccCCCCcCCc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQ-TQTLATIGYMAPEYGREGRVSTN 158 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~ 158 (273)
.|++.||.||| +.|++|+||||+||+++.++.++|+|||++............ ....++..|+|||.+.+..++.+
T Consensus 115 ~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 191 (284)
T cd05081 115 SQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVA 191 (284)
T ss_pred HHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChH
Confidence 99999999999 999999999999999999999999999999865332221111 11123445999999988889999
Q ss_pred chhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccC-ccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 159 GDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLP-ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 159 ~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
+|+||||++++++++|..|+...... .......... ........... ........+..++.++.+|+.+||..+
T Consensus 192 ~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~cl~~~ 266 (284)
T cd05081 192 SDVWSFGVVLYELFTYSDKSCSPPAE---FMRMMGNDKQGQMIVYHLIELL--KNNGRLPAPPGCPAEIYAIMKECWNND 266 (284)
T ss_pred HHHHHHHHHHHHHhhcCCcCCCcchh---hhhhcccccccccchHHHHHHH--hcCCcCCCCCCCCHHHHHHHHHHccCC
Confidence 99999999999999987765432110 0000000000 00000000000 000111123456778999999999999
Q ss_pred ccCCCCHHHHHHHHHHH
Q 024027 238 PEQRINAKEIVTKLLKI 254 (273)
Q Consensus 238 p~~Rps~~~~l~~l~~~ 254 (273)
|++|||+.++++.|+++
T Consensus 267 p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 267 PSQRPSFSELALQVEAI 283 (284)
T ss_pred hhhCCCHHHHHHHHHhc
Confidence 99999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=266.52 Aligned_cols=228 Identities=27% Similarity=0.419 Sum_probs=179.2
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC------CCCCHHH
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN------CILDIFQ 74 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~ 74 (273)
.||+|.+.... ......+..|+.+++.++|+||+++++++.+....++||||+++++|.+++...+ ..+++..
T Consensus 38 ~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~ 117 (277)
T cd05036 38 QVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKD 117 (277)
T ss_pred eEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHH
Confidence 58899886443 3344678999999999999999999999999999999999999999999986543 2488899
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCC---ceEEeecccccccccCCCcceeecccccCCCCCCcccC
Q 024027 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNL---VAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR 151 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~---~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 151 (273)
++.++.|++.|+.||| +.+++|+||+|+||+++.++ .++|+|||++.................+..|+|||.+.
T Consensus 118 ~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 194 (277)
T cd05036 118 LLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFL 194 (277)
T ss_pred HHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHh
Confidence 9999999999999999 99999999999999998654 68999999987652221111111223356799999998
Q ss_pred CCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHH
Q 024027 152 EGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLA 230 (273)
Q Consensus 152 ~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 230 (273)
+..++.++|||||||++|+|++ |..||........ . ...... .....+..++..+.+++
T Consensus 195 ~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~-~-~~~~~~------------------~~~~~~~~~~~~~~~~i 254 (277)
T cd05036 195 DGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV-M-EFVTGG------------------GRLDPPKGCPGPVYRIM 254 (277)
T ss_pred cCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-H-HHHHcC------------------CcCCCCCCCCHHHHHHH
Confidence 8889999999999999999997 9999875332211 1 110000 00011344567799999
Q ss_pred hhcCCCCccCCCCHHHHHHHHH
Q 024027 231 MACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 231 ~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
.+||..+|++|||+.+++++|+
T Consensus 255 ~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 255 TDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHcCCCcccCcCHHHHHHHhh
Confidence 9999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=264.80 Aligned_cols=232 Identities=23% Similarity=0.373 Sum_probs=183.5
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
+||+|.+.... .....++..|+.++..++||||+++++++.. ...++++||+++|+|.+++......+++..+..++.
T Consensus 38 ~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~ 116 (279)
T cd05111 38 PVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCV 116 (279)
T ss_pred EEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHH
Confidence 47888886443 2345678888989999999999999998764 457799999999999999987666799999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
|++.||.||| +.|++|+||||+||+++.++.++|+|||.+................++..|+|||.+.+..++.++|
T Consensus 117 qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~D 193 (279)
T cd05111 117 QIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSD 193 (279)
T ss_pred HHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhh
Confidence 9999999999 9999999999999999999999999999997653332222223345667899999998888999999
Q ss_pred hHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCcc
Q 024027 161 VYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239 (273)
Q Consensus 161 iwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 239 (273)
+||||+++|++++ |..||....... ......... ....+..++..+.+++.+||..||+
T Consensus 194 v~slG~il~el~t~g~~p~~~~~~~~--~~~~~~~~~------------------~~~~~~~~~~~~~~li~~c~~~~p~ 253 (279)
T cd05111 194 VWSYGVTVWEMMSYGAEPYAGMRPHE--VPDLLEKGE------------------RLAQPQICTIDVYMVMVKCWMIDEN 253 (279)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHCCC------------------cCCCCCCCCHHHHHHHHHHcCCCcc
Confidence 9999999999998 999986532211 111111000 0001223456688999999999999
Q ss_pred CCCCHHHHHHHHHHHHHh
Q 024027 240 QRINAKEIVTKLLKIRDS 257 (273)
Q Consensus 240 ~Rps~~~~l~~l~~~~~~ 257 (273)
+|||+.++++.|..+.++
T Consensus 254 ~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 254 VRPTFKELANEFTRMARD 271 (279)
T ss_pred cCcCHHHHHHHHHHHHhC
Confidence 999999999999887654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=279.21 Aligned_cols=231 Identities=21% Similarity=0.281 Sum_probs=179.7
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||||+++... ......+..|+++++.++||||+++++++.++..+++||||+++|+|.+++.+.. .+++..+..
T Consensus 27 ~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~e~~~~~ 105 (381)
T cd05626 27 ALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRME-VFPEVLARF 105 (381)
T ss_pred CEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhcC-CCCHHHHHH
Confidence 369999997542 3345678899999999999999999999999999999999999999999996544 588999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCC--------------------------
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQ-------------------------- 131 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~-------------------------- 131 (273)
++.|++.||.||| ..|++||||||+||+++.++.++|+|||++..+.....
T Consensus 106 ~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (381)
T cd05626 106 YIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182 (381)
T ss_pred HHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccc
Confidence 9999999999999 99999999999999999999999999998753311000
Q ss_pred -------------------cceeecccccCCCCCCcccCCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhh
Q 024027 132 -------------------SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWV 192 (273)
Q Consensus 132 -------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~ 192 (273)
.......+||+.|+|||.+.+..++.++|||||||++|+|++|..||........... ..
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~-i~ 261 (381)
T cd05626 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLK-VI 261 (381)
T ss_pred cccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHH-HH
Confidence 0001234689999999999888899999999999999999999999976432221111 00
Q ss_pred hhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcC--CCCccCCCCHHHHHHHHH
Q 024027 193 NDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACT--VESPEQRINAKEIVTKLL 252 (273)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l--~~dp~~Rps~~~~l~~l~ 252 (273)
.. ......+....++.++.+|+.+|+ ..+|..||+++++++|-.
T Consensus 262 ~~----------------~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~ 307 (381)
T cd05626 262 NW----------------ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPF 307 (381)
T ss_pred cc----------------ccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcc
Confidence 00 000011112346678999999955 455666999999999843
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=267.67 Aligned_cols=232 Identities=25% Similarity=0.428 Sum_probs=184.3
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcC--------------
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-------------- 66 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------------- 66 (273)
.||+|.++... ......+.+|+++++.++||||+++++.+..++..++++||+++++|.+++...
T Consensus 32 ~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 111 (290)
T cd05045 32 TVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNR 111 (290)
T ss_pred eEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCcccccccccccc
Confidence 48888887543 234567889999999999999999999999999999999999999999998532
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeec
Q 024027 67 ---------NCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQ 137 (273)
Q Consensus 67 ---------~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~ 137 (273)
...+++..++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++..............
T Consensus 112 ~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 188 (290)
T cd05045 112 NSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSK 188 (290)
T ss_pred ccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccC
Confidence 124788899999999999999999 99999999999999999999999999999876533222112223
Q ss_pred ccccCCCCCCcccCCCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhh
Q 024027 138 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHF 216 (273)
Q Consensus 138 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (273)
..++..|+|||.+.+..++.++||||||+++++|++ |..||....... ..... ... ...
T Consensus 189 ~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~------------~~~------~~~ 248 (290)
T cd05045 189 GRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER--LFNLL------------KTG------YRM 248 (290)
T ss_pred CCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHH------------hCC------CCC
Confidence 345678999999888889999999999999999998 999986532211 11100 000 011
Q ss_pred hhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHHHHHH
Q 024027 217 VAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLLKIRD 256 (273)
Q Consensus 217 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 256 (273)
..+..++.++.+++.+||..+|++||++.++++.|+++..
T Consensus 249 ~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 249 ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 1134456779999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=263.55 Aligned_cols=228 Identities=25% Similarity=0.320 Sum_probs=182.1
Q ss_pred CeEEEEEeecccC-----hhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHH
Q 024027 1 MEVAVKVFNLQCG-----RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQR 75 (273)
Q Consensus 1 ~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (273)
++||+|.+..... .....+.+|+++++.++||||+++++++.++...++++||+++++|.+++.... .+++..+
T Consensus 28 ~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~ 106 (263)
T cd06625 28 RELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG-ALTETVT 106 (263)
T ss_pred cEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHhC-CCCHHHH
Confidence 4789999875421 234568889999999999999999999999999999999999999999986543 5889999
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcce-eecccccCCCCCCcccCCCC
Q 024027 76 LNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMT-QTQTLATIGYMAPEYGREGR 154 (273)
Q Consensus 76 ~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~ 154 (273)
..++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||++........... .....++..|+|||.+.+..
T Consensus 107 ~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 183 (263)
T cd06625 107 RKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG 183 (263)
T ss_pred HHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCC
Confidence 999999999999999 99999999999999999999999999999875532211111 12345678899999999888
Q ss_pred cCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcC
Q 024027 155 VSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACT 234 (273)
Q Consensus 155 ~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 234 (273)
++.++|+||+|+++|++++|..||........... .. ........+..++.++.+++.+||
T Consensus 184 ~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-~~------------------~~~~~~~~~~~~~~~~~~li~~~l 244 (263)
T cd06625 184 YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFK-IA------------------TQPTNPQLPSHVSPDARNFLRRTF 244 (263)
T ss_pred CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHH-Hh------------------ccCCCCCCCccCCHHHHHHHHHHh
Confidence 99999999999999999999999865322111100 00 000111123456777999999999
Q ss_pred CCCccCCCCHHHHHHHH
Q 024027 235 VESPEQRINAKEIVTKL 251 (273)
Q Consensus 235 ~~dp~~Rps~~~~l~~l 251 (273)
..+|.+|||+.+++++.
T Consensus 245 ~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 245 VENAKKRPSAEELLRHF 261 (263)
T ss_pred hcCcccCCCHHHHhhCC
Confidence 99999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=268.85 Aligned_cols=233 Identities=27% Similarity=0.417 Sum_probs=185.3
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC------------
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN------------ 67 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------ 67 (273)
.||+|+++... ......+.+|+.+++.+ +||||+++++++...+..+++|||+++++|.+++....
T Consensus 49 ~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 128 (304)
T cd05101 49 TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIAR 128 (304)
T ss_pred eEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCccccccccccc
Confidence 58999987542 34567899999999999 89999999999999999999999999999999996532
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCC
Q 024027 68 ---CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGY 144 (273)
Q Consensus 68 ---~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~ 144 (273)
..+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||.+..+.............++..|
T Consensus 129 ~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y 205 (304)
T cd05101 129 VPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKW 205 (304)
T ss_pred CCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCcee
Confidence 24677889999999999999999 999999999999999999999999999999766333222222233456779
Q ss_pred CCCcccCCCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhH
Q 024027 145 MAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCV 223 (273)
Q Consensus 145 ~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (273)
+|||.+.+..++.++||||||+++|++++ |..||......+ ...... .. .....+..++
T Consensus 206 ~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----~~~~~~---------~~------~~~~~~~~~~ 265 (304)
T cd05101 206 MAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-----LFKLLK---------EG------HRMDKPANCT 265 (304)
T ss_pred eCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-----HHHHHH---------cC------CcCCCCCCCC
Confidence 99999988889999999999999999998 778875432111 111000 00 0001133566
Q ss_pred HHHHHHHhhcCCCCccCCCCHHHHHHHHHHHHHh
Q 024027 224 SFVFNLAMACTVESPEQRINAKEIVTKLLKIRDS 257 (273)
Q Consensus 224 ~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~ 257 (273)
.++.+|+.+||..+|.+|||+.++++.|.++..-
T Consensus 266 ~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 266 NELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 7799999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=274.62 Aligned_cols=223 Identities=29% Similarity=0.325 Sum_probs=175.2
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHH-HHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECE-MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (273)
+.||||++.... ......+..|.. +++.++||||+++++++.+....++||||+++|+|..++... ..+++..+.
T Consensus 21 ~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~ 99 (323)
T cd05575 21 KFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRE-RSFPEPRAR 99 (323)
T ss_pred CEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhc-CCCCHHHHH
Confidence 469999997542 223344555544 567789999999999999999999999999999999998654 368999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcC
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVS 156 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 156 (273)
.++.|++.||.||| +.|++||||||+||+++.++.++|+|||++...... ........|++.|+|||.+.+..++
T Consensus 100 ~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~ 174 (323)
T cd05575 100 FYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKTTSTFCGTPEYLAPEVLRKQPYD 174 (323)
T ss_pred HHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCccccccCChhhcChhhhcCCCCC
Confidence 99999999999999 999999999999999999999999999998643211 1223345689999999999988899
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++|||||||++|+|++|..||......+. ....... . ...+...+.++.+++.+||..
T Consensus 175 ~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~----------------~----~~~~~~~~~~~~~li~~~l~~ 233 (323)
T cd05575 175 RTVDWWCLGAVLYEMLYGLPPFYSRDTAEM-YDNILNK----------------P----LRLKPNISVSARHLLEGLLQK 233 (323)
T ss_pred ccccccccchhhhhhhcCCCCCCCCCHHHH-HHHHHcC----------------C----CCCCCCCCHHHHHHHHHHhhc
Confidence 999999999999999999999875322111 0000000 0 011234567799999999999
Q ss_pred CccCCCCHH----HHHHH
Q 024027 237 SPEQRINAK----EIVTK 250 (273)
Q Consensus 237 dp~~Rps~~----~~l~~ 250 (273)
||.+||++. ++++|
T Consensus 234 ~p~~R~~~~~~~~~il~~ 251 (323)
T cd05575 234 DRTKRLGAKDDFLEIKNH 251 (323)
T ss_pred CHHhCCCCCCCHHHHHcC
Confidence 999999984 66654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=263.95 Aligned_cols=228 Identities=23% Similarity=0.323 Sum_probs=180.3
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
++||+|+++.........+.+|+.+++.++||||+++++++......++++||+++++|.+++...+ .+++..++.++.
T Consensus 35 ~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ 113 (267)
T cd06645 35 ELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG-PLSESQIAYVSR 113 (267)
T ss_pred cEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcC-CCCHHHHHHHHH
Confidence 4799999986655556678899999999999999999999999999999999999999999986544 689999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccC---CCCcCC
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR---EGRVST 157 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~ 157 (273)
|++.|+.||| +.|++|+||+|+||+++.++.++|+|||++...... ........++..|+|||.+. ...++.
T Consensus 114 ~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 188 (267)
T cd06645 114 ETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT--IAKRKSFIGTPYWMAPEVAAVERKGGYNQ 188 (267)
T ss_pred HHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc--ccccccccCcccccChhhhccccCCCCCc
Confidence 9999999999 999999999999999999999999999998755321 11223456888999999874 345788
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
++|+||+||++|+|++|..||.................... .......++..+.+++.+||..|
T Consensus 189 ~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~li~~~l~~~ 252 (267)
T cd06645 189 LCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP----------------KLKDKMKWSNSFHHFVKMALTKN 252 (267)
T ss_pred hhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCC----------------cccccCCCCHHHHHHHHHHccCC
Confidence 99999999999999999999865332211111000000000 00001134556899999999999
Q ss_pred ccCCCCHHHHHHH
Q 024027 238 PEQRINAKEIVTK 250 (273)
Q Consensus 238 p~~Rps~~~~l~~ 250 (273)
|++|||++++++|
T Consensus 253 P~~R~~~~~ll~~ 265 (267)
T cd06645 253 PKKRPTAEKLLQH 265 (267)
T ss_pred chhCcCHHHHhcC
Confidence 9999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=261.05 Aligned_cols=229 Identities=31% Similarity=0.465 Sum_probs=183.3
Q ss_pred CeEEEEEeecccCh-hhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 1 ~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
+.||+|+++..... ....+..|++++++++|+||+++++++.+....++|+||+++++|.+++......++...+..++
T Consensus 20 ~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~ 99 (251)
T cd05041 20 TEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMS 99 (251)
T ss_pred CcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHH
Confidence 46899998765433 56789999999999999999999999999999999999999999999997665578899999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 159 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 159 (273)
.+++.|+.||| +++++|+||+|+||+++.++.++|+|||.+.................+..|+|||.+.+..++.++
T Consensus 100 ~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~ 176 (251)
T cd05041 100 LDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSES 176 (251)
T ss_pred HHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcch
Confidence 99999999999 999999999999999999999999999998754211111111122335669999999888899999
Q ss_pred hhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc
Q 024027 160 DVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238 (273)
Q Consensus 160 DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 238 (273)
|+||||++++++++ |..||.......... .... . .....+..++.++.+++.+||..+|
T Consensus 177 Di~slG~i~~~l~t~~~~p~~~~~~~~~~~--~~~~------------~------~~~~~~~~~~~~~~~li~~~l~~~p 236 (251)
T cd05041 177 DVWSYGILLWETFSLGDTPYPGMSNQQTRE--RIES------------G------YRMPAPQLCPEEIYRLMLQCWAYDP 236 (251)
T ss_pred hHHHHHHHHHHHHhccCCCCccCCHHHHHH--HHhc------------C------CCCCCCccCCHHHHHHHHHHhccCh
Confidence 99999999999998 888886543221110 0000 0 0001134456779999999999999
Q ss_pred cCCCCHHHHHHHHH
Q 024027 239 EQRINAKEIVTKLL 252 (273)
Q Consensus 239 ~~Rps~~~~l~~l~ 252 (273)
.+|||+.++++.|+
T Consensus 237 ~~Rp~~~ell~~l~ 250 (251)
T cd05041 237 ENRPSFSEIYNELQ 250 (251)
T ss_pred hhCcCHHHHHHHhh
Confidence 99999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=269.47 Aligned_cols=233 Identities=28% Similarity=0.426 Sum_probs=184.3
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC------------
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN------------ 67 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------ 67 (273)
.||+|+++... ......+..|+++++.+ +|+||+++++++......++||||+++++|.+++....
T Consensus 52 ~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~ 131 (307)
T cd05098 52 KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQ 131 (307)
T ss_pred eEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCccccccccccc
Confidence 48999997542 34556788999999999 79999999999999999999999999999999996532
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCC
Q 024027 68 ---CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGY 144 (273)
Q Consensus 68 ---~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~ 144 (273)
..+++..++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||.+................++..|
T Consensus 132 ~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y 208 (307)
T cd05098 132 VPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKW 208 (307)
T ss_pred CccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccce
Confidence 24788899999999999999999 999999999999999999999999999998755321111111122234679
Q ss_pred CCCcccCCCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhH
Q 024027 145 MAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCV 223 (273)
Q Consensus 145 ~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (273)
+|||.+.+..++.++|+||||+++|+|++ |..||...... ..... .... .....+..++
T Consensus 209 ~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~-----~~~~~---------~~~~------~~~~~~~~~~ 268 (307)
T cd05098 209 MAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-----ELFKL---------LKEG------HRMDKPSNCT 268 (307)
T ss_pred eChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH-----HHHHH---------HHcC------CCCCCCCcCC
Confidence 99999988889999999999999999998 88887542211 11100 0000 0011134566
Q ss_pred HHHHHHHhhcCCCCccCCCCHHHHHHHHHHHHHh
Q 024027 224 SFVFNLAMACTVESPEQRINAKEIVTKLLKIRDS 257 (273)
Q Consensus 224 ~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~ 257 (273)
.++.+|+.+||..+|.+|||+.++++.|.++...
T Consensus 269 ~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 269 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 7899999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=276.70 Aligned_cols=228 Identities=23% Similarity=0.276 Sum_probs=177.9
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||||+++... ......+..|+.++..++|+||+++++++.+...+++||||++||+|.+++.+.+ .+++..+..
T Consensus 27 ~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~l~~~~~~~ 105 (363)
T cd05628 27 HVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKD-TLTEEETQF 105 (363)
T ss_pred CEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhcC-CCCHHHHHH
Confidence 479999997542 2344668889999999999999999999999999999999999999999996543 689999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCc-------------------------
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQS------------------------- 132 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~------------------------- 132 (273)
++.|++.||.||| +.|++||||||+||+++.++.++|+|||++..+......
T Consensus 106 ~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (363)
T cd05628 106 YIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182 (363)
T ss_pred HHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccccccccccccccccccccccccc
Confidence 9999999999999 999999999999999999999999999998754221100
Q ss_pred --------ceeecccccCCCCCCcccCCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhh
Q 024027 133 --------MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVV 204 (273)
Q Consensus 133 --------~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 204 (273)
......+||+.|+|||++.+..++.++|+|||||++|+|++|..||......+ ........
T Consensus 183 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~-~~~~i~~~---------- 251 (363)
T cd05628 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQE-TYKKVMNW---------- 251 (363)
T ss_pred chhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHH-HHHHHHcC----------
Confidence 00123468999999999998899999999999999999999999997533221 11111100
Q ss_pred hhhccccchhhhhhhhhhHHHHHHHHhhcCCCCcc---CCCCHHHHHHH
Q 024027 205 DANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE---QRINAKEIVTK 250 (273)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~---~Rps~~~~l~~ 250 (273)
......+....++.++.+++.+|+. +|. .||+++++++|
T Consensus 252 ------~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 252 ------KETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTN 293 (363)
T ss_pred ------cCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCC
Confidence 0000011112356778999999775 444 46899999998
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=280.45 Aligned_cols=215 Identities=24% Similarity=0.302 Sum_probs=181.9
Q ss_pred eEEEEEeeccc---ChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 2 EVAVKVFNLQC---GRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 2 ~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
-+|||++|++. ..+.+....|-+|+... +||.++.++.+|+.+.++|+||||+.||++..+ .+...+++..+.-
T Consensus 395 ~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~--~~~~~F~e~rarf 472 (694)
T KOG0694|consen 395 YYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHH--IHTDVFSEPRARF 472 (694)
T ss_pred EEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcEEEE--EecccccHHHHHH
Confidence 58999999874 56677888999999888 599999999999999999999999999994333 3334699999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
++..|+.||.||| ++||++||||.+|||+|.+|.+||+|||++..-.+ ........+||+.|+|||++.+..|+.
T Consensus 473 yaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~ 547 (694)
T KOG0694|consen 473 YAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG--QGDRTSTFCGTPEFLAPEVLTEQSYTR 547 (694)
T ss_pred HHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccCC--CCCccccccCChhhcChhhhccCcccc
Confidence 9999999999999 99999999999999999999999999999986432 333567789999999999999999999
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
+.|.|||||+||+|+.|..||.+.++++. ...+... +...|..++.++.++++++|..|
T Consensus 548 aVDWW~lGVLlyeML~Gq~PF~gddEee~-FdsI~~d--------------------~~~yP~~ls~ea~~il~~ll~k~ 606 (694)
T KOG0694|consen 548 AVDWWGLGVLLYEMLVGESPFPGDDEEEV-FDSIVND--------------------EVRYPRFLSKEAIAIMRRLLRKN 606 (694)
T ss_pred hhhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHhcC--------------------CCCCCCcccHHHHHHHHHHhccC
Confidence 99999999999999999999987444332 1111111 11126678899999999999999
Q ss_pred ccCCCCH
Q 024027 238 PEQRINA 244 (273)
Q Consensus 238 p~~Rps~ 244 (273)
|++|..+
T Consensus 607 p~kRLG~ 613 (694)
T KOG0694|consen 607 PEKRLGS 613 (694)
T ss_pred cccccCC
Confidence 9999955
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=263.56 Aligned_cols=230 Identities=26% Similarity=0.429 Sum_probs=181.0
Q ss_pred eEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCc------eeEEEeccCCCCHHHhhhcC-----CC
Q 024027 2 EVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEF------KALVLEYMPHGSLEKYLYSS-----NC 68 (273)
Q Consensus 2 ~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~------~~lv~e~~~~~~L~~~l~~~-----~~ 68 (273)
.||||.++... ......+..|+++++.++||||+++++++..... .++++||+++++|..++... ..
T Consensus 29 ~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~ 108 (273)
T cd05035 29 KVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPE 108 (273)
T ss_pred eEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcc
Confidence 59999997542 3345678999999999999999999998765543 78999999999999888432 23
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCc
Q 024027 69 ILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPE 148 (273)
Q Consensus 69 ~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE 148 (273)
.+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++..+.............++..|+|||
T Consensus 109 ~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe 185 (273)
T cd05035 109 KLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIE 185 (273)
T ss_pred cCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHh
Confidence 5888999999999999999999 9999999999999999999999999999987653322211122223456799999
Q ss_pred ccCCCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHH
Q 024027 149 YGREGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVF 227 (273)
Q Consensus 149 ~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 227 (273)
.+.+..++.++|+|||||++|++++ |..||......+. ....... .....+..++.++.
T Consensus 186 ~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~-~~~~~~~-------------------~~~~~~~~~~~~~~ 245 (273)
T cd05035 186 SLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEI-YDYLRHG-------------------NRLKQPEDCLDELY 245 (273)
T ss_pred hcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHcC-------------------CCCCCCcCCCHHHH
Confidence 9988889999999999999999999 8888865332111 1100000 00111345677899
Q ss_pred HHHhhcCCCCccCCCCHHHHHHHHHHH
Q 024027 228 NLAMACTVESPEQRINAKEIVTKLLKI 254 (273)
Q Consensus 228 ~li~~~l~~dp~~Rps~~~~l~~l~~~ 254 (273)
+++.+||..||.+|||+.+++++|+++
T Consensus 246 ~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 246 DLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=279.97 Aligned_cols=241 Identities=22% Similarity=0.223 Sum_probs=180.2
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~q 81 (273)
+||||.+... ....+|+++++.++||||+++++++......+++||++. ++|.+++. ....+++..++.++.|
T Consensus 121 ~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~-~~~~l~~~~~~~i~~q 193 (392)
T PHA03207 121 KVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYVD-RSGPLPLEQAITIQRR 193 (392)
T ss_pred eEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHHH-hcCCCCHHHHHHHHHH
Confidence 6888887543 345689999999999999999999999999999999996 58999984 3446999999999999
Q ss_pred HHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcchh
Q 024027 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 161 (273)
Q Consensus 82 l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di 161 (273)
++.||.||| +.|++|+||||+||+++.++.++|+|||++..+.............|++.|+|||++.+..++.++||
T Consensus 194 l~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv 270 (392)
T PHA03207 194 LLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDI 270 (392)
T ss_pred HHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhH
Confidence 999999999 99999999999999999999999999999876543332222334568999999999998889999999
Q ss_pred HHHHHHHHHHHhCCCCCccccccc--cchhhhhhhcc--Cccch--------hhhhhhc-cccchh---hhhhhhhhHHH
Q 024027 162 YSFGIMLMETFTGKKPTYEFFNGE--MTLKHWVNDWL--PISTM--------EVVDANL-LSQEDI---HFVAKEQCVSF 225 (273)
Q Consensus 162 wslG~~l~~ll~g~~pf~~~~~~~--~~~~~~~~~~~--~~~~~--------~~~~~~~-~~~~~~---~~~~~~~~~~~ 225 (273)
|||||++|+|++|..||....... ..+........ +.... ....... ...... ........+.+
T Consensus 271 wslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (392)
T PHA03207 271 WSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMD 350 (392)
T ss_pred HHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchh
Confidence 999999999999999987644322 11111111000 00000 0000000 000000 00001234567
Q ss_pred HHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 226 VFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 226 l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
+.++|.+||..||++|||+.+++.|=.
T Consensus 351 ~~~li~~ml~~dp~~Rpsa~e~l~~p~ 377 (392)
T PHA03207 351 VEYLIAKMLTFDQEFRPSAQDILSLPL 377 (392)
T ss_pred HHHHHHHHhccChhhCCCHHHHhhCch
Confidence 899999999999999999999999854
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=290.73 Aligned_cols=232 Identities=24% Similarity=0.461 Sum_probs=204.2
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
.||||-+|.+. +..+.+|..|+.||-+++||||+++.|+........||.|||++|+|..||+.+.+.+...+...++.
T Consensus 659 ~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLr 738 (996)
T KOG0196|consen 659 TVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLR 738 (996)
T ss_pred eEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHH
Confidence 79999999774 56788999999999999999999999999999999999999999999999998888899999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecc--cccCCCCCCcccCCCCcCCc
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQT--LATIGYMAPEYGREGRVSTN 158 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~--~~~~~~~aPE~~~~~~~~~~ 158 (273)
.|+.|++||. +.|++||||..+|||++.+...|++|||+++.+...... ..... .-+..|.|||.+...+++.+
T Consensus 739 GIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~-~ytt~GGKIPiRWTAPEAIa~RKFTsA 814 (996)
T KOG0196|consen 739 GIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA-AYTTLGGKIPIRWTAPEAIAYRKFTSA 814 (996)
T ss_pred HHHHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccceeecccCCCc-cccccCCccceeecChhHhhhcccCch
Confidence 9999999999 999999999999999999999999999999976443321 11222 22678999999999999999
Q ss_pred chhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 159 GDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 159 ~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
||+||+|++|||.++ |..||.++.+.+.-.. .....+.+.|.+|+..+..|+..||++|
T Consensus 815 SDVWSyGIVmWEVmSyGERPYWdmSNQdVIka--------------------Ie~gyRLPpPmDCP~aL~qLMldCWqkd 874 (996)
T KOG0196|consen 815 SDVWSYGIVMWEVMSYGERPYWDMSNQDVIKA--------------------IEQGYRLPPPMDCPAALYQLMLDCWQKD 874 (996)
T ss_pred hhccccceEEEEecccCCCcccccchHHHHHH--------------------HHhccCCCCCCCCcHHHHHHHHHHHHHH
Confidence 999999999999887 9999988766543221 1344566668999999999999999999
Q ss_pred ccCCCCHHHHHHHHHHHHHh
Q 024027 238 PEQRINAKEIVTKLLKIRDS 257 (273)
Q Consensus 238 p~~Rps~~~~l~~l~~~~~~ 257 (273)
-..||.+.+|+..|.++..+
T Consensus 875 R~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 875 RNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred hhcCCCHHHHHHHHHHHhcC
Confidence 99999999999999999864
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=265.47 Aligned_cols=227 Identities=22% Similarity=0.280 Sum_probs=181.9
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
+.||+|++...+....+.+..|+++++.++|+||+++++++..++.+++||||+++++|..++.+....+++..+..++.
T Consensus 38 ~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ 117 (292)
T cd06644 38 ALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICR 117 (292)
T ss_pred ceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHH
Confidence 36899999877666678899999999999999999999999999999999999999999988866666799999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccC-----CCCc
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR-----EGRV 155 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~ 155 (273)
|++.++.+|| +.|++|+||+|+||+++.++.++|+|||.+...... ........++..|+|||.+. ...+
T Consensus 118 ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 192 (292)
T cd06644 118 QMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--LQRRDSFIGTPYWMAPEVVMCETMKDTPY 192 (292)
T ss_pred HHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceecccc--ccccceecCCccccCceeeccccccCCCC
Confidence 9999999999 999999999999999999999999999988654221 11223345788899999874 3346
Q ss_pred CCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCC
Q 024027 156 STNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTV 235 (273)
Q Consensus 156 ~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 235 (273)
+.++|+|||||++|+|++|..||........ ........ ......+..++.++.+++.+||.
T Consensus 193 ~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~-----------------~~~~~~~~~~~~~~~~li~~~l~ 254 (292)
T cd06644 193 DYKADIWSLGITLIEMAQIEPPHHELNPMRV-LLKIAKSE-----------------PPTLSQPSKWSMEFRDFLKTALD 254 (292)
T ss_pred CchhhhHhHHHHHHHHhcCCCCCccccHHHH-HHHHhcCC-----------------CccCCCCcccCHHHHHHHHHHhc
Confidence 7899999999999999999999865332111 11110000 00001123455678999999999
Q ss_pred CCccCCCCHHHHHHH
Q 024027 236 ESPEQRINAKEIVTK 250 (273)
Q Consensus 236 ~dp~~Rps~~~~l~~ 250 (273)
.||.+||++.++++|
T Consensus 255 ~~p~~Rp~~~~il~~ 269 (292)
T cd06644 255 KHPETRPSAAQLLEH 269 (292)
T ss_pred CCcccCcCHHHHhcC
Confidence 999999999999886
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=263.63 Aligned_cols=230 Identities=24% Similarity=0.458 Sum_probs=183.8
Q ss_pred eEEEEEeecc-cChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
.||||+++.. +......|..|+.+++.++||||+++++++.++...++|+||+++++|.+++......+++..++.++.
T Consensus 34 ~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ 113 (269)
T cd05065 34 FVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR 113 (269)
T ss_pred eEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHH
Confidence 5999999754 344567899999999999999999999999999999999999999999999976666789999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeeccc---ccCCCCCCcccCCCCcCC
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTL---ATIGYMAPEYGREGRVST 157 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~---~~~~~~aPE~~~~~~~~~ 157 (273)
|++.|+.||| +.|++|+||+|+||+++.++.++|+|||++................ .+..|+|||.+.+..++.
T Consensus 114 ~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~ 190 (269)
T cd05065 114 GIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTS 190 (269)
T ss_pred HHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccc
Confidence 9999999999 9999999999999999999999999999987553322211111111 134699999998888999
Q ss_pred cchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 158 NGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
++|+||+|+++|++++ |..||........ ...... ......+..++..+.+++.+||..
T Consensus 191 ~~DvwslG~~l~e~l~~g~~p~~~~~~~~~--~~~i~~------------------~~~~~~~~~~~~~~~~li~~~l~~ 250 (269)
T cd05065 191 ASDVWSYGIVMWEVMSYGERPYWDMSNQDV--INAIEQ------------------DYRLPPPMDCPTALHQLMLDCWQK 250 (269)
T ss_pred hhhhhhhHHHHHHHhcCCCCCCCCCCHHHH--HHHHHc------------------CCcCCCcccCCHHHHHHHHHHcCC
Confidence 9999999999999886 9999865322211 000000 001111345667799999999999
Q ss_pred CccCCCCHHHHHHHHHHH
Q 024027 237 SPEQRINAKEIVTKLLKI 254 (273)
Q Consensus 237 dp~~Rps~~~~l~~l~~~ 254 (273)
+|.+||++.+++..|+++
T Consensus 251 ~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 251 DRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ChhhCcCHHHHHHHHHhh
Confidence 999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=265.45 Aligned_cols=228 Identities=22% Similarity=0.292 Sum_probs=182.4
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~q 81 (273)
.||+|.+...+......+.+|+++++.++|||++++++++..+...++|+||+++++|..++......+++..+..++.|
T Consensus 32 ~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~q 111 (282)
T cd06643 32 LAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQ 111 (282)
T ss_pred EEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHH
Confidence 57888887665556778899999999999999999999999999999999999999999988665567999999999999
Q ss_pred HHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccC-----CCCcC
Q 024027 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR-----EGRVS 156 (273)
Q Consensus 82 l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~ 156 (273)
++.||.||| +.|++|+||+|+||+++.++.++++|||++....... .......++..|+|||.+. +..++
T Consensus 112 i~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~ 186 (282)
T cd06643 112 TLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYD 186 (282)
T ss_pred HHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEccccccccccccc--cccccccccccccCHhhccccCCCCCCCC
Confidence 999999999 9999999999999999999999999999986542211 1223345788999999874 34477
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++|+||+||++|+|++|.+||........... ....... ....+..++.++.+|+.+||..
T Consensus 187 ~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~-~~~~~~~-----------------~~~~~~~~~~~~~~li~~~l~~ 248 (282)
T cd06643 187 YKADVWSLGITLIEMAQIEPPHHELNPMRVLLK-IAKSEPP-----------------TLAQPSRWSSEFKDFLKKCLEK 248 (282)
T ss_pred ccchhhhHHHHHHHHccCCCCccccCHHHHHHH-HhhcCCC-----------------CCCCccccCHHHHHHHHHHccC
Confidence 899999999999999999999876432211111 0000000 0011234566799999999999
Q ss_pred CccCCCCHHHHHHHHH
Q 024027 237 SPEQRINAKEIVTKLL 252 (273)
Q Consensus 237 dp~~Rps~~~~l~~l~ 252 (273)
||.+|||+.++++|-.
T Consensus 249 ~p~~Rp~~~~il~~~~ 264 (282)
T cd06643 249 NVDARWTTTQLLQHPF 264 (282)
T ss_pred ChhhCcCHHHHhcCCC
Confidence 9999999999987754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=262.21 Aligned_cols=225 Identities=23% Similarity=0.301 Sum_probs=183.0
Q ss_pred CeEEEEEeecc--cChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcC-CCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~ 77 (273)
+.||+|.+... .......+..|+++++.++|||++++++++.+++..++|+||+++++|.+++... ...+++..++.
T Consensus 26 ~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 105 (256)
T cd08529 26 RVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWR 105 (256)
T ss_pred cEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHH
Confidence 36899998643 2455678899999999999999999999999999999999999999999999764 45689999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++..+.... .......+++.|+|||.+.+..++.
T Consensus 106 i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~ 180 (256)
T cd08529 106 FFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT--NFANTIVGTPYYLSPELCEDKPYNE 180 (256)
T ss_pred HHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc--chhhccccCccccCHHHhcCCCCCC
Confidence 9999999999999 9999999999999999999999999999987653222 1123345788999999998888999
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
++|+||||+++++|++|..||........ ....... . ....+..++..+.+++.+||..+
T Consensus 181 ~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~-------------~------~~~~~~~~~~~~~~~i~~~l~~~ 240 (256)
T cd08529 181 KSDVWALGVVLYECCTGKHPFDANNQGAL-ILKIIRG-------------V------FPPVSQMYSQQLAQLIDQCLTKD 240 (256)
T ss_pred ccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHcC-------------C------CCCCccccCHHHHHHHHHHccCC
Confidence 99999999999999999999875432111 1100000 0 00012245667999999999999
Q ss_pred ccCCCCHHHHHHH
Q 024027 238 PEQRINAKEIVTK 250 (273)
Q Consensus 238 p~~Rps~~~~l~~ 250 (273)
|++||++.+++++
T Consensus 241 p~~Rp~~~~ll~~ 253 (256)
T cd08529 241 YRQRPDTFQLLRN 253 (256)
T ss_pred cccCcCHHHHhhC
Confidence 9999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=273.40 Aligned_cols=229 Identities=21% Similarity=0.252 Sum_probs=180.6
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (273)
+.||+|+++... ......+..|..++..+ +||+|+++++++.+...+++||||+++++|..++...+ .+++..+.
T Consensus 21 ~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~ 99 (327)
T cd05617 21 QIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQR-KLPEEHAR 99 (327)
T ss_pred CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHH
Confidence 368999998542 34456688999999888 69999999999999999999999999999999886543 69999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcC
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVS 156 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 156 (273)
.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++...... .......+|++.|+|||.+.+..++
T Consensus 100 ~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~ 174 (327)
T cd05617 100 FYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDTTSTFCGTPNYIAPEILRGEEYG 174 (327)
T ss_pred HHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCceecccCCcccCCHHHHCCCCCC
Confidence 99999999999999 999999999999999999999999999998643211 1223345789999999999988999
Q ss_pred CcchhHHHHHHHHHHHhCCCCCcccccccc-chhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEM-TLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTV 235 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 235 (273)
.++|+|||||++|+|++|..||........ ...... ...... .....+...+..+.+++.+||.
T Consensus 175 ~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~------------~~~~~~---~~~~~p~~~~~~~~~li~~~L~ 239 (327)
T cd05617 175 FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYL------------FQVILE---KPIRIPRFLSVKASHVLKGFLN 239 (327)
T ss_pred chheeehhHHHHHHHHhCCCCCCccCCCcccccHHHH------------HHHHHh---CCCCCCCCCCHHHHHHHHHHhc
Confidence 999999999999999999999964322211 000000 000000 0011244566779999999999
Q ss_pred CCccCCCCH------HHHHHH
Q 024027 236 ESPEQRINA------KEIVTK 250 (273)
Q Consensus 236 ~dp~~Rps~------~~~l~~ 250 (273)
.||++|+++ +++++|
T Consensus 240 ~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 240 KDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred cCHHHcCCCCCCCCHHHHHcC
Confidence 999999984 577766
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=276.22 Aligned_cols=240 Identities=20% Similarity=0.208 Sum_probs=177.1
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
+.||||... ...+.+|+++++.++||||++++++|..+...++|+|++. ++|..++... ..+++..++.++.
T Consensus 118 ~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~ 189 (391)
T PHA03212 118 EHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCYLAAK-RNIAICDILAIER 189 (391)
T ss_pred CEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHHHHHhc-CCCCHHHHHHHHH
Confidence 368888653 2356789999999999999999999999999999999995 5998888654 3588999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
|++.||.||| +.|++|+||||+||+++.++.++|+|||++....... ........||+.|+|||++.+..++.++|
T Consensus 190 qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 265 (391)
T PHA03212 190 SVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-ANKYYGWAGTIATNAPELLARDPYGPAVD 265 (391)
T ss_pred HHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-ccccccccCccCCCChhhhcCCCCCcHHH
Confidence 9999999999 9999999999999999999999999999986532211 11223456899999999999888999999
Q ss_pred hHHHHHHHHHHHhCCCCCccccccc------cchhhhhhhccC--cc----chhhhh-------hhcccc--chhhhhhh
Q 024027 161 VYSFGIMLMETFTGKKPTYEFFNGE------MTLKHWVNDWLP--IS----TMEVVD-------ANLLSQ--EDIHFVAK 219 (273)
Q Consensus 161 iwslG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~~~~--~~----~~~~~~-------~~~~~~--~~~~~~~~ 219 (273)
||||||++|+|++|..||....... ............ .. ...... ...... ....+...
T Consensus 266 iwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (391)
T PHA03212 266 IWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNL 345 (391)
T ss_pred HHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHH
Confidence 9999999999999998875432111 111111111000 00 000000 000000 00011112
Q ss_pred hhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 220 EQCVSFVFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 220 ~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
...+.++.+|+.+||..||++|||++++++|=+
T Consensus 346 ~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~ 378 (391)
T PHA03212 346 YELPIDLEYLICKMLAFDAHHRPSAEALLDFAA 378 (391)
T ss_pred hhhhhhHHHHHHHHhcCChhhCCCHHHHhcChh
Confidence 345678999999999999999999999998754
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=261.71 Aligned_cols=225 Identities=25% Similarity=0.332 Sum_probs=183.8
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
+.||+|.++.... ...+.+|+++++.++|+||+++++++.++...++++||+++++|.+++...+..+++..+..++.
T Consensus 29 ~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~ 106 (256)
T cd06612 29 QVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILY 106 (256)
T ss_pred cEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHH
Confidence 3689999875532 67899999999999999999999999999999999999999999999977667799999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
|++.|+.||| +.+++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|
T Consensus 107 ~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~D 181 (256)
T cd06612 107 QTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKAD 181 (256)
T ss_pred HHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--ccccccCCccccCHHHHhcCCCCchhh
Confidence 9999999999 99999999999999999999999999999876533221 223345788899999998888999999
Q ss_pred hHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccC
Q 024027 161 VYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQ 240 (273)
Q Consensus 161 iwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 240 (273)
|||+|+++++|++|..||............ .. ........+..++.++.+++.+||..||.+
T Consensus 182 i~s~G~il~~l~~g~~p~~~~~~~~~~~~~--~~----------------~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~ 243 (256)
T cd06612 182 IWSLGITAIEMAEGKPPYSDIHPMRAIFMI--PN----------------KPPPTLSDPEKWSPEFNDFVKKCLVKDPEE 243 (256)
T ss_pred HHHHHHHHHHHHhCCCCCCCcchhhhhhhh--cc----------------CCCCCCCchhhcCHHHHHHHHHHHhcChhh
Confidence 999999999999999998753222111000 00 000011113345667999999999999999
Q ss_pred CCCHHHHHHH
Q 024027 241 RINAKEIVTK 250 (273)
Q Consensus 241 Rps~~~~l~~ 250 (273)
|||+.+++++
T Consensus 244 Rps~~~il~~ 253 (256)
T cd06612 244 RPSAIQLLQH 253 (256)
T ss_pred CcCHHHHhcC
Confidence 9999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=265.70 Aligned_cols=229 Identities=23% Similarity=0.321 Sum_probs=184.8
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
++||+|+++.........+..|+++++.++|+||+++++++..+...++||||+++++|.+++...+..+++..+..++.
T Consensus 31 ~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ 110 (280)
T cd06611 31 LFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCR 110 (280)
T ss_pred cEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHH
Confidence 36999999877666677899999999999999999999999999999999999999999999977666799999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccC-----CCCc
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR-----EGRV 155 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~ 155 (273)
|++.|+.||| +.|++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||.+. ...+
T Consensus 111 ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~ 185 (280)
T cd06611 111 QMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL--QKRDTFIGTPYWMAPEVVACETFKDNPY 185 (280)
T ss_pred HHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhcccc--cccceeecchhhcCHHHHhhcccCCCCC
Confidence 9999999999 9999999999999999999999999999876542211 1223345788899999874 2346
Q ss_pred CCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCC
Q 024027 156 STNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTV 235 (273)
Q Consensus 156 ~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 235 (273)
+.++|+||+|+++|++++|..||........ ....... .......+..++.++.+++.+||.
T Consensus 186 ~~~sDi~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~-----------------~~~~~~~~~~~~~~~~~li~~~l~ 247 (280)
T cd06611 186 DYKADIWSLGITLIELAQMEPPHHELNPMRV-LLKILKS-----------------EPPTLDQPSKWSSSFNDFLKSCLV 247 (280)
T ss_pred CccccHHHHHHHHHHHHhCCCCcccCCHHHH-HHHHhcC-----------------CCCCcCCcccCCHHHHHHHHHHhc
Confidence 7899999999999999999999876432211 1100000 000011133456779999999999
Q ss_pred CCccCCCCHHHHHHHHH
Q 024027 236 ESPEQRINAKEIVTKLL 252 (273)
Q Consensus 236 ~dp~~Rps~~~~l~~l~ 252 (273)
.+|.+|||+.++++|-+
T Consensus 248 ~~p~~Rps~~~il~~~~ 264 (280)
T cd06611 248 KDPDDRPTAAELLKHPF 264 (280)
T ss_pred cChhhCcCHHHHhcChh
Confidence 99999999999998844
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=267.14 Aligned_cols=227 Identities=26% Similarity=0.308 Sum_probs=182.8
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
+.||+|.+..........+.+|+.+++.++|+|++++++.+..+...++||||+++++|.+++... .+++..+..++.
T Consensus 46 ~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~i~~ 123 (296)
T cd06654 46 QEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCR 123 (296)
T ss_pred cEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHhc--CCCHHHHHHHHH
Confidence 368999998665555677899999999999999999999999999999999999999999998643 478999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
|++.||.||| +.|++|+||+|+||+++.++.++|+|||.+....... .......+++.|+|||.+.+..++.++|
T Consensus 124 ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~D 198 (296)
T cd06654 124 ECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVD 198 (296)
T ss_pred HHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhccccc--cccCcccCCccccCHHHHcCCCCCccch
Confidence 9999999999 9999999999999999999999999999887542221 1122345788999999998888899999
Q ss_pred hHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccC
Q 024027 161 VYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQ 240 (273)
Q Consensus 161 iwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 240 (273)
+|||||++|++++|..||.......... ... .... .....+..++..+.+++.+||..||++
T Consensus 199 v~s~Gvil~~l~~g~~pf~~~~~~~~~~-~~~---~~~~--------------~~~~~~~~~~~~l~~li~~~l~~~p~~ 260 (296)
T cd06654 199 IWSLGIMAIEMIEGEPPYLNENPLRALY-LIA---TNGT--------------PELQNPEKLSAIFRDFLNRCLDMDVEK 260 (296)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHhHH-HHh---cCCC--------------CCCCCccccCHHHHHHHHHHCcCCccc
Confidence 9999999999999999996533211110 000 0000 000112345567999999999999999
Q ss_pred CCCHHHHHHHHH
Q 024027 241 RINAKEIVTKLL 252 (273)
Q Consensus 241 Rps~~~~l~~l~ 252 (273)
|||+.+++++-.
T Consensus 261 Rpt~~eil~~~~ 272 (296)
T cd06654 261 RGSAKELLQHQF 272 (296)
T ss_pred CcCHHHHhhChh
Confidence 999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=259.21 Aligned_cols=233 Identities=22% Similarity=0.309 Sum_probs=184.8
Q ss_pred CeEEEEEeecc---cChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhc---CCCCCCHHH
Q 024027 1 MEVAVKVFNLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS---SNCILDIFQ 74 (273)
Q Consensus 1 ~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~ 74 (273)
+.||+|.++.. +......+.+|+++++.++|+|++++++++.+....+++|||+++++|.+++.. .+..+++..
T Consensus 28 ~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 107 (267)
T cd08224 28 RVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERT 107 (267)
T ss_pred CEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHH
Confidence 46899988643 233466789999999999999999999999999999999999999999999853 234588999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCC
Q 024027 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGR 154 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 154 (273)
++.++.+++.|+.+|| +.|++|+||+|+||+++.++.++|+|||.+....... .......++..|.|||.+.+..
T Consensus 108 ~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~apE~~~~~~ 182 (267)
T cd08224 108 IWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENG 182 (267)
T ss_pred HHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC--cccceecCCccccCHHHhccCC
Confidence 9999999999999999 9999999999999999999999999999987543221 1123345788899999998888
Q ss_pred cCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcC
Q 024027 155 VSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACT 234 (273)
Q Consensus 155 ~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 234 (273)
++.++|+||+|+++|++++|..||...... ........ .... ........++..+.+++.+||
T Consensus 183 ~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~---------~~~~-----~~~~~~~~~~~~~~~~i~~cl 245 (267)
T cd08224 183 YNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKKI---------EKCD-----YPPLPADHYSEELRDLVSRCI 245 (267)
T ss_pred CCchhcHHHHHHHHHHHHHCCCCcccCCcc---HHHHHhhh---------hcCC-----CCCCChhhcCHHHHHHHHHHc
Confidence 999999999999999999999998543211 11111100 0000 000001245667999999999
Q ss_pred CCCccCCCCHHHHHHHHHHHH
Q 024027 235 VESPEQRINAKEIVTKLLKIR 255 (273)
Q Consensus 235 ~~dp~~Rps~~~~l~~l~~~~ 255 (273)
..+|.+|||+.++++.|+.+.
T Consensus 246 ~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 246 NPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCCcccCCCHHHHHHHHHHhc
Confidence 999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=279.04 Aligned_cols=229 Identities=22% Similarity=0.309 Sum_probs=179.0
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||||++.... ......+.+|+.+++.++|+||+++++++.++..+++||||+++|+|.+++.+.+ .+++..+..
T Consensus 27 ~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~e~~~~~ 105 (382)
T cd05625 27 ALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG-IFPEDLARF 105 (382)
T ss_pred CEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHH
Confidence 368999997542 2345678899999999999999999999999999999999999999999996553 688999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCC--------------------------
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQ-------------------------- 131 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~-------------------------- 131 (273)
++.|++.||.||| +.|++||||||+||+++.++.++|+|||++..+.....
T Consensus 106 ~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (382)
T cd05625 106 YIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182 (382)
T ss_pred HHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccccccccccccccccccccccccc
Confidence 9999999999999 99999999999999999999999999999753311000
Q ss_pred -------------------cceeecccccCCCCCCcccCCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhh
Q 024027 132 -------------------SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWV 192 (273)
Q Consensus 132 -------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~ 192 (273)
.......+|++.|+|||++.+..++.++||||+||++|+|++|..||......+.... ..
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~-i~ 261 (382)
T cd05625 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMK-VI 261 (382)
T ss_pred ccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHH-HH
Confidence 0001124689999999999988999999999999999999999999975332211111 00
Q ss_pred hhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccCCCC---HHHHHHHH
Q 024027 193 NDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRIN---AKEIVTKL 251 (273)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~~l~~l 251 (273)
. .......+....++.++.+++.+|+ .+|.+|++ ++++++|-
T Consensus 262 ~----------------~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp 306 (382)
T cd05625 262 N----------------WQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHP 306 (382)
T ss_pred c----------------cCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCC
Confidence 0 0000111112345677999999976 59999997 99988873
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=264.97 Aligned_cols=228 Identities=27% Similarity=0.425 Sum_probs=182.0
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC---------CCCC
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN---------CILD 71 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~ 71 (273)
.||+|.+.... ......+.+|+.+++.++|+||+++++++......++||||+++++|.+++.... ..++
T Consensus 38 ~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 117 (277)
T cd05032 38 RVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPT 117 (277)
T ss_pred eEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCC
Confidence 68999987553 3445678899999999999999999999999999999999999999999986432 2367
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccC
Q 024027 72 IFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR 151 (273)
Q Consensus 72 ~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 151 (273)
+..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++..+.............++..|+|||.+.
T Consensus 118 ~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 194 (277)
T cd05032 118 LQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLK 194 (277)
T ss_pred HHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHh
Confidence 8899999999999999999 9999999999999999999999999999987653322211222334567899999998
Q ss_pred CCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHH
Q 024027 152 EGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLA 230 (273)
Q Consensus 152 ~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 230 (273)
+..++.++||||||+++|++++ |..||......+. ...... ......+..++.++.+++
T Consensus 195 ~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-~~~~~~-------------------~~~~~~~~~~~~~~~~li 254 (277)
T cd05032 195 DGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV-LKFVID-------------------GGHLDLPENCPDKLLELM 254 (277)
T ss_pred cCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH-HHHHhc-------------------CCCCCCCCCCCHHHHHHH
Confidence 8889999999999999999998 8999865322211 111100 001111344567799999
Q ss_pred hhcCCCCccCCCCHHHHHHHHH
Q 024027 231 MACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 231 ~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
.+||..+|++|||+.++++.|+
T Consensus 255 ~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 255 RMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHHcCCChhhCCCHHHHHHHhc
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=260.66 Aligned_cols=224 Identities=32% Similarity=0.489 Sum_probs=182.5
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC-CCCCHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIM 79 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ 79 (273)
+.||||.++.... ..+.+..|+.+++.++|+||+++++++.+....++||||+++++|.+++.... ..+++..+..++
T Consensus 30 ~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ 108 (256)
T cd05039 30 QKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFA 108 (256)
T ss_pred cEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHH
Confidence 4799999976643 56788999999999999999999999999999999999999999999996543 258999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 159 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 159 (273)
.|++.||.||| +.|++|+||+|+||+++.++.++|+|||.+....... .....+..|.|||.+....++.++
T Consensus 109 ~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-----~~~~~~~~~~ape~~~~~~~~~~~ 180 (256)
T cd05039 109 LDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-----DSGKLPVKWTAPEALREKKFSTKS 180 (256)
T ss_pred HHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEccccccccccccc-----ccCCCcccccCchhhcCCcCCcHH
Confidence 99999999999 9999999999999999999999999999987652111 122345679999999888889999
Q ss_pred hhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc
Q 024027 160 DVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238 (273)
Q Consensus 160 DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 238 (273)
|+||||++++++++ |..||......+. ...... . .....+..++.++.+++.+||..+|
T Consensus 181 Di~slG~il~~l~~~g~~p~~~~~~~~~-~~~~~~-------------~------~~~~~~~~~~~~~~~li~~~l~~~p 240 (256)
T cd05039 181 DVWSFGILLWEIYSFGRVPYPRIPLKDV-VPHVEK-------------G------YRMEAPEGCPPEVYKVMKDCWELDP 240 (256)
T ss_pred HHHHHHHHHHHHHhcCCCCCCCCCHHHH-HHHHhc-------------C------CCCCCccCCCHHHHHHHHHHhccCh
Confidence 99999999999997 9999865322211 000000 0 0011133456779999999999999
Q ss_pred cCCCCHHHHHHHHHH
Q 024027 239 EQRINAKEIVTKLLK 253 (273)
Q Consensus 239 ~~Rps~~~~l~~l~~ 253 (273)
.+|||+.++++.|+.
T Consensus 241 ~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 241 AKRPTFKQLREQLAL 255 (256)
T ss_pred hhCcCHHHHHHHHhc
Confidence 999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=259.87 Aligned_cols=228 Identities=28% Similarity=0.388 Sum_probs=181.7
Q ss_pred CeEEEEEeecccC-hhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 1 MEVAVKVFNLQCG-RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 1 ~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
+.||+|+++.... .....+.+|+++++.++||||+++++++...+..++||||+++++|.+++......+++..+..++
T Consensus 20 ~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ 99 (250)
T cd05085 20 TPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFA 99 (250)
T ss_pred cEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHH
Confidence 3689999876543 334568899999999999999999999999999999999999999999997666668999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 159 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 159 (273)
.|++.||.|+| +.|++|+||+|+||+++.++.++|+|||++....... ........++..|+|||.+.+..++.++
T Consensus 100 ~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 175 (250)
T cd05085 100 LDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI-YSSSGLKQIPIKWTAPEALNYGRYSSES 175 (250)
T ss_pred HHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccc-cccCCCCCCcccccCHHHhccCCCCchh
Confidence 99999999999 9999999999999999999999999999986532111 1111122345679999999888899999
Q ss_pred hhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc
Q 024027 160 DVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238 (273)
Q Consensus 160 DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 238 (273)
|+||||+++|++++ |..||.......... .. ... .....+..++..+.+++.+||..+|
T Consensus 176 Di~slG~ll~~~~~~g~~p~~~~~~~~~~~-~~-~~~------------------~~~~~~~~~~~~~~~li~~~l~~~p 235 (250)
T cd05085 176 DVWSYGILLWETFSLGVCPYPGMTNQQARE-QV-EKG------------------YRMSCPQKCPDDVYKVMQRCWDYKP 235 (250)
T ss_pred HHHHHHHHHHHHhcCCCCCCCCCCHHHHHH-HH-HcC------------------CCCCCCCCCCHHHHHHHHHHcccCc
Confidence 99999999999998 999986532221110 00 000 0001133456779999999999999
Q ss_pred cCCCCHHHHHHHHH
Q 024027 239 EQRINAKEIVTKLL 252 (273)
Q Consensus 239 ~~Rps~~~~l~~l~ 252 (273)
++|||+.++++.|.
T Consensus 236 ~~Rp~~~~l~~~l~ 249 (250)
T cd05085 236 ENRPKFSELQKELA 249 (250)
T ss_pred ccCCCHHHHHHHhc
Confidence 99999999998875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=279.05 Aligned_cols=230 Identities=23% Similarity=0.293 Sum_probs=178.7
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||||++.... ......+.+|+++++.++||||+++++++.++...++||||+++|+|.+++... ..+++..+..
T Consensus 27 ~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~ 105 (377)
T cd05629 27 KIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKY-DTFSEDVTRF 105 (377)
T ss_pred CEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhc-CCCCHHHHHH
Confidence 369999986532 334567889999999999999999999999999999999999999999999654 4688999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCc-----------c-------------
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQS-----------M------------- 133 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~-----------~------------- 133 (273)
++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++..+...... .
T Consensus 106 ~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (377)
T cd05629 106 YMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVD 182 (377)
T ss_pred HHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999 999999999999999999999999999998643211000 0
Q ss_pred ---------------------eeecccccCCCCCCcccCCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhh
Q 024027 134 ---------------------TQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWV 192 (273)
Q Consensus 134 ---------------------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~ 192 (273)
.....+|++.|+|||++.+..++.++|||||||++|+|++|..||......+ .+....
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~-~~~~i~ 261 (377)
T cd05629 183 SINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHE-TYRKII 261 (377)
T ss_pred cccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHH-HHHHHH
Confidence 0012468999999999988889999999999999999999999996533211 111111
Q ss_pred hhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccCC---CCHHHHHHHHH
Q 024027 193 NDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQR---INAKEIVTKLL 252 (273)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R---ps~~~~l~~l~ 252 (273)
. + ......+....++.++.+|+.+||. +|.+| +|+.+++.|-+
T Consensus 262 ~-~---------------~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~ 307 (377)
T cd05629 262 N-W---------------RETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPF 307 (377)
T ss_pred c-c---------------CCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCC
Confidence 0 0 0000001112356779999999998 77765 59999999853
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=264.34 Aligned_cols=244 Identities=22% Similarity=0.387 Sum_probs=184.0
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecC--CceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNE--EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
.||+|.++... ......+.+|+++++.++|||++++++++.+. ...++||||++|++|.+++.+....+++..+..+
T Consensus 35 ~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i 114 (284)
T cd05079 35 QVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKY 114 (284)
T ss_pred eEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHH
Confidence 68999987553 34456799999999999999999999998775 5688999999999999999766556899999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcc-eeecccccCCCCCCcccCCCCcCC
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSM-TQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
+.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++..+....... ......++..|+|||.+.+..++.
T Consensus 115 ~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~ 191 (284)
T cd05079 115 AVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYI 191 (284)
T ss_pred HHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCc
Confidence 999999999999 9999999999999999999999999999987654322211 122344667799999998888999
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCc-cchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPI-STMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
++||||||+++|+++++..|+...... ........... ......... ........+..++..+.+|+.+||..
T Consensus 192 ~~Di~slG~il~ellt~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~ 265 (284)
T cd05079 192 ASDVWSFGVTLYELLTYCDSESSPMTL---FLKMIGPTHGQMTVTRLVRVL---EEGKRLPRPPNCPEEVYQLMRKCWEF 265 (284)
T ss_pred cccchhhhhhhhhhhcCCCCCccccch---hhhhcccccccccHHHHHHHH---HcCccCCCCCCCCHHHHHHHHHHccC
Confidence 999999999999999987764321110 00000000000 000000000 00001112345678899999999999
Q ss_pred CccCCCCHHHHHHHHHHH
Q 024027 237 SPEQRINAKEIVTKLLKI 254 (273)
Q Consensus 237 dp~~Rps~~~~l~~l~~~ 254 (273)
||.+|||++++++.++++
T Consensus 266 ~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 266 QPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred CcccCcCHHHHHHHHHhh
Confidence 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=266.57 Aligned_cols=235 Identities=25% Similarity=0.384 Sum_probs=183.3
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC----------CCC
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN----------CIL 70 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~ 70 (273)
+||+|++.... ......+.+|+++++.++||||+++++++..++..++++|++++++|.+++.... ..+
T Consensus 48 ~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 127 (296)
T cd05051 48 LVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127 (296)
T ss_pred eEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCC
Confidence 58999997553 3456778999999999999999999999999999999999999999999986543 258
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCccc
Q 024027 71 DIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYG 150 (273)
Q Consensus 71 ~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 150 (273)
++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++................++..|+|||.+
T Consensus 128 ~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 204 (296)
T cd05051 128 SFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESV 204 (296)
T ss_pred CHHHHHHHHHHHHHHHHHHH---HcCccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHh
Confidence 99999999999999999999 999999999999999999999999999998765332222222334456789999999
Q ss_pred CCCCcCCcchhHHHHHHHHHHHh--CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHH
Q 024027 151 REGRVSTNGDVYSFGIMLMETFT--GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFN 228 (273)
Q Consensus 151 ~~~~~~~~~DiwslG~~l~~ll~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 228 (273)
.+..++.++||||||+++|++++ |..||........ ........... ........+..++.++.+
T Consensus 205 ~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~-~~~~~~~~~~~------------~~~~~~~~~~~~~~~l~~ 271 (296)
T cd05051 205 LLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQV-IENAGHFFRDD------------GRQIYLPRPPNCPKDIYE 271 (296)
T ss_pred hcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHH-HHHHHhccccc------------cccccCCCccCCCHHHHH
Confidence 88889999999999999999998 6777754332211 11100000000 000001113345678999
Q ss_pred HHhhcCCCCccCCCCHHHHHHHHH
Q 024027 229 LAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 229 li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
++.+||..||.+|||+.++++.|.
T Consensus 272 li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 272 LMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHHhccChhcCCCHHHHHHHhc
Confidence 999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=261.76 Aligned_cols=230 Identities=26% Similarity=0.463 Sum_probs=184.4
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
.||+|+++... ......+..|+++++.++|+|++++.+++.+....++||||+++++|.+++......+++..+..++.
T Consensus 35 ~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~ 114 (268)
T cd05063 35 AVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR 114 (268)
T ss_pred EEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHH
Confidence 58999987552 34456788999999999999999999999999999999999999999999977666789999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCccee-ecccccCCCCCCcccCCCCcCCcc
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQ-TQTLATIGYMAPEYGREGRVSTNG 159 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~ 159 (273)
|++.|+.||| +.|++|+||+|+||+++.++.++++|||++............ .....+..|+|||.+.+..++.++
T Consensus 115 ~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~ 191 (268)
T cd05063 115 GIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSAS 191 (268)
T ss_pred HHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHh
Confidence 9999999999 999999999999999999999999999998765332221111 112234579999999888899999
Q ss_pred hhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc
Q 024027 160 DVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238 (273)
Q Consensus 160 DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 238 (273)
|+||||+++|++++ |..||....... ........ ...+.+..++.++.+++.+||..+|
T Consensus 192 Dv~slG~il~ell~~g~~p~~~~~~~~-~~~~i~~~-------------------~~~~~~~~~~~~~~~li~~c~~~~p 251 (268)
T cd05063 192 DVWSFGIVMWEVMSFGERPYWDMSNHE-VMKAINDG-------------------FRLPAPMDCPSAVYQLMLQCWQQDR 251 (268)
T ss_pred HHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHHhcC-------------------CCCCCCCCCCHHHHHHHHHHcCCCc
Confidence 99999999999997 999986532211 11111000 0011123456779999999999999
Q ss_pred cCCCCHHHHHHHHHHH
Q 024027 239 EQRINAKEIVTKLLKI 254 (273)
Q Consensus 239 ~~Rps~~~~l~~l~~~ 254 (273)
.+||++.++++.|+++
T Consensus 252 ~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 252 ARRPRFVDIVNLLDKL 267 (268)
T ss_pred ccCcCHHHHHHHHHhh
Confidence 9999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=277.53 Aligned_cols=243 Identities=20% Similarity=0.243 Sum_probs=184.0
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCC------CccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC-CCCCHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIR------HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIF 73 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~ 73 (273)
+.||||+++.. ..-..+...|+.+|..++ .-|+|+++++|...+++|||+|.+.. +|.++++.++ .+++..
T Consensus 212 e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL~~-NLYellK~n~f~Glsl~ 289 (586)
T KOG0667|consen 212 EIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELLST-NLYELLKNNKFRGLSLP 289 (586)
T ss_pred cEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhhhh-hHHHHHHhcCCCCCCHH
Confidence 36999999866 556677888999999995 46899999999999999999999965 9999997654 459999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCC--CCceEEeecccccccccCCCcceeecccccCCCCCCcccC
Q 024027 74 QRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDD--NLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR 151 (273)
Q Consensus 74 ~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~--~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 151 (273)
.++.++.||+.||.+|| +.||+|+||||+|||+.. ...||++|||.+++. .......+.+..|+|||++.
T Consensus 290 ~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~-----~q~vytYiQSRfYRAPEVIL 361 (586)
T KOG0667|consen 290 LVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE-----SQRVYTYIQSRFYRAPEVIL 361 (586)
T ss_pred HHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccccccc-----CCcceeeeeccccccchhhc
Confidence 99999999999999999 999999999999999963 448999999999864 11222567888999999999
Q ss_pred CCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCcc--ch-------hhhhh----------------
Q 024027 152 EGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPIS--TM-------EVVDA---------------- 206 (273)
Q Consensus 152 ~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~-------~~~~~---------------- 206 (273)
|..|+.+.||||||||++||++|.+.|.+..+ .+.+..+++....+. .. ...+.
T Consensus 362 GlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne-~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~ 440 (586)
T KOG0667|consen 362 GLPYDTAIDMWSLGCILAELFTGEPLFPGDNE-YDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRG 440 (586)
T ss_pred cCCCCCccceeehhhhHHhHhcCccccCCCCH-HHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeeccccc
Confidence 99999999999999999999999887765322 222333322111100 00 00000
Q ss_pred ----------------hccc--cchhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHHHH
Q 024027 207 ----------------NLLS--QEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLLKI 254 (273)
Q Consensus 207 ----------------~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 254 (273)
...+ ........+......+.+++.+||++||.+|+|+.++++|-.--
T Consensus 441 ~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~ 506 (586)
T KOG0667|consen 441 TKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLT 506 (586)
T ss_pred ccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCcccc
Confidence 0000 00001111113345689999999999999999999999997633
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=265.50 Aligned_cols=229 Identities=22% Similarity=0.277 Sum_probs=181.2
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcC-CCCCCHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~ 76 (273)
+.||||++.... ......+.+|+.+++.++||||+++++++..+..+++||||+++++|.+++... ...+++..+.
T Consensus 26 ~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~ 105 (285)
T cd05605 26 KMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAV 105 (285)
T ss_pred ceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHH
Confidence 369999997542 222345778999999999999999999999999999999999999999888543 3458999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcC
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVS 156 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 156 (273)
.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++....... ......++..|+|||.+.+..++
T Consensus 106 ~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~ 179 (285)
T cd05605 106 FYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE---TIRGRVGTVGYMAPEVVKNERYT 179 (285)
T ss_pred HHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC---ccccccCCCCccCcHHhcCCCCC
Confidence 99999999999999 9999999999999999999999999999987642211 12334688999999999888899
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++|+||+|+++|++++|..||....... ........ ... .....+..++..+.+|+.+||..
T Consensus 180 ~~~Diws~G~~l~el~~g~~pf~~~~~~~-~~~~~~~~---------~~~-------~~~~~~~~~~~~~~~li~~~l~~ 242 (285)
T cd05605 180 FSPDWWGLGCLIYEMIEGKSPFRQRKEKV-KREEVERR---------VKE-------DQEEYSEKFSEAARSICRQLLTK 242 (285)
T ss_pred ccccchhHHHHHHHHHHCCCCCCCCchhh-HHHHHHHH---------hhh-------cccccCcccCHHHHHHHHHHccC
Confidence 99999999999999999999997532211 11111000 000 00011234667799999999999
Q ss_pred CccCCC-----CHHHHHHHHH
Q 024027 237 SPEQRI-----NAKEIVTKLL 252 (273)
Q Consensus 237 dp~~Rp-----s~~~~l~~l~ 252 (273)
||++|| +++++++|-+
T Consensus 243 ~P~~R~~~~~~~~~~l~~~~~ 263 (285)
T cd05605 243 DPGFRLGCRGEGAEEVKAHPF 263 (285)
T ss_pred CHHHhcCCCCCCHHHHhcCcC
Confidence 999999 8889988743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=267.76 Aligned_cols=235 Identities=27% Similarity=0.428 Sum_probs=183.6
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC------------
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN------------ 67 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------ 67 (273)
.||+|.++... ......+.+|+.++.++ +|+||+++++++..++..++|+||+++++|.+++....
T Consensus 36 ~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 115 (303)
T cd05088 36 DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 115 (303)
T ss_pred eEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccc
Confidence 46788776432 33456788999999999 89999999999999999999999999999999996432
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCC
Q 024027 68 ---CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGY 144 (273)
Q Consensus 68 ---~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~ 144 (273)
..+++..++.++.|++.|++||| +.|++|+||||+||+++.++.++|+|||++..... .........+..|
T Consensus 116 ~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~---~~~~~~~~~~~~y 189 (303)
T cd05088 116 STASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV---YVKKTMGRLPVRW 189 (303)
T ss_pred cccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCcEEeCccccCcccch---hhhcccCCCcccc
Confidence 25788999999999999999999 99999999999999999999999999999853211 1111112235679
Q ss_pred CCCcccCCCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhH
Q 024027 145 MAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCV 223 (273)
Q Consensus 145 ~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (273)
+|||.+.+..++.++||||||++++++++ |..||......+. ...... ......+..++
T Consensus 190 ~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-----~~~~~~---------------~~~~~~~~~~~ 249 (303)
T cd05088 190 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-----YEKLPQ---------------GYRLEKPLNCD 249 (303)
T ss_pred cCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH-----HHHHhc---------------CCcCCCCCCCC
Confidence 99999988888999999999999999998 9999865322211 000000 00001123356
Q ss_pred HHHHHHHhhcCCCCccCCCCHHHHHHHHHHHHHhhhhhc
Q 024027 224 SFVFNLAMACTVESPEQRINAKEIVTKLLKIRDSLLRNV 262 (273)
Q Consensus 224 ~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~~ 262 (273)
.++.+|+.+||..+|.+|||+++++..|.++...-..-.
T Consensus 250 ~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~~ 288 (303)
T cd05088 250 DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV 288 (303)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhhh
Confidence 679999999999999999999999999998876654333
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=270.48 Aligned_cols=249 Identities=18% Similarity=0.249 Sum_probs=180.5
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcC-CCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~ 77 (273)
+.||||.++... ......+.+|+++++.++||||++++++|..+...++|+||+++++|.+++... ...+++..++.
T Consensus 26 ~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~ 105 (327)
T cd08227 26 EYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAY 105 (327)
T ss_pred cEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHH
Confidence 369999997542 234456788999999999999999999999999999999999999999999653 33589999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcc-----eeecccccCCCCCCcccCC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSM-----TQTQTLATIGYMAPEYGRE 152 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~ 152 (273)
++.|++.||.||| +.|++|+||||+||+++.++.++++||+............ ......++..|+|||.+.+
T Consensus 106 i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 182 (327)
T cd08227 106 ILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQ 182 (327)
T ss_pred HHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhc
Confidence 9999999999999 9999999999999999999999999998654332111110 1122345677999999875
Q ss_pred --CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCcc-----chhhh---------h-----------
Q 024027 153 --GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPIS-----TMEVV---------D----------- 205 (273)
Q Consensus 153 --~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-----~~~~~---------~----------- 205 (273)
..++.++|||||||+++++++|..||..................... ..+.. +
T Consensus 183 ~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (327)
T cd08227 183 NLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVST 262 (327)
T ss_pred ccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCC
Confidence 45889999999999999999999999754332211111110000000 00000 0
Q ss_pred hhccccchhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 206 ANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
................++.++.+|+.+||+.||++|||++++++|-.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~ 309 (327)
T cd08227 263 PRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 309 (327)
T ss_pred cCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChh
Confidence 00000000001112345677999999999999999999999998754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=273.01 Aligned_cols=241 Identities=22% Similarity=0.231 Sum_probs=176.8
Q ss_pred CeEEEEEeecc--cChhhhhHHHHHHHHhcCCCccceeeeeeeecCC------ceeEEEeccCCCCHHHhhhcCCCCCCH
Q 024027 1 MEVAVKVFNLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEE------FKALVLEYMPHGSLEKYLYSSNCILDI 72 (273)
Q Consensus 1 ~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~ 72 (273)
++||||+++.. .......+.+|+.+++.++||||+++++++.... ..++||||+++ +|.+.+.. .++.
T Consensus 47 ~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~ 122 (359)
T cd07876 47 INVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIHM---ELDH 122 (359)
T ss_pred ceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHhc---cCCH
Confidence 37999999644 2344567889999999999999999999986543 46899999976 77777643 3788
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC
Q 024027 73 FQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE 152 (273)
Q Consensus 73 ~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 152 (273)
..+..++.|++.||.||| +.|++||||||+||+++.++.++|+|||++...... .......+++.|+|||.+.+
T Consensus 123 ~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~ 196 (359)
T cd07876 123 ERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN---FMMTPYVVTRYYRAPEVILG 196 (359)
T ss_pred HHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCccccccC---ccCCCCcccCCCCCchhccC
Confidence 899999999999999999 999999999999999999999999999998654221 11233467889999999999
Q ss_pred CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccc--h--------hhhhhhcc-cc----------
Q 024027 153 GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPIST--M--------EVVDANLL-SQ---------- 211 (273)
Q Consensus 153 ~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~--------~~~~~~~~-~~---------- 211 (273)
..++.++|||||||++|+|++|..||....... .............. . ........ ..
T Consensus 197 ~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (359)
T cd07876 197 MGYKENVDIWSVGCIMGELVKGSVIFQGTDHID-QWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDW 275 (359)
T ss_pred CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhcccc
Confidence 899999999999999999999999997643211 11111111100000 0 00000000 00
Q ss_pred -chhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 212 -EDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 212 -~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
...........+.++.+|+.+||..||++|||++++++|-+
T Consensus 276 ~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 317 (359)
T cd07876 276 IFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY 317 (359)
T ss_pred ccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCch
Confidence 00000011224567899999999999999999999999865
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=265.65 Aligned_cols=231 Identities=26% Similarity=0.426 Sum_probs=182.9
Q ss_pred eEEEEEeecc-cChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC------------
Q 024027 2 EVAVKVFNLQ-CGRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN------------ 67 (273)
Q Consensus 2 ~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------ 67 (273)
.||+|.++.. .....+.+..|+++++++ +||||+++++++...+..++++||+++++|.+++....
T Consensus 31 ~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 110 (297)
T cd05089 31 NAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEH 110 (297)
T ss_pred eeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhcccccccccccccc
Confidence 4688888743 234456789999999999 79999999999999999999999999999999996432
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCC
Q 024027 68 ---CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGY 144 (273)
Q Consensus 68 ---~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~ 144 (273)
..+++..++.++.|++.||+||| +.|++|+||||+||+++.++.++|+|||++..... .........+..|
T Consensus 111 ~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~---~~~~~~~~~~~~y 184 (297)
T cd05089 111 GTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSRGEEV---YVKKTMGRLPVRW 184 (297)
T ss_pred CccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeEEECCcCCCccccc---eeccCCCCcCccc
Confidence 24788999999999999999999 99999999999999999999999999999863211 0111112234569
Q ss_pred CCCcccCCCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhH
Q 024027 145 MAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCV 223 (273)
Q Consensus 145 ~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (273)
+|||.+.+..++.++|||||||++|+|++ |..||........ .... .. ......+..++
T Consensus 185 ~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~-~~~~-------------~~------~~~~~~~~~~~ 244 (297)
T cd05089 185 MAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL-YEKL-------------PQ------GYRMEKPRNCD 244 (297)
T ss_pred cCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHH-------------hc------CCCCCCCCCCC
Confidence 99999988889999999999999999997 9999865322211 0000 00 00111134466
Q ss_pred HHHHHHHhhcCCCCccCCCCHHHHHHHHHHHHHhh
Q 024027 224 SFVFNLAMACTVESPEQRINAKEIVTKLLKIRDSL 258 (273)
Q Consensus 224 ~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 258 (273)
.++.+|+.+||..+|.+|||++++++.|.++....
T Consensus 245 ~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 245 DEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 77999999999999999999999999999888765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=263.81 Aligned_cols=244 Identities=23% Similarity=0.237 Sum_probs=179.6
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC--CCCCHHHHH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN--CILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~ 76 (273)
++||||+++... ......+.+|+.+++.++||||+++++++.++...++||||++ ++|.+++.... ..+++..++
T Consensus 26 ~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~ 104 (285)
T cd07861 26 QIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVK 104 (285)
T ss_pred cEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHH
Confidence 369999987542 2234678899999999999999999999999999999999997 48988886432 468999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCC-Cc
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG-RV 155 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~ 155 (273)
.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++....... .......+++.|+|||.+.+. .+
T Consensus 105 ~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~ 179 (285)
T cd07861 105 SYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV--RVYTHEVVTLWYRAPEVLLGSPRY 179 (285)
T ss_pred HHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc--ccccCCcccccccChHHhcCCCCc
Confidence 99999999999999 9999999999999999999999999999987542211 112233567889999987654 47
Q ss_pred CCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccC-------cc-chhhhhhhccccchhhhhhhhhhHHHHH
Q 024027 156 STNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLP-------IS-TMEVVDANLLSQEDIHFVAKEQCVSFVF 227 (273)
Q Consensus 156 ~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-------~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 227 (273)
+.++|+||||++++++++|..||................... .. ......................++.++.
T Consensus 180 ~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (285)
T cd07861 180 STPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGL 259 (285)
T ss_pred CcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHH
Confidence 889999999999999999999997543322111111000000 00 0000000000000111111234678899
Q ss_pred HHHhhcCCCCccCCCCHHHHHHH
Q 024027 228 NLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 228 ~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
+++.+||..||.+|||+.++++|
T Consensus 260 ~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 260 DLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHHHHhcCChhhCCCHHHHhcC
Confidence 99999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=263.68 Aligned_cols=228 Identities=30% Similarity=0.483 Sum_probs=181.1
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcC------CCCCCHHH
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS------NCILDIFQ 74 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~ 74 (273)
.||||.+.... ......+.+|+++++.++||||+++++++......+++|||+++++|.+++... ...+++..
T Consensus 28 ~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 107 (269)
T cd05044 28 RVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKE 107 (269)
T ss_pred eehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHH
Confidence 57888886543 345678899999999999999999999999999999999999999999999642 23478899
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCC-----ceEEeecccccccccCCCcceeecccccCCCCCCcc
Q 024027 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNL-----VAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEY 149 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~-----~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~ 149 (273)
+..++.|++.||.||| +.+++|+||+|+||+++.++ .++++|||++................++..|+|||.
T Consensus 108 ~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 184 (269)
T cd05044 108 LLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPES 184 (269)
T ss_pred HHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHH
Confidence 9999999999999999 99999999999999999877 899999999875532221112223345678999999
Q ss_pred cCCCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHH
Q 024027 150 GREGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFN 228 (273)
Q Consensus 150 ~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 228 (273)
+.+..++.++||||||+++|+|++ |..||......+. .. ... .. .....+..++..+.+
T Consensus 185 ~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~-~~-~~~------------~~------~~~~~~~~~~~~~~~ 244 (269)
T cd05044 185 LLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV-LQ-HVT------------AG------GRLQKPENCPDKIYQ 244 (269)
T ss_pred HccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHH-HH-HHh------------cC------CccCCcccchHHHHH
Confidence 988889999999999999999998 9999865322111 00 000 00 001113446677999
Q ss_pred HHhhcCCCCccCCCCHHHHHHHHH
Q 024027 229 LAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 229 li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
++.+||..+|.+||+++++++.|+
T Consensus 245 li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 245 LMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred HHHHHcCCCcccCCCHHHHHHHHh
Confidence 999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=275.73 Aligned_cols=229 Identities=22% Similarity=0.277 Sum_probs=180.3
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||+|+++... ......+..|+.+++.++||||+++++++.++...++||||+++|+|.+++... .+++..+..
T Consensus 69 ~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~--~l~~~~~~~ 146 (370)
T cd05596 69 QVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY--DIPEKWARF 146 (370)
T ss_pred CEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHH
Confidence 369999996432 233455778999999999999999999999999999999999999999998654 478889999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCC----
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG---- 153 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---- 153 (273)
++.|++.||.||| +.|++||||||+||+++.++.++|+|||++........ .......|++.|+|||.+.+.
T Consensus 147 ~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ 222 (370)
T cd05596 147 YTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDG 222 (370)
T ss_pred HHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCC
Confidence 9999999999999 99999999999999999999999999999876532211 122345689999999988653
Q ss_pred CcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhc
Q 024027 154 RVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMAC 233 (273)
Q Consensus 154 ~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 233 (273)
.++.++|+|||||++|+|++|..||....... .+..+... ......+....++.++.+|+.+|
T Consensus 223 ~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~i~~~----------------~~~~~~~~~~~~s~~~~~li~~~ 285 (370)
T cd05596 223 YYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-TYSKIMDH----------------KNSLTFPDDIEISKQAKDLICAF 285 (370)
T ss_pred CCCCceeeeehhHHHHHHHhCCCCcCCCCHHH-HHHHHHcC----------------CCcCCCCCcCCCCHHHHHHHHHH
Confidence 37899999999999999999999997533211 11111100 00011111224677899999999
Q ss_pred CCCCccC--CCCHHHHHHHHH
Q 024027 234 TVESPEQ--RINAKEIVTKLL 252 (273)
Q Consensus 234 l~~dp~~--Rps~~~~l~~l~ 252 (273)
|..+|.+ |+|++++++|-+
T Consensus 286 L~~~p~r~~R~s~~ell~h~~ 306 (370)
T cd05596 286 LTDREVRLGRNGVDEIKSHPF 306 (370)
T ss_pred ccChhhccCCCCHHHHhcCcc
Confidence 9999988 999999998853
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=266.60 Aligned_cols=249 Identities=21% Similarity=0.270 Sum_probs=186.7
Q ss_pred CeEEEEEeecc--cChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcC-CCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~ 77 (273)
++||||+++.. +......+..|+++++.++|+||+++++++.++...+++|||+++++|.+++... ...+++..+..
T Consensus 26 ~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~ 105 (314)
T cd08216 26 TLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF 105 (314)
T ss_pred CEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHH
Confidence 47999999755 3456678999999999999999999999999999999999999999999999754 34588999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCc-----ceeecccccCCCCCCcccCC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQS-----MTQTQTLATIGYMAPEYGRE 152 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~ 152 (273)
++.|++.||.||| +.+++|+||+|+||+++.++.++++||+.+..+...... .......++..|+|||.+..
T Consensus 106 ~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 182 (314)
T cd08216 106 ILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQ 182 (314)
T ss_pred HHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcC
Confidence 9999999999999 999999999999999999999999999988655322211 11122345678999999865
Q ss_pred --CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccC---ccchhhhh----------hhccccchhhhh
Q 024027 153 --GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLP---ISTMEVVD----------ANLLSQEDIHFV 217 (273)
Q Consensus 153 --~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~----------~~~~~~~~~~~~ 217 (273)
..++.++|+||+||+++++++|..||................... ........ ............
T Consensus 183 ~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (314)
T cd08216 183 NLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHP 262 (314)
T ss_pred CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcc
Confidence 358899999999999999999999997643322221111100000 00000000 000001111222
Q ss_pred hhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 218 AKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 218 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
....++.++.+|+.+||..||++|||++++++|-.
T Consensus 263 ~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~ 297 (314)
T cd08216 263 YTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297 (314)
T ss_pred hhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence 23456678999999999999999999999999866
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=262.00 Aligned_cols=228 Identities=27% Similarity=0.443 Sum_probs=179.9
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC------------
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN------------ 67 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------ 67 (273)
.||+|.++... ......+..|+++++.+ +||||+++++++...+..+++|||+++++|.+++....
T Consensus 24 ~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~ 103 (270)
T cd05047 24 DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 103 (270)
T ss_pred EEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhcccccccccccccc
Confidence 47888887432 34556788999999999 89999999999999999999999999999999986432
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCC
Q 024027 68 ---CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGY 144 (273)
Q Consensus 68 ---~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~ 144 (273)
..+++..+..++.|++.|++||| +.|++|+||||+||+++.++.++++|||++..... .........+..|
T Consensus 104 ~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~---~~~~~~~~~~~~y 177 (270)
T cd05047 104 STASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV---YVKKTMGRLPVRW 177 (270)
T ss_pred CCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCCCccccch---hhhccCCCCcccc
Confidence 24788999999999999999999 99999999999999999999999999998753211 1111112235679
Q ss_pred CCCcccCCCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhH
Q 024027 145 MAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCV 223 (273)
Q Consensus 145 ~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (273)
+|||.+.+..++.++|+||||+++++|++ |..||......+. .... .. . .....+..++
T Consensus 178 ~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~-~~~~----~~---------~------~~~~~~~~~~ 237 (270)
T cd05047 178 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-YEKL----PQ---------G------YRLEKPLNCD 237 (270)
T ss_pred CChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHH-HHHH----hC---------C------CCCCCCCcCC
Confidence 99999988889999999999999999997 9999865322111 1100 00 0 0001123456
Q ss_pred HHHHHHHhhcCCCCccCCCCHHHHHHHHHHHH
Q 024027 224 SFVFNLAMACTVESPEQRINAKEIVTKLLKIR 255 (273)
Q Consensus 224 ~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 255 (273)
.++.+++.+||..||.+|||+.+++..|.++.
T Consensus 238 ~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 238 DEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred HHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 67999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=259.38 Aligned_cols=229 Identities=28% Similarity=0.421 Sum_probs=182.0
Q ss_pred eEEEEEeecccC-hhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQCG-RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
.||+|.+..... ...+.+..|+++++.++|+||+++++++.. ...+++|||+++++|.+++.... .+++..+..++.
T Consensus 25 ~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ 102 (257)
T cd05060 25 EVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPLGPLLKYLKKRR-EIPVSDLKELAH 102 (257)
T ss_pred eEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCCCcHHHHHHhCC-CCCHHHHHHHHH
Confidence 589999975543 355678999999999999999999998764 45789999999999999997554 689999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcce-eecccccCCCCCCcccCCCCcCCcc
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMT-QTQTLATIGYMAPEYGREGRVSTNG 159 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~ 159 (273)
|++.|+.+|| ..+++|+||+|+||+++.++.++|+|||.+........... .....++..|+|||.+.+..++.++
T Consensus 103 qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 179 (257)
T cd05060 103 QVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKS 179 (257)
T ss_pred HHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccc
Confidence 9999999999 99999999999999999999999999999876533222111 1111234579999999888899999
Q ss_pred hhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc
Q 024027 160 DVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238 (273)
Q Consensus 160 DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 238 (273)
||||||+++|++++ |..||......+ ........ .....+..++..+.+++.+||..+|
T Consensus 180 Di~slG~~l~~~~~~g~~p~~~~~~~~--~~~~~~~~------------------~~~~~~~~~~~~l~~li~~cl~~~p 239 (257)
T cd05060 180 DVWSYGVTLWEAFSYGAKPYGEMKGAE--VIAMLESG------------------ERLPRPEECPQEIYSIMLSCWKYRP 239 (257)
T ss_pred hHHHHHHHHHHHHcCCCCCcccCCHHH--HHHHHHcC------------------CcCCCCCCCCHHHHHHHHHHhcCCh
Confidence 99999999999997 999986543211 11111100 0011234566779999999999999
Q ss_pred cCCCCHHHHHHHHHHHH
Q 024027 239 EQRINAKEIVTKLLKIR 255 (273)
Q Consensus 239 ~~Rps~~~~l~~l~~~~ 255 (273)
.+|||+.++++.|+++.
T Consensus 240 ~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 240 EDRPTFSELESTFRRDP 256 (257)
T ss_pred hhCcCHHHHHHHHHhcc
Confidence 99999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=265.43 Aligned_cols=227 Identities=26% Similarity=0.328 Sum_probs=183.9
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
++||||.+..........+.+|+.+++.++|||++++++++......++|+||+++++|..++... .+++..+..++.
T Consensus 45 ~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~ 122 (296)
T cd06655 45 QEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET--CMDEAQIAAVCR 122 (296)
T ss_pred cEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHhc--CCCHHHHHHHHH
Confidence 479999997665555677889999999999999999999999999999999999999999998643 489999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
|++.|+.+|| +.|++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|
T Consensus 123 ~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~D 197 (296)
T cd06655 123 ECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVD 197 (296)
T ss_pred HHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc--cCCCcCCCccccCcchhcCCCCCchhh
Confidence 9999999999 99999999999999999999999999998875432211 122345788899999998888999999
Q ss_pred hHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccC
Q 024027 161 VYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQ 240 (273)
Q Consensus 161 iwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 240 (273)
+|||||++|++++|..||.......... ...... ......+..++..+.+++.+||..||.+
T Consensus 198 v~slGvil~~lltg~~pf~~~~~~~~~~-~~~~~~-----------------~~~~~~~~~~~~~~~~li~~~l~~dp~~ 259 (296)
T cd06655 198 IWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNG-----------------TPELQNPEKLSPIFRDFLNRCLEMDVEK 259 (296)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcC-----------------CcccCCcccCCHHHHHHHHHHhhcChhh
Confidence 9999999999999999986533221110 000000 0001113346677999999999999999
Q ss_pred CCCHHHHHHHHH
Q 024027 241 RINAKEIVTKLL 252 (273)
Q Consensus 241 Rps~~~~l~~l~ 252 (273)
|||+.++++|=+
T Consensus 260 Rpt~~~il~~~~ 271 (296)
T cd06655 260 RGSAKELLQHPF 271 (296)
T ss_pred CCCHHHHhhChH
Confidence 999999997744
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=259.37 Aligned_cols=228 Identities=26% Similarity=0.376 Sum_probs=184.3
Q ss_pred eEEEEEeecccC-hhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC-CCCCHHHHHHHH
Q 024027 2 EVAVKVFNLQCG-RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIM 79 (273)
Q Consensus 2 ~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ 79 (273)
+||||.++.... ...+.+..|+++++.++||||+++++++.+ ...++++||+++++|.+++.... ..+++..++.++
T Consensus 25 ~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 103 (257)
T cd05040 25 PVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYA 103 (257)
T ss_pred EEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHH
Confidence 589999987655 567789999999999999999999999988 88999999999999999997654 468999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcc-eeecccccCCCCCCcccCCCCcCCc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSM-TQTQTLATIGYMAPEYGREGRVSTN 158 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~ 158 (273)
.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++..+....... ......++..|+|||.+.+..++.+
T Consensus 104 ~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~ 180 (257)
T cd05040 104 VQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHA 180 (257)
T ss_pred HHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCch
Confidence 99999999999 9999999999999999999999999999987764322211 1123346778999999988889999
Q ss_pred chhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 159 GDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 159 ~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
+||||||+++++|++ |..||......+. ....... ......+..++..+.+++.+||..+
T Consensus 181 ~Di~slG~~l~el~t~g~~p~~~~~~~~~-~~~~~~~------------------~~~~~~~~~~~~~~~~li~~~l~~~ 241 (257)
T cd05040 181 SDVWMFGVTLWEMFTYGEEPWAGLSGSQI-LKKIDKE------------------GERLERPEACPQDIYNVMLQCWAHN 241 (257)
T ss_pred hhhHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHhc------------------CCcCCCCccCCHHHHHHHHHHCCCC
Confidence 999999999999998 9999864322211 1100000 0000112345667999999999999
Q ss_pred ccCCCCHHHHHHHHH
Q 024027 238 PEQRINAKEIVTKLL 252 (273)
Q Consensus 238 p~~Rps~~~~l~~l~ 252 (273)
|++|||+.++++.|.
T Consensus 242 p~~Rps~~~~~~~l~ 256 (257)
T cd05040 242 PADRPTFAALREFLP 256 (257)
T ss_pred cccCCCHHHHHHHhc
Confidence 999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=260.73 Aligned_cols=230 Identities=26% Similarity=0.456 Sum_probs=184.3
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
.||+|.++... ....+.+..|+.+++.++||||+++++++..+...++||||+++++|.+++......+++..+..++.
T Consensus 34 ~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ 113 (267)
T cd05066 34 PVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR 113 (267)
T ss_pred EEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHH
Confidence 58999987543 33456789999999999999999999999999999999999999999999977666789999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcce-eecccccCCCCCCcccCCCCcCCcc
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMT-QTQTLATIGYMAPEYGREGRVSTNG 159 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~ 159 (273)
|++.|+.+|| +.|++|+||+|+||+++.++.++++|||++..+........ .....++..|+|||.+.+..++.++
T Consensus 114 ~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~ 190 (267)
T cd05066 114 GIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSAS 190 (267)
T ss_pred HHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchh
Confidence 9999999999 99999999999999999999999999999976543221111 1112234579999999888899999
Q ss_pred hhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc
Q 024027 160 DVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238 (273)
Q Consensus 160 DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 238 (273)
|+||||++++++++ |..||......+. ....... .....+..++..+.+++.+||+.+|
T Consensus 191 Dv~slG~~l~ell~~g~~p~~~~~~~~~-~~~~~~~-------------------~~~~~~~~~~~~~~~li~~~l~~~p 250 (267)
T cd05066 191 DVWSYGIVMWEVMSYGERPYWEMSNQDV-IKAIEEG-------------------YRLPAPMDCPAALHQLMLDCWQKDR 250 (267)
T ss_pred hhHHHHHHHHHHhcCCCCCcccCCHHHH-HHHHhCC-------------------CcCCCCCCCCHHHHHHHHHHcccCc
Confidence 99999999999886 9999865432211 1111000 0011123456779999999999999
Q ss_pred cCCCCHHHHHHHHHHH
Q 024027 239 EQRINAKEIVTKLLKI 254 (273)
Q Consensus 239 ~~Rps~~~~l~~l~~~ 254 (273)
.+|||+.++++.|.++
T Consensus 251 ~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 251 NERPKFEQIVSILDKL 266 (267)
T ss_pred hhCCCHHHHHHHHHhh
Confidence 9999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=283.29 Aligned_cols=227 Identities=23% Similarity=0.265 Sum_probs=181.4
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCC--------ceeEEEeccCCCCHHHhhhcC---C
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEE--------FKALVLEYMPHGSLEKYLYSS---N 67 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--------~~~lv~e~~~~~~L~~~l~~~---~ 67 (273)
+.||||++.... ......+.+|+.++..++|+|++++.+.+.... .+++||||+++|+|.+++... .
T Consensus 58 ~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~ 137 (496)
T PTZ00283 58 EPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTN 137 (496)
T ss_pred CEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccC
Confidence 479999997542 345567889999999999999999988775432 367999999999999998542 3
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCC
Q 024027 68 CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 147 (273)
Q Consensus 68 ~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aP 147 (273)
..+++..+..++.|++.||.||| +.|++|+||||+||+++.++.+||+|||++..+.............|++.|+||
T Consensus 138 ~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aP 214 (496)
T PTZ00283 138 RTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAP 214 (496)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCH
Confidence 46889999999999999999999 999999999999999999999999999998765433222233445789999999
Q ss_pred cccCCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHH
Q 024027 148 EYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVF 227 (273)
Q Consensus 148 E~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 227 (273)
|.+.+..++.++|||||||++|+|++|..||......+ ....... ......+..++.++.
T Consensus 215 E~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~-----~~~~~~~---------------~~~~~~~~~~~~~l~ 274 (496)
T PTZ00283 215 EIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE-----VMHKTLA---------------GRYDPLPPSISPEMQ 274 (496)
T ss_pred HHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-----HHHHHhc---------------CCCCCCCCCCCHHHH
Confidence 99998889999999999999999999999986532211 1110000 000112445677899
Q ss_pred HHHhhcCCCCccCCCCHHHHHHH
Q 024027 228 NLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 228 ~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
+++.+||..||.+|||+.+++++
T Consensus 275 ~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 275 EIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHHHHcccChhhCcCHHHHHhC
Confidence 99999999999999999999986
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=261.87 Aligned_cols=232 Identities=25% Similarity=0.367 Sum_probs=186.2
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
+||+|+++... ......+.+|+.+++.++||||+++++++.. ...++++||+++|+|.+++......+++..+..++.
T Consensus 38 ~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 116 (279)
T cd05057 38 PVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCV 116 (279)
T ss_pred EEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHH
Confidence 58999887554 3345678899999999999999999999887 788999999999999999987766799999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
|++.|++||| +.|++|+||+|+||+++.++.++|+|||.+................++..|+|||.+....++.++|
T Consensus 117 qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~D 193 (279)
T cd05057 117 QIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSD 193 (279)
T ss_pred HHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhh
Confidence 9999999999 9999999999999999999999999999997664322211111222356799999998888999999
Q ss_pred hHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCcc
Q 024027 161 VYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239 (273)
Q Consensus 161 iwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 239 (273)
+||||++++++++ |..||......+ ....... . .....+..++..+.+++.+||..||.
T Consensus 194 i~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~------------~------~~~~~~~~~~~~~~~~~~~~l~~~p~ 253 (279)
T cd05057 194 VWSYGVTVWELMTFGAKPYEGIPAVE--IPDLLEK------------G------ERLPQPPICTIDVYMVLVKCWMIDAE 253 (279)
T ss_pred HHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHHhC------------C------CCCCCCCCCCHHHHHHHHHHcCCChh
Confidence 9999999999998 999986532211 1111000 0 00111334556789999999999999
Q ss_pred CCCCHHHHHHHHHHHHHh
Q 024027 240 QRINAKEIVTKLLKIRDS 257 (273)
Q Consensus 240 ~Rps~~~~l~~l~~~~~~ 257 (273)
+|||+.++++.|..+.++
T Consensus 254 ~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 254 SRPTFKELINEFSKMARD 271 (279)
T ss_pred hCCCHHHHHHHHHHHHhC
Confidence 999999999999988664
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=278.87 Aligned_cols=230 Identities=22% Similarity=0.325 Sum_probs=179.7
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||||++.... ......+.+|+++++.++|+||+++++.+.+++.+++||||+++|+|.+++...+ .+++..+..
T Consensus 27 ~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~-~~~~~~~~~ 105 (376)
T cd05598 27 ALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLG-IFEEDLARF 105 (376)
T ss_pred CEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHH
Confidence 469999996432 2345668899999999999999999999999999999999999999999996554 688999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCC--------------------------
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQ-------------------------- 131 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~-------------------------- 131 (273)
++.|++.||.||| +.|++||||||+||+++.++.++|+|||++..+.....
T Consensus 106 ~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (376)
T cd05598 106 YIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182 (376)
T ss_pred HHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccccccccccccccccccccccccc
Confidence 9999999999999 99999999999999999999999999998753310000
Q ss_pred ---------------cceeecccccCCCCCCcccCCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhcc
Q 024027 132 ---------------SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWL 196 (273)
Q Consensus 132 ---------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 196 (273)
.......+|++.|+|||++.+..++.++|||||||++|+|++|..||......+.... ... +
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~-i~~-~- 259 (376)
T cd05598 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLK-VIN-W- 259 (376)
T ss_pred ccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHH-Hhc-c-
Confidence 0001124689999999999988899999999999999999999999976432211110 000 0
Q ss_pred CccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccCCC---CHHHHHHHHH
Q 024027 197 PISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRI---NAKEIVTKLL 252 (273)
Q Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~~l~~l~ 252 (273)
...........++.++.+++.+|+ .+|.+|+ |+.++++|-+
T Consensus 260 --------------~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~ 303 (376)
T cd05598 260 --------------ETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPF 303 (376)
T ss_pred --------------CccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCC
Confidence 000011112345677899999976 5999999 9999999843
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=264.90 Aligned_cols=244 Identities=25% Similarity=0.256 Sum_probs=180.7
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
+.||+|.++... ......+.+|+++++.++|+||+++++++.+....++++||+++ +|.+++......+++..++.+
T Consensus 26 ~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~ 104 (284)
T cd07839 26 EIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSF 104 (284)
T ss_pred cEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCCC-CHHHHHHhcCCCCCHHHHHHH
Confidence 368999987542 22345678899999999999999999999999999999999975 898888766667999999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCC-CcCC
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG-RVST 157 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~ 157 (273)
+.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+. .++.
T Consensus 105 ~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~ 179 (284)
T cd07839 105 MFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYST 179 (284)
T ss_pred HHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC--CCcCCCccccCCcChHHHhCCcccCc
Confidence 999999999999 9999999999999999999999999999987542211 112234567889999988664 4789
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhh--h----hhh---ccccchhhhhhhhhhHHHHHH
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEV--V----DAN---LLSQEDIHFVAKEQCVSFVFN 228 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~----~~~---~~~~~~~~~~~~~~~~~~l~~ 228 (273)
++|||||||++|+|++|..||.........+............... . ... ..............++.++.+
T Consensus 180 ~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (284)
T cd07839 180 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRD 259 (284)
T ss_pred HHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHH
Confidence 9999999999999999998864433322222221111111000000 0 000 000000001122456788999
Q ss_pred HHhhcCCCCccCCCCHHHHHHH
Q 024027 229 LAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 229 li~~~l~~dp~~Rps~~~~l~~ 250 (273)
++.+||..||.+|||++++++|
T Consensus 260 li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 260 LLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred HHHHHhcCChhhcCCHHHHhcC
Confidence 9999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=270.46 Aligned_cols=223 Identities=21% Similarity=0.265 Sum_probs=177.9
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (273)
+.||||+++... ......+..|..++..+ +|++|+++++++.+...+++||||+++|+|.+++...+ .+++..+.
T Consensus 26 ~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~-~~~~~~~~ 104 (323)
T cd05616 26 ELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVG-RFKEPHAV 104 (323)
T ss_pred CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHcC-CCCHHHHH
Confidence 369999997542 23345567788888877 68999999999999999999999999999999986544 58999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcC
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVS 156 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 156 (273)
.++.|++.||.||| +.|++||||||+||+++.++.++|+|||++...... ........|++.|+|||.+.+..++
T Consensus 105 ~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~ 179 (323)
T cd05616 105 FYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD--GVTTKTFCGTPDYIAPEIIAYQPYG 179 (323)
T ss_pred HHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC--CCccccCCCChhhcCHHHhcCCCCC
Confidence 99999999999999 999999999999999999999999999998653211 1122345689999999999988999
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++|+|||||++|+|++|..||........ ...+... ....+...+.++.+++.+||..
T Consensus 180 ~~~DiwSlGvil~elltg~~Pf~~~~~~~~-~~~i~~~--------------------~~~~p~~~s~~~~~li~~~l~~ 238 (323)
T cd05616 180 KSVDWWAFGVLLYEMLAGQAPFEGEDEDEL-FQSIMEH--------------------NVAYPKSMSKEAVAICKGLMTK 238 (323)
T ss_pred CccchhchhHHHHHHHhCCCCCCCCCHHHH-HHHHHhC--------------------CCCCCCcCCHHHHHHHHHHccc
Confidence 999999999999999999999975332211 1111100 0011334667799999999999
Q ss_pred CccCCCCH-----HHHHHH
Q 024027 237 SPEQRINA-----KEIVTK 250 (273)
Q Consensus 237 dp~~Rps~-----~~~l~~ 250 (273)
||.+|++. .++++|
T Consensus 239 ~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 239 HPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred CHHhcCCCCCCCHHHHhcC
Confidence 99999985 667655
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=262.81 Aligned_cols=220 Identities=24% Similarity=0.338 Sum_probs=174.9
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~q 81 (273)
.||+|++..........+.+|+.+++.++||||+++++++.++...++||||+++++|..++......+++..+..++.|
T Consensus 46 ~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~q 125 (274)
T cd05076 46 RVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQ 125 (274)
T ss_pred eEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHH
Confidence 58999997654445567889999999999999999999999999999999999999999999766667899999999999
Q ss_pred HHHHHHHHhcCCCCCeEeccCCCCceeeCCCC-------ceEEeecccccccccCCCcceeecccccCCCCCCcccCC-C
Q 024027 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNL-------VAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE-G 153 (273)
Q Consensus 82 l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~-------~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~ 153 (273)
++.||.||| +.|++|+||||+||+++..+ .++++|||.+..... .....++..|+|||.+.+ .
T Consensus 126 i~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~ 196 (274)
T cd05076 126 LASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGN 196 (274)
T ss_pred HHHHHHHHH---cCCccCCCCCcccEEEeccCcccCccceeeecCCcccccccc------ccccccCCcccCchhhcCCC
Confidence 999999999 99999999999999997543 479999998754311 122346778999998865 5
Q ss_pred CcCCcchhHHHHHHHHHHH-hCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhh
Q 024027 154 RVSTNGDVYSFGIMLMETF-TGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMA 232 (273)
Q Consensus 154 ~~~~~~DiwslG~~l~~ll-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 232 (273)
.++.++|+||||+++|+++ +|..||......+. ..... ... ..+...+..+.+++.+
T Consensus 197 ~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--~~~~~------------~~~--------~~~~~~~~~~~~li~~ 254 (274)
T cd05076 197 SLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK--ERFYE------------KKH--------RLPEPSCKELATLISQ 254 (274)
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH--HHHHH------------hcc--------CCCCCCChHHHHHHHH
Confidence 5899999999999999985 68898865332211 00000 000 0011223458999999
Q ss_pred cCCCCccCCCCHHHHHHHHH
Q 024027 233 CTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 233 ~l~~dp~~Rps~~~~l~~l~ 252 (273)
||..+|.+|||+.++++.|.
T Consensus 255 cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 255 CLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HcccChhhCcCHHHHHHhhC
Confidence 99999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=263.83 Aligned_cols=235 Identities=26% Similarity=0.406 Sum_probs=179.5
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC-----------CC
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-----------CI 69 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~ 69 (273)
.||+|+++... ......+.+|+++++.++|+|++++++++......++||||+++++|.+++.... ..
T Consensus 46 ~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 125 (295)
T cd05097 46 LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPS 125 (295)
T ss_pred EEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCc
Confidence 48999997543 3345678999999999999999999999999999999999999999999985432 23
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcc
Q 024027 70 LDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEY 149 (273)
Q Consensus 70 ~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~ 149 (273)
+++..++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++..+.............++..|+|||.
T Consensus 126 ~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 202 (295)
T cd05097 126 VSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWES 202 (295)
T ss_pred ccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhh
Confidence 678889999999999999999 99999999999999999999999999999875432221111222344678999999
Q ss_pred cCCCCcCCcchhHHHHHHHHHHHh--CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHH
Q 024027 150 GREGRVSTNGDVYSFGIMLMETFT--GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVF 227 (273)
Q Consensus 150 ~~~~~~~~~~DiwslG~~l~~ll~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 227 (273)
+.+..++.++|+||||+++++|++ |..||......... ....... ... ........+..++..+.
T Consensus 203 ~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~-~~~~~~~---------~~~---~~~~~~~~~~~~~~~l~ 269 (295)
T cd05097 203 ILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVI-ENTGEFF---------RNQ---GRQIYLSQTPLCPSPVF 269 (295)
T ss_pred hccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHH-HHHHHhh---------hhc---cccccCCCCCCCCHHHH
Confidence 988889999999999999999988 66677653322110 0000000 000 00000011233566799
Q ss_pred HHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 228 NLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 228 ~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
+|+.+||..||.+|||++++++.|.
T Consensus 270 ~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 270 KLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHcCCCchhCcCHHHHHHHHh
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=273.20 Aligned_cols=232 Identities=24% Similarity=0.389 Sum_probs=183.6
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCC-CccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC------------
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIR-HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN------------ 67 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------ 67 (273)
.||||+++... ....+.+..|+++|..+. ||||+++++++..++..++|+||+++|+|.+++...+
T Consensus 69 ~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~ 148 (401)
T cd05107 69 KVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNR 148 (401)
T ss_pred EEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhccccc
Confidence 69999998653 333457889999999997 9999999999999999999999999999999986431
Q ss_pred --------------------------------------------------------------------------------
Q 024027 68 -------------------------------------------------------------------------------- 67 (273)
Q Consensus 68 -------------------------------------------------------------------------------- 67 (273)
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (401)
T cd05107 149 DDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDT 228 (401)
T ss_pred ccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhh
Confidence
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccC
Q 024027 68 -----CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATI 142 (273)
Q Consensus 68 -----~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~ 142 (273)
..+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++................++.
T Consensus 229 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~ 305 (401)
T cd05107 229 LINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPL 305 (401)
T ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCC
Confidence 13566778889999999999999 9999999999999999999999999999987653222212222334677
Q ss_pred CCCCCcccCCCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhh
Q 024027 143 GYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQ 221 (273)
Q Consensus 143 ~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (273)
.|+|||.+.+..++.++|+||||++++++++ |..||......+.......... ....+..
T Consensus 306 ~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~-------------------~~~~p~~ 366 (401)
T cd05107 306 KWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGY-------------------RMAKPAH 366 (401)
T ss_pred ceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCC-------------------CCCCCCC
Confidence 8999999988889999999999999999998 8889865332221111110000 0011334
Q ss_pred hHHHHHHHHhhcCCCCccCCCCHHHHHHHHHHHH
Q 024027 222 CVSFVFNLAMACTVESPEQRINAKEIVTKLLKIR 255 (273)
Q Consensus 222 ~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 255 (273)
++.++.+|+.+||..+|.+||+++++++.|+++.
T Consensus 367 ~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 367 ASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 6678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=260.77 Aligned_cols=225 Identities=20% Similarity=0.257 Sum_probs=181.5
Q ss_pred CeEEEEEeecc-cChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcC-CCCCCHHHHHHH
Q 024027 1 MEVAVKVFNLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNI 78 (273)
Q Consensus 1 ~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~ 78 (273)
+.||+|.++.. .....+.+..|+.+++.++|+||+++++++.++..+++++||+++++|.+++... ...+++..++.+
T Consensus 26 ~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 105 (255)
T cd08219 26 QKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW 105 (255)
T ss_pred ceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHH
Confidence 36899998754 3445677889999999999999999999999999999999999999999988643 345889999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCc
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTN 158 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 158 (273)
+.|++.||.+|| +.|++|+||+|+||+++.++.++++|||.+....... .......+++.|+|||.+.+..++.+
T Consensus 106 ~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~ 180 (255)
T cd08219 106 FVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG--AYACTYVGTPYYVPPEIWENMPYNNK 180 (255)
T ss_pred HHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeecccc--cccccccCCccccCHHHHccCCcCch
Confidence 999999999999 9999999999999999999999999999987653221 12233467888999999988889999
Q ss_pred chhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc
Q 024027 159 GDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238 (273)
Q Consensus 159 ~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 238 (273)
+|+||+|+++|+|++|..||........ ....... .....+..++..+.+|+.+||..||
T Consensus 181 ~Dv~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~~~-------------------~~~~~~~~~~~~~~~li~~~l~~~P 240 (255)
T cd08219 181 SDIWSLGCILYELCTLKHPFQANSWKNL-ILKVCQG-------------------SYKPLPSHYSYELRSLIKQMFKRNP 240 (255)
T ss_pred hhhhhhchhheehhhccCCCCCCCHHHH-HHHHhcC-------------------CCCCCCcccCHHHHHHHHHHHhCCc
Confidence 9999999999999999999865321111 0000000 0001123455678999999999999
Q ss_pred cCCCCHHHHHHH
Q 024027 239 EQRINAKEIVTK 250 (273)
Q Consensus 239 ~~Rps~~~~l~~ 250 (273)
.+|||+.+++..
T Consensus 241 ~~Rp~~~~il~~ 252 (255)
T cd08219 241 RSRPSATTILSR 252 (255)
T ss_pred ccCCCHHHHhhc
Confidence 999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=261.03 Aligned_cols=230 Identities=26% Similarity=0.418 Sum_probs=178.9
Q ss_pred eEEEEEeecc--cChhhhhHHHHHHHHhcCCCccceeeeeeeecC------CceeEEEeccCCCCHHHhhhc-----CCC
Q 024027 2 EVAVKVFNLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNE------EFKALVLEYMPHGSLEKYLYS-----SNC 68 (273)
Q Consensus 2 ~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~-----~~~ 68 (273)
.||+|.++.. +....+.+..|+++++.++|+||+++++++... ...++++||+++|+|.+++.. ...
T Consensus 28 ~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 107 (272)
T cd05075 28 KVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQ 107 (272)
T ss_pred eEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcc
Confidence 5899998754 234567788999999999999999999976432 246899999999999988742 223
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCc
Q 024027 69 ILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPE 148 (273)
Q Consensus 69 ~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE 148 (273)
.+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++..+.............++..|++||
T Consensus 108 ~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe 184 (272)
T cd05075 108 YLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIE 184 (272)
T ss_pred cCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHH
Confidence 4889999999999999999999 9999999999999999999999999999987653222111122234567899999
Q ss_pred ccCCCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHH
Q 024027 149 YGREGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVF 227 (273)
Q Consensus 149 ~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 227 (273)
...+..++.++|+||||+++|++++ |..||....... ......... ....+..++..+.
T Consensus 185 ~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-~~~~~~~~~-------------------~~~~~~~~~~~~~ 244 (272)
T cd05075 185 SLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE-IYDYLRQGN-------------------RLKQPPDCLDGLY 244 (272)
T ss_pred HccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHHcCC-------------------CCCCCCCCCHHHH
Confidence 9988889999999999999999999 788986532211 111110000 0011334567799
Q ss_pred HHHhhcCCCCccCCCCHHHHHHHHHHH
Q 024027 228 NLAMACTVESPEQRINAKEIVTKLLKI 254 (273)
Q Consensus 228 ~li~~~l~~dp~~Rps~~~~l~~l~~~ 254 (273)
+++.+||..||.+|||+.++++.|+++
T Consensus 245 ~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 245 SLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=271.88 Aligned_cols=219 Identities=27% Similarity=0.314 Sum_probs=172.3
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHH-HHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVEC-EMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (273)
+.||+|++.... ......+..|. .+++.++||||+++++++......++||||+++++|.+++.... .+.+..+.
T Consensus 21 ~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~ 99 (325)
T cd05602 21 KFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER-CFLEPRAR 99 (325)
T ss_pred CEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhcC-CCCHHHHH
Confidence 368999997542 22233444444 45678899999999999999999999999999999999996543 57888899
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcC
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVS 156 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 156 (273)
.++.|++.||.||| +.|++||||||+||+++.++.++|+|||++....... .......|++.|+|||++.+..++
T Consensus 100 ~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~ 174 (325)
T cd05602 100 FYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GTTSTFCGTPEYLAPEVLHKQPYD 174 (325)
T ss_pred HHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CCcccccCCccccCHHHHcCCCCC
Confidence 99999999999999 9999999999999999999999999999986532211 123345689999999999988899
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++|||||||++|+|++|..||......+. ....... ....+..++..+.+++.+||..
T Consensus 175 ~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~--------------------~~~~~~~~~~~~~~li~~~l~~ 233 (325)
T cd05602 175 RTVDWWCLGAVLYEMLYGLPPFYSRNTAEM-YDNILNK--------------------PLQLKPNITNSARHLLEGLLQK 233 (325)
T ss_pred CccccccccHHHHHHhcCCCCCCCCCHHHH-HHHHHhC--------------------CcCCCCCCCHHHHHHHHHHccc
Confidence 999999999999999999999975332211 1110000 0011235667799999999999
Q ss_pred CccCCCCHHH
Q 024027 237 SPEQRINAKE 246 (273)
Q Consensus 237 dp~~Rps~~~ 246 (273)
||.+||++.+
T Consensus 234 ~p~~R~~~~~ 243 (325)
T cd05602 234 DRTKRLGAKD 243 (325)
T ss_pred CHHHCCCCCC
Confidence 9999998873
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=260.36 Aligned_cols=226 Identities=27% Similarity=0.398 Sum_probs=181.0
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCC--CHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCIL--DIFQRLNIM 79 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~ 79 (273)
.||+|.++.......+.+.+|+.+++.++|+||+++++++..+...++++||+++++|.+++......+ ++..+..++
T Consensus 35 ~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 114 (268)
T cd06624 35 RIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYT 114 (268)
T ss_pred EEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHH
Confidence 689999887766677889999999999999999999999999999999999999999999997654445 788899999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCC-CCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCC--cC
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDD-NLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGR--VS 156 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~-~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~ 156 (273)
.|++.|++||| +.|++|+||+|+||+++. ++.++|+|||.+........ ......++..|+|||.+.+.. ++
T Consensus 115 ~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~ 189 (268)
T cd06624 115 KQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYG 189 (268)
T ss_pred HHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC--ccccCCCCccccChhhhccccccCC
Confidence 99999999999 999999999999999976 67999999999876532221 122335788999999886543 78
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++|+||+|+++|++++|..||............. . ........+..++.++.+++.+||..
T Consensus 190 ~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~---------------~---~~~~~~~~~~~~~~~~~~li~~~l~~ 251 (268)
T cd06624 190 APADIWSLGCTIVEMATGKPPFIELGEPQAAMFKV---------------G---MFKIHPEIPESLSAEAKNFILRCFEP 251 (268)
T ss_pred chhhhHHHHHHHHHHHhCCCCCccccChhhhHhhh---------------h---hhccCCCCCcccCHHHHHHHHHHcCC
Confidence 89999999999999999999986532211111000 0 00001112345667799999999999
Q ss_pred CccCCCCHHHHHHH
Q 024027 237 SPEQRINAKEIVTK 250 (273)
Q Consensus 237 dp~~Rps~~~~l~~ 250 (273)
+|.+|||+.+++.|
T Consensus 252 ~p~~Rpt~~~ll~~ 265 (268)
T cd06624 252 DPDKRASAHDLLQD 265 (268)
T ss_pred CchhCCCHHHHHhC
Confidence 99999999999876
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=263.70 Aligned_cols=233 Identities=25% Similarity=0.387 Sum_probs=181.5
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC---------CCCC
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN---------CILD 71 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~ 71 (273)
+||+|.++... ......+.+|+.+++.++||||+++++++.+....++||||+++|+|.+++.... ....
T Consensus 38 ~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 117 (288)
T cd05061 38 RVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 117 (288)
T ss_pred EEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCC
Confidence 68999986443 2344567889999999999999999999999999999999999999999996422 2356
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccC
Q 024027 72 IFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR 151 (273)
Q Consensus 72 ~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 151 (273)
...+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++................++..|+|||.+.
T Consensus 118 ~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~ 194 (288)
T cd05061 118 LQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLK 194 (288)
T ss_pred HHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhc
Confidence 6788999999999999999 9999999999999999999999999999987543222211122233467799999998
Q ss_pred CCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHH
Q 024027 152 EGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLA 230 (273)
Q Consensus 152 ~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 230 (273)
+..++.++|+|||||++|++++ |..||......+ ........ . ....+..++..+.+++
T Consensus 195 ~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~~----~---------------~~~~~~~~~~~~~~li 254 (288)
T cd05061 195 DGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ-VLKFVMDG----G---------------YLDQPDNCPERVTDLM 254 (288)
T ss_pred cCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHcC----C---------------CCCCCCCCCHHHHHHH
Confidence 8889999999999999999998 788886532211 11000000 0 0011234456799999
Q ss_pred hhcCCCCccCCCCHHHHHHHHHHHHHh
Q 024027 231 MACTVESPEQRINAKEIVTKLLKIRDS 257 (273)
Q Consensus 231 ~~~l~~dp~~Rps~~~~l~~l~~~~~~ 257 (273)
.+||..||.+|||+.++++.|.+....
T Consensus 255 ~~~l~~~p~~Rps~~~ll~~l~~~~~~ 281 (288)
T cd05061 255 RMCWQFNPKMRPTFLEIVNLLKDDLHP 281 (288)
T ss_pred HHHcCCChhHCcCHHHHHHHHHhhcCC
Confidence 999999999999999999988876543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=278.43 Aligned_cols=240 Identities=25% Similarity=0.299 Sum_probs=175.4
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecC--------CceeEEEeccCCCCHHHhhh---cCCCC
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNE--------EFKALVLEYMPHGSLEKYLY---SSNCI 69 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~---~~~~~ 69 (273)
+.||||++.... ....+|+.+++.++||||+++++++... ..+++||||+++ +|.+++. ..+..
T Consensus 92 ~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~ 166 (440)
T PTZ00036 92 EKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHA 166 (440)
T ss_pred CEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCC
Confidence 479999886432 3455799999999999999999876432 246799999976 8877764 23456
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCC-ceEEeecccccccccCCCcceeecccccCCCCCCc
Q 024027 70 LDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNL-VAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPE 148 (273)
Q Consensus 70 ~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~-~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE 148 (273)
+++..++.++.|++.||.||| +.|++||||||+||+++.++ .+||+|||++..+..... .....+++.|+|||
T Consensus 167 l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~---~~~~~~t~~y~aPE 240 (440)
T PTZ00036 167 LPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR---SVSYICSRFYRAPE 240 (440)
T ss_pred CCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeeccccchhccCCCC---cccCCCCcCccCHH
Confidence 899999999999999999999 99999999999999998654 799999999976532221 22346789999999
Q ss_pred ccCCC-CcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhh-------hh--hccccchhhhhh
Q 024027 149 YGREG-RVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVV-------DA--NLLSQEDIHFVA 218 (273)
Q Consensus 149 ~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~--~~~~~~~~~~~~ 218 (273)
++.+. .++.++|||||||++|+|++|.+||......+ ...........+...... .. ............
T Consensus 241 ~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~-~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 319 (440)
T PTZ00036 241 LMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD-QLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVF 319 (440)
T ss_pred HhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHh
Confidence 88664 68999999999999999999999997643322 111111111111100000 00 000111122233
Q ss_pred hhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 219 KEQCVSFVFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 219 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
+...+.++.+|+.+||.+||.+|||+.+++.|-+
T Consensus 320 p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~ 353 (440)
T PTZ00036 320 PKGTPDDAINFISQFLKYEPLKRLNPIEALADPF 353 (440)
T ss_pred ccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChh
Confidence 4456788999999999999999999999998854
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=282.91 Aligned_cols=233 Identities=24% Similarity=0.315 Sum_probs=185.9
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCC-Cccceeeeeee-ecC------CceeEEEeccCCCCHHHhhhcC-CCCCC
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIR-HRNLIKVISSC-SNE------EFKALVLEYMPHGSLEKYLYSS-NCILD 71 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~-~~~------~~~~lv~e~~~~~~L~~~l~~~-~~~~~ 71 (273)
++||+|.+-..++.+.+...+|+++|+.|+ |+|||.++|.. ... -..+|+||||.||.|-|+++.. ...++
T Consensus 63 ~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lt 142 (738)
T KOG1989|consen 63 KKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLT 142 (738)
T ss_pred ceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCC
Confidence 479999998888889999999999999996 99999999932 211 2357999999999999999632 23499
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcce-------eecccccCCC
Q 024027 72 IFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMT-------QTQTLATIGY 144 (273)
Q Consensus 72 ~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~-------~~~~~~~~~~ 144 (273)
+.++++|+.|++.|+++||.+ +-.++|||||-+|||++.++..||||||.++-......... .-...-|+.|
T Consensus 143 e~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~Y 221 (738)
T KOG1989|consen 143 EDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQY 221 (738)
T ss_pred hHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccc
Confidence 999999999999999999922 33499999999999999999999999999864322211110 1123468999
Q ss_pred CCCccc---CCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhh
Q 024027 145 MAPEYG---REGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQ 221 (273)
Q Consensus 145 ~aPE~~---~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (273)
+|||.+ .+..++.|+|||+|||+||.|++...||+....-.+. .....++..+.
T Consensus 222 RsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIl-----------------------ng~Y~~P~~p~ 278 (738)
T KOG1989|consen 222 RSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAIL-----------------------NGNYSFPPFPN 278 (738)
T ss_pred cChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEE-----------------------eccccCCCCcc
Confidence 999955 5677999999999999999999999999874332221 11222222356
Q ss_pred hHHHHHHHHhhcCCCCccCCCCHHHHHHHHHHHHHh
Q 024027 222 CVSFVFNLAMACTVESPEQRINAKEIVTKLLKIRDS 257 (273)
Q Consensus 222 ~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~ 257 (273)
.+..+.+||+.||+.||.+||++-+++.++-++...
T Consensus 279 ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 279 YSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred HHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 788899999999999999999999999999998754
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=265.27 Aligned_cols=245 Identities=22% Similarity=0.248 Sum_probs=182.4
Q ss_pred CeEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 1 MEVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 1 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
++||+|.++... ......+.+|+.+++.++||||+++++++..+...++|+||+++ +|.+++......+++..+..++
T Consensus 32 ~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~ 110 (301)
T cd07873 32 NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFL 110 (301)
T ss_pred cEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecccc-CHHHHHHhcCCCCCHHHHHHHH
Confidence 379999997543 33345678899999999999999999999999999999999975 9999987766678999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCC-CcCCc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG-RVSTN 158 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~ 158 (273)
.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++........ ......+++.|+|||.+.+. .++.+
T Consensus 111 ~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~ 185 (301)
T cd07873 111 FQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--TYSNEVVTLWYRPPDILLGSTDYSTQ 185 (301)
T ss_pred HHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC--cccccceeecccCcHHHhCCCCCccH
Confidence 99999999999 99999999999999999999999999999875422111 12234567889999987654 47889
Q ss_pred chhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCc--cchh-hhhhhcc-----cc--chhhhhhhhhhHHHHHH
Q 024027 159 GDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPI--STME-VVDANLL-----SQ--EDIHFVAKEQCVSFVFN 228 (273)
Q Consensus 159 ~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~-~~~~~~~-----~~--~~~~~~~~~~~~~~l~~ 228 (273)
+||||||+++|+|++|.+||......+ ............ .... ....... .. ..........++.++.+
T Consensus 186 ~Dv~slG~~l~el~tg~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (301)
T cd07873 186 IDMWGVGCIFYEMSTGRPLFPGSTVEE-QLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAE 264 (301)
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHH
Confidence 999999999999999999997543221 111111110000 0000 0000000 00 00001112356778999
Q ss_pred HHhhcCCCCccCCCCHHHHHHHHH
Q 024027 229 LAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 229 li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
|+.+||..||.+|||++++++|-+
T Consensus 265 li~~ml~~dp~~R~t~~eil~h~~ 288 (301)
T cd07873 265 LLSKLLQFEGRKRISAEEAMKHPY 288 (301)
T ss_pred HHHHHhcCCcccCcCHHHHhcCcc
Confidence 999999999999999999998643
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=274.15 Aligned_cols=238 Identities=23% Similarity=0.418 Sum_probs=195.9
Q ss_pred CeEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCC-CCHHHHHHH
Q 024027 1 MEVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNI 78 (273)
Q Consensus 1 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~ 78 (273)
.+||||.++... ...+.+|..|+++|.+++||||++++|+|..+..+++|+||++.|+|.+|+..+..+ ..-....++
T Consensus 563 lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi 642 (807)
T KOG1094|consen 563 LKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSI 642 (807)
T ss_pred eEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHH
Confidence 379999999764 455789999999999999999999999999999999999999999999999877533 355567789
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCc
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTN 158 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 158 (273)
+.||++|++||. +.+++||||.+.|+|++.++++||+|||+++-+...+........+-+..|+|+|.+...+++.+
T Consensus 643 ~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFtta 719 (807)
T KOG1094|consen 643 CTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTA 719 (807)
T ss_pred HHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccch
Confidence 999999999999 99999999999999999999999999999986644444444556667889999999999999999
Q ss_pred chhHHHHHHHHHHHh--CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 159 GDVYSFGIMLMETFT--GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 159 ~DiwslG~~l~~ll~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
+|+|+||+++||+++ ...||.+...+...-. .....+. .........|..|+.++.+++.+||..
T Consensus 720 SDvWafgvTlwE~~~~C~e~Py~~lt~e~vven--~~~~~~~-----------~~~~~~l~~P~~cp~~lyelml~Cw~~ 786 (807)
T KOG1094|consen 720 SDVWAFGVTLWEVFMLCREQPYSQLTDEQVVEN--AGEFFRD-----------QGRQVVLSRPPACPQGLYELMLRCWRR 786 (807)
T ss_pred hhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHh--hhhhcCC-----------CCcceeccCCCcCcHHHHHHHHHHhch
Confidence 999999999999887 7788876544321110 0000000 011223344788999999999999999
Q ss_pred CccCCCCHHHHHHHHHHH
Q 024027 237 SPEQRINAKEIVTKLLKI 254 (273)
Q Consensus 237 dp~~Rps~~~~l~~l~~~ 254 (273)
|..+|||++++..+|++.
T Consensus 787 es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 787 ESEQRPSFEQLHLFLQED 804 (807)
T ss_pred hhhcCCCHHHHHHHHHHh
Confidence 999999999999998753
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=259.35 Aligned_cols=232 Identities=25% Similarity=0.411 Sum_probs=178.7
Q ss_pred eEEEEEeecc-cChhhhhHHHHHHHHhcCCCccceeeeeeee-cCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 2 EVAVKVFNLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCS-NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 2 ~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
.||||.+... .......+.+|+.+++.++||||+++++++. .++..++++||+++++|.+++.......++..+..++
T Consensus 25 ~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ 104 (262)
T cd05058 25 HCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFG 104 (262)
T ss_pred EEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHH
Confidence 5899998543 2345678889999999999999999999765 4566889999999999999997655557788889999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCC--cceeecccccCCCCCCcccCCCCcCC
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQ--SMTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++........ ........++..|+|||.+.+..++.
T Consensus 105 ~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 181 (262)
T cd05058 105 LQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTT 181 (262)
T ss_pred HHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccch
Confidence 99999999999 99999999999999999999999999999875422111 01111233566899999998888999
Q ss_pred cchhHHHHHHHHHHHhC-CCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 158 NGDVYSFGIMLMETFTG-KKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
++||||||+++|+|++| .+||......+ ........ .....+..++..+.+++.+||..
T Consensus 182 ~~Di~slG~~l~el~~~~~~~~~~~~~~~--~~~~~~~~------------------~~~~~~~~~~~~~~~li~~cl~~ 241 (262)
T cd05058 182 KSDVWSFGVLLWELMTRGAPPYPDVDSFD--ITVYLLQG------------------RRLLQPEYCPDPLYEVMLSCWHP 241 (262)
T ss_pred HHHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHhcC------------------CCCCCCCcCCHHHHHHHHHHcCC
Confidence 99999999999999995 55554321111 11000000 00011223456799999999999
Q ss_pred CccCCCCHHHHHHHHHHHHH
Q 024027 237 SPEQRINAKEIVTKLLKIRD 256 (273)
Q Consensus 237 dp~~Rps~~~~l~~l~~~~~ 256 (273)
+|++||++.++++.|+++..
T Consensus 242 ~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 242 KPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred ChhhCCCHHHHHHHHHHHhc
Confidence 99999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=272.67 Aligned_cols=223 Identities=28% Similarity=0.324 Sum_probs=174.9
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHH-HHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECE-MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (273)
+.||||++.... ......+..|.. +++.++||||+++++++..+...++||||+++|+|..++... ..+++..+.
T Consensus 21 ~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~ 99 (325)
T cd05604 21 KCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRE-RSFPEPRAR 99 (325)
T ss_pred CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHc-CCCCHHHHH
Confidence 369999997542 233345555554 467789999999999999999999999999999999988654 468999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcC
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVS 156 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 156 (273)
.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++...... .......+|++.|+|||.+.+..++
T Consensus 100 ~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~ 174 (325)
T cd05604 100 FYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDTTTTFCGTPEYLAPEVIRKQPYD 174 (325)
T ss_pred HHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCCcccccCChhhCCHHHHcCCCCC
Confidence 99999999999999 999999999999999999999999999998643211 1223345689999999999988899
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++|||||||++|+|++|..||......+. ...... . ....++..+..+.+++.+||..
T Consensus 175 ~~~DvwslG~il~el~~G~~pf~~~~~~~~-~~~~~~------------~--------~~~~~~~~~~~~~~ll~~ll~~ 233 (325)
T cd05604 175 NTVDWWCLGAVLYEMLYGLPPFYCRDVAEM-YDNILH------------K--------PLVLRPGASLTAWSILEELLEK 233 (325)
T ss_pred CcCccccccceehhhhcCCCCCCCCCHHHH-HHHHHc------------C--------CccCCCCCCHHHHHHHHHHhcc
Confidence 999999999999999999999975322211 110000 0 0011234566789999999999
Q ss_pred CccCCCCHH----HHHHH
Q 024027 237 SPEQRINAK----EIVTK 250 (273)
Q Consensus 237 dp~~Rps~~----~~l~~ 250 (273)
||.+||++. ++++|
T Consensus 234 ~p~~R~~~~~~~~~i~~h 251 (325)
T cd05604 234 DRQRRLGAKEDFLEIQEH 251 (325)
T ss_pred CHHhcCCCCCCHHHHhcC
Confidence 999999875 55554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=264.66 Aligned_cols=228 Identities=26% Similarity=0.446 Sum_probs=180.0
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC-------------
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN------------- 67 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------- 67 (273)
.||+|+++... ......+.+|+.+++.++||||+++++++.++...++++||+++++|.+++....
T Consensus 37 ~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 116 (288)
T cd05050 37 MVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSS 116 (288)
T ss_pred eEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccc
Confidence 68999987553 3345679999999999999999999999999999999999999999999996321
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeeccc
Q 024027 68 --------CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTL 139 (273)
Q Consensus 68 --------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~ 139 (273)
..+++..++.++.|++.||.||| ..+++|+||+|+||+++.++.++|+|||++..+.............
T Consensus 117 ~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 193 (288)
T cd05050 117 ARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDA 193 (288)
T ss_pred cccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhheEecCCCceEECccccceecccCccccccCCCc
Confidence 23678889999999999999999 9999999999999999999999999999987543222111122223
Q ss_pred ccCCCCCCcccCCCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhh
Q 024027 140 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVA 218 (273)
Q Consensus 140 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (273)
.+..|+|||.+.+..++.++|+|||||++|+|++ |..||......+. ...... .. ....
T Consensus 194 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~-~~~~~~-------------~~------~~~~ 253 (288)
T cd05050 194 IPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV-IYYVRD-------------GN------VLSC 253 (288)
T ss_pred cChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHhc-------------CC------CCCC
Confidence 4567999999988889999999999999999997 8888754322211 000000 00 0011
Q ss_pred hhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 219 KEQCVSFVFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 219 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
+..++.++.+|+.+||..||.+|||+.|+++.|+
T Consensus 254 ~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 254 PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 3345677999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=265.10 Aligned_cols=244 Identities=20% Similarity=0.198 Sum_probs=172.4
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeec--CCceeEEEeccCCCCHHHhhhcC--------CCCC
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSN--EEFKALVLEYMPHGSLEKYLYSS--------NCIL 70 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~--------~~~~ 70 (273)
+.||+|.++... ....+.+|+++++.++||||+++++++.. +...++++||+++ +|.+++... ...+
T Consensus 29 ~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l 105 (317)
T cd07868 29 RDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQL 105 (317)
T ss_pred ceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC-CHHHHHHhcccccccCCcccC
Confidence 368999986442 23457889999999999999999998854 4568899999965 898887532 1248
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceee----CCCCceEEeecccccccccCCCc-ceeecccccCCCC
Q 024027 71 DIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLL----DDNLVAYLSDFGIAKLLIGEDQS-MTQTQTLATIGYM 145 (273)
Q Consensus 71 ~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~----~~~~~~kl~Df~~~~~~~~~~~~-~~~~~~~~~~~~~ 145 (273)
++..+..++.|++.||.||| +.|++|+||||+||++ +.++.+||+|||++..+...... .......+++.|+
T Consensus 106 ~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~ 182 (317)
T cd07868 106 PRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182 (317)
T ss_pred CHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCcccccccc
Confidence 88999999999999999999 9999999999999999 45678999999999765332211 1223456789999
Q ss_pred CCcccCCC-CcCCcchhHHHHHHHHHHHhCCCCCccccccccc--------hhhhhhhccCccc--hhhhh---------
Q 024027 146 APEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMT--------LKHWVNDWLPIST--MEVVD--------- 205 (273)
Q Consensus 146 aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~--------~~~~~~~~~~~~~--~~~~~--------- 205 (273)
|||++.+. .++.++||||+||++|+|++|.+||......... ............. .+...
T Consensus 183 aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (317)
T cd07868 183 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLM 262 (317)
T ss_pred CCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhh
Confidence 99998764 5899999999999999999999999753332111 0111110000000 00000
Q ss_pred ----hhccccch---hhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHH
Q 024027 206 ----ANLLSQED---IHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 206 ----~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
........ .........+.++.+|+.+||.+||.+|||++++++|
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h 314 (317)
T cd07868 263 KDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 314 (317)
T ss_pred hhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000 0000011234568899999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=259.58 Aligned_cols=228 Identities=31% Similarity=0.494 Sum_probs=182.4
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC-CCCCHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIM 79 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ 79 (273)
+.||||.+... ......+.+|+++++.++|+||+++++++......+++|||+++++|.+++.... ..+++..+..++
T Consensus 31 ~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~ 109 (261)
T cd05034 31 TKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMA 109 (261)
T ss_pred ceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHH
Confidence 36899999754 3345779999999999999999999999999899999999999999999996543 468999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 159 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 159 (273)
.|++.|+.||| +.|++|+||+|+||+++.++.++|+|||.+..+.... .........+..|+|||.+.+..++.++
T Consensus 110 ~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~ 185 (261)
T cd05034 110 AQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE-YTAREGAKFPIKWTAPEAANYGRFTIKS 185 (261)
T ss_pred HHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchh-hhhhhccCCCccccCHHHhccCCcCchh
Confidence 99999999999 9999999999999999999999999999987653211 1111122345679999999888899999
Q ss_pred hhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc
Q 024027 160 DVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238 (273)
Q Consensus 160 DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 238 (273)
|+||+|++++++++ |+.||....... ........ .....+..++.++.+++.+||..+|
T Consensus 186 Di~slG~il~~l~t~g~~p~~~~~~~~-~~~~~~~~-------------------~~~~~~~~~~~~~~~~i~~~l~~~p 245 (261)
T cd05034 186 DVWSFGILLTEIVTYGRVPYPGMTNRE-VLEQVERG-------------------YRMPRPPNCPEELYDLMLQCWDKDP 245 (261)
T ss_pred HHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHcC-------------------CCCCCCCCCCHHHHHHHHHHcccCc
Confidence 99999999999998 999986532211 11111000 0011123446679999999999999
Q ss_pred cCCCCHHHHHHHHHH
Q 024027 239 EQRINAKEIVTKLLK 253 (273)
Q Consensus 239 ~~Rps~~~~l~~l~~ 253 (273)
.+||+++++.+.|+.
T Consensus 246 ~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 246 EERPTFEYLQSFLED 260 (261)
T ss_pred ccCCCHHHHHHHHhc
Confidence 999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=259.27 Aligned_cols=225 Identities=24% Similarity=0.341 Sum_probs=183.1
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
+||||+++... ......+..|+.+++.+.|+||+++++++.++...++||||+++++|.+++... .+++..+..++.
T Consensus 31 ~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~--~l~~~~~~~~~~ 108 (277)
T cd06640 31 VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAG--PFDEFQIATMLK 108 (277)
T ss_pred EEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhcC--CCCHHHHHHHHH
Confidence 68999987543 345677899999999999999999999999999999999999999999998643 588899999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
|++.|+.+|| +.+++|+||+|+||+++.++.++++|||++....... .......++..|.|||.+.+..++.++|
T Consensus 109 ~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~D 183 (277)
T cd06640 109 EILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIQQSAYDSKAD 183 (277)
T ss_pred HHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc--cccccccCcccccCHhHhccCCCccHHH
Confidence 9999999999 9999999999999999999999999999987653222 1222345778899999998888999999
Q ss_pred hHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccC
Q 024027 161 VYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQ 240 (273)
Q Consensus 161 iwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 240 (273)
+||||+++|+|++|..||........... .... .....+..++..+.+++.+||..+|.+
T Consensus 184 v~slG~il~el~tg~~p~~~~~~~~~~~~--------------~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~ 243 (277)
T cd06640 184 IWSLGITAIELAKGEPPNSDMHPMRVLFL--------------IPKN------NPPTLTGEFSKPFKEFIDACLNKDPSF 243 (277)
T ss_pred HHHHHHHHHHHHHCCCCCCCcChHhHhhh--------------hhcC------CCCCCchhhhHHHHHHHHHHcccCccc
Confidence 99999999999999999865332211100 0000 001113346677999999999999999
Q ss_pred CCCHHHHHHHHHH
Q 024027 241 RINAKEIVTKLLK 253 (273)
Q Consensus 241 Rps~~~~l~~l~~ 253 (273)
||++.+++.|-.-
T Consensus 244 Rp~~~~il~~~~~ 256 (277)
T cd06640 244 RPTAKELLKHKFI 256 (277)
T ss_pred CcCHHHHHhChHh
Confidence 9999999998553
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=273.66 Aligned_cols=245 Identities=22% Similarity=0.226 Sum_probs=180.8
Q ss_pred CeEEEEEeecc--cChhhhhHHHHHHHHhcCCCccceeeeeeeecCC-----ceeEEEeccCCCCHHHhhhcCCCCCCHH
Q 024027 1 MEVAVKVFNLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEE-----FKALVLEYMPHGSLEKYLYSSNCILDIF 73 (273)
Q Consensus 1 ~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 73 (273)
+.||||++... .....+.+.+|+++++.++|+||+++++++..+. ..++|+||+.+ +|.+++... ..+++.
T Consensus 26 ~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~l~~~ 103 (372)
T cd07853 26 KRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSP-QPLSSD 103 (372)
T ss_pred CEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeecccc-CHHHHHhcC-CCCCHH
Confidence 47999998643 2334567889999999999999999999998776 78999999965 888888544 468999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCC
Q 024027 74 QRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG 153 (273)
Q Consensus 74 ~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 153 (273)
.+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++....... ........++..|+|||.+.+.
T Consensus 104 ~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~ 179 (372)
T cd07853 104 HVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE-SKHMTQEVVTQYYRAPEILMGS 179 (372)
T ss_pred HHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeecccCc-cccCCCCCcCCCcCCHHHHcCC
Confidence 99999999999999999 9999999999999999999999999999987543221 1122334578899999998774
Q ss_pred -CcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhh----------hhccccc--hhhhhhhh
Q 024027 154 -RVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVD----------ANLLSQE--DIHFVAKE 220 (273)
Q Consensus 154 -~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~--~~~~~~~~ 220 (273)
.++.++||||+||++|+|++|+.||....... ................... ....... ........
T Consensus 180 ~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (372)
T cd07853 180 RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ-QLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSS 258 (372)
T ss_pred CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCC
Confidence 47899999999999999999999997643221 1111111111110000000 0000000 00001123
Q ss_pred hhHHHHHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 221 QCVSFVFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 221 ~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
..+.++.+|+.+||..||++|||+.++++|-+
T Consensus 259 ~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 290 (372)
T cd07853 259 QATHEAVHLLCRMLVFDPDKRISAADALAHPY 290 (372)
T ss_pred CCCHHHHHHHHHhCCCChhhCcCHHHHhcCHh
Confidence 45677999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=261.33 Aligned_cols=219 Identities=27% Similarity=0.377 Sum_probs=175.0
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~q 81 (273)
+||+|.+..........+..|+.+++.++|||++++++++..+...++||||+++|+|.+++...+..+++..++.++.|
T Consensus 29 ~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~q 108 (258)
T cd05078 29 EVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQ 108 (258)
T ss_pred hhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHH
Confidence 47888886554555677899999999999999999999999989999999999999999999776667899999999999
Q ss_pred HHHHHHHHhcCCCCCeEeccCCCCceeeCCCCc--------eEEeecccccccccCCCcceeecccccCCCCCCcccCCC
Q 024027 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLV--------AYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG 153 (273)
Q Consensus 82 l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~--------~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 153 (273)
++.||+||| +.|++|+||||+||+++.++. ++++|||.+..... .....++..|+|||.+.+.
T Consensus 109 i~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~ 179 (258)
T cd05078 109 LAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP------KEILLERIPWVPPECIENP 179 (258)
T ss_pred HHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccccccCC------chhccccCCccCchhccCC
Confidence 999999999 999999999999999987654 68999998865421 1224567789999998764
Q ss_pred -CcCCcchhHHHHHHHHHHHhCC-CCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHh
Q 024027 154 -RVSTNGDVYSFGIMLMETFTGK-KPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAM 231 (273)
Q Consensus 154 -~~~~~~DiwslG~~l~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 231 (273)
.++.++|+||||+++|++++|. .||....... .. ..... ....+...+.++.+|+.
T Consensus 180 ~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~-~~-~~~~~--------------------~~~~~~~~~~~~~~li~ 237 (258)
T cd05078 180 QNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK-KL-QFYED--------------------RHQLPAPKWTELANLIN 237 (258)
T ss_pred CCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH-HH-HHHHc--------------------cccCCCCCcHHHHHHHH
Confidence 5789999999999999999985 5544321111 00 00000 00113334567999999
Q ss_pred hcCCCCccCCCCHHHHHHHH
Q 024027 232 ACTVESPEQRINAKEIVTKL 251 (273)
Q Consensus 232 ~~l~~dp~~Rps~~~~l~~l 251 (273)
+||..||.+|||++++++.|
T Consensus 238 ~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 238 QCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred HHhccChhhCCCHHHHHHhc
Confidence 99999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=261.14 Aligned_cols=233 Identities=24% Similarity=0.371 Sum_probs=184.1
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeec-CCceeEEEeccCCCCHHHhhhcCC-------CCCCH
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSN-EEFKALVLEYMPHGSLEKYLYSSN-------CILDI 72 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~ 72 (273)
.||+|.++... ......+.+|+.+++.++|+||+++++++.. +...+++++|+++++|.+++.... ..+++
T Consensus 37 ~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~ 116 (280)
T cd05043 37 EVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALST 116 (280)
T ss_pred EEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCH
Confidence 68899887542 3456778899999999999999999998765 567889999999999999986432 35889
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC
Q 024027 73 FQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE 152 (273)
Q Consensus 73 ~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 152 (273)
..++.++.|++.||.||| +.+++|+||+|+||+++.++.++++|||++..+.............++..|+|||.+.+
T Consensus 117 ~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~ 193 (280)
T cd05043 117 QQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVN 193 (280)
T ss_pred HHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhc
Confidence 999999999999999999 99999999999999999999999999999875532221111122345667999999988
Q ss_pred CCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHh
Q 024027 153 GRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAM 231 (273)
Q Consensus 153 ~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 231 (273)
..++.++||||||+++|++++ |..||......+ ........ .....+..++.++.+++.
T Consensus 194 ~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~------------------~~~~~~~~~~~~~~~li~ 253 (280)
T cd05043 194 KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE--MAAYLKDG------------------YRLAQPINCPDELFAVMA 253 (280)
T ss_pred CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH--HHHHHHcC------------------CCCCCCCcCCHHHHHHHH
Confidence 889999999999999999998 999986532211 11111100 000112345677999999
Q ss_pred hcCCCCccCCCCHHHHHHHHHHHHHh
Q 024027 232 ACTVESPEQRINAKEIVTKLLKIRDS 257 (273)
Q Consensus 232 ~~l~~dp~~Rps~~~~l~~l~~~~~~ 257 (273)
+||..||++|||+.++++.|..+.+.
T Consensus 254 ~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 254 CCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred HHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 99999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=258.44 Aligned_cols=223 Identities=30% Similarity=0.440 Sum_probs=177.6
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeee-ecCCceeEEEeccCCCCHHHhhhcCCC-CCCHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSC-SNEEFKALVLEYMPHGSLEKYLYSSNC-ILDIFQRLNI 78 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~ 78 (273)
++||+|.++... ..+.+.+|+.+++.++|+|++++++++ ..++..++++||+++++|.+++..... .+++..++.+
T Consensus 30 ~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ 107 (256)
T cd05082 30 NKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 107 (256)
T ss_pred CcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHH
Confidence 368999986442 346788999999999999999999975 455678999999999999999975443 4889999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCc
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTN 158 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 158 (273)
+.|++.||+||| +.|++|+||+|+||+++.++.++|+|||++....... ....++..|+|||.+.+..++.+
T Consensus 108 ~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~ 179 (256)
T cd05082 108 SLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTK 179 (256)
T ss_pred HHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccC-----CCCccceeecCHHHHccCCCCch
Confidence 999999999999 9999999999999999999999999999987542211 12234567999999988889999
Q ss_pred chhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 159 GDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 159 ~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
+|+|||||++|+|++ |..||....... .... .... .....+..++..+.+++.+||..+
T Consensus 180 ~Dv~slG~i~~~l~~~g~~p~~~~~~~~-----~~~~---------~~~~------~~~~~~~~~~~~~~~li~~~l~~~ 239 (256)
T cd05082 180 SDVWSFGILLWEIYSFGRVPYPRIPLKD-----VVPR---------VEKG------YKMDAPDGCPPVVYDVMKQCWHLD 239 (256)
T ss_pred hhhHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHH---------HhcC------CCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999999999999997 999986422111 0000 0000 000113456778999999999999
Q ss_pred ccCCCCHHHHHHHHHH
Q 024027 238 PEQRINAKEIVTKLLK 253 (273)
Q Consensus 238 p~~Rps~~~~l~~l~~ 253 (273)
|++|||+.++++.|+.
T Consensus 240 p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 240 AATRPSFLQLREQLEH 255 (256)
T ss_pred hhhCcCHHHHHHHHhc
Confidence 9999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=262.79 Aligned_cols=245 Identities=25% Similarity=0.393 Sum_probs=186.4
Q ss_pred eEEEEEeecccCh-hhhhHHHHHHHHhcCCCccceeeeeeeec--CCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 2 EVAVKVFNLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCSN--EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 2 ~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
.||||+++..... ....+..|+++++.++|+||+++++++.. ....+++|||+++++|.+++......+++..+..+
T Consensus 35 ~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~ 114 (284)
T cd05038 35 QVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLF 114 (284)
T ss_pred EEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHH
Confidence 6899999865443 56789999999999999999999999877 55789999999999999999776656999999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcce-eecccccCCCCCCcccCCCCcCC
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMT-QTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
+.|++.||.||| +.|++|+||+|+||+++.++.++|+|||.+........... .....++..|+|||.+.+..++.
T Consensus 115 ~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~ 191 (284)
T cd05038 115 SSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSS 191 (284)
T ss_pred HHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCc
Confidence 999999999999 99999999999999999999999999999987642222111 11223455699999998888999
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
++|+||||+++++|++|..||.......... .................. .......+..++.++.+++.+||..+
T Consensus 192 ~~Di~slG~~l~el~tg~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~cl~~~ 266 (284)
T cd05038 192 ASDVWSFGVTLYELFTYGDPSQSPPAEFLRM---IGIAQGQMIVTRLLELLK--EGERLPRPPSCPDEVYDLMKLCWEAE 266 (284)
T ss_pred ccchHHHhhhhheeeccCCCcccccchhccc---cccccccccHHHHHHHHH--cCCcCCCCccCCHHHHHHHHHHhccC
Confidence 9999999999999999999975532221110 000000000000000000 01111223456678999999999999
Q ss_pred ccCCCCHHHHHHHHHHH
Q 024027 238 PEQRINAKEIVTKLLKI 254 (273)
Q Consensus 238 p~~Rps~~~~l~~l~~~ 254 (273)
|.+|||+.++++.|+++
T Consensus 267 p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 267 PQDRPSFADLILIVDRL 283 (284)
T ss_pred hhhCCCHHHHHHHHhhc
Confidence 99999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=260.06 Aligned_cols=226 Identities=23% Similarity=0.336 Sum_probs=180.2
Q ss_pred CeEEEEEeecccCh---------hhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCC
Q 024027 1 MEVAVKVFNLQCGR---------AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILD 71 (273)
Q Consensus 1 ~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 71 (273)
+.||+|.+...... ..+.+.+|+.+++.++||||+++++++......++++||+++++|.+++... ..++
T Consensus 26 ~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~ 104 (267)
T cd06628 26 ELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY-GAFE 104 (267)
T ss_pred cEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhc-cCcc
Confidence 36899988654321 2356889999999999999999999999999999999999999999999665 3688
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCc----ceeecccccCCCCCC
Q 024027 72 IFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQS----MTQTQTLATIGYMAP 147 (273)
Q Consensus 72 ~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~----~~~~~~~~~~~~~aP 147 (273)
+..+..++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||.+......... .......++..|+||
T Consensus 105 ~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~p 181 (267)
T cd06628 105 ETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181 (267)
T ss_pred HHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccCh
Confidence 8999999999999999999 999999999999999999999999999998766421111 111233577889999
Q ss_pred cccCCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHH
Q 024027 148 EYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVF 227 (273)
Q Consensus 148 E~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 227 (273)
|.+.+..++.++|+||+|++++++++|..||........ ...... ......+..++..+.
T Consensus 182 e~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~-------------------~~~~~~~~~~~~~~~ 241 (267)
T cd06628 182 EVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA-IFKIGE-------------------NASPEIPSNISSEAI 241 (267)
T ss_pred hHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH-HHHHhc-------------------cCCCcCCcccCHHHH
Confidence 999888889999999999999999999999875322111 000000 000111344667799
Q ss_pred HHHhhcCCCCccCCCCHHHHHHH
Q 024027 228 NLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 228 ~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
+++.+||..||.+||++.+++++
T Consensus 242 ~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 242 DFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred HHHHHHccCCchhCcCHHHHhhC
Confidence 99999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=255.46 Aligned_cols=227 Identities=22% Similarity=0.250 Sum_probs=180.5
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcC-CCccceeeeeeeec----CCceeEEEeccCCCCHHHhhhcCC-CCCCHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSI-RHRNLIKVISSCSN----EEFKALVLEYMPHGSLEKYLYSSN-CILDIFQR 75 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~ 75 (273)
++|+|++. +....++|+++=-.. .|||||+++++|+. ...+.+|||+++||.|+..++..+ ..+.+.++
T Consensus 89 kfALKvL~-----Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea 163 (400)
T KOG0604|consen 89 KFALKVLL-----DSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREA 163 (400)
T ss_pred hhHHHHHh-----cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHH
Confidence 35666664 235667777764333 69999999998865 456789999999999999998665 35999999
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeC---CCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC
Q 024027 76 LNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLD---DNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE 152 (273)
Q Consensus 76 ~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~---~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 152 (273)
..++.||+.|+.||| +.+|.||||||+|+|++ .+..+||+|||++..-.. .......+.|++|.|||++..
T Consensus 164 ~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~---~~~L~TPc~TPyYvaPevlg~ 237 (400)
T KOG0604|consen 164 SEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE---PGDLMTPCFTPYYVAPEVLGP 237 (400)
T ss_pred HHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEecccccccccCC---CccccCCcccccccCHHHhCc
Confidence 999999999999999 99999999999999996 467899999999986422 233456789999999999999
Q ss_pred CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhh
Q 024027 153 GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMA 232 (273)
Q Consensus 153 ~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 232 (273)
..|+...|+||+|+++|-|+.|.+||........ ++.... +-......+..+.+..++.+..++|++
T Consensus 238 eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai----------spgMk~---rI~~gqy~FP~pEWs~VSe~aKdlIR~ 304 (400)
T KOG0604|consen 238 EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI----------SPGMKR---RIRTGQYEFPEPEWSCVSEAAKDLIRK 304 (400)
T ss_pred hhcCCCCCccchhHHHHHhhcCCCcccccCCccC----------ChhHHh---HhhccCccCCChhHhHHHHHHHHHHHH
Confidence 9999999999999999999999999987433211 001111 111223334445577899999999999
Q ss_pred cCCCCccCCCCHHHHHHHHH
Q 024027 233 CTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 233 ~l~~dp~~Rps~~~~l~~l~ 252 (273)
+|..+|.+|.|+.++++|=+
T Consensus 305 LLkt~PteRlTI~~~m~hpw 324 (400)
T KOG0604|consen 305 LLKTEPTERLTIEEVMDHPW 324 (400)
T ss_pred HhcCCchhheeHHHhhcCch
Confidence 99999999999999998865
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=257.38 Aligned_cols=228 Identities=29% Similarity=0.449 Sum_probs=180.4
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcC-CCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~ 80 (273)
.||||+++... ...+.+.+|+++++.++|+||+++++.+.. ...++||||+++++|.+++... ...+++..+..++.
T Consensus 32 ~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ 109 (262)
T cd05071 32 RVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 109 (262)
T ss_pred eEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHH
Confidence 58999997542 234678999999999999999999998754 5578999999999999999754 33578999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
|++.||.+|| +.+++|+||+|+||+++.++.++|+|||.+..+..... .......++..|+|||...+..++.++|
T Consensus 110 ~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~D 185 (262)
T cd05071 110 QIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSD 185 (262)
T ss_pred HHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeecccccc-ccccCCcccceecCHhHhccCCCCchhh
Confidence 9999999999 99999999999999999999999999999876532221 1112234566799999998888999999
Q ss_pred hHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCcc
Q 024027 161 VYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239 (273)
Q Consensus 161 iwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 239 (273)
+||||+++|++++ |..||........ ....... .....+..++..+.+++.+|+..||+
T Consensus 186 vwslG~~l~ellt~g~~p~~~~~~~~~-~~~~~~~-------------------~~~~~~~~~~~~l~~li~~~l~~~p~ 245 (262)
T cd05071 186 VWSFGILLTELTTKGRVPYPGMVNREV-LDQVERG-------------------YRMPCPPECPESLHDLMCQCWRKEPE 245 (262)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCChHHH-HHHHhcC-------------------CCCCCccccCHHHHHHHHHHccCCcc
Confidence 9999999999999 8888865332211 1100000 00011234567799999999999999
Q ss_pred CCCCHHHHHHHHHHHH
Q 024027 240 QRINAKEIVTKLLKIR 255 (273)
Q Consensus 240 ~Rps~~~~l~~l~~~~ 255 (273)
+|||+.++++.|+++.
T Consensus 246 ~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 246 ERPTFEYLQAFLEDYF 261 (262)
T ss_pred cCCCHHHHHHHHHHhc
Confidence 9999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=262.32 Aligned_cols=235 Identities=24% Similarity=0.404 Sum_probs=180.6
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC----------CCC
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN----------CIL 70 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~ 70 (273)
.||+|+++... ......+.+|+++++.++|+||+++++++..++..+++|||+++++|.+++.... ..+
T Consensus 48 ~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 127 (296)
T cd05095 48 LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTI 127 (296)
T ss_pred EEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCccccccccccccc
Confidence 48999997553 3345679999999999999999999999999999999999999999999986532 236
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCccc
Q 024027 71 DIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYG 150 (273)
Q Consensus 71 ~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 150 (273)
++..+..++.|++.||+||| +.|++|+||||+||+++.++.++|+|||++..+..............+..|++||..
T Consensus 128 ~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~ 204 (296)
T cd05095 128 SYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESI 204 (296)
T ss_pred CHHHHHHHHHHHHHHHHHHH---HCCeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHH
Confidence 67889999999999999999 999999999999999999999999999998765322211112223345679999988
Q ss_pred CCCCcCCcchhHHHHHHHHHHHh--CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHH
Q 024027 151 REGRVSTNGDVYSFGIMLMETFT--GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFN 228 (273)
Q Consensus 151 ~~~~~~~~~DiwslG~~l~~ll~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 228 (273)
.+..++.++|+|||||++|+|++ |..||......+... .. ....... ........+..++..+.+
T Consensus 205 ~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~-~~---------~~~~~~~---~~~~~~~~~~~~~~~~~~ 271 (296)
T cd05095 205 LLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIE-NT---------GEFFRDQ---GRQVYLPKPALCPDSLYK 271 (296)
T ss_pred hcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHH-HH---------HHHHhhc---cccccCCCCCCCCHHHHH
Confidence 87889999999999999999998 778876533221110 00 0000000 000011113446677999
Q ss_pred HHhhcCCCCccCCCCHHHHHHHHH
Q 024027 229 LAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 229 li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
|+.+||..||.+|||+.++++.|+
T Consensus 272 li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 272 LMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHcCCCcccCCCHHHHHHHHh
Confidence 999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=276.79 Aligned_cols=240 Identities=19% Similarity=0.197 Sum_probs=176.8
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~q 81 (273)
.||||... ...+.+|+++|+.++|+||+++++++...+..++|||++. ++|.+++......+++..++.++.|
T Consensus 196 ~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~q 268 (461)
T PHA03211 196 RVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQ 268 (461)
T ss_pred EEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHH
Confidence 57888542 2356789999999999999999999999999999999995 5999998766567999999999999
Q ss_pred HHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcchh
Q 024027 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 161 (273)
Q Consensus 82 l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di 161 (273)
++.||.||| +.|++|+||||+||+++.++.++|+|||++................|+..|+|||++.+..++.++||
T Consensus 269 i~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDv 345 (461)
T PHA03211 269 LLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDI 345 (461)
T ss_pred HHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHH
Confidence 999999999 99999999999999999999999999999976533222222233568999999999998889999999
Q ss_pred HHHHHHHHHHHhCCCCCcccccccc------chhhhhhh-ccCc-cchh-----h---hhhh-----ccccchhhhhhhh
Q 024027 162 YSFGIMLMETFTGKKPTYEFFNGEM------TLKHWVND-WLPI-STME-----V---VDAN-----LLSQEDIHFVAKE 220 (273)
Q Consensus 162 wslG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~~-~~~~-~~~~-----~---~~~~-----~~~~~~~~~~~~~ 220 (273)
|||||++|+|++|..|+........ ........ .... .... . .... ........+....
T Consensus 346 wSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (461)
T PHA03211 346 WSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYY 425 (461)
T ss_pred HHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhc
Confidence 9999999999998876543221110 01111110 0000 0000 0 0000 0000000111122
Q ss_pred hhHHHHHHHHhhcCCCCccCCCCHHHHHHHH
Q 024027 221 QCVSFVFNLAMACTVESPEQRINAKEIVTKL 251 (273)
Q Consensus 221 ~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l 251 (273)
..+.++.+|+.+||..||++|||+.|+|+|=
T Consensus 426 ~~~~~~~dli~~mL~~DP~~RPsa~elL~hp 456 (461)
T PHA03211 426 KLDLDVEYLVCRALTFDGARRPSAAELLRLP 456 (461)
T ss_pred cccchHHHHHHHHcccChhhCcCHHHHhhCc
Confidence 3455789999999999999999999999873
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=263.89 Aligned_cols=226 Identities=26% Similarity=0.310 Sum_probs=182.7
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
+.||+|.+........+.+.+|+.+++.++|+||+++++++..+...++||||+++++|.+++.+. .+++..+..++.
T Consensus 45 ~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ 122 (297)
T cd06656 45 QEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCR 122 (297)
T ss_pred CEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHhC--CCCHHHHHHHHH
Confidence 479999998665555677889999999999999999999999999999999999999999998653 478899999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
|++.||.||| +.|++|+||+|+||+++.++.++|+|||++........ ......+++.|+|||.+.+..++.++|
T Consensus 123 ~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~D 197 (297)
T cd06656 123 ECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVD 197 (297)
T ss_pred HHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc--CcCcccCCccccCHHHHcCCCCCcHHH
Confidence 9999999999 99999999999999999999999999999875432211 122345788899999998888999999
Q ss_pred hHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccC
Q 024027 161 VYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQ 240 (273)
Q Consensus 161 iwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 240 (273)
+||+|+++|++++|..||............... .......+...+..+.+|+.+||..||.+
T Consensus 198 i~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 259 (297)
T cd06656 198 IWSLGIMAIEMVEGEPPYLNENPLRALYLIATN------------------GTPELQNPERLSAVFRDFLNRCLEMDVDR 259 (297)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCcchheeeeccC------------------CCCCCCCccccCHHHHHHHHHHccCChhh
Confidence 999999999999999999653321111100000 00000113345666899999999999999
Q ss_pred CCCHHHHHHHH
Q 024027 241 RINAKEIVTKL 251 (273)
Q Consensus 241 Rps~~~~l~~l 251 (273)
|||+.++++|=
T Consensus 260 Rps~~~il~~~ 270 (297)
T cd06656 260 RGSAKELLQHP 270 (297)
T ss_pred CcCHHHHhcCc
Confidence 99999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=267.74 Aligned_cols=223 Identities=20% Similarity=0.257 Sum_probs=176.8
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCC-CccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIR-HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (273)
+.||||+++... ....+.+..|..++..+. |++|+++++++.+...+++||||+++|+|.+++.... .+++..+.
T Consensus 26 ~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~-~l~~~~~~ 104 (323)
T cd05615 26 ELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVG-KFKEPQAV 104 (323)
T ss_pred CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHcC-CCCHHHHH
Confidence 369999997542 334556778999998885 6788899999999999999999999999999986544 58999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcC
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVS 156 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 156 (273)
.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++...... ........|++.|+|||++.+..++
T Consensus 105 ~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~ 179 (323)
T cd05615 105 FYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD--GVTTRTFCGTPDYIAPEIIAYQPYG 179 (323)
T ss_pred HHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCC--CccccCccCCccccCHHHHcCCCCC
Confidence 99999999999999 999999999999999999999999999998653211 1122345689999999999888899
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++|+||+||++|+|++|..||........ ....... ....+..++.++.+++.+||..
T Consensus 180 ~~~DiwslGvil~elltG~~pf~~~~~~~~-~~~i~~~--------------------~~~~p~~~~~~~~~li~~~l~~ 238 (323)
T cd05615 180 KSVDWWAYGVLLYEMLAGQPPFDGEDEDEL-FQSIMEH--------------------NVSYPKSLSKEAVSICKGLMTK 238 (323)
T ss_pred CccchhhhHHHHHHHHhCCCCCCCCCHHHH-HHHHHhC--------------------CCCCCccCCHHHHHHHHHHccc
Confidence 999999999999999999999875332111 1110000 0011334567789999999999
Q ss_pred CccCCCCH-----HHHHHH
Q 024027 237 SPEQRINA-----KEIVTK 250 (273)
Q Consensus 237 dp~~Rps~-----~~~l~~ 250 (273)
||.+|++. +++++|
T Consensus 239 ~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 239 HPSKRLGCGPEGERDIREH 257 (323)
T ss_pred CHhhCCCCCCCCHHHHhcC
Confidence 99999974 566655
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=269.61 Aligned_cols=223 Identities=26% Similarity=0.299 Sum_probs=173.5
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHH-HHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECE-MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (273)
+.||+|++.... ......+..|.. +++.++||||+++++++.+....++||||+++++|..++... ..+++..+.
T Consensus 21 ~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~ 99 (321)
T cd05603 21 SFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRE-RCFLEPRAR 99 (321)
T ss_pred CEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHc-CCCCHHHHH
Confidence 368999997542 223344555554 678889999999999999999999999999999999888654 358889999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcC
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVS 156 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 156 (273)
.++.|++.||.||| +.|++||||||+||+++.++.+||+|||++...... ........|++.|+|||.+.+..++
T Consensus 100 ~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~ 174 (321)
T cd05603 100 FYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EETTSTFCGTPEYLAPEVLRKEPYD 174 (321)
T ss_pred HHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCccccccCCcccCCHHHhcCCCCC
Confidence 99999999999999 999999999999999999999999999998643211 1122345689999999999888899
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++|||||||++|+|++|..||........ ...... . ....+...+.++.+++.+||..
T Consensus 175 ~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~----------------~----~~~~~~~~~~~~~~li~~~l~~ 233 (321)
T cd05603 175 RTVDWWCLGAVLYEMLYGLPPFYSRDVSQM-YDNILH----------------K----PLQLPGGKTVAACDLLVGLLHK 233 (321)
T ss_pred CcCcccccchhhhhhhcCCCCCCCCCHHHH-HHHHhc----------------C----CCCCCCCCCHHHHHHHHHHccC
Confidence 999999999999999999999865321110 000000 0 0111334566799999999999
Q ss_pred CccCCCCHH----HHHHH
Q 024027 237 SPEQRINAK----EIVTK 250 (273)
Q Consensus 237 dp~~Rps~~----~~l~~ 250 (273)
||.+||++. ++++|
T Consensus 234 ~p~~R~~~~~~~~~~~~~ 251 (321)
T cd05603 234 DQRRRLGAKADFLEIKNH 251 (321)
T ss_pred CHhhcCCCCCCHHHHhCC
Confidence 999999764 55544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=264.26 Aligned_cols=227 Identities=25% Similarity=0.326 Sum_probs=182.6
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
+.||||++........+.+.+|+.+++.++|||++++++++..+...++++||+++++|.+++... .+++..++.++.
T Consensus 47 ~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ 124 (297)
T cd06659 47 RQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQT--RLNEEQIATVCE 124 (297)
T ss_pred CEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhhc--CCCHHHHHHHHH
Confidence 469999997655455667889999999999999999999999999999999999999999987543 488999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
|++.||.+|| +.|++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+..++.++|
T Consensus 125 qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~D 199 (297)
T cd06659 125 SVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRTPYGTEVD 199 (297)
T ss_pred HHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc--ccccceecCccccCHHHHccCCCCchhh
Confidence 9999999999 9999999999999999999999999999986542211 1223356788999999998888999999
Q ss_pred hHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccC
Q 024027 161 VYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQ 240 (273)
Q Consensus 161 iwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 240 (273)
+||+|+++++|++|..||......+ ..... .... ..........+.++.+++.+||..+|.+
T Consensus 200 v~slG~il~el~~g~~p~~~~~~~~-~~~~~-~~~~----------------~~~~~~~~~~~~~l~~~i~~~l~~~P~~ 261 (297)
T cd06659 200 IWSLGIMVIEMVDGEPPYFSDSPVQ-AMKRL-RDSP----------------PPKLKNAHKISPVLRDFLERMLTREPQE 261 (297)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHH-HHHHH-hccC----------------CCCccccCCCCHHHHHHHHHHhcCCccc
Confidence 9999999999999999986432211 11110 0000 0000112235567899999999999999
Q ss_pred CCCHHHHHHHHH
Q 024027 241 RINAKEIVTKLL 252 (273)
Q Consensus 241 Rps~~~~l~~l~ 252 (273)
||++++++++-.
T Consensus 262 Rps~~~ll~~~~ 273 (297)
T cd06659 262 RATAQELLDHPF 273 (297)
T ss_pred CcCHHHHhhChh
Confidence 999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=264.00 Aligned_cols=225 Identities=26% Similarity=0.356 Sum_probs=181.2
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
+.||||++........+.+.+|+.+++.++|+||+++++.+......++||||+++++|.+++... .+++..+..++.
T Consensus 48 ~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~~~~ 125 (292)
T cd06658 48 KQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIATVCL 125 (292)
T ss_pred CEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhcC--CCCHHHHHHHHH
Confidence 368999997665556677899999999999999999999999999999999999999999988543 488999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
|++.|+.||| +.|++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|
T Consensus 126 qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~D 200 (292)
T cd06658 126 SVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRKSLVGTPYWMAPEVISRLPYGTEVD 200 (292)
T ss_pred HHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCceeecCccccCHHHHccCCCCchhh
Confidence 9999999999 99999999999999999999999999999875432221 123346788999999998888999999
Q ss_pred hHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccC
Q 024027 161 VYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQ 240 (273)
Q Consensus 161 iwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 240 (273)
+||+|++++++++|..||....... ........ .. .........+..+.+++.+||..||++
T Consensus 201 v~slGvil~el~~g~~p~~~~~~~~-~~~~~~~~-~~----------------~~~~~~~~~~~~~~~li~~~l~~~P~~ 262 (292)
T cd06658 201 IWSLGIMVIEMIDGEPPYFNEPPLQ-AMRRIRDN-LP----------------PRVKDSHKVSSVLRGFLDLMLVREPSQ 262 (292)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhc-CC----------------CccccccccCHHHHHHHHHHccCChhH
Confidence 9999999999999999986422211 00000000 00 000012234566899999999999999
Q ss_pred CCCHHHHHHH
Q 024027 241 RINAKEIVTK 250 (273)
Q Consensus 241 Rps~~~~l~~ 250 (273)
|||+++++++
T Consensus 263 Rpt~~~il~~ 272 (292)
T cd06658 263 RATAQELLQH 272 (292)
T ss_pred CcCHHHHhhC
Confidence 9999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=263.04 Aligned_cols=236 Identities=25% Similarity=0.392 Sum_probs=185.6
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
+||+|.+.... ......+.+|+.+++.++||||+++++++... ..++++||+++|+|.+++......+++..+..++.
T Consensus 38 ~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~ 116 (303)
T cd05110 38 PVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCV 116 (303)
T ss_pred eEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHH
Confidence 57999887543 23344688999999999999999999998754 46799999999999999977666689999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
|++.||.||| +.|++|+||||+||+++.++.+||+|||++..+.............++..|+|||.+.+..++.++|
T Consensus 117 qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~D 193 (303)
T cd05110 117 QIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSD 193 (303)
T ss_pred HHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHH
Confidence 9999999999 9999999999999999999999999999998664332222222334567899999998888999999
Q ss_pred hHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCcc
Q 024027 161 VYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239 (273)
Q Consensus 161 iwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 239 (273)
|||||+++|++++ |..||....... ......... ....+..++..+.+++.+||..+|+
T Consensus 194 iwslG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~------------------~~~~~~~~~~~~~~li~~c~~~~p~ 253 (303)
T cd05110 194 VWSYGVTIWELMTFGGKPYDGIPTRE--IPDLLEKGE------------------RLPQPPICTIDVYMVMVKCWMIDAD 253 (303)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHCCC------------------CCCCCCCCCHHHHHHHHHHcCCChh
Confidence 9999999999997 889986532111 111111000 0011233456689999999999999
Q ss_pred CCCCHHHHHHHHHHHHHhhhhh
Q 024027 240 QRINAKEIVTKLLKIRDSLLRN 261 (273)
Q Consensus 240 ~Rps~~~~l~~l~~~~~~~~~~ 261 (273)
+||++.++++.|.++.++-.+.
T Consensus 254 ~Rp~~~~l~~~l~~~~~~~~~~ 275 (303)
T cd05110 254 SRPKFKELAAEFSRMARDPQRY 275 (303)
T ss_pred hCcCHHHHHHHHHHHHhchhhh
Confidence 9999999999999987664433
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=266.72 Aligned_cols=233 Identities=28% Similarity=0.431 Sum_probs=183.8
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC------------
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN------------ 67 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------ 67 (273)
.||+|+++... ......+.+|+++++.+ +||||+++++++..+...++++||+++|+|.+++....
T Consensus 46 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 125 (334)
T cd05100 46 TVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCK 125 (334)
T ss_pred eEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCccccccccccc
Confidence 58999987542 34467899999999999 79999999999999999999999999999999986432
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCC
Q 024027 68 ---CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGY 144 (273)
Q Consensus 68 ---~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~ 144 (273)
..+++..+..++.|++.||+||| +.|++|+||+|+||+++.++.++|+|||++................++..|
T Consensus 126 ~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y 202 (334)
T cd05100 126 LPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKW 202 (334)
T ss_pred CccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceE
Confidence 23777889999999999999999 999999999999999999999999999998765322211111222334679
Q ss_pred CCCcccCCCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhH
Q 024027 145 MAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCV 223 (273)
Q Consensus 145 ~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (273)
+|||.+.+..++.++||||||+++|+|++ |..||......+ ........ .....+..++
T Consensus 203 ~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-~~~~~~~~-------------------~~~~~~~~~~ 262 (334)
T cd05100 203 MAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-LFKLLKEG-------------------HRMDKPANCT 262 (334)
T ss_pred cCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH-HHHHHHcC-------------------CCCCCCCCCC
Confidence 99999988889999999999999999998 888876532111 11000000 0001133456
Q ss_pred HHHHHHHhhcCCCCccCCCCHHHHHHHHHHHHHh
Q 024027 224 SFVFNLAMACTVESPEQRINAKEIVTKLLKIRDS 257 (273)
Q Consensus 224 ~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~ 257 (273)
.++.+++.+||..+|.+|||+.+++++|.++...
T Consensus 263 ~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 263 HELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred HHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 6799999999999999999999999999988853
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=271.54 Aligned_cols=229 Identities=26% Similarity=0.412 Sum_probs=197.8
Q ss_pred EEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHH
Q 024027 3 VAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81 (273)
Q Consensus 3 vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~q 81 (273)
||||.-|.++ ..+.+.|..|.-+++.++||||++++|+|.+. ..+||||.++-|.|..|++.++..++......+++|
T Consensus 421 VAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Q 499 (974)
T KOG4257|consen 421 VAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQ 499 (974)
T ss_pred eeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEecccchhHHHHHHhccccchHHHHHHHHHH
Confidence 8999998764 56688899999999999999999999999865 468999999999999999988888999999999999
Q ss_pred HHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcchh
Q 024027 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 161 (273)
Q Consensus 82 l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di 161 (273)
|+.||+||| +..++||||..+||++....-|||+|||+++.+.... ........-+..|+|||.++...++.+||+
T Consensus 500 i~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~-yYkaS~~kLPIKWmaPESINfRrFTtASDV 575 (974)
T KOG4257|consen 500 ICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA-YYKASRGKLPIKWMAPESINFRRFTTASDV 575 (974)
T ss_pred HHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhccccc-hhhccccccceeecCccccchhcccchhhH
Confidence 999999999 9999999999999999999999999999998763322 222233334677999999999999999999
Q ss_pred HHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccC
Q 024027 162 YSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQ 240 (273)
Q Consensus 162 wslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 240 (273)
|.||+++||++. |..||....+.+.-... ....+.+.|++|++.++.|+.+||.+||.+
T Consensus 576 WMFgVCmWEIl~lGvkPfqgvkNsDVI~~i--------------------EnGeRlP~P~nCPp~LYslmskcWayeP~k 635 (974)
T KOG4257|consen 576 WMFGVCMWEILSLGVKPFQGVKNSDVIGHI--------------------ENGERLPCPPNCPPALYSLMSKCWAYEPSK 635 (974)
T ss_pred HHHHHHHHHHHHhcCCccccccccceEEEe--------------------cCCCCCCCCCCCChHHHHHHHHHhccCccc
Confidence 999999999998 99999876554432211 122345568999999999999999999999
Q ss_pred CCCHHHHHHHHHHHHH
Q 024027 241 RINAKEIVTKLLKIRD 256 (273)
Q Consensus 241 Rps~~~~l~~l~~~~~ 256 (273)
||.+.++...|.++.+
T Consensus 636 RPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 636 RPRFTEIKAILSDVLQ 651 (974)
T ss_pred CCcHHHHHHHHHHHHH
Confidence 9999999999999887
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=272.39 Aligned_cols=229 Identities=22% Similarity=0.287 Sum_probs=178.6
Q ss_pred CeEEEEEeecc---cChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||+|++... .......+.+|+.+++.++||||+++++++.++...++||||+++|+|.+++... .+++..+..
T Consensus 69 ~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~ 146 (370)
T cd05621 69 KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY--DVPEKWAKF 146 (370)
T ss_pred CEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHH
Confidence 36899998643 1234456889999999999999999999999999999999999999999999654 488899999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCC---
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGR--- 154 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--- 154 (273)
++.|++.||.||| +.|++||||||+||+++.++.+||+|||++..+.... ........|++.|+|||++.+..
T Consensus 147 ~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~ 222 (370)
T cd05621 147 YTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG-MVRCDTAVGTPDYISPEVLKSQGGDG 222 (370)
T ss_pred HHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceecccCC-ceecccCCCCcccCCHHHHhccCCCC
Confidence 9999999999999 9999999999999999999999999999987653211 11223456899999999986543
Q ss_pred -cCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhc
Q 024027 155 -VSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMAC 233 (273)
Q Consensus 155 -~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 233 (273)
++.++|+||+||++|+|++|..||....... ....+... ......+....++..+.+++.+|
T Consensus 223 ~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~-~~~~i~~~----------------~~~~~~p~~~~~s~~~~~li~~~ 285 (370)
T cd05621 223 YYGRECDWWSVGVFLFEMLVGDTPFYADSLVG-TYSKIMDH----------------KNSLNFPEDVEISKHAKNLICAF 285 (370)
T ss_pred CCCcccCEEeehHHHHHHHhCCCCCCCCCHHH-HHHHHHhC----------------CcccCCCCcccCCHHHHHHHHHH
Confidence 7889999999999999999999997532211 11111100 00001111234567799999999
Q ss_pred CCCCccC--CCCHHHHHHHHH
Q 024027 234 TVESPEQ--RINAKEIVTKLL 252 (273)
Q Consensus 234 l~~dp~~--Rps~~~~l~~l~ 252 (273)
|..+|.+ |+|+.++++|-+
T Consensus 286 L~~~~~r~~R~~~~e~l~hp~ 306 (370)
T cd05621 286 LTDREVRLGRNGVEEIKQHPF 306 (370)
T ss_pred ccCchhccCCCCHHHHhcCcc
Confidence 9865543 899999999954
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=265.72 Aligned_cols=235 Identities=24% Similarity=0.389 Sum_probs=181.0
Q ss_pred CeEEEEEeeccc-ChhhhhHHHHHHHHhcC-CCccceeeeeeeecC-CceeEEEeccCCCCHHHhhhcCC----------
Q 024027 1 MEVAVKVFNLQC-GRAFKSFDVECEMMKSI-RHRNLIKVISSCSNE-EFKALVLEYMPHGSLEKYLYSSN---------- 67 (273)
Q Consensus 1 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~---------- 67 (273)
+.||||+++... ......+.+|+.++..+ +||||+++++++... ...+++|||+++|+|.+++....
T Consensus 38 ~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~ 117 (343)
T cd05103 38 RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKD 117 (343)
T ss_pred eeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccc
Confidence 369999997643 33456788999999999 789999999987654 56789999999999999986421
Q ss_pred --------------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHhc
Q 024027 68 --------------------------------------------------------CILDIFQRLNIMIDVASALEYLHF 91 (273)
Q Consensus 68 --------------------------------------------------------~~~~~~~~~~~~~ql~~~l~~lh~ 91 (273)
..+++..+..++.|++.||.|||
T Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH- 196 (343)
T cd05103 118 ARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA- 196 (343)
T ss_pred cccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH-
Confidence 13577788899999999999999
Q ss_pred CCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcchhHHHHHHHHHH
Q 024027 92 GCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMET 171 (273)
Q Consensus 92 ~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l 171 (273)
+.|++|+||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||++++++
T Consensus 197 --~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el 274 (343)
T cd05103 197 --SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 274 (343)
T ss_pred --hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHH
Confidence 999999999999999999999999999998765322221222223356679999999888899999999999999999
Q ss_pred Hh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHH
Q 024027 172 FT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 172 l~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
++ |..||................. ....+...+.++.+++.+||..||.+|||+.+++++
T Consensus 275 ~~~g~~p~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 275 FSLGASPYPGVKIDEEFCRRLKEGT-------------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HHCCCCCCCCccccHHHHHHHhccC-------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 97 8999865322211111000000 000122345568999999999999999999999999
Q ss_pred HHHHHHh
Q 024027 251 LLKIRDS 257 (273)
Q Consensus 251 l~~~~~~ 257 (273)
|+.+.+.
T Consensus 336 l~~~~~~ 342 (343)
T cd05103 336 LGNLLQA 342 (343)
T ss_pred HHHHHhc
Confidence 9988763
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=260.42 Aligned_cols=224 Identities=24% Similarity=0.331 Sum_probs=181.2
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
+||+|+++... ......+..|+++++.++||||+++++++..+...++|+||+++++|.+++... .+++..+..++.
T Consensus 31 ~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ 108 (277)
T cd06642 31 VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPG--PLEETYIATILR 108 (277)
T ss_pred EEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhcC--CCCHHHHHHHHH
Confidence 68999987443 345567899999999999999999999999999999999999999999998643 588999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
|++.|+.||| +.|++|+||+|+||+++.++.++++|||++..+.... .......++..|+|||.+.+..++.++|
T Consensus 109 ~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~D 183 (277)
T cd06642 109 EILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDFKAD 183 (277)
T ss_pred HHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcc--hhhhcccCcccccCHHHhCcCCCchhhh
Confidence 9999999999 9999999999999999999999999999987653221 1122335778899999998888999999
Q ss_pred hHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccC
Q 024027 161 VYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQ 240 (273)
Q Consensus 161 iwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 240 (273)
+||||++++++++|..||........... . .... .......++.++.+++.+||..+|.+
T Consensus 184 v~slG~il~el~tg~~p~~~~~~~~~~~~--~------------~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~ 243 (277)
T cd06642 184 IWSLGITAIELAKGEPPNSDLHPMRVLFL--I------------PKNS------PPTLEGQYSKPFKEFVEACLNKDPRF 243 (277)
T ss_pred HHHHHHHHHHHHhCCCCCcccchhhHHhh--h------------hcCC------CCCCCcccCHHHHHHHHHHccCCccc
Confidence 99999999999999999865332211100 0 0000 00112235667899999999999999
Q ss_pred CCCHHHHHHHHH
Q 024027 241 RINAKEIVTKLL 252 (273)
Q Consensus 241 Rps~~~~l~~l~ 252 (273)
|||+.++++|-+
T Consensus 244 Rp~~~~il~~~~ 255 (277)
T cd06642 244 RPTAKELLKHKF 255 (277)
T ss_pred CcCHHHHHHhHH
Confidence 999999999754
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=256.55 Aligned_cols=226 Identities=33% Similarity=0.569 Sum_probs=181.8
Q ss_pred eEEEEEeecccCh-hhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCC-CCHHHHHHHH
Q 024027 2 EVAVKVFNLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIM 79 (273)
Q Consensus 2 ~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~ 79 (273)
+||+|+++..... ....+..|+.+++.++|+||+++++++.+.+..+++|||+++++|.+++...... +++..+..++
T Consensus 30 ~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 109 (258)
T smart00219 30 EVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFA 109 (258)
T ss_pred eEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHH
Confidence 6899999765433 5678999999999999999999999999999999999999999999999765544 8999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 159 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 159 (273)
.|++.||++|| +.|++|+||+|+||+++.++.++|+|||.+........... ....++..|+|||.+.+..++.++
T Consensus 110 ~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~ 185 (258)
T smart00219 110 LQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKK-KGGKLPIRWMAPESLKDGKFTSKS 185 (258)
T ss_pred HHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccccccccc-ccCCCcccccChHHhccCCCCcch
Confidence 99999999999 99999999999999999999999999999976643321111 122367889999999888899999
Q ss_pred hhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc
Q 024027 160 DVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238 (273)
Q Consensus 160 DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 238 (273)
|+||+|++++++++ |..||........ ... ... .. ....+..++.++.+++.+||..||
T Consensus 186 Di~slG~i~~~l~~~g~~p~~~~~~~~~-~~~-~~~------------~~------~~~~~~~~~~~~~~~i~~~l~~~p 245 (258)
T smart00219 186 DVWSFGVLLWEIFTLGESPYPGMSNEEV-LEY-LKK------------GY------RLPKPENCPPEIYKLMLQCWAEDP 245 (258)
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHH-Hhc------------CC------CCCCCCcCCHHHHHHHHHHCcCCh
Confidence 99999999999998 7888765221111 000 000 00 001123366779999999999999
Q ss_pred cCCCCHHHHHHHH
Q 024027 239 EQRINAKEIVTKL 251 (273)
Q Consensus 239 ~~Rps~~~~l~~l 251 (273)
.+|||+.++++.|
T Consensus 246 ~~Rpt~~~ll~~l 258 (258)
T smart00219 246 EDRPTFSELVEIL 258 (258)
T ss_pred hhCcCHHHHHhhC
Confidence 9999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=261.46 Aligned_cols=242 Identities=22% Similarity=0.244 Sum_probs=175.5
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcC---CCccceeeeeeeec-----CCceeEEEeccCCCCHHHhhhcCC-CC
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSI---RHRNLIKVISSCSN-----EEFKALVLEYMPHGSLEKYLYSSN-CI 69 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~-~~ 69 (273)
+.||+|.++... ......+.+|+.+++.+ +||||+++++++.. ....++++||+++ +|.+++.... ..
T Consensus 26 ~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~ 104 (288)
T cd07863 26 HFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPG 104 (288)
T ss_pred cEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEccccc-CHHHHHHhcCCCC
Confidence 369999997542 22234566787777765 69999999998864 3457899999975 8988886543 35
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcc
Q 024027 70 LDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEY 149 (273)
Q Consensus 70 ~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~ 149 (273)
+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++....... ......++..|+|||.
T Consensus 105 ~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~ 178 (288)
T cd07863 105 LPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQM---ALTPVVVTLWYRAPEV 178 (288)
T ss_pred CCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccccccCcc---cCCCccccccccCchH
Confidence 899999999999999999999 9999999999999999999999999999987653221 1223457889999999
Q ss_pred cCCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhh------hhcc-ccchhhhhhhhhh
Q 024027 150 GREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVD------ANLL-SQEDIHFVAKEQC 222 (273)
Q Consensus 150 ~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~-~~~~~~~~~~~~~ 222 (273)
+.+..++.++||||+||++|+|++|.+||....... ................... .... ..........+.+
T Consensus 179 ~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (288)
T cd07863 179 LLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEI 257 (288)
T ss_pred hhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH-HHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCc
Confidence 988889999999999999999999999986533221 1111111100000000000 0000 0000011122356
Q ss_pred HHHHHHHHhhcCCCCccCCCCHHHHHHH
Q 024027 223 VSFVFNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 223 ~~~l~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
+.++.+++.+||.+||++|||+.+++.|
T Consensus 258 ~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 258 EESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred CHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 7779999999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=256.36 Aligned_cols=226 Identities=22% Similarity=0.279 Sum_probs=183.6
Q ss_pred CeEEEEEeecc--cChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcC-CCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~ 77 (273)
+.||+|.+... +......+.+|++++++++|+||+++++++.+...++++|||+++++|.+++... ...+++..+..
T Consensus 26 ~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~ 105 (256)
T cd08221 26 SLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW 105 (256)
T ss_pred cEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHH
Confidence 36899988654 2445667889999999999999999999999999999999999999999999765 44689999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
++.|++.|+.||| +.|++|+||+|+||+++.++.++|+|||.+........ ......+++.|.|||.+.+..++.
T Consensus 106 ~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~ 180 (256)
T cd08221 106 YLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--MAETVVGTPYYMSPELCQGVKYNF 180 (256)
T ss_pred HHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc--cccccCCCccccCHhhcCCCCCCC
Confidence 9999999999999 99999999999999999999999999999876533221 223456788999999998888899
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
++|+||+|+++++|++|..||......+. ....... . ....+..++.++.+++.+||..+
T Consensus 181 ~~Dv~slG~i~~~l~~g~~~~~~~~~~~~-~~~~~~~-------------~------~~~~~~~~~~~~~~~i~~~l~~~ 240 (256)
T cd08221 181 KSDIWALGCVLYELLTLKRTFDATNPLNL-VVKIVQG-------------N------YTPVVSVYSSELISLVHSLLQQD 240 (256)
T ss_pred cchhHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHcC-------------C------CCCCccccCHHHHHHHHHHcccC
Confidence 99999999999999999999864222111 1110000 0 00112445677999999999999
Q ss_pred ccCCCCHHHHHHHH
Q 024027 238 PEQRINAKEIVTKL 251 (273)
Q Consensus 238 p~~Rps~~~~l~~l 251 (273)
|.+|||++++++++
T Consensus 241 p~~R~s~~~ll~~~ 254 (256)
T cd08221 241 PEKRPTADEVLDQP 254 (256)
T ss_pred cccCCCHHHHhhCc
Confidence 99999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=270.62 Aligned_cols=240 Identities=22% Similarity=0.206 Sum_probs=175.9
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecC------CceeEEEeccCCCCHHHhhhcCCCCCCH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNE------EFKALVLEYMPHGSLEKYLYSSNCILDI 72 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 72 (273)
+.||||+++... ......+.+|+.+++.++||||+++++++... ...++||||+++ ++.+.+.. .++.
T Consensus 43 ~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~l~~ 118 (355)
T cd07874 43 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM---ELDH 118 (355)
T ss_pred ceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhcc-cHHHHHhh---cCCH
Confidence 468999997542 33456778899999999999999999988654 356899999976 78777743 3788
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC
Q 024027 73 FQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE 152 (273)
Q Consensus 73 ~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 152 (273)
..+..++.|++.||.||| +.|++||||||+||+++.++.++|+|||++...... .......++..|+|||++.+
T Consensus 119 ~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~ 192 (355)
T cd07874 119 ERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILG 192 (355)
T ss_pred HHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCcccccCCCc---cccCCccccCCccCHHHHcC
Confidence 899999999999999999 999999999999999999999999999999754221 12233468899999999998
Q ss_pred CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCc----------cchhhhhhhc----------ccc-
Q 024027 153 GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPI----------STMEVVDANL----------LSQ- 211 (273)
Q Consensus 153 ~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~----------~~~- 211 (273)
..++.++|||||||++|+|++|..||........ ........... .......... ...
T Consensus 193 ~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (355)
T cd07874 193 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDS 271 (355)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhcccc
Confidence 8899999999999999999999999975332111 11111100000 0000000000 000
Q ss_pred -chhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHH
Q 024027 212 -EDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKL 251 (273)
Q Consensus 212 -~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l 251 (273)
.......+...+.++.+|+.+||..||++|||+.++++|-
T Consensus 272 ~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp 312 (355)
T cd07874 272 LFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHP 312 (355)
T ss_pred ccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCc
Confidence 0000011222456789999999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=259.16 Aligned_cols=245 Identities=21% Similarity=0.223 Sum_probs=184.4
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
+.||||++.... ......+.+|+.+++.++||||+++++++..+...++|+||+ +++|.+++......+++..++.+
T Consensus 26 ~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~ 104 (286)
T cd07832 26 ETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSY 104 (286)
T ss_pred ceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHH
Confidence 369999997653 334567899999999999999999999999999999999999 88999999766667999999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCC-CcCC
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG-RVST 157 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~ 157 (273)
+.|++.||.||| +.|++|+||+|+||+++.++.++|+|||.+........ .......++..|+|||.+.+. .++.
T Consensus 105 ~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~ 180 (286)
T cd07832 105 MRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDP 180 (286)
T ss_pred HHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-CccccccCcccccCceeeeccccCCc
Confidence 999999999999 99999999999999999999999999999876533221 112334678899999988654 4689
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchh---------hhhhhccccch-hhhhhhhhhHHHHH
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTME---------VVDANLLSQED-IHFVAKEQCVSFVF 227 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~-~~~~~~~~~~~~l~ 227 (273)
++||||+|++++++++|.+||...... ................. ........... .........+.++.
T Consensus 181 ~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (286)
T cd07832 181 GVDLWAVGCIFAELLNGSPLFPGENDI-EQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEAL 259 (286)
T ss_pred hhHHHHHHHHHHHHHcCCcCcCCCCHH-HHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHH
Confidence 999999999999999998887653322 11111111111100000 00000000000 00111234567899
Q ss_pred HHHhhcCCCCccCCCCHHHHHHHH
Q 024027 228 NLAMACTVESPEQRINAKEIVTKL 251 (273)
Q Consensus 228 ~li~~~l~~dp~~Rps~~~~l~~l 251 (273)
+++.+||..||++|||+++++.|-
T Consensus 260 ~li~~~l~~~p~~R~~~~~~l~h~ 283 (286)
T cd07832 260 DLLKGLLVYDPSKRLSAAEALRHP 283 (286)
T ss_pred HHHHHHhccChhhCCCHHHHhhCc
Confidence 999999999999999999999873
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=269.82 Aligned_cols=241 Identities=21% Similarity=0.201 Sum_probs=176.7
Q ss_pred CeEEEEEeecc--cChhhhhHHHHHHHHhcCCCccceeeeeeeecC------CceeEEEeccCCCCHHHhhhcCCCCCCH
Q 024027 1 MEVAVKVFNLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNE------EFKALVLEYMPHGSLEKYLYSSNCILDI 72 (273)
Q Consensus 1 ~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 72 (273)
+.||||+++.. .......+.+|+.+++.++||||+++++++... ...++||||+++ +|.+++.. .++.
T Consensus 50 ~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~ 125 (364)
T cd07875 50 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQM---ELDH 125 (364)
T ss_pred cEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCCC-CHHHHHHh---cCCH
Confidence 36899999754 234456788999999999999999999987543 357999999976 88887743 3788
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC
Q 024027 73 FQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE 152 (273)
Q Consensus 73 ~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 152 (273)
..+..++.|++.||.||| +.|++||||||+||+++.++.++|+|||++...... .......++..|+|||++.+
T Consensus 126 ~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~---~~~~~~~~t~~y~aPE~~~~ 199 (364)
T cd07875 126 ERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILG 199 (364)
T ss_pred HHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCC---CcccCCcccCCcCCHHHHhC
Confidence 899999999999999999 999999999999999999999999999999754221 12233468899999999999
Q ss_pred CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCc--cchhhh--------hhhc----------cc--
Q 024027 153 GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPI--STMEVV--------DANL----------LS-- 210 (273)
Q Consensus 153 ~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~--------~~~~----------~~-- 210 (273)
..++.++|||||||++|+|++|..||......+. ........... ...... .... ..
T Consensus 200 ~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (364)
T cd07875 200 MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-WNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDV 278 (364)
T ss_pred CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccc
Confidence 8999999999999999999999999976433211 11111110000 000000 0000 00
Q ss_pred cchhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 211 QEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 211 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
............+.++.+|+.+||..||.+|||++++++|-+
T Consensus 279 ~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~ 320 (364)
T cd07875 279 LFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320 (364)
T ss_pred cccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcc
Confidence 000000011123456899999999999999999999999843
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=256.64 Aligned_cols=226 Identities=30% Similarity=0.466 Sum_probs=178.7
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcC-CCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~ 80 (273)
.||+|.++... .....+.+|+.+++.++|+|++++++++.. ...+++|||+++++|.+++... ...+++..+..++.
T Consensus 32 ~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ 109 (260)
T cd05070 32 KVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAA 109 (260)
T ss_pred eeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHH
Confidence 58999987543 345679999999999999999999998854 5678999999999999999654 33589999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
|++.||.||| +.|++|+||+|+||+++.++.++|+|||.+..+..... .......++..|+|||.+.+..++.++|
T Consensus 110 ~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~D 185 (260)
T cd05070 110 QVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSD 185 (260)
T ss_pred HHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc-ccccCCCCCccccChHHHhcCCCcchhh
Confidence 9999999999 99999999999999999999999999999976532211 1111223456799999998888999999
Q ss_pred hHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCcc
Q 024027 161 VYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239 (273)
Q Consensus 161 iwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 239 (273)
+||||+++|++++ |..||......+. ....... .....+...+..+.+|+.+||..||.
T Consensus 186 i~slG~~l~~l~~~g~~p~~~~~~~~~-~~~~~~~-------------------~~~~~~~~~~~~~~~li~~~l~~~p~ 245 (260)
T cd05070 186 VWSFGILLTELVTKGRVPYPGMNNREV-LEQVERG-------------------YRMPCPQDCPISLHELMLQCWKKDPE 245 (260)
T ss_pred hHHHHHHHHHHHhcCCCCCCCCCHHHH-HHHHHcC-------------------CCCCCCCcCCHHHHHHHHHHcccCcc
Confidence 9999999999999 8899865322211 1110000 00011334567799999999999999
Q ss_pred CCCCHHHHHHHHHH
Q 024027 240 QRINAKEIVTKLLK 253 (273)
Q Consensus 240 ~Rps~~~~l~~l~~ 253 (273)
+|||+.++.+.|++
T Consensus 246 ~Rpt~~~l~~~l~~ 259 (260)
T cd05070 246 ERPTFEYLQSFLED 259 (260)
T ss_pred cCcCHHHHHHHHhc
Confidence 99999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=256.44 Aligned_cols=227 Identities=26% Similarity=0.453 Sum_probs=180.4
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcC-CCCCCHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIM 79 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ 79 (273)
+.||+|.+.... .....+.+|+.+++.++|+||+++++++. ....+++|||+++++|.+++... +..+++..+..++
T Consensus 31 ~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~ 108 (260)
T cd05067 31 TKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMA 108 (260)
T ss_pred ceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHH
Confidence 469999997553 34568899999999999999999999875 45689999999999999998643 3468899999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 159 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 159 (273)
.|++.||.||| +.|++|+||+|+||+++.++.++|+|||.+....... ........++..|+|||.+.+..++.++
T Consensus 109 ~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~~pe~~~~~~~~~~~ 184 (260)
T cd05067 109 AQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKS 184 (260)
T ss_pred HHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC-cccccCCcccccccCHHHhccCCcCccc
Confidence 99999999999 9999999999999999999999999999987653211 1111223456789999999888899999
Q ss_pred hhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc
Q 024027 160 DVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238 (273)
Q Consensus 160 DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 238 (273)
|+||||++++++++ |..||......+. .... .. . .....+..++.++.+++.+||..+|
T Consensus 185 Di~slG~~l~el~~~g~~p~~~~~~~~~-~~~~-~~------------~------~~~~~~~~~~~~~~~li~~~l~~~p 244 (260)
T cd05067 185 DVWSFGILLTEIVTYGRIPYPGMTNPEV-IQNL-ER------------G------YRMPRPDNCPEELYELMRLCWKEKP 244 (260)
T ss_pred chHHHHHHHHHHHhCCCCCCCCCChHHH-HHHH-Hc------------C------CCCCCCCCCCHHHHHHHHHHccCCh
Confidence 99999999999998 9999875332211 1000 00 0 0001133456679999999999999
Q ss_pred cCCCCHHHHHHHHHH
Q 024027 239 EQRINAKEIVTKLLK 253 (273)
Q Consensus 239 ~~Rps~~~~l~~l~~ 253 (273)
++|||++++++.|++
T Consensus 245 ~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 245 EERPTFEYLRSVLED 259 (260)
T ss_pred hhCCCHHHHHHHhhc
Confidence 999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=256.11 Aligned_cols=225 Identities=28% Similarity=0.475 Sum_probs=179.7
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~q 81 (273)
.+|+|.++... .....+.+|+++++.++|||++++++++......++++||+++++|.+++......+++..++.++.|
T Consensus 30 ~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ 108 (256)
T cd05112 30 KVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLD 108 (256)
T ss_pred eEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHH
Confidence 68999887542 23467899999999999999999999999999999999999999999999766666899999999999
Q ss_pred HHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcchh
Q 024027 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 161 (273)
Q Consensus 82 l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di 161 (273)
++.|+.+|| +.+++|+||+|+||+++.++.++|+|||.+....... ........++..|+|||.+.+..++.++|+
T Consensus 109 l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv 184 (256)
T cd05112 109 VCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWSSPEVFSFSKYSSKSDV 184 (256)
T ss_pred HHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCc-ccccCCCccchhhcCHhHhccCCcChHHHH
Confidence 999999999 9999999999999999999999999999987542211 111112234568999999988889999999
Q ss_pred HHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccC
Q 024027 162 YSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQ 240 (273)
Q Consensus 162 wslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 240 (273)
||+|+++|++++ |..||........ .... ... .....+...+..+.+|+.+||..+|++
T Consensus 185 ~slG~~l~el~~~g~~p~~~~~~~~~-----~~~~---------~~~------~~~~~~~~~~~~~~~l~~~~l~~~p~~ 244 (256)
T cd05112 185 WSFGVLMWEVFSEGKTPYENRSNSEV-----VETI---------NAG------FRLYKPRLASQSVYELMQHCWKERPED 244 (256)
T ss_pred HHHHHHHHHHHcCCCCCCCcCCHHHH-----HHHH---------hCC------CCCCCCCCCCHHHHHHHHHHcccChhh
Confidence 999999999998 9999865332211 1000 000 000012234567999999999999999
Q ss_pred CCCHHHHHHHH
Q 024027 241 RINAKEIVTKL 251 (273)
Q Consensus 241 Rps~~~~l~~l 251 (273)
|||+.+++++|
T Consensus 245 Rp~~~~~l~~l 255 (256)
T cd05112 245 RPSFSLLLHQL 255 (256)
T ss_pred CCCHHHHHHhh
Confidence 99999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=259.33 Aligned_cols=226 Identities=23% Similarity=0.315 Sum_probs=183.0
Q ss_pred CeEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 1 MEVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 1 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
+.||+|++.... ......+.+|+++++.++|+|++++++++.++...++|+||+++++|.+++... .+++..++.++
T Consensus 27 ~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~ 104 (274)
T cd06609 27 QVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG--KLDETYIAFIL 104 (274)
T ss_pred eEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc--CCCHHHHHHHH
Confidence 368999997553 445567889999999999999999999999999999999999999999999654 68999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 159 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 159 (273)
.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+..++.++
T Consensus 105 ~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~s 179 (274)
T cd06609 105 REVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SKRNTFVGTPFWMAPEVIKQSGYDEKA 179 (274)
T ss_pred HHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--cccccccCCccccChhhhccCCCCchh
Confidence 99999999999 9999999999999999999999999999997764321 222345678889999999888899999
Q ss_pred hhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCcc
Q 024027 160 DVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239 (273)
Q Consensus 160 DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 239 (273)
|+||||+++|++++|..||.......... ..... . ... .....++.++.+++.+||..||.
T Consensus 180 Dv~slG~il~~l~tg~~p~~~~~~~~~~~-~~~~~-------------~--~~~---~~~~~~~~~~~~~l~~~l~~~p~ 240 (274)
T cd06609 180 DIWSLGITAIELAKGEPPLSDLHPMRVLF-LIPKN-------------N--PPS---LEGNKFSKPFKDFVSLCLNKDPK 240 (274)
T ss_pred hHHHHHHHHHHHHhCCCCcccCchHHHHH-Hhhhc-------------C--CCC---CcccccCHHHHHHHHHHhhCChh
Confidence 99999999999999999986533211100 00000 0 000 00111566799999999999999
Q ss_pred CCCCHHHHHHHHH
Q 024027 240 QRINAKEIVTKLL 252 (273)
Q Consensus 240 ~Rps~~~~l~~l~ 252 (273)
+|||++++++|=.
T Consensus 241 ~Rpt~~~il~~~~ 253 (274)
T cd06609 241 ERPSAKELLKHKF 253 (274)
T ss_pred hCcCHHHHhhChh
Confidence 9999999988643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=255.80 Aligned_cols=226 Identities=29% Similarity=0.465 Sum_probs=178.7
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC-CCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~ 80 (273)
.||+|.+.... ...+.+.+|+++++.++|+|++++++++.. ...+++|||+++++|.+++.... ..+++..+..++.
T Consensus 32 ~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ 109 (260)
T cd05069 32 KVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAA 109 (260)
T ss_pred eEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHH
Confidence 58999886542 344678899999999999999999998864 56789999999999999996543 3488999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
|++.||.||| +.|++|+||+|+||+++.++.++|+|||.+........ .......++..|+|||...+..++.++|
T Consensus 110 ~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~D 185 (260)
T cd05069 110 QIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSD 185 (260)
T ss_pred HHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc-cccCCCccchhhCCHHHhccCCcChHHH
Confidence 9999999999 99999999999999999999999999999876532211 1112234567799999998888999999
Q ss_pred hHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCcc
Q 024027 161 VYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239 (273)
Q Consensus 161 iwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 239 (273)
+||||+++|++++ |..||......+. ........ ....+...+..+.+++.+||..||.
T Consensus 186 i~slG~~l~el~t~g~~p~~~~~~~~~-~~~~~~~~-------------------~~~~~~~~~~~~~~li~~~l~~~p~ 245 (260)
T cd05069 186 VWSFGILLTELVTKGRVPYPGMVNREV-LEQVERGY-------------------RMPCPQGCPESLHELMKLCWKKDPD 245 (260)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHcCC-------------------CCCCCcccCHHHHHHHHHHccCCcc
Confidence 9999999999999 8999875332211 11110000 0011234567799999999999999
Q ss_pred CCCCHHHHHHHHHH
Q 024027 240 QRINAKEIVTKLLK 253 (273)
Q Consensus 240 ~Rps~~~~l~~l~~ 253 (273)
+||+++++++.|++
T Consensus 246 ~Rp~~~~i~~~l~~ 259 (260)
T cd05069 246 ERPTFEYIQSFLED 259 (260)
T ss_pred cCcCHHHHHHHHhc
Confidence 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=259.53 Aligned_cols=229 Identities=29% Similarity=0.417 Sum_probs=180.0
Q ss_pred eEEEEEeecccChh--hhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRA--FKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 2 ~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
.||+|++....... ......|+.++++++||||+++++++.+....+++||++++++|.+++. ....++...+..++
T Consensus 26 ~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~-~~~~~~~~~~~~~~ 104 (260)
T PF00069_consen 26 KVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQ-KNKPLSEEEILKIA 104 (260)
T ss_dssp EEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHH-HHSSBBHHHHHHHH
T ss_pred EEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccccccccccccc-cccccccccccccc
Confidence 69999998764322 2234569999999999999999999999999999999999999999997 33468999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccC-CCCcCCc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR-EGRVSTN 158 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~ 158 (273)
.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||.+... ...........++..|.|||... +..++.+
T Consensus 105 ~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 179 (260)
T PF00069_consen 105 YQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKL--SENNENFNPFVGTPEYMAPEVLQQGKKYTRK 179 (260)
T ss_dssp HHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEES--TSTTSEBSSSSSSGGGSCHHHHTTTSSBSTH
T ss_pred ccccccccccc---ccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccc
Confidence 99999999999 999999999999999999999999999998754 12223344566788999999998 7889999
Q ss_pred chhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc
Q 024027 159 GDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238 (273)
Q Consensus 159 ~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 238 (273)
+|+||+|+++++|++|..||....... ....... ................+.++.+++.+||..||
T Consensus 180 ~Di~slG~il~~l~~~~~p~~~~~~~~-~~~~~~~-------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 245 (260)
T PF00069_consen 180 SDIWSLGIILYELLTGKLPFEESNSDD-QLEIIEK-------------ILKRPLPSSSQQSREKSEELRDLIKKMLSKDP 245 (260)
T ss_dssp HHHHHHHHHHHHHHHSSSSSTTSSHHH-HHHHHHH-------------HHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSG
T ss_pred ccccccccccccccccccccccccchh-hhhhhhh-------------cccccccccccccchhHHHHHHHHHHHccCCh
Confidence 999999999999999999987641111 1111000 00000000111111223779999999999999
Q ss_pred cCCCCHHHHHHH
Q 024027 239 EQRINAKEIVTK 250 (273)
Q Consensus 239 ~~Rps~~~~l~~ 250 (273)
++|||+.++++|
T Consensus 246 ~~R~~~~~l~~~ 257 (260)
T PF00069_consen 246 EQRPSAEELLKH 257 (260)
T ss_dssp GGSTTHHHHHTS
T ss_pred hHCcCHHHHhcC
Confidence 999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=261.73 Aligned_cols=240 Identities=21% Similarity=0.276 Sum_probs=182.3
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
.||+|.++... ......+.+|+++++.++||||++++++|.+++..++++||+++++|.+++... ..+++..+..++.
T Consensus 28 ~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~-~~~~~~~~~~~~~ 106 (308)
T cd06615 28 IMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPENILGKISI 106 (308)
T ss_pred EEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhc-CCCCHHHHHHHHH
Confidence 57888887543 234566889999999999999999999999999999999999999999999765 4689999999999
Q ss_pred HHHHHHHHHhcCCC-CCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcc
Q 024027 81 DVASALEYLHFGCS-APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 159 (273)
Q Consensus 81 ql~~~l~~lh~~~~-~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 159 (273)
|++.||.||| + .+++|+||+|+||+++.++.++|+|||++...... ......++..|+|||.+.+..++.++
T Consensus 107 ~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~ 179 (308)
T cd06615 107 AVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYTVQS 179 (308)
T ss_pred HHHHHHHHHH---hhCCEEECCCChHHEEEecCCcEEEccCCCccccccc----ccccCCCCcCccChhHhcCCCCCccc
Confidence 9999999999 7 58999999999999999999999999988654221 12334678899999999888899999
Q ss_pred hhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccc---------------------hhhhhhhccccchhhhhh
Q 024027 160 DVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPIST---------------------MEVVDANLLSQEDIHFVA 218 (273)
Q Consensus 160 DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~ 218 (273)
|+||||++++++++|..||....... ............. .+..+... ........
T Consensus 180 DiwslG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 255 (308)
T cd06615 180 DIWSLGLSLVEMAIGRYPIPPPDAKE--LEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIV--NEPPPKLP 255 (308)
T ss_pred hHHHHHHHHHHHHhCCCCCCCcchhh--HHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHh--cCCCccCc
Confidence 99999999999999999986433211 1111110000000 00000000 00000001
Q ss_pred hhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHHH
Q 024027 219 KEQCVSFVFNLAMACTVESPEQRINAKEIVTKLLK 253 (273)
Q Consensus 219 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 253 (273)
...++.++.+|+.+||..||++|||+.+++++-+-
T Consensus 256 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~ 290 (308)
T cd06615 256 SGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290 (308)
T ss_pred CcccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 12356779999999999999999999999999763
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=255.46 Aligned_cols=217 Identities=24% Similarity=0.404 Sum_probs=173.8
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~q 81 (273)
.|++|+++..... ...+.+|+.+++.++||||+++++++.. ...++||||+++++|.+++......+++..+..++.|
T Consensus 32 ~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 109 (259)
T cd05037 32 SVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQ 109 (259)
T ss_pred eeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHH
Confidence 4788887655332 6789999999999999999999999888 7789999999999999999766557899999999999
Q ss_pred HHHHHHHHhcCCCCCeEeccCCCCceeeCCCC-------ceEEeecccccccccCCCcceeecccccCCCCCCcccCCC-
Q 024027 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNL-------VAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG- 153 (273)
Q Consensus 82 l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~-------~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~- 153 (273)
++.||.||| +.|++|+||||+||+++.++ .++|+|||++..... .....++..|+|||.+.+.
T Consensus 110 i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~ 180 (259)
T cd05037 110 LASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS------REERVERIPWIAPECIRNGQ 180 (259)
T ss_pred HHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCccccccc------ccccccCCCccChhhhcCCC
Confidence 999999999 99999999999999999877 799999999876422 2234466779999998776
Q ss_pred -CcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHh
Q 024027 154 -RVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAM 231 (273)
Q Consensus 154 -~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 231 (273)
.++.++|+||||++++++++ |..||........ ....... .. .+......+.+++.
T Consensus 181 ~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~--~~~~~~~-----------~~---------~~~~~~~~~~~li~ 238 (259)
T cd05037 181 ASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK--ERFYQDQ-----------HR---------LPMPDCAELANLIN 238 (259)
T ss_pred CCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH--HHHHhcC-----------CC---------CCCCCchHHHHHHH
Confidence 68999999999999999999 5777765432111 1110000 00 01111256899999
Q ss_pred hcCCCCccCCCCHHHHHHHH
Q 024027 232 ACTVESPEQRINAKEIVTKL 251 (273)
Q Consensus 232 ~~l~~dp~~Rps~~~~l~~l 251 (273)
+||..+|.+|||+.++++.|
T Consensus 239 ~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 239 QCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred HHhccChhhCCCHHHHHHhc
Confidence 99999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=257.68 Aligned_cols=230 Identities=23% Similarity=0.304 Sum_probs=183.7
Q ss_pred CeEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 1 MEVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 1 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
+.||+|.+.... ......+.+|+++++.++||||+++++++..+..+++++||+++++|.+++......+++..+..++
T Consensus 27 ~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ 106 (265)
T cd06605 27 KIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIA 106 (265)
T ss_pred cEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHH
Confidence 368999987653 3455678899999999999999999999999999999999999999999997665678999999999
Q ss_pred HHHHHHHHHHhcCCC-CCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCc
Q 024027 80 IDVASALEYLHFGCS-APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTN 158 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~-~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 158 (273)
.|++.|+.+|| + .|++|+||+|+||+++.++.++|+|||.+........ ....++..|+|||.+.+..++.+
T Consensus 107 ~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~----~~~~~~~~y~~PE~~~~~~~~~~ 179 (265)
T cd06605 107 VAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA----KTFVGTSSYMAPERIQGNDYSVK 179 (265)
T ss_pred HHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh----hcccCChhccCHHHHcCCCCCch
Confidence 99999999999 8 9999999999999999999999999998865422111 11567788999999988889999
Q ss_pred chhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc
Q 024027 159 GDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238 (273)
Q Consensus 159 ~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 238 (273)
+|+||+|++++++++|..||................... .... ......++.++.++|.+||..||
T Consensus 180 ~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------~~~~--~~~~~~~~~~~~~li~~~l~~~p 245 (265)
T cd06605 180 SDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN------------EPPP--RLPSGKFSPDFQDFVNLCLIKDP 245 (265)
T ss_pred hhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc------------CCCC--CCChhhcCHHHHHHHHHHcCCCc
Confidence 999999999999999999987643221111111111000 0000 00011266779999999999999
Q ss_pred cCCCCHHHHHHHH
Q 024027 239 EQRINAKEIVTKL 251 (273)
Q Consensus 239 ~~Rps~~~~l~~l 251 (273)
.+|||+.+++.+=
T Consensus 246 ~~Rpt~~~ll~~~ 258 (265)
T cd06605 246 RERPSYKELLEHP 258 (265)
T ss_pred hhCcCHHHHhhCc
Confidence 9999999999763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=267.95 Aligned_cols=239 Identities=23% Similarity=0.229 Sum_probs=175.4
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecC------CceeEEEeccCCCCHHHhhhcCCCCCCH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNE------EFKALVLEYMPHGSLEKYLYSSNCILDI 72 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 72 (273)
+.||||+++... ......+.+|+++++.++||||+++++++... ...+++++++ +++|.+++... .+++
T Consensus 41 ~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~~--~l~~ 117 (343)
T cd07878 41 QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQ--KLSD 117 (343)
T ss_pred CEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHhcC--CCCH
Confidence 379999997542 23345677899999999999999999988643 3468999998 66999888543 5899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC
Q 024027 73 FQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE 152 (273)
Q Consensus 73 ~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 152 (273)
..+..++.|++.||.||| +.|++|+||||+||+++.++.+||+|||++..... ......++..|+|||++.+
T Consensus 118 ~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~-----~~~~~~~t~~y~aPE~~~~ 189 (343)
T cd07878 118 EHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD-----EMTGYVATRWYRAPEIMLN 189 (343)
T ss_pred HHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCccceecCC-----CcCCccccccccCchHhcC
Confidence 999999999999999999 99999999999999999999999999999876422 1223468899999999876
Q ss_pred -CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhh-----------hcc-ccchhhhhhh
Q 024027 153 -GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDA-----------NLL-SQEDIHFVAK 219 (273)
Q Consensus 153 -~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~-~~~~~~~~~~ 219 (273)
..++.++|||||||++|+|++|..||....... ............. ...... ... ..........
T Consensus 190 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (343)
T cd07878 190 WMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID-QLKRIMEVVGTPS-PEVLKKISSEHARKYIQSLPHMPQQDLKKIF 267 (343)
T ss_pred CccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCC-HHHHHhcchhhHHHHhhccccccchhHHHhc
Confidence 468899999999999999999999986532211 1111111100000 000000 000 0000000011
Q ss_pred hhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 220 EQCVSFVFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 220 ~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
...+..+.+|+.+||..||.+|||+.++++|=+
T Consensus 268 ~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~ 300 (343)
T cd07878 268 RGANPLAIDLLEKMLVLDSDKRISASEALAHPY 300 (343)
T ss_pred cCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence 234556889999999999999999999998854
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=256.36 Aligned_cols=232 Identities=26% Similarity=0.362 Sum_probs=174.8
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC----CCCCHHHHH
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN----CILDIFQRL 76 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~ 76 (273)
.||+|.++... ......+.+|+.+++.++||||+++++++.+....++||||+++|+|.+++.... ...++..+.
T Consensus 24 ~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 103 (269)
T cd05087 24 QVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQ 103 (269)
T ss_pred EEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHH
Confidence 58899887553 2344578889999999999999999999999999999999999999999986432 235677888
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCC---
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG--- 153 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--- 153 (273)
.++.|++.|+.||| +.+++|+||||+||+++.++.++|+|||.+................++..|+|||++.+.
T Consensus 104 ~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 180 (269)
T cd05087 104 RMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGN 180 (269)
T ss_pred HHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhcccccc
Confidence 99999999999999 999999999999999999999999999998654222221122234567789999987542
Q ss_pred ----CcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHH
Q 024027 154 ----RVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFN 228 (273)
Q Consensus 154 ----~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 228 (273)
.++.++|+||||+++|++++ |..||......+........... ..... ......+..+.+
T Consensus 181 ~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-----------~~~~~----~~~~~~~~~~~~ 245 (269)
T cd05087 181 LLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQL-----------KLPKP----RLKLPLSDRWYE 245 (269)
T ss_pred ccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccC-----------CCCCC----ccCCCCChHHHH
Confidence 35789999999999999996 99999764333211110000000 00000 001234566889
Q ss_pred HHhhcCCCCccCCCCHHHHHHHHH
Q 024027 229 LAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 229 li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
++.+|+ .+|.+|||+++|+..|+
T Consensus 246 l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 246 VMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred HHHHHh-cCcccCCCHHHHHHHhc
Confidence 999998 68999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=272.75 Aligned_cols=228 Identities=22% Similarity=0.302 Sum_probs=178.6
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||||+++... ......+..|+.++..++|++|+++++++.++..+++||||++||+|.+++.+.+ .+++..+..
T Consensus 27 ~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~l~~~~~~~ 105 (360)
T cd05627 27 HIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKD-TLSEEATQF 105 (360)
T ss_pred CEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHH
Confidence 368999997432 3345678889999999999999999999999999999999999999999996543 689999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCc-------------------------
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQS------------------------- 132 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~------------------------- 132 (273)
++.|++.||.||| +.|++||||||+||+++.++.++|+|||++..+......
T Consensus 106 ~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (360)
T cd05627 106 YIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182 (360)
T ss_pred HHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCccccccccccccccc
Confidence 9999999999999 999999999999999999999999999998654211100
Q ss_pred --------ceeecccccCCCCCCcccCCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhh
Q 024027 133 --------MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVV 204 (273)
Q Consensus 133 --------~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 204 (273)
......+|++.|+|||++.+..++.++|+|||||++|+|++|..||........ ......
T Consensus 183 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~-~~~i~~----------- 250 (360)
T cd05627 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQET-YRKVMN----------- 250 (360)
T ss_pred ccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHHH-HHHHHc-----------
Confidence 001134689999999999999999999999999999999999999975432211 111100
Q ss_pred hhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccCCCC---HHHHHHH
Q 024027 205 DANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRIN---AKEIVTK 250 (273)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~~l~~ 250 (273)
.......+....++.++.+|+.+|+ .||.+|++ +.++++|
T Consensus 251 -----~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 251 -----WKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred -----CCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 0000011111235677999999987 49999984 7888887
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=258.96 Aligned_cols=226 Identities=23% Similarity=0.316 Sum_probs=178.6
Q ss_pred CeEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 1 MEVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 1 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
+.||+|++.... ......+..|+++++.++||||+++++++..+...++|+||+++++|..+. .+++..+..++
T Consensus 27 ~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~ 101 (279)
T cd06619 27 RILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYR-----KIPEHVLGRIA 101 (279)
T ss_pred cEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHhh-----cCCHHHHHHHH
Confidence 469999987542 334567889999999999999999999999999999999999999997653 36788899999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 159 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 159 (273)
.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++...... ......++..|+|||.+.+..++.++
T Consensus 102 ~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~ 174 (279)
T cd06619 102 VAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERISGEQYGIHS 174 (279)
T ss_pred HHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----cccCCCCChhhcCceeecCCCCCCcc
Confidence 99999999999 999999999999999999999999999998754221 22335688899999999888899999
Q ss_pred hhHHHHHHHHHHHhCCCCCccccccccchh--hhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 160 DVYSFGIMLMETFTGKKPTYEFFNGEMTLK--HWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 160 DiwslG~~l~~ll~g~~pf~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
|+||||+++|++++|..||........... ......... .. ........+.++.+++.+||..|
T Consensus 175 DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------~~--~~~~~~~~~~~~~~li~~~l~~~ 240 (279)
T cd06619 175 DVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE------------DP--PVLPVGQFSEKFVHFITQCMRKQ 240 (279)
T ss_pred hHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc------------CC--CCCCCCcCCHHHHHHHHHHhhCC
Confidence 999999999999999999876332221110 000000000 00 00001234566899999999999
Q ss_pred ccCCCCHHHHHHHHH
Q 024027 238 PEQRINAKEIVTKLL 252 (273)
Q Consensus 238 p~~Rps~~~~l~~l~ 252 (273)
|++||+++++++|-+
T Consensus 241 P~~Rp~~~eil~~~~ 255 (279)
T cd06619 241 PKERPAPENLMDHPF 255 (279)
T ss_pred hhhCCCHHHHhcCcc
Confidence 999999999999854
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=258.99 Aligned_cols=225 Identities=26% Similarity=0.341 Sum_probs=181.0
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
++||+|+++.......+.+.+|+.+++.++|||++++++++......++++||+++++|.+++.. ..++...+..++.
T Consensus 45 ~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ 122 (285)
T cd06648 45 RQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCL 122 (285)
T ss_pred CEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh--CCCCHHHHHHHHH
Confidence 36999998765555566788999999999999999999999999999999999999999999866 3589999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
|++.|+++|| +.|++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++|
T Consensus 123 ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~D 197 (285)
T cd06648 123 AVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAPEVISRLPYGTEVD 197 (285)
T ss_pred HHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC--cccccccCCccccCHHHhcCCCCCCccc
Confidence 9999999999 9999999999999999999999999999876542221 1122345788999999998888999999
Q ss_pred hHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccC
Q 024027 161 VYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQ 240 (273)
Q Consensus 161 iwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 240 (273)
+||+|++++++++|..||....... ........ .. .....+..++..+.+++.+||..+|++
T Consensus 198 v~slGv~l~ell~g~~p~~~~~~~~-~~~~~~~~-~~----------------~~~~~~~~~~~~l~~li~~~l~~~p~~ 259 (285)
T cd06648 198 IWSLGIMVIEMVDGEPPYFNEPPLQ-AMKRIRDN-LP----------------PKLKNLHKVSPRLRSFLDRMLVRDPAQ 259 (285)
T ss_pred HHHHHHHHHHHHhCCCCCcCCCHHH-HHHHHHhc-CC----------------CCCcccccCCHHHHHHHHHHcccChhh
Confidence 9999999999999999986522111 11110000 00 000012235667999999999999999
Q ss_pred CCCHHHHHHH
Q 024027 241 RINAKEIVTK 250 (273)
Q Consensus 241 Rps~~~~l~~ 250 (273)
|||+.++++|
T Consensus 260 Rpt~~~il~~ 269 (285)
T cd06648 260 RATAAELLNH 269 (285)
T ss_pred CcCHHHHccC
Confidence 9999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=255.49 Aligned_cols=225 Identities=22% Similarity=0.297 Sum_probs=179.7
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeec-CCceeEEEeccCCCCHHHhhhcC-CCCCCHHHHH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSN-EEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~ 76 (273)
++||+|++.... ....+.+..|+++++.++|+|++++++.+.. +..+++++||+++++|.+++... ...+++..++
T Consensus 26 ~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~ 105 (257)
T cd08223 26 KQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVV 105 (257)
T ss_pred cEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHH
Confidence 369999997542 3445678899999999999999999998764 44678999999999999998653 3458999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcC
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVS 156 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 156 (273)
.++.|++.|+.+|| +.|++|+||+|+||+++.++.++|+|||++....... .......+++.|+|||.+.+..++
T Consensus 106 ~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~ 180 (257)
T cd08223 106 EWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC--DMASTLIGTPYYMSPELFSNKPYN 180 (257)
T ss_pred HHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccC--CccccccCCcCccChhHhcCCCCC
Confidence 99999999999999 9999999999999999999999999999987653222 122344578899999999888899
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++|+||+|++++++++|..||.......... ...... ....+...+.++.+++.+||..
T Consensus 181 ~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~-~~~~~~-------------------~~~~~~~~~~~~~~li~~~l~~ 240 (257)
T cd08223 181 YKSDVWALGCCVYEMATLKHAFNAKDMNSLVY-RIIEGK-------------------LPPMPKDYSPELGELIATMLSK 240 (257)
T ss_pred chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHH-HHHhcC-------------------CCCCccccCHHHHHHHHHHhcc
Confidence 99999999999999999999986432211100 000000 0011334667799999999999
Q ss_pred CccCCCCHHHHHHH
Q 024027 237 SPEQRINAKEIVTK 250 (273)
Q Consensus 237 dp~~Rps~~~~l~~ 250 (273)
||.+|||+.++++|
T Consensus 241 ~p~~Rp~~~~~l~~ 254 (257)
T cd08223 241 RPEKRPSVKSILRQ 254 (257)
T ss_pred CcccCCCHHHHhcC
Confidence 99999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=259.59 Aligned_cols=229 Identities=22% Similarity=0.303 Sum_probs=181.1
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC-CCCCHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~ 76 (273)
+.||||.+.... ......+..|+.+++.++|++++++++.+.+....++||||+++++|.+++...+ ..+++..+.
T Consensus 26 ~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~ 105 (285)
T cd05630 26 KMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAV 105 (285)
T ss_pred ceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHH
Confidence 479999986542 2223457789999999999999999999999999999999999999999885432 358899999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcC
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVS 156 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 156 (273)
.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++....... ......|+..|+|||.+.+..++
T Consensus 106 ~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~ 179 (285)
T cd05630 106 FYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYT 179 (285)
T ss_pred HHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc---cccCCCCCccccChHHHcCCCCC
Confidence 99999999999999 9999999999999999999999999999986542211 12234688999999999888899
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++|+||+|+++|+|++|..||........ .... .. ... ......+..++.++.+|+.+||+.
T Consensus 180 ~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~-~~~~-~~--------~~~-------~~~~~~~~~~~~~~~~li~~~l~~ 242 (285)
T cd05630 180 FSPDWWALGCLLYEMIAGQSPFQQRKKKIK-REEV-ER--------LVK-------EVQEEYSEKFSPDARSLCKMLLCK 242 (285)
T ss_pred CccccHHHHHHHHHHHhCCCCCCCCCccch-HHHH-Hh--------hhh-------hhhhhcCccCCHHHHHHHHHHhhc
Confidence 999999999999999999999975322110 0000 00 000 000011334567799999999999
Q ss_pred CccCCCC-----HHHHHHHHH
Q 024027 237 SPEQRIN-----AKEIVTKLL 252 (273)
Q Consensus 237 dp~~Rps-----~~~~l~~l~ 252 (273)
||.+||| ++++++|-+
T Consensus 243 ~p~~R~s~~~~~~~~~~~h~~ 263 (285)
T cd05630 243 DPKERLGCQGGGAREVKEHPL 263 (285)
T ss_pred CHHHccCCCCCchHHHHcChh
Confidence 9999999 899999755
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=276.52 Aligned_cols=225 Identities=27% Similarity=0.405 Sum_probs=194.2
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCC--CHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCIL--DIFQRLNIM 79 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~ 79 (273)
.+|||-+...+++..+.+.+|+.+=+.++|.|||+.+|++..++.+-|.||-++||+|.+++...++++ ++..+.-+.
T Consensus 602 rIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYt 681 (1226)
T KOG4279|consen 602 RIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYT 681 (1226)
T ss_pred EEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHH
Confidence 579999988888888999999999999999999999999999999999999999999999999888888 888999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeC-CCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCC--CcC
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLD-DNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG--RVS 156 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~-~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~ 156 (273)
.||+.||.||| ++.|+|||||-+|++++ -.|.+||+|||.+..+.+-.. ......||..|+|||++..+ .|+
T Consensus 682 kQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP--~TETFTGTLQYMAPEvIDqG~RGYG 756 (1226)
T KOG4279|consen 682 KQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP--CTETFTGTLQYMAPEVIDQGPRGYG 756 (1226)
T ss_pred HHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccCCc--cccccccchhhhChHhhccCCcCCC
Confidence 99999999999 99999999999999996 689999999999988755433 23456799999999999754 499
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++|||||||.+.||.||++||....+....+-+ . .......+.|...+.++.++|.+|+.+
T Consensus 757 ~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk---------------V---GmyKvHP~iPeelsaeak~FilrcFep 818 (1226)
T KOG4279|consen 757 KAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK---------------V---GMYKVHPPIPEELSAEAKNFILRCFEP 818 (1226)
T ss_pred chhhhhhccceeEeeccCCCCeeecCChhHhhhh---------------h---cceecCCCCcHHHHHHHHHHHHHHcCC
Confidence 9999999999999999999999886665432221 0 111122233778899999999999999
Q ss_pred CccCCCCHHHHHH
Q 024027 237 SPEQRINAKEIVT 249 (273)
Q Consensus 237 dp~~Rps~~~~l~ 249 (273)
||.+|||++++|.
T Consensus 819 d~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 819 DPCDRPSAKDLLQ 831 (1226)
T ss_pred CcccCccHHHhcc
Confidence 9999999999985
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=269.67 Aligned_cols=229 Identities=24% Similarity=0.289 Sum_probs=178.4
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||+|++.... ......+.+|..+++.++||||+++++++.++...++||||+++|+|.+++... .+++..+..
T Consensus 69 ~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~ 146 (371)
T cd05622 69 KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARF 146 (371)
T ss_pred cEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHH
Confidence 368999986432 234456788999999999999999999999999999999999999999998654 478889999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCC---
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGR--- 154 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--- 154 (273)
++.|++.||.||| +.|++||||||+||+++.++.++|+|||++....... ........|++.|+|||++.+..
T Consensus 147 ~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~ 222 (371)
T cd05622 147 YTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDG 222 (371)
T ss_pred HHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC-cccccCcccCccccCHHHHhccCCCc
Confidence 9999999999999 9999999999999999999999999999997653221 11223456899999999986543
Q ss_pred -cCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhc
Q 024027 155 -VSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMAC 233 (273)
Q Consensus 155 -~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 233 (273)
++.++|||||||++|+|++|..||....... ....+... ......+....++.++.+++.+|
T Consensus 223 ~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~~----------------~~~~~~~~~~~~s~~~~~li~~~ 285 (371)
T cd05622 223 YYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-TYSKIMNH----------------KNSLTFPDDNDISKEAKNLICAF 285 (371)
T ss_pred cCCCccceeehhHHHHHHHhCCCCCCCCCHHH-HHHHHHcC----------------CCcccCCCcCCCCHHHHHHHHHH
Confidence 7899999999999999999999997532211 11111100 00011111235677799999999
Q ss_pred CCCCccC--CCCHHHHHHHHH
Q 024027 234 TVESPEQ--RINAKEIVTKLL 252 (273)
Q Consensus 234 l~~dp~~--Rps~~~~l~~l~ 252 (273)
|..++.+ |+++.++++|.+
T Consensus 286 L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 286 LTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred cCChhhhcCCCCHHHHhcCcc
Confidence 9844433 789999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=257.90 Aligned_cols=228 Identities=25% Similarity=0.442 Sum_probs=181.5
Q ss_pred eEEEEEeecccCh-hhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC--------CCCCH
Q 024027 2 EVAVKVFNLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN--------CILDI 72 (273)
Q Consensus 2 ~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------~~~~~ 72 (273)
.||+|.+...... ....+..|+++++.++|+||+++++++.+....++||||+++++|.+++.... ..+++
T Consensus 37 ~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~ 116 (275)
T cd05046 37 LVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLST 116 (275)
T ss_pred eEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCH
Confidence 5889988655433 56789999999999999999999999999999999999999999999996543 15899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC
Q 024027 73 FQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE 152 (273)
Q Consensus 73 ~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 152 (273)
..+..++.|++.||.||| +.+++|+||||+||+++.++.++++|||++....... ........++..|+|||.+.+
T Consensus 117 ~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~ 192 (275)
T cd05046 117 KQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSE-YYKLRNALIPLRWLAPEAVQE 192 (275)
T ss_pred HHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEcccccccccCccc-ccccCCceeEEeecChhhhcc
Confidence 999999999999999999 9999999999999999999999999999886432211 112223345677999999888
Q ss_pred CCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHh
Q 024027 153 GRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAM 231 (273)
Q Consensus 153 ~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 231 (273)
..++.++|+||||++++++++ |..||........ ...... .......+..++..+.+++.
T Consensus 193 ~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~-~~~~~~------------------~~~~~~~~~~~~~~l~~~i~ 253 (275)
T cd05046 193 DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV-LNRLQA------------------GKLELPVPEGCPSRLYKLMT 253 (275)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHH-HHHHHc------------------CCcCCCCCCCCCHHHHHHHH
Confidence 888999999999999999998 7888864322111 110000 00011113346677999999
Q ss_pred hcCCCCccCCCCHHHHHHHHH
Q 024027 232 ACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 232 ~~l~~dp~~Rps~~~~l~~l~ 252 (273)
+||..||.+|||+.++++.|+
T Consensus 254 ~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 254 RCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHcCCCcccCCCHHHHHHHhc
Confidence 999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=258.25 Aligned_cols=228 Identities=21% Similarity=0.301 Sum_probs=179.7
Q ss_pred CeEEEEEeecc-cChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcC--CCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS--NCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~ 77 (273)
+.||+|.++.. +......+.+|+++++.++|+||+++++++..++.+++|+||+++++|..++... ...+++..+..
T Consensus 27 ~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 106 (286)
T cd06622 27 VTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRR 106 (286)
T ss_pred cEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHH
Confidence 36899998754 2344567889999999999999999999999999999999999999999998653 23689999999
Q ss_pred HHHHHHHHHHHHhcCCC-CCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCC--
Q 024027 78 IMIDVASALEYLHFGCS-APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGR-- 154 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~-~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-- 154 (273)
++.|++.||.||| . .|++|+||+|+||+++.++.++|+|||.+..+... ......++..|+|||.+.+..
T Consensus 107 ~~~~i~~~l~~LH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~ 179 (286)
T cd06622 107 ITYAVVKGLKFLK---EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS----LAKTNIGCQSYMAPERIKSGGPN 179 (286)
T ss_pred HHHHHHHHHHHHH---hcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC----ccccCCCccCccCcchhcCCCCC
Confidence 9999999999999 6 59999999999999999999999999998754221 122345777899999885443
Q ss_pred ----cCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHH
Q 024027 155 ----VSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLA 230 (273)
Q Consensus 155 ----~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 230 (273)
++.++|+||+||++|++++|..||........ ...... . . .......+..++.++.+|+
T Consensus 180 ~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~-~--------~-------~~~~~~~~~~~~~~~~~li 242 (286)
T cd06622 180 QNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI-FAQLSA-I--------V-------DGDPPTLPSGYSDDAQDFV 242 (286)
T ss_pred ccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH-HHHHHH-H--------h-------hcCCCCCCcccCHHHHHHH
Confidence 57899999999999999999999865322111 000000 0 0 0000111344677799999
Q ss_pred hhcCCCCccCCCCHHHHHHHHH
Q 024027 231 MACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 231 ~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
.+||..+|.+||++++++.+-+
T Consensus 243 ~~~l~~~p~~Rp~~~~l~~~~~ 264 (286)
T cd06622 243 AKCLNKIPNRRPTYAQLLEHPW 264 (286)
T ss_pred HHHcccCcccCCCHHHHhcChh
Confidence 9999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=256.85 Aligned_cols=225 Identities=22% Similarity=0.283 Sum_probs=175.7
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcC-CCccceeeeeeeecC------CceeEEEeccCCCCHHHhhhcCC-CCCCH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSI-RHRNLIKVISSCSNE------EFKALVLEYMPHGSLEKYLYSSN-CILDI 72 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~-~~~~~ 72 (273)
+.||+|++.... .....+..|+.+++.+ +|+||+++++++... ..++++|||+++++|.+++.... ..+++
T Consensus 32 ~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~ 110 (272)
T cd06637 32 QLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE 110 (272)
T ss_pred cEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCH
Confidence 368999997553 3446788999999998 799999999998653 45789999999999999987643 45899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccC-
Q 024027 73 FQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR- 151 (273)
Q Consensus 73 ~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~- 151 (273)
..+..++.|++.|++||| +.+++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.
T Consensus 111 ~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~ 185 (272)
T cd06637 111 EWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIAC 185 (272)
T ss_pred HHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCceeccccc--ccCCcccccccccCHhHhcc
Confidence 999999999999999999 9999999999999999999999999999987542211 1223346788999999875
Q ss_pred ----CCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHH
Q 024027 152 ----EGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVF 227 (273)
Q Consensus 152 ----~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 227 (273)
+..++.++|+||+||++|+|++|..||............ . ...........++.++.
T Consensus 186 ~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~----~---------------~~~~~~~~~~~~~~~~~ 246 (272)
T cd06637 186 DENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI----P---------------RNPAPRLKSKKWSKKFQ 246 (272)
T ss_pred ccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH----h---------------cCCCCCCCCCCcCHHHH
Confidence 235788999999999999999999998643221111000 0 00000011223556799
Q ss_pred HHHhhcCCCCccCCCCHHHHHHH
Q 024027 228 NLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 228 ~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
+|+.+||..||.+|||+.++++|
T Consensus 247 ~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 247 SFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred HHHHHHcCCChhhCCCHHHHhhC
Confidence 99999999999999999999876
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=257.84 Aligned_cols=243 Identities=22% Similarity=0.249 Sum_probs=179.7
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
+.||+|++.... ....+.+.+|+++++.++|+|++++++++......++||||++++.|..++... ..+++..++.+
T Consensus 27 ~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~ 105 (286)
T cd07847 27 QIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNP-RGVPEHLIKKI 105 (286)
T ss_pred cEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCC-CCCCHHHHHHH
Confidence 369999987542 223456789999999999999999999999999999999999998887776443 36899999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC-CCcCC
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE-GRVST 157 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~ 157 (273)
+.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+ ..++.
T Consensus 106 ~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~ 180 (286)
T cd07847 106 IWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--DYTDYVATRWYRAPELLVGDTQYGP 180 (286)
T ss_pred HHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc--cccCcccccccCCHHHHhCCCCcCc
Confidence 999999999999 99999999999999999999999999999976533221 1223346788999998866 45789
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCc--cchhhhh------hhccccch---hhhhhhhhhHHHH
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPI--STMEVVD------ANLLSQED---IHFVAKEQCVSFV 226 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~------~~~~~~~~---~~~~~~~~~~~~l 226 (273)
++|+||+|+++++|++|..||......+.... ........ ....... ........ .........+..+
T Consensus 181 ~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (286)
T cd07847 181 PVDVWAIGCVFAELLTGQPLWPGKSDVDQLYL-IRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPA 259 (286)
T ss_pred hhhhHHHHHHHHHHHhCCCCCCCCChHHHHHH-HHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHH
Confidence 99999999999999999999976443222111 11000000 0000000 00000000 0001123456779
Q ss_pred HHHHhhcCCCCccCCCCHHHHHHH
Q 024027 227 FNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 227 ~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
.+|+.+||..||++|||+.+++.|
T Consensus 260 ~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 260 LSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred HHHHHHHhcCCccccCCHHHHhcC
Confidence 999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=264.46 Aligned_cols=231 Identities=21% Similarity=0.235 Sum_probs=178.5
Q ss_pred CeEEEEEeecc---cChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||||+++.. .......+.+|..+++.++|+||+++++++.++..+++||||+++|+|.+++.+....+++..+..
T Consensus 27 ~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~ 106 (331)
T cd05597 27 QVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARF 106 (331)
T ss_pred CEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHH
Confidence 46999999743 123455688999999999999999999999999999999999999999999976666799999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC-----
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE----- 152 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~----- 152 (273)
++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++..+..... .......|++.|+|||++.+
T Consensus 107 ~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ 182 (331)
T cd05597 107 YLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-VQSNVAVGTPDYISPEILQAMEDGK 182 (331)
T ss_pred HHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC-ccccceeccccccCHHHHhhccccc
Confidence 9999999999999 99999999999999999999999999999865432211 11223468999999999863
Q ss_pred CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhh
Q 024027 153 GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMA 232 (273)
Q Consensus 153 ~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 232 (273)
..++.++||||+||++|+|++|..||......+. ......... .... ......++.++.+++.+
T Consensus 183 ~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~-~~~i~~~~~--------------~~~~-~~~~~~~~~~~~~li~~ 246 (331)
T cd05597 183 GRYGPECDWWSLGVCMYEMLYGETPFYAESLVET-YGKIMNHKE--------------HFQF-PPDVTDVSEEAKDLIRR 246 (331)
T ss_pred cCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH-HHHHHcCCC--------------cccC-CCccCCCCHHHHHHHHH
Confidence 3478899999999999999999999865322111 111100000 0000 00012367779999999
Q ss_pred cCCCCccC--CCCHHHHHHHH
Q 024027 233 CTVESPEQ--RINAKEIVTKL 251 (273)
Q Consensus 233 ~l~~dp~~--Rps~~~~l~~l 251 (273)
||..+++. |+++.++++|-
T Consensus 247 ll~~~~~r~~r~~~~~~l~hp 267 (331)
T cd05597 247 LICSPETRLGRNGLQDFKDHP 267 (331)
T ss_pred HccCcccccCCCCHHHHhcCC
Confidence 98764443 88999999994
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=255.47 Aligned_cols=227 Identities=22% Similarity=0.335 Sum_probs=180.3
Q ss_pred eEEEEEeeccc------ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHH
Q 024027 2 EVAVKVFNLQC------GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQR 75 (273)
Q Consensus 2 ~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (273)
.||||.++... .+....+.+|+++++.++|+||+++++++.+....++++||+++++|.+++.+.. .+++..+
T Consensus 26 ~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~ 104 (265)
T cd06631 26 LIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFG-PLPEPVF 104 (265)
T ss_pred eEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhcC-CCCHHHH
Confidence 58999886442 1234568899999999999999999999999999999999999999999996544 5889999
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCC----cceeecccccCCCCCCcccC
Q 024027 76 LNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQ----SMTQTQTLATIGYMAPEYGR 151 (273)
Q Consensus 76 ~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~----~~~~~~~~~~~~~~aPE~~~ 151 (273)
..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+........ ........++..|+|||.+.
T Consensus 105 ~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 181 (265)
T cd06631 105 CKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN 181 (265)
T ss_pred HHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhc
Confidence 999999999999999 99999999999999999999999999999875422111 11112345788999999998
Q ss_pred CCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHh
Q 024027 152 EGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAM 231 (273)
Q Consensus 152 ~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 231 (273)
+..++.++|+||||++++++++|..||........... .... .......+..++.++.+++.
T Consensus 182 ~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~-~~~~-----------------~~~~~~~~~~~~~~~~~~i~ 243 (265)
T cd06631 182 ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFY-IGAH-----------------RGLMPRLPDSFSAAAIDFVT 243 (265)
T ss_pred CCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHH-hhhc-----------------cCCCCCCCCCCCHHHHHHHH
Confidence 88899999999999999999999999865322111100 0000 00001113446677999999
Q ss_pred hcCCCCccCCCCHHHHHHH
Q 024027 232 ACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 232 ~~l~~dp~~Rps~~~~l~~ 250 (273)
+||..+|.+||++.+++++
T Consensus 244 ~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 244 SCLTRDQHERPSALQLLRH 262 (265)
T ss_pred HHhcCCcccCCCHHHHhcC
Confidence 9999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=257.58 Aligned_cols=228 Identities=21% Similarity=0.252 Sum_probs=179.6
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC-CCCCHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~ 76 (273)
+.||+|++.... ......+.+|+++++.++|++++++.+.+..++..++++||+++++|.+++...+ ..+++..+.
T Consensus 26 ~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~ 105 (285)
T cd05632 26 KMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERAL 105 (285)
T ss_pred cEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHH
Confidence 368999986542 2234557889999999999999999999999999999999999999998886433 359999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcC
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVS 156 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 156 (273)
.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++....... ......++..|+|||.+.+..++
T Consensus 106 ~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~~~aPE~~~~~~~~ 179 (285)
T cd05632 106 FYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---SIRGRVGTVGYMAPEVLNNQRYT 179 (285)
T ss_pred HHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC---cccCCCCCcCccChHHhcCCCCC
Confidence 99999999999999 9999999999999999999999999999886542211 12234688999999999888899
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++|+||+|+++|++++|..||........ .......... . ....+..++.++.+|+.+||..
T Consensus 180 ~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~~~~~~~~~~-------------~---~~~~~~~~~~~~~~li~~~l~~ 242 (285)
T cd05632 180 LSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-REEVDRRVLE-------------T---EEVYSAKFSEEAKSICKMLLTK 242 (285)
T ss_pred cccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhhhc-------------c---ccccCccCCHHHHHHHHHHccC
Confidence 999999999999999999999875322111 0000000000 0 0011234566789999999999
Q ss_pred CccCCCC-----HHHHHHHH
Q 024027 237 SPEQRIN-----AKEIVTKL 251 (273)
Q Consensus 237 dp~~Rps-----~~~~l~~l 251 (273)
||++||+ +.+++.|-
T Consensus 243 ~P~~R~~~~~~~~~~l~~~~ 262 (285)
T cd05632 243 DPKQRLGCQEEGAGEVKRHP 262 (285)
T ss_pred CHhHcCCCcccChHHHHcCh
Confidence 9999999 77777763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=267.69 Aligned_cols=226 Identities=23% Similarity=0.335 Sum_probs=179.9
Q ss_pred EEEEEeec--ccChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 3 VAVKVFNL--QCGRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 3 vavK~~~~--~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
+|+|++.. .+.....-|..|+.+|.+| .|.+|+++++|-..++.+||||||-+. +|..+|++.+...+...++.++
T Consensus 388 yalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~Gd~-DL~kiL~k~~~~~~~~~lk~yw 466 (677)
T KOG0596|consen 388 YALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECGDI-DLNKILKKKKSIDPDWFLKFYW 466 (677)
T ss_pred hhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecccc-cHHHHHHhccCCCchHHHHHHH
Confidence 44554432 2345677799999999999 599999999999999999999999965 9999998777666656899999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCC-----
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGR----- 154 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~----- 154 (273)
.|++.|+.++| +.||+|.||||.|+++-+ |.+||+|||.+..+............+||+.|++||.+....
T Consensus 467 kqML~aV~~IH---~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~ 542 (677)
T KOG0596|consen 467 KQMLLAVKTIH---QHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSREN 542 (677)
T ss_pred HHHHHHHHHHH---HhceeecCCCcccEEEEe-eeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccC
Confidence 99999999999 999999999999999875 699999999999887777777777889999999999875322
Q ss_pred ------cCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHH
Q 024027 155 ------VSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFN 228 (273)
Q Consensus 155 ------~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 228 (273)
.++++||||||||+|+|++|+.||+...+....+..+.. +....++. ...-..++.+
T Consensus 543 ~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~---P~~~Iefp--------------~~~~~~~li~ 605 (677)
T KOG0596|consen 543 GKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITD---PNHEIEFP--------------DIPENDELID 605 (677)
T ss_pred CCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcC---CCcccccc--------------CCCCchHHHH
Confidence 578999999999999999999999875443222221111 10000000 0011223899
Q ss_pred HHhhcCCCCccCCCCHHHHHHH
Q 024027 229 LAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 229 li~~~l~~dp~~Rps~~~~l~~ 250 (273)
+++.||..||.+|||+.++|+|
T Consensus 606 ~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 606 VMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HHHHHHhcCcccCCCcHHHhcC
Confidence 9999999999999999999986
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=254.77 Aligned_cols=231 Identities=25% Similarity=0.336 Sum_probs=173.3
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCC----CCCHHHHH
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNC----ILDIFQRL 76 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~ 76 (273)
.||+|.+.... ......+.+|+.+++.++|+||+++++++......++||||+++|+|.+++..... ..++..+.
T Consensus 24 ~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 103 (269)
T cd05042 24 RVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQ 103 (269)
T ss_pred EEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHH
Confidence 57888776443 33456788999999999999999999999999999999999999999999965432 24677889
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccC-----
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR----- 151 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~----- 151 (273)
.++.|++.|++||| +.|++|+||||+||+++.++.++|+|||++................++..|+|||++.
T Consensus 104 ~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 180 (269)
T cd05042 104 RMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQD 180 (269)
T ss_pred HHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhcccc
Confidence 99999999999999 9999999999999999999999999999986532221111122334567799999864
Q ss_pred --CCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHH
Q 024027 152 --EGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFN 228 (273)
Q Consensus 152 --~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 228 (273)
...++.++|||||||++|+|++ |..||......+. ............ .....+..++..+.+
T Consensus 181 ~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~ 245 (269)
T cd05042 181 LLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV-LKQVVREQDIKL--------------PKPQLDLKYSDRWYE 245 (269)
T ss_pred ccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH-HHHHhhccCccC--------------CCCcccccCCHHHHH
Confidence 2346889999999999999999 7888765432221 111111100000 000113345666888
Q ss_pred HHhhcCCCCccCCCCHHHHHHHH
Q 024027 229 LAMACTVESPEQRINAKEIVTKL 251 (273)
Q Consensus 229 li~~~l~~dp~~Rps~~~~l~~l 251 (273)
++..|+ .||.+|||+++|++.|
T Consensus 246 ~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 246 VMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred HHHHHh-cCcccccCHHHHHHHh
Confidence 999998 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=254.42 Aligned_cols=225 Identities=20% Similarity=0.281 Sum_probs=181.4
Q ss_pred CeEEEEEeecc--cChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC-CCCCHHHHHH
Q 024027 1 MEVAVKVFNLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~ 77 (273)
+.||+|.++.. .......+.+|+.+++.++||||+++++++...+..++|+||+++++|.+++.... ..+++..+..
T Consensus 26 ~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~ 105 (256)
T cd08218 26 KQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILD 105 (256)
T ss_pred CEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHH
Confidence 46899998754 23445678999999999999999999999999999999999999999999986543 3578999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
++.|++.|+.+|| +.|++|+||+|+||+++.++.++++|||++....... .......+++.|+|||.+.+..++.
T Consensus 106 ~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~ 180 (256)
T cd08218 106 WFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV--ELARTCIGTPYYLSPEICENRPYNN 180 (256)
T ss_pred HHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch--hhhhhccCCccccCHHHhCCCCCCC
Confidence 9999999999999 9999999999999999999999999999987553221 1122345778899999998888999
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
++|+||||++++++++|..||......+... ..... .....+..++.++.+++.+||..+
T Consensus 181 ~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~-~~~~~-------------------~~~~~~~~~~~~~~~li~~~l~~~ 240 (256)
T cd08218 181 KSDIWALGCVLYEMCTLKHAFEAGNMKNLVL-KIIRG-------------------SYPPVSSHYSYDLRNLVSQLFKRN 240 (256)
T ss_pred ccchhHHHHHHHHHHcCCCCccCCCHHHHHH-HHhcC-------------------CCCCCcccCCHHHHHHHHHHhhCC
Confidence 9999999999999999999986432211100 00000 001113456677999999999999
Q ss_pred ccCCCCHHHHHHH
Q 024027 238 PEQRINAKEIVTK 250 (273)
Q Consensus 238 p~~Rps~~~~l~~ 250 (273)
|.+||++.++++|
T Consensus 241 p~~Rp~~~~vl~~ 253 (256)
T cd08218 241 PRDRPSVNSILEK 253 (256)
T ss_pred hhhCcCHHHHhhC
Confidence 9999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=253.63 Aligned_cols=228 Identities=26% Similarity=0.314 Sum_probs=183.3
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
++||+|++.... ......+..|+++++.++||||+++++++.++...++++||+++++|.+++.+.. .+++..+..
T Consensus 19 ~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~ 97 (262)
T cd05572 19 RTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRG-LFDEYTARF 97 (262)
T ss_pred cEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhcC-CCCHHHHHH
Confidence 479999997542 2345678999999999999999999999999999999999999999999996543 588999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||.+....... ......++..|++||.+.+..++.
T Consensus 98 ~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~ 171 (262)
T cd05572 98 YIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYDF 171 (262)
T ss_pred HHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCcCccChhHhcCCCCCC
Confidence 9999999999999 9999999999999999999999999999987653322 122346788899999988888999
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
++|+||+|+++|++++|..||.....+...... .. . ........+..++.++.+++.+||..|
T Consensus 172 ~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~------------~--~~~~~~~~~~~~~~~~~~~i~~~l~~~ 234 (262)
T cd05572 172 SVDYWSLGILLYELLTGRPPFGEDDEDPMEIYN---DI------------L--KGNGKLEFPNYIDKAAKDLIKQLLRRN 234 (262)
T ss_pred hhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHH---HH------------h--ccCCCCCCCcccCHHHHHHHHHHccCC
Confidence 999999999999999999998764421111100 00 0 000111113344677999999999999
Q ss_pred ccCCCC-----HHHHHHHHH
Q 024027 238 PEQRIN-----AKEIVTKLL 252 (273)
Q Consensus 238 p~~Rps-----~~~~l~~l~ 252 (273)
|.+||+ ++|+++|=+
T Consensus 235 p~~R~~~~~~~~~~l~~~~~ 254 (262)
T cd05572 235 PEERLGNLKGGIKDIKKHKW 254 (262)
T ss_pred hhhCcCCcccCHHHHhcChh
Confidence 999999 888888644
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=257.09 Aligned_cols=243 Identities=22% Similarity=0.260 Sum_probs=178.0
Q ss_pred CeEEEEEeecccC-hhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 1 MEVAVKVFNLQCG-RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 1 ~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
++||||.+..... .....+.+|+++++.++|+||+++++++.++...++||||+++ +|.+++......+++..+..++
T Consensus 31 ~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~ 109 (291)
T cd07844 31 QLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFL 109 (291)
T ss_pred cEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHH
Confidence 4699999975432 2234567899999999999999999999999999999999975 9999987766678999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC-CCcCCc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE-GRVSTN 158 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~ 158 (273)
.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+ ..++.+
T Consensus 110 ~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~ 184 (291)
T cd07844 110 FQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS--KTYSNEVVTLWYRPPDVLLGSTEYSTS 184 (291)
T ss_pred HHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCC--ccccccccccccCCcHHhhcCcccCcH
Confidence 99999999999 9999999999999999999999999999986432111 11122346778999998865 457899
Q ss_pred chhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhh--h-hh--------hccccchhhhhhhhhhH--HH
Q 024027 159 GDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEV--V-DA--------NLLSQEDIHFVAKEQCV--SF 225 (273)
Q Consensus 159 ~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~-~~--------~~~~~~~~~~~~~~~~~--~~ 225 (273)
+|+||+|+++|+|++|..||......................... . .. ........ .......+ .+
T Consensus 185 ~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 263 (291)
T cd07844 185 LDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPL-INHAPRLDRIPH 263 (291)
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhH-HHhCcCCCCchh
Confidence 999999999999999999996543222222111111100000000 0 00 00000000 00011222 66
Q ss_pred HHHHHhhcCCCCccCCCCHHHHHHH
Q 024027 226 VFNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 226 l~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
+.+++.+||..||.+|||+.+++.+
T Consensus 264 ~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 264 GEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred HHHHHHHHhccCcccccCHHHHhcC
Confidence 8899999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=253.98 Aligned_cols=230 Identities=25% Similarity=0.339 Sum_probs=183.4
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC--CCCCHHHHHHH
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN--CILDIFQRLNI 78 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~ 78 (273)
+||+|++.... ......+.+|+++++.++|+|++++++.+..+...++++|++++++|.+++.... ..+++..+..+
T Consensus 28 ~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 107 (267)
T cd06610 28 KVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATV 107 (267)
T ss_pred EEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHH
Confidence 68999997542 3466789999999999999999999999999999999999999999999996542 35899999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcc--eeecccccCCCCCCcccCCC-Cc
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSM--TQTQTLATIGYMAPEYGREG-RV 155 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~-~~ 155 (273)
+.|++.|+.+|| +.|++|+||+|+||+++.++.++|+|||++..+....... ......++..|+|||.+... .+
T Consensus 108 ~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~ 184 (267)
T cd06610 108 LKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGY 184 (267)
T ss_pred HHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCc
Confidence 999999999999 9999999999999999999999999999987664332221 22334578899999988766 68
Q ss_pred CCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhh-hhhhhhHHHHHHHHhhcC
Q 024027 156 STNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHF-VAKEQCVSFVFNLAMACT 234 (273)
Q Consensus 156 ~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l 234 (273)
+.++|+||||+++++|++|..||........... ..... ...... .....++.++.+++.+||
T Consensus 185 ~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~-~~~~~---------------~~~~~~~~~~~~~~~~~~~li~~~l 248 (267)
T cd06610 185 DFKADIWSFGITAIELATGAAPYSKYPPMKVLML-TLQND---------------PPSLETGADYKKYSKSFRKMISLCL 248 (267)
T ss_pred CcccchHhHhHHHHHHHhCCCCccccChhhhHHH-HhcCC---------------CCCcCCccccccccHHHHHHHHHHc
Confidence 9999999999999999999999875433221111 11000 000000 002355677999999999
Q ss_pred CCCccCCCCHHHHHHH
Q 024027 235 VESPEQRINAKEIVTK 250 (273)
Q Consensus 235 ~~dp~~Rps~~~~l~~ 250 (273)
..||.+|||+.++++|
T Consensus 249 ~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 249 QKDPSKRPTAEELLKH 264 (267)
T ss_pred CCChhhCcCHHHHhhC
Confidence 9999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=258.13 Aligned_cols=222 Identities=24% Similarity=0.277 Sum_probs=181.4
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
++||+|+++... ......+.+|+++++.++||||+++++++.+....++||||+++++|.+++... ..++...+..
T Consensus 27 ~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~ 105 (290)
T cd05580 27 KYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKS-GRFPEPVARF 105 (290)
T ss_pred CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHc-CCCCHHHHHH
Confidence 479999997542 234567889999999999999999999999999999999999999999999665 4689999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||++...... .....+++.|+|||.+.+..++.
T Consensus 106 ~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~ 177 (290)
T cd05580 106 YAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGK 177 (290)
T ss_pred HHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----CCCCCCCccccChhhhcCCCCCc
Confidence 9999999999999 999999999999999999999999999998765322 23346788999999998888899
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
++|+||||+++++|++|..||....... ........ ....+...+..+.+++.+||..|
T Consensus 178 ~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~--------------------~~~~~~~~~~~l~~li~~~l~~~ 236 (290)
T cd05580 178 AVDWWALGILIYEMLAGYPPFFDDNPIQ-IYEKILEG--------------------KVRFPSFFSPDAKDLIRNLLQVD 236 (290)
T ss_pred cccHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHhcC--------------------CccCCccCCHHHHHHHHHHccCC
Confidence 9999999999999999999986533111 11111000 00112334667899999999999
Q ss_pred ccCCC-----CHHHHHHHHH
Q 024027 238 PEQRI-----NAKEIVTKLL 252 (273)
Q Consensus 238 p~~Rp-----s~~~~l~~l~ 252 (273)
|.+|+ +++++++|-.
T Consensus 237 p~~R~~~~~~~~~~l~~~~~ 256 (290)
T cd05580 237 LTKRLGNLKNGVNDIKNHPW 256 (290)
T ss_pred HHHccCcccCCHHHHHcCcc
Confidence 99999 8888887743
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=268.18 Aligned_cols=225 Identities=22% Similarity=0.240 Sum_probs=174.2
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcC---CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSI---RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQ 74 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (273)
+.||||++.... ......+..|..++... +||||+++++++......++||||+++|+|.+++... ..+++..
T Consensus 19 ~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~ 97 (330)
T cd05586 19 RIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKE-GRFSEDR 97 (330)
T ss_pred CEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHhc-CCCCHHH
Confidence 479999996432 22334455677777655 6999999999999999999999999999999998654 4689999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCC-
Q 024027 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG- 153 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~- 153 (273)
++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++....... ......+|+..|+|||.+.+.
T Consensus 98 ~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~ 172 (330)
T cd05586 98 AKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTTNTFCGTTEYLAPEVLLDEK 172 (330)
T ss_pred HHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCccCccCCccccCHHHHcCCC
Confidence 9999999999999999 9999999999999999999999999999986532211 122345689999999988754
Q ss_pred CcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhc
Q 024027 154 RVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMAC 233 (273)
Q Consensus 154 ~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 233 (273)
.++.++||||+||++|+|++|..||......+. ....... ... .....++.++.+++.+|
T Consensus 173 ~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~-~~~i~~~----------------~~~---~~~~~~~~~~~~li~~~ 232 (330)
T cd05586 173 GYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM-YRNIAFG----------------KVR---FPKNVLSDEGRQFVKGL 232 (330)
T ss_pred CCCCccceeccccEEEEeccCCCCCCCCCHHHH-HHHHHcC----------------CCC---CCCccCCHHHHHHHHHH
Confidence 478999999999999999999999865322111 0000000 000 00123566789999999
Q ss_pred CCCCccCCC----CHHHHHHHH
Q 024027 234 TVESPEQRI----NAKEIVTKL 251 (273)
Q Consensus 234 l~~dp~~Rp----s~~~~l~~l 251 (273)
|..||.+|| ++.++++|-
T Consensus 233 L~~~P~~R~~~~~~~~~ll~h~ 254 (330)
T cd05586 233 LNRNPQHRLGAHRDAVELKEHP 254 (330)
T ss_pred cCCCHHHCCCCCCCHHHHhcCc
Confidence 999999998 678887764
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=261.15 Aligned_cols=243 Identities=19% Similarity=0.192 Sum_probs=171.7
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeec--CCceeEEEeccCCCCHHHhhhcC--------CCCCC
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSN--EEFKALVLEYMPHGSLEKYLYSS--------NCILD 71 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~ 71 (273)
.||+|.++... ....+.+|+++++.++||||+++++++.. +...++++||+++ +|.+++... ...++
T Consensus 30 ~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~ 106 (317)
T cd07867 30 EYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLP 106 (317)
T ss_pred eEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-cHHHHHHhhhccccCCCCccCC
Confidence 68999886442 23467889999999999999999998853 5678899999965 888887422 22478
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceee----CCCCceEEeecccccccccCCC-cceeecccccCCCCC
Q 024027 72 IFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLL----DDNLVAYLSDFGIAKLLIGEDQ-SMTQTQTLATIGYMA 146 (273)
Q Consensus 72 ~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~----~~~~~~kl~Df~~~~~~~~~~~-~~~~~~~~~~~~~~a 146 (273)
+..+..++.|++.||.||| +.|++|+||||+||++ +.++.++|+|||++........ ........+++.|+|
T Consensus 107 ~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~a 183 (317)
T cd07867 107 RSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183 (317)
T ss_pred HHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccC
Confidence 8899999999999999999 9999999999999999 4667999999999976533221 112234467889999
Q ss_pred CcccCCC-CcCCcchhHHHHHHHHHHHhCCCCCccccccccch--------hhhhhhccCccchhhhh------------
Q 024027 147 PEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTL--------KHWVNDWLPISTMEVVD------------ 205 (273)
Q Consensus 147 PE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~------------ 205 (273)
||.+.+. .++.++||||+||++|+|++|.+||.......... .................
T Consensus 184 PE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (317)
T cd07867 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQK 263 (317)
T ss_pred cHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhh
Confidence 9988764 57899999999999999999999997533221110 00000000000000000
Q ss_pred ---hhccccchh---hhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHH
Q 024027 206 ---ANLLSQEDI---HFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 206 ---~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
......... ........+..+.+|+.+||..||.+|||+.++++|
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 264 DFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred hhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 000000000 000011234568899999999999999999999976
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=253.52 Aligned_cols=226 Identities=27% Similarity=0.452 Sum_probs=179.5
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcC-CCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~ 80 (273)
.||+|.++.. ......+.+|+++++.++|+||+++++++.. ...+++|||+++++|.+++... ...+++..+..++.
T Consensus 32 ~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ 109 (260)
T cd05073 32 KVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA 109 (260)
T ss_pred cEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHH
Confidence 5889988754 3345678899999999999999999999887 7789999999999999999653 34578889999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
|++.||.||| +.|++|+||+|+||+++.++.++|+|||.+........ .......++..|+|||.+.+..++.++|
T Consensus 110 ~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~D 185 (260)
T cd05073 110 QIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSD 185 (260)
T ss_pred HHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc-ccccCCcccccccCHhHhccCCcCcccc
Confidence 9999999999 99999999999999999999999999999875532111 1112233556799999998888999999
Q ss_pred hHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCcc
Q 024027 161 VYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239 (273)
Q Consensus 161 iwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 239 (273)
+||||++++++++ |..||........ ....... .....+...+.++.+++.+||..+|+
T Consensus 186 i~slG~~l~~l~t~g~~p~~~~~~~~~-~~~~~~~-------------------~~~~~~~~~~~~~~~~i~~~l~~~p~ 245 (260)
T cd05073 186 VWSFGILLMEIVTYGRIPYPGMSNPEV-IRALERG-------------------YRMPRPENCPEELYNIMMRCWKNRPE 245 (260)
T ss_pred chHHHHHHHHHHhcCCCCCCCCCHHHH-HHHHhCC-------------------CCCCCcccCCHHHHHHHHHHcccCcc
Confidence 9999999999998 8999865322111 1000000 00011234566799999999999999
Q ss_pred CCCCHHHHHHHHHH
Q 024027 240 QRINAKEIVTKLLK 253 (273)
Q Consensus 240 ~Rps~~~~l~~l~~ 253 (273)
+||++.++++.|+.
T Consensus 246 ~Rp~~~~l~~~L~~ 259 (260)
T cd05073 246 ERPTFEYIQSVLDD 259 (260)
T ss_pred cCcCHHHHHHHHhc
Confidence 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=256.40 Aligned_cols=228 Identities=28% Similarity=0.333 Sum_probs=183.7
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
++||+|+++.... ..+.+..|+++++.++|+|++++++++..+...++++||+++++|.+++......+++..+..++.
T Consensus 45 ~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ 123 (286)
T cd06614 45 KEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCR 123 (286)
T ss_pred cEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHH
Confidence 3689999986543 567789999999999999999999999999999999999999999999976654799999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
|++.||.+|| +.|++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++.++|
T Consensus 124 ~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~D 198 (286)
T cd06614 124 EVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVD 198 (286)
T ss_pred HHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh--hhccccCCcccCCHhHhcCCCCCCccc
Confidence 9999999999 99999999999999999999999999998865432211 112334677899999998888999999
Q ss_pred hHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccC
Q 024027 161 VYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQ 240 (273)
Q Consensus 161 iwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 240 (273)
+||||+++|++++|..||........ ....... .......+..++.++.+++.+||..+|.+
T Consensus 199 v~slGvil~~l~~g~~p~~~~~~~~~-~~~~~~~-----------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 260 (286)
T cd06614 199 IWSLGIMCIEMAEGEPPYLREPPLRA-LFLITTK-----------------GIPPLKNPEKWSPEFKDFLNKCLVKDPEK 260 (286)
T ss_pred cHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhc-----------------CCCCCcchhhCCHHHHHHHHHHhccChhh
Confidence 99999999999999999864322111 1100000 00001112335677999999999999999
Q ss_pred CCCHHHHHHHHH
Q 024027 241 RINAKEIVTKLL 252 (273)
Q Consensus 241 Rps~~~~l~~l~ 252 (273)
|||+.+++++-.
T Consensus 261 Rpt~~~il~~~~ 272 (286)
T cd06614 261 RPSAEELLQHPF 272 (286)
T ss_pred CcCHHHHhhChH
Confidence 999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=266.38 Aligned_cols=236 Identities=20% Similarity=0.226 Sum_probs=172.1
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~q 81 (273)
.||+|+.... ....|+.+++.++|+||+++++++......++|+|++.+ +|.+++......+++..+..++.|
T Consensus 93 ~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~q 165 (357)
T PHA03209 93 PVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQ 165 (357)
T ss_pred eEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccCC-cHHHHHHhccCCCCHHHHHHHHHH
Confidence 6888875322 335699999999999999999999999999999999965 999998776667999999999999
Q ss_pred HHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcchh
Q 024027 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 161 (273)
Q Consensus 82 l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di 161 (273)
++.||.||| +.|++||||||+||+++.++.++|+|||++...... .......|+..|+|||.+.+..++.++||
T Consensus 166 i~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 239 (357)
T PHA03209 166 ILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA---PAFLGLAGTVETNAPEVLARDKYNSKADI 239 (357)
T ss_pred HHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccC---cccccccccccccCCeecCCCCCCchhhH
Confidence 999999999 999999999999999999999999999998643211 11223468899999999998889999999
Q ss_pred HHHHHHHHHHHhCCCCCccccccc-c--------chhhhhhhc--cCccc-----hhhhhhhc-------cccchhhhhh
Q 024027 162 YSFGIMLMETFTGKKPTYEFFNGE-M--------TLKHWVNDW--LPIST-----MEVVDANL-------LSQEDIHFVA 218 (273)
Q Consensus 162 wslG~~l~~ll~g~~pf~~~~~~~-~--------~~~~~~~~~--~~~~~-----~~~~~~~~-------~~~~~~~~~~ 218 (273)
|||||++|+|+++..|+....... . .+....... .+... ........ ..........
T Consensus 240 wSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (357)
T PHA03209 240 WSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQ 319 (357)
T ss_pred HHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHh
Confidence 999999999998655543221111 0 000000000 00000 00000000 0000000111
Q ss_pred hhhhHHHHHHHHhhcCCCCccCCCCHHHHHHH
Q 024027 219 KEQCVSFVFNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 219 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
...++.++.+||.+||..||++|||+.++++|
T Consensus 320 ~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 320 RVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred ccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 12456668889999999999999999999987
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=269.75 Aligned_cols=230 Identities=28% Similarity=0.421 Sum_probs=192.2
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC-CCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~ 80 (273)
.||||.+|.+ ....++|..|..+++.++|||+|+++|+|..+..+|||+|||..|+|.+||.+-+ ...+.-..+.++.
T Consensus 294 TvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAt 372 (1157)
T KOG4278|consen 294 TVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMAT 372 (1157)
T ss_pred eeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHH
Confidence 5899999866 5677999999999999999999999999999999999999999999999996543 2355566788999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
||.+|+.||. .++++||||...|+|+..+..||++|||+++.+.+..-... ....-+..|.|||-+....++.++|
T Consensus 373 QIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAH-AGAKFPIKWTAPEsLAyNtFSiKSD 448 (1157)
T KOG4278|consen 373 QISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAH-AGAKFPIKWTAPESLAYNTFSIKSD 448 (1157)
T ss_pred HHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceecc-cCccCcccccCcccccccccccchh
Confidence 9999999999 99999999999999999999999999999998754332221 2223466799999999999999999
Q ss_pred hHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCcc
Q 024027 161 VYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239 (273)
Q Consensus 161 iwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 239 (273)
+|+||+++||+.+ |..||.+.+.. +. ...++ ...+...|.+|++..++|++.||+++|.
T Consensus 449 VWAFGVLLWEIATYGMsPYPGidlS-----qV---------Y~LLE------kgyRM~~PeGCPpkVYeLMraCW~WsPs 508 (1157)
T KOG4278|consen 449 VWAFGVLLWEIATYGMSPYPGIDLS-----QV---------YGLLE------KGYRMDGPEGCPPKVYELMRACWNWSPS 508 (1157)
T ss_pred hHHHHHHHHHHHhcCCCCCCCccHH-----HH---------HHHHh------ccccccCCCCCCHHHHHHHHHHhcCCcc
Confidence 9999999999998 88887653221 11 11111 1223334889999999999999999999
Q ss_pred CCCCHHHHHHHHHHHHH
Q 024027 240 QRINAKEIVTKLLKIRD 256 (273)
Q Consensus 240 ~Rps~~~~l~~l~~~~~ 256 (273)
+||++.|+-+.++.+..
T Consensus 509 DRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 509 DRPSFAEIHQAFETMFS 525 (1157)
T ss_pred cCccHHHHHHHHHHHhc
Confidence 99999999999998874
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=252.50 Aligned_cols=222 Identities=28% Similarity=0.481 Sum_probs=176.9
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC-CCCCHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIM 79 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ 79 (273)
+.||+|.++... ....+.+|+.+++.++|||++++++++..+. .+++|||+++++|.+++.... ..+++..++.++
T Consensus 30 ~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 106 (254)
T cd05083 30 QKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFS 106 (254)
T ss_pred CceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHH
Confidence 368999986542 3467889999999999999999999987654 689999999999999996543 358899999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 159 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 159 (273)
.|++.|+.||| +.|++||||+|+||+++.++.++|+|||.+...... ......+..|+|||.+.+..++.++
T Consensus 107 ~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~ 178 (254)
T cd05083 107 LDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----VDNSKLPVKWTAPEALKHKKFSSKS 178 (254)
T ss_pred HHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceecccc-----CCCCCCCceecCHHHhccCCcCchh
Confidence 99999999999 999999999999999999999999999988653211 1122345679999999888899999
Q ss_pred hhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc
Q 024027 160 DVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238 (273)
Q Consensus 160 DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 238 (273)
|+||||+++|+|++ |..||......+. ..... .. .....+..++.++.+++.+||..+|
T Consensus 179 Dv~slG~~l~el~~~g~~p~~~~~~~~~--~~~~~------------~~------~~~~~~~~~~~~~~~li~~~l~~~p 238 (254)
T cd05083 179 DVWSYGVLLWEVFSYGRAPYPKMSLKEV--KECVE------------KG------YRMEPPEGCPADVYVLMTSCWETEP 238 (254)
T ss_pred hHHHHHHHHHHHHhCCCCCCccCCHHHH--HHHHh------------CC------CCCCCCCcCCHHHHHHHHHHcCCCh
Confidence 99999999999997 9999865332211 00000 00 0001123456779999999999999
Q ss_pred cCCCCHHHHHHHHHH
Q 024027 239 EQRINAKEIVTKLLK 253 (273)
Q Consensus 239 ~~Rps~~~~l~~l~~ 253 (273)
.+||+++++++.|++
T Consensus 239 ~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 239 KKRPSFHKLREKLEK 253 (254)
T ss_pred hhCcCHHHHHHHHcc
Confidence 999999999998763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=257.76 Aligned_cols=243 Identities=22% Similarity=0.220 Sum_probs=179.8
Q ss_pred CeEEEEEeecccCh-----hhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHH
Q 024027 1 MEVAVKVFNLQCGR-----AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQR 75 (273)
Q Consensus 1 ~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (273)
++||||.++..... ....+..|+++++.++|+||+++++++.++..+++||||+ +++|.+++......+++..+
T Consensus 26 ~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~ 104 (298)
T cd07841 26 RIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADI 104 (298)
T ss_pred cEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccCCCCCHHHH
Confidence 47999999765322 2345678999999999999999999999999999999999 88999999765546999999
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC-CC
Q 024027 76 LNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE-GR 154 (273)
Q Consensus 76 ~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~ 154 (273)
+.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+ ..
T Consensus 105 ~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~ 179 (298)
T cd07841 105 KSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR--KMTHQVVTRWYRAPELLFGARH 179 (298)
T ss_pred HHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc--cccccccceeeeCHHHHhCCCC
Confidence 999999999999999 99999999999999999999999999999876533221 1222345678999998755 45
Q ss_pred cCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhh------h--hhccccchhhhhhhhhhHHHH
Q 024027 155 VSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVV------D--ANLLSQEDIHFVAKEQCVSFV 226 (273)
Q Consensus 155 ~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~--~~~~~~~~~~~~~~~~~~~~l 226 (273)
++.++|+|||||+++++++|.+||...... ................... . .................+.++
T Consensus 180 ~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (298)
T cd07841 180 YGVGVDMWSVGCIFAELLLRVPFLPGDSDI-DQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDA 258 (298)
T ss_pred CCcHHHHHHHHHHHHHHHcCCccccCCccH-HHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHH
Confidence 789999999999999999998777653321 1111111110000000000 0 000000000111123456779
Q ss_pred HHHHhhcCCCCccCCCCHHHHHHH
Q 024027 227 FNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 227 ~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
.+++.+||.+||++|||+++++.|
T Consensus 259 ~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 259 LDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred HHHHHHHhcCCcccCcCHHHHhhC
Confidence 999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=255.91 Aligned_cols=244 Identities=20% Similarity=0.214 Sum_probs=177.0
Q ss_pred CeEEEEEeecccC-hhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 1 MEVAVKVFNLQCG-RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 1 ~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
+.||+|+++.... .....+.+|+.+++.++|+||+++++++..+...++|+||++ +++.+++......+.+..+..++
T Consensus 31 ~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~ 109 (291)
T cd07870 31 QLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFM 109 (291)
T ss_pred cEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHH
Confidence 3689999975432 223467789999999999999999999999999999999996 58888776555568888899999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCC-CcCCc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG-RVSTN 158 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~ 158 (273)
.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+. .++.+
T Consensus 110 ~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~ 184 (291)
T cd07870 110 FQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ--TYSSEVVTLWYRPPDVLLGATDYSSA 184 (291)
T ss_pred HHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC--CCCCccccccccCCceeecCCCCCcH
Confidence 99999999999 99999999999999999999999999998865422111 12334568889999998754 57889
Q ss_pred chhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccch------------hhhhhhccccchhhhhhhhhhHHHH
Q 024027 159 GDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTM------------EVVDANLLSQEDIHFVAKEQCVSFV 226 (273)
Q Consensus 159 ~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~l 226 (273)
+|+||||++++++++|..||...................+... .....................+.++
T Consensus 185 ~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (291)
T cd07870 185 LDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKA 264 (291)
T ss_pred HHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHH
Confidence 9999999999999999999975443222222111111000000 0000000000000000001124568
Q ss_pred HHHHhhcCCCCccCCCCHHHHHHH
Q 024027 227 FNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 227 ~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
.+++.+|+..||++|||+++++.|
T Consensus 265 ~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 265 EDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred HHHHHHHhCcCcccCcCHHHHhcC
Confidence 999999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=253.41 Aligned_cols=230 Identities=24% Similarity=0.326 Sum_probs=180.8
Q ss_pred CeEEEEEeeccc------ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHH
Q 024027 1 MEVAVKVFNLQC------GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQ 74 (273)
Q Consensus 1 ~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (273)
+.||+|+++... ......+.+|+++++.++|+||+++++++.+....++|+||+++++|.+++...+ .+++..
T Consensus 26 ~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~ 104 (268)
T cd06630 26 TLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG-AFKEAV 104 (268)
T ss_pred cEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHhC-CCCHHH
Confidence 368999997432 1235678899999999999999999999999999999999999999999996544 688999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCC-ceEEeecccccccccCCCc--ceeecccccCCCCCCcccC
Q 024027 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNL-VAYLSDFGIAKLLIGEDQS--MTQTQTLATIGYMAPEYGR 151 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~-~~kl~Df~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~ 151 (273)
+..++.|++.||.+|| +.|++|+||+|+||+++.++ .++|+|||.+......... .......++..|+|||.+.
T Consensus 105 ~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~ 181 (268)
T cd06630 105 IINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181 (268)
T ss_pred HHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhc
Confidence 9999999999999999 99999999999999998765 6999999998766432111 1122345788999999998
Q ss_pred CCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHh
Q 024027 152 EGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAM 231 (273)
Q Consensus 152 ~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 231 (273)
+..++.++|+||+|++++++++|..||........ ....... . ........+...+.++.+++.
T Consensus 182 ~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~-------------~--~~~~~~~~~~~~~~~~~~~i~ 245 (268)
T cd06630 182 GEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH-LALIFKI-------------A--SATTAPSIPEHLSPGLRDVTL 245 (268)
T ss_pred cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch-HHHHHHH-------------h--ccCCCCCCchhhCHHHHHHHH
Confidence 88899999999999999999999999864322111 0000000 0 000011123456677999999
Q ss_pred hcCCCCccCCCCHHHHHHH
Q 024027 232 ACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 232 ~~l~~dp~~Rps~~~~l~~ 250 (273)
+||..+|.+|||+.++++|
T Consensus 246 ~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 246 RCLELQPEDRPPSRELLKH 264 (268)
T ss_pred HHcCCCcccCcCHHHHhcC
Confidence 9999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=257.20 Aligned_cols=239 Identities=22% Similarity=0.315 Sum_probs=184.3
Q ss_pred CeEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 1 MEVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 1 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
+.||+|++.... ......+.+|+++++.++||||+++++++.....+++|+||+++++|.+++... ..+++..+..++
T Consensus 31 ~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ 109 (284)
T cd06620 31 TVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKG-GPIPVEILGKIA 109 (284)
T ss_pred cEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhc-cCCCHHHHHHHH
Confidence 368999887543 345678899999999999999999999999999999999999999999998654 368999999999
Q ss_pred HHHHHHHHHHhcCCC-CCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCc
Q 024027 80 IDVASALEYLHFGCS-APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTN 158 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~-~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 158 (273)
.+++.|+.||| + .+++|+||+|+||+++.++.++|+|||++...... ......++..|+|||.+.+..++.+
T Consensus 110 ~~i~~~l~~LH---~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~ 182 (284)
T cd06620 110 VAVVEGLTYLY---NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS----IADTFVGTSTYMSPERIQGGKYTVK 182 (284)
T ss_pred HHHHHHHHHHH---HhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh----ccCccccCcccCCHHHHccCCCCcc
Confidence 99999999999 6 58999999999999999999999999987654221 1223468889999999988889999
Q ss_pred chhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc
Q 024027 159 GDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238 (273)
Q Consensus 159 ~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 238 (273)
+|+||+||+++++++|..||........... ................. .......++.++.+|+.+||..||
T Consensus 183 ~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp 254 (284)
T cd06620 183 SDVWSLGISIIELALGKFPFAFSNIDDDGQD------DPMGILDLLQQIVQEPP--PRLPSSDFPEDLRDFVDACLLKDP 254 (284)
T ss_pred chHHHHHHHHHHHHhCCCCCcccchhhhhhh------hhhHHHHHHHHHhhccC--CCCCchhcCHHHHHHHHHHhcCCc
Confidence 9999999999999999999976443211000 00000000000000000 000012256679999999999999
Q ss_pred cCCCCHHHHHHHHHHHH
Q 024027 239 EQRINAKEIVTKLLKIR 255 (273)
Q Consensus 239 ~~Rps~~~~l~~l~~~~ 255 (273)
.+|||+++++++..-+.
T Consensus 255 ~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 255 TERPTPQQLCAMPPFIQ 271 (284)
T ss_pred ccCcCHHHHhcCccccc
Confidence 99999999999866443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=254.74 Aligned_cols=226 Identities=23% Similarity=0.267 Sum_probs=176.6
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcC-CCccceeeeeeeecCC------ceeEEEeccCCCCHHHhhhcC---CCCC
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEE------FKALVLEYMPHGSLEKYLYSS---NCIL 70 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~---~~~~ 70 (273)
+.||+|+++... .....+.+|+.+++.+ .|+||+++++++.... .+++||||+++++|.+++... +..+
T Consensus 32 ~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 110 (275)
T cd06608 32 QLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRL 110 (275)
T ss_pred cEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCC
Confidence 368999987553 3456799999999999 7999999999996644 489999999999999988643 3568
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCccc
Q 024027 71 DIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYG 150 (273)
Q Consensus 71 ~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 150 (273)
++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||.+
T Consensus 111 ~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~ 185 (275)
T cd06608 111 KEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTL--GRRNTFIGTPYWMAPEVI 185 (275)
T ss_pred CHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCccceecccch--hhhcCccccccccCHhHh
Confidence 99999999999999999999 9999999999999999999999999999987653221 122334578889999987
Q ss_pred CC-----CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHH
Q 024027 151 RE-----GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSF 225 (273)
Q Consensus 151 ~~-----~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (273)
.. ..++.++|+||||++++++++|..||......... ...... .......+...+.+
T Consensus 186 ~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~-----------------~~~~~~~~~~~~~~ 247 (275)
T cd06608 186 ACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL-FKIPRN-----------------PPPTLKSPENWSKK 247 (275)
T ss_pred cccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHH-HHhhcc-----------------CCCCCCchhhcCHH
Confidence 53 24678899999999999999999998653221111 110000 00011112345667
Q ss_pred HHHHHhhcCCCCccCCCCHHHHHHH
Q 024027 226 VFNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 226 l~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
+.+|+.+||..||++|||+.++++|
T Consensus 248 ~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 248 FNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred HHHHHHHHhhcChhhCcCHHHHhcC
Confidence 9999999999999999999999875
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=249.30 Aligned_cols=226 Identities=27% Similarity=0.350 Sum_probs=184.3
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
+.||+|++..........+.+|+++++.++|+|++++++++..+...++++||+++++|.+++......+++..+..++.
T Consensus 26 ~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ 105 (253)
T cd05122 26 KEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCK 105 (253)
T ss_pred cEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHH
Confidence 36899999766555678899999999999999999999999999999999999999999999977656799999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
|++.|+.+|| ..|++|+||+|+||+++.++.++|+|||.+........ .....++..|+|||.+.+..++.++|
T Consensus 106 ~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~D 179 (253)
T cd05122 106 ELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKAD 179 (253)
T ss_pred HHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---ccceecCCcccCHHHHcCCCCCcccc
Confidence 9999999999 99999999999999999999999999999876533221 23456788899999998888899999
Q ss_pred hHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccC
Q 024027 161 VYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQ 240 (273)
Q Consensus 161 iwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 240 (273)
+||||++++++++|..||............. . .. ......+...+..+.+++.+||..||++
T Consensus 180 v~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~---~~-------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~ 241 (253)
T cd05122 180 IWSLGITAIELAEGKPPYSELPPMKALFKIA--T---NG-------------PPGLRNPEKWSDEFKDFLKKCLQKNPEK 241 (253)
T ss_pred HHHHHHHHHHHHhCCCCCCCCchHHHHHHHH--h---cC-------------CCCcCcccccCHHHHHHHHHHccCChhh
Confidence 9999999999999999986542211111000 0 00 0000001223567999999999999999
Q ss_pred CCCHHHHHHH
Q 024027 241 RINAKEIVTK 250 (273)
Q Consensus 241 Rps~~~~l~~ 250 (273)
|||+.++++|
T Consensus 242 R~t~~~~l~~ 251 (253)
T cd05122 242 RPTAEQLLKH 251 (253)
T ss_pred CCCHHHHhcC
Confidence 9999999876
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=254.05 Aligned_cols=231 Identities=26% Similarity=0.336 Sum_probs=178.6
Q ss_pred CeEEEEEeecccC----------hhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCC
Q 024027 1 MEVAVKVFNLQCG----------RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCIL 70 (273)
Q Consensus 1 ~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 70 (273)
+.||||.++.... ...+.+..|+++++.++|+|++++++++......++|+||+++++|.+++... ..+
T Consensus 27 ~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l 105 (272)
T cd06629 27 EMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTY-GRF 105 (272)
T ss_pred ceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhc-cCC
Confidence 3689998864311 12346788999999999999999999999999999999999999999999765 468
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCccc
Q 024027 71 DIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYG 150 (273)
Q Consensus 71 ~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 150 (273)
++..+..++.|++.||.+|| +.+++|+||+|+||+++.++.++++|||.+................++..|+|||.+
T Consensus 106 ~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~ 182 (272)
T cd06629 106 EEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVI 182 (272)
T ss_pred CHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHh
Confidence 99999999999999999999 999999999999999999999999999998754322111122334578889999988
Q ss_pred CCCC--cCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHH
Q 024027 151 REGR--VSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFN 228 (273)
Q Consensus 151 ~~~~--~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 228 (273)
.... ++.++|+||||++++++++|..||......... ....... ............++.++.+
T Consensus 183 ~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~-----------~~~~~~~~~~~~~~~~~~~ 247 (272)
T cd06629 183 HSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAM----FKLGNKR-----------SAPPIPPDVSMNLSPVALD 247 (272)
T ss_pred ccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHH----HHhhccc-----------cCCcCCccccccCCHHHHH
Confidence 7654 789999999999999999999998542221111 0000000 0000000112335677999
Q ss_pred HHhhcCCCCccCCCCHHHHHHH
Q 024027 229 LAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 229 li~~~l~~dp~~Rps~~~~l~~ 250 (273)
++.+||.++|.+|||++++++|
T Consensus 248 li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 248 FLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred HHHHHhcCChhhCCCHHHHhhC
Confidence 9999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=255.31 Aligned_cols=243 Identities=22% Similarity=0.217 Sum_probs=178.4
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcC-CCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~ 77 (273)
+.||||.++... ......+..|+++++.++||||+++++++.+....++||||++ ++|..++... ...+++..++.
T Consensus 26 ~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~ 104 (284)
T cd07860 26 EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKS 104 (284)
T ss_pred CEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHH
Confidence 368999987543 2234578899999999999999999999999999999999996 5898888643 34589999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCC-cC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGR-VS 156 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~ 156 (273)
++.|++.||+||| ..|++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+.. ++
T Consensus 105 ~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~ 179 (284)
T cd07860 105 YLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYS 179 (284)
T ss_pred HHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc--cccccccccccccCCeEEecCCCCC
Confidence 9999999999999 9999999999999999999999999999987542211 1122334678899999886644 68
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCcc--chhhhh------hhc-cccchhhhhhhhhhHHHHH
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPIS--TMEVVD------ANL-LSQEDIHFVAKEQCVSFVF 227 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~------~~~-~~~~~~~~~~~~~~~~~l~ 227 (273)
.++|+||||+++|++++|..||........ ............ ..+... ... .............++.++.
T Consensus 180 ~~~Dv~slG~il~~l~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (284)
T cd07860 180 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQ-LFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGR 258 (284)
T ss_pred cHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHH
Confidence 899999999999999999999865332221 111111111000 000000 000 0000001111234567789
Q ss_pred HHHhhcCCCCccCCCCHHHHHHH
Q 024027 228 NLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 228 ~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
+++.+||..||.+|||+.++++|
T Consensus 259 ~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 259 DLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHHhcCCCcccCCCHHHHhcC
Confidence 99999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=251.13 Aligned_cols=224 Identities=23% Similarity=0.373 Sum_probs=180.2
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcC-CCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~ 77 (273)
+.||||.+.... ......+..|+++++.++|||++++++.+......++|+||+++++|.+++... +..+++..+..
T Consensus 26 ~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~ 105 (256)
T cd08220 26 KLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILH 105 (256)
T ss_pred cEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHH
Confidence 368999987542 345678899999999999999999999999999999999999999999999754 34589999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCC-CceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDN-LVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVS 156 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~-~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 156 (273)
++.+++.++.+|| ++|++|+||+|+||+++.+ +.++|+|||.+....... ......++..|+|||.+.+..++
T Consensus 106 ~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~ 179 (256)
T cd08220 106 FFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS---KAYTVVGTPCYISPELCEGKPYN 179 (256)
T ss_pred HHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc---cccccccCCcccCchhccCCCCC
Confidence 9999999999999 9999999999999999854 468999999997653221 11234578899999999888889
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++|+||+|++++++++|..||............ .. ......+..++.++.+++.+||..
T Consensus 180 ~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~-~~-------------------~~~~~~~~~~~~~l~~li~~~l~~ 239 (256)
T cd08220 180 QKSDIWALGCVLYELASLKRAFEAANLPALVLKI-MS-------------------GTFAPISDRYSPDLRQLILSMLNL 239 (256)
T ss_pred cccchHHHHHHHHHHHhCCCCcccCchHHHHHHH-Hh-------------------cCCCCCCCCcCHHHHHHHHHHccC
Confidence 9999999999999999999998653322111000 00 000011334667799999999999
Q ss_pred CccCCCCHHHHHHH
Q 024027 237 SPEQRINAKEIVTK 250 (273)
Q Consensus 237 dp~~Rps~~~~l~~ 250 (273)
||.+|||+.+++.|
T Consensus 240 ~p~~Rpt~~~ll~~ 253 (256)
T cd08220 240 DPSKRPQLSQIMAQ 253 (256)
T ss_pred ChhhCCCHHHHhhC
Confidence 99999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=257.76 Aligned_cols=228 Identities=23% Similarity=0.294 Sum_probs=176.7
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||||.+.... ......+.+|+++++.++||||+++++++..++..++||||++|++|.+++...+ .+++..+..
T Consensus 27 ~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~ 105 (305)
T cd05609 27 QRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIG-ALPVDMARM 105 (305)
T ss_pred cEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHH
Confidence 479999987553 2345678899999999999999999999999999999999999999999996554 689999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCC-------------cceeecccccCCC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQ-------------SMTQTQTLATIGY 144 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~-------------~~~~~~~~~~~~~ 144 (273)
++.|++.|+.||| +.|++|+||+|+||+++.++.++|+|||.+........ ........++..|
T Consensus 106 ~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y 182 (305)
T cd05609 106 YFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEY 182 (305)
T ss_pred HHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccc
Confidence 9999999999999 99999999999999999999999999998763211000 0011123467789
Q ss_pred CCCcccCCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHH
Q 024027 145 MAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVS 224 (273)
Q Consensus 145 ~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (273)
+|||.+.+..++.++|+||||+++|++++|..||......+. ....... ... .......++.
T Consensus 183 ~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~-~~~~~~~----------------~~~-~~~~~~~~~~ 244 (305)
T cd05609 183 IAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL-FGQVISD----------------DIE-WPEGDEALPA 244 (305)
T ss_pred cCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhc----------------ccC-CCCccccCCH
Confidence 999999888899999999999999999999999864322111 1100000 000 0000124667
Q ss_pred HHHHHHhhcCCCCccCCCC---HHHHHHH
Q 024027 225 FVFNLAMACTVESPEQRIN---AKEIVTK 250 (273)
Q Consensus 225 ~l~~li~~~l~~dp~~Rps---~~~~l~~ 250 (273)
++.+++.+||..||++||+ +.+++++
T Consensus 245 ~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 245 DAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 7999999999999999998 4555655
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=256.79 Aligned_cols=226 Identities=27% Similarity=0.322 Sum_probs=182.3
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
+.||+|.+........+.+..|+.+++.++|||++++++++......++|+||+++++|.+++.+. .+++..+..++.
T Consensus 45 ~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~ 122 (293)
T cd06647 45 QEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCR 122 (293)
T ss_pred CEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhhc--CCCHHHHHHHHH
Confidence 368999987655555677899999999999999999999999999999999999999999998654 478899999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
|++.|+.||| +.|++|+||+|+||+++.++.++|+|||++........ ......+++.|+|||.+.+..++.++|
T Consensus 123 ~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~D 197 (293)
T cd06647 123 ECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVD 197 (293)
T ss_pred HHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--ccccccCChhhcCchhhccCCCCchhh
Confidence 9999999999 99999999999999999999999999998865532221 223345788899999998888899999
Q ss_pred hHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccC
Q 024027 161 VYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQ 240 (273)
Q Consensus 161 iwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 240 (273)
+||||+++|++++|..||........... . .. ........+...+..+.+++.+||..+|.+
T Consensus 198 v~slG~ll~~ll~g~~pf~~~~~~~~~~~-~-~~----------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 259 (293)
T cd06647 198 IWSLGIMAIEMVEGEPPYLNENPLRALYL-I-AT----------------NGTPELQNPEKLSAIFRDFLNRCLEMDVEK 259 (293)
T ss_pred HHHHHHHHHHHHhCCCCCCCCChhhheee-h-hc----------------CCCCCCCCccccCHHHHHHHHHHccCChhh
Confidence 99999999999999999965332211100 0 00 000001113345667999999999999999
Q ss_pred CCCHHHHHHHH
Q 024027 241 RINAKEIVTKL 251 (273)
Q Consensus 241 Rps~~~~l~~l 251 (273)
||++.+++.|-
T Consensus 260 Rp~~~~il~h~ 270 (293)
T cd06647 260 RGSAKELLQHP 270 (293)
T ss_pred CcCHHHHhcCH
Confidence 99999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=251.34 Aligned_cols=224 Identities=25% Similarity=0.303 Sum_probs=181.1
Q ss_pred CeEEEEEeeccc-----ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHH
Q 024027 1 MEVAVKVFNLQC-----GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQR 75 (273)
Q Consensus 1 ~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (273)
++||+|.+.... .+..+.+..|+++++.++|+||+++++++.+...+++++||+++++|.+++.+.. .+++..+
T Consensus 26 ~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~ 104 (258)
T cd06632 26 DFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYG-SFPEPVI 104 (258)
T ss_pred cEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhcC-CCCHHHH
Confidence 369999987543 2345678999999999999999999999999999999999999999999996553 5889999
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCC-
Q 024027 76 LNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGR- 154 (273)
Q Consensus 76 ~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~- 154 (273)
..++.|++.|+.+|| +.|++|+||+|+||+++.++.++|+|||.+....... ......++..|++||.+....
T Consensus 105 ~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~ 178 (258)
T cd06632 105 RLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGG 178 (258)
T ss_pred HHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc---cccccCCCcceeCHHHhcCCCC
Confidence 999999999999999 9999999999999999999999999999987653322 223455788899999887766
Q ss_pred cCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcC
Q 024027 155 VSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACT 234 (273)
Q Consensus 155 ~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 234 (273)
++.++|+||+|+++|++++|..||........... .. . .......+..++..+.+++.+||
T Consensus 179 ~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~-~~-~-----------------~~~~~~~~~~~~~~~~~li~~~l 239 (258)
T cd06632 179 YGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFK-IG-R-----------------SKELPPIPDHLSDEAKDFILKCL 239 (258)
T ss_pred CCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHH-HH-h-----------------cccCCCcCCCcCHHHHHHHHHHh
Confidence 89999999999999999999999876432111100 00 0 00001113446677999999999
Q ss_pred CCCccCCCCHHHHHHH
Q 024027 235 VESPEQRINAKEIVTK 250 (273)
Q Consensus 235 ~~dp~~Rps~~~~l~~ 250 (273)
..+|.+||++.+++.|
T Consensus 240 ~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 240 QRDPSLRPTAAELLEH 255 (258)
T ss_pred hcCcccCcCHHHHhcC
Confidence 9999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=280.88 Aligned_cols=235 Identities=24% Similarity=0.292 Sum_probs=182.4
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcC----------C
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS----------N 67 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------~ 67 (273)
+.||||+++... ....+.+.+|+++++.++||||+++++++.+++..+++|||++|++|.+++... .
T Consensus 28 ~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~ 107 (932)
T PRK13184 28 RRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELA 107 (932)
T ss_pred cEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhh
Confidence 479999997542 233567889999999999999999999999999999999999999999998532 1
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCC----------------
Q 024027 68 CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQ---------------- 131 (273)
Q Consensus 68 ~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~---------------- 131 (273)
...+...++.++.|++.||.||| +.|++||||||+||+++.++.++|+|||++........
T Consensus 108 ~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~ 184 (932)
T PRK13184 108 EKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184 (932)
T ss_pred cccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccc
Confidence 23456678899999999999999 99999999999999999999999999999976521110
Q ss_pred cceeecccccCCCCCCcccCCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhcccc
Q 024027 132 SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 211 (273)
Q Consensus 132 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (273)
.......+|++.|+|||.+.+..++.++||||+||++|+|++|..||............. . .
T Consensus 185 ~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~---i---------------~ 246 (932)
T PRK13184 185 MTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDV---I---------------L 246 (932)
T ss_pred cccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhh---c---------------c
Confidence 011123468999999999998899999999999999999999999986532211111000 0 0
Q ss_pred chhhhhhhhhhHHHHHHHHhhcCCCCccCCC-CHHHHHHHHHHHHH
Q 024027 212 EDIHFVAKEQCVSFVFNLAMACTVESPEQRI-NAKEIVTKLLKIRD 256 (273)
Q Consensus 212 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-s~~~~l~~l~~~~~ 256 (273)
.+........++..+.+++.+||..||++|| +++++++.|+.+.+
T Consensus 247 ~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 247 SPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred ChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0000011234567789999999999999997 67777777877765
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=253.82 Aligned_cols=229 Identities=22% Similarity=0.259 Sum_probs=180.9
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC-CCCCHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~ 76 (273)
+.||+|++.... ......+..|+++++.++||||+++++++...+..++||||+++++|.+++.... ..+++..+.
T Consensus 19 ~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 98 (277)
T cd05577 19 KMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAI 98 (277)
T ss_pred cEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHH
Confidence 368999986532 2234567789999999999999999999999999999999999999999986544 358999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcC
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVS 156 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 156 (273)
.++.|++.|+.||| +.|++|+||+|+||+++.++.++|+|||.+..... ........++..|+|||.+.+..++
T Consensus 99 ~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~ 172 (277)
T cd05577 99 FYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGTPGYMAPEVLQGEVYD 172 (277)
T ss_pred HHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccccCCCCcCCHHHhcCCCCC
Confidence 99999999999999 99999999999999999999999999998875432 1112234567789999999888899
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++|+||+|++++++++|..||........ ........ .......+...+.++.+++.+||..
T Consensus 173 ~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~----------------~~~~~~~~~~~~~~~~~li~~~l~~ 235 (277)
T cd05577 173 FSVDWFALGCTLYEMIAGRSPFRQRKEKVE-KEELKRRT----------------LEMAVEYPDKFSPEAKDLCEALLQK 235 (277)
T ss_pred chhhhHHHHHHHHHHhhCCCCCCCCccccc-HHHHHhcc----------------ccccccCCccCCHHHHHHHHHHccC
Confidence 999999999999999999999865332111 11000000 0001112334577799999999999
Q ss_pred CccCCC-----CHHHHHHHHH
Q 024027 237 SPEQRI-----NAKEIVTKLL 252 (273)
Q Consensus 237 dp~~Rp-----s~~~~l~~l~ 252 (273)
||.+|| ++.+++.|-+
T Consensus 236 ~p~~R~~~~~~~~~~ll~h~~ 256 (277)
T cd05577 236 DPEKRLGCRGGSADEVREHPL 256 (277)
T ss_pred ChhHccCCCcccHHHHHhChh
Confidence 999999 7788887654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=267.77 Aligned_cols=225 Identities=25% Similarity=0.337 Sum_probs=188.8
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
+.||||.+.... ....+.+.+|++++..++||||++++.+...+..+|+||||+.+|.+++++.+++. ..+..+..+
T Consensus 82 ~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~gr-~~e~~ar~~ 160 (596)
T KOG0586|consen 82 TEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHGR-MKEKEARAK 160 (596)
T ss_pred ceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhccc-chhhhhhhh
Confidence 479999998663 44556789999999999999999999999999999999999999999999987764 555999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCc-CC
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRV-ST 157 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~ 157 (273)
+.|++.|++||| +.+++|+|||+.|++++.+-++||+|||+++++. ........+|++.|.|||++.+..| ++
T Consensus 161 F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~---~~~~lqt~cgsppyAaPEl~~g~~y~gp 234 (596)
T KOG0586|consen 161 FRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFD---YGLMLQTFCGSPPYAAPELFNGKKYDGP 234 (596)
T ss_pred hHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeec---ccccccccCCCCCccChHhhcCcccCCc
Confidence 999999999999 9999999999999999999999999999999874 2333456789999999999998876 68
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
..|+||+|+++|.++.|..||.+..-.+-.-. .. ....-.+.-.+.+..++|+++|.++
T Consensus 235 e~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~r-----------------vl----~gk~rIp~~ms~dce~lLrk~lvl~ 293 (596)
T KOG0586|consen 235 EVDIWSLGVVLYALVEGSLPFDGQNLKELRPR-----------------VL----RGKYRIPFYMSCDCEDLLRKFLVLN 293 (596)
T ss_pred ceehhhhhhhheeeeecccccCCcccccccch-----------------he----eeeecccceeechhHHHHHHhhccC
Confidence 89999999999999999999976332221110 00 0111114445666889999999999
Q ss_pred ccCCCCHHHHHHHHHH
Q 024027 238 PEQRINAKEIVTKLLK 253 (273)
Q Consensus 238 p~~Rps~~~~l~~l~~ 253 (273)
|.+|++++++.++-|.
T Consensus 294 Pskr~~~dqim~~~W~ 309 (596)
T KOG0586|consen 294 PSKRGPCDQIMKDRWR 309 (596)
T ss_pred ccccCCHHHhhhhccc
Confidence 9999999999998764
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=259.01 Aligned_cols=249 Identities=19% Similarity=0.286 Sum_probs=181.5
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC-CCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~ 77 (273)
+.||||+++... ....+.+.+|+.+++.++||||++++++|..+...++|+||+.++++.+++.... ..+++..+..
T Consensus 26 ~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~ 105 (328)
T cd08226 26 TLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGN 105 (328)
T ss_pred cEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHH
Confidence 479999997543 2335678899999999999999999999999999999999999999999987543 3488999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcce-----eecccccCCCCCCcccCC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMT-----QTQTLATIGYMAPEYGRE 152 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~ 152 (273)
++.|++.||+||| +.|++|+||||+||+++.++.++++||+.+........... .....++..|+|||.+.+
T Consensus 106 ~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 182 (328)
T cd08226 106 ILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQ 182 (328)
T ss_pred HHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcC
Confidence 9999999999999 99999999999999999999999999976543321111100 111224556999999876
Q ss_pred C--CcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCcc--------chhhh-----------hhh----
Q 024027 153 G--RVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPIS--------TMEVV-----------DAN---- 207 (273)
Q Consensus 153 ~--~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--------~~~~~-----------~~~---- 207 (273)
. .++.++||||+||+++++++|..||...................+. ..... +..
T Consensus 183 ~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (328)
T cd08226 183 DLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAG 262 (328)
T ss_pred CCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccc
Confidence 3 4789999999999999999999999765433222111111000000 00000 000
Q ss_pred ---ccccchhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 208 ---LLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 208 ---~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
...........+..++..+.+|+.+||..||++|||++++++|-+
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~ 310 (328)
T cd08226 263 MTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAF 310 (328)
T ss_pred cccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHH
Confidence 000011122224457788999999999999999999999998765
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=250.48 Aligned_cols=229 Identities=29% Similarity=0.373 Sum_probs=181.9
Q ss_pred CeEEEEEeecccC--hhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 1 MEVAVKVFNLQCG--RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 1 ~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
++||+|+++.... .....+..|+++++.++|+||+++++++......++|+||+++++|.+++... ..+++..+..+
T Consensus 26 ~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i 104 (264)
T cd06626 26 ELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHG-RILDEHVIRVY 104 (264)
T ss_pred cEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhc-CCCChHHHHHH
Confidence 4799999986643 36788999999999999999999999999999999999999999999999654 35889999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcce--eecccccCCCCCCcccCCCC--
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMT--QTQTLATIGYMAPEYGREGR-- 154 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~-- 154 (273)
+.|++.|+.||| +.|++|+||+|+||+++.++.++|+|||++........... .....++..|+|||.+.+..
T Consensus 105 ~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~ 181 (264)
T cd06626 105 TLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGK 181 (264)
T ss_pred HHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCC
Confidence 999999999999 99999999999999999999999999999876643322111 12345678899999987765
Q ss_pred -cCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhc
Q 024027 155 -VSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMAC 233 (273)
Q Consensus 155 -~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 233 (273)
++.++|+||+|++++++++|..||............ ...... ...+....++..+.+++.+|
T Consensus 182 ~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~----------------~~~~~~~~~~~~~~~li~~~ 244 (264)
T cd06626 182 GHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFH-VGAGHK----------------PPIPDSLQLSPEGKDFLDRC 244 (264)
T ss_pred CCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHH-HhcCCC----------------CCCCcccccCHHHHHHHHHH
Confidence 889999999999999999999999754322111110 000000 00000123466789999999
Q ss_pred CCCCccCCCCHHHHHHH
Q 024027 234 TVESPEQRINAKEIVTK 250 (273)
Q Consensus 234 l~~dp~~Rps~~~~l~~ 250 (273)
|..+|.+|||+.+++.+
T Consensus 245 l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 245 LESDPKKRPTASELLQH 261 (264)
T ss_pred ccCCcccCCCHHHHhcC
Confidence 99999999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=254.71 Aligned_cols=227 Identities=21% Similarity=0.260 Sum_probs=174.7
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcC-CCccceeeeeeee-----cCCceeEEEeccCCCCHHHhhhc---CCCCCC
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSI-RHRNLIKVISSCS-----NEEFKALVLEYMPHGSLEKYLYS---SNCILD 71 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~ 71 (273)
+.||+|+++.. ......+..|+.+++.+ +||||+++++++. .....++||||+++++|.+++.. ....++
T Consensus 44 ~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 122 (286)
T cd06638 44 SKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERME 122 (286)
T ss_pred ceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCcccc
Confidence 36899988643 22346788899999999 6999999999873 44578999999999999998752 334588
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccC
Q 024027 72 IFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR 151 (273)
Q Consensus 72 ~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 151 (273)
+..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.
T Consensus 123 ~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~ 197 (286)
T cd06638 123 EPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIA 197 (286)
T ss_pred HHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCEEEccCCceeecccCC--CccccccCCCcccChhhhc
Confidence 8999999999999999999 9999999999999999999999999999987653221 1223346888999999875
Q ss_pred C-----CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHH
Q 024027 152 E-----GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFV 226 (273)
Q Consensus 152 ~-----~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 226 (273)
. ..++.++|+||+||++|++++|..||......... ...... .......+..++.++
T Consensus 198 ~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~-~~~~~~-----------------~~~~~~~~~~~~~~~ 259 (286)
T cd06638 198 CEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL-FKIPRN-----------------PPPTLHQPELWSNEF 259 (286)
T ss_pred hhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH-hhcccc-----------------CCCcccCCCCcCHHH
Confidence 3 34788999999999999999999998653221110 000000 000000122345669
Q ss_pred HHHHhhcCCCCccCCCCHHHHHHHH
Q 024027 227 FNLAMACTVESPEQRINAKEIVTKL 251 (273)
Q Consensus 227 ~~li~~~l~~dp~~Rps~~~~l~~l 251 (273)
.+++.+||..||.+|||+.+++++.
T Consensus 260 ~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 260 NDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred HHHHHHHccCCcccCCCHHHHhhcc
Confidence 9999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=253.91 Aligned_cols=243 Identities=23% Similarity=0.219 Sum_probs=179.1
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC-CCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~ 77 (273)
++||||++.... ......+..|+++++.++|||++++++++.++...++++||++ ++|.+++.... ..+++..++.
T Consensus 25 ~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~ 103 (283)
T cd07835 25 EIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKS 103 (283)
T ss_pred CEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHH
Confidence 468999997553 2234568889999999999999999999999999999999996 59999986543 3589999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCC-CcC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG-RVS 156 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~ 156 (273)
++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||.+.+. .++
T Consensus 104 ~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~ 178 (283)
T cd07835 104 YLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGSRQYS 178 (283)
T ss_pred HHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc--cccCccccccCCCCCceeecCcccC
Confidence 9999999999999 9999999999999999999999999999987542211 112233567889999987654 478
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccch---------hhhhhhccccchhhhhhhhhhHHHHH
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTM---------EVVDANLLSQEDIHFVAKEQCVSFVF 227 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~l~ 227 (273)
.++|+||||+++|++++|..||........ .............. .....................+.++.
T Consensus 179 ~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (283)
T cd07835 179 TPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ-LFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGL 257 (283)
T ss_pred cHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHH
Confidence 899999999999999999999865332211 11111110000000 00000000000011112344567799
Q ss_pred HHHhhcCCCCccCCCCHHHHHHH
Q 024027 228 NLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 228 ~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
+++.+||..||++|||+++++++
T Consensus 258 ~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 258 DLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred HHHHHHhcCChhhCcCHHHHhcC
Confidence 99999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=257.81 Aligned_cols=228 Identities=26% Similarity=0.330 Sum_probs=181.2
Q ss_pred CeEEEEEeecccC---hhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcC-CCCCCHHHHH
Q 024027 1 MEVAVKVFNLQCG---RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~ 76 (273)
+.||||.+..... ...+.+..|+++++.++|+||+++++.+.+....++||||+.+++|.+++... +..+++..+.
T Consensus 27 ~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~ 106 (316)
T cd05574 27 KLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVAR 106 (316)
T ss_pred cEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHH
Confidence 4789999976532 24567889999999999999999999999999999999999999999998654 3468999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCc------------------------
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQS------------------------ 132 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~------------------------ 132 (273)
.++.|++.||+||| +.|++|+||||+||+++.++.++|+|||++.........
T Consensus 107 ~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (316)
T cd05574 107 FYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSE 183 (316)
T ss_pred HHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcc
Confidence 99999999999999 999999999999999999999999999988654221110
Q ss_pred ---ceeecccccCCCCCCcccCCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhcc
Q 024027 133 ---MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLL 209 (273)
Q Consensus 133 ---~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (273)
.......|+..|+|||.+.+..++.++||||||+++|++++|..||........ +..... .
T Consensus 184 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~-~~~~~~------------~--- 247 (316)
T cd05574 184 EPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET-FSNILK------------K--- 247 (316)
T ss_pred cccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH-HHHHhc------------C---
Confidence 011123578889999999888899999999999999999999999875433211 111000 0
Q ss_pred ccchhhhhhhhhhHHHHHHHHhhcCCCCccCCCC----HHHHHHH
Q 024027 210 SQEDIHFVAKEQCVSFVFNLAMACTVESPEQRIN----AKEIVTK 250 (273)
Q Consensus 210 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~~~l~~ 250 (273)
..........+.++.+++.+||..||++||| +++++.|
T Consensus 248 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 248 ---EVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred ---CccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 0000111225677999999999999999999 8888886
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=254.67 Aligned_cols=243 Identities=20% Similarity=0.199 Sum_probs=179.3
Q ss_pred CeEEEEEeecccC--hhhhhHHHHHHHHhcCCCccceeeeeeeecC--CceeEEEeccCCCCHHHhhhcCCCCCCHHHHH
Q 024027 1 MEVAVKVFNLQCG--RAFKSFDVECEMMKSIRHRNLIKVISSCSNE--EFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (273)
++||+|.++.... .....+.+|+.+++.++||||+++++++... ...++|+||+++ +|.+++......+++..++
T Consensus 31 ~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~ 109 (293)
T cd07843 31 EIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVK 109 (293)
T ss_pred cEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcCc-CHHHHHHhccCCCCHHHHH
Confidence 4699999975532 2234567899999999999999999998877 889999999975 9999987666579999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCC-c
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGR-V 155 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~ 155 (273)
.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||.+..+..... ......++..|+|||.+.+.. +
T Consensus 110 ~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~ 184 (293)
T cd07843 110 CLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK--PYTQLVVTLWYRAPELLLGAKEY 184 (293)
T ss_pred HHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc--ccccccccccccCchhhcCCccc
Confidence 99999999999999 99999999999999999999999999999876533221 122345678899999886544 6
Q ss_pred CCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccc--hh------hhh-hh--ccccchhhhhhhhh-hH
Q 024027 156 STNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPIST--ME------VVD-AN--LLSQEDIHFVAKEQ-CV 223 (273)
Q Consensus 156 ~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~------~~~-~~--~~~~~~~~~~~~~~-~~ 223 (273)
+.++|+||+|+++++|++|..||........ ..........+.. .. ... .. ...........+.. .+
T Consensus 185 ~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (293)
T cd07843 185 STAIDMWSVGCIFAELLTKKPLFPGKSEIDQ-LNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLS 263 (293)
T ss_pred cchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCC
Confidence 8999999999999999999999875432211 1111111000000 00 000 00 00000111111222 47
Q ss_pred HHHHHHHhhcCCCCccCCCCHHHHHHH
Q 024027 224 SFVFNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 224 ~~l~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
..+.+++.+||..||++|||+.++++|
T Consensus 264 ~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 264 DNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hHHHHHHHHHhccCccccCCHHHHhcC
Confidence 779999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=249.48 Aligned_cols=232 Identities=22% Similarity=0.356 Sum_probs=171.5
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC---CCCCHHHHHH
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN---CILDIFQRLN 77 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~ 77 (273)
.+++|.++... ......+.+|+.+++.++||||+++++.+.+....++||||+++|+|.+++.+.. ...+...+..
T Consensus 24 ~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 103 (268)
T cd05086 24 RVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR 103 (268)
T ss_pred eEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHH
Confidence 35667665443 3345679999999999999999999999999999999999999999999996542 2356677889
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC-----
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE----- 152 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~----- 152 (273)
++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++................++..|+|||++..
T Consensus 104 ~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 180 (268)
T cd05086 104 MACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGL 180 (268)
T ss_pred HHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCcc
Confidence 9999999999999 99999999999999999999999999998754211111112234467888999998743
Q ss_pred --CCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHH
Q 024027 153 --GRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNL 229 (273)
Q Consensus 153 --~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 229 (273)
..++.++||||||+++|+|++ |..||......+ ........... .. .....+...+..+.++
T Consensus 181 ~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~~~~~----~~----------~~~~~~~~~~~~~~~l 245 (268)
T cd05086 181 ITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE-VLNHVIKDQQV----KL----------FKPQLELPYSERWYEV 245 (268)
T ss_pred ccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHhhccc----cc----------CCCccCCCCcHHHHHH
Confidence 235788999999999999997 566775432211 11111100000 00 0011122355668889
Q ss_pred HhhcCCCCccCCCCHHHHHHHHH
Q 024027 230 AMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 230 i~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
+.+|| .+|.+|||++++++.|.
T Consensus 246 ~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 246 LQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHHHh-hCcccCCCHHHHHHHhc
Confidence 99999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=261.38 Aligned_cols=230 Identities=19% Similarity=0.223 Sum_probs=177.9
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||+|++.... ......+..|..++..++|++|+++++++.++..+++||||+++|+|.+++.+....+++..+..
T Consensus 27 ~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~ 106 (332)
T cd05623 27 KVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARF 106 (332)
T ss_pred CEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHH
Confidence 368999986431 22344588899999999999999999999999999999999999999999977666789999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccC-----C
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR-----E 152 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~ 152 (273)
++.|++.||.||| +.|++||||||+||+++.++.++|+|||++....... ........|++.|+|||++. .
T Consensus 107 ~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ 182 (332)
T cd05623 107 YLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAVGTPDYISPEILQAMEDGK 182 (332)
T ss_pred HHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCC-cceecccccCccccCHHHHhccccCC
Confidence 9999999999999 9999999999999999999999999999986542221 11223356899999999885 2
Q ss_pred CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhh
Q 024027 153 GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMA 232 (273)
Q Consensus 153 ~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 232 (273)
..++.++|+|||||++|+|++|..||......+. .......... .. .......++.++.+|+.+
T Consensus 183 ~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~-~~~i~~~~~~--------------~~-~p~~~~~~s~~~~~li~~ 246 (332)
T cd05623 183 GKYGPECDWWSLGVCMYEMLYGETPFYAESLVET-YGKIMNHKER--------------FQ-FPAQVTDVSEDAKDLIRR 246 (332)
T ss_pred CCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH-HHHHhCCCcc--------------cc-CCCccccCCHHHHHHHHH
Confidence 4578899999999999999999999975322111 1111000000 00 000123467789999999
Q ss_pred cCCCCccC--CCCHHHHHHH
Q 024027 233 CTVESPEQ--RINAKEIVTK 250 (273)
Q Consensus 233 ~l~~dp~~--Rps~~~~l~~ 250 (273)
||..+|.. |+++.++++|
T Consensus 247 ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 247 LICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HccChhhhcCCCCHHHHhCC
Confidence 99765444 7899999999
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=255.70 Aligned_cols=243 Identities=24% Similarity=0.296 Sum_probs=179.2
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
++||+|++.... ....+.+.+|+++++.++||||+++++++.++...++|+||+++++|.++.... ..+++..+..+
T Consensus 27 ~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~ 105 (286)
T cd07846 27 QIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYP-NGLDESRVRKY 105 (286)
T ss_pred CEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhcc-CCCCHHHHHHH
Confidence 479999986542 223566889999999999999999999999999999999999998888776543 35899999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC-CCcCC
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE-GRVST 157 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~ 157 (273)
+.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+ ..++.
T Consensus 106 ~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~ 180 (286)
T cd07846 106 LFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYTDYVATRWYRAPELLVGDTKYGR 180 (286)
T ss_pred HHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc--ccCcccceeeccCcHHhccccccCc
Confidence 999999999999 99999999999999999999999999999876533221 1223456788999998865 34788
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccC--ccchhhhh------hhccc---cchhhhhhhhhhHHHH
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLP--ISTMEVVD------ANLLS---QEDIHFVAKEQCVSFV 226 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~------~~~~~---~~~~~~~~~~~~~~~l 226 (273)
++|+||||++++++++|.+||......+ ........... ........ ..... ...........++..+
T Consensus 181 ~~Dv~slG~~l~el~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (286)
T cd07846 181 AVDIWAVGCLVTEMLTGEPLFPGDSDID-QLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLV 259 (286)
T ss_pred hHhHHHHHHHHHHHHcCCCCCCCCchHH-HHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHH
Confidence 9999999999999999999986433211 11111100000 00000000 00000 0000111133567789
Q ss_pred HHHHhhcCCCCccCCCCHHHHHHH
Q 024027 227 FNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 227 ~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
.+|+.+||..+|.+||++.++++|
T Consensus 260 ~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 260 LDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred HHHHHHHhcCCcccchhHHHHhcC
Confidence 999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=248.85 Aligned_cols=227 Identities=24% Similarity=0.293 Sum_probs=184.2
Q ss_pred CeEEEEEeecccC-hhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 1 MEVAVKVFNLQCG-RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 1 ~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
+.||||++..... .....+..|+++++.++|+|++++++++..+...++++||+++++|.+++... ..+++..++.++
T Consensus 27 ~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~ 105 (264)
T cd06623 27 KIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKV-GKIPEPVLAYIA 105 (264)
T ss_pred cEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHH
Confidence 3689999976643 45678999999999999999999999999999999999999999999999655 468999999999
Q ss_pred HHHHHHHHHHhcCCC-CCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCc
Q 024027 80 IDVASALEYLHFGCS-APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTN 158 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~-~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 158 (273)
.|++.|+.+|| + .|++|+||+|+||+++.++.++|+|||.+........ ......++..|.|||.+.+..++.+
T Consensus 106 ~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~ 180 (264)
T cd06623 106 RQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD--QCNTFVGTVTYMSPERIQGESYSYA 180 (264)
T ss_pred HHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC--cccceeecccccCHhhhCCCCCCch
Confidence 99999999999 8 9999999999999999999999999999876532222 1123457788999999988889999
Q ss_pred chhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhh-hHHHHHHHHhhcCCCC
Q 024027 159 GDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQ-CVSFVFNLAMACTVES 237 (273)
Q Consensus 159 ~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~d 237 (273)
+|+||||+++|++++|..||....... ........... . ....+.. ++..+.+++.+||..+
T Consensus 181 ~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~--------------~-~~~~~~~~~~~~l~~li~~~l~~~ 243 (264)
T cd06623 181 ADIWSLGLTLLECALGKFPFLPPGQPS--FFELMQAICDG--------------P-PPSLPAEEFSPEFRDFISACLQKD 243 (264)
T ss_pred hhHHHHHHHHHHHHhCCCCCccccccC--HHHHHHHHhcC--------------C-CCCCCcccCCHHHHHHHHHHccCC
Confidence 999999999999999999987654211 11111110000 0 0001222 6677999999999999
Q ss_pred ccCCCCHHHHHHH
Q 024027 238 PEQRINAKEIVTK 250 (273)
Q Consensus 238 p~~Rps~~~~l~~ 250 (273)
|++|||+.+++++
T Consensus 244 p~~R~~~~~ll~~ 256 (264)
T cd06623 244 PKKRPSAAELLQH 256 (264)
T ss_pred hhhCCCHHHHHhC
Confidence 9999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=249.93 Aligned_cols=226 Identities=22% Similarity=0.312 Sum_probs=175.0
Q ss_pred CeEEEEEeeccc-----ChhhhhHHHHHHHHhcCCCccceeeeeeeec--CCceeEEEeccCCCCHHHhhhcCCCCCCHH
Q 024027 1 MEVAVKVFNLQC-----GRAFKSFDVECEMMKSIRHRNLIKVISSCSN--EEFKALVLEYMPHGSLEKYLYSSNCILDIF 73 (273)
Q Consensus 1 ~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 73 (273)
+.||+|+++... ......+.+|+.+++.++||||+++++++.+ ...+++++||+++++|.+++.... .+++.
T Consensus 28 ~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~-~l~~~ 106 (266)
T cd06651 28 RELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG-ALTES 106 (266)
T ss_pred cEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcC-CCCHH
Confidence 368999886432 2334568899999999999999999998875 357789999999999999996544 58899
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCC-cceeecccccCCCCCCcccCC
Q 024027 74 QRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQ-SMTQTQTLATIGYMAPEYGRE 152 (273)
Q Consensus 74 ~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~ 152 (273)
.++.++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++........ ........++..|+|||.+.+
T Consensus 107 ~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 183 (266)
T cd06651 107 VTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG 183 (266)
T ss_pred HHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCC
Confidence 99999999999999999 99999999999999999999999999999875432111 111123457888999999988
Q ss_pred CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhh
Q 024027 153 GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMA 232 (273)
Q Consensus 153 ~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 232 (273)
..++.++|+||+||++|++++|..||............ . ........+..++..+.+++ +
T Consensus 184 ~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~-~------------------~~~~~~~~~~~~~~~~~~li-~ 243 (266)
T cd06651 184 EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKI-A------------------TQPTNPQLPSHISEHARDFL-G 243 (266)
T ss_pred CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHH-h------------------cCCCCCCCchhcCHHHHHHH-H
Confidence 88999999999999999999999998753221111000 0 00000111334556678888 6
Q ss_pred cCCCCccCCCCHHHHHHH
Q 024027 233 CTVESPEQRINAKEIVTK 250 (273)
Q Consensus 233 ~l~~dp~~Rps~~~~l~~ 250 (273)
||..+|++|||++++++|
T Consensus 244 ~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 244 CIFVEARHRPSAEELLRH 261 (266)
T ss_pred HhcCChhhCcCHHHHhcC
Confidence 888899999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=252.40 Aligned_cols=227 Identities=28% Similarity=0.362 Sum_probs=180.0
Q ss_pred CeEEEEEeecccC---hhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQCG---RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
++||+|++..... .....+.+|+++++.++|+||+++++.+......++++||+++++|.+++.+.+ .+++..+..
T Consensus 19 ~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~ 97 (265)
T cd05579 19 DIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVG-SLDEDVARI 97 (265)
T ss_pred CEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHH
Confidence 4799999975532 456778899999999999999999999999999999999999999999997655 689999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCC------cceeecccccCCCCCCcccC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQ------SMTQTQTLATIGYMAPEYGR 151 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~------~~~~~~~~~~~~~~aPE~~~ 151 (273)
++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||++........ ........++..|+|||...
T Consensus 98 i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~ 174 (265)
T cd05579 98 YIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL 174 (265)
T ss_pred HHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhc
Confidence 9999999999999 99999999999999999999999999999875432211 11223345778899999998
Q ss_pred CCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHh
Q 024027 152 EGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAM 231 (273)
Q Consensus 152 ~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 231 (273)
....+.++|+||||++++++++|..||........ ...... ...........+..+.+++.
T Consensus 175 ~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-~~~~~~------------------~~~~~~~~~~~~~~~~~~i~ 235 (265)
T cd05579 175 GQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI-FQNILN------------------GKIEWPEDVEVSDEAIDLIS 235 (265)
T ss_pred CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHhc------------------CCcCCCccccCCHHHHHHHH
Confidence 88889999999999999999999999865332211 100000 00000001113677999999
Q ss_pred hcCCCCccCCCCH---HHHHHH
Q 024027 232 ACTVESPEQRINA---KEIVTK 250 (273)
Q Consensus 232 ~~l~~dp~~Rps~---~~~l~~ 250 (273)
+||..+|.+|||+ .+++++
T Consensus 236 ~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 236 KLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred HHhcCCHhhcCCCccHHHHhcC
Confidence 9999999999999 666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=270.37 Aligned_cols=239 Identities=21% Similarity=0.227 Sum_probs=170.1
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCC------CccceeeeeeeecC-CceeEEEeccCCCCHHHhhhcCCCCCCHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIR------HRNLIKVISSCSNE-EFKALVLEYMPHGSLEKYLYSSNCILDIF 73 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 73 (273)
+.||||+++.. ......+..|+++++.++ |.++++++++|..+ ..+++|||++ +++|.+++.+. ..+++.
T Consensus 155 ~~vAvK~i~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~ 231 (467)
T PTZ00284 155 EYCAVKIVRNV-PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKH-GPFSHR 231 (467)
T ss_pred eEEEEEEEecc-hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHc-CCCCHH
Confidence 36999999643 223455677888877764 45588899988764 5788999998 66999988654 368999
Q ss_pred HHHHHHHHHHHHHHHHhcCCC-CCeEeccCCCCceeeCCCC----------------ceEEeecccccccccCCCcceee
Q 024027 74 QRLNIMIDVASALEYLHFGCS-APVIHCDLKPDNVLLDDNL----------------VAYLSDFGIAKLLIGEDQSMTQT 136 (273)
Q Consensus 74 ~~~~~~~ql~~~l~~lh~~~~-~~i~h~di~p~nil~~~~~----------------~~kl~Df~~~~~~~~~~~~~~~~ 136 (273)
.+..++.|++.||.||| . .||+||||||+|||++.++ .+||+|||.+... .....
T Consensus 232 ~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~-----~~~~~ 303 (467)
T PTZ00284 232 HLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDE-----RHSRT 303 (467)
T ss_pred HHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccC-----ccccc
Confidence 99999999999999999 7 5999999999999998665 4999999987542 11223
Q ss_pred cccccCCCCCCcccCCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhh------------h
Q 024027 137 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEV------------V 204 (273)
Q Consensus 137 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------------~ 204 (273)
..+|++.|+|||++.+..++.++|||||||++|+|++|+.||......+. ...+... .......+ .
T Consensus 304 ~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~-~~~i~~~-~g~~p~~~~~~~~~~~~~~~~ 381 (467)
T PTZ00284 304 AIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH-LHLMEKT-LGRLPSEWAGRCGTEEARLLY 381 (467)
T ss_pred cccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHH-cCCCCHHHHhhccchhHHHHh
Confidence 45789999999999999999999999999999999999999976433211 1111110 00000000 0
Q ss_pred hhhcc---ccchh--------hhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 205 DANLL---SQEDI--------HFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 205 ~~~~~---~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
..... ..... ...........+.+||.+||.+||++|||++|+++|=+
T Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~ 440 (467)
T PTZ00284 382 NSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPY 440 (467)
T ss_pred hhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcc
Confidence 00000 00000 00000112455889999999999999999999999754
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=251.57 Aligned_cols=225 Identities=25% Similarity=0.299 Sum_probs=182.3
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||+|++.... ....+.+.+|++++++++||||+++++++..+...++|+||+++++|.+++... ..+++..+..
T Consensus 26 ~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~ 104 (258)
T cd05578 26 KMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK-VKFSEEQVKF 104 (258)
T ss_pred cEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhc-CCcCHHHHHH
Confidence 368999997542 245678899999999999999999999999999999999999999999999665 4689999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+..++.
T Consensus 105 ~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~ 178 (258)
T cd05578 105 WICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSV 178 (258)
T ss_pred HHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc---cccccCCChhhcCHHHHcccCCCC
Confidence 9999999999999 9999999999999999999999999999987653322 223345778899999998888999
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
++|+||+|+++|++++|..||....... ...+...... .....+...+.++.+++.+||..|
T Consensus 179 ~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~----------------~~~~~~~~~~~~~~~~i~~~l~~~ 240 (258)
T cd05578 179 AVDWWSLGVTAYECLRGKRPYRGHSRTI--RDQIRAKQET----------------ADVLYPATWSTEAIDAINKLLERD 240 (258)
T ss_pred cccchhhHHHHHHHHhCCCCCCCCCccH--HHHHHHHhcc----------------ccccCcccCcHHHHHHHHHHccCC
Confidence 9999999999999999999987643321 1111110000 011113445677999999999999
Q ss_pred ccCCCCH--HHHHHH
Q 024027 238 PEQRINA--KEIVTK 250 (273)
Q Consensus 238 p~~Rps~--~~~l~~ 250 (273)
|.+||++ +++++|
T Consensus 241 p~~R~~~~~~~l~~~ 255 (258)
T cd05578 241 PQKRLGDNLKDLKNH 255 (258)
T ss_pred hhHcCCccHHHHhcC
Confidence 9999999 777654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=254.70 Aligned_cols=224 Identities=25% Similarity=0.310 Sum_probs=179.6
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~q 81 (273)
.||||++..........+.+|+.+++.++|+|++++++++......+++|||+++++|.+++... .+++..+..++.|
T Consensus 47 ~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~q 124 (292)
T cd06657 47 LVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLA 124 (292)
T ss_pred EEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhcC--CCCHHHHHHHHHH
Confidence 68999987555555667889999999999999999999999999999999999999999987543 4889999999999
Q ss_pred HHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcchh
Q 024027 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 161 (273)
Q Consensus 82 l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di 161 (273)
++.|++||| +.|++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||.+.+..++.++|+
T Consensus 125 l~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv 199 (292)
T cd06657 125 VLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDI 199 (292)
T ss_pred HHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceeccccc--ccccccccCccccCHHHhcCCCCCchhhH
Confidence 999999999 9999999999999999999999999999886553221 12233457888999999888888999999
Q ss_pred HHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccCC
Q 024027 162 YSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQR 241 (273)
Q Consensus 162 wslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 241 (273)
||+|+++|++++|..||........ ...... .. .........++..+.+++.+||..||.+|
T Consensus 200 ~slGvil~el~tg~~p~~~~~~~~~-~~~~~~-------------~~----~~~~~~~~~~~~~l~~li~~~l~~~P~~R 261 (292)
T cd06657 200 WSLGIMVIEMVDGEPPYFNEPPLKA-MKMIRD-------------NL----PPKLKNLHKVSPSLKGFLDRLLVRDPAQR 261 (292)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHh-------------hC----CcccCCcccCCHHHHHHHHHHHhCCcccC
Confidence 9999999999999999864221110 000000 00 00000122345668999999999999999
Q ss_pred CCHHHHHHH
Q 024027 242 INAKEIVTK 250 (273)
Q Consensus 242 ps~~~~l~~ 250 (273)
|++.++++|
T Consensus 262 ~~~~~ll~~ 270 (292)
T cd06657 262 ATAAELLKH 270 (292)
T ss_pred cCHHHHhcC
Confidence 999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=250.86 Aligned_cols=230 Identities=27% Similarity=0.445 Sum_probs=177.8
Q ss_pred eEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCC------ceeEEEeccCCCCHHHhhhcC-----CC
Q 024027 2 EVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEE------FKALVLEYMPHGSLEKYLYSS-----NC 68 (273)
Q Consensus 2 ~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~-----~~ 68 (273)
.||||+++... ....+.+.+|+++++.++||||+++++++.... ..++++||+++|+|.+++... ..
T Consensus 29 ~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 108 (273)
T cd05074 29 KVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPF 108 (273)
T ss_pred EEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCC
Confidence 68999997542 345667889999999999999999999886532 246889999999998887422 12
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCc
Q 024027 69 ILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPE 148 (273)
Q Consensus 69 ~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE 148 (273)
.++...+..++.|++.|++||| +.|++|+||||+||+++.++.++++|||.+................++..|++||
T Consensus 109 ~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe 185 (273)
T cd05074 109 TLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALE 185 (273)
T ss_pred CCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHh
Confidence 4788899999999999999999 9999999999999999999999999999987653222111222334556799999
Q ss_pred ccCCCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHH
Q 024027 149 YGREGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVF 227 (273)
Q Consensus 149 ~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 227 (273)
.+.+..++.++||||||+++|++++ |.+||......+ ......... ....+..++..+.
T Consensus 186 ~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~-~~~~~~~~~-------------------~~~~~~~~~~~~~ 245 (273)
T cd05074 186 SLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE-IYNYLIKGN-------------------RLKQPPDCLEDVY 245 (273)
T ss_pred HHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH-HHHHHHcCC-------------------cCCCCCCCCHHHH
Confidence 9988889999999999999999999 888886533211 111111000 0001234556799
Q ss_pred HHHhhcCCCCccCCCCHHHHHHHHHHH
Q 024027 228 NLAMACTVESPEQRINAKEIVTKLLKI 254 (273)
Q Consensus 228 ~li~~~l~~dp~~Rps~~~~l~~l~~~ 254 (273)
+++.+||..+|.+|||+.++++.|+++
T Consensus 246 ~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 246 ELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=249.41 Aligned_cols=228 Identities=20% Similarity=0.250 Sum_probs=180.6
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeec--CCceeEEEeccCCCCHHHhhhcC---CCCCCHH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSN--EEFKALVLEYMPHGSLEKYLYSS---NCILDIF 73 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~ 73 (273)
+.||+|.++... ....+.+..|+++++.++|+||+++++++.. ....++++||+++++|.+++... ...+++.
T Consensus 26 ~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~ 105 (265)
T cd08217 26 KILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEE 105 (265)
T ss_pred CEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHH
Confidence 368999987542 3445678899999999999999999998754 45678999999999999998653 4568999
Q ss_pred HHHHHHHHHHHHHHHHhcCC--CCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccC
Q 024027 74 QRLNIMIDVASALEYLHFGC--SAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR 151 (273)
Q Consensus 74 ~~~~~~~ql~~~l~~lh~~~--~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 151 (273)
.++.++.|++.||.+||..+ +.+++|+||+|+||+++.++.++|+|||++........ ......+++.|+|||.+.
T Consensus 106 ~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~ 183 (265)
T cd08217 106 FIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSS--FAKTYVGTPYYMSPEQLN 183 (265)
T ss_pred HHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCCcc--cccccccCCCccChhhhc
Confidence 99999999999999999433 56899999999999999999999999999886633221 123346788999999998
Q ss_pred CCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHh
Q 024027 152 EGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAM 231 (273)
Q Consensus 152 ~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 231 (273)
+..++.++|+||||++++++++|..||....... ...... ... ....+...+..+.+++.
T Consensus 184 ~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~------------~~~------~~~~~~~~~~~~~~l~~ 243 (265)
T cd08217 184 HMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ--LASKIK------------EGK------FRRIPYRYSSELNEVIK 243 (265)
T ss_pred CCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH--HHHHHh------------cCC------CCCCccccCHHHHHHHH
Confidence 8889999999999999999999999987643211 111100 000 00113345677999999
Q ss_pred hcCCCCccCCCCHHHHHHH
Q 024027 232 ACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 232 ~~l~~dp~~Rps~~~~l~~ 250 (273)
+||..+|.+|||+.++++|
T Consensus 244 ~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 244 SMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHccCCcccCCCHHHHhhC
Confidence 9999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=254.39 Aligned_cols=223 Identities=25% Similarity=0.317 Sum_probs=176.8
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
++||+|++.... ......+.+|+++++.++||||+++++++.++...++|+||+++ ++.+++......+++..+..
T Consensus 41 ~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~ 119 (307)
T cd06607 41 EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDILEVHKKPLQEVEIAA 119 (307)
T ss_pred cEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhCC-CHHHHHHHcccCCCHHHHHH
Confidence 479999986432 23446788999999999999999999999999999999999975 88888766556799999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccC---CCC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR---EGR 154 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~ 154 (273)
++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++..... .....++..|+|||.+. ...
T Consensus 120 ~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~ 190 (307)
T cd06607 120 ICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP------ANSFVGTPYWMAPEVILAMDEGQ 190 (307)
T ss_pred HHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCC------CCCccCCccccCceeeeccCCCC
Confidence 9999999999999 99999999999999999999999999998865421 12345677899999874 345
Q ss_pred cCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcC
Q 024027 155 VSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACT 234 (273)
Q Consensus 155 ~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 234 (273)
++.++|+||||+++|++++|..||........... .... .. ....+..++.++.+++.+||
T Consensus 191 ~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~-~~~~-~~-----------------~~~~~~~~~~~~~~li~~~l 251 (307)
T cd06607 191 YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-IAQN-DS-----------------PTLSSNDWSDYFRNFVDSCL 251 (307)
T ss_pred CCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHH-HhcC-CC-----------------CCCCchhhCHHHHHHHHHHh
Confidence 78899999999999999999999865322111100 0000 00 00002235567999999999
Q ss_pred CCCccCCCCHHHHHHHHH
Q 024027 235 VESPEQRINAKEIVTKLL 252 (273)
Q Consensus 235 ~~dp~~Rps~~~~l~~l~ 252 (273)
..||.+||++.+++.|.+
T Consensus 252 ~~~p~~Rp~~~~il~~~~ 269 (307)
T cd06607 252 QKIPQDRPSSEELLKHRF 269 (307)
T ss_pred cCChhhCcCHHHHhcChh
Confidence 999999999999999755
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=250.14 Aligned_cols=236 Identities=22% Similarity=0.218 Sum_probs=178.7
Q ss_pred CeEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeec--CCceeEEEeccCCCCHHHhhhc---CCCCCCHHH
Q 024027 1 MEVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSN--EEFKALVLEYMPHGSLEKYLYS---SNCILDIFQ 74 (273)
Q Consensus 1 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~ 74 (273)
+.||+|.+.... ......+.+|+++++.++||||++++++|.+ .+.+++||||+++++|.+++.. ....+++..
T Consensus 27 ~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~ 106 (287)
T cd06621 27 MIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKV 106 (287)
T ss_pred eEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHH
Confidence 368999997543 3445678999999999999999999998865 3478999999999999888643 334588899
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCC
Q 024027 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGR 154 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 154 (273)
+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++....... .....++..|+|||.+.+..
T Consensus 107 ~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~~pE~~~~~~ 179 (287)
T cd06621 107 LGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL----AGTFTGTSFYMAPERIQGKP 179 (287)
T ss_pred HHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccccc----cccccCCccccCHHHhcCCC
Confidence 9999999999999999 9999999999999999999999999999986542211 12335678899999998888
Q ss_pred cCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcC
Q 024027 155 VSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACT 234 (273)
Q Consensus 155 ~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 234 (273)
++.++|+||+|+++|+|++|..||....................... .. ..........+..+.+++.+||
T Consensus 180 ~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~--------~~~~~~~~~~~~~~~~li~~~l 250 (287)
T cd06621 180 YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNP-EL--------KDEPGNGIKWSEEFKDFIKQCL 250 (287)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCch-hh--------ccCCCCCCchHHHHHHHHHHHc
Confidence 99999999999999999999999875422111111111100000000 00 0000000123567899999999
Q ss_pred CCCccCCCCHHHHHHHHH
Q 024027 235 VESPEQRINAKEIVTKLL 252 (273)
Q Consensus 235 ~~dp~~Rps~~~~l~~l~ 252 (273)
..||.+|||+.+++++-+
T Consensus 251 ~~~p~~Rpt~~eil~~~~ 268 (287)
T cd06621 251 EKDPTRRPTPWDMLEHPW 268 (287)
T ss_pred CCCcccCCCHHHHHhCcc
Confidence 999999999999999765
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=255.44 Aligned_cols=246 Identities=20% Similarity=0.214 Sum_probs=178.2
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecC--CceeEEEeccCCCCHHHhhhcC----CCCCC
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNE--EFKALVLEYMPHGSLEKYLYSS----NCILD 71 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~----~~~~~ 71 (273)
+.||||++.... ......+.+|+.+++.++||||+++++++.+. ...++||||+++ ++.+++... ...++
T Consensus 28 ~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~ 106 (316)
T cd07842 28 KEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIP 106 (316)
T ss_pred CeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcC
Confidence 369999998632 33346678899999999999999999999888 889999999975 787776432 23588
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCC----CCceEEeecccccccccCCC-cceeecccccCCCCC
Q 024027 72 IFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDD----NLVAYLSDFGIAKLLIGEDQ-SMTQTQTLATIGYMA 146 (273)
Q Consensus 72 ~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~----~~~~kl~Df~~~~~~~~~~~-~~~~~~~~~~~~~~a 146 (273)
+..++.++.|++.||.||| +.+++|+||+|+||+++. ++.++|+|||++........ ........++..|+|
T Consensus 107 ~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~a 183 (316)
T cd07842 107 PSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRA 183 (316)
T ss_pred HHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccC
Confidence 9999999999999999999 999999999999999999 99999999999876533222 111223457888999
Q ss_pred CcccCCC-CcCCcchhHHHHHHHHHHHhCCCCCcccccccc--------chhhhhhhccCccch------------h---
Q 024027 147 PEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEM--------TLKHWVNDWLPISTM------------E--- 202 (273)
Q Consensus 147 PE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~--------~~~~~~~~~~~~~~~------------~--- 202 (273)
||.+.+. .++.++|+||||+++++|++|.+||........ ............... .
T Consensus 184 PE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 263 (316)
T cd07842 184 PELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMK 263 (316)
T ss_pred HHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhh
Confidence 9987664 578999999999999999999999976443320 001111000000000 0
Q ss_pred hhhhhccccchhhhhhhh--hhHHHHHHHHhhcCCCCccCCCCHHHHHHH
Q 024027 203 VVDANLLSQEDIHFVAKE--QCVSFVFNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
.................. ..+.++.+++.+||..||++|||+.++++|
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 264 DFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred hccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000000000011111111 456679999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=249.41 Aligned_cols=226 Identities=22% Similarity=0.264 Sum_probs=176.4
Q ss_pred CeEEEEEeeccc-----ChhhhhHHHHHHHHhcCCCccceeeeeeeecC--CceeEEEeccCCCCHHHhhhcCCCCCCHH
Q 024027 1 MEVAVKVFNLQC-----GRAFKSFDVECEMMKSIRHRNLIKVISSCSNE--EFKALVLEYMPHGSLEKYLYSSNCILDIF 73 (273)
Q Consensus 1 ~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 73 (273)
+.||||.+.... ......+.+|+.+++.++||||+++++++.+. ..+++++||+++++|.+++.+.. .+++.
T Consensus 28 ~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~ 106 (265)
T cd06652 28 RELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG-ALTEN 106 (265)
T ss_pred cEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcC-CCCHH
Confidence 369999986431 12356788899999999999999999998764 46789999999999999986553 57889
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCc-ceeecccccCCCCCCcccCC
Q 024027 74 QRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQS-MTQTQTLATIGYMAPEYGRE 152 (273)
Q Consensus 74 ~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~ 152 (273)
.+..++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||.+......... .......++..|+|||.+.+
T Consensus 107 ~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 183 (265)
T cd06652 107 VTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183 (265)
T ss_pred HHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcC
Confidence 99999999999999999 999999999999999999999999999988755321111 11223457888999999988
Q ss_pred CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhh
Q 024027 153 GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMA 232 (273)
Q Consensus 153 ~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 232 (273)
..++.++|+||||+++|++++|..||......... ..... .......+...+..+.+++.+
T Consensus 184 ~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~----~~~~~---------------~~~~~~~~~~~~~~~~~~i~~ 244 (265)
T cd06652 184 EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI----FKIAT---------------QPTNPVLPPHVSDHCRDFLKR 244 (265)
T ss_pred CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHH----HHHhc---------------CCCCCCCchhhCHHHHHHHHH
Confidence 88999999999999999999999998653221111 00000 000111244556678999999
Q ss_pred cCCCCccCCCCHHHHHHH
Q 024027 233 CTVESPEQRINAKEIVTK 250 (273)
Q Consensus 233 ~l~~dp~~Rps~~~~l~~ 250 (273)
|+. +|++||+++++++|
T Consensus 245 ~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 245 IFV-EAKLRPSADELLRH 261 (265)
T ss_pred Hhc-ChhhCCCHHHHhcC
Confidence 995 99999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=246.87 Aligned_cols=228 Identities=26% Similarity=0.321 Sum_probs=185.6
Q ss_pred CeEEEEEeecccC--hhhhhHHHHHHHHhcCCCccceeeeeeeecC--CceeEEEeccCCCCHHHhhhcCCCCCCHHHHH
Q 024027 1 MEVAVKVFNLQCG--RAFKSFDVECEMMKSIRHRNLIKVISSCSNE--EFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (273)
++|++|+++.... .....+.+|+++++.++|+||+++++.+.+. ...++++||+++++|.+++.... .+++..++
T Consensus 26 ~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~ 104 (260)
T cd06606 26 ELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG-KLPEPVIR 104 (260)
T ss_pred cEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcC-CCCHHHHH
Confidence 3699999976542 4567899999999999999999999999988 88999999999999999997655 79999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcC
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVS 156 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 156 (273)
.++.|++.|+.||| +.|++|+||+|+||+++.++.++|+|||.+................++..|.|||.+.+...+
T Consensus 105 ~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~ 181 (260)
T cd06606 105 KYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYG 181 (260)
T ss_pred HHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCC
Confidence 99999999999999 999999999999999999999999999998876433321123345678889999999888899
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++|+||||++++++++|..||.............. ........+...+.++.+++.+||..
T Consensus 182 ~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~l~~~i~~~l~~ 243 (260)
T cd06606 182 RAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIG------------------SSGEPPEIPEHLSEEAKDFLRKCLRR 243 (260)
T ss_pred chhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhcc------------------ccCCCcCCCcccCHHHHHHHHHhCcC
Confidence 999999999999999999999876441111111000 00011112334467799999999999
Q ss_pred CccCCCCHHHHHHH
Q 024027 237 SPEQRINAKEIVTK 250 (273)
Q Consensus 237 dp~~Rps~~~~l~~ 250 (273)
||.+||++.+++.|
T Consensus 244 ~p~~Rp~~~~ll~~ 257 (260)
T cd06606 244 DPKKRPTADELLQH 257 (260)
T ss_pred ChhhCCCHHHHhhC
Confidence 99999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=253.16 Aligned_cols=244 Identities=23% Similarity=0.274 Sum_probs=180.8
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
++||||+++... ......+.+|+++++.++|+||+++++++..++..++++||++++.+..+. .....+++..+..+
T Consensus 27 ~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~-~~~~~~~~~~~~~~ 105 (288)
T cd07833 27 EIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLE-ASPGGLPPDAVRSY 105 (288)
T ss_pred cEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHH-hcCCCCCHHHHHHH
Confidence 369999987542 334577899999999999999999999999999999999999886665555 44446899999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCC-CcCC
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG-RVST 157 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~ 157 (273)
+.|++.|+.||| +.|++|+||+|+||+++.++.++|+|||.+........ .......++..|+|||.+.+. .++.
T Consensus 106 ~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~ 181 (288)
T cd07833 106 IWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SPLTDYVATRWYRAPELLVGDTNYGK 181 (288)
T ss_pred HHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-ccccCcccccCCcCCchhcCCCCcCc
Confidence 999999999999 99999999999999999999999999999876543322 122234577889999998877 7899
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccc--hhhhh------h-h---ccccchhhhhhhhhhHHH
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPIST--MEVVD------A-N---LLSQEDIHFVAKEQCVSF 225 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~------~-~---~~~~~~~~~~~~~~~~~~ 225 (273)
++|+||||+++|++++|..||......+. ............. ..... . . ...........+..++.+
T Consensus 182 ~~Dv~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (288)
T cd07833 182 PVDVWAIGCIMAELLDGEPLFPGDSDIDQ-LYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSP 260 (288)
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchH
Confidence 99999999999999999999875432211 1111110000000 00000 0 0 000000111112335788
Q ss_pred HHHHHhhcCCCCccCCCCHHHHHHH
Q 024027 226 VFNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 226 l~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
+.+|+.+||..+|.+|||+++++++
T Consensus 261 ~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 261 ALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred HHHHHHHHhccCchhcccHHHHhcC
Confidence 9999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=260.53 Aligned_cols=231 Identities=19% Similarity=0.208 Sum_probs=178.8
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||+|+++... ......+.+|..++..++|++|+++++++.++...++||||++||+|.+++......+++..+..
T Consensus 27 ~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~ 106 (331)
T cd05624 27 RIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARF 106 (331)
T ss_pred CEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHH
Confidence 368999997531 23345578899999999999999999999999999999999999999999977556789999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC-----
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE----- 152 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~----- 152 (273)
++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++........ .......|++.|+|||.+.+
T Consensus 107 ~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ 182 (331)
T cd05624 107 YIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-VQSSVAVGTPDYISPEILQAMEDGM 182 (331)
T ss_pred HHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc-eeeccccCCcccCCHHHHhccccCC
Confidence 9999999999999 99999999999999999999999999999876533221 12233568999999998865
Q ss_pred CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhh
Q 024027 153 GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMA 232 (273)
Q Consensus 153 ~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 232 (273)
..++.++|+||+|+++|+|++|..||......+. .......... ... ......++.++.+++.+
T Consensus 183 ~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~-~~~i~~~~~~--------------~~~-p~~~~~~~~~~~~li~~ 246 (331)
T cd05624 183 GKYGPECDWWSLGVCMYEMLYGETPFYAESLVET-YGKIMNHEER--------------FQF-PSHITDVSEEAKDLIQR 246 (331)
T ss_pred CCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH-HHHHHcCCCc--------------ccC-CCccccCCHHHHHHHHH
Confidence 4578899999999999999999999965322111 1111000000 000 00012356779999999
Q ss_pred cCCCCccC--CCCHHHHHHHH
Q 024027 233 CTVESPEQ--RINAKEIVTKL 251 (273)
Q Consensus 233 ~l~~dp~~--Rps~~~~l~~l 251 (273)
||..++++ |++++++++|-
T Consensus 247 ll~~~~~~~~~~~~~~~~~h~ 267 (331)
T cd05624 247 LICSRERRLGQNGIEDFKKHA 267 (331)
T ss_pred HccCchhhcCCCCHHHHhcCC
Confidence 99876654 56899999884
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=250.96 Aligned_cols=226 Identities=25% Similarity=0.348 Sum_probs=179.5
Q ss_pred CeEEEEEeecc-cChhhhhHHHHHHHHhcCC---CccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHH
Q 024027 1 MEVAVKVFNLQ-CGRAFKSFDVECEMMKSIR---HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (273)
+.||+|.++.+ .......+.+|+.+++.++ |||++++++++......+++|||+++++|.+++... .+++..++
T Consensus 27 ~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~ 104 (277)
T cd06917 27 RVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAG--PIAEKYIS 104 (277)
T ss_pred cEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHcc--CCCHHHHH
Confidence 36899998754 2445667889999999996 999999999999999999999999999999998653 68999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC-CCc
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE-GRV 155 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~ 155 (273)
.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||.+..+.... .......++..|+|||.+.+ ..+
T Consensus 105 ~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~ 179 (277)
T cd06917 105 VIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--SKRSTFVGTPYWMAPEVITEGKYY 179 (277)
T ss_pred HHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc--cccccccCCcceeCHHHhccCCcc
Confidence 99999999999999 9999999999999999999999999999987664332 12233467888999998765 447
Q ss_pred CCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCC
Q 024027 156 STNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTV 235 (273)
Q Consensus 156 ~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 235 (273)
+.++|+||||+++|+|++|..||.......... ..... . ... ......+.++.+++.+||.
T Consensus 180 ~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~--~~~~~------------~--~~~---~~~~~~~~~~~~~i~~~l~ 240 (277)
T cd06917 180 DTKADIWSLGITIYEMATGNPPYSDVDAFRAMM--LIPKS------------K--PPR---LEDNGYSKLLREFVAACLD 240 (277)
T ss_pred ccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh--ccccC------------C--CCC---CCcccCCHHHHHHHHHHcC
Confidence 899999999999999999999986532211100 00000 0 000 0011255679999999999
Q ss_pred CCccCCCCHHHHHHHHH
Q 024027 236 ESPEQRINAKEIVTKLL 252 (273)
Q Consensus 236 ~dp~~Rps~~~~l~~l~ 252 (273)
.||.+||++.+++++-+
T Consensus 241 ~~p~~R~~~~~il~~~~ 257 (277)
T cd06917 241 EEPKERLSAEELLKSKW 257 (277)
T ss_pred CCcccCcCHHHHhhChH
Confidence 99999999999998643
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=252.05 Aligned_cols=225 Identities=22% Similarity=0.284 Sum_probs=174.6
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcC-CCccceeeeeeeec------CCceeEEEeccCCCCHHHhhhcCC-CCCCH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSI-RHRNLIKVISSCSN------EEFKALVLEYMPHGSLEKYLYSSN-CILDI 72 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~ 72 (273)
+.||+|++... ......+..|+.+++.+ +|+||+++++++.. ...++++|||+++++|.+++.... ..+++
T Consensus 42 ~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~ 120 (282)
T cd06636 42 QLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKE 120 (282)
T ss_pred cEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCH
Confidence 36899998654 33456788999999999 79999999999853 457899999999999999996533 35888
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccC-
Q 024027 73 FQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR- 151 (273)
Q Consensus 73 ~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~- 151 (273)
..+..++.|++.|+.||| +.|++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.
T Consensus 121 ~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~ 195 (282)
T cd06636 121 DWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIAC 195 (282)
T ss_pred HHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhccc--cCCCcccccccccCHhhcCc
Confidence 889999999999999999 9999999999999999999999999999987542211 1223356788999999875
Q ss_pred ----CCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHH
Q 024027 152 ----EGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVF 227 (273)
Q Consensus 152 ----~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 227 (273)
...++.++|+||||+++|+|++|..||.......... .. .. ..........++.++.
T Consensus 196 ~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~----~~----------~~-----~~~~~~~~~~~~~~~~ 256 (282)
T cd06636 196 DENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF----LI----------PR-----NPPPKLKSKKWSKKFI 256 (282)
T ss_pred ccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh----hH----------hh-----CCCCCCcccccCHHHH
Confidence 3457889999999999999999999986532211110 00 00 0000001224567799
Q ss_pred HHHhhcCCCCccCCCCHHHHHHH
Q 024027 228 NLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 228 ~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
+|+.+||..||.+|||+.++++|
T Consensus 257 ~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 257 DFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred HHHHHHhCCChhhCcCHHHHhcC
Confidence 99999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=251.45 Aligned_cols=226 Identities=22% Similarity=0.270 Sum_probs=174.1
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcC-CCccceeeeeeeecC-----CceeEEEeccCCCCHHHhhhc---CCCCCC
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSI-RHRNLIKVISSCSNE-----EFKALVLEYMPHGSLEKYLYS---SNCILD 71 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~---~~~~~~ 71 (273)
++||+|++.... .....+.+|+.+++.+ +|||++++++++... +..++|+||+++++|.+++.. ....++
T Consensus 48 ~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~ 126 (291)
T cd06639 48 SLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLD 126 (291)
T ss_pred CEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCC
Confidence 468999986542 2346678899999999 899999999998653 358999999999999998853 334689
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccC
Q 024027 72 IFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR 151 (273)
Q Consensus 72 ~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 151 (273)
+..++.++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.
T Consensus 127 ~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~ 201 (291)
T cd06639 127 EAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIA 201 (291)
T ss_pred HHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEeecccchhccccc--ccccCccCCccccChhhhc
Confidence 9999999999999999999 9999999999999999999999999999987653211 1122345788899999875
Q ss_pred CC-----CcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHH
Q 024027 152 EG-----RVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFV 226 (273)
Q Consensus 152 ~~-----~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 226 (273)
.. .++.++|+||+||++|++++|+.||......... ........ .....+...+..+
T Consensus 202 ~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~-~~~~~~~~-----------------~~~~~~~~~~~~l 263 (291)
T cd06639 202 CEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL-FKIPRNPP-----------------PTLLHPEKWCRSF 263 (291)
T ss_pred CCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH-HHHhcCCC-----------------CCCCcccccCHHH
Confidence 43 3688999999999999999999998653321111 11100000 0000122344569
Q ss_pred HHHHhhcCCCCccCCCCHHHHHHH
Q 024027 227 FNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 227 ~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
.+++.+||..||++|||+.++++|
T Consensus 264 ~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 264 NHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HHHHHHHhhcChhhCcCHHHHhcC
Confidence 999999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=248.66 Aligned_cols=224 Identities=25% Similarity=0.363 Sum_probs=190.8
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~q 81 (273)
.||||.+... .+.+++-.|+.++++.+.|++|++||.|-....++||||||..|++.+.++..++++.++++..++..
T Consensus 60 v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~ 137 (502)
T KOG0574|consen 60 VLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRD 137 (502)
T ss_pred EEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHH
Confidence 5899998544 47789999999999999999999999999999999999999999999999988889999999999999
Q ss_pred HHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcchh
Q 024027 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 161 (273)
Q Consensus 82 l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di 161 (273)
.+.||.||| ...-+|||||..|||++.+|..||+|||.+-.+. +.....+...||+.|+|||++..-.|..++||
T Consensus 138 TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT--DTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADI 212 (502)
T KOG0574|consen 138 TLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLT--DTMAKRNTVIGTPFWMAPEVIEEIGYDTKADI 212 (502)
T ss_pred HHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhh--hhHHhhCccccCcccccHHHHHHhccchhhhH
Confidence 999999999 8999999999999999999999999999987663 22334456789999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccCC
Q 024027 162 YSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQR 241 (273)
Q Consensus 162 wslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 241 (273)
||||+...+|..|++||.+.-.-..-+ ..+. .++-.+..|..-+.++-+++++||.++|++|
T Consensus 213 WSLGITaIEMAEG~PPYsDIHPMRAIF------MIPT------------~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R 274 (502)
T KOG0574|consen 213 WSLGITAIEMAEGRPPYSDIHPMRAIF------MIPT------------KPPPTFKKPEEWSSEFNDFIRSCLIKKPEER 274 (502)
T ss_pred hhhcchhhhhhcCCCCcccccccceeE------eccC------------CCCCCCCChHhhhhHHHHHHHHHhcCCHHHH
Confidence 999999999999999987632211100 0111 1122222366677889999999999999999
Q ss_pred CCHHHHHHH
Q 024027 242 INAKEIVTK 250 (273)
Q Consensus 242 ps~~~~l~~ 250 (273)
-|+.++++|
T Consensus 275 ~TA~~L~~H 283 (502)
T KOG0574|consen 275 KTALRLCEH 283 (502)
T ss_pred HHHHHHhhh
Confidence 999999987
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=249.88 Aligned_cols=224 Identities=25% Similarity=0.349 Sum_probs=180.2
Q ss_pred CeEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 1 MEVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 1 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
+.||||++.... ......+.+|+++++.++||||+++++++..+...++|+||+++++|.+++... .+++..+..++
T Consensus 30 ~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~--~~~~~~~~~~~ 107 (277)
T cd06641 30 KVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATIL 107 (277)
T ss_pred cEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhcC--CCCHHHHHHHH
Confidence 368999986443 334567889999999999999999999999999999999999999999998643 58899999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 159 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 159 (273)
.|++.|+.+|| +.|++|+||+|+||+++.++.++++|||++..+.... .......++..|+|||.+.+...+.++
T Consensus 108 ~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~ 182 (277)
T cd06641 108 REILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKA 182 (277)
T ss_pred HHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccch--hhhccccCCccccChhhhccCCCCchh
Confidence 99999999999 9999999999999999999999999999886553221 112234578889999999888889999
Q ss_pred hhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCcc
Q 024027 160 DVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239 (273)
Q Consensus 160 DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 239 (273)
|+||+|++++++++|..||.......... .... .. ....+..++.++.+++.+||..+|.
T Consensus 183 Dv~slG~~l~~l~~g~~p~~~~~~~~~~~--~~~~------------~~------~~~~~~~~~~~~~~~i~~~l~~~p~ 242 (277)
T cd06641 183 DIWSLGITAIELAKGEPPHSELHPMKVLF--LIPK------------NN------PPTLEGNYSKPLKEFVEACLNKEPS 242 (277)
T ss_pred hHHHHHHHHHHHHcCCCCCCccchHHHHH--HHhc------------CC------CCCCCcccCHHHHHHHHHHccCChh
Confidence 99999999999999999986532211000 0000 00 0011234567799999999999999
Q ss_pred CCCCHHHHHHHH
Q 024027 240 QRINAKEIVTKL 251 (273)
Q Consensus 240 ~Rps~~~~l~~l 251 (273)
+||++.+++.|-
T Consensus 243 ~Rp~~~~~l~~~ 254 (277)
T cd06641 243 FRPTAKELLKHK 254 (277)
T ss_pred hCcCHHHHHhCH
Confidence 999999999973
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=254.76 Aligned_cols=245 Identities=22% Similarity=0.198 Sum_probs=178.5
Q ss_pred CeEEEEEeecccC--hhhhhHHHHHHHHhcCCCccceeeeeeeecC--CceeEEEeccCCCCHHHhhhcCCCCCCHHHHH
Q 024027 1 MEVAVKVFNLQCG--RAFKSFDVECEMMKSIRHRNLIKVISSCSNE--EFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (273)
+.||+|+++.... .....+.+|+.+++.++|+||+++++++... +..++||||+++ +|.+++......+++..++
T Consensus 33 ~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~ 111 (309)
T cd07845 33 EIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVK 111 (309)
T ss_pred cEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCCC-CHHHHHHhcccCCCHHHHH
Confidence 3699999975532 2233566899999999999999999998755 568999999975 8999887665679999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC-CCc
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE-GRV 155 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~ 155 (273)
.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+ ..+
T Consensus 112 ~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~ 186 (309)
T cd07845 112 CLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK--PMTPKVVTLWYRAPELLLGCTTY 186 (309)
T ss_pred HHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCCccC--CCCcccccccccChhhhcCCCCc
Confidence 99999999999999 99999999999999999999999999999876533221 1122345778999998865 457
Q ss_pred CCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCc--cchh------hhhhhccccc--hhhhhhhhhhHHH
Q 024027 156 STNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPI--STME------VVDANLLSQE--DIHFVAKEQCVSF 225 (273)
Q Consensus 156 ~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~------~~~~~~~~~~--~~~~~~~~~~~~~ 225 (273)
+.++|+||+|+++|+|++|..||......+ ............ ...+ .......... ..........+.+
T Consensus 187 ~~~~DvwslG~il~el~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (309)
T cd07845 187 TTAIDMWAVGCILAELLAHKPLLPGKSEIE-QLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEA 265 (309)
T ss_pred CchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHH
Confidence 899999999999999999999997533221 111111110000 0000 0000000000 0000111224677
Q ss_pred HHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 226 VFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 226 l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
+.+++.+||..||++|||+++++.|-+
T Consensus 266 ~~~li~~ml~~dp~~R~t~~~il~h~~ 292 (309)
T cd07845 266 GLRLLNFLLMYDPKKRATAEEALESSY 292 (309)
T ss_pred HHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 899999999999999999999998755
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=250.29 Aligned_cols=242 Identities=23% Similarity=0.261 Sum_probs=179.9
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC--CCCCHHHHHHH
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN--CILDIFQRLNI 78 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~ 78 (273)
.||||+++... ......+.+|+++++.++|+||+++++++.+.+..++||||+++ +|.+++.... ..+++..+..+
T Consensus 27 ~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~ 105 (284)
T cd07836 27 IVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSF 105 (284)
T ss_pred EEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHH
Confidence 68999997653 23346677899999999999999999999999999999999986 8989886543 45899999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCC-CcCC
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG-RVST 157 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~ 157 (273)
+.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++....... .......++..|++||.+.+. .++.
T Consensus 106 ~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~ 180 (284)
T cd07836 106 TYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV--NTFSNEVVTLWYRAPDVLLGSRTYST 180 (284)
T ss_pred HHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--cccccccccccccChHHhcCCCCCCc
Confidence 999999999999 9999999999999999999999999999987542211 112234567889999987654 5789
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCcc--chhhhh------hhcc-ccchhhhhhhhhhHHHHHH
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPIS--TMEVVD------ANLL-SQEDIHFVAKEQCVSFVFN 228 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~------~~~~-~~~~~~~~~~~~~~~~l~~ 228 (273)
++|+||+|+++|++++|..||......+. ..........+. ..+... .... ............++.++.+
T Consensus 181 ~~Dv~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (284)
T cd07836 181 SIDIWSVGCIMAEMITGRPLFPGTNNEDQ-LLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGID 259 (284)
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHH
Confidence 99999999999999999999876433221 111111110000 000000 0000 0000111122345778999
Q ss_pred HHhhcCCCCccCCCCHHHHHHH
Q 024027 229 LAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 229 li~~~l~~dp~~Rps~~~~l~~ 250 (273)
++.+||..||.+||++.+++++
T Consensus 260 ~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 260 LLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred HHHHHhcCCcccCCCHHHHhcC
Confidence 9999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=280.78 Aligned_cols=223 Identities=21% Similarity=0.284 Sum_probs=172.9
Q ss_pred eEEEEEeecc--cChhhhhHHHHHHHHhcCCCccceeeeeeeec--CCceeEEEeccCCCCHHHhhhcC---CCCCCHHH
Q 024027 2 EVAVKVFNLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSN--EEFKALVLEYMPHGSLEKYLYSS---NCILDIFQ 74 (273)
Q Consensus 2 ~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~ 74 (273)
.||+|++... .......+..|+.+++.++||||++++++|.+ ...++|||||+++++|.++|... ...+++..
T Consensus 40 ~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~ 119 (1021)
T PTZ00266 40 FFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHA 119 (1021)
T ss_pred EEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHH
Confidence 5899998754 23446678899999999999999999998854 45689999999999999998642 34699999
Q ss_pred HHHHHHHHHHHHHHHhcCCC-------CCeEeccCCCCceeeCC-----------------CCceEEeecccccccccCC
Q 024027 75 RLNIMIDVASALEYLHFGCS-------APVIHCDLKPDNVLLDD-----------------NLVAYLSDFGIAKLLIGED 130 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~-------~~i~h~di~p~nil~~~-----------------~~~~kl~Df~~~~~~~~~~ 130 (273)
++.++.||+.||.||| . .+|+|+||||+|||++. .+.++|+|||++..+....
T Consensus 120 Il~Ia~QIL~ALaYLH---s~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s 196 (1021)
T PTZ00266 120 IVDITRQLLHALAYCH---NLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES 196 (1021)
T ss_pred HHHHHHHHHHHHHHHH---hcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccc
Confidence 9999999999999999 6 45999999999999964 2358999999987652211
Q ss_pred CcceeecccccCCCCCCcccCC--CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhc
Q 024027 131 QSMTQTQTLATIGYMAPEYGRE--GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANL 208 (273)
Q Consensus 131 ~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (273)
......+++.|+|||++.+ ..++.++|||||||++|+|++|..||........ ........
T Consensus 197 ---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~q----li~~lk~~---------- 259 (1021)
T PTZ00266 197 ---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQ----LISELKRG---------- 259 (1021)
T ss_pred ---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHH----HHHHHhcC----------
Confidence 1234468999999998864 3488999999999999999999999965322111 11100000
Q ss_pred cccchhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHH
Q 024027 209 LSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 209 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
.. ......+.++.+||.+||..+|.+|||+.+++.+
T Consensus 260 ---p~---lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 260 ---PD---LPIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred ---CC---CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 00 0012345679999999999999999999999976
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=247.39 Aligned_cols=225 Identities=26% Similarity=0.299 Sum_probs=184.4
Q ss_pred CeEEEEEeecccC--hhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcC---CCCCCHHHH
Q 024027 1 MEVAVKVFNLQCG--RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS---NCILDIFQR 75 (273)
Q Consensus 1 ~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~ 75 (273)
++||+|++..... .....+..|+++++.++|+|++++.+.+......++++||+++++|.+++... +..+++..+
T Consensus 26 ~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 105 (258)
T cd08215 26 KLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQI 105 (258)
T ss_pred cEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHH
Confidence 4789999976532 56778899999999999999999999999999999999999999999999765 367999999
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCc
Q 024027 76 LNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRV 155 (273)
Q Consensus 76 ~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~ 155 (273)
..++.+++.||.+|| +.|++|+||+|+||+++.++.++|+|||.+....... .......+++.|+|||...+..+
T Consensus 106 ~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~ 180 (258)
T cd08215 106 LDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPY 180 (258)
T ss_pred HHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc--ceecceeeeecccChhHhccCCC
Confidence 999999999999999 9999999999999999999999999999987653322 12334467888999999888889
Q ss_pred CCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCC
Q 024027 156 STNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTV 235 (273)
Q Consensus 156 ~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 235 (273)
+.++|+||+|++++++++|..||....... ......... ....+..++.++.+++.+||.
T Consensus 181 ~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~~~~~~~~~---------------~~~~~~~~~~~~~~~i~~~l~ 240 (258)
T cd08215 181 NYKSDIWSLGCVLYELCTLKHPFEGENLLE-----LALKILKGQ---------------YPPIPSQYSSELRNLVSSLLQ 240 (258)
T ss_pred CccccHHHHHHHHHHHHcCCCCCCCCcHHH-----HHHHHhcCC---------------CCCCCCCCCHHHHHHHHHHcC
Confidence 999999999999999999999986533211 111100000 001123566779999999999
Q ss_pred CCccCCCCHHHHHHH
Q 024027 236 ESPEQRINAKEIVTK 250 (273)
Q Consensus 236 ~dp~~Rps~~~~l~~ 250 (273)
.+|.+|||+.+++++
T Consensus 241 ~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 241 KDPEERPSIAQILQS 255 (258)
T ss_pred CChhhCcCHHHHhcC
Confidence 999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=266.21 Aligned_cols=221 Identities=25% Similarity=0.341 Sum_probs=185.1
Q ss_pred eEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 2 EVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 2 ~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
.||||++..+. .+.-.++..|+..|+.+.|||++.+-|+|..+.+.++|||||-| +-.|++.-+++++.+.+|..+
T Consensus 53 vVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClG-SAsDlleVhkKplqEvEIAAi 131 (948)
T KOG0577|consen 53 VVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAI 131 (948)
T ss_pred eeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHhc-cHHHHHHHHhccchHHHHHHH
Confidence 69999997553 34456788999999999999999999999999999999999955 999999888889999999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC---CCc
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE---GRV 155 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~ 155 (273)
+.+.+.||+||| +.+.+|||||..|||++..|.|||+|||.+..+ .....++|||+|+|||++.. +.|
T Consensus 132 ~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~------~PAnsFvGTPywMAPEVILAMDEGqY 202 (948)
T KOG0577|consen 132 THGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIM------APANSFVGTPYWMAPEVILAMDEGQY 202 (948)
T ss_pred HHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhc------CchhcccCCccccchhHheecccccc
Confidence 999999999999 999999999999999999999999999999865 34566899999999998864 459
Q ss_pred CCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCC
Q 024027 156 STNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTV 235 (273)
Q Consensus 156 ~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 235 (273)
+.+.||||||++..++...++|+..++.-...+ .+.....+ ... ...-+..++.|+.+||.
T Consensus 203 dgkvDvWSLGITCIELAERkPPlFnMNAMSALY-HIAQNesP-tLq-----------------s~eWS~~F~~Fvd~CLq 263 (948)
T KOG0577|consen 203 DGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNESP-TLQ-----------------SNEWSDYFRNFVDSCLQ 263 (948)
T ss_pred CCccceeeccchhhhhhhcCCCccCchHHHHHH-HHHhcCCC-CCC-----------------CchhHHHHHHHHHHHHh
Confidence 999999999999999999999976543322211 11111111 000 23346679999999999
Q ss_pred CCccCCCCHHHHHHHH
Q 024027 236 ESPEQRINAKEIVTKL 251 (273)
Q Consensus 236 ~dp~~Rps~~~~l~~l 251 (273)
+=|.+|||..+++.|-
T Consensus 264 KipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 264 KIPQERPTSEELLKHR 279 (948)
T ss_pred hCcccCCcHHHHhhcc
Confidence 9999999999999873
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=252.02 Aligned_cols=225 Identities=25% Similarity=0.332 Sum_probs=179.0
Q ss_pred eEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 2 EVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 2 ~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
.||+|++.... ......+..|+++++.++|+|++++++++.++...++||||++| +|.+.+......+++..+..+
T Consensus 52 ~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i 130 (317)
T cd06635 52 VVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAI 130 (317)
T ss_pred EEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHH
Confidence 68999986442 23455788999999999999999999999999999999999975 888888666667999999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccC---CCCc
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR---EGRV 155 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~ 155 (273)
+.|++.|+.||| +.|++|+||+|+||+++.++.++|+|||++..... .....++..|+|||.+. ...+
T Consensus 131 ~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~ 201 (317)
T cd06635 131 THGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP------ANSFVGTPYWMAPEVILAMDEGQY 201 (317)
T ss_pred HHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCC------cccccCCccccChhhhhcCCCCCC
Confidence 999999999999 99999999999999999999999999998764321 22345778899999874 3458
Q ss_pred CCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCC
Q 024027 156 STNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTV 235 (273)
Q Consensus 156 ~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 235 (273)
+.++|+||+|+++++|++|..||.......... ....... ........+..+.+++.+||.
T Consensus 202 ~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~-~~~~~~~------------------~~~~~~~~~~~l~~li~~~l~ 262 (317)
T cd06635 202 DGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNES------------------PTLQSNEWSDYFRNFVDSCLQ 262 (317)
T ss_pred CccccHHHHHHHHHHHHhCCCCCCCccHHHHHH-HHHhccC------------------CCCCCccccHHHHHHHHHHcc
Confidence 889999999999999999999986532211111 1110000 000122355679999999999
Q ss_pred CCccCCCCHHHHHHHHHHHH
Q 024027 236 ESPEQRINAKEIVTKLLKIR 255 (273)
Q Consensus 236 ~dp~~Rps~~~~l~~l~~~~ 255 (273)
.+|.+||++.++++++..+.
T Consensus 263 ~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 263 KIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred CCcccCcCHHHHHhChhhhc
Confidence 99999999999999876443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=247.42 Aligned_cols=217 Identities=22% Similarity=0.289 Sum_probs=169.5
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
.+|+|+++...... . |+.....+ +|+||+++++++..+...++||||+++++|.+++.... .+++..+..++.
T Consensus 43 ~~~~k~~~~~~~~~---~--e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~ 116 (267)
T PHA03390 43 LFVQKIIKAKNFNA---I--EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIR 116 (267)
T ss_pred EEEEEEEehhhcch---h--hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHH
Confidence 57888886442111 1 22222223 79999999999999999999999999999999997654 799999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCC-ceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcc
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNL-VAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 159 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~-~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 159 (273)
|++.||.+|| +.|++|+||+|+||+++.++ .++|+|||.+...... ....++..|+|||.+.+..++.++
T Consensus 117 qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~ 187 (267)
T PHA03390 117 QLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSF 187 (267)
T ss_pred HHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC------ccCCCCCcccChhhhcCCCCCchh
Confidence 9999999999 99999999999999999888 9999999988754221 123578889999999888899999
Q ss_pred hhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCcc
Q 024027 160 DVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239 (273)
Q Consensus 160 DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 239 (273)
|+||+|++++++++|..||............+.... ......+...+..+.+++.+||..||.
T Consensus 188 DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~li~~~l~~~p~ 250 (267)
T PHA03390 188 DWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-----------------QKKLPFIKNVSKNANDFVQSMLKYNIN 250 (267)
T ss_pred hHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-----------------cccCCcccccCHHHHHHHHHHhccChh
Confidence 999999999999999999975433322221111110 000111235677799999999999999
Q ss_pred CCCC-HHHHHHH
Q 024027 240 QRIN-AKEIVTK 250 (273)
Q Consensus 240 ~Rps-~~~~l~~ 250 (273)
+||+ ++++++|
T Consensus 251 ~R~~~~~~~l~h 262 (267)
T PHA03390 251 YRLTNYNEIIKH 262 (267)
T ss_pred hCCchHHHHhcC
Confidence 9996 6999875
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=249.25 Aligned_cols=243 Identities=21% Similarity=0.199 Sum_probs=183.3
Q ss_pred CeEEEEEeecccC--hhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 1 MEVAVKVFNLQCG--RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 1 ~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
++||+|.++.... .....+..|+++++.++|+||+++++++.++...++|+||+++ +|.+++......+++..+..+
T Consensus 25 ~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~ 103 (283)
T cd05118 25 EIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSY 103 (283)
T ss_pred cEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhhcccCCHHHHHHH
Confidence 3689999875532 3456788999999999999999999999999999999999976 999988776567999999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCC-CcCC
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG-RVST 157 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~ 157 (273)
+.|++.||.||| +.|++|+||+|+||+++.++.++|+|||.+....... .......++..|.|||.+.+. .++.
T Consensus 104 ~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~ 178 (283)
T cd05118 104 LYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYTHYVVTRWYRAPELLLGDKGYST 178 (283)
T ss_pred HHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--ccccCccCcccccCcHHHhcCCCCCc
Confidence 999999999999 9999999999999999999999999999987653322 112223567789999988776 6899
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccch---hhhh---hh----ccccchhhhhhhhhhHHHHH
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTM---EVVD---AN----LLSQEDIHFVAKEQCVSFVF 227 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~---~~----~~~~~~~~~~~~~~~~~~l~ 227 (273)
++|+||+|+++|++++|+.||......+ ............... .... .. ..............++.++.
T Consensus 179 ~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (283)
T cd05118 179 PVDIWSVGCIFAELLSRRPLFPGKSEID-QLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQAL 257 (283)
T ss_pred hhHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHH
Confidence 9999999999999999999986543321 111111111110000 0000 00 00000001112345778899
Q ss_pred HHHhhcCCCCccCCCCHHHHHHH
Q 024027 228 NLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 228 ~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
+++.+||.+||.+||++.+++.|
T Consensus 258 ~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 258 DLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred HHHHHHhccCcccCcCHHHHhhC
Confidence 99999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=249.21 Aligned_cols=227 Identities=26% Similarity=0.325 Sum_probs=173.2
Q ss_pred CeEEEEEeeccc-ChhhhhHHHHHHH-HhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhc---CCCCCCHHHH
Q 024027 1 MEVAVKVFNLQC-GRAFKSFDVECEM-MKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS---SNCILDIFQR 75 (273)
Q Consensus 1 ~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~ 75 (273)
+.||||.++... ......+..|+.+ ++.++||||+++++++..++..+++|||+++ +|.+++.. .+..+++..+
T Consensus 27 ~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~ 105 (283)
T cd06617 27 TIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDIL 105 (283)
T ss_pred cEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhcc-cHHHHHHHhccCCCCCCHHHH
Confidence 369999997553 2334455566665 5666999999999999999999999999974 88888753 2346899999
Q ss_pred HHHHHHHHHHHHHHhcCCCC-CeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC--
Q 024027 76 LNIMIDVASALEYLHFGCSA-PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE-- 152 (273)
Q Consensus 76 ~~~~~ql~~~l~~lh~~~~~-~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-- 152 (273)
+.++.|++.||.||| ++ +++|+||+|+||+++.++.++|+|||++...... .......++..|+|||.+.+
T Consensus 106 ~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~ 179 (283)
T cd06617 106 GKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS---VAKTIDAGCKPYMAPERINPEL 179 (283)
T ss_pred HHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecccccccccc---cccccccCCccccChhhcCCcc
Confidence 999999999999999 87 9999999999999999999999999998765221 11223457788999998865
Q ss_pred --CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHH
Q 024027 153 --GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLA 230 (273)
Q Consensus 153 --~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 230 (273)
..++.++|+||+||++|+|++|..||.................. .......++.++.+++
T Consensus 180 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~l~~li 241 (283)
T cd06617 180 NQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS------------------PQLPAEKFSPEFQDFV 241 (283)
T ss_pred cccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCC------------------CCCCccccCHHHHHHH
Confidence 34688999999999999999999998653322111111110000 0000123567799999
Q ss_pred hhcCCCCccCCCCHHHHHHHHH
Q 024027 231 MACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 231 ~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
.+||..+|.+|||++++++|-.
T Consensus 242 ~~~l~~~p~~Rp~~~~il~~~~ 263 (283)
T cd06617 242 NKCLKKNYKERPNYPELLQHPF 263 (283)
T ss_pred HHHccCChhhCcCHHHHhcCch
Confidence 9999999999999999998644
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=249.72 Aligned_cols=226 Identities=19% Similarity=0.205 Sum_probs=174.1
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhc---CCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKS---IRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQ 74 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~---l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (273)
+.||||++.... ......+.+|..+++. .+||+|+.+++++..++..++||||+++++|.+++...+ .+++..
T Consensus 20 ~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~-~l~~~~ 98 (279)
T cd05633 20 KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG-VFSEKE 98 (279)
T ss_pred cEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhcC-CCCHHH
Confidence 479999986542 1122234445444443 479999999999999999999999999999999986554 589999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccC-CC
Q 024027 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR-EG 153 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~ 153 (273)
+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++...... ......++..|+|||.+. +.
T Consensus 99 ~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~ 171 (279)
T cd05633 99 MRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKGT 171 (279)
T ss_pred HHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc----CccCcCCCcCccCHHHhcCCC
Confidence 9999999999999999 999999999999999999999999999998654221 122346889999999886 45
Q ss_pred CcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhc
Q 024027 154 RVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMAC 233 (273)
Q Consensus 154 ~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 233 (273)
.++.++|+||+||+++++++|..||.......... ..... .......+..++.++.+++.+|
T Consensus 172 ~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~--~~~~~----------------~~~~~~~~~~~~~~~~~li~~~ 233 (279)
T cd05633 172 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--IDRMT----------------LTVNVELPDSFSPELKSLLEGL 233 (279)
T ss_pred CCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH--HHHHh----------------hcCCcCCccccCHHHHHHHHHH
Confidence 68899999999999999999999997543322111 00000 0001112445677899999999
Q ss_pred CCCCccCCC-----CHHHHHHHHH
Q 024027 234 TVESPEQRI-----NAKEIVTKLL 252 (273)
Q Consensus 234 l~~dp~~Rp-----s~~~~l~~l~ 252 (273)
|..||++|| |++++++|-.
T Consensus 234 l~~~p~~R~~~~~~~~~~~~~h~~ 257 (279)
T cd05633 234 LQRDVSKRLGCLGRGAQEVKEHVF 257 (279)
T ss_pred hcCCHHHhcCCCCCCHHHHHhCcc
Confidence 999999999 6999999843
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=246.74 Aligned_cols=227 Identities=22% Similarity=0.332 Sum_probs=178.2
Q ss_pred CeEEEEEeecc----------cChhhhhHHHHHHHHhc-CCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhc---C
Q 024027 1 MEVAVKVFNLQ----------CGRAFKSFDVECEMMKS-IRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS---S 66 (273)
Q Consensus 1 ~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~ 66 (273)
+.||+|.+... .......+..|+.++.. ++||||+++++++..++..+++|||+++++|.+++.. .
T Consensus 27 ~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~ 106 (269)
T cd08528 27 NLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEK 106 (269)
T ss_pred ceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhc
Confidence 36899988532 12234557788888875 6999999999999999999999999999999988743 3
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCC
Q 024027 67 NCILDIFQRLNIMIDVASALEYLHFGCS-APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYM 145 (273)
Q Consensus 67 ~~~~~~~~~~~~~~ql~~~l~~lh~~~~-~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (273)
...+++..++.++.|++.||.+|| + .+++|+||+|+||+++.++.++|+|||.+....... ......++..|+
T Consensus 107 ~~~~~~~~~~~~~~~l~~~l~~lh---~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~ 180 (269)
T cd08528 107 KQRFTEERIWNIFVQMVLALRYLH---KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYS 180 (269)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHhc---cCCceeecCCCHHHEEECCCCcEEEecccceeeccccc---ccccccCcccCc
Confidence 446899999999999999999999 6 689999999999999999999999999997653322 223456788899
Q ss_pred CCcccCCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHH
Q 024027 146 APEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSF 225 (273)
Q Consensus 146 aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (273)
|||.+.+..++.++|+||||+++|++++|..||........ ........ ........++.+
T Consensus 181 ~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~-~~~~~~~~------------------~~~~~~~~~~~~ 241 (269)
T cd08528 181 CPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL-ATKIVEAV------------------YEPLPEGMYSED 241 (269)
T ss_pred ChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH-HHHHhhcc------------------CCcCCcccCCHH
Confidence 99999888899999999999999999999999864322110 00000000 000001234567
Q ss_pred HHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 226 VFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 226 l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
+.+++.+||..||.+||++.++..++.
T Consensus 242 l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 242 VTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=262.22 Aligned_cols=213 Identities=25% Similarity=0.372 Sum_probs=176.2
Q ss_pred cChhhhhHHHHHHHHhcCCCccceeeeeeeecCCc--eeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHH
Q 024027 12 CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEF--KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL 89 (273)
Q Consensus 12 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~--~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ql~~~l~~l 89 (273)
+++..+.|..|+.+|+.|+||||+++|++|.+... +.+|+|.+..|+|..|+++.+ ..+...+.+|+.||+.||.||
T Consensus 81 ~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yL 159 (632)
T KOG0584|consen 81 SPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYL 159 (632)
T ss_pred ChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhh
Confidence 35567889999999999999999999999987655 789999999999999998776 688899999999999999999
Q ss_pred hcCCCCCeEeccCCCCceeeC-CCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcchhHHHHHHH
Q 024027 90 HFGCSAPVIHCDLKPDNVLLD-DNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIML 168 (273)
Q Consensus 90 h~~~~~~i~h~di~p~nil~~-~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l 168 (273)
|++ .-.|+|||||.+||+++ ..|.|||+|+|++..+. ........|||.|||||... ..|+...||||||+++
T Consensus 160 Hs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r----~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCm 233 (632)
T KOG0584|consen 160 HSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR----KSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCM 233 (632)
T ss_pred hcC-CCCccccccccceEEEcCCcCceeecchhHHHHhh----ccccceeccCccccChHHHh-hhcchhhhhhhhhHHH
Confidence 954 55799999999999998 56899999999998762 22334478999999999987 7899999999999999
Q ss_pred HHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHH
Q 024027 169 METFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIV 248 (273)
Q Consensus 169 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l 248 (273)
+||.|+..||..=.+...-+.....+..+.....+. .+++++||.+||.. ..+|||+.|+|
T Consensus 234 LEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~------------------dPevr~fIekCl~~-~~~R~sa~eLL 294 (632)
T KOG0584|consen 234 LEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVK------------------DPEVREFIEKCLAT-KSERLSAKELL 294 (632)
T ss_pred HHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccC------------------CHHHHHHHHHHhcC-chhccCHHHHh
Confidence 999999999876444444444333333222222111 34589999999999 99999999999
Q ss_pred HH
Q 024027 249 TK 250 (273)
Q Consensus 249 ~~ 250 (273)
.+
T Consensus 295 ~d 296 (632)
T KOG0584|consen 295 KD 296 (632)
T ss_pred hC
Confidence 75
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=246.68 Aligned_cols=223 Identities=22% Similarity=0.270 Sum_probs=171.9
Q ss_pred CeEEEEEeecccC---hhhhhHHHHHHHHh-cCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHH
Q 024027 1 MEVAVKVFNLQCG---RAFKSFDVECEMMK-SIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~~~---~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (273)
++||||+++.... .....+..|..++. ..+|+|++++++++.....+++|+||+++++|.+++.... .+++..+.
T Consensus 22 ~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~ 100 (260)
T cd05611 22 DYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLG-GLPEDWAK 100 (260)
T ss_pred CeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHcC-CCCHHHHH
Confidence 4799999965421 22334455555544 4589999999999999999999999999999999996543 68999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcC
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVS 156 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 156 (273)
.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++..... .....++..|+|||.+.+..++
T Consensus 101 ~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~~~~y~~pe~~~~~~~~ 171 (260)
T cd05611 101 QYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVGTPDYLAPETILGVGDD 171 (260)
T ss_pred HHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cccCCCCcCccChhhhcCCCCc
Confidence 99999999999999 99999999999999999999999999998865322 2234577889999999888889
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++|+||+|+++|++++|..||........ ....... ...........++.++.+++.+||..
T Consensus 172 ~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~----------------~~~~~~~~~~~~~~~~~~~i~~~l~~ 234 (260)
T cd05611 172 KMSDWWSLGCVIFEFLFGYPPFHAETPDAV-FDNILSR----------------RINWPEEVKEFCSPEAVDLINRLLCM 234 (260)
T ss_pred chhhhHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHhc----------------ccCCCCcccccCCHHHHHHHHHHccC
Confidence 999999999999999999999865322111 1100000 00000011234677799999999999
Q ss_pred CccCCCCH---HHHHHH
Q 024027 237 SPEQRINA---KEIVTK 250 (273)
Q Consensus 237 dp~~Rps~---~~~l~~ 250 (273)
||.+|||+ .++++|
T Consensus 235 ~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 235 DPAKRLGANGYQEIKSH 251 (260)
T ss_pred CHHHccCCCcHHHHHcC
Confidence 99999965 576665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=245.52 Aligned_cols=224 Identities=28% Similarity=0.371 Sum_probs=183.3
Q ss_pred CeEEEEEeecccC--hhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 1 MEVAVKVFNLQCG--RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 1 ~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
++||+|.+..... .....+.+|+++++.++|+|++++++++.++...++++||+++++|.+++... ..+++..++.+
T Consensus 26 ~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~ 104 (254)
T cd06627 26 DFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKF-GPFPESLVAVY 104 (254)
T ss_pred cEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhc-cCCCHHHHHHH
Confidence 3799999976643 46678999999999999999999999999999999999999999999999665 46899999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCc
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTN 158 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 158 (273)
+.|++.|+.+|| +.|++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||...+..++.+
T Consensus 105 ~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~ 179 (254)
T cd06627 105 VYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK--DDASVVGTPYWMAPEVIEMSGASTA 179 (254)
T ss_pred HHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc--cccccccchhhcCHhhhcCCCCCcc
Confidence 999999999999 99999999999999999999999999999986633222 1233457888999999887778999
Q ss_pred chhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc
Q 024027 159 GDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238 (273)
Q Consensus 159 ~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 238 (273)
+|+|++|++++++++|..||........... ... ......+..++..+.+++.+||..+|
T Consensus 180 ~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~----~~~----------------~~~~~~~~~~~~~~~~~i~~~l~~~p 239 (254)
T cd06627 180 SDIWSLGCTVIELLTGNPPYYDLNPMAALFR----IVQ----------------DDHPPLPEGISPELKDFLMQCFQKDP 239 (254)
T ss_pred hhHHHHHHHHHHHHhCCCCCCCccHHHHHHH----Hhc----------------cCCCCCCCCCCHHHHHHHHHHHhCCh
Confidence 9999999999999999999865332111100 000 00011134556779999999999999
Q ss_pred cCCCCHHHHHHH
Q 024027 239 EQRINAKEIVTK 250 (273)
Q Consensus 239 ~~Rps~~~~l~~ 250 (273)
++|||+.+++.+
T Consensus 240 ~~R~~~~~~l~~ 251 (254)
T cd06627 240 NLRPTAKQLLKH 251 (254)
T ss_pred hhCcCHHHHhcC
Confidence 999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=248.28 Aligned_cols=241 Identities=18% Similarity=0.186 Sum_probs=175.8
Q ss_pred CeEEEEEeeccc-ChhhhhHHHHHHHHhcCC-CccceeeeeeeecC--CceeEEEeccCCCCHHHhhhcCCCCCCHHHHH
Q 024027 1 MEVAVKVFNLQC-GRAFKSFDVECEMMKSIR-HRNLIKVISSCSNE--EFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (273)
+.||+|+++... .........|+.+++++. |+|++++++++.++ +.+++|+||+++ +|.+++......+++..++
T Consensus 25 ~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~ 103 (282)
T cd07831 25 KYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVK 103 (282)
T ss_pred cEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCCc-cHHHHHHhccCCCCHHHHH
Confidence 368999987542 223334557899999885 99999999999887 889999999975 8888887655678999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC-CCc
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE-GRV 155 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~ 155 (273)
.++.|++.||.||| +.|++|+||+|+||+++. +.++|+|||++........ .....++..|+|||.+.. ..+
T Consensus 104 ~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~ 176 (282)
T cd07831 104 SYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP---YTEYISTRWYRAPECLLTDGYY 176 (282)
T ss_pred HHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCCC---cCCCCCCcccCChhHhhcCCCC
Confidence 99999999999999 999999999999999999 9999999999876532221 122356788999997644 457
Q ss_pred CCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccc--hhhhhhhccc-------cchhhhhhhhhhHHHH
Q 024027 156 STNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPIST--MEVVDANLLS-------QEDIHFVAKEQCVSFV 226 (273)
Q Consensus 156 ~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~-------~~~~~~~~~~~~~~~l 226 (273)
+.++|+||+||++|+|++|..||......+. ............. .......... ...........++.++
T Consensus 177 ~~~~Di~slGv~l~el~~~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (282)
T cd07831 177 GPKMDIWAVGCVFFEILSLFPLFPGTNELDQ-IAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEG 255 (282)
T ss_pred CcchhHHHHHHHHHHHHcCCcCCCCCCHHHH-HHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHH
Confidence 8899999999999999999999965332211 1111110000000 0000000000 0000111123567889
Q ss_pred HHHHhhcCCCCccCCCCHHHHHHH
Q 024027 227 FNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 227 ~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
.+++.+||.+||++|||++++++|
T Consensus 256 ~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 256 LDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred HHHHHHHhccCcccccCHHHHhhC
Confidence 999999999999999999999976
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=263.97 Aligned_cols=225 Identities=22% Similarity=0.298 Sum_probs=185.3
Q ss_pred EEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHHHH
Q 024027 4 AVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVA 83 (273)
Q Consensus 4 avK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ql~ 83 (273)
|-|++...+.+..+++.-|++||...+||+|+++++.|..++.++|+.|||.||.+...+-.-+..+.+.+|.-+++|++
T Consensus 61 AaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~l 140 (1187)
T KOG0579|consen 61 AAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVL 140 (1187)
T ss_pred hhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHH
Confidence 55777767778889999999999999999999999999999999999999999999999988888899999999999999
Q ss_pred HHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccC-----CCCcCCc
Q 024027 84 SALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR-----EGRVSTN 158 (273)
Q Consensus 84 ~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~ 158 (273)
.||.||| +++|+|||||..|||++-+|.++|+|||.+... ...........|||+|+|||+.. ..+|+.+
T Consensus 141 dALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn--~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDyk 215 (1187)
T KOG0579|consen 141 DALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKN--KSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYK 215 (1187)
T ss_pred HHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccc--hhHHhhhccccCCcccccchheeeccccCCCchhh
Confidence 9999999 999999999999999999999999999998643 11222345678999999999764 4468999
Q ss_pred chhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc
Q 024027 159 GDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238 (273)
Q Consensus 159 ~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 238 (273)
+||||||+.+.+|..+.+|-+....-... -.+....+ -....|..-+..+.||+.+||..||
T Consensus 216 aDiWSlGITLIEMAqiEPPHhelnpMRVl-lKiaKSeP-----------------PTLlqPS~Ws~~F~DfLk~cL~Knp 277 (1187)
T KOG0579|consen 216 ADIWSLGITLIEMAQIEPPHHELNPMRVL-LKIAKSEP-----------------PTLLQPSHWSRSFSDFLKRCLVKNP 277 (1187)
T ss_pred hhHHhhhhHHHHHhccCCCccccchHHHH-HHHhhcCC-----------------CcccCcchhhhHHHHHHHHHHhcCC
Confidence 99999999999999999995543222111 11111111 1111244456669999999999999
Q ss_pred cCCCCHHHHHHHH
Q 024027 239 EQRINAKEIVTKL 251 (273)
Q Consensus 239 ~~Rps~~~~l~~l 251 (273)
..||++.++++|-
T Consensus 278 ~~Rp~aaqll~Hp 290 (1187)
T KOG0579|consen 278 RNRPPAAQLLKHP 290 (1187)
T ss_pred ccCCCHHHHhhCc
Confidence 9999999999874
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=249.33 Aligned_cols=243 Identities=23% Similarity=0.198 Sum_probs=176.7
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC-CCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~ 77 (273)
++||+|.++... ......+.+|+++++.++||||+++++++.+....++||||+++ +|.+++.... ...++..+..
T Consensus 28 ~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~ 106 (294)
T PLN00009 28 ETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKT 106 (294)
T ss_pred cEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecccc-cHHHHHHhCCCCCcCHHHHHH
Confidence 369999986543 22345688999999999999999999999999999999999965 8888875433 3367888999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCC-CCceEEeecccccccccCCCcceeecccccCCCCCCcccCCC-Cc
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDD-NLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG-RV 155 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~-~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~ 155 (273)
++.|++.||.||| +.+++|+||+|+||+++. ++.+||+|||++....... .......++..|+|||.+.+. .+
T Consensus 107 ~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~ 181 (294)
T PLN00009 107 YLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV--RTFTHEVVTLWYRAPEILLGSRHY 181 (294)
T ss_pred HHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc--cccccCceeecccCHHHHhCCCCC
Confidence 9999999999999 999999999999999985 5679999999987542221 111233567889999987664 57
Q ss_pred CCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCc--cc-------hhhhhhhccccchhhhhhhhhhHHHH
Q 024027 156 STNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPI--ST-------MEVVDANLLSQEDIHFVAKEQCVSFV 226 (273)
Q Consensus 156 ~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--~~-------~~~~~~~~~~~~~~~~~~~~~~~~~l 226 (273)
+.++|+||+|+++|++++|..||......+.... ........ .. ...................+..+.++
T Consensus 182 ~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (294)
T PLN00009 182 STPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFK-IFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAG 260 (294)
T ss_pred CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHH
Confidence 8999999999999999999999976433221111 11100000 00 00000000000111111234567779
Q ss_pred HHHHhhcCCCCccCCCCHHHHHHH
Q 024027 227 FNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 227 ~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
.+++.+||..+|++||++.++++|
T Consensus 261 ~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 261 VDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred HHHHHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999999986
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=246.46 Aligned_cols=224 Identities=22% Similarity=0.295 Sum_probs=178.5
Q ss_pred eEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC-CCCCHHHHHHH
Q 024027 2 EVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNI 78 (273)
Q Consensus 2 ~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~ 78 (273)
.||+|.+.... ......+.+|+++++.++|+||+++++.+......++|+||+++++|.+++.... ..+++..+..+
T Consensus 27 ~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ 106 (257)
T cd08225 27 HCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW 106 (257)
T ss_pred eEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHH
Confidence 58999986542 2345678899999999999999999999999999999999999999999986543 35789999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCC-ceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCC
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNL-VAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~-~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
+.|++.|+.||| +.+++|+||+|+||+++.++ .++++|||.+........ ......+++.|+|||.+.+..++.
T Consensus 107 ~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~ 181 (257)
T cd08225 107 FVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME--LAYTCVGTPYYLSPEICQNRPYNN 181 (257)
T ss_pred HHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc--cccccCCCccccCHHHHcCCCCCc
Confidence 999999999999 99999999999999998875 569999998876532221 122345788899999998888999
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
++|+||+|++++++++|..||.......... ..... .. .......+.++.+++.+||..+
T Consensus 182 ~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~------------~~-------~~~~~~~~~~~~~~i~~~l~~~ 241 (257)
T cd08225 182 KTDIWSLGCVLYELCTLKHPFEGNNLHQLVL-KICQG------------YF-------APISPNFSRDLRSLISQLFKVS 241 (257)
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCccHHHHHH-HHhcc------------cC-------CCCCCCCCHHHHHHHHHHhccC
Confidence 9999999999999999999986432211110 00000 00 0012345567999999999999
Q ss_pred ccCCCCHHHHHHH
Q 024027 238 PEQRINAKEIVTK 250 (273)
Q Consensus 238 p~~Rps~~~~l~~ 250 (273)
|++|||+++++.+
T Consensus 242 p~~Rpt~~~ll~~ 254 (257)
T cd08225 242 PRDRPSITSILKR 254 (257)
T ss_pred hhhCcCHHHHhhC
Confidence 9999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=247.52 Aligned_cols=243 Identities=23% Similarity=0.264 Sum_probs=181.2
Q ss_pred eEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecC--CceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 2 EVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNE--EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 2 ~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
.||+|+++... ......+.+|+++++.++|+|++++++++.+. +..++|+||+++ +|.+++......+++..++.
T Consensus 26 ~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~ 104 (287)
T cd07840 26 LVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKC 104 (287)
T ss_pred EEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccc-cHHHHHhccCCCCCHHHHHH
Confidence 68999998663 33456688999999999999999999999888 899999999975 99999876656799999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC-CCcC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE-GRVS 156 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~ 156 (273)
++.|++.||++|| +.|++|+||+|+||+++.++.++|+|||.+........ .......++..|+|||.+.+ ..++
T Consensus 105 i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~ 180 (287)
T cd07840 105 YMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-ADYTNRVITLWYRPPELLLGATRYG 180 (287)
T ss_pred HHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-ccccccccccccCCceeeEccccCC
Confidence 9999999999999 99999999999999999999999999999876633321 11233456778999997765 4578
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhh-------hhhccc----cchhhhhhhhhhHHH
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVV-------DANLLS----QEDIHFVAKEQCVSF 225 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~----~~~~~~~~~~~~~~~ 225 (273)
.++|+||||++++++++|..||...... ................... ...... ...........++.+
T Consensus 181 ~~~Dv~slG~~l~el~t~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (287)
T cd07840 181 PEVDMWSVGCILAELFLGKPIFQGSTEL-EQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPS 259 (287)
T ss_pred hHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHH
Confidence 9999999999999999999998764432 1112111111111000000 000000 000011111123778
Q ss_pred HHHHHhhcCCCCccCCCCHHHHHHH
Q 024027 226 VFNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 226 l~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
+.+++.+||..+|.+||++.+++++
T Consensus 260 ~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 260 ALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred HHHHHHHHcCCChhhCcCHHHHhhC
Confidence 9999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=249.01 Aligned_cols=243 Identities=21% Similarity=0.164 Sum_probs=175.7
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCc-----eeEEEeccCCCCHHHhhhcC----CC
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEF-----KALVLEYMPHGSLEKYLYSS----NC 68 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~----~~ 68 (273)
++||||+++... ......+.+|+.+++.+ +|+||+++++++..... .+++|||+++ +|.+++... ..
T Consensus 27 ~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~ 105 (295)
T cd07837 27 KLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGR 105 (295)
T ss_pred cEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCC
Confidence 479999987543 22345788899999999 56999999999877665 8999999986 898888543 23
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCC-CCceEEeecccccccccCCCcceeecccccCCCCCC
Q 024027 69 ILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDD-NLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 147 (273)
Q Consensus 69 ~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~-~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aP 147 (273)
.+++..++.++.|++.||.||| ..|++|+||+|+||+++. ++.++|+|||.+..+..... ......+++.|.||
T Consensus 106 ~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~aP 180 (295)
T cd07837 106 PLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK--SYTHEIVTLWYRAP 180 (295)
T ss_pred CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecccceecCCCcc--ccCCcccccCCCCh
Confidence 5899999999999999999999 999999999999999998 88999999999875532211 12223467889999
Q ss_pred cccCC-CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhh------hhhh--ccccchhhhhh
Q 024027 148 EYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEV------VDAN--LLSQEDIHFVA 218 (273)
Q Consensus 148 E~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~--~~~~~~~~~~~ 218 (273)
|.+.+ ..++.++|+||||+++|+|++|..||........... ............. .... ...........
T Consensus 181 E~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (295)
T cd07837 181 EVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLH-IFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRA 259 (295)
T ss_pred HHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-HHHHhCCCChhhCcchhhccchhhcCcccchhHHHh
Confidence 98765 4578999999999999999999999875433221111 1111000000000 0000 00000001111
Q ss_pred hhhhHHHHHHHHhhcCCCCccCCCCHHHHHHH
Q 024027 219 KEQCVSFVFNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 219 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
.+.++.++.++|.+||.+||.+|||+++++.|
T Consensus 260 ~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 260 VPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred ccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 23467789999999999999999999999876
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=244.18 Aligned_cols=249 Identities=20% Similarity=0.185 Sum_probs=184.3
Q ss_pred eEEEEEeecccCh--hhhhHHHHHHHHhcCCCccceeeeeeeec-CCceeEEEeccCCCCHHHhhhcCC----CCCCHHH
Q 024027 2 EVAVKVFNLQCGR--AFKSFDVECEMMKSIRHRNLIKVISSCSN-EEFKALVLEYMPHGSLEKYLYSSN----CILDIFQ 74 (273)
Q Consensus 2 ~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~ 74 (273)
++|||+++...+. .-...-+|+-+++.++|||++.+..+|.. +...++++||.+. +|+..|+.++ ..++...
T Consensus 55 ~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~m 133 (438)
T KOG0666|consen 55 EYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSM 133 (438)
T ss_pred hhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHH
Confidence 6789999865322 23456789999999999999999999877 8889999999987 9999996442 3488899
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCC----CceEEeecccccccccCCCcc-eeecccccCCCCCCcc
Q 024027 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDN----LVAYLSDFGIAKLLIGEDQSM-TQTQTLATIGYMAPEY 149 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~----~~~kl~Df~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~ 149 (273)
+.++++||+.|+.||| ++=+.||||||.||++..+ |.|||+|+|+++.+.+.-... .....+.|.+|+|||+
T Consensus 134 vKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPEL 210 (438)
T KOG0666|consen 134 VKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPEL 210 (438)
T ss_pred HHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHH
Confidence 9999999999999999 9999999999999999876 899999999999886554333 3445577999999999
Q ss_pred cCCCC-cCCcchhHHHHHHHHHHHhCCCCCcccccccc--------chhhhhhh--ccCccchhhhhhhccc-----cch
Q 024027 150 GREGR-VSTNGDVYSFGIMLMETFTGKKPTYEFFNGEM--------TLKHWVND--WLPISTMEVVDANLLS-----QED 213 (273)
Q Consensus 150 ~~~~~-~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~--------~~~~~~~~--~~~~~~~~~~~~~~~~-----~~~ 213 (273)
+.|.. |+.+.|+|++||++.||++-.+-|........ .+..+.+. .+..+.++.+...-.. ...
T Consensus 211 LLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~ 290 (438)
T KOG0666|consen 211 LLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFR 290 (438)
T ss_pred hcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhH
Confidence 99876 89999999999999999999988865333211 11222221 1111111111110000 000
Q ss_pred ----------hhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHHHH
Q 024027 214 ----------IHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLLKI 254 (273)
Q Consensus 214 ----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 254 (273)
........-++...+|+.+||.+||.+|+|++++++|.--.
T Consensus 291 ~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~ 341 (438)
T KOG0666|consen 291 RHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFT 341 (438)
T ss_pred HhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccc
Confidence 00000111233488999999999999999999999986533
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=255.65 Aligned_cols=241 Identities=22% Similarity=0.207 Sum_probs=176.5
Q ss_pred CeEEEEEeecc--cChhhhhHHHHHHHHhcCCCccceeeeeeeecC------CceeEEEeccCCCCHHHhhhcCCCCCCH
Q 024027 1 MEVAVKVFNLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNE------EFKALVLEYMPHGSLEKYLYSSNCILDI 72 (273)
Q Consensus 1 ~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 72 (273)
+.||||++... +......+.+|+.+++.++|+||++++++|... ...++||||+++ +|.+.+... ++.
T Consensus 42 ~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~---l~~ 117 (353)
T cd07850 42 QNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD---LDH 117 (353)
T ss_pred CEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccCC-CHHHHHhhc---CCH
Confidence 46899998643 233455677899999999999999999988644 357999999965 898888543 888
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC
Q 024027 73 FQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE 152 (273)
Q Consensus 73 ~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 152 (273)
..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||.+....... ......++..|+|||.+.+
T Consensus 118 ~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~ 191 (353)
T cd07850 118 ERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILG 191 (353)
T ss_pred HHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCC---CCCCCcccccccCHHHHhC
Confidence 999999999999999999 9999999999999999999999999999997653211 1223457788999999998
Q ss_pred CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCc--cchhh--------hhhhccc-cchh-------
Q 024027 153 GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPI--STMEV--------VDANLLS-QEDI------- 214 (273)
Q Consensus 153 ~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~--------~~~~~~~-~~~~------- 214 (273)
..++.++|+|||||++++|++|..||....... ...........+ ..... ....... ....
T Consensus 192 ~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (353)
T cd07850 192 MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHID-QWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDV 270 (353)
T ss_pred CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCccc
Confidence 899999999999999999999999997543211 111111110000 00000 0000000 0000
Q ss_pred -----hhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 215 -----HFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 215 -----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
....+...+.++.+++.+||..||++|||+++++.|=+
T Consensus 271 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~ 313 (353)
T cd07850 271 LFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPY 313 (353)
T ss_pred ccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChh
Confidence 00002234667899999999999999999999998854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=249.41 Aligned_cols=237 Identities=20% Similarity=0.236 Sum_probs=180.3
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcC-C-Cc----cceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC-CCCCHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSI-R-HR----NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQ 74 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l-~-h~----~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~ 74 (273)
.||||+++.- ....++..-|+++|.++ + .| -++.+.++|.-.++.|||+|.+ |.++++++..++ .+++...
T Consensus 116 ~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ 193 (415)
T KOG0671|consen 116 HVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDH 193 (415)
T ss_pred eehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHH
Confidence 6899999755 56778888999999999 2 22 3777888899999999999999 669999997654 4589999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCC--------------------CCceEEeecccccccccCCCcce
Q 024027 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDD--------------------NLVAYLSDFGIAKLLIGEDQSMT 134 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~--------------------~~~~kl~Df~~~~~~~~~~~~~~ 134 (273)
+..+.+|++.++++|| +.+++|-||||+||++.. +..|+++|||.++.- ...
T Consensus 194 ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~-----~e~ 265 (415)
T KOG0671|consen 194 IRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFD-----HEH 265 (415)
T ss_pred HHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCccee-----ccC
Confidence 9999999999999999 999999999999999832 235899999999864 222
Q ss_pred eecccccCCCCCCcccCCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhh----ccc
Q 024027 135 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDAN----LLS 210 (273)
Q Consensus 135 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~ 210 (273)
....+.|..|+|||++.+.+++.+.||||+|||++|+.+|...|....+.+-. ..++....+-+...+.+. ...
T Consensus 266 hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHL--aMMerIlGp~P~~mi~r~~~~Kyf~ 343 (415)
T KOG0671|consen 266 HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHL--AMMERILGPIPSRMIKKTRKEKYFR 343 (415)
T ss_pred cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHH--HHHHHhhCCCcHHHhhhhhhHhhhh
Confidence 35678899999999999999999999999999999999999999876644311 222222211111111111 000
Q ss_pred c-----------c--------h----hhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHH
Q 024027 211 Q-----------E--------D----IHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 211 ~-----------~--------~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
. . + ......+.....+.||+++||++||.+|+|+.|+++|
T Consensus 344 ~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 344 RGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred cccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcC
Confidence 0 0 0 0111112344559999999999999999999999987
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=250.11 Aligned_cols=245 Identities=20% Similarity=0.245 Sum_probs=174.6
Q ss_pred CeEEEEEeecccC--hhhhhHHHHHHHHhcCCCccceeeeeeeecCC--------ceeEEEeccCCCCHHHhhhcCCCCC
Q 024027 1 MEVAVKVFNLQCG--RAFKSFDVECEMMKSIRHRNLIKVISSCSNEE--------FKALVLEYMPHGSLEKYLYSSNCIL 70 (273)
Q Consensus 1 ~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--------~~~lv~e~~~~~~L~~~l~~~~~~~ 70 (273)
+.||||.+..... .....+.+|+++++.++||||+++++++.... ..++|+||+.+ +|.+++......+
T Consensus 38 ~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~ 116 (310)
T cd07865 38 QIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKF 116 (310)
T ss_pred cEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCCc-CHHHHHHhcccCC
Confidence 4799999875432 22345668999999999999999999886654 45999999965 8998887766678
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCc--ceeecccccCCCCCCc
Q 024027 71 DIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQS--MTQTQTLATIGYMAPE 148 (273)
Q Consensus 71 ~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~--~~~~~~~~~~~~~aPE 148 (273)
++..++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||.+..+...... .......++..|+|||
T Consensus 117 ~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE 193 (310)
T cd07865 117 TLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPE 193 (310)
T ss_pred CHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcH
Confidence 99999999999999999999 999999999999999999999999999999765332211 1122345678899999
Q ss_pred ccCCCC-cCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhh--ccCccch------hhhhhhccccchh----h
Q 024027 149 YGREGR-VSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVND--WLPISTM------EVVDANLLSQEDI----H 215 (273)
Q Consensus 149 ~~~~~~-~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~------~~~~~~~~~~~~~----~ 215 (273)
.+.+.. ++.++|+||+|+++|+|++|..||...... ......... ..+.... ............. .
T Consensus 194 ~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (310)
T cd07865 194 LLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ-HQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKE 272 (310)
T ss_pred HhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHH
Confidence 876643 788999999999999999999998653321 111111110 0000000 0000000000000 0
Q ss_pred hhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHH
Q 024027 216 FVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 216 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
...+...+..+.+|+.+||..||.+|||++++++|
T Consensus 273 ~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 273 RLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00011234567899999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=248.91 Aligned_cols=220 Identities=24% Similarity=0.285 Sum_probs=175.3
Q ss_pred eEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 2 EVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 2 ~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
.||+|++.... ......+..|+++++.++|||++++++++.+....++||||+.+ ++.+++......+++..++.+
T Consensus 48 ~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~ 126 (313)
T cd06633 48 VVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAI 126 (313)
T ss_pred EEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCCC-CHHHHHHhcCCCCCHHHHHHH
Confidence 68999986432 23446788899999999999999999999999999999999965 888888766667899999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccC---CCCc
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR---EGRV 155 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~ 155 (273)
+.|++.|+.||| +.|++|+||+|+||+++.++.++|+|||++.... ......++..|+|||.+. ...+
T Consensus 127 ~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~ 197 (313)
T cd06633 127 THGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS------PANSFVGTPYWMAPEVILAMDEGQY 197 (313)
T ss_pred HHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccC------CCCCccccccccChhhccccCCCCC
Confidence 999999999999 9999999999999999999999999999875421 122346788899999874 3457
Q ss_pred CCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCC
Q 024027 156 STNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTV 235 (273)
Q Consensus 156 ~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 235 (273)
+.++|+||||+++|+|++|..||............ ..... ........+..+.+|+.+||.
T Consensus 198 ~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~-~~~~~------------------~~~~~~~~~~~l~~li~~~l~ 258 (313)
T cd06633 198 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-AQNDS------------------PTLQSNEWTDSFRGFVDYCLQ 258 (313)
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-HhcCC------------------CCCCccccCHHHHHHHHHHcc
Confidence 88999999999999999999998654322111110 00000 000012344568999999999
Q ss_pred CCccCCCCHHHHHHH
Q 024027 236 ESPEQRINAKEIVTK 250 (273)
Q Consensus 236 ~dp~~Rps~~~~l~~ 250 (273)
.+|.+||++.+++.|
T Consensus 259 ~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 259 KIPQERPASAELLRH 273 (313)
T ss_pred CChhhCcCHHHHhcC
Confidence 999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=253.84 Aligned_cols=247 Identities=22% Similarity=0.229 Sum_probs=179.9
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeec----CCceeEEEeccCCCCHHHhhhcCCCCCCHHH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSN----EEFKALVLEYMPHGSLEKYLYSSNCILDIFQ 74 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (273)
++||+|+++... ......+..|+.+++.++||||+++++++.. ....++|+||+. ++|.+++.... .+++..
T Consensus 31 ~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~ 108 (334)
T cd07855 31 KKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQ-PLTEEH 108 (334)
T ss_pred CEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhccCC-CCCHHH
Confidence 379999997542 2345667789999999999999999998753 356899999996 59999986544 599999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCc--ceeecccccCCCCCCcccCC
Q 024027 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQS--MTQTQTLATIGYMAPEYGRE 152 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~ 152 (273)
++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++......... .......++..|+|||.+.+
T Consensus 109 ~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 185 (334)
T cd07855 109 IRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLS 185 (334)
T ss_pred HHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcC
Confidence 9999999999999999 999999999999999999999999999998765332221 11223467889999998765
Q ss_pred -CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhh--ccCccchhh-----hhh---hccccchh-hhhhhh
Q 024027 153 -GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVND--WLPISTMEV-----VDA---NLLSQEDI-HFVAKE 220 (273)
Q Consensus 153 -~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~-----~~~---~~~~~~~~-~~~~~~ 220 (273)
..++.++|+||+|+++|+|++|+.||....... ........ .++...... ... ........ ......
T Consensus 186 ~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~-~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (334)
T cd07855 186 LPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH-QLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFP 264 (334)
T ss_pred CcccccccchHHHHHHHHHHHcCCCccCCCChHH-HHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcc
Confidence 458899999999999999999999996532211 11111110 000000000 000 00000000 011123
Q ss_pred hhHHHHHHHHhhcCCCCccCCCCHHHHHHHHHH
Q 024027 221 QCVSFVFNLAMACTVESPEQRINAKEIVTKLLK 253 (273)
Q Consensus 221 ~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 253 (273)
..+.++.+++.+||..||.+|||+.+++.|-+-
T Consensus 265 ~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~ 297 (334)
T cd07855 265 KASPEALDLLSQMLQFDPEERITVEQALQHPFL 297 (334)
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHHhChhh
Confidence 457889999999999999999999999998663
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=253.59 Aligned_cols=245 Identities=24% Similarity=0.217 Sum_probs=184.3
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCC-----ceeEEEeccCCCCHHHhhhcCCCCCCHH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEE-----FKALVLEYMPHGSLEKYLYSSNCILDIF 73 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 73 (273)
+.||||++.... ....+.+.+|+.+++.++|+||+++++++.... .++++|||+++ +|.+++.... .+++.
T Consensus 26 ~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~-~l~~~ 103 (330)
T cd07834 26 RKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQ-PLTDD 103 (330)
T ss_pred cEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchhh-hHHHHHhCCC-CCCHH
Confidence 368999997543 345577899999999999999999999998775 78999999975 8999986544 79999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCc-ceeecccccCCCCCCcccCC
Q 024027 74 QRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQS-MTQTQTLATIGYMAPEYGRE 152 (273)
Q Consensus 74 ~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~ 152 (273)
.++.++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||.+......... .......++..|+|||.+.+
T Consensus 104 ~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 180 (330)
T cd07834 104 HIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLS 180 (330)
T ss_pred HHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeec
Confidence 99999999999999999 999999999999999999999999999999876433210 11233457888999999988
Q ss_pred C-CcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCcc-----------chhhhhhhccccchhhhhhhh
Q 024027 153 G-RVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPIS-----------TMEVVDANLLSQEDIHFVAKE 220 (273)
Q Consensus 153 ~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~ 220 (273)
. .++.++|+||+|+++++|++|..||......+. ............ ....................+
T Consensus 181 ~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (330)
T cd07834 181 SSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ-LNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFP 259 (330)
T ss_pred ccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH-HHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcc
Confidence 7 789999999999999999999999976543211 111111111000 000011000000111111123
Q ss_pred hhHHHHHHHHhhcCCCCccCCCCHHHHHHHH
Q 024027 221 QCVSFVFNLAMACTVESPEQRINAKEIVTKL 251 (273)
Q Consensus 221 ~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l 251 (273)
.++.++.+++.+||..+|.+|||+.+++.|-
T Consensus 260 ~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 290 (330)
T cd07834 260 GASPEAIDLLEKMLVFDPKKRITADEALAHP 290 (330)
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHHhCc
Confidence 4677899999999999999999999999873
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=252.33 Aligned_cols=246 Identities=20% Similarity=0.193 Sum_probs=180.2
Q ss_pred CeEEEEEeecccChh--------------hhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcC
Q 024027 1 MEVAVKVFNLQCGRA--------------FKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS 66 (273)
Q Consensus 1 ~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 66 (273)
+.||||+++...... ...+.+|+++++.++|+||+++++++..+...+++|||+++ +|.+++...
T Consensus 35 ~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~ 113 (335)
T PTZ00024 35 KIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRK 113 (335)
T ss_pred CeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCCcEEEEEecccc-CHHHHHHhc
Confidence 469999987543211 12477899999999999999999999999999999999975 999998643
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCC------------cce
Q 024027 67 NCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQ------------SMT 134 (273)
Q Consensus 67 ~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~------------~~~ 134 (273)
..+++..+..++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||.+........ ...
T Consensus 114 -~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (335)
T PTZ00024 114 -IRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189 (335)
T ss_pred -CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEECCccceeeccccccccccccccccccccc
Confidence 46899999999999999999999 99999999999999999999999999999876531110 111
Q ss_pred eecccccCCCCCCcccCCC-CcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhh--------
Q 024027 135 QTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVD-------- 205 (273)
Q Consensus 135 ~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 205 (273)
.....++..|+|||.+.+. .++.++|+||||++++++++|..||......+ .+................+
T Consensus 190 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~ 268 (335)
T PTZ00024 190 MTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID-QLGRIFELLGTPNEDNWPQAKKLPLYT 268 (335)
T ss_pred ccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCchhhCcchhhccccc
Confidence 1223457789999988764 46899999999999999999999987644322 1111111111110000000
Q ss_pred hhccccchhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 206 ANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
................++.++.+++.+||..+|.+|||+++++.|-+
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~ 315 (335)
T PTZ00024 269 EFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEY 315 (335)
T ss_pred ccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcc
Confidence 00000011111122345677999999999999999999999998765
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=244.48 Aligned_cols=223 Identities=24% Similarity=0.285 Sum_probs=181.2
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcC---CCCCCHHHH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS---NCILDIFQR 75 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~ 75 (273)
+.||+|.+.... ......+.+|+++++.++|+||+++.+++......++|+||+++++|.+++... +..+++..+
T Consensus 26 ~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~ 105 (256)
T cd08530 26 QFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEI 105 (256)
T ss_pred CEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHH
Confidence 368999987542 344567788999999999999999999999999999999999999999998652 345899999
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCc
Q 024027 76 LNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRV 155 (273)
Q Consensus 76 ~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~ 155 (273)
+.++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||++...... ......++..|+|||.+.+..+
T Consensus 106 ~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~ 178 (256)
T cd08530 106 WRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN----MAKTQIGTPHYMAPEVWKGRPY 178 (256)
T ss_pred HHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC----CcccccCCccccCHHHHCCCCC
Confidence 999999999999999 999999999999999999999999999998765332 2223457888999999988889
Q ss_pred CCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCC
Q 024027 156 STNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTV 235 (273)
Q Consensus 156 ~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 235 (273)
+.++|+||+|++++++++|..||......+. ...... . .....+...+.++.+++.+||.
T Consensus 179 ~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~--~~~~~~------------~------~~~~~~~~~~~~~~~li~~~l~ 238 (256)
T cd08530 179 SYKSDIWSLGCLLYEMATFAPPFEARSMQDL--RYKVQR------------G------KYPPIPPIYSQDLQNFIRSMLQ 238 (256)
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHhc------------C------CCCCCchhhCHHHHHHHHHHcC
Confidence 9999999999999999999999865432211 000000 0 0001123456779999999999
Q ss_pred CCccCCCCHHHHHHH
Q 024027 236 ESPEQRINAKEIVTK 250 (273)
Q Consensus 236 ~dp~~Rps~~~~l~~ 250 (273)
.+|.+|||+.++++|
T Consensus 239 ~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 239 VKPKLRPNCDKILAS 253 (256)
T ss_pred CCcccCCCHHHHhcC
Confidence 999999999999876
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=242.98 Aligned_cols=223 Identities=29% Similarity=0.323 Sum_probs=180.7
Q ss_pred CeEEEEEeecccC---hhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQCG---RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
++||+|+++.... .....+..|+++++.++|+||+++++.+..+...+++|||+++++|.+++.... .+++..+..
T Consensus 19 ~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~ 97 (250)
T cd05123 19 KLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEG-RFSEERARF 97 (250)
T ss_pred cEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhcC-CCCHHHHHH
Confidence 4789999875532 245678999999999999999999999999999999999999999999997654 589999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
++.|++.|+.+|| +.+++|+||+|+||+++.++.++|+|||.+....... .......++..|.|||...+...+.
T Consensus 98 ~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~ 172 (250)
T cd05123 98 YAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTPEYLAPEVLLGKGYGK 172 (250)
T ss_pred HHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcCCccccChHHhCCCCCCc
Confidence 9999999999999 9999999999999999999999999999987653321 1223345778899999998888899
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
++|+||||++++++++|..||....... ....... .....+...+..+.+++.+||..|
T Consensus 173 ~~D~~slG~~~~~l~~g~~p~~~~~~~~-~~~~~~~--------------------~~~~~~~~~~~~l~~~i~~~l~~~ 231 (250)
T cd05123 173 AVDWWSLGVLLYEMLTGKPPFYAEDRKE-IYEKILK--------------------DPLRFPEFLSPEARDLISGLLQKD 231 (250)
T ss_pred hhhHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHhc--------------------CCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9999999999999999999986533211 0100000 011123344677999999999999
Q ss_pred ccCCCCH---HHHHHH
Q 024027 238 PEQRINA---KEIVTK 250 (273)
Q Consensus 238 p~~Rps~---~~~l~~ 250 (273)
|.+||++ .++++|
T Consensus 232 p~~R~~~~~~~~l~~~ 247 (250)
T cd05123 232 PTKRLGSGGAEEIKAH 247 (250)
T ss_pred HhhCCCcccHHHHHhC
Confidence 9999999 666654
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=253.07 Aligned_cols=242 Identities=22% Similarity=0.223 Sum_probs=175.5
Q ss_pred CeEEEEEeecc-cChhhhhHHHHHHHHhcCCCccceeeeeeeecC-----CceeEEEeccCCCCHHHhhhcCCCCCCHHH
Q 024027 1 MEVAVKVFNLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNE-----EFKALVLEYMPHGSLEKYLYSSNCILDIFQ 74 (273)
Q Consensus 1 ~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (273)
++||||+++.. .......+.+|+.+++.++|+||+++++++... ...++++||+++ +|.+++... .+++..
T Consensus 31 ~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~--~l~~~~ 107 (336)
T cd07849 31 VKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQ--HLSNDH 107 (336)
T ss_pred CeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhccc-CHHHHHhcC--CCCHHH
Confidence 47999998643 234456688899999999999999999987544 357899999965 898888543 589999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCc-ceeecccccCCCCCCcccCC-
Q 024027 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQS-MTQTQTLATIGYMAPEYGRE- 152 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~- 152 (273)
+..++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||++......... .......++..|+|||.+.+
T Consensus 108 ~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 184 (336)
T cd07849 108 IQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNS 184 (336)
T ss_pred HHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCC
Confidence 9999999999999999 999999999999999999999999999998765322211 11223467889999998654
Q ss_pred CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhh-----------ccccchh-hhhhhh
Q 024027 153 GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDAN-----------LLSQEDI-HFVAKE 220 (273)
Q Consensus 153 ~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~-~~~~~~ 220 (273)
..++.++|+||+|+++|+|++|+.||....... ............ ..+..... ....... .....+
T Consensus 185 ~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (336)
T cd07849 185 KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH-QLNLILGVLGTP-SQEDLNCIISLRARNYIKSLPFKPKVPWNKLFP 262 (336)
T ss_pred CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCC-CHHHHHHhhchhhhhHHhhcCcCCcccHHHHhc
Confidence 468899999999999999999999996532211 111111100000 00000000 0000000 011123
Q ss_pred hhHHHHHHHHhhcCCCCccCCCCHHHHHHH
Q 024027 221 QCVSFVFNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 221 ~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
..+.++.+++.+||..||++|||+.++++|
T Consensus 263 ~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 263 NADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred ccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 456779999999999999999999999998
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=242.60 Aligned_cols=211 Identities=20% Similarity=0.162 Sum_probs=167.0
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
+.||+|+++..+ .+..|...+....||||+++++++.+....+++|||+++++|.+++.+.. .+++..+..++.
T Consensus 19 ~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~ 92 (237)
T cd05576 19 QTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFL-NIPEECVKRWAA 92 (237)
T ss_pred cEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhc-CCCHHHHHHHHH
Confidence 368999997552 23445555556679999999999999999999999999999999986543 589999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
|++.||.||| +.|++|+||||+||+++.++.++++|||.+...... .....++..|+|||...+..++.++|
T Consensus 93 ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~D 164 (237)
T cd05576 93 EMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYCAPEVGGISEETEACD 164 (237)
T ss_pred HHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCccccCCcccCCCCCCchhh
Confidence 9999999999 999999999999999999999999999987654221 12234566799999998888899999
Q ss_pred hHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccC
Q 024027 161 VYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQ 240 (273)
Q Consensus 161 iwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 240 (273)
+||+|+++|++++|..|+........ .......+..++..+.+++.+||..||.+
T Consensus 165 vwslG~il~el~~g~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~ 219 (237)
T cd05576 165 WWSLGAILFELLTGKTLVECHPSGIN-------------------------THTTLNIPEWVSEEARSLLQQLLQFNPTE 219 (237)
T ss_pred HHHHHHHHHHHHHCcchhhcCchhcc-------------------------cccccCCcccCCHHHHHHHHHHccCCHHH
Confidence 99999999999999988643211000 00000113445677999999999999999
Q ss_pred CCCH-----HHHHHH
Q 024027 241 RINA-----KEIVTK 250 (273)
Q Consensus 241 Rps~-----~~~l~~ 250 (273)
||++ +++++|
T Consensus 220 R~~~~~~~~~~~~~h 234 (237)
T cd05576 220 RLGAGVAGVEDIKSH 234 (237)
T ss_pred hcCCCccchHHHHcC
Confidence 9996 565543
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=248.12 Aligned_cols=230 Identities=24% Similarity=0.282 Sum_probs=175.9
Q ss_pred CeEEEEEeeccc-ChhhhhHHHHHHHHhcCC-CccceeeeeeeecCCceeEEEeccCCCCHHHhhh----cCCCCCCHHH
Q 024027 1 MEVAVKVFNLQC-GRAFKSFDVECEMMKSIR-HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY----SSNCILDIFQ 74 (273)
Q Consensus 1 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~ 74 (273)
+.||||.+.... ......+..|+.++.++. |+||+++++++..+...+++|||+.. ++.++.. .....+++..
T Consensus 30 ~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~ 108 (288)
T cd06616 30 TIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEI 108 (288)
T ss_pred CEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-CHHHHHHHHHHhhcCCCCHHH
Confidence 468999987543 345667889999999996 99999999999999999999999964 6655432 1234689999
Q ss_pred HHHHHHHHHHHHHHHhcCCC-CCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCC
Q 024027 75 RLNIMIDVASALEYLHFGCS-APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG 153 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~-~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 153 (273)
+..++.|++.||+||| + .+++|+||+|+||+++.++.++|+|||++..+.... ......++..|+|||.+.+.
T Consensus 109 ~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~ 182 (288)
T cd06616 109 LGKIAVATVKALNYLK---EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPS 182 (288)
T ss_pred HHHHHHHHHHHHHHHh---hcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC---ccccccCccCccCHHHhccc
Confidence 9999999999999999 6 599999999999999999999999999987653221 11233577889999998766
Q ss_pred ---CcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHH
Q 024027 154 ---RVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLA 230 (273)
Q Consensus 154 ---~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 230 (273)
.++.++|+||+|+++|++++|..||................. ........+..++.++.+|+
T Consensus 183 ~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~l~~li 247 (288)
T cd06616 183 ARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGD---------------PPILSNSEEREFSPSFVNFI 247 (288)
T ss_pred cccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCC---------------CCcCCCcCCCccCHHHHHHH
Confidence 588999999999999999999999875431100000000000 00001111234677899999
Q ss_pred hhcCCCCccCCCCHHHHHHHHH
Q 024027 231 MACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 231 ~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
.+||..||.+|||+++++.+-.
T Consensus 248 ~~~l~~~p~~Rpt~~~i~~~~~ 269 (288)
T cd06616 248 NLCLIKDESKRPKYKELLEHPF 269 (288)
T ss_pred HHHccCChhhCcCHHHHhcChh
Confidence 9999999999999999999844
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=247.90 Aligned_cols=228 Identities=23% Similarity=0.281 Sum_probs=175.6
Q ss_pred CeEEEEEeeccc-ChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 1 MEVAVKVFNLQC-GRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 1 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
++||||.++... ......+..|+.++... .|+||+++++++.+....+++|||+++ ++.+++......+++..+..+
T Consensus 41 ~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i 119 (296)
T cd06618 41 HVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMST-CLDKLLKRIQGPIPEDILGKM 119 (296)
T ss_pred eEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccCc-CHHHHHHHhcCCCCHHHHHHH
Confidence 479999997543 33455677788777777 599999999999999999999999955 888887665557899999999
Q ss_pred HHHHHHHHHHHhcCCC-CCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCC---
Q 024027 79 MIDVASALEYLHFGCS-APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGR--- 154 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~-~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--- 154 (273)
+.|++.|+.||| + .|++|+||+|+||+++.++.++|+|||++..+..... .....++..|+|||.+.+..
T Consensus 120 ~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~ 193 (296)
T cd06618 120 TVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA---KTRSAGCAAYMAPERIDPPDPNP 193 (296)
T ss_pred HHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc---ccCCCCCccccCHhhcCCCCCcc
Confidence 999999999999 7 5999999999999999999999999999876532211 12234677899999887553
Q ss_pred -cCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhc
Q 024027 155 -VSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMAC 233 (273)
Q Consensus 155 -~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 233 (273)
++.++|+||||+++|+|++|..||................... . ......++.++.+|+.+|
T Consensus 194 ~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~------------~-----~~~~~~~~~~l~~li~~~ 256 (296)
T cd06618 194 KYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPP------------S-----LPPNEGFSPDFCSFVDLC 256 (296)
T ss_pred ccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCC------------C-----CCCCCCCCHHHHHHHHHH
Confidence 7889999999999999999999986532221111111110000 0 000113566799999999
Q ss_pred CCCCccCCCCHHHHHHHHH
Q 024027 234 TVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 234 l~~dp~~Rps~~~~l~~l~ 252 (273)
|..||.+||++++++.+-+
T Consensus 257 l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 257 LTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred ccCChhhCCCHHHHhcChh
Confidence 9999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=252.79 Aligned_cols=248 Identities=23% Similarity=0.215 Sum_probs=181.0
Q ss_pred CeEEEEEeecc--cChhhhhHHHHHHHHhcCCCccceeeeeeeecC-----CceeEEEeccCCCCHHHhhhcCCCCCCHH
Q 024027 1 MEVAVKVFNLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNE-----EFKALVLEYMPHGSLEKYLYSSNCILDIF 73 (273)
Q Consensus 1 ~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 73 (273)
+.||||.++.. .......+.+|+.+++.++|+||+++++++... ...++++||+. ++|.+++... ..+++.
T Consensus 31 ~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~l~~~ 108 (337)
T cd07858 31 EKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRSS-QTLSDD 108 (337)
T ss_pred CeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHhcC-CCCCHH
Confidence 36999998753 233455677899999999999999999988654 34799999996 5999998654 469999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC-
Q 024027 74 QRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE- 152 (273)
Q Consensus 74 ~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~- 152 (273)
.+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+
T Consensus 109 ~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~ 183 (337)
T cd07858 109 HCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNC 183 (337)
T ss_pred HHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc--ccccccccccCccChHHHhcC
Confidence 99999999999999999 9999999999999999999999999999987653221 12233457888999998765
Q ss_pred CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCc-----------cchhhhhhhccccchhhhhhhhh
Q 024027 153 GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPI-----------STMEVVDANLLSQEDIHFVAKEQ 221 (273)
Q Consensus 153 ~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~ 221 (273)
..++.++|+||||+++|+|++|..||...... ............. .....................+.
T Consensus 184 ~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (337)
T cd07858 184 SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV-HQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPH 262 (337)
T ss_pred CCCCCcccHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHccc
Confidence 45899999999999999999999998653211 1111111100000 00000000000000111112345
Q ss_pred hHHHHHHHHhhcCCCCccCCCCHHHHHHH--HHHHHH
Q 024027 222 CVSFVFNLAMACTVESPEQRINAKEIVTK--LLKIRD 256 (273)
Q Consensus 222 ~~~~l~~li~~~l~~dp~~Rps~~~~l~~--l~~~~~ 256 (273)
++.++.+++.+||..||++|||++++++| +..+..
T Consensus 263 ~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~ 299 (337)
T cd07858 263 ANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299 (337)
T ss_pred CCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence 77889999999999999999999999999 554433
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=248.13 Aligned_cols=225 Identities=24% Similarity=0.349 Sum_probs=178.2
Q ss_pred eEEEEEeecc---cChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 2 EVAVKVFNLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 2 ~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
.||||.+... .......+.+|+++++.++|+|++++++++......++|+||+. +++.+++......+++..+..+
T Consensus 42 ~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~ 120 (308)
T cd06634 42 VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAV 120 (308)
T ss_pred EEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHH
Confidence 6899998642 23345678889999999999999999999999999999999997 4888887655566899999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccC---CCCc
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR---EGRV 155 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~ 155 (273)
+.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||++..... .....++..|+|||.+. ...+
T Consensus 121 ~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~ 191 (308)
T cd06634 121 THGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANXFVGTPYWMAPEVILAMDEGQY 191 (308)
T ss_pred HHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecC------cccccCCccccCHHHHhhcccCCC
Confidence 999999999999 99999999999999999999999999999875422 12345778899999874 3457
Q ss_pred CCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCC
Q 024027 156 STNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTV 235 (273)
Q Consensus 156 ~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 235 (273)
+.++|||||||+++++++|..||.......... ..... .........++..+.+|+.+||.
T Consensus 192 ~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~~~~~------------------~~~~~~~~~~~~~~~~li~~cl~ 252 (308)
T cd06634 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQN------------------ESPALQSGHWSEYFRNFVDSCLQ 252 (308)
T ss_pred CcccchHHHHHHHHHHHcCCCCCccccHHHHHH-HHhhc------------------CCCCcCcccccHHHHHHHHHHhh
Confidence 889999999999999999999986532221111 00000 00001123456679999999999
Q ss_pred CCccCCCCHHHHHHHHHHHH
Q 024027 236 ESPEQRINAKEIVTKLLKIR 255 (273)
Q Consensus 236 ~dp~~Rps~~~~l~~l~~~~ 255 (273)
.+|.+||++++++++-+...
T Consensus 253 ~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 253 KIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred CCcccCCCHHHHhhCccccc
Confidence 99999999999999876443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=247.65 Aligned_cols=225 Identities=27% Similarity=0.406 Sum_probs=181.8
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCC-CccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIR-HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (273)
++||+|++.... ......+..|+++++.+. |+||+++++++..+...+++||++++++|.+++...+ .+++..++
T Consensus 27 ~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~ 105 (280)
T cd05581 27 KEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYG-SLDEKCTR 105 (280)
T ss_pred CEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHcC-CCCHHHHH
Confidence 479999997532 334567889999999998 9999999999999999999999999999999997654 69999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCc------------------ceeecc
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQS------------------MTQTQT 138 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~------------------~~~~~~ 138 (273)
.++.|++.||.+|| +.|++|+||+|+||+++.++.++++|||++......... ......
T Consensus 106 ~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (280)
T cd05581 106 FYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASF 182 (280)
T ss_pred HHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccc
Confidence 99999999999999 999999999999999999999999999998765432221 112233
Q ss_pred cccCCCCCCcccCCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhh
Q 024027 139 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVA 218 (273)
Q Consensus 139 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (273)
.++..|+|||...+..++.++|+||||++++++++|..||........ ..... ......
T Consensus 183 ~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~--------------------~~~~~~ 241 (280)
T cd05581 183 VGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT-FQKIL--------------------KLEYSF 241 (280)
T ss_pred cCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH-HHHHH--------------------hcCCCC
Confidence 567889999998888899999999999999999999999875431110 00000 011111
Q ss_pred hhhhHHHHHHHHhhcCCCCccCCCCH----HHHHHH
Q 024027 219 KEQCVSFVFNLAMACTVESPEQRINA----KEIVTK 250 (273)
Q Consensus 219 ~~~~~~~l~~li~~~l~~dp~~Rps~----~~~l~~ 250 (273)
+...+..+.+++.+||..||.+|||+ .++++|
T Consensus 242 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 242 PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred CCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 33446679999999999999999999 888875
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=245.23 Aligned_cols=243 Identities=26% Similarity=0.241 Sum_probs=181.3
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
++||+|+++... ......+..|+.+++.++|+|++++++++.+....++|+||+++ +|.+++......+++..+..+
T Consensus 25 ~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~i~~~~~~~~~~~~~~~ 103 (282)
T cd07829 25 EIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSI 103 (282)
T ss_pred cEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcCc-CHHHHHHhhccCCCHHHHHHH
Confidence 479999998653 33456788899999999999999999999999999999999975 999999776557999999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCC-CcCC
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG-RVST 157 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~ 157 (273)
+.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+. .++.
T Consensus 104 ~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~ 178 (282)
T cd07829 104 MYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--TYTHEVVTLWYRAPEILLGSKHYST 178 (282)
T ss_pred HHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--ccCccccCcCcCChHHhcCCcCCCc
Confidence 999999999999 99999999999999999999999999999876533221 12223456789999988766 7899
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhh--------hhhhcccc-chhhhhhhhhhHHHHHH
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEV--------VDANLLSQ-EDIHFVAKEQCVSFVFN 228 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~-~~~~~~~~~~~~~~l~~ 228 (273)
++|+||||++++++++|..||........ ................ ........ ........+..+..+.+
T Consensus 179 ~~Dv~slG~~l~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (282)
T cd07829 179 AVDIWSVGCIFAEMITGKPLFPGDSEIDQ-LFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGID 257 (282)
T ss_pred cccHHHHHHHHHHHHhCCCCCCCccHHHH-HHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHH
Confidence 99999999999999999999866432211 1111111000000000 00000000 00000111233677999
Q ss_pred HHhhcCCCCccCCCCHHHHHHH
Q 024027 229 LAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 229 li~~~l~~dp~~Rps~~~~l~~ 250 (273)
++.+||..||++||++.+++.|
T Consensus 258 ~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 258 LLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred HHHHhhccCcccCCCHHHHhhC
Confidence 9999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=244.83 Aligned_cols=226 Identities=19% Similarity=0.224 Sum_probs=173.4
Q ss_pred CeEEEEEeecccC---hhhhhHHHHHH---HHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHH
Q 024027 1 MEVAVKVFNLQCG---RAFKSFDVECE---MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQ 74 (273)
Q Consensus 1 ~~vavK~~~~~~~---~~~~~~~~E~~---~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (273)
+.||+|++..... .....+..|.. +++...||+|+++++++..+...++||||++|++|.+++... ..+++..
T Consensus 20 ~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~-~~l~~~~ 98 (278)
T cd05606 20 KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEAE 98 (278)
T ss_pred CEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhc-CCCCHHH
Confidence 4799999865421 11122334433 444557999999999999999999999999999999998654 4689999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCC-
Q 024027 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG- 153 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~- 153 (273)
+..++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||++..+... ......++..|+|||.+.+.
T Consensus 99 ~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~ 171 (278)
T cd05606 99 MRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKGV 171 (278)
T ss_pred HHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc----CCcCcCCCcCCcCcHHhcCCC
Confidence 9999999999999999 999999999999999999999999999998754221 12234688899999998744
Q ss_pred CcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhc
Q 024027 154 RVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMAC 233 (273)
Q Consensus 154 ~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 233 (273)
.++.++|+||+|+++++|++|..||............ .. .. ......+..++.++.+++.+|
T Consensus 172 ~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~--~~------------~~----~~~~~~~~~~s~~~~~li~~~ 233 (278)
T cd05606 172 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID--RM------------TL----TMAVELPDSFSPELRSLLEGL 233 (278)
T ss_pred CCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH--HH------------hh----ccCCCCCCcCCHHHHHHHHHH
Confidence 5889999999999999999999998764222111000 00 00 001111334567799999999
Q ss_pred CCCCccCCC-----CHHHHHHHHH
Q 024027 234 TVESPEQRI-----NAKEIVTKLL 252 (273)
Q Consensus 234 l~~dp~~Rp-----s~~~~l~~l~ 252 (273)
|..+|.+|| ++.++++|-+
T Consensus 234 l~~~p~~R~~~~~~~~~~ll~~~~ 257 (278)
T cd05606 234 LQRDVNRRLGCLGRGAQEVKEHPF 257 (278)
T ss_pred hhcCHHhccCCCCCCHHHHHhCcc
Confidence 999999999 9999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=264.44 Aligned_cols=233 Identities=18% Similarity=0.194 Sum_probs=167.5
Q ss_pred hhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC----CCCCHHHHHHHHHHHHHHHHHHh
Q 024027 15 AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN----CILDIFQRLNIMIDVASALEYLH 90 (273)
Q Consensus 15 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~ql~~~l~~lh 90 (273)
....+.+|+.+|+.++||||+++++++..+...+++++++.+ +|.+++.... .......+..++.|++.||.|||
T Consensus 206 ~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH 284 (501)
T PHA03210 206 AAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH 284 (501)
T ss_pred HHHHHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 455688999999999999999999999999999999999955 8888774332 12345677889999999999999
Q ss_pred cCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcchhHHHHHHHHH
Q 024027 91 FGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLME 170 (273)
Q Consensus 91 ~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ 170 (273)
+.|++|+||||+||+++.++.+||+|||++..+..... .......|+..|+|||++.+..++.++|||||||++|+
T Consensus 285 ---~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e 360 (501)
T PHA03210 285 ---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLD 360 (501)
T ss_pred ---hCCeecCCCCHHHEEECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHH
Confidence 99999999999999999999999999999976532211 12223568999999999999899999999999999999
Q ss_pred HHhCCCCCccccccc--cchhhhhhhcc------Cc---cchhhhhhhccc---cchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 171 TFTGKKPTYEFFNGE--MTLKHWVNDWL------PI---STMEVVDANLLS---QEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 171 ll~g~~pf~~~~~~~--~~~~~~~~~~~------~~---~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
|++|..++....... ..+........ +. .....+...... ............+..+.+++.+||.+
T Consensus 361 ll~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~ 440 (501)
T PHA03210 361 MLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTF 440 (501)
T ss_pred HHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhcc
Confidence 999875433222211 11111111100 00 000000000000 00001111123456688999999999
Q ss_pred CccCCCCHHHHHHHHH
Q 024027 237 SPEQRINAKEIVTKLL 252 (273)
Q Consensus 237 dp~~Rps~~~~l~~l~ 252 (273)
||++|||+.|+++|-.
T Consensus 441 DP~~Rpsa~elL~hp~ 456 (501)
T PHA03210 441 DWHLRPGAAELLALPL 456 (501)
T ss_pred CcccCcCHHHHhhChh
Confidence 9999999999998744
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=250.74 Aligned_cols=243 Identities=26% Similarity=0.294 Sum_probs=177.1
Q ss_pred CeEEEEEeecc--cChhhhhHHHHHHHHhcC-CCccceeeeeeeecC--CceeEEEeccCCCCHHHhhhcCCCCCCHHHH
Q 024027 1 MEVAVKVFNLQ--CGRAFKSFDVECEMMKSI-RHRNLIKVISSCSNE--EFKALVLEYMPHGSLEKYLYSSNCILDIFQR 75 (273)
Q Consensus 1 ~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (273)
++||||++... .......+.+|+.+++++ +||||++++++|... ...++||||+++ +|.+++... .+++..+
T Consensus 33 ~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~--~~~~~~~ 109 (337)
T cd07852 33 EVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRAN--ILEDVHK 109 (337)
T ss_pred eEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEeccccc-CHHHHHhcC--CCCHHHH
Confidence 36899988542 233456677899999999 999999999998653 468999999975 999998654 6888999
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCc---ceeecccccCCCCCCcccCC
Q 024027 76 LNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQS---MTQTQTLATIGYMAPEYGRE 152 (273)
Q Consensus 76 ~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~ 152 (273)
..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||.+......... .......++..|+|||.+.+
T Consensus 110 ~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 186 (337)
T cd07852 110 RYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLG 186 (337)
T ss_pred HHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeec
Confidence 999999999999999 999999999999999999999999999998765433221 12223457889999998765
Q ss_pred -CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccc-----------hhhhhhhccccchhhhhhhh
Q 024027 153 -GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPIST-----------MEVVDANLLSQEDIHFVAKE 220 (273)
Q Consensus 153 -~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~ 220 (273)
..++.++|+||||+++|+|++|+.||........ ............. ....................
T Consensus 187 ~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (337)
T cd07852 187 STRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLP 265 (337)
T ss_pred cccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhcc
Confidence 4578899999999999999999999865433221 1111111100000 00000000000000011112
Q ss_pred hhHHHHHHHHhhcCCCCccCCCCHHHHHHH
Q 024027 221 QCVSFVFNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 221 ~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
.++.++.+++.+||..||.+|||+.+++++
T Consensus 266 ~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 266 KASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred CCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 367789999999999999999999999987
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=259.69 Aligned_cols=226 Identities=24% Similarity=0.372 Sum_probs=188.4
Q ss_pred eEEEEEeecccCh-hhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhc-CCCCCCHHHHHHHH
Q 024027 2 EVAVKVFNLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIM 79 (273)
Q Consensus 2 ~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ 79 (273)
.||||+++.+... ...+|.+|+.+|.+|+|+|++++||++.+ ....||||.++.|+|.+.|.+ ....+.....-.++
T Consensus 140 ~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya 218 (1039)
T KOG0199|consen 140 NVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYA 218 (1039)
T ss_pred eEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHH
Confidence 6999999977644 78889999999999999999999999987 667899999999999999987 44557788889999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCccee-ecccccCCCCCCcccCCCCcCCc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQ-TQTLATIGYMAPEYGREGRVSTN 158 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~ 158 (273)
.||+.|+.||. .++++|||+...|+++.....|||+|||+.+.+......... ....-..-|+|||.+....++.+
T Consensus 219 ~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFSha 295 (1039)
T KOG0199|consen 219 MQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHA 295 (1039)
T ss_pred HHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhcccccccc
Confidence 99999999999 999999999999999999999999999999887544443322 23334667999999999999999
Q ss_pred chhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 159 GDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 159 ~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
+|+|++||.+|||++ |..||.+-..-. +++ ..........+..|++.+++++..||..+
T Consensus 296 SDvWmyGVTiWEMFtyGEePW~G~~g~q-----------------IL~---~iD~~erLpRPk~csedIY~imk~cWah~ 355 (1039)
T KOG0199|consen 296 SDVWMYGVTIWEMFTYGEEPWVGCRGIQ-----------------ILK---NIDAGERLPRPKYCSEDIYQIMKNCWAHN 355 (1039)
T ss_pred chhhhhhhhHHhhhccCCCCCCCCCHHH-----------------HHH---hccccccCCCCCCChHHHHHHHHHhccCC
Confidence 999999999999998 888986522111 111 11133344557889999999999999999
Q ss_pred ccCCCCHHHHHHHH
Q 024027 238 PEQRINAKEIVTKL 251 (273)
Q Consensus 238 p~~Rps~~~~l~~l 251 (273)
|++|||+..|.+.+
T Consensus 356 paDRptFsair~~~ 369 (1039)
T KOG0199|consen 356 PADRPTFSAIREDL 369 (1039)
T ss_pred ccccccHHHHHHhH
Confidence 99999999997443
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=245.84 Aligned_cols=244 Identities=23% Similarity=0.219 Sum_probs=177.8
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCC----------ceeEEEeccCCCCHHHhhhcCCC
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEE----------FKALVLEYMPHGSLEKYLYSSNC 68 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----------~~~lv~e~~~~~~L~~~l~~~~~ 68 (273)
+.||||+++... ......+.+|+++++.++|||++++++++.+.. .+++++||+++ ++..++.....
T Consensus 33 ~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~ 111 (302)
T cd07864 33 ELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLV 111 (302)
T ss_pred cEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCCC
Confidence 368999997553 223456778999999999999999999987654 78999999976 88888866555
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCc
Q 024027 69 ILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPE 148 (273)
Q Consensus 69 ~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE 148 (273)
.+++..++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||.+........ .......++..|+|||
T Consensus 112 ~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE 187 (302)
T cd07864 112 HFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES-RPYTNKVITLWYRPPE 187 (302)
T ss_pred CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCcccccccccCCcc-cccccceeccCccChH
Confidence 7999999999999999999999 99999999999999999999999999999876533221 1112234577899999
Q ss_pred ccCCC-CcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchh---hhhhhcc-------ccchhhhh
Q 024027 149 YGREG-RVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTME---VVDANLL-------SQEDIHFV 217 (273)
Q Consensus 149 ~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~-------~~~~~~~~ 217 (273)
.+.+. .++.++|+||+||+++++++|++||..... ......+........... ....... ........
T Consensus 188 ~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (302)
T cd07864 188 LLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-LAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLRE 266 (302)
T ss_pred HhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCChhhcccccccccccccccccccccchhh
Confidence 87653 478899999999999999999999875322 122222221111110000 0000000 00000011
Q ss_pred hhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHH
Q 024027 218 AKEQCVSFVFNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 218 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
....++..+.+++.+||..||.+|||+.+++++
T Consensus 267 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 267 EFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 122356779999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=252.72 Aligned_cols=244 Identities=22% Similarity=0.238 Sum_probs=176.3
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecC--------------CceeEEEeccCCCCHHHhhhcC
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNE--------------EFKALVLEYMPHGSLEKYLYSS 66 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--------------~~~~lv~e~~~~~~L~~~l~~~ 66 (273)
+.||+|++........+.+.+|+++++.++||||+++++++... ...++|+||+++ +|.+++...
T Consensus 31 ~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~ 109 (342)
T cd07854 31 KRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQG 109 (342)
T ss_pred cEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeecccc-cHHHHHHcC
Confidence 37999999876666677899999999999999999999876554 357899999975 998888543
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeC-CCCceEEeecccccccccCCCcc-eeecccccCCC
Q 024027 67 NCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLD-DNLVAYLSDFGIAKLLIGEDQSM-TQTQTLATIGY 144 (273)
Q Consensus 67 ~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~-~~~~~kl~Df~~~~~~~~~~~~~-~~~~~~~~~~~ 144 (273)
.+++..++.++.|++.||.||| +.|++|+||+|+||+++ .++.++++|||.+.......... ......++..|
T Consensus 110 --~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y 184 (342)
T cd07854 110 --PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWY 184 (342)
T ss_pred --CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccc
Confidence 5889999999999999999999 99999999999999997 45678999999987653221111 11223567889
Q ss_pred CCCcccCC-CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhh------hhhh----ccccch
Q 024027 145 MAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEV------VDAN----LLSQED 213 (273)
Q Consensus 145 ~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~----~~~~~~ 213 (273)
+|||.+.. ..++.++|||||||++|+|++|+.||......+. ........+....... .... ......
T Consensus 185 ~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (342)
T cd07854 185 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ-MQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRR 263 (342)
T ss_pred cCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCC
Confidence 99997654 4578899999999999999999999965432211 1111111100000000 0000 000000
Q ss_pred hhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHH
Q 024027 214 IHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKL 251 (273)
Q Consensus 214 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l 251 (273)
.........+.++.+|+.+||..||.+|||+.+++.|=
T Consensus 264 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~ 301 (342)
T cd07854 264 PLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHP 301 (342)
T ss_pred CHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCC
Confidence 00111234667899999999999999999999999873
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=235.15 Aligned_cols=226 Identities=23% Similarity=0.262 Sum_probs=182.8
Q ss_pred eEEEEEeecc-cChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 2 EVAVKVFNLQ-CGRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 2 ~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
-+|||.+... +.+..+.+...+.++..- ++|.||+++|+|..+....+.||.|.- .+..++++...++++..+-++.
T Consensus 119 iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~-C~ekLlkrik~piPE~ilGk~t 197 (391)
T KOG0983|consen 119 IIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST-CAEKLLKRIKGPIPERILGKMT 197 (391)
T ss_pred EEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhH
Confidence 4799999755 456667788888887766 599999999999999999999999944 8888888888889999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCC---CcC
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG---RVS 156 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~ 156 (273)
..++.||.||.+ ++|++|||+||+|||+|..|++||+|||.+-++.. +.......|-+-|+|||.+... .|+
T Consensus 198 va~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd---SkAhtrsAGC~~YMaPERidp~~~~kYD 272 (391)
T KOG0983|consen 198 VAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD---SKAHTRSAGCAAYMAPERIDPPDKPKYD 272 (391)
T ss_pred HHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeec---ccccccccCCccccCccccCCCCCCccc
Confidence 999999999997 78999999999999999999999999999876532 2233445577789999988644 589
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++|+||||+.++|+.||+.||..-..+=..+.......++ ......++++.+.+|+..||.+
T Consensus 273 iRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP-----------------~L~~~~gFSp~F~~fv~~CL~k 335 (391)
T KOG0983|consen 273 IRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPP-----------------LLPGHMGFSPDFQSFVKDCLTK 335 (391)
T ss_pred hhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCC-----------------CCCcccCcCHHHHHHHHHHhhc
Confidence 99999999999999999999998744433333333322111 1111233778899999999999
Q ss_pred CccCCCCHHHHHHH
Q 024027 237 SPEQRINAKEIVTK 250 (273)
Q Consensus 237 dp~~Rps~~~~l~~ 250 (273)
|+.+||...++++|
T Consensus 336 d~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 336 DHRKRPKYNKLLEH 349 (391)
T ss_pred CcccCcchHHHhcC
Confidence 99999999999986
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=234.89 Aligned_cols=251 Identities=18% Similarity=0.252 Sum_probs=187.4
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeec--------CCceeEEEeccCCCCHHHhhhcCCCCC
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSN--------EEFKALVLEYMPHGSLEKYLYSSNCIL 70 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~~~ 70 (273)
++||+|+....+ ........+|+++|..++|+|++.++..|.. ..++|+||++|+. +|..++....-.+
T Consensus 43 kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~ 121 (376)
T KOG0669|consen 43 KKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRF 121 (376)
T ss_pred chhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhcCccccc
Confidence 357777765543 2334567889999999999999999998743 3568999999987 9999998777789
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCC--cceeecccccCCCCCCc
Q 024027 71 DIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQ--SMTQTQTLATIGYMAPE 148 (273)
Q Consensus 71 ~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~--~~~~~~~~~~~~~~aPE 148 (273)
+..+|.+++.++..||.|+| ...|+|||+|+.|++++.++.++|+|||+++.+..... .......+.|.+|++||
T Consensus 122 sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppE 198 (376)
T KOG0669|consen 122 SLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPE 198 (376)
T ss_pred cHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHH
Confidence 99999999999999999999 99999999999999999999999999999976643222 22234567799999999
Q ss_pred ccCCC-CcCCcchhHHHHHHHHHHHhCCCCCccccccccch--hhhh-----hhccCccchhhhhhhccc---cchh---
Q 024027 149 YGREG-RVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTL--KHWV-----NDWLPISTMEVVDANLLS---QEDI--- 214 (273)
Q Consensus 149 ~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~--~~~~-----~~~~~~~~~~~~~~~~~~---~~~~--- 214 (273)
.+.|. .|+++.|||+.||++.+|++|.+-+.+..+..... +... +.|+..+..+..+..... ....
T Consensus 199 llLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv 278 (376)
T KOG0669|consen 199 LLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKV 278 (376)
T ss_pred HhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhh
Confidence 98876 59999999999999999999999887644432111 1111 223333333332222111 1100
Q ss_pred -hhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHHHHH
Q 024027 215 -HFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLLKIR 255 (273)
Q Consensus 215 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 255 (273)
....+..-.++..+|+.+||..||.+|+++++++.|-.-..
T Consensus 279 ~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 279 KNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK 320 (376)
T ss_pred hhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence 11112223457899999999999999999999998865443
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=245.08 Aligned_cols=228 Identities=22% Similarity=0.268 Sum_probs=176.2
Q ss_pred CeEEEEEeeccc----ChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHH
Q 024027 1 MEVAVKVFNLQC----GRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQR 75 (273)
Q Consensus 1 ~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (273)
++||||+++... ......+..|+++++.+ +||||+++++++..+...++||||+++++|.+++... ..+++..+
T Consensus 29 ~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~ 107 (288)
T cd05583 29 KLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQR-EHFTESEV 107 (288)
T ss_pred cEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhc-CCcCHHHH
Confidence 369999997432 23446688999999999 6999999999999999999999999999999998654 35889999
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCC-
Q 024027 76 LNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGR- 154 (273)
Q Consensus 76 ~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~- 154 (273)
..++.|++.+|.||| +.|++|+||+|+||+++.++.++|+|||++........ .......++..|+|||...+..
T Consensus 108 ~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~ 183 (288)
T cd05583 108 RVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE-ERAYSFCGTIEYMAPEVIRGGSG 183 (288)
T ss_pred HHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccccccccc-cccccccCCccccCHHHhcCCCC
Confidence 999999999999999 99999999999999999999999999999876533221 1122345788999999987654
Q ss_pred -cCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhc
Q 024027 155 -VSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMAC 233 (273)
Q Consensus 155 -~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 233 (273)
.+.++|+||+|+++++|++|..||....... ....+..... ......+..++..+.+++.+|
T Consensus 184 ~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~~~~~~~~~----------------~~~~~~~~~~~~~l~~li~~~ 246 (288)
T cd05583 184 GHDKAVDWWSLGVLTFELLTGASPFTVDGEQN-SQSEISRRIL----------------KSKPPFPKTMSAEARDFIQKL 246 (288)
T ss_pred CCcchhhhHHHHHHHHHHHhCCCCcccCcccc-hHHHHHHHHH----------------ccCCCCCcccCHHHHHHHHHH
Confidence 7889999999999999999999986422111 1111111000 000112344567799999999
Q ss_pred CCCCccCCCCHHHHHHH
Q 024027 234 TVESPEQRINAKEIVTK 250 (273)
Q Consensus 234 l~~dp~~Rps~~~~l~~ 250 (273)
|..||++|||+.++.+.
T Consensus 247 l~~~p~~R~t~~~~~~~ 263 (288)
T cd05583 247 LEKDPKKRLGANGADEI 263 (288)
T ss_pred hcCCHhhccCcchHHHH
Confidence 99999999997655443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=242.01 Aligned_cols=242 Identities=22% Similarity=0.238 Sum_probs=177.4
Q ss_pred CeEEEEEeecccC--hhhhhHHHHHHHHhcC---CCccceeeeeeeecCCc-----eeEEEeccCCCCHHHhhhcCC-CC
Q 024027 1 MEVAVKVFNLQCG--RAFKSFDVECEMMKSI---RHRNLIKVISSCSNEEF-----KALVLEYMPHGSLEKYLYSSN-CI 69 (273)
Q Consensus 1 ~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~-~~ 69 (273)
++||||+++.... .....+..|+.+++.+ .|+|++++++++..... .+++|||+++ +|.+++.... ..
T Consensus 25 ~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~-~l~~~l~~~~~~~ 103 (287)
T cd07838 25 RFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPG 103 (287)
T ss_pred CEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhccc-CHHHHHHHccCCC
Confidence 4799999975422 2234566788877766 59999999999988776 8999999975 8999886543 35
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcc
Q 024027 70 LDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEY 149 (273)
Q Consensus 70 ~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~ 149 (273)
+++..++.++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||.+..+..... .....++..|+|||.
T Consensus 104 l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~PE~ 177 (287)
T cd07838 104 LPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA---LTSVVVTLWYRAPEV 177 (287)
T ss_pred CCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCcceeccCCcc---cccccccccccChHH
Confidence 899999999999999999999 99999999999999999999999999999876532221 122346788999999
Q ss_pred cCCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhh------c-cccchhhhhhhhhh
Q 024027 150 GREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDAN------L-LSQEDIHFVAKEQC 222 (273)
Q Consensus 150 ~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~-~~~~~~~~~~~~~~ 222 (273)
+.+..++.++|+||+||++|+|++|.+||......+ ....+................ . ..............
T Consensus 178 ~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (287)
T cd07838 178 LLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD-QLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEI 256 (287)
T ss_pred hccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH-HHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhh
Confidence 988889999999999999999999999987643322 122221111110000000000 0 00000001112345
Q ss_pred HHHHHHHHhhcCCCCccCCCCHHHHHHH
Q 024027 223 VSFVFNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 223 ~~~l~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
+..+.+++.+||..||.+||++.+++.|
T Consensus 257 ~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 257 CEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred hHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 6778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=240.82 Aligned_cols=226 Identities=20% Similarity=0.260 Sum_probs=177.9
Q ss_pred CeEEEEEeecc-----cChhhhhHHHHHHHHhcCCCccceeeeeeeecC--CceeEEEeccCCCCHHHhhhcCCCCCCHH
Q 024027 1 MEVAVKVFNLQ-----CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNE--EFKALVLEYMPHGSLEKYLYSSNCILDIF 73 (273)
Q Consensus 1 ~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 73 (273)
++||+|.+... .......+.+|+++++.++|+||+++++++.+. ..+++++||+++++|.+++...+ .+++.
T Consensus 28 ~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~l~~~ 106 (264)
T cd06653 28 RELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG-ALTEN 106 (264)
T ss_pred CEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcC-CCCHH
Confidence 36999988532 134456788999999999999999999998764 46889999999999999986544 48889
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCC-cceeecccccCCCCCCcccCC
Q 024027 74 QRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQ-SMTQTQTLATIGYMAPEYGRE 152 (273)
Q Consensus 74 ~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~ 152 (273)
.+..++.|++.|+.||| +.|++|+||+|+||+++.++.++|+|||++........ ........++..|+|||.+.+
T Consensus 107 ~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 183 (264)
T cd06653 107 VTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG 183 (264)
T ss_pred HHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcC
Confidence 99999999999999999 99999999999999999999999999999876532111 111123457888999999988
Q ss_pred CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhh
Q 024027 153 GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMA 232 (273)
Q Consensus 153 ~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 232 (273)
..++.++|+||||++++++++|..||........ ..... ........+...+.++.+++.+
T Consensus 184 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~---------------~~~~~~~~p~~~~~~~~~~i~~ 244 (264)
T cd06653 184 EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA----IFKIA---------------TQPTKPMLPDGVSDACRDFLKQ 244 (264)
T ss_pred CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH----HHHHH---------------cCCCCCCCCcccCHHHHHHHHH
Confidence 8899999999999999999999999865321111 10000 0011112255677889999999
Q ss_pred cCCCCccCCCCHHHHHHH
Q 024027 233 CTVESPEQRINAKEIVTK 250 (273)
Q Consensus 233 ~l~~dp~~Rps~~~~l~~ 250 (273)
||. +|..||++.+++.|
T Consensus 245 ~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 245 IFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred Hhc-CcccCccHHHHhcC
Confidence 999 57999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=248.75 Aligned_cols=239 Identities=22% Similarity=0.210 Sum_probs=175.7
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCC------ceeEEEeccCCCCHHHhhhcCCCCCCH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEE------FKALVLEYMPHGSLEKYLYSSNCILDI 72 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~ 72 (273)
+.||||+++... ......+..|+.+++.++||||+++++++..+. .+++|+||+ +++|.+++... .+++
T Consensus 41 ~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~--~l~~ 117 (343)
T cd07880 41 AKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHE--KLSE 117 (343)
T ss_pred cEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhcC--CCCH
Confidence 369999986432 233456889999999999999999999987654 358999999 66999888643 5899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC
Q 024027 73 FQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE 152 (273)
Q Consensus 73 ~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 152 (273)
..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++..... ......+++.|+|||.+.+
T Consensus 118 ~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~ 189 (343)
T cd07880 118 DRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS-----EMTGYVVTRWYRAPEVILN 189 (343)
T ss_pred HHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeccccccccc-----CccccccCCcccCHHHHhC
Confidence 999999999999999999 99999999999999999999999999999875422 1123356788999998875
Q ss_pred -CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccC-----------ccchhhhhhhccccchhhhhhhh
Q 024027 153 -GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLP-----------ISTMEVVDANLLSQEDIHFVAKE 220 (273)
Q Consensus 153 -~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~ 220 (273)
..++.++|+||+|++++++++|..||........ .......... .......................
T Consensus 190 ~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (343)
T cd07880 190 WMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ-LMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLP 268 (343)
T ss_pred CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhcc
Confidence 4588999999999999999999999975432211 1111110000 00000000000000001111234
Q ss_pred hhHHHHHHHHhhcCCCCccCCCCHHHHHHHH
Q 024027 221 QCVSFVFNLAMACTVESPEQRINAKEIVTKL 251 (273)
Q Consensus 221 ~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l 251 (273)
.++.++.+++.+||..||++|||+.+++.|=
T Consensus 269 ~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~ 299 (343)
T cd07880 269 NANPLAVNVLEKMLVLDAESRITAAEALAHP 299 (343)
T ss_pred CCChHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 5677799999999999999999999999663
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=241.99 Aligned_cols=228 Identities=23% Similarity=0.283 Sum_probs=176.8
Q ss_pred CeEEEEEeeccc----ChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHH
Q 024027 1 MEVAVKVFNLQC----GRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQR 75 (273)
Q Consensus 1 ~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (273)
+.||+|+++... ....+.+..|+++++.+ +|+||+++++++..+...++|+||+++++|.+++.... .+++..+
T Consensus 29 ~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~ 107 (290)
T cd05613 29 KLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRE-RFKEQEV 107 (290)
T ss_pred ceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHcC-CCCHHHH
Confidence 368999997532 23346688899999999 69999999999999999999999999999999996543 5889999
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCC--
Q 024027 76 LNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG-- 153 (273)
Q Consensus 76 ~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-- 153 (273)
..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++....... ........++..|+|||.+.+.
T Consensus 108 ~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~ 183 (290)
T cd05613 108 QIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE-VERAYSFCGTIEYMAPDIVRGGDG 183 (290)
T ss_pred HHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc-ccccccccCCcccCChhhccCCCC
Confidence 999999999999999 9999999999999999999999999999987642221 1112234578889999988653
Q ss_pred CcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhc
Q 024027 154 RVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMAC 233 (273)
Q Consensus 154 ~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 233 (273)
.++.++|+||||+++|++++|..||....... ......... .... ...+..++..+.+++.+|
T Consensus 184 ~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-~~~~~~~~~------------~~~~----~~~~~~~~~~~~~ll~~~ 246 (290)
T cd05613 184 GHDKAVDWWSMGVLMYELLTGASPFTVDGEKN-SQAEISRRI------------LKSE----PPYPQEMSALAKDIIQRL 246 (290)
T ss_pred CCCccccHHHHHHHHHHHhcCCCCCCcCCccc-cHHHHHHHh------------hccC----CCCCccCCHHHHHHHHHH
Confidence 46789999999999999999999986421111 111111100 0000 011334566789999999
Q ss_pred CCCCccCCC-----CHHHHHHH
Q 024027 234 TVESPEQRI-----NAKEIVTK 250 (273)
Q Consensus 234 l~~dp~~Rp-----s~~~~l~~ 250 (273)
|..||.+|| ++.++++|
T Consensus 247 l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 247 LMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred hcCCHHHhcCCCCCCHHHHHcC
Confidence 999999997 78888887
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=280.53 Aligned_cols=225 Identities=27% Similarity=0.354 Sum_probs=184.0
Q ss_pred EEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 3 VAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 3 vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
.|+|-++... ........+|.++|..+.|||+++.+|+=.+....+|.||||+||+|.+.++ .+...++....-+..
T Consensus 1263 lAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~-~gri~dE~vt~vyt~ 1341 (1509)
T KOG4645|consen 1263 LAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLE-HGRIEDEMVTRVYTK 1341 (1509)
T ss_pred hhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHH-hcchhhhhHHHHHHH
Confidence 3566665432 3456678899999999999999999999999999999999999999999985 444677778888999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcc--eeecccccCCCCCCcccCCCC---c
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSM--TQTQTLATIGYMAPEYGREGR---V 155 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~---~ 155 (273)
|++.|++||| +.|||||||||.||+++.+|.+|++|||.+..+.+.-+.. ......||+-|||||++.+.. .
T Consensus 1342 qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~ 1418 (1509)
T KOG4645|consen 1342 QLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGH 1418 (1509)
T ss_pred HHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCC
Confidence 9999999999 9999999999999999999999999999998875543211 123557999999999998754 6
Q ss_pred CCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCC
Q 024027 156 STNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTV 235 (273)
Q Consensus 156 ~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 235 (273)
..+.|||||||++.||+||+.||..+++.-.-+.+....- ..+.|..++.+-++||..||+
T Consensus 1419 ~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh-------------------~Pq~P~~ls~~g~dFle~Cl~ 1479 (1509)
T KOG4645|consen 1419 GGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGH-------------------KPQIPERLSSEGRDFLEHCLE 1479 (1509)
T ss_pred CcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccC-------------------CCCCchhhhHhHHHHHHHHHh
Confidence 7889999999999999999999998776543332221111 112255588889999999999
Q ss_pred CCccCCCCHHHHHHH
Q 024027 236 ESPEQRINAKEIVTK 250 (273)
Q Consensus 236 ~dp~~Rps~~~~l~~ 250 (273)
.||++|.++.++++|
T Consensus 1480 ~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1480 QDPKMRWTASQLLEH 1494 (1509)
T ss_pred cCchhhhHHHHHHHh
Confidence 999999999988876
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=237.08 Aligned_cols=240 Identities=22% Similarity=0.301 Sum_probs=187.7
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
.+|||++......++....+|++++.+. .|+||+.++++|+++..+|+|||.+.||+|...|++.. -+++.++..+..
T Consensus 105 EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~-~F~E~EAs~vvk 183 (463)
T KOG0607|consen 105 EYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRK-HFNEREASRVVK 183 (463)
T ss_pred hhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHHHhh-hccHHHHHHHHH
Confidence 5799999877677888999999999999 59999999999999999999999999999999997665 599999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCC---ceEEeecccccccccCCC-----cceeecccccCCCCCCccc--
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNL---VAYLSDFGIAKLLIGEDQ-----SMTQTQTLATIGYMAPEYG-- 150 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~---~~kl~Df~~~~~~~~~~~-----~~~~~~~~~~~~~~aPE~~-- 150 (273)
+|+.||.+|| .+||.|||+||+|||-.... -|||+||.+....-.... ......++|+..|||||+.
T Consensus 184 dia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~ 260 (463)
T KOG0607|consen 184 DIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDV 260 (463)
T ss_pred HHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhh
Confidence 9999999999 99999999999999986543 489999988754321111 1122356788899999964
Q ss_pred -CC--CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccc-----cchhhhhhhhhh
Q 024027 151 -RE--GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLS-----QEDIHFVAKEQC 222 (273)
Q Consensus 151 -~~--~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~ 222 (273)
.+ ..|+.+.|.||||+++|-|+.|++||.+....+= .|........-+..+.. ...+...-+..+
T Consensus 261 fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC-------GWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahI 333 (463)
T KOG0607|consen 261 FVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC-------GWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHI 333 (463)
T ss_pred hccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC-------CccCCCccHHHHHHHHHHHhccCCcCChhhhHHh
Confidence 23 3489999999999999999999999987544321 12222222221111111 111222224568
Q ss_pred HHHHHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 223 VSFVFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 223 ~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
+.+..+++..+|..|+.+|.++..++.|-+
T Consensus 334 S~eakdlisnLlvrda~~rlsa~~vlnhPw 363 (463)
T KOG0607|consen 334 SSEAKDLISNLLVRDAKQRLSAAQVLNHPW 363 (463)
T ss_pred hHHHHHHHHHHHhccHHhhhhhhhccCCcc
Confidence 899999999999999999999999998654
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=275.90 Aligned_cols=240 Identities=27% Similarity=0.429 Sum_probs=179.0
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
+.||||.++.... ....|++++++++||||++++++|.++...++||||+++|+|.++++ .+++..+..++.
T Consensus 716 ~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~ 787 (968)
T PLN00113 716 MQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR----NLSWERRRKIAI 787 (968)
T ss_pred cEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh----cCCHHHHHHHHH
Confidence 3689999864322 22356889999999999999999999999999999999999999995 378999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
|++.|++|||..++.+++||||||+||+++.++..++. ++...... ......+++.|+|||++.+..++.++|
T Consensus 788 ~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~sD 860 (968)
T PLN00113 788 GIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC------TDTKCFISSAYVAPETRETKDITEKSD 860 (968)
T ss_pred HHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc------cCCCccccccccCcccccCCCCCcccc
Confidence 99999999995556699999999999999988887775 54433221 111235788999999999888999999
Q ss_pred hHHHHHHHHHHHhCCCCCccccccccchhhhhhhccC-ccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCcc
Q 024027 161 VYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLP-ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239 (273)
Q Consensus 161 iwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 239 (273)
||||||++|||++|+.||............+...... .......+..... ....+.....++.+++.+||..||+
T Consensus 861 v~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~~Cl~~~P~ 936 (968)
T PLN00113 861 IYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG----DVSVNQNEIVEVMNLALHCTATDPT 936 (968)
T ss_pred hhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC----CCCccHHHHHHHHHHHHhhCcCCch
Confidence 9999999999999999985433332223322221111 0111111111100 0011223445688999999999999
Q ss_pred CCCCHHHHHHHHHHHHHhhh
Q 024027 240 QRINAKEIVTKLLKIRDSLL 259 (273)
Q Consensus 240 ~Rps~~~~l~~l~~~~~~~~ 259 (273)
+|||+.++++.|+++.+...
T Consensus 937 ~RPt~~evl~~L~~~~~~~~ 956 (968)
T PLN00113 937 ARPCANDVLKTLESASRSSS 956 (968)
T ss_pred hCcCHHHHHHHHHHhhcccc
Confidence 99999999999998876543
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=244.49 Aligned_cols=245 Identities=20% Similarity=0.211 Sum_probs=174.8
Q ss_pred CeEEEEEeecccC--hhhhhHHHHHHHHhcCCCccceeeeeeeecC--------CceeEEEeccCCCCHHHhhhcCCCCC
Q 024027 1 MEVAVKVFNLQCG--RAFKSFDVECEMMKSIRHRNLIKVISSCSNE--------EFKALVLEYMPHGSLEKYLYSSNCIL 70 (273)
Q Consensus 1 ~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~ 70 (273)
+.||||++..... .....+.+|+++++.++|+||+++++++.+. ..+++|+||+.+ ++...+......+
T Consensus 34 ~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~ 112 (311)
T cd07866 34 RVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKL 112 (311)
T ss_pred cEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCCc-CHHHHHhccccCC
Confidence 3689999865432 2234678899999999999999999987543 346899999965 8888887666679
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcce---------eeccccc
Q 024027 71 DIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMT---------QTQTLAT 141 (273)
Q Consensus 71 ~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~---------~~~~~~~ 141 (273)
++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++........... .....++
T Consensus 113 ~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (311)
T cd07866 113 TESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVT 189 (311)
T ss_pred CHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceec
Confidence 99999999999999999999 99999999999999999999999999999876532221111 1123457
Q ss_pred CCCCCCcccCCC-CcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCcc--chhhh------h--hhccc
Q 024027 142 IGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPIS--TMEVV------D--ANLLS 210 (273)
Q Consensus 142 ~~~~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~------~--~~~~~ 210 (273)
..|+|||.+.+. .++.++|+||+|+++|+|++|.+||....... ............. ..+.. . .....
T Consensus 190 ~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (311)
T cd07866 190 RWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID-QLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTN 268 (311)
T ss_pred cCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChhhchhhhhcccccccccCCC
Confidence 789999987654 47899999999999999999999986533321 1111111100000 00000 0 00000
Q ss_pred cchhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHH
Q 024027 211 QEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 211 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
...............+.+++.+||..||.+|||+.+++.|
T Consensus 269 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 269 YPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred CCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 0000011112344668999999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=263.90 Aligned_cols=232 Identities=29% Similarity=0.463 Sum_probs=191.9
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC------------
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN------------ 67 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------ 67 (273)
.||||.++... ..+.+.+..|+++++.+ +|+||+.++|+|...+..++|.||+..|+|..+++..+
T Consensus 330 ~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~ 409 (609)
T KOG0200|consen 330 TVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFP 409 (609)
T ss_pred EEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCc
Confidence 69999998653 46788899999999999 79999999999999999999999999999999997665
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeeccc--ccC
Q 024027 68 ---CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTL--ATI 142 (273)
Q Consensus 68 ---~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~--~~~ 142 (273)
..+......++++||+.|++||+ +.+++|||+..+||+++.+..+|++|||+++.......... .... -+.
T Consensus 410 ~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~ 485 (609)
T KOG0200|consen 410 NERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRT-KSSAGTLPV 485 (609)
T ss_pred cccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEe-cCCCCccce
Confidence 34888899999999999999999 99999999999999999999999999999986533222211 1111 345
Q ss_pred CCCCCcccCCCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhh
Q 024027 143 GYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQ 221 (273)
Q Consensus 143 ~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (273)
.|+|||.+....++.++||||+|+++||+++ |..||.+......... + + ....+...|..
T Consensus 486 kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~-~------------l------~~G~r~~~P~~ 546 (609)
T KOG0200|consen 486 KWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLE-F------------L------KEGNRMEQPEH 546 (609)
T ss_pred eecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHH-H------------H------hcCCCCCCCCC
Confidence 6999999999899999999999999999999 8899865221111111 1 1 12223344778
Q ss_pred hHHHHHHHHhhcCCCCccCCCCHHHHHHHHHHHHH
Q 024027 222 CVSFVFNLAMACTVESPEQRINAKEIVTKLLKIRD 256 (273)
Q Consensus 222 ~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 256 (273)
|+.+++++++.||..+|++||++.++.+.+..+.+
T Consensus 547 c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 547 CSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred CCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 89999999999999999999999999999999654
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=249.54 Aligned_cols=238 Identities=23% Similarity=0.245 Sum_probs=175.6
Q ss_pred CeEEEEEeecc--cChhhhhHHHHHHHHhcCCCccceeeeeeeecCCc------eeEEEeccCCCCHHHhhhcCCCCCCH
Q 024027 1 MEVAVKVFNLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEF------KALVLEYMPHGSLEKYLYSSNCILDI 72 (273)
Q Consensus 1 ~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~------~~lv~e~~~~~~L~~~l~~~~~~~~~ 72 (273)
+.||||++... +......+.+|+.+++.++|+|++++.+++..... .++|+||+ +++|.+++... .+++
T Consensus 41 ~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~l~~ 117 (343)
T cd07851 41 RKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQ--KLSD 117 (343)
T ss_pred cEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhcC--CCCH
Confidence 36999998753 23344667789999999999999999998876554 89999999 56999998653 5899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC
Q 024027 73 FQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE 152 (273)
Q Consensus 73 ~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 152 (273)
..++.++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||.+...... .....++..|+|||.+.+
T Consensus 118 ~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~ 189 (343)
T cd07851 118 DHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLN 189 (343)
T ss_pred HHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEcccccccccccc-----ccCCcccccccCHHHHhC
Confidence 999999999999999999 999999999999999999999999999998765221 223356788999998765
Q ss_pred -CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCc--cchh---------hhhhhccccchhhhhhhh
Q 024027 153 -GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPI--STME---------VVDANLLSQEDIHFVAKE 220 (273)
Q Consensus 153 -~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~---------~~~~~~~~~~~~~~~~~~ 220 (273)
..++.++|+||||+++|++++|..||....... ....+....... .... ..................
T Consensus 190 ~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (343)
T cd07851 190 WMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID-QLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFS 268 (343)
T ss_pred CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhc
Confidence 357899999999999999999999997543221 111111111000 0000 000000000000011122
Q ss_pred hhHHHHHHHHhhcCCCCccCCCCHHHHHHH
Q 024027 221 QCVSFVFNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 221 ~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
..+.++.+++.+||..||.+|||+.+++.|
T Consensus 269 ~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 269 GANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred cCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 357789999999999999999999999987
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=244.54 Aligned_cols=238 Identities=24% Similarity=0.243 Sum_probs=173.9
Q ss_pred CeEEEEEeecc--cChhhhhHHHHHHHHhcCCCccceeeeeeeec-CCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSN-EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||||++... .....+.+..|+++++.++||||+++.++|.. ....++++||+ +++|.++++.. .++...+..
T Consensus 36 ~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~ 112 (328)
T cd07856 36 QNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTSR--PLEKQFIQY 112 (328)
T ss_pred CEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHhcC--CCCHHHHHH
Confidence 36899988543 23345678899999999999999999999865 56788999999 45999888543 478888999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC-CCcC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE-GRVS 156 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~ 156 (273)
++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||.+..... ......++..|+|||.+.+ ..++
T Consensus 113 ~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~ 184 (328)
T cd07856 113 FLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDP-----QMTGYVSTRYYRAPEIMLTWQKYD 184 (328)
T ss_pred HHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccccccCC-----CcCCCcccccccCceeeeccCCcC
Confidence 9999999999999 99999999999999999999999999999875421 1122356778999998765 5689
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhh-----------hccCccchhhhhhhccccchhhhhhhhhhHHH
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVN-----------DWLPISTMEVVDANLLSQEDIHFVAKEQCVSF 225 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (273)
.++|+||+|++++++++|..||....... ....... ........+...................++.+
T Consensus 185 ~~~Dv~slG~il~el~tg~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (328)
T cd07856 185 VEVDIWSAGCIFAEMLEGKPLFPGKDHVN-QFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPS 263 (328)
T ss_pred cHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHH
Confidence 99999999999999999999986533211 1100000 00000000000000000000001112345678
Q ss_pred HHHHHhhcCCCCccCCCCHHHHHHH
Q 024027 226 VFNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 226 l~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
+.+++.+||..+|++|||+++++.+
T Consensus 264 ~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 264 AIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHHHHHcCCChhhCCCHHHHhcC
Confidence 9999999999999999999999887
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=246.75 Aligned_cols=243 Identities=21% Similarity=0.207 Sum_probs=175.3
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCC------ceeEEEeccCCCCHHHhhhcCCCCCCH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEE------FKALVLEYMPHGSLEKYLYSSNCILDI 72 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~ 72 (273)
++||||+++... ......+.+|+.+++.++||||+++++++.... ..++|+||+.. +|..++. ..+++
T Consensus 41 ~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~ 116 (342)
T cd07879 41 EKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMG---HPLSE 116 (342)
T ss_pred cEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEeccccc-CHHHHHc---CCCCH
Confidence 369999987532 233456889999999999999999999987543 45899999965 8877652 25889
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC
Q 024027 73 FQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE 152 (273)
Q Consensus 73 ~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 152 (273)
..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++..... ......++..|+|||.+.+
T Consensus 117 ~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~ 188 (342)
T cd07879 117 DKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA-----EMTGYVVTRWYRAPEVILN 188 (342)
T ss_pred HHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC-----CCCCceeeecccChhhhcC
Confidence 999999999999999999 99999999999999999999999999999875421 1123456788999998866
Q ss_pred -CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCc--cchhhh---------hhhccccchhhhhhhh
Q 024027 153 -GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPI--STMEVV---------DANLLSQEDIHFVAKE 220 (273)
Q Consensus 153 -~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~---------~~~~~~~~~~~~~~~~ 220 (273)
..++.++|+||||+++++|++|+.||....... ............ ...+.. ...............+
T Consensus 189 ~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (342)
T cd07879 189 WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFP 267 (342)
T ss_pred ccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhc
Confidence 458899999999999999999999997532211 111111110000 000000 0000000000011122
Q ss_pred hhHHHHHHHHhhcCCCCccCCCCHHHHHHH--HHHHHH
Q 024027 221 QCVSFVFNLAMACTVESPEQRINAKEIVTK--LLKIRD 256 (273)
Q Consensus 221 ~~~~~l~~li~~~l~~dp~~Rps~~~~l~~--l~~~~~ 256 (273)
.++.++.+|+.+||..||.+||++++++.| ++.+++
T Consensus 268 ~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 268 KASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 456779999999999999999999999977 665543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=238.26 Aligned_cols=241 Identities=18% Similarity=0.194 Sum_probs=176.2
Q ss_pred CeEEEEEeecccC-hhhhhHHHHHHHHhcCC-CccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC-CCCCHHHHHH
Q 024027 1 MEVAVKVFNLQCG-RAFKSFDVECEMMKSIR-HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~ 77 (273)
+.||||.+..... .......+|+..++.++ |+|++++++++.++...++||||+ +++|.+++.... ..+++..+..
T Consensus 25 ~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~ 103 (283)
T cd07830 25 ELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRS 103 (283)
T ss_pred cEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHH
Confidence 3689999875422 23334567999999998 999999999999999999999999 679999886654 4689999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccC-CCCcC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR-EGRVS 156 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~ 156 (273)
++.|++.+|.||| +.|++|+||+|+||+++.++.++|+|||.+........ .....++..|+|||.+. +..++
T Consensus 104 ~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~ 177 (283)
T cd07830 104 IIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP---YTDYVSTRWYRAPEILLRSTSYS 177 (283)
T ss_pred HHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC---cCCCCCcccccCceeeecCcCcC
Confidence 9999999999999 99999999999999999999999999999876532211 12345678899999874 44578
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchh---hh------hhhcc--ccchhhhhhhhhhHHH
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTME---VV------DANLL--SQEDIHFVAKEQCVSF 225 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~------~~~~~--~~~~~~~~~~~~~~~~ 225 (273)
.++|+||||++++++++|.+||......+... ............. .. ..... ...... ......+..
T Consensus 178 ~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 255 (283)
T cd07830 178 SPVDIWALGCIMAELYTLRPLFPGSSEIDQLY-KICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLH-QLIPNASPE 255 (283)
T ss_pred CccchhhHHHHHHHHHhCCCccCCCChHHHHH-HHHHhcCCCChhhhhhHhhhhccccccccccccccHH-HHcccCCHH
Confidence 99999999999999999999986543322111 1111000000000 00 00000 000000 001122567
Q ss_pred HHHHHhhcCCCCccCCCCHHHHHHH
Q 024027 226 VFNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 226 l~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
+.+++++||..||.+|||+++++.+
T Consensus 256 ~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 256 AIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred HHHHHHHhcccCcccCCCHHHHhhC
Confidence 9999999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=253.06 Aligned_cols=216 Identities=24% Similarity=0.237 Sum_probs=175.2
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
..++|++... ..+..+|+.++... +||||++..+.+.+..+.++|||.+.|+-+.+.+.... .....+..|+.
T Consensus 349 ~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~--~~~~e~~~w~~ 422 (612)
T KOG0603|consen 349 EPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKP--EFCSEASQWAA 422 (612)
T ss_pred chhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcc--hhHHHHHHHHH
Confidence 3466777533 23455677676666 79999999999999999999999999988888875443 33378889999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceee-CCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcc
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLL-DDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 159 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~-~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 159 (273)
+|+.|+.||| ++|++|||+||+|||+ +..+.++|+|||.+...... ....+-|..|.|||++....|+.++
T Consensus 423 ~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~ac 494 (612)
T KOG0603|consen 423 ELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEAC 494 (612)
T ss_pred HHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-----hcccchhhcccChhhhccCCCCcch
Confidence 9999999999 9999999999999999 58899999999999865332 2234668889999999999999999
Q ss_pred hhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCcc
Q 024027 160 DVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239 (273)
Q Consensus 160 DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 239 (273)
|+||||+++|+|++|+.||.....+...+.... .+. ....++.++++|+.+||..||.
T Consensus 495 D~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~------------------~~~----~s~~vS~~AKdLl~~LL~~dP~ 552 (612)
T KOG0603|consen 495 DWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQ------------------MPK----FSECVSDEAKDLLQQLLQVDPA 552 (612)
T ss_pred hhHHHHHHHHHHHhCCCccccCCchHHHHHhhc------------------CCc----cccccCHHHHHHHHHhccCChh
Confidence 999999999999999999987655521111110 000 0266788899999999999999
Q ss_pred CCCCHHHHHHHHHH
Q 024027 240 QRINAKEIVTKLLK 253 (273)
Q Consensus 240 ~Rps~~~~l~~l~~ 253 (273)
+||+++++..|-+.
T Consensus 553 ~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 553 LRLGADEIGAHPWF 566 (612)
T ss_pred hCcChhhhccCcch
Confidence 99999999998775
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=245.56 Aligned_cols=240 Identities=22% Similarity=0.229 Sum_probs=173.8
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecC------CceeEEEeccCCCCHHHhhhcCCCCCCH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNE------EFKALVLEYMPHGSLEKYLYSSNCILDI 72 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 72 (273)
+.||+|+++... ....+.+.+|+.++++++|+||+++++++... ...+++++++ +++|.+++... .+++
T Consensus 43 ~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~ 119 (345)
T cd07877 43 LRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTD 119 (345)
T ss_pred eEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhcC--CCCH
Confidence 369999997542 22345678899999999999999999988643 3467888887 67999888543 4899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC
Q 024027 73 FQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE 152 (273)
Q Consensus 73 ~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 152 (273)
..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++..... ......++..|+|||.+.+
T Consensus 120 ~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~ 191 (345)
T cd07877 120 DHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLN 191 (345)
T ss_pred HHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEEEecccccccccc-----cccccccCCCccCHHHHhC
Confidence 999999999999999999 99999999999999999999999999999875421 1223457888999998766
Q ss_pred -CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccC--ccchhhhh----hh----ccccch-hhhhhhh
Q 024027 153 -GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLP--ISTMEVVD----AN----LLSQED-IHFVAKE 220 (273)
Q Consensus 153 -~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~----~~----~~~~~~-~~~~~~~ 220 (273)
..++.++|+||+||+++++++|..||....... ........... ........ .. ...... .......
T Consensus 192 ~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (345)
T cd07877 192 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 270 (345)
T ss_pred ccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcC
Confidence 457889999999999999999999986532211 11111111000 00000000 00 000000 0000011
Q ss_pred hhHHHHHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 221 QCVSFVFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 221 ~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
..+.++.+++.+||..||.+|||+.+++.|=.
T Consensus 271 ~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 302 (345)
T cd07877 271 GANPLAVDLLEKMLVLDSDKRITAAQALAHAY 302 (345)
T ss_pred CCCHHHHHHHHHHcCCChhhcCCHHHHhcChh
Confidence 34667899999999999999999999999854
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=232.87 Aligned_cols=225 Identities=30% Similarity=0.351 Sum_probs=181.9
Q ss_pred CeEEEEEeecccChh-hhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRA-FKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 1 ~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
++||+|++....... ...+.+|++.++.++|+|++++++++......++++|++++++|..++.... .++...++.++
T Consensus 15 ~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~~ 93 (244)
T smart00220 15 KLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRG-RLSEDEARFYA 93 (244)
T ss_pred cEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhcc-CCCHHHHHHHH
Confidence 369999998665444 6889999999999999999999999999999999999999999999986544 38899999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 159 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 159 (273)
.+++.++.+|| +.+++|+||+|+||+++.++.++++|||.+....... ......++..|++||.+.+..++.++
T Consensus 94 ~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~ 167 (244)
T smart00220 94 RQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMAPEVLLGKGYGKAV 167 (244)
T ss_pred HHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCCHHHHccCCCCchh
Confidence 99999999999 9999999999999999999999999999998763321 22344577889999999888889999
Q ss_pred hhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhh-hhHHHHHHHHhhcCCCCc
Q 024027 160 DVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKE-QCVSFVFNLAMACTVESP 238 (273)
Q Consensus 160 DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~dp 238 (273)
|+|++|++++++++|..||................ ........ .++.++.+++.+||..+|
T Consensus 168 Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~i~~~l~~~p 229 (244)
T smart00220 168 DVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKP------------------KPPFPPPEWKISPEAKDLIRKLLVKDP 229 (244)
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhcc------------------CCCCccccccCCHHHHHHHHHHccCCc
Confidence 99999999999999999986532221111110000 00000011 156679999999999999
Q ss_pred cCCCCHHHHHHH
Q 024027 239 EQRINAKEIVTK 250 (273)
Q Consensus 239 ~~Rps~~~~l~~ 250 (273)
.+||++.+++++
T Consensus 230 ~~Rp~~~~~~~~ 241 (244)
T smart00220 230 EKRLTAEEALQH 241 (244)
T ss_pred hhccCHHHHhhC
Confidence 999999999874
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=237.09 Aligned_cols=222 Identities=20% Similarity=0.250 Sum_probs=172.8
Q ss_pred EEEEEeeccc-----ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhc---CCCCCCHHH
Q 024027 3 VAVKVFNLQC-----GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS---SNCILDIFQ 74 (273)
Q Consensus 3 vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~ 74 (273)
+++|+++... ......+..|+.+++.++||||+++++++.+....++|+||+++++|.+++.. ....+++..
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~ 107 (260)
T cd08222 28 ERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQ 107 (260)
T ss_pred ceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHH
Confidence 4556655321 22334577899999999999999999999999999999999999999988853 345689999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCC
Q 024027 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGR 154 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 154 (273)
++.++.|++.|+.||| +.|++|+||+|+||+++. +.++|+|||.+........ ......++..|+|||.+.+..
T Consensus 108 ~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~ 181 (260)
T cd08222 108 VCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQG 181 (260)
T ss_pred HHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecCCCcc--cccCCCCCcCccCHHHHccCC
Confidence 9999999999999999 999999999999999975 5699999999876532221 222345678899999988888
Q ss_pred cCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcC
Q 024027 155 VSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACT 234 (273)
Q Consensus 155 ~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 234 (273)
++.++|+||+|++++++++|..||......... ..... ......+..++.++.+++.+||
T Consensus 182 ~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~-~~~~~-------------------~~~~~~~~~~~~~~~~li~~~l 241 (260)
T cd08222 182 YDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVV-LRIVE-------------------GPTPSLPETYSRQLNSIMQSML 241 (260)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH-HHHHc-------------------CCCCCCcchhcHHHHHHHHHHh
Confidence 899999999999999999999998542211100 00000 0000113456677999999999
Q ss_pred CCCccCCCCHHHHHHH
Q 024027 235 VESPEQRINAKEIVTK 250 (273)
Q Consensus 235 ~~dp~~Rps~~~~l~~ 250 (273)
..||.+||++.++++|
T Consensus 242 ~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 242 NKDPSLRPSAAEILRN 257 (260)
T ss_pred cCChhhCcCHHHHhhC
Confidence 9999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=242.85 Aligned_cols=244 Identities=20% Similarity=0.158 Sum_probs=174.0
Q ss_pred eEEEEEeeccc--ChhhhhHHHHHHHHhcC-CCccceeeeeeeec----CCceeEEEeccCCCCHHHhhhcCCCCCCHHH
Q 024027 2 EVAVKVFNLQC--GRAFKSFDVECEMMKSI-RHRNLIKVISSCSN----EEFKALVLEYMPHGSLEKYLYSSNCILDIFQ 74 (273)
Q Consensus 2 ~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (273)
.||||++.... ....+.+.+|+.+++.+ +||||+++++.+.. ....+++++++. ++|.+++... ..+++..
T Consensus 29 ~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~-~~~~~~~ 106 (332)
T cd07857 29 TVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRSG-QPLTDAH 106 (332)
T ss_pred eEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHhcC-CCCCHHH
Confidence 68999986432 22345678899999999 59999999987532 245788999996 5999998543 4689999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCc--ceeecccccCCCCCCcccCC
Q 024027 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQS--MTQTQTLATIGYMAPEYGRE 152 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~ 152 (273)
++.++.|++.||.||| ..|++|+||||+||+++.++.++|+|||++..+...... .......++..|+|||.+.+
T Consensus 107 ~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 183 (332)
T cd07857 107 FQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLS 183 (332)
T ss_pred HHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhC
Confidence 9999999999999999 999999999999999999999999999998765322111 11223467889999998765
Q ss_pred -CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCcc-----------chhhhhhhccccchhhhhhhh
Q 024027 153 -GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPIS-----------TMEVVDANLLSQEDIHFVAKE 220 (273)
Q Consensus 153 -~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~ 220 (273)
..++.++|+||+|++++++++|..||...... .............. .....................
T Consensus 184 ~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (332)
T cd07857 184 FQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV-DQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFP 262 (332)
T ss_pred CCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH-HHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCC
Confidence 46899999999999999999999998753321 11111111100000 000000000000000011122
Q ss_pred hhHHHHHHHHhhcCCCCccCCCCHHHHHHHH
Q 024027 221 QCVSFVFNLAMACTVESPEQRINAKEIVTKL 251 (273)
Q Consensus 221 ~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l 251 (273)
.++..+.+++.+||..||++|||+++++.+=
T Consensus 263 ~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~ 293 (332)
T cd07857 263 NANPLALDLLEKLLAFDPTKRISVEEALEHP 293 (332)
T ss_pred CCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 3467799999999999999999999999774
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=233.91 Aligned_cols=221 Identities=21% Similarity=0.254 Sum_probs=181.9
Q ss_pred eEEEEEeecccC---hhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 2 EVAVKVFNLQCG---RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 2 ~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
-+|+|+++...- .....-..|-++|+..+||.+..+--.|+....+|+||||.+||.|...+++. ..+++...+-+
T Consensus 195 ~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsre-r~FsE~RtRFY 273 (516)
T KOG0690|consen 195 LYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRE-RVFSEDRTRFY 273 (516)
T ss_pred eeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhh-hcccchhhhhh
Confidence 579999987642 23344556889999999999999999999999999999999999999999654 46999999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCc
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTN 158 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 158 (273)
...|+.||.||| +++|+.||+|.+|.+++++|.+||.|||++..-. .........||||.|+|||++....|+.+
T Consensus 274 GaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I--~~g~t~kTFCGTPEYLAPEVleDnDYgra 348 (516)
T KOG0690|consen 274 GAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI--KYGDTTKTFCGTPEYLAPEVLEDNDYGRA 348 (516)
T ss_pred hHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhcc--cccceeccccCChhhcCchhhccccccce
Confidence 999999999999 9999999999999999999999999999997431 22334567899999999999999999999
Q ss_pred chhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc
Q 024027 159 GDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238 (273)
Q Consensus 159 ~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 238 (273)
.|.|.+|+++|+|+.|+.||...+.+.. +..+. ..+...|...++++..|+..+|.+||
T Consensus 349 VDWWG~GVVMYEMmCGRLPFyn~dh~kL-FeLIl--------------------~ed~kFPr~ls~eAktLLsGLL~kdP 407 (516)
T KOG0690|consen 349 VDWWGVGVVMYEMMCGRLPFYNKDHEKL-FELIL--------------------MEDLKFPRTLSPEAKTLLSGLLKKDP 407 (516)
T ss_pred eehhhhhHHHHHHHhccCcccccchhHH-HHHHH--------------------hhhccCCccCCHHHHHHHHHHhhcCh
Confidence 9999999999999999999987443321 11100 00112267788899999999999999
Q ss_pred cCCC--CHHHHHH
Q 024027 239 EQRI--NAKEIVT 249 (273)
Q Consensus 239 ~~Rp--s~~~~l~ 249 (273)
++|. ..+++.+
T Consensus 408 ~kRLGgGpdDakE 420 (516)
T KOG0690|consen 408 KKRLGGGPDDAKE 420 (516)
T ss_pred HhhcCCCchhHHH
Confidence 9998 3344433
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=252.34 Aligned_cols=251 Identities=25% Similarity=0.273 Sum_probs=185.9
Q ss_pred CeEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCC------ceeEEEeccCCCCHHHhhhcC--CCCCC
Q 024027 1 MEVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEE------FKALVLEYMPHGSLEKYLYSS--NCILD 71 (273)
Q Consensus 1 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~--~~~~~ 71 (273)
+.||||.++... .+..+..-+|+++|++++|+|||+++++=+... ...+|||||.||+|...+++. ...++
T Consensus 39 ~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLp 118 (732)
T KOG4250|consen 39 RLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLP 118 (732)
T ss_pred cchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCC
Confidence 369999998643 456677889999999999999999999765543 457999999999999999754 34699
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCC----CCceEEeecccccccccCCCcceeecccccCCCCCC
Q 024027 72 IFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDD----NLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 147 (273)
Q Consensus 72 ~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~----~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aP 147 (273)
+.+++.++.+++.||.||| ++||+||||||.||++-. .-..||+|||.++.+.. ...-...+||..|++|
T Consensus 119 E~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d---~s~~~S~vGT~~YLhP 192 (732)
T KOG4250|consen 119 ESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDD---NSLFTSLVGTEEYLHP 192 (732)
T ss_pred HHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeecccccccCCC---CCeeeeecCchhhcCh
Confidence 9999999999999999999 999999999999999842 23579999999987632 2245667899999999
Q ss_pred cccCC-CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhh--hccCccchhhhhhhcc------ccchhhhhh
Q 024027 148 EYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVN--DWLPISTMEVVDANLL------SQEDIHFVA 218 (273)
Q Consensus 148 E~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~------~~~~~~~~~ 218 (273)
|+... ..|+...|.|||||++|+++||..||..+..+......... ...+............ ..-+.....
T Consensus 193 el~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~L 272 (732)
T KOG4250|consen 193 ELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHL 272 (732)
T ss_pred HHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccc
Confidence 99984 78999999999999999999999999876555321111111 1111111111111000 000111111
Q ss_pred hhhhHHHHHHHHhhcCCCCccCCC--CHHHHHHHHHHHHHh
Q 024027 219 KEQCVSFVFNLAMACTVESPEQRI--NAKEIVTKLLKIRDS 257 (273)
Q Consensus 219 ~~~~~~~l~~li~~~l~~dp~~Rp--s~~~~l~~l~~~~~~ 257 (273)
......-+-.++..||+.+|++|. .+.+....+..+...
T Consensus 273 s~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 273 SRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred cHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 222333366788899999999999 888888888887753
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=255.92 Aligned_cols=234 Identities=26% Similarity=0.375 Sum_probs=202.1
Q ss_pred eEEEEEeecc-cChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
|||||++... ..++-.++..|+-+|.+++|||++++++++.... +.||++|+++|+|.+|++.++..+.....+.|..
T Consensus 727 pVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~ 805 (1177)
T KOG1025|consen 727 PVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCY 805 (1177)
T ss_pred eeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhhccccHHHHHHHHH
Confidence 8999999754 3556688999999999999999999999998765 7899999999999999999988899999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
||++|+.||| ++.++||||-.+|+|+..-..+|+.|||++..+...............+-|+|-|.+....++.++|
T Consensus 806 QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSD 882 (1177)
T KOG1025|consen 806 QIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSD 882 (1177)
T ss_pred HHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhh
Confidence 9999999999 9999999999999999999999999999999887666655555556677899999999999999999
Q ss_pred hHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCcc
Q 024027 161 VYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239 (273)
Q Consensus 161 iwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 239 (273)
|||+||.+||++| |..|+......+.. .+ ...+. +.+.|+.|+.+++-++.+||..|+.
T Consensus 883 VWsfGVtiWElmTFGa~Py~gi~~~eI~--dl-----------------le~ge-RLsqPpiCtiDVy~~mvkCwmid~~ 942 (1177)
T KOG1025|consen 883 VWSFGVTIWELMTFGAKPYDGIPAEEIP--DL-----------------LEKGE-RLSQPPICTIDVYMVMVKCWMIDAD 942 (1177)
T ss_pred hhhhhhhHHHHHhcCCCccCCCCHHHhh--HH-----------------Hhccc-cCCCCCCccHHHHHHHHHHhccCcc
Confidence 9999999999998 99997664333221 11 11122 2455889999999999999999999
Q ss_pred CCCCHHHHHHHHHHHHHhhh
Q 024027 240 QRINAKEIVTKLLKIRDSLL 259 (273)
Q Consensus 240 ~Rps~~~~l~~l~~~~~~~~ 259 (273)
.||+++++...+.++.++..
T Consensus 943 ~rp~fkel~~~fs~~ardpq 962 (1177)
T KOG1025|consen 943 SRPTFKELAEEFSRMARDPQ 962 (1177)
T ss_pred cCccHHHHHHHHHHHhcCcc
Confidence 99999999999999887654
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=210.36 Aligned_cols=243 Identities=22% Similarity=0.211 Sum_probs=185.2
Q ss_pred eEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 2 EVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 2 ~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
-||+|.++.++ +.-.....+|+-+|+.++|.||++++++.-.+..+.+|+|||+. +|..|...-++.++...+++++
T Consensus 29 ivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq-dlkkyfdslng~~d~~~~rsfm 107 (292)
T KOG0662|consen 29 IVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSLNGDLDPEIVRSFM 107 (292)
T ss_pred eEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-HHHHHHHhcCCcCCHHHHHHHH
Confidence 48999998664 33356788999999999999999999999999999999999976 9999997777789999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCC-cCCc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGR-VSTN 158 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~ 158 (273)
.|++.||.++| ++++.|+|+||.|.+++.+|.+|++|||+++.+.- ...-....+.|.+|.+|.++.+.. |+..
T Consensus 108 lqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgi--pvrcysaevvtlwyrppdvlfgakly~ts 182 (292)
T KOG0662|consen 108 LQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGI--PVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182 (292)
T ss_pred HHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCC--ceEeeeceeeeeeccCcceeeeeehhccc
Confidence 99999999999 99999999999999999999999999999987622 222334456799999999998876 8999
Q ss_pred chhHHHHHHHHHHHh-CCCCCccccccccchhhhhh-hccCccchhhhhh----hcccc---chhhhhhhhhhHHHHHHH
Q 024027 159 GDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVN-DWLPISTMEVVDA----NLLSQ---EDIHFVAKEQCVSFVFNL 229 (273)
Q Consensus 159 ~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~----~~~~~---~~~~~~~~~~~~~~l~~l 229 (273)
.|+||.||++.|+.. |++.|.+.+-.+.....+.. ..+..+.++.... ...+. ...-...-+..+..-++|
T Consensus 183 idmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdl 262 (292)
T KOG0662|consen 183 IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDL 262 (292)
T ss_pred hHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHH
Confidence 999999999999998 66666654433332222221 1111111111100 00000 000011123344557899
Q ss_pred HhhcCCCCccCCCCHHHHHHH
Q 024027 230 AMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 230 i~~~l~~dp~~Rps~~~~l~~ 250 (273)
++++|.-+|.+|++++.+++|
T Consensus 263 lqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 263 LQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred HHHHhccCcccccCHHHHhcC
Confidence 999999999999999999876
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=217.76 Aligned_cols=238 Identities=18% Similarity=0.236 Sum_probs=181.5
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCC-CccceeeeeeeecC--CceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIR-HRNLIKVISSCSNE--EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
+++||+++. -..+.+.+|+.+|+.++ ||||++++++..++ ....+|+||+++.+...+.. .++...+.-+
T Consensus 65 K~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~----tl~d~dIryY 137 (338)
T KOG0668|consen 65 KCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYP----TLTDYDIRYY 137 (338)
T ss_pred eEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhh----hhchhhHHHH
Confidence 689999983 35578999999999996 99999999999775 56789999999877766652 4777889999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCC-CCceEEeecccccccccCCCcceeecccccCCCCCCcccCCC-CcC
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDD-NLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG-RVS 156 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~-~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~ 156 (273)
+.+++.||.||| +.||.|||+||.|++++. ...++|+|+|++.++-. ....+-.+.+..|-.||++..- .|+
T Consensus 138 ~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp---~~eYnVRVASRyfKGPELLVdy~~YD 211 (338)
T KOG0668|consen 138 IYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP---GKEYNVRVASRYFKGPELLVDYQMYD 211 (338)
T ss_pred HHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCC---CceeeeeeehhhcCCchheeechhcc
Confidence 999999999999 999999999999999984 56899999999998733 2233445667789999998764 489
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhh-----------------hccccchhhhhhh
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDA-----------------NLLSQEDIHFVAK 219 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~ 219 (273)
.+-|+|||||++..|++.+.||........++..++...........+.. +............
T Consensus 212 YSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~ 291 (338)
T KOG0668|consen 212 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQ 291 (338)
T ss_pred ccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCcccc
Confidence 99999999999999999999987655555555544432222211111111 1111111111122
Q ss_pred hhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 220 EQCVSFVFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 220 ~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
.-+++++.||+.++|.+|..+|+|++|++.|-.
T Consensus 292 hl~~peaiDlldklLrYDHqeRlTakEam~Hpy 324 (338)
T KOG0668|consen 292 HLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPY 324 (338)
T ss_pred ccCChHHHHHHHHHHhhccccccchHHHhcCch
Confidence 335688999999999999999999999998743
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=239.12 Aligned_cols=207 Identities=23% Similarity=0.304 Sum_probs=173.2
Q ss_pred hhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 024027 16 FKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCS 94 (273)
Q Consensus 16 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~~ 94 (273)
......|-++|+.++.+.||.+--.|+....+|+|+..|+||+|...|.+.+ +.+++..++-++.+|+.||.+|| .
T Consensus 229 e~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~ 305 (591)
T KOG0986|consen 229 ETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---R 305 (591)
T ss_pred hHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---h
Confidence 3457789999999999999999999999999999999999999999886654 45999999999999999999999 9
Q ss_pred CCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcchhHHHHHHHHHHHhC
Q 024027 95 APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTG 174 (273)
Q Consensus 95 ~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~g 174 (273)
.+|+.||+||.|||+|+.|.++|+|+|++..+... ......+||.+|||||++.+..|+...|-|||||++|+|+.|
T Consensus 306 ~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g---~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G 382 (591)
T KOG0986|consen 306 RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG---KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAG 382 (591)
T ss_pred cceeeccCChhheeeccCCCeEeeccceEEecCCC---CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcc
Confidence 99999999999999999999999999999876332 223445899999999999999999999999999999999999
Q ss_pred CCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHH
Q 024027 175 KKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAK 245 (273)
Q Consensus 175 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 245 (273)
+.||....... ..+.++.+...... ..++.+++++.+|.+.+|..||.+|....
T Consensus 383 ~sPFr~~KeKv--------------k~eEvdrr~~~~~~---ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 383 HSPFRQRKEKV--------------KREEVDRRTLEDPE---EYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred cCchhhhhhhh--------------hHHHHHHHHhcchh---hcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 99997643321 11122222222211 12577899999999999999999997543
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=232.38 Aligned_cols=212 Identities=20% Similarity=0.275 Sum_probs=157.3
Q ss_pred HHHHHhcCCCccceeeeeeeecCC----ceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 024027 22 ECEMMKSIRHRNLIKVISSCSNEE----FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPV 97 (273)
Q Consensus 22 E~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i 97 (273)
+...+..++|++++++++++.... ..+++++++.. ++.+.+... ...++..+..++.|++.||.||| +.++
T Consensus 73 ~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~i 147 (294)
T PHA02882 73 LWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIH---EHGI 147 (294)
T ss_pred HHHHhccCCCCCCCcEEEeeeEecCCceEEEEEEehhcc-CHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHH---hCCe
Confidence 334456678999999999765443 34678888744 777777543 23678889999999999999999 9999
Q ss_pred EeccCCCCceeeCCCCceEEeecccccccccCCCc-----ceeecccccCCCCCCcccCCCCcCCcchhHHHHHHHHHHH
Q 024027 98 IHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQS-----MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETF 172 (273)
Q Consensus 98 ~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ll 172 (273)
+||||||+||+++.++.++|+|||++..+...... .......||+.|+|||++.+..++.++|||||||++++|+
T Consensus 148 iHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~ 227 (294)
T PHA02882 148 SHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWA 227 (294)
T ss_pred ecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999766322211 1122346899999999999999999999999999999999
Q ss_pred hCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHH
Q 024027 173 TGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKL 251 (273)
Q Consensus 173 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l 251 (273)
+|..||................. ...+.. .......++.++.+++..|+..+|.+||+++++++.+
T Consensus 228 ~g~~P~~~~~~~~~~~~~~~~~~-----~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 228 GIKLPWKGFGHNGNLIHAAKCDF-----IKRLHE--------GKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred hCCCCCCccccchHHHHHhHHHH-----HHHhhh--------hhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 99999986533221111100000 000000 0011234567799999999999999999999999875
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=229.48 Aligned_cols=240 Identities=22% Similarity=0.227 Sum_probs=176.6
Q ss_pred CeEEEEEeecc--cChhhhhHHHHHHHHhcCCCccceeeeeeeecCC------ceeEEEeccCCCCHHHhhhcCCCCCCH
Q 024027 1 MEVAVKVFNLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEE------FKALVLEYMPHGSLEKYLYSSNCILDI 72 (273)
Q Consensus 1 ~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~ 72 (273)
++||+|++-.. +...-+...+|+.++..+.|+||++++.+|.-.. ..|+|||++.. +|.+.+. ..++=
T Consensus 42 ~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~-nl~~vi~---~elDH 117 (369)
T KOG0665|consen 42 RPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDA-NLCQVIL---MELDH 117 (369)
T ss_pred CceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhhh-HHHHHHH---Hhcch
Confidence 57999998544 2334567889999999999999999999996653 56899999966 9999986 23667
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC
Q 024027 73 FQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE 152 (273)
Q Consensus 73 ~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 152 (273)
..+..++.|++.|++||| +.||+||||||+||++..++.+|+.|||++..-. .....+..+.+..|.|||++.+
T Consensus 118 ~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~---~~~~mtpyVvtRyyrapevil~ 191 (369)
T KOG0665|consen 118 ETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED---TDFMMTPYVVTRYYRAPEVILG 191 (369)
T ss_pred HHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcccC---cccccCchhheeeccCchheec
Confidence 789999999999999999 9999999999999999999999999999997532 2234455678889999999999
Q ss_pred CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhh--------------------hhhhccccc
Q 024027 153 GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEV--------------------VDANLLSQE 212 (273)
Q Consensus 153 ~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~ 212 (273)
..+....||||+||++.+|+.|..-|.+... ...+.+..+....++..-. ......+..
T Consensus 192 ~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~-idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~ 270 (369)
T KOG0665|consen 192 MGYKENVDIWSVGCIMGELILGTVLFPGKDH-IDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDS 270 (369)
T ss_pred cCCcccchhhhhhhHHHHHhhceEEecCchH-HHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcc
Confidence 9999999999999999999999988763111 1111111111111100000 000000000
Q ss_pred hh--hhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHH
Q 024027 213 DI--HFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKL 251 (273)
Q Consensus 213 ~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l 251 (273)
.. ....+..-+..+++++.+||..||++|.|++++|.|=
T Consensus 271 ~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HP 311 (369)
T KOG0665|consen 271 LFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHP 311 (369)
T ss_pred cccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCC
Confidence 00 0011112344589999999999999999999999873
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=243.21 Aligned_cols=227 Identities=22% Similarity=0.275 Sum_probs=184.8
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
|+||||++.+-. ......+++|+.||++++||+|+.+...|+.....+.|||.+.|.-|...+....+.+++..-.-+
T Consensus 590 rdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFl 669 (888)
T KOG4236|consen 590 RDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDMLEMILSSEKGRLPERITKFL 669 (888)
T ss_pred ceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchHHHHHHHhhcccchHHHHHHH
Confidence 589999996432 334477899999999999999999999999999999999999774455555666677998888889
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCC---CceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCc
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDN---LVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRV 155 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~---~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~ 155 (273)
+.||+.||.||| ..+|+|+||||+|||+... -.+||+|||++++.. ........+||+-|+|||++.+..|
T Consensus 670 vtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg---EksFRrsVVGTPAYLaPEVLrnkGy 743 (888)
T KOG4236|consen 670 VTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIG---EKSFRRSVVGTPAYLAPEVLRNKGY 743 (888)
T ss_pred HHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecc---hhhhhhhhcCCccccCHHHHhhccc
Confidence 999999999999 9999999999999999643 379999999999863 2334456789999999999999999
Q ss_pred CCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCC
Q 024027 156 STNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTV 235 (273)
Q Consensus 156 ~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 235 (273)
...-|+||+|+++|--++|..||... +.-..+++.. ........+..++.++.+||..+|+
T Consensus 744 NrSLDMWSVGVIiYVsLSGTFPFNEd---EdIndQIQNA----------------aFMyPp~PW~eis~~AidlIn~LLq 804 (888)
T KOG4236|consen 744 NRSLDMWSVGVIIYVSLSGTFPFNED---EDINDQIQNA----------------AFMYPPNPWSEISPEAIDLINNLLQ 804 (888)
T ss_pred cccccceeeeEEEEEEecccccCCCc---cchhHHhhcc----------------ccccCCCchhhcCHHHHHHHHHHHH
Confidence 99999999999999999999998652 2111111111 0011111245678889999999999
Q ss_pred CCccCCCCHHHHHHHHH
Q 024027 236 ESPEQRINAKEIVTKLL 252 (273)
Q Consensus 236 ~dp~~Rps~~~~l~~l~ 252 (273)
..-++|.|++..++|.|
T Consensus 805 Vkm~kRysvdk~lsh~W 821 (888)
T KOG4236|consen 805 VKMRKRYSVDKSLSHPW 821 (888)
T ss_pred HHHHHhcchHhhccchh
Confidence 99999999999999866
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=228.90 Aligned_cols=255 Identities=23% Similarity=0.237 Sum_probs=187.6
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcC--CCccceeeeeeeecCC----ceeEEEeccCCCCHHHhhhcCCCCCCHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSI--RHRNLIKVISSCSNEE----FKALVLEYMPHGSLEKYLYSSNCILDIFQ 74 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (273)
+.||||+|. .+..+.|..|-+|++.. +|+||+++++.-.... .+.||++|.+.|+|-+||..+ .++|..
T Consensus 234 ~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~n--tisw~~ 308 (534)
T KOG3653|consen 234 RLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKAN--TISWNS 308 (534)
T ss_pred ceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhc--cccHHH
Confidence 579999997 44668899999998865 8999999999765544 788999999999999999766 499999
Q ss_pred HHHHHHHHHHHHHHHhc------CCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCc
Q 024027 75 RLNIMIDVASALEYLHF------GCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPE 148 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~------~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE 148 (273)
..+++..++.||+|||+ +-+..|+|||||..|||+..+++..|+|||++..+............+||.+|||||
T Consensus 309 ~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPE 388 (534)
T KOG3653|consen 309 LCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPE 388 (534)
T ss_pred HHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHH
Confidence 99999999999999992 224569999999999999999999999999998886554444445578999999999
Q ss_pred ccCCCC-cC-----CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhh---hhccccchhhhhhh
Q 024027 149 YGREGR-VS-----TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVD---ANLLSQEDIHFVAK 219 (273)
Q Consensus 149 ~~~~~~-~~-----~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 219 (273)
++.+.- +. .+.||||+|.++||++++..-+.....++..+....+....+...+.-. .......-...-..
T Consensus 389 vLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~ 468 (534)
T KOG3653|consen 389 VLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRK 468 (534)
T ss_pred HHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhc
Confidence 998753 22 3689999999999999865543221222222222211111111111100 00000000111111
Q ss_pred hhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHHHHHHhhhh
Q 024027 220 EQCVSFVFNLAMACTVESPEQRINAKEIVTKLLKIRDSLLR 260 (273)
Q Consensus 220 ~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~ 260 (273)
..-...+.+.+..||..||+-|.|+.-+.++++++......
T Consensus 469 h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 469 HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 23345589999999999999999999999999999887655
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=249.47 Aligned_cols=120 Identities=28% Similarity=0.383 Sum_probs=107.9
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||||+++... ......+..|+.++..++|+||+++++++......++||||+.+++|.+++...+ .+++..++.
T Consensus 30 ~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~~-~l~~~~~~~ 108 (669)
T cd05610 30 KLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYG-YFDEEMAVK 108 (669)
T ss_pred cEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhcC-CCCHHHHHH
Confidence 479999997542 2335678899999999999999999999999999999999999999999996544 588999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeeccccc
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 124 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~ 124 (273)
++.||+.||.||| ..||+|+||||+|||++.++.++|+|||++.
T Consensus 109 i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 109 YISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred HHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999 9999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=251.53 Aligned_cols=223 Identities=26% Similarity=0.374 Sum_probs=174.4
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCC--CCH-HHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI--LDI-FQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~-~~~~ 76 (273)
|+||||.+-.. ...-+.+|+..|+.- +||||+++++.-.+++..||..|.|.. +|.+++...... ... ...+
T Consensus 534 R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-sL~dlie~~~~d~~~~~~i~~~ 609 (903)
T KOG1027|consen 534 REVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-SLQDLIESSGLDVEMQSDIDPI 609 (903)
T ss_pred ceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-hHHHHHhccccchhhcccccHH
Confidence 57899988533 345678999999998 699999999999999999999999976 999999764111 111 3458
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCC---C--CceEEeecccccccccCCCcc-eeecccccCCCCCCccc
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDD---N--LVAYLSDFGIAKLLIGEDQSM-TQTQTLATIGYMAPEYG 150 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~---~--~~~kl~Df~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~ 150 (273)
.++.|++.||++|| +.+|+||||||.|||++. + ..++|+|||++..+....... ......||.+|.|||.+
T Consensus 610 ~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L 686 (903)
T KOG1027|consen 610 SVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQL 686 (903)
T ss_pred HHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHH
Confidence 89999999999999 999999999999999975 2 478999999999987654432 34556799999999999
Q ss_pred CCCCcCCcchhHHHHHHHHHHHhC-CCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHH
Q 024027 151 REGRVSTNGDVYSFGIMLMETFTG-KKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNL 229 (273)
Q Consensus 151 ~~~~~~~~~DiwslG~~l~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 229 (273)
....-+.+.||||+||++|+.++| ..||.+....+..... .........+..-. ++.+|
T Consensus 687 ~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~-------------------~~~~L~~L~~~~d~-eA~dL 746 (903)
T KOG1027|consen 687 REDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILT-------------------GNYTLVHLEPLPDC-EAKDL 746 (903)
T ss_pred hccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhc-------------------CccceeeeccCchH-HHHHH
Confidence 998888899999999999999995 8999874443221110 00111111111111 79999
Q ss_pred HhhcCCCCccCCCCHHHHHHH
Q 024027 230 AMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 230 i~~~l~~dp~~Rps~~~~l~~ 250 (273)
|.+|+.+||..||++.+|+.|
T Consensus 747 I~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 747 ISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred HHHhcCCCcccCCCHHHHhCC
Confidence 999999999999999999876
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=230.07 Aligned_cols=232 Identities=25% Similarity=0.377 Sum_probs=181.2
Q ss_pred eEEEEEeeccc-------ChhhhhHHHHHHHHhcCCCccceeeeeeee-cCCceeEEEeccCCCCHHHhhhcCCCCCCHH
Q 024027 2 EVAVKVFNLQC-------GRAFKSFDVECEMMKSIRHRNLIKVISSCS-NEEFKALVLEYMPHGSLEKYLYSSNCILDIF 73 (273)
Q Consensus 2 ~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 73 (273)
=||||+-.... ....+..-+|..|-+.|+||.||++|++|. +...+|-|+|||+|.+|.-|++.++ .+++.
T Consensus 490 YvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhk-lmSEK 568 (775)
T KOG1151|consen 490 YVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHK-LMSEK 568 (775)
T ss_pred eeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhh-hhhHH
Confidence 48999875432 223445678999999999999999999986 4567899999999999999986554 79999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeC---CCCceEEeecccccccccCCCc-----ceeecccccCCCC
Q 024027 74 QRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLD---DNLVAYLSDFGIAKLLIGEDQS-----MTQTQTLATIGYM 145 (273)
Q Consensus 74 ~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~---~~~~~kl~Df~~~~~~~~~~~~-----~~~~~~~~~~~~~ 145 (273)
++++++.||+.||.||.+. +-.|+|-||||.|||+. ..|.+||.|||++.++...+.. .......||.||+
T Consensus 569 EARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYL 647 (775)
T KOG1151|consen 569 EARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYL 647 (775)
T ss_pred HHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeec
Confidence 9999999999999999953 55799999999999994 5689999999999988544322 2234667999999
Q ss_pred CCcccCC----CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhh
Q 024027 146 APEYGRE----GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQ 221 (273)
Q Consensus 146 aPE~~~~----~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (273)
+||.+.- +.++.+.||||+|+++|+++.|+.||.........+.. .........-++..+.
T Consensus 648 PPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe---------------NTIlkAtEVqFP~KPv 712 (775)
T KOG1151|consen 648 PPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE---------------NTILKATEVQFPPKPV 712 (775)
T ss_pred CcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh---------------hchhcceeccCCCCCc
Confidence 9998753 34789999999999999999999999764332211110 0111122223334567
Q ss_pred hHHHHHHHHhhcCCCCccCCCCHHHHHHH
Q 024027 222 CVSFVFNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 222 ~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
++.++.+||++||.+--++|..+.++..+
T Consensus 713 VsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 713 VSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred cCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 88889999999999999999999888754
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=252.36 Aligned_cols=182 Identities=23% Similarity=0.290 Sum_probs=134.8
Q ss_pred ceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccc
Q 024027 46 FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL 125 (273)
Q Consensus 46 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~ 125 (273)
.+||-||||+.-.+.+++.++...-..+..|+++.+|+.||.|+| +.|++||||||.||+++.++.|||+|||+++.
T Consensus 670 ~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~ 746 (1351)
T KOG1035|consen 670 ILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATD 746 (1351)
T ss_pred EEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH---hCceeeccCCcceeEEcCCCCeeecccccchh
Confidence 368899999886666666554422257899999999999999999 99999999999999999999999999999987
Q ss_pred cc--------------c--CCCcceeecccccCCCCCCcccCCCC---cCCcchhHHHHHHHHHHHhCCCCCcccccccc
Q 024027 126 LI--------------G--EDQSMTQTQTLATIGYMAPEYGREGR---VSTNGDVYSFGIMLMETFTGKKPTYEFFNGEM 186 (273)
Q Consensus 126 ~~--------------~--~~~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~ 186 (273)
.. . .......+..+||.-|.|||++.+.. |+.|+||||||++++||+. ||....+...
T Consensus 747 ~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~ 823 (1351)
T KOG1035|consen 747 LKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERAS 823 (1351)
T ss_pred hhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHH
Confidence 21 0 01111345668999999999997655 9999999999999999985 3555433333
Q ss_pred chhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHH
Q 024027 187 TLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVT 249 (273)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~ 249 (273)
.+........+.. ......-...-..+|++|+..||.+|||+.++|.
T Consensus 824 iL~~LR~g~iP~~----------------~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 824 ILTNLRKGSIPEP----------------ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHhcccCCCCCC----------------cccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 3332222211111 0011222233678999999999999999999986
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=235.55 Aligned_cols=224 Identities=21% Similarity=0.250 Sum_probs=186.4
Q ss_pred EEEEEeecc---cChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 3 VAVKVFNLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 3 vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
+|+|+++.. +....+.+..|-++|...+.|.|+++|-.|.++.+.|++||-|-||.|+..+... +.++...+.-++
T Consensus 448 fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdR-g~Fdd~tarF~~ 526 (732)
T KOG0614|consen 448 FALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDR-GSFDDYTARFYV 526 (732)
T ss_pred HHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhc-CCcccchhhhhH
Confidence 356666543 4556778889999999999999999999999999999999999999999999554 479999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 159 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 159 (273)
..++.|+.||| .+||+.|||||+|.+++.+|.+||.|||++..+....+ ....+||+.|.|||++.+...+.+.
T Consensus 527 acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K---TwTFcGTpEYVAPEIILnKGHD~av 600 (732)
T KOG0614|consen 527 ACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK---TWTFCGTPEYVAPEIILNKGHDRAV 600 (732)
T ss_pred HHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccCCc---eeeecCCcccccchhhhccCcchhh
Confidence 99999999999 99999999999999999999999999999998744333 4457999999999999999999999
Q ss_pred hhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCcc
Q 024027 160 DVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239 (273)
Q Consensus 160 DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 239 (273)
|.||||+++||+++|.+||...++-.+ +..+... --....|..++....+|++++...+|.
T Consensus 601 DyWaLGIli~ELL~G~pPFs~~dpmkt-Yn~ILkG------------------id~i~~Pr~I~k~a~~Lik~LCr~~P~ 661 (732)
T KOG0614|consen 601 DYWALGILIYELLTGSPPFSGVDPMKT-YNLILKG------------------IDKIEFPRRITKTATDLIKKLCRDNPT 661 (732)
T ss_pred HHHHHHHHHHHHHcCCCCCCCCchHHH-HHHHHhh------------------hhhhhcccccchhHHHHHHHHHhcCcH
Confidence 999999999999999999987443222 1111111 011122556777799999999999999
Q ss_pred CCCC-----HHHHHHHHH
Q 024027 240 QRIN-----AKEIVTKLL 252 (273)
Q Consensus 240 ~Rps-----~~~~l~~l~ 252 (273)
+|.. +.+|-+|-|
T Consensus 662 ERLG~~~~gI~DIkkH~W 679 (732)
T KOG0614|consen 662 ERLGYQKGGINDIKKHRW 679 (732)
T ss_pred hhhccccCChHHHHhhhh
Confidence 9986 777777765
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=221.51 Aligned_cols=230 Identities=24% Similarity=0.247 Sum_probs=177.8
Q ss_pred CeEEEEEeecccC-hhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhh----cCCCCCCHHH
Q 024027 1 MEVAVKVFNLQCG-RAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY----SSNCILDIFQ 74 (273)
Q Consensus 1 ~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~ 74 (273)
+.+|||.++.... .+.+.+..|.+...+- ++||||++||.+-.++.++|.||.|+- +|..+.+ -....+++..
T Consensus 90 ~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~I 168 (361)
T KOG1006|consen 90 KLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENI 168 (361)
T ss_pred cEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhh
Confidence 4689999986653 5677788888876655 799999999999999999999999965 8866543 1234588888
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCC-
Q 024027 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG- 153 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~- 153 (273)
+-++..-.+.||.||.+ ..+++|||+||+|||++..|.+||+|||.+-.+.. +...+...|-..|+|||.+...
T Consensus 169 lg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~---SiAkT~daGCrpYmAPERi~p~~ 243 (361)
T KOG1006|consen 169 LGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD---SIAKTVDAGCRPYMAPERIDPSD 243 (361)
T ss_pred hhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHH---HHHhhhccCCccccChhccCCcc
Confidence 88999999999999996 77999999999999999999999999999876532 2223344566679999988653
Q ss_pred -CcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhh
Q 024027 154 -RVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMA 232 (273)
Q Consensus 154 -~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 232 (273)
.|+.+||+||||++++|+.+|..|+..+..--..+...+...++ ..... .. ....+..+..++.-
T Consensus 244 ~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp----~l~~~----~~------~~~~s~~~~~fint 309 (361)
T KOG1006|consen 244 KGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPP----ILLFD----KE------CVHYSFSMVRFINT 309 (361)
T ss_pred CCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCC----eecCc----cc------ccccCHHHHHHHHH
Confidence 48999999999999999999999998876633333222222111 10000 00 12356669999999
Q ss_pred cCCCCccCCCCHHHHHHH
Q 024027 233 CTVESPEQRINAKEIVTK 250 (273)
Q Consensus 233 ~l~~dp~~Rps~~~~l~~ 250 (273)
||.+|..+||+.++++++
T Consensus 310 Cl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 310 CLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HhhcccccCcchhhhhcC
Confidence 999999999999999875
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-32 Score=221.00 Aligned_cols=241 Identities=25% Similarity=0.389 Sum_probs=186.3
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcC--CCccceeeeeeeecC----CceeEEEeccCCCCHHHhhhcCCCCCCHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSI--RHRNLIKVISSCSNE----EFKALVLEYMPHGSLEKYLYSSNCILDIFQR 75 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (273)
.||||+|... +.+.+.+|.++++-+ +|+||+.+++.-..+ .++++|++|.+.|||+|||++. .++....
T Consensus 236 ~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~--tv~~~~m 310 (513)
T KOG2052|consen 236 DVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRN--TVTTEGM 310 (513)
T ss_pred ceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhc--cCCHHHH
Confidence 6999999744 447888888888765 999999999875433 2678999999999999999774 5999999
Q ss_pred HHHHHHHHHHHHHHh-----cCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCC--cceeecccccCCCCCCc
Q 024027 76 LNIMIDVASALEYLH-----FGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQ--SMTQTQTLATIGYMAPE 148 (273)
Q Consensus 76 ~~~~~ql~~~l~~lh-----~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~--~~~~~~~~~~~~~~aPE 148 (273)
++++..+++||++|| +|.+-.|.|||||..|||+.+++...|+|+|++........ ....+..+||-.|+|||
T Consensus 311 l~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPE 390 (513)
T KOG2052|consen 311 LKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPE 390 (513)
T ss_pred HHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChH
Confidence 999999999999999 66677899999999999999999999999999987754422 23456778999999999
Q ss_pred ccCCCC----c--CCcchhHHHHHHHHHHHhC----------CCCCccccccccchhhhhhhccCccchhhhhhhccccc
Q 024027 149 YGREGR----V--STNGDVYSFGIMLMETFTG----------KKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQE 212 (273)
Q Consensus 149 ~~~~~~----~--~~~~DiwslG~~l~~ll~g----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (273)
++...- + -..+||||||.++||+.-+ ++||.+....+....+.....=.....+.+...
T Consensus 391 vLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnr----- 465 (513)
T KOG2052|consen 391 VLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNR----- 465 (513)
T ss_pred HhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcc-----
Confidence 986542 1 2469999999999999853 468877766666555443321111111111111
Q ss_pred hhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHHHHHH
Q 024027 213 DIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLLKIRD 256 (273)
Q Consensus 213 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 256 (273)
+ ....+-..+..+++.||..+|.-|.|+=.+-+.|.++.+
T Consensus 466 ---W-~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 466 ---W-KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred ---c-ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 1 123344558889999999999999999999999988875
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=250.57 Aligned_cols=227 Identities=25% Similarity=0.333 Sum_probs=180.5
Q ss_pred EEEEEeecc---cChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 3 VAVKVFNLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 3 vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
+|.|+++.- ...+-.-|..|=.+|..-+.+=|+.+.-.|+|+.++|+||||++||+|-.++.+.. .+++..++-++
T Consensus 103 YAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~ 181 (1317)
T KOG0612|consen 103 YAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYT 181 (1317)
T ss_pred hhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcC-CChHHHHHHHH
Confidence 566666532 12233457788888988899999999999999999999999999999999998887 89999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC-----CC
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE-----GR 154 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~ 154 (273)
..|+.||..|| +.|++||||||+|||+|..|.+||+|||.+-.+...+ .......+|||.|.+||++.. +.
T Consensus 182 aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~ 257 (1317)
T KOG0612|consen 182 AEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGE 257 (1317)
T ss_pred HHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccc
Confidence 99999999999 9999999999999999999999999999998774333 334566789999999998852 35
Q ss_pred cCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcC
Q 024027 155 VSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACT 234 (273)
Q Consensus 155 ~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 234 (273)
|+...|.||+||++|+|+.|.-||+...--+ ++..++.- ...+.++-...+|.++.+||.+.+
T Consensus 258 yG~ecDwWSlGV~~YEMlyG~TPFYadslve-TY~KIm~h----------------k~~l~FP~~~~VSeeakdLI~~ll 320 (1317)
T KOG0612|consen 258 YGRECDWWSLGVFMYEMLYGETPFYADSLVE-TYGKIMNH----------------KESLSFPDETDVSEEAKDLIEALL 320 (1317)
T ss_pred cCCccchhhhHHHHHHHHcCCCcchHHHHHH-HHHHHhch----------------hhhcCCCcccccCHHHHHHHHHHh
Confidence 8999999999999999999999998633222 22222211 111222212458888999999987
Q ss_pred CCCccCCCC---HHHHHHHHH
Q 024027 235 VESPEQRIN---AKEIVTKLL 252 (273)
Q Consensus 235 ~~dp~~Rps---~~~~l~~l~ 252 (273)
. +|..|.. ++++-.|--
T Consensus 321 ~-~~e~RLgrngiedik~HpF 340 (1317)
T KOG0612|consen 321 C-DREVRLGRNGIEDIKNHPF 340 (1317)
T ss_pred c-ChhhhcccccHHHHHhCcc
Confidence 6 5777776 888887754
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=237.71 Aligned_cols=226 Identities=23% Similarity=0.308 Sum_probs=182.8
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcC-CCccceeeeeeeec-----CCceeEEEeccCCCCHHHhhhcC-CCCCCHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSI-RHRNLIKVISSCSN-----EEFKALVLEYMPHGSLEKYLYSS-NCILDIF 73 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~ 73 (273)
+.+|||+..... ...++++.|.++|+.. .|||++.++|+|.- ++.+++|||||.||++.|+++.- +..+.+.
T Consensus 45 ~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~ 123 (953)
T KOG0587|consen 45 QLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEE 123 (953)
T ss_pred ceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhH
Confidence 357888887553 3447899999999998 69999999998843 56899999999999999999644 4469999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCC
Q 024027 74 QRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG 153 (273)
Q Consensus 74 ~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 153 (273)
.|..++..++.|+.+|| .+.++|+|||-.||+++.++.|||+|||.+..+ ..........+||+.|+|||++...
T Consensus 124 ~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl--dsT~grRnT~iGtP~WMAPEViac~ 198 (953)
T KOG0587|consen 124 WIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DSTVGRRNTFIGTPYWMAPEVIACD 198 (953)
T ss_pred HHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEeeeeeeeee--ecccccccCcCCCcccccceeeecc
Confidence 99999999999999999 999999999999999999999999999999876 3333445567899999999998643
Q ss_pred -----CcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHH
Q 024027 154 -----RVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFN 228 (273)
Q Consensus 154 -----~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 228 (273)
.|+.++|+||||++..||.-|.+|+-+.-.-...+. .+ ..++.....+..-+.++.+
T Consensus 199 e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~------Ip------------RNPPPkLkrp~kWs~~Fnd 260 (953)
T KOG0587|consen 199 ESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFL------IP------------RNPPPKLKRPKKWSKKFND 260 (953)
T ss_pred cCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhcc------CC------------CCCCccccchhhHHHHHHH
Confidence 378899999999999999999999766433221111 11 1111122224556777999
Q ss_pred HHhhcCCCCccCCCCHHHHHHH
Q 024027 229 LAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 229 li~~~l~~dp~~Rps~~~~l~~ 250 (273)
+|..||.+|...||+..++++|
T Consensus 261 FIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 261 FISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred HHHHHHhhccccCcchhhhccC
Confidence 9999999999999999999876
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-33 Score=232.64 Aligned_cols=239 Identities=23% Similarity=0.243 Sum_probs=177.7
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCC------CccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCC--CCCHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIR------HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNC--ILDIF 73 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~ 73 (273)
.||||++... ..-.+.=..|+++|++|. --|+++++-.|....++|||||.+. .+|.+.+++.+. .+...
T Consensus 459 ~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ik 536 (752)
T KOG0670|consen 459 EVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIK 536 (752)
T ss_pred eeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeeh
Confidence 6999999765 223455668999999993 5689999999999999999999994 599999986643 47888
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCC-CceEEeecccccccccCCCcceeecccccCCCCCCcccCC
Q 024027 74 QRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDN-LVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE 152 (273)
Q Consensus 74 ~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~-~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 152 (273)
.+..+++|+.-||..|- ..|++|.||||+|||++.. ..+||||||.+.+..... . .....+..|.|||++.|
T Consensus 537 aVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~ene---i-tPYLVSRFYRaPEIiLG 609 (752)
T KOG0670|consen 537 AVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDFGSASFASENE---I-TPYLVSRFYRAPEIILG 609 (752)
T ss_pred HHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccCcccccccccc---c-cHHHHHHhccCcceeec
Confidence 99999999999999999 9999999999999999854 578999999998652211 1 22334567999999999
Q ss_pred CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhh-hccCc---------------------------------
Q 024027 153 GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVN-DWLPI--------------------------------- 198 (273)
Q Consensus 153 ~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~~--------------------------------- 198 (273)
..|+...|+||+||+|||+.+|+..|.+..+..+.-...-. +..+.
T Consensus 610 ~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~ 689 (752)
T KOG0670|consen 610 LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKR 689 (752)
T ss_pred CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeE
Confidence 99999999999999999999999998876665432111100 00000
Q ss_pred ------cchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHH
Q 024027 199 ------STMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 199 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
.+...+...+...+. ...-.+..-..+++|+.+||..||++|.|+.++|.|
T Consensus 690 ~vm~~vkPtkdl~s~l~~~q~-~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 690 TVMVNVKPTKDLGSELIAVQR-LPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKH 746 (752)
T ss_pred EEecccCcchhHHHHHhccCC-CCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcC
Confidence 000000000000000 001123345569999999999999999999999987
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=223.23 Aligned_cols=216 Identities=21% Similarity=0.258 Sum_probs=176.0
Q ss_pred eEEEEEeeccc---ChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 2 EVAVKVFNLQC---GRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 2 ~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
-+|||+++.+. ..+.+--..|-++|... +-|.++++..+|+.-..+|+||||+.||+|-..+++-+ .+.+..+.-
T Consensus 376 LyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~G-kFKEp~AvF 454 (683)
T KOG0696|consen 376 LYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-KFKEPVAVF 454 (683)
T ss_pred hhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhc-ccCCchhhh
Confidence 36899998763 23334445566667665 68899999999999999999999999999988886655 688999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
++..|+-||-+|| ++||+.||||.+|||++.+|.+||+|||++..-. .........+||+.|+|||++..++|+.
T Consensus 455 YAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni--~~~~TTkTFCGTPdYiAPEIi~YqPYgk 529 (683)
T KOG0696|consen 455 YAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI--FDGVTTKTFCGTPDYIAPEIIAYQPYGK 529 (683)
T ss_pred hhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeecccccccc--cCCcceeeecCCCcccccceEEeccccc
Confidence 9999999999999 9999999999999999999999999999997432 2233456789999999999999999999
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
+.|.||+|+++|||+.|++||.+.++.+. +..+.+. .-.-|...+.++.++....|...
T Consensus 530 svDWWa~GVLLyEmlaGQpPFdGeDE~el-F~aI~eh--------------------nvsyPKslSkEAv~ickg~ltK~ 588 (683)
T KOG0696|consen 530 SVDWWAFGVLLYEMLAGQPPFDGEDEDEL-FQAIMEH--------------------NVSYPKSLSKEAVAICKGLLTKH 588 (683)
T ss_pred chhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHHc--------------------cCcCcccccHHHHHHHHHHhhcC
Confidence 99999999999999999999987544332 2211111 01114557888999999999999
Q ss_pred ccCCCCH
Q 024027 238 PEQRINA 244 (273)
Q Consensus 238 p~~Rps~ 244 (273)
|.+|...
T Consensus 589 P~kRLGc 595 (683)
T KOG0696|consen 589 PGKRLGC 595 (683)
T ss_pred CccccCC
Confidence 9999743
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-32 Score=217.43 Aligned_cols=232 Identities=23% Similarity=0.319 Sum_probs=184.6
Q ss_pred EEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeee-cCCceeEEEeccCCCCHHHhhh-----cCC--CCCCHHHH
Q 024027 5 VKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCS-NEEFKALVLEYMPHGSLEKYLY-----SSN--CILDIFQR 75 (273)
Q Consensus 5 vK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~-----~~~--~~~~~~~~ 75 (273)
+|-++... .-....+..|.-++...+|||+.++.+++. +....+.++.+...|+|..|+. ... ......+.
T Consensus 319 vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~ql 398 (563)
T KOG1024|consen 319 VKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQL 398 (563)
T ss_pred HHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHH
Confidence 44444332 233445667777788889999999999875 4567889999999999999997 222 23677788
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCc
Q 024027 76 LNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRV 155 (273)
Q Consensus 76 ~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~ 155 (273)
..++.|++.|++||| ..|++|.||..+|+++++...+||+|-.+++.+...+-.--......+..|++||.+.+..|
T Consensus 399 V~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~y 475 (563)
T KOG1024|consen 399 VLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHY 475 (563)
T ss_pred HHHHHHHHHHHHHHH---hcCcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhh
Confidence 999999999999999 99999999999999999999999999999987744333222333345778999999999999
Q ss_pred CCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcC
Q 024027 156 STNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACT 234 (273)
Q Consensus 156 ~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 234 (273)
+.++|+||||+++|||++ |+.|+.+.++.+... +. ....+...|.+|++++..++.-||
T Consensus 476 ssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~--yl------------------kdGyRlaQP~NCPDeLf~vMacCW 535 (563)
T KOG1024|consen 476 SSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEH--YL------------------KDGYRLAQPFNCPDELFTVMACCW 535 (563)
T ss_pred cchhhhHHHHHHHHHHHhcCCCCccccCHHHHHH--HH------------------hccceecCCCCCcHHHHHHHHHHH
Confidence 999999999999999999 999987654433211 11 122233347899999999999999
Q ss_pred CCCccCCCCHHHHHHHHHHHHHhhh
Q 024027 235 VESPEQRINAKEIVTKLLKIRDSLL 259 (273)
Q Consensus 235 ~~dp~~Rps~~~~l~~l~~~~~~~~ 259 (273)
..+|++|||++++...|.++-..+.
T Consensus 536 allpeeRPsf~Qlv~cLseF~~qlt 560 (563)
T KOG1024|consen 536 ALLPEERPSFSQLVICLSEFHTQLT 560 (563)
T ss_pred hcCcccCCCHHHHHHHHHHHHHHHh
Confidence 9999999999999999999877654
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=226.15 Aligned_cols=206 Identities=21% Similarity=0.315 Sum_probs=166.2
Q ss_pred hhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 024027 15 AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCS 94 (273)
Q Consensus 15 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~ 94 (273)
.....+.|-.||..-+.+=||++|-.|++...+|+||||++||++-.+|-+.+ .+.+..++-++..+..|+.+.| .
T Consensus 672 QvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVH---k 747 (1034)
T KOG0608|consen 672 QVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVH---K 747 (1034)
T ss_pred hhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHH---h
Confidence 34556778888888899999999999999999999999999999999986665 6889999999999999999999 9
Q ss_pred CCeEeccCCCCceeeCCCCceEEeecccccccccCCCc----------------------------------------ce
Q 024027 95 APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQS----------------------------------------MT 134 (273)
Q Consensus 95 ~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~----------------------------------------~~ 134 (273)
.|++||||||+|||+|.+|.+||.|||+|+-+...... ..
T Consensus 748 mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ 827 (1034)
T KOG0608|consen 748 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRIL 827 (1034)
T ss_pred ccceecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhh
Confidence 99999999999999999999999999999766321110 01
Q ss_pred eecccccCCCCCCcccCCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchh
Q 024027 135 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDI 214 (273)
Q Consensus 135 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (273)
....+||+.|+|||++....++...|.||.|++||+|+.|++||.....++..+.-. .+...+
T Consensus 828 ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~-----------------nw~~~l 890 (1034)
T KOG0608|consen 828 AHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVI-----------------NWRNFL 890 (1034)
T ss_pred hhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeee-----------------ehhhcc
Confidence 113468999999999999999999999999999999999999999877766544321 112223
Q ss_pred hhhhhhhhHHHHHHHHhhcCCCCccCCC
Q 024027 215 HFVAKEQCVSFVFNLAMACTVESPEQRI 242 (273)
Q Consensus 215 ~~~~~~~~~~~l~~li~~~l~~dp~~Rp 242 (273)
......+++.+..++|.++.. ++..|.
T Consensus 891 ~~~~~~~ls~e~~~li~kLc~-sad~RL 917 (1034)
T KOG0608|consen 891 HIPYQGNLSKEALDLIQKLCC-SADSRL 917 (1034)
T ss_pred ccccccccCHHHHHHHHHHhc-Chhhhh
Confidence 333345677778888887543 445554
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-33 Score=215.17 Aligned_cols=246 Identities=22% Similarity=0.231 Sum_probs=180.2
Q ss_pred CeEEEEEeecc--cChhhhhHHHHHHHHhcCCCccceeeeeeeecCC-----ceeEEEeccCCCCHHHhhhcCCCCCCHH
Q 024027 1 MEVAVKVFNLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEE-----FKALVLEYMPHGSLEKYLYSSNCILDIF 73 (273)
Q Consensus 1 ~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 73 (273)
|.||+|++..- +-.+.+.+.+|+++|+.++|.|++..+++.+... .+|.++|.+.. +|...+-.. ..++.+
T Consensus 79 rrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQS-DLHKIIVSP-Q~Ls~D 156 (449)
T KOG0664|consen 79 KRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQS-DLHKIIVSP-QALTPD 156 (449)
T ss_pred cchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHHh-hhhheeccC-CCCCcc
Confidence 35778877532 3345678999999999999999999999876543 46789999966 888887443 468999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCC
Q 024027 74 QRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG 153 (273)
Q Consensus 74 ~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 153 (273)
.+.-+++||+.||+||| +.+|.||||||.|.+++.+..+||+|||+++.... .........+-|.+|+|||++.|.
T Consensus 157 HvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~-d~~~hMTqEVVTQYYRAPEiLMGa 232 (449)
T KOG0664|consen 157 HVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ-RDRLNMTHEVVTQYYRAPELLMGA 232 (449)
T ss_pred hhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccch-hhhhhhHHHHHHHHhccHHHhhcc
Confidence 99999999999999999 99999999999999999999999999999986422 223345566788999999999987
Q ss_pred C-cCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccc------hhhhhhhccccch--------hhhhh
Q 024027 154 R-VSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPIST------MEVVDANLLSQED--------IHFVA 218 (273)
Q Consensus 154 ~-~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~--------~~~~~ 218 (273)
. |+.+.||||+||++.|++.++..|.....- ..+..+.+-...+.. .+........... .....
T Consensus 233 RhYs~AvDiWSVGCIFaELLgRrILFQAq~Pi-qQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS 311 (449)
T KOG0664|consen 233 RRYTGAVDIWSVGCIFAELLQRKILFQAAGPI-EQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIAS 311 (449)
T ss_pred hhhcCccceehhhHHHHHHHhhhhhhhccChH-HHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecC
Confidence 5 899999999999999999998887653221 111111111111110 1111111111000 01111
Q ss_pred hhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHHH
Q 024027 219 KEQCVSFVFNLAMACTVESPEQRINAKEIVTKLLK 253 (273)
Q Consensus 219 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 253 (273)
+..-..+..+++.+|+..||.+|.+..+++.|+..
T Consensus 312 ~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~ 346 (449)
T KOG0664|consen 312 PDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL 346 (449)
T ss_pred CcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence 23344568889999999999999999999988753
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=201.14 Aligned_cols=194 Identities=34% Similarity=0.507 Sum_probs=167.8
Q ss_pred CeEEEEEeecccCh-hhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 1 ~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
+++++|++...... ....+.+|++.++.++|++++++++++......++++|++++++|.+++......++...++.++
T Consensus 19 ~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ 98 (215)
T cd00180 19 KKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRIL 98 (215)
T ss_pred cEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHH
Confidence 36899999765332 35679999999999999999999999999999999999999899999997653468999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCC-CCceEEeecccccccccCCCcceeecccccCCCCCCcccCCC-CcCC
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDD-NLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG-RVST 157 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~-~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~ 157 (273)
.+++.++.+|| +.|++|+||+|.||+++. ++.++|+||+.+........ ......+...|.+||..... .++.
T Consensus 99 ~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~ 173 (215)
T cd00180 99 LQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMAPEVLLGKGYYSE 173 (215)
T ss_pred HHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCCCCccChhHhcccCCCCc
Confidence 99999999999 999999999999999999 89999999999976533221 12334567789999998877 7889
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
++|+|++|++++++ ..+.+++.+|+..|
T Consensus 174 ~~D~~~lg~~~~~l----------------------------------------------------~~~~~~l~~~l~~~ 201 (215)
T cd00180 174 KSDIWSLGVILYEL----------------------------------------------------PELKDLIRKMLQKD 201 (215)
T ss_pred hhhhHHHHHHHHHH----------------------------------------------------HHHHHHHHHHhhCC
Confidence 99999999999999 23888999999999
Q ss_pred ccCCCCHHHHHHHH
Q 024027 238 PEQRINAKEIVTKL 251 (273)
Q Consensus 238 p~~Rps~~~~l~~l 251 (273)
|.+||++.++++++
T Consensus 202 p~~R~~~~~l~~~~ 215 (215)
T cd00180 202 PEKRPSAKEILEHL 215 (215)
T ss_pred cccCcCHHHHhhCC
Confidence 99999999998764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=211.30 Aligned_cols=221 Identities=21% Similarity=0.237 Sum_probs=177.0
Q ss_pred eEEEEEeecc---cChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 2 EVAVKVFNLQ---CGRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 2 ~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
-+|+|++|.. +.+++.=.+.|-.+..+- +||.++.+..+|+.++.+++|.||.+||+|--.+++++ ++++..++-
T Consensus 277 iyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhmqrqr-klpeeharf 355 (593)
T KOG0695|consen 277 IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARF 355 (593)
T ss_pred eeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeehhhhh-cCcHHHhhh
Confidence 5788988754 355666677888888877 79999999999999999999999999999988887665 699999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
+...|+.||.||| ++||+.+|+|.+|++++..|.+||.|||++..- .......+..+||+.|.|||++.+..|..
T Consensus 356 ys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~--l~~gd~tstfcgtpnyiapeilrgeeygf 430 (593)
T KOG0695|consen 356 YSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG--LGPGDTTSTFCGTPNYIAPEILRGEEYGF 430 (593)
T ss_pred hhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcC--CCCCcccccccCCCcccchhhhcccccCc
Confidence 9999999999999 999999999999999999999999999999753 22334456789999999999999999999
Q ss_pred cchhHHHHHHHHHHHhCCCCCcccccccc--chhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEM--TLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTV 235 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 235 (273)
..|.|+||+++++|+.|+.||.-...+.. ....+. ..++-... ...|...+-.+..+++.-|+
T Consensus 431 svdwwalgvlmfemmagrspfdivgm~n~d~ntedyl--------fqvilekq-------iriprslsvkas~vlkgfln 495 (593)
T KOG0695|consen 431 SVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYL--------FQVILEKQ-------IRIPRSLSVKASHVLKGFLN 495 (593)
T ss_pred eehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHH--------HHHHhhhc-------ccccceeehhhHHHHHHhhc
Confidence 99999999999999999999975332211 111110 00000000 11144455567789999999
Q ss_pred CCccCCCC
Q 024027 236 ESPEQRIN 243 (273)
Q Consensus 236 ~dp~~Rps 243 (273)
+||++|..
T Consensus 496 kdp~erlg 503 (593)
T KOG0695|consen 496 KDPKERLG 503 (593)
T ss_pred CCcHHhcC
Confidence 99999864
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=232.64 Aligned_cols=203 Identities=19% Similarity=0.164 Sum_probs=133.5
Q ss_pred ecCCceeEEEeccCCCCHHHhhhcCCCC-------------------CCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccC
Q 024027 42 SNEEFKALVLEYMPHGSLEKYLYSSNCI-------------------LDIFQRLNIMIDVASALEYLHFGCSAPVIHCDL 102 (273)
Q Consensus 42 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------------------~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di 102 (273)
..+...++|+||+++++|.+++...... .....+..++.|++.||.||| +.+|+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcC
Confidence 4556789999999999999998654321 123346789999999999999 999999999
Q ss_pred CCCceeeCC-CCceEEeecccccccccCCCcceeecccccCCCCCCcccCCC----------------------CcCCcc
Q 024027 103 KPDNVLLDD-NLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG----------------------RVSTNG 159 (273)
Q Consensus 103 ~p~nil~~~-~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----------------------~~~~~~ 159 (273)
||+|||++. ++.+||+|||++..+.... ........+++.|+|||.+... .++.++
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 999999985 6799999999997553221 1223445788999999965322 133456
Q ss_pred hhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhh---hhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 160 DVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEV---VDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 160 DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
||||+||++|+|+++..|+... ...+...... ...+.... ................+......++|+.+||.+
T Consensus 361 DVwSlGviL~el~~~~~~~~~~---~~~~~~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSN---LIQFNRQLKR-NDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchH---HHHHHHHHHh-cCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence 9999999999999977664321 0011110000 00000000 000000000000111122234467999999999
Q ss_pred CccCCCCHHHHHHHHH
Q 024027 237 SPEQRINAKEIVTKLL 252 (273)
Q Consensus 237 dp~~Rps~~~~l~~l~ 252 (273)
||++|||++++++|=.
T Consensus 437 dP~kR~ta~e~L~Hpf 452 (566)
T PLN03225 437 KGRQRISAKAALAHPY 452 (566)
T ss_pred CcccCCCHHHHhCCcC
Confidence 9999999999999843
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=224.89 Aligned_cols=239 Identities=18% Similarity=0.193 Sum_probs=161.9
Q ss_pred eEEEEEeecccChhhhh--------------HHHHHHHHhcCCCcc-----ceeeeeeeec--------CCceeEEEecc
Q 024027 2 EVAVKVFNLQCGRAFKS--------------FDVECEMMKSIRHRN-----LIKVISSCSN--------EEFKALVLEYM 54 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~--------------~~~E~~~l~~l~h~~-----i~~~~~~~~~--------~~~~~lv~e~~ 54 (273)
.||||.++.......++ ...|+.++..++|.+ +++++++|.. .+..++||||+
T Consensus 188 ~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~ 267 (507)
T PLN03224 188 RVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFE 267 (507)
T ss_pred eEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcC
Confidence 69999997553322233 334666777776554 4677777653 35678999999
Q ss_pred CCCCHHHhhhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCC
Q 024027 55 PHGSLEKYLYSSN-----------------------CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDD 111 (273)
Q Consensus 55 ~~~~L~~~l~~~~-----------------------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~ 111 (273)
++++|.+++.... ..+++..++.++.|++.+|.||| +.+++|+||||+||+++.
T Consensus 268 ~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~ 344 (507)
T PLN03224 268 SDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTV 344 (507)
T ss_pred CCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECC
Confidence 9999999986421 12456778999999999999999 999999999999999999
Q ss_pred CCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCC--------------------c--CCcchhHHHHHHHH
Q 024027 112 NLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGR--------------------V--STNGDVYSFGIMLM 169 (273)
Q Consensus 112 ~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--------------------~--~~~~DiwslG~~l~ 169 (273)
++.++|+|||++....... ........+++.|+|||.+.... + ..+.|+||+||+++
T Consensus 345 ~~~~kL~DFGla~~~~~~~-~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~ 423 (507)
T PLN03224 345 DGQVKIIDFGAAVDMCTGI-NFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLM 423 (507)
T ss_pred CCcEEEEeCcCccccccCC-ccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHH
Confidence 9999999999986542211 11111223478999999875432 1 13469999999999
Q ss_pred HHHhCCC-CCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc---cCCCCHH
Q 024027 170 ETFTGKK-PTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP---EQRINAK 245 (273)
Q Consensus 170 ~ll~g~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp---~~Rps~~ 245 (273)
+|++|.. ||.....-........... .. ..............+.++...++|+.+||..+| .+|+|++
T Consensus 424 em~~~~l~p~~~~~~f~~~~~~~~~~~-----~~---~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~ 495 (507)
T PLN03224 424 QMCVPELRPVANIRLFNTELRQYDNDL-----NR---WRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVG 495 (507)
T ss_pred HHHhCCCCCccchhhhhhHHhhccchH-----HH---HHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHH
Confidence 9999875 6543211111111100000 00 000111122233355677889999999999866 7899999
Q ss_pred HHHHHHH
Q 024027 246 EIVTKLL 252 (273)
Q Consensus 246 ~~l~~l~ 252 (273)
++|+|-+
T Consensus 496 eaL~Hp~ 502 (507)
T PLN03224 496 QALSHRF 502 (507)
T ss_pred HHhCCCC
Confidence 9999843
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=196.61 Aligned_cols=170 Identities=21% Similarity=0.181 Sum_probs=130.6
Q ss_pred CCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceee
Q 024027 57 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQT 136 (273)
Q Consensus 57 ~~L~~~l~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~ 136 (273)
|+|.+++...+..+++..++.++.|++.||.||| +.+ ||+||+++.++.+++ ||.+......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~------- 62 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPE------- 62 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeeccc-------
Confidence 6899999876667999999999999999999999 777 999999999999999 9988764221
Q ss_pred cccccCCCCCCcccCCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhh
Q 024027 137 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHF 216 (273)
Q Consensus 137 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (273)
...+++.|+|||++.+..++.++|||||||++|+|++|..||..................... ....
T Consensus 63 ~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------------~~~~ 129 (176)
T smart00750 63 QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD-------------PRDR 129 (176)
T ss_pred cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC-------------cccc
Confidence 125789999999999999999999999999999999999998653322222222111111100 0000
Q ss_pred hhhhhhHH--HHHHHHhhcCCCCccCCCCHHHHHHHHHHHHHh
Q 024027 217 VAKEQCVS--FVFNLAMACTVESPEQRINAKEIVTKLLKIRDS 257 (273)
Q Consensus 217 ~~~~~~~~--~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~ 257 (273)
..+...+. ++.+++.+||..||.+|||+.++++|+.....+
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 11223333 699999999999999999999999999887654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=192.51 Aligned_cols=187 Identities=25% Similarity=0.307 Sum_probs=154.2
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhh---cCCCCCCHHHHH
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY---SSNCILDIFQRL 76 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~ 76 (273)
-+|+|.++..- .+..+....|+.+..+. .+|.++.+||.+.+++...|.||.|+- +|..+.. ..+...++..+-
T Consensus 73 imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlG 151 (282)
T KOG0984|consen 73 IMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLG 151 (282)
T ss_pred EEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhh
Confidence 47999998663 45667788899887766 799999999999999999999999966 8877754 446679999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC----
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE---- 152 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---- 152 (273)
+++..++.||.|||. +..++|||+||+|||++.+|.||++|||.+-.+... ...+...|-..|+|||.+..
T Consensus 152 kIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS---iAkt~daGCkpYmaPEri~~e~n~ 226 (282)
T KOG0984|consen 152 KIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS---IAKTMDAGCKPYMAPERINPELNQ 226 (282)
T ss_pred HhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhh---hHHHHhcCCCccCChhhcCcccCc
Confidence 999999999999995 669999999999999999999999999998766332 12222445567999998754
Q ss_pred CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhh
Q 024027 153 GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVND 194 (273)
Q Consensus 153 ~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~ 194 (273)
..|+.++||||||+.+.||.+++.||..+..+=..+.+.+++
T Consensus 227 ~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 227 KGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred ccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 368999999999999999999999998877765555554443
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=243.19 Aligned_cols=200 Identities=17% Similarity=0.205 Sum_probs=142.8
Q ss_pred hcCCC-ccceeeeeee-------ecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 024027 27 KSIRH-RNLIKVISSC-------SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVI 98 (273)
Q Consensus 27 ~~l~h-~~i~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~ 98 (273)
+.++| +||++++++| .....++.++||+ +++|.+++......+++..++.++.||+.||.||| ++||+
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~gIv 102 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH---SQGIV 102 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH---hCCee
Confidence 44566 7889999988 3335678889998 45999999766667999999999999999999999 99999
Q ss_pred eccCCCCceeeCCCCceE-------------------EeecccccccccCCC--------------cceeecccccCCCC
Q 024027 99 HCDLKPDNVLLDDNLVAY-------------------LSDFGIAKLLIGEDQ--------------SMTQTQTLATIGYM 145 (273)
Q Consensus 99 h~di~p~nil~~~~~~~k-------------------l~Df~~~~~~~~~~~--------------~~~~~~~~~~~~~~ 145 (273)
||||||+|||++..+.++ ++|||++........ ........+|++|+
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 999999999996655444 555555432110000 00001135788899
Q ss_pred CCcccCCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHH
Q 024027 146 APEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSF 225 (273)
Q Consensus 146 aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (273)
|||++.+..++.++|||||||++|||++|.+|+..... .......... ... .......
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---~~~~~~~~~~--------------~~~-----~~~~~~~ 240 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR---TMSSLRHRVL--------------PPQ-----ILLNWPK 240 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---HHHHHHHhhc--------------Chh-----hhhcCHH
Confidence 99999998999999999999999999998888643111 0111000000 000 0111233
Q ss_pred HHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 226 VFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 226 l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
..+++.+||.+||.+|||+.++++|-.
T Consensus 241 ~~~~~~~~L~~~P~~Rps~~eil~h~~ 267 (793)
T PLN00181 241 EASFCLWLLHPEPSCRPSMSELLQSEF 267 (793)
T ss_pred HHHHHHHhCCCChhhCcChHHHhhchh
Confidence 568899999999999999999998754
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=203.76 Aligned_cols=105 Identities=28% Similarity=0.375 Sum_probs=89.4
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCC--------Cccceeeeeeeec----CCceeEEEeccCCCCHHHhhhcCC-
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIR--------HRNLIKVISSCSN----EEFKALVLEYMPHGSLEKYLYSSN- 67 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~- 67 (273)
|=||+|+.|.. ....+....|+++|++++ ..+||++++.|.. ..+.|||+|++ |-+|..+|...+
T Consensus 104 r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~Y 181 (590)
T KOG1290|consen 104 RYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNY 181 (590)
T ss_pred eEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCC
Confidence 35999999744 445677889999999982 3579999999965 56899999999 559999997654
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceee
Q 024027 68 CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLL 109 (273)
Q Consensus 68 ~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~ 109 (273)
..++...+..|++||+.||.|||+ ..||+|.||||+|||+
T Consensus 182 rGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 182 RGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLL 221 (590)
T ss_pred CCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeee
Confidence 359999999999999999999997 7799999999999997
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=214.00 Aligned_cols=171 Identities=23% Similarity=0.363 Sum_probs=148.6
Q ss_pred eEEEEEeeccc--------ChhhhhHHHHHHHHhcCC---CccceeeeeeeecCCceeEEEecc-CCCCHHHhhhcCCCC
Q 024027 2 EVAVKVFNLQC--------GRAFKSFDVECEMMKSIR---HRNLIKVISSCSNEEFKALVLEYM-PHGSLEKYLYSSNCI 69 (273)
Q Consensus 2 ~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~-~~~~L~~~l~~~~~~ 69 (273)
.|+||.+.+.. ++..-..-.|++||..++ |+||++++++|++++++||+||.. +|.+|+++|... +.
T Consensus 588 eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~k-p~ 666 (772)
T KOG1152|consen 588 EVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFK-PR 666 (772)
T ss_pred EEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhcc-Cc
Confidence 58999986541 233445678999999996 999999999999999999999986 678999999654 46
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcc
Q 024027 70 LDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEY 149 (273)
Q Consensus 70 ~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~ 149 (273)
+++.++..++.|++.|+++|| +.||+|||||-+|+.++.+|-+||+|||.+... +.......+||..|.|||+
T Consensus 667 m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfgsaa~~----ksgpfd~f~gtv~~aapev 739 (772)
T KOG1152|consen 667 MDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYT----KSGPFDVFVGTVDYAAPEV 739 (772)
T ss_pred cchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeeccchhhh----cCCCcceeeeeccccchhh
Confidence 999999999999999999999 999999999999999999999999999998754 2223345689999999999
Q ss_pred cCCCCc-CCcchhHHHHHHHHHHHhCCCCCcc
Q 024027 150 GREGRV-STNGDVYSFGIMLMETFTGKKPTYE 180 (273)
Q Consensus 150 ~~~~~~-~~~~DiwslG~~l~~ll~g~~pf~~ 180 (273)
+.|..| +..-|||++|+++|.++....||..
T Consensus 740 l~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 740 LGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 999886 5668999999999999999999864
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-29 Score=201.43 Aligned_cols=241 Identities=22% Similarity=0.302 Sum_probs=177.7
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
+.||+|.+...+. ...+..|+++|..+ -+.||+++.+++..++..++|+||++.....++... ++...+..++
T Consensus 65 ~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl 138 (418)
T KOG1167|consen 65 RYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS----LSLAEIRWYL 138 (418)
T ss_pred ceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHHhc----CCHHHHHHHH
Confidence 3689999975543 35699999999999 599999999999999999999999999899888843 6688999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCC-CCceEEeecccccccccCCC-----c---------------------
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDD-NLVAYLSDFGIAKLLIGEDQ-----S--------------------- 132 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~-~~~~kl~Df~~~~~~~~~~~-----~--------------------- 132 (273)
+.++.||.++| .+||+||||||+|++++. .+.-.|.|||++........ .
T Consensus 139 ~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~ 215 (418)
T KOG1167|consen 139 RNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVAT 215 (418)
T ss_pred HHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCccccccccc
Confidence 99999999999 999999999999999984 56789999999973311110 0
Q ss_pred ----------------ceeecccccCCCCCCcccCC-CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhc
Q 024027 133 ----------------MTQTQTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDW 195 (273)
Q Consensus 133 ----------------~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~ 195 (273)
.......||++|.|||++.. +.-++++||||.|++++.++++..||.....+.....+++...
T Consensus 216 ~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tif 295 (418)
T KOG1167|consen 216 ASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIF 295 (418)
T ss_pred ccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHh
Confidence 00012358999999998764 4578999999999999999999999976555544443333111
Q ss_pred cCc----------c--chh---------hhhhhcc-------c-cc--hhhhhhhhhhHHHHHHHHhhcCCCCccCCCCH
Q 024027 196 LPI----------S--TME---------VVDANLL-------S-QE--DIHFVAKEQCVSFVFNLAMACTVESPEQRINA 244 (273)
Q Consensus 196 ~~~----------~--~~~---------~~~~~~~-------~-~~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 244 (273)
... . .++ ....... . .. .......+..+..+.+|+.+||+.||.+|+|+
T Consensus 296 G~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitA 375 (418)
T KOG1167|consen 296 GSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITA 375 (418)
T ss_pred ChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccH
Confidence 110 0 000 0000000 0 00 00111123345579999999999999999999
Q ss_pred HHHHHH
Q 024027 245 KEIVTK 250 (273)
Q Consensus 245 ~~~l~~ 250 (273)
+++|+|
T Consensus 376 EeALkH 381 (418)
T KOG1167|consen 376 EDALKH 381 (418)
T ss_pred HHHhcC
Confidence 999986
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=188.94 Aligned_cols=176 Identities=30% Similarity=0.406 Sum_probs=152.2
Q ss_pred CeEEEEEeecccCh-hhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGR-AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 1 ~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
++||+|.+...... ....+.+|++.++.++|+|++++++++......++++|++++++|.+++......+++..+..++
T Consensus 25 ~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ 104 (225)
T smart00221 25 ELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYL 104 (225)
T ss_pred cEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHH
Confidence 36899999876544 67889999999999999999999999999899999999999999999997655338899999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCccc-CCCCcCCc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYG-REGRVSTN 158 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~ 158 (273)
.+++.++.+|| +.+++|+|++|+||+++.++.++|+|||.+........ .......++..|++||.. ....++.+
T Consensus 105 ~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~ 180 (225)
T smart00221 105 RQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALLKTVKGTPFYLAPEVLLGGKGYGEA 180 (225)
T ss_pred HHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-ccccceeccCCcCCHhHhcCCCCCCch
Confidence 99999999999 99999999999999999999999999999877633221 022334567789999988 56667889
Q ss_pred chhHHHHHHHHHHHhCCCCCcc
Q 024027 159 GDVYSFGIMLMETFTGKKPTYE 180 (273)
Q Consensus 159 ~DiwslG~~l~~ll~g~~pf~~ 180 (273)
+|+|++|++++++++|+.||..
T Consensus 181 ~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 181 VDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred hhHHHHHHHHHHHHHCCCCccc
Confidence 9999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=190.15 Aligned_cols=220 Identities=20% Similarity=0.261 Sum_probs=167.5
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcC-CCccceeeeee-eecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSI-RHRNLIKVISS-CSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~-~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
+.||+|.+... ....++|.+|...--.| .|.||+..|++ |+..+.+++++||++.|+|..-+..++ +.+.....+
T Consensus 50 t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~~G--igE~~~K~v 126 (378)
T KOG1345|consen 50 TRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEAAG--IGEANTKKV 126 (378)
T ss_pred eEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCccc--ccHHHHHHH
Confidence 36888888655 44678999999887777 59999999874 777888889999999999998886654 888889999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeC--CCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC---C
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLD--DNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE---G 153 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~--~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~ 153 (273)
+.|+++|+.|+| +.+++|||||.+|||+- +...|||+|||++..... .....-....|.+||+... .
T Consensus 127 ~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~-----tV~~~~~~~~y~~pe~~~~~~ne 198 (378)
T KOG1345|consen 127 FAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT-----TVKYLEYVNNYHAPELCDTVVNE 198 (378)
T ss_pred HHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccCc-----eehhhhhhcccCCcHHHhhcccc
Confidence 999999999999 99999999999999993 334899999999976421 2222233455889986532 2
Q ss_pred C--cCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHh
Q 024027 154 R--VSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAM 231 (273)
Q Consensus 154 ~--~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 231 (273)
. ..+.+|+|.||+++|.+++|.+||......+..+..+.......... .+. .-..+++.+..+++
T Consensus 199 ~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~---------~P~----~F~~fs~~a~r~Fk 265 (378)
T KOG1345|consen 199 KLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPA---------LPK----KFNPFSEKALRLFK 265 (378)
T ss_pred ceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCcc---------Cch----hhcccCHHHHHHHH
Confidence 2 57889999999999999999999997666666665554432221110 000 01234566889999
Q ss_pred hcCCCCccCCCCH
Q 024027 232 ACTVESPEQRINA 244 (273)
Q Consensus 232 ~~l~~dp~~Rps~ 244 (273)
+-|..+|++|-..
T Consensus 266 k~lt~~~~drcki 278 (378)
T KOG1345|consen 266 KSLTPRFKDRCKI 278 (378)
T ss_pred HhcCCcccccchh
Confidence 9999999999433
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-28 Score=206.92 Aligned_cols=227 Identities=24% Similarity=0.355 Sum_probs=179.5
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~q 81 (273)
+.|||+++..-..+..-++.|+-+++..+||||+.+++.+.....+++.||||.||+|.+..+-. +++++.++..++..
T Consensus 42 laavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~T-gplselqiayvcRe 120 (829)
T KOG0576|consen 42 LAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVT-GPLSELQIAYVCRE 120 (829)
T ss_pred hhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeeec-ccchhHHHHHHHhh
Confidence 57999999877778889999999999999999999999999999999999999999998877544 47999999999999
Q ss_pred HHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccC---CCCcCCc
Q 024027 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR---EGRVSTN 158 (273)
Q Consensus 82 l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~ 158 (273)
.+.+++||| +.|-.|||||-.||+++..|.+|+.|||.+-.+.. .........||++|+|||+-. ...|...
T Consensus 121 tl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqita--ti~KrksfiGtpywmapEvaaverkggynql 195 (829)
T KOG0576|consen 121 TLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA--TIAKRKSFIGTPYWMAPEVAAVERKGGYNQL 195 (829)
T ss_pred hhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhh--hhhhhhcccCCccccchhHHHHHhccccccc
Confidence 999999999 99999999999999999999999999998866522 122334578999999999753 3468999
Q ss_pred chhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc
Q 024027 159 GDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238 (273)
Q Consensus 159 ~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 238 (273)
+|||++|+..-++-.-++|....-..... +....-..+.....+ +..-++.+.+|++.+|..+|
T Consensus 196 cdiwa~gitAiel~eLqpplfdlhpmr~l---~LmTkS~~qpp~lkD-------------k~kws~~fh~fvK~altknp 259 (829)
T KOG0576|consen 196 CDIWALGITAIELGELQPPLFDLHPMRAL---FLMTKSGFQPPTLKD-------------KTKWSEFFHNFVKGALTKNP 259 (829)
T ss_pred ccccccccchhhhhhcCCcccccchHHHH---HHhhccCCCCCcccC-------------CccchHHHHHHHHHHhcCCC
Confidence 99999999999988877774332111111 111111111111111 22234558999999999999
Q ss_pred cCCCCHHHHHHH
Q 024027 239 EQRINAKEIVTK 250 (273)
Q Consensus 239 ~~Rps~~~~l~~ 250 (273)
++|||++.+|.|
T Consensus 260 KkRptaeklL~h 271 (829)
T KOG0576|consen 260 KKRPTAEKLLQH 271 (829)
T ss_pred ccCCChhhheec
Confidence 999999998875
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-26 Score=178.39 Aligned_cols=225 Identities=24% Similarity=0.374 Sum_probs=177.6
Q ss_pred eEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCC-CCCHHHHHHH
Q 024027 2 EVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNC-ILDIFQRLNI 78 (273)
Q Consensus 2 ~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~ 78 (273)
++++|+++... .+.-++|..|+-.|+.+.||||+.+++.|..+.++.++..|++.|+|++.+..... ..+..++.++
T Consensus 215 divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~f 294 (448)
T KOG0195|consen 215 DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRF 294 (448)
T ss_pred chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHH
Confidence 56788887553 55668899999999999999999999999999999999999999999999976543 3777899999
Q ss_pred HHHHHHHHHHHhcCCCCC--eEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCC--
Q 024027 79 MIDVASALEYLHFGCSAP--VIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGR-- 154 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~--i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-- 154 (273)
+.+++.|++||| +.. +..--++...++++++.+.+|+- +-+.+ +.........+.|++||.+....
T Consensus 295 aldiargmaflh---slep~ipr~~lns~hvmidedltarism-ad~kf------sfqe~gr~y~pawmspealqrkped 364 (448)
T KOG0195|consen 295 ALDIARGMAFLH---SLEPMIPRFYLNSKHVMIDEDLTARISM-ADTKF------SFQEVGRAYSPAWMSPEALQRKPED 364 (448)
T ss_pred HHHHHhhHHHHh---hcchhhhhhhcccceEEecchhhhheec-cccee------eeeccccccCcccCCHHHHhcCchh
Confidence 999999999999 542 44446888999999988877752 11111 11112233567799999886544
Q ss_pred -cCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhc
Q 024027 155 -VSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMAC 233 (273)
Q Consensus 155 -~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 233 (273)
.-.+.|+|||++++||+.+...||.+..+-+-.+.- .-+.++-..|++.+..+..|+.-|
T Consensus 365 ~n~raadmwsfaillwel~trevpfadlspmecgmki-------------------aleglrv~ippgis~hm~klm~ic 425 (448)
T KOG0195|consen 365 LNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI-------------------ALEGLRVHIPPGISRHMNKLMNIC 425 (448)
T ss_pred cchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh-------------------hhccccccCCCCccHHHHHHHHHH
Confidence 345799999999999999999999887665544332 223334445778888899999999
Q ss_pred CCCCccCCCCHHHHHHHHHHHH
Q 024027 234 TVESPEQRINAKEIVTKLLKIR 255 (273)
Q Consensus 234 l~~dp~~Rps~~~~l~~l~~~~ 255 (273)
++.||.+||.++.++-.|++++
T Consensus 426 mnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 426 MNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred hcCCCCcCCCcceehhhHHHhc
Confidence 9999999999999999998875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.2e-26 Score=201.46 Aligned_cols=215 Identities=20% Similarity=0.200 Sum_probs=170.3
Q ss_pred HHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 024027 19 FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVI 98 (273)
Q Consensus 19 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~ 98 (273)
+..|+-+-..++|+|++..+..+.+.....-.||||++ +|+.++... ..+....+-.++.|++.|++|+| +.|+.
T Consensus 368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h---~~Gia 442 (601)
T KOG0590|consen 368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLH---SMGLA 442 (601)
T ss_pred hhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHH---hcCce
Confidence 55677777788999999988887776655556999999 999999655 35888899999999999999999 99999
Q ss_pred eccCCCCceeeCCCCceEEeecccccccccCCCc--ceeecccccCCCCCCcccCCCCcCC-cchhHHHHHHHHHHHhCC
Q 024027 99 HCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQS--MTQTQTLATIGYMAPEYGREGRVST-NGDVYSFGIMLMETFTGK 175 (273)
Q Consensus 99 h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~-~~DiwslG~~l~~ll~g~ 175 (273)
|+|+|++|++++.+|.+|++|||.+..+...... ......+|+..|+|||++.+..|.+ ..||||.|+++..|++|+
T Consensus 443 hrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~ 522 (601)
T KOG0590|consen 443 HRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGR 522 (601)
T ss_pred eccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCC
Confidence 9999999999999999999999999876544443 4456678999999999999998865 589999999999999999
Q ss_pred CCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHH
Q 024027 176 KPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 176 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
.||......+..+..... ... ..............+..-+.+|.+||++||.+|.|+++|++-
T Consensus 523 ~~Wk~a~~~~~~~~~~~~----------~~~--~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 523 FPWKVAKKSDNSFKTNNY----------SDQ--RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred Cccccccccccchhhhcc----------ccc--cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 999875554443211000 000 011112222345567778999999999999999999999864
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.3e-23 Score=175.99 Aligned_cols=217 Identities=28% Similarity=0.362 Sum_probs=165.2
Q ss_pred HhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCC
Q 024027 26 MKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPD 105 (273)
Q Consensus 26 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~ 105 (273)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+....-.+++.....+..+++.||.|+|+ +...+||.++++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHN--SPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhc--Ccceeeeeeccc
Confidence 467899999999999999999999999999999999998877789999999999999999999994 333399999999
Q ss_pred ceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCC-------cCCcchhHHHHHHHHHHHhCCCCC
Q 024027 106 NVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGR-------VSTNGDVYSFGIMLMETFTGKKPT 178 (273)
Q Consensus 106 nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-------~~~~~DiwslG~~l~~ll~g~~pf 178 (273)
|++++....+|++|||+.....................|.|||.+.+.. .+.+.|+||+|++++++++...||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 9999999999999999988763211112222333556799999887642 466799999999999999999999
Q ss_pred ccccccccc--hhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHHHHHH
Q 024027 179 YEFFNGEMT--LKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLLKIRD 256 (273)
Q Consensus 179 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 256 (273)
......... ..............+.+. . ...+++++..++..||..+|.+||+++.+-..+..+..
T Consensus 159 ~~~~~~~~~~eii~~~~~~~~~~~rP~i~-----------~-~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKKGGSNPFRPSIE-----------L-LNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred ccccccCChHHHHHHHHhcCCCCcCcchh-----------h-hhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 875444332 111111100000000000 0 01344579999999999999999999999888877665
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6e-24 Score=191.03 Aligned_cols=224 Identities=22% Similarity=0.256 Sum_probs=161.0
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHh--cCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMK--SIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~--~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
.|+||++-..+ .-..+.|.++++-++ ..++||++++.-+...+...|||-+|... +|.|.+. .++.+..-+.+=+
T Consensus 48 ~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh-nLyDRlS-TRPFL~~iEKkWi 125 (1431)
T KOG1240|consen 48 LVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVKH-NLYDRLS-TRPFLVLIEKKWI 125 (1431)
T ss_pred eEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHhh-hhhhhhc-cchHHHHHHHHHH
Confidence 48999996554 445666666555544 44899999999998888899999999977 9999994 4456777777778
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeeccccccccc--CCCcce---eecccccCCCCCCcccCCC
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIG--EDQSMT---QTQTLATIGYMAPEYGREG 153 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~--~~~~~~---~~~~~~~~~~~aPE~~~~~ 153 (273)
+.|++.|+..+| ..||||||||.+|||++.=+++.|+||......-- +..... ......-..|.|||.+...
T Consensus 126 aFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~ 202 (1431)
T KOG1240|consen 126 AFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSA 202 (1431)
T ss_pred HHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhcc
Confidence 999999999999 99999999999999999999999999987643321 111111 1111233469999987542
Q ss_pred C-----------cCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhh
Q 024027 154 R-----------VSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQ 221 (273)
Q Consensus 154 ~-----------~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (273)
. .+++=||||+||+++|+++ |++||.-. .+-.+.... .......+. .-
T Consensus 203 ~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----QL~aYr~~~-~~~~e~~Le--------------~I 262 (1431)
T KOG1240|consen 203 LGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----QLLAYRSGN-ADDPEQLLE--------------KI 262 (1431)
T ss_pred ccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----HHHhHhccC-ccCHHHHHH--------------hC
Confidence 1 4677899999999999998 78887531 011111000 001110010 01
Q ss_pred hHHHHHHHHhhcCCCCccCCCCHHHHHHH
Q 024027 222 CVSFVFNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 222 ~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
-+..++.++..|++.||.+|.|+++.|+.
T Consensus 263 ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 263 EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 11238899999999999999999999987
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8e-22 Score=164.81 Aligned_cols=237 Identities=30% Similarity=0.386 Sum_probs=179.8
Q ss_pred CeEEEEEeecccCh---hhhhHHHHHHHHhcCCCc-cceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC--CCCCHHH
Q 024027 1 MEVAVKVFNLQCGR---AFKSFDVECEMMKSIRHR-NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN--CILDIFQ 74 (273)
Q Consensus 1 ~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~ 74 (273)
+.+|+|.+...... ....+.+|+.++..+.|+ +++++++.+......+++++++.++++.+++.... ..+....
T Consensus 23 ~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 102 (384)
T COG0515 23 KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESE 102 (384)
T ss_pred cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHH
Confidence 36899999765322 477899999999999887 79999999988777899999999999997775543 2689999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCC-ceEEeecccccccccCCCcc----eeecccccCCCCCCcc
Q 024027 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNL-VAYLSDFGIAKLLIGEDQSM----TQTQTLATIGYMAPEY 149 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~-~~kl~Df~~~~~~~~~~~~~----~~~~~~~~~~~~aPE~ 149 (273)
+..++.|++.++.++| ..+++|+|+||+||+++..+ .++++|||.+..+....... ......++..|.+||.
T Consensus 103 ~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~ 179 (384)
T COG0515 103 ALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV 179 (384)
T ss_pred HHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHH
Confidence 9999999999999999 99999999999999999888 79999999987553332221 2356678999999999
Q ss_pred cCC---CCcCCcchhHHHHHHHHHHHhCCCCCcccccc--ccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHH
Q 024027 150 GRE---GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNG--EMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVS 224 (273)
Q Consensus 150 ~~~---~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (273)
+.+ ...+...|+|++|+++++++.|..||...... ................ ..............
T Consensus 180 ~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~ 249 (384)
T COG0515 180 LLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL----------ASPLSPSNPELISK 249 (384)
T ss_pred hcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccc----------ccccCccccchhhH
Confidence 987 57899999999999999999999997654431 1111111111111000 00000000022235
Q ss_pred HHHHHHhhcCCCCccCCCCHHHHHHH
Q 024027 225 FVFNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 225 ~l~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
.+.+++.+++..+|..|.+..+...+
T Consensus 250 ~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 250 AASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 68899999999999999999988876
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-21 Score=161.63 Aligned_cols=236 Identities=22% Similarity=0.255 Sum_probs=178.9
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCC----Cccceeeeeee-ecCCceeEEEeccCCCCHHHhhhcCC-CCCCHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIR----HRNLIKVISSC-SNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQR 75 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~----h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~ 75 (273)
.+|+|+-..........+..|..++..+. .+++..+++.. ..+...++||+.+ |.+|.++..... ..++...+
T Consensus 46 ~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~ 124 (322)
T KOG1164|consen 46 EYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTV 124 (322)
T ss_pred eEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHH
Confidence 47888876553333337889999999986 36899999998 5788889999999 779999886554 67999999
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCC-----CceEEeeccccc--ccccCCCcc--e----eecccccC
Q 024027 76 LNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDN-----LVAYLSDFGIAK--LLIGEDQSM--T----QTQTLATI 142 (273)
Q Consensus 76 ~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~-----~~~kl~Df~~~~--~~~~~~~~~--~----~~~~~~~~ 142 (273)
..++.|++.+|.++| +.|++||||||.|+++... ..+.+.|||++. .+....... . .....||.
T Consensus 125 l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ 201 (322)
T KOG1164|consen 125 LRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTL 201 (322)
T ss_pred HHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCcc
Confidence 999999999999999 9999999999999999754 469999999998 433222211 1 12345999
Q ss_pred CCCCCcccCCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhh
Q 024027 143 GYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQC 222 (273)
Q Consensus 143 ~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (273)
.|.++..+.+...+.+.|+||++.++.++..|..||........ ...+...... ..... .....
T Consensus 202 ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~~~~~~~~~----------~~~~~-----~~~~~ 265 (322)
T KOG1164|consen 202 RYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KSKFEKDPRK----------LLTDR-----FGDLK 265 (322)
T ss_pred ccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HHHHHHHhhh----------hcccc-----ccCCC
Confidence 99999999999999999999999999999999999966443221 1111000000 00000 12334
Q ss_pred HHHHHHHHhhcCCCCccCCCCHHHHHHHHHHHHHh
Q 024027 223 VSFVFNLAMACTVESPEQRINAKEIVTKLLKIRDS 257 (273)
Q Consensus 223 ~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~ 257 (273)
+.++..+...+-..+..++|....+...+.....+
T Consensus 266 ~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 266 PEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred hHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 55677788888889999999999999998777665
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-21 Score=157.82 Aligned_cols=198 Identities=19% Similarity=0.265 Sum_probs=144.9
Q ss_pred CCccceeeeeeeec---------------------------CCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHHH
Q 024027 30 RHRNLIKVISSCSN---------------------------EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDV 82 (273)
Q Consensus 30 ~h~~i~~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ql 82 (273)
+||||+++.+.|.+ +.++|+||.-++. +|..++-... .+.....-++.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHHH
Confidence 69999999988743 2478999999987 9999995443 5566677899999
Q ss_pred HHHHHHHhcCCCCCeEeccCCCCceeeC--CC--CceEEeecccccccccCCCcc----eeecccccCCCCCCcccCCCC
Q 024027 83 ASALEYLHFGCSAPVIHCDLKPDNVLLD--DN--LVAYLSDFGIAKLLIGEDQSM----TQTQTLATIGYMAPEYGREGR 154 (273)
Q Consensus 83 ~~~l~~lh~~~~~~i~h~di~p~nil~~--~~--~~~kl~Df~~~~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~ 154 (273)
++|+.||| ++|+.|+|+|.+||++. ++ -++.++|||.+-.-...+-.. ..-...|.-..+|||+.....
T Consensus 351 LEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 351 LEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 99999999 99999999999999993 33 367889999874321111111 111223566789999875432
Q ss_pred ------cCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHH
Q 024027 155 ------VSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFN 228 (273)
Q Consensus 155 ------~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 228 (273)
.-.++|.|+.|.+.||++....||.....-.-....+.+.. ....+..|+..+++
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~q-------------------LPalp~~vpp~~rq 488 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQ-------------------LPALPSRVPPVARQ 488 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhh-------------------CCCCcccCChHHHH
Confidence 23579999999999999999999987333222222222221 22235677888999
Q ss_pred HHhhcCCCCccCCCCHHHHHHHHH
Q 024027 229 LAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 229 li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
++..+|+.||.+|+|..=+...|.
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHHH
Confidence 999999999999999877666554
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.1e-21 Score=159.42 Aligned_cols=138 Identities=20% Similarity=0.141 Sum_probs=103.8
Q ss_pred eEEEEEeecc-----cChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHH
Q 024027 2 EVAVKVFNLQ-----CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 76 (273)
Q Consensus 2 ~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (273)
.||||++... .....+.+.+|+++|+.++|+|+++.+..+ +..++||||++|++|.. +...+ ..
T Consensus 46 ~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~~~~LVmE~~~G~~L~~-~~~~~-------~~ 114 (365)
T PRK09188 46 ARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---GKDGLVRGWTEGVPLHL-ARPHG-------DP 114 (365)
T ss_pred EEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---CCcEEEEEccCCCCHHH-hCccc-------hH
Confidence 4799987532 122456799999999999999998533322 45799999999999963 21111 14
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccC-CCCceeeCCCCceEEeecccccccccCCCcce------eecccccCCCCCCcc
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDL-KPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMT------QTQTLATIGYMAPEY 149 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di-~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~------~~~~~~~~~~~aPE~ 149 (273)
.++.+++.+|.||| +.|++|||| ||+||+++.++.++|+|||++..+........ .....+++.|.|||.
T Consensus 115 ~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~ 191 (365)
T PRK09188 115 AWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDA 191 (365)
T ss_pred HHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCccc
Confidence 68899999999999 999999999 99999999999999999999987643321111 123456778999998
Q ss_pred cCCC
Q 024027 150 GREG 153 (273)
Q Consensus 150 ~~~~ 153 (273)
+...
T Consensus 192 ~~~~ 195 (365)
T PRK09188 192 LTPR 195 (365)
T ss_pred CChh
Confidence 7643
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.5e-19 Score=142.83 Aligned_cols=240 Identities=18% Similarity=0.123 Sum_probs=185.4
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
.+||||.-...+ ....+.-|...++.| ..++|..++-+-....+-.||+|.+ |.+|+|++.-=+..++...+..++
T Consensus 54 e~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA 130 (449)
T KOG1165|consen 54 EPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIA 130 (449)
T ss_pred ceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHH
Confidence 489999975443 336788899999988 6899999998888888888999999 789999986555679999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCC-----CCceEEeecccccccccCCCcc-----eeecccccCCCCCCcc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDD-----NLVAYLSDFGIAKLLIGEDQSM-----TQTQTLATIGYMAPEY 149 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~-----~~~~kl~Df~~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~ 149 (273)
.|++.-+.++| ++.++.|||||+|+|+.. ...+.++|||++..+....... ......||..||+-..
T Consensus 131 ~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINT 207 (449)
T KOG1165|consen 131 KQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINT 207 (449)
T ss_pred HHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeec
Confidence 99999999999 999999999999999963 3468999999998875433221 2234468999999999
Q ss_pred cCCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHH
Q 024027 150 GREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNL 229 (273)
Q Consensus 150 ~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 229 (273)
+.+..-+.+.|+-|||-++++.|-|..||.+...+.--.. .+.... .+...-....-.+++.++..-
T Consensus 208 HlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~k--YeKIGe-----------~Kr~T~i~~Lc~g~P~efa~Y 274 (449)
T KOG1165|consen 208 HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEK--YEKIGE-----------TKRSTPIEVLCEGFPEEFATY 274 (449)
T ss_pred cccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHH--HHHhcc-----------ccccCCHHHHHhcCHHHHHHH
Confidence 9999999999999999999999999999987544432111 111110 001111112234577788888
Q ss_pred HhhcCCCCccCCCCHHHHHHHHHHHHHhhh
Q 024027 230 AMACTVESPEQRINAKEIVTKLLKIRDSLL 259 (273)
Q Consensus 230 i~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 259 (273)
+...-..+-.+-|..+-+..-+..+.+.+.
T Consensus 275 l~yvR~L~F~E~PDYdylr~Lf~dvldr~g 304 (449)
T KOG1165|consen 275 LRYVRRLDFFETPDYDYLRKLFDDVLDRLG 304 (449)
T ss_pred HHHHHhcCcccCCCHHHHHHHHHHHHHhcC
Confidence 888888888888998888887777776554
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.7e-20 Score=149.79 Aligned_cols=206 Identities=20% Similarity=0.246 Sum_probs=128.1
Q ss_pred eEEEEEeeccc---ChhhhhHHHHHHHHhcCC----------CccceeeeeeeecC------------C-----ceeEEE
Q 024027 2 EVAVKVFNLQC---GRAFKSFDVECEMMKSIR----------HRNLIKVISSCSNE------------E-----FKALVL 51 (273)
Q Consensus 2 ~vavK~~~~~~---~~~~~~~~~E~~~l~~l~----------h~~i~~~~~~~~~~------------~-----~~~lv~ 51 (273)
++|||++.... ....+.+.+|.-....+. |-.++-.++..... . +.+++|
T Consensus 39 ~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~ 118 (288)
T PF14531_consen 39 EFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLM 118 (288)
T ss_dssp EEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS-SEEEECETTEEEEEESEEEEE
T ss_pred eEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCCCcceecCCCCccceeehhhhcc
Confidence 78999997553 345666777765555542 33444444443211 1 346788
Q ss_pred eccCCCCHHHhhhc----CCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccc
Q 024027 52 EYMPHGSLEKYLYS----SNC--ILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL 125 (273)
Q Consensus 52 e~~~~~~L~~~l~~----~~~--~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~ 125 (273)
+-+.+ +|.+++.. ... .+.......+..|++..+++|| ..|++|+||+|+|++++.+|.++|+||+....
T Consensus 119 P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r 194 (288)
T PF14531_consen 119 PRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHGDIKPENFLLDQDGGVFLGDFSSLVR 194 (288)
T ss_dssp E--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEE-TTS-EEE--GGGEEE
T ss_pred chhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEecccceeeEEEcCCCCEEEcChHHHee
Confidence 88855 99888641 111 1233344667799999999999 99999999999999999999999999988765
Q ss_pred cccCCCcceeecccccCCCCCCcccCC--------CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccC
Q 024027 126 LIGEDQSMTQTQTLATIGYMAPEYGRE--------GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLP 197 (273)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 197 (273)
.. ..... ...+..|.+||.... ..++.+.|.|+||+++|.++.+..||...........
T Consensus 195 ~g----~~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~-------- 261 (288)
T PF14531_consen 195 AG----TRYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW-------- 261 (288)
T ss_dssp TT----EEEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG--------
T ss_pred cC----ceeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc--------
Confidence 31 11111 334567899986533 2368899999999999999999999876433322111
Q ss_pred ccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccCC
Q 024027 198 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQR 241 (273)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 241 (273)
. ...+. ..++.+..||..+|++||.+|
T Consensus 262 ---------------~-f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 262 ---------------D-FSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp ---------------G-GTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ---------------c-chhcC-CcCHHHHHHHHHHccCCcccC
Confidence 0 00112 567779999999999999998
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.1e-21 Score=149.58 Aligned_cols=145 Identities=14% Similarity=0.173 Sum_probs=109.0
Q ss_pred CeEEEEEeecccChhhh---h------HHHHHHHHhcCCCccceeeeeeeecC--------CceeEEEeccCCCCHHHhh
Q 024027 1 MEVAVKVFNLQCGRAFK---S------FDVECEMMKSIRHRNLIKVISSCSNE--------EFKALVLEYMPHGSLEKYL 63 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~---~------~~~E~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l 63 (273)
+++|||+++........ . +.+|++.+.++.|++|..+.+++... +..+++|||++|.+|.++.
T Consensus 55 ~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~ 134 (232)
T PRK10359 55 GKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP 134 (232)
T ss_pred CcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhh
Confidence 36999999755322222 2 68999999999999999999986543 3578999999999998874
Q ss_pred hcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCC
Q 024027 64 YSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIG 143 (273)
Q Consensus 64 ~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~ 143 (273)
. +++ ....+++.++..+| ..|++|||++|+||+++.++ ++|+|||........... .
T Consensus 135 ~-----~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~---d------- 191 (232)
T PRK10359 135 E-----ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAK---D------- 191 (232)
T ss_pred h-----ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-EEEEECCCcccccchhhH---H-------
Confidence 2 222 34569999999999 99999999999999999988 999999987654111000 0
Q ss_pred CCCCcccCCCCcCCcchhHHHHHHHHHHH
Q 024027 144 YMAPEYGREGRVSTNGDVYSFGIMLMETF 172 (273)
Q Consensus 144 ~~aPE~~~~~~~~~~~DiwslG~~l~~ll 172 (273)
.+.....+..++|+|+||+.+..+.
T Consensus 192 ----~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 192 ----RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred ----HHHHHhHhcccccccceeEeehHHH
Confidence 0222334567899999999876654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.1e-19 Score=137.33 Aligned_cols=239 Identities=19% Similarity=0.173 Sum_probs=180.2
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCC-CccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIR-HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
.||||+-+... -...+..|.++.+.++ ...|..+..+..+..+-.+|||.. |.+|.++++-=...++..+++-++-
T Consensus 42 ~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaD 118 (341)
T KOG1163|consen 42 EVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLAD 118 (341)
T ss_pred eEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHH
Confidence 69999975432 2356888999999995 678888888888888999999999 8899999975555688899999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeC---CCCceEEeecccccccccCCCcc-----eeecccccCCCCCCcccCC
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLD---DNLVAYLSDFGIAKLLIGEDQSM-----TQTQTLATIGYMAPEYGRE 152 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~---~~~~~kl~Df~~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~ 152 (273)
|++.-++|+| .++++||||||+|+++. ....+.++|||++..+-...... ......||..|.+--.+.+
T Consensus 119 Qml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g 195 (341)
T KOG1163|consen 119 QMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLG 195 (341)
T ss_pred HHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhh
Confidence 9999999999 99999999999999996 45679999999998774332221 2234468889998888888
Q ss_pred CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhh
Q 024027 153 GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMA 232 (273)
Q Consensus 153 ~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 232 (273)
..-+.+.|+-|+|.++..+.-|..||.+.......... +.+.... ......+.-.++|.++.-.+..
T Consensus 196 ~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKy-----------EkI~EkK--~s~~ie~LC~G~P~EF~myl~Y 262 (341)
T KOG1163|consen 196 IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKY-----------EKISEKK--MSTPIEVLCKGFPAEFAMYLNY 262 (341)
T ss_pred hhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHH-----------HHHHHhh--cCCCHHHHhCCCcHHHHHHHHH
Confidence 88899999999999999999999999875544322221 1111111 1111222234567788888888
Q ss_pred cCCCCccCCCCHHHHHHHHHHHHHhhh
Q 024027 233 CTVESPEQRINAKEIVTKLLKIRDSLL 259 (273)
Q Consensus 233 ~l~~dp~~Rps~~~~l~~l~~~~~~~~ 259 (273)
|-..--++-|.-.-+.+.+.-+...+.
T Consensus 263 ~R~L~F~E~Pdy~ylrqlFriLfr~ln 289 (341)
T KOG1163|consen 263 CRGLGFEEKPDYMYLRQLFRILFRTLN 289 (341)
T ss_pred HhhcCCCCCCcHHHHHHHHHHHHhhcc
Confidence 888877888887777666665554443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.7e-21 Score=164.76 Aligned_cols=205 Identities=24% Similarity=0.265 Sum_probs=164.9
Q ss_pred EEEEEeeccc--ChhhhhHHHHHHHHhcCC-CccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 3 VAVKVFNLQC--GRAFKSFDVECEMMKSIR-HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 3 vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
+|.|+++... .........|-.++...+ ||.++++...++.++..+++.++..||.|...+.... .+.+.....+.
T Consensus 25 yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~-~f~~~~~~~~~ 103 (612)
T KOG0603|consen 25 YAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEV-MFDELDVAFYL 103 (612)
T ss_pred hhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccCC-chHHHHHHHHH
Confidence 4566665432 222335556888888886 9999999999999999999999999999999886554 46666777788
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 159 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 159 (273)
..++-++.++| +.+++++|+|++||+++.+|.+++.|||++....... ..+|+..|+|||++. ....++
T Consensus 104 aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~------~~cgt~eymApEI~~--gh~~a~ 172 (612)
T KOG0603|consen 104 AELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK------IACGTYEYRAPEIIN--GHLSAA 172 (612)
T ss_pred HHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhh------hcccchhhhhhHhhh--ccCCcc
Confidence 89999999999 9999999999999999999999999999997653222 128999999999997 678899
Q ss_pred hhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCcc
Q 024027 160 DVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239 (273)
Q Consensus 160 DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 239 (273)
|.||+|++++++++|..||.. .....+. ......|...+.++.+++.+++..+|.
T Consensus 173 D~ws~gvl~felltg~~pf~~-----~~~~~Il--------------------~~~~~~p~~l~~~a~~~~~~l~~r~p~ 227 (612)
T KOG0603|consen 173 DWWSFGVLAFELLTGTLPFGG-----DTMKRIL--------------------KAELEMPRELSAEARSLFRQLFKRNPE 227 (612)
T ss_pred cchhhhhhHHHHhhCCCCCch-----HHHHHHh--------------------hhccCCchhhhHHHHHHHHHHHhhCHH
Confidence 999999999999999999876 1111111 112223677888899999999999999
Q ss_pred CCCCH
Q 024027 240 QRINA 244 (273)
Q Consensus 240 ~Rps~ 244 (273)
.|.-.
T Consensus 228 nrLg~ 232 (612)
T KOG0603|consen 228 NRLGA 232 (612)
T ss_pred HHhcc
Confidence 99855
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.5e-20 Score=158.22 Aligned_cols=173 Identities=25% Similarity=0.368 Sum_probs=129.3
Q ss_pred CceeEEEeccCCCCHHHhhhcC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeeccc
Q 024027 45 EFKALVLEYMPHGSLEKYLYSS--NCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGI 122 (273)
Q Consensus 45 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~ 122 (273)
.+++|.|++|...+|.+++... ....++.....++.|+..|+.| +|..|+|+||.||++..+..+||+|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence 3588999999999999999644 3347778899999999999987 6899999999999999999999999999
Q ss_pred ccccccCC----CcceeecccccCCCCCCcccCCCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccC
Q 024027 123 AKLLIGED----QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLP 197 (273)
Q Consensus 123 ~~~~~~~~----~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~ 197 (273)
........ .........||.+|++||.+.+..|+.++||||||+++++++. -..+| .....+..+.....+
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~----er~~t~~d~r~g~ip 478 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQF----ERIATLTDIRDGIIP 478 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHH----HHHHhhhhhhcCCCC
Confidence 98764433 1223456689999999999999999999999999999999997 22221 111222222111111
Q ss_pred ccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHH
Q 024027 198 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKE 246 (273)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 246 (273)
+... .+ .++-.+|+.+|+.+.|.+||++.+
T Consensus 479 ~~~~------------------~d-~p~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 479 PEFL------------------QD-YPEEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred hHHh------------------hc-CcHHHHHHHHhcCCCcccCchHHH
Confidence 1000 01 112568999999999999994443
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.9e-19 Score=134.62 Aligned_cols=151 Identities=16% Similarity=0.114 Sum_probs=112.7
Q ss_pred hHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 024027 18 SFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAP 96 (273)
Q Consensus 18 ~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~ 96 (273)
.+.+|+++|+++ +++++.+++++ ...+++|||+.|.+|...+.. ....++.|++.++.++| ..|
T Consensus 47 l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH---~~G 111 (218)
T PRK12274 47 LARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR--------GDLAYFRAARRLLQQLH---RCG 111 (218)
T ss_pred HHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh--------hhHHHHHHHHHHHHHHH---HCc
Confidence 588999999999 46889999886 346899999999888654321 11357889999999999 999
Q ss_pred eEeccC-CCCceeeCCCCceEEeecccccccccCCCc---ce--------eecccccCCCCCCcccCCC-CcC-CcchhH
Q 024027 97 VIHCDL-KPDNVLLDDNLVAYLSDFGIAKLLIGEDQS---MT--------QTQTLATIGYMAPEYGREG-RVS-TNGDVY 162 (273)
Q Consensus 97 i~h~di-~p~nil~~~~~~~kl~Df~~~~~~~~~~~~---~~--------~~~~~~~~~~~aPE~~~~~-~~~-~~~Diw 162 (273)
++|+|| ||+||+++.++.++|+|||++......... .. ......++.+++|+...-. ..+ .+.+.+
T Consensus 112 IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~ 191 (218)
T PRK12274 112 VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWF 191 (218)
T ss_pred CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHH
Confidence 999999 799999999999999999999854322210 00 0112245666677643322 233 567888
Q ss_pred HHHHHHHHHHhCCCCCccccc
Q 024027 163 SFGIMLMETFTGKKPTYEFFN 183 (273)
Q Consensus 163 slG~~l~~ll~g~~pf~~~~~ 183 (273)
+.|+-+|.++|+..++.+..+
T Consensus 192 ~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 192 ATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred HhcchHHHHHhccCCccccCC
Confidence 999999999999998655433
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.2e-19 Score=136.44 Aligned_cols=100 Identities=15% Similarity=0.177 Sum_probs=80.1
Q ss_pred HHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeE
Q 024027 20 DVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYL-HFGCSAPVI 98 (273)
Q Consensus 20 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ql~~~l~~l-h~~~~~~i~ 98 (273)
..|++++..+.++++.....+... ..+|||||++|+++...... ...++...+..++.|++.+|.++ | +.|++
T Consensus 67 ~~E~~~l~~l~~~~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H---~~gii 140 (190)
T cd05147 67 EKEMRNLKRLVTAGIPCPEPILLK--SHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQ---DCRLV 140 (190)
T ss_pred HHHHHHHHHHHHCCCCCCcEEEec--CCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHH---hCCcc
Confidence 349999999988777544433222 23799999998777655322 24688999999999999999999 8 88999
Q ss_pred eccCCCCceeeCCCCceEEeeccccccc
Q 024027 99 HCDLKPDNVLLDDNLVAYLSDFGIAKLL 126 (273)
Q Consensus 99 h~di~p~nil~~~~~~~kl~Df~~~~~~ 126 (273)
|+||||+||+++ ++.++|+|||++...
T Consensus 141 HrDlkP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 141 HADLSEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred cCCCCHHHEEEE-CCcEEEEEccccccC
Confidence 999999999998 478999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.6e-18 Score=131.61 Aligned_cols=113 Identities=12% Similarity=0.220 Sum_probs=90.1
Q ss_pred EEEEeecccChhhhhHHHHHHHHhcC-----CCccceeeeeeeecCC---cee-EEEec--cCCCCHHHhhhcCCCCCCH
Q 024027 4 AVKVFNLQCGRAFKSFDVECEMMKSI-----RHRNLIKVISSCSNEE---FKA-LVLEY--MPHGSLEKYLYSSNCILDI 72 (273)
Q Consensus 4 avK~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~---~~~-lv~e~--~~~~~L~~~l~~~~~~~~~ 72 (273)
+||+.........+.+.+|+.+++.+ .||||++++|+++++. ..+ +|+|| +.+++|.+++++. .+++
T Consensus 28 ~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~--~~~e 105 (210)
T PRK10345 28 CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQC--RYEE 105 (210)
T ss_pred EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHcc--cccH
Confidence 68887655444567899999999999 5799999999998874 333 78999 5579999999653 3555
Q ss_pred HHHHHHHHHHHHHH-HHHhcCCCCCeEeccCCCCceeeCC----CCceEEeecccc
Q 024027 73 FQRLNIMIDVASAL-EYLHFGCSAPVIHCDLKPDNVLLDD----NLVAYLSDFGIA 123 (273)
Q Consensus 73 ~~~~~~~~ql~~~l-~~lh~~~~~~i~h~di~p~nil~~~----~~~~kl~Df~~~ 123 (273)
. ..++.+++.++ .||| +++|+|+||||+||+++. ++.++|+|++.+
T Consensus 106 ~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 106 D--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred h--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 5 35678888777 9999 999999999999999974 347999995443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.4e-17 Score=128.88 Aligned_cols=101 Identities=18% Similarity=0.179 Sum_probs=81.6
Q ss_pred HHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCe
Q 024027 19 FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCS-APV 97 (273)
Q Consensus 19 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~-~~i 97 (273)
+..|.+.+..+.++++.....+.... .++||||++|+++...... ...++...+..++.|++.++.++| . .|+
T Consensus 66 ~~~E~~~l~~l~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH---~~~gi 139 (190)
T cd05145 66 AEKEFRNLKRLYEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLY---QEAGL 139 (190)
T ss_pred HHHHHHHHHHHHhCCCCCceEEEecC--CEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHH---HhCCE
Confidence 35789999999998875555443332 4799999988755433222 235778889999999999999999 8 999
Q ss_pred EeccCCCCceeeCCCCceEEeeccccccc
Q 024027 98 IHCDLKPDNVLLDDNLVAYLSDFGIAKLL 126 (273)
Q Consensus 98 ~h~di~p~nil~~~~~~~kl~Df~~~~~~ 126 (273)
+|+||||.||+++ ++.++|+|||++...
T Consensus 140 vHrDlkP~NIll~-~~~~~liDFG~a~~~ 167 (190)
T cd05145 140 VHGDLSEYNILYH-DGKPYIIDVSQAVEL 167 (190)
T ss_pred ecCCCChhhEEEE-CCCEEEEEcccceec
Confidence 9999999999999 889999999999765
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.4e-17 Score=148.80 Aligned_cols=170 Identities=23% Similarity=0.251 Sum_probs=140.2
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCC---CccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIR---HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||||+=+..+. -+|.-=.+++.+|+ -+.|..+...+.-....++|+||.+.|+|.++++ ....+++.....
T Consensus 723 ~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~ 798 (974)
T KOG1166|consen 723 KLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMF 798 (974)
T ss_pred cEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccccccHHHhhc-cCCCCCchhhhH
Confidence 4789999875543 45555556666665 3455566665566667789999999999999997 555799999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeC-------CCCceEEeecccccccccCCCcceeecccccCCCCCCccc
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLD-------DNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYG 150 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~-------~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 150 (273)
+..|++..+.+|| ..+|+||||||+|+++. ....++|+|||.+..+............+++..+-.+|..
T Consensus 799 ~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~ 875 (974)
T KOG1166|consen 799 FSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMR 875 (974)
T ss_pred HHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHh
Confidence 9999999999999 99999999999999993 3457999999999887655544555667889999999999
Q ss_pred CCCCcCCcchhHHHHHHHHHHHhCCCC
Q 024027 151 REGRVSTNGDVYSFGIMLMETFTGKKP 177 (273)
Q Consensus 151 ~~~~~~~~~DiwslG~~l~~ll~g~~p 177 (273)
.|..++...|-|.|+.+++.|++|+.-
T Consensus 876 ~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 876 EGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred cCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999763
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=3e-18 Score=152.67 Aligned_cols=233 Identities=22% Similarity=0.253 Sum_probs=179.3
Q ss_pred EEEEEeeccc--ChhhhhHHHHHHHHhcCC-CccceeeeeeeecCCceeEEEeccCCCCHHHhh-hcCCCCCCHHHHHHH
Q 024027 3 VAVKVFNLQC--GRAFKSFDVECEMMKSIR-HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-YSSNCILDIFQRLNI 78 (273)
Q Consensus 3 vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l-~~~~~~~~~~~~~~~ 78 (273)
+|+|.+.... .........|..+-..+. |+|++++++...+.+..++++++..|+++.+.+ .......+...+..+
T Consensus 49 ~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~ 128 (601)
T KOG0590|consen 49 SATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRY 128 (601)
T ss_pred eeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhh
Confidence 4445444332 233444555777777776 999999999999999999999999999999998 444335777788899
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCC-ceEEeeccccccccc-CCCcceeecccc-cCCCCCCcccCCC-C
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNL-VAYLSDFGIAKLLIG-EDQSMTQTQTLA-TIGYMAPEYGREG-R 154 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~-~~kl~Df~~~~~~~~-~~~~~~~~~~~~-~~~~~aPE~~~~~-~ 154 (273)
+.|+..++.|+|. ..+++|+|++|+|.+++..+ .+++.|||+++.+.. .+........+| ++.|.|||...+. .
T Consensus 129 ~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~ 206 (601)
T KOG0590|consen 129 LPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAY 206 (601)
T ss_pred hhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhh
Confidence 9999999999995 67999999999999999999 999999999998866 444444556678 9999999999885 4
Q ss_pred cCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcC
Q 024027 155 VSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACT 234 (273)
Q Consensus 155 ~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 234 (273)
.....|+||.|+++..+++|..|+.........+..+.+.... .........+....+++.+++
T Consensus 207 ~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~l~k~l 270 (601)
T KOG0590|consen 207 RGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGR----------------FTQLPWNSISDQAHDLLHKIL 270 (601)
T ss_pred cCCCcccccccccccccccCCCCccccccccccceeecccccc----------------cccCccccCChhhhhcccccc
Confidence 5788999999999999999999987655554433333322100 111123445556889999999
Q ss_pred CCCccCCCCHHHHHHHHHH
Q 024027 235 VESPEQRINAKEIVTKLLK 253 (273)
Q Consensus 235 ~~dp~~Rps~~~~l~~l~~ 253 (273)
..+|..|.+.+++-..=+.
T Consensus 271 ~~~~~~r~s~~~~~~d~~~ 289 (601)
T KOG0590|consen 271 KENPSNRLSIEELKLDNWL 289 (601)
T ss_pred cCCchhccccccccccccc
Confidence 9999999999987655443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=5.5e-16 Score=122.07 Aligned_cols=116 Identities=24% Similarity=0.333 Sum_probs=97.2
Q ss_pred CeEEEEEeecccCh--------hhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCH
Q 024027 1 MEVAVKVFNLQCGR--------AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDI 72 (273)
Q Consensus 1 ~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 72 (273)
++|+||+....... ....+.+|+.++..+.|+++.....++.+....+++|||++|++|.+++.... .
T Consensus 20 ~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~~----~ 95 (211)
T PRK14879 20 IKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNG----M 95 (211)
T ss_pred CceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhcc----H
Confidence 36889987543211 12457789999999999999888888777788899999999999999986433 1
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccc
Q 024027 73 FQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL 125 (273)
Q Consensus 73 ~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~ 125 (273)
.+..++.+++.+|.++| +.|++|+|++|.||+++ ++.++++|||.+..
T Consensus 96 -~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 96 -EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred -HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 78899999999999999 99999999999999999 78999999998763
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.1e-16 Score=126.24 Aligned_cols=208 Identities=20% Similarity=0.305 Sum_probs=143.8
Q ss_pred HHHHhcCCCccceeeeeeeecCC-----ceeEEEeccCCCCHHHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 024027 23 CEMMKSIRHRNLIKVISSCSNEE-----FKALVLEYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFGCS 94 (273)
Q Consensus 23 ~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~ql~~~l~~lh~~~~ 94 (273)
+..|-++-|.||+++..||.+.. ...++.||+..|++..+|++. ...+.+..-.+|+.||++||.||| .++
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLh-s~~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLH-SCD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhh-ccC
Confidence 34455667999999999987643 467899999999999999754 334777778899999999999999 336
Q ss_pred CCeEeccCCCCceeeCCCCceEEeeccc--ccccccCCCcceeecccccCCCCCCcccCCCCcCCcchhHHHHHHHHHHH
Q 024027 95 APVIHCDLKPDNVLLDDNLVAYLSDFGI--AKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETF 172 (273)
Q Consensus 95 ~~i~h~di~p~nil~~~~~~~kl~Df~~--~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ll 172 (273)
-.+.|+++..+.|++..++-+|++--.- .................+.++|.+||.-.....+.++|||++|+...+|.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 6799999999999999999888863211 11100001111112234678899999988888899999999999999998
Q ss_pred hCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 173 TGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 173 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
.+..--........... ......+..+ ..--++++.+|++..|..||++.+++-|.-
T Consensus 277 ilEiq~tnseS~~~~ee-------------~ia~~i~~le----------n~lqr~~i~kcl~~eP~~rp~ar~llfHpl 333 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEE-------------NIANVIIGLE----------NGLQRGSITKCLEGEPNGRPDARLLLFHPL 333 (458)
T ss_pred HheeccCCCcceeehhh-------------hhhhheeecc----------CccccCcCcccccCCCCCCcchhhhhcCce
Confidence 87654211111100000 0000000000 011456899999999999999999988764
Q ss_pred HH
Q 024027 253 KI 254 (273)
Q Consensus 253 ~~ 254 (273)
.+
T Consensus 334 lf 335 (458)
T KOG1266|consen 334 LF 335 (458)
T ss_pred ee
Confidence 43
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.3e-16 Score=119.96 Aligned_cols=113 Identities=19% Similarity=0.326 Sum_probs=91.8
Q ss_pred CeEEEEEeecccC---h-----hhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCH
Q 024027 1 MEVAVKVFNLQCG---R-----AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDI 72 (273)
Q Consensus 1 ~~vavK~~~~~~~---~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 72 (273)
++|++|+...... . ....+.+|+++++.++|+++.....++..+...+++|||++|++|.+++.....
T Consensus 18 ~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~~---- 93 (199)
T TIGR03724 18 LKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGND---- 93 (199)
T ss_pred ccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcHH----
Confidence 4789999754321 1 135577899999999888766666666666778899999999999998754321
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccc
Q 024027 73 FQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL 125 (273)
Q Consensus 73 ~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~ 125 (273)
.++.+++.+|.++| ..|++|+|++|.||+++ ++.++++|||.+..
T Consensus 94 ----~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 94 ----ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ----HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 78999999999999 99999999999999999 88999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.65 E-value=1e-15 Score=122.04 Aligned_cols=99 Identities=16% Similarity=0.183 Sum_probs=78.9
Q ss_pred HHHHHHHHhcCCCc--cceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 024027 19 FDVECEMMKSIRHR--NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAP 96 (273)
Q Consensus 19 ~~~E~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~ 96 (273)
+..|+.++..+.+. .+.+++++ ...++||||++|.+|...... ........+..++.|++.++.+|| +.|
T Consensus 97 ~~~E~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~g 168 (237)
T smart00090 97 AEKEFRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLY---KEG 168 (237)
T ss_pred HHHHHHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHH---hcC
Confidence 56899999999653 34444442 234799999999888765422 234566677899999999999999 999
Q ss_pred -eEeccCCCCceeeCCCCceEEeeccccccc
Q 024027 97 -VIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 126 (273)
Q Consensus 97 -i~h~di~p~nil~~~~~~~kl~Df~~~~~~ 126 (273)
++|+||||+||+++ ++.++|+|||.+...
T Consensus 169 ~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 169 ELVHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred CEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 99999999999999 889999999988743
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.4e-16 Score=143.86 Aligned_cols=143 Identities=27% Similarity=0.309 Sum_probs=108.3
Q ss_pred HHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCC-------------cceeecccccCCCCCCcc
Q 024027 83 ASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQ-------------SMTQTQTLATIGYMAPEY 149 (273)
Q Consensus 83 ~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~-------------~~~~~~~~~~~~~~aPE~ 149 (273)
+.+++|+| ..||+|+|+||+|.+++.-|.+|+.|||+...-..... .....+.+||+.|.|||+
T Consensus 153 vla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV 229 (1205)
T KOG0606|consen 153 VLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV 229 (1205)
T ss_pred hHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhh
Confidence 78999999 99999999999999999999999999998764311100 011234589999999999
Q ss_pred cCCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHH
Q 024027 150 GREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNL 229 (273)
Q Consensus 150 ~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 229 (273)
+....|+...|.|++|+++|+.+.|..||.+...+ ..+..++....... + .....+.++.++
T Consensus 230 ilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe-elfg~visd~i~wp------------E-----~dea~p~Ea~dl 291 (1205)
T KOG0606|consen 230 ILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-ELFGQVISDDIEWP------------E-----EDEALPPEAQDL 291 (1205)
T ss_pred hhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH-HHHhhhhhhhcccc------------c-----cCcCCCHHHHHH
Confidence 99999999999999999999999999998774332 22332222211100 0 023456779999
Q ss_pred HhhcCCCCccCCCCHHH
Q 024027 230 AMACTVESPEQRINAKE 246 (273)
Q Consensus 230 i~~~l~~dp~~Rps~~~ 246 (273)
+.++|+.+|..|--...
T Consensus 292 i~~LL~qnp~~Rlgt~g 308 (1205)
T KOG0606|consen 292 IEQLLRQNPLCRLGTGG 308 (1205)
T ss_pred HHHHHHhChHhhcccch
Confidence 99999999999985443
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.5e-14 Score=125.74 Aligned_cols=165 Identities=18% Similarity=0.216 Sum_probs=128.5
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
.+|.|.+++...........+-++-|+.++||||+++++.++.++++|+|+|-+. .|..++++.+ .....--++
T Consensus 38 ~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----~~~v~~Gl~ 111 (690)
T KOG1243|consen 38 GPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----KEEVCLGLF 111 (690)
T ss_pred CceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH----HHHHHHHHH
Confidence 3788888887755445668888999999999999999999999999999999983 6777876543 445556788
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
||+.||.+||+ +.+++|++++-++++++..|..||++|.++........ ......-...|..|+.+.... -..|
T Consensus 112 qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--~s~D 185 (690)
T KOG1243|consen 112 QILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--WSID 185 (690)
T ss_pred HHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--cchh
Confidence 99999999986 78999999999999999999999999998875432222 112222333466666553322 3569
Q ss_pred hHHHHHHHHHHHhCCCC
Q 024027 161 VYSFGIMLMETFTGKKP 177 (273)
Q Consensus 161 iwslG~~l~~ll~g~~p 177 (273)
.|.|||++++++.|..+
T Consensus 186 ~~~Lg~li~el~ng~~~ 202 (690)
T KOG1243|consen 186 SWGLGCLIEELFNGSLL 202 (690)
T ss_pred hhhHHHHHHHHhCcccC
Confidence 99999999999999443
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.60 E-value=8.1e-15 Score=117.15 Aligned_cols=115 Identities=19% Similarity=0.218 Sum_probs=89.0
Q ss_pred eEEEEEeeccc-------------ChhhhhHHHHHHHHhcCCCccc--eeeeeeeecCCc----eeEEEeccCC-CCHHH
Q 024027 2 EVAVKVFNLQC-------------GRAFKSFDVECEMMKSIRHRNL--IKVISSCSNEEF----KALVLEYMPH-GSLEK 61 (273)
Q Consensus 2 ~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~~i--~~~~~~~~~~~~----~~lv~e~~~~-~~L~~ 61 (273)
.+|||.++.+. ......+.+|++++..+.|+++ ++++++...... .++|+|+++| .+|.+
T Consensus 57 ~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~ 136 (239)
T PRK01723 57 NWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVA 136 (239)
T ss_pred eEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHH
Confidence 57888885421 1223567889999999988775 677776443222 2599999997 69998
Q ss_pred hhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccc
Q 024027 62 YLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL 125 (273)
Q Consensus 62 ~l~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~ 125 (273)
++... .++.. .+.+++.++.+|| +.|++|+||||.||+++.++.++|+|||.+..
T Consensus 137 ~l~~~--~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 137 LLQEA--PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred HHhcC--CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 88543 34443 3678999999999 99999999999999999988999999998875
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.2e-14 Score=129.60 Aligned_cols=97 Identities=24% Similarity=0.366 Sum_probs=87.1
Q ss_pred hhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 024027 16 FKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSA 95 (273)
Q Consensus 16 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~ 95 (273)
...+.+|+++++.++|++++.+..++.++...++||||++|++|.+++. ....++.+++.+|.+|| +.
T Consensus 380 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH---~~ 447 (535)
T PRK09605 380 TERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLH---KA 447 (535)
T ss_pred HHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHH---hC
Confidence 3568899999999999999988888777777899999999999999884 35678999999999999 99
Q ss_pred CeEeccCCCCceeeCCCCceEEeecccccc
Q 024027 96 PVIHCDLKPDNVLLDDNLVAYLSDFGIAKL 125 (273)
Q Consensus 96 ~i~h~di~p~nil~~~~~~~kl~Df~~~~~ 125 (273)
|++|||+||+||++ .++.++|+|||++..
T Consensus 448 giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 448 GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999999 678999999999874
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.2e-14 Score=111.85 Aligned_cols=95 Identities=20% Similarity=0.215 Sum_probs=77.4
Q ss_pred hHHHHHHHHhcCCCc--cceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 024027 18 SFDVECEMMKSIRHR--NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSA 95 (273)
Q Consensus 18 ~~~~E~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~ 95 (273)
.+..|+.++..+.++ .+.++++. ...+++|||++|++|...... .....++.+++.++.++| +.
T Consensus 79 ~~~~E~~~l~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh---~~ 144 (198)
T cd05144 79 AAQKEFAALKALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAY---KH 144 (198)
T ss_pred HHHHHHHHHHHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHH---HC
Confidence 367789999998776 44444442 345899999999998765431 245678899999999999 99
Q ss_pred CeEeccCCCCceeeCCCCceEEeeccccccc
Q 024027 96 PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 126 (273)
Q Consensus 96 ~i~h~di~p~nil~~~~~~~kl~Df~~~~~~ 126 (273)
|++|+||+|+||+++.++.++|+|||.+...
T Consensus 145 gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 145 GIIHGDLSEFNILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred CCCcCCCCcccEEEcCCCcEEEEECCccccC
Confidence 9999999999999999999999999998644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.4e-14 Score=104.90 Aligned_cols=114 Identities=20% Similarity=0.260 Sum_probs=94.7
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCC--ccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRH--RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
.++||..+.... ...+..|+.+++.+++ .++.++++++..++..++++||++++.+..+ +......++
T Consensus 23 ~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~--------~~~~~~~~~ 92 (155)
T cd05120 23 DYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV--------SEEEKEDIA 92 (155)
T ss_pred eEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC--------CHHHHHHHH
Confidence 688999865433 4678999999999976 5899999998888889999999998777544 456667889
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL 125 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~ 125 (273)
.+++.++..+|.....+++|+|++|+||+++..+.++++||+.+..
T Consensus 93 ~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 93 EQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred HHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 9999999999921124799999999999999989999999998763
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.45 E-value=2.2e-12 Score=107.07 Aligned_cols=204 Identities=14% Similarity=0.084 Sum_probs=138.9
Q ss_pred eeEEEeccCCCC-HHHhhh-----cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeec
Q 024027 47 KALVLEYMPHGS-LEKYLY-----SSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDF 120 (273)
Q Consensus 47 ~~lv~e~~~~~~-L~~~l~-----~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df 120 (273)
+.++|..++|.. +.++++ ++-+-..|+..+.+...++.+.+.|| ..|.+-||++++|+|+++++.|.|.|-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVds 161 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDS 161 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcc
Confidence 678888887643 233332 22344899999999999999999999 999999999999999999999999986
Q ss_pred ccccccccCCCcceeecccccCCCCCCcccC-----CCCcCCcchhHHHHHHHHHHHhC-CCCCcccccccc----chhh
Q 024027 121 GIAKLLIGEDQSMTQTQTLATIGYMAPEYGR-----EGRVSTNGDVYSFGIMLMETFTG-KKPTYEFFNGEM----TLKH 190 (273)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~~l~~ll~g-~~pf~~~~~~~~----~~~~ 190 (273)
+..... .........+|.+.|.+||... +..-+...|.|.||+++++++.| +.||.+...... .-..
T Consensus 162 Dsfqi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~ 238 (637)
T COG4248 162 DSFQIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD 238 (637)
T ss_pred cceeec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh
Confidence 655432 1222344567899999999754 33457789999999999999996 899876322211 0001
Q ss_pred hhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC--CccCCCCHHHHHHHHHHHHHhhhh
Q 024027 191 WVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE--SPEQRINAKEIVTKLLKIRDSLLR 260 (273)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~--dp~~Rps~~~~l~~l~~~~~~~~~ 260 (273)
+.... ...-.+........-........+..+..|+.+|+.. ++.-|||++-++..|.++.++|..
T Consensus 239 Ia~g~----f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~ 306 (637)
T COG4248 239 IAHGR----FAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK 306 (637)
T ss_pred hhcce----eeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence 11100 0000000000000001111234566788999999876 477999999999999999998864
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.43 E-value=7.3e-13 Score=102.24 Aligned_cols=95 Identities=21% Similarity=0.222 Sum_probs=68.7
Q ss_pred HHHHHHhcCCCc--cceeeeeeeecCCceeEEEeccCCCCHHHh-hhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CC
Q 024027 21 VECEMMKSIRHR--NLIKVISSCSNEEFKALVLEYMPHGSLEKY-LYSSNCILDIFQRLNIMIDVASALEYLHFGCS-AP 96 (273)
Q Consensus 21 ~E~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~-l~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~-~~ 96 (273)
.|.+.+..+.+. .+.+++++ ...+++|||++++++... +.... .. ..+..++.+++.++.++| . .|
T Consensus 66 ~e~~~l~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh---~~~~ 135 (187)
T cd05119 66 KEFRNLKRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLY---REAG 135 (187)
T ss_pred HHHHHHHHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHh---hccC
Confidence 455666665333 24444443 235899999998543211 11110 11 567889999999999999 8 99
Q ss_pred eEeccCCCCceeeCCCCceEEeeccccccc
Q 024027 97 VIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 126 (273)
Q Consensus 97 i~h~di~p~nil~~~~~~~kl~Df~~~~~~ 126 (273)
++|+||+|+||+++ ++.++++|||.+...
T Consensus 136 ivH~Dl~p~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 136 LVHGDLSEYNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred cCcCCCChhhEEEE-CCcEEEEECcccccc
Confidence 99999999999999 899999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.34 E-value=2e-12 Score=111.31 Aligned_cols=223 Identities=22% Similarity=0.213 Sum_probs=160.4
Q ss_pred eEEEEEeecc--cChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 2 EVAVKVFNLQ--CGRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 2 ~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
.+|+|.=+.. .......-.+|+..-+.+ .|++.++.+..+...+..++-+|.|. .+|..+.......++...++..
T Consensus 145 ~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~ 223 (524)
T KOG0601|consen 145 KFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNS 223 (524)
T ss_pred ccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeeecccc-chhHHhhhcccccCCchhhhhH
Confidence 4566663322 223344455677666667 59999999999999999999999995 5888888766666888889999
Q ss_pred HHHHHH----HHHHHhcCCCCCeEeccCCCCceeeCCC-CceEEeecccccccccCCCcce---eecccccCCCCCCccc
Q 024027 79 MIDVAS----ALEYLHFGCSAPVIHCDLKPDNVLLDDN-LVAYLSDFGIAKLLIGEDQSMT---QTQTLATIGYMAPEYG 150 (273)
Q Consensus 79 ~~ql~~----~l~~lh~~~~~~i~h~di~p~nil~~~~-~~~kl~Df~~~~~~~~~~~~~~---~~~~~~~~~~~aPE~~ 150 (273)
+.+... |+.++| ..+++|.|++|.||+...+ ...+++||++...+....-... .....+...|++||..
T Consensus 224 ~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~ 300 (524)
T KOG0601|consen 224 LRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL 300 (524)
T ss_pred HhhhhhcccccccccC---CCcccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhh
Confidence 999988 999999 9999999999999999999 8899999999887643321111 1122567789999998
Q ss_pred CCCCcCCcchhHHHHHHHHHHHhCCCCCcccc-ccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHH
Q 024027 151 REGRVSTNGDVYSFGIMLMETFTGKKPTYEFF-NGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNL 229 (273)
Q Consensus 151 ~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 229 (273)
. ..++..+|+|++|.++.+...+..+..... ........ .. ...+. -..-+.++...
T Consensus 301 ~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~---~~---ip~e~---------------~~~~s~~l~~~ 358 (524)
T KOG0601|consen 301 N-GLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ---GY---IPLEF---------------CEGGSSSLRSV 358 (524)
T ss_pred c-cccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc---cc---Cchhh---------------hcCcchhhhhH
Confidence 5 457889999999999999988776643211 11111100 00 00000 11223446669
Q ss_pred HhhcCCCCccCCCCHHHHHHH
Q 024027 230 AMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 230 i~~~l~~dp~~Rps~~~~l~~ 250 (273)
+..|+..+|..|++++.+..+
T Consensus 359 ~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 359 TSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred HHHhcCcchhhhhHHHHHhcc
Confidence 999999999999999887654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.31 E-value=7.5e-12 Score=94.96 Aligned_cols=107 Identities=25% Similarity=0.252 Sum_probs=79.2
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccce-eeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLI-KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
+|+||+...... ....+..|+.+++.+.+.+++ +++.+.. ...++||||++|.++...- ......+.
T Consensus 23 ~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~~~~---------~~~~~~~~ 90 (170)
T cd05151 23 KYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELLTED---------FSDPENLE 90 (170)
T ss_pred EEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcccccc---------ccCHHHHH
Confidence 689999764422 234678899999998654443 4554433 3457999999998775430 11234567
Q ss_pred HHHHHHHHHhcCCCCC-----eEeccCCCCceeeCCCCceEEeeccccc
Q 024027 81 DVASALEYLHFGCSAP-----VIHCDLKPDNVLLDDNLVAYLSDFGIAK 124 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~-----i~h~di~p~nil~~~~~~~kl~Df~~~~ 124 (273)
+++.++..|| ..+ ++|+|++|.||+++ ++.++++||+.+.
T Consensus 91 ~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 91 KIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred HHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 9999999999 776 49999999999999 6789999999876
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.3e-11 Score=107.09 Aligned_cols=102 Identities=20% Similarity=0.233 Sum_probs=70.2
Q ss_pred HHHHHHHHhcC----CCccceeeeeee-ecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHHHHH-HHHHHhcC
Q 024027 19 FDVECEMMKSI----RHRNLIKVISSC-SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS-ALEYLHFG 92 (273)
Q Consensus 19 ~~~E~~~l~~l----~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ql~~-~l~~lh~~ 92 (273)
|.+|...+..+ ++.+-+.+-.++ ...+..++||||++|++|.++........+ ...++.+++. .+..+|
T Consensus 200 f~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~-- 274 (437)
T TIGR01982 200 LRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVL-- 274 (437)
T ss_pred HHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHH--
Confidence 44455555554 233333333333 224456899999999999887643221222 2345555555 467889
Q ss_pred CCCCeEeccCCCCceeeCCCCceEEeeccccccc
Q 024027 93 CSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 126 (273)
Q Consensus 93 ~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~ 126 (273)
..|++|+|++|.||+++.++.++++|||++..+
T Consensus 275 -~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 275 -RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred -hCCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 999999999999999999999999999998765
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.30 E-value=4.4e-11 Score=91.83 Aligned_cols=96 Identities=18% Similarity=0.189 Sum_probs=72.6
Q ss_pred HHHHHHhcCC--CccceeeeeeeecCCceeEEEeccCCCCHH-HhhhcCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCC
Q 024027 21 VECEMMKSIR--HRNLIKVISSCSNEEFKALVLEYMPHGSLE-KYLYSSNCILDIFQRLNIMIDVASALEYL-HFGCSAP 96 (273)
Q Consensus 21 ~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~-~~l~~~~~~~~~~~~~~~~~ql~~~l~~l-h~~~~~~ 96 (273)
+|+..|+++. .-++.+++++ ..-++||||+.+..+. ..++. ..++...+..++.+++.++..+ | ..|
T Consensus 75 kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H---~~g 145 (197)
T cd05146 75 KEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYK---ECN 145 (197)
T ss_pred HHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHH---hCC
Confidence 7999999884 3456666654 3457999999764332 12222 1345566778889999999998 8 899
Q ss_pred eEeccCCCCceeeCCCCceEEeeccccccc
Q 024027 97 VIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 126 (273)
Q Consensus 97 i~h~di~p~nil~~~~~~~kl~Df~~~~~~ 126 (273)
++|||+++.||+++ ++.+.++|||.+...
T Consensus 146 lVHGDLs~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 146 LVHADLSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred eecCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence 99999999999997 468999999988754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=4.3e-11 Score=89.17 Aligned_cols=97 Identities=23% Similarity=0.389 Sum_probs=81.5
Q ss_pred hhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 024027 17 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAP 96 (273)
Q Consensus 17 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~ 96 (273)
..-.+|+.++..++--.|.-.+=+..++....|+|||++|..|.+++... ...++..+-.-+.-|| ..|
T Consensus 44 ~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH---~~g 112 (204)
T COG3642 44 ERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA--------RPDLLREVGRLVGKLH---KAG 112 (204)
T ss_pred HHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc--------chHHHHHHHHHHHHHH---hcC
Confidence 34567999999997767777777777888888999999999999898654 2566777778888999 999
Q ss_pred eEeccCCCCceeeCCCCceEEeecccccc
Q 024027 97 VIHCDLKPDNVLLDDNLVAYLSDFGIAKL 125 (273)
Q Consensus 97 i~h~di~p~nil~~~~~~~kl~Df~~~~~ 125 (273)
++|||+.++||+++.++ +.++|||++.+
T Consensus 113 ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 113 IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999999998765 99999999874
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.23 E-value=5.6e-10 Score=95.05 Aligned_cols=201 Identities=15% Similarity=0.150 Sum_probs=142.2
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeec----CCceeEEEeccCC-CCHHHhhh------------
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSN----EEFKALVLEYMPH-GSLEKYLY------------ 64 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~-~~L~~~l~------------ 64 (273)
-|++|.++.......-.-..-+++++++.|.|+|++-++|.. +..+++|++|+++ ++|.++.-
T Consensus 303 ~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~ 382 (655)
T KOG3741|consen 303 AYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSF 382 (655)
T ss_pred eeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccc
Confidence 367888854433333345567889999999999999998863 4578999999976 56666541
Q ss_pred --cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccC
Q 024027 65 --SSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATI 142 (273)
Q Consensus 65 --~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~ 142 (273)
..+.+.++..+|.++.|+..||.++| +.|+...-+.|.+|+++.+-+++|+..|....+.....
T Consensus 383 ~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~----------- 448 (655)
T KOG3741|consen 383 YPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPT----------- 448 (655)
T ss_pred cccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeecCCCC-----------
Confidence 11345788999999999999999999 99999999999999999888999987776554422220
Q ss_pred CCCCCcccCCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhh
Q 024027 143 GYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQC 222 (273)
Q Consensus 143 ~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (273)
+.+ .-..+.|.-.||.+++.|.+|..--.. .+... ...........
T Consensus 449 -----~~l---e~~Qq~D~~~lG~ll~aLAt~~~ns~~---~d~~~-----------------------~s~~~~I~~~y 494 (655)
T KOG3741|consen 449 -----EPL---ESQQQNDLRDLGLLLLALATGTENSNR---TDSTQ-----------------------SSHLTRITTTY 494 (655)
T ss_pred -----cch---hHHhhhhHHHHHHHHHHHhhccccccc---ccchH-----------------------HHHHHHhhhhh
Confidence 011 112456999999999999998553100 00000 00011114556
Q ss_pred HHHHHHHHhhcCCCCccCCCCHHHHHHHH
Q 024027 223 VSFVFNLAMACTVESPEQRINAKEIVTKL 251 (273)
Q Consensus 223 ~~~l~~li~~~l~~dp~~Rps~~~~l~~l 251 (273)
+.++++++.-....++++ -++.+++.++
T Consensus 495 S~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 495 STDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred hHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 777888999988888887 6888877665
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.2e-11 Score=112.66 Aligned_cols=205 Identities=24% Similarity=0.252 Sum_probs=147.8
Q ss_pred HHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 024027 19 FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVI 98 (273)
Q Consensus 19 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~ 98 (273)
...+-.++-..++|-++...-.+......+++++|..+++|...++..+ ..+...+......+..++++|| ...+.
T Consensus 851 ~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~---s~~r~ 926 (1205)
T KOG0606|consen 851 IRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLH---SSLRK 926 (1205)
T ss_pred cCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccc---cchhh
Confidence 3333333333456777766666667778899999999999999997665 4666677788889999999999 88899
Q ss_pred eccCCCCceeeCCCCceEEeeccccccccc------CC---------------C--------cceeecccccCCCCCCcc
Q 024027 99 HCDLKPDNVLLDDNLVAYLSDFGIAKLLIG------ED---------------Q--------SMTQTQTLATIGYMAPEY 149 (273)
Q Consensus 99 h~di~p~nil~~~~~~~kl~Df~~~~~~~~------~~---------------~--------~~~~~~~~~~~~~~aPE~ 149 (273)
|+|++|.|.+...++..++.||+....... .. . ........+++.|.+||.
T Consensus 927 h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~ 1006 (1205)
T KOG0606|consen 927 HRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEI 1006 (1205)
T ss_pred cccccccchhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcc
Confidence 999999999999999999999874322210 00 0 001123357899999999
Q ss_pred cCCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHH
Q 024027 150 GREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNL 229 (273)
Q Consensus 150 ~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 229 (273)
..+......+|.|++|+++++.++|.+||......... +..... ..--...+...+.+..++
T Consensus 1007 ~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f-----~ni~~~-------------~~~~p~g~~~~s~~aq~~ 1068 (1205)
T KOG0606|consen 1007 LLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIF-----ENILNR-------------DIPWPEGPEEGSYEAQDL 1068 (1205)
T ss_pred cccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhh-----hccccC-------------CCCCCCCccccChhhhhh
Confidence 99999999999999999999999999998764333211 111110 000011133455668899
Q ss_pred HhhcCCCCccCCCCHH
Q 024027 230 AMACTVESPEQRINAK 245 (273)
Q Consensus 230 i~~~l~~dp~~Rps~~ 245 (273)
+.+.+..+|.+|..+.
T Consensus 1069 ~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1069 INRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhhhccCchhccCcc
Confidence 9999999999998775
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.13 E-value=4.8e-10 Score=90.75 Aligned_cols=121 Identities=18% Similarity=0.131 Sum_probs=88.5
Q ss_pred eEEEEEeecccC-hhhh----------hHHHHHHHHhcCCCccc--eeeeeeeec-----CCceeEEEeccCCC-CHHHh
Q 024027 2 EVAVKVFNLQCG-RAFK----------SFDVECEMMKSIRHRNL--IKVISSCSN-----EEFKALVLEYMPHG-SLEKY 62 (273)
Q Consensus 2 ~vavK~~~~~~~-~~~~----------~~~~E~~~l~~l~h~~i--~~~~~~~~~-----~~~~~lv~e~~~~~-~L~~~ 62 (273)
.|.||......- +..+ .+.+|...+..+...+| ..++++.+. ....++|+|++++. +|.++
T Consensus 47 ~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~ 126 (268)
T PRK15123 47 SYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDY 126 (268)
T ss_pred EEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHH
Confidence 578887754321 1111 47899999988843333 344555543 23467999999875 79888
Q ss_pred hhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCC-------CCceEEeecccccc
Q 024027 63 LYSS-NCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDD-------NLVAYLSDFGIAKL 125 (273)
Q Consensus 63 l~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~-------~~~~kl~Df~~~~~ 125 (273)
+... ....+......++.+++..+..|| ..|++|+|++++||+++. +..+.++||+.+..
T Consensus 127 ~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 127 CADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 8531 234566777899999999999999 999999999999999975 46899999998753
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=4.4e-11 Score=104.80 Aligned_cols=156 Identities=19% Similarity=0.228 Sum_probs=106.8
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceee-------cccccCCCCCCc
Q 024027 76 LNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQT-------QTLATIGYMAPE 148 (273)
Q Consensus 76 ~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~-------~~~~~~~~~aPE 148 (273)
..=+.+++.|+.++|+ +.+++|++|.|++|.++.++..||+.|+.+....+........ .......|.|||
T Consensus 102 f~nl~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE 179 (700)
T KOG2137|consen 102 FANLGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPE 179 (700)
T ss_pred hhhhhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccch
Confidence 3445566689999997 8899999999999999999999999999886553322111111 112345699999
Q ss_pred ccCCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHH
Q 024027 149 YGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFN 228 (273)
Q Consensus 149 ~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 228 (273)
++.+...+.++|+||+|+++|.+..|..+-.........+...... ...........++.++.+
T Consensus 180 ~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~----------------~~~~~~~~s~~~p~el~~ 243 (700)
T KOG2137|consen 180 YLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNL----------------LNAGAFGYSNNLPSELRE 243 (700)
T ss_pred hhccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcc----------------cccccccccccCcHHHHH
Confidence 9998888999999999999999995444422222221111111000 000011112567888999
Q ss_pred HHhhcCCCCccCCCCHHHHHH
Q 024027 229 LAMACTVESPEQRINAKEIVT 249 (273)
Q Consensus 229 li~~~l~~dp~~Rps~~~~l~ 249 (273)
=+.+++..++.-||++..+..
T Consensus 244 ~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 244 SLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HHHHHhcCCcccCcchhhhhc
Confidence 999999999999997776643
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.07 E-value=8.6e-10 Score=84.36 Aligned_cols=99 Identities=23% Similarity=0.301 Sum_probs=65.9
Q ss_pred hhHHHHHHHHhcCCCc--cceeeeeeeecCCceeEEEeccC--CCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHH-Hhc
Q 024027 17 KSFDVECEMMKSIRHR--NLIKVISSCSNEEFKALVLEYMP--HGSLEKYLYSSNCILDIFQRLNIMIDVASALEY-LHF 91 (273)
Q Consensus 17 ~~~~~E~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~~~~~~~~~ql~~~l~~-lh~ 91 (273)
....+|++.|..+..- ++.+++++- .-++||||++ |..+..+. ... ++......++.+++..+.. +|
T Consensus 53 ~~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~-~~~--~~~~~~~~~~~~il~~~~~~~~- 124 (188)
T PF01163_consen 53 EWAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLK-DVD--LSPEEPKELLEEILEEIIKMLH- 124 (188)
T ss_dssp HHHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHH-HCG--GGGSTHHHHHHHHHHHHHHHHH-
T ss_pred HHHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHH-hcc--ccchhHHHHHHHHHHHHHHHHH-
Confidence 4467899999999655 466666543 3469999998 64444332 222 1234456778888884444 68
Q ss_pred CCCCCeEeccCCCCceeeCCCCceEEeeccccccc
Q 024027 92 GCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 126 (273)
Q Consensus 92 ~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~ 126 (273)
..|++|||+++.||+++.+ .+.++|||.+...
T Consensus 125 --~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 125 --KAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp --CTTEEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred --hcCceecCCChhhEEeecc-eEEEEecCcceec
Confidence 9999999999999999987 9999999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.07 E-value=7.4e-10 Score=82.44 Aligned_cols=107 Identities=17% Similarity=0.228 Sum_probs=84.3
Q ss_pred hhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCC-CCHHHhhhcCCCCCCHHHH-HHHHHHHHHHHHHHhcCC
Q 024027 16 FKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPH-GSLEKYLYSSNCILDIFQR-LNIMIDVASALEYLHFGC 93 (273)
Q Consensus 16 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~-~~~~~ql~~~l~~lh~~~ 93 (273)
...-.+|+++|.++.--.|.-.--++.+...-.|+|||++| .++.+++......-..+.. ..++.++-..+.-||
T Consensus 54 r~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH--- 130 (229)
T KOG3087|consen 54 RKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH--- 130 (229)
T ss_pred HHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---
Confidence 45567899999888766666666677777777899999976 5788888655433333343 789999999999999
Q ss_pred CCCeEeccCCCCceeeCCCC---ceEEeecccccc
Q 024027 94 SAPVIHCDLKPDNVLLDDNL---VAYLSDFGIAKL 125 (273)
Q Consensus 94 ~~~i~h~di~p~nil~~~~~---~~kl~Df~~~~~ 125 (273)
.++++||||..+||++..++ .+.++|||++..
T Consensus 131 ~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 131 DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99999999999999996443 458999999864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.06 E-value=8.5e-11 Score=101.42 Aligned_cols=203 Identities=20% Similarity=0.173 Sum_probs=145.8
Q ss_pred HHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 024027 21 VECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIH 99 (273)
Q Consensus 21 ~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h 99 (273)
.|+-+...+ .|.++++.+..|....+.++=-|||+++++...+. -...+++..++.+..|++.++.++| +..++|
T Consensus 314 ~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~-~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~ 389 (524)
T KOG0601|consen 314 GEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSV-TSQMLDEDPRLRLTAQILTALNVIH---SKLFVH 389 (524)
T ss_pred hhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhhH-HHHhcCcchhhhhHHHHHhcccccc---chhhhc
Confidence 455555555 58999998888888888889999999989877762 2234788889999999999999999 999999
Q ss_pred ccCCCCceeeCCC-CceEEeecccccccccCCCcceeecccccCCC-CCCcccCCCCcCCcchhHHHHHHHHHHHhCCCC
Q 024027 100 CDLKPDNVLLDDN-LVAYLSDFGIAKLLIGEDQSMTQTQTLATIGY-MAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 177 (273)
Q Consensus 100 ~di~p~nil~~~~-~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~-~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~p 177 (273)
+|++|+||++..+ +.-+++||+....+........ ..+..| .++.......+..+.|+++||.-+.+.+++...
T Consensus 390 ~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~~~~----~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l 465 (524)
T KOG0601|consen 390 LDVKPSNILISNDGFFSKLGDFGCWTRLAFSSGVFH----HIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL 465 (524)
T ss_pred ccccccceeeccchhhhhccccccccccceeccccc----ccccccccchhhccccccccccccccccccccccccCccc
Confidence 9999999999876 7888999998865422222111 122223 355555566789999999999999999988764
Q ss_pred CccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHHHHH
Q 024027 178 TYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLLKIR 255 (273)
Q Consensus 178 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 255 (273)
-.....- . .+.... .+........+..+...|+..++..||++.++..+.+...
T Consensus 466 s~~~~~~----~-------------~i~~~~-------~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 466 SESGVQS----L-------------TIRSGD-------TPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred Ccccccc----e-------------eeeccc-------ccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 2221110 0 000000 0112223366888999999999999999999887766543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.2e-09 Score=84.99 Aligned_cols=121 Identities=18% Similarity=0.194 Sum_probs=89.6
Q ss_pred eEEEEEeecccC-hhhhhHHHHHHHHhcCCC--ccceeeeeeeecC---CceeEEEeccCCCCHHHhhhcCCCCCCHHHH
Q 024027 2 EVAVKVFNLQCG-RAFKSFDVECEMMKSIRH--RNLIKVISSCSNE---EFKALVLEYMPHGSLEKYLYSSNCILDIFQR 75 (273)
Q Consensus 2 ~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~~i~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (273)
++++|+...... .....+..|+++++.+.+ .++.+++.+.... +..++||||++|.++.+.+.. ..++....
T Consensus 24 ~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~--~~~~~~~~ 101 (223)
T cd05154 24 RLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR--PELSPEER 101 (223)
T ss_pred ceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC--CCCCHHHH
Confidence 688998764422 245678999999999965 3457777776654 366899999999888775532 23666667
Q ss_pred HHHHHHHHHHHHHHhcC-----------------------------------------------------CCCCeEeccC
Q 024027 76 LNIMIDVASALEYLHFG-----------------------------------------------------CSAPVIHCDL 102 (273)
Q Consensus 76 ~~~~~ql~~~l~~lh~~-----------------------------------------------------~~~~i~h~di 102 (273)
..++.+++.+|..||.. ....++|||+
T Consensus 102 ~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~ 181 (223)
T cd05154 102 RALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDY 181 (223)
T ss_pred HHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCC
Confidence 77777777777777721 0245799999
Q ss_pred CCCceeeCC--CCceEEeeccccc
Q 024027 103 KPDNVLLDD--NLVAYLSDFGIAK 124 (273)
Q Consensus 103 ~p~nil~~~--~~~~kl~Df~~~~ 124 (273)
.|+||+++. ++.+.++||+.+.
T Consensus 182 ~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 182 RLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred CcccEEEcCCCCcEEEEEeccccc
Confidence 999999998 6678999999875
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.00 E-value=9e-10 Score=97.06 Aligned_cols=99 Identities=16% Similarity=0.173 Sum_probs=63.2
Q ss_pred HHHHHHHHhcC----CCccceeeeeeeec-CCceeEEEeccCCCCHHHh--hhcCCC---CCCHHHHHHHHHHHHHHHHH
Q 024027 19 FDVECEMMKSI----RHRNLIKVISSCSN-EEFKALVLEYMPHGSLEKY--LYSSNC---ILDIFQRLNIMIDVASALEY 88 (273)
Q Consensus 19 ~~~E~~~l~~l----~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~--l~~~~~---~~~~~~~~~~~~ql~~~l~~ 88 (273)
+.+|+..+.++ .+.+.+.+-.++.+ .+..++||||++|+.+.++ +...+. .+....+..++.|
T Consensus 203 ~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q------- 275 (537)
T PRK04750 203 LMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ------- 275 (537)
T ss_pred HHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH-------
Confidence 33444444444 23444444443332 4456799999999999875 322221 1222333334444
Q ss_pred HhcCCCCCeEeccCCCCceeeCCCC----ceEEeecccccccc
Q 024027 89 LHFGCSAPVIHCDLKPDNVLLDDNL----VAYLSDFGIAKLLI 127 (273)
Q Consensus 89 lh~~~~~~i~h~di~p~nil~~~~~----~~kl~Df~~~~~~~ 127 (273)
+. ..|++|+|++|.||+++.++ .++++|||++..+.
T Consensus 276 if---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 276 VF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 34 57999999999999999887 99999999987663
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.93 E-value=7.6e-09 Score=80.98 Aligned_cols=106 Identities=24% Similarity=0.290 Sum_probs=83.3
Q ss_pred hhhHHHHHHHHhcCC--CccceeeeeeeecCC----ceeEEEeccCC-CCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHH
Q 024027 16 FKSFDVECEMMKSIR--HRNLIKVISSCSNEE----FKALVLEYMPH-GSLEKYLYSSNCILDIFQRLNIMIDVASALEY 88 (273)
Q Consensus 16 ~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~----~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~ql~~~l~~ 88 (273)
...+.+|...+..+. .=...+++++.+... ..++|+|++++ .+|.+++..... .+......++.+++..+.-
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAK 133 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHH
Confidence 345788888888884 333455566555422 34799999987 479999865332 5666788999999999999
Q ss_pred HhcCCCCCeEeccCCCCceeeCCCC---ceEEeecccccc
Q 024027 89 LHFGCSAPVIHCDLKPDNVLLDDNL---VAYLSDFGIAKL 125 (273)
Q Consensus 89 lh~~~~~~i~h~di~p~nil~~~~~---~~kl~Df~~~~~ 125 (273)
|| ..|++|+|+++.|||++.++ .+.++||+.+..
T Consensus 134 lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 134 LH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99 99999999999999999877 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.80 E-value=3.4e-08 Score=78.25 Aligned_cols=98 Identities=19% Similarity=0.190 Sum_probs=76.0
Q ss_pred hhhhHHHHHHHHhcCCCc--cceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 024027 15 AFKSFDVECEMMKSIRHR--NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFG 92 (273)
Q Consensus 15 ~~~~~~~E~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ql~~~l~~lh~~ 92 (273)
++...++|.++|..|... .+.+.+++- .-++|||+++|..|...- ++...+..++..|+.-+..+-
T Consensus 152 sRl~A~rEf~~L~~L~~~G~~VP~P~~~n----RHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~-- 219 (304)
T COG0478 152 SRLAAEREFEALQRLYPEGVKVPKPIAWN----RHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAY-- 219 (304)
T ss_pred HHHHHHHHHHHHHHhhhcCCCCCCccccc----cceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHH--
Confidence 356678899999999654 777777743 456999999996665432 233445566777777777777
Q ss_pred CCCCeEeccCCCCceeeCCCCceEEeecccccc
Q 024027 93 CSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL 125 (273)
Q Consensus 93 ~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~ 125 (273)
..|++|||+++-||+++.+|.+.++||-.+..
T Consensus 220 -~~GiVHGDlSefNIlV~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 220 -RRGIVHGDLSEFNILVTEDGDIVVIDWPQAVP 251 (304)
T ss_pred -HcCccccCCchheEEEecCCCEEEEeCccccc
Confidence 78999999999999999999999999988764
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.61 E-value=1.5e-07 Score=73.03 Aligned_cols=67 Identities=22% Similarity=0.297 Sum_probs=52.7
Q ss_pred CceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeeccccc
Q 024027 45 EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 124 (273)
Q Consensus 45 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~ 124 (273)
...+++|||++|..|.+... +++ .+...+.+++.-+| +.|++|||..|+|++++.+ .++++|++...
T Consensus 116 ~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNN-GIRIIDTQGKR 182 (229)
T ss_pred eEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECC-cEEEEECcccc
Confidence 34568999999988876542 222 24466778899999 9999999999999999955 59999997654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.56 E-value=7.3e-07 Score=68.94 Aligned_cols=107 Identities=17% Similarity=0.069 Sum_probs=81.5
Q ss_pred hhhhHHHHHHHHhcCC--Cccceeeeeeeec-----CCceeEEEeccCC-CCHHHhhhcCC-CCCCHHHHHHHHHHHHHH
Q 024027 15 AFKSFDVECEMMKSIR--HRNLIKVISSCSN-----EEFKALVLEYMPH-GSLEKYLYSSN-CILDIFQRLNIMIDVASA 85 (273)
Q Consensus 15 ~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~-----~~~~~lv~e~~~~-~~L~~~l~~~~-~~~~~~~~~~~~~ql~~~ 85 (273)
-...|.+|+..|+.+. .-.+.+++ ++.. .-.-+||+|-++| .+|.+++.... .+.+......++.+++.+
T Consensus 62 g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ 140 (216)
T PRK09902 62 GRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALA 140 (216)
T ss_pred CchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHH
Confidence 3567999999999994 22344444 3321 1235699997753 58888885432 245777778999999999
Q ss_pred HHHHhcCCCCCeEeccCCCCceeeCCCCc--eEEeecccccc
Q 024027 86 LEYLHFGCSAPVIHCDLKPDNVLLDDNLV--AYLSDFGIAKL 125 (273)
Q Consensus 86 l~~lh~~~~~~i~h~di~p~nil~~~~~~--~kl~Df~~~~~ 125 (273)
+.-|| +.|+.|+|+.+.||+++.++. +.++||..+..
T Consensus 141 ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 141 FKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred HHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 99999 999999999999999986666 99999988764
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.50 E-value=1e-05 Score=62.25 Aligned_cols=103 Identities=25% Similarity=0.277 Sum_probs=81.6
Q ss_pred HHHHHHHhcCCC-ccceeeeeeeecCCceeEEEeccCCCCHHHhhh--cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 024027 20 DVECEMMKSIRH-RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY--SSNCILDIFQRLNIMIDVASALEYLHFGCSAP 96 (273)
Q Consensus 20 ~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~ 96 (273)
..|.-+++.+++ +++.+++|+|-+ +++.||.+.+++..... .+....+|..+.+++.+++..+.+++++....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 358888888864 699999999943 58999998766542110 11124789999999999999999999554466
Q ss_pred eEeccCCCCceeeCCCCceEEeeccccccc
Q 024027 97 VIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 126 (273)
Q Consensus 97 i~h~di~p~nil~~~~~~~kl~Df~~~~~~ 126 (273)
+.-.|++|+|+-++.++++|++|.+.+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888899999999999999999999877544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.36 E-value=6.9e-06 Score=65.21 Aligned_cols=120 Identities=11% Similarity=0.105 Sum_probs=70.5
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCcc--ceeeeeeeecCCceeEEEeccCCCC-HHHhh---------------
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRN--LIKVISSCSNEEFKALVLEYMPHGS-LEKYL--------------- 63 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~-L~~~l--------------- 63 (273)
++++|...... ......+|.++++.+..-+ +.+++++..+.+...+|||+++|.+ +...+
T Consensus 24 ~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~~~~~~~~~~~~~l~~~la 101 (226)
T TIGR02172 24 KWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFSRIISDNPSRLEEIAKIFA 101 (226)
T ss_pred CEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchhhhhcCCHHHHHHHHHHHH
Confidence 45677775432 2355789999999985433 5777888888888889999999863 21111
Q ss_pred ------hcCC-CCCCHHHHH-HHHHH----------HHHH-HHHHh-cCCCCCeEeccCCCCceeeCCCCceEEeecccc
Q 024027 64 ------YSSN-CILDIFQRL-NIMID----------VASA-LEYLH-FGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 123 (273)
Q Consensus 64 ------~~~~-~~~~~~~~~-~~~~q----------l~~~-l~~lh-~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~ 123 (273)
+.-. ......... .+..+ +... ..+|. -.....++|||+.|.||+++.++ +.++||+.+
T Consensus 102 ~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a 180 (226)
T TIGR02172 102 EMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDF 180 (226)
T ss_pred HHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCCcEEEcCCC-cEEEechhc
Confidence 0000 001111100 00000 0011 11111 01134578999999999999888 999999987
Q ss_pred c
Q 024027 124 K 124 (273)
Q Consensus 124 ~ 124 (273)
.
T Consensus 181 ~ 181 (226)
T TIGR02172 181 G 181 (226)
T ss_pred C
Confidence 5
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.36 E-value=3.8e-06 Score=66.09 Aligned_cols=96 Identities=21% Similarity=0.216 Sum_probs=65.3
Q ss_pred HHHHHHhcCC--CccceeeeeeeecCCceeEEEeccCCC-CHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CC
Q 024027 21 VECEMMKSIR--HRNLIKVISSCSNEEFKALVLEYMPHG-SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCS-AP 96 (273)
Q Consensus 21 ~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~-~~ 96 (273)
.|+.-|+++- +=.+.+.+++. .-.+||||+... .-.-.|+. ..+....+..+..+++..+.-|- . .+
T Consensus 117 kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD--v~~e~~e~~~~~~~~v~~~~~l~---~~a~ 187 (268)
T COG1718 117 KEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD--VPLELEEAEGLYEDVVEYMRRLY---KEAG 187 (268)
T ss_pred HHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc--CCcCchhHHHHHHHHHHHHHHHH---HhcC
Confidence 4555555552 33333444433 235999999552 11111211 12333467888899999998888 5 89
Q ss_pred eEeccCCCCceeeCCCCceEEeeccccccc
Q 024027 97 VIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 126 (273)
Q Consensus 97 i~h~di~p~nil~~~~~~~kl~Df~~~~~~ 126 (273)
++|+||+.-|||+. ++.+.++|++.+...
T Consensus 188 LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 188 LVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred cccccchhhheEEE-CCeEEEEECcccccc
Confidence 99999999999999 889999999998754
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.35 E-value=2.5e-06 Score=79.75 Aligned_cols=201 Identities=20% Similarity=0.213 Sum_probs=137.3
Q ss_pred hhhhHHHHHHHHhcCCCccceeeeeeeecCC----ceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHh
Q 024027 15 AFKSFDVECEMMKSIRHRNLIKVISSCSNEE----FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 90 (273)
Q Consensus 15 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ql~~~l~~lh 90 (273)
.+....-|++.+....|+|+.+++.|-.... ...+..++|...++...++.- ...+....+.+..+++.|+.++|
T Consensus 225 ~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v-~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 225 EIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV-GSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc-cccCHHHHHHHHHHHhhhHHHHH
Confidence 3445566788888889999999999865443 234667888888888888544 36888899999999999999999
Q ss_pred cCCCCCeEeccCCCC---ceeeCCCCceEEe--ecccccccccCCCcceeecccccCCCCCCcccCCCCc--CCcchhHH
Q 024027 91 FGCSAPVIHCDLKPD---NVLLDDNLVAYLS--DFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRV--STNGDVYS 163 (273)
Q Consensus 91 ~~~~~~i~h~di~p~---nil~~~~~~~kl~--Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~--~~~~Diws 163 (273)
+....|.-+..+ +--.+..+.+..+ ||+....+..... ......+..+.+||....... +...|+|.
T Consensus 304 ---~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~ 377 (1351)
T KOG1035|consen 304 ---SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---SFSDLLAEIRNADEDLKENTAKKSRLTDLWC 377 (1351)
T ss_pred ---HhccceeEEecccccccccCccceeecchhhhcccccCCCccc---chhhcCccccccccccccccchhhhhhHHHH
Confidence 665555544444 3334555666666 8877765532222 222334556777877765554 44479999
Q ss_pred HHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccCCCC
Q 024027 164 FGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRIN 243 (273)
Q Consensus 164 lG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps 243 (273)
+|.+...+..|..+-....... ... +..+..+..+...+|+.-++++|++
T Consensus 378 lgll~~~~~~~~~i~~~~~~~~----------------~~l--------------~~~~~~~~~d~~~~~~~~~~~~Rl~ 427 (1351)
T KOG1035|consen 378 LGLLLLQLSQGEDISEKSAVPV----------------SLL--------------DVLSTSELLDALPKCLDEDSEERLS 427 (1351)
T ss_pred HHHHHhhhhhcCcccccccchh----------------hhh--------------ccccchhhhhhhhhhcchhhhhccc
Confidence 9999999998876522111100 000 1112225788999999999999999
Q ss_pred HHHHHHHHH
Q 024027 244 AKEIVTKLL 252 (273)
Q Consensus 244 ~~~~l~~l~ 252 (273)
+.+++.+.-
T Consensus 428 ~~~ll~~~f 436 (1351)
T KOG1035|consen 428 ALELLTHPF 436 (1351)
T ss_pred hhhhhhchh
Confidence 999998764
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.30 E-value=8.1e-06 Score=65.68 Aligned_cols=120 Identities=18% Similarity=0.137 Sum_probs=73.1
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCC-CccceeeeeeeecCCceeEEEeccCCCCHHHhhh----------------
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIR-HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLY---------------- 64 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---------------- 64 (273)
+++||...... ...+.+|+++++.+. +-.+.+++++....+..++|||+++|.++.....
T Consensus 24 ~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~~~~~~~~~~l~~~l~ 100 (244)
T cd05150 24 GLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAALWEELEPERLVDALAEALR 100 (244)
T ss_pred cEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHhhcccCHHHHHHHHHHHHH
Confidence 46667764332 346788999999883 4556677887777777889999999977764321
Q ss_pred ---cC---CCCCCHH--HHHHH-----------------------HHHHHHHHHHHh-cCCCCCeEeccCCCCceeeCCC
Q 024027 65 ---SS---NCILDIF--QRLNI-----------------------MIDVASALEYLH-FGCSAPVIHCDLKPDNVLLDDN 112 (273)
Q Consensus 65 ---~~---~~~~~~~--~~~~~-----------------------~~ql~~~l~~lh-~~~~~~i~h~di~p~nil~~~~ 112 (273)
.. ..++... ..... ..+++..+.... ......++|+|+.|.||+++.+
T Consensus 101 ~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~ 180 (244)
T cd05150 101 RLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEEDLVVTHGDACLPNIIVDPG 180 (244)
T ss_pred HHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCceEEECCCCCCccEEEeCC
Confidence 00 0011100 00000 111122221111 0113568999999999999998
Q ss_pred CceEEeeccccc
Q 024027 113 LVAYLSDFGIAK 124 (273)
Q Consensus 113 ~~~kl~Df~~~~ 124 (273)
+.+.|+||+.+.
T Consensus 181 ~~~~iIDwe~a~ 192 (244)
T cd05150 181 KFSGFIDLGRLG 192 (244)
T ss_pred cEEEEEEccccc
Confidence 788999999775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.20 E-value=3.2e-05 Score=59.78 Aligned_cols=108 Identities=19% Similarity=0.261 Sum_probs=77.2
Q ss_pred EEEEEeeccc----------------ChhhhhHHHHHHHHhcCC------CccceeeeeeeecCCceeEEEeccC-----
Q 024027 3 VAVKVFNLQC----------------GRAFKSFDVECEMMKSIR------HRNLIKVISSCSNEEFKALVLEYMP----- 55 (273)
Q Consensus 3 vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~~~~lv~e~~~----- 55 (273)
.+||+.+... .....+..+|+.....+. +.+|.+++|+.+.+....+|+|.+.
T Consensus 26 ~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~ 105 (199)
T PF10707_consen 26 LCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGN 105 (199)
T ss_pred eEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCC
Confidence 5788886554 123566777777776665 8999999999999999999999863
Q ss_pred -CCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCC--C-C-ceEEee
Q 024027 56 -HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDD--N-L-VAYLSD 119 (273)
Q Consensus 56 -~~~L~~~l~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~--~-~-~~kl~D 119 (273)
..+|.+++.... ++. .....+.++. .+|- +.+|+.+|++|+||++.. + . .+.++|
T Consensus 106 ~s~TL~~~l~~~~--~~~-~~~~~L~~f~---~~l~---~~~Iv~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 106 ISPTLEDYLKEGG--LTE-ELRQALDEFK---RYLL---DHHIVIRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred cCccHHHHHHcCC--ccH-HHHHHHHHHH---HHHH---HcCCeecCCCcccEEEEecCCCceEEEEEe
Confidence 246788885443 554 4444444444 4555 777999999999999953 2 2 577777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.10 E-value=1.2e-06 Score=77.16 Aligned_cols=150 Identities=20% Similarity=0.250 Sum_probs=112.5
Q ss_pred hhHHHHHHHHhcCCCcc-ceeeeeeeecCCceeEEEeccCCC-CHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 024027 17 KSFDVECEMMKSIRHRN-LIKVISSCSNEEFKALVLEYMPHG-SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCS 94 (273)
Q Consensus 17 ~~~~~E~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~ 94 (273)
....-++++|.+++||| .++.++.++-+....+.++++.++ +...-+......+.+.+....+..-+.+++++| +
T Consensus 278 l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~---~ 354 (829)
T KOG0576|consen 278 LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELH---S 354 (829)
T ss_pred hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccc---c
Confidence 45666899999999999 777777778888899999999876 333333223333555566667777788999999 6
Q ss_pred CCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcchhHHHHHHHHHHHhC
Q 024027 95 APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTG 174 (273)
Q Consensus 95 ~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~g 174 (273)
..-+|+| ||+-+. +..+.+||+....+.... ......+++.++|||+.....+....|.|++|.--.++.-|
T Consensus 355 ~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~ 426 (829)
T KOG0576|consen 355 SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPG 426 (829)
T ss_pred ccccCcc----cccccc-cccccccccCCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCC
Confidence 5556776 665554 688999999887663322 34556789999999999999999999999999876677766
Q ss_pred CCC
Q 024027 175 KKP 177 (273)
Q Consensus 175 ~~p 177 (273)
.+|
T Consensus 427 ~pP 429 (829)
T KOG0576|consen 427 LPP 429 (829)
T ss_pred CCC
Confidence 665
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.05 E-value=3.2e-05 Score=61.46 Aligned_cols=121 Identities=20% Similarity=0.277 Sum_probs=66.4
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCc--cceeeeeeee---cCCceeEEEeccCCCCHHH---------------
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHR--NLIKVISSCS---NEEFKALVLEYMPHGSLEK--------------- 61 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--~i~~~~~~~~---~~~~~~lv~e~~~~~~L~~--------------- 61 (273)
++++|+.... .....+..|..+++.+... .+.+++.... .....+++|++++|..+..
T Consensus 22 ~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~ 99 (239)
T PF01636_consen 22 RYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDDELSPEQRPELLRQLG 99 (239)
T ss_dssp EEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHHTSTHHHHHHHHHHHH
T ss_pred EEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccccccccccccccccccch
Confidence 6788887544 4567788999999888432 3556666432 2345689999999988877
Q ss_pred -hhh---cC---CCCCCHHH---------HHHH------------HHHHHH-HHHHHh----cCCCCCeEeccCCCCcee
Q 024027 62 -YLY---SS---NCILDIFQ---------RLNI------------MIDVAS-ALEYLH----FGCSAPVIHCDLKPDNVL 108 (273)
Q Consensus 62 -~l~---~~---~~~~~~~~---------~~~~------------~~ql~~-~l~~lh----~~~~~~i~h~di~p~nil 108 (273)
.+. .. ........ .... ...+.. .+..++ ......++|||+.|.||+
T Consensus 100 ~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil 179 (239)
T PF01636_consen 100 RALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALLPKPLPPVLIHGDLHPGNIL 179 (239)
T ss_dssp HHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCSCEEEE-SS-SGGGEE
T ss_pred hhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhhccCCCcEEEEeccccccce
Confidence 110 11 00111100 0000 011111 222222 012567999999999999
Q ss_pred eC-CCCceEEeeccccc
Q 024027 109 LD-DNLVAYLSDFGIAK 124 (273)
Q Consensus 109 ~~-~~~~~kl~Df~~~~ 124 (273)
++ .++.+.++||+.+.
T Consensus 180 ~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 180 VDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp EESSTTEEEE--GTT-E
T ss_pred eeeccceeEEEecccce
Confidence 99 66666899998775
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.99 E-value=2.9e-05 Score=68.55 Aligned_cols=103 Identities=16% Similarity=0.189 Sum_probs=67.3
Q ss_pred HHHHHHHHhcC----C-CccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 024027 19 FDVECEMMKSI----R-HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGC 93 (273)
Q Consensus 19 ~~~E~~~l~~l----~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~ 93 (273)
+.+|...+..+ + .+++.=..=+++-.+...++|||++|..+.+...-.....+...+...+.++.-- .+-
T Consensus 208 y~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~--q~~--- 282 (517)
T COG0661 208 YRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLR--QLL--- 282 (517)
T ss_pred HHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHH--HHH---
Confidence 34444444444 2 3333333333344566789999999999988843222346644444444333322 222
Q ss_pred CCCeEeccCCCCceeeCCCCceEEeeccccccc
Q 024027 94 SAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 126 (273)
Q Consensus 94 ~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~ 126 (273)
..|+.|.|..|.||+++.+|.+.+.|||+...+
T Consensus 283 ~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 283 RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred hcCccccCCCccceEEecCCcEEEEcCcceecC
Confidence 459999999999999999999999999998765
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00012 Score=69.15 Aligned_cols=58 Identities=12% Similarity=0.249 Sum_probs=40.3
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCC-Cccc--eeeeeeeecC---CceeEEEeccCCCCH
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIR-HRNL--IKVISSCSNE---EFKALVLEYMPHGSL 59 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~~i--~~~~~~~~~~---~~~~lv~e~~~~~~L 59 (273)
.+++|+..... ......+.+|+++++.+. |.++ .+++.++.+. +..++||||++|..+
T Consensus 67 ~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~~ 131 (822)
T PLN02876 67 RYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRIF 131 (822)
T ss_pred eEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCccc
Confidence 45666654322 123356889999999995 6654 7788888765 467899999988543
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00014 Score=58.25 Aligned_cols=31 Identities=32% Similarity=0.518 Sum_probs=26.7
Q ss_pred CCCeEeccCCCCceeeCCCCceEEeeccccc
Q 024027 94 SAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 124 (273)
Q Consensus 94 ~~~i~h~di~p~nil~~~~~~~kl~Df~~~~ 124 (273)
..+++|||+.+.|++++.++..-++||+.+.
T Consensus 163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred CceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 4568999999999999977667899999875
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00013 Score=59.09 Aligned_cols=118 Identities=14% Similarity=0.120 Sum_probs=65.0
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccc-eeeeeeeecCCceeEEEeccCCCCHHHh--------------h---
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNL-IKVISSCSNEEFKALVLEYMPHGSLEKY--------------L--- 63 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~L~~~--------------l--- 63 (273)
++++|........-.-...+|..+++.+...++ .+++.... -++|+||++|..+..- +
T Consensus 21 ~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~~~~~~~~~~~la~~l~~l 96 (256)
T TIGR02721 21 SFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLDQFVALDLLLELAALLHQL 96 (256)
T ss_pred cEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccccccCchhHHHHHHHHHHH
Confidence 567776543322211356889999999954333 34444332 3689999998665321 0
Q ss_pred hcC---CCCCCHH-HHHHHHHHH---------HHHHHHHhc-----CCCCCeEeccCCCCceeeCCCCceEEeeccccc
Q 024027 64 YSS---NCILDIF-QRLNIMIDV---------ASALEYLHF-----GCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 124 (273)
Q Consensus 64 ~~~---~~~~~~~-~~~~~~~ql---------~~~l~~lh~-----~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~ 124 (273)
+.. +.+++.. .+..+..++ ...+..+-. .....++|+|+.|.||+++.++ +.++||+.+.
T Consensus 97 H~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 97 HSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred hCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence 111 1112221 122222111 111111210 1123689999999999999876 7899999875
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00042 Score=55.31 Aligned_cols=31 Identities=19% Similarity=0.295 Sum_probs=27.3
Q ss_pred CCCeEeccCCCCceeeCC-CCceEEeeccccc
Q 024027 94 SAPVIHCDLKPDNVLLDD-NLVAYLSDFGIAK 124 (273)
Q Consensus 94 ~~~i~h~di~p~nil~~~-~~~~kl~Df~~~~ 124 (273)
..+++|+|+.+.||+++. ++.+.++||..+.
T Consensus 169 ~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 169 PIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred CEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 357999999999999997 5789999999875
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00016 Score=63.90 Aligned_cols=78 Identities=17% Similarity=0.242 Sum_probs=56.1
Q ss_pred CCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCC----CCceEEee
Q 024027 44 EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDD----NLVAYLSD 119 (273)
Q Consensus 44 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~----~~~~kl~D 119 (273)
.....++|||++|..+.|.-.-....++...+...+.+...-+-+ ..|++|+|-.|.||++.. ++.+.+.|
T Consensus 274 st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf-----~~GffHaDPHPGNilv~~~~~~~~~ivllD 348 (538)
T KOG1235|consen 274 STKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIF-----KTGFFHADPHPGNILVRPNPEGDEEIVLLD 348 (538)
T ss_pred CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHH-----hcCCccCCCCCCcEEEecCCCCCccEEEEc
Confidence 345789999999988866543223346666655555554444333 457999999999999983 67899999
Q ss_pred ccccccc
Q 024027 120 FGIAKLL 126 (273)
Q Consensus 120 f~~~~~~ 126 (273)
||+....
T Consensus 349 hGl~~~i 355 (538)
T KOG1235|consen 349 HGLYAVI 355 (538)
T ss_pred ccccccc
Confidence 9998654
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00054 Score=51.38 Aligned_cols=107 Identities=21% Similarity=0.268 Sum_probs=74.7
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCcccee-eeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIK-VISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~-~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
+||+|+-+.++ .+..+..|+++|..+...++.+ ++.|-.+ .+.|||++|..|...-... +. +-+.
T Consensus 47 ~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~L~~~~~~~----~r----k~l~ 112 (201)
T COG2112 47 EVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRPLGKLEIGG----DR----KHLL 112 (201)
T ss_pred eEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcchhhhhhcc----cH----HHHH
Confidence 68899876554 4588999999999997666654 4443332 3559999998887654321 22 2334
Q ss_pred HHHHHHHHHhcCCCCCeEeccCC-CCceeeCCCCceEEeecccccc
Q 024027 81 DVASALEYLHFGCSAPVIHCDLK-PDNVLLDDNLVAYLSDFGIAKL 125 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~-p~nil~~~~~~~kl~Df~~~~~ 125 (273)
.++.+..-|- ..||-|+.|+ |...++..++.+.|+||..+++
T Consensus 113 ~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 113 RVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred HHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 5556656666 7899999987 5555555556999999999874
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00026 Score=55.59 Aligned_cols=120 Identities=22% Similarity=0.165 Sum_probs=61.6
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCC-ccceeeeeeeecCCceeEEEeccCCCCHHH--h-----h---------
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRH-RNLIKVISSCSNEEFKALVLEYMPHGSLEK--Y-----L--------- 63 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~--~-----l--------- 63 (273)
++|+|++.... ....-.-..|..+++.+.. ..-.++++.+... .|.+|++|..|.. + +
T Consensus 3 ~~~~~Ri~g~~-t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~~ 77 (211)
T PF01633_consen 3 EKYLVRIPGEG-TENFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTLSPEDFRNPEILKRIAKLLAK 77 (211)
T ss_dssp SEEEEEEEESC-GCSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE--CGGGGSHHHHHHHHHHHHH
T ss_pred CEEEEEeCCCC-cccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEecccccChhhccChHHHHHHHHHHHH
Confidence 47899998766 3445677889999998854 4445566665443 6779987766422 1 0
Q ss_pred -h---c--CCC-CCCHHHHHHH----------------------HHHHHHHHHHHh-----cCCCCCeEeccCCCCceee
Q 024027 64 -Y---S--SNC-ILDIFQRLNI----------------------MIDVASALEYLH-----FGCSAPVIHCDLKPDNVLL 109 (273)
Q Consensus 64 -~---~--~~~-~~~~~~~~~~----------------------~~ql~~~l~~lh-----~~~~~~i~h~di~p~nil~ 109 (273)
+ . ... .--+..+..| +..+..-+..+. ......++|+|+.|.||++
T Consensus 78 lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil~ 157 (211)
T PF01633_consen 78 LHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNILI 157 (211)
T ss_dssp HHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEEE
T ss_pred HhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEEe
Confidence 0 0 000 0011112112 111111122111 0113468999999999999
Q ss_pred -CCCCceEEeecccccc
Q 024027 110 -DDNLVAYLSDFGIAKL 125 (273)
Q Consensus 110 -~~~~~~kl~Df~~~~~ 125 (273)
+.++.++++||..+..
T Consensus 158 ~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 158 NNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp TSSSSCEEE--GTT-EE
T ss_pred ccCCCeEEEecHHHHhh
Confidence 8899999999998853
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00031 Score=58.22 Aligned_cols=120 Identities=19% Similarity=0.193 Sum_probs=68.6
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCc--cceeeeee------eecCCceeEEEeccCCCCHHH-----------h
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHR--NLIKVISS------CSNEEFKALVLEYMPHGSLEK-----------Y 62 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--~i~~~~~~------~~~~~~~~lv~e~~~~~~L~~-----------~ 62 (273)
++++|+... ........|+.++..+.+. .+.+++.. ...++..+++++|++|..+.. .
T Consensus 39 ~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~ 115 (296)
T cd05153 39 RYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEA 115 (296)
T ss_pred cEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHH
Confidence 467888753 2345677788888888432 24444432 233456689999999866532 0
Q ss_pred h---hc--CC--C------CCCHHHH----------HHHHHHHHHHHHHHhc----CCCCCeEeccCCCCceeeCCCCce
Q 024027 63 L---YS--SN--C------ILDIFQR----------LNIMIDVASALEYLHF----GCSAPVIHCDLKPDNVLLDDNLVA 115 (273)
Q Consensus 63 l---~~--~~--~------~~~~~~~----------~~~~~ql~~~l~~lh~----~~~~~i~h~di~p~nil~~~~~~~ 115 (273)
+ +. .. . ...+... ......+..++.++.. ....+++|||+.|.|++++.++.+
T Consensus 116 La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~ 195 (296)
T cd05153 116 LARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGVIHADLFRDNVLFDGDELS 195 (296)
T ss_pred HHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCCceE
Confidence 0 00 00 0 0011100 0011112223333331 123579999999999999998778
Q ss_pred EEeeccccc
Q 024027 116 YLSDFGIAK 124 (273)
Q Consensus 116 kl~Df~~~~ 124 (273)
.|+||+.+.
T Consensus 196 ~iIDfe~a~ 204 (296)
T cd05153 196 GVIDFYFAC 204 (296)
T ss_pred EEeehhhhc
Confidence 999999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00061 Score=56.63 Aligned_cols=31 Identities=32% Similarity=0.353 Sum_probs=27.6
Q ss_pred CCCeEeccCCCCceeeCCC----CceEEeeccccc
Q 024027 94 SAPVIHCDLKPDNVLLDDN----LVAYLSDFGIAK 124 (273)
Q Consensus 94 ~~~i~h~di~p~nil~~~~----~~~kl~Df~~~~ 124 (273)
..++||+|+.|.||+++.+ +.+.++||+.+.
T Consensus 178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 5679999999999999975 889999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0022 Score=53.30 Aligned_cols=107 Identities=16% Similarity=0.195 Sum_probs=70.1
Q ss_pred ChhhhhHHHHHHHHhcCC--CccceeeeeeeecCC--ceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH-HHHHHHHH
Q 024027 13 GRAFKSFDVECEMMKSIR--HRNLIKVISSCSNEE--FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM-IDVASALE 87 (273)
Q Consensus 13 ~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~-~ql~~~l~ 87 (273)
........+|+.+++.+. .-.+.+.+++|.++. ..+.||+|++|..+.+..... ... .... ..+...|.
T Consensus 62 ~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~----~~~--~~~~~~~l~~~La 135 (321)
T COG3173 62 VESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPE----SLG--RQFALDALADFLA 135 (321)
T ss_pred chhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcc----cch--HHHHHHHHHHHHH
Confidence 345567778999998884 445566677777766 779999999885443332111 111 1111 24444444
Q ss_pred HHhc-------------------------------------------------------CCCCCeEeccCCCCceeeCCC
Q 024027 88 YLHF-------------------------------------------------------GCSAPVIHCDLKPDNVLLDDN 112 (273)
Q Consensus 88 ~lh~-------------------------------------------------------~~~~~i~h~di~p~nil~~~~ 112 (273)
.||. .....++|||+.+.|++++.+
T Consensus 136 ~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~ 215 (321)
T COG3173 136 ELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPG 215 (321)
T ss_pred HHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCC
Confidence 4440 002357899999999999988
Q ss_pred CceEEeecccccc
Q 024027 113 LVAYLSDFGIAKL 125 (273)
Q Consensus 113 ~~~kl~Df~~~~~ 125 (273)
+-+-++||+++..
T Consensus 216 ~~~gVlDwe~~~l 228 (321)
T COG3173 216 RPTGVLDWELATL 228 (321)
T ss_pred CeeEEEecccccc
Confidence 8899999999864
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.004 Score=51.65 Aligned_cols=55 Identities=11% Similarity=-0.036 Sum_probs=39.4
Q ss_pred EEEEEeecccChhhhhHHHHHHHHhcCCC---ccceeeeeeeec---CCceeEEEeccCCCCH
Q 024027 3 VAVKVFNLQCGRAFKSFDVECEMMKSIRH---RNLIKVISSCSN---EEFKALVLEYMPHGSL 59 (273)
Q Consensus 3 vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~~i~~~~~~~~~---~~~~~lv~e~~~~~~L 59 (273)
+.+|..+.. .....+..|...|+.+.. -.+.++++++.+ .+..++|||+++|.++
T Consensus 40 ~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 40 PMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSV 100 (297)
T ss_pred EEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEec
Confidence 456665421 133588999999999842 468888887754 3668999999998754
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0008 Score=58.65 Aligned_cols=165 Identities=21% Similarity=0.280 Sum_probs=92.5
Q ss_pred hhHHHHHHHHhcCCCccceeeeeeeec-CCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 024027 17 KSFDVECEMMKSIRHRNLIKVISSCSN-EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSA 95 (273)
Q Consensus 17 ~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~ 95 (273)
....-..++++.+.|+|....+++-.. ..+..+|+|++. .+|++.+.... +-... +. .+
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~~--l~~~s---~~--------------~~ 86 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTGN--LKDES---LL--------------AH 86 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhcc--cchhh---hc--------------cc
Confidence 345667888999999999999987644 334678999995 59999985443 11000 00 12
Q ss_pred CeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcchhHHHHHHHHHHHhCC
Q 024027 96 PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGK 175 (273)
Q Consensus 96 ~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~ 175 (273)
++.|- | .++.+| .+... | | ....+++|||++|.++.++..|.
T Consensus 87 ~~~~~-----~-------~~~~td-~~~t~------------------~--~-----~~~~pKsdVwsl~~i~~el~L~~ 128 (725)
T KOG1093|consen 87 GVLHL-----N-------IIYITD-HFLTK------------------Y--P-----SPIGPKSDVWSLGFIILELYLGI 128 (725)
T ss_pred cccee-----h-------hhhccc-ccccc------------------C--C-----CCCCcchhhhhHHHHHHHHHHhh
Confidence 22222 1 222333 11100 0 1 01114999999999999999987
Q ss_pred CCCccccccccchhhhhhh-ccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHH
Q 024027 176 KPTYEFFNGEMTLKHWVND-WLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVT 249 (273)
Q Consensus 176 ~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~ 249 (273)
.-+......+ ....... .......... .......-.++..+..+..+|+-..|..||...++.+
T Consensus 129 ~l~~~~~~s~--~l~~i~k~~~~d~~~~~~--------a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k 193 (725)
T KOG1093|consen 129 SLEAELTESE--YLEILLKYYTDDQELLST--------AMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSK 193 (725)
T ss_pred HHHHHHHHHH--HHHHHHHhccCchhHHHH--------HHHHHHHHhhhHhHHHHhccCCccccccccchhHHhc
Confidence 7654422211 1111111 0000000000 0011234456777889999999999999886665544
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0028 Score=53.69 Aligned_cols=118 Identities=17% Similarity=0.214 Sum_probs=68.1
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccc-eeeeeeeecCCceeEEEeccCCCCHHHh-----------------h
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNL-IKVISSCSNEEFKALVLEYMPHGSLEKY-----------------L 63 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~L~~~-----------------l 63 (273)
+|++|+..... ...-.-..|..+++.+...++ .++++.+... .|.+|+++.++..- +
T Consensus 67 ~~v~Ri~g~~t-~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~l 141 (344)
T PLN02236 67 KVLVRIYGEGV-ELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHARTLSAADLRDPEISALIAAKLREF 141 (344)
T ss_pred eEEEEEccCCC-CeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHH
Confidence 57888775543 333345789999999854333 3556665432 58999987665321 0
Q ss_pred hcCC---C--CCCHHHHHHHHHHHH-----------------HHHHH----Hhc-CCCCCeEeccCCCCceeeCC-CCce
Q 024027 64 YSSN---C--ILDIFQRLNIMIDVA-----------------SALEY----LHF-GCSAPVIHCDLKPDNVLLDD-NLVA 115 (273)
Q Consensus 64 ~~~~---~--~~~~~~~~~~~~ql~-----------------~~l~~----lh~-~~~~~i~h~di~p~nil~~~-~~~~ 115 (273)
+... . ...+..+..++.++. ..+.. +.. .....++|+|+++.||+++. ++.+
T Consensus 142 H~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~ 221 (344)
T PLN02236 142 HSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAI 221 (344)
T ss_pred hCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcE
Confidence 1111 0 111233333332221 11111 110 11447899999999999976 4789
Q ss_pred EEeeccccc
Q 024027 116 YLSDFGIAK 124 (273)
Q Consensus 116 kl~Df~~~~ 124 (273)
.++||..+.
T Consensus 222 ~lID~Eya~ 230 (344)
T PLN02236 222 TIIDYEYAS 230 (344)
T ss_pred EEEeehhcc
Confidence 999999875
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.00078 Score=55.52 Aligned_cols=96 Identities=18% Similarity=0.147 Sum_probs=70.5
Q ss_pred hhhHHHHHHHHhcCC-C-ccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 024027 16 FKSFDVECEMMKSIR-H-RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGC 93 (273)
Q Consensus 16 ~~~~~~E~~~l~~l~-h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~ 93 (273)
+-...+|+..|+.|. | -.+.+.+++. .-++|||.+.|..|...-+-.+ +..+...+..-+--|.
T Consensus 154 Rlaa~kEfafmkaL~e~gfpVPkpiD~~----RH~Vvmelv~g~Pl~~v~~v~d-------~~~ly~~lm~~Iv~la--- 219 (465)
T KOG2268|consen 154 RLAATKEFAFMKALYERGFPVPKPIDHN----RHCVVMELVDGYPLRQVRHVED-------PPTLYDDLMGLIVRLA--- 219 (465)
T ss_pred HHHHHHHHHHHHHHHHcCCCCCCccccc----ceeeHHHhhcccceeeeeecCC-------hHHHHHHHHHHHHHHH---
Confidence 345667888888883 2 3445555543 4579999999977766543222 3455666666777788
Q ss_pred CCCeEeccCCCCceeeCCCCceEEeecccccc
Q 024027 94 SAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL 125 (273)
Q Consensus 94 ~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~ 125 (273)
..|++|||++--||+++.++.++++||-....
T Consensus 220 ~~GlIHgDFNEFNimv~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 220 NHGLIHGDFNEFNIMVKDDDKIVVIDFPQMVS 251 (465)
T ss_pred HcCceecccchheeEEecCCCEEEeechHhhc
Confidence 89999999999999999999999999987643
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.00013 Score=70.83 Aligned_cols=159 Identities=12% Similarity=-0.036 Sum_probs=112.9
Q ss_pred HHHHHHHHhcCCCccceeeeeeeecC--CceeEEEeccCCCCHHHhhhcC---CCCCCHHHHHHHHHHHHHHHHHHhcC-
Q 024027 19 FDVECEMMKSIRHRNLIKVISSCSNE--EFKALVLEYMPHGSLEKYLYSS---NCILDIFQRLNIMIDVASALEYLHFG- 92 (273)
Q Consensus 19 ~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~ql~~~l~~lh~~- 92 (273)
...|..-++...|+++.....-.... ...+..++++.+|.+.+.+-+. ...++...+.....+.+.+..-+|.+
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 33344445556788887776655432 3457899999999999998543 22344444444444546666666622
Q ss_pred -CCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcchhHHHHHHHHHH
Q 024027 93 -CSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMET 171 (273)
Q Consensus 93 -~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l 171 (273)
.+.-.+|.++++-|.++..+..++++++|+.... ...........+++.|++|++...-.++.++|+|+.|+.+|..
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIk--np~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIK--NPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred cCCccchhhhhhhhccceecCCccccccccccccc--CchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence 2334689999999999999999999999998833 1222233455678888999988877888889999999999998
Q ss_pred HhCCCCCc
Q 024027 172 FTGKKPTY 179 (273)
Q Consensus 172 l~g~~pf~ 179 (273)
-.|..+|.
T Consensus 1434 s~~n~~fi 1441 (2724)
T KOG1826|consen 1434 SDGNAYFI 1441 (2724)
T ss_pred hcccHHHH
Confidence 88877664
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.039 Score=47.57 Aligned_cols=55 Identities=22% Similarity=0.133 Sum_probs=36.5
Q ss_pred eEEEEEeecc-----c--ChhhhhHHHHHHHHhcCC---CccceeeeeeeecCCceeEEEeccCCCC
Q 024027 2 EVAVKVFNLQ-----C--GRAFKSFDVECEMMKSIR---HRNLIKVISSCSNEEFKALVLEYMPHGS 58 (273)
Q Consensus 2 ~vavK~~~~~-----~--~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 58 (273)
.|+||..... . .........|.+.|+.+. ..++.+++.+ ++...++||||+++..
T Consensus 53 svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lVME~L~~~~ 117 (401)
T PRK09550 53 SVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTVMEDLSDHK 117 (401)
T ss_pred EEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEEEecCCCcc
Confidence 6889985411 1 224556778888888872 3456677776 3455789999997643
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.0049 Score=51.95 Aligned_cols=118 Identities=13% Similarity=0.160 Sum_probs=67.5
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccc-eeeeeeeecCCceeEEEeccCCCCHHH--h-----h----------
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNL-IKVISSCSNEEFKALVLEYMPHGSLEK--Y-----L---------- 63 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~L~~--~-----l---------- 63 (273)
+|++|+..... ...-.-.+|..+++.+..-++ .++++++. .+ +|.+|++|..+.. + +
T Consensus 44 ~~v~Ri~g~~t-~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~l 118 (330)
T PLN02421 44 SVTVRLFGPNT-DYVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINARTLTPSDMRKPKVAAEIAKELRRL 118 (330)
T ss_pred eEEEEEecCCc-CeEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcCCCCChHHCCCHHHHHHHHHHHHHH
Confidence 67888875442 234456789999999865444 35566553 22 5899998765521 1 1
Q ss_pred hcCC----CCC-CHHHHHHHHHHH----------------------HHHHHH---Hhc--CCCCCeEeccCCCCceeeCC
Q 024027 64 YSSN----CIL-DIFQRLNIMIDV----------------------ASALEY---LHF--GCSAPVIHCDLKPDNVLLDD 111 (273)
Q Consensus 64 ~~~~----~~~-~~~~~~~~~~ql----------------------~~~l~~---lh~--~~~~~i~h~di~p~nil~~~ 111 (273)
+... ... -+..+..++.++ ..-+.. +.. ....-.||+|+.+.||+++.
T Consensus 119 H~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~ 198 (330)
T PLN02421 119 HQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEITDSLKAPVVFAHNDLLSGNLMLNE 198 (330)
T ss_pred hCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHhccCCCCeEEEECCCCcccEEEeC
Confidence 1111 001 123333333222 111111 110 11234899999999999974
Q ss_pred -CCceEEeeccccc
Q 024027 112 -NLVAYLSDFGIAK 124 (273)
Q Consensus 112 -~~~~kl~Df~~~~ 124 (273)
++.++++||+.+-
T Consensus 199 ~~~~l~lID~EYag 212 (330)
T PLN02421 199 DEGKLYFIDFEYGS 212 (330)
T ss_pred CCCcEEEEcccccC
Confidence 5789999999875
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.022 Score=47.67 Aligned_cols=31 Identities=39% Similarity=0.482 Sum_probs=27.0
Q ss_pred CCCeEeccCCCCceeeCCCCceEEeeccccc
Q 024027 94 SAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 124 (273)
Q Consensus 94 ~~~i~h~di~p~nil~~~~~~~kl~Df~~~~ 124 (273)
..+++|+|+.|+||+++.+...-++||+.+.
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 4589999999999999977666899999875
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.015 Score=45.02 Aligned_cols=86 Identities=22% Similarity=0.394 Sum_probs=61.9
Q ss_pred hhhHHHHHHHHhcCC---Cccc--eeeeeeeecC------------------CceeEEEeccCCCCHHHhhhcCCCCCCH
Q 024027 16 FKSFDVECEMMKSIR---HRNL--IKVISSCSNE------------------EFKALVLEYMPHGSLEKYLYSSNCILDI 72 (273)
Q Consensus 16 ~~~~~~E~~~l~~l~---h~~i--~~~~~~~~~~------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 72 (273)
...|..|++..-+|+ +.++ ++++||..-. ....||.||.+... .+.
T Consensus 98 ~~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~- 166 (207)
T PF13095_consen 98 ADPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQ- 166 (207)
T ss_pred cChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccc-
Confidence 346888999988874 5566 9999987221 12357888876533 122
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccc
Q 024027 73 FQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIA 123 (273)
Q Consensus 73 ~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~ 123 (273)
..-+.+++.-+..+| ..||+-+|+++.|.. .-+|+|||.+
T Consensus 167 ---~~~~~~~~~dl~~~~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 167 ---IRDIPQMLRDLKILH---KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred ---hhHHHHHHHHHHHHH---HCCeeeccCcccccc-----CCEEEecccC
Confidence 334557777888899 999999999999988 4578898864
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.48 E-value=0.055 Score=45.69 Aligned_cols=72 Identities=22% Similarity=0.255 Sum_probs=54.8
Q ss_pred CceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeeccccc
Q 024027 45 EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 124 (273)
Q Consensus 45 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~ 124 (273)
.+.|++|++- |+++. .++ .-.+.++.+++++-+..+.-+.- ....-|+++...||+++ +|.|.|+||.+++
T Consensus 299 ~y~yl~~kdh-gt~is-~ik----~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfklsR 369 (488)
T COG5072 299 LYLYLHFKDH-GTPIS-IIK----ADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFKLSR 369 (488)
T ss_pred eEEEEEEecC-Cceee-eee----cccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEeeeee
Confidence 3556777776 44553 222 24577888899888877777772 44789999999999999 9999999999998
Q ss_pred c
Q 024027 125 L 125 (273)
Q Consensus 125 ~ 125 (273)
.
T Consensus 370 l 370 (488)
T COG5072 370 L 370 (488)
T ss_pred c
Confidence 3
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.93 E-value=0.057 Score=46.43 Aligned_cols=29 Identities=31% Similarity=0.273 Sum_probs=24.8
Q ss_pred CCeEeccCCCCceeeCCCCceEEeeccccc
Q 024027 95 APVIHCDLKPDNVLLDDNLVAYLSDFGIAK 124 (273)
Q Consensus 95 ~~i~h~di~p~nil~~~~~~~kl~Df~~~~ 124 (273)
...||.|+.+.||+.+. +.+.++||..+.
T Consensus 227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEecC-CCEEEEEecccc
Confidence 57899999999999764 469999998875
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.44 E-value=0.15 Score=44.85 Aligned_cols=29 Identities=24% Similarity=0.364 Sum_probs=24.7
Q ss_pred CCeEeccCCCCceeeCCCCceEEeeccccc
Q 024027 95 APVIHCDLKPDNVLLDDNLVAYLSDFGIAK 124 (273)
Q Consensus 95 ~~i~h~di~p~nil~~~~~~~kl~Df~~~~ 124 (273)
..+||+|+.+.||+.+.+ .++++||..+.
T Consensus 284 ~VfCHNDl~~~NiL~~~~-~l~LIDfEYAg 312 (442)
T PTZ00296 284 IVFCHNDLQENNIINTNK-CLRLIDFEYSG 312 (442)
T ss_pred eeEEeCCCCccceeecCC-CEEEEeecccc
Confidence 468999999999988654 49999999875
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=95.39 E-value=0.025 Score=47.18 Aligned_cols=31 Identities=48% Similarity=0.594 Sum_probs=27.9
Q ss_pred CCCeEeccCCCCceeeCCCCceEEeeccccc
Q 024027 94 SAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 124 (273)
Q Consensus 94 ~~~i~h~di~p~nil~~~~~~~kl~Df~~~~ 124 (273)
..+++|+|+.+.|++++.++.+.++||+.+.
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 4789999999999999988877899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=95.34 E-value=0.039 Score=45.06 Aligned_cols=47 Identities=30% Similarity=0.347 Sum_probs=37.5
Q ss_pred HHHHHHHHHHHHHHHhcCCCC--CeEeccCCCCceeeCCCCceEEeeccccc
Q 024027 75 RLNIMIDVASALEYLHFGCSA--PVIHCDLKPDNVLLDDNLVAYLSDFGIAK 124 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~--~i~h~di~p~nil~~~~~~~kl~Df~~~~ 124 (273)
....+..+-.++.-.+ .. -+||+|+.|+|++.++.+.++|+||..+.
T Consensus 134 ~~~~~~~l~~~l~~~~---~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg 182 (269)
T COG0510 134 LRKKLKELRRALEEVP---KDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAG 182 (269)
T ss_pred HHHHHHHHHHHhhhcC---CCceeeecCCCCccceEEcCCCcEEEEecccCC
Confidence 3445556666666666 33 69999999999999999999999999875
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.14 E-value=0.073 Score=45.07 Aligned_cols=100 Identities=15% Similarity=0.122 Sum_probs=66.8
Q ss_pred HHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 024027 20 DVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIH 99 (273)
Q Consensus 20 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h 99 (273)
..|.+-|.+++...|.-.--+.. ..-.|||+++.. +=+-.-.-....++...+..+.++++.-+.-|-+ ..++||
T Consensus 214 EKE~RNLkRl~~aGIP~PePIlL--k~hVLVM~FlGr-dgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~--~c~LVH 288 (520)
T KOG2270|consen 214 EKEMRNLKRLNNAGIPCPEPILL--KNHVLVMEFLGR-DGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQ--KCRLVH 288 (520)
T ss_pred HHHHHHHHHHHhcCCCCCCceee--ecceEeeeeccC-CCCcCcccccccCChHHHHHHHHHHHHHHHHHHH--Hhceec
Confidence 34666666665444332222221 123599999943 3322211222347777888999999998888874 779999
Q ss_pred ccCCCCceeeCCCCceEEeecccccc
Q 024027 100 CDLKPDNVLLDDNLVAYLSDFGIAKL 125 (273)
Q Consensus 100 ~di~p~nil~~~~~~~kl~Df~~~~~ 125 (273)
.||+--|+|+-. |.+.++|-+.+..
T Consensus 289 ADLSEfN~Lyhd-G~lyiIDVSQSVE 313 (520)
T KOG2270|consen 289 ADLSEFNLLYHD-GKLYIIDVSQSVE 313 (520)
T ss_pred cchhhhhheEEC-CEEEEEEcccccc
Confidence 999999999874 6899999887754
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.04 E-value=0.057 Score=44.99 Aligned_cols=30 Identities=30% Similarity=0.390 Sum_probs=26.0
Q ss_pred CCCeEeccCCCCceeeCCCCceEEeeccccc
Q 024027 94 SAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 124 (273)
Q Consensus 94 ~~~i~h~di~p~nil~~~~~~~kl~Df~~~~ 124 (273)
..+++|||+.+.|++++. +.+.++||+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 368999999999999987 678899999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=94.99 E-value=0.5 Score=40.93 Aligned_cols=30 Identities=20% Similarity=0.302 Sum_probs=24.6
Q ss_pred CCCeEeccCCCCceeeCCCCceEEeeccccc
Q 024027 94 SAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 124 (273)
Q Consensus 94 ~~~i~h~di~p~nil~~~~~~~kl~Df~~~~ 124 (273)
...++|||+.|.||+++.++ ++++|...+.
T Consensus 229 ~~~L~HGDl~~g~i~~~~~~-~~~id~ef~~ 258 (418)
T PLN02756 229 AQALVHGDLHTGSVMVTPDS-TQVIDPEFAF 258 (418)
T ss_pred ccceeecCCCCCcEEEcCCC-ceEecchhhc
Confidence 56789999999999999875 8888866553
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.76 E-value=0.025 Score=43.29 Aligned_cols=29 Identities=21% Similarity=0.257 Sum_probs=25.4
Q ss_pred CCeEeccCCCCceeeCCCCceEEeeccccc
Q 024027 95 APVIHCDLKPDNVLLDDNLVAYLSDFGIAK 124 (273)
Q Consensus 95 ~~i~h~di~p~nil~~~~~~~kl~Df~~~~ 124 (273)
...+|+|+.|.|++++.++ ++++||+.+.
T Consensus 77 ~~p~H~D~~~~N~~~~~~~-~~lIDwe~a~ 105 (188)
T PRK10271 77 LAPLHMDVHAGNLVHSASG-LRLIDWEYAG 105 (188)
T ss_pred eeeecCCCCCccEEEECCC-EEEEeCCccc
Confidence 3569999999999998877 8899999875
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=94.32 E-value=0.24 Score=39.19 Aligned_cols=56 Identities=27% Similarity=0.424 Sum_probs=42.0
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCC---CccceeeeeeeecCCceeEEEeccCCCCHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIR---HRNLIKVISSCSNEEFKALVLEYMPHGSLE 60 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 60 (273)
++-||+-. .+....|..|+.-|+.+. .-.+.+++.+-.+..+-|+|+||++.+.+.
T Consensus 41 ~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 41 PFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred ceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 44555532 345577889998888883 456888888888999999999999876664
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.31 E-value=0.33 Score=41.88 Aligned_cols=61 Identities=21% Similarity=0.149 Sum_probs=41.9
Q ss_pred eeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCC
Q 024027 47 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDD 111 (273)
Q Consensus 47 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~ 111 (273)
..++=+|..|.++..+++..+ .++.....++.-.+.|+..+-. -.+++|.|+.|.||++-.
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~--~pe~l~kkva~lg~~AllkMl~--vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKS--QPEALVKKVAKLGVNALLKMLI--VDNFVHADLHPGNVLIRF 380 (565)
T ss_pred ceeeeeccccccHHhhhhccc--ChHHHHHHHHHHHHHHHHHHHH--hhcceecccCCCcEEEEe
Confidence 456777888999999986544 3334455555555555544331 568999999999999853
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.28 E-value=0.078 Score=44.27 Aligned_cols=32 Identities=22% Similarity=0.390 Sum_probs=28.7
Q ss_pred CCCeEeccCCCCceeeCCCCceEEeecccccc
Q 024027 94 SAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL 125 (273)
Q Consensus 94 ~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~ 125 (273)
..++||||+.++|++++.++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 45899999999999999999999999998763
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=94.05 E-value=0.18 Score=41.57 Aligned_cols=53 Identities=26% Similarity=0.293 Sum_probs=34.0
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcC---CCccceeeeeeeecCCceeEEEeccCCC
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSI---RHRNLIKVISSCSNEEFKALVLEYMPHG 57 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 57 (273)
++.||+-. ......|..|..-|+.+ ..-.+.+++++....+..++|+||++.+
T Consensus 42 ~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 42 SYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred cEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 56777765 33446788999988888 3556778888887777779999999775
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=93.69 E-value=0.074 Score=41.81 Aligned_cols=87 Identities=15% Similarity=0.103 Sum_probs=56.9
Q ss_pred hhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 024027 17 KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAP 96 (273)
Q Consensus 17 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~ 96 (273)
.-|..++.++.+++ +|+++..- +...+.+|.|+|..... .... +..--+.+|.-.|. ...+
T Consensus 103 ~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i----------~~~N----~i~agi~~L~~fH~-~~~~ 163 (308)
T PF07387_consen 103 ALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI----------NFSN----FITAGIKDLMDFHS-ENQH 163 (308)
T ss_pred hhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc----------chhH----HHHHhHHHHHHhhc-cCCC
Confidence 44566777777664 46666632 34456789999844211 1111 11112456667772 2678
Q ss_pred eEeccCCCCceeeCCCCceEEeeccc
Q 024027 97 VIHCDLKPDNVLLDDNLVAYLSDFGI 122 (273)
Q Consensus 97 i~h~di~p~nil~~~~~~~kl~Df~~ 122 (273)
..|||.+|+|||-++.|-+||.|=+.
T Consensus 164 ~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 164 CLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred eecCCCChhheeecCCCCEEecChhh
Confidence 99999999999999999999998653
|
The function of this family is unknown. |
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=93.49 E-value=0.23 Score=38.47 Aligned_cols=31 Identities=23% Similarity=0.279 Sum_probs=26.0
Q ss_pred CCCeEeccCCCCceeeCCCC-----ceEEeeccccc
Q 024027 94 SAPVIHCDLKPDNVLLDDNL-----VAYLSDFGIAK 124 (273)
Q Consensus 94 ~~~i~h~di~p~nil~~~~~-----~~kl~Df~~~~ 124 (273)
...++|||+.+.|+++..++ .+.++||..+.
T Consensus 119 ~~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 119 FNVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred ceEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 45789999999999997543 68999999875
|
subfamily of choline kinases |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=92.58 E-value=0.1 Score=42.79 Aligned_cols=31 Identities=32% Similarity=0.569 Sum_probs=25.7
Q ss_pred CCeEeccCCCCceeeCCCCc-eEEeecccccc
Q 024027 95 APVIHCDLKPDNVLLDDNLV-AYLSDFGIAKL 125 (273)
Q Consensus 95 ~~i~h~di~p~nil~~~~~~-~kl~Df~~~~~ 125 (273)
..++|||+.|.||+++.++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999997454 56999998763
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=92.55 E-value=0.18 Score=42.24 Aligned_cols=39 Identities=28% Similarity=0.464 Sum_probs=26.8
Q ss_pred HHHHHHHHHHHHHHHHHH-hcCCCCCeEeccCCCCceeeC
Q 024027 72 IFQRLNIMIDVASALEYL-HFGCSAPVIHCDLKPDNVLLD 110 (273)
Q Consensus 72 ~~~~~~~~~ql~~~l~~l-h~~~~~~i~h~di~p~nil~~ 110 (273)
..-++-++.|++--.-.+ ...+..+.+|-||||+|||+-
T Consensus 274 ~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiF 313 (434)
T PF05445_consen 274 VEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIF 313 (434)
T ss_pred HHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEe
Confidence 345667788876544323 233356799999999999983
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 273 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-27 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-26 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-25 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-24 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-23 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-21 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-20 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-19 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-19 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-19 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 7e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-19 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-19 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 9e-19 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-19 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-19 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 9e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 9e-19 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-18 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-18 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-18 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-18 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-18 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-18 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 8e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 9e-18 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-17 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-16 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 9e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 8e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 9e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-14 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-14 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-14 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-14 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-14 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-14 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-14 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-14 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 7e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 8e-14 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 8e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 8e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 8e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 8e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 8e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-13 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-13 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-13 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-13 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-13 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-13 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-13 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-13 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-13 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-13 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-13 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 7e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 7e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 7e-13 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 8e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 9e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-12 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-12 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 8e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-11 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 9e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 9e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-10 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-10 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-10 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-10 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-10 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-10 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-10 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-10 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-10 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 7e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 8e-10 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 8e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 8e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 9e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-10 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-09 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-09 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-09 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-09 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-09 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-09 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-09 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-09 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-09 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-09 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 7e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 8e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-08 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-08 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-08 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-08 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-08 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-08 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-08 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-08 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-08 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-08 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-08 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-08 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-08 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-08 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-08 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-08 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 7e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 7e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 7e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-08 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 7e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 8e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 8e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 8e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 8e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 8e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 8e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 8e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 8e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 8e-08 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-08 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 8e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 9e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 9e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 9e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 9e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 9e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-07 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-07 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-07 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-07 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-07 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-07 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-07 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-07 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-07 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-07 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-07 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-07 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-07 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-07 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-07 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-07 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-07 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-07 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-07 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-07 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-07 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-07 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-07 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-07 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-07 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-07 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-07 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-07 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-07 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 6e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-07 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 6e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 7e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 7e-07 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 7e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 7e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 7e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 7e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 7e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 7e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-07 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 8e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 8e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 8e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 8e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 8e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 8e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 9e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 9e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 9e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 9e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 9e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 9e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 9e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 9e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 9e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-06 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-06 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-06 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-06 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-06 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-06 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-06 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-06 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-06 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-06 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-06 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-06 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-06 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-06 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-06 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-06 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 5e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-06 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-06 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-06 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 6e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 6e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 6e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 7e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 7e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 7e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 7e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 7e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 7e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 7e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 7e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 8e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 8e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 8e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 8e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 8e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 8e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 9e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 9e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 9e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 9e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 9e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-05 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-05 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-05 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-05 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-05 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-05 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 5e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-05 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-05 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-05 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 7e-05 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-05 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-05 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 8e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 8e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 9e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 9e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-04 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-04 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-04 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-04 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-04 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-04 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-04 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-04 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 5e-04 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 6e-04 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-04 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 4e-67
Identities = 79/267 (29%), Positives = 132/267 (49%), Gaps = 17/267 (6%)
Query: 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 60
+VA+K + + + F+ E E + RH +L+ +I C L+ +YM +G+L+
Sbjct: 64 AKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123
Query: 61 KYLYSSN---CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYL 117
++LY S+ + QRL I I A L YLH +IH D+K N+LLD+N V +
Sbjct: 124 RHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKI 180
Query: 118 SDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 177
+DFGI+K DQ+ T T+GY+ PEY +GR++ DVYSFG++L E +
Sbjct: 181 TDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240
Query: 178 T-YEFFNGEMTLKHWVNDWLPIST-MEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTV 235
+ L W + ++VD NL + + K + A+ C
Sbjct: 241 IVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRK------FGDTAVKCLA 294
Query: 236 ESPEQRINAKEIVTKL---LKIRDSLL 259
S E R + +++ KL L++++S++
Sbjct: 295 LSSEDRPSMGDVLWKLEYALRLQESVI 321
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 198 bits (507), Expect = 1e-62
Identities = 81/260 (31%), Positives = 123/260 (47%), Gaps = 19/260 (7%)
Query: 2 EVAVKVFNLQCGRAFKS-FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 60
VAVK + + + F E EM+ HRNL+++ C + LV YM +GS+
Sbjct: 56 LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVA 115
Query: 61 KYLY---SSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYL 117
L S LD +R I + A L YLH C +IH D+K N+LLD+ A +
Sbjct: 116 SCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175
Query: 118 SDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 177
DFG+AKL+ + T TIG++APEY G+ S DV+ +G+ML+E TG++
Sbjct: 176 GDFGLAKLM-DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRA 234
Query: 178 T-YEFFNGE--MTLKHWVNDWLPIST---MEVVDANLLSQEDIHFVAKEQCVSFVFNLAM 231
+ + L WV + +VD +L ++ +E V + +A+
Sbjct: 235 FDLARLANDDDVMLLDWV--KGLLKEKKLEALVDVDLQG----NYKDEE--VEQLIQVAL 286
Query: 232 ACTVESPEQRINAKEIVTKL 251
CT SP +R E+V L
Sbjct: 287 LCTQSSPMERPKMSEVVRML 306
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 1e-57
Identities = 70/264 (26%), Positives = 116/264 (43%), Gaps = 20/264 (7%)
Query: 2 EVAVKVFNLQCGRA----FKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHG 57
VAVK + FD E ++M +H NL++++ S+ + LV YMP+G
Sbjct: 56 TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNG 115
Query: 58 SLEKYLY--SSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVA 115
SL L L R I A+ + +LH IH D+K N+LLD+ A
Sbjct: 116 SLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTA 172
Query: 116 YLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGK 175
+SDFG+A+ Q++ ++ + T YMAPE R G ++ D+YSFG++L+E TG
Sbjct: 173 KISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGL 231
Query: 176 KPTYEFFNGEMTLKHWVNDWL--PISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMAC 233
+ L + + + +D + D + E ++A C
Sbjct: 232 PAV-DEHREPQLLLDIKEEIEDEEKTIEDYIDKKM---NDADSTSVEAMY----SVASQC 283
Query: 234 TVESPEQRINAKEIVTKLLKIRDS 257
E +R + K++ L ++ S
Sbjct: 284 LHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 3e-55
Identities = 56/271 (20%), Positives = 108/271 (39%), Gaps = 21/271 (7%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKA----LVLEYMPHG 57
VAVK+F +Q ++++ + E + ++H N+++ I + L+ + G
Sbjct: 49 YVAVKIFPIQDKQSWQ-NEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKG 107
Query: 58 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLH-------FGCSAPVIHCDLKPDNVLLD 110
SL +L ++ ++ + +I +A L YLH G + H D+K NVLL
Sbjct: 108 SLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK 165
Query: 111 DNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG-----DVYSFG 165
+NL A ++DFG+A + + T YMAPE D+Y+ G
Sbjct: 166 NNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMG 225
Query: 166 IMLMETFTGKKP-TYEFFNGEMTLKHWVNDWLPISTM-EVVDANLLSQEDIHFVAKEQCV 223
++L E + + + + + M EVV + K +
Sbjct: 226 LVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGM 285
Query: 224 SFVFNLAMACTVESPEQRINAKEIVTKLLKI 254
+ + C E R++A + ++ ++
Sbjct: 286 AMLCETIEECWDHDAEARLSAGCVGERITQM 316
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 9e-55
Identities = 68/262 (25%), Positives = 115/262 (43%), Gaps = 26/262 (9%)
Query: 2 EVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
+VAVK+ Q F E +MK +RH N++ + + + ++V EY+ GSL
Sbjct: 62 DVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSL 121
Query: 60 EKYLYSSNCI--LDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYL 117
+ L+ S LD +RL++ DVA + YLH + P++H +LK N+L+D +
Sbjct: 122 YRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKV 180
Query: 118 SDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 177
DFG+++L S T +MAPE R+ + DVYSFG++L E T ++P
Sbjct: 181 CDFGLSRLKASTFLSS--KSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238
Query: 178 TYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237
+ ++ +VV A + + V + C
Sbjct: 239 ----WGN-------------LNPAQVVAA--VGFKCKRLEIPRNLNPQVAAIIEGCWTNE 279
Query: 238 PEQRINAKEIVTKLLKIRDSLL 259
P +R + I+ L + S +
Sbjct: 280 PWKRPSFATIMDLLRPLIKSAV 301
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 4e-54
Identities = 61/255 (23%), Positives = 116/255 (45%), Gaps = 24/255 (9%)
Query: 2 EVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
+VAVK+ N+ + ++F E +++ RH N++ + + + A+V ++ SL
Sbjct: 48 DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSL 106
Query: 60 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSD 119
+L++S ++ + ++I A ++YLH + +IH DLK +N+ L ++ + D
Sbjct: 107 YHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGD 163
Query: 120 FGIAKLLIGEDQSMTQTQTLATIGYMAPE---YGREGRVSTNGDVYSFGIMLMETFTGKK 176
FG+A S Q +I +MAPE S DVY+FGI+L E TG+
Sbjct: 164 FGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQL 223
Query: 177 PTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236
P Y + + + +E+V LS + + C + L C +
Sbjct: 224 P-YS----NINNRDQI--------IEMVGRGSLSPDLS--KVRSNCPKRMKRLMAECLKK 268
Query: 237 SPEQRINAKEIVTKL 251
++R + I+ ++
Sbjct: 269 KRDERPSFPRILAEI 283
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 2e-53
Identities = 58/263 (22%), Positives = 108/263 (41%), Gaps = 35/263 (13%)
Query: 2 EVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFK--ALVLEYMPHG 57
++ VKV ++ R + F+ EC ++ H N++ V+ +C + L+ +MP+G
Sbjct: 35 DIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYG 94
Query: 58 SLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAY 116
SL L+ +D Q + +D+A + +LH + L +V++D+++ A
Sbjct: 95 SLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTAR 153
Query: 117 LSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG---DVYSFGIMLMETFT 173
+S + S + ++APE ++ TN D++SF ++L E T
Sbjct: 154 ISMADVKF-------SFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVT 206
Query: 174 GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMAC 233
+ P F +S ME+ ++ E + V L C
Sbjct: 207 REVP----FAD-------------LSNMEIGMK--VALEGLRPTIPPGISPHVSKLMKIC 247
Query: 234 TVESPEQRINAKEIVTKLLKIRD 256
E P +R IV L K++D
Sbjct: 248 MNEDPAKRPKFDMIVPILEKMQD 270
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 5e-53
Identities = 60/270 (22%), Positives = 111/270 (41%), Gaps = 45/270 (16%)
Query: 2 EVAVKVFNLQCGRA-------FKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM 54
VA+K L F+ F E +M ++ H N++K+ N +V+E++
Sbjct: 46 VVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFV 103
Query: 55 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLD---- 110
P G L L + +L +M+D+A +EY+ + P++H DL+ N+ L
Sbjct: 104 PCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDE 162
Query: 111 -DNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPE--YGREGRVSTNGDVYSFGIM 167
+ A ++DFG+++ + + L +MAPE E + D YSF ++
Sbjct: 163 NAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMI 217
Query: 168 LMETFTGKKPTYEFFNGEMTLKHWVNDW---LPISTMEVVDANLLSQEDIHFVAKEQCVS 224
L TG+ P E+ G++ + + + I E C
Sbjct: 218 LYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIP--------------------EDCPP 257
Query: 225 FVFNLAMACTVESPEQRINAKEIVTKLLKI 254
+ N+ C P++R + IV +L ++
Sbjct: 258 RLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 3e-51
Identities = 65/262 (24%), Positives = 104/262 (39%), Gaps = 34/262 (12%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 61
+VA+K + K+F VE + + H N++K+ +C N LV+EY GSL
Sbjct: 33 DVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYN 88
Query: 62 YLYSSN--CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDN-LVAYLS 118
L+ + ++ + + + YLH +IH DLKP N+LL V +
Sbjct: 89 VLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKIC 148
Query: 119 DFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPT 178
DFG A D T + +MAPE S DV+S+GI+L E T +KP
Sbjct: 149 DFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPF 203
Query: 179 YEFFNGEMTLKHWVNDWL--PISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236
E + V++ P+ + + +L C +
Sbjct: 204 DEIGGPAFRIMWAVHNGTRPPLI--------------------KNLPKPIESLMTRCWSK 243
Query: 237 SPEQRINAKEIVTKLLKIRDSL 258
P QR + +EIV + +
Sbjct: 244 DPSQRPSMEEIVKIMTHLMRYF 265
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 1e-50
Identities = 63/265 (23%), Positives = 102/265 (38%), Gaps = 37/265 (13%)
Query: 2 EVAVKVFNLQC----GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHG 57
EVAVK + ++ E ++ ++H N+I + C E LV+E+ G
Sbjct: 32 EVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGG 91
Query: 58 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLD------- 110
L + L + +N + +A + YLH P+IH DLK N+L+
Sbjct: 92 PLNRVLSGKR--IPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGD 149
Query: 111 -DNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLM 169
N + ++DFG+A+ M+ +MAPE R S DV+S+G++L
Sbjct: 150 LSNKILKITDFGLAR-EWHRTTKMSAA---GAYAWMAPEVIRASMFSKGSDVWSYGVLLW 205
Query: 170 ETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNL 229
E TG+ P F G I + V ++ + C L
Sbjct: 206 ELLTGEVP----FRG-------------IDGLAVAYG--VAMNKLALPIPSTCPEPFAKL 246
Query: 230 AMACTVESPEQRINAKEIVTKLLKI 254
C P R + I+ +L I
Sbjct: 247 MEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 1e-50
Identities = 45/267 (16%), Positives = 104/267 (38%), Gaps = 37/267 (13%)
Query: 2 EVAVKVFNLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
EVA+++ +++ K+F E + RH N++ + +C + A++ +L
Sbjct: 57 EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTL 116
Query: 60 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSD 119
+ + +LD+ + I ++ + YLH + ++H DLK NV D+ V ++D
Sbjct: 117 YSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYDNGKVV-ITD 172
Query: 120 FGIAKL---LIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG---------DVYSFGIM 167
FG+ + L + + ++APE R+ T DV++ G +
Sbjct: 173 FGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTI 232
Query: 168 LMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVF 227
E + P ++ + + + + +++ +
Sbjct: 233 WYELHAREWP-FK----TQP---------AEAIIWQMGTGMKPN-----LSQIGMGKEIS 273
Query: 228 NLAMACTVESPEQRINAKEIVTKLLKI 254
++ + C E+R +++ L K+
Sbjct: 274 DILLFCWAFEQEERPTFTKLMDMLEKL 300
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 3e-49
Identities = 63/283 (22%), Positives = 113/283 (39%), Gaps = 37/283 (13%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 61
+ +K ++F E ++M+ + H N++K I ++ + EY+ G+L
Sbjct: 37 VMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRG 96
Query: 62 YLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFG 121
+ S + QR++ D+AS + YLH S +IH DL N L+ +N ++DFG
Sbjct: 97 IIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFG 153
Query: 122 IAKLLIGEDQSMTQTQTLA------------TIGYMAPEYGREGRVSTNGDVYSFGIMLM 169
+A+L++ E ++L +MAPE DV+SFGI+L
Sbjct: 154 LARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLC 213
Query: 170 ETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNL 229
E D+LP + +D L + + C F +
Sbjct: 214 EIIGRVNADP--------------DYLPRT----MDFGLNVRGFLDRYCPPNCPPSFFPI 255
Query: 230 AMACTVESPEQRINAKEIVTKLLKIRDSLLRNVGGRRIRQSNL 272
+ C PE+R + ++ L ++L ++ G L
Sbjct: 256 TVRCCDLDPEKRPSFVKLEHWL----ETLRMHLAGHLPLGPQL 294
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 7e-48
Identities = 60/275 (21%), Positives = 102/275 (37%), Gaps = 21/275 (7%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFK----ALVLEYMPHG 57
+VAVKVF ++ + E +RH N++ I++ L+ +Y +G
Sbjct: 62 KVAVKVFFTTEEASWF-RETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENG 120
Query: 58 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLH-----FGCSAPVIHCDLKPDNVLLDDN 112
SL YL S+ LD L + S L +LH + H DLK N+L+ N
Sbjct: 121 SLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN 178
Query: 113 LVAYLSDFGIAKLLIGEDQSMTQTQTLA--TIGYMAPE------YGREGRVSTNGDVYSF 164
++D G+A I + + T YM PE + D+YSF
Sbjct: 179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSF 238
Query: 165 GIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDI-HFVAKEQCV 223
G++L E ++ V M + + + + ++C+
Sbjct: 239 GLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECL 298
Query: 224 SFVFNLAMACTVESPEQRINAKEIVTKLLKIRDSL 258
+ L C +P R+ A + L K+ +S
Sbjct: 299 RQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 3e-46
Identities = 64/291 (21%), Positives = 102/291 (35%), Gaps = 36/291 (12%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECEMMK--SIRHRNLIKVISSC-----SNEEFKALVLEYM 54
VAVKVF+ ++F E + + + H N+ + I LV+EY
Sbjct: 38 PVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYY 94
Query: 55 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLH------FGCSAPVIHCDLKPDNVL 108
P+GSL KYL D + V L YLH + H DL NVL
Sbjct: 95 PNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVL 152
Query: 109 LDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLA------TIGYMAPEYGRE-------GRV 155
+ ++ +SDFG++ L G + A TI YMAPE
Sbjct: 153 VKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESA 212
Query: 156 STNGDVYSFGIMLMETFTGKKPTYEFFNGE---MTLKHWVNDWLPISTME--VVDANLLS 210
D+Y+ G++ E F + + M + V + M+ V
Sbjct: 213 LKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRP 272
Query: 211 QEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLLKIRDSLLRN 261
+ + V + C + E R+ A+ ++ ++ RN
Sbjct: 273 KFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERN 323
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-45
Identities = 60/275 (21%), Positives = 101/275 (36%), Gaps = 29/275 (10%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKA----LVLEYMPHG 57
VAVK+F+ + +++ + E +RH N++ I+S + L+ Y G
Sbjct: 33 NVAVKIFSSRDEKSWF-RETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMG 91
Query: 58 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLH-----FGCSAPVIHCDLKPDNVLLDDN 112
SL YL LD L I++ +AS L +LH + H DLK N+L+ N
Sbjct: 92 SLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN 149
Query: 113 LVAYLSDFGIAKLLIGEDQSMTQTQTLA--TIGYMAPE------YGREGRVSTNGDVYSF 164
++D G+A + + T YMAPE D+++F
Sbjct: 150 GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAF 209
Query: 165 GIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTME--VVDANL---LSQEDIHFVAK 219
G++L E + + V + M V +
Sbjct: 210 GLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNR----WFS 265
Query: 220 EQCVSFVFNLAMACTVESPEQRINAKEIVTKLLKI 254
+ ++ + L C ++P R+ A I L KI
Sbjct: 266 DPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-42
Identities = 55/275 (20%), Positives = 102/275 (37%), Gaps = 23/275 (8%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKA----LVLEYMPHG 57
EVAVK+F+ + R++ + E +RH N++ I++ + + LV +Y HG
Sbjct: 67 EVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHG 125
Query: 58 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLH-----FGCSAPVIHCDLKPDNVLLDDN 112
SL YL + + + + + AS L +LH + H DLK N+L+ N
Sbjct: 126 SLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 183
Query: 113 LVAYLSDFGIAKLLIGEDQSMTQTQTLA--TIGYMAPE------YGREGRVSTNGDVYSF 164
++D G+A ++ T YMAPE + D+Y+
Sbjct: 184 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM 243
Query: 165 GIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTME--VVDANLLSQEDIHFVAKEQC 222
G++ E + ++ V + M V + L + +
Sbjct: 244 GLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRW-QSCEA 302
Query: 223 VSFVFNLAMACTVESPEQRINAKEIVTKLLKIRDS 257
+ + + C + R+ A I L ++
Sbjct: 303 LRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-38
Identities = 69/264 (26%), Positives = 108/264 (40%), Gaps = 39/264 (14%)
Query: 1 MEVAVKVFNLQCG-RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
VAVK F E ++K H N++++I C+ ++ +V+E + G
Sbjct: 140 TLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 199
Query: 60 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSD 119
+L + L + L ++ D A+ +EYL S IH DL N L+ + V +SD
Sbjct: 200 LTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISD 256
Query: 120 FGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPT 178
FG+++ + + + + APE GR S+ DV+SFGI+L ETF+ G P
Sbjct: 257 FGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASP- 315
Query: 179 YEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAK-------EQCVSFVFNLAM 231
Y ++ + + FV K E C VF L
Sbjct: 316 YP----NLSNQ------------QT----------REFVEKGGRLPCPELCPDAVFRLME 349
Query: 232 ACTVESPEQRINAKEIVTKLLKIR 255
C P QR + I +L IR
Sbjct: 350 QCWAYEPGQRPSFSTIYQELQSIR 373
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-36
Identities = 67/270 (24%), Positives = 113/270 (41%), Gaps = 46/270 (17%)
Query: 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 60
+VA+K + + + F E E+M + H L+++ C + LV E+M HG L
Sbjct: 33 DKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLS 91
Query: 61 KYLYSSNCILDIFQRLNIMIDVASALEYL---HFGCSAPVIHCDLKPDNVLLDDNLVAYL 117
YL + + L + +DV + YL IH DL N L+ +N V +
Sbjct: 92 DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV------IHRDLAARNCLVGENQVIKV 145
Query: 118 SDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKK 176
SDFG+ + + +DQ + T T + + +PE R S+ DV+SFG+++ E F+ GK
Sbjct: 146 SDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 204
Query: 177 PTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAK-------EQCVSFVFNL 229
P YE + E + ++ + V+ +
Sbjct: 205 P-YE----NRSN----------------------SEVVEDISTGFRLYKPRLASTHVYQI 237
Query: 230 AMACTVESPEQRINAKEIVTKLLKIRDSLL 259
C E PE R ++ +L +I +S L
Sbjct: 238 MNHCWRERPEDRPAFSRLLRQLAEIAESGL 267
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-36
Identities = 68/269 (25%), Positives = 118/269 (43%), Gaps = 35/269 (13%)
Query: 2 EVAVKVFNLQCGR--AFKS-FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGS 58
+VA+K + F+ E + H+N++ +I ++ LV+EY+ +
Sbjct: 38 KVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPT 97
Query: 59 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLS 118
L +Y+ S+ L + +N + +++ H ++H D+KP N+L+D N +
Sbjct: 98 LSEYI-ESHGPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIF 153
Query: 119 DFGIAKLLIGEDQSMTQTQT-LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 177
DFGIAK L + S+TQT L T+ Y +PE + D+YS GI+L E G+ P
Sbjct: 154 DFGIAKAL--SETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211
Query: 178 TYEFFNGE----MTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMAC 233
FNGE + +KH + D +P T +V + Q + N+ +
Sbjct: 212 ----FNGETAVSIAIKH-IQDSVPNVTTDVRKD--IPQS-------------LSNVILRA 251
Query: 234 TVESPEQR-INAKEIVTKLLKIRDSLLRN 261
T + R +E+ L + N
Sbjct: 252 TEKDKANRYKTIQEMKDDLSSVLHENRAN 280
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 7e-36
Identities = 62/261 (23%), Positives = 120/261 (45%), Gaps = 10/261 (3%)
Query: 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKA--LVLEYMPHGS 58
VAVK + F+ E E++KS++H N++K C + + L++EY+P+GS
Sbjct: 40 EVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGS 99
Query: 59 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLS 118
L YL +D + L + +EYL + IH DL N+L+++ +
Sbjct: 100 LRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIG 156
Query: 119 DFGIAKLLI-GEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 177
DFG+ K+L ++ + + I + APE E + S DV+SFG++L E FT +
Sbjct: 157 DFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK 216
Query: 178 TYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237
+ M + + +++ L + + + C ++ + C +
Sbjct: 217 SKSPPAEFMRMIGNDKQG-QMIVFHLIE---LLKNNGRLPRPDGCPDEIYMIMTECWNNN 272
Query: 238 PEQRINAKEIVTKLLKIRDSL 258
QR + +++ ++ +IRD++
Sbjct: 273 VNQRPSFRDLALRVDQIRDNM 293
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-35
Identities = 62/261 (23%), Positives = 119/261 (45%), Gaps = 10/261 (3%)
Query: 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKA--LVLEYMPHGS 58
VAVK + F+ E E++KS++H N++K C + + L++EY+P+GS
Sbjct: 71 EVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGS 130
Query: 59 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLS 118
L YL +D + L + +EYL + IH DL N+L+++ +
Sbjct: 131 LRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIG 187
Query: 119 DFGIAKLLI-GEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 177
DFG+ K+L ++ + + I + APE E + S DV+SFG++L E FT +
Sbjct: 188 DFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK 247
Query: 178 TYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237
+ M + + +++ L + + + C ++ + C +
Sbjct: 248 SKSPPAEFMRMIGNDKQG-QMIVFHLIE---LLKNNGRLPRPDGCPDEIYMIMTECWNNN 303
Query: 238 PEQRINAKEIVTKLLKIRDSL 258
QR + +++ ++ +IRD +
Sbjct: 304 VNQRPSFRDLALRVDQIRDQM 324
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-35
Identities = 63/274 (22%), Positives = 114/274 (41%), Gaps = 42/274 (15%)
Query: 1 MEVAVKVFNLQCG--RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKA-----LVLEY 53
++VAVK L R + F E MK H N+I+++ C + ++L +
Sbjct: 63 LKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPF 122
Query: 54 MPHGSLEKYL-----YSSNCILDIFQRLNIMIDVASALEYL---HFGCSAPVIHCDLKPD 105
M +G L YL + + + L M+D+A +EYL +F +H DL
Sbjct: 123 MKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNF------LHRDLAAR 176
Query: 106 NVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFG 165
N +L D++ ++DFG++K + D + ++A E + ++ DV++FG
Sbjct: 177 NCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFG 236
Query: 166 IMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVS 224
+ + E T G P N EM + ++ + L Q E C+
Sbjct: 237 VTMWEIATRGMTPYPGVQNHEM-YDY------------LLHGHRLKQ-------PEDCLD 276
Query: 225 FVFNLAMACTVESPEQRINAKEIVTKLLKIRDSL 258
++ + +C P R + +L K+ +SL
Sbjct: 277 ELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-35
Identities = 66/256 (25%), Positives = 111/256 (43%), Gaps = 27/256 (10%)
Query: 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 60
+ VAVK + + F E +MK I+H NL++++ C+ E ++ E+M +G+L
Sbjct: 246 LTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 304
Query: 61 KYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSD 119
YL N + L + ++SA+EYL IH +L N L+ +N + ++D
Sbjct: 305 DYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVAD 361
Query: 120 FGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPT 178
FG+++ L+ D I + APE + S DV++FG++L E T G P
Sbjct: 362 FGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP- 419
Query: 179 YEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238
Y + L +V + ++D E C V+ L AC +P
Sbjct: 420 YP----GIDLS------------QVYEL---LEKDYRMERPEGCPEKVYELMRACWQWNP 460
Query: 239 EQRINAKEIVTKLLKI 254
R + EI +
Sbjct: 461 SDRPSFAEIHQAFETM 476
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-35
Identities = 47/182 (25%), Positives = 88/182 (48%), Gaps = 12/182 (6%)
Query: 1 MEVAVKVFNLQCG-RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
+ V +KV + G ++F++ + S+ H ++++++ C + LV +Y+P GSL
Sbjct: 43 IPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSL 101
Query: 60 EKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGCSAPVIHCDLKPDNVLLDDNLVAY 116
++ L LN + +A + YL +H +L NVLL
Sbjct: 102 LDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGM------VHRNLAARNVLLKSPSQVQ 155
Query: 117 LSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GK 175
++DFG+A LL +D+ + ++ I +MA E G+ + DV+S+G+ + E T G
Sbjct: 156 VADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGA 215
Query: 176 KP 177
+P
Sbjct: 216 EP 217
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 4e-35
Identities = 73/276 (26%), Positives = 121/276 (43%), Gaps = 45/276 (16%)
Query: 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 60
M VAVK A K F E E++ +++H +++K C + + +V EYM HG L
Sbjct: 46 MLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLN 105
Query: 61 KYL---------------YSSNCILDIFQRLNIMIDVASALEYL---HFGCSAPVIHCDL 102
K+L + L + Q L+I +AS + YL HF +H DL
Sbjct: 106 KFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHF------VHRDL 159
Query: 103 KPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVY 162
N L+ NL+ + DFG+++ + D T+ I +M PE + +T DV+
Sbjct: 160 ATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVW 219
Query: 163 SFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQ 221
SFG++L E FT GK+P + + ++ + +L +
Sbjct: 220 SFGVILWEIFTYGKQP-WFQLSNTEVIEC------------ITQGRVLER-------PRV 259
Query: 222 CVSFVFNLAMACTVESPEQRINAKEIVTKLLKIRDS 257
C V+++ + C P+QR+N KEI L + +
Sbjct: 260 CPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGKA 295
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-35
Identities = 58/275 (21%), Positives = 112/275 (40%), Gaps = 48/275 (17%)
Query: 1 MEVAVKVFNLQCG-RAFKSFDVECEMMKSIRHRNLIKVISSCSNEE-FKALVLEYMPHGS 58
++ A+K + + ++F E +M+ + H N++ +I E ++L YM HG
Sbjct: 50 IQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGD 109
Query: 59 LEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGCSAPVIHCDLKPDNVLLDDNLVA 115
L +++ S + ++ + VA +EYL F +H DL N +LD++
Sbjct: 110 LLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKF------VHRDLAARNCMLDESFTV 163
Query: 116 YLSDFGIAKLLIGED--QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 173
++DFG+A+ ++ + + + A E + R +T DV+SFG++L E T
Sbjct: 164 KVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223
Query: 174 -GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAK-------EQCVSF 225
G P ++ HF+A+ E C
Sbjct: 224 RGAPPYRHIDPFDL---------------------------THFLAQGRRLPQPEYCPDS 256
Query: 226 VFNLAMACTVESPEQRINAKEIVTKLLKIRDSLLR 260
++ + C P R + +V ++ +I +LL
Sbjct: 257 LYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-35
Identities = 58/273 (21%), Positives = 107/273 (39%), Gaps = 48/273 (17%)
Query: 1 MEVAVKVFNLQCG-RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKAL-VLEYMPHGS 58
+ AVK N F E +MK H N++ ++ C E L VL YM HG
Sbjct: 54 IHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGD 113
Query: 59 LEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGCSAPVIHCDLKPDNVLLDDNLVA 115
L ++ + + + + VA ++YL F +H DL N +LD+
Sbjct: 114 LRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKF------VHRDLAARNCMLDEKFTV 167
Query: 116 YLSDFGIAKLLIGED--QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 173
++DFG+A+ + ++ +T + +MA E + + +T DV+SFG++L E T
Sbjct: 168 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227
Query: 174 -GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAK-------EQCVSF 225
G P + ++ ++ + E C
Sbjct: 228 RGAPPYPDVNTFDI---------------------------TVYLLQGRRLLQPEYCPDP 260
Query: 226 VFNLAMACTVESPEQRINAKEIVTKLLKIRDSL 258
++ + + C E R + E+V+++ I +
Sbjct: 261 LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 7e-35
Identities = 57/273 (20%), Positives = 110/273 (40%), Gaps = 34/273 (12%)
Query: 1 MEVAVKVFNLQCG-RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKA--LVLEYMPHG 57
+VAVK + G E E+++++ H N++K C+ + L++E++P G
Sbjct: 51 EQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSG 110
Query: 58 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYL 117
SL++YL + +++ Q+L + + ++YL S +H DL NVL++ +
Sbjct: 111 SLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKI 167
Query: 118 SDFGIAKLLIGEDQSMTQTQTLAT--IGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-G 174
DFG+ K I D+ + + + APE + + DV+SFG+ L E T
Sbjct: 168 GDFGLTK-AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYC 226
Query: 175 KKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAK-------EQCVSFVF 227
+ + M V ++ + + C V+
Sbjct: 227 DSDSSPMALFLKMIGP------THGQMTVTRL-------VNTLKEGKRLPCPPNCPDEVY 273
Query: 228 NLAMACTVESPEQRINAKEIVTKLLKIRDSLLR 260
L C P R + + ++ ++LL+
Sbjct: 274 QLMRKCWEFQPSNRTSFQNLIEGF----EALLK 302
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 7e-35
Identities = 67/263 (25%), Positives = 115/263 (43%), Gaps = 42/263 (15%)
Query: 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 60
VA+K + ++F E ++MK +RH L+++ + S E +V EYM GSL
Sbjct: 292 TRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLL 349
Query: 61 KYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSD 119
+L L + Q +++ +AS + Y+ +H DL+ N+L+ +NLV ++D
Sbjct: 350 DFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVAD 406
Query: 120 FGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPT 178
FG+A+L I +++ + I + APE GR + DV+SFGI+L E T G+ P
Sbjct: 407 FGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP- 464
Query: 179 YEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAK-------EQCVSFVFNLAM 231
Y M +E + V + +C + +L
Sbjct: 465 YP----GMVN----------------------REVLDQVERGYRMPCPPECPESLHDLMC 498
Query: 232 ACTVESPEQRINAKEIVTKLLKI 254
C + PE+R + + L
Sbjct: 499 QCWRKEPEERPTFEYLQAFLEDY 521
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 7e-35
Identities = 65/268 (24%), Positives = 102/268 (38%), Gaps = 34/268 (12%)
Query: 1 MEVAVKVFN---LQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHG 57
+ VAVK L A F E M S+ HRNLI++ K +V E P G
Sbjct: 47 VSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLG 105
Query: 58 SLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGCSAPVIHCDLKPDNVLLDDNLV 114
SL L + + VA + YL F IH DL N+LL +
Sbjct: 106 SLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF------IHRDLAARNLLLATRDL 159
Query: 115 AYLSDFGIAKLLIGEDQSMTQTQ-TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 173
+ DFG+ + L D + + APE + S D + FG+ L E FT
Sbjct: 160 VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219
Query: 174 -GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMA 232
G++P W+ ++ +++ + +E E C ++N+ +
Sbjct: 220 YGQEP-----------------WIGLNGSQILHK--IDKEGERLPRPEDCPQDIYNVMVQ 260
Query: 233 CTVESPEQRINAKEIVTKLLKIRDSLLR 260
C PE R + LL+ + + +R
Sbjct: 261 CWAHKPEDRPTFVALRDFLLEAQPTDMR 288
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-34
Identities = 47/182 (25%), Positives = 79/182 (43%), Gaps = 12/182 (6%)
Query: 1 MEVAVKVFNLQCG-RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
+ VA+K +A K E +M S+ + ++ +++ C + L+ + MP G L
Sbjct: 45 IPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCL 103
Query: 60 EKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGCSAPVIHCDLKPDNVLLDDNLVAY 116
Y+ + LN + +A + YL +H DL NVL+
Sbjct: 104 LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL------VHRDLAARNVLVKTPQHVK 157
Query: 117 LSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GK 175
++DFG+AKLL E++ I +MA E + DV+S+G+ + E T G
Sbjct: 158 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 217
Query: 176 KP 177
KP
Sbjct: 218 KP 219
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-34
Identities = 61/275 (22%), Positives = 114/275 (41%), Gaps = 43/275 (15%)
Query: 1 MEVAVKVFNLQCG--RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKA------LVLE 52
++VAVK+ + F E MK H ++ K++ K ++L
Sbjct: 52 VKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILP 111
Query: 53 YMPHGSLEKYLYSS-----NCILDIFQRLNIMIDVASALEYL---HFGCSAPVIHCDLKP 104
+M HG L +L +S L + + M+D+A +EYL +F IH DL
Sbjct: 112 FMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNF------IHRDLAA 165
Query: 105 DNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSF 164
N +L +++ ++DFG+++ + D + + ++A E + + + DV++F
Sbjct: 166 RNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAF 225
Query: 165 GIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCV 223
G+ + E T G+ P N E+ + ++ N L Q +C+
Sbjct: 226 GVTMWEIMTRGQTPYAGIENAEI-YNY------------LIGGNRLKQ-------PPECM 265
Query: 224 SFVFNLAMACTVESPEQRINAKEIVTKLLKIRDSL 258
V++L C P+QR + + +L I L
Sbjct: 266 EEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-34
Identities = 59/268 (22%), Positives = 114/268 (42%), Gaps = 46/268 (17%)
Query: 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 60
+VA+K+ + + F E ++M ++ H L+++ C+ + ++ EYM +G L
Sbjct: 49 YDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 107
Query: 61 KYLYSSNCILDIFQRLNIMIDVASALEYL---HFGCSAPVIHCDLKPDNVLLDDNLVAYL 117
YL Q L + DV A+EYL F +H DL N L++D V +
Sbjct: 108 NYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF------LHRDLAARNCLVNDQGVVKV 161
Query: 118 SDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKK 176
SDFG+++ + +D+ + + + + PE + S+ D+++FG+++ E ++ GK
Sbjct: 162 SDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKM 220
Query: 177 PTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAK-------EQCVSFVFNL 229
P YE T E +A+ V+ +
Sbjct: 221 P-YE----RFTN----------------------SETAEHIAQGLRLYRPHLASEKVYTI 253
Query: 230 AMACTVESPEQRINAKEIVTKLLKIRDS 257
+C E ++R K +++ +L + D
Sbjct: 254 MYSCWHEKADERPTFKILLSNILDVMDE 281
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-34
Identities = 58/275 (21%), Positives = 109/275 (39%), Gaps = 48/275 (17%)
Query: 1 MEVAVKVFNLQCG-RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKAL-VLEYMPHGS 58
+ AVK N F E +MK H N++ ++ C E L VL YM HG
Sbjct: 118 IHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGD 177
Query: 59 LEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGCSAPVIHCDLKPDNVLLDDNLVA 115
L ++ + + + + VA +++L F +H DL N +LD+
Sbjct: 178 LRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF------VHRDLAARNCMLDEKFTV 231
Query: 116 YLSDFGIAKLLIGEDQSMTQTQTLAT--IGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 173
++DFG+A+ + ++ +T A + +MA E + + +T DV+SFG++L E T
Sbjct: 232 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291
Query: 174 -GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAK-------EQCVSF 225
G P + ++ ++ + E C
Sbjct: 292 RGAPPYPDVNTFDI---------------------------TVYLLQGRRLLQPEYCPDP 324
Query: 226 VFNLAMACTVESPEQRINAKEIVTKLLKIRDSLLR 260
++ + + C E R + E+V+++ I + +
Sbjct: 325 LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-34
Identities = 64/263 (24%), Positives = 115/263 (43%), Gaps = 42/263 (15%)
Query: 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 60
+VAVK + ++F E +MK+++H L+K+ + + E ++ E+M GSL
Sbjct: 213 TKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPI-YIITEFMAKGSLL 270
Query: 61 KYLYSS-NCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSD 119
+L S + + ++ +A + ++ IH DL+ N+L+ +LV ++D
Sbjct: 271 DFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIAD 327
Query: 120 FGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPT 178
FG+A+ +I +++ + I + APE G + DV+SFGI+LME T G+ P
Sbjct: 328 FGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP- 385
Query: 179 YEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAK-------EQCVSFVFNLAM 231
Y M+ E I + + E C ++N+ M
Sbjct: 386 YP----GMSN----------------------PEVIRALERGYRMPRPENCPEELYNIMM 419
Query: 232 ACTVESPEQRINAKEIVTKLLKI 254
C PE+R + I + L
Sbjct: 420 RCWKNRPEERPTFEYIQSVLDDF 442
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-34
Identities = 67/263 (25%), Positives = 115/263 (43%), Gaps = 42/263 (15%)
Query: 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 60
VA+K + ++F E ++MK +RH L+++ + S E +V EYM GSL
Sbjct: 209 TRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLL 266
Query: 61 KYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSD 119
+L L + Q +++ +AS + Y+ +H DL+ N+L+ +NLV ++D
Sbjct: 267 DFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVAD 323
Query: 120 FGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPT 178
FG+A+L I +++ + I + APE GR + DV+SFGI+L E T G+ P
Sbjct: 324 FGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP- 381
Query: 179 YEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAK-------EQCVSFVFNLAM 231
Y M +E + V + +C + +L
Sbjct: 382 YP----GMVN----------------------REVLDQVERGYRMPCPPECPESLHDLMC 415
Query: 232 ACTVESPEQRINAKEIVTKLLKI 254
C + PE+R + + L
Sbjct: 416 QCWRKEPEERPTFEYLQAFLEDY 438
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-34
Identities = 67/267 (25%), Positives = 116/267 (43%), Gaps = 46/267 (17%)
Query: 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 60
+VAVK+ + + F E + M + H L+K CS E +V EY+ +G L
Sbjct: 33 YDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLL 91
Query: 61 KYLYSSNCILDIFQRLNIMIDVASALEYL---HFGCSAPVIHCDLKPDNVLLDDNLVAYL 117
YL S L+ Q L + DV + +L F IH DL N L+D +L +
Sbjct: 92 NYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF------IHRDLAARNCLVDRDLCVKV 145
Query: 118 SDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKK 176
SDFG+ + + +DQ ++ T + + APE + S+ DV++FGI++ E F+ GK
Sbjct: 146 SDFGMTR-YVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKM 204
Query: 177 PTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAK-------EQCVSFVFNL 229
P Y+ T E + V++ ++ +
Sbjct: 205 P-YD----LYTN----------------------SEVVLKVSQGHRLYRPHLASDTIYQI 237
Query: 230 AMACTVESPEQRINAKEIVTKLLKIRD 256
+C E PE+R +++++ + +R+
Sbjct: 238 MYSCWHELPEKRPTFQQLLSSIEPLRE 264
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-34
Identities = 67/275 (24%), Positives = 115/275 (41%), Gaps = 44/275 (16%)
Query: 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 60
M VAVK A + F E E++ ++H+++++ C+ +V EYM HG L
Sbjct: 72 MLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLN 131
Query: 61 KYLYSS--------------NCILDIFQRLNIMIDVASALEYL---HFGCSAPVIHCDLK 103
++L S L + Q L + VA+ + YL HF +H DL
Sbjct: 132 RFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHF------VHRDLA 185
Query: 104 PDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYS 163
N L+ LV + DFG+++ + D +T+ I +M PE + +T DV+S
Sbjct: 186 TRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWS 245
Query: 164 FGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQC 222
FG++L E FT GK+P + + + + L + C
Sbjct: 246 FGVVLWEIFTYGKQP-WYQLSNTEAIDC------------ITQGRELER-------PRAC 285
Query: 223 VSFVFNLAMACTVESPEQRINAKEIVTKLLKIRDS 257
V+ + C P+QR + K++ +L + +
Sbjct: 286 PPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-34
Identities = 63/277 (22%), Positives = 105/277 (37%), Gaps = 31/277 (11%)
Query: 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKA--LVLEYMPHGS 58
VAVK + F E +++K++ ++K ++ LV+EY+P G
Sbjct: 53 ALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGC 112
Query: 59 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLS 118
L +L LD + L + +EYL S +H DL N+L++ ++
Sbjct: 113 LRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIA 169
Query: 119 DFGIAKLL-IGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKK 176
DFG+AKLL + +D + + + I + APE + S DV+SFG++L E FT K
Sbjct: 170 DFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDK 229
Query: 177 PTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAK-------EQCVSFVFNL 229
+ M + + + C + V L
Sbjct: 230 S-------------CSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHEL 276
Query: 230 AMACTVESPEQRINAKEIVTKLLKIRDSLLRNVGGRR 266
C SP+ R + + +L D L G
Sbjct: 277 MKLCWAPSPQDRPSFSALGPQL----DMLWSGSRGCE 309
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 5e-34
Identities = 47/196 (23%), Positives = 84/196 (42%), Gaps = 17/196 (8%)
Query: 2 EVAVKVFNLQCGR--AFKS-FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGS 58
VA+K+ + F++ E ++ +++ + + + + +
Sbjct: 61 IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVD 120
Query: 59 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLS 118
L L L + + I+ + SAL+ H +A H D+KP+N+L+ + AYL
Sbjct: 121 LAAML-RRQGPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLV 176
Query: 119 DFGIAKLLIGEDQSMTQTQT-LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 177
DFGIA D+ +TQ + T+ YMAPE E + D+Y+ +L E TG P
Sbjct: 177 DFGIASAT--TDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234
Query: 178 TYEFFNGE---MTLKH 190
+ G+ + H
Sbjct: 235 ----YQGDQLSVMGAH 246
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 5e-34
Identities = 58/273 (21%), Positives = 117/273 (42%), Gaps = 34/273 (12%)
Query: 1 MEVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
VA+K N R F E +MK ++++++ S + +++E M G L
Sbjct: 56 TRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDL 115
Query: 60 EKYL---------YSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLD 110
+ YL + + + + ++A + YL+ + +H DL N ++
Sbjct: 116 KSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVA 172
Query: 111 DNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLME 170
++ + DFG+ + + D + L + +M+PE ++G +T DV+SFG++L E
Sbjct: 173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE 232
Query: 171 TFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNL 229
T ++P Y+ + E L+ V++ LL + + C +F L
Sbjct: 233 IATLAEQP-YQGLSNEQVLRF------------VMEGGLLDK-------PDNCPDMLFEL 272
Query: 230 AMACTVESPEQRINAKEIVTKLLKIRDSLLRNV 262
C +P+ R + EI++ + + + R V
Sbjct: 273 MRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 305
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 5e-34
Identities = 75/268 (27%), Positives = 117/268 (43%), Gaps = 47/268 (17%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKA-LVLEYMPHGSLE 60
+VAVK ++ ++F E +M +RH NL++++ E+ +V EYM GSL
Sbjct: 218 KVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 275
Query: 61 KYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSD 119
YL S +L L +DV A+EYL +H DL NVL+ ++ VA +SD
Sbjct: 276 DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSD 332
Query: 120 FGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPT 178
FG+ K + S TQ + + APE RE + ST DV+SFGI+L E ++ G+ P
Sbjct: 333 FGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP- 386
Query: 179 YEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAK-------EQCVSFVFNLAM 231
Y + L ++ + V K + C V+++
Sbjct: 387 YP----RIPL----------------------KDVVPRVEKGYKMDAPDGCPPAVYDVMK 420
Query: 232 ACTVESPEQRINAKEIVTKLLKIRDSLL 259
C R ++ +L IR L
Sbjct: 421 NCWHLDAATRPTFLQLREQLEHIRTHEL 448
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 6e-34
Identities = 59/262 (22%), Positives = 102/262 (38%), Gaps = 42/262 (16%)
Query: 2 EVAVKVFNL--QCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKA----LVLEYMP 55
EVA + F E EM+K ++H N+++ S + LV E M
Sbjct: 53 EVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMT 112
Query: 56 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNL-V 114
G+L+ YL ++ I + + L++LH + P+IH DLK DN+ +
Sbjct: 113 SGTLKTYL-KRFKVMKIKVLRSWCRQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGS 170
Query: 115 AYLSDFGIAKLLIGEDQSMTQTQTLATIG---YMAPEYGREGRVSTNGDVYSFGIMLMET 171
+ D G+A L + A IG +MAPE E + DVY+FG+ ++E
Sbjct: 171 VKIGDLGLATL-------KRASFAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEM 222
Query: 172 FTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAM 231
T + P Y + V + ++ + + E +
Sbjct: 223 ATSEYP-YSECQNAAQIYRRVTSGVKPASFD----KVAIPEVKEIIEG------------ 265
Query: 232 ACTVESPEQRINAKEIVTKLLK 253
C ++ ++R + K+ LL
Sbjct: 266 -CIRQNKDERYSIKD----LLN 282
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 7e-34
Identities = 60/271 (22%), Positives = 106/271 (39%), Gaps = 40/271 (14%)
Query: 1 MEVAVKVFNLQCG-RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
++VAVK C + F +E ++ H+N+++ I + +++E M G L
Sbjct: 61 LQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDL 120
Query: 60 EKYLYSS------NCILDIFQRLNIMIDVASALEYL---HFGCSAPVIHCDLKPDNVLLD 110
+ +L + L + L++ D+A +YL HF IH D+ N LL
Sbjct: 121 KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHF------IHRDIAARNCLLT 174
Query: 111 ---DNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIM 167
VA + DFG+A+ + + + +M PE EG ++ D +SFG++
Sbjct: 175 CPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 234
Query: 168 LMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFV 226
L E F+ G P Y + + L+ V + + C V
Sbjct: 235 LWEIFSLGYMP-YPSKSNQEVLEF------------VTSGGRMDP-------PKNCPGPV 274
Query: 227 FNLAMACTVESPEQRINAKEIVTKLLKIRDS 257
+ + C PE R N I+ ++
Sbjct: 275 YRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-33
Identities = 62/267 (23%), Positives = 117/267 (43%), Gaps = 46/267 (17%)
Query: 1 MEVAVKVFNLQCG-RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
+ VA+K + F E +M H N+I++ S + ++ EYM +G+L
Sbjct: 74 VPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGAL 133
Query: 60 EKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGCSAPVIHCDLKPDNVLLDDNLVAY 116
+K+L + + Q + ++ +A+ ++YL ++ +H DL N+L++ NLV
Sbjct: 134 DKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNY------VHRDLAARNILVNSNLVCK 187
Query: 117 LSDFGIAKLLIGEDQSMTQTQ-TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-G 174
+SDFG++++L + ++ T I + APE + ++ DV+SFGI++ E T G
Sbjct: 188 VSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYG 247
Query: 175 KKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAK-------EQCVSFVF 227
++P Y N E + + C S ++
Sbjct: 248 ERP-YW---------ELSN-----------------HEVMKAINDGFRLPTPMDCPSAIY 280
Query: 228 NLAMACTVESPEQRINAKEIVTKLLKI 254
L M C + +R +IV+ L K+
Sbjct: 281 QLMMQCWQQERARRPKFADIVSILDKL 307
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-33
Identities = 64/274 (23%), Positives = 121/274 (44%), Gaps = 50/274 (18%)
Query: 1 MEVAVKVFNLQCG-RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
+ VA+K + + + F E +M H N+I++ + + +V EYM +GSL
Sbjct: 74 ISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL 133
Query: 60 EKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGCSAPVIHCDLKPDNVLLDDNLVAY 116
+ +L + + Q + ++ +AS ++YL + +H DL N+L++ NLV
Sbjct: 134 DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY------VHRDLAARNILINSNLVCK 187
Query: 117 LSDFGIAKLL-IGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-G 174
+SDFG+ ++L + + T I + +PE + ++ DV+S+GI+L E + G
Sbjct: 188 VSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 175 KKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAK-------EQCVSFVF 227
++P +E N Q+ I V + C + ++
Sbjct: 248 ERPYWEMSN---------------------------QDVIKAVDEGYRLPPPMDCPAALY 280
Query: 228 NLAMACTVESPEQRINAKEIVTKLLKIRDSLLRN 261
L + C + R ++IV+ L D L+RN
Sbjct: 281 QLMLDCWQKDRNNRPKFEQIVSIL----DKLIRN 310
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-33
Identities = 65/270 (24%), Positives = 116/270 (42%), Gaps = 38/270 (14%)
Query: 2 EVAVKV--FNLQCGRAFKS-FDVECEMMKSIRHRNLIKVISSCSNEEFKA----LVLEYM 54
+VAVKV +L +F F E + ++ H ++ V + E +V+EY+
Sbjct: 39 DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 98
Query: 55 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLV 114
+L + + + + + ++ D AL + H +IH D+KP N+++
Sbjct: 99 DGVTLRDIV-HTEGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNA 154
Query: 115 AYLSDFGIAKLLIGEDQSMTQTQT-LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 173
+ DFGIA+ + S+TQT + T Y++PE R V DVYS G +L E T
Sbjct: 155 VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 214
Query: 174 GKKPTYEFFNGE----MTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNL 229
G+ P F G+ + +H V + PI + LS + + +
Sbjct: 215 GEPP----FTGDSPVSVAYQH-VRE-DPIPPSARHEG--LSAD-------------LDAV 253
Query: 230 AMACTVESPEQR-INAKEIVTKLLKIRDSL 258
+ ++PE R A E+ L+++ +
Sbjct: 254 VLKALAKNPENRYQTAAEMRADLVRVHNGE 283
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-33
Identities = 60/269 (22%), Positives = 110/269 (40%), Gaps = 30/269 (11%)
Query: 1 MEVAVKVFNLQCG-RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKA--LVLEYMPHG 57
VAVK G + + E ++++++ H ++IK C + + LV+EY+P G
Sbjct: 61 EMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLG 120
Query: 58 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYL 117
SL YL + + + Q L + + YLH + IH DL NVLLD++ + +
Sbjct: 121 SLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKI 175
Query: 118 SDFGIAKLL-IGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GK 175
DFG+AK + G + + + + + APE +E + DV+SFG+ L E T
Sbjct: 176 GDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCD 235
Query: 176 KPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAK-------EQCVSFVFN 228
+ + M V+ + + ++C + V++
Sbjct: 236 SSQSPPTKFLELIG------IAQGQMTVLRL-------TELLERGERLPRPDKCPAEVYH 282
Query: 229 LAMACTVESPEQRINAKEIVTKLLKIRDS 257
L C R + ++ L + +
Sbjct: 283 LMKNCWETEASFRPTFENLIPILKTVHEK 311
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-33
Identities = 70/274 (25%), Positives = 117/274 (42%), Gaps = 50/274 (18%)
Query: 1 MEVAVKVFNLQCG-RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
+ VA+K R + F E +M H N+I++ + +V EYM +GSL
Sbjct: 78 VPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL 137
Query: 60 EKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGCSAPVIHCDLKPDNVLLDDNLVAY 116
+ +L + + I Q + ++ V + + YL + +H DL NVL+D NLV
Sbjct: 138 DTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY------VHRDLAARNVLVDSNLVCK 191
Query: 117 LSDFGIAKLLIG-EDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-G 174
+SDFG++++L D + T T I + APE S+ DV+SFG+++ E G
Sbjct: 192 VSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYG 251
Query: 175 KKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAK-------EQCVSFVF 227
++P Y MT ++ I V + C +
Sbjct: 252 ERP-YW----NMTN----------------------RDVISSVEEGYRLPAPMGCPHALH 284
Query: 228 NLAMACTVESPEQRINAKEIVTKLLKIRDSLLRN 261
L + C + QR +IV+ L D+L+R+
Sbjct: 285 QLMLDCWHKDRAQRPRFSQIVSVL----DALIRS 314
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-33
Identities = 61/284 (21%), Positives = 113/284 (39%), Gaps = 51/284 (17%)
Query: 1 MEVAVKVFNLQCGRAFKS---FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHG 57
++VA+KV L+ G E ++M + + ++++I C E LV+E G
Sbjct: 38 IDVAIKV--LKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGG 94
Query: 58 SLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGCSAPVIHCDLKPDNVLLDDNLV 114
L K+L + + ++ V+ ++YL +F +H DL NVLL +
Sbjct: 95 PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF------VHRDLAARNVLLVNRHY 148
Query: 115 AYLSDFGIAKLL-IGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 173
A +SDFG++K L + ++ + + APE + S+ DV+S+G+ + E +
Sbjct: 149 AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 208
Query: 174 -GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAK-------EQCVSF 225
G+KP Y+ G E + F+ + +C
Sbjct: 209 YGQKP-YKKMKG--------------------------PEVMAFIEQGKRMECPPECPPE 241
Query: 226 VFNLAMACTVESPEQRINAKEIVTKLLKIRDSLLRNVGGRRIRQ 269
++ L C + E R + + ++ SL V G
Sbjct: 242 LYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHHHHH 285
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-33
Identities = 61/271 (22%), Positives = 106/271 (39%), Gaps = 40/271 (14%)
Query: 1 MEVAVKVFNLQCG-RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
++VAVK C + F +E ++ H+N+++ I + ++LE M G L
Sbjct: 102 LQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDL 161
Query: 60 EKYLYSS------NCILDIFQRLNIMIDVASALEYL---HFGCSAPVIHCDLKPDNVLLD 110
+ +L + L + L++ D+A +YL HF IH D+ N LL
Sbjct: 162 KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHF------IHRDIAARNCLLT 215
Query: 111 ---DNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIM 167
VA + DFG+A+ + + + +M PE EG ++ D +SFG++
Sbjct: 216 CPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 275
Query: 168 LMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFV 226
L E F+ G P Y + + L+ V + + C V
Sbjct: 276 LWEIFSLGYMP-YPSKSNQEVLEF------------VTSGGRMDP-------PKNCPGPV 315
Query: 227 FNLAMACTVESPEQRINAKEIVTKLLKIRDS 257
+ + C PE R N I+ ++
Sbjct: 316 YRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-33
Identities = 37/191 (19%), Positives = 75/191 (39%), Gaps = 26/191 (13%)
Query: 2 EVAVKVFNLQCGRAFKS-FDVECEMMKSIRHRNLIKVI-----SSCSNEEFKALVLEYMP 55
V +K ++ E + + + H +++++ + + +V+EY+
Sbjct: 108 PVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVG 167
Query: 56 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVA 115
SL++ L + + + ++++ AL YLH S +++ DLKP+N++L + +
Sbjct: 168 GQSLKRSKGQK---LPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEEQL- 220
Query: 116 YLSDFGIAKLLIGEDQSMTQTQT-LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTG 174
L D G + T G+ APE R + D+Y+ G L
Sbjct: 221 KLIDLGAVS-------RINSFGYLYGTPGFQAPEIVR-TGPTVATDIYTVGRTLAALTLD 272
Query: 175 KKPTYEFFNGE 185
NG
Sbjct: 273 LPT----RNGR 279
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-33
Identities = 71/282 (25%), Positives = 114/282 (40%), Gaps = 49/282 (17%)
Query: 1 MEVAVKVFNLQCGRAFKS-FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
+ VAVK L+ F E +MK I+H NL++++ C+ E ++ E+M +G+L
Sbjct: 39 LTVAVKT--LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 96
Query: 60 EKYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLS 118
YL N + L + ++SA+EYL IH DL N L+ +N + ++
Sbjct: 97 LDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVA 153
Query: 119 DFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 177
DFG+++ L+ D I + APE + S DV++FG++L E T G P
Sbjct: 154 DFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212
Query: 178 TYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAK-------EQCVSFVFNLA 230
Y I +V + K E C V+ L
Sbjct: 213 -YPG----------------IDLSQV----------YELLEKDYRMERPEGCPEKVYELM 245
Query: 231 MACTVESPEQRINAKEIVTKLLKI------RDSLLRNVGGRR 266
AC +P R + EI + D + + +G R
Sbjct: 246 RACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKRG 287
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-33
Identities = 74/266 (27%), Positives = 115/266 (43%), Gaps = 47/266 (17%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKA-LVLEYMPHGSLE 60
+VAVK ++ ++F E +M +RH NL++++ E+ +V EYM GSL
Sbjct: 46 KVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 103
Query: 61 KYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSD 119
YL S +L L +DV A+EYL +H DL NVL+ ++ VA +SD
Sbjct: 104 DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSD 160
Query: 120 FGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPT 178
FG+ K + S TQ + + APE RE + ST DV+SFGI+L E ++ G+ P
Sbjct: 161 FGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP- 214
Query: 179 YEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAK-------EQCVSFVFNLAM 231
Y I +V + V K + C V+ +
Sbjct: 215 YPR----------------IPLKDV----------VPRVEKGYKMDAPDGCPPAVYEVMK 248
Query: 232 ACTVESPEQRINAKEIVTKLLKIRDS 257
C R + ++ +L I+
Sbjct: 249 NCWHLDAAMRPSFLQLREQLEHIKTH 274
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 6e-33
Identities = 47/182 (25%), Positives = 79/182 (43%), Gaps = 12/182 (6%)
Query: 1 MEVAVKVFNLQCG-RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
+ VA+K +A K E +M S+ + ++ +++ C + L+ + MP G L
Sbjct: 45 IPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCL 103
Query: 60 EKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGCSAPVIHCDLKPDNVLLDDNLVAY 116
Y+ + LN + +A + YL +H DL NVL+
Sbjct: 104 LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL------VHRDLAARNVLVKTPQHVK 157
Query: 117 LSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GK 175
++DFG+AKLL E++ I +MA E + DV+S+G+ + E T G
Sbjct: 158 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 217
Query: 176 KP 177
KP
Sbjct: 218 KP 219
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 8e-33
Identities = 61/284 (21%), Positives = 115/284 (40%), Gaps = 51/284 (17%)
Query: 1 MEVAVKVFNLQCGRAFKS---FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHG 57
++VA+KV L+ G E ++M + + ++++I C E LV+E G
Sbjct: 364 IDVAIKV--LKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGG 420
Query: 58 SLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGCSAPVIHCDLKPDNVLLDDNLV 114
L K+L + + ++ V+ ++YL +F +H +L NVLL +
Sbjct: 421 PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF------VHRNLAARNVLLVNRHY 474
Query: 115 AYLSDFGIAKLLIGEDQS-MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 173
A +SDFG++K L +D ++ + + APE + S+ DV+S+G+ + E +
Sbjct: 475 AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534
Query: 174 -GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAK-------EQCVSF 225
G+KP Y+ G E + F+ + +C
Sbjct: 535 YGQKP-YKKMKG--------------------------PEVMAFIEQGKRMECPPECPPE 567
Query: 226 VFNLAMACTVESPEQRINAKEIVTKLLKIRDSLLRNVGGRRIRQ 269
++ L C + E R + + ++ SL V G +
Sbjct: 568 LYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGGSALE 611
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-32
Identities = 54/269 (20%), Positives = 97/269 (36%), Gaps = 47/269 (17%)
Query: 1 MEVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
+ VA+K + F E M+ H +++K+I + +++E G L
Sbjct: 44 LAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGEL 102
Query: 60 EKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGCSAPVIHCDLKPDNVLLDDNLVAY 116
+L LD+ + +++AL YL F +H D+ NVL+ N
Sbjct: 103 RSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF------VHRDIAARNVLVSSNDCVK 156
Query: 117 LSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GK 175
L DFG+++ + + ++ I +MAPE R ++ DV+ FG+ + E G
Sbjct: 157 LGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV 215
Query: 176 KPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAK-------EQCVSFVFN 228
KP N + I + C +++
Sbjct: 216 KPFQGVKN---------------------------NDVIGRIENGERLPMPPNCPPTLYS 248
Query: 229 LAMACTVESPEQRINAKEIVTKLLKIRDS 257
L C P +R E+ +L I +
Sbjct: 249 LMTKCWAYDPSRRPRFTELKAQLSTILEE 277
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-32
Identities = 54/192 (28%), Positives = 98/192 (51%), Gaps = 9/192 (4%)
Query: 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 60
+VAVK Q + +F E +MK ++H+ L+++ + + E ++ EYM +GSL
Sbjct: 38 TKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLV 95
Query: 61 KYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSD 119
+L + + L I + L++ +A + ++ IH DL+ N+L+ D L ++D
Sbjct: 96 DFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIAD 152
Query: 120 FGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPT 178
FG+A+L I +++ + I + APE G + DV+SFGI+L E T G+ P
Sbjct: 153 FGLARL-IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP- 210
Query: 179 YEFFNGEMTLKH 190
Y +++
Sbjct: 211 YPGMTNPEVIQN 222
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-32
Identities = 63/275 (22%), Positives = 108/275 (39%), Gaps = 55/275 (20%)
Query: 1 MEVAVKVFNLQCG----RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPH 56
VAVK+ L+ E +M+ + + ++++I C E + LV+E
Sbjct: 45 KTVAVKI--LKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAEL 101
Query: 57 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGCSAPVIHCDLKPDNVLLDDNL 113
G L KYL N + + ++ V+ ++YL +F +H DL NVLL
Sbjct: 102 GPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEESNF------VHRDLAARNVLLVTQH 154
Query: 114 VAYLSDFGIAKLLIGEDQSMTQTQTLAT--IGYMAPEYGREGRVSTNGDVYSFGIMLMET 171
A +SDFG++K + D++ + QT + + APE + S+ DV+SFG+++ E
Sbjct: 155 YAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEA 213
Query: 172 FT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAK-------EQCV 223
F+ G+KP Y G E + K C
Sbjct: 214 FSYGQKP-YRGMKG--------------------------SEVTAMLEKGERMGCPAGCP 246
Query: 224 SFVFNLAMACTVESPEQRINAKEIVTKLLKIRDSL 258
+++L C E R + +L +
Sbjct: 247 REMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-32
Identities = 59/276 (21%), Positives = 121/276 (43%), Gaps = 46/276 (16%)
Query: 1 MEVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
VA+K + G + F E + ++H N++ ++ + ++ +++ Y HG L
Sbjct: 40 QAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDL 99
Query: 60 EKYL---------------YSSNCILDIFQRLNIMIDVASALEYL---HFGCSAPVIHCD 101
++L + L+ ++++ +A+ +EYL H +H D
Sbjct: 100 HEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHV------VHKD 153
Query: 102 LKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 161
L NVL+ D L +SD G+ + + D +L I +MAPE G+ S + D+
Sbjct: 154 LATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDI 213
Query: 162 YSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKE 220
+S+G++L E F+ G +P Y ++ + ++ + + +L +
Sbjct: 214 WSYGVVLWEVFSYGLQP-YCGYSNQDVVEM------------IRNRQVLPC-------PD 253
Query: 221 QCVSFVFNLAMACTVESPEQRINAKEIVTKLLKIRD 256
C ++V+ L + C E P +R K+I ++L +
Sbjct: 254 DCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN 289
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-32
Identities = 47/198 (23%), Positives = 82/198 (41%), Gaps = 25/198 (12%)
Query: 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 60
EV +KV + +SF MM + H++L+ C + LV E++ GSL+
Sbjct: 41 TEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLD 100
Query: 61 KYLYSSNCILDIFQRLNIMIDVASALEYL---HFGCSAPVIHCDLKPDNVLLD------- 110
YL + ++I +L + +A+A+ +L IH ++ N+LL
Sbjct: 101 TYLKKNKNCINILWKLEVAKQLAAAMHFLEENTL------IHGNVCAKNILLIREEDRKT 154
Query: 111 -DNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIML 168
+ LSD GI+ + + + Q I ++ PE + + D +SFG L
Sbjct: 155 GNPPFIKLSDPGISITV--LPKDILQ----ERIPWVPPECIENPKNLNLATDKWSFGTTL 208
Query: 169 METFT-GKKPTYEFFNGE 185
E + G KP +
Sbjct: 209 WEICSGGDKPLSALDSQR 226
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 7e-32
Identities = 65/275 (23%), Positives = 114/275 (41%), Gaps = 47/275 (17%)
Query: 1 MEVAVKVFNLQCG-RAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGS 58
+ VAVK+ + E EMMK I +H+N+I ++ +C+ + +++EY G+
Sbjct: 114 VTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 173
Query: 59 LEKYLYSS---------------NCILDIFQRLNIMIDVASALEYL---HFGCSAPVIHC 100
L +YL + + ++ +A +EYL IH
Sbjct: 174 LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC------IHR 227
Query: 101 DLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160
DL NVL+ +N V ++DFG+A+ + D T + +MAPE + + D
Sbjct: 228 DLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 287
Query: 161 VYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAK 219
V+SFG+++ E FT G P Y E K + + + + +
Sbjct: 288 VWSFGVLMWEIFTLGGSP-YPGIPVEELFKL------------LKEGHRMDK-------P 327
Query: 220 EQCVSFVFNLAMACTVESPEQRINAKEIVTKLLKI 254
C + ++ + C P QR K++V L +I
Sbjct: 328 ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 7e-32
Identities = 56/266 (21%), Positives = 105/266 (39%), Gaps = 47/266 (17%)
Query: 1 MEVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
+ VAVK C + F E +MK++ H +++K+I E +++E P+G L
Sbjct: 41 INVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGEL 99
Query: 60 EKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGCSAPVIHCDLKPDNVLLDDNLVAY 116
YL + L + + + + A+ YL + +H D+ N+L+
Sbjct: 100 GHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC------VHRDIAVRNILVASPECVK 153
Query: 117 LSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GK 175
L DFG+++ I ++ + T I +M+PE R +T DV+ F + + E + GK
Sbjct: 154 LGDFGLSR-YIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGK 212
Query: 176 KPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAK-------EQCVSFVFN 228
+P + + +++ I + K + C ++
Sbjct: 213 QP-FF----WLE----------------------NKDVIGVLEKGDRLPKPDLCPPVLYT 245
Query: 229 LAMACTVESPEQRINAKEIVTKLLKI 254
L C P R E+V L +
Sbjct: 246 LMTRCWDYDPSDRPRFTELVCSLSDV 271
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 9e-32
Identities = 66/285 (23%), Positives = 114/285 (40%), Gaps = 54/285 (18%)
Query: 1 MEVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
VAVK+ + F E +M + N++K++ C+ + L+ EYM +G L
Sbjct: 78 TMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDL 137
Query: 60 EKYLYSS-----------------------NCILDIFQRLNIMIDVASALEYL---HFGC 93
++L S L ++L I VA+ + YL F
Sbjct: 138 NEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF-- 195
Query: 94 SAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG 153
+H DL N L+ +N+V ++DFG+++ + D I +M PE
Sbjct: 196 ----VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN 251
Query: 154 RVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQE 212
R +T DV+++G++L E F+ G +P Y E + + V D N+L+
Sbjct: 252 RYTTESDVWAYGVVLWEIFSYGLQP-YYGMAHEEVIYY------------VRDGNILAC- 297
Query: 213 DIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLLKIRDS 257
E C ++NL C + P R + I L ++ +
Sbjct: 298 ------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-31
Identities = 58/282 (20%), Positives = 111/282 (39%), Gaps = 54/282 (19%)
Query: 1 MEVAVKVFNLQCG-RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
VAVK+ + E ++K + H ++IK+ +CS + L++EY +GSL
Sbjct: 54 TTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSL 113
Query: 60 EKYLYSS-----------------------NCILDIFQRLNIMIDVASALEYL---HFGC 93
+L S L + ++ ++ ++YL
Sbjct: 114 RGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKL-- 171
Query: 94 SAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG 153
+H DL N+L+ + +SDFG+++ + ED + ++Q + +MA E +
Sbjct: 172 ----VHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH 227
Query: 154 RVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQE 212
+T DV+SFG++L E T G P Y E + + + +
Sbjct: 228 IYTTQSDVWSFGVLLWEIVTLGGNP-YPGIPPERLFNL------------LKTGHRMER- 273
Query: 213 DIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLLKI 254
+ C ++ L + C + P++R +I L K+
Sbjct: 274 ------PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-31
Identities = 65/275 (23%), Positives = 114/275 (41%), Gaps = 47/275 (17%)
Query: 1 MEVAVKVFNLQCG-RAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGS 58
+ VAVK+ + E EMMK I +H+N+I ++ +C+ + +++EY G+
Sbjct: 68 VTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 127
Query: 59 LEKYLYSS---------------NCILDIFQRLNIMIDVASALEYL---HFGCSAPVIHC 100
L +YL + + ++ +A +EYL IH
Sbjct: 128 LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC------IHR 181
Query: 101 DLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160
DL NVL+ +N V ++DFG+A+ + D T + +MAPE + + D
Sbjct: 182 DLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 241
Query: 161 VYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAK 219
V+SFG+++ E FT G P Y E K + + + + +
Sbjct: 242 VWSFGVLMWEIFTLGGSP-YPGIPVEELFKL------------LKEGHRMDK-------P 281
Query: 220 EQCVSFVFNLAMACTVESPEQRINAKEIVTKLLKI 254
C + ++ + C P QR K++V L +I
Sbjct: 282 ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-31
Identities = 54/262 (20%), Positives = 99/262 (37%), Gaps = 33/262 (12%)
Query: 1 MEVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
M VA+K + F E M+ H +++K+I + +++E G L
Sbjct: 419 MAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGEL 477
Query: 60 EKYLYSSNCILDIFQRLNIMIDVASALEYL---HFGCSAPVIHCDLKPDNVLLDDNLVAY 116
+L LD+ + +++AL YL F +H D+ NVL+ N
Sbjct: 478 RSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF------VHRDIAARNVLVSSNDCVK 531
Query: 117 LSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GK 175
L DFG+++ + + ++ I +MAPE R ++ DV+ FG+ + E G
Sbjct: 532 LGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV 590
Query: 176 KPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTV 235
KP ++ + + + L C +++L C
Sbjct: 591 KP-FQGVKNNDVIGR------------IENGERLPM-------PPNCPPTLYSLMTKCWA 630
Query: 236 ESPEQRINAKEIVTKLLKIRDS 257
P +R E+ +L I +
Sbjct: 631 YDPSRRPRFTELKAQLSTILEE 652
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-30
Identities = 56/273 (20%), Positives = 109/273 (39%), Gaps = 44/273 (16%)
Query: 1 MEVAVKVFNLQC-GRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGS 58
++VAVK+ ++ E ++M + +H N++ ++ +C++ ++ EY +G
Sbjct: 77 LKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 136
Query: 59 LEKYL-------------YSSNCILDIFQRLNIMIDVASALEYL---HFGCSAPVIHCDL 102
L +L +N L+ VA + +L + IH D+
Sbjct: 137 LLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNC------IHRDV 190
Query: 103 KPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVY 162
NVLL + VA + DFG+A+ ++ + + + + +MAPE + + DV+
Sbjct: 191 AARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVW 250
Query: 163 SFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQ 221
S+GI+L E F+ G P K V D ++Q
Sbjct: 251 SYGILLWEIFSLGLNPYPGILVNSKFYKL------------VKDGYQMAQ-------PAF 291
Query: 222 CVSFVFNLAMACTVESPEQRINAKEIVTKLLKI 254
++++ AC P R ++I + L +
Sbjct: 292 APKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-30
Identities = 67/275 (24%), Positives = 114/275 (41%), Gaps = 47/275 (17%)
Query: 1 MEVAVKVFNLQC-GRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGS 58
+VAVK+ + E EMMK I +H+N+I ++ +C+ + +++EY G+
Sbjct: 102 TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 161
Query: 59 LEKYLYSS---------------NCILDIFQRLNIMIDVASALEYL---HFGCSAPVIHC 100
L +YL + L ++ VA +EYL IH
Sbjct: 162 LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC------IHR 215
Query: 101 DLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160
DL NVL+ ++ V ++DFG+A+ + D T + +MAPE + + D
Sbjct: 216 DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 275
Query: 161 VYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAK 219
V+SFG++L E FT G P Y E K + + + + +
Sbjct: 276 VWSFGVLLWEIFTLGGSP-YPGVPVEELFKL------------LKEGHRMDK-------P 315
Query: 220 EQCVSFVFNLAMACTVESPEQRINAKEIVTKLLKI 254
C + ++ + C P QR K++V L +I
Sbjct: 316 SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-30
Identities = 55/274 (20%), Positives = 102/274 (37%), Gaps = 42/274 (15%)
Query: 1 MEVAVKVFNLQCG-RAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGS 58
M VAVK+ ++ E +++ + H N++ ++ +C+ ++ EY +G
Sbjct: 54 MTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGD 113
Query: 59 LEKYL-----------------YSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCD 101
L +L LD+ L+ VA + +L S IH D
Sbjct: 114 LLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRD 170
Query: 102 LKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 161
L N+LL + + DFG+A+ + + + + + +MAPE + DV
Sbjct: 171 LAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDV 230
Query: 162 YSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKE 220
+S+GI L E F+ G P K + + + E
Sbjct: 231 WSYGIFLWELFSLGSSPYPGMPVDSKFYKM------------IKEGFRMLS-------PE 271
Query: 221 QCVSFVFNLAMACTVESPEQRINAKEIVTKLLKI 254
+ ++++ C P +R K+IV + K
Sbjct: 272 HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 8e-30
Identities = 54/269 (20%), Positives = 94/269 (34%), Gaps = 35/269 (13%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 61
+ AVK L+ R E + ++ + + + + +E + GSL +
Sbjct: 85 QCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ 139
Query: 62 YLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDN-LVAYLSDF 120
+ C L + L + LEYLH + ++H D+K DNVLL + A L DF
Sbjct: 140 LIKQMGC-LPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDF 195
Query: 121 GIAKLLIGEDQSMTQTQTLATIG---YMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 177
G A L + + G +MAPE D++S M++ G P
Sbjct: 196 GHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
Query: 178 TYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237
+ + ++ PI + + + + +
Sbjct: 256 -WTQYFRGPLCLKIASEPPPIREI----PPSCAPLTAQAIQE-------------GLRKE 297
Query: 238 PEQRINAKEIVTKLLKIRDSLLRNVGGRR 266
P R +A E L + L+ VGG +
Sbjct: 298 PVHRASAME----LRRKVGKALQEVGGLK 322
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-29
Identities = 56/273 (20%), Positives = 103/273 (37%), Gaps = 41/273 (15%)
Query: 1 MEVAVKVFNLQC-GRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALV-LEYMPHG 57
VAVK+ ++ E +++ I H N++ ++ +C+ +V +E+ G
Sbjct: 58 RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 117
Query: 58 SLEKYLYSS---------------NCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDL 102
+L YL S L + + VA +E+L S IH DL
Sbjct: 118 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDL 174
Query: 103 KPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVY 162
N+LL + V + DFG+A+ + + + + + +MAPE + + DV+
Sbjct: 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVW 234
Query: 163 SFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQ 221
SFG++L E F+ G P E + + + + +
Sbjct: 235 SFGVLLWEIFSLGASPYPGVKIDEEFCRR------------LKEGTRMRA-------PDY 275
Query: 222 CVSFVFNLAMACTVESPEQRINAKEIVTKLLKI 254
++ + C P QR E+V L +
Sbjct: 276 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-29
Identities = 54/258 (20%), Positives = 105/258 (40%), Gaps = 38/258 (14%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECEMMK-SIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 60
+VAVK +C F D E ++++ S H N+I+ + + +F+ + +E +L+
Sbjct: 50 DVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQ 105
Query: 61 KYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLL-----DDNLVA 115
+Y+ + + + ++ S L +LH S ++H DLKP N+L+ + A
Sbjct: 106 EYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKA 162
Query: 116 YLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAPEY---GREGRVSTNGDVYSFGIMLMET 171
+SDFG+ K L S ++ + T G++APE + + D++S G +
Sbjct: 163 MISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYV 222
Query: 172 FTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQE-DIHFVAKEQCVSFVF-NL 229
+ F AN+L + + E+ + L
Sbjct: 223 ISEGSH---PFGKS----------------LQRQANILLGACSLDCLHPEKHEDVIAREL 263
Query: 230 AMACTVESPEQRINAKEI 247
P++R +AK +
Sbjct: 264 IEKMIAMDPQKRPSAKHV 281
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-28
Identities = 55/279 (19%), Positives = 102/279 (36%), Gaps = 47/279 (16%)
Query: 1 MEVAVKVFNLQCG-RAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGS 58
++VAVK+ + ++ E +MM + H N++ ++ +C+ L+ EY +G
Sbjct: 76 IQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGD 135
Query: 59 LEKYL----------------------YSSNCILDIFQRLNIMIDVASALEYLHFGCSAP 96
L YL +L L VA +E+L
Sbjct: 136 LLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKS 192
Query: 97 VIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVS 156
+H DL NVL+ V + DFG+A+ ++ + + + + +MAPE EG +
Sbjct: 193 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT 252
Query: 157 TNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIH 215
DV+S+GI+L E F+ G P K + + + Q
Sbjct: 253 IKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKL------------IQNGFKMDQ---- 296
Query: 216 FVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLLKI 254
++ + +C +R + + + L
Sbjct: 297 ---PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 332
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-28
Identities = 53/261 (20%), Positives = 105/261 (40%), Gaps = 39/261 (14%)
Query: 2 EVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNL--IKVISSCSNEEFKALVLEYMPHG 57
A+K NL+ + S+ E + ++ + I++ +++ +V+E +
Sbjct: 54 IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NI 112
Query: 58 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYL 117
L +L +D ++R + ++ A+ +H ++H DLKP N L+ D ++ L
Sbjct: 113 DLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDGMLK-L 167
Query: 118 SDFGIAKLLIGEDQSMTQTQTLATIGYMAPE-----------YGREGRVSTNGDVYSFGI 166
DFGIA + + S+ + + T+ YM PE + ++S DV+S G
Sbjct: 168 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGC 227
Query: 167 MLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFV 226
+L GK P + N L ++ I ++ ++ +
Sbjct: 228 ILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE-----FPDIPEKDLQDVLKC------- 275
Query: 227 FNLAMACTVESPEQRINAKEI 247
C P+QRI+ E+
Sbjct: 276 ------CLKRDPKQRISIPEL 290
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-28
Identities = 57/189 (30%), Positives = 90/189 (47%), Gaps = 14/189 (7%)
Query: 3 VAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKY 62
+A+K + R + E + K ++H+N+++ + S S F + +E +P GSL
Sbjct: 50 IAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSAL 109
Query: 63 LYSSNCILDIFQRL--NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLD-DNLVAYLSD 119
L S L ++ + L+YLH ++H D+K DNVL++ + V +SD
Sbjct: 110 LRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISD 166
Query: 120 FGIAKLLIGEDQSMTQTQTLA-TIGYMAPE---YGREGRVSTNGDVYSFGIMLMETFTGK 175
FG +K L G T+T T+ YMAPE G G D++S G ++E TGK
Sbjct: 167 FGTSKRLAG---INPCTETFTGTLQYMAPEIIDKGPRGY-GKAADIWSLGCTIIEMATGK 222
Query: 176 KPTYEFFNG 184
P YE
Sbjct: 223 PPFYELGEP 231
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 5e-28
Identities = 53/261 (20%), Positives = 105/261 (40%), Gaps = 39/261 (14%)
Query: 2 EVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNL--IKVISSCSNEEFKALVLEYMPHG 57
A+K NL+ + S+ E + ++ + I++ +++ +V+E +
Sbjct: 35 IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNI 93
Query: 58 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYL 117
L +L +D ++R + ++ A+ +H ++H DLKP N L+ D ++ L
Sbjct: 94 DLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDGMLK-L 148
Query: 118 SDFGIAKLLIGEDQSMTQTQTLATIGYMAPE-----------YGREGRVSTNGDVYSFGI 166
DFGIA + + S+ + + T+ YM PE + ++S DV+S G
Sbjct: 149 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGC 208
Query: 167 MLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFV 226
+L GK P + N L ++ I ++ ++ +
Sbjct: 209 ILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE-----FPDIPEKDLQDVLKC------- 256
Query: 227 FNLAMACTVESPEQRINAKEI 247
C P+QRI+ E+
Sbjct: 257 ------CLKRDPKQRISIPEL 271
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-28
Identities = 53/261 (20%), Positives = 106/261 (40%), Gaps = 39/261 (14%)
Query: 2 EVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNL--IKVISSCSNEEFKALVLEYMPHG 57
A+K NL+ + S+ E + ++ + I++ +++ +V+E +
Sbjct: 82 IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNI 140
Query: 58 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYL 117
L +L +D ++R + ++ A+ +H ++H DLKP N L+ D ++ L
Sbjct: 141 DLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDGMLK-L 195
Query: 118 SDFGIAKLLIGEDQSMTQTQTLATIGYMAPE-----------YGREGRVSTNGDVYSFGI 166
DFGIA + + S+ + + + YM PE + ++S DV+S G
Sbjct: 196 IDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGC 255
Query: 167 MLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFV 226
+L GK P + N L ++ I ++ + +L
Sbjct: 256 ILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQ----------------- 298
Query: 227 FNLAMACTVESPEQRINAKEI 247
++ C P+QRI+ E+
Sbjct: 299 -DVLKCCLKRDPKQRISIPEL 318
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-27
Identities = 55/274 (20%), Positives = 93/274 (33%), Gaps = 44/274 (16%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKA----LVLEYMPHG 57
A+K + + E +M + H N++++++ C E L+L + G
Sbjct: 56 FYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRG 115
Query: 58 SLEKYLYSSNCILDIF---QRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLV 114
+L + + Q L +++ + LE +H + H DLKP N+LL D
Sbjct: 116 TLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQ 172
Query: 115 AYLSDFGIAKLLIGEDQSMTQTQTLA-------TIGYMAPE----YGREGRVSTNGDVYS 163
L D G + Q TL TI Y APE + DV+S
Sbjct: 173 PVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCV-IDERTDVWS 231
Query: 164 FGIMLMETFTGKKP-TYEFFNGEMTLKHWVNDW-LPISTMEVVDANLLSQEDIHFVAKEQ 221
G +L G+ P F G+ N +P S S +
Sbjct: 232 LGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPR-------HSSALWQLLNS-- 282
Query: 222 CVSFVFNLAMACTVESPEQRINAKEIVTKLLKIR 255
P QR + ++++L ++
Sbjct: 283 -----------MMTVDPHQRPHIPLLLSQLEALQ 305
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-26
Identities = 55/200 (27%), Positives = 96/200 (48%), Gaps = 34/200 (17%)
Query: 1 MEVAVKVFNLQCG---RAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPH 56
M+ A+K ++ + F E E++ + H N+I ++ +C + + L +EY PH
Sbjct: 53 MDAAIKR--MKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 110
Query: 57 GSLEKYL---------------YSSNCILDIFQRLNIMIDVASALEYL---HFGCSAPVI 98
G+L +L S+ L Q L+ DVA ++YL F I
Sbjct: 111 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQF------I 164
Query: 99 HCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTN 158
H DL N+L+ +N VA ++DFG+++ G++ + +T + +MA E +TN
Sbjct: 165 HRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVRWMAIESLNYSVYTTN 221
Query: 159 GDVYSFGIMLMETFT-GKKP 177
DV+S+G++L E + G P
Sbjct: 222 SDVWSYGVLLWEIVSLGGTP 241
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 1e-25
Identities = 34/205 (16%), Positives = 65/205 (31%), Gaps = 20/205 (9%)
Query: 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL- 59
+ +KV F E +K +K S+ + LV E +G+L
Sbjct: 96 QKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLL 155
Query: 60 ---EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAY 116
Y + ++ ++ + + +E +H +IH D+KPDN +L + +
Sbjct: 156 NAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQ 212
Query: 117 -----------LSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG-DVYSF 164
L D G + + + T T G+ E + D +
Sbjct: 213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEM-LSNKPWNYQIDYFGV 271
Query: 165 GIMLMETFTGKKPTYEFFNGEMTLK 189
+ G + GE +
Sbjct: 272 AATVYCMLFGTYMKVKNEGGECKPE 296
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-25
Identities = 50/202 (24%), Positives = 84/202 (41%), Gaps = 25/202 (12%)
Query: 2 EVAVKVFN-LQCGRAFKSFDVECEMMKSIRHRNLIK---VISSCSNEEFKALVLEYMPHG 57
A+KVFN + R E E++K + H+N++K + + L++E+ P G
Sbjct: 36 LFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK-VLIMEFCPCG 94
Query: 58 SLEKYLYS--SNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLL----DD 111
SL L + L + L ++ DV + +L ++H ++KP N++ D
Sbjct: 95 SLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDG 151
Query: 112 NLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPE-YGREGRVSTNG-------DVYS 163
V L+DFG A+ L ED + T Y+ P+ Y R + D++S
Sbjct: 152 QSVYKLTDFGAAREL--EDDEQFVSL-YGTEEYLHPDMYERAVLRKDHQKKYGATVDLWS 208
Query: 164 FGIMLMETFTGKKPTYEFFNGE 185
G+ TG P F
Sbjct: 209 IGVTFYHAATGSLPFRPFEGPR 230
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-25
Identities = 52/202 (25%), Positives = 91/202 (45%), Gaps = 18/202 (8%)
Query: 1 MEVAVKVFNLQ-CGRAFKSFDVECEMMKSIRHRNLIKVI------SSCSNEEFKALVLEY 53
+VA+K + + + + +E ++MK + H N++ + + L +EY
Sbjct: 40 EQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEY 99
Query: 54 MPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLD- 110
G L KYL + + C L ++ D++SAL YLH +IH DLKP+N++L
Sbjct: 100 CEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQP 156
Query: 111 --DNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIML 168
L+ + D G AK L + + + T+ Y+APE + + + D +SFG +
Sbjct: 157 GPQRLIHKIIDLGYAKEL--DQGELCTEF-VGTLQYLAPELLEQKKYTVTVDYWSFGTLA 213
Query: 169 METFTGKKPTYEFFNGEMTLKH 190
E TG +P +
Sbjct: 214 FECITGFRPFLPNWQPVQWHGK 235
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-25
Identities = 55/283 (19%), Positives = 94/283 (33%), Gaps = 67/283 (23%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECE-MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 60
VAVK + +E + + +S H N+I+ S + + F + LE +L+
Sbjct: 41 PVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQ 96
Query: 61 KYLYSSNCILDIFQRL------NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLD---- 110
+ S N + + +++ +AS + +LH S +IH DLKP N+L+
Sbjct: 97 DLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSR 153
Query: 111 ---------DNLVAYLSDFGIAKLLIGEDQSMTQTQTLA--TIGYMAPEYGREGRVSTNG 159
+NL +SDFG+ K L S T G+ APE E
Sbjct: 154 FTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTK 213
Query: 160 -------DVYSFGIMLMETFTGKKP--------TYEFFNGEMTLKHWVNDWLPISTMEVV 204
D++S G + + K G +L
Sbjct: 214 RRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDR------- 266
Query: 205 DANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEI 247
L E +++ P +R A ++
Sbjct: 267 ---SLIAEATDLISQ-------------MIDHDPLKRPTAMKV 293
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 6e-25
Identities = 45/171 (26%), Positives = 70/171 (40%), Gaps = 13/171 (7%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKAL--VLEYMPHGSLEKYLYSSNCILDIF---QRL 76
E +++ ++H N+++ + L V+EY G L + L
Sbjct: 55 EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
Query: 77 NIMIDVASALEYLH--FGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMT 134
+M + AL+ H V+H DLKP NV LD L DFG+A++L D S
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFA 173
Query: 135 QTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGE 185
+T + T YM+PE + D++S G +L E P F
Sbjct: 174 KTF-VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP----FTAF 219
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 7e-25
Identities = 50/203 (24%), Positives = 84/203 (41%), Gaps = 25/203 (12%)
Query: 1 MEVAVKVFN-LQCGRAFKSFDVECEMMKSIRHRNLIK---VISSCSNEEFKALVLEYMPH 56
A+KVFN + R E E++K + H+N++K + + L++E+ P
Sbjct: 35 DLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK-VLIMEFCPC 93
Query: 57 GSLEKYLYS--SNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLL----D 110
GSL L + L + L ++ DV + +L ++H ++KP N++ D
Sbjct: 94 GSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGED 150
Query: 111 DNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPE-YGREGRVSTNG-------DVY 162
V L+DFG A+ L ED + T Y+ P+ Y R + D++
Sbjct: 151 GQSVYKLTDFGAAREL--EDDEQFVSL-YGTEEYLHPDMYERAVLRKDHQKKYGATVDLW 207
Query: 163 SFGIMLMETFTGKKPTYEFFNGE 185
S G+ TG P F
Sbjct: 208 SIGVTFYHAATGSLPFRPFEGPR 230
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 8e-25
Identities = 36/157 (22%), Positives = 71/157 (45%), Gaps = 6/157 (3%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-YSSNCILDIFQRLNIMI 80
E ++ +++H N+++ S +V++Y G L K + + Q L+ +
Sbjct: 73 EVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFV 132
Query: 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLA 140
+ AL+++H ++H D+K N+ L + L DFGIA++L + +
Sbjct: 133 QICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL-NSTVELARACI-G 187
Query: 141 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 177
T Y++PE + D+++ G +L E T K
Sbjct: 188 TPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-24
Identities = 45/226 (19%), Positives = 75/226 (33%), Gaps = 36/226 (15%)
Query: 25 MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVAS 84
K +H +++ + L E SL+++ + L Q + D
Sbjct: 110 HEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLL 168
Query: 85 ALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLA-TIG 143
AL +LH S ++H D+KP N+ L L DFG+ L + +
Sbjct: 169 ALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL----GTAGAGEVQEGDPR 221
Query: 144 YMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPI--STM 201
YMAPE + T DV+S G+ ++E + GE W + +
Sbjct: 222 YMAPELLQGSY-GTAADVFSLGLTILEVACNMEL---PHGGE--------GWQQLRQGYL 269
Query: 202 EVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEI 247
LS E + P+ R A+ +
Sbjct: 270 PPEFTAGLSSELRSVLVM-------------MLEPDPKLRATAEAL 302
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-24
Identities = 41/159 (25%), Positives = 69/159 (43%), Gaps = 8/159 (5%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF---QRLNI 78
E +++K + H N+IK +S + +VLE G L + + +
Sbjct: 82 EIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKY 141
Query: 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQT 138
+ + SALE++H S V+H D+KP NV + V L D G+ + + +
Sbjct: 142 FVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLV 197
Query: 139 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 177
T YM+PE E + D++S G +L E + P
Sbjct: 198 -GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 99.4 bits (247), Expect = 4e-24
Identities = 28/189 (14%), Positives = 65/189 (34%), Gaps = 16/189 (8%)
Query: 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM-PHGSL 59
+ + + N + + F +++K + + +I+V + + Y +L
Sbjct: 132 LRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNL 191
Query: 60 EKYL------YSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNL 113
+ + S++ L RL + + V L LH ++H L+P +++LD
Sbjct: 192 QTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRG 248
Query: 114 VAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPE-----YGREGRVSTNGDVYSFGIML 168
+L+ F G + A A ++ D ++ G+ +
Sbjct: 249 GVFLTGFEHLVRD-GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307
Query: 169 METFTGKKP 177
+ P
Sbjct: 308 YWIWCADLP 316
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 7e-24
Identities = 46/263 (17%), Positives = 91/263 (34%), Gaps = 52/263 (19%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKA------------- 48
+K +A + E + + + H N++ ++
Sbjct: 38 TYVIKRVKYNNEKAER----EVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTK 93
Query: 49 ---LVLEYMPHGSLEKYLYSSNCI-LDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKP 104
+ +E+ G+LE+++ LD L + + ++Y+H S +I+ DLKP
Sbjct: 94 CLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKP 150
Query: 105 DNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSF 164
N+ L D + DFG+ L +T++ T+ YM+PE D+Y+
Sbjct: 151 SNIFLVDTKQVKIGDFGLVTSL---KNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYAL 207
Query: 165 GIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVS 224
G++L E F + + ++ +++ + K
Sbjct: 208 GLILAELLHVCDT---AFETSKFFTDLRDGIIS---------DIFDKKEKTLLQK----- 250
Query: 225 FVFNLAMACTVESPEQRINAKEI 247
+ PE R N EI
Sbjct: 251 --------LLSKKPEDRPNTSEI 265
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 97.8 bits (243), Expect = 1e-23
Identities = 28/283 (9%), Positives = 61/283 (21%), Gaps = 56/283 (19%)
Query: 2 EVAVKVFN---LQCGRAFKSFDVECEMMKSIRHRNLI---------------------KV 37
+ A+KVF + + +
Sbjct: 89 DFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPF 148
Query: 38 ISSCSNEEFKA-----LVLEYM-----PHGSLEKYLYSSNCILDIFQRLNIMIDVASALE 87
++ A L++ S ++Y I + +
Sbjct: 149 AQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAA 208
Query: 88 YLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 147
L S ++H PDN+ + + L D +G + + Y
Sbjct: 209 NLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW-KVGTRGPASSV----PVTYAPR 260
Query: 148 EY--GREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVD 205
E+ + + + G+ + + P F +
Sbjct: 261 EFLNASTATFTHALNAWQLGLSIYRVWCLFLP----FGLVTPGIKGSWKRPSLRVPGTDS 316
Query: 206 ANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIV 248
S + K L +R+ E +
Sbjct: 317 LAFGSCTPLPDFVKT--------LIGRFLNFDRRRRLLPLEAM 351
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-22
Identities = 51/177 (28%), Positives = 84/177 (47%), Gaps = 9/177 (5%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 61
EVA++ NLQ + E +M+ ++ N++ + S + +V+EY+ GSL
Sbjct: 47 EVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD 106
Query: 62 YLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFG 121
+ + +D Q + + ALE+LH S VIH D+K DN+LL + L+DFG
Sbjct: 107 VV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFG 161
Query: 122 IAKLLIGEDQSMTQTQTLA-TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 177
+ ++ T+ T +MAPE D++S GIM +E G+ P
Sbjct: 162 FCAQI---TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 1e-22
Identities = 40/178 (22%), Positives = 77/178 (43%), Gaps = 21/178 (11%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-------YSSNCILDIFQ 74
E +++ I++ + +N + ++ EYM + S+ K+ + C + I
Sbjct: 93 ELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQV 152
Query: 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMT 134
I+ V ++ Y+H + + H D+KP N+L+D N LSDFG ++ ++ +
Sbjct: 153 IKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK---- 206
Query: 135 QTQTLA-TIGYMAPE--YGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLK 189
+ T +M PE D++S GI L F P F+ +++L
Sbjct: 207 -IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP----FSLKISLV 259
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-22
Identities = 68/264 (25%), Positives = 103/264 (39%), Gaps = 55/264 (20%)
Query: 3 VAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKY 62
VA+K ++ + E +M+ +++K S +V+EY GS+
Sbjct: 57 VAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDI 114
Query: 63 LYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGI 122
+ N L + I+ LEYLH IH D+K N+LL+ A L+DFG+
Sbjct: 115 IRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGV 171
Query: 123 AKLLIGEDQSMTQTQTLATIG---YMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTY 179
A L +M + T+ IG +MAPE +E + D++S GI +E GK P
Sbjct: 172 AGQL---TDTMAKRNTV--IGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYA 226
Query: 180 EF------F----NGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNL 229
+ F N T + L S FV +
Sbjct: 227 DIHPMRAIFMIPTNPPPTFR---------------KPELWSDNFTDFVKQ---------- 261
Query: 230 AMACTVESPEQRINAKEIVTKLLK 253
C V+SPEQR A + LL+
Sbjct: 262 ---CLVKSPEQRATATQ----LLQ 278
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-22
Identities = 51/179 (28%), Positives = 92/179 (51%), Gaps = 13/179 (7%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 61
+VAVK+ +L+ + + E +M+ +H N++++ S E +++E++ G+L
Sbjct: 72 QVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTD 131
Query: 62 YLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFG 121
+ S L+ Q + V AL YLH + VIH D+K D++LL + LSDFG
Sbjct: 132 IV--SQVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFG 186
Query: 122 IAKLLIGEDQSMTQTQTLATIG---YMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 177
+ + + + ++L +G +MAPE +T D++S GIM++E G+ P
Sbjct: 187 FCAQI---SKDVPKRKSL--VGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 4e-22
Identities = 60/281 (21%), Positives = 101/281 (35%), Gaps = 51/281 (18%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIR-HRNLIKVISSCS-------NEEFKALVLEY 53
E A+K ++ E MK + H N+++ S+ S + + L+L
Sbjct: 55 EYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTE 114
Query: 54 MPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDD 111
+ G L ++L S L L I A++++H P+IH DLK +N+LL +
Sbjct: 115 LCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSN 173
Query: 112 NLVAYLSDFGIAKLLIGEDQSMTQTQTLA----------TIGYMAPE----YGREGRVST 157
L DFG A + Q A T Y PE Y +
Sbjct: 174 QGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFP-IGE 232
Query: 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFV 217
D+++ G +L + P F L+ +V+
Sbjct: 233 KQDIWALGCILYLLCFRQHP----FEDGAKLR-------------IVNGKYSIPPHDTQ- 274
Query: 218 AKEQCVSFVF-NLAMACTVESPEQRINAKEIVTKLLKIRDS 257
VF +L A +PE+R++ E+V +L +I +
Sbjct: 275 ------YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 92.4 bits (229), Expect = 9e-22
Identities = 30/195 (15%), Positives = 72/195 (36%), Gaps = 27/195 (13%)
Query: 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM-PHGSL 59
+ + + N + + F +++K + + +I+V + + Y +L
Sbjct: 127 LRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNL 186
Query: 60 EKYL------YSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNL 113
+ + S++ L RL + + V L LH ++H L+P +++LD
Sbjct: 187 QTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRG 243
Query: 114 VAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEY-----------GREGRVSTNGDVY 162
+L+ F D + + + G+ PE R ++ + D +
Sbjct: 244 GVFLTGFEHLV----RDGARVVSSV--SRGFEPPELEARRATISYHRDRRTLMTFSFDAW 297
Query: 163 SFGIMLMETFTGKKP 177
+ G+++ + P
Sbjct: 298 ALGLVIYWIWCADLP 312
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-21
Identities = 43/183 (23%), Positives = 85/183 (46%), Gaps = 16/183 (8%)
Query: 3 VAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKY 62
A KV + + + VE E++ + H ++K++ + ++ +++E+ P G+++
Sbjct: 47 AAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAI 106
Query: 63 LYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGI 122
+ + L Q + + AL +LH S +IH DLK NVL+ L+DFG+
Sbjct: 107 MLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGV 163
Query: 123 AKLLIGEDQSMTQTQTLATIG---YMAPE-----YGREGRVSTNGDVYSFGIMLMETFTG 174
+ +++ + + IG +MAPE ++ D++S GI L+E
Sbjct: 164 SAKN---LKTLQKRDSF--IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218
Query: 175 KKP 177
+ P
Sbjct: 219 EPP 221
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-21
Identities = 50/278 (17%), Positives = 95/278 (34%), Gaps = 61/278 (21%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKA------------- 48
A+K + E ++ S+ H+ +++ ++
Sbjct: 33 YYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLF 91
Query: 49 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVL 108
+ +EY +G+L ++S N + + + AL Y+H S +IH DLKP N+
Sbjct: 92 IQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIF 148
Query: 109 LDDNLVAYLSDFGIAKLL--------IGEDQSMTQTQTLAT-IG---YMAPE-------Y 149
+D++ + DFG+AK + + + L + IG Y+A E Y
Sbjct: 149 IDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHY 208
Query: 150 GREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLL 209
+ D+YS GI+ E F G + + V
Sbjct: 209 NEK------IDMYSLGIIFFEMIYP------FSTGM-------ERVNILKKLRSVSIEFP 249
Query: 210 SQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEI 247
D + + E+ + P +R A+ +
Sbjct: 250 PDFDDNKMKVEK------KIIRLLIDHDPNKRPGARTL 281
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 91.5 bits (227), Expect = 2e-21
Identities = 37/185 (20%), Positives = 72/185 (38%), Gaps = 13/185 (7%)
Query: 3 VAVKVFNL--QCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 60
V V+ NL E + K H N++ ++ + +V +M +GS +
Sbjct: 55 VTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAK 114
Query: 61 KYL-YSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSD 119
+ ++ I+ V AL+Y+H +H +K ++L+ + YLS
Sbjct: 115 DLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSG 171
Query: 120 FGIAKLLI--GEDQSMTQTQTLATIG---YMAPEYGREGRVSTNG--DVYSFGIMLMETF 172
+I G+ Q + ++ +++PE ++ + D+YS GI E
Sbjct: 172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELA 231
Query: 173 TGKKP 177
G P
Sbjct: 232 NGHVP 236
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-21
Identities = 51/209 (24%), Positives = 88/209 (42%), Gaps = 34/209 (16%)
Query: 3 VAVKVFN---LQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
+A+KV L+ E E+ +RH N++++ + L+LEY P G++
Sbjct: 37 LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV 96
Query: 60 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSD 119
+ L + + + ++A+AL Y H S VIH D+KP+N+LL ++D
Sbjct: 97 YRELQKLSKFDEQRTA-TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIAD 152
Query: 120 FGIAKLLIGEDQSMTQTQTL-ATIGYMAPE------YGREGRVSTNGDVYSFGIMLMETF 172
FG + + L T+ Y+ PE + + D++S G++ E
Sbjct: 153 FGWSVHAPSS-----RRTDLCGTLDYLPPEMIEGRMHDEK------VDLWSLGVLCYEFL 201
Query: 173 TGKKP--------TYE-FFNGEMTLKHWV 192
GK P TY+ E T +V
Sbjct: 202 VGKPPFEANTYQETYKRISRVEFTFPDFV 230
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 5e-21
Identities = 63/271 (23%), Positives = 106/271 (39%), Gaps = 46/271 (16%)
Query: 3 VAVKVFNL-QCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL-- 59
VA+K NL +C + E + M H N++ +S ++ LV++ + GS+
Sbjct: 43 VAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLD 102
Query: 60 -----EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLV 114
+ +LD I+ +V LEYLH IH D+K N+LL ++
Sbjct: 103 IIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGS 159
Query: 115 AYLSDFGIAKLLIGEDQSMTQTQTLATIG---YMAPEYGREGRV-STNGDVYSFGIMLME 170
++DFG++ L +G +MAPE + R D++SFGI +E
Sbjct: 160 VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIE 219
Query: 171 TFTGKKPTYEF------FNGEMTLKHWVND--WLPISTMEVVDANLLSQEDIHFVAKEQC 222
TG P +++ +TL+ ND L + + ++
Sbjct: 220 LATGAAPYHKYPPMKVLM---LTLQ---NDPPSLETGVQDKEMLKKYGKSFRKMISL--- 270
Query: 223 VSFVFNLAMACTVESPEQRINAKEIVTKLLK 253
C + PE+R A E LL+
Sbjct: 271 ----------CLQKDPEKRPTAAE----LLR 287
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 9e-21
Identities = 48/179 (26%), Positives = 81/179 (45%), Gaps = 14/179 (7%)
Query: 3 VAVKVFNL-QCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 61
VA+K+ +L + + E ++ + K S + +++EY+ GS
Sbjct: 50 VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD 109
Query: 62 YLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFG 121
L LD Q I+ ++ L+YLH S IH D+K NVLL ++ L+DFG
Sbjct: 110 LL--EPGPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFG 164
Query: 122 IAKLLIGEDQSMTQTQTLATIG---YMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 177
+A L + + T +G +MAPE ++ + D++S GI +E G+ P
Sbjct: 165 VAGQL---TDTQIKRNTF--VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 1e-20
Identities = 37/175 (21%), Positives = 73/175 (41%), Gaps = 15/175 (8%)
Query: 18 SFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI--LDIFQR 75
+ V+ M +N + + S + + + ++ +L+ ++ + +
Sbjct: 107 APSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC 166
Query: 76 LNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQ 135
L+I I +A A+E+LH S ++H DLKP N+ + V + DFG+ + +++ T
Sbjct: 167 LHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 136 TQTLA----------TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYE 180
+ T YM+PE S D++S G++L E E
Sbjct: 224 LTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME 278
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-20
Identities = 47/214 (21%), Positives = 85/214 (39%), Gaps = 44/214 (20%)
Query: 3 VAVKVFN---LQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
+A+KV L+ E E+ +RH N++++ + + + L+LE+ P G L
Sbjct: 42 MALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGEL 101
Query: 60 EKYLYSSNCILDIFQRLN------IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNL 113
K L R + M ++A AL Y H VIH D+KP+N+L+
Sbjct: 102 YKELQKH-------GRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKG 151
Query: 114 VAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPE------YGREGRVSTNGDVYSFGIM 167
++DFG + +T T+ Y+ PE + + D++ G++
Sbjct: 152 ELKIADFGWSVH---APSLRRRT-MCGTLDYLPPEMIEGKTHDEK------VDLWCAGVL 201
Query: 168 LMETFTGKKP--------TYE-FFNGEMTLKHWV 192
E G P T+ N ++ ++
Sbjct: 202 CYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFL 235
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 3e-20
Identities = 36/193 (18%), Positives = 77/193 (39%), Gaps = 28/193 (14%)
Query: 3 VAVKVFNL-QCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKA------------L 49
A+K L A + E + + + H +++ ++ + +
Sbjct: 33 YAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYI 92
Query: 50 VLEYMPHGSLEKYL--YSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNV 107
++ +L+ ++ + + L+I + +A A+E+LH S ++H DLKP N+
Sbjct: 93 QMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNI 149
Query: 108 LLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIG----------YMAPEYGREGRVST 157
+ V + DFG+ + +++ T + YM+PE S
Sbjct: 150 FFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSH 209
Query: 158 NGDVYSFGIMLME 170
D++S G++L E
Sbjct: 210 KVDIFSLGLILFE 222
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 4e-20
Identities = 45/186 (24%), Positives = 84/186 (45%), Gaps = 22/186 (11%)
Query: 2 EVAVKVFN---LQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGS 58
EVA+K+ + + + E ++ ++H +++++ + + + LVLE +G
Sbjct: 38 EVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGE 97
Query: 59 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLS 118
+ +YL + + + M + + + YLH S ++H DL N+LL N+ ++
Sbjct: 98 MNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIA 154
Query: 119 DFGIAKLLIGEDQSMTQTQTL-ATIGYMAPE------YGREGRVSTNGDVYSFGIMLMET 171
DFG+A L + TL T Y++PE +G E DV+S G M
Sbjct: 155 DFGLATQLKMPHEKH---YTLCGTPNYISPEIATRSAHGLE------SDVWSLGCMFYTL 205
Query: 172 FTGKKP 177
G+ P
Sbjct: 206 LIGRPP 211
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 4e-20
Identities = 42/189 (22%), Positives = 75/189 (39%), Gaps = 29/189 (15%)
Query: 2 EVAVKVFN---LQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGS 58
A K+ L + +E + +S+ H++++ + +F +VLE S
Sbjct: 42 VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 101
Query: 59 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLS 118
L + + + R + + +YLH VIH DLK N+ L+++L +
Sbjct: 102 LLELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIG 157
Query: 119 DFGIAKLLIGEDQSMTQTQTLATI-G---YMAPE------YGREGRVSTNGDVYSFGIML 168
DFG+A + + + G Y+APE + E DV+S G ++
Sbjct: 158 DFGLATKV------EYDGERKKVLCGTPNYIAPEVLSKKGHSFE------VDVWSIGCIM 205
Query: 169 METFTGKKP 177
GK P
Sbjct: 206 YTLLVGKPP 214
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 4e-20
Identities = 42/189 (22%), Positives = 75/189 (39%), Gaps = 29/189 (15%)
Query: 2 EVAVKVFN---LQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGS 58
A K+ L + +E + +S+ H++++ + +F +VLE S
Sbjct: 68 VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 127
Query: 59 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLS 118
L + + + R + + +YLH VIH DLK N+ L+++L +
Sbjct: 128 LLELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIG 183
Query: 119 DFGIAKLLIGEDQSMTQTQTLATI-G---YMAPE------YGREGRVSTNGDVYSFGIML 168
DFG+A + + + G Y+APE + E DV+S G ++
Sbjct: 184 DFGLATKV------EYDGERKKVLCGTPNYIAPEVLSKKGHSFE------VDVWSIGCIM 231
Query: 169 METFTGKKP 177
GK P
Sbjct: 232 YTLLVGKPP 240
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 5e-20
Identities = 42/176 (23%), Positives = 80/176 (45%), Gaps = 8/176 (4%)
Query: 3 VAVKVFNLQCGRA-FKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 61
+A K+ +L+ A E +++ ++ + ++ ++ +E+M GSL++
Sbjct: 61 MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 120
Query: 62 YLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFG 121
+ + + I V L YL ++H D+KP N+L++ L DFG
Sbjct: 121 -VLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFG 177
Query: 122 IAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 177
++ LI SM + + T YM+PE + S D++S G+ L+E G+ P
Sbjct: 178 VSGQLI---DSMANS-FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 7e-20
Identities = 48/189 (25%), Positives = 82/189 (43%), Gaps = 43/189 (22%)
Query: 1 MEVAVKVFNLQCGRAFKSFDV--ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGS 58
E A + N + A + E + + ++H N++++ S S E L+ + + G
Sbjct: 37 QEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGE 96
Query: 59 L-----EKYLYS----SNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLL 109
L + YS S+CI I A+ + H V+H +LKP+N+LL
Sbjct: 97 LFEDIVAREYYSEADASHCIQQIL----------EAVLHCH---QMGVVHRNLKPENLLL 143
Query: 110 ---DDNLVAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAPE------YGREGRVSTNG 159
L+DFG+A + GE Q+ A T GY++PE YG+
Sbjct: 144 ASKLKGAAVKLADFGLAIEVEGEQQAWF---GFAGTPGYLSPEVLRKDPYGKP------V 194
Query: 160 DVYSFGIML 168
D+++ G++L
Sbjct: 195 DLWACGVIL 203
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-19
Identities = 51/236 (21%), Positives = 87/236 (36%), Gaps = 36/236 (15%)
Query: 25 MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCIL-DIFQRLNIMIDVA 83
++KS +++ + + +E M + + I I + + + +
Sbjct: 77 VLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGK--MTVAIV 134
Query: 84 SALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIG 143
AL YL VIH D+KP N+LLD+ L DFGI+ L+ + ++
Sbjct: 135 KALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLV---DDKAKDRSAGCAA 189
Query: 144 YMAPE-----YGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEM-TLKHWVNDWLP 197
YMAPE + DV+S GI L+E TG+ P Y+ + L + + P
Sbjct: 190 YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP-YKNCKTDFEVLTKVLQEEPP 248
Query: 198 ISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLLK 253
+ S + FV C + +R + LL+
Sbjct: 249 LLP----GHMGFSGDFQSFVKD-------------CLTKDHRKRPKYNK----LLE 283
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-19
Identities = 57/239 (23%), Positives = 90/239 (37%), Gaps = 37/239 (15%)
Query: 25 MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN------I 78
+M+S +++ + E + +E M S +K+ + + I
Sbjct: 74 VMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFY--KYVYSVLDDVIPEEILGKI 130
Query: 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQT 138
+ AL +L +IH D+KP N+LLD + L DFGI+ L+ S+ +T+
Sbjct: 131 TLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLV---DSIAKTRD 185
Query: 139 LATIGYMAPE----YGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVND 194
YMAPE DV+S GI L E TG+ P ++ + L V
Sbjct: 186 AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKG 245
Query: 195 WLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLLK 253
P + + S I+FV C + +R KE LLK
Sbjct: 246 DPP--QLSNSEEREFSPSFINFVNL-------------CLTKDESKRPKYKE----LLK 285
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 4e-19
Identities = 52/239 (21%), Positives = 95/239 (39%), Gaps = 41/239 (17%)
Query: 25 MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN------I 78
M+++ + + E + +E M SL+K+ ++D Q + I
Sbjct: 59 SMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQ---VIDKGQTIPEDILGKI 114
Query: 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQT 138
+ + ALE+LH S VIH D+KP NVL++ + DFGI+ L+ + +
Sbjct: 115 AVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLV---DDVAKDID 169
Query: 139 LATIGYMAPE----YGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVND 194
YMAPE + S D++S GI ++E + P Y+ + V +
Sbjct: 170 AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP-YDSWGTPFQQLKQVVE 228
Query: 195 WLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLLK 253
+ A+ S E + F ++ C ++ ++R E L++
Sbjct: 229 EPSPQ----LPADKFSAEFVDFTSQ-------------CLKKNSKERPTYPE----LMQ 266
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 4e-19
Identities = 44/159 (27%), Positives = 78/159 (49%), Gaps = 6/159 (3%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81
E ++M + H +K+ + ++E L Y +G L KY+ + R +
Sbjct: 80 ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-E 138
Query: 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTL-A 140
+ SALEYLH +IH DLKP+N+LL++++ ++DFG AK+L E + +
Sbjct: 139 IVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR-ANSFVG 194
Query: 141 TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTY 179
T Y++PE E + D+++ G ++ + G P
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR 233
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 4e-19
Identities = 40/251 (15%), Positives = 86/251 (34%), Gaps = 58/251 (23%)
Query: 22 ECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF---QRLN 77
E + +H ++++ S+ + ++ + EY GSL + + I+ F + +
Sbjct: 60 EVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD 119
Query: 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAY-------------------LS 118
+++ V L Y+H S ++H D+KP N+ + + +
Sbjct: 120 LLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIG 176
Query: 119 DFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTN-GDVYSFGIMLMETFTGKKP 177
D G + S Q + ++A E +E D+++ + ++ +
Sbjct: 177 DLGHVTRI-----SSPQVEE-GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
Query: 178 TYEFFNGEMTLKHWVNDWLPISTMEVVDA-NLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236
NG+ W I + +LSQE +
Sbjct: 231 ---PRNGDQ--------WHEIRQGRLPRIPQVLSQEFTELLKV-------------MIHP 266
Query: 237 SPEQRINAKEI 247
PE+R +A +
Sbjct: 267 DPERRPSAMAL 277
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 4e-19
Identities = 45/186 (24%), Positives = 82/186 (44%), Gaps = 43/186 (23%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL-- 59
A+K S + E ++K I+H N++ + + LV++ + G L
Sbjct: 36 LFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFD 95
Query: 60 ---EKYLYS----SNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLL--- 109
E+ +Y+ S I + SA++YLH ++H DLKP+N+L
Sbjct: 96 RILERGVYTEKDASLVIQQVL----------SAVKYLH---ENGIVHRDLKPENLLYLTP 142
Query: 110 DDNLVAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAPE------YGREGRVSTNGDVY 162
++N ++DFG++K + ++ M+ T T GY+APE Y + D +
Sbjct: 143 EENSKIMITDFGLSK--MEQNGIMS---TACGTPGYVAPEVLAQKPYSKA------VDCW 191
Query: 163 SFGIML 168
S G++
Sbjct: 192 SIGVIT 197
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 5e-19
Identities = 47/199 (23%), Positives = 85/199 (42%), Gaps = 53/199 (26%)
Query: 1 MEVAVKVFNLQCGRAFKSFDV---------ECEMMKSI-RHRNLIKVISSCSNEEFKALV 50
E AVK+ ++ G +F + +V E ++++ + H N+I++ + F LV
Sbjct: 43 KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLV 102
Query: 51 LEYMPHGSL-----EKYLYS----SNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCD 101
+ M G L EK S + + + LH ++H D
Sbjct: 103 FDLMKKGELFDYLTEKVTLSEKETRKIMRALL----------EVICALH---KLNIVHRD 149
Query: 102 LKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPE------------Y 149
LKP+N+LLDD++ L+DFG + + + + + T Y+APE Y
Sbjct: 150 LKPENILLDDDMNIKLTDFGFSC-QLDPGEKL--REVCGTPSYLAPEIIECSMNDNHPGY 206
Query: 150 GREGRVSTNGDVYSFGIML 168
G+E D++S G+++
Sbjct: 207 GKE------VDMWSTGVIM 219
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 6e-19
Identities = 46/187 (24%), Positives = 82/187 (43%), Gaps = 42/187 (22%)
Query: 2 EVAVKVFN--LQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
E A K+ N R F+ + E + + ++H N++++ S E F LV + + G L
Sbjct: 56 EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL 115
Query: 60 -----EKYLYS----SNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLL- 109
+ YS S+CI I ++ Y H S ++H +LKP+N+LL
Sbjct: 116 FEDIVAREFYSEADASHCIQQIL----------ESIAYCH---SNGIVHRNLKPENLLLA 162
Query: 110 --DDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPE------YGREGRVSTNGDV 161
L+DFG+A + + ++ T GY++PE Y + D+
Sbjct: 163 SKAKGAAVKLADFGLAI-EVNDSEAW--HGFAGTPGYLSPEVLKKDPYSKP------VDI 213
Query: 162 YSFGIML 168
++ G++L
Sbjct: 214 WACGVIL 220
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 7e-19
Identities = 50/184 (27%), Positives = 74/184 (40%), Gaps = 22/184 (11%)
Query: 3 VAVKVFNLQCGRA---FKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
VA+K + ++ ++ E ++ +RH N I+ E LV+EY GS
Sbjct: 82 VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSA 140
Query: 60 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSD 119
L L + + L YLH S +IH D+K N+LL + + L D
Sbjct: 141 SDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGD 197
Query: 120 FGIAKLLIGEDQSMTQTQTLATIG---YMAPE---YGREGRVSTNGDVYSFGIMLMETFT 173
FG A M + +G +MAPE EG+ DV+S GI +E
Sbjct: 198 FGSA-------SIMAPANSF--VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 248
Query: 174 GKKP 177
K P
Sbjct: 249 RKPP 252
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 8e-19
Identities = 46/188 (24%), Positives = 84/188 (44%), Gaps = 42/188 (22%)
Query: 1 MEVAVKVFNLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGS 58
+E A K+ N + R F+ + E + + ++H N++++ S E F LV + + G
Sbjct: 32 LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE 91
Query: 59 L-----EKYLYS----SNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLL 109
L + YS S+CI I ++ Y H S ++H +LKP+N+LL
Sbjct: 92 LFEDIVAREFYSEADASHCIQQIL----------ESIAYCH---SNGIVHRNLKPENLLL 138
Query: 110 ---DDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPE------YGREGRVSTNGD 160
L+DFG+A + + ++ T GY++PE Y + D
Sbjct: 139 ASKAKGAAVKLADFGLAI-EVNDSEAW--HGFAGTPGYLSPEVLKKDPYSKP------VD 189
Query: 161 VYSFGIML 168
+++ G++L
Sbjct: 190 IWACGVIL 197
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 1e-18
Identities = 47/199 (23%), Positives = 84/199 (42%), Gaps = 37/199 (18%)
Query: 2 EVAVKVFNLQCGRAFKSFDV--ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
E A+K+ + + E ++K + H N++K+ ++ LV+E G L
Sbjct: 64 ERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL 123
Query: 60 -----EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLL---DD 111
+ ++ I+ V S + YLH ++H DLKP+N+LL +
Sbjct: 124 FDEIIHRMKFNEV------DAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEK 174
Query: 112 NLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPE-----YGREGRVSTNGDVYSFGI 166
+ + + DFG++ + + M + L T Y+APE Y + DV+S G+
Sbjct: 175 DALIKIVDFGLSA-VFENQKKM--KERLGTAYYIAPEVLRKKYDEK------CDVWSIGV 225
Query: 167 MLMETFTGKKPTYEFFNGE 185
+L G P F G+
Sbjct: 226 ILFILLAGYPP----FGGQ 240
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 1e-18
Identities = 50/200 (25%), Positives = 86/200 (43%), Gaps = 38/200 (19%)
Query: 2 EVAVKVFN---LQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGS 58
E AVKV + ++ +S E +++K + H N++K+ ++ + LV E G
Sbjct: 53 ECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGE 112
Query: 59 L-----EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLL---D 110
L + +S I ++ V S + Y+H ++H DLKP+N+LL
Sbjct: 113 LFDEIISRKRFSEVDAARIIRQ------VLSGITYMH---KNKIVHRDLKPENLLLESKS 163
Query: 111 DNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPE-----YGREGRVSTNGDVYSFG 165
+ + DFG++ + M + T Y+APE Y + DV+S G
Sbjct: 164 KDANIRIIDFGLST-HFEASKKM--KDKIGTAYYIAPEVLHGTYDEK------CDVWSTG 214
Query: 166 IMLMETFTGKKPTYEFFNGE 185
++L +G P FNG
Sbjct: 215 VILYILLSGCPP----FNGA 230
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-18
Identities = 43/195 (22%), Positives = 78/195 (40%), Gaps = 48/195 (24%)
Query: 1 MEVAVKVFN---LQCGRAFKSFDVECEM--MKSIRHRNLIKVISSCSNEEFKALVLEYMP 55
+ AVK+ + + D++ E ++H ++++++ + S++ +V E+M
Sbjct: 50 QQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMD 109
Query: 56 HGSL---------EKYLYS----SNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDL 102
L ++YS S+ + I AL Y H +IH D+
Sbjct: 110 GADLCFEIVKRADAGFVYSEAVASHYMRQIL----------EALRYCH---DNNIIHRDV 156
Query: 103 KPDNVLL---DDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPE------YGREG 153
KP VLL +++ L FG+A L + T +MAPE YG+
Sbjct: 157 KPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA--GGRVGTPHFMAPEVVKREPYGKP- 213
Query: 154 RVSTNGDVYSFGIML 168
DV+ G++L
Sbjct: 214 -----VDVWGCGVIL 223
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-18
Identities = 53/193 (27%), Positives = 87/193 (45%), Gaps = 46/193 (23%)
Query: 2 EVAVKVFN---LQCGRAFKSFDV-----ECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 53
+VA+++ + G A ++ E E++K + H +IK+ + E++ +VLE
Sbjct: 162 KVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLEL 220
Query: 54 MPHGSL-----EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVL 108
M G L F + A++YLH +IH DLKP+NVL
Sbjct: 221 MEGGELFDKVVGNKRLKEATCKLYFY------QMLLAVQYLH---ENGIIHRDLKPENVL 271
Query: 109 L---DDNLVAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAPE---------YGREGRV 155
L +++ + ++DFG +K ++GE M TL T Y+APE Y R V
Sbjct: 272 LSSQEEDCLIKITDFGHSK-ILGETSLMR---TLCGTPTYLAPEVLVSVGTAGYNRA--V 325
Query: 156 STNGDVYSFGIML 168
D +S G++L
Sbjct: 326 ----DCWSLGVIL 334
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-18
Identities = 51/168 (30%), Positives = 85/168 (50%), Gaps = 24/168 (14%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81
E ++M+ + H L+ + S +EE +V++ + G L +L + + +L I +
Sbjct: 65 ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC-E 123
Query: 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLA- 140
+ AL+YL + +IH D+KPDN+LLD++ +++DF IA +L E TQ T+A
Sbjct: 124 LVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE----TQITTMAG 176
Query: 141 TIGYMAPE---------YGREGRVSTNGDVYSFGIMLMETFTGKKPTY 179
T YMAPE Y V D +S G+ E G++P +
Sbjct: 177 TKPYMAPEMFSSRKGAGYSFA--V----DWWSLGVTAYELLRGRRPYH 218
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 4e-18
Identities = 54/193 (27%), Positives = 87/193 (45%), Gaps = 46/193 (23%)
Query: 2 EVAVKVFN---LQCGRAFKSFDV-----ECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 53
+VA+K+ + G A ++ E E++K + H +IK+ + E++ +VLE
Sbjct: 37 KVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLEL 95
Query: 54 MPHGSL-----EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVL 108
M G L F + A++YLH +IH DLKP+NVL
Sbjct: 96 MEGGELFDKVVGNKRLKEATCKLYFY------QMLLAVQYLH---ENGIIHRDLKPENVL 146
Query: 109 L---DDNLVAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAPE---------YGREGRV 155
L +++ + ++DFG +K ++GE M TL T Y+APE Y R V
Sbjct: 147 LSSQEEDCLIKITDFGHSK-ILGETSLMR---TLCGTPTYLAPEVLVSVGTAGYNRA--V 200
Query: 156 STNGDVYSFGIML 168
D +S G++L
Sbjct: 201 ----DCWSLGVIL 209
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 4e-18
Identities = 45/189 (23%), Positives = 76/189 (40%), Gaps = 47/189 (24%)
Query: 2 EVAVKVFN--LQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
E AVKV N + + E E++K + H N++K+ + +V E G L
Sbjct: 49 EYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL 108
Query: 60 EKYLYSSNCILDIFQRL------------NIMIDVASALEYLHFGCSAPVIHCDLKPDNV 107
F + I+ V S + Y+H ++H DLKP+N+
Sbjct: 109 -------------FDEIIKRKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENI 152
Query: 108 LL---DDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPE-----YGREGRVSTNG 159
LL + + + DFG++ ++ M + T Y+APE Y +
Sbjct: 153 LLESKEKDCDIKIIDFGLST-CFQQNTKM--KDRIGTAYYIAPEVLRGTYDEK------C 203
Query: 160 DVYSFGIML 168
DV+S G++L
Sbjct: 204 DVWSAGVIL 212
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 5e-18
Identities = 46/174 (26%), Positives = 80/174 (45%), Gaps = 26/174 (14%)
Query: 22 ECEMMKSIRHRNLIK---VISSCSNEEFKALVLEYMPHGSLEKYL----YSSNCILDIFQ 74
E ++K + H N++K V+ + + +V E + G + + S + FQ
Sbjct: 86 EIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVMEVPTLKPLSEDQARFYFQ 144
Query: 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMT 134
D+ +EYLH +IH D+KP N+L+ ++ ++DFG++ G D ++
Sbjct: 145 ------DLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD-ALL 194
Query: 135 QTQTLATIGYMAPEYGREGRVSTNG---DVYSFGIMLMETFTGKKPTYEFFNGE 185
T+ T +MAPE E R +G DV++ G+ L G+ P F E
Sbjct: 195 SN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP----FMDE 243
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 6e-18
Identities = 27/179 (15%), Positives = 50/179 (27%), Gaps = 38/179 (21%)
Query: 2 EVAVKVFNLQCGRA--FKS-FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGS 58
+VA+ + Q + I + +V+ +V E++ GS
Sbjct: 58 QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGS 117
Query: 59 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLS 118
L++ +S + M +A+A + H A V P V + +
Sbjct: 118 LQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSID------ 165
Query: 119 DFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 177
G LA M ++ D+ G L + P
Sbjct: 166 --GDVV--------------LAYPATMPDANPQD-------DIRGIGASLYALLVNRWP 201
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 1e-17
Identities = 49/199 (24%), Positives = 85/199 (42%), Gaps = 37/199 (18%)
Query: 2 EVAVKVFNLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
E AVKV N + + E E++K + H N++K+ + +V E G L
Sbjct: 49 EYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL 108
Query: 60 -----EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLL---DD 111
++ +S + I+ V S + Y+H ++H DLKP+N+LL +
Sbjct: 109 FDEIIKRKRFSEH------DAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEK 159
Query: 112 NLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPE-----YGREGRVSTNGDVYSFGI 166
+ + DFG++ ++ M + T Y+APE Y + DV+S G+
Sbjct: 160 DCDIKIIDFGLST-CFQQNTKM--KDRIGTAYYIAPEVLRGTYDEK------CDVWSAGV 210
Query: 167 MLMETFTGKKPTYEFFNGE 185
+L +G P F G+
Sbjct: 211 ILYILLSGTPP----FYGK 225
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 1e-17
Identities = 49/183 (26%), Positives = 79/183 (43%), Gaps = 17/183 (9%)
Query: 4 AVKVFNLQCGRAFKSFDVECEM-----MKSIRHRNLIKVISSCSNEEFKALVLEYMPHGS 58
A K L R K + M + + R ++ + + + LV+ M G
Sbjct: 214 ACKK--LNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGD 271
Query: 59 LEKYLYSSNCILDIF--QRLNIMI-DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVA 115
+ ++Y+ + F R + S LE+LH +I+ DLKP+NVLLDD+
Sbjct: 272 IRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNV 328
Query: 116 YLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTG 174
+SD G+A L T+T+ A T G+MAPE + D ++ G+ L E
Sbjct: 329 RISDLGLAVELKAGQ---TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAA 385
Query: 175 KKP 177
+ P
Sbjct: 386 RGP 388
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-17
Identities = 48/181 (26%), Positives = 73/181 (40%), Gaps = 31/181 (17%)
Query: 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL- 59
+ A K F E E+MKS+ H N+I++ + + LV+E G L
Sbjct: 35 IRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELF 94
Query: 60 ----EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLL---DDN 112
K ++ + I + DV SA+ Y H V H DLKP+N L +
Sbjct: 95 ERVVHKRVFRESDAARIMK------DVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPD 145
Query: 113 LVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPE-----YGREGRVSTNGDVYSFGIM 167
L DFG+A + M + T Y++P+ YG E D +S G+M
Sbjct: 146 SPLKLIDFGLAA-RFKPGKMM--RTKVGTPYYVSPQVLEGLYGPE------CDEWSAGVM 196
Query: 168 L 168
+
Sbjct: 197 M 197
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-17
Identities = 44/194 (22%), Positives = 75/194 (38%), Gaps = 57/194 (29%)
Query: 1 MEVAVKVFNLQCGRAFKSFDVECE---MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHG 57
ME AVK+ + D E +++ +H N+I + + ++ +V E M G
Sbjct: 48 MEFAVKIIDK------SKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGG 101
Query: 58 SLEKYLYSSNCILDIFQRL------------NIMIDVASALEYLHFGCSAPVIHCDLKPD 105
L ++ ++ + +EYLH + V+H DLKP
Sbjct: 102 EL-------------LDKILRQKFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPS 145
Query: 106 NVLL----DDNLVAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAPE------YGREGR 154
N+L + + DFG AK L E+ + T T ++APE Y
Sbjct: 146 NILYVDESGNPESIRICDFGFAKQLRAENGLLM---TPCYTANFVAPEVLERQGYDAA-- 200
Query: 155 VSTNGDVYSFGIML 168
D++S G++L
Sbjct: 201 C----DIWSLGVLL 210
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 2e-17
Identities = 36/156 (23%), Positives = 68/156 (43%), Gaps = 11/156 (7%)
Query: 24 EMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVA 83
++ + ++ + + + + +L+ M G L +L + R ++
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA-EII 302
Query: 84 SALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLA-TI 142
LE++H + V++ DLKP N+LLD++ +SD G+A + + T
Sbjct: 303 LGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-----KPHASVGTH 354
Query: 143 GYMAPE-YGREGRVSTNGDVYSFGIMLMETFTGKKP 177
GYMAPE + ++ D +S G ML + G P
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-17
Identities = 51/194 (26%), Positives = 79/194 (40%), Gaps = 42/194 (21%)
Query: 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIR-HRNLIKVISSCSNEEFKALVLEYMPHGSL 59
E AVK+ Q G E EM+ + HRN++++I E+ LV E M GS+
Sbjct: 39 QEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI 98
Query: 60 EKYLYSSNCILDIFQRL------------NIMIDVASALEYLHFGCSAPVIHCDLKPDNV 107
+ ++ DVASAL++LH + + H DLKP+N+
Sbjct: 99 -------------LSHIHKRRHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENI 142
Query: 108 LL---DDNLVAYLSDFGIAKLL-IGEDQSMTQTQTLATI----GYMAPEYGREGRVSTNG 159
L + + DF + + + D S T L T YMAPE +
Sbjct: 143 LCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASI 202
Query: 160 -----DVYSFGIML 168
D++S G++L
Sbjct: 203 YDKRCDLWSLGVIL 216
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 3e-17
Identities = 46/197 (23%), Positives = 78/197 (39%), Gaps = 25/197 (12%)
Query: 2 EVAVKVFN----LQCGRAFKSFDVECEMMKSIRHRNLIK---VISSCSNEEFKALVLEYM 54
AVK+ + + E ++++ +RH+N+I+ V+ + ++ +V+EY
Sbjct: 32 RRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM-YMVMEYC 90
Query: 55 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLV 114
G E + Q + LEYLH S ++H D+KP N+LL
Sbjct: 91 VCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGT 147
Query: 115 AYLSDFGIAKLLIGEDQSMTQTQTLATI----GYMAPE--YGREGRVSTNGDVYSFGIML 168
+S G+A+ L T T + PE G + D++S G+ L
Sbjct: 148 LKISALGVAEAL----HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTL 203
Query: 169 METFTGKKPTYEFFNGE 185
TG P F G+
Sbjct: 204 YNITTGLYP----FEGD 216
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 3e-17
Identities = 44/177 (24%), Positives = 80/177 (45%), Gaps = 35/177 (19%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYSSNCILDIFQRL 76
E ++KS+ H N+IK+ ++++ LV E+ G L ++ + +I ++
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQ- 154
Query: 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLL---DDNLVAYLSDFGIAKLLIGEDQSM 133
+ S + YLH ++H D+KP+N+LL + L + DFG++ +D +
Sbjct: 155 -----ILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSS-FFSKDYKL 205
Query: 134 TQTQTLATIGYMAPE-----YGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGE 185
L T Y+APE Y + DV+S G+++ G P F G+
Sbjct: 206 --RDRLGTAYYIAPEVLKKKYNEK------CDVWSCGVIMYILLCGYPP----FGGQ 250
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 4e-17
Identities = 39/177 (22%), Positives = 72/177 (40%), Gaps = 22/177 (12%)
Query: 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL- 59
K N + E +M + H LI + + ++ L+LE++ G L
Sbjct: 77 RVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELF 136
Query: 60 -----EKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNL 113
E Y S + I N M L+++H ++H D+KP+N++ +
Sbjct: 137 DRIAAEDYKMSEAEVI-------NYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKK 186
Query: 114 VAYL--SDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIML 168
+ + DFG+A + D+ + T AT + APE V D+++ G++
Sbjct: 187 ASSVKIIDFGLAT-KLNPDEIV--KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-17
Identities = 47/166 (28%), Positives = 73/166 (43%), Gaps = 42/166 (25%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYS----SNCILDI 72
E ++ + H N+IK+ +LVLE + G L EK YS ++ + I
Sbjct: 98 EIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQI 157
Query: 73 FQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLL---DDNLVAYLSDFGIAKLLIGE 129
A+ YLH ++H DLKP+N+L + ++DFG++K ++
Sbjct: 158 L----------EAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSK-IVEH 203
Query: 130 DQSMTQTQTLA-TIGYMAPE------YGREGRVSTNGDVYSFGIML 168
M T+ T GY APE YG E V D++S GI+
Sbjct: 204 QVLMK---TVCGTPGYCAPEILRGCAYGPE--V----DMWSVGIIT 240
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 4e-17
Identities = 48/190 (25%), Positives = 79/190 (41%), Gaps = 49/190 (25%)
Query: 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIR-HRNLIKVISSCSNEEFKALVLEYMPHGSL 59
AVK+ + R + E +K H N++K+ ++ LV+E + G L
Sbjct: 37 QAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93
Query: 60 EKYLYSSNCILDIFQRL------------NIMIDVASALEYLHFGCSAPVIHCDLKPDNV 107
F+R+ IM + SA+ ++H V+H DLKP+N+
Sbjct: 94 -------------FERIKKKKHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENL 137
Query: 108 LL---DDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPE------YGREGRVSTN 158
L +DNL + DFG A+L ++Q + T+ Y APE Y
Sbjct: 138 LFTDENDNLEIKIIDFGFARLKPPDNQPL--KTPCFTLHYAAPELLNQNGYDES------ 189
Query: 159 GDVYSFGIML 168
D++S G++L
Sbjct: 190 CDLWSLGVIL 199
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 1e-16
Identities = 41/167 (24%), Positives = 70/167 (41%), Gaps = 6/167 (3%)
Query: 12 CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILD 71
R K + + R ++ SS S+ + L + + LY L
Sbjct: 134 RFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKD--FLT 191
Query: 72 IFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQ 131
+ + VA +E+L S IH DL N+LL + V + DFG+A+ + +
Sbjct: 192 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248
Query: 132 SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKP 177
+ + + +MAPE + + DV+SFG++L E F+ G P
Sbjct: 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 1e-16
Identities = 50/191 (26%), Positives = 78/191 (40%), Gaps = 25/191 (13%)
Query: 3 VAVKVFNLQCGRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKA------LVLEYMP 55
A+KV ++ G + E M+K HRN+ + + LV+E+
Sbjct: 52 AAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCG 110
Query: 56 HGSL-EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLV 114
GS+ + + L I ++ L +LH VIH D+K NVLL +N
Sbjct: 111 AGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAE 167
Query: 115 AYLSDFGIAKLLIGEDQSMTQTQTLATIG---YMAPEYGREGRVSTNG-----DVYSFGI 166
L DFG++ L D+++ + T IG +MAPE D++S GI
Sbjct: 168 VKLVDFGVSAQL---DRTVGRRNTF--IGTPYWMAPEVIACDENPDATYDFKSDLWSLGI 222
Query: 167 MLMETFTGKKP 177
+E G P
Sbjct: 223 TAIEMAEGAPP 233
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 1e-16
Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 60/202 (29%)
Query: 1 MEVAVKVFNL--------QCGRAFKSFDVECEMMKSIR-HRNLIKVISSCSNEEFKALVL 51
E AVK+ + Q ++ E +++ + H ++I +I S + F LV
Sbjct: 120 HEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVF 179
Query: 52 EYMPHGSLEKYLYSSNCILDIFQRL------------NIMIDVASALEYLHFGCSAPVIH 99
+ M G L F L +IM + A+ +LH + ++H
Sbjct: 180 DLMRKGEL-------------FDYLTEKVALSEKETRSIMRSLLEAVSFLH---ANNIVH 223
Query: 100 CDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAPE---------- 148
DLKP+N+LLDDN+ LSDFG + + + + L T GY+APE
Sbjct: 224 RDLKPENILLDDNMQIRLSDFGFSC-HLEPGEKLR---ELCGTPGYLAPEILKCSMDETH 279
Query: 149 --YGREGRVSTNGDVYSFGIML 168
YG+E D+++ G++L
Sbjct: 280 PGYGKE------VDLWACGVIL 295
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 1e-16
Identities = 51/188 (27%), Positives = 82/188 (43%), Gaps = 32/188 (17%)
Query: 3 VAVK----VFNLQ--CGRAFKSFDVECEMMKSIRHRNLIKV----ISSCSNEEFKA--LV 50
VA+K F Q RA++ E +MK + H+N+I + S EEF+ +V
Sbjct: 53 VAIKKLSRPFQNQTHAKRAYR----ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIV 108
Query: 51 LEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNV 107
+E M ++ L ++Q L +++LH SA +IH DLKP N+
Sbjct: 109 MELMDANLCQVIQMELDHERMSYLLYQMLC-------GIKHLH---SAGIIHRDLKPSNI 158
Query: 108 LLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIM 167
++ + + DFG+A+ S T + T Y APE N D++S G +
Sbjct: 159 VVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 215
Query: 168 LMETFTGK 175
+ E G
Sbjct: 216 MGEMIKGG 223
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-16
Identities = 38/166 (22%), Positives = 62/166 (37%), Gaps = 25/166 (15%)
Query: 22 ECEMMKSIRHRNLIK---VISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCILDIFQRL 76
E ++ H N++ + LV E M L + ++ ++
Sbjct: 79 EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQ 137
Query: 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQT 136
M + L LH A V+H DL P N+LL DN + DF +A+ D + T
Sbjct: 138 YFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAR-EDTADANK--T 191
Query: 137 QTLATIGYMAPE-------YGREGRVSTNGDVYSFGIMLMETFTGK 175
+ Y APE + + D++S G ++ E F K
Sbjct: 192 HYVTHRWYRAPELVMQFKGF------TKLVDMWSAGCVMAEMFNRK 231
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 2e-16
Identities = 38/177 (21%), Positives = 65/177 (36%), Gaps = 22/177 (12%)
Query: 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL- 59
A K ++ E + M +RH L+ + + ++ ++ E+M G L
Sbjct: 183 NNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELF 242
Query: 60 -----EKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNL 113
E S + M V L ++H +H DLKP+N++
Sbjct: 243 EKVADEHNKMSEDEAV-------EYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKR 292
Query: 114 VAYL--SDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIML 168
L DFG+ + QS+ T T + APE V D++S G++
Sbjct: 293 SNELKLIDFGLTA-HLDPKQSV--KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 2e-16
Identities = 51/234 (21%), Positives = 78/234 (33%), Gaps = 57/234 (24%)
Query: 2 EVAVKVFNLQCGRAFKSFDV-----ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPH 56
A+K+ N R DV E +MK + H N+ ++ +E++ LV+E
Sbjct: 53 IRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHG 112
Query: 57 GSLEKYLYSSNCILDIFQRL---------------------------------------N 77
G L L + N
Sbjct: 113 GHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISN 172
Query: 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLL--DDNLVAYLSDFGIAKLLIGEDQSMTQ 135
IM + SAL YLH + + H D+KP+N L + + L DFG++K +
Sbjct: 173 IMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYY 229
Query: 136 --TQTLATIGYMAPE--YGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGE 185
T T ++APE D +S G++L G P F G
Sbjct: 230 GMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP----FPGV 279
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 5e-16
Identities = 34/180 (18%), Positives = 69/180 (38%), Gaps = 34/180 (18%)
Query: 20 DVEC-----EMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQ 74
+ C +++ + + + + + ++ LV++Y G L L
Sbjct: 117 ETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLL----------S 166
Query: 75 RLNIMID----------VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 124
+ + + A++ +H +H D+KPDN+L+D N L+DFG
Sbjct: 167 KFEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCL 223
Query: 125 LLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG-----DVYSFGIMLMETFTGKKPTY 179
L+ + + + T Y++PE + D +S G+ + E G+ P Y
Sbjct: 224 KLMEDGTVQSSV-AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY 282
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 6e-16
Identities = 43/166 (25%), Positives = 81/166 (48%), Gaps = 12/166 (7%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81
E ++K ++H+N++++ +++ LV E+ L+KY S N LD + +
Sbjct: 51 EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQ 109
Query: 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLAT 141
+ L + H S V+H DLKP N+L++ N L++FG+A+ + + + T
Sbjct: 110 LLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVT 164
Query: 142 IGYMAPE--YGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGE 185
+ Y P+ +G + ST+ D++S G + E +P F G
Sbjct: 165 LWYRPPDVLFGAK-LYSTSIDMWSAGCIFAELANAGRP---LFPGN 206
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 6e-16
Identities = 45/183 (24%), Positives = 81/183 (44%), Gaps = 20/183 (10%)
Query: 4 AVKVFNLQCGRAFKSFDVECEM-----MKSIRHRNLIKVISSCSNEEFKALVLEYMPHGS 58
A K L+ R K + ++ + R ++ + + ++ LVL M G
Sbjct: 213 ACKK--LEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGD 270
Query: 59 LEKYLYSSNCILDIFQRLNIMI---DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVA 115
L+ ++Y + F + ++ LE LH +++ DLKP+N+LLDD+
Sbjct: 271 LKFHIY--HMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHI 325
Query: 116 YLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTG 174
+SD G+A + + T+GYMAPE + R + + D ++ G +L E G
Sbjct: 326 RISDLGLAVHVPEGQ----TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG 381
Query: 175 KKP 177
+ P
Sbjct: 382 QSP 384
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 6e-16
Identities = 46/179 (25%), Positives = 78/179 (43%), Gaps = 24/179 (13%)
Query: 2 EVAVKVFN-LQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 60
E +K N + + + E E++KS+ H N+IK+ + +V+E G L
Sbjct: 49 ERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELL 108
Query: 61 KYLYSSNCILDIF---QRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLL---DDNLV 114
+ + S+ +M + +AL Y H S V+H DLKP+N+L +
Sbjct: 109 ERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSP 165
Query: 115 AYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPE-----YGREGRVSTNGDVYSFGIML 168
+ DFG+A+ L D+ T T YMAPE + D++S G+++
Sbjct: 166 IKIIDFGLAE-LFKSDEHS--TNAAGTALYMAPEVFKRDVTFK------CDIWSAGVVM 215
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 7e-16
Identities = 46/176 (26%), Positives = 73/176 (41%), Gaps = 38/176 (21%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81
E ++M ++++ + ++ + +V+EYMP G L + ++
Sbjct: 119 ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM----------SNYDVPEK 168
Query: 82 VA--------SALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSM 133
A AL+ +H S IH D+KPDN+LLD + L+DFG + E
Sbjct: 169 WARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 225
Query: 134 TQTQTLATIGYMAPE----------YGREGRVSTNGDVYSFGIMLMETFTGKKPTY 179
T + T Y++PE YGRE D +S G+ L E G P Y
Sbjct: 226 CDT-AVGTPDYISPEVLKSQGGDGYYGRE--C----DWWSVGVFLYEMLVGDTPFY 274
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-15
Identities = 40/178 (22%), Positives = 78/178 (43%), Gaps = 24/178 (13%)
Query: 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL- 59
+++A K+ + + + E +M + H NLI++ + ++ LV+EY+ G L
Sbjct: 115 LKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF 174
Query: 60 -----EKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLL---D 110
E Y + + I M + + ++H ++H DLKP+N+L D
Sbjct: 175 DRIIDESYNLTELDTI-------LFMKQICEGIRHMH---QMYILHLDLKPENILCVNRD 224
Query: 111 DNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIML 168
+ + DFG+A+ + + T ++APE VS D++S G++
Sbjct: 225 AKQIK-IIDFGLAR-RYKPREKL--KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-15
Identities = 43/165 (26%), Positives = 75/165 (45%), Gaps = 23/165 (13%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81
E +++++ L+K+ S + +V+EY+ G + +L + R
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-Q 149
Query: 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTL-A 140
+ EYLH S +I+ DLKP+N+L+D ++DFG AK + G +T TL
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCG 200
Query: 141 TIGYMAPE------YGREGRVSTNGDVYSFGIMLMETFTGKKPTY 179
T +APE Y + V D ++ G+++ E G P +
Sbjct: 201 TPEALAPEIILSKGYNKA--V----DWWALGVLIYEMAAGYPPFF 239
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-15
Identities = 57/243 (23%), Positives = 100/243 (41%), Gaps = 47/243 (19%)
Query: 3 VAVK----VFNLQ--CGRAFKSFDVECEMMKSIRHRNLIK----VISSCSNEEFKA--LV 50
VA+K F + RA++ E ++K ++H N+I + S F LV
Sbjct: 52 VAIKKLSRPFQSEIFAKRAYR----ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV 107
Query: 51 LEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNV 107
+ +M + ++Q L L+Y+H SA V+H DLKP N+
Sbjct: 108 MPFMQTDLQKIMGLKFSEEKIQYLVYQMLK-------GLKYIH---SAGVVHRDLKPGNL 157
Query: 108 LLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPE-YGREGRVSTNGDVYSFGI 166
++++ + DFG+A+ D M T + T Y APE + D++S G
Sbjct: 158 AVNEDCELKILDFGLAR---HADAEM--TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGC 212
Query: 167 MLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFV 226
++ E TGK F G K +++ I ++V E + + + S++
Sbjct: 213 IMAEMLTGK----TLFKG----KDYLDQLTQI--LKVTGV--PGTEFVQKLNDKAAKSYI 260
Query: 227 FNL 229
+L
Sbjct: 261 QSL 263
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 3e-15
Identities = 51/188 (27%), Positives = 83/188 (44%), Gaps = 32/188 (17%)
Query: 3 VAVK----VFN--LQCGRAFKSFDVECEMMKSIRHRNLIKVI----SSCSNEEFKA--LV 50
VA+K F RA++ E +MK + H+N+I ++ + EEF+ LV
Sbjct: 90 VAIKKLSRPFQNQTHAKRAYR----ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 145
Query: 51 LEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNV 107
+E M ++ L ++Q L +++LH SA +IH DLKP N+
Sbjct: 146 MELMDANLCQVIQMELDHERMSYLLYQMLC-------GIKHLH---SAGIIHRDLKPSNI 195
Query: 108 LLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIM 167
++ + + DFG+A+ G M T + T Y APE N D++S G +
Sbjct: 196 VVKSDCTLKILDFGLAR-TAGTSFMM--TPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 252
Query: 168 LMETFTGK 175
+ E K
Sbjct: 253 MGEMVRHK 260
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 4e-15
Identities = 42/161 (26%), Positives = 67/161 (41%), Gaps = 19/161 (11%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81
E M+K ++H NL+ ++ + LV EY H ++ L + +I
Sbjct: 52 EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQ 110
Query: 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLAT 141
A+ + H IH D+KP+N+L+ + V L DFG A+LL G +AT
Sbjct: 111 TLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY--DDEVAT 165
Query: 142 IGYMAPE-------YGREGRVSTNGDVYSFGIMLMETFTGK 175
Y +PE Y DV++ G + E +G
Sbjct: 166 RWYRSPELLVGDTQY------GPPVDVWAIGCVFAELLSGV 200
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 5e-15
Identities = 44/156 (28%), Positives = 77/156 (49%), Gaps = 9/156 (5%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81
E ++K + H N++ +I +E LV E+M L+K L + L Q +
Sbjct: 69 EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQ 127
Query: 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLAT 141
+ + + H ++H DLKP N+L++ + L+DFG+A+ +S T + T
Sbjct: 128 LLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVT 182
Query: 142 IGYMAPE--YGREGRVSTNGDVYSFGIMLMETFTGK 175
+ Y AP+ G + + ST+ D++S G + E TGK
Sbjct: 183 LWYRAPDVLMGSK-KYSTSVDIWSIGCIFAEMITGK 217
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 6e-15
Identities = 58/241 (24%), Positives = 101/241 (41%), Gaps = 40/241 (16%)
Query: 2 EVAVK----VFN--LQCGRAFKSFDVECEMMKSIRHRNLIKV----ISSCSNEEFKA--L 49
VAVK F + R ++ E ++K ++H N+I + + S EEF L
Sbjct: 56 RVAVKKLSRPFQSIIHAKRTYR----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 111
Query: 50 VLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLL 109
V M L + D Q ++ + L+Y+H SA +IH DLKP N+ +
Sbjct: 112 VTHLMGA-DLNNIVKCQKLTDDHVQ--FLIYQILRGLKYIH---SADIIHRDLKPSNLAV 165
Query: 110 DDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPE-YGREGRVSTNGDVYSFGIML 168
+++ + DFG+A+ M T +AT Y APE + D++S G ++
Sbjct: 166 NEDCELKILDFGLAR---HTADEM--TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 220
Query: 169 METFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFN 228
E TG+ F G ++ I + +V E + ++ E +++ +
Sbjct: 221 AELLTGR----TLFPG----TDHIDQLKLI--LRLVGT--PGAELLKKISSESARNYIQS 268
Query: 229 L 229
L
Sbjct: 269 L 269
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 6e-15
Identities = 53/223 (23%), Positives = 89/223 (39%), Gaps = 44/223 (19%)
Query: 2 EVAVKVFNLQCGRAFKSFDV------ECEMMKSIRHRNLIK---VISSCSNEEFKALVLE 52
VAVK+ +++ ++ D E + K + H N++K N ++ L LE
Sbjct: 34 AVAVKIVDMK-----RAVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQY--LFLE 85
Query: 53 YMPHGSLEKYLYSSNCI-----LDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNV 107
Y G L + + F +L + + YLH + H D+KP+N+
Sbjct: 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLH---GIGITHRDIKPENL 136
Query: 108 LLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPE--YGRE--GRVSTNGDVYS 163
LLD+ +SDFG+A + ++ + T+ Y+APE RE DV+S
Sbjct: 137 LLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV---DVWS 193
Query: 164 FGIMLMETFTGKKPTYEFFNGEMTLKHWVN------DWLPIST 200
GI+L G+ P + + W W I +
Sbjct: 194 CGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 236
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 6e-15
Identities = 51/172 (29%), Positives = 80/172 (46%), Gaps = 28/172 (16%)
Query: 20 DVEC-----EMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQ 74
VE M+ + H +I++ + + + ++++Y+ G L L S +
Sbjct: 49 QVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA 108
Query: 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMT 134
+ +V ALEYLH S +I+ DLKP+N+LLD N ++DFG AK +
Sbjct: 109 KFYAA-EVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP------D 158
Query: 135 QTQTL-ATIGYMAPE------YGREGRVSTNGDVYSFGIMLMETFTGKKPTY 179
T TL T Y+APE Y + + D +SFGI++ E G P Y
Sbjct: 159 VTYTLCGTPDYIAPEVVSTKPYNKS--I----DWWSFGILIYEMLAGYTPFY 204
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 6e-15
Identities = 60/245 (24%), Positives = 111/245 (45%), Gaps = 46/245 (18%)
Query: 3 VAVK---VFN--LQCGRAFKSFDVECEMMKSIRHRNLIK---VISSCSNEEFKA--LVLE 52
VA+K F C R + E +++ RH N+I +I + + E+ K +V +
Sbjct: 55 VAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQD 110
Query: 53 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDN 112
M L K L + + + + + L+Y+H SA V+H DLKP N+LL+
Sbjct: 111 LME-TDLYKLLKT-QHLSNDHICY-FLYQILRGLKYIH---SANVLHRDLKPSNLLLNTT 164
Query: 113 LVAYLSDFGIAKLLIGEDQSMTQ-TQTLATIGYMAPE-------YGREGRVSTNGDVYSF 164
+ DFG+A++ + T+ +AT Y APE Y + + D++S
Sbjct: 165 CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY------TKSIDIWSV 218
Query: 165 GIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVS 224
G +L E + + F G KH+++ I + ++ + SQED++ + + +
Sbjct: 219 GCILAEMLSNR----PIFPG----KHYLDQLNHI--LGILGS--PSQEDLNCIINLKARN 266
Query: 225 FVFNL 229
++ +L
Sbjct: 267 YLLSL 271
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 7e-15
Identities = 35/157 (22%), Positives = 62/157 (39%), Gaps = 23/157 (14%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYS-SNCILDIFQR 75
E +++ + H N+I + N L+LE + G L +K S
Sbjct: 65 EVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT------ 118
Query: 76 LNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLL----DDNLVAYLSDFGIAKLLIGEDQ 131
+ + + + YLH + + H DLKP+N++L L DFG+A I +
Sbjct: 119 -SFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGV 173
Query: 132 SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIML 168
T ++APE + D++S G++
Sbjct: 174 EF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 8e-15
Identities = 46/191 (24%), Positives = 82/191 (42%), Gaps = 34/191 (17%)
Query: 2 EVAVKVFNLQCGRAFKSFDV-----ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPH 56
EVA+K+ + + E +MK + H N++K+ E+ L++EY
Sbjct: 42 EVAIKIID---KTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASG 98
Query: 57 GSLEKYLYSSNCILD-----IFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDD 111
G + YL + + + F+++ SA++Y H ++H DLK +N+LLD
Sbjct: 99 GEVFDYLVAHGRMKEKEARSKFRQI------VSAVQYCH---QKRIVHRDLKAENLLLDA 149
Query: 112 NLVAYLSDFGIAKLLIGEDQSMTQTQTLATI----GYMAPE-YGREGRVSTNGDVYSFGI 166
++ ++DFG + T L Y APE + + DV+S G+
Sbjct: 150 DMNIKIADFGFS-------NEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGV 202
Query: 167 MLMETFTGKKP 177
+L +G P
Sbjct: 203 ILYTLVSGSLP 213
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 71.4 bits (176), Expect = 8e-15
Identities = 44/184 (23%), Positives = 71/184 (38%), Gaps = 29/184 (15%)
Query: 1 MEVAVKVFN------LQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYM 54
E A K + G + + + E +++ IRH N+I + N+ L+LE +
Sbjct: 31 KEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELV 90
Query: 55 PHGSL-----EKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVL 108
G L EK + + + + YLH S + H DLKP+N++
Sbjct: 91 SGGELFDFLAEKESLTEDEAT-------QFLKQILDGVHYLH---SKRIAHFDLKPENIM 140
Query: 109 L----DDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSF 164
L N L DFGIA I T ++APE + D++S
Sbjct: 141 LLDKNVPNPRIKLIDFGIAH-KIEAGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSI 197
Query: 165 GIML 168
G++
Sbjct: 198 GVIT 201
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 9e-15
Identities = 35/157 (22%), Positives = 62/157 (39%), Gaps = 23/157 (14%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYS-SNCILDIFQR 75
E +++ + H N+I + N L+LE + G L +K S
Sbjct: 65 EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT------ 118
Query: 76 LNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLL----DDNLVAYLSDFGIAKLLIGEDQ 131
+ + + + YLH + + H DLKP+N++L L DFG+A I +
Sbjct: 119 -SFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGV 173
Query: 132 SMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIML 168
T ++APE + D++S G++
Sbjct: 174 EF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-14
Identities = 33/180 (18%), Positives = 70/180 (38%), Gaps = 29/180 (16%)
Query: 1 MEVAVKVFNLQCGRAFKSFDV--ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGS 58
K + V E ++ RHRN++ + S + E ++ E++
Sbjct: 31 KTYMAKFVK---VKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLD 87
Query: 59 L------EKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLL-- 109
+ + + + + + V AL++LH S + H D++P+N++
Sbjct: 88 IFERINTSAFELNEREIV-------SYVHQVCEALQFLH---SHNIGHFDIRPENIIYQT 137
Query: 110 -DDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIML 168
+ + + +FG A+ + + Y APE + VST D++S G ++
Sbjct: 138 RRSSTIK-IIEFGQAR-QLKPGDNF--RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-14
Identities = 40/156 (25%), Positives = 73/156 (46%), Gaps = 9/156 (5%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81
E ++K ++H N++ + E+ LV EY+ L++YL I+++ +
Sbjct: 50 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQ 108
Query: 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLAT 141
+ L Y H V+H DLKP N+L+++ L+DFG+A+ ++ + T
Sbjct: 109 LLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY--DNEVVT 163
Query: 142 IGYMAPE--YGREGRVSTNGDVYSFGIMLMETFTGK 175
+ Y P+ G ST D++ G + E TG+
Sbjct: 164 LWYRPPDILLGST-DYSTQIDMWGVGCIFYEMATGR 198
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 2e-14
Identities = 57/200 (28%), Positives = 93/200 (46%), Gaps = 39/200 (19%)
Query: 2 EVAVKVFN---LQCGRAFKSFDVECEMMKSIRHRNLIK---VISSCSNEEFKALVLEYMP 55
+VAVK+ N ++ E + +K RH ++IK VIS+ + F +V+EY+
Sbjct: 38 KVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST-PTDFF--MVMEYVS 94
Query: 56 HGSLEKYLYSSNCI-----LDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLD 110
G L Y+ + +FQ++ SA++Y H V+H DLKP+NVLLD
Sbjct: 95 GGELFDYICKHGRVEEMEARRLFQQI------LSAVDYCH---RHMVVHRDLKPENVLLD 145
Query: 111 DNLVAYLSDFGIAKLLIGEDQSMTQTQTLATI----GYMAPE-YGREGRVSTNGDVYSFG 165
++ A ++DFG++ + M+ + L T Y APE D++S G
Sbjct: 146 AHMNAKIADFGLSNM-------MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCG 198
Query: 166 IMLMETFTGKKPTYEFFNGE 185
++L G P F+ E
Sbjct: 199 VILYALLCGTLP----FDDE 214
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 2e-14
Identities = 37/158 (23%), Positives = 64/158 (40%), Gaps = 25/158 (15%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL-----EKYLYS-SNCILDIFQR 75
E ++K I+H N+I + N+ L+LE + G L EK +
Sbjct: 64 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT------ 117
Query: 76 LNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLL-----DDNLVAYLSDFGIAKLLIGED 130
+ + + + YLH S + H DLKP+N++L + + DFG+A I
Sbjct: 118 -EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIK-IIDFGLAH-KIDFG 171
Query: 131 QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIML 168
T ++APE + D++S G++
Sbjct: 172 NEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 70.6 bits (174), Expect = 2e-14
Identities = 39/156 (25%), Positives = 75/156 (48%), Gaps = 9/156 (5%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81
E ++K ++H N++K+ ++ LV E++ L+K L L+ + ++
Sbjct: 50 EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQ 108
Query: 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLAT 141
+ + + Y H V+H DLKP N+L++ ++DFG+A+ + T + T
Sbjct: 109 LLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEIVT 163
Query: 142 IGYMAPE--YGREGRVSTNGDVYSFGIMLMETFTGK 175
+ Y AP+ G + + ST D++S G + E G
Sbjct: 164 LWYRAPDVLMGSK-KYSTTIDIWSVGCIFAEMVNGT 198
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 2e-14
Identities = 39/182 (21%), Positives = 67/182 (36%), Gaps = 36/182 (19%)
Query: 20 DVECEM-----MKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQ 74
+V C + + R + ++ + +E + LV+EY G L L
Sbjct: 104 EVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLL----------S 153
Query: 75 RLNIMID----------VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 124
+ I + A++ +H +H D+KPDN+LLD L+DFG
Sbjct: 154 KFGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCL 210
Query: 125 LLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVY-------SFGIMLMETFTGKKP 177
L + + + T Y++PE + Y + G+ E F G+ P
Sbjct: 211 KLRADGTVRSLV-AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
Query: 178 TY 179
Y
Sbjct: 270 FY 271
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-14
Identities = 53/223 (23%), Positives = 89/223 (39%), Gaps = 44/223 (19%)
Query: 2 EVAVKVFNLQCGRAFKSFDV------ECEMMKSIRHRNLIK---VISSCSNEEFKALVLE 52
VAVK+ +++ ++ D E + K + H N++K N ++ L LE
Sbjct: 34 AVAVKIVDMK-----RAVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQY--LFLE 85
Query: 53 YMPHGSLEKYLYSSNCI-----LDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNV 107
Y G L + + F +L + + YLH + H D+KP+N+
Sbjct: 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQL------MAGVVYLH---GIGITHRDIKPENL 136
Query: 108 LLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPE--YGRE--GRVSTNGDVYS 163
LLD+ +SDFG+A + ++ + T+ Y+APE RE DV+S
Sbjct: 137 LLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV---DVWS 193
Query: 164 FGIMLMETFTGKKPTYEFFNGEMTLKHWVN------DWLPIST 200
GI+L G+ P + + W W I +
Sbjct: 194 CGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 236
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-14
Identities = 58/240 (24%), Positives = 104/240 (43%), Gaps = 40/240 (16%)
Query: 3 VAVK----VFN--LQCGRAFKSFDVECEMMKSIRHRNLIKVI----SSCSNEEFKA--LV 50
VA+K F L RA++ E ++K +RH N+I ++ + ++F LV
Sbjct: 53 VAIKKLYRPFQSELFAKRAYR----ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV 108
Query: 51 LEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLD 110
+ +M L K + L + ++ + L Y+H +A +IH DLKP N+ ++
Sbjct: 109 MPFMGT-DLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVN 162
Query: 111 DNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEY-GREGRVSTNGDVYSFGIMLM 169
++ + DFG+A+ D M T + T Y APE R + D++S G ++
Sbjct: 163 EDCELKILDFGLAR---QADSEM--TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMA 217
Query: 170 ETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNL 229
E TGK F G ++ I M+V E + + ++ +++ L
Sbjct: 218 EMITGK----TLFKG----SDHLDQLKEI--MKVTGT--PPAEFVQRLQSDEAKNYMKGL 265
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 2e-14
Identities = 47/166 (28%), Positives = 83/166 (50%), Gaps = 13/166 (7%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81
E ++++ + H N+I ++ + ++ +LV ++M LE + ++ +L M+
Sbjct: 62 EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLM 120
Query: 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLAT 141
LEYLH ++H DLKP+N+LLD+N V L+DFG+AK +++ T + T
Sbjct: 121 TLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVT 175
Query: 142 IGYMAPE--YGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGE 185
Y APE +G D+++ G +L E P F G+
Sbjct: 176 RWYRAPELLFGAR-MYGVGVDMWAVGCILAELLLR-VP---FLPGD 216
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-14
Identities = 56/231 (24%), Positives = 90/231 (38%), Gaps = 46/231 (19%)
Query: 2 EVAVKVFN--------LQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEY 53
EV VK +E ++ + H N+IKV+ N+ F LV+E
Sbjct: 51 EVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEK 110
Query: 54 MPHGSLEKYLY-SSNCILD------IFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDN 106
G L+ + + + LD IF++L SA+ YL +IH D+K +N
Sbjct: 111 HGSG-LDLFAFIDRHPRLDEPLASYIFRQL------VSAVGYLR---LKDIIHRDIKDEN 160
Query: 107 VLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPE------Y-GREGRVSTNG 159
+++ ++ L DFG A L E + T TI Y APE Y G E
Sbjct: 161 IVIAEDFTIKLIDFGSAAYL--ERGKLFYT-FCGTIEYCAPEVLMGNPYRGPE------L 211
Query: 160 DVYSFGIMLMETFTGKKPTYEF---FNGEMTLKHWVNDWLP--ISTMEVVD 205
+++S G+ L + P E + + V+ L +S +
Sbjct: 212 EMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELMSLVSGLLQPV 262
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 3e-14
Identities = 43/156 (27%), Positives = 77/156 (49%), Gaps = 9/156 (5%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81
E +++K +RH NL+ ++ C ++ LV E++ H ++ L LD +
Sbjct: 74 EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQ 132
Query: 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLAT 141
+ + + + H S +IH D+KP+N+L+ + V L DFG A+ L + +AT
Sbjct: 133 IINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--DDEVAT 187
Query: 142 IGYMAPE--YGREGRVSTNGDVYSFGIMLMETFTGK 175
Y APE G + + DV++ G ++ E F G+
Sbjct: 188 RWYRAPELLVG-DVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 4e-14
Identities = 39/195 (20%), Positives = 77/195 (39%), Gaps = 57/195 (29%)
Query: 1 MEVAVKVFNLQCGRAFKSFDVECE---MMKSIRHRNLIKVI----SSCSNEEFKALVLEY 53
+ A+K+ S E ++ +++ ++ + + +++E
Sbjct: 55 QKCALKLLY-------DSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMEC 107
Query: 54 MPHGSLEKYLYSSNCILD-IFQRLN----------IMIDVASALEYLHFGCSAPVIHCDL 102
M G L I +R + IM D+ +A+++LH S + H D+
Sbjct: 108 MEGGEL----------FSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDV 154
Query: 103 KPDNVLL---DDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPE------YGREG 153
KP+N+L + + V L+DFG AK ++ T Y+APE Y +
Sbjct: 155 KPENLLYTSKEKDAVLKLTDFGFAKET--TQNAL--QTPCYTPYYVAPEVLGPEKYDKS- 209
Query: 154 RVSTNGDVYSFGIML 168
D++S G+++
Sbjct: 210 -----CDMWSLGVIM 219
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 4e-14
Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 45/203 (22%)
Query: 2 EVAVKVFNLQCGRAFKSFDV------ECEMMKSIRHRNLIK---VISSCSNEEFKALVLE 52
+VAVK+ N Q +S DV E + +K RH ++IK VIS+ ++ F +V+E
Sbjct: 43 KVAVKILNRQ---KIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST-PSDIF--MVME 96
Query: 53 YMPHGSLEKYLYSSNCI-----LDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNV 107
Y+ G L Y+ + + +FQ++ S ++Y H V+H DLKP+NV
Sbjct: 97 YVSGGELFDYICKNGRLDEKESRRLFQQI------LSGVDYCH---RHMVVHRDLKPENV 147
Query: 108 LLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATI----GYMAPE-YGREGRVSTNGDVY 162
LLD ++ A ++DFG++ + M+ + L T Y APE D++
Sbjct: 148 LLDAHMNAKIADFGLSNM-------MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIW 200
Query: 163 SFGIMLMETFTGKKPTYEFFNGE 185
S G++L G P F+ +
Sbjct: 201 SSGVILYALLCGTLP----FDDD 219
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 7e-14
Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 6/100 (6%)
Query: 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLAT 141
+ ALE+LH +I+ D+K +N+LLD N L+DFG++K + ++ T
Sbjct: 168 IVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGT 223
Query: 142 IGYMAPEYGREGRVSTNGDV--YSFGIMLMETFTGKKPTY 179
I YMAP+ R G + V +S G+++ E TG P
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 263
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 7e-14
Identities = 38/184 (20%), Positives = 72/184 (39%), Gaps = 31/184 (16%)
Query: 1 MEVAVKVFNLQCGRAFKSFDV-----ECEMMKSIRHR-NLIKVISSCSNEEFKALVLEYM 54
E A K R E +++ + +I + N L+LEY
Sbjct: 55 QEYAAKFLKK---RRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYA 111
Query: 55 PHGSL-EKYLYSSNCILDIFQRL------NIMIDVASALEYLHFGCSAPVIHCDLKPDNV 107
G + C+ ++ + + ++ + + YLH ++H DLKP N+
Sbjct: 112 AGGEIFSL------CLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNI 162
Query: 108 LL---DDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSF 164
LL + DFG+++ IG + + + T Y+APE ++T D+++
Sbjct: 163 LLSSIYPLGDIKIVDFGMSR-KIGHACEL--REIMGTPEYLAPEILNYDPITTATDMWNI 219
Query: 165 GIML 168
GI+
Sbjct: 220 GIIA 223
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 7e-14
Identities = 46/172 (26%), Positives = 78/172 (45%), Gaps = 24/172 (13%)
Query: 20 DVECEM-----MKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQ 74
+V + +++ RH L + S + V+EY G L +L +
Sbjct: 191 EVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA 250
Query: 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMT 134
R ++ SAL+YLH + V++ DLK +N++LD + ++DFG+ K I + +
Sbjct: 251 RFYGA-EIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT-- 305
Query: 135 QTQTL-ATIGYMAPE------YGREGRVSTNGDVYSFGIMLMETFTGKKPTY 179
+T T Y+APE YGR V D + G+++ E G+ P Y
Sbjct: 306 -MKTFCGTPEYLAPEVLEDNDYGRA--V----DWWGLGVVMYEMMCGRLPFY 350
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 7e-14
Identities = 46/172 (26%), Positives = 77/172 (44%), Gaps = 25/172 (14%)
Query: 20 DVECEMM-----KSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQ 74
+V + ++ RH L + + + V+EY G L +L +
Sbjct: 48 EVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERA 107
Query: 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMT 134
R ++ SALEYLH S V++ D+K +N++LD + ++DFG+ K I + +
Sbjct: 108 RFYGA-EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-- 161
Query: 135 QTQTL-ATIGYMAPE------YGREGRVSTNGDVYSFGIMLMETFTGKKPTY 179
+T T Y+APE YGR V D + G+++ E G+ P Y
Sbjct: 162 -MKTFCGTPEYLAPEVLEDNDYGRA--V----DWWGLGVVMYEMMCGRLPFY 206
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 7e-14
Identities = 39/195 (20%), Positives = 75/195 (38%), Gaps = 56/195 (28%)
Query: 1 MEVAVKVFNLQCGRAFKSFDVECE---MMKSIRHRNLIKVI----SSCSNEEFKALVLEY 53
+ A+K+ E ++ + ++++++ + + + +V+E
Sbjct: 88 EKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 140
Query: 54 MPHGSLEKYLYSSNCILD-IFQRLN----------IMIDVASALEYLHFGCSAPVIHCDL 102
+ G L I R + IM + A++YLH S + H D+
Sbjct: 141 LDGGEL----------FSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDV 187
Query: 103 KPDNVLL---DDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPE------YGREG 153
KP+N+L N + L+DFG AK + T T Y+APE Y +
Sbjct: 188 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT---PCYTPYYVAPEVLGPEKYDKS- 243
Query: 154 RVSTNGDVYSFGIML 168
D++S G+++
Sbjct: 244 -----CDMWSLGVIM 253
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 8e-14
Identities = 45/171 (26%), Positives = 79/171 (46%), Gaps = 30/171 (17%)
Query: 22 ECEMMKSIRHRNLIKVI------SSCSNEEFKALVLEYMP---HGSLEKYLYSSNCILDI 72
E ++M+ + H N++++ +E + LVL+Y+P + Y + + I
Sbjct: 97 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 156
Query: 73 FQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAY-LSDFGIAKLLIGEDQ 131
+ +L M + +L Y+H S + H D+KP N+LLD + L DFG AK L+ +
Sbjct: 157 YVKL-YMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGE 211
Query: 132 SMTQTQTLATIGYMAPE-------YGREGRVSTNGDVYSFGIMLMETFTGK 175
+ + Y APE Y +++ DV+S G +L E G+
Sbjct: 212 PN--VSYICSRYYRAPELIFGATDY------TSSIDVWSAGCVLAELLLGQ 254
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 1e-13
Identities = 35/105 (33%), Positives = 56/105 (53%), Gaps = 19/105 (18%)
Query: 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTL-A 140
+A AL++LH S +I+ DLKP+N+LLD+ L+DFG++K I ++ +
Sbjct: 135 LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK---AYSFCG 188
Query: 141 TIGYMAPE------YGREGRVSTNGDVYSFGIMLMETFTGKKPTY 179
T+ YMAPE + + D +SFG+++ E TG P
Sbjct: 189 TVEYMAPEVVNRRGHTQS--A----DWWSFGVLMFEMLTGTLPFQ 227
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-13
Identities = 38/169 (22%), Positives = 67/169 (39%), Gaps = 29/169 (17%)
Query: 25 MMKSIRHRNLIK---VISSCSNEEFK----ALVLEYMP---HGSLEKYLYSSNCILDIFQ 74
+ + H N+++ + + + +V+EY+P H Y I
Sbjct: 72 DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILI 131
Query: 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLD-DNLVAYLSDFGIAKLLIGEDQSM 133
++ + + ++ LH S V H D+KP NVL++ + L DFG AK L +
Sbjct: 132 KV-FLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL-SPSEPN 188
Query: 134 TQTQTLATIGYMAPE-------YGREGRVSTNGDVYSFGIMLMETFTGK 175
+ + Y APE Y +T D++S G + E G+
Sbjct: 189 --VAYICSRYYRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLGE 229
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 1e-13
Identities = 37/111 (33%), Positives = 54/111 (48%), Gaps = 23/111 (20%)
Query: 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLA- 140
++ AL +LH +I+ DLKP+N++L+ L+DFG+ K I + T T
Sbjct: 130 ISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV---THTFCG 183
Query: 141 TIGYMAPE------YGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGE 185
TI YMAPE + R V D +S G ++ + TG P F GE
Sbjct: 184 TIEYMAPEILMRSGHNRA--V----DWWSLGALMYDMLTGAPP----FTGE 224
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 1e-13
Identities = 52/181 (28%), Positives = 75/181 (41%), Gaps = 30/181 (16%)
Query: 20 DVECEMM------KSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 73
DVEC M + H L ++ + V+E++ G L ++ S +
Sbjct: 66 DVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEAR 125
Query: 74 QRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSM 133
R ++ SAL +LH +I+ DLK DNVLLD L+DFG+ K I +
Sbjct: 126 ARF-YAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT- 180
Query: 134 TQTQTL-ATIGYMAPE------YGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEM 186
T T T Y+APE YG V D ++ G++L E G P F E
Sbjct: 181 --TATFCGTPDYIAPEILQEMLYGPA--V----DWWAMGVLLYEMLCGHAP----FEAEN 228
Query: 187 T 187
Sbjct: 229 E 229
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 69.7 bits (170), Expect = 1e-13
Identities = 50/179 (27%), Positives = 78/179 (43%), Gaps = 30/179 (16%)
Query: 20 DVECEMM------KSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 73
DVEC M+ + L ++ S + V+EY+ G L ++ +
Sbjct: 384 DVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPH 443
Query: 74 QRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSM 133
++A L +L S +I+ DLK DNV+LD ++DFG+ K I +
Sbjct: 444 AVFYAA-EIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV-- 497
Query: 134 TQTQTLA-TIGYMAPE------YGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGE 185
T+T T Y+APE YG+ V D ++FG++L E G+ P F GE
Sbjct: 498 -TTKTFCGTPDYIAPEIIAYQPYGKS--V----DWWAFGVLLYEMLAGQAP----FEGE 545
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 1e-13
Identities = 48/173 (27%), Positives = 81/173 (46%), Gaps = 18/173 (10%)
Query: 20 DVECEMM------KSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 73
DVEC M+ + H L + + +E V+EY+ G L ++ S +
Sbjct: 60 DVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSR 119
Query: 74 QRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSM 133
++ L++LH S +++ DLK DN+LLD + ++DFG+ K + D
Sbjct: 120 ATFYAA-EIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK- 174
Query: 134 TQTQTL-ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGE 185
T T T Y+APE + + + D +SFG++L E G+ P F+G+
Sbjct: 175 --TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP----FHGQ 221
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-13
Identities = 48/184 (26%), Positives = 78/184 (42%), Gaps = 39/184 (21%)
Query: 2 EVAVKVFNLQCGRAFKSFDV------ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMP 55
VAVK + + E +S+RH N+++ A+++EY
Sbjct: 47 LVAVKYIE-------RGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYAS 99
Query: 56 HGSLEKYLYSSNCI-----LDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLD 110
G L + + ++ FQ+L S + Y H S + H DLK +N LLD
Sbjct: 100 GGELYERICNAGRFSEDEARFFFQQL------LSGVSYCH---SMQICHRDLKLENTLLD 150
Query: 111 DNLVAYL--SDFGIAKLLIGEDQSMTQTQTLATIGYMAPE--YGRE--GRVSTNGDVYSF 164
+ L DFG +K S ++ T+ T Y+APE +E G+++ DV+S
Sbjct: 151 GSPAPRLKICDFGYSKSS--VLHSQPKS-TVGTPAYIAPEVLLRQEYDGKIA---DVWSC 204
Query: 165 GIML 168
G+ L
Sbjct: 205 GVTL 208
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-13
Identities = 51/198 (25%), Positives = 86/198 (43%), Gaps = 41/198 (20%)
Query: 3 VAVK---VFN--LQCGRAFKSFDVECEMMKSIRHRNLIK---VISSCSNEEFKA--LVLE 52
VA+K F+ L R + E +++K +H N+I + S E F ++ E
Sbjct: 39 VAIKKIEPFDKPLFALRTLR----EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQE 94
Query: 53 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDN 112
M L + + S+ + D + + A++ LH + VIH DLKP N+L++ N
Sbjct: 95 LMQ-TDLHRVI-STQMLSDDHIQY-FIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSN 148
Query: 113 LVAYLSDFGIAKLLIGEDQSMTQ--------TQTLATIGYMAPE-------YGREGRVST 157
+ DFG+A+++ ++ + +AT Y APE Y S
Sbjct: 149 CDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKY------SR 202
Query: 158 NGDVYSFGIMLMETFTGK 175
DV+S G +L E F +
Sbjct: 203 AMDVWSCGCILAELFLRR 220
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-13
Identities = 42/153 (27%), Positives = 65/153 (42%), Gaps = 23/153 (15%)
Query: 49 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVL 108
V+EY+ G L ++ + + R +++ AL YLH +I+ DLK DNVL
Sbjct: 87 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLH---ERGIIYRDLKLDNVL 142
Query: 109 LDDNLVAYLSDFGIAKLLIGEDQSMTQTQTL-ATIGYMAPE------YGREGRVSTNGDV 161
LD L+D+G+ K + T T T Y+APE YG V D
Sbjct: 143 LDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYIAPEILRGEDYGFS--V----DW 193
Query: 162 YSFGIMLMETFTGKKPTYEFFNGEMTLKHWVND 194
++ G+++ E G+ P F + N
Sbjct: 194 WALGVLMFEMMAGRSP---FDIVGSSDNPDQNT 223
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-13
Identities = 39/105 (37%), Positives = 52/105 (49%), Gaps = 19/105 (18%)
Query: 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTL-A 140
+ASAL YLH S +++ DLKP+N+LLD L+DFG+ K I + + T T
Sbjct: 148 IASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST---TSTFCG 201
Query: 141 TIGYMAPE------YGREGRVSTNGDVYSFGIMLMETFTGKKPTY 179
T Y+APE Y R V D + G +L E G P Y
Sbjct: 202 TPEYLAPEVLHKQPYDRT--V----DWWCLGAVLYEMLYGLPPFY 240
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-13
Identities = 51/196 (26%), Positives = 85/196 (43%), Gaps = 44/196 (22%)
Query: 2 EVAVK-VFNLQC--GRAFKSFDVECEMMKSIRHRNLIK----VISSCSNEEFKA--LVLE 52
EVA+K V + R E ++M+ ++H N++ S+ ++ LVLE
Sbjct: 66 EVAIKKVLQDKRFKNR-------ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE 118
Query: 53 YMPHGSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLL 109
Y+P ++ + + + M + +L Y+H S + H D+KP N+LL
Sbjct: 119 YVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLL 174
Query: 110 D---DNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPE-------YGREGRVSTNG 159
D L L DFG AK+LI + + + Y APE Y +TN
Sbjct: 175 DPPSGVLK--LIDFGSAKILI-AGEPN--VSYICSRYYRAPELIFGATNY------TTNI 223
Query: 160 DVYSFGIMLMETFTGK 175
D++S G ++ E G+
Sbjct: 224 DIWSTGCVMAELMQGQ 239
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 3e-13
Identities = 38/166 (22%), Positives = 74/166 (44%), Gaps = 17/166 (10%)
Query: 22 ECEMMKSIRHRN---LIKVISSCSNEEFKA-----LVLEYMPHGSLEKYLYSSNCILDIF 73
E ++++ ++H N LI++ + ++ + LV ++ H L L + +
Sbjct: 66 EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLS 124
Query: 74 QRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSM 133
+ +M + + L Y+H ++H D+K NVL+ + V L+DFG+A+ S
Sbjct: 125 EIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 181
Query: 134 TQ--TQTLATIGYMAPE--YGREGRVSTNGDVYSFGIMLMETFTGK 175
T + T+ Y PE G E D++ G ++ E +T
Sbjct: 182 PNRYTNRVVTLWYRPPELLLG-ERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 4e-13
Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 20/136 (14%)
Query: 49 LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVL 108
V+EY+ G L ++ + + R +++ AL YLH +I+ DLK DNVL
Sbjct: 130 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLH---ERGIIYRDLKLDNVL 185
Query: 109 LDDNLVAYLSDFGIAKLLIGEDQSMTQTQTL-ATIGYMAPE------YGREGRVSTNGDV 161
LD L+D+G+ K + T T T Y+APE YG V D
Sbjct: 186 LDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYIAPEILRGEDYGFS--V----DW 236
Query: 162 YSFGIMLMETFTGKKP 177
++ G+++ E G+ P
Sbjct: 237 WALGVLMFEMMAGRSP 252
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 5e-13
Identities = 44/147 (29%), Positives = 66/147 (44%), Gaps = 30/147 (20%)
Query: 49 LVLEYMPHGSLEKYLYSSNCILDIF--QRLNIMI-DVASALEYLHFGCSAPVIHCDLKPD 105
V+EY+ G L ++ F ++A L +L S +I+ DLK D
Sbjct: 98 FVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLD 150
Query: 106 NVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTL-ATIGYMAPE------YGREGRVSTN 158
NV+LD ++DFG+ K I + T+T T Y+APE YG+ V
Sbjct: 151 NVMLDSEGHIKIADFGMCKENIWDGV---TTKTFCGTPDYIAPEIIAYQPYGKS--V--- 202
Query: 159 GDVYSFGIMLMETFTGKKPTYEFFNGE 185
D ++FG++L E G+ P F GE
Sbjct: 203 -DWWAFGVLLYEMLAGQAP----FEGE 224
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-12
Identities = 48/200 (24%), Positives = 84/200 (42%), Gaps = 43/200 (21%)
Query: 3 VAVK--VFN--LQCGRAFKSFDVECEMMKSIRHRNLIKVI------------SSCSNEEF 46
VA+K V A + E ++++ + H N++KV S E
Sbjct: 39 VAIKKIVLTDPQSVKHALR----EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTEL 94
Query: 47 KA--LVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKP 104
+ +V EYM L L + + + M + L+Y+H SA V+H DLKP
Sbjct: 95 NSVYIVQEYME-TDLANVLEQGPLLEEHAR--LFMYQLLRGLKYIH---SANVLHRDLKP 148
Query: 105 DNVLLD-DNLVAYLSDFGIAKLLIGEDQSMTQ-TQTLATIGYMAPE-------YGREGRV 155
N+ ++ ++LV + DFG+A+++ ++ L T Y +P Y
Sbjct: 149 ANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNY------ 202
Query: 156 STNGDVYSFGIMLMETFTGK 175
+ D+++ G + E TGK
Sbjct: 203 TKAIDMWAAGCIFAEMLTGK 222
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 1e-12
Identities = 33/167 (19%), Positives = 71/167 (42%), Gaps = 20/167 (11%)
Query: 3 VAVK----VFN--LQCGRAFKSFDVECEMMKSIRHRNLIK---VISSCSNEEFKA--LVL 51
VA+K VF + C R + E ++ + H +++K ++ E+F +VL
Sbjct: 81 VAIKKILRVFEDLIDCKRILR----EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVL 136
Query: 52 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDD 111
E +K + + ++ + ++ ++ ++Y+H SA ++H DLKP N L++
Sbjct: 137 EIADS-DFKKLFRTPVYLTELHIKT-LLYNLLVGVKYVH---SAGILHRDLKPANCLVNQ 191
Query: 112 NLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTN 158
+ + DFG+A+ + + +Q M +
Sbjct: 192 DCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKR 238
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 2e-12
Identities = 41/159 (25%), Positives = 71/159 (44%), Gaps = 17/159 (10%)
Query: 25 MMKSIRHRN---LIKVISSCSNEEFKA--LVLEYMPHGSLEKYLYSSNCI-LDIFQRLNI 78
+++ H N L+ V ++ + LV E++ L YL + L ++
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDL 125
Query: 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQT 138
M L++LH + ++H DLKP+N+L+ L+DFG+A++ M T
Sbjct: 126 MRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALTPV 179
Query: 139 LATIGYMAPE--YGREGRVSTNGDVYSFGIMLMETFTGK 175
+ T+ Y APE +T D++S G + E F K
Sbjct: 180 VVTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEMFRRK 216
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-12
Identities = 57/200 (28%), Positives = 90/200 (45%), Gaps = 40/200 (20%)
Query: 2 EVAVKVFN---LQCGRAFKSFDVECEMMKSIRHRNLIK---VISSCSNEEFKALVLEYMP 55
+VA+K + L+ + E +K +RH ++IK VI++ + +V+EY
Sbjct: 36 KVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT-PTDIV--MVIEYA- 91
Query: 56 HGSLEKYLYSSNCI-----LDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLD 110
G L Y+ + FQ++ A+EY H ++H DLKP+N+LLD
Sbjct: 92 GGELFDYIVEKKRMTEDEGRRFFQQI------ICAIEYCH---RHKIVHRDLKPENLLLD 142
Query: 111 DNLVAYLSDFGIAKLLIGEDQSMTQTQTLATI----GYMAPE-YGREGRVSTNGDVYSFG 165
DNL ++DFG++ + MT L T Y APE + DV+S G
Sbjct: 143 DNLNVKIADFGLSNI-------MTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCG 195
Query: 166 IMLMETFTGKKPTYEFFNGE 185
I+L G+ P F+ E
Sbjct: 196 IVLYVMLVGRLP----FDDE 211
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 2e-12
Identities = 44/161 (27%), Positives = 75/161 (46%), Gaps = 14/161 (8%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI-----LDIFQRL 76
E +MK ++H N++++ E LV E+M + L+KY+ S L++
Sbjct: 53 EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVK 111
Query: 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQT 136
+ L + H ++H DLKP N+L++ L DFG+A+ + +
Sbjct: 112 YFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF--S 166
Query: 137 QTLATIGYMAPE--YGREGRVSTNGDVYSFGIMLMETFTGK 175
+ T+ Y AP+ G ST+ D++S G +L E TGK
Sbjct: 167 SEVVTLWYRAPDVLMGSR-TYSTSIDIWSCGCILAEMITGK 206
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 3e-12
Identities = 48/281 (17%), Positives = 100/281 (35%), Gaps = 69/281 (24%)
Query: 3 VAVK----VFN--LQCGRAFKSFDVECEMMKSIRHRNLIK---VISSCSNEEFKA--LVL 51
VA+K +F + C R + E ++ ++ +I+ +I +F +VL
Sbjct: 54 VAIKKVNRMFEDLIDCKRILR----EITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVL 109
Query: 52 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDD 111
E L+K + + + + I+ ++ ++H + +IH DLKP N LL+
Sbjct: 110 EIADS-DLKKLFKTPIFLTEEHIKT-ILYNLLLGENFIH---ESGIIHRDLKPANCLLNQ 164
Query: 112 NLVAYLSDFGIAKLLIGEDQSMTQ--------------------TQTLATIGYMAPE--- 148
+ + DFG+A+ + E + T + T Y APE
Sbjct: 165 DCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELIL 224
Query: 149 ----YGREGRVSTNGDVYSFGIMLMETFTGKKPTYE-------FFNGEMTLKHWVNDWLP 197
Y + + D++S G + E + F G +
Sbjct: 225 LQENY------TKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSK 278
Query: 198 ISTME-VVD-----ANLL---SQEDIHFVAKEQCVSFVFNL 229
+ D N++ +++D+ + K + + ++
Sbjct: 279 KVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLF 319
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 4e-12
Identities = 39/161 (24%), Positives = 73/161 (45%), Gaps = 15/161 (9%)
Query: 22 ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81
E ++K ++HRN+I++ S + L+ EY + L+KY+ N + + + +
Sbjct: 83 EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYM-DKNPDVSMRVIKSFLYQ 140
Query: 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAY-----LSDFGIAKLLIGEDQSMTQT 136
+ + + + H S +H DLKP N+LL + + + DFG+A+ + T
Sbjct: 141 LINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF--T 195
Query: 137 QTLATIGYMAPE--YGREGRVSTNGDVYSFGIMLMETFTGK 175
+ T+ Y PE G ST+ D++S + E
Sbjct: 196 HEIITLWYRPPEILLGSR-HYSTSVDIWSIACIWAEMLMKT 235
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 6e-12
Identities = 42/159 (26%), Positives = 69/159 (43%), Gaps = 17/159 (10%)
Query: 25 MMKSIRHRN---LIKVISSCSNEEFKA--LVLEYMPHGSLEKYLYS-SNCILDIFQRLNI 78
+++ H N L V + + LV E++ L YL + ++
Sbjct: 67 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDM 125
Query: 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQT 138
M + L++LH S V+H DLKP N+L+ + L+DFG+A++ M T
Sbjct: 126 MFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSV 179
Query: 139 LATIGYMAPE--YGREGRVSTNGDVYSFGIMLMETFTGK 175
+ T+ Y APE +T D++S G + E F K
Sbjct: 180 VVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRK 216
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-11
Identities = 37/150 (24%), Positives = 67/150 (44%), Gaps = 28/150 (18%)
Query: 39 SSCSNEEFKALVLEYMP---HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSA 95
+ S ++ +++EY+P H L+ ++ S I + + + A+ ++H S
Sbjct: 105 VNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISI-YIYQLFRAVGFIH---SL 160
Query: 96 PVIHCDLKPDNVLLD---DNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPE---- 148
+ H D+KP N+L++ + L L DFG AK LI + + + Y APE
Sbjct: 161 GICHRDIKPQNLLVNSKDNTLK--LCDFGSAKKLI-PSEPS--VAYICSRFYRAPELMLG 215
Query: 149 ---YGREGRVSTNGDVYSFGIMLMETFTGK 175
Y + + D++S G + E GK
Sbjct: 216 ATEY------TPSIDLWSIGCVFGELILGK 239
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 4e-11
Identities = 47/186 (25%), Positives = 74/186 (39%), Gaps = 33/186 (17%)
Query: 2 EVAVKVFN----LQCGRAFKSFDV--ECEMMKSIR----HRNLIKVISSCSNEEFKALVL 51
+VA+KV L S E ++ + H +I+++ +E LVL
Sbjct: 58 QVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVL 117
Query: 52 EY-MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLD 110
E +P L Y+ + + R V +A+++ H S V+H D+K +N+L+D
Sbjct: 118 ERPLPAQDLFDYITEKGPLGEGPSR-CFFGQVVAAIQHCH---SRGVVHRDIKDENILID 173
Query: 111 -DNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEY-------GREGRVSTNGDVY 162
A L DFG LL D+ T T Y PE+ V+
Sbjct: 174 LRRGCAKLIDFGSGALL--HDEPYTDFD--GTRVYSPPEWISRHQYHALP------ATVW 223
Query: 163 SFGIML 168
S GI+L
Sbjct: 224 SLGILL 229
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 6e-11
Identities = 42/184 (22%), Positives = 70/184 (38%), Gaps = 31/184 (16%)
Query: 2 EVAVKVFN----LQCGRAFKSFDV--ECEMMKSIRHR--NLIKVISSCSNEEFKALVLEY 53
VA+K G V E ++K + +I+++ + L+LE
Sbjct: 70 PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER 129
Query: 54 -MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDN 112
P L ++ + + R + V A+ + H + V+H D+K +N+L+D N
Sbjct: 130 PEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLN 185
Query: 113 -LVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEY-------GREGRVSTNGDVYSF 164
L DFG LL ++ T Y PE+ GR V+S
Sbjct: 186 RGELKLIDFGSGALL---KDTVYTD-FDGTRVYSPPEWIRYHRYHGRS------AAVWSL 235
Query: 165 GIML 168
GI+L
Sbjct: 236 GILL 239
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 8e-11
Identities = 37/177 (20%), Positives = 69/177 (38%), Gaps = 34/177 (19%)
Query: 22 ECEMMKSIRHRN---LIKVISSCSNEEFKALVLEYMPHGSLEKYL--------YSSNCIL 70
E +++ ++H N L KV S ++ + L+ +Y H L + L
Sbjct: 68 EIALLRELKHPNVISLQKVFLSHADRKV-WLLFDYAEH-DLWHIIKFHRASKANKKPVQL 125
Query: 71 DIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAY----LSDFGIAKLL 126
+++ + + YLH + V+H DLKP N+L+ ++D G A+L
Sbjct: 126 PRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182
Query: 127 IGEDQSMTQ-TQTLATIGYMAPE-------YGREGRVSTNGDVYSFGIMLMETFTGK 175
+ + + T Y APE Y + D+++ G + E T +
Sbjct: 183 NSPLKPLADLDPVVVTFWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTSE 233
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-10
Identities = 31/153 (20%), Positives = 59/153 (38%), Gaps = 47/153 (30%)
Query: 1 MEVAVKVFNLQCGRAFKSFDVECE---MMKSIRHRNLIKVI----SSCSNEEFKALVLEY 53
+ A+K+ E ++ + ++++++ + + + +V+E
Sbjct: 44 EKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 96
Query: 54 MPHGSLEKYLYSSNCILDIFQRL--------------NIMIDVASALEYLHFGCSAPVIH 99
+ G L F R+ IM + A++YLH S + H
Sbjct: 97 LDGGEL-------------FSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAH 140
Query: 100 CDLKPDNVLL---DDNLVAYLSDFGIAKLLIGE 129
D+KP+N+L N + L+DFG AK GE
Sbjct: 141 RDVKPENLLYTSKRPNAILKLTDFGFAKETTGE 173
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 3e-10
Identities = 45/200 (22%), Positives = 85/200 (42%), Gaps = 45/200 (22%)
Query: 3 VAVKVFNL-QCGRAFKSFDVECEMMKSIR-HRNLIK----VISSCSNEEFKALVLEYMPH 56
V VK+ + + + E ++++++R N+I V S ALV E++ +
Sbjct: 64 VVVKILKPVKKKKIKR----EIKILENLRGGPNIITLADIVKDPVSRTP--ALVFEHVNN 117
Query: 57 GSLEKYLYS---SNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLD-DN 112
++ + + +++ L AL+Y H S ++H D+KP NV++D ++
Sbjct: 118 TDFKQLYQTLTDYDIRFYMYEILK-------ALDYCH---SMGIMHRDVKPHNVMIDHEH 167
Query: 113 LVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPE-------YGREGRVSTNGDVYSFG 165
L D+G+A+ Q +A+ + PE Y + D++S G
Sbjct: 168 RKLRLIDWGLAEFYH-PGQEY--NVRVASRYFKGPELLVDYQMY------DYSLDMWSLG 218
Query: 166 IMLMETFTGKKPTYEFFNGE 185
ML K+P FF+G
Sbjct: 219 CMLASMIFRKEP---FFHGH 235
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-10
Identities = 57/262 (21%), Positives = 106/262 (40%), Gaps = 63/262 (24%)
Query: 3 VAVK-VFN-----LQCGRAFKSFDVECEMMKSIR-HRNLIKVISSCSNEEFKA--LVLEY 53
VAVK +F+ R F+ E ++ + H N++ +++ + + LV +Y
Sbjct: 37 VAVKKIFDAFQNSTDAQRTFR----EIMILTELSGHENIVNLLNVLRADNDRDVYLVFDY 92
Query: 54 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNL 113
M L + ++ IL+ + ++ + ++YLH S ++H D+KP N+LL+
Sbjct: 93 MET-DLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAEC 146
Query: 114 VAYLSDFGIAKLLIGEDQSMTQ-------------------TQTLATIGYMAPE------ 148
++DFG+++ + + T +AT Y APE
Sbjct: 147 HVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGST 206
Query: 149 -YGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDAN 207
Y + D++S G +L E G KP F G +N I + V+D
Sbjct: 207 KY------TKGIDMWSLGCILGEILCG-KP---IFPG----SSTMNQLERI--IGVIDF- 249
Query: 208 LLSQEDIHFVAKEQCVSFVFNL 229
S ED+ + + + +L
Sbjct: 250 -PSNEDVESIQSPFAKTMIESL 270
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-09
Identities = 27/98 (27%), Positives = 43/98 (43%), Gaps = 15/98 (15%)
Query: 85 ALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAY------LSDFGIAKLLIGEDQSMTQT-Q 137
L+Y+H C +IH D+KP+NVL++ ++D G A D+ T + Q
Sbjct: 143 GLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA---CWYDEHYTNSIQ 197
Query: 138 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGK 175
T Y +PE D++S ++ E TG
Sbjct: 198 TRE---YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 7e-09
Identities = 33/131 (25%), Positives = 60/131 (45%), Gaps = 16/131 (12%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLI-KVISSCSNEEFKALVLEYMPHG-SL 59
VA+K+ ++ +E K + + I +V ++ A+VLE + G SL
Sbjct: 36 YVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL--GPSL 91
Query: 60 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLL------DDNL 113
E + + L I I + S +EY+H S +I+ D+KP+N L+ +
Sbjct: 92 EDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQV 148
Query: 114 VAYLSDFGIAK 124
+ ++ DF +AK
Sbjct: 149 I-HIIDFALAK 158
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-08
Identities = 31/101 (30%), Positives = 44/101 (43%), Gaps = 12/101 (11%)
Query: 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAY--LSDFGIAKLLIGEDQSMTQ 135
+ L+ LH +IHCDLKP+N+LL + + DFG + E Q +
Sbjct: 205 FAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY---EHQRVYT 258
Query: 136 T-QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGK 175
Q+ Y APE R D++S G +L E TG
Sbjct: 259 YIQSRF---YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-08
Identities = 23/110 (20%), Positives = 43/110 (39%), Gaps = 12/110 (10%)
Query: 22 ECEMMKSIRHRNLI-KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80
E K + I V LV++ + SLE L +
Sbjct: 55 EYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAK 113
Query: 81 DVASALEYLHFGCSAPVIHCDLKPDNVLL------DDNLVAYLSDFGIAK 124
+ + ++ +H +++ D+KPDN L+ + N++ Y+ DFG+ K
Sbjct: 114 QMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMI-YVVDFGMVK 159
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 5e-08
Identities = 27/118 (22%), Positives = 50/118 (42%), Gaps = 13/118 (11%)
Query: 14 RAFKSFDVECEM-MKSIRHRNLIKVISSCSNE-EFKALVLEYMPHG-SLEKYL-YSSNCI 69
RA K V + S + + ++ +++ LVL + G SL+ L S +
Sbjct: 98 RAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHV 155
Query: 70 LDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLL---DDNLVAYLSDFGIAK 124
L L + + ALE+LH +H ++ +N+ + D + V L+ +G A
Sbjct: 156 LSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQV-TLAGYGFAF 209
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 5e-08
Identities = 20/87 (22%), Positives = 42/87 (48%), Gaps = 10/87 (11%)
Query: 42 SNEEFKALVLEYMPHG-SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHC 100
+ + ++ ++++ G L+K ++ L + + + LEY+H +H
Sbjct: 122 NGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH---EHEYVHG 176
Query: 101 DLKPDNVLL---DDNLVAYLSDFGIAK 124
D+K N+LL + + V YL D+G+A
Sbjct: 177 DIKASNLLLNYKNPDQV-YLVDYGLAY 202
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 1e-07
Identities = 27/93 (29%), Positives = 41/93 (44%), Gaps = 8/93 (8%)
Query: 85 ALEYLHFGCSAPVIHCDLKPDNVLL--DDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATI 142
AL +L +IHCDLKP+N+LL + DFG + Q + +
Sbjct: 169 ALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC-----QLGQRIYQYIQSR 222
Query: 143 GYMAPEYGREGRVSTNGDVYSFGIMLMETFTGK 175
Y +PE D++S G +L+E TG+
Sbjct: 223 FYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 1e-07
Identities = 25/92 (27%), Positives = 46/92 (50%), Gaps = 21/92 (22%)
Query: 42 SNEEFKALVLEYMPHG-SLEKYL-----YSSNCILDIFQRLNIMIDVASALEYLHFGCSA 95
++ +V+E + G L+K + + +L + R M+DV LEY+H
Sbjct: 122 KGRSYRFMVMERL--GIDLQKISGQNGTFKKSTVLQLGIR---MLDV---LEYIH---EN 170
Query: 96 PVIHCDLKPDNVLL---DDNLVAYLSDFGIAK 124
+H D+K N+LL + + V YL+D+G++
Sbjct: 171 EYVHGDIKAANLLLGYKNPDQV-YLADYGLSY 201
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 50.8 bits (121), Expect = 2e-07
Identities = 26/107 (24%), Positives = 49/107 (45%), Gaps = 8/107 (7%)
Query: 22 ECEMMKSIRHRNLI-KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80
E ++ + ++ I V ++ LV++ + SLE + L + L +
Sbjct: 52 ESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLAD 110
Query: 81 DVASALEYLHFGCSAPVIHCDLKPDNVLL---DDNLVAYLSDFGIAK 124
+ + +E++H S +H D+KPDN L+ Y+ DFG+AK
Sbjct: 111 QMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 2e-07
Identities = 28/107 (26%), Positives = 50/107 (46%), Gaps = 8/107 (7%)
Query: 22 ECEMMKSIRHRNLI-KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80
E ++ K ++ I + + ++ +V+E + SLE + + L +
Sbjct: 54 ESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLAD 112
Query: 81 DVASALEYLHFGCSAPVIHCDLKPDNVLL---DDNLVAYLSDFGIAK 124
+ S +EY+H S IH D+KPDN L+ + Y+ DFG+AK
Sbjct: 113 QMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 3e-07
Identities = 55/288 (19%), Positives = 85/288 (29%), Gaps = 107/288 (37%)
Query: 49 LVLEYMPHGSLEKYLYSSNCI---LDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPD 105
+V E + H L K++ SN L ++ I+ V L+YLH C +IH D+KP+
Sbjct: 122 MVFEVLGH-HLLKWIIKSNYQGLPLPCVKK--IIQQVLQGLDYLHTKCR--IIHTDIKPE 176
Query: 106 NVLL-------------------------------------------------DDNLVAY 116
N+LL + L
Sbjct: 177 NILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVK 236
Query: 117 LSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGK- 175
++D G A + QT+ Y + E +T D++S M E TG
Sbjct: 237 IADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNTPADIWSTACMAFELATGDY 291
Query: 176 -----------------------------------KPTYEFFNGEMTLKHWVNDWLPIST 200
K + EFF + LKH
Sbjct: 292 LFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLF 351
Query: 201 MEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIV 248
+V+ SQE+ F+ + PE+R A E +
Sbjct: 352 EVLVEKYEWSQEE-----AAGFTDFL----LPMLELIPEKRATAAECL 390
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-06
Identities = 24/111 (21%), Positives = 39/111 (35%), Gaps = 29/111 (26%)
Query: 85 ALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQ----------SMT 134
AL +LH + H DLKP+N+L ++ L + + +
Sbjct: 135 ALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF 191
Query: 135 QTQTLATI----GYMAPE------YGREGRVSTNGDVYSFGIMLMETFTGK 175
+ TI Y PE + + DV+S G +L E + G
Sbjct: 192 DHEHHTTIVATRHYRPPEVILELGW------AQPCDVWSIGCILFEYYRGF 236
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 2e-06
Identities = 24/111 (21%), Positives = 41/111 (36%), Gaps = 29/111 (26%)
Query: 85 ALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQS----------MT 134
++ +LH S + H DLKP+N+L + + I +
Sbjct: 130 SVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY 186
Query: 135 QTQTLATI----GYMAPE------YGREGRVSTNGDVYSFGIMLMETFTGK 175
+ +T+ Y APE + S DV+S G +L+E + G
Sbjct: 187 DDEHHSTLVSTRHYRAPEVILALGW------SQPCDVWSIGCILIEYYLGF 231
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 3e-06
Identities = 28/117 (23%), Positives = 42/117 (35%), Gaps = 35/117 (29%)
Query: 85 ALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQ------------- 131
AL YL + H DLKP+N+LLDD + Q
Sbjct: 149 ALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLID 205
Query: 132 ---SMTQTQTLATI----GYMAPE------YGREGRVSTNGDVYSFGIMLMETFTGK 175
+ ++ +I Y APE + + D++SFG +L E +TG
Sbjct: 206 FGCATFKSDYHGSIINTRQYRAPEVILNLGW------DVSSDMWSFGCVLAELYTGS 256
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 1e-05
Identities = 17/77 (22%), Positives = 28/77 (36%), Gaps = 6/77 (7%)
Query: 49 LVLEYMPHG-SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNV 107
+VLE+ G LE+ + + +I+ + ++L H DL NV
Sbjct: 139 IVLEFEFGGIDLEQMRTK---LSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNV 193
Query: 108 LLDDNLVAYLSDFGIAK 124
LL + L K
Sbjct: 194 LLKKTSLKKLHYTLNGK 210
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 273 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.83 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.65 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.49 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.34 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.18 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.04 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.89 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.58 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.55 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.42 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.35 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.24 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.12 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.84 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.79 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.56 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.45 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.39 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.38 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.27 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.99 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.92 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.8 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.57 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.16 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.68 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 95.49 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 93.55 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 93.06 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 92.79 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 91.53 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 90.83 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.07 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-56 Score=364.45 Aligned_cols=238 Identities=26% Similarity=0.396 Sum_probs=190.0
Q ss_pred eEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 2 EVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 2 ~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
.||||+++... ....+.|.+|++++++++||||++++|++.+ +.++||||||+||+|.+++......+++..+..++
T Consensus 60 ~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~ 138 (307)
T 3omv_A 60 DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIA 138 (307)
T ss_dssp EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHH
T ss_pred cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHH
Confidence 69999997543 4456789999999999999999999998865 56899999999999999998777789999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC---CCcC
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE---GRVS 156 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~ 156 (273)
.|++.||.||| +.+|+||||||+|||++.++.+||+|||++...............+||+.|+|||++.+ ..++
T Consensus 139 ~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~ 215 (307)
T 3omv_A 139 RQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFS 215 (307)
T ss_dssp HHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCC
T ss_pred HHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCC
Confidence 99999999999 99999999999999999999999999999987644333334455689999999999864 3589
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++|||||||++|||++|+.||...................+. ....+..++.++.+|+.+||..
T Consensus 216 ~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~---------------~~~~~~~~~~~l~~li~~cl~~ 280 (307)
T 3omv_A 216 FQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPD---------------LSKLYKNCPKAMKRLVADCVKK 280 (307)
T ss_dssp HHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCC---------------STTSCTTSCHHHHHHHHHHTCS
T ss_pred cHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCC---------------cccccccchHHHHHHHHHHcCC
Confidence 9999999999999999999999764433222211111111110 0112456788899999999999
Q ss_pred CccCCCCHHHHHHHHHHHHHhh
Q 024027 237 SPEQRINAKEIVTKLLKIRDSL 258 (273)
Q Consensus 237 dp~~Rps~~~~l~~l~~~~~~~ 258 (273)
||++|||+.+++++|+.++.++
T Consensus 281 dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 281 VKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp SSTTSCCHHHHHHHHHHHHTTC
T ss_pred CHhHCcCHHHHHHHHHHHhccC
Confidence 9999999999999999887665
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-56 Score=369.09 Aligned_cols=233 Identities=30% Similarity=0.494 Sum_probs=197.3
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC------------CC
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN------------CI 69 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------~~ 69 (273)
.||||+++..+....+.|.+|+++|++++||||++++|+|.+++.++||||||++|+|.+++...+ ..
T Consensus 45 ~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~ 124 (299)
T 4asz_A 45 LVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTE 124 (299)
T ss_dssp EEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCC
T ss_pred EEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCC
Confidence 599999987766677889999999999999999999999999999999999999999999996542 46
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcc
Q 024027 70 LDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEY 149 (273)
Q Consensus 70 ~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~ 149 (273)
+++..++.++.|++.||.||| +++|+||||||+|||++.++.+||+|||++................||+.|+|||+
T Consensus 125 l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~ 201 (299)
T 4asz_A 125 LTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPES 201 (299)
T ss_dssp CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHH
Confidence 999999999999999999999 99999999999999999999999999999986644333333344568999999999
Q ss_pred cCCCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHH
Q 024027 150 GREGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFN 228 (273)
Q Consensus 150 ~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 228 (273)
+.+..++.++|||||||++|||++ |+.||......+. ....... .....|..++.++.+
T Consensus 202 ~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~-~~~i~~~-------------------~~~~~p~~~~~~~~~ 261 (299)
T 4asz_A 202 IMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV-IECITQG-------------------RVLQRPRTCPQEVYE 261 (299)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-HHHHHHT-------------------CCCCCCTTCCHHHHH
T ss_pred HcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHcC-------------------CCCCCCccchHHHHH
Confidence 999999999999999999999998 8999976433221 1111110 011225567888999
Q ss_pred HHhhcCCCCccCCCCHHHHHHHHHHHHHh
Q 024027 229 LAMACTVESPEQRINAKEIVTKLLKIRDS 257 (273)
Q Consensus 229 li~~~l~~dp~~Rps~~~~l~~l~~~~~~ 257 (273)
|+.+||..||++|||++++.+.|+++.+.
T Consensus 262 li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 262 LMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999999988765
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-56 Score=370.96 Aligned_cols=233 Identities=28% Similarity=0.485 Sum_probs=189.6
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC--------------
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-------------- 67 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------- 67 (273)
.||||+++..+....+.|.+|+++|++++|||||+++|+|.+++.++||||||++|+|.+++....
T Consensus 73 ~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~ 152 (329)
T 4aoj_A 73 LVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAP 152 (329)
T ss_dssp EEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------C
T ss_pred EEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccC
Confidence 699999987766677889999999999999999999999999999999999999999999996542
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCC
Q 024027 68 CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP 147 (273)
Q Consensus 68 ~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aP 147 (273)
.++++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++..+.............||+.|+||
T Consensus 153 ~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAP 229 (329)
T 4aoj_A 153 GPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPP 229 (329)
T ss_dssp CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccCh
Confidence 35899999999999999999999 999999999999999999999999999999876444333334456789999999
Q ss_pred cccCCCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHH
Q 024027 148 EYGREGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFV 226 (273)
Q Consensus 148 E~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 226 (273)
|++.+..++.++|||||||++|||++ |+.||......+. ....... .....|..+++++
T Consensus 230 E~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~-~~~i~~g-------------------~~~~~p~~~~~~~ 289 (329)
T 4aoj_A 230 ESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA-IDCITQG-------------------RELERPRACPPEV 289 (329)
T ss_dssp HHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH-HHHHHHT-------------------CCCCCCTTCCHHH
T ss_pred hhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH-HHHHHcC-------------------CCCCCcccccHHH
Confidence 99999999999999999999999998 8999976433221 1111100 0112255678889
Q ss_pred HHHHhhcCCCCccCCCCHHHHHHHHHHHHHh
Q 024027 227 FNLAMACTVESPEQRINAKEIVTKLLKIRDS 257 (273)
Q Consensus 227 ~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~ 257 (273)
.+|+.+||..||++|||+++|+++|+.+.+.
T Consensus 290 ~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 290 YAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 9999999999999999999999999998764
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-55 Score=367.36 Aligned_cols=227 Identities=24% Similarity=0.294 Sum_probs=191.4
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
+.||||+++.......+.+.+|+++|+.++||||++++++|.+++.+|||||||+||+|.+++.+. .+++..++.++.
T Consensus 100 ~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~--~l~e~~~~~~~~ 177 (346)
T 4fih_A 100 KLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCL 177 (346)
T ss_dssp CEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHHS--CCCHHHHHHHHH
T ss_pred CEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHH
Confidence 479999998776666778999999999999999999999999999999999999999999999764 499999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
||+.||.||| ++||+||||||+|||++.++.+||+|||++..+.... ......+||+.|+|||++.+..|+.++|
T Consensus 178 qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~D 252 (346)
T 4fih_A 178 AVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVD 252 (346)
T ss_dssp HHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHH
T ss_pred HHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC--CcccccccCcCcCCHHHHCCCCCCcHHH
Confidence 9999999999 9999999999999999999999999999998763322 2334568999999999999999999999
Q ss_pred hHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccC
Q 024027 161 VYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQ 240 (273)
Q Consensus 161 iwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 240 (273)
||||||++|+|++|.+||......+ .+..+..... .....+..++.++.+||.+||+.||++
T Consensus 253 iWSlGvilyeml~G~~PF~~~~~~~-~~~~i~~~~~-----------------~~~~~~~~~s~~~~dli~~~L~~dP~~ 314 (346)
T 4fih_A 253 IWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLP-----------------PRLKNLHKVSPSLKGFLDRLLVRDPAQ 314 (346)
T ss_dssp HHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSSC-----------------CCCSCGGGSCHHHHHHHHHHSCSSTTT
T ss_pred HHHHHHHHHHHHHCCCCCCCcCHHH-HHHHHHcCCC-----------------CCCCccccCCHHHHHHHHHHcCCChhH
Confidence 9999999999999999997532211 1111111100 011114467788999999999999999
Q ss_pred CCCHHHHHHHHH
Q 024027 241 RINAKEIVTKLL 252 (273)
Q Consensus 241 Rps~~~~l~~l~ 252 (273)
|||++|+++|=+
T Consensus 315 R~ta~e~l~Hp~ 326 (346)
T 4fih_A 315 RATAAELLKHPF 326 (346)
T ss_dssp SCCHHHHTTCGG
T ss_pred CcCHHHHhcCHh
Confidence 999999998844
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-56 Score=365.11 Aligned_cols=244 Identities=23% Similarity=0.316 Sum_probs=202.3
Q ss_pred CeEEEEEeecc---cChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||||+++.. +....+.+.+|+++|+.++||||++++++|++++.+|||||||+||+|.+++.+.+ .+++..++.
T Consensus 58 ~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~~-~l~e~~~~~ 136 (311)
T 4aw0_A 58 REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRF 136 (311)
T ss_dssp CEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS-SCCHHHHHH
T ss_pred CEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcC-CCCHHHHHH
Confidence 47999999754 23456779999999999999999999999999999999999999999999997654 699999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
++.||+.||.||| ++||+||||||+|||++.++.+||+|||++..+............+||+.|+|||++.+..|+.
T Consensus 137 ~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~ 213 (311)
T 4aw0_A 137 YTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK 213 (311)
T ss_dssp HHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCH
T ss_pred HHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCc
Confidence 9999999999999 9999999999999999999999999999998875444444455678999999999999999999
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
++||||+||++|+|++|..||......+ ....+.... ...+..++.++.+||.+||++|
T Consensus 214 ~~DiWSlGvilyeml~G~~PF~~~~~~~-~~~~i~~~~--------------------~~~p~~~s~~~~dli~~lL~~d 272 (311)
T 4aw0_A 214 SSDLWALGCIIYQLVAGLPPFRAGNEGL-IFAKIIKLE--------------------YDFPEKFFPKARDLVEKLLVLD 272 (311)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTC--------------------CCCCTTCCHHHHHHHHHHSCSS
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHcCC--------------------CCCCcccCHHHHHHHHHHccCC
Confidence 9999999999999999999997533221 111111110 0113456778999999999999
Q ss_pred ccCCCCHHHHHHHHHHHHHhhhhhcccccccc
Q 024027 238 PEQRINAKEIVTKLLKIRDSLLRNVGGRRIRQ 269 (273)
Q Consensus 238 p~~Rps~~~~l~~l~~~~~~~~~~~~~~~~~~ 269 (273)
|++|||++|++.+-+-..--+.+++++...++
T Consensus 273 p~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~~ 304 (311)
T 4aw0_A 273 ATKRLGCEEMEGYGPLKAHPFFESVTWENLHQ 304 (311)
T ss_dssp GGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGG
T ss_pred HhHCcChHHHcCCHHHHCCCCcCCCCHHHhcC
Confidence 99999999987775533335777777776654
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-55 Score=361.02 Aligned_cols=232 Identities=22% Similarity=0.256 Sum_probs=190.3
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
+.||||+++... ...+|+.+++.++|||||+++++|.+++.+|||||||+||+|.++++..+ .+++..++.++.
T Consensus 84 ~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~ 157 (336)
T 4g3f_A 84 FQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG-CLPEDRALYYLG 157 (336)
T ss_dssp CEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHH
T ss_pred CEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHcC-CCCHHHHHHHHH
Confidence 479999997542 23479999999999999999999999999999999999999999997654 699999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCC-ceEEeecccccccccCCCc---ceeecccccCCCCCCcccCCCCcC
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNL-VAYLSDFGIAKLLIGEDQS---MTQTQTLATIGYMAPEYGREGRVS 156 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~-~~kl~Df~~~~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~ 156 (273)
|++.||.||| ++||+||||||+|||++.++ .+||+|||++..+...... ......+||+.|+|||++.+..|+
T Consensus 158 qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~ 234 (336)
T 4g3f_A 158 QALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 234 (336)
T ss_dssp HHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCC
T ss_pred HHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCC
Confidence 9999999999 99999999999999999887 6999999999876432211 122345799999999999999999
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++|||||||++|+|++|..||......... ..+.... ......+..++.++.+|+.+||..
T Consensus 235 ~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-~~i~~~~-----------------~~~~~~~~~~s~~~~~li~~~L~~ 296 (336)
T 4g3f_A 235 AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC-LKIASEP-----------------PPIREIPPSCAPLTAQAIQEGLRK 296 (336)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSTTTCCSCCH-HHHHHSC-----------------CGGGGSCTTSCHHHHHHHHHHTCS
T ss_pred cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH-HHHHcCC-----------------CCchhcCccCCHHHHHHHHHHccC
Confidence 9999999999999999999999764443321 1111110 001112456788899999999999
Q ss_pred CccCCCCHHHHHHHHHHHHHhhh
Q 024027 237 SPEQRINAKEIVTKLLKIRDSLL 259 (273)
Q Consensus 237 dp~~Rps~~~~l~~l~~~~~~~~ 259 (273)
||.+|||+.|++++|....+++.
T Consensus 297 dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 297 EPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp SGGGSCCHHHHHHHHHHHHHHTT
T ss_pred CHhHCcCHHHHHHHHHHHHhhhh
Confidence 99999999999999998887643
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-55 Score=362.63 Aligned_cols=230 Identities=26% Similarity=0.460 Sum_probs=192.1
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC-------------
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN------------- 67 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------- 67 (273)
.||||+++... ....+.|.+|+.++++++||||++++|+|.+++.++||||||++|+|.++|....
T Consensus 58 ~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~ 137 (308)
T 4gt4_A 58 AVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 137 (308)
T ss_dssp EEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CC
T ss_pred EEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccc
Confidence 69999997553 3456789999999999999999999999999999999999999999999996432
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCC
Q 024027 68 --CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYM 145 (273)
Q Consensus 68 --~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (273)
..+++..+..++.|++.||.||| +.+++||||||+|||++.++.+||+|||++..+............+||+.|+
T Consensus 138 ~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ym 214 (308)
T 4gt4_A 138 VKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWM 214 (308)
T ss_dssp EECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGC
T ss_pred cccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCccc
Confidence 35899999999999999999999 9999999999999999999999999999998764443333344567899999
Q ss_pred CCcccCCCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHH
Q 024027 146 APEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVS 224 (273)
Q Consensus 146 aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (273)
|||++.+..++.++|||||||++|||++ |..||......+. ..... .. ...+.|..++.
T Consensus 215 APE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~-~~~i~-------------~~------~~~~~p~~~~~ 274 (308)
T 4gt4_A 215 APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV-VEMIR-------------NR------QVLPCPDDCPA 274 (308)
T ss_dssp CHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH-HHHHH-------------TT------CCCCCCTTCCH
T ss_pred CHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHH-HHHHH-------------cC------CCCCCcccchH
Confidence 9999999999999999999999999998 8999976433221 11110 00 01122567888
Q ss_pred HHHHHHhhcCCCCccCCCCHHHHHHHHHHH
Q 024027 225 FVFNLAMACTVESPEQRINAKEIVTKLLKI 254 (273)
Q Consensus 225 ~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 254 (273)
++.+|+.+||..||++|||+++|+++|+++
T Consensus 275 ~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 275 WVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 899999999999999999999999999754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-55 Score=363.44 Aligned_cols=227 Identities=19% Similarity=0.284 Sum_probs=189.2
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC-CCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~ 77 (273)
+.||||+++... ....+.+.+|+++|+.++||||++++++|.+++.+|||||||+||+|.+++...+ ..+++..++.
T Consensus 50 ~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~ 129 (350)
T 4b9d_A 50 RQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILD 129 (350)
T ss_dssp CEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHH
T ss_pred CEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHH
Confidence 479999997552 3456789999999999999999999999999999999999999999999997543 4579999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
++.||+.||.||| ++||+||||||+|||++.++.+||+|||++..+... .......+||+.|+|||++.+..|+.
T Consensus 130 ~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--~~~~~~~~GT~~YmAPE~l~~~~y~~ 204 (350)
T 4b9d_A 130 WFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST--VELARACIGTPYYLSPEICENKPYNN 204 (350)
T ss_dssp HHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH--HHHHHHHHSCCTTCCHHHHTTCCCCH
T ss_pred HHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCC--cccccccCCCccccCHHHHCCCCCCc
Confidence 9999999999999 999999999999999999999999999999865221 11223467999999999999999999
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
++|||||||++|+|++|+.||......+. +..+.....+ ..+..++.++.+||.+||+.|
T Consensus 205 ~~DiwSlGvilyemltG~~PF~~~~~~~~-~~~i~~~~~~-------------------~~~~~~s~~~~~li~~~L~~d 264 (350)
T 4b9d_A 205 KSDIWALGCVLYELCTLKHAFEAGSMKNL-VLKIISGSFP-------------------PVSLHYSYDLRSLVSQLFKRN 264 (350)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHTCCC-------------------CCCTTSCHHHHHHHHHHTCSS
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCcCHHHH-HHHHHcCCCC-------------------CCCccCCHHHHHHHHHHccCC
Confidence 99999999999999999999976432221 1111111000 113456788999999999999
Q ss_pred ccCCCCHHHHHHHHH
Q 024027 238 PEQRINAKEIVTKLL 252 (273)
Q Consensus 238 p~~Rps~~~~l~~l~ 252 (273)
|++|||++++++|=+
T Consensus 265 P~~R~s~~e~l~hp~ 279 (350)
T 4b9d_A 265 PRDRPSVNSILEKGF 279 (350)
T ss_dssp GGGSCCHHHHHTSHH
T ss_pred hhHCcCHHHHhcCHH
Confidence 999999999998744
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-54 Score=368.24 Aligned_cols=227 Identities=24% Similarity=0.294 Sum_probs=191.1
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
+.||||+++.......+.+.+|+.+|+.++||||++++++|.+++.+|||||||+||+|.+++... .+++..++.++.
T Consensus 177 ~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~~--~l~e~~~~~~~~ 254 (423)
T 4fie_A 177 KLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCL 254 (423)
T ss_dssp CEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHS--CCCHHHHHHHHH
T ss_pred CEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhcc--CCCHHHHHHHHH
Confidence 479999998776666788999999999999999999999999999999999999999999999754 499999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
||+.||.||| ++||+||||||+|||++.++.+||+|||++..+.... ......+||+.|+|||++.+..|+.++|
T Consensus 255 qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~D 329 (423)
T 4fie_A 255 AVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVD 329 (423)
T ss_dssp HHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--CCBCCCEECTTTCCHHHHTTCCBCTHHH
T ss_pred HHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC--ccccccccCcCcCCHHHHCCCCCCcHHH
Confidence 9999999999 9999999999999999999999999999998763322 2334568999999999999999999999
Q ss_pred hHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccC
Q 024027 161 VYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQ 240 (273)
Q Consensus 161 iwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 240 (273)
||||||++|+|++|..||......+ .+..+..... .....+..++.++.+||.+||..||++
T Consensus 330 iWSlGvilyeml~G~~PF~~~~~~~-~~~~i~~~~~-----------------~~~~~~~~~s~~~~dli~~~L~~dP~~ 391 (423)
T 4fie_A 330 IWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLP-----------------PRLKNLHKVSPSLKGFLDRLLVRDPAQ 391 (423)
T ss_dssp HHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCC-----------------CCCSCTTSSCHHHHHHHHHHSCSSTTT
T ss_pred HHHHHHHHHHHHHCCCCCCCcCHHH-HHHHHHcCCC-----------------CCCcccccCCHHHHHHHHHHcCCChhH
Confidence 9999999999999999997532221 1111111100 001113456788999999999999999
Q ss_pred CCCHHHHHHHHH
Q 024027 241 RINAKEIVTKLL 252 (273)
Q Consensus 241 Rps~~~~l~~l~ 252 (273)
|||++|+++|=+
T Consensus 392 R~ta~ell~Hp~ 403 (423)
T 4fie_A 392 RATAAELLKHPF 403 (423)
T ss_dssp SCCHHHHTTCGG
T ss_pred CcCHHHHhcCHH
Confidence 999999999744
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-54 Score=349.20 Aligned_cols=224 Identities=24% Similarity=0.357 Sum_probs=182.0
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeec----CCceeEEEeccCCCCHHHhhhcCCCCCCHHH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSN----EEFKALVLEYMPHGSLEKYLYSSNCILDIFQ 74 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (273)
+.||||++.... ....+.|.+|+++++.++||||++++++|.+ +..++||||||+||+|.+++.+. ..+++..
T Consensus 52 ~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~-~~l~~~~ 130 (290)
T 3fpq_A 52 VEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKV 130 (290)
T ss_dssp CEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHH-SSCCHHH
T ss_pred eEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhc-CCCCHHH
Confidence 479999997542 3456779999999999999999999999865 45689999999999999999764 4699999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCC--eEeccCCCCceeeC-CCCceEEeecccccccccCCCcceeecccccCCCCCCcccC
Q 024027 75 RLNIMIDVASALEYLHFGCSAP--VIHCDLKPDNVLLD-DNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR 151 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~~--i~h~di~p~nil~~-~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 151 (273)
++.++.||+.||.||| ++| |+||||||+|||++ .++.+||+|||++..... ......+||+.|+|||++.
T Consensus 131 ~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~----~~~~~~~GTp~YmAPE~~~ 203 (290)
T 3fpq_A 131 LRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGTPEFMAPEMYE 203 (290)
T ss_dssp HHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT----TSBEESCSSCCCCCGGGGG
T ss_pred HHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC----CccCCcccCccccCHHHcC
Confidence 9999999999999999 888 99999999999998 478999999999975321 2234568999999999986
Q ss_pred CCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHh
Q 024027 152 EGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAM 231 (273)
Q Consensus 152 ~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 231 (273)
+ .|+.++|||||||++|+|++|+.||................. .....+..+++++.+|+.
T Consensus 204 ~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~------------------~~~~~~~~~~~~~~~li~ 264 (290)
T 3fpq_A 204 E-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV------------------KPASFDKVAIPEVKEIIE 264 (290)
T ss_dssp T-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC------------------CCGGGGGCCCHHHHHHHH
T ss_pred C-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCC------------------CCCCCCccCCHHHHHHHH
Confidence 5 699999999999999999999999975433222222111110 011113445677999999
Q ss_pred hcCCCCccCCCCHHHHHHHH
Q 024027 232 ACTVESPEQRINAKEIVTKL 251 (273)
Q Consensus 232 ~~l~~dp~~Rps~~~~l~~l 251 (273)
+||..||++|||++++++|=
T Consensus 265 ~~L~~dP~~R~s~~e~l~Hp 284 (290)
T 3fpq_A 265 GCIRQNKDERYSIKDLLNHA 284 (290)
T ss_dssp HHSCSSGGGSCCHHHHHTSG
T ss_pred HHccCChhHCcCHHHHhcCc
Confidence 99999999999999999873
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=345.29 Aligned_cols=223 Identities=22% Similarity=0.329 Sum_probs=176.3
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||||+++... ......+.+|+++++.++||||+++++++.+++.+|+||||| +|+|.+++.+.+ .+++..++.
T Consensus 39 ~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~~-~l~e~~~~~ 116 (275)
T 3hyh_A 39 QKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRD-KMSEQEARR 116 (275)
T ss_dssp CEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHHSC-SCCHHHHHH
T ss_pred CEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHHcC-CCCHHHHHH
Confidence 479999997542 334567999999999999999999999999999999999999 569999997654 699999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCc-C
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRV-S 156 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~ 156 (273)
++.|++.||+||| ++||+||||||+|||++.++.+||+|||++...... ......+||+.|+|||++.+..+ +
T Consensus 117 ~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~---~~~~~~~GT~~Y~APE~~~~~~y~~ 190 (275)
T 3hyh_A 117 FFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG---NFLKTSCGSPNYAAPEVISGKLYAG 190 (275)
T ss_dssp HHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC------------------CTTSCHHHHSSSSCCC
T ss_pred HHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCC---CccCCeeECcccCChhhhcCCCCCC
Confidence 9999999999999 999999999999999999999999999999765322 22345689999999999998876 5
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++||||+||++|+|++|+.||....... ........ ....+..+++++.+|+.+||+.
T Consensus 191 ~~~DiwSlGvily~lltg~~PF~~~~~~~-~~~~i~~~--------------------~~~~p~~~s~~~~~li~~~L~~ 249 (275)
T 3hyh_A 191 PEVDVWSCGVILYVMLCRRLPFDDESIPV-LFKNISNG--------------------VYTLPKFLSPGAAGLIKRMLIV 249 (275)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHT--------------------CCCCCTTSCHHHHHHHHHHSCS
T ss_pred ChhhhHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHcC--------------------CCCCCCCCCHHHHHHHHHHccC
Confidence 79999999999999999999997532211 11111110 0011345678899999999999
Q ss_pred CccCCCCHHHHHHHHH
Q 024027 237 SPEQRINAKEIVTKLL 252 (273)
Q Consensus 237 dp~~Rps~~~~l~~l~ 252 (273)
||++|||++|+++|=+
T Consensus 250 dP~~R~s~~eil~hpw 265 (275)
T 3hyh_A 250 NPLNRISIHEIMQDDW 265 (275)
T ss_dssp SGGGSCCHHHHHHCHH
T ss_pred ChhHCcCHHHHHcCcc
Confidence 9999999999999865
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-54 Score=353.98 Aligned_cols=224 Identities=25% Similarity=0.302 Sum_probs=179.2
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
+.||||+++... ......+.+|+++|+.++||||++++++|.+++.+|+|||||+||+|.+++.+.+ .+++..++.+
T Consensus 53 ~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~-~l~e~~~~~~ 131 (304)
T 3ubd_A 53 QLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV-MFTEEDVKFY 131 (304)
T ss_dssp CEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHHC-CCCHHHHHHH
T ss_pred EEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhcC-CCCHHHHHHH
Confidence 369999997542 3345678899999999999999999999999999999999999999999997654 6999999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCc
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTN 158 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 158 (273)
+.|++.||.||| ++||+||||||+|||++.++.+||+|||++....... ......+||+.|+|||++.+..++.+
T Consensus 132 ~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~ 206 (304)
T 3ubd_A 132 LAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQS 206 (304)
T ss_dssp HHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-------CCCCSCCCCGGGCCHHHHHTSCCCTH
T ss_pred HHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC--ccccccccCcccCCHHHhccCCCCCC
Confidence 999999999999 9999999999999999999999999999997653222 22345689999999999999999999
Q ss_pred chhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc
Q 024027 159 GDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238 (273)
Q Consensus 159 ~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 238 (273)
+||||+||++|+|++|..||......+. ...+... ....|..+++++.+|+.+||+.||
T Consensus 207 ~DiwSlGvilyemltG~~PF~~~~~~~~-~~~i~~~--------------------~~~~p~~~s~~~~~li~~~L~~dP 265 (304)
T 3ubd_A 207 ADWWSFGVLMFEMLTGTLPFQGKDRKET-MTMILKA--------------------KLGMPQFLSPEAQSLLRMLFKRNP 265 (304)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHC--------------------CCCCCTTSCHHHHHHHHHHTCSSG
T ss_pred CcccchHHHHHHHHhCCCCCCCcCHHHH-HHHHHcC--------------------CCCCCCcCCHHHHHHHHHHcccCH
Confidence 9999999999999999999976332211 1111110 001144577889999999999999
Q ss_pred cCCCCH-----HHHHHHH
Q 024027 239 EQRINA-----KEIVTKL 251 (273)
Q Consensus 239 ~~Rps~-----~~~l~~l 251 (273)
++|||+ +|+++|=
T Consensus 266 ~~R~ta~~~~~~eil~Hp 283 (304)
T 3ubd_A 266 ANRLGAGPDGVEEIKRHS 283 (304)
T ss_dssp GGSTTCSTTTHHHHHTSG
T ss_pred HHCCCCCcCCHHHHHcCc
Confidence 999984 6777763
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-53 Score=357.39 Aligned_cols=234 Identities=24% Similarity=0.387 Sum_probs=194.3
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCC-CccceeeeeeeecC-CceeEEEeccCCCCHHHhhhcC------------
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIR-HRNLIKVISSCSNE-EFKALVLEYMPHGSLEKYLYSS------------ 66 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~------------ 66 (273)
.||||+++... ....+.|.+|+++|+++. ||||++++|+|.++ +.++||||||++|+|.++|+..
T Consensus 96 ~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~ 175 (353)
T 4ase_A 96 TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 175 (353)
T ss_dssp EEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-----
T ss_pred EEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccch
Confidence 69999998654 345678999999999995 59999999998664 5689999999999999999643
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCC
Q 024027 67 ---NCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIG 143 (273)
Q Consensus 67 ---~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~ 143 (273)
...+++..+..++.|++.||.||| +++++||||||+|||++.++.+||+|||++..+............+||+.
T Consensus 176 ~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ 252 (353)
T 4ase_A 176 DLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 252 (353)
T ss_dssp --CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGG
T ss_pred hhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeecccccccc
Confidence 234899999999999999999999 99999999999999999999999999999987654444444455678999
Q ss_pred CCCCcccCCCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhh
Q 024027 144 YMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQC 222 (273)
Q Consensus 144 ~~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (273)
|+|||++.+..++.++|||||||++|||++ |..||......+......... .....|..+
T Consensus 253 ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g-------------------~~~~~p~~~ 313 (353)
T 4ase_A 253 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG-------------------TRMRAPDYT 313 (353)
T ss_dssp GCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHT-------------------CCCCCCTTC
T ss_pred ccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcC-------------------CCCCCCccC
Confidence 999999999999999999999999999998 999997654332222111111 011224567
Q ss_pred HHHHHHHHhhcCCCCccCCCCHHHHHHHHHHHHHh
Q 024027 223 VSFVFNLAMACTVESPEQRINAKEIVTKLLKIRDS 257 (273)
Q Consensus 223 ~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~ 257 (273)
++++.+|+.+||..||++|||++++++||+++.++
T Consensus 314 ~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 314 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 78899999999999999999999999999998764
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=339.99 Aligned_cols=249 Identities=22% Similarity=0.261 Sum_probs=180.0
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCC----ceeEEEeccCCCCHHHhhhcCCCCCCHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEE----FKALVLEYMPHGSLEKYLYSSNCILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (273)
+.||||+++... .....++.|+..+..++||||+++++++.++. .++||||||++|+|.++++.. .+++..+.
T Consensus 27 ~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~--~l~~~~~~ 103 (303)
T 3hmm_A 27 EEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMI 103 (303)
T ss_dssp EEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHH
T ss_pred EEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHhC--CCCHHHHH
Confidence 379999997542 22223345666667889999999999997653 579999999999999999765 48999999
Q ss_pred HHHHHHHHHHHHHhcCCCC--------CeEeccCCCCceeeCCCCceEEeecccccccccCCCc--ceeecccccCCCCC
Q 024027 77 NIMIDVASALEYLHFGCSA--------PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQS--MTQTQTLATIGYMA 146 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~--------~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~--~~~~~~~~~~~~~a 146 (273)
.++.|++.||+||| +. +|+||||||+|||++.++.+||+|||++......... ......+||+.|+|
T Consensus 104 ~i~~~ia~gl~ylH---~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymA 180 (303)
T 3hmm_A 104 KLALSTASGLAHLH---MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180 (303)
T ss_dssp HHHHHHHHHHHHHH---CCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCC
T ss_pred HHHHHHHHHHHHHH---HhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccC
Confidence 99999999999999 65 9999999999999999999999999999876433321 12234579999999
Q ss_pred CcccCCC------CcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhh---hccccchhhhh
Q 024027 147 PEYGREG------RVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDA---NLLSQEDIHFV 217 (273)
Q Consensus 147 PE~~~~~------~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 217 (273)
||++.+. .++.++|||||||++|||++|.+||.........+....... ......... ...........
T Consensus 181 PE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~--~~~~~~~~~~~~~~~rp~~p~~~ 258 (303)
T 3hmm_A 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD--PSVEEMRKVVCEQKLRPNIPNRW 258 (303)
T ss_dssp HHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS--CCHHHHHHHHTTSCCCCCCCGGG
T ss_pred HHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc--chHHHHHHHHhcccCCCCCCccc
Confidence 9998754 367899999999999999999888765433222111110000 000000000 00000000011
Q ss_pred hhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHHHHHHh
Q 024027 218 AKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLLKIRDS 257 (273)
Q Consensus 218 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~ 257 (273)
....++..+.+|+.+||..||++|||+.+|++.|+++.++
T Consensus 259 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 259 QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp GSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 1234567799999999999999999999999999988764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=333.46 Aligned_cols=225 Identities=21% Similarity=0.311 Sum_probs=170.0
Q ss_pred CeEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCC------------ceeEEEeccCCCCHHHhhhcCC
Q 024027 1 MEVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEE------------FKALVLEYMPHGSLEKYLYSSN 67 (273)
Q Consensus 1 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------------~~~lv~e~~~~~~L~~~l~~~~ 67 (273)
+.||||+++... ....+.+.+|+++|+.++||||++++++|.+.+ .+|+|||||+||+|.+++....
T Consensus 31 ~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~ 110 (299)
T 4g31_A 31 CNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRC 110 (299)
T ss_dssp CEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCC
T ss_pred CEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcC
Confidence 479999997654 345677999999999999999999999986544 3789999999999999997654
Q ss_pred C--CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcc----------ee
Q 024027 68 C--ILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSM----------TQ 135 (273)
Q Consensus 68 ~--~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~----------~~ 135 (273)
. ..++..++.++.||+.||+||| ++||+||||||+|||++.++.+||+|||++..+....... ..
T Consensus 111 ~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~ 187 (299)
T 4g31_A 111 TIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187 (299)
T ss_dssp SGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCCCC----------------------
T ss_pred CCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEccCccceecCCCcccccccccccccccc
Confidence 2 2556778999999999999999 9999999999999999999999999999998764322211 12
Q ss_pred ecccccCCCCCCcccCCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhh
Q 024027 136 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIH 215 (273)
Q Consensus 136 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (273)
...+||+.|+|||++.+..|+.++|||||||++|+|++ ||............... ...+
T Consensus 188 ~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~~---------------~~~p--- 246 (299)
T 4g31_A 188 TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRN---------------LKFP--- 246 (299)
T ss_dssp ----CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHT---------------TCCC---
T ss_pred CCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHhc---------------CCCC---
Confidence 34579999999999999999999999999999999996 76532111111110000 0000
Q ss_pred hhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHH
Q 024027 216 FVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 216 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
......++.+.+|+.+||..||++|||+.++++|
T Consensus 247 -~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 247 -PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp -HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1123344557899999999999999999999986
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=336.71 Aligned_cols=246 Identities=22% Similarity=0.190 Sum_probs=184.4
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeec------CCceeEEEeccCCCCHHHhhhcCCCCCCH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSN------EEFKALVLEYMPHGSLEKYLYSSNCILDI 72 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 72 (273)
+.||||+++... ....+.+.+|+++|+.++||||+++++++.. .+.+|||||||+ |+|.+++... ..+++
T Consensus 80 ~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~-~~l~~ 157 (398)
T 4b99_A 80 QQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHSS-QPLTL 157 (398)
T ss_dssp CEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTSS-SCCCH
T ss_pred CEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHhc-CCCCH
Confidence 479999997542 3345678899999999999999999998754 467899999996 5899999654 47999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCC--cceeecccccCCCCCCccc
Q 024027 73 FQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQ--SMTQTQTLATIGYMAPEYG 150 (273)
Q Consensus 73 ~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~--~~~~~~~~~~~~~~aPE~~ 150 (273)
..+..++.||+.||.||| ++||+||||||+|||++.++.+||+|||++..+..... .......+||+.|+|||++
T Consensus 158 ~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~ 234 (398)
T 4b99_A 158 EHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELM 234 (398)
T ss_dssp HHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHh
Confidence 999999999999999999 99999999999999999999999999999987643221 2233456899999999998
Q ss_pred CCC-CcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhh-----------hhhhccccchhhhhh
Q 024027 151 REG-RVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEV-----------VDANLLSQEDIHFVA 218 (273)
Q Consensus 151 ~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~ 218 (273)
.+. .++.++||||+||++|+|++|.+||.+....+ .+..+............ ...............
T Consensus 235 ~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~-~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (398)
T 4b99_A 235 LSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH-QLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETV 313 (398)
T ss_dssp TTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHH
T ss_pred cCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH-HHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHh
Confidence 775 46999999999999999999999997643322 22222221111111000 000000000001111
Q ss_pred hhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 219 KEQCVSFVFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 219 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
...++.++.+||.+||.+||++|||++|+++|=+
T Consensus 314 ~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~ 347 (398)
T 4b99_A 314 YPGADRQALSLLGRMLRFEPSARISAAAALRHPF 347 (398)
T ss_dssp STTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGG
T ss_pred CCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHh
Confidence 2356788999999999999999999999999743
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-49 Score=350.85 Aligned_cols=227 Identities=19% Similarity=0.231 Sum_probs=191.5
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
+.||||+++.......+.+.+|+++|+.++||||++++++|.++..++||||||+||+|.+++......+++..+..++.
T Consensus 183 ~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~ 262 (573)
T 3uto_A 183 NNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR 262 (573)
T ss_dssp CEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHH
T ss_pred CEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHH
Confidence 47999999877666677899999999999999999999999999999999999999999999977666799999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCC--CceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCc
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDN--LVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTN 158 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~--~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 158 (273)
||+.||.||| ++||+||||||+|||++.+ +.+||+|||++..+.. .......+||+.|+|||++.+..|+.+
T Consensus 263 qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~---~~~~~~~~GT~~y~APEv~~~~~y~~~ 336 (573)
T 3uto_A 263 QVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP---KQSVKVTTGTAEFAAPEVAEGKPVGYY 336 (573)
T ss_dssp HHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT---TSEEEEECSSGGGCCHHHHTTCCBCHH
T ss_pred HHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccC---CCceeeeEECccccCHHHhCCCCCCcH
Confidence 9999999999 9999999999999999854 8999999999987632 223345689999999999999999999
Q ss_pred chhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc
Q 024027 159 GDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238 (273)
Q Consensus 159 ~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 238 (273)
+||||+||++|+|++|..||......+. +..+... ...........++.++.+||.+||..||
T Consensus 337 ~DiWSlGvilyeml~G~~Pf~~~~~~~~-~~~i~~~----------------~~~~~~~~~~~~s~~~~dli~~~L~~dp 399 (573)
T 3uto_A 337 TDMWSVGVLSYILLSGLSPFGGENDDET-LRNVKSC----------------DWNMDDSAFSGISEDGKDFIRKLLLADP 399 (573)
T ss_dssp HHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHHHTT----------------CCCCCSGGGTTSCHHHHHHHHTTSCSSG
T ss_pred HHHHHHHHHHHHHHHCCCCCCCcCHHHH-HHHHHhC----------------CCCCCcccccCCCHHHHHHHHHHccCCh
Confidence 9999999999999999999976433221 1111111 0111112245577889999999999999
Q ss_pred cCCCCHHHHHHH
Q 024027 239 EQRINAKEIVTK 250 (273)
Q Consensus 239 ~~Rps~~~~l~~ 250 (273)
.+|||++|+++|
T Consensus 400 ~~R~t~~e~l~H 411 (573)
T 3uto_A 400 NTRMTIHQALEH 411 (573)
T ss_dssp GGSCCHHHHHHS
T ss_pred hHCcCHHHHhcC
Confidence 999999999987
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=330.00 Aligned_cols=241 Identities=18% Similarity=0.238 Sum_probs=180.4
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
.||||++.... ....+.+|+++|+.+ +||||++++++|.+++++|+||||++||+|.++++ .+++..++.++.
T Consensus 51 ~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~ 124 (361)
T 4f9c_A 51 KIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN----SLSFQEVREYML 124 (361)
T ss_dssp EEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT----TCCHHHHHHHHH
T ss_pred EEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHc----CCCHHHHHHHHH
Confidence 69999986543 335688999999998 69999999999999999999999999999999984 489999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCC-CceEEeecccccccccCCC--------------------------cc
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDN-LVAYLSDFGIAKLLIGEDQ--------------------------SM 133 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~-~~~kl~Df~~~~~~~~~~~--------------------------~~ 133 (273)
|++.||.||| ++||+||||||+|||++.+ +.+||+|||++........ ..
T Consensus 125 qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (361)
T 4f9c_A 125 NLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQ 201 (361)
T ss_dssp HHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC----------------------
T ss_pred HHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccc
Confidence 9999999999 9999999999999999876 7999999999975432211 01
Q ss_pred eeecccccCCCCCCcccCCC-CcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCc--------------
Q 024027 134 TQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPI-------------- 198 (273)
Q Consensus 134 ~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-------------- 198 (273)
.....+||+.|+|||++.+. .++.++||||+||++|+|++|+.||....+....+..+.......
T Consensus 202 ~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~ 281 (361)
T 4f9c_A 202 QVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSIL 281 (361)
T ss_dssp ----CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEE
T ss_pred cccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhcccccc
Confidence 12335799999999998775 589999999999999999999999976444333333222111000
Q ss_pred --------cchhhhhhhc------------cccchhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHH
Q 024027 199 --------STMEVVDANL------------LSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKL 251 (273)
Q Consensus 199 --------~~~~~~~~~~------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l 251 (273)
.......... .............+++++.+|+.+||++||++|||++|+++|=
T Consensus 282 ~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp 354 (361)
T 4f9c_A 282 CSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHP 354 (361)
T ss_dssp ESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSG
T ss_pred ccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCc
Confidence 0000000000 0000001112245678899999999999999999999999873
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=336.49 Aligned_cols=226 Identities=19% Similarity=0.218 Sum_probs=181.1
Q ss_pred CeEEEEEeeccc---ChhhhhHH---HHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFD---VECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQ 74 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~---~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (273)
+.||||+++... ......+. .++.+++.++||||++++++|.++..+|+|||||+||+|.+++.+.+ .+++..
T Consensus 215 ~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~-~l~E~~ 293 (689)
T 3v5w_A 215 KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-VFSEAD 293 (689)
T ss_dssp CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHC-CCCHHH
T ss_pred CEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhcC-CCCHHH
Confidence 479999997442 12222333 34677778899999999999999999999999999999999997654 699999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccC-CC
Q 024027 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR-EG 153 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~ 153 (273)
++.++.||+.||.||| ++||+||||||+|||++.+|.+||+|||++..+... .....+||+.|+|||++. +.
T Consensus 294 a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~----~~~t~~GTp~YmAPEvl~~~~ 366 (689)
T 3v5w_A 294 MRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKGV 366 (689)
T ss_dssp HHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC----CCCSCCSCGGGCCHHHHSTTC
T ss_pred HHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecCCC----CCCCccCCcCccCHHHHhCCC
Confidence 9999999999999999 999999999999999999999999999999876322 234468999999999986 45
Q ss_pred CcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhc
Q 024027 154 RVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMAC 233 (273)
Q Consensus 154 ~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 233 (273)
.|+.++|+|||||++|+|++|.+||......... ..... .. ......+..++.++.+||.+|
T Consensus 367 ~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~--~i~~~------------i~----~~~~~~p~~~S~~a~dLI~~l 428 (689)
T 3v5w_A 367 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRM------------TL----TMAVELPDSFSPELRSLLEGL 428 (689)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH--HHHHH------------HH----HCCCCCCTTSCHHHHHHHHHH
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHHh------------hc----CCCCCCCccCCHHHHHHHHHH
Confidence 7999999999999999999999999764332211 10000 00 000112456788899999999
Q ss_pred CCCCccCCCC-----HHHHHHHHH
Q 024027 234 TVESPEQRIN-----AKEIVTKLL 252 (273)
Q Consensus 234 l~~dp~~Rps-----~~~~l~~l~ 252 (273)
|..||.+|++ ++++++|=+
T Consensus 429 L~~dP~~Rl~~~~~ga~ei~~Hpf 452 (689)
T 3v5w_A 429 LQRDVNRRLGCLGRGAQEVKESPF 452 (689)
T ss_dssp TCSCGGGCTTCSSSTHHHHTTSGG
T ss_pred ccCCHhHCCCCCCCCHHHHhcCcc
Confidence 9999999998 688888753
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=309.16 Aligned_cols=239 Identities=24% Similarity=0.360 Sum_probs=197.9
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
+.||+|++...+....+.+.+|+++++.++||||+++++++.+++..++||||+++++|.+++......+++..++.++.
T Consensus 36 ~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ 115 (310)
T 3s95_A 36 EVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAK 115 (310)
T ss_dssp CEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHH
T ss_pred cEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHH
Confidence 46999998766667778899999999999999999999999999999999999999999999988777899999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcce------------eecccccCCCCCCc
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMT------------QTQTLATIGYMAPE 148 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~------------~~~~~~~~~~~aPE 148 (273)
|++.||.||| +.|++|+||||+||+++.++.+||+|||++........... .....|++.|+|||
T Consensus 116 qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 192 (310)
T 3s95_A 116 DIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192 (310)
T ss_dssp HHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHH
T ss_pred HHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHH
Confidence 9999999999 99999999999999999999999999999986633222110 11446899999999
Q ss_pred ccCCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHH
Q 024027 149 YGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFN 228 (273)
Q Consensus 149 ~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 228 (273)
.+.+..++.++||||||+++|+|++|..||.............. ........+..++.++.+
T Consensus 193 ~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~l~~ 254 (310)
T 3s95_A 193 MINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV------------------RGFLDRYCPPNCPPSFFP 254 (310)
T ss_dssp HHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH------------------HHHHHHTCCTTCCTTHHH
T ss_pred HhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh------------------hccccccCCCCCCHHHHH
Confidence 99999999999999999999999999999876443322111100 001111124556677999
Q ss_pred HHhhcCCCCccCCCCHHHHHHHHHHHHHhhhh
Q 024027 229 LAMACTVESPEQRINAKEIVTKLLKIRDSLLR 260 (273)
Q Consensus 229 li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~ 260 (273)
|+.+||..||++|||+.++++.|+.++..+..
T Consensus 255 li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~ 286 (310)
T 3s95_A 255 ITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG 286 (310)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence 99999999999999999999999999987654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=306.19 Aligned_cols=227 Identities=26% Similarity=0.314 Sum_probs=189.1
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
+.||||++........+.+.+|+.+++.++||||+++++++..++..++||||+++++|.+++... .+++..++.++.
T Consensus 46 ~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ 123 (297)
T 3fxz_A 46 QEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCR 123 (297)
T ss_dssp CEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHH
T ss_pred cEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhhc--CCCHHHHHHHHH
Confidence 479999998776666778999999999999999999999999999999999999999999999765 489999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
|++.||.||| +.|++|+||||+||+++.++.+||+|||++....... .......|++.|+|||.+.+..++.++|
T Consensus 124 qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~D 198 (297)
T 3fxz_A 124 ECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVD 198 (297)
T ss_dssp HHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--CCBCCCCSCGGGCCHHHHHCSCBCTHHH
T ss_pred HHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc--cccCCccCCcCccChhhhcCCCCCcHHH
Confidence 9999999999 9999999999999999999999999999987653322 2234457899999999999999999999
Q ss_pred hHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccC
Q 024027 161 VYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQ 240 (273)
Q Consensus 161 iwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 240 (273)
||||||++|+|++|..||............ .... ......+..++..+.+|+.+||..||++
T Consensus 199 iwslG~il~ell~g~~pf~~~~~~~~~~~~-~~~~-----------------~~~~~~~~~~~~~~~~li~~~l~~dp~~ 260 (297)
T 3fxz_A 199 IWSLGIMAIEMIEGEPPYLNENPLRALYLI-ATNG-----------------TPELQNPEKLSAIFRDFLNRCLEMDVEK 260 (297)
T ss_dssp HHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-HHHC-----------------SCCCSCGGGSCHHHHHHHHHHSCSSTTT
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhCC-----------------CCCCCCccccCHHHHHHHHHHccCChhH
Confidence 999999999999999999654322111110 0000 0011114556778999999999999999
Q ss_pred CCCHHHHHHHHH
Q 024027 241 RINAKEIVTKLL 252 (273)
Q Consensus 241 Rps~~~~l~~l~ 252 (273)
|||+.++++|-+
T Consensus 261 Rps~~ell~h~~ 272 (297)
T 3fxz_A 261 RGSAKELLQHQF 272 (297)
T ss_dssp SCCHHHHTTCGG
T ss_pred CcCHHHHhhChh
Confidence 999999998744
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=304.64 Aligned_cols=247 Identities=30% Similarity=0.484 Sum_probs=197.8
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC---CCCCHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN---CILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~ 77 (273)
+.||||++........+.+.+|+++++.++||||+++++++.+.+..++||||+++++|.+++.... ..+++..++.
T Consensus 64 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 143 (321)
T 2qkw_B 64 AKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLE 143 (321)
T ss_dssp CEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHH
T ss_pred CEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHH
Confidence 4799999987766777889999999999999999999999999999999999999999999996543 3489999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
++.|++.||.||| +.|++|+||||+||+++.++.+||+|||++................|++.|+|||.+.+..++.
T Consensus 144 i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 220 (321)
T 2qkw_B 144 ICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTE 220 (321)
T ss_dssp HHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCT
T ss_pred HHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCc
Confidence 9999999999999 9999999999999999999999999999997654333333334456899999999998888999
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccc-hhhhhhh-ccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMT-LKHWVND-WLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTV 235 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 235 (273)
++||||||+++|+|++|+.||......+.. ...+... .......... ........+..++..+.+++.+||.
T Consensus 221 ~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~~l~ 294 (321)
T 2qkw_B 221 KSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIV------DPNLADKIRPESLRKFGDTAVKCLA 294 (321)
T ss_dssp HHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSS------SSSCTTCSCHHHHHHHHHHHHHHTC
T ss_pred ccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhc------ChhhccccCHHHHHHHHHHHHHHcC
Confidence 999999999999999999999764443221 1111100 0000000001 1111122245678889999999999
Q ss_pred CCccCCCCHHHHHHHHHHHHH
Q 024027 236 ESPEQRINAKEIVTKLLKIRD 256 (273)
Q Consensus 236 ~dp~~Rps~~~~l~~l~~~~~ 256 (273)
.||++|||+.+++++|+.+.+
T Consensus 295 ~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 295 LSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp SSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcccCcCHHHHHHHHHHHhh
Confidence 999999999999999998875
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=309.98 Aligned_cols=236 Identities=27% Similarity=0.430 Sum_probs=192.6
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
+||||+++... ....+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|.+++......+++..++.++.
T Consensus 79 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ 158 (325)
T 3kul_A 79 PVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLR 158 (325)
T ss_dssp EEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHH
T ss_pred eEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHH
Confidence 59999998653 44567899999999999999999999999999999999999999999999977766799999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCc-ceeecccccCCCCCCcccCCCCcCCcc
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQS-MTQTQTLATIGYMAPEYGREGRVSTNG 159 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~ 159 (273)
|++.||.||| +.|++|+||||+||+++.++.++|+|||++......... .......+++.|+|||.+.+..++.++
T Consensus 159 qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 235 (325)
T 3kul_A 159 GVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSAS 235 (325)
T ss_dssp HHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHH
T ss_pred HHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHH
Confidence 9999999999 999999999999999999999999999999876433221 122233457789999999888899999
Q ss_pred hhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc
Q 024027 160 DVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238 (273)
Q Consensus 160 DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 238 (273)
||||||+++|+|++ |..||........... .... .....+..++.++.+|+.+||..||
T Consensus 236 Di~slG~il~ell~~g~~p~~~~~~~~~~~~-~~~~-------------------~~~~~~~~~~~~l~~li~~~l~~dp 295 (325)
T 3kul_A 236 DVWSFGVVMWEVLAYGERPYWNMTNRDVISS-VEEG-------------------YRLPAPMGCPHALHQLMLDCWHKDR 295 (325)
T ss_dssp HHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH-HHTT-------------------CCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred HHHHHHHHHHHHHcCCCCCcccCCHHHHHHH-HHcC-------------------CCCCCCCCcCHHHHHHHHHHccCCh
Confidence 99999999999999 9999866433221110 0000 0111234577789999999999999
Q ss_pred cCCCCHHHHHHHHHHHHHhhhh
Q 024027 239 EQRINAKEIVTKLLKIRDSLLR 260 (273)
Q Consensus 239 ~~Rps~~~~l~~l~~~~~~~~~ 260 (273)
.+|||+.++++.|+.+.++...
T Consensus 296 ~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 296 AQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp GGSCCHHHHHHHHHHHHHSCC-
T ss_pred hhCcCHHHHHHHHHHHHhCccc
Confidence 9999999999999999876543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=307.58 Aligned_cols=250 Identities=21% Similarity=0.259 Sum_probs=189.6
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCC----ceeEEEeccCCCCHHHhhhcCCCCCCHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEE----FKALVLEYMPHGSLEKYLYSSNCILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (273)
+.||||+++.. ......+..|+.+++.++||||+++++++.+.. .+++||||+++|+|.+++... .+++..++
T Consensus 48 ~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~ 124 (322)
T 3soc_A 48 EYVAVKIFPIQ-DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELC 124 (322)
T ss_dssp EEEEEEEECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHH
T ss_pred CEEEEEEeecC-chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhc--CCCHHHHH
Confidence 37999999755 334456677999999999999999999998754 369999999999999999765 38999999
Q ss_pred HHHHHHHHHHHHHhcCCCC----------CeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCC
Q 024027 77 NIMIDVASALEYLHFGCSA----------PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMA 146 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~----------~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~a 146 (273)
.++.|++.||.||| +. |++|+||||+||+++.++.+||+|||++..+.............|++.|+|
T Consensus 125 ~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~a 201 (322)
T 3soc_A 125 HIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMA 201 (322)
T ss_dssp HHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCC
T ss_pred HHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccC
Confidence 99999999999999 88 999999999999999999999999999987654433333344578999999
Q ss_pred CcccCCC-----CcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhh---hhccccchhhhhh
Q 024027 147 PEYGREG-----RVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVD---ANLLSQEDIHFVA 218 (273)
Q Consensus 147 PE~~~~~-----~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 218 (273)
||++.+. .++.++|||||||++|+|++|..||............. ............. .............
T Consensus 202 PE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (322)
T 3soc_A 202 PEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE-EIGQHPSLEDMQEVVVHKKKRPVLRDYWQ 280 (322)
T ss_dssp HHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH-HHCSSCCHHHHHHHHTTSCCCCCCCGGGG
T ss_pred HhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh-hhccCCchhhhhhhhhcccCCCCcccccc
Confidence 9998763 46678999999999999999999997643322111110 0000001111100 0000011111112
Q ss_pred hhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHHHHHHh
Q 024027 219 KEQCVSFVFNLAMACTVESPEQRINAKEIVTKLLKIRDS 257 (273)
Q Consensus 219 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~ 257 (273)
...++.++.+|+.+||..||++|||+.++++.|+++.+.
T Consensus 281 ~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 281 KHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp SSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 334667799999999999999999999999999998865
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=312.32 Aligned_cols=234 Identities=28% Similarity=0.432 Sum_probs=192.7
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC------------
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN------------ 67 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------ 67 (273)
.||||+++... ....+.+.+|+++++.+ +||||++++++|.+++.+++||||+++|+|.+++....
T Consensus 115 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 194 (370)
T 2psq_A 115 TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 194 (370)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC----------
T ss_pred eEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccc
Confidence 59999997653 34567899999999999 89999999999999999999999999999999997543
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCC
Q 024027 68 ---CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGY 144 (273)
Q Consensus 68 ---~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~ 144 (273)
..+++..++.++.|++.||.||| +.|++||||||+||+++.++.+||+|||++................+++.|
T Consensus 195 ~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y 271 (370)
T 2psq_A 195 VPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKW 271 (370)
T ss_dssp -CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGG
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccce
Confidence 24789999999999999999999 999999999999999999999999999999866433322223344567889
Q ss_pred CCCcccCCCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhH
Q 024027 145 MAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCV 223 (273)
Q Consensus 145 ~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (273)
+|||++.+..++.++|||||||++|+|++ |..||......+. ....... . ....+..++
T Consensus 272 ~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~-~~~~~~~-------------~------~~~~~~~~~ 331 (370)
T 2psq_A 272 MAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-FKLLKEG-------------H------RMDKPANCT 331 (370)
T ss_dssp CCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-HHHHHTT-------------C------CCCCCTTSC
T ss_pred ECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHhcC-------------C------CCCCCCCCC
Confidence 99999988889999999999999999999 9999876432211 1100000 0 011144577
Q ss_pred HHHHHHHhhcCCCCccCCCCHHHHHHHHHHHHHhh
Q 024027 224 SFVFNLAMACTVESPEQRINAKEIVTKLLKIRDSL 258 (273)
Q Consensus 224 ~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 258 (273)
.++.+|+.+||..||.+|||+.+++++|+++....
T Consensus 332 ~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 332 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 78999999999999999999999999999988654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=305.22 Aligned_cols=237 Identities=27% Similarity=0.377 Sum_probs=183.5
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCC--CCCHHHHH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNC--ILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~ 76 (273)
+.||||++.... ......+.+|+++++.++||||+++++++.+....++||||+++++|.+++..... .+++..++
T Consensus 61 ~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 140 (309)
T 3p86_A 61 SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRL 140 (309)
T ss_dssp EEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHH
T ss_pred CcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHH
Confidence 369999997553 34456789999999999999999999999999999999999999999999976542 38999999
Q ss_pred HHHHHHHHHHHHHhcCCCCC--eEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCC
Q 024027 77 NIMIDVASALEYLHFGCSAP--VIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGR 154 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~--i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 154 (273)
.++.|++.||.||| +.| ++||||||+||+++.++.+||+|||++..... .........|++.|+|||++.+..
T Consensus 141 ~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~ 215 (309)
T 3p86_A 141 SMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS--TFLSSKSAAGTPEWMAPEVLRDEP 215 (309)
T ss_dssp HHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC-------------------CCTTSCHHHHTTCC
T ss_pred HHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccc--cccccccCCCCccccChhhhcCCC
Confidence 99999999999999 999 99999999999999999999999999875422 112234457899999999999989
Q ss_pred cCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcC
Q 024027 155 VSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACT 234 (273)
Q Consensus 155 ~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 234 (273)
++.++||||||+++|+|++|..||............ .. .......+..++.++.+|+.+||
T Consensus 216 ~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~-~~------------------~~~~~~~~~~~~~~l~~li~~~l 276 (309)
T 3p86_A 216 SNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV-GF------------------KCKRLEIPRNLNPQVAAIIEGCW 276 (309)
T ss_dssp CCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH-HH------------------SCCCCCCCTTSCHHHHHHHHHHT
T ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-Hh------------------cCCCCCCCccCCHHHHHHHHHHc
Confidence 999999999999999999999999764322111100 00 00011124456778999999999
Q ss_pred CCCccCCCCHHHHHHHHHHHHHhhhhh
Q 024027 235 VESPEQRINAKEIVTKLLKIRDSLLRN 261 (273)
Q Consensus 235 ~~dp~~Rps~~~~l~~l~~~~~~~~~~ 261 (273)
..||.+|||+.++++.|+.+.++..-.
T Consensus 277 ~~dP~~Rps~~~ll~~L~~~~~~~~p~ 303 (309)
T 3p86_A 277 TNEPWKRPSFATIMDLLRPLIKSAVPP 303 (309)
T ss_dssp CSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred cCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence 999999999999999999998765433
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=308.01 Aligned_cols=224 Identities=22% Similarity=0.313 Sum_probs=185.3
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
+.||||++.... ....+.+.+|+++++.++||||+++++++.+++..++||||+++++|.+++...+ .+++..++.+
T Consensus 41 ~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~ 119 (328)
T 3fe3_A 41 REVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG-RMKEKEARSK 119 (328)
T ss_dssp CEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHC-CCCHHHHHHH
T ss_pred CEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHcC-CCCHHHHHHH
Confidence 479999997552 3456778899999999999999999999999999999999999999999996543 5999999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcC-C
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVS-T 157 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~ 157 (273)
+.|++.||.||| +.|++||||||+||+++.++.+||+|||++....... .....+|++.|+|||++.+..+. .
T Consensus 120 ~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~ 193 (328)
T 3fe3_A 120 FRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG---KLDAFCGAPPYAAPELFQGKKYDGP 193 (328)
T ss_dssp HHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC---GGGTTSSSGGGCCHHHHHTCCCCSH
T ss_pred HHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC---ccccccCCcceeCcccccCCCcCCc
Confidence 999999999999 9999999999999999999999999999997653222 23456799999999999887764 7
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
++||||+||++|+|++|..||......... ..... . ....+..++.++.+|+.+||..|
T Consensus 194 ~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~i~~-------------~-------~~~~p~~~s~~~~~li~~~L~~d 252 (328)
T 3fe3_A 194 EVDVWSLGVILYTLVSGSLPFDGQNLKELR-ERVLR-------------G-------KYRIPFYMSTDCENLLKRFLVLN 252 (328)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHH-------------C-------CCCCCTTSCHHHHHHHHHHCCSS
T ss_pred hhhhhhhHHHHHHHHhCCCCCCCCCHHHHH-HHHHh-------------C-------CCCCCCCCCHHHHHHHHHHCCCC
Confidence 899999999999999999999763322111 00000 0 00113346677999999999999
Q ss_pred ccCCCCHHHHHHHHH
Q 024027 238 PEQRINAKEIVTKLL 252 (273)
Q Consensus 238 p~~Rps~~~~l~~l~ 252 (273)
|.+|||++++++|-+
T Consensus 253 P~~R~t~~eil~h~~ 267 (328)
T 3fe3_A 253 PIKRGTLEQIMKDRW 267 (328)
T ss_dssp TTTSCCHHHHTTCTT
T ss_pred hhHCcCHHHHhcCHh
Confidence 999999999998844
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=304.72 Aligned_cols=227 Identities=20% Similarity=0.288 Sum_probs=189.2
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~q 81 (273)
.||+|+++.. ......+.+|+.+++.++||||+++++++.+....++||||++|++|.+++......+++..++.++.|
T Consensus 32 ~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~q 110 (321)
T 1tki_A 32 TYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQ 110 (321)
T ss_dssp EEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHH
T ss_pred EEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHH
Confidence 6899999755 445567899999999999999999999999999999999999999999999776667999999999999
Q ss_pred HHHHHHHHhcCCCCCeEeccCCCCceeeCC--CCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcc
Q 024027 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDD--NLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 159 (273)
Q Consensus 82 l~~~l~~lh~~~~~~i~h~di~p~nil~~~--~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 159 (273)
++.||.||| +.|++|+||||+||+++. ++.+||+|||++..+... .......+++.|+|||++.+..++.++
T Consensus 111 i~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~ 184 (321)
T 1tki_A 111 VCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG---DNFRLLFTAPEYYAPEVHQHDVVSTAT 184 (321)
T ss_dssp HHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT---CEEEEEESCGGGSCHHHHTTCEECHHH
T ss_pred HHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC---CccccccCChhhcCcHHhcCCCCCchh
Confidence 999999999 999999999999999987 789999999999876322 223456789999999999988899999
Q ss_pred hhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCcc
Q 024027 160 DVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239 (273)
Q Consensus 160 DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 239 (273)
||||||+++|+|++|..||........ ....... ...........++.++.+|+.+||..||.
T Consensus 185 DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~----------------~~~~~~~~~~~~s~~~~~li~~~L~~dp~ 247 (321)
T 1tki_A 185 DMWSLGTLVYVLLSGINPFLAETNQQI-IENIMNA----------------EYTFDEEAFKEISIEAMDFVDRLLVKERK 247 (321)
T ss_dssp HHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHHT----------------CCCCCHHHHTTSCHHHHHHHHTTSCSSGG
T ss_pred hHHHHHHHHHHHHhCCCCCcCCCHHHH-HHHHHcC----------------CCCCChhhhccCCHHHHHHHHHHcCCChh
Confidence 999999999999999999976332211 1111111 01111122345678899999999999999
Q ss_pred CCCCHHHHHHHHH
Q 024027 240 QRINAKEIVTKLL 252 (273)
Q Consensus 240 ~Rps~~~~l~~l~ 252 (273)
+|||+.++++|-+
T Consensus 248 ~Rpt~~e~l~hp~ 260 (321)
T 1tki_A 248 SRMTASEALQHPW 260 (321)
T ss_dssp GSCCHHHHHHSHH
T ss_pred HCcCHHHHhcChh
Confidence 9999999999876
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=315.60 Aligned_cols=234 Identities=29% Similarity=0.417 Sum_probs=191.2
Q ss_pred CeEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 1 MEVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 1 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
+.||||+++... ......+.+|+++++.++||||+++++++.+++..++||||+++|+|.+++...+..+++..++.++
T Consensus 140 ~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 219 (377)
T 3cbl_A 140 TLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMV 219 (377)
T ss_dssp CEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHH
T ss_pred eEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHH
Confidence 479999998553 3445678999999999999999999999999999999999999999999998766679999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 159 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 159 (273)
.|++.||.||| +.|++||||||+||+++.++.+||+|||++................++..|+|||.+.+..++.++
T Consensus 220 ~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 296 (377)
T 3cbl_A 220 GDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSES 296 (377)
T ss_dssp HHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHH
T ss_pred HHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchh
Confidence 99999999999 999999999999999999999999999998754221111111222356789999999888899999
Q ss_pred hhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc
Q 024027 160 DVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238 (273)
Q Consensus 160 DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 238 (273)
||||||+++|++++ |..||......+. ...... . .....+..++.++.+|+.+||..||
T Consensus 297 DvwslG~il~el~t~g~~p~~~~~~~~~--~~~~~~------------~------~~~~~~~~~~~~l~~li~~cl~~dP 356 (377)
T 3cbl_A 297 DVWSFGILLWETFSLGASPYPNLSNQQT--REFVEK------------G------GRLPCPELCPDAVFRLMEQCWAYEP 356 (377)
T ss_dssp HHHHHHHHHHHHHTTSCCSSTTSCHHHH--HHHHHT------------T------CCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHHHc------------C------CCCCCCCCCCHHHHHHHHHHcCCCc
Confidence 99999999999998 9999876433211 111100 0 0111244577789999999999999
Q ss_pred cCCCCHHHHHHHHHHHHHh
Q 024027 239 EQRINAKEIVTKLLKIRDS 257 (273)
Q Consensus 239 ~~Rps~~~~l~~l~~~~~~ 257 (273)
++|||+.++++.|+++.+.
T Consensus 357 ~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 357 GQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp GGSCCHHHHHHHHHHHHHH
T ss_pred hhCcCHHHHHHHHHHHHhh
Confidence 9999999999999998765
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=298.90 Aligned_cols=231 Identities=28% Similarity=0.473 Sum_probs=190.4
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~q 81 (273)
+||||+++... ...+.+.+|+++++.++||||+++++++.+++..++||||+++++|.+++......+++..++.++.|
T Consensus 36 ~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~ 114 (269)
T 4hcu_A 36 KVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 114 (269)
T ss_dssp EEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHH
T ss_pred eEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHH
Confidence 69999997653 34467999999999999999999999999999999999999999999999877777999999999999
Q ss_pred HHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcchh
Q 024027 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 161 (273)
Q Consensus 82 l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di 161 (273)
++.||.||| +.|++|+||||+||+++.++.++|+|||++....... ........+++.|+|||.+.+..++.++||
T Consensus 115 i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 190 (269)
T 4hcu_A 115 VCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDV 190 (269)
T ss_dssp HHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHH
T ss_pred HHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccccc-cccccCcccccccCCHHHhcCCCCCchhhh
Confidence 999999999 9999999999999999999999999999997652211 112223445678999999988889999999
Q ss_pred HHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccC
Q 024027 162 YSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQ 240 (273)
Q Consensus 162 wslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 240 (273)
||+|+++|+|++ |..||........ ....... .....+..++.++.+++.+||..||++
T Consensus 191 ~slG~~l~~ll~~g~~p~~~~~~~~~-~~~~~~~-------------------~~~~~~~~~~~~~~~li~~~l~~~p~~ 250 (269)
T 4hcu_A 191 WSFGVLMWEVFSEGKIPYENRSNSEV-VEDISTG-------------------FRLYKPRLASTHVYQIMNHCWRERPED 250 (269)
T ss_dssp HHHHHHHHHHHTTSCCTTTTCCHHHH-HHHHHTT-------------------CCCCCCTTSCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHHHHHHhcCCCCCCCCCCHHHH-HHHHhcC-------------------ccCCCCCcCCHHHHHHHHHHccCCccc
Confidence 999999999999 9999875332211 1111000 001113345677999999999999999
Q ss_pred CCCHHHHHHHHHHHHHh
Q 024027 241 RINAKEIVTKLLKIRDS 257 (273)
Q Consensus 241 Rps~~~~l~~l~~~~~~ 257 (273)
|||+.+++++|+++.++
T Consensus 251 Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 251 RPAFSRLLRQLAEIAES 267 (269)
T ss_dssp SCCHHHHHHHHHHHHHC
T ss_pred CcCHHHHHHHHHHHHHc
Confidence 99999999999998764
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=303.46 Aligned_cols=251 Identities=24% Similarity=0.385 Sum_probs=190.1
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeec--CCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSN--EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
.||||+++.......+.+.+|+++++.++||||+++++++.. ....++||||+++++|.+++......+++..++.++
T Consensus 41 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 120 (295)
T 3ugc_A 41 VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 120 (295)
T ss_dssp EEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHH
T ss_pred EEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHH
Confidence 699999987766667889999999999999999999999855 356899999999999999998777679999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCc-ceeecccccCCCCCCcccCCCCcCCc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQS-MTQTQTLATIGYMAPEYGREGRVSTN 158 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~ 158 (273)
.|++.||.||| +.|++|+||||+||+++.++.++|+|||++......... .......++..|+|||.+.+..++.+
T Consensus 121 ~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 197 (295)
T 3ugc_A 121 SQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVA 197 (295)
T ss_dssp HHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHH
T ss_pred HHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChH
Confidence 99999999999 999999999999999999999999999999876433221 12223446777999999988889999
Q ss_pred chhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc
Q 024027 159 GDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238 (273)
Q Consensus 159 ~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 238 (273)
+||||||+++|+|++|..||...... ............... ...............+..++.++.+|+.+||..||
T Consensus 198 ~Di~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 273 (295)
T 3ugc_A 198 SDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIGNDKQGQMIV-FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNV 273 (295)
T ss_dssp HHHHHHHHHHHHHHHTTCTTCSHHHH---HHHHHCTTCCTHHHH-HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSG
T ss_pred HHHHHHHHHHHHHHhcccccCCChHH---HHhhhcCccccchhH-HHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCCh
Confidence 99999999999999999997653211 000000000000000 00000000111122255678889999999999999
Q ss_pred cCCCCHHHHHHHHHHHHHhhh
Q 024027 239 EQRINAKEIVTKLLKIRDSLL 259 (273)
Q Consensus 239 ~~Rps~~~~l~~l~~~~~~~~ 259 (273)
++|||+.++++.|+.+++++.
T Consensus 274 ~~Rps~~el~~~L~~l~~~l~ 294 (295)
T 3ugc_A 274 NQRPSFRDLALRVDQIRDNMA 294 (295)
T ss_dssp GGSCCHHHHHHHHHHHHHC--
T ss_pred hhCCCHHHHHHHHHHHHHhcc
Confidence 999999999999999988763
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=305.26 Aligned_cols=228 Identities=21% Similarity=0.306 Sum_probs=186.7
Q ss_pred CeEEEEEeecccCh------hhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHH
Q 024027 1 MEVAVKVFNLQCGR------AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQ 74 (273)
Q Consensus 1 ~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (273)
+.||||+++..... ..+.+.+|+.+++.++||||+++++++.+....++||||++||+|.+++... ..+++..
T Consensus 38 ~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~l~~~~ 116 (361)
T 2yab_A 38 LEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQK-ESLSEEE 116 (361)
T ss_dssp CEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTC-SCCBHHH
T ss_pred CEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhc-CCCCHHH
Confidence 47999999865322 3567999999999999999999999999999999999999999999999654 4699999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCC----ceEEeecccccccccCCCcceeecccccCCCCCCccc
Q 024027 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNL----VAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYG 150 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~----~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 150 (273)
++.++.|++.||.||| +.|++|+||||+||+++.++ .+||+|||++...... ......+|++.|+|||++
T Consensus 117 ~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~ 190 (361)
T 2yab_A 117 ATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG---VEFKNIFGTPEFVAPEIV 190 (361)
T ss_dssp HHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTT---CCCCCCCSCGGGCCHHHH
T ss_pred HHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCC---CccccCCCCccEECchHH
Confidence 9999999999999999 99999999999999998776 7999999999865332 122345799999999999
Q ss_pred CCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHH
Q 024027 151 REGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLA 230 (273)
Q Consensus 151 ~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 230 (273)
.+..++.++|||||||++|+|++|..||......+ ....+... ........+..++.++.+||
T Consensus 191 ~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~-~~~~i~~~----------------~~~~~~~~~~~~s~~~~~li 253 (361)
T 2yab_A 191 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLANITAV----------------SYDFDEEFFSQTSELAKDFI 253 (361)
T ss_dssp TTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHTT----------------CCCCCHHHHTTSCHHHHHHH
T ss_pred cCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhc----------------CCCCCchhccCCCHHHHHHH
Confidence 98899999999999999999999999997632221 11111110 11111122456778899999
Q ss_pred hhcCCCCccCCCCHHHHHHHHH
Q 024027 231 MACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 231 ~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
.+||..||.+|||+.++++|-+
T Consensus 254 ~~~L~~dP~~R~t~~e~l~hp~ 275 (361)
T 2yab_A 254 RKLLVKETRKRLTIQEALRHPW 275 (361)
T ss_dssp HHHSCSSTTTSCCHHHHHTSTT
T ss_pred HHHCCCChhHCcCHHHHhcCcC
Confidence 9999999999999999998643
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=307.54 Aligned_cols=229 Identities=21% Similarity=0.293 Sum_probs=189.7
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
+.||||+++.......+.+.+|+++++.++||||+++++++.+.+..++||||+++++|.+++......+++..++.++.
T Consensus 115 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~ 194 (373)
T 2x4f_A 115 LKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMK 194 (373)
T ss_dssp CEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHH
T ss_pred cEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHH
Confidence 47999999876556678899999999999999999999999999999999999999999999977666799999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceee--CCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCc
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLL--DDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTN 158 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~--~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 158 (273)
|++.||.||| +.|++|+||||+||++ +.++.+||+|||++..+.... ......|++.|+|||++.+..++.+
T Consensus 195 qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~ 268 (373)
T 2x4f_A 195 QICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLAPEVVNYDFVSFP 268 (373)
T ss_dssp HHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---BCCCCCSSCTTCCHHHHTTCBCCHH
T ss_pred HHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---ccccccCCCcEeChhhccCCCCCcH
Confidence 9999999999 9999999999999999 567899999999998763322 2234568999999999988889999
Q ss_pred chhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc
Q 024027 159 GDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238 (273)
Q Consensus 159 ~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 238 (273)
+|||||||++|+|++|..||......+ ....+..... .........++.++.+|+.+||..||
T Consensus 269 ~DiwslG~il~elltg~~pf~~~~~~~-~~~~i~~~~~----------------~~~~~~~~~~~~~~~~li~~~L~~dp 331 (373)
T 2x4f_A 269 TDMWSVGVIAYMLLSGLSPFLGDNDAE-TLNNILACRW----------------DLEDEEFQDISEEAKEFISKLLIKEK 331 (373)
T ss_dssp HHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTCC----------------CSCSGGGTTSCHHHHHHHHTTSCSSG
T ss_pred HhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhccC----------------CCChhhhccCCHHHHHHHHHHcCCCh
Confidence 999999999999999999997643221 1111111100 00111134567789999999999999
Q ss_pred cCCCCHHHHHHHHH
Q 024027 239 EQRINAKEIVTKLL 252 (273)
Q Consensus 239 ~~Rps~~~~l~~l~ 252 (273)
.+|||+.++++|-+
T Consensus 332 ~~Rps~~e~l~hp~ 345 (373)
T 2x4f_A 332 SWRISASEALKHPW 345 (373)
T ss_dssp GGSCCHHHHHHSHH
T ss_pred hhCCCHHHHhcCcC
Confidence 99999999999754
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=297.59 Aligned_cols=231 Identities=28% Similarity=0.447 Sum_probs=189.5
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~q 81 (273)
.||||+++... .....+.+|+++++.++||||+++++++.++...++||||+++++|.+++...+..+++..++.++.|
T Consensus 34 ~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~q 112 (268)
T 3sxs_A 34 DVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYD 112 (268)
T ss_dssp EEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHH
T ss_pred eEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHH
Confidence 69999997653 34467999999999999999999999999999999999999999999999876667999999999999
Q ss_pred HHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcchh
Q 024027 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 161 (273)
Q Consensus 82 l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di 161 (273)
++.||.||| +.|++|+||||+||+++.++.++|+|||.+....... ........+++.|+|||.+.+..++.++||
T Consensus 113 i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 188 (268)
T 3sxs_A 113 VCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ-YVSSVGTKFPVKWSAPEVFHYFKYSSKSDV 188 (268)
T ss_dssp HHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC-EEECCSCCCCGGGCCHHHHHHSEEETTHHH
T ss_pred HHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhh-hhcccCCCcCcccCCHHHHhccCCchhhhh
Confidence 999999999 9999999999999999999999999999997653322 112233445677999999988889999999
Q ss_pred HHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccC
Q 024027 162 YSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQ 240 (273)
Q Consensus 162 wslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 240 (273)
||||+++++|++ |..||........... .... .....+..++.++.+++.+||..||.+
T Consensus 189 ~slG~il~~l~~~g~~p~~~~~~~~~~~~-~~~~-------------------~~~~~~~~~~~~l~~li~~~l~~~p~~ 248 (268)
T 3sxs_A 189 WAFGILMWEVFSLGKMPYDLYTNSEVVLK-VSQG-------------------HRLYRPHLASDTIYQIMYSCWHELPEK 248 (268)
T ss_dssp HHHHHHHHHHHTTTCCTTTTSCHHHHHHH-HHTT-------------------CCCCCCTTSCHHHHHHHHHTTCSSGGG
T ss_pred HHHHHHHHHHHcCCCCCccccChHHHHHH-HHcC-------------------CCCCCCCcChHHHHHHHHHHcCCChhh
Confidence 999999999998 9999865433221111 0000 000113345667999999999999999
Q ss_pred CCCHHHHHHHHHHHHHh
Q 024027 241 RINAKEIVTKLLKIRDS 257 (273)
Q Consensus 241 Rps~~~~l~~l~~~~~~ 257 (273)
|||+.+++++|+.++++
T Consensus 249 Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 249 RPTFQQLLSSIEPLREK 265 (268)
T ss_dssp SCCHHHHHHHHGGGCC-
T ss_pred CcCHHHHHHHHHHhhhc
Confidence 99999999999987654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=302.09 Aligned_cols=233 Identities=24% Similarity=0.398 Sum_probs=192.3
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC-------------
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN------------- 67 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------- 67 (273)
.||||+++... ....+.+.+|+++++.++||||+++++++.+.+..++||||+++++|.+++....
T Consensus 55 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 134 (314)
T 2ivs_A 55 TVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134 (314)
T ss_dssp EEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC------
T ss_pred eEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccc
Confidence 69999997553 3456789999999999999999999999999999999999999999999997543
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeec
Q 024027 68 ----------CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQ 137 (273)
Q Consensus 68 ----------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~ 137 (273)
..+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++..............
T Consensus 135 ~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 211 (314)
T 2ivs_A 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQ 211 (314)
T ss_dssp ----------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSC
T ss_pred cccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccchheEEEcCCCCEEEccccccccccccccceeccC
Confidence 23889999999999999999999 99999999999999999999999999999986644333333334
Q ss_pred ccccCCCCCCcccCCCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhh
Q 024027 138 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHF 216 (273)
Q Consensus 138 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (273)
..+++.|+|||.+.+..++.++||||||+++|+|++ |..||......... ...... . ..
T Consensus 212 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~--~~~~~~------------~------~~ 271 (314)
T 2ivs_A 212 GRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLF--NLLKTG------------H------RM 271 (314)
T ss_dssp CCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH--HHHHTT------------C------CC
T ss_pred CCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH--HHhhcC------------C------cC
Confidence 456788999999988889999999999999999999 99998754332111 111000 0 01
Q ss_pred hhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHHHHHHh
Q 024027 217 VAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLLKIRDS 257 (273)
Q Consensus 217 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~ 257 (273)
..+..++.++.+|+.+||..||.+|||+.+++++|+++..+
T Consensus 272 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 272 ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 11345677899999999999999999999999999998765
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=304.16 Aligned_cols=239 Identities=23% Similarity=0.339 Sum_probs=190.3
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCC-----------
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNC----------- 68 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------- 68 (273)
.||||+++... ....+.+.+|+.+++.+ +||||+++++++...+..++||||+++|+|.+++.....
T Consensus 77 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 156 (344)
T 1rjb_A 77 QVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 156 (344)
T ss_dssp EEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------
T ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhh
Confidence 69999997542 44567899999999999 899999999999999999999999999999999976542
Q ss_pred -----------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeec
Q 024027 69 -----------ILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQ 137 (273)
Q Consensus 69 -----------~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~ 137 (273)
.+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++..............
T Consensus 157 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 233 (344)
T 1rjb_A 157 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGN 233 (344)
T ss_dssp ------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETT
T ss_pred hcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccC
Confidence 3788999999999999999999 99999999999999999999999999999987654443333445
Q ss_pred ccccCCCCCCcccCCCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhh
Q 024027 138 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHF 216 (273)
Q Consensus 138 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (273)
..+++.|+|||.+.+..++.++||||||+++|+|++ |..||................ ...
T Consensus 234 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-------------------~~~ 294 (344)
T 1rjb_A 234 ARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNG-------------------FKM 294 (344)
T ss_dssp EEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTT-------------------CCC
T ss_pred ccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcC-------------------CCC
Confidence 567889999999988889999999999999999998 999997654332211111110 001
Q ss_pred hhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHHHHHHhhhhhc
Q 024027 217 VAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLLKIRDSLLRNV 262 (273)
Q Consensus 217 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~~ 262 (273)
..+..++.++.+|+.+||..||.+|||+.+++++|+.+..+...+.
T Consensus 295 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~ 340 (344)
T 1rjb_A 295 DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEAM 340 (344)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-------
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHHHH
Confidence 1134466779999999999999999999999999999887765543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=306.67 Aligned_cols=235 Identities=24% Similarity=0.381 Sum_probs=191.8
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcC-CCccceeeeeeeecCC-ceeEEEeccCCCCHHHhhhcCCC----------
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEE-FKALVLEYMPHGSLEKYLYSSNC---------- 68 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~---------- 68 (273)
.||||+++... ....+.+.+|+++++.+ +||||+++++++.+.+ ..++||||+++|+|.+++.....
T Consensus 54 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 133 (359)
T 3vhe_A 54 TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGA 133 (359)
T ss_dssp EEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----
T ss_pred EEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccc
Confidence 69999998653 34456799999999999 7999999999988755 48999999999999999975432
Q ss_pred -------------------------------------------------------CCCHHHHHHHHHHHHHHHHHHhcCC
Q 024027 69 -------------------------------------------------------ILDIFQRLNIMIDVASALEYLHFGC 93 (273)
Q Consensus 69 -------------------------------------------------------~~~~~~~~~~~~ql~~~l~~lh~~~ 93 (273)
.+++..++.++.|++.||.|||
T Consensus 134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH--- 210 (359)
T 3vhe_A 134 RFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--- 210 (359)
T ss_dssp --------------------------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---
T ss_pred hhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---
Confidence 1889999999999999999999
Q ss_pred CCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcchhHHHHHHHHHHHh
Q 024027 94 SAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 173 (273)
Q Consensus 94 ~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~ 173 (273)
+.|++|+||||+||+++.++.++|+|||++................+++.|+|||++.+..++.++||||||+++|+|++
T Consensus 211 ~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt 290 (359)
T 3vhe_A 211 SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290 (359)
T ss_dssp HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTT
T ss_pred HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHh
Confidence 99999999999999999999999999999986644443334455678889999999988889999999999999999998
Q ss_pred -CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 174 -GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 174 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
|..||................. ....+..++.++.+++.+||..||.+|||+.+++++|+
T Consensus 291 ~g~~p~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 351 (359)
T 3vhe_A 291 LGASPYPGVKIDEEFCRRLKEGT-------------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 351 (359)
T ss_dssp TSCCSSTTCCCSHHHHHHHHHTC-------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cCCCCCCccchhHHHHHHHHcCC-------------------CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence 9999976443322222111110 01113446677999999999999999999999999999
Q ss_pred HHHHhh
Q 024027 253 KIRDSL 258 (273)
Q Consensus 253 ~~~~~~ 258 (273)
++.++.
T Consensus 352 ~~~~~~ 357 (359)
T 3vhe_A 352 NLLQAN 357 (359)
T ss_dssp HHHHHH
T ss_pred HHHHHh
Confidence 998754
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=302.09 Aligned_cols=225 Identities=22% Similarity=0.299 Sum_probs=186.1
Q ss_pred CeEEEEEeecc---cChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||||+++.. .......+.+|+.+++.++||||+++++++.+...+++||||++||+|.+++...+ .+++..++.
T Consensus 31 ~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~ 109 (337)
T 1o6l_A 31 RYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARF 109 (337)
T ss_dssp CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHH
T ss_pred CEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHH
Confidence 47999999754 23455678899999999999999999999999999999999999999999996543 689999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
++.|++.||.||| +.|++||||||+||+++.++.+||+|||++...... .......+||+.|+|||++.+..++.
T Consensus 110 ~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~ 184 (337)
T 1o6l_A 110 YGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLEDNDYGR 184 (337)
T ss_dssp HHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT--TCCBCCCEECGGGCCGGGGSSSCBCT
T ss_pred HHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC--CCcccccccChhhCChhhhcCCCCCc
Confidence 9999999999999 999999999999999999999999999998754221 12234567999999999999989999
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
++|+|||||++|+|++|..||........ ....... ....+..++.++.+||.+||..|
T Consensus 185 ~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~i~~~--------------------~~~~p~~~s~~~~~li~~lL~~d 243 (337)
T 1o6l_A 185 AVDWWGLGVVMYEMMCGRLPFYNQDHERL-FELILME--------------------EIRFPRTLSPEAKSLLAGLLKKD 243 (337)
T ss_dssp THHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHC--------------------CCCCCTTSCHHHHHHHHHHTCSS
T ss_pred hhhcccchhHHHHHhcCCCCCCCCCHHHH-HHHHHcC--------------------CCCCCCCCCHHHHHHHHHHhhcC
Confidence 99999999999999999999975322111 1111000 00113456778999999999999
Q ss_pred ccCCC-----CHHHHHHHHH
Q 024027 238 PEQRI-----NAKEIVTKLL 252 (273)
Q Consensus 238 p~~Rp-----s~~~~l~~l~ 252 (273)
|++|| +++++++|-.
T Consensus 244 P~~R~g~~~~~~~ei~~h~~ 263 (337)
T 1o6l_A 244 PKQRLGGGPSDAKEVMEHRF 263 (337)
T ss_dssp TTTSTTCSTTTHHHHHTSGG
T ss_pred HHHhcCCCCCCHHHHHcCCC
Confidence 99999 8999998843
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=299.92 Aligned_cols=227 Identities=25% Similarity=0.335 Sum_probs=187.9
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
+.||||+++.......+.+.+|+.+++.++||||+++++++......++||||+++++|.+++... .+++..+..++.
T Consensus 71 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~l~~~~~~~i~~ 148 (321)
T 2c30_A 71 RQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCE 148 (321)
T ss_dssp CEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC--CCCHHHHHHHHH
T ss_pred cEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHH
Confidence 479999998766666778999999999999999999999999999999999999999999998653 599999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
|++.||.||| +.|++|+||||+||+++.++.+||+|||++....... .......|++.|+|||.+.+..++.++|
T Consensus 149 qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~D 223 (321)
T 2c30_A 149 AVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRSLYATEVD 223 (321)
T ss_dssp HHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHH
T ss_pred HHHHHHHHHH---HCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc--cccccccCCccccCHhhhcCCCCCchhh
Confidence 9999999999 9999999999999999999999999999987653322 1233457899999999999888999999
Q ss_pred hHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccC
Q 024027 161 VYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQ 240 (273)
Q Consensus 161 iwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 240 (273)
|||||+++|+|++|..||........ ....... .. ........++.++.+|+.+||..||++
T Consensus 224 v~slG~il~el~~g~~pf~~~~~~~~-~~~~~~~-~~----------------~~~~~~~~~~~~l~~li~~~l~~dp~~ 285 (321)
T 2c30_A 224 IWSLGIMVIEMVDGEPPYFSDSPVQA-MKRLRDS-PP----------------PKLKNSHKVSPVLRDFLERMLVRDPQE 285 (321)
T ss_dssp HHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHS-SC----------------CCCTTGGGSCHHHHHHHHHHSCSSTTT
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHhcC-CC----------------CCcCccccCCHHHHHHHHHHccCChhh
Confidence 99999999999999999865322111 1111000 00 001113456677999999999999999
Q ss_pred CCCHHHHHHHHH
Q 024027 241 RINAKEIVTKLL 252 (273)
Q Consensus 241 Rps~~~~l~~l~ 252 (273)
|||+.++++|-+
T Consensus 286 Rps~~ell~hp~ 297 (321)
T 2c30_A 286 RATAQELLDHPF 297 (321)
T ss_dssp SCCHHHHHTSGG
T ss_pred CcCHHHHhcChh
Confidence 999999999755
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=308.27 Aligned_cols=237 Identities=26% Similarity=0.415 Sum_probs=190.5
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC-------------
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN------------- 67 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------- 67 (273)
.||||+++... ....+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|.+++....
T Consensus 79 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 158 (343)
T 1luf_A 79 MVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 158 (343)
T ss_dssp EEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC------------
T ss_pred eEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCccccccccccccc
Confidence 69999998653 3446779999999999999999999999999999999999999999999997542
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeec
Q 024027 68 ----------CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQ 137 (273)
Q Consensus 68 ----------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~ 137 (273)
..+++..++.++.|++.||.||| +.|++|+||||+||+++.++.+||+|||++..............
T Consensus 159 ~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 235 (343)
T 1luf_A 159 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGN 235 (343)
T ss_dssp ----------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----
T ss_pred ccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCC
Confidence 46899999999999999999999 99999999999999999999999999999976543332223344
Q ss_pred ccccCCCCCCcccCCCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhh
Q 024027 138 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHF 216 (273)
Q Consensus 138 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (273)
..+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+.. ...... . ..
T Consensus 236 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~-~~~~~~-------------~------~~ 295 (343)
T 1luf_A 236 DAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVI-YYVRDG-------------N------IL 295 (343)
T ss_dssp CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-HHHHTT-------------C------CC
T ss_pred CcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHH-HHHhCC-------------C------cC
Confidence 567889999999988889999999999999999999 99998754322111 110000 0 00
Q ss_pred hhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHHHHHHhhhhh
Q 024027 217 VAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLLKIRDSLLRN 261 (273)
Q Consensus 217 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~ 261 (273)
..+..++.++.+|+.+||..||.+|||+.+++++|+++.+.+...
T Consensus 296 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~~~ 340 (343)
T 1luf_A 296 ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAEGT 340 (343)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-----
T ss_pred CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhhhh
Confidence 113456778999999999999999999999999999988766543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=297.10 Aligned_cols=243 Identities=22% Similarity=0.250 Sum_probs=185.5
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
+.||||+++... ......+.+|+++++.++||||+++++++.++...++||||+++ +|.+++......+++..++.+
T Consensus 46 ~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~ 124 (311)
T 3niz_A 46 RIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIY 124 (311)
T ss_dssp CEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHH
T ss_pred CEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHH
Confidence 469999997543 33456788999999999999999999999999999999999976 899998877777999999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC-CCcCC
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE-GRVST 157 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~ 157 (273)
+.|++.||.||| +.|++|+||||+||+++.++.+||+|||++...... ........+++.|+|||++.+ ..++.
T Consensus 125 ~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~ 199 (311)
T 3niz_A 125 LYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP--VRSYTHEVVTLWYRAPDVLMGSKKYST 199 (311)
T ss_dssp HHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC--CC---CCCCCCTTCCHHHHTTCCSCCT
T ss_pred HHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCC--cccccCCcccCCcCCHHHhcCCCCCCc
Confidence 999999999999 999999999999999999999999999999865322 222334568999999999876 45899
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhh--h-------hc-cccchhhhhhhhhhHHHHH
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVD--A-------NL-LSQEDIHFVAKEQCVSFVF 227 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~-------~~-~~~~~~~~~~~~~~~~~l~ 227 (273)
++|||||||++|+|++|..||......+. .................. . .. .............++.++.
T Consensus 200 ~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (311)
T 3niz_A 200 SVDIWSIGCIFAEMITGKPLFPGVTDDDQ-LPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGI 278 (311)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCCSSTTTH-HHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHH
T ss_pred hHHhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHH
Confidence 99999999999999999999986544432 222221111111100000 0 00 0000111122345677899
Q ss_pred HHHhhcCCCCccCCCCHHHHHHH
Q 024027 228 NLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 228 ~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
+|+.+||..||++|||++++++|
T Consensus 279 ~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 279 DLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHcCCChhHCCCHHHHhcC
Confidence 99999999999999999999986
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=299.31 Aligned_cols=227 Identities=20% Similarity=0.284 Sum_probs=185.7
Q ss_pred CeEEEEEeecccC------hhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHH
Q 024027 1 MEVAVKVFNLQCG------RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQ 74 (273)
Q Consensus 1 ~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (273)
+.||||+++.... ...+.+.+|+.+++.++||||+++++++.++...++||||+++++|.+++... ..+++..
T Consensus 37 ~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~ 115 (326)
T 2y0a_A 37 LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEE 115 (326)
T ss_dssp CEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTS-SCCBHHH
T ss_pred cEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhc-CCcCHHH
Confidence 4799999976532 13577999999999999999999999999999999999999999999999654 4699999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCC----ceEEeecccccccccCCCcceeecccccCCCCCCccc
Q 024027 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNL----VAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYG 150 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~----~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 150 (273)
++.++.|++.||.||| +.|++|+||||+||+++.++ .+||+|||++....... ......|++.|+|||++
T Consensus 116 ~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~ 189 (326)
T 2y0a_A 116 ATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIV 189 (326)
T ss_dssp HHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTS---CCCCCCSCTTTCCHHHH
T ss_pred HHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCC---ccccccCCcCcCCceee
Confidence 9999999999999999 99999999999999998877 89999999998663222 22345689999999999
Q ss_pred CCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHH
Q 024027 151 REGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLA 230 (273)
Q Consensus 151 ~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 230 (273)
.+..++.++|||||||++|+|++|..||......+. ....... ...........++..+.+|+
T Consensus 190 ~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~----------------~~~~~~~~~~~~~~~~~~li 252 (326)
T 2y0a_A 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-LANVSAV----------------NYEFEDEYFSNTSALAKDFI 252 (326)
T ss_dssp TTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHHHHT----------------CCCCCHHHHTTSCHHHHHHH
T ss_pred cCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHHHhc----------------CCCcCccccccCCHHHHHHH
Confidence 888899999999999999999999999865322211 1111000 00111122345677899999
Q ss_pred hhcCCCCccCCCCHHHHHHHH
Q 024027 231 MACTVESPEQRINAKEIVTKL 251 (273)
Q Consensus 231 ~~~l~~dp~~Rps~~~~l~~l 251 (273)
.+||..||++|||+.++++|-
T Consensus 253 ~~~L~~dP~~Rpt~~e~l~hp 273 (326)
T 2y0a_A 253 RRLLVKDPKKRMTIQDSLQHP 273 (326)
T ss_dssp HHHSCSSGGGSCCHHHHHHST
T ss_pred HHHccCChhhCCCHHHHhcCC
Confidence 999999999999999999874
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=302.19 Aligned_cols=234 Identities=23% Similarity=0.349 Sum_probs=187.3
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
+||+|.++... ....+.+.+|+.+++.++||||+++++++.++. .++|+|++++|+|.+++......+++..++.++.
T Consensus 46 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 124 (327)
T 3poz_A 46 PVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 124 (327)
T ss_dssp EEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHH
T ss_pred EEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHH
Confidence 57899886443 345678999999999999999999999998764 7799999999999999988777899999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
|++.||.||| +.|++||||||+||+++.++.+||+|||++................++..|+|||.+.+..++.++|
T Consensus 125 qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 201 (327)
T 3poz_A 125 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSD 201 (327)
T ss_dssp HHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHH
T ss_pred HHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhh
Confidence 9999999999 9999999999999999999999999999998764444333334455678999999999889999999
Q ss_pred hHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCcc
Q 024027 161 VYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239 (273)
Q Consensus 161 iwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 239 (273)
|||||+++|+|++ |..||........ ...... .. ....+..++.++.+++.+||..||.
T Consensus 202 i~slG~il~ellt~g~~p~~~~~~~~~--~~~~~~------------~~------~~~~~~~~~~~~~~li~~~l~~~p~ 261 (327)
T 3poz_A 202 VWSYGVTVWELMTFGSKPYDGIPASEI--SSILEK------------GE------RLPQPPICTIDVYMIMVKCWMIDAD 261 (327)
T ss_dssp HHHHHHHHHHHHTTSCCTTTTCCGGGH--HHHHHT------------TC------CCCCCTTBCHHHHHHHHHHTCSCGG
T ss_pred hhhhHHHHHHHHhcCCCCccCCCHHHH--HHHHHc------------CC------CCCCCccCCHHHHHHHHHHcCCChh
Confidence 9999999999999 9999976433221 111110 00 0111345667799999999999999
Q ss_pred CCCCHHHHHHHHHHHHHhhh
Q 024027 240 QRINAKEIVTKLLKIRDSLL 259 (273)
Q Consensus 240 ~Rps~~~~l~~l~~~~~~~~ 259 (273)
+|||+.+++++|+.+.++..
T Consensus 262 ~Rps~~ell~~l~~~~~~~~ 281 (327)
T 3poz_A 262 SRPKFRELIIEFSKMARDPQ 281 (327)
T ss_dssp GSCCHHHHHHHHHHHHTSHH
T ss_pred hCCCHHHHHHHHHHHHhhhh
Confidence 99999999999999887543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=306.03 Aligned_cols=228 Identities=18% Similarity=0.238 Sum_probs=187.9
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
+.||+|++..........+.+|+.+++.++||||+++++++.+....++||||+++++|.+++......+++..++.++.
T Consensus 77 ~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~ 156 (387)
T 1kob_A 77 RVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR 156 (387)
T ss_dssp CEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHH
T ss_pred CEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHH
Confidence 46999999876555667899999999999999999999999999999999999999999999987766799999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCC--CCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCc
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDD--NLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTN 158 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~--~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 158 (273)
|++.||.||| +.|++|+||||+||+++. ++.+||+|||++....... ......+++.|+|||++.+..++.+
T Consensus 157 qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~ 230 (387)
T 1kob_A 157 QACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFY 230 (387)
T ss_dssp HHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHH
T ss_pred HHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCCc---ceeeeccCCCccCchhccCCCCCCc
Confidence 9999999999 999999999999999974 5679999999998763322 2334578999999999998889999
Q ss_pred chhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc
Q 024027 159 GDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238 (273)
Q Consensus 159 ~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 238 (273)
+|||||||++|+|++|..||........ ........ ..........++.++.+|+.+||..||
T Consensus 231 ~DiwSlG~il~elltg~~Pf~~~~~~~~-~~~i~~~~----------------~~~~~~~~~~~s~~~~~li~~~L~~dP 293 (387)
T 1kob_A 231 TDMWAIGVLGYVLLSGLSPFAGEDDLET-LQNVKRCD----------------WEFDEDAFSSVSPEAKDFIKNLLQKEP 293 (387)
T ss_dssp HHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHHHHCC----------------CCCCSSTTTTSCHHHHHHHHTTSCSSG
T ss_pred ccEeeHhHHHHHHHhCCCCCCCCCHHHH-HHHHHhCC----------------CCCCccccccCCHHHHHHHHHHcCCCh
Confidence 9999999999999999999976322111 11111100 000111133567789999999999999
Q ss_pred cCCCCHHHHHHHH
Q 024027 239 EQRINAKEIVTKL 251 (273)
Q Consensus 239 ~~Rps~~~~l~~l 251 (273)
.+|||+.++++|-
T Consensus 294 ~~Rpt~~ell~hp 306 (387)
T 1kob_A 294 RKRLTVHDALEHP 306 (387)
T ss_dssp GGSCCHHHHHTST
T ss_pred hHCcCHHHHhhCc
Confidence 9999999999874
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=298.37 Aligned_cols=236 Identities=23% Similarity=0.352 Sum_probs=195.2
Q ss_pred eEEEEEeecccC-hhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCC-----------
Q 024027 2 EVAVKVFNLQCG-RAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNC----------- 68 (273)
Q Consensus 2 ~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------- 68 (273)
.||||+++.... ...+.+.+|+.+++.+ +||||+++++++.+++..++||||+++|+|.+++.....
T Consensus 55 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 134 (313)
T 1t46_A 55 TVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134 (313)
T ss_dssp EEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC---------
T ss_pred hhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccc
Confidence 699999986543 4567899999999999 999999999999999999999999999999999976542
Q ss_pred ------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccC
Q 024027 69 ------ILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATI 142 (273)
Q Consensus 69 ------~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~ 142 (273)
.+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++................+++
T Consensus 135 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~ 211 (313)
T 1t46_A 135 MEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPV 211 (313)
T ss_dssp -----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECG
T ss_pred cccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcc
Confidence 4899999999999999999999 9999999999999999999999999999998765443333334456788
Q ss_pred CCCCCcccCCCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhh
Q 024027 143 GYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQ 221 (273)
Q Consensus 143 ~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (273)
.|+|||.+.+..++.++||||||+++|+|++ |..||................. ....+..
T Consensus 212 ~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~-------------------~~~~~~~ 272 (313)
T 1t46_A 212 KWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGF-------------------RMLSPEH 272 (313)
T ss_dssp GGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTC-------------------CCCCCTT
T ss_pred eeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCC-------------------CCCCccc
Confidence 8999999988889999999999999999998 9999876443322211111100 0011344
Q ss_pred hHHHHHHHHhhcCCCCccCCCCHHHHHHHHHHHHHhhh
Q 024027 222 CVSFVFNLAMACTVESPEQRINAKEIVTKLLKIRDSLL 259 (273)
Q Consensus 222 ~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 259 (273)
++.++.+|+.+||..||.+|||+.+++++|+++..+..
T Consensus 273 ~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 273 APAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 66779999999999999999999999999999887654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=293.81 Aligned_cols=244 Identities=28% Similarity=0.419 Sum_probs=192.4
Q ss_pred CeEEEEEeeccc----ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcC--CCCCCHHH
Q 024027 1 MEVAVKVFNLQC----GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS--NCILDIFQ 74 (273)
Q Consensus 1 ~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~ 74 (273)
++||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|.+++... ...+++..
T Consensus 55 ~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 134 (307)
T 2nru_A 55 TTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 134 (307)
T ss_dssp CEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHH
T ss_pred ceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHH
Confidence 479999997532 344677999999999999999999999999999999999999999999998643 34589999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCC
Q 024027 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGR 154 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 154 (273)
++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++................|++.|+|||.+.+ .
T Consensus 135 ~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~ 210 (307)
T 2nru_A 135 RCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-E 210 (307)
T ss_dssp HHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-E
T ss_pred HHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-C
Confidence 9999999999999999 99999999999999999999999999999986643333333344578999999998865 5
Q ss_pred cCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhc--cCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhh
Q 024027 155 VSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDW--LPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMA 232 (273)
Q Consensus 155 ~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 232 (273)
++.++||||||+++|+|++|..||.......... .+.... .........+... ...+..++..+.+++.+
T Consensus 211 ~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~ 282 (307)
T 2nru_A 211 ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL-DIKEEIEDEEKTIEDYIDKKM-------NDADSTSVEAMYSVASQ 282 (307)
T ss_dssp ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT-HHHHHHHTTSCCHHHHSCSSC-------SCCCHHHHHHHHHHHHH
T ss_pred CCccchhHHHHHHHHHHHHCCCCcccCcchHHHH-HHHHHhhhhhhhhhhhccccc-------cccchHHHHHHHHHHHH
Confidence 8899999999999999999999997654433211 111110 0111111111111 11244567789999999
Q ss_pred cCCCCccCCCCHHHHHHHHHHHHH
Q 024027 233 CTVESPEQRINAKEIVTKLLKIRD 256 (273)
Q Consensus 233 ~l~~dp~~Rps~~~~l~~l~~~~~ 256 (273)
||..||.+|||+.+++++|+++..
T Consensus 283 cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 283 CLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HcCCCcccCcCHHHHHHHHHHHhc
Confidence 999999999999999999998754
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=308.42 Aligned_cols=235 Identities=29% Similarity=0.427 Sum_probs=193.8
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC------------
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN------------ 67 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------ 67 (273)
.||||+++... ......+.+|+++++.+ +||||+++++++.+++..++||||+++|+|.+++....
T Consensus 103 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 182 (382)
T 3tt0_A 103 KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 182 (382)
T ss_dssp EEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCS
T ss_pred EEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhccccccccccccc
Confidence 59999998653 34567799999999999 89999999999999999999999999999999997543
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCC
Q 024027 68 ---CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGY 144 (273)
Q Consensus 68 ---~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~ 144 (273)
..+++..++.++.|++.||.||| +.|++|+||||+||+++.++.+||+|||++................+++.|
T Consensus 183 ~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y 259 (382)
T 3tt0_A 183 NPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKW 259 (382)
T ss_dssp SCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGG
T ss_pred ccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcce
Confidence 35899999999999999999999 999999999999999999999999999999866443333333445578889
Q ss_pred CCCcccCCCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhH
Q 024027 145 MAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCV 223 (273)
Q Consensus 145 ~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (273)
+|||++.+..++.++|||||||++++|++ |..||......+. ....... . ....+..++
T Consensus 260 ~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~-~~~~~~~-------------~------~~~~~~~~~ 319 (382)
T 3tt0_A 260 MAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL-FKLLKEG-------------H------RMDKPSNCT 319 (382)
T ss_dssp SCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-HHHHHTT-------------C------CCCCCSSCC
T ss_pred eCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHcC-------------C------CCCCCccCC
Confidence 99999998889999999999999999999 9999865332211 1100000 0 011134567
Q ss_pred HHHHHHHhhcCCCCccCCCCHHHHHHHHHHHHHhhh
Q 024027 224 SFVFNLAMACTVESPEQRINAKEIVTKLLKIRDSLL 259 (273)
Q Consensus 224 ~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 259 (273)
.++.+|+.+||..||++|||+.+++++|+++.....
T Consensus 320 ~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 355 (382)
T 3tt0_A 320 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 355 (382)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 789999999999999999999999999999986543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=301.74 Aligned_cols=230 Identities=23% Similarity=0.311 Sum_probs=186.2
Q ss_pred CeEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 1 MEVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 1 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
+.||||++.... ....+.+.+|+.+++.++||||+++++++.+++..++||||+++++|.+++... ..+++..++.++
T Consensus 33 ~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~ 111 (323)
T 3tki_A 33 EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFF 111 (323)
T ss_dssp CEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTT-TBCCHHHHHHHH
T ss_pred cEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhc-CCCCHHHHHHHH
Confidence 479999997553 334577899999999999999999999999999999999999999999999654 469999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCc-CCc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRV-STN 158 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~ 158 (273)
.|++.||.||| +.|++|+||||+||+++.++.+||+|||++..+.............|++.|+|||++.+..+ +.+
T Consensus 112 ~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 188 (323)
T 3tki_A 112 HQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188 (323)
T ss_dssp HHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHH
T ss_pred HHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCc
Confidence 99999999999 99999999999999999999999999999986643333333345678999999999987765 778
Q ss_pred chhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc
Q 024027 159 GDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238 (273)
Q Consensus 159 ~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 238 (273)
+|||||||++|+|++|..||............+..... .......++.++.+|+.+||..||
T Consensus 189 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~li~~~L~~dP 250 (323)
T 3tki_A 189 VDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT------------------YLNPWKKIDSAPLALLHKILVENP 250 (323)
T ss_dssp HHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT------------------TSTTGGGSCHHHHHHHHHHSCSST
T ss_pred ccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc------------------cCCccccCCHHHHHHHHHHccCCh
Confidence 99999999999999999999764443322222211100 011124566779999999999999
Q ss_pred cCCCCHHHHHHHHH
Q 024027 239 EQRINAKEIVTKLL 252 (273)
Q Consensus 239 ~~Rps~~~~l~~l~ 252 (273)
.+|||+.++++|-+
T Consensus 251 ~~R~t~~eil~h~~ 264 (323)
T 3tki_A 251 SARITIPDIKKDRW 264 (323)
T ss_dssp TTSCCHHHHTTCTT
T ss_pred hhCcCHHHHhhChh
Confidence 99999999998865
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=310.24 Aligned_cols=228 Identities=21% Similarity=0.300 Sum_probs=186.2
Q ss_pred eEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 2 EVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 2 ~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
.||+|+++... ....+.+.+|+++++.++||||+++++++.+++..++||||++||+|.+++.... .+++..+..++
T Consensus 38 ~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~-~~~e~~~~~i~ 116 (444)
T 3soa_A 38 EYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE-YYSEADASHCI 116 (444)
T ss_dssp EEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHCS-CCCHHHHHHHH
T ss_pred EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHcC-CCCHHHHHHHH
Confidence 68999997653 3456678999999999999999999999999999999999999999999997654 69999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeC---CCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcC
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLD---DNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVS 156 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~---~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 156 (273)
.|++.||.||| +.|++||||||+||+++ .++.+||+|||++....... .......|++.|+|||++.+..++
T Consensus 117 ~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~ 191 (444)
T 3soa_A 117 QQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ--QAWFGFAGTPGYLSPEVLRKDPYG 191 (444)
T ss_dssp HHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC--CBCCCSCSCGGGCCHHHHTTCCBC
T ss_pred HHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC--ceeecccCCcccCCHHHhcCCCCC
Confidence 99999999999 99999999999999998 56789999999997653322 222346799999999999988999
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++||||+||++|+|++|..||........ ........ ..........++.++.+|+.+||..
T Consensus 192 ~~~DIwSlGvilyell~G~~Pf~~~~~~~~-~~~i~~~~----------------~~~~~~~~~~~s~~~~~li~~~L~~ 254 (444)
T 3soa_A 192 KPVDLWACGVILYILLVGYPPFWDEDQHRL-YQQIKAGA----------------YDFPSPEWDTVTPEAKDLINKMLTI 254 (444)
T ss_dssp THHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHTC----------------CCCCTTTTTTSCHHHHHHHHHHSCS
T ss_pred CccccHHHHHHHHHHHhCCCCCCCccHHHH-HHHHHhCC----------------CCCCccccccCCHHHHHHHHHHcCC
Confidence 999999999999999999999965332211 11111110 0001111245677899999999999
Q ss_pred CccCCCCHHHHHHHHH
Q 024027 237 SPEQRINAKEIVTKLL 252 (273)
Q Consensus 237 dp~~Rps~~~~l~~l~ 252 (273)
||.+|||+.++++|-+
T Consensus 255 dP~~Rpta~e~L~hp~ 270 (444)
T 3soa_A 255 NPSKRITAAEALKHPW 270 (444)
T ss_dssp STTTSCCHHHHHHSCT
T ss_pred ChhHCCCHHHHhcCcc
Confidence 9999999999998744
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=296.79 Aligned_cols=231 Identities=25% Similarity=0.463 Sum_probs=189.8
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~q 81 (273)
.||||+++... ...+.+.+|+++++.++||||+++++++.+....++||||+++++|.+++......+++..++.++.|
T Consensus 50 ~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~q 128 (283)
T 3gen_A 50 DVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKD 128 (283)
T ss_dssp EEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHH
T ss_pred eEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHH
Confidence 69999998653 34467999999999999999999999999999999999999999999999775667999999999999
Q ss_pred HHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcchh
Q 024027 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 161 (273)
Q Consensus 82 l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di 161 (273)
++.||.||| +.|++|+||||+||+++.++.++|+|||++....... ........+++.|+|||.+.+..++.++||
T Consensus 129 i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 204 (283)
T 3gen_A 129 VCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 204 (283)
T ss_dssp HHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-HHSTTSTTSCGGGCCHHHHHHCCCSHHHHH
T ss_pred HHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccccccccccccc-cccccCCccCcccCCHHHhccCCCCchhhH
Confidence 999999999 9999999999999999999999999999997652211 111223345678999999988889999999
Q ss_pred HHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccC
Q 024027 162 YSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQ 240 (273)
Q Consensus 162 wslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 240 (273)
||||+++|+|++ |..||......... ...... .....+..++..+.+|+.+||..||.+
T Consensus 205 ~slG~~l~~l~t~g~~p~~~~~~~~~~-~~~~~~-------------------~~~~~~~~~~~~l~~li~~~l~~~p~~ 264 (283)
T 3gen_A 205 WAFGVLMWEIYSLGKMPYERFTNSETA-EHIAQG-------------------LRLYRPHLASEKVYTIMYSCWHEKADE 264 (283)
T ss_dssp HHHHHHHHHHHTTTCCTTTTSCHHHHH-HHHHTT-------------------CCCCCCTTCCHHHHHHHHHTTCSSGGG
T ss_pred HHHHHHHHHHHhCCCCCccccChhHHH-HHHhcc-------------------cCCCCCCcCCHHHHHHHHHHccCChhH
Confidence 999999999998 99998764332211 111100 001113345677999999999999999
Q ss_pred CCCHHHHHHHHHHHHHh
Q 024027 241 RINAKEIVTKLLKIRDS 257 (273)
Q Consensus 241 Rps~~~~l~~l~~~~~~ 257 (273)
|||+.+++++|+++.++
T Consensus 265 Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 265 RPTFKILLSNILDVMDE 281 (283)
T ss_dssp SCCHHHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHHhhc
Confidence 99999999999998764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=291.12 Aligned_cols=227 Identities=26% Similarity=0.442 Sum_probs=183.7
Q ss_pred CeEEEEEeecccCh-------hhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHH
Q 024027 1 MEVAVKVFNLQCGR-------AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 73 (273)
Q Consensus 1 ~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 73 (273)
+.||||++...... ..+.+.+|+++++.++||||+++++++.+.. ++||||+++++|.+++......+++.
T Consensus 45 ~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~ 122 (287)
T 4f0f_A 45 SVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWS 122 (287)
T ss_dssp CEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHH
T ss_pred eEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhcccCCccHH
Confidence 47999999754321 1267899999999999999999999997765 69999999999999998777789999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCC--eEeccCCCCceeeCCCCc-----eEEeecccccccccCCCcceeecccccCCCCC
Q 024027 74 QRLNIMIDVASALEYLHFGCSAP--VIHCDLKPDNVLLDDNLV-----AYLSDFGIAKLLIGEDQSMTQTQTLATIGYMA 146 (273)
Q Consensus 74 ~~~~~~~ql~~~l~~lh~~~~~~--i~h~di~p~nil~~~~~~-----~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~a 146 (273)
.++.++.|++.||.||| +.| ++|+||||+||+++.++. ++|+|||++.... .......+++.|+|
T Consensus 123 ~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~-----~~~~~~~g~~~y~a 194 (287)
T 4f0f_A 123 VKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV-----HSVSGLLGNFQWMA 194 (287)
T ss_dssp HHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCS-----SCEECCCCCCTTSC
T ss_pred HHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCcccccc-----ccccccCCCccccC
Confidence 99999999999999999 999 999999999999987776 9999999987432 22344678999999
Q ss_pred CcccC--CCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHH
Q 024027 147 PEYGR--EGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVS 224 (273)
Q Consensus 147 PE~~~--~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (273)
||.+. ...++.++||||||+++|+|++|..||................. ......+..++.
T Consensus 195 PE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~ 257 (287)
T 4f0f_A 195 PETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE-----------------GLRPTIPEDCPP 257 (287)
T ss_dssp GGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS-----------------CCCCCCCTTSCH
T ss_pred chhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc-----------------CCCCCCCcccCH
Confidence 99984 44578999999999999999999999976544332221111110 001112345677
Q ss_pred HHHHHHhhcCCCCccCCCCHHHHHHHHHHH
Q 024027 225 FVFNLAMACTVESPEQRINAKEIVTKLLKI 254 (273)
Q Consensus 225 ~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 254 (273)
++.+|+.+||..||.+|||++++++.|+++
T Consensus 258 ~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 258 RLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 899999999999999999999999999753
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=309.48 Aligned_cols=235 Identities=25% Similarity=0.375 Sum_probs=191.3
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC------CCCCHHH
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN------CILDIFQ 74 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~ 74 (273)
.||||+++... ......+.+|+.+++.++||||+++++++.+....++||||+++|+|.+++...+ ..+++..
T Consensus 103 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 182 (367)
T 3l9p_A 103 QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 182 (367)
T ss_dssp EEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHH
T ss_pred eEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHH
Confidence 69999997542 4455678899999999999999999999999999999999999999999997543 3589999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCC---ceEEeecccccccccCCCcceeecccccCCCCCCcccC
Q 024027 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNL---VAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR 151 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~---~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 151 (273)
++.++.|++.||.||| +.|++||||||+||+++.++ .+||+|||++................+++.|+|||++.
T Consensus 183 ~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 259 (367)
T 3l9p_A 183 LLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFM 259 (367)
T ss_dssp HHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHH
T ss_pred HHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhc
Confidence 9999999999999999 99999999999999999554 59999999997653333333334456788999999998
Q ss_pred CCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHH
Q 024027 152 EGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLA 230 (273)
Q Consensus 152 ~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 230 (273)
+..++.++|||||||++|+|++ |..||......+.. ...... . ....+..++..+.+|+
T Consensus 260 ~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~-~~i~~~-------------~------~~~~~~~~~~~l~~li 319 (367)
T 3l9p_A 260 EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL-EFVTSG-------------G------RMDPPKNCPGPVYRIM 319 (367)
T ss_dssp HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-HHHHTT-------------C------CCCCCTTCCHHHHHHH
T ss_pred CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHcC-------------C------CCCCCccCCHHHHHHH
Confidence 8889999999999999999998 99998764322111 100000 0 0111345677799999
Q ss_pred hhcCCCCccCCCCHHHHHHHHHHHHHhhh
Q 024027 231 MACTVESPEQRINAKEIVTKLLKIRDSLL 259 (273)
Q Consensus 231 ~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 259 (273)
.+||..||.+|||+.+++++|+.+.++..
T Consensus 320 ~~~l~~dP~~Rps~~eil~~l~~~~~~~~ 348 (367)
T 3l9p_A 320 TQCWQHQPEDRPNFAIILERIEYCTQDPD 348 (367)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred HHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence 99999999999999999999999987654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=293.93 Aligned_cols=244 Identities=22% Similarity=0.230 Sum_probs=186.5
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
+.||||+++... ......+.+|+.+++.++||||+++++++.+++..++||||+++ ++.+++......+++..++.+
T Consensus 28 ~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~ 106 (292)
T 3o0g_A 28 EIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSF 106 (292)
T ss_dssp CEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHH
T ss_pred ceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHH
Confidence 469999997553 33457788999999999999999999999999999999999976 777777666667999999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCC-cCC
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGR-VST 157 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~ 157 (273)
+.|++.||.||| +.|++|+||||+||+++.++.+||+|||++...... ........+++.|+|||++.+.. ++.
T Consensus 107 ~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~ 181 (292)
T 3o0g_A 107 LFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP--VRCYSAEVVTLWYRPPDVLFGAKLYST 181 (292)
T ss_dssp HHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC--CSCCCSCCSCGGGCCHHHHTTCSCCCT
T ss_pred HHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc--cccccCCccccCCcChHHHcCCCCcCc
Confidence 999999999999 999999999999999999999999999999865322 22234456899999999987765 799
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhc---------cccchhhhhhhhhhHHHHHH
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANL---------LSQEDIHFVAKEQCVSFVFN 228 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~l~~ 228 (273)
++||||+||++|+|++|..||.............................. .............++.++.+
T Consensus 182 ~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (292)
T 3o0g_A 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRD 261 (292)
T ss_dssp HHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHH
T ss_pred hHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHH
Confidence 999999999999999988886543333333333222211111110000000 00000111122356778999
Q ss_pred HHhhcCCCCccCCCCHHHHHHH
Q 024027 229 LAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 229 li~~~l~~dp~~Rps~~~~l~~ 250 (273)
|+.+||..||++|||++++++|
T Consensus 262 li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 262 LLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp HHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhccChhhCCCHHHHhcC
Confidence 9999999999999999999986
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=297.40 Aligned_cols=247 Identities=20% Similarity=0.251 Sum_probs=188.5
Q ss_pred CeEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCC--ceeEEEeccCCCCHHHhhhcCCC--CCCHHHH
Q 024027 1 MEVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEE--FKALVLEYMPHGSLEKYLYSSNC--ILDIFQR 75 (273)
Q Consensus 1 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~ 75 (273)
+.||||+++... ....+.+.+|+++++.++||||+++++++.... ..++||||+++++|.+++..... .+++..+
T Consensus 35 ~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 114 (319)
T 4euu_A 35 DLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF 114 (319)
T ss_dssp CEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHH
T ss_pred cEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHH
Confidence 479999997543 344677889999999999999999999987755 77999999999999999975432 3899999
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeEeccCCCCceee----CCCCceEEeecccccccccCCCcceeecccccCCCCCCcccC
Q 024027 76 LNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLL----DDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR 151 (273)
Q Consensus 76 ~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~----~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 151 (273)
+.++.|++.||.||| +.|++|+||||+||++ +.++.+||+|||++....... ......+++.|+|||++.
T Consensus 115 ~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~ 188 (319)
T 4euu_A 115 LIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYE 188 (319)
T ss_dssp HHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHH
T ss_pred HHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCC---ceeecccCCCccCHHHhh
Confidence 999999999999999 9999999999999999 788889999999998763322 223456899999999875
Q ss_pred --------CCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhh---hhccCccchhhhh---hhc--cccchhh
Q 024027 152 --------EGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWV---NDWLPISTMEVVD---ANL--LSQEDIH 215 (273)
Q Consensus 152 --------~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~~---~~~--~~~~~~~ 215 (273)
+..++.++|||||||++|+|++|..||.............. ...+......... ... .......
T Consensus 189 ~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 268 (319)
T 4euu_A 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVS 268 (319)
T ss_dssp HHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTT
T ss_pred hccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcc
Confidence 46789999999999999999999999976444332222211 1111100000000 000 0001111
Q ss_pred hhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHHH
Q 024027 216 FVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLLK 253 (273)
Q Consensus 216 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 253 (273)
......++..+.+|+.+||+.||++|||++++++|..+
T Consensus 269 ~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d 306 (319)
T 4euu_A 269 CSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (319)
T ss_dssp CSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred cccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence 12345678889999999999999999999999999885
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=297.86 Aligned_cols=243 Identities=33% Similarity=0.480 Sum_probs=189.8
Q ss_pred CeEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC---CCCCHHHHH
Q 024027 1 MEVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN---CILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~ 76 (273)
+.||||+++... ......+.+|+++++.++||||+++++++.++...++||||+++|+|.+++.... ..+++..+.
T Consensus 55 ~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 134 (326)
T 3uim_A 55 TLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ 134 (326)
T ss_dssp CCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHH
T ss_pred CEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHH
Confidence 469999997653 2334578999999999999999999999999999999999999999999997543 349999999
Q ss_pred HHHHHHHHHHHHHhcCCCC---CeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCC
Q 024027 77 NIMIDVASALEYLHFGCSA---PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG 153 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~---~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 153 (273)
.++.|++.||.||| +. |++|+||||+||+++.++.++|+|||++........ .......|++.|+|||.+.+.
T Consensus 135 ~i~~~i~~~l~~lH---~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~ 210 (326)
T 3uim_A 135 RIALGSARGLAYLH---DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTG 210 (326)
T ss_dssp HHHHHHHHHHHHHH---HSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHS
T ss_pred HHHHHHHHHHHHHH---hCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcccc-cccccccCCcCccCHHHhccC
Confidence 99999999999999 77 999999999999999999999999999986633222 223445689999999999888
Q ss_pred CcCCcchhHHHHHHHHHHHhCCCCCcccc---ccccchhhhhhhccCc-cchhhhhhhccccchhhhhhhhhhHHHHHHH
Q 024027 154 RVSTNGDVYSFGIMLMETFTGKKPTYEFF---NGEMTLKHWVNDWLPI-STMEVVDANLLSQEDIHFVAKEQCVSFVFNL 229 (273)
Q Consensus 154 ~~~~~~DiwslG~~l~~ll~g~~pf~~~~---~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 229 (273)
.++.++||||||+++|+|++|..||.... ........+....... ......+ .......+...+..+.++
T Consensus 211 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~l 284 (326)
T 3uim_A 211 KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVD------VDLQGNYKDEEVEQLIQV 284 (326)
T ss_dssp EECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSC------TTCTTSCCHHHHHHHHHH
T ss_pred CCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcC------hhhccccCHHHHHHHHHH
Confidence 89999999999999999999999996321 1111222222211111 1111111 111122245667889999
Q ss_pred HhhcCCCCccCCCCHHHHHHHHHH
Q 024027 230 AMACTVESPEQRINAKEIVTKLLK 253 (273)
Q Consensus 230 i~~~l~~dp~~Rps~~~~l~~l~~ 253 (273)
+.+||..||.+|||+.+++++|+.
T Consensus 285 i~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 285 ALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp HHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HHHHhCcCCccCCCHHHHHHHhcC
Confidence 999999999999999999999985
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=306.71 Aligned_cols=234 Identities=26% Similarity=0.472 Sum_probs=182.1
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
.||||+++... ....+.+.+|+.+++.++||||+++++++.+....++||||+++++|.+++...+..+++..++.++.
T Consensus 75 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~ 154 (373)
T 2qol_A 75 SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR 154 (373)
T ss_dssp CEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHH
T ss_pred eEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHH
Confidence 59999998653 34567899999999999999999999999999999999999999999999987777799999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcc-eeecccccCCCCCCcccCCCCcCCcc
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSM-TQTQTLATIGYMAPEYGREGRVSTNG 159 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~ 159 (273)
|++.||.||| +.|++||||||+||+++.++.+||+|||++.......... ......++..|+|||.+.+..++.++
T Consensus 155 qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 231 (373)
T 2qol_A 155 GIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSAS 231 (373)
T ss_dssp HHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHH
T ss_pred HHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchh
Confidence 9999999999 9999999999999999999999999999998664322211 11222356789999999888899999
Q ss_pred hhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc
Q 024027 160 DVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238 (273)
Q Consensus 160 DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 238 (273)
||||||+++|++++ |..||......+.. .. .... .....+..++.++.+|+.+||..||
T Consensus 232 Dv~SlG~il~ellt~g~~P~~~~~~~~~~-~~-------------i~~~------~~~~~~~~~~~~l~~li~~cl~~dp 291 (373)
T 2qol_A 232 DVWSYGIVLWEVMSYGERPYWEMSNQDVI-KA-------------VDEG------YRLPPPMDCPAALYQLMLDCWQKDR 291 (373)
T ss_dssp HHHHHHHHHHHHHTTC-CTTTTCCHHHHH-HH-------------HHTT------EECCCCTTCBHHHHHHHHHHTCSSG
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HH-------------HHcC------CCCCCCccccHHHHHHHHHHhCcCh
Confidence 99999999999998 99998654322111 00 0000 0011134567779999999999999
Q ss_pred cCCCCHHHHHHHHHHHHHhh
Q 024027 239 EQRINAKEIVTKLLKIRDSL 258 (273)
Q Consensus 239 ~~Rps~~~~l~~l~~~~~~~ 258 (273)
.+|||+.++++.|+.+.++.
T Consensus 292 ~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 292 NNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp GGSCCHHHHHHHHHHHHHCG
T ss_pred hhCcCHHHHHHHHHHHHhCc
Confidence 99999999999999998753
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=301.85 Aligned_cols=228 Identities=21% Similarity=0.338 Sum_probs=185.4
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
+.||||+++... ....+.+.+|+.+++.++||||+++++++.+++..++||||+++|+|.+++... ..+++..++.+
T Consensus 55 ~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~ 133 (362)
T 2bdw_A 55 LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHC 133 (362)
T ss_dssp CEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTC-SCCCHHHHHHH
T ss_pred CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHH
Confidence 479999997553 345677899999999999999999999999999999999999999999999654 46899999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCC---CceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCc
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDN---LVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRV 155 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~---~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~ 155 (273)
+.|++.||.||| +.|++|+||||+||+++.+ +.+||+|||++....... ......|++.|+|||++.+..+
T Consensus 134 ~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~ 207 (362)
T 2bdw_A 134 IQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPY 207 (362)
T ss_dssp HHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC---SCCCSCSCTTTCCHHHHTTCCC
T ss_pred HHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc---ccccCCCCccccCHHHHccCCC
Confidence 999999999999 9999999999999999864 459999999997653221 2234578999999999998889
Q ss_pred CCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCC
Q 024027 156 STNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTV 235 (273)
Q Consensus 156 ~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 235 (273)
+.++|||||||++|+|++|..||........ ........ ..........++.++.+|+.+||.
T Consensus 208 ~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-~~~i~~~~----------------~~~~~~~~~~~~~~~~~li~~~L~ 270 (362)
T 2bdw_A 208 SKPVDIWACGVILYILLVGYPPFWDEDQHRL-YAQIKAGA----------------YDYPSPEWDTVTPEAKSLIDSMLT 270 (362)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHTC----------------CCCCTTGGGGSCHHHHHHHHHHSC
T ss_pred CchhhHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHhCC----------------CCCCcccccCCCHHHHHHHHHHcC
Confidence 9999999999999999999999875332111 11111100 000111134567789999999999
Q ss_pred CCccCCCCHHHHHHHHH
Q 024027 236 ESPEQRINAKEIVTKLL 252 (273)
Q Consensus 236 ~dp~~Rps~~~~l~~l~ 252 (273)
.||.+|||+.++++|-+
T Consensus 271 ~dP~~R~t~~e~l~hp~ 287 (362)
T 2bdw_A 271 VNPKKRITADQALKVPW 287 (362)
T ss_dssp SSGGGSCCHHHHTTSHH
T ss_pred CChhhCcCHHHHhcCcc
Confidence 99999999999998854
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=295.73 Aligned_cols=236 Identities=23% Similarity=0.394 Sum_probs=186.6
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||||++.... ....+.+.+|+.+++.++||||+++++++.+++..++||||++|++|.+++...+ .+++..++.
T Consensus 37 ~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~ 115 (294)
T 4eqm_A 37 IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-PLSVDTAIN 115 (294)
T ss_dssp SEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC-SCCHHHHHH
T ss_pred CeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhcC-CCCHHHHHH
Confidence 479999986542 3445778999999999999999999999999999999999999999999997554 699999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++....... ........|++.|+|||.+.+..++.
T Consensus 116 ~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ 191 (294)
T 4eqm_A 116 FTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS-LTQTNHVLGTVQYFSPEQAKGEATDE 191 (294)
T ss_dssp HHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--------------CCSSCCHHHHHTCCCCT
T ss_pred HHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc-ccccCccccCccccCHhHhcCCCCCc
Confidence 9999999999999 9999999999999999999999999999997653221 12233456899999999999988999
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
++||||||+++|+|++|..||................ ........+..++..+.+++.+||..|
T Consensus 192 ~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~l~~li~~~l~~d 255 (294)
T 4eqm_A 192 CTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDS----------------VPNVTTDVRKDIPQSLSNVILRATEKD 255 (294)
T ss_dssp THHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSC----------------CCCHHHHSCTTSCHHHHHHHHHHSCSS
T ss_pred hHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcc----------------CCCcchhcccCCCHHHHHHHHHHhcCC
Confidence 9999999999999999999997643322211111110 011111223456778999999999999
Q ss_pred ccCCC-CHHHHHHHHHHHHHh
Q 024027 238 PEQRI-NAKEIVTKLLKIRDS 257 (273)
Q Consensus 238 p~~Rp-s~~~~l~~l~~~~~~ 257 (273)
|.+|| +++++.+.|..+..+
T Consensus 256 p~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 256 KANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp GGGSCSSHHHHHHHHHTSSSS
T ss_pred HhHccccHHHHHHHHHHHHhh
Confidence 99999 899999888876544
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=303.40 Aligned_cols=229 Identities=20% Similarity=0.293 Sum_probs=184.1
Q ss_pred CeEEEEEeeccc-----ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcC---CCCCCH
Q 024027 1 MEVAVKVFNLQC-----GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS---NCILDI 72 (273)
Q Consensus 1 ~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~ 72 (273)
+.||||+++... ....+.+.+|+.+++.++||||+++++++.+++..++||||+++++|.+++... +..+++
T Consensus 50 ~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~ 129 (351)
T 3c0i_A 50 QQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSE 129 (351)
T ss_dssp CEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCH
T ss_pred CEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCH
Confidence 479999996431 124577999999999999999999999999999999999999999998887532 345899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCc---eEEeecccccccccCCCcceeecccccCCCCCCcc
Q 024027 73 FQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLV---AYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEY 149 (273)
Q Consensus 73 ~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~---~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~ 149 (273)
..++.++.|++.||.||| +.|++|+||||+||+++.++. +||+|||++....... ......+|++.|+|||+
T Consensus 130 ~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~ 204 (351)
T 3c0i_A 130 AVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG--LVAGGRVGTPHFMAPEV 204 (351)
T ss_dssp HHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTS--CBCCCCCSCGGGCCHHH
T ss_pred HHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcceeEecCCC--eeecCCcCCcCccCHHH
Confidence 999999999999999999 999999999999999986554 9999999998763321 22344578999999999
Q ss_pred cCCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHH
Q 024027 150 GREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNL 229 (273)
Q Consensus 150 ~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 229 (273)
+.+..++.++|||||||++|+|++|..||..... ......... ...........++.++.+|
T Consensus 205 ~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~i~~~----------------~~~~~~~~~~~~s~~~~~l 266 (351)
T 3c0i_A 205 VKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--RLFEGIIKG----------------KYKMNPRQWSHISESAKDL 266 (351)
T ss_dssp HTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--HHHHHHHHT----------------CCCCCHHHHTTSCHHHHHH
T ss_pred HcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--HHHHHHHcC----------------CCCCCccccccCCHHHHHH
Confidence 9988899999999999999999999999975311 111111110 0001111234567789999
Q ss_pred HhhcCCCCccCCCCHHHHHHHHH
Q 024027 230 AMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 230 i~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
+.+||..||++|||+.++++|-+
T Consensus 267 i~~~L~~dP~~R~s~~e~l~hp~ 289 (351)
T 3c0i_A 267 VRRMLMLDPAERITVYEALNHPW 289 (351)
T ss_dssp HHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HHHHCCCChhHCcCHHHHhcChh
Confidence 99999999999999999998754
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=298.33 Aligned_cols=228 Identities=23% Similarity=0.348 Sum_probs=184.2
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~q 81 (273)
+||+|+++.......+.+.+|+++++.++||||+++++++.+++..++||||+++++|.+++......+++..++.++.|
T Consensus 42 ~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~q 121 (289)
T 4fvq_A 42 EVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQ 121 (289)
T ss_dssp EEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHH
T ss_pred hhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHH
Confidence 59999998766667788999999999999999999999999999999999999999999999877666999999999999
Q ss_pred HHHHHHHHhcCCCCCeEeccCCCCceeeCCCCc--------eEEeecccccccccCCCcceeecccccCCCCCCcccCC-
Q 024027 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLV--------AYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE- 152 (273)
Q Consensus 82 l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~--------~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~- 152 (273)
++.||.||| +.|++|+||||+||+++.++. ++|+|||.+.... ......+++.|+|||.+.+
T Consensus 122 i~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~------~~~~~~~~~~y~aPE~~~~~ 192 (289)
T 4fvq_A 122 LAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL------PKDILQERIPWVPPECIENP 192 (289)
T ss_dssp HHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTS------CHHHHHHTTTTSCHHHHHCG
T ss_pred HHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeeeccCccccccc------CccccCCcCcccCHHHhCCC
Confidence 999999999 999999999999999988776 9999999986541 1233457889999999987
Q ss_pred CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhh
Q 024027 153 GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMA 232 (273)
Q Consensus 153 ~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 232 (273)
..++.++||||||+++|+|++|..|+................ ...+...+.++.+|+.+
T Consensus 193 ~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~l~~li~~ 251 (289)
T 4fvq_A 193 KNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR---------------------HQLPAPKAAELANLINN 251 (289)
T ss_dssp GGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT---------------------CCCCCCSSCTTHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhcc---------------------CCCCCCCCHHHHHHHHH
Confidence 668999999999999999999655543322211111110000 00122234558899999
Q ss_pred cCCCCccCCCCHHHHHHHHHHHHHhhh
Q 024027 233 CTVESPEQRINAKEIVTKLLKIRDSLL 259 (273)
Q Consensus 233 ~l~~dp~~Rps~~~~l~~l~~~~~~~~ 259 (273)
||..||.+|||+.+++++|+++...-.
T Consensus 252 ~l~~dp~~Rps~~~ll~~l~~l~~p~~ 278 (289)
T 4fvq_A 252 CMDYEPDHRPSFRAIIRDLNSLFTPDL 278 (289)
T ss_dssp HSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred HcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 999999999999999999998876433
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=294.55 Aligned_cols=236 Identities=25% Similarity=0.379 Sum_probs=178.2
Q ss_pred eEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 2 EVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 2 ~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
.||||+++... ....+.+.+|+++++.++||||+++++++ .....++||||+++++|.+++......+++..++.++
T Consensus 48 ~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~ 126 (289)
T 3og7_A 48 DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIA 126 (289)
T ss_dssp EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHH
T ss_pred ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHH
Confidence 58999997553 34567799999999999999999999965 4566899999999999999998777789999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccC---CCCcC
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR---EGRVS 156 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~ 156 (273)
.|++.||.||| +.|++|+||||+||+++.++.++|+|||++................+++.|+|||.+. +..++
T Consensus 127 ~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 203 (289)
T 3og7_A 127 RQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 203 (289)
T ss_dssp HHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSC
T ss_pred HHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCC
Confidence 99999999999 9999999999999999999999999999997654333333334557899999999886 55678
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++||||||+++|+|++|..||...................... ......++.++.+|+.+||..
T Consensus 204 ~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~l~~li~~~l~~ 268 (289)
T 3og7_A 204 FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDL---------------SKVRSNCPKRMKRLMAECLKK 268 (289)
T ss_dssp HHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCT---------------TSSCTTSCHHHHHHHHHHTCS
T ss_pred cccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcch---------------hhccccCCHHHHHHHHHHccC
Confidence 89999999999999999999997644332222211111111000 011235677899999999999
Q ss_pred CccCCCCHHHHHHHHHHHHH
Q 024027 237 SPEQRINAKEIVTKLLKIRD 256 (273)
Q Consensus 237 dp~~Rps~~~~l~~l~~~~~ 256 (273)
||.+|||+.++++.|+++.+
T Consensus 269 ~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 269 KRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp SGGGSCCHHHHHHHHHHTTC
T ss_pred ChhhCCCHHHHHHHHHHHhh
Confidence 99999999999999998754
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=299.42 Aligned_cols=235 Identities=25% Similarity=0.417 Sum_probs=179.1
Q ss_pred eEEEEEeecc--cChhhhhHHHHHHHHhcCCCccceeeeeeeecCCce------eEEEeccCCCCHHHhhhcC-----CC
Q 024027 2 EVAVKVFNLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFK------ALVLEYMPHGSLEKYLYSS-----NC 68 (273)
Q Consensus 2 ~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~------~lv~e~~~~~~L~~~l~~~-----~~ 68 (273)
+||||+++.. .....+.+.+|+++++.++||||+++++++...... ++||||+++++|.+++... ..
T Consensus 53 ~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~ 132 (323)
T 3qup_A 53 KVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPF 132 (323)
T ss_dssp EEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CC
T ss_pred eEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhcccccc
Confidence 6999999765 355678899999999999999999999999877655 8999999999999998532 22
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCc
Q 024027 69 ILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPE 148 (273)
Q Consensus 69 ~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE 148 (273)
.+++..++.++.|++.||.||| +.|++|+||||+||+++.++.+||+|||++................+++.|+|||
T Consensus 133 ~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE 209 (323)
T 3qup_A 133 NLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALE 209 (323)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHH
T ss_pred ccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCch
Confidence 5899999999999999999999 9999999999999999999999999999998664333323333445677899999
Q ss_pred ccCCCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHH
Q 024027 149 YGREGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVF 227 (273)
Q Consensus 149 ~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 227 (273)
.+.+..++.++|||||||++|+|++ |..||......+... ...... ....+..++.++.
T Consensus 210 ~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~-~~~~~~-------------------~~~~~~~~~~~l~ 269 (323)
T 3qup_A 210 SLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN-YLIGGN-------------------RLKQPPECMEEVY 269 (323)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH-HHHTTC-------------------CCCCCTTCCHHHH
T ss_pred hhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHH-HHhcCC-------------------CCCCCCccCHHHH
Confidence 9988889999999999999999999 999987643332111 111000 0111345667799
Q ss_pred HHHhhcCCCCccCCCCHHHHHHHHHHHHHhhh
Q 024027 228 NLAMACTVESPEQRINAKEIVTKLLKIRDSLL 259 (273)
Q Consensus 228 ~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 259 (273)
+|+.+||..||++|||+.++++.|+++.....
T Consensus 270 ~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 270 DLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 99999999999999999999999999988643
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=295.47 Aligned_cols=222 Identities=25% Similarity=0.300 Sum_probs=185.1
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||||+++... ....+.+.+|..+++.++||||+++++++.+...+++||||++||+|.+++.... .+++..++.
T Consensus 32 ~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~ 110 (318)
T 1fot_A 32 RYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ-RFPNPVAKF 110 (318)
T ss_dssp CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTS-SCCHHHHHH
T ss_pred CEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHcC-CCCHHHHHH
Confidence 479999997542 2345678899999999999999999999999999999999999999999997654 689999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
++.|++.||.||| +.|++||||||+||+++.++.+||+|||++..... .....+||+.|+|||++.+..++.
T Consensus 111 ~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ 182 (318)
T 1fot_A 111 YAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIAPEVVSTKPYNK 182 (318)
T ss_dssp HHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-----CBCCCCSCTTTCCHHHHTTCCBCT
T ss_pred HHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCC-----ccccccCCccccCHhHhcCCCCCc
Confidence 9999999999999 99999999999999999999999999999986522 223457899999999999989999
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
++|+|||||++|+|++|..||....... ......... ...+..++.++.+|+.+||..|
T Consensus 183 ~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~--------------------~~~p~~~~~~~~~li~~lL~~d 241 (318)
T 1fot_A 183 SIDWWSFGILIYEMLAGYTPFYDSNTMK-TYEKILNAE--------------------LRFPPFFNEDVKDLLSRLITRD 241 (318)
T ss_dssp THHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHCC--------------------CCCCTTSCHHHHHHHHHHTCSC
T ss_pred ccchhhhHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCC--------------------CCCCCCCCHHHHHHHHHHhccC
Confidence 9999999999999999999997532211 111111100 0113456678999999999999
Q ss_pred ccCCC-----CHHHHHHHHH
Q 024027 238 PEQRI-----NAKEIVTKLL 252 (273)
Q Consensus 238 p~~Rp-----s~~~~l~~l~ 252 (273)
|++|| +++++++|-+
T Consensus 242 p~~R~~~~~~~~~~i~~hp~ 261 (318)
T 1fot_A 242 LSQRLGNLQNGTEDVKNHPW 261 (318)
T ss_dssp TTTCTTSSTTTTHHHHTSGG
T ss_pred HHHcCCCcCCCHHHHhcCcc
Confidence 99999 8999998743
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=297.00 Aligned_cols=248 Identities=21% Similarity=0.368 Sum_probs=189.1
Q ss_pred CeEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecC--CceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNE--EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||||+++... ....+.+.+|+++++.++||||+++++++.++ ...++||||+++++|.+++......+++..++.
T Consensus 51 ~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 130 (302)
T 4e5w_A 51 EQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLK 130 (302)
T ss_dssp EEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHH
T ss_pred eEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHH
Confidence 379999997543 34567899999999999999999999999876 668999999999999999976666799999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCc-ceeecccccCCCCCCcccCCCCcC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQS-MTQTQTLATIGYMAPEYGREGRVS 156 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~ 156 (273)
++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++......... .......++..|+|||.+.+..++
T Consensus 131 ~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 207 (302)
T 4e5w_A 131 YAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFY 207 (302)
T ss_dssp HHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEE
T ss_pred HHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCC
Confidence 9999999999999 999999999999999999999999999999876433321 223345578889999999888899
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++||||||+++|+|++|..|+...... .................... .........+..++.++.+|+.+||..
T Consensus 208 ~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~~l~~ 282 (302)
T 4e5w_A 208 IASDVWSFGVTLHELLTYCDSDSSPMAL---FLKMIGPTHGQMTVTRLVNT--LKEGKRLPCPPNCPDEVYQLMRKCWEF 282 (302)
T ss_dssp HHHHHHHHHHHHHHHHTTTCGGGSHHHH---HHHHHCSCCGGGHHHHHHHH--HHTTCCCCCCTTCCHHHHHHHHHTTCS
T ss_pred cchhHHHHHHHHHHHHHccCCCcchhhH---HhhccCCcccccCHHHHHHH--HhccCCCCCCCCCCHHHHHHHHHHcCC
Confidence 9999999999999999999986432111 00000000000000000000 001111122456778899999999999
Q ss_pred CccCCCCHHHHHHHHHHHHH
Q 024027 237 SPEQRINAKEIVTKLLKIRD 256 (273)
Q Consensus 237 dp~~Rps~~~~l~~l~~~~~ 256 (273)
||.+|||+.++++.|+++.+
T Consensus 283 dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 283 QPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp SGGGSCCHHHHHHHHHHHHC
T ss_pred CCCCCCCHHHHHHHHHHHhC
Confidence 99999999999999998753
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=299.39 Aligned_cols=223 Identities=26% Similarity=0.361 Sum_probs=183.7
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||||++.... ......+.+|+.+++.++||||+++++++.++...++||||+ +|+|.+++...+ .+++..++.
T Consensus 35 ~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~~-~l~~~~~~~ 112 (336)
T 3h4j_B 35 QKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKK-RMTEDEGRR 112 (336)
T ss_dssp CEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHHC-SCCHHHHHH
T ss_pred CEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHcC-CCCHHHHHH
Confidence 479999997542 233467899999999999999999999999999999999999 679999986543 699999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCc-C
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRV-S 156 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~ 156 (273)
++.|++.||.||| +.|++||||||+||+++.++.+||+|||++...... ......+|++.|+|||++.+..+ +
T Consensus 113 i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~ 186 (336)
T 3h4j_B 113 FFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG---NFLKTSCGSPNYAAPEVINGKLYAG 186 (336)
T ss_dssp HHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS---BTTCCCTTSTTTSCGGGSCCSGGGC
T ss_pred HHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC---cccccccCCcCcCCHHHHcCCCCCC
Confidence 9999999999999 999999999999999999999999999999765322 22234578999999999988776 7
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++|||||||++|+|++|..||........... . .......+..++.++.+|+.+||..
T Consensus 187 ~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~-----i----------------~~~~~~~p~~~s~~~~~li~~~L~~ 245 (336)
T 3h4j_B 187 PEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK-----V----------------NSCVYVMPDFLSPGAQSLIRRMIVA 245 (336)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC-----C----------------CSSCCCCCTTSCHHHHHHHHTTSCS
T ss_pred CccchhHHHHHHHHHHhCCCCCCCccHHHHHHH-----H----------------HcCCCCCcccCCHHHHHHHHHHcCC
Confidence 899999999999999999999975332211100 0 0001112445677899999999999
Q ss_pred CccCCCCHHHHHHHHH
Q 024027 237 SPEQRINAKEIVTKLL 252 (273)
Q Consensus 237 dp~~Rps~~~~l~~l~ 252 (273)
||.+|||++++++|-+
T Consensus 246 dP~~Rpt~~eil~hp~ 261 (336)
T 3h4j_B 246 DPMQRITIQEIRRDPW 261 (336)
T ss_dssp SGGGSCCHHHHTTCHH
T ss_pred ChhHCcCHHHHHhChh
Confidence 9999999999999876
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=290.67 Aligned_cols=240 Identities=15% Similarity=0.113 Sum_probs=194.5
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
++||||++.... ....+.+|+.+++.+ +|+|++++++++.+....++||||+ +++|.+++...+..+++..++.++
T Consensus 36 ~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~ 112 (298)
T 1csn_A 36 QQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAA 112 (298)
T ss_dssp EEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHH
T ss_pred cEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHH
Confidence 379999986543 346789999999999 7999999999999999999999999 889999998776679999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCc-----eEEeecccccccccCCCc-----ceeecccccCCCCCCcc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLV-----AYLSDFGIAKLLIGEDQS-----MTQTQTLATIGYMAPEY 149 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~-----~kl~Df~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~ 149 (273)
.|++.||.||| +.|++|+||||+||+++.++. ++|+|||++......... .......|++.|+|||.
T Consensus 113 ~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 189 (298)
T 1csn_A 113 KQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 189 (298)
T ss_dssp HHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHH
T ss_pred HHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchh
Confidence 99999999999 999999999999999987765 999999999876433221 12344568999999999
Q ss_pred cCCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccch--hhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHH
Q 024027 150 GREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTL--KHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVF 227 (273)
Q Consensus 150 ~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 227 (273)
+.+..++.++||||||+++|+|++|..||.......... ....... ...........++.++.
T Consensus 190 ~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~l~ 254 (298)
T 1csn_A 190 HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK---------------QSTPLRELCAGFPEEFY 254 (298)
T ss_dssp HTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH---------------HHSCHHHHTTTSCHHHH
T ss_pred hcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc---------------cCccHHHHHhhCcHHHH
Confidence 998889999999999999999999999997643322111 0000000 00001111235678899
Q ss_pred HHHhhcCCCCccCCCCHHHHHHHHHHHHHhhhhh
Q 024027 228 NLAMACTVESPEQRINAKEIVTKLLKIRDSLLRN 261 (273)
Q Consensus 228 ~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~ 261 (273)
+|+.+||..||.+|||++++++.|+++.+++...
T Consensus 255 ~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~ 288 (298)
T 1csn_A 255 KYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 288 (298)
T ss_dssp HHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCC
Confidence 9999999999999999999999999999876543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-44 Score=304.09 Aligned_cols=247 Identities=17% Similarity=0.234 Sum_probs=184.1
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcC-CCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~ 77 (273)
+.||||+++... ....+.+.+|+.+++.++||||+++++++.+++..++||||+++++|.+++... ...+++..++.
T Consensus 53 ~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 132 (389)
T 3gni_B 53 EYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAY 132 (389)
T ss_dssp CEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHH
T ss_pred CEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHH
Confidence 479999998653 344567888999999999999999999999999999999999999999999754 34599999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCc-----ceeecccccCCCCCCcccCC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQS-----MTQTQTLATIGYMAPEYGRE 152 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~ 152 (273)
++.|++.||.||| +.|++||||||+||+++.++.++|+|||.+......... .......|++.|+|||++.+
T Consensus 133 ~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 209 (389)
T 3gni_B 133 ILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ 209 (389)
T ss_dssp HHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHST
T ss_pred HHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhc
Confidence 9999999999999 999999999999999999999999999988654322111 11223468889999999987
Q ss_pred --CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhh-------------------------hh
Q 024027 153 --GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEV-------------------------VD 205 (273)
Q Consensus 153 --~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~ 205 (273)
..++.++|||||||++|+|++|..||......................... ..
T Consensus 210 ~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (389)
T 3gni_B 210 NLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTST 289 (389)
T ss_dssp TSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------------------------------------
T ss_pred cCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCc
Confidence 578999999999999999999999997644433322211111000000000 00
Q ss_pred hhccccchhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHH
Q 024027 206 ANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
.............+..++.++.+|+.+||..||++|||+.++++|
T Consensus 290 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 290 PRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ----------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 000000001112345577889999999999999999999999987
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=293.01 Aligned_cols=237 Identities=23% Similarity=0.377 Sum_probs=194.0
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
.||||+++... ....+.+.+|+++++.++||||+++++++ .....++||||+++++|.+++......+++..++.++.
T Consensus 39 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 117 (287)
T 1u59_A 39 DVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLH 117 (287)
T ss_dssp EEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHH
T ss_pred eEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHH
Confidence 59999998653 34567899999999999999999999999 45568999999999999999977766799999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCc-ceeecccccCCCCCCcccCCCCcCCcc
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQS-MTQTQTLATIGYMAPEYGREGRVSTNG 159 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~ 159 (273)
|++.||.||| +.|++|+||+|+||+++.++.++|+|||++......... .......+++.|+|||.+.+..++.++
T Consensus 118 qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 194 (287)
T 1u59_A 118 QVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRS 194 (287)
T ss_dssp HHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHH
T ss_pred HHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchh
Confidence 9999999999 999999999999999999999999999999876433221 112233457889999999888899999
Q ss_pred hhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc
Q 024027 160 DVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238 (273)
Q Consensus 160 DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 238 (273)
||||||+++|+|++ |..||......+.. .. ... .. ....+..++.++.+++.+||..||
T Consensus 195 Di~slG~il~ellt~g~~p~~~~~~~~~~-~~-i~~------------~~------~~~~~~~~~~~l~~li~~~l~~~p 254 (287)
T 1u59_A 195 DVWSYGVTMWEALSYGQKPYKKMKGPEVM-AF-IEQ------------GK------RMECPPECPPELYALMSDCWIYKW 254 (287)
T ss_dssp HHHHHHHHHHHHHTTSCCTTTTCCTHHHH-HH-HHT------------TC------CCCCCTTCCHHHHHHHHHTTCSSG
T ss_pred hHHHHHHHHHHHHcCCCCCcccCCHHHHH-HH-Hhc------------CC------cCCCCCCcCHHHHHHHHHHcCCCh
Confidence 99999999999998 99999764332211 11 100 00 011134567789999999999999
Q ss_pred cCCCCHHHHHHHHHHHHHhhhhhc
Q 024027 239 EQRINAKEIVTKLLKIRDSLLRNV 262 (273)
Q Consensus 239 ~~Rps~~~~l~~l~~~~~~~~~~~ 262 (273)
.+|||+.+++++|+++..+.....
T Consensus 255 ~~Rps~~~l~~~l~~~~~~~~~~~ 278 (287)
T 1u59_A 255 EDRPDFLTVEQRMRACYYSLASKV 278 (287)
T ss_dssp GGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred hhCcCHHHHHHHHHHHHHhcCCcc
Confidence 999999999999999998866543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=299.10 Aligned_cols=238 Identities=23% Similarity=0.378 Sum_probs=194.5
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcC-------------
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS------------- 66 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------------- 66 (273)
.||||+++... ....+.+.+|+.+++.+ +||||+++++++.+++..++||||+++|+|.+++...
T Consensus 78 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~ 157 (333)
T 2i1m_A 78 KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIA 157 (333)
T ss_dssp EEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC------
T ss_pred HHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhccccccccccccc
Confidence 69999997653 34567799999999999 8999999999999999999999999999999998643
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCC
Q 024027 67 NCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMA 146 (273)
Q Consensus 67 ~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~a 146 (273)
...+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++................+++.|+|
T Consensus 158 ~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 234 (333)
T 2i1m_A 158 NSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMA 234 (333)
T ss_dssp -CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSC
T ss_pred ccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccC
Confidence 235799999999999999999999 99999999999999999999999999999986644433333344567888999
Q ss_pred CcccCCCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHH
Q 024027 147 PEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSF 225 (273)
Q Consensus 147 PE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (273)
||.+.+..++.++||||||+++|+|++ |..||................. ....+..++.+
T Consensus 235 PE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~ 295 (333)
T 2i1m_A 235 PESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGY-------------------QMAQPAFAPKN 295 (333)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTC-------------------CCCCCTTCCHH
T ss_pred HHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCC-------------------CCCCCCCCCHH
Confidence 999988889999999999999999998 9999876433322111111000 00113345677
Q ss_pred HHHHHhhcCCCCccCCCCHHHHHHHHHHHHHhhhhh
Q 024027 226 VFNLAMACTVESPEQRINAKEIVTKLLKIRDSLLRN 261 (273)
Q Consensus 226 l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~ 261 (273)
+.+|+.+||..||.+|||+.+++++|+++.++..++
T Consensus 296 l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~ 331 (333)
T 2i1m_A 296 IYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRRE 331 (333)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhhcc
Confidence 999999999999999999999999999998876543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=308.74 Aligned_cols=226 Identities=31% Similarity=0.439 Sum_probs=186.6
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCC-ceeEEEeccCCCCHHHhhhcCCC-CCCHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEE-FKALVLEYMPHGSLEKYLYSSNC-ILDIFQRLNIM 79 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~ 79 (273)
+||||+++... ..+.+.+|+++++.++||||+++++++.+.. ..++||||+++|+|.+++...+. .+++..++.++
T Consensus 218 ~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 295 (450)
T 1k9a_A 218 KVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 295 (450)
T ss_dssp EEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHH
T ss_pred eEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHH
Confidence 69999997553 5578999999999999999999999986654 78999999999999999976543 37999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 159 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 159 (273)
.|++.||.||| +.|++||||||+||+++.++.+||+|||++...... .....++..|+|||.+.+..++.++
T Consensus 296 ~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~s 367 (450)
T 1k9a_A 296 LDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKS 367 (450)
T ss_dssp HHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-----------CCCTTTSCHHHHHSSCCCHHH
T ss_pred HHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc-----ccCCCCCcceeCHHHhcCCCCCcHH
Confidence 99999999999 999999999999999999999999999998754211 1223567889999999988999999
Q ss_pred hhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc
Q 024027 160 DVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238 (273)
Q Consensus 160 DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 238 (273)
||||||+++|+|++ |..||......+.. .... .. .....+..++.++.+|+.+||..||
T Consensus 368 DvwslG~~l~el~t~g~~P~~~~~~~~~~-~~i~-------------~~------~~~~~p~~~~~~l~~li~~cl~~dp 427 (450)
T 1k9a_A 368 DVWSFGILLWEIYSFGRVPYPRIPLKDVV-PRVE-------------KG------YKMDAPDGCPPAVYDVMKNCWHLDA 427 (450)
T ss_dssp HHHHHHHHHHHHHTTTCCSSTTSCTTTHH-HHHH-------------TT------CCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred HHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHH-------------cC------CCCCCCCcCCHHHHHHHHHHcCCCh
Confidence 99999999999998 99999764333211 1100 00 0112245678889999999999999
Q ss_pred cCCCCHHHHHHHHHHHHHh
Q 024027 239 EQRINAKEIVTKLLKIRDS 257 (273)
Q Consensus 239 ~~Rps~~~~l~~l~~~~~~ 257 (273)
.+|||+.++++.|+.+...
T Consensus 428 ~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 428 ATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp GGSCCHHHHHHHHHHHHHT
T ss_pred hHCcCHHHHHHHHHHHHHh
Confidence 9999999999999998764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=303.22 Aligned_cols=225 Identities=24% Similarity=0.267 Sum_probs=181.0
Q ss_pred CeEEEEEeecc---cChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHH
Q 024027 1 MEVAVKVFNLQ---CGRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (273)
+.||||+++.. .....+.+..|..+++.+ +||||+++++++.++..+++||||++||+|.+++...+ .+++..++
T Consensus 49 ~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~ 127 (353)
T 3txo_A 49 DLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSR-RFDEARAR 127 (353)
T ss_dssp CEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHH
T ss_pred CEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHH
Confidence 46999999754 233456788999999988 79999999999999999999999999999999996653 69999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcC
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVS 156 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 156 (273)
.++.|++.||.||| +.|++||||||+||+++.++.+||+|||++..... ........+||+.|+|||++.+..++
T Consensus 128 ~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~ 202 (353)
T 3txo_A 128 FYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC--NGVTTATFCGTPDYIAPEILQEMLYG 202 (353)
T ss_dssp HHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-----------CCGGGCCHHHHHHHHCT
T ss_pred HHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeeccc--CCccccccCCCcCeEChhhcCCCCcC
Confidence 99999999999999 99999999999999999999999999999875322 12233456799999999999888899
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++|+|||||++|+|++|..||......+. ...+.... ...+..++.++.+|+.+||..
T Consensus 203 ~~~DiwslG~il~ell~G~~Pf~~~~~~~~-~~~i~~~~--------------------~~~p~~~~~~~~~li~~lL~~ 261 (353)
T 3txo_A 203 PAVDWWAMGVLLYEMLCGHAPFEAENEDDL-FEAILNDE--------------------VVYPTWLHEDATGILKSFMTK 261 (353)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCC--------------------CCCCTTSCHHHHHHHHHHTCS
T ss_pred CccCCCcchHHHHHHHhCCCCCCCCCHHHH-HHHHHcCC--------------------CCCCCCCCHHHHHHHHHHhhh
Confidence 999999999999999999999976432211 11111100 011334667799999999999
Q ss_pred CccCCCCH------HHHHHHHH
Q 024027 237 SPEQRINA------KEIVTKLL 252 (273)
Q Consensus 237 dp~~Rps~------~~~l~~l~ 252 (273)
||++||++ +++++|-.
T Consensus 262 dP~~R~~~~~~~~~~~il~hp~ 283 (353)
T 3txo_A 262 NPTMRLGSLTQGGEHAILRHPF 283 (353)
T ss_dssp SGGGSTTSGGGTCTHHHHTSGG
T ss_pred CHHHccCCcccCCHHHHhhCCc
Confidence 99999998 88887643
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=290.92 Aligned_cols=231 Identities=28% Similarity=0.468 Sum_probs=189.6
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~q 81 (273)
+||||+++... ...+.+.+|+++++.++||||+++++++.+++..++||||+++++|.+++......+++..++.++.|
T Consensus 34 ~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ 112 (267)
T 3t9t_A 34 KVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 112 (267)
T ss_dssp EEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHH
T ss_pred eEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHH
Confidence 69999997653 34478999999999999999999999999999999999999999999999877667999999999999
Q ss_pred HHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcchh
Q 024027 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 161 (273)
Q Consensus 82 l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di 161 (273)
++.||.||| +.|++|+||+|+||+++.++.++|+|||++....... ........++..|+|||.+.+..++.++||
T Consensus 113 i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 188 (267)
T 3t9t_A 113 VCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDV 188 (267)
T ss_dssp HHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHH
T ss_pred HHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccccccccccccc-ccccccccccccccChhhhcCCCccchhch
Confidence 999999999 9999999999999999999999999999987652211 111223446778999999988889999999
Q ss_pred HHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccC
Q 024027 162 YSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQ 240 (273)
Q Consensus 162 wslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 240 (273)
||||+++|+|++ |..||........ ....... .....+..++..+.+++.+||..||++
T Consensus 189 ~slG~il~~l~~~g~~p~~~~~~~~~-~~~i~~~-------------------~~~~~~~~~~~~l~~li~~~l~~~p~~ 248 (267)
T 3t9t_A 189 WSFGVLMWEVFSEGKIPYENRSNSEV-VEDISTG-------------------FRLYKPRLASTHVYQIMNHCWRERPED 248 (267)
T ss_dssp HHHHHHHHHHHTTSCCTTTTCCHHHH-HHHHHTT-------------------CCCCCCTTSCHHHHHHHHHHTCSSGGG
T ss_pred hhhHHHHHHHhccCCCCCCCCCHHHH-HHHHhcC-------------------CcCCCCccCcHHHHHHHHHHccCChhh
Confidence 999999999999 8999875322211 1111000 000113345677999999999999999
Q ss_pred CCCHHHHHHHHHHHHHh
Q 024027 241 RINAKEIVTKLLKIRDS 257 (273)
Q Consensus 241 Rps~~~~l~~l~~~~~~ 257 (273)
|||+.+++++|+++.++
T Consensus 249 Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 249 RPAFSRLLRQLAEIAES 265 (267)
T ss_dssp SCCHHHHHHHHHHHHHC
T ss_pred CcCHHHHHHHHHHHHhc
Confidence 99999999999998763
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=292.53 Aligned_cols=232 Identities=24% Similarity=0.362 Sum_probs=179.9
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
.||||+++... ....+.+.+|+.+++.++||||+++++++. ++..++||||+++++|.+++......+++..++.++.
T Consensus 45 ~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 123 (281)
T 1mp8_A 45 AVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 123 (281)
T ss_dssp EEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHH
T ss_pred EEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHH
Confidence 48999987543 345677999999999999999999999985 4568899999999999999987766799999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
|++.||.||| +.|++|+||||+||+++.++.++|+|||++........ .......+++.|+|||.+.+..++.++|
T Consensus 124 qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~D 199 (281)
T 1mp8_A 124 QLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASD 199 (281)
T ss_dssp HHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCCCSHHHH
T ss_pred HHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccCcccc-cccccCCCcccccChhhcccCCCCCccC
Confidence 9999999999 99999999999999999999999999999976532221 1223344677899999998888999999
Q ss_pred hHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCcc
Q 024027 161 VYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239 (273)
Q Consensus 161 iwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 239 (273)
|||||+++|+|++ |..||......+. ........ ....+..++.++.+++.+||..||+
T Consensus 200 i~slG~~l~ell~~g~~pf~~~~~~~~-~~~i~~~~-------------------~~~~~~~~~~~l~~li~~~l~~~p~ 259 (281)
T 1mp8_A 200 VWMFGVCMWEILMHGVKPFQGVKNNDV-IGRIENGE-------------------RLPMPPNCPPTLYSLMTKCWAYDPS 259 (281)
T ss_dssp HHHHHHHHHHHHTTSCCTTTTCCGGGH-HHHHHTTC-------------------CCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred chHHHHHHHHHHhcCCCCCCcCCHHHH-HHHHHcCC-------------------CCCCCCCCCHHHHHHHHHHccCChh
Confidence 9999999999996 9999876433221 11110000 0011345677899999999999999
Q ss_pred CCCCHHHHHHHHHHHHHhh
Q 024027 240 QRINAKEIVTKLLKIRDSL 258 (273)
Q Consensus 240 ~Rps~~~~l~~l~~~~~~~ 258 (273)
+|||+.+++++|+++.++.
T Consensus 260 ~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 260 RRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp GSCCHHHHHHHHHHHHHHH
T ss_pred hCcCHHHHHHHHHHHHHHh
Confidence 9999999999999998764
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=293.85 Aligned_cols=235 Identities=26% Similarity=0.414 Sum_probs=180.3
Q ss_pred eEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCC-----ceeEEEeccCCCCHHHhhhc-----CCCC
Q 024027 2 EVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEE-----FKALVLEYMPHGSLEKYLYS-----SNCI 69 (273)
Q Consensus 2 ~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~-----~~~~ 69 (273)
+||||+++... ....+.+.+|+.+++.++||||+++++++.+.. ..++||||+++++|.+++.. ....
T Consensus 64 ~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~ 143 (313)
T 3brb_A 64 KVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKH 143 (313)
T ss_dssp EEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCC
T ss_pred EEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCcc
Confidence 69999997553 344677999999999999999999999997754 35899999999999999842 2346
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcc
Q 024027 70 LDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEY 149 (273)
Q Consensus 70 ~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~ 149 (273)
+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++................+++.|+|||.
T Consensus 144 ~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 220 (313)
T 3brb_A 144 IPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIES 220 (313)
T ss_dssp CCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchh
Confidence 999999999999999999999 99999999999999999999999999999976643332223334456788999999
Q ss_pred cCCCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHH
Q 024027 150 GREGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFN 228 (273)
Q Consensus 150 ~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 228 (273)
+.+..++.++||||||+++|+|++ |..||.......... ...... ....+..++.++.+
T Consensus 221 ~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~-~~~~~~-------------------~~~~~~~~~~~l~~ 280 (313)
T 3brb_A 221 LADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD-YLLHGH-------------------RLKQPEDCLDELYE 280 (313)
T ss_dssp HHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH-HHHTTC-------------------CCCCBTTCCHHHHH
T ss_pred hcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH-HHHcCC-------------------CCCCCccccHHHHH
Confidence 998889999999999999999999 889986643322111 111000 00113456677999
Q ss_pred HHhhcCCCCccCCCCHHHHHHHHHHHHHhhh
Q 024027 229 LAMACTVESPEQRINAKEIVTKLLKIRDSLL 259 (273)
Q Consensus 229 li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 259 (273)
|+.+||..||.+|||+.+++++|+++.+++.
T Consensus 281 li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 281 IMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred HHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 9999999999999999999999999988653
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=300.12 Aligned_cols=233 Identities=23% Similarity=0.376 Sum_probs=188.2
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
+||+|++.... ......+.+|+.+++.++||||+++++++. ++..++|+||+++|+|.+++...+..+++..++.++.
T Consensus 44 kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 122 (325)
T 3kex_A 44 PVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV 122 (325)
T ss_dssp EEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHH
T ss_pred EEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHH
Confidence 48888886443 344577889999999999999999999986 4568899999999999999987766799999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
|++.||.||| +.|++||||||+||+++.++.+||+|||++..+.............++..|+|||.+.+..++.++|
T Consensus 123 qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 199 (325)
T 3kex_A 123 QIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSD 199 (325)
T ss_dssp HHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHH
T ss_pred HHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhH
Confidence 9999999999 9999999999999999999999999999998765444433445566788999999998888999999
Q ss_pred hHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCcc
Q 024027 161 VYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239 (273)
Q Consensus 161 iwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 239 (273)
|||||+++|+|++ |..||......+.. ..... .. ....+..++.++.+++.+||..||.
T Consensus 200 i~slG~~l~el~~~g~~p~~~~~~~~~~--~~~~~------------~~------~~~~~~~~~~~~~~li~~~l~~dp~ 259 (325)
T 3kex_A 200 VWSYGVTVWELMTFGAEPYAGLRLAEVP--DLLEK------------GE------RLAQPQICTIDVYMVMVKCWMIDEN 259 (325)
T ss_dssp HHHHHHHHHHHHTTSCCTTTTSCTTHHH--HHHHT------------TC------BCCCCTTBCTTTTHHHHHHTCSCTT
T ss_pred hHHhHHHHHHHHhCCCCCccccCHHHHH--HHHHc------------CC------CCCCCCcCcHHHHHHHHHHcCCChh
Confidence 9999999999999 99999764332211 11100 00 0011233555688999999999999
Q ss_pred CCCCHHHHHHHHHHHHHhh
Q 024027 240 QRINAKEIVTKLLKIRDSL 258 (273)
Q Consensus 240 ~Rps~~~~l~~l~~~~~~~ 258 (273)
+|||+.+++++|+.+.+..
T Consensus 260 ~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 260 IRPTFKELANEFTRMARDP 278 (325)
T ss_dssp TSCCHHHHHHHHHHHTTSH
T ss_pred hCcCHHHHHHHHHHHHhcc
Confidence 9999999999999987654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=297.26 Aligned_cols=233 Identities=23% Similarity=0.351 Sum_probs=184.1
Q ss_pred eEEEEEeecc-cChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
+||+|.++.. .......+.+|+.+++.++||||+++++++..+. .++|++++.+|+|.+++......+++..++.++.
T Consensus 46 kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~ 124 (327)
T 3lzb_A 46 PVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 124 (327)
T ss_dssp EEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHH
T ss_pred EEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHH
Confidence 4788888644 3456678999999999999999999999998765 7899999999999999988777899999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
|++.||.||| +.|++|+||||+||+++.++.++|+|||++................+++.|+|||.+.+..++.++|
T Consensus 125 qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 201 (327)
T 3lzb_A 125 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSD 201 (327)
T ss_dssp HHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHH
T ss_pred HHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHH
Confidence 9999999999 9999999999999999999999999999998764433333334445677899999999888999999
Q ss_pred hHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCcc
Q 024027 161 VYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239 (273)
Q Consensus 161 iwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 239 (273)
|||||+++|+|++ |..||......... ..... .. ....+..++.++.+|+.+||..||.
T Consensus 202 i~slG~il~ell~~g~~p~~~~~~~~~~--~~~~~------------~~------~~~~~~~~~~~l~~li~~~l~~dp~ 261 (327)
T 3lzb_A 202 VWSYGVTVWELMTFGSKPYDGIPASEIS--SILEK------------GE------RLPQPPICTIDVYMIMRKCWMIDAD 261 (327)
T ss_dssp HHHHHHHHHHHHTTSCCTTTTCCGGGHH--HHHHT------------TC------CCCCCTTBCHHHHHHHHHHTCSSGG
T ss_pred HHHHHHHHHHHHHCCCCCCCCCCHHHHH--HHHHc------------CC------CCCCCccCCHHHHHHHHHHcCCChh
Confidence 9999999999999 99999764333211 11100 00 1111345677799999999999999
Q ss_pred CCCCHHHHHHHHHHHHHhh
Q 024027 240 QRINAKEIVTKLLKIRDSL 258 (273)
Q Consensus 240 ~Rps~~~~l~~l~~~~~~~ 258 (273)
+|||+.++++.|+++....
T Consensus 262 ~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 262 SRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp GSCCHHHHHHHHHHHHTSH
T ss_pred HCcCHHHHHHHHHHHHhCc
Confidence 9999999999999998653
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=299.70 Aligned_cols=242 Identities=23% Similarity=0.385 Sum_probs=194.2
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC---------CCCC
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN---------CILD 71 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~ 71 (273)
.||||+++... ......+.+|+.+++.++||||+++++++.+....++||||+++++|.+++.... ..++
T Consensus 57 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 136 (322)
T 1p4o_A 57 RVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136 (322)
T ss_dssp EEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCC
T ss_pred EEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcC
Confidence 69999997553 3455678999999999999999999999999999999999999999999996432 3478
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccC
Q 024027 72 IFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR 151 (273)
Q Consensus 72 ~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 151 (273)
+..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++................+++.|+|||.+.
T Consensus 137 ~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 213 (322)
T 1p4o_A 137 LSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK 213 (322)
T ss_dssp HHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhc
Confidence 9999999999999999999 9999999999999999999999999999997653332222223345678899999998
Q ss_pred CCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHH
Q 024027 152 EGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLA 230 (273)
Q Consensus 152 ~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 230 (273)
+..++.++||||||+++|+|++ |..||........ ........ ....+..++.++.+|+
T Consensus 214 ~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-~~~~~~~~-------------------~~~~~~~~~~~l~~li 273 (322)
T 1p4o_A 214 DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV-LRFVMEGG-------------------LLDKPDNCPDMLFELM 273 (322)
T ss_dssp HCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH-HHHHHTTC-------------------CCCCCTTCCHHHHHHH
T ss_pred cCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHH-HHHHHcCC-------------------cCCCCCCCCHHHHHHH
Confidence 8889999999999999999999 8899865432211 11100000 0011345677799999
Q ss_pred hhcCCCCccCCCCHHHHHHHHHHHHHhhhhhccccc
Q 024027 231 MACTVESPEQRINAKEIVTKLLKIRDSLLRNVGGRR 266 (273)
Q Consensus 231 ~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~~~~~~ 266 (273)
.+||..||.+|||+.+++++|+++......+.....
T Consensus 274 ~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~~~~ 309 (322)
T 1p4o_A 274 RMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYY 309 (322)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHCSTT
T ss_pred HHHcCCCcccCcCHHHHHHHHHHhhccCCccccccc
Confidence 999999999999999999999988766655554443
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=304.60 Aligned_cols=232 Identities=21% Similarity=0.238 Sum_probs=181.8
Q ss_pred eEEEEEeeccc---ChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 2 EVAVKVFNLQC---GRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 2 ~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
.||||+++... ......+..|..++..+ +||||++++++|.+++.+++||||++||+|..++...+ .+++..++.
T Consensus 79 ~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~ 157 (396)
T 4dc2_A 79 IYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARF 157 (396)
T ss_dssp EEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHH
T ss_pred EEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHcC-CCCHHHHHH
Confidence 69999998652 33456688999999887 89999999999999999999999999999999997643 699999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
++.|++.||.||| +.|++||||||+||+++.++.+||+|||++..... ........+||+.|+|||++.+..++.
T Consensus 158 ~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~--~~~~~~~~~gt~~Y~aPE~l~~~~~~~ 232 (396)
T 4dc2_A 158 YSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PGDTTSTFCGTPNYIAPEILRGEDYGF 232 (396)
T ss_dssp HHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--TTCCBCCCCBCGGGCCHHHHTTCCBCT
T ss_pred HHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeeccc--CCCccccccCCcccCCchhhcCCCCCh
Confidence 9999999999999 99999999999999999999999999999975322 122344568999999999999999999
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
++|+|||||++|+|++|..||............... .....+.. .....+..++.++.+||.+||..|
T Consensus 233 ~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~-----~~~~~i~~-------~~~~~p~~~s~~~~~li~~lL~~d 300 (396)
T 4dc2_A 233 SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTED-----YLFQVILE-------KQIRIPRSLSVKAASVLKSFLNKD 300 (396)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSTTTTC------CCHH-----HHHHHHHH-------CCCCCCTTSCHHHHHHHHHHTCSC
T ss_pred HHHHHHHHHHHHHHHhCCCCCcccccccccchhhHH-----HHHHHHhc-------cccCCCCcCCHHHHHHHHHHhcCC
Confidence 999999999999999999999643222110000000 00000000 001124457788999999999999
Q ss_pred ccCCCCH------HHHHHHH
Q 024027 238 PEQRINA------KEIVTKL 251 (273)
Q Consensus 238 p~~Rps~------~~~l~~l 251 (273)
|++||++ .++++|-
T Consensus 301 P~~R~~~~~~~~~~ei~~Hp 320 (396)
T 4dc2_A 301 PKERLGCHPQTGFADIQGHP 320 (396)
T ss_dssp TTTSTTCSTTTHHHHHHHST
T ss_pred HhHcCCCCCCCCHHHHhcCc
Confidence 9999985 6777664
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=297.08 Aligned_cols=233 Identities=21% Similarity=0.258 Sum_probs=166.3
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCC-CccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIR-HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
+.||||++... ....+.+|+.+++.+. ||||+++++++.++...++||||+++++|.+++... ..+++..++.++
T Consensus 37 ~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~ 112 (325)
T 3kn6_A 37 QAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKK-KHFSETEASYIM 112 (325)
T ss_dssp CEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHC-SCCCHHHHHHHH
T ss_pred CEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhc-CCCCHHHHHHHH
Confidence 47999999743 4467889999999996 999999999999999999999999999999999765 469999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCC---ceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcC
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNL---VAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVS 156 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~---~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 156 (273)
.|++.||.||| +.|++||||||+||+++.++ .++|+|||++...... .......++++.|+|||++.+..++
T Consensus 113 ~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~ 187 (325)
T 3kn6_A 113 RKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQPLKTPCFTLHYAAPELLNQNGYD 187 (325)
T ss_dssp HHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------------------------CCCC
T ss_pred HHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC--CCcccccCCCcCccCHHHhcCCCCC
Confidence 99999999999 99999999999999997665 8999999999765322 2223445689999999999988999
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++||||||+++|+|++|..||.......... ...+...................++.++.+|+.+||..
T Consensus 188 ~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~----------~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 257 (325)
T 3kn6_A 188 ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCT----------SAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTV 257 (325)
T ss_dssp HHHHHHHHHHHHHHHHHSSCTTC-------CC----------CHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCC
T ss_pred CccchHHHHHHHHHHHhCCCCCCCCccccccc----------cHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCC
Confidence 99999999999999999999997643321100 00001111111111112222356788899999999999
Q ss_pred CccCCCCHHHHHHHHH
Q 024027 237 SPEQRINAKEIVTKLL 252 (273)
Q Consensus 237 dp~~Rps~~~~l~~l~ 252 (273)
||.+|||+.++++|-+
T Consensus 258 dP~~Rpt~~ell~h~w 273 (325)
T 3kn6_A 258 DPNKRLKMSGLRYNEW 273 (325)
T ss_dssp CTTTCCCTTTSTTCGG
T ss_pred ChhHCCCHHHHhcChh
Confidence 9999999999987744
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=297.13 Aligned_cols=248 Identities=23% Similarity=0.369 Sum_probs=192.7
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecC--CceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNE--EFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
.||||+++... ....+.+.+|+++++.++||||+++++++.+. ..+++||||+++++|.+++.... +++..++.+
T Consensus 62 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~i 139 (318)
T 3lxp_A 62 MVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLF 139 (318)
T ss_dssp EEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGSC--CCHHHHHHH
T ss_pred EEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhCC--CCHHHHHHH
Confidence 69999998653 34567799999999999999999999999874 57899999999999999997654 899999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCc-ceeecccccCCCCCCcccCCCCcCC
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQS-MTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
+.|++.||.||| +.|++|+||||+||+++.++.++|+|||++......... .......++..|+|||.+.+..++.
T Consensus 140 ~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 216 (318)
T 3lxp_A 140 AQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYY 216 (318)
T ss_dssp HHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEH
T ss_pred HHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCc
Confidence 999999999999 999999999999999999999999999999876433221 1223445778899999998888999
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhc-cCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDW-LPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
++||||||+++|+|++|..||................. .......... .......+..++.++.+|+.+||..
T Consensus 217 ~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~ 290 (318)
T 3lxp_A 217 ASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE------RGERLPRPDKCPAEVYHLMKNCWET 290 (318)
T ss_dssp HHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH------TTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred HHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh------cccCCCCCccccHHHHHHHHHHcCC
Confidence 99999999999999999999865322111110000000 0000000010 1111122456778899999999999
Q ss_pred CccCCCCHHHHHHHHHHHHHhhhh
Q 024027 237 SPEQRINAKEIVTKLLKIRDSLLR 260 (273)
Q Consensus 237 dp~~Rps~~~~l~~l~~~~~~~~~ 260 (273)
||.+|||+.++++.|+.+.+++..
T Consensus 291 dP~~Rps~~ell~~L~~l~~~~~~ 314 (318)
T 3lxp_A 291 EASFRPTFENLIPILKTVHEKYQG 314 (318)
T ss_dssp SGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred CcccCcCHHHHHHHHHHHHHhhcc
Confidence 999999999999999999888753
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=297.34 Aligned_cols=235 Identities=28% Similarity=0.428 Sum_probs=192.3
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCC-----------
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNC----------- 68 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------- 68 (273)
.||||+++... ......+.+|+++++.+ +||||+++++++.+.+..++||||+++++|.+++.....
T Consensus 69 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 148 (334)
T 2pvf_A 69 TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148 (334)
T ss_dssp EEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC----
T ss_pred EEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccc
Confidence 69999998653 34567799999999999 899999999999999999999999999999999975432
Q ss_pred ----CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCC
Q 024027 69 ----ILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGY 144 (273)
Q Consensus 69 ----~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~ 144 (273)
.+++..++.++.|++.||.||| +.|++|+||||+||+++.++.+||+|||++................+++.|
T Consensus 149 ~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y 225 (334)
T 2pvf_A 149 VPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKW 225 (334)
T ss_dssp ----CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGG
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccce
Confidence 3889999999999999999999 999999999999999999999999999999876443322223344567889
Q ss_pred CCCcccCCCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhH
Q 024027 145 MAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCV 223 (273)
Q Consensus 145 ~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (273)
+|||++.+..++.++||||||+++|+|++ |..||......+. ....... . ....+..++
T Consensus 226 ~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~~~~~~~-------------~------~~~~~~~~~ 285 (334)
T 2pvf_A 226 MAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-FKLLKEG-------------H------RMDKPANCT 285 (334)
T ss_dssp CCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-HHHHHHT-------------C------CCCCCTTCC
T ss_pred eChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH-HHHHhcC-------------C------CCCCCccCC
Confidence 99999988889999999999999999999 9999865322211 1000000 0 001134567
Q ss_pred HHHHHHHhhcCCCCccCCCCHHHHHHHHHHHHHhhh
Q 024027 224 SFVFNLAMACTVESPEQRINAKEIVTKLLKIRDSLL 259 (273)
Q Consensus 224 ~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 259 (273)
.++.+++.+||..||.+|||+.+++++|+++.....
T Consensus 286 ~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 286 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 789999999999999999999999999999987543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=294.21 Aligned_cols=240 Identities=19% Similarity=0.166 Sum_probs=192.4
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
+.||||++.... ....+.+|+++++.+ +||||+++++++......++||||+ +++|.+++......+++..++.++
T Consensus 35 ~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~ 111 (330)
T 2izr_A 35 EYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIA 111 (330)
T ss_dssp EEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHH
T ss_pred cEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHH
Confidence 379999997553 235789999999999 9999999999999999999999999 889999998766679999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCc-----eEEeecccccccccCCCcc-----eeecccccCCCCCCcc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLV-----AYLSDFGIAKLLIGEDQSM-----TQTQTLATIGYMAPEY 149 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~-----~kl~Df~~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~ 149 (273)
.|++.||.||| +.|++||||||+||+++.++. ++|+|||++..+....... ......||+.|+|||+
T Consensus 112 ~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 188 (330)
T 2izr_A 112 IQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINT 188 (330)
T ss_dssp HHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHH
T ss_pred HHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHH
Confidence 99999999999 999999999999999998887 9999999998764332211 1235678999999999
Q ss_pred cCCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHH
Q 024027 150 GREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNL 229 (273)
Q Consensus 150 ~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 229 (273)
+.+..++.++|||||||++|+|++|..||.......... ..... ..... ..........++ ++.++
T Consensus 189 ~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~--~~~~i--------~~~~~---~~~~~~~~~~~p-~~~~l 254 (330)
T 2izr_A 189 HLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKE--RYQKI--------GDTKR---ATPIEVLCENFP-EMATY 254 (330)
T ss_dssp HTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHH--HHHHH--------HHHHH---HSCHHHHTTTCH-HHHHH
T ss_pred HcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHH--HHHHH--------Hhhhc---cCCHHHHhccCh-HHHHH
Confidence 999999999999999999999999999998653322111 00000 00000 000000112345 79999
Q ss_pred HhhcCCCCccCCCCHHHHHHHHHHHHHhhhh
Q 024027 230 AMACTVESPEQRINAKEIVTKLLKIRDSLLR 260 (273)
Q Consensus 230 i~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~ 260 (273)
+.+||..||.+||+++++.+.|+++.+.+..
T Consensus 255 i~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~ 285 (330)
T 2izr_A 255 LRYVRRLDFFEKPDYDYLRKLFTDLFDRKGY 285 (330)
T ss_dssp HHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HHHHHhCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 9999999999999999999999999887643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=290.93 Aligned_cols=244 Identities=21% Similarity=0.225 Sum_probs=182.6
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
+.||||+++... ......+.+|+++++.++||||+++++++.+++..++||||+++ +|.+++......+++..++.+
T Consensus 27 ~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~ 105 (288)
T 1ob3_A 27 ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSF 105 (288)
T ss_dssp CEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHTSTTCCCHHHHHHH
T ss_pred CEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHhcccCCCHHHHHHH
Confidence 479999997543 23346788999999999999999999999999999999999976 999999776667999999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCC-CcCC
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG-RVST 157 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~ 157 (273)
+.|++.||.||| +.|++|+||||+||+++.++.+||+|||++...... ........+++.|+|||++.+. .++.
T Consensus 106 ~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~ 180 (288)
T 1ob3_A 106 LLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VRKYTHEIVTLWYRAPDVLMGSKKYST 180 (288)
T ss_dssp HHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCT
T ss_pred HHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc--ccccccccccccccCchheeCCCCCCc
Confidence 999999999999 999999999999999999999999999999765321 1122345689999999998764 5899
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCcc--chh------hhhhhccccc-hhhhhhhhhhHHHHHH
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPIS--TME------VVDANLLSQE-DIHFVAKEQCVSFVFN 228 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~------~~~~~~~~~~-~~~~~~~~~~~~~l~~ 228 (273)
++|||||||++|+|++|..||......+.. ........... ... ..+....... .........++.++.+
T Consensus 181 ~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (288)
T 1ob3_A 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQL-MRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGID 259 (288)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHH
Confidence 999999999999999999999764332221 11111100000 000 0000000000 0001112346778999
Q ss_pred HHhhcCCCCccCCCCHHHHHHHH
Q 024027 229 LAMACTVESPEQRINAKEIVTKL 251 (273)
Q Consensus 229 li~~~l~~dp~~Rps~~~~l~~l 251 (273)
|+.+||..||++|||++++++|-
T Consensus 260 li~~~L~~dP~~Rpt~~e~l~hp 282 (288)
T 1ob3_A 260 LLSKMLKLDPNQRITAKQALEHA 282 (288)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTSG
T ss_pred HHHHHcCCCcccCCCHHHHhcCc
Confidence 99999999999999999999863
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=288.87 Aligned_cols=226 Identities=20% Similarity=0.315 Sum_probs=165.9
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
++||||++.... ....+.+.+|+.+++.++||||+++++++.+....++||||+++++|.+++......+++..++.
T Consensus 37 ~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 116 (278)
T 3cok_A 37 LEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARH 116 (278)
T ss_dssp CEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHH
T ss_pred ceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHH
Confidence 479999997542 23356789999999999999999999999999999999999999999999987767799999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||.+........ ......+++.|+|||.+.+..++.
T Consensus 117 ~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~ 191 (278)
T 3cok_A 117 FMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE--KHYTLCGTPNYISPEIATRSAHGL 191 (278)
T ss_dssp HHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC------------------------------
T ss_pred HHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC--cceeccCCCCcCCcchhcCCCCCc
Confidence 9999999999999 99999999999999999999999999999976532211 223356889999999998888999
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
++||||||+++|+|++|..||........... . .. . ....+..++.++.+|+.+||..|
T Consensus 192 ~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-~----~~------------~----~~~~~~~~~~~~~~li~~~l~~d 250 (278)
T 3cok_A 192 ESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK-V----VL------------A----DYEMPSFLSIEAKDLIHQLLRRN 250 (278)
T ss_dssp CTHHHHHHHHHHHHHHSSCSSCCCSCC------C----CS------------S----CCCCCTTSCHHHHHHHHHHSCSS
T ss_pred hhhHHHHHHHHHHHHhCCCCCCChhHHHHHHH-H----hh------------c----ccCCccccCHHHHHHHHHHcccC
Confidence 99999999999999999999875332211100 0 00 0 00113346677999999999999
Q ss_pred ccCCCCHHHHHHHHH
Q 024027 238 PEQRINAKEIVTKLL 252 (273)
Q Consensus 238 p~~Rps~~~~l~~l~ 252 (273)
|++|||++++++|-.
T Consensus 251 p~~Rps~~~~l~h~~ 265 (278)
T 3cok_A 251 PADRLSLSSVLDHPF 265 (278)
T ss_dssp GGGSCCHHHHTTSTT
T ss_pred HhhCCCHHHHhcCcc
Confidence 999999999998643
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=300.37 Aligned_cols=250 Identities=24% Similarity=0.309 Sum_probs=191.7
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeee--cCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS--NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
.||||+++.......+.+.+|+++++.++||||+++++++. +....++||||+++++|.+++......+++..++.++
T Consensus 54 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~ 133 (327)
T 3lxl_A 54 LVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS 133 (327)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHH
T ss_pred EEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHH
Confidence 69999998776666778999999999999999999999886 4567899999999999999998766679999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcc-eeecccccCCCCCCcccCCCCcCCc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSM-TQTQTLATIGYMAPEYGREGRVSTN 158 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~ 158 (273)
.|++.||.||| +.|++|+||||+||+++.++.++|+|||++.......... ......++..|+|||.+.+..++.+
T Consensus 134 ~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 210 (327)
T 3lxl_A 134 SQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQ 210 (327)
T ss_dssp HHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHH
T ss_pred HHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChH
Confidence 99999999999 9999999999999999999999999999998764332211 2233457788999999988889999
Q ss_pred chhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc
Q 024027 159 GDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238 (273)
Q Consensus 159 ~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 238 (273)
+||||||+++|+|++|..||........... ................ ........+..++.++.+|+.+||..||
T Consensus 211 ~Di~slG~il~~ll~g~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~dP 285 (327)
T 3lxl_A 211 SDVWSFGVVLYELFTYCDKSCSPSAEFLRMM--GCERDVPALSRLLELL---EEGQRLPAPPACPAEVHELMKLCWAPSP 285 (327)
T ss_dssp HHHHHHHHHHHHHHTTTCGGGSHHHHHHHHC--C----CCHHHHHHHHH---HTTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred HhHHHHHHHHHHHHhCCCCCccccchhhhhc--ccccccccHHHHHHHh---hcccCCCCCCcccHHHHHHHHHHcCCCh
Confidence 9999999999999999999865322111000 0000000000000000 0111112245678889999999999999
Q ss_pred cCCCCHHHHHHHHHHHHHhhh
Q 024027 239 EQRINAKEIVTKLLKIRDSLL 259 (273)
Q Consensus 239 ~~Rps~~~~l~~l~~~~~~~~ 259 (273)
.+|||+.+++++|+.+.....
T Consensus 286 ~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 286 QDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp GGSCCHHHHHHHHHHC-----
T ss_pred hhCcCHHHHHHHHHHHHhhhc
Confidence 999999999999998876543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=294.31 Aligned_cols=235 Identities=24% Similarity=0.375 Sum_probs=191.9
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcC-CCccceeeeeeeecCC-ceeEEEeccCCCCHHHhhhcCCCC---------
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEE-FKALVLEYMPHGSLEKYLYSSNCI--------- 69 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~--------- 69 (273)
.||||+++... ....+.+.+|+.+++.+ +||||+++++++...+ ..++||||+++++|.+++......
T Consensus 59 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 138 (316)
T 2xir_A 59 TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 138 (316)
T ss_dssp EEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-----
T ss_pred EEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccch
Confidence 69999998653 33456789999999999 7999999999987654 589999999999999999765432
Q ss_pred ------CCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCC
Q 024027 70 ------LDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIG 143 (273)
Q Consensus 70 ------~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~ 143 (273)
+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++................+++.
T Consensus 139 ~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~ 215 (316)
T 2xir_A 139 DLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 215 (316)
T ss_dssp --CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGG
T ss_pred hhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCccee
Confidence 789999999999999999999 99999999999999999999999999999987644433334445567889
Q ss_pred CCCCcccCCCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhh
Q 024027 144 YMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQC 222 (273)
Q Consensus 144 ~~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (273)
|+|||.+.+..++.++||||||+++|+|++ |..||................. ....+..+
T Consensus 216 y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~ 276 (316)
T 2xir_A 216 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT-------------------RMRAPDYT 276 (316)
T ss_dssp GCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTC-------------------CCCCCTTC
T ss_pred ecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCc-------------------cCCCCCCC
Confidence 999999988889999999999999999998 9999876443322221111110 00113345
Q ss_pred HHHHHHHHhhcCCCCccCCCCHHHHHHHHHHHHHhh
Q 024027 223 VSFVFNLAMACTVESPEQRINAKEIVTKLLKIRDSL 258 (273)
Q Consensus 223 ~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 258 (273)
+.++.+++.+||..||.+|||+.+++++|+++.++.
T Consensus 277 ~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 277 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 677999999999999999999999999999998754
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=297.98 Aligned_cols=222 Identities=20% Similarity=0.213 Sum_probs=185.3
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||||+++... ....+.+.+|+++++.++||||+++++++.++..+++||||++||+|.+++...+ .+++..++.
T Consensus 67 ~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~ 145 (350)
T 1rdq_E 67 NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARF 145 (350)
T ss_dssp CEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHC-CCCHHHHHH
T ss_pred CEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHH
Confidence 479999997542 3445678899999999999999999999999999999999999999999997644 589999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
++.|++.||.||| +.|++||||||+||+++.++.+||+|||++...... ....+||+.|+|||++.+..++.
T Consensus 146 ~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~ 217 (350)
T 1rdq_E 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNK 217 (350)
T ss_dssp HHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCT
T ss_pred HHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCC-----cccccCCccccCHHHhcCCCCCC
Confidence 9999999999999 999999999999999999999999999999865321 23457899999999999989999
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
++|+|||||++|+|++|..||....... ....+.... ...+..++.++.+|+.+||..|
T Consensus 218 ~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~i~~~~--------------------~~~p~~~~~~~~~li~~lL~~d 276 (350)
T 1rdq_E 218 AVDWWALGVLIYEMAAGYPPFFADQPIQ-IYEKIVSGK--------------------VRFPSHFSSDLKDLLRNLLQVD 276 (350)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCC--------------------CCCCTTCCHHHHHHHHHHSCSC
T ss_pred cCCEecccHhHhHHhhCCCCCCCCCHHH-HHHHHHcCC--------------------CCCCCCCCHHHHHHHHHHhhcC
Confidence 9999999999999999999997532211 111111100 0113456778999999999999
Q ss_pred ccCCCC-----HHHHHHHHH
Q 024027 238 PEQRIN-----AKEIVTKLL 252 (273)
Q Consensus 238 p~~Rps-----~~~~l~~l~ 252 (273)
|.+||+ ++++++|-.
T Consensus 277 p~~R~~~~~~~~~ei~~h~~ 296 (350)
T 1rdq_E 277 LTKRFGNLKNGVNDIKNHKW 296 (350)
T ss_dssp TTTCTTSSTTTTHHHHTSGG
T ss_pred HHhccCCccCCHHHHHhCcC
Confidence 999998 899988754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=297.46 Aligned_cols=226 Identities=22% Similarity=0.279 Sum_probs=170.4
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
+.||||+++... ..+.+.+|+++++.++||||+++++++.++...++||||+++++|.+++... ..+++..++.++.
T Consensus 79 ~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~ 155 (349)
T 2w4o_A 79 KPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEK-GYYSERDAADAVK 155 (349)
T ss_dssp CEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTC-SSCCHHHHHHHHH
T ss_pred cEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHH
Confidence 469999997553 3467889999999999999999999999999999999999999999999654 4689999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCC---CCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCC
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDD---NLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~---~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
|++.||.||| +.|++|+||||+||+++. ++.+||+|||++...... .......|++.|+|||++.+..++.
T Consensus 156 qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~ 229 (349)
T 2w4o_A 156 QILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ---VLMKTVCGTPGYCAPEILRGCAYGP 229 (349)
T ss_dssp HHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------------------CGGGSCHHHHTTCCCCT
T ss_pred HHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc---cccccccCCCCccCHHHhcCCCCCc
Confidence 9999999999 999999999999999975 889999999998765321 1223456899999999999888999
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
++|||||||++|+|++|..||................... ........++.++.+|+.+||..|
T Consensus 230 ~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~----------------~~~~~~~~~~~~~~~li~~~L~~d 293 (349)
T 2w4o_A 230 EVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYY----------------FISPWWDEVSLNAKDLVRKLIVLD 293 (349)
T ss_dssp HHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCC----------------CCTTTTTTSCHHHHHHHHTTSCSS
T ss_pred ccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCc----------------cCCchhhhCCHHHHHHHHHHccCC
Confidence 9999999999999999999997644332222222111100 001112456778999999999999
Q ss_pred ccCCCCHHHHHHHH
Q 024027 238 PEQRINAKEIVTKL 251 (273)
Q Consensus 238 p~~Rps~~~~l~~l 251 (273)
|++|||+.++++|-
T Consensus 294 P~~Rpt~~e~l~hp 307 (349)
T 2w4o_A 294 PKKRLTTFQALQHP 307 (349)
T ss_dssp GGGSCCHHHHHHST
T ss_pred hhhCcCHHHHhcCc
Confidence 99999999999873
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=296.42 Aligned_cols=235 Identities=27% Similarity=0.456 Sum_probs=186.6
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
+||||+++... ......+.+|+.+++.++||||+++++++.+.+..++||||+++++|.+++......+++..++.++.
T Consensus 75 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ 154 (333)
T 1mqb_A 75 PVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR 154 (333)
T ss_dssp EEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHH
T ss_pred cEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHH
Confidence 59999998653 34556789999999999999999999999999999999999999999999987767799999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCc-ceeecccccCCCCCCcccCCCCcCCcc
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQS-MTQTQTLATIGYMAPEYGREGRVSTNG 159 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~ 159 (273)
|++.||.||| +.|++|+||||+||+++.++.+||+|||++......... .......++..|+|||.+.+..++.++
T Consensus 155 qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 231 (333)
T 1mqb_A 155 GIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSAS 231 (333)
T ss_dssp HHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHH
T ss_pred HHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchh
Confidence 9999999999 999999999999999999999999999999866432211 112223457789999999888899999
Q ss_pred hhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc
Q 024027 160 DVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238 (273)
Q Consensus 160 DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 238 (273)
||||||+++|+|++ |..||......+. ....... .....+..++.++.+++.+||..||
T Consensus 232 Di~slG~il~ellt~g~~pf~~~~~~~~-~~~~~~~-------------------~~~~~~~~~~~~l~~li~~~l~~~p 291 (333)
T 1mqb_A 232 DVWSFGIVMWEVMTYGERPYWELSNHEV-MKAINDG-------------------FRLPTPMDCPSAIYQLMMQCWQQER 291 (333)
T ss_dssp HHHHHHHHHHHHHTTSCCTTTTCCHHHH-HHHHHTT-------------------CCCCCCTTCBHHHHHHHHHHTCSST
T ss_pred hhHHHHHHHHHHHcCCCCCcccCCHHHH-HHHHHCC-------------------CcCCCcccCCHHHHHHHHHHcCCCh
Confidence 99999999999998 9999865432211 1110000 0011134567779999999999999
Q ss_pred cCCCCHHHHHHHHHHHHHhhh
Q 024027 239 EQRINAKEIVTKLLKIRDSLL 259 (273)
Q Consensus 239 ~~Rps~~~~l~~l~~~~~~~~ 259 (273)
.+|||+.+++++|+++.....
T Consensus 292 ~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 292 ARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp TTSCCHHHHHHHHHHHHHSGG
T ss_pred hhCcCHHHHHHHHHHHHhcch
Confidence 999999999999999987543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=287.40 Aligned_cols=227 Identities=24% Similarity=0.399 Sum_probs=185.3
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecC--CceeEEEeccCCCCHHHhhhcCCC-CCCHHHH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNE--EFKALVLEYMPHGSLEKYLYSSNC-ILDIFQR 75 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~ 75 (273)
++||||+++... ....+.+.+|+.+++.++||||+++++++.+. ...++||||+++++|.+++..... .+++..+
T Consensus 34 ~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 113 (271)
T 3kmu_A 34 NDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQA 113 (271)
T ss_dssp EEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHH
T ss_pred eeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHH
Confidence 369999998653 34566799999999999999999999999887 788999999999999999976543 5899999
Q ss_pred HHHHHHHHHHHHHHhcCCCCC--eEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCC
Q 024027 76 LNIMIDVASALEYLHFGCSAP--VIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG 153 (273)
Q Consensus 76 ~~~~~ql~~~l~~lh~~~~~~--i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 153 (273)
+.++.|++.||.||| +.| ++|+||||+||+++.++.++++||+++... ......+++.|+|||.+.+.
T Consensus 114 ~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~ 183 (271)
T 3kmu_A 114 VKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAPEALQKK 183 (271)
T ss_dssp HHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT-------SCTTCBSCGGGSCHHHHHSC
T ss_pred HHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeee-------cccCccCCccccChhhhccC
Confidence 999999999999999 889 999999999999999999999998887542 12234678899999999876
Q ss_pred CcCC---cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHH
Q 024027 154 RVST---NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLA 230 (273)
Q Consensus 154 ~~~~---~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 230 (273)
.++. ++||||||+++|+|++|..||................ .....+..++.++.+++
T Consensus 184 ~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~li 244 (271)
T 3kmu_A 184 PEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEG-------------------LRPTIPPGISPHVSKLM 244 (271)
T ss_dssp GGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSC-------------------CCCCCCTTCCHHHHHHH
T ss_pred CCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcC-------------------CCCCCCCCCCHHHHHHH
Confidence 5544 7999999999999999999997643322211111000 00111345677899999
Q ss_pred hhcCCCCccCCCCHHHHHHHHHHHHH
Q 024027 231 MACTVESPEQRINAKEIVTKLLKIRD 256 (273)
Q Consensus 231 ~~~l~~dp~~Rps~~~~l~~l~~~~~ 256 (273)
.+||..||++|||++++++.|+++.+
T Consensus 245 ~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 245 KICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred HHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 99999999999999999999998754
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=292.53 Aligned_cols=245 Identities=24% Similarity=0.285 Sum_probs=185.0
Q ss_pred CeEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcC-----CCCCCHHH
Q 024027 1 MEVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-----NCILDIFQ 74 (273)
Q Consensus 1 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~ 74 (273)
+.||||+++... ......+.+|+++++.++||||+++++++.+++..++||||+++ +|.+++... ...+++..
T Consensus 31 ~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~ 109 (317)
T 2pmi_A 31 VYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNL 109 (317)
T ss_dssp CEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCCC-BHHHHHHHHHSSSCCCCCCHHH
T ss_pred cEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecCC-CHHHHHHhccccccccCCCHHH
Confidence 479999997653 33456788999999999999999999999999999999999985 999998543 23589999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCC-
Q 024027 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG- 153 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~- 153 (273)
+..++.|++.||.||| +.|++|+||||+||+++.++.+||+|||++...... ........+++.|+|||++.+.
T Consensus 110 ~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~ 184 (317)
T 2pmi_A 110 VKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP--VNTFSSEVVTLWYRAPDVLMGSR 184 (317)
T ss_dssp HHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSC--CCCCCCCCSCCTTCCHHHHTTCC
T ss_pred HHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecCCC--cccCCCCcccccccCchHhhCCC
Confidence 9999999999999999 999999999999999999999999999999865322 1223345689999999998764
Q ss_pred CcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccC--ccchhhhhh------hccc--c----chhhhhhh
Q 024027 154 RVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLP--ISTMEVVDA------NLLS--Q----EDIHFVAK 219 (273)
Q Consensus 154 ~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~------~~~~--~----~~~~~~~~ 219 (273)
.++.++|||||||++|+|++|..||......+ ........... ......... .... . .......+
T Consensus 185 ~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (317)
T 2pmi_A 185 TYSTSIDIWSCGCILAEMITGKPLFPGTNDEE-QLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTK 263 (317)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCS
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhccccc
Confidence 58999999999999999999999997643322 12211111100 000000000 0000 0 00011112
Q ss_pred hhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 220 EQCVSFVFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 220 ~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
..++.++.+|+.+||..||++|||+.++++|-+
T Consensus 264 ~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~ 296 (317)
T 2pmi_A 264 EPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW 296 (317)
T ss_dssp SCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred ccCCHHHHHHHHHHCCCCcccCCCHHHHhCChh
Confidence 346778999999999999999999999998743
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=295.01 Aligned_cols=225 Identities=21% Similarity=0.266 Sum_probs=175.5
Q ss_pred CeEEEEEeeccc----ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHH
Q 024027 1 MEVAVKVFNLQC----GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (273)
+.||||+++... ......+.+|+.+++.++||||+++++++.+.+..++||||+++++|.+++...+ .+++..++
T Consensus 46 ~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~ 124 (327)
T 3a62_A 46 KIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREG-IFMEDTAC 124 (327)
T ss_dssp CEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHHS-SCCHHHHH
T ss_pred cEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCC-CCCHHHHH
Confidence 469999997542 2345668899999999999999999999999999999999999999999996543 58999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcC
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVS 156 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 156 (273)
.++.|++.||.||| +.|++||||||+||+++.++.+||+|||++....... .......|++.|+|||++.+..++
T Consensus 125 ~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~ 199 (327)
T 3a62_A 125 FYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG--TVTHTFCGTIEYMAPEILMRSGHN 199 (327)
T ss_dssp HHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC------------CTTSSCCTTSCHHHHTTSCCC
T ss_pred HHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCcccccccCC--ccccccCCCcCccCHhhCcCCCCC
Confidence 99999999999999 9999999999999999999999999999987542211 123345789999999999988899
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++||||||+++|+|++|..||........ ....... ....+..++.++.+|+.+||..
T Consensus 200 ~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~--------------------~~~~p~~~~~~~~~li~~~L~~ 258 (327)
T 3a62_A 200 RAVDWWSLGALMYDMLTGAPPFTGENRKKT-IDKILKC--------------------KLNLPPYLTQEARDLLKKLLKR 258 (327)
T ss_dssp THHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHT--------------------CCCCCTTSCHHHHHHHHHHSCS
T ss_pred CcccchhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHhC--------------------CCCCCCCCCHHHHHHHHHHHhc
Confidence 999999999999999999999975332211 1111110 0011345677899999999999
Q ss_pred CccCCC-----CHHHHHHHHH
Q 024027 237 SPEQRI-----NAKEIVTKLL 252 (273)
Q Consensus 237 dp~~Rp-----s~~~~l~~l~ 252 (273)
||++|| ++.++++|-.
T Consensus 259 dp~~R~~~~~~~~~e~l~hp~ 279 (327)
T 3a62_A 259 NAASRLGAGPGDAGEVQAHPF 279 (327)
T ss_dssp CGGGSTTSSTTTHHHHHHSGG
T ss_pred CHhhccCCCCCCHHHHHcCCc
Confidence 999999 7889988754
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=287.13 Aligned_cols=237 Identities=23% Similarity=0.370 Sum_probs=190.8
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCce-eEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFK-ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~-~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
.||+|+++... ....+.+.+|+.+++.++||||+++++++.+.... ++|+||+.+++|.+++......+++..++.++
T Consensus 51 ~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~ 130 (298)
T 3pls_A 51 QCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFG 130 (298)
T ss_dssp EEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHH
T ss_pred eeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHH
Confidence 58999997543 34567899999999999999999999999876655 89999999999999998777779999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCC--CcceeecccccCCCCCCcccCCCCcCC
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED--QSMTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~--~~~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
.|++.||.||| +.|++|+||||+||+++.++.++|+|||++....... .........+++.|+|||.+.+..++.
T Consensus 131 ~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 207 (298)
T 3pls_A 131 LQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTT 207 (298)
T ss_dssp HHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCH
T ss_pred HHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCCh
Confidence 99999999999 9999999999999999999999999999997653322 112223446788999999999889999
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
++||||||+++|+|++|..|+................. ....+..++.++.+|+.+||..|
T Consensus 208 ~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~l~~li~~~l~~~ 268 (298)
T 3pls_A 208 KSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR-------------------RLPQPEYCPDSLYQVMQQCWEAD 268 (298)
T ss_dssp HHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC-------------------CCCCCTTCCHHHHHHHHHHTCSS
T ss_pred hhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC-------------------CCCCCccchHHHHHHHHHHccCC
Confidence 99999999999999996655433222221111111110 01113446677999999999999
Q ss_pred ccCCCCHHHHHHHHHHHHHhhhh
Q 024027 238 PEQRINAKEIVTKLLKIRDSLLR 260 (273)
Q Consensus 238 p~~Rps~~~~l~~l~~~~~~~~~ 260 (273)
|.+|||+.++++.|+++.+++..
T Consensus 269 p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 269 PAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp GGGSCCHHHHHHHHHHHHHHCCS
T ss_pred hhhCcCHHHHHHHHHHHHHHHhc
Confidence 99999999999999999988643
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=286.17 Aligned_cols=226 Identities=23% Similarity=0.249 Sum_probs=185.5
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~q 81 (273)
.||+|++........+.+.+|+++++.++||||+++++++.+....++||||+++++|.+++.... .+++..++.++.|
T Consensus 36 ~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~ 114 (277)
T 3f3z_A 36 RRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKR-VFRESDAARIMKD 114 (277)
T ss_dssp EEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHH
T ss_pred EEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHcC-CCCHHHHHHHHHH
Confidence 689999987666667889999999999999999999999999999999999999999999986543 5899999999999
Q ss_pred HHHHHHHHhcCCCCCeEeccCCCCceee---CCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCc
Q 024027 82 VASALEYLHFGCSAPVIHCDLKPDNVLL---DDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTN 158 (273)
Q Consensus 82 l~~~l~~lh~~~~~~i~h~di~p~nil~---~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 158 (273)
++.||.||| +.|++|+||||+||++ +.++.++|+|||++..+.... ......+++.|+|||.+.+. ++.+
T Consensus 115 i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~ 187 (277)
T 3f3z_A 115 VLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---MMRTKVGTPYYVSPQVLEGL-YGPE 187 (277)
T ss_dssp HHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHTTC-BCTT
T ss_pred HHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc---chhccCCCCCccChHHhccc-CCch
Confidence 999999999 9999999999999999 788899999999997653222 23345689999999998654 8999
Q ss_pred chhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc
Q 024027 159 GDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238 (273)
Q Consensus 159 ~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 238 (273)
+||||||+++++|++|..||......+.. ...... ...........++.++.+|+.+||..||
T Consensus 188 ~Di~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~----------------~~~~~~~~~~~~~~~~~~li~~~l~~dp 250 (277)
T 3f3z_A 188 CDEWSAGVMMYVLLCGYPPFSAPTDSEVM-LKIREG----------------TFTFPEKDWLNVSPQAESLIRRLLTKSP 250 (277)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHC----------------CCCCCHHHHTTSCHHHHHHHHHHTCSST
T ss_pred hhehhHHHHHHHHHHCCCCCCCCCHHHHH-HHHHhC----------------CCCCCchhhhcCCHHHHHHHHHHccCCh
Confidence 99999999999999999999764322111 111110 0001111123567789999999999999
Q ss_pred cCCCCHHHHHHHHH
Q 024027 239 EQRINAKEIVTKLL 252 (273)
Q Consensus 239 ~~Rps~~~~l~~l~ 252 (273)
.+|||+.++++|-+
T Consensus 251 ~~R~s~~~~l~h~~ 264 (277)
T 3f3z_A 251 KQRITSLQALEHEW 264 (277)
T ss_dssp TTSCCHHHHTTSHH
T ss_pred hhCcCHHHHhcCHH
Confidence 99999999998755
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=301.28 Aligned_cols=237 Identities=24% Similarity=0.409 Sum_probs=183.7
Q ss_pred eEEEEEeecc-cChhhhhHHHHHHHHhcCCCccceeeeeeee-cCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 2 EVAVKVFNLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCS-NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 2 ~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
.||||.++.. .....+.+.+|+.+++.++||||+++++++. .++..++||||+++|+|.+++......+++..++.++
T Consensus 119 ~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~ 198 (373)
T 3c1x_A 119 HCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 198 (373)
T ss_dssp EEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHH
T ss_pred EEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHH
Confidence 5899999754 3456778999999999999999999999864 4567899999999999999998777778999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCc--ceeecccccCCCCCCcccCCCCcCC
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQS--MTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
.|++.||.||| +.|++||||||+||+++.++.+||+|||++..+...... .......+++.|+|||.+.+..++.
T Consensus 199 ~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 275 (373)
T 3c1x_A 199 LQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT 275 (373)
T ss_dssp HHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCH
T ss_pred HHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCc
Confidence 99999999999 999999999999999999999999999999765332211 1123345677899999998888999
Q ss_pred cchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 158 NGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
++||||||+++|+|++ |.+||......+... ...... ....+..++..+.+++.+||..
T Consensus 276 ~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~-~~~~~~-------------------~~~~p~~~~~~l~~li~~cl~~ 335 (373)
T 3c1x_A 276 KSDVWSFGVLLWELMTRGAPPYPDVNTFDITV-YLLQGR-------------------RLLQPEYCPDPLYEVMLKCWHP 335 (373)
T ss_dssp HHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHH-HHHTTC-------------------CCCCCTTCCHHHHHHHHHHTCS
T ss_pred HHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHH-HHHcCC-------------------CCCCCCCCCHHHHHHHHHHcCC
Confidence 9999999999999999 677776543322111 111000 0011345677899999999999
Q ss_pred CccCCCCHHHHHHHHHHHHHhhhhh
Q 024027 237 SPEQRINAKEIVTKLLKIRDSLLRN 261 (273)
Q Consensus 237 dp~~Rps~~~~l~~l~~~~~~~~~~ 261 (273)
||++|||+.+++++|+++..++..+
T Consensus 336 dp~~RPs~~ell~~L~~i~~~~~~~ 360 (373)
T 3c1x_A 336 KAEMRPSFSELVSRISAIFSTFIGE 360 (373)
T ss_dssp SGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred ChhhCcCHHHHHHHHHHHHHhcccc
Confidence 9999999999999999999886643
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=296.42 Aligned_cols=258 Identities=24% Similarity=0.294 Sum_probs=181.3
Q ss_pred CeEEEEEeecccChhhhhHHHHHHH--HhcCCCccceeeeeeee-----cCCceeEEEeccCCCCHHHhhhcCCCCCCHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEM--MKSIRHRNLIKVISSCS-----NEEFKALVLEYMPHGSLEKYLYSSNCILDIF 73 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 73 (273)
++||||+++... ...+..|.++ +..++||||+++++.+. ....+++||||+++|+|.+++.... .++.
T Consensus 37 ~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~ 111 (336)
T 3g2f_A 37 RPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWV 111 (336)
T ss_dssp EEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHCC--BCHH
T ss_pred eEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhcc--cchh
Confidence 379999997542 2344445444 44579999999998542 3446789999999999999997654 5889
Q ss_pred HHHHHHHHHHHHHHHHhcCCCC---------CeEeccCCCCceeeCCCCceEEeecccccccccCCC------cceeecc
Q 024027 74 QRLNIMIDVASALEYLHFGCSA---------PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQ------SMTQTQT 138 (273)
Q Consensus 74 ~~~~~~~ql~~~l~~lh~~~~~---------~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~------~~~~~~~ 138 (273)
.++.++.|++.||.||| +. |++|+||||+||+++.++.+||+|||++..+..... .......
T Consensus 112 ~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~ 188 (336)
T 3g2f_A 112 SSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE 188 (336)
T ss_dssp HHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCT
T ss_pred HHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccC
Confidence 99999999999999999 88 999999999999999999999999999987643221 1122244
Q ss_pred cccCCCCCCcccCC-------CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhh-----h
Q 024027 139 LATIGYMAPEYGRE-------GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVD-----A 206 (273)
Q Consensus 139 ~~~~~~~aPE~~~~-------~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~ 206 (273)
.|++.|+|||++.+ ..++.++|||||||++|+|++|..||............+.............. .
T Consensus 189 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (336)
T 3g2f_A 189 VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSRE 268 (336)
T ss_dssp TSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTS
T ss_pred CCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhccc
Confidence 68999999999876 34678899999999999999997776543332211111111110000000000 0
Q ss_pred hccccchhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHHHHHHhhhhhccccc
Q 024027 207 NLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLLKIRDSLLRNVGGRR 266 (273)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~~~~~~ 266 (273)
...............++.++.+|+.+||..||++|||++++++.|+++...+.++.++..
T Consensus 269 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~~~~~ 328 (336)
T 3g2f_A 269 KQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSP 328 (336)
T ss_dssp CCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC------
T ss_pred ccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcccCCC
Confidence 000011111111234677899999999999999999999999999999999988776543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=289.95 Aligned_cols=232 Identities=27% Similarity=0.414 Sum_probs=192.1
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcC-CCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~ 80 (273)
.||||+++.. ....+.+.+|+++++.++||||+++++++.+++..++||||+++++|.+++... ...+++..++.++.
T Consensus 40 ~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ 118 (288)
T 3kfa_A 40 TVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118 (288)
T ss_dssp EEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHH
T ss_pred EEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHH
Confidence 6999999755 456678999999999999999999999999999999999999999999999764 34589999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
|++.||.||| +.|++|+||||+||+++.++.++|+|||.+....... ........+++.|+|||.+.+..++.++|
T Consensus 119 ~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 194 (288)
T 3kfa_A 119 QISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSD 194 (288)
T ss_dssp HHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS-SEEETTEEECGGGCCHHHHHHCCCCHHHH
T ss_pred HHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc-cccccCCccccCcCChhhhccCCCCchhh
Confidence 9999999999 9999999999999999999999999999998654322 22233445678899999998888999999
Q ss_pred hHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCcc
Q 024027 161 VYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239 (273)
Q Consensus 161 iwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 239 (273)
|||||+++|+|++ |..||......... .... .. .....+..++.++.+|+.+||..||.
T Consensus 195 i~slG~il~~ll~~g~~p~~~~~~~~~~--~~~~------------~~------~~~~~~~~~~~~l~~li~~~l~~dp~ 254 (288)
T 3kfa_A 195 VWAFGVLLWEIATYGMSPYPGIDLSQVY--ELLE------------KD------YRMERPEGCPEKVYELMRACWQWNPS 254 (288)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCGGGHH--HHHH------------TT------CCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCHHHHH--HHHh------------cc------CCCCCCCCCCHHHHHHHHHHhCCChh
Confidence 9999999999999 99998764322211 1000 00 01111345677899999999999999
Q ss_pred CCCCHHHHHHHHHHHHHhh
Q 024027 240 QRINAKEIVTKLLKIRDSL 258 (273)
Q Consensus 240 ~Rps~~~~l~~l~~~~~~~ 258 (273)
+|||+.++++.|+.+.++.
T Consensus 255 ~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 255 DRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp GSCCHHHHHHHHHHHHHHH
T ss_pred hCcCHHHHHHHHHHHHHhc
Confidence 9999999999999988753
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=290.31 Aligned_cols=236 Identities=24% Similarity=0.409 Sum_probs=188.2
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeee-ecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSC-SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
.||+|.++... ....+.+.+|+.+++.++||||+++++++ ..++..++||||+++++|.+++......+++..++.++
T Consensus 55 ~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~ 134 (298)
T 3f66_A 55 HCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 134 (298)
T ss_dssp EEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHH
T ss_pred EEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHH
Confidence 48999987543 34567799999999999999999999985 55678899999999999999998777779999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCC--cceeecccccCCCCCCcccCCCCcCC
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQ--SMTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
.|++.||.||| +.|++|+||||+||+++.++.++|+|||++........ ........+++.|+|||.+.+..++.
T Consensus 135 ~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 211 (298)
T 3f66_A 135 LQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT 211 (298)
T ss_dssp HHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCH
T ss_pred HHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCCh
Confidence 99999999999 99999999999999999999999999999976533221 11223345678899999998888999
Q ss_pred cchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 158 NGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
++||||||+++|++++ |.+||......+. ........ ....+..++..+.+++.+||..
T Consensus 212 ~~Di~slG~il~~l~~~~~~~~~~~~~~~~-~~~~~~~~-------------------~~~~~~~~~~~l~~li~~~l~~ 271 (298)
T 3f66_A 212 KSDVWSFGVLLWELMTRGAPPYPDVNTFDI-TVYLLQGR-------------------RLLQPEYCPDPLYEVMLKCWHP 271 (298)
T ss_dssp HHHHHHHHHHHHHHHTTSCCSSTTSCTTTH-HHHHHTTC-------------------CCCCCTTCCHHHHHHHHHHTCS
T ss_pred HHHHHHHHHHHHHHHhCCCCCCccCCHHHH-HHHHhcCC-------------------CCCCCccCCHHHHHHHHHHcCC
Confidence 9999999999999999 5556554332221 11111100 0011334567799999999999
Q ss_pred CccCCCCHHHHHHHHHHHHHhhhh
Q 024027 237 SPEQRINAKEIVTKLLKIRDSLLR 260 (273)
Q Consensus 237 dp~~Rps~~~~l~~l~~~~~~~~~ 260 (273)
||.+|||+.++++.|+++..++..
T Consensus 272 ~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 272 KAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp SGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred ChhhCcCHHHHHHHHHHHHHhhcc
Confidence 999999999999999999887643
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=298.92 Aligned_cols=225 Identities=24% Similarity=0.296 Sum_probs=182.7
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||||+++... ......+.+|+++++.++||||++++++|.+....++||||++||+|.+++... ..+++..++.
T Consensus 41 ~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~ 119 (384)
T 4fr4_A 41 KMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN-VHFKEETVKL 119 (384)
T ss_dssp CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTT-CCCCHHHHHH
T ss_pred CEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHH
Confidence 369999997542 344567889999999999999999999999999999999999999999999654 4699999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC---CC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE---GR 154 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~ 154 (273)
++.|++.||.||| +.|++||||||+||+++.++.++|+|||++..+... ......+||+.|+|||++.+ ..
T Consensus 120 ~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~---~~~~~~~gt~~Y~aPE~~~~~~~~~ 193 (384)
T 4fr4_A 120 FICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE---TQITTMAGTKPYMAPEMFSSRKGAG 193 (384)
T ss_dssp HHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT---CCBCCCCSCGGGCCGGGTCCCSSCC
T ss_pred HHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCC---CceeccCCCccccCCeeeccCCCCC
Confidence 9999999999999 999999999999999999999999999999865322 22345679999999999864 45
Q ss_pred cCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcC
Q 024027 155 VSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACT 234 (273)
Q Consensus 155 ~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 234 (273)
++.++|+|||||++|+|++|..||........ ...... ... .....+..++.++.+|+.+||
T Consensus 194 ~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~--~~~~~~---------~~~-------~~~~~p~~~s~~~~~li~~lL 255 (384)
T 4fr4_A 194 YSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS--KEIVHT---------FET-------TVVTYPSAWSQEMVSLLKKLL 255 (384)
T ss_dssp BCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH--HHHHHH---------HHH-------CCCCCCTTSCHHHHHHHHHHS
T ss_pred CCccceeechHHHHHHHHhCCCCCCCCCCccH--HHHHHH---------Hhh-------cccCCCCcCCHHHHHHHHHHh
Confidence 89999999999999999999999975332211 111000 000 001113456778999999999
Q ss_pred CCCccCCCC-HHHHHHH
Q 024027 235 VESPEQRIN-AKEIVTK 250 (273)
Q Consensus 235 ~~dp~~Rps-~~~~l~~ 250 (273)
..||.+||+ ++++++|
T Consensus 256 ~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 256 EPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp CSSGGGSCCSHHHHHTS
T ss_pred cCCHhHhcccHHHHHcC
Confidence 999999998 7777664
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=288.82 Aligned_cols=239 Identities=22% Similarity=0.298 Sum_probs=182.2
Q ss_pred CeEEEEEeecc---cChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhc---CCCCCCHHH
Q 024027 1 MEVAVKVFNLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS---SNCILDIFQ 74 (273)
Q Consensus 1 ~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~ 74 (273)
++||||+++.. .......+.+|+.+++.++||||+++++++...+..++||||+++++|.+++.. ....+++..
T Consensus 58 ~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 137 (310)
T 2wqm_A 58 VPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERT 137 (310)
T ss_dssp CEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHH
T ss_pred ceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHH
Confidence 47999999753 234567789999999999999999999999999999999999999999999863 345689999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCC
Q 024027 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGR 154 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 154 (273)
++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++....... .......+++.|+|||.+.+..
T Consensus 138 ~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~ 212 (310)
T 2wqm_A 138 VWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENG 212 (310)
T ss_dssp HHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC--------------------CCSSCCHHHHTTCC
T ss_pred HHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC--ccccccCCCeeEeChHHhCCCC
Confidence 9999999999999999 9999999999999999999999999999987653221 1223456889999999998888
Q ss_pred cCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcC
Q 024027 155 VSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACT 234 (273)
Q Consensus 155 ~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 234 (273)
++.++||||||+++|+|++|..||................. . ........++.++.+|+.+||
T Consensus 213 ~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------------~-----~~~~~~~~~~~~l~~li~~~l 275 (310)
T 2wqm_A 213 YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC------------D-----YPPLPSDHYSEELRQLVNMCI 275 (310)
T ss_dssp CCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTT------------C-----SCCCCTTTSCHHHHHHHHHHT
T ss_pred CCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcc------------c-----CCCCcccccCHHHHHHHHHHc
Confidence 99999999999999999999999865332211111111000 0 000012346677999999999
Q ss_pred CCCccCCCCHHHHHHHHHHHHHhhhhh
Q 024027 235 VESPEQRINAKEIVTKLLKIRDSLLRN 261 (273)
Q Consensus 235 ~~dp~~Rps~~~~l~~l~~~~~~~~~~ 261 (273)
..||.+|||+.+++++|+++.......
T Consensus 276 ~~dp~~Rps~~~il~~l~~l~~~~~~~ 302 (310)
T 2wqm_A 276 NPDPEKRPDVTYVYDVAKRMHACTASS 302 (310)
T ss_dssp CSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred CCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence 999999999999999999998765543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=294.75 Aligned_cols=250 Identities=24% Similarity=0.384 Sum_probs=193.4
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCC--ceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEE--FKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
.||||+++.......+.+.+|+++++.++||||+++++++...+ ..++||||+++++|.+++......+++..++.++
T Consensus 72 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~ 151 (326)
T 2w1i_A 72 VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 151 (326)
T ss_dssp EEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHH
T ss_pred EEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHH
Confidence 69999998776777788999999999999999999999987654 7899999999999999998776679999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcce-eecccccCCCCCCcccCCCCcCCc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMT-QTQTLATIGYMAPEYGREGRVSTN 158 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~ 158 (273)
.|++.||.+|| +.|++|+||||+||+++.++.++|+|||++........... .....++..|+|||.+.+..++.+
T Consensus 152 ~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 228 (326)
T 2w1i_A 152 SQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVA 228 (326)
T ss_dssp HHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHH
T ss_pred HHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCch
Confidence 99999999999 99999999999999999999999999999987643322111 123346677999999988889999
Q ss_pred chhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccc-hhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 159 GDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPIST-MEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 159 ~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
+||||||+++++|++|..||...... ............. ........ ........+..++.++.+|+.+||..|
T Consensus 229 ~Di~slG~il~el~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~d 303 (326)
T 2w1i_A 229 SDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIGNDKQGQMIVFHLIELL--KNNGRLPRPDGCPDEIYMIMTECWNNN 303 (326)
T ss_dssp HHHHHHHHHHHHHHHTTCGGGSHHHH---HHHHHCTTCCTHHHHHHHHHHH--HTTCCCCCCTTCCHHHHHHHHHHSCSS
T ss_pred hhHHHHHHHHHHHHhcCCCCCCCHHH---HHHhhccccchhhhHHHHHHHh--hcCCCCCCCCcccHHHHHHHHHHcCCC
Confidence 99999999999999999987542110 0000000000000 00000000 000011124567788999999999999
Q ss_pred ccCCCCHHHHHHHHHHHHHhhh
Q 024027 238 PEQRINAKEIVTKLLKIRDSLL 259 (273)
Q Consensus 238 p~~Rps~~~~l~~l~~~~~~~~ 259 (273)
|++|||+.++++.|+.+++++.
T Consensus 304 P~~Rps~~el~~~L~~l~~~l~ 325 (326)
T 2w1i_A 304 VNQRPSFRDLALRVDQIRDQMA 325 (326)
T ss_dssp GGGSCCHHHHHHHHHHHHHHHH
T ss_pred hhhCcCHHHHHHHHHHHHHHhc
Confidence 9999999999999999988764
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=305.57 Aligned_cols=224 Identities=25% Similarity=0.344 Sum_probs=185.3
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||||+++... ......+.+|+.+++.++||||+++++++.+++..++||||+++|+|.+++... ..+++..++.
T Consensus 42 ~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~ 120 (476)
T 2y94_A 42 HKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKN-GRLDEKESRR 120 (476)
T ss_dssp CEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSS-SSCCHHHHHH
T ss_pred CEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHH
Confidence 479999997542 234567899999999999999999999999999999999999999999999654 4699999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCc-C
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRV-S 156 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~ 156 (273)
++.|++.||.||| +.|++||||||+||+++.++.+||+|||++...... ......+|++.|+|||++.+..+ +
T Consensus 121 i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~ 194 (476)
T 2y94_A 121 LFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---EFLRTSCGSPNYAAPEVISGRLYAG 194 (476)
T ss_dssp HHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT---CCBCCCCSCSTTCCHHHHTTCCBCS
T ss_pred HHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhcccc---ccccccCCCcCeEChhhccCCCCCC
Confidence 9999999999999 999999999999999999999999999999865322 22334579999999999988765 6
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++||||+||++|+|++|..||....... ........ . ...+..++.++.+|+.+||..
T Consensus 195 ~~~DiwSlGvil~elltG~~Pf~~~~~~~-~~~~i~~~-------------~-------~~~p~~~s~~~~~Li~~~L~~ 253 (476)
T 2y94_A 195 PEVDIWSSGVILYALLCGTLPFDDDHVPT-LFKKICDG-------------I-------FYTPQYLNPSVISLLKHMLQV 253 (476)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSSCCSSSHH-HHHHHHTT-------------C-------CCCCTTCCHHHHHHHHHHTCS
T ss_pred CcceehhhHHHHHHHhhCCCCCCCCCHHH-HHHHHhcC-------------C-------cCCCccCCHHHHHHHHHHcCC
Confidence 89999999999999999999997533221 11111110 0 011334667799999999999
Q ss_pred CccCCCCHHHHHHHHH
Q 024027 237 SPEQRINAKEIVTKLL 252 (273)
Q Consensus 237 dp~~Rps~~~~l~~l~ 252 (273)
||.+|||+.++++|-+
T Consensus 254 dP~~Rpt~~eil~hp~ 269 (476)
T 2y94_A 254 DPMKRATIKDIREHEW 269 (476)
T ss_dssp STTTSCCHHHHHTCHH
T ss_pred CchhCcCHHHHHhCHH
Confidence 9999999999999855
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=298.78 Aligned_cols=229 Identities=23% Similarity=0.249 Sum_probs=174.6
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
+.||||++... ....+.+.+|+.+++.++||||+++++++.++...++||||+++|+|.+++...+ .+++..++.++.
T Consensus 46 ~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~ 123 (361)
T 3uc3_A 46 ELVAVKYIERG-AAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAG-RFSEDEARFFFQ 123 (361)
T ss_dssp CEEEEEEEESS-TTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHH
T ss_pred cEEEEEEEecC-ccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcC-CCCHHHHHHHHH
Confidence 46999999755 3334678899999999999999999999999999999999999999999996543 699999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCc--eEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCc
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLV--AYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTN 158 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~--~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 158 (273)
|++.||.||| +.|++||||||+||+++.++. +||+|||++..... ........|++.|+|||++.+..++.+
T Consensus 124 ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~ 197 (361)
T 3uc3_A 124 QLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL---HSQPKSTVGTPAYIAPEVLLRQEYDGK 197 (361)
T ss_dssp HHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------------------CTTSCHHHHHCSSCCHH
T ss_pred HHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc---cCCCCCCcCCCCcCChhhhcCCCCCCC
Confidence 9999999999 999999999999999987665 99999999874321 122334579999999999988777655
Q ss_pred -chhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 159 -GDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 159 -~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
+|||||||++|+|++|..||................ ... .........++.++.+|+.+||..|
T Consensus 198 ~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~-~~~--------------~~~~~~~~~~s~~~~~li~~~L~~d 262 (361)
T 3uc3_A 198 IADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRI-LSV--------------KYSIPDDIRISPECCHLISRIFVAD 262 (361)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHH-HTT--------------CCCCCTTSCCCHHHHHHHHHHSCSC
T ss_pred eeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHH-hcC--------------CCCCCCcCCCCHHHHHHHHHHccCC
Confidence 899999999999999999997644332222111110 000 0000112245677999999999999
Q ss_pred ccCCCCHHHHHHHHH
Q 024027 238 PEQRINAKEIVTKLL 252 (273)
Q Consensus 238 p~~Rps~~~~l~~l~ 252 (273)
|++|||+.++++|-+
T Consensus 263 P~~Rps~~ell~hp~ 277 (361)
T 3uc3_A 263 PATRISIPEIKTHSW 277 (361)
T ss_dssp TTTSCCHHHHHTSHH
T ss_pred hhHCcCHHHHHhCcc
Confidence 999999999999966
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=297.75 Aligned_cols=246 Identities=15% Similarity=0.162 Sum_probs=187.5
Q ss_pred CeEEEEEeecccChh-----------hhhHHHHHHHHhcCCCccceeeeeeeecC----CceeEEEeccCCCCHHHhhhc
Q 024027 1 MEVAVKVFNLQCGRA-----------FKSFDVECEMMKSIRHRNLIKVISSCSNE----EFKALVLEYMPHGSLEKYLYS 65 (273)
Q Consensus 1 ~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~ 65 (273)
+.||||++....... ...+..|+..++.++||||+++++++... ...++||||+ +++|.+++..
T Consensus 66 ~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~ 144 (364)
T 3op5_A 66 APCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA 144 (364)
T ss_dssp CSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH
T ss_pred cceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh
Confidence 368999987553211 11233455566677899999999998765 4589999999 8899999987
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeC--CCCceEEeecccccccccCCCcc-----eeecc
Q 024027 66 SNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLD--DNLVAYLSDFGIAKLLIGEDQSM-----TQTQT 138 (273)
Q Consensus 66 ~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~--~~~~~kl~Df~~~~~~~~~~~~~-----~~~~~ 138 (273)
....+++..++.++.|++.||.||| +.|++||||||+||+++ .++.+||+|||++..+....... .....
T Consensus 145 ~~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~ 221 (364)
T 3op5_A 145 NAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCH 221 (364)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCC
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCccccc
Confidence 7678999999999999999999999 99999999999999998 88999999999997664322111 11334
Q ss_pred cccCCCCCCcccCCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhh
Q 024027 139 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVA 218 (273)
Q Consensus 139 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (273)
.||+.|+|||.+.+..++.++|||||||++|+|++|..||............. ............+... .
T Consensus 222 ~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~---------~ 291 (364)
T 3op5_A 222 DGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDS-KIRYRENIASLMDKCF---------P 291 (364)
T ss_dssp CCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHH-HHHHHHCHHHHHHHHS---------C
T ss_pred CCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHH-HHHhhhhHHHHHHHhc---------c
Confidence 58999999999999889999999999999999999999998643332211111 1111111111111110 0
Q ss_pred hhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHHHHHHhhhh
Q 024027 219 KEQCVSFVFNLAMACTVESPEQRINAKEIVTKLLKIRDSLLR 260 (273)
Q Consensus 219 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~ 260 (273)
...++.++.+++.+||..||.+||++.++++.|+++.+++..
T Consensus 292 ~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~ 333 (364)
T 3op5_A 292 AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGS 333 (364)
T ss_dssp TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 134578899999999999999999999999999999987653
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=290.82 Aligned_cols=228 Identities=21% Similarity=0.296 Sum_probs=185.8
Q ss_pred CeEEEEEeecccCh------hhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHH
Q 024027 1 MEVAVKVFNLQCGR------AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQ 74 (273)
Q Consensus 1 ~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (273)
+.||||+++..... ..+.+.+|+.+++.++||||+++++++.+....++||||+++++|.+++... ..+++..
T Consensus 38 ~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~ 116 (321)
T 2a2a_A 38 LEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK-ESLSEEE 116 (321)
T ss_dssp CEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTC-SCEEHHH
T ss_pred eEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHhc-CCCCHHH
Confidence 47999999765321 3567999999999999999999999999999999999999999999999654 4689999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCC----ceEEeecccccccccCCCcceeecccccCCCCCCccc
Q 024027 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNL----VAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYG 150 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~----~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 150 (273)
++.++.|++.||.||| +.|++|+||||+||+++.++ .++|+|||++....... ......+++.|+|||.+
T Consensus 117 ~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~ 190 (321)
T 2a2a_A 117 ATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIV 190 (321)
T ss_dssp HHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTC---CCCCCCSCGGGCCHHHH
T ss_pred HHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCccc---cccccCCCCCccCcccc
Confidence 9999999999999999 99999999999999999887 79999999997653321 22345689999999999
Q ss_pred CCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHH
Q 024027 151 REGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLA 230 (273)
Q Consensus 151 ~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 230 (273)
.+..++.++||||||+++|+|++|..||......+. ....... ...........++..+.+|+
T Consensus 191 ~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~i~~~----------------~~~~~~~~~~~~~~~~~~li 253 (321)
T 2a2a_A 191 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-LANITSV----------------SYDFDEEFFSHTSELAKDFI 253 (321)
T ss_dssp TTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHHHTT----------------CCCCCHHHHTTCCHHHHHHH
T ss_pred cCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHhc----------------ccccChhhhcccCHHHHHHH
Confidence 988899999999999999999999999865322211 1111100 00111122345677899999
Q ss_pred hhcCCCCccCCCCHHHHHHHHH
Q 024027 231 MACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 231 ~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
.+||..||.+|||+.++++|-+
T Consensus 254 ~~~l~~dp~~Rps~~e~l~hp~ 275 (321)
T 2a2a_A 254 RKLLVKETRKRLTIQEALRHPW 275 (321)
T ss_dssp HTTSCSSTTTSCCHHHHHHSTT
T ss_pred HHHcCCChhhCcCHHHHhcCcc
Confidence 9999999999999999998743
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=289.30 Aligned_cols=242 Identities=26% Similarity=0.361 Sum_probs=182.7
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcC--CCccceeeeeeeecC----CceeEEEeccCCCCHHHhhhcCCCCCCHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSI--RHRNLIKVISSCSNE----EFKALVLEYMPHGSLEKYLYSSNCILDIFQ 74 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (273)
++||||++... ....+..|.+++... +||||+++++++... ...++||||+++|+|.+++... .+++..
T Consensus 61 ~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~ 135 (337)
T 3mdy_A 61 EKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKS 135 (337)
T ss_dssp EEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC--CBCHHH
T ss_pred ceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhcc--CCCHHH
Confidence 37999999744 224455566666655 899999999998877 6789999999999999999765 489999
Q ss_pred HHHHHHHHHHHHHHHhcCCCC--------CeEeccCCCCceeeCCCCceEEeecccccccccCCCcc--eeecccccCCC
Q 024027 75 RLNIMIDVASALEYLHFGCSA--------PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSM--TQTQTLATIGY 144 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~--------~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~--~~~~~~~~~~~ 144 (273)
++.++.|++.||.||| +. |++|+||||+||+++.++.+||+|||++..+....... ......|++.|
T Consensus 136 ~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y 212 (337)
T 3mdy_A 136 MLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212 (337)
T ss_dssp HHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGG
T ss_pred HHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcce
Confidence 9999999999999999 88 99999999999999999999999999997653322211 12245789999
Q ss_pred CCCcccCCCCcCCc------chhHHHHHHHHHHHhC----------CCCCccccccccchhhhhhhccCccchhhhhhhc
Q 024027 145 MAPEYGREGRVSTN------GDVYSFGIMLMETFTG----------KKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANL 208 (273)
Q Consensus 145 ~aPE~~~~~~~~~~------~DiwslG~~l~~ll~g----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (273)
+|||++.+...... +|||||||++|+|++| ..||.................... .
T Consensus 213 ~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~---------~ 283 (337)
T 3mdy_A 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIK---------K 283 (337)
T ss_dssp CCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTS---------C
T ss_pred eChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhh---------c
Confidence 99999987766554 9999999999999999 555554433332222221111000 0
Q ss_pred cccchhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHHHHHHhhh
Q 024027 209 LSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLLKIRDSLL 259 (273)
Q Consensus 209 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 259 (273)
.............++.++.+|+.+||..||++|||+.+++++|+.+.++..
T Consensus 284 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 284 LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 001111111234678889999999999999999999999999999988643
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=297.23 Aligned_cols=232 Identities=21% Similarity=0.242 Sum_probs=182.6
Q ss_pred eEEEEEeeccc---ChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 2 EVAVKVFNLQC---GRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 2 ~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
.||||+++... ......+.+|..+++.+ +||||+++++++.++..+++||||++||+|.+++...+ .+++..++.
T Consensus 36 ~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~ 114 (345)
T 3a8x_A 36 IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARF 114 (345)
T ss_dssp EEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS-SCCHHHHHH
T ss_pred EEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHH
Confidence 69999998552 33456688999999988 89999999999999999999999999999999997543 699999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
++.|++.||.||| +.|++||||||+||+++.++.+||+|||++...... .......+||+.|+|||++.+..++.
T Consensus 115 ~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~ 189 (345)
T 3a8x_A 115 YSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTTSTFCGTPNYIAPEILRGEDYGF 189 (345)
T ss_dssp HHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT--TCCBCCCCSCGGGCCHHHHTTCCBCT
T ss_pred HHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccCC--CCcccccCCCccccCccccCCCCCCh
Confidence 9999999999999 999999999999999999999999999999753221 12234567999999999999989999
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
++|+|||||++|+|++|..||............... .....+... ....+..++.++.+|+.+||..|
T Consensus 190 ~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~-----~~~~~i~~~-------~~~~p~~~s~~~~~li~~lL~~d 257 (345)
T 3a8x_A 190 SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTED-----YLFQVILEK-------QIRIPRSLSVKAASVLKSFLNKD 257 (345)
T ss_dssp HHHHHHHHHHHHHHHHSSCTTTTTTC-------CHH-----HHHHHHHHC-------CCCCCTTSCHHHHHHHHHHTCSS
T ss_pred HHhHHHHHHHHHHHHhCCCCcCCcccccccccccHH-----HHHHHHHcC-------CCCCCCCCCHHHHHHHHHHhcCC
Confidence 999999999999999999999653221110000000 000000000 01113456778999999999999
Q ss_pred ccCCCCH------HHHHHHH
Q 024027 238 PEQRINA------KEIVTKL 251 (273)
Q Consensus 238 p~~Rps~------~~~l~~l 251 (273)
|++||++ .++++|-
T Consensus 258 P~~R~~~~~~~~~~~i~~hp 277 (345)
T 3a8x_A 258 PKERLGCHPQTGFADIQGHP 277 (345)
T ss_dssp TTTSTTCCTTTHHHHHHTSG
T ss_pred HhHCCCCCCcCCHHHHhcCC
Confidence 9999995 6777764
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=284.85 Aligned_cols=229 Identities=23% Similarity=0.314 Sum_probs=187.2
Q ss_pred CeEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 1 MEVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 1 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
+.||||+++... ....+.+.+|+.+++.++||||+++++++.+++..++||||+++++|.+++... ..+++..++.++
T Consensus 33 ~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~ 111 (276)
T 2yex_A 33 EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFF 111 (276)
T ss_dssp CEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTT-TBCCHHHHHHHH
T ss_pred cEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhc-cCCCHHHHHHHH
Confidence 479999997553 345678999999999999999999999999999999999999999999999644 469999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCc-CCc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRV-STN 158 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~ 158 (273)
.|++.||.||| +.|++|+||+|+||+++.++.++|+|||.+..+.............+++.|+|||.+.+..+ +.+
T Consensus 112 ~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 188 (276)
T 2yex_A 112 HQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188 (276)
T ss_dssp HHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHH
T ss_pred HHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCc
Confidence 99999999999 99999999999999999999999999999976543332222344568999999999987665 778
Q ss_pred chhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc
Q 024027 159 GDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238 (273)
Q Consensus 159 ~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 238 (273)
+||||||+++|+|++|..||............+..... .......++..+.+|+.+||..||
T Consensus 189 ~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~li~~~l~~~p 250 (276)
T 2yex_A 189 VDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT------------------YLNPWKKIDSAPLALLHKILVENP 250 (276)
T ss_dssp HHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCT------------------TSTTGGGSCHHHHHHHHHHSCSST
T ss_pred chHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccc------------------ccCchhhcCHHHHHHHHHHCCCCc
Confidence 99999999999999999999765443322222211100 001123566779999999999999
Q ss_pred cCCCCHHHHHHHH
Q 024027 239 EQRINAKEIVTKL 251 (273)
Q Consensus 239 ~~Rps~~~~l~~l 251 (273)
.+|||+.++++|-
T Consensus 251 ~~Rps~~~il~~~ 263 (276)
T 2yex_A 251 SARITIPDIKKDR 263 (276)
T ss_dssp TTSCCHHHHTTCT
T ss_pred hhCCCHHHHhcCc
Confidence 9999999999864
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=298.99 Aligned_cols=222 Identities=23% Similarity=0.292 Sum_probs=182.3
Q ss_pred eEEEEEeeccc---ChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 2 EVAVKVFNLQC---GRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 2 ~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
.||||+++... ......+..|..+++.+ +||||+++++++.++..+++||||++||+|.+++...+ .+++..++.
T Consensus 44 ~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~ 122 (345)
T 1xjd_A 44 FFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATF 122 (345)
T ss_dssp EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHH
T ss_pred EEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHH
Confidence 69999997642 34456788899999877 99999999999999999999999999999999997543 689999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
++.|++.||.||| +.|++||||||+||+++.++.+||+|||++...... .......+||+.|+|||++.+..++.
T Consensus 123 ~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~ 197 (345)
T 1xjd_A 123 YAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG--DAKTNTFCGTPDYIAPEILLGQKYNH 197 (345)
T ss_dssp HHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--TCCBCCCCSCGGGCCHHHHTTCCBCT
T ss_pred HHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC--CCcccCCCCCcccCChhhhcCCCCCC
Confidence 9999999999999 999999999999999999999999999998754221 12234567999999999999989999
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
++|+|||||++|+|++|..||......+. ....... . ...+..++.++.+|+.+||..|
T Consensus 198 ~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~i~~~----------------~----~~~p~~~s~~~~~li~~lL~~d 256 (345)
T 1xjd_A 198 SVDWWSFGVLLYEMLIGQSPFHGQDEEEL-FHSIRMD----------------N----PFYPRWLEKEAKDLLVKLFVRE 256 (345)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHC----------------C----CCCCTTSCHHHHHHHHHHSCSS
T ss_pred hhhhHHHHHHHHHHhcCCCCCCCCCHHHH-HHHHHhC----------------C----CCCCcccCHHHHHHHHHHhcCC
Confidence 99999999999999999999975332211 1111100 0 0113346778999999999999
Q ss_pred ccCCCCHH-HHHHH
Q 024027 238 PEQRINAK-EIVTK 250 (273)
Q Consensus 238 p~~Rps~~-~~l~~ 250 (273)
|++||++. ++++|
T Consensus 257 p~~R~~~~~~i~~h 270 (345)
T 1xjd_A 257 PEKRLGVRGDIRQH 270 (345)
T ss_dssp GGGSBTTBSCGGGS
T ss_pred HhHcCCChHHHHcC
Confidence 99999997 77655
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=289.23 Aligned_cols=231 Identities=25% Similarity=0.403 Sum_probs=186.3
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
.||||+++... ....+.+.+|+.+++.++||||+++++++.++ ..++||||+++++|.+++......+++..++.++.
T Consensus 42 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 120 (281)
T 3cc6_A 42 NVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL 120 (281)
T ss_dssp EEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHH
T ss_pred eEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHH
Confidence 49999998653 34567899999999999999999999998754 56899999999999999987666799999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
|++.||.||| +.|++|+||||+||+++.++.++|+|||++........ .......+++.|+|||.+.+..++.++|
T Consensus 121 ~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~D 196 (281)
T 3cc6_A 121 QICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY-YKASVTRLPIKWMSPESINFRRFTTASD 196 (281)
T ss_dssp HHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHH
T ss_pred HHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCcccccccc-cccccCCCCcceeCchhhccCCCCchhc
Confidence 9999999999 99999999999999999999999999999976533221 1223345677899999998888999999
Q ss_pred hHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCcc
Q 024027 161 VYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239 (273)
Q Consensus 161 iwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 239 (273)
|||||+++|+|++ |..||......... ...... . ....+..++..+.+++.+||..||.
T Consensus 197 i~slG~il~~llt~g~~p~~~~~~~~~~-~~~~~~-------------~------~~~~~~~~~~~l~~li~~~l~~~p~ 256 (281)
T 3cc6_A 197 VWMFAVCMWEILSFGKQPFFWLENKDVI-GVLEKG-------------D------RLPKPDLCPPVLYTLMTRCWDYDPS 256 (281)
T ss_dssp HHHHHHHHHHHHTTTCCTTTTSCGGGHH-HHHHHT-------------C------CCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred cHHHHHHHHHHHhCCCCCcccCChHHHH-HHHhcC-------------C------CCCCCCCCCHHHHHHHHHHccCCch
Confidence 9999999999998 99998754332211 100000 0 0011344667799999999999999
Q ss_pred CCCCHHHHHHHHHHHHHh
Q 024027 240 QRINAKEIVTKLLKIRDS 257 (273)
Q Consensus 240 ~Rps~~~~l~~l~~~~~~ 257 (273)
+|||+.+++++|+++.+.
T Consensus 257 ~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 257 DRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp GSCCHHHHHHHHHHHHHH
T ss_pred hCcCHHHHHHHHHHHHHh
Confidence 999999999999998764
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=292.97 Aligned_cols=246 Identities=22% Similarity=0.261 Sum_probs=181.4
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
+.||||+++.........+.+|++++.++ +||||+++++++.+++..++||||+++++|.+++.... .+++..++.++
T Consensus 39 ~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~ 117 (316)
T 2ac3_A 39 QEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR-HFNELEASVVV 117 (316)
T ss_dssp CEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHH
T ss_pred cEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHH
Confidence 47999999876666677899999999985 79999999999999999999999999999999996543 68999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCc---eEEeecccccccccCCC-----cceeecccccCCCCCCcccC
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLV---AYLSDFGIAKLLIGEDQ-----SMTQTQTLATIGYMAPEYGR 151 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~---~kl~Df~~~~~~~~~~~-----~~~~~~~~~~~~~~aPE~~~ 151 (273)
.|++.||.||| +.|++|+||||+||+++.++. +||+|||++........ ........|++.|+|||++.
T Consensus 118 ~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 194 (316)
T 2ac3_A 118 QDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194 (316)
T ss_dssp HHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHH
T ss_pred HHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhh
Confidence 99999999999 999999999999999988765 99999999876532211 11122345899999999986
Q ss_pred C-----CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHH
Q 024027 152 E-----GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFV 226 (273)
Q Consensus 152 ~-----~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 226 (273)
+ ..++.++|||||||++|+|++|..||.............. ...........................++.++
T Consensus 195 ~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 272 (316)
T 2ac3_A 195 AFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE--ACPACQNMLFESIQEGKYEFPDKDWAHISCAA 272 (316)
T ss_dssp HTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC------CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHH
T ss_pred cccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccc--cchhHHHHHHHHHhccCcccCchhcccCCHHH
Confidence 5 4588999999999999999999999976543321110000 00000000000000000011111123567789
Q ss_pred HHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 227 FNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 227 ~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
.+|+.+||..||.+|||+.++++|-+
T Consensus 273 ~~li~~~L~~dP~~Rps~~e~l~hp~ 298 (316)
T 2ac3_A 273 KDLISKLLVRDAKQRLSAAQVLQHPW 298 (316)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHHSTT
T ss_pred HHHHHHHhhCChhhCCCHHHHhcChh
Confidence 99999999999999999999998743
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=286.42 Aligned_cols=225 Identities=26% Similarity=0.402 Sum_probs=173.7
Q ss_pred eEEEEEeeccc----ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 2 EVAVKVFNLQC----GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 2 ~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
.||||+++... ....+.+.+|+++++.++||||+++++++.+++..++||||+++++|.+++... .+++..++.
T Consensus 32 ~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~ 109 (271)
T 3dtc_A 32 EVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK--RIPPDILVN 109 (271)
T ss_dssp EEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHTSS--CCCHHHHHH
T ss_pred eEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhhcC--CCCHHHHHH
Confidence 69999997543 233567899999999999999999999999999999999999999999998543 599999999
Q ss_pred HHHHHHHHHHHHhcCCCCC---eEeccCCCCceeeCC--------CCceEEeecccccccccCCCcceeecccccCCCCC
Q 024027 78 IMIDVASALEYLHFGCSAP---VIHCDLKPDNVLLDD--------NLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMA 146 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~---i~h~di~p~nil~~~--------~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~a 146 (273)
++.|++.||.||| +.| ++|+||||+||+++. ++.++|+|||++....... .....+++.|+|
T Consensus 110 i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~a 182 (271)
T 3dtc_A 110 WAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT----KMSAAGAYAWMA 182 (271)
T ss_dssp HHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-----------------CCGGGSC
T ss_pred HHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEEccCCccccccccc----ccCCCCccceeC
Confidence 9999999999999 888 899999999999985 7789999999997653221 224568999999
Q ss_pred CcccCCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHH
Q 024027 147 PEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFV 226 (273)
Q Consensus 147 PE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 226 (273)
||.+.+..++.++||||||+++++|++|..||............... ......+..++.++
T Consensus 183 PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~ 243 (271)
T 3dtc_A 183 PEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN-------------------KLALPIPSTCPEPF 243 (271)
T ss_dssp HHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTS-------------------CCCCCCCTTCCHHH
T ss_pred HHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcC-------------------CCCCCCCcccCHHH
Confidence 99998888999999999999999999999999764322211111000 00111234567789
Q ss_pred HHHHhhcCCCCccCCCCHHHHHHHHHHH
Q 024027 227 FNLAMACTVESPEQRINAKEIVTKLLKI 254 (273)
Q Consensus 227 ~~li~~~l~~dp~~Rps~~~~l~~l~~~ 254 (273)
.+++.+||..||.+|||+.+++++|+++
T Consensus 244 ~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 244 AKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred HHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 9999999999999999999999999753
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=294.52 Aligned_cols=232 Identities=22% Similarity=0.281 Sum_probs=180.4
Q ss_pred CeEEEEEeecc-----cChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcC---------
Q 024027 1 MEVAVKVFNLQ-----CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS--------- 66 (273)
Q Consensus 1 ~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------- 66 (273)
+.||||+++.. .....+.+.+|+++++.++||||+++++++.+.+..++||||+++|+|.+++...
T Consensus 52 ~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~ 131 (345)
T 3hko_A 52 AIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCA 131 (345)
T ss_dssp CEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEE
T ss_pred ceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccc
Confidence 36899999754 2455678999999999999999999999999999999999999999999998521
Q ss_pred ------------------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCC--c
Q 024027 67 ------------------------------NCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNL--V 114 (273)
Q Consensus 67 ------------------------------~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~--~ 114 (273)
...+++..++.++.|++.||.||| +.|++|+||||+||+++.++ .
T Consensus 132 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~ 208 (345)
T 3hko_A 132 MDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFE 208 (345)
T ss_dssp EEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSCC
T ss_pred cccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEecCCCce
Confidence 112457788999999999999999 99999999999999998776 8
Q ss_pred eEEeecccccccccCCCc--ceeecccccCCCCCCcccCC--CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhh
Q 024027 115 AYLSDFGIAKLLIGEDQS--MTQTQTLATIGYMAPEYGRE--GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKH 190 (273)
Q Consensus 115 ~kl~Df~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~ 190 (273)
+||+|||++..+...... .......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||......+.. ..
T Consensus 209 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~ 287 (345)
T 3hko_A 209 IKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTI-SQ 287 (345)
T ss_dssp EEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HH
T ss_pred EEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHH-HH
Confidence 999999999865332221 12345678999999999865 56899999999999999999999999764332211 11
Q ss_pred hhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 191 WVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
.... ...........++.++.+|+.+||..||.+|||+.++++|-+
T Consensus 288 ~~~~----------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~ 333 (345)
T 3hko_A 288 VLNK----------------KLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPW 333 (345)
T ss_dssp HHHC----------------CCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHH
T ss_pred HHhc----------------ccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChh
Confidence 1111 111111123346778999999999999999999999998754
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=287.37 Aligned_cols=229 Identities=28% Similarity=0.361 Sum_probs=180.1
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCC--CCCHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNC--ILDIFQRLNI 78 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~ 78 (273)
+.||||+++.. ...+.+.+|+++++.++||||+++++++.+ ..++||||+++++|.+++..... .++...++.+
T Consensus 32 ~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 107 (307)
T 2eva_A 32 KDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW 107 (307)
T ss_dssp EEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHH
T ss_pred eeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHH
Confidence 36999998643 356789999999999999999999999874 47899999999999999976543 3788999999
Q ss_pred HHHHHHHHHHHhcCCC---CCeEeccCCCCceeeCCCCc-eEEeecccccccccCCCcceeecccccCCCCCCcccCCCC
Q 024027 79 MIDVASALEYLHFGCS---APVIHCDLKPDNVLLDDNLV-AYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGR 154 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~---~~i~h~di~p~nil~~~~~~-~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 154 (273)
+.|++.||.||| + .|++|+||||+||+++.++. +||+|||++..... ......|++.|+|||.+.+..
T Consensus 108 ~~qi~~~l~~LH---~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~ 179 (307)
T 2eva_A 108 CLQCSQGVAYLH---SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT-----HMTNNKGSAAWMAPEVFEGSN 179 (307)
T ss_dssp HHHHHHHHHHHH---TCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------------CCTTSSCHHHHTCCC
T ss_pred HHHHHHHHHHHH---hCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc-----ccccCCCCCceEChhhhCCCC
Confidence 999999999999 7 89999999999999988776 79999999875422 122346899999999999889
Q ss_pred cCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcC
Q 024027 155 VSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACT 234 (273)
Q Consensus 155 ~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 234 (273)
++.++||||||+++|+|++|..||................. .....+..++..+.+|+.+||
T Consensus 180 ~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~l~~li~~~l 241 (307)
T 2eva_A 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG------------------TRPPLIKNLPKPIESLMTRCW 241 (307)
T ss_dssp CCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTT------------------CCCCCBTTCCHHHHHHHHHHT
T ss_pred CCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcC------------------CCCCcccccCHHHHHHHHHHh
Confidence 99999999999999999999999975433221111100000 000113446677999999999
Q ss_pred CCCccCCCCHHHHHHHHHHHHHhhh
Q 024027 235 VESPEQRINAKEIVTKLLKIRDSLL 259 (273)
Q Consensus 235 ~~dp~~Rps~~~~l~~l~~~~~~~~ 259 (273)
..||++|||+.+++++|+.+.+.+.
T Consensus 242 ~~dp~~Rps~~ell~~L~~~~~~~~ 266 (307)
T 2eva_A 242 SKDPSQRPSMEEIVKIMTHLMRYFP 266 (307)
T ss_dssp CSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred cCChhhCcCHHHHHHHHHHHHHhcc
Confidence 9999999999999999999887654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=314.93 Aligned_cols=239 Identities=23% Similarity=0.376 Sum_probs=192.3
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
.||||+++... ....+.+.+|+++++.++||||+++++++.. ...++||||+++|+|.+++......+++..++.++.
T Consensus 365 ~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~ 443 (613)
T 2ozo_A 365 DVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLH 443 (613)
T ss_dssp EEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHH
T ss_pred EEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHH
Confidence 59999998653 4467889999999999999999999999976 568999999999999999977777799999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcc-eeecccccCCCCCCcccCCCCcCCcc
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSM-TQTQTLATIGYMAPEYGREGRVSTNG 159 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~ 159 (273)
|++.||.||| +.|++||||||+||+++.++.+||+|||++..+....... ......+++.|+|||++.+..++.++
T Consensus 444 qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~s 520 (613)
T 2ozo_A 444 QVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRS 520 (613)
T ss_dssp HHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHH
T ss_pred HHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHH
Confidence 9999999999 9999999999999999999999999999998653322111 11223456789999999888899999
Q ss_pred hhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc
Q 024027 160 DVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238 (273)
Q Consensus 160 DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 238 (273)
|||||||++|+|++ |..||......+.. .. .. .. .....+..++.++.+|+.+||..||
T Consensus 521 DvwSlGv~l~ellt~G~~Pf~~~~~~~~~-~~-i~------------~~------~~~~~p~~~~~~l~~li~~cl~~dP 580 (613)
T 2ozo_A 521 DVWSYGVTMWEALSYGQKPYKKMKGPEVM-AF-IE------------QG------KRMECPPECPPELYALMSDCWIYKW 580 (613)
T ss_dssp HHHHHHHHHHHHHTTSCCTTTTCCSHHHH-HH-HH------------TT------CCCCCCTTCCHHHHHHHHHTTCSST
T ss_pred HHHHHHHHHHHHHHCCCCCCCCCCHHHHH-HH-HH------------cC------CCCCCCCcCCHHHHHHHHHHcCCCh
Confidence 99999999999998 99999764433211 11 10 00 0111245677889999999999999
Q ss_pred cCCCCHHHHHHHHHHHHHhhhhhccc
Q 024027 239 EQRINAKEIVTKLLKIRDSLLRNVGG 264 (273)
Q Consensus 239 ~~Rps~~~~l~~l~~~~~~~~~~~~~ 264 (273)
.+|||+.++++.|+.+..++......
T Consensus 581 ~~RPs~~~l~~~L~~~~~~~~~~~~~ 606 (613)
T 2ozo_A 581 EDRPDFLTVEQRMRACYYSLASKVEG 606 (613)
T ss_dssp TTSCCHHHHHHHHHHHHHHHSCSCCC
T ss_pred hHCcCHHHHHHHHHHHHHHhccccCC
Confidence 99999999999999998877654433
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=288.37 Aligned_cols=211 Identities=24% Similarity=0.320 Sum_probs=169.6
Q ss_pred hhhHHHHHHHHhcCCCccceeeeeeeec--CCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 024027 16 FKSFDVECEMMKSIRHRNLIKVISSCSN--EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGC 93 (273)
Q Consensus 16 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~ 93 (273)
.+.+.+|+++++.++||||+++++++.+ ....++||||+++++|.+++.. ..+++..++.++.|++.||.|||
T Consensus 80 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH--- 154 (298)
T 2zv2_A 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLH--- 154 (298)
T ss_dssp -CHHHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHH---
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---
Confidence 4678999999999999999999999986 5678999999999999887643 35999999999999999999999
Q ss_pred CCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCC---cCCcchhHHHHHHHHH
Q 024027 94 SAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGR---VSTNGDVYSFGIMLME 170 (273)
Q Consensus 94 ~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~DiwslG~~l~~ 170 (273)
+.|++|+||||+||+++.++.+||+|||++....... .......|++.|+|||.+.+.. ++.++|||||||++|+
T Consensus 155 ~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~ 232 (298)
T 2zv2_A 155 YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYC 232 (298)
T ss_dssp HTTEECCCCCGGGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHH
T ss_pred HCCeeccCCCHHHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHH
Confidence 9999999999999999999999999999998653322 2234457899999999997655 4788999999999999
Q ss_pred HHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHH
Q 024027 171 TFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 171 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
|++|..||........ ....... .........++.++.+|+.+||..||++|||+.++++|
T Consensus 233 l~~g~~pf~~~~~~~~-~~~~~~~------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 233 FVFGQCPFMDERIMCL-HSKIKSQ------------------ALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp HHHSSCSSCCSSHHHH-HHHHHHC------------------CCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred HHHCCCCCCCccHHHH-HHHHhcc------------------cCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 9999999865322110 0000000 00001123466779999999999999999999999987
Q ss_pred HH
Q 024027 251 LL 252 (273)
Q Consensus 251 l~ 252 (273)
-+
T Consensus 294 p~ 295 (298)
T 2zv2_A 294 PW 295 (298)
T ss_dssp HH
T ss_pred cc
Confidence 43
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=292.17 Aligned_cols=235 Identities=27% Similarity=0.432 Sum_probs=187.2
Q ss_pred eEEEEEeecc-cChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC------------
Q 024027 2 EVAVKVFNLQ-CGRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN------------ 67 (273)
Q Consensus 2 ~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------ 67 (273)
.||||.++.. .....+.+.+|+++++.+ +||||+++++++.+.+..++||||+++++|.+++....
T Consensus 54 ~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 133 (327)
T 1fvr_A 54 DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 133 (327)
T ss_dssp EEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHT
T ss_pred ceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccc
Confidence 4699999754 345567899999999999 89999999999999999999999999999999997553
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCC
Q 024027 68 ---CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGY 144 (273)
Q Consensus 68 ---~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~ 144 (273)
..+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++..... ........+++.|
T Consensus 134 ~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~---~~~~~~~~~~~~y 207 (327)
T 1fvr_A 134 STASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV---YVKKTMGRLPVRW 207 (327)
T ss_dssp TBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEESSCE---ECCC----CCTTT
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeEEEcccCcCccccc---cccccCCCCCccc
Confidence 36899999999999999999999 99999999999999999999999999999864311 1112334567889
Q ss_pred CCCcccCCCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhH
Q 024027 145 MAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCV 223 (273)
Q Consensus 145 ~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (273)
+|||.+.+..++.++||||||+++|+|++ |..||......+. ....... .....+..++
T Consensus 208 ~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~-~~~~~~~-------------------~~~~~~~~~~ 267 (327)
T 1fvr_A 208 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-YEKLPQG-------------------YRLEKPLNCD 267 (327)
T ss_dssp CCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-HHHGGGT-------------------CCCCCCTTBC
T ss_pred cChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH-HHHhhcC-------------------CCCCCCCCCC
Confidence 99999988889999999999999999998 9999865432211 0000000 0011134567
Q ss_pred HHHHHHHhhcCCCCccCCCCHHHHHHHHHHHHHhhhhhc
Q 024027 224 SFVFNLAMACTVESPEQRINAKEIVTKLLKIRDSLLRNV 262 (273)
Q Consensus 224 ~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~~ 262 (273)
.++.+|+.+||..||.+|||+.+++++|..+..+.....
T Consensus 268 ~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~ 306 (327)
T 1fvr_A 268 DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV 306 (327)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSB
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCcc
Confidence 789999999999999999999999999999988755433
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=295.71 Aligned_cols=223 Identities=21% Similarity=0.246 Sum_probs=183.5
Q ss_pred eEEEEEeeccc---ChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 2 EVAVKVFNLQC---GRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 2 ~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
.||||+++... ....+.+..|..++..+ +||+|+++++++.+.+.+++||||++||+|.+++...+ .+++..++.
T Consensus 47 ~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~ 125 (353)
T 2i0e_A 47 LYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-RFKEPHAVF 125 (353)
T ss_dssp EEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHH
T ss_pred EEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHH
Confidence 69999997542 34456788999999988 89999999999999999999999999999999997543 599999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
++.|++.||.||| +.|++||||||+||+++.++.+||+|||++...... .......+||+.|+|||++.+..++.
T Consensus 126 ~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~ 200 (353)
T 2i0e_A 126 YAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD--GVTTKTFCGTPDYIAPEIIAYQPYGK 200 (353)
T ss_dssp HHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--TCCBCCCCSCGGGCCHHHHTTCCBST
T ss_pred HHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC--CcccccccCCccccChhhhcCCCcCC
Confidence 9999999999999 999999999999999999999999999999753221 12234567999999999999989999
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
++|+|||||++|+|++|..||......+ ....+.... ...+..++.++.+|+.+||..|
T Consensus 201 ~~DiwslG~il~ell~G~~Pf~~~~~~~-~~~~i~~~~--------------------~~~p~~~s~~~~~li~~lL~~d 259 (353)
T 2i0e_A 201 SVDWWAFGVLLYEMLAGQAPFEGEDEDE-LFQSIMEHN--------------------VAYPKSMSKEAVAICKGLMTKH 259 (353)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCC--------------------CCCCTTSCHHHHHHHHHHTCSC
T ss_pred cccccchHHHHHHHHcCCCCCCCCCHHH-HHHHHHhCC--------------------CCCCCCCCHHHHHHHHHHhhcC
Confidence 9999999999999999999997533221 111111100 0113456778999999999999
Q ss_pred ccCCCC-----HHHHHHHH
Q 024027 238 PEQRIN-----AKEIVTKL 251 (273)
Q Consensus 238 p~~Rps-----~~~~l~~l 251 (273)
|.+||+ ++++++|-
T Consensus 260 P~~R~~~~~~~~~~i~~h~ 278 (353)
T 2i0e_A 260 PGKRLGCGPEGERDIKEHA 278 (353)
T ss_dssp TTSCTTCSTTHHHHHHTSG
T ss_pred HHHcCCCCCCCHHHHhcCc
Confidence 999995 58888773
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=285.34 Aligned_cols=228 Identities=21% Similarity=0.328 Sum_probs=184.8
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
+.||+|+++... ....+.+.+|+.+++.++||||+++++++.+++..++||||+++++|.+++... ..+++..++.+
T Consensus 32 ~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~ 110 (284)
T 3kk8_A 32 LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHC 110 (284)
T ss_dssp CEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHH
T ss_pred ceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHH
Confidence 479999997553 345677889999999999999999999999999999999999999999988654 36899999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCc---eEEeecccccccccCCCcceeecccccCCCCCCcccCCCCc
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLV---AYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRV 155 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~---~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~ 155 (273)
+.|++.||.||| +.|++|+||||+||+++.++. ++|+|||.+...... .......+++.|+|||.+.+..+
T Consensus 111 ~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~ 184 (284)
T 3kk8_A 111 IQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS---EAWHGFAGTPGYLSPEVLKKDPY 184 (284)
T ss_dssp HHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS---CBCCCSCSCGGGCCHHHHTTCCB
T ss_pred HHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC---ccccCCCCCcCCcCchhhcCCCC
Confidence 999999999999 999999999999999986655 999999999765322 12234568999999999999899
Q ss_pred CCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCC
Q 024027 156 STNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTV 235 (273)
Q Consensus 156 ~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 235 (273)
+.++||||||+++++|++|..||........ ........ ..........++.++.+|+.+||.
T Consensus 185 ~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~----------------~~~~~~~~~~~~~~~~~li~~~l~ 247 (284)
T 3kk8_A 185 SKPVDIWACGVILYILLVGYPPFWDEDQHRL-YAQIKAGA----------------YDYPSPEWDTVTPEAKSLIDSMLT 247 (284)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHTC----------------CCCCTTTTTTSCHHHHHHHHHHSC
T ss_pred CcccchHHHHHHHHHHHHCCCCCCCCchhHH-HHHHHhcc----------------ccCCchhhcccCHHHHHHHHHHcc
Confidence 9999999999999999999999865332211 11111100 000111123566779999999999
Q ss_pred CCccCCCCHHHHHHHHH
Q 024027 236 ESPEQRINAKEIVTKLL 252 (273)
Q Consensus 236 ~dp~~Rps~~~~l~~l~ 252 (273)
.||.+|||+.++++|-+
T Consensus 248 ~dp~~Rps~~~~l~h~~ 264 (284)
T 3kk8_A 248 VNPKKRITADQALKVPW 264 (284)
T ss_dssp SSTTTSCCHHHHTTSHH
T ss_pred cChhhCCCHHHHhcCcc
Confidence 99999999999999865
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=285.65 Aligned_cols=240 Identities=27% Similarity=0.363 Sum_probs=181.7
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhc--CCCccceeeeeeeec----CCceeEEEeccCCCCHHHhhhcCCCCCCHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKS--IRHRNLIKVISSCSN----EEFKALVLEYMPHGSLEKYLYSSNCILDIFQ 74 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (273)
++||||++... ....+..|.+++.. ++||||+++++++.. ....++||||+++|+|.++++.. .+++..
T Consensus 32 ~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~ 106 (301)
T 3q4u_A 32 ENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT--TLDTVS 106 (301)
T ss_dssp EEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTTC--CBCHHH
T ss_pred EEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhhc--ccCHHH
Confidence 36999999744 33556667777766 799999999998654 35689999999999999999544 599999
Q ss_pred HHHHHHHHHHHHHHHhcC-----CCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcc--eeecccccCCCCCC
Q 024027 75 RLNIMIDVASALEYLHFG-----CSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSM--TQTQTLATIGYMAP 147 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~-----~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~--~~~~~~~~~~~~aP 147 (273)
++.++.|++.||.|||+. .+.|++|+||||+||+++.++.+||+|||++.......... ......|++.|+||
T Consensus 107 ~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aP 186 (301)
T 3q4u_A 107 CLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186 (301)
T ss_dssp HHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCH
T ss_pred HHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeCh
Confidence 999999999999999932 15689999999999999999999999999997654332221 12334789999999
Q ss_pred cccCCC------CcCCcchhHHHHHHHHHHHhC----------CCCCccccccccchhhhhhhccCccchhhhhhhcccc
Q 024027 148 EYGREG------RVSTNGDVYSFGIMLMETFTG----------KKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 211 (273)
Q Consensus 148 E~~~~~------~~~~~~DiwslG~~l~~ll~g----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (273)
|.+.+. .++.++||||||+++|+|++| ..||....................... .
T Consensus 187 E~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~---------~ 257 (301)
T 3q4u_A 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQR---------P 257 (301)
T ss_dssp HHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCC---------C
T ss_pred hhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCC---------C
Confidence 998876 456799999999999999999 778766544433333222211110000 0
Q ss_pred chhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHHHH
Q 024027 212 EDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLLKI 254 (273)
Q Consensus 212 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 254 (273)
.......+..++.++.+|+.+||..||++|||+.++++.|+++
T Consensus 258 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 258 NIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 0001112345778899999999999999999999999999875
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=297.13 Aligned_cols=229 Identities=21% Similarity=0.263 Sum_probs=174.7
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhc-CCCccceeeeeeeec----CCceeEEEeccCCCCHHHhhhcCC-CCCCHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKS-IRHRNLIKVISSCSN----EEFKALVLEYMPHGSLEKYLYSSN-CILDIFQ 74 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~ 74 (273)
+.||||+++.. ..+.+|+.++.+ .+||||++++++|.. ...+++||||++||+|.+++.... ..+++..
T Consensus 88 ~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~ 162 (400)
T 1nxk_A 88 EKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE 162 (400)
T ss_dssp CEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHH
T ss_pred CEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHH
Confidence 36999999633 467788888754 589999999998865 667899999999999999997653 3599999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCC---CCceEEeecccccccccCCCcceeecccccCCCCCCcccC
Q 024027 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDD---NLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR 151 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~---~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 151 (273)
++.++.|++.||.||| +.|++||||||+||+++. ++.+||+|||++...... ......+||+.|+|||++.
T Consensus 163 ~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~ 236 (400)
T 1nxk_A 163 ASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH---NSLTTPCYTPYYVAPEVLG 236 (400)
T ss_dssp HHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--------------CTTCCGGGSC
T ss_pred HHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEecccccccCCC---CccccCCCCCCccCHhhcC
Confidence 9999999999999999 999999999999999987 789999999999865321 2234567899999999999
Q ss_pred CCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHh
Q 024027 152 EGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAM 231 (273)
Q Consensus 152 ~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 231 (273)
+..++.++|||||||++|+|++|..||............. ..+... ...........++.++.+||.
T Consensus 237 ~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~----------~~i~~~---~~~~~~~~~~~~s~~~~~li~ 303 (400)
T 1nxk_A 237 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK----------TRIRMG---QYEFPNPEWSEVSEEVKMLIR 303 (400)
T ss_dssp CCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHH----------HHHHHT---CCCCCTTTTTTSCHHHHHHHH
T ss_pred CCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHH----------HHHHcC---cccCCCcccccCCHHHHHHHH
Confidence 8899999999999999999999999997643322110000 000000 000001112456788999999
Q ss_pred hcCCCCccCCCCHHHHHHHHHH
Q 024027 232 ACTVESPEQRINAKEIVTKLLK 253 (273)
Q Consensus 232 ~~l~~dp~~Rps~~~~l~~l~~ 253 (273)
+||..||.+|||+.++++|-+-
T Consensus 304 ~~L~~dP~~Rpt~~eil~hp~~ 325 (400)
T 1nxk_A 304 NLLKTEPTQRMTITEFMNHPWI 325 (400)
T ss_dssp TTSCSSGGGSCCHHHHHHSHHH
T ss_pred HHCCCChhHCcCHHHHhcCccc
Confidence 9999999999999999998663
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=290.10 Aligned_cols=239 Identities=20% Similarity=0.213 Sum_probs=179.7
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||||+++... ....+.+.+|+.+++.++||||+++++++..++..++||||+++++|.+++.... .+++..++.
T Consensus 60 ~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~ 138 (309)
T 2h34_A 60 RIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG-PLAPPRAVA 138 (309)
T ss_dssp EEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHHC-SCCHHHHHH
T ss_pred eEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhcC-CCCHHHHHH
Confidence 369999997542 2335778999999999999999999999999999999999999999999997543 689999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++....... ........+++.|+|||.+.+..++.
T Consensus 139 i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~ 214 (309)
T 2h34_A 139 IVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK-LTQLGNTVGTLYYMAPERFSESHATY 214 (309)
T ss_dssp HHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC-----------------CCGGGCCGGGTCC----C
T ss_pred HHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc-cccccccCCCcCccCHHHHcCCCCCc
Confidence 9999999999999 9999999999999999999999999999987653221 11223456889999999999888999
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
++||||||+++|+|++|..||...... ........ ........+..++.++.+++.+||..|
T Consensus 215 ~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~----------------~~~~~~~~~~~~~~~l~~li~~~l~~d 276 (309)
T 2h34_A 215 RADIYALTCVLYECLTGSPPYQGDQLS--VMGAHINQ----------------AIPRPSTVRPGIPVAFDAVIARGMAKN 276 (309)
T ss_dssp CCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHHS----------------CCCCGGGTSTTCCTHHHHHHHHHTCSS
T ss_pred hHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhcc----------------CCCCccccCCCCCHHHHHHHHHhccCC
Confidence 999999999999999999998753221 11111100 000111124456778999999999999
Q ss_pred ccCCC-CHHHHHHHHHHHHHhhhhhc
Q 024027 238 PEQRI-NAKEIVTKLLKIRDSLLRNV 262 (273)
Q Consensus 238 p~~Rp-s~~~~l~~l~~~~~~~~~~~ 262 (273)
|++|| |++++++.|++...+.....
T Consensus 277 P~~Rp~s~~~l~~~l~~~l~~~~~~~ 302 (309)
T 2h34_A 277 PEDRYVTCGDLSAAAHAALATADQDR 302 (309)
T ss_dssp GGGSCSSHHHHHHHHHHTCC------
T ss_pred HHHHHHhHHHHHHHHHHHHHhhcccc
Confidence 99999 99999999988766554433
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=289.64 Aligned_cols=235 Identities=21% Similarity=0.276 Sum_probs=186.9
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeee----cCCceeEEEeccCCCCHHHhhhc---CCCCCCHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS----NEEFKALVLEYMPHGSLEKYLYS---SNCILDIF 73 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~ 73 (273)
+.||||++........+.+.+|+++++.++||||+++++++. .....++||||+++++|.+++.. .+..+++.
T Consensus 55 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 134 (317)
T 2buj_A 55 HFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTED 134 (317)
T ss_dssp CEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHH
T ss_pred cEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHH
Confidence 479999998766667788999999999999999999999986 34578999999999999999865 35579999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcc-------eeecccccCCCCC
Q 024027 74 QRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSM-------TQTQTLATIGYMA 146 (273)
Q Consensus 74 ~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~-------~~~~~~~~~~~~a 146 (273)
.++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||.+.......... ......|++.|+|
T Consensus 135 ~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 211 (317)
T 2buj_A 135 QILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211 (317)
T ss_dssp HHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCC
T ss_pred HHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCC
Confidence 99999999999999999 9999999999999999999999999999887542211110 0123356899999
Q ss_pred CcccCCCC---cCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhH
Q 024027 147 PEYGREGR---VSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCV 223 (273)
Q Consensus 147 PE~~~~~~---~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (273)
||.+.+.. ++.++||||||+++|+|++|..||................ ......+..++
T Consensus 212 PE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~ 273 (317)
T 2buj_A 212 PELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN------------------QLSIPQSPRHS 273 (317)
T ss_dssp GGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC------------------C--CCCCTTSC
T ss_pred HhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc------------------cCCCCccccCC
Confidence 99987654 6899999999999999999999986532221111111100 00011123466
Q ss_pred HHHHHHHhhcCCCCccCCCCHHHHHHHHHHHHH
Q 024027 224 SFVFNLAMACTVESPEQRINAKEIVTKLLKIRD 256 (273)
Q Consensus 224 ~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 256 (273)
.++.+|+.+||..||.+|||+.+++++|+.+..
T Consensus 274 ~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 274 SALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred HHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 779999999999999999999999999987654
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=293.97 Aligned_cols=235 Identities=25% Similarity=0.386 Sum_probs=188.7
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC------CCCCHHH
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN------CILDIFQ 74 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~ 74 (273)
.||||++.... ......+.+|+.+++.++||||+++++++.+....++||||+++++|.+++.... ..+++..
T Consensus 62 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 141 (327)
T 2yfx_A 62 QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLD 141 (327)
T ss_dssp EEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHH
T ss_pred eEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHH
Confidence 69999997543 4456678999999999999999999999999999999999999999999997653 3488999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCC---CCceEEeecccccccccCCCcceeecccccCCCCCCcccC
Q 024027 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDD---NLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR 151 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~---~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 151 (273)
++.++.|++.||.||| +.|++|+||||+||+++. +..++|+|||++................+++.|+|||.+.
T Consensus 142 ~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 218 (327)
T 2yfx_A 142 LLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFM 218 (327)
T ss_dssp HHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHH
T ss_pred HHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhc
Confidence 9999999999999999 999999999999999984 4569999999987654333333334456788999999998
Q ss_pred CCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHH
Q 024027 152 EGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLA 230 (273)
Q Consensus 152 ~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 230 (273)
+..++.++||||||+++|+|++ |..||........ ....... . ....+..++..+.+|+
T Consensus 219 ~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~~~~~~~-------------~------~~~~~~~~~~~l~~li 278 (327)
T 2yfx_A 219 EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV-LEFVTSG-------------G------RMDPPKNCPGPVYRIM 278 (327)
T ss_dssp HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-HHHHHTT-------------C------CCCCCTTCCHHHHHHH
T ss_pred CCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHH-HHHHhcC-------------C------CCCCCCCCCHHHHHHH
Confidence 8889999999999999999998 9999865322211 1100000 0 0011345667799999
Q ss_pred hhcCCCCccCCCCHHHHHHHHHHHHHhhh
Q 024027 231 MACTVESPEQRINAKEIVTKLLKIRDSLL 259 (273)
Q Consensus 231 ~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 259 (273)
.+||..||.+|||+.+++++|+.+..+-.
T Consensus 279 ~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 307 (327)
T 2yfx_A 279 TQCWQHQPEDRPNFAIILERIEYCTQDPD 307 (327)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred HHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence 99999999999999999999999987543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=295.49 Aligned_cols=231 Identities=23% Similarity=0.342 Sum_probs=175.7
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCce----eEEEeccCCCCHHHhhhcCCCCCCHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFK----ALVLEYMPHGSLEKYLYSSNCILDIF 73 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~----~lv~e~~~~~~L~~~l~~~~~~~~~~ 73 (273)
+.||||+++... ......+.+|+++++.++||||+++++++...... ++||||+++++|.+++...+ .+++.
T Consensus 38 ~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~ 116 (311)
T 3ork_A 38 RDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPK 116 (311)
T ss_dssp EEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHC-SCCHH
T ss_pred ceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcC-CCCHH
Confidence 379999997653 23456788999999999999999999998776544 99999999999999996544 68999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCc-ceeecccccCCCCCCcccCC
Q 024027 74 QRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQS-MTQTQTLATIGYMAPEYGRE 152 (273)
Q Consensus 74 ~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~ 152 (273)
.++.++.|++.||.||| +.|++|+||||+||+++.++.+||+|||++..+...... .......|++.|+|||.+.+
T Consensus 117 ~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 193 (311)
T 3ork_A 117 RAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193 (311)
T ss_dssp HHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHT
T ss_pred HHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcC
Confidence 99999999999999999 999999999999999999999999999999765432221 22234568999999999998
Q ss_pred CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhh
Q 024027 153 GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMA 232 (273)
Q Consensus 153 ~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 232 (273)
..++.++||||||+++|+|++|..||............... ...........++.++.+|+.+
T Consensus 194 ~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~l~~li~~ 256 (311)
T 3ork_A 194 DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE-----------------DPIPPSARHEGLSADLDAVVLK 256 (311)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC-----------------CCCCHHHHSTTCCHHHHHHHHH
T ss_pred CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC-----------------CCCCcccccCCCCHHHHHHHHH
Confidence 89999999999999999999999999764332211111110 0011111234577889999999
Q ss_pred cCCCCccCCCCHHHHHHHHH
Q 024027 233 CTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 233 ~l~~dp~~Rps~~~~l~~l~ 252 (273)
||..||.+||++.+++.+-.
T Consensus 257 ~l~~dP~~R~~~~~~l~~~l 276 (311)
T 3ork_A 257 ALAKNPENRYQTAAEMRADL 276 (311)
T ss_dssp HTCSSGGGSCSSHHHHHHHH
T ss_pred HHhcCHhhChhhHHHHHHHH
Confidence 99999999997776665433
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=284.03 Aligned_cols=223 Identities=24% Similarity=0.322 Sum_probs=181.7
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||||++.... ......+.+|+.+++.++||||+++++++.+....++||||+++++|.+++.... .+++..++.
T Consensus 35 ~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~ 113 (279)
T 3fdn_A 35 FILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTAT 113 (279)
T ss_dssp CEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS-SCCHHHHHH
T ss_pred cEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhcC-CCCHHHHHH
Confidence 369999996542 2235678899999999999999999999999999999999999999999996543 589999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++..... .......+++.|+|||.+.+..++.
T Consensus 114 ~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~ 186 (279)
T 3fdn_A 114 YITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS----SRRTDLCGTLDYLPPEMIEGRMHDE 186 (279)
T ss_dssp HHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC------------CCCCTTCCHHHHTTCCCCT
T ss_pred HHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCc----ccccccCCCCCccCHhHhccCCCCc
Confidence 9999999999999 99999999999999999999999999998864322 1223456899999999999888999
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
++||||||+++|+|++|..||......... ..... .....+..++..+.+|+.+||..|
T Consensus 187 ~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~--------------------~~~~~~~~~~~~~~~li~~~l~~~ 245 (279)
T 3fdn_A 187 KVDLWSLGVLCYEFLVGKPPFEANTYQETY-KRISR--------------------VEFTFPDFVTEGARDLISRLLKHN 245 (279)
T ss_dssp THHHHHHHHHHHHHHHSSCTTCCSSHHHHH-HHHHH--------------------TCCCCCTTSCHHHHHHHHHHCCSS
T ss_pred cchhHhHHHHHHHHHHCCCCCCCCcHHHHH-HHHHh--------------------CCCCCCCcCCHHHHHHHHHHhccC
Confidence 999999999999999999998753222111 00000 001113446677999999999999
Q ss_pred ccCCCCHHHHHHHHH
Q 024027 238 PEQRINAKEIVTKLL 252 (273)
Q Consensus 238 p~~Rps~~~~l~~l~ 252 (273)
|.+|||+.++++|-+
T Consensus 246 p~~Rps~~e~l~h~~ 260 (279)
T 3fdn_A 246 PSQRPMLREVLEHPW 260 (279)
T ss_dssp GGGSCCHHHHHHCHH
T ss_pred hhhCCCHHHHhhCcc
Confidence 999999999999976
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=309.26 Aligned_cols=230 Identities=27% Similarity=0.419 Sum_probs=189.6
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcC-CCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~ 80 (273)
.||||+++.. ....+.|.+|+.+++.++||||++++++|.+...+++||||+++|+|.+++... ...+++..++.++.
T Consensus 247 ~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~ 325 (495)
T 1opk_A 247 TVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 325 (495)
T ss_dssp EEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHH
T ss_pred EEEEEEecCc-ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHH
Confidence 6999999765 345678999999999999999999999999999999999999999999999754 34589999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
|++.||.||| +.|++||||||+||+++.++.+||+|||++....... ........++..|+|||.+.+..++.++|
T Consensus 326 qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sD 401 (495)
T 1opk_A 326 QISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSD 401 (495)
T ss_dssp HHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-EECCTTCCCCGGGCCHHHHHHCEECHHHH
T ss_pred HHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCCc-eeecCCCcCCcceeCHhHHhcCCCCcHHh
Confidence 9999999999 9999999999999999999999999999998653221 11122334567899999998888999999
Q ss_pred hHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCcc
Q 024027 161 VYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239 (273)
Q Consensus 161 iwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 239 (273)
||||||++|+|++ |..||........ .... ... .....+..++.++.+|+.+||..||.
T Consensus 402 vwSlG~~l~el~t~g~~p~~~~~~~~~--~~~~------------~~~------~~~~~~~~~~~~l~~li~~cl~~dP~ 461 (495)
T 1opk_A 402 VWAFGVLLWEIATYGMSPYPGIDLSQV--YELL------------EKD------YRMERPEGCPEKVYELMRACWQWNPS 461 (495)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCGGGH--HHHH------------HTT------CCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred HHhHHHHHHHHHhCCCCCCCCCCHHHH--HHHH------------HcC------CCCCCCCCCCHHHHHHHHHHcCcChh
Confidence 9999999999999 9999876433211 1100 000 01112456778899999999999999
Q ss_pred CCCCHHHHHHHHHHHHH
Q 024027 240 QRINAKEIVTKLLKIRD 256 (273)
Q Consensus 240 ~Rps~~~~l~~l~~~~~ 256 (273)
+|||+.++++.|+.+.+
T Consensus 462 ~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 462 DRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp GSCCHHHHHHHHHTSCS
T ss_pred HCcCHHHHHHHHHHHHh
Confidence 99999999999988753
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=297.38 Aligned_cols=244 Identities=21% Similarity=0.278 Sum_probs=179.8
Q ss_pred CeEEEEEeecc--cChhhhhHHHHHHHHhcCC-CccceeeeeeeecC--CceeEEEeccCCCCHHHhhhcCCCCCCHHHH
Q 024027 1 MEVAVKVFNLQ--CGRAFKSFDVECEMMKSIR-HRNLIKVISSCSNE--EFKALVLEYMPHGSLEKYLYSSNCILDIFQR 75 (273)
Q Consensus 1 ~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (273)
+.||||++... .......+.+|+.+++.+. ||||+++++++..+ ..+++||||+++ +|.+++... .+++..+
T Consensus 35 ~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~--~~~~~~~ 111 (388)
T 3oz6_A 35 EVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRAN--ILEPVHK 111 (388)
T ss_dssp CEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCSE-EHHHHHHHT--CCCHHHH
T ss_pred CEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccCc-CHHHHHHcC--CCCHHHH
Confidence 47999998643 2445677889999999997 99999999999754 378999999975 999999764 5899999
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCC-------------------Ccceee
Q 024027 76 LNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGED-------------------QSMTQT 136 (273)
Q Consensus 76 ~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~-------------------~~~~~~ 136 (273)
..++.|++.||.||| +.|++||||||+||+++.++.+||+|||++..+.... ......
T Consensus 112 ~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (388)
T 3oz6_A 112 QYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILT 188 (388)
T ss_dssp HHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC--------------
T ss_pred HHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccccccccccccccccccccccccccc
Confidence 999999999999999 9999999999999999999999999999997653211 111223
Q ss_pred cccccCCCCCCcccCC-CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhh--------
Q 024027 137 QTLATIGYMAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDAN-------- 207 (273)
Q Consensus 137 ~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 207 (273)
..+||++|+|||++.+ ..++.++|||||||++|+|++|.+||....... .+..+......+.........
T Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~p~~~~~~~~~~~~~~~~~ 267 (388)
T 3oz6_A 189 DYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN-QLERIIGVIDFPSNEDVESIQSPFAKTMI 267 (388)
T ss_dssp -CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCHHHHHTSCCSSHHHHH
T ss_pred CCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHHhccCHHHHHHH
Confidence 4578999999999876 568999999999999999999999997643322 222222111111110000000
Q ss_pred ----------c-cccc--------hhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHH
Q 024027 208 ----------L-LSQE--------DIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKL 251 (273)
Q Consensus 208 ----------~-~~~~--------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l 251 (273)
. .... ......+..++.++.+|+.+||..||++|||++++++|-
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp 330 (388)
T 3oz6_A 268 ESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHP 330 (388)
T ss_dssp HHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTST
T ss_pred HhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCH
Confidence 0 0000 000001125677899999999999999999999999983
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=307.24 Aligned_cols=225 Identities=23% Similarity=0.292 Sum_probs=175.3
Q ss_pred CeEEEEEeecc---cChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||||+++.. .......+.+|+.+++.++||||++++++|.+.+.+++||||+++|+|.+++.... .+++..+..
T Consensus 174 ~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~ 252 (446)
T 4ejn_A 174 RYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARF 252 (446)
T ss_dssp CEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHHS-CCCHHHHHH
T ss_pred CEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhcC-CCCHHHHHH
Confidence 47999999754 23445678889999999999999999999999999999999999999999996543 689999999
Q ss_pred HHHHHHHHHHHHhcCCC-CCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcC
Q 024027 78 IMIDVASALEYLHFGCS-APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVS 156 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~-~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 156 (273)
++.|++.||.||| + .|++||||||+||+++.++.+||+|||++...... .......+||+.|+|||++.+..++
T Consensus 253 ~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~ 327 (446)
T 4ejn_A 253 YGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKTFCGTPEYLAPEVLEDNDYG 327 (446)
T ss_dssp HHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCC
T ss_pred HHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC--CcccccccCCccccCHhhcCCCCCC
Confidence 9999999999999 8 89999999999999999999999999998753221 2223456799999999999999999
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++|||||||++|+|++|..||........ ....... ....+..++.++.+||.+||..
T Consensus 328 ~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~i~~~--------------------~~~~p~~~~~~~~~li~~~L~~ 386 (446)
T 4ejn_A 328 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-FELILME--------------------EIRFPRTLGPEAKSLLSGLLKK 386 (446)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHC--------------------CCCCCTTSCHHHHHHHHHHTCS
T ss_pred CccchhhhHHHHHHHhhCCCCCCCCCHHHH-HHHHHhC--------------------CCCCCccCCHHHHHHHHHHccc
Confidence 999999999999999999999965332211 1111000 0011344667899999999999
Q ss_pred CccCCC-----CHHHHHHHHH
Q 024027 237 SPEQRI-----NAKEIVTKLL 252 (273)
Q Consensus 237 dp~~Rp-----s~~~~l~~l~ 252 (273)
||.+|| |++++++|-.
T Consensus 387 dP~~R~~~~~~t~~ell~hp~ 407 (446)
T 4ejn_A 387 DPKQRLGGGSEDAKEIMQHRF 407 (446)
T ss_dssp STTTSTTCSTTTHHHHHTSGG
T ss_pred CHHHhCCCCCCCHHHHHhCcc
Confidence 999999 9999998743
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=288.07 Aligned_cols=227 Identities=20% Similarity=0.301 Sum_probs=182.5
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
+.||||+++.........+.+|+.+++.++||||+++++++.+....++||||+++++|.+++...+ .+++..++.++.
T Consensus 35 ~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ 113 (304)
T 2jam_A 35 KLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERG-VYTEKDASLVIQ 113 (304)
T ss_dssp CEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHH
T ss_pred CEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHcC-CCCHHHHHHHHH
Confidence 4799999986654455678999999999999999999999999999999999999999999986543 589999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceee---CCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCC
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLL---DDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~---~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
|++.||.||| +.|++|+||+|+||++ +.++.++|+|||++..... .......+++.|+|||.+.+..++.
T Consensus 114 qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~ 186 (304)
T 2jam_A 114 QVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN----GIMSTACGTPGYVAPEVLAQKPYSK 186 (304)
T ss_dssp HHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC----BTTHHHHSCCCBCCTTTBSSCSCCH
T ss_pred HHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC----CccccccCCCCccChHHhccCCCCc
Confidence 9999999999 9999999999999999 7788999999999875421 1223456899999999999888999
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
++||||||+++|+|++|..||....... ......... ..........++.++.+|+.+||..|
T Consensus 187 ~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~----------------~~~~~~~~~~~~~~~~~li~~~l~~d 249 (304)
T 2jam_A 187 AVDCWSIGVITYILLCGYPPFYEETESK-LFEKIKEGY----------------YEFESPFWDDISESAKDFICHLLEKD 249 (304)
T ss_dssp HHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHCC----------------CCCCTTTTTTSCHHHHHHHHHHHCSS
T ss_pred hhhHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHcCC----------------CCCCccccccCCHHHHHHHHHHcCCC
Confidence 9999999999999999999987532211 111111110 00011113456778999999999999
Q ss_pred ccCCCCHHHHHHHHH
Q 024027 238 PEQRINAKEIVTKLL 252 (273)
Q Consensus 238 p~~Rps~~~~l~~l~ 252 (273)
|.+|||+.++++|-+
T Consensus 250 p~~Rps~~~~l~h~~ 264 (304)
T 2jam_A 250 PNERYTCEKALSHPW 264 (304)
T ss_dssp TTTSCCHHHHHTSHH
T ss_pred hhHCcCHHHHhcCcc
Confidence 999999999998755
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=287.63 Aligned_cols=235 Identities=24% Similarity=0.383 Sum_probs=188.1
Q ss_pred eEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 2 EVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 2 ~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
.||||+++... ....+.+.+|+++++.++||||+++++++ .....++||||+++++|.+++.... .+++..++.++
T Consensus 46 ~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~ 123 (291)
T 1xbb_A 46 TVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELV 123 (291)
T ss_dssp EEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHCT-TCCHHHHHHHH
T ss_pred eEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhCc-CCCHHHHHHHH
Confidence 69999997553 33467899999999999999999999999 5667889999999999999997653 68999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcc-eeecccccCCCCCCcccCCCCcCCc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSM-TQTQTLATIGYMAPEYGREGRVSTN 158 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~ 158 (273)
.|++.||.||| +.|++|+||||+||+++.++.++|+|||++.......... ......+++.|+|||.+.+..++.+
T Consensus 124 ~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 200 (291)
T 1xbb_A 124 HQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK 200 (291)
T ss_dssp HHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHH
T ss_pred HHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChh
Confidence 99999999999 9999999999999999999999999999998664332211 1222345678999999988889999
Q ss_pred chhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 159 GDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 159 ~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
+||||||+++|+|++ |..||........ ...... .. ....+..++.++.+++.+||..|
T Consensus 201 ~Di~slG~il~~l~~~g~~p~~~~~~~~~--~~~~~~------------~~------~~~~~~~~~~~l~~li~~~l~~d 260 (291)
T 1xbb_A 201 SDVWSFGVLMWEAFSYGQKPYRGMKGSEV--TAMLEK------------GE------RMGCPAGCPREMYDLMNLCWTYD 260 (291)
T ss_dssp HHHHHHHHHHHHHHTTTCCSSTTCCHHHH--HHHHHT------------TC------CCCCCTTCCHHHHHHHHHHTCSS
T ss_pred hhHHHHHHHHHHHHhcCCCCCCCCCHHHH--HHHHHc------------CC------CCCCCCCCCHHHHHHHHHHcCCC
Confidence 999999999999999 9999876432211 110000 00 01113456778999999999999
Q ss_pred ccCCCCHHHHHHHHHHHHHhhhhh
Q 024027 238 PEQRINAKEIVTKLLKIRDSLLRN 261 (273)
Q Consensus 238 p~~Rps~~~~l~~l~~~~~~~~~~ 261 (273)
|.+|||+.++++.|+++..+...+
T Consensus 261 p~~Rps~~~l~~~L~~~~~~~~~~ 284 (291)
T 1xbb_A 261 VENRPGFAAVELRLRNYYYDVVNE 284 (291)
T ss_dssp TTTSCCHHHHHHHHHHHHHHHHHH
T ss_pred hhhCcCHHHHHHHHHHHHHHHhhc
Confidence 999999999999999998876544
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=301.27 Aligned_cols=241 Identities=22% Similarity=0.197 Sum_probs=176.5
Q ss_pred CeEEEEEeecc--cChhhhhHHHHHHHHhcCCCccceeeeeeeecCC------ceeEEEeccCCCCHHHhhhcCCCCCCH
Q 024027 1 MEVAVKVFNLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEE------FKALVLEYMPHGSLEKYLYSSNCILDI 72 (273)
Q Consensus 1 ~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~ 72 (273)
+.||||++... .....+.+.+|+.+++.++||||+++++++.... ..++||||+++ +|.+.+.. .+++
T Consensus 88 ~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~~---~l~~ 163 (464)
T 3ttj_A 88 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM---ELDH 163 (464)
T ss_dssp EEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHTS---CCCH
T ss_pred CEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHhh---cCCH
Confidence 36999999754 3345677889999999999999999999996653 56999999976 67777743 3899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC
Q 024027 73 FQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE 152 (273)
Q Consensus 73 ~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 152 (273)
..+..++.|++.||.||| +.|++||||||+||+++.++.+||+|||++..... .......+||+.|+|||++.+
T Consensus 164 ~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~ 237 (464)
T 3ttj_A 164 ERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILG 237 (464)
T ss_dssp HHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC--------CCCC----CCCTTCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC---CcccCCCcccccccCHHHHcC
Confidence 999999999999999999 99999999999999999999999999999976532 122345678999999999999
Q ss_pred CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccch----------hhhhhhcc-cc----------
Q 024027 153 GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTM----------EVVDANLL-SQ---------- 211 (273)
Q Consensus 153 ~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~-~~---------- 211 (273)
..++.++|||||||++|+|++|+.||.+....+ .+.........+... ........ ..
T Consensus 238 ~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~-~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (464)
T 3ttj_A 238 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDS 316 (464)
T ss_dssp CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGG
T ss_pred CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCccc
Confidence 999999999999999999999999997643221 111111111110000 00000000 00
Q ss_pred -chhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 212 -EDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 212 -~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
...........+.++.+|+.+||..||++|||++++++|-+
T Consensus 317 ~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~ 358 (464)
T 3ttj_A 317 LFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 358 (464)
T ss_dssp GSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred ccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChh
Confidence 00001112233678999999999999999999999999843
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=289.14 Aligned_cols=225 Identities=21% Similarity=0.291 Sum_probs=176.5
Q ss_pred CeEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCC----------------------------------
Q 024027 1 MEVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEE---------------------------------- 45 (273)
Q Consensus 1 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---------------------------------- 45 (273)
+.||||+++... ....+.+.+|+++++.++||||++++++|.+..
T Consensus 32 ~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 111 (332)
T 3qd2_B 32 CNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVK 111 (332)
T ss_dssp CEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC------------------------
T ss_pred cEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccc
Confidence 479999998553 445678999999999999999999999885543
Q ss_pred -----------------------ceeEEEeccCCCCHHHhhhcCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEec
Q 024027 46 -----------------------FKALVLEYMPHGSLEKYLYSSNC--ILDIFQRLNIMIDVASALEYLHFGCSAPVIHC 100 (273)
Q Consensus 46 -----------------------~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~ 100 (273)
..++||||+++++|.+++..... ..++..++.++.|++.||.||| +.|++|+
T Consensus 112 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~ 188 (332)
T 3qd2_B 112 IRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHR 188 (332)
T ss_dssp --------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred eeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHH---hCCeeec
Confidence 37899999999999999976542 3566678999999999999999 9999999
Q ss_pred cCCCCceeeCCCCceEEeecccccccccCCCc----------ceeecccccCCCCCCcccCCCCcCCcchhHHHHHHHHH
Q 024027 101 DLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQS----------MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLME 170 (273)
Q Consensus 101 di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~----------~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ 170 (273)
||||+||+++.++.+||+|||++......... .......|++.|+|||.+.+..++.++||||||+++|+
T Consensus 189 Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~e 268 (332)
T 3qd2_B 189 DLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFE 268 (332)
T ss_dssp CCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHH
T ss_pred CCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHH
Confidence 99999999999999999999999876433211 12233568999999999998899999999999999999
Q ss_pred HHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHH
Q 024027 171 TFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 171 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
|++|..|+..... ..... .. ..........+.++.+|+.+||..||++|||+.++++|
T Consensus 269 l~~~~~~~~~~~~-------~~~~~---------~~------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 269 LLYSFSTQMERVR-------IITDV---------RN------LKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHSCCCCHHHHHH-------HHHHH---------HT------TCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHcCCChhHHHH-------HHHHh---------hc------cCCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 9998777432110 00000 00 00011133455668999999999999999999999986
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=293.34 Aligned_cols=245 Identities=21% Similarity=0.239 Sum_probs=180.5
Q ss_pred CeEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 1 MEVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 1 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
+.||||+++... ......+.+|+++++.++||||+++++++.+++..++||||+++ +|.+++...+..+++..++.++
T Consensus 28 ~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~ 106 (324)
T 3mtl_A 28 NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFL 106 (324)
T ss_dssp CEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHH
T ss_pred cEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccccc-CHHHHHHhcCCCCCHHHHHHHH
Confidence 469999997553 22334566899999999999999999999999999999999975 9999998777779999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC-CCcCCc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE-GRVSTN 158 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~ 158 (273)
.|++.||.||| +.|++|+||||+||+++.++.++|+|||++...... ........+++.|+|||++.+ ..++.+
T Consensus 107 ~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 181 (324)
T 3mtl_A 107 FQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP--TKTYDNEVVTLWYRPPDILLGSTDYSTQ 181 (324)
T ss_dssp HHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC--------------CGGGCCHHHHTTCCCCCTH
T ss_pred HHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCC--ccccccccCcccccChhhhcCCCCCCcH
Confidence 99999999999 999999999999999999999999999998754221 222334567999999999876 568999
Q ss_pred chhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccch---hhhhh-----hc--cccchhhhhhhhhhHHHHHH
Q 024027 159 GDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTM---EVVDA-----NL--LSQEDIHFVAKEQCVSFVFN 228 (273)
Q Consensus 159 ~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~~-----~~--~~~~~~~~~~~~~~~~~l~~ 228 (273)
+|||||||++|+|++|..||......+. .............. ..... .. .............++.++.+
T Consensus 182 ~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (324)
T 3mtl_A 182 IDMWGVGCIFYEMATGRPLFPGSTVEEQ-LHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGAD 260 (324)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHH
Confidence 9999999999999999999976433221 11111111110000 00000 00 00011112223456788999
Q ss_pred HHhhcCCCCccCCCCHHHHHHHHH
Q 024027 229 LAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 229 li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
|+.+||..||++|||+.++++|-+
T Consensus 261 li~~~L~~dP~~R~t~~e~l~hp~ 284 (324)
T 3mtl_A 261 LLTKLLQFEGRNRISAEDAMKHPF 284 (324)
T ss_dssp HHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred HHHHHcCcCcccCCCHHHHhcChh
Confidence 999999999999999999999754
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=288.73 Aligned_cols=244 Identities=21% Similarity=0.224 Sum_probs=180.0
Q ss_pred CeEEEEEeecccC--hhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 1 MEVAVKVFNLQCG--RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 1 ~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
+.||||++..... ...+.+.+|+++++.++||||+++++++.+.+..++||||+++++|.+++... ..+++..+..+
T Consensus 29 ~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~i 107 (311)
T 4agu_A 29 QIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQ-RGVPEHLVKSI 107 (311)
T ss_dssp CEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTS-SCCCHHHHHHH
T ss_pred cEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhh-cCCCHHHHHHH
Confidence 4699999865532 33567889999999999999999999999999999999999998998887544 46999999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC-CCcCC
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE-GRVST 157 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~ 157 (273)
+.|++.||.||| +.|++|+||||+||+++.++.++|+|||++....... .......+++.|+|||.+.+ ..++.
T Consensus 108 ~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~ 182 (311)
T 4agu_A 108 TWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS--DYYDDEVATRWYRSPELLVGDTQYGP 182 (311)
T ss_dssp HHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--------------GGGCCHHHHHTCSCCCT
T ss_pred HHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc--cccCCCcCCccccChHHHhcCCCCCc
Confidence 999999999999 9999999999999999999999999999998653222 22234568999999999876 56899
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCcc--chhhhh------hhccc---cchhhhhhhhhhHHHH
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPIS--TMEVVD------ANLLS---QEDIHFVAKEQCVSFV 226 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~------~~~~~---~~~~~~~~~~~~~~~l 226 (273)
++||||||+++|+|++|..||......+... .......... ...... ..... ...........++.++
T Consensus 183 ~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (311)
T 4agu_A 183 PVDVWAIGCVFAELLSGVPLWPGKSDVDQLY-LIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPA 261 (311)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-HHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHH
T ss_pred chhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHH
Confidence 9999999999999999999997644332211 1111100000 000000 00000 0000111124567789
Q ss_pred HHHHhhcCCCCccCCCCHHHHHHHH
Q 024027 227 FNLAMACTVESPEQRINAKEIVTKL 251 (273)
Q Consensus 227 ~~li~~~l~~dp~~Rps~~~~l~~l 251 (273)
.+|+.+||..||.+|||++++++|-
T Consensus 262 ~~li~~~L~~dP~~Rpt~~ell~hp 286 (311)
T 4agu_A 262 LGLLKGCLHMDPTERLTCEQLLHHP 286 (311)
T ss_dssp HHHHHHHCCSSTTTSCCHHHHHTSG
T ss_pred HHHHHHHccCChhhcCCHHHHhcCh
Confidence 9999999999999999999999873
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=299.30 Aligned_cols=251 Identities=20% Similarity=0.244 Sum_probs=190.7
Q ss_pred CeEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCC--ceeEEEeccCCCCHHHhhhcCCC--CCCHHHH
Q 024027 1 MEVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEE--FKALVLEYMPHGSLEKYLYSSNC--ILDIFQR 75 (273)
Q Consensus 1 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~ 75 (273)
+.||||+++... ....+.+.+|+++++.++||||+++++++.... ..++||||+++|+|.+++..... .+++..+
T Consensus 35 ~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~ 114 (396)
T 4eut_A 35 DLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF 114 (396)
T ss_dssp CEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHH
T ss_pred cEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHH
Confidence 479999997543 344567889999999999999999999998755 67999999999999999975432 3899999
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeEeccCCCCceee----CCCCceEEeecccccccccCCCcceeecccccCCCCCCcccC
Q 024027 76 LNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLL----DDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR 151 (273)
Q Consensus 76 ~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~----~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 151 (273)
+.++.|++.||.||| +.|++||||||+||++ +.++.+||+|||++....... ......|++.|+|||++.
T Consensus 115 ~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~ 188 (396)
T 4eut_A 115 LIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYE 188 (396)
T ss_dssp HHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGG---GSSCSSSCCTTCCHHHHH
T ss_pred HHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCC---ccccccCCccccCHHHhh
Confidence 999999999999999 9999999999999999 778889999999998653222 223456899999999876
Q ss_pred C--------CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhh---hccCccchhhhh---hh--ccccchhh
Q 024027 152 E--------GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVN---DWLPISTMEVVD---AN--LLSQEDIH 215 (273)
Q Consensus 152 ~--------~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~---~~--~~~~~~~~ 215 (273)
+ ..++.++|||||||++|+|++|..||............... ..+......... .. ........
T Consensus 189 ~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 268 (396)
T 4eut_A 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVS 268 (396)
T ss_dssp HHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTT
T ss_pred ccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcc
Confidence 4 45788999999999999999999999765443322222111 111100000000 00 00001111
Q ss_pred hhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHHHHHHh
Q 024027 216 FVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLLKIRDS 257 (273)
Q Consensus 216 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~ 257 (273)
......++..+.+++.+||..||++|||++++++.+.++.+.
T Consensus 269 ~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 269 CSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp CSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred cccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 122356778899999999999999999999999999988764
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=285.02 Aligned_cols=232 Identities=27% Similarity=0.444 Sum_probs=187.0
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC-CCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~ 80 (273)
+||||+++.. ....+.+.+|+++++.++||||+++++++.+ +..++||||+++++|.+++.... ..+++..++.++.
T Consensus 39 ~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ 116 (279)
T 1qpc_A 39 KVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 116 (279)
T ss_dssp EEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHH
T ss_pred EEEEEEecCC-cccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHH
Confidence 6999999755 3345789999999999999999999999874 45889999999999999996532 2589999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
|++.||.||| +.|++|+||+|+||+++.++.++|+|||.+........ .......++..|+|||.+.+..++.++|
T Consensus 117 qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~D 192 (279)
T 1qpc_A 117 QIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSD 192 (279)
T ss_dssp HHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHH
T ss_pred HHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc-ccccCCCCccCccChhhhccCCCCchhh
Confidence 9999999999 99999999999999999999999999999986532211 1122344677899999998888999999
Q ss_pred hHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCcc
Q 024027 161 VYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239 (273)
Q Consensus 161 iwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 239 (273)
|||||+++++|++ |..||......+. ....... .....+..++.++.+|+.+||..||+
T Consensus 193 i~slG~il~el~~~g~~p~~~~~~~~~-~~~~~~~-------------------~~~~~~~~~~~~l~~li~~~l~~~p~ 252 (279)
T 1qpc_A 193 VWSFGILLTEIVTHGRIPYPGMTNPEV-IQNLERG-------------------YRMVRPDNCPEELYQLMRLCWKERPE 252 (279)
T ss_dssp HHHHHHHHHHHHTTTCCSSTTCCHHHH-HHHHHTT-------------------CCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred hHHHHHHHHHHHhCCCCCCcccCHHHH-HHHHhcc-------------------cCCCCcccccHHHHHHHHHHhccChh
Confidence 9999999999999 9999875432211 1110000 00111345677899999999999999
Q ss_pred CCCCHHHHHHHHHHHHHhhh
Q 024027 240 QRINAKEIVTKLLKIRDSLL 259 (273)
Q Consensus 240 ~Rps~~~~l~~l~~~~~~~~ 259 (273)
+|||++++++.|+++.....
T Consensus 253 ~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 253 DRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp GSCCHHHHHHHHHHHHHHC-
T ss_pred hCCCHHHHHHHHHHHHHhcc
Confidence 99999999999999887654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=299.60 Aligned_cols=229 Identities=24% Similarity=0.289 Sum_probs=185.0
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||||+++... ......+.+|..+++.++||||++++++|.++..+++||||++||+|.+++... .+++..++.
T Consensus 95 ~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~ 172 (410)
T 3v8s_A 95 KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARF 172 (410)
T ss_dssp CEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHC--CCCHHHHHH
T ss_pred cEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHH
Confidence 369999997532 234556889999999999999999999999999999999999999999999764 489999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCC---
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGR--- 154 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--- 154 (273)
++.|++.||.||| +.|++||||||+||+++.++.+||+|||++....... .......+||+.|+|||++.+..
T Consensus 173 ~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~ 248 (410)
T 3v8s_A 173 YTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDG 248 (410)
T ss_dssp HHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTC
T ss_pred HHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC-cccccCCcCCccccCHHHhhccCCCc
Confidence 9999999999999 9999999999999999999999999999997653222 12233567999999999987655
Q ss_pred -cCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhc
Q 024027 155 -VSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMAC 233 (273)
Q Consensus 155 -~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 233 (273)
++.++|+|||||++|+|++|..||....... ....+... ......+....++.++.+||.+|
T Consensus 249 ~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~~----------------~~~~~~p~~~~~s~~~~~li~~l 311 (410)
T 3v8s_A 249 YYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-TYSKIMNH----------------KNSLTFPDDNDISKEAKNLICAF 311 (410)
T ss_dssp EEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTH----------------HHHCCCCTTCCCCHHHHHHHHHH
T ss_pred CCCCcceEecchHHHHHHHhCCCCCCCCChhh-HHHHHHhc----------------cccccCCCcccccHHHHHHHHHH
Confidence 7899999999999999999999997532221 11111110 00011111235678899999999
Q ss_pred CCCCccC--CCCHHHHHHHHH
Q 024027 234 TVESPEQ--RINAKEIVTKLL 252 (273)
Q Consensus 234 l~~dp~~--Rps~~~~l~~l~ 252 (273)
|..+|.+ ||+++++++|-+
T Consensus 312 L~~~~~rlgR~~~~ei~~Hp~ 332 (410)
T 3v8s_A 312 LTDREVRLGRNGVEEIKRHLF 332 (410)
T ss_dssp SSCGGGCTTSSCHHHHHTSGG
T ss_pred ccChhhhCCCCCHHHHhcCcc
Confidence 9999988 999999999865
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=294.78 Aligned_cols=228 Identities=22% Similarity=0.291 Sum_probs=180.3
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
.||||+++... ....+|++++.++ +||||+++++++.++...++||||++||+|.+++...+ .+++..+..++.
T Consensus 49 ~~avK~~~~~~----~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~-~~~~~~~~~~~~ 123 (342)
T 2qr7_A 49 EFAVKIIDKSK----RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK-FFSEREASAVLF 123 (342)
T ss_dssp EEEEEEEETTT----CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCT-TCCHHHHHHHHH
T ss_pred EEEEEEEEccc----CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHH
Confidence 69999997553 3456788888888 79999999999999999999999999999999996554 699999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCC----CceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcC
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDN----LVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVS 156 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~----~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 156 (273)
|++.||.||| +.|++||||||+||++..+ +.+||+|||++........ .....++++.|+|||++.+..++
T Consensus 124 qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~ 198 (342)
T 2qr7_A 124 TITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYD 198 (342)
T ss_dssp HHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHH
T ss_pred HHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC--ceeccCCCccccCHHHhcCCCCC
Confidence 9999999999 9999999999999998533 3599999999986533222 23345789999999999887899
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++|||||||++|+|++|..||....... ......... . .........+..++.++.+|+.+||..
T Consensus 199 ~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~i~---------~---~~~~~~~~~~~~~s~~~~~li~~~L~~ 264 (342)
T 2qr7_A 199 AACDIWSLGVLLYTMLTGYTPFANGPDDT--PEEILARIG---------S---GKFSLSGGYWNSVSDTAKDLVSKMLHV 264 (342)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSSCSSTTSC--HHHHHHHHH---------H---CCCCCCSTTTTTSCHHHHHHHHHHTCS
T ss_pred CccCeeeHhHHHHHHhcCCCCCCCCCcCC--HHHHHHHHc---------c---CCcccCccccccCCHHHHHHHHHHCCC
Confidence 99999999999999999999997532211 111111000 0 000001111345678899999999999
Q ss_pred CccCCCCHHHHHHHHHH
Q 024027 237 SPEQRINAKEIVTKLLK 253 (273)
Q Consensus 237 dp~~Rps~~~~l~~l~~ 253 (273)
||++|||+.++++|-+-
T Consensus 265 dP~~R~t~~~il~hp~~ 281 (342)
T 2qr7_A 265 DPHQRLTAALVLRHPWI 281 (342)
T ss_dssp STTTSCCHHHHTTSHHH
T ss_pred ChhHCcCHHHHhcCCee
Confidence 99999999999998764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=308.34 Aligned_cols=230 Identities=27% Similarity=0.440 Sum_probs=186.6
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC-CCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~ 80 (273)
+||||+++.. ....+.+.+|+++++.++||||+++++++. ....++||||+++|+|.+++.... ..+++..++.++.
T Consensus 214 ~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~ 291 (454)
T 1qcf_A 214 KVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA 291 (454)
T ss_dssp EEEEEEECTT-SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHH
T ss_pred EEEEEEecCC-CccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHH
Confidence 6999999865 345688999999999999999999999987 567899999999999999997542 3588899999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
|++.||.||| +.|++||||||+||+++.++.+||+|||++....... ........++..|+|||++.+..++.++|
T Consensus 292 qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 367 (454)
T 1qcf_A 292 QIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSD 367 (454)
T ss_dssp HHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH-HHTTCSSSSCGGGSCHHHHHHCCCCHHHH
T ss_pred HHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc-eeccCCCcccccccCHHHhccCCCCcHHH
Confidence 9999999999 9999999999999999999999999999998652211 11112234567899999998888999999
Q ss_pred hHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCcc
Q 024027 161 VYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239 (273)
Q Consensus 161 iwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 239 (273)
|||||+++|+|++ |..||......+.. .... .. .....+..++.++.+|+.+||..||.
T Consensus 368 vwslG~~l~el~t~g~~P~~~~~~~~~~-~~i~-------------~~------~~~~~~~~~~~~l~~li~~cl~~dp~ 427 (454)
T 1qcf_A 368 VWSFGILLMEIVTYGRIPYPGMSNPEVI-RALE-------------RG------YRMPRPENCPEELYNIMMRCWKNRPE 427 (454)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCHHHHH-HHHH-------------HT------CCCCCCTTSCHHHHHHHHHHTCSSGG
T ss_pred HHhHHHHHHHHHhCCCCCCCCCCHHHHH-HHHH-------------cC------CCCCCCCCCCHHHHHHHHHHccCChh
Confidence 9999999999999 99999764332211 0000 00 01112456778899999999999999
Q ss_pred CCCCHHHHHHHHHHHHHh
Q 024027 240 QRINAKEIVTKLLKIRDS 257 (273)
Q Consensus 240 ~Rps~~~~l~~l~~~~~~ 257 (273)
+|||++++++.|+++..+
T Consensus 428 ~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 428 ERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp GSCCHHHHHHHHHTSSSS
T ss_pred HCcCHHHHHHHHHHHHhc
Confidence 999999999999877654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=302.76 Aligned_cols=227 Identities=23% Similarity=0.312 Sum_probs=183.2
Q ss_pred CeEEEEEeecc--cChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 1 MEVAVKVFNLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 1 ~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
+.||||+++.. .......+.+|+++++.++||||+++++++.+...+++||||+++++|.+++.... .+++..++.+
T Consensus 48 ~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i 126 (486)
T 3mwu_A 48 QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARI 126 (486)
T ss_dssp CEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS-SCCHHHHHHH
T ss_pred CEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHH
Confidence 47999999744 23456789999999999999999999999999999999999999999999986543 6999999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeC---CCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCc
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLD---DNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRV 155 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~---~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~ 155 (273)
+.|++.||.||| +.|++||||||+||+++ .++.+||+|||++..+... ......+|++.|+|||++.+ .+
T Consensus 127 ~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~ 199 (486)
T 3mwu_A 127 IKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAPEVLRG-TY 199 (486)
T ss_dssp HHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CC
T ss_pred HHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC---CccCCCcCCCCCCCHHHhCC-CC
Confidence 999999999999 99999999999999995 4567999999999765322 22334578999999999876 58
Q ss_pred CCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCC
Q 024027 156 STNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTV 235 (273)
Q Consensus 156 ~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 235 (273)
+.++||||+||++|+|++|..||......+. ....... ......+....++.++.+|+.+||.
T Consensus 200 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~----------------~~~~~~~~~~~~s~~~~~li~~~L~ 262 (486)
T 3mwu_A 200 DEKCDVWSAGVILYILLSGTPPFYGKNEYDI-LKRVETG----------------KYAFDLPQWRTISDDAKDLIRKMLT 262 (486)
T ss_dssp CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHT----------------CCCSCSGGGGGSCHHHHHHHHHHTC
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhC----------------CCCCCCcccCCCCHHHHHHHHHHcC
Confidence 9999999999999999999999976332211 1111110 1111112235577889999999999
Q ss_pred CCccCCCCHHHHHHHHH
Q 024027 236 ESPEQRINAKEIVTKLL 252 (273)
Q Consensus 236 ~dp~~Rps~~~~l~~l~ 252 (273)
.||.+|||+.++++|-+
T Consensus 263 ~dp~~R~t~~~~l~hp~ 279 (486)
T 3mwu_A 263 FHPSLRITATQCLEHPW 279 (486)
T ss_dssp SSTTTSCCHHHHHHCHH
T ss_pred CChhhCcCHHHHhcCHh
Confidence 99999999999999855
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=298.56 Aligned_cols=246 Identities=19% Similarity=0.181 Sum_probs=177.6
Q ss_pred eEEEEEeecc--cChhhhhHHHHHHHHhcCCCccceeeeeeeecC-----CceeEEEeccCCCCHHHhhhcCCCCCCHHH
Q 024027 2 EVAVKVFNLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNE-----EFKALVLEYMPHGSLEKYLYSSNCILDIFQ 74 (273)
Q Consensus 2 ~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (273)
.||||+++.. .....+.+.+|+++|+.++||||+++++++... ...|+||||+++ +|.+++... ..+++..
T Consensus 53 ~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~-~~l~~~~ 130 (432)
T 3n9x_A 53 NVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTP-IFLTEEH 130 (432)
T ss_dssp EEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCSE-EHHHHHHSS-CCCCHHH
T ss_pred EEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCCc-CHHHHHhcc-CCCCHHH
Confidence 6999999754 234567789999999999999999999999776 578999999965 999999654 4699999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCc--------------------ce
Q 024027 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQS--------------------MT 134 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~--------------------~~ 134 (273)
++.++.||+.||.||| +.|++||||||+||+++.++.+||+|||++......... ..
T Consensus 131 ~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (432)
T 3n9x_A 131 IKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQ 207 (432)
T ss_dssp HHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC----------------------------
T ss_pred HHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhcc
Confidence 9999999999999999 999999999999999999999999999999876432211 11
Q ss_pred eecccccCCCCCCccc-CCCCcCCcchhHHHHHHHHHHHhCCCCCccccccc---------------------------c
Q 024027 135 QTQTLATIGYMAPEYG-REGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGE---------------------------M 186 (273)
Q Consensus 135 ~~~~~~~~~~~aPE~~-~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~---------------------------~ 186 (273)
....+||++|+|||++ .+..++.++|||||||++|+|++|..||.....+. .
T Consensus 208 ~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ 287 (432)
T 3n9x_A 208 LTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRD 287 (432)
T ss_dssp ---CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHH
T ss_pred ccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHH
Confidence 2456789999999985 55669999999999999999998665554321110 0
Q ss_pred chhhhhhhccCccc-----------hhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 187 TLKHWVNDWLPIST-----------MEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 187 ~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
.+..+......+.. ...................+.++.++.+|+.+||..||++|||++++++|-.
T Consensus 288 ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~ 364 (432)
T 3n9x_A 288 QLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPY 364 (432)
T ss_dssp HHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGG
T ss_pred HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChh
Confidence 00001110000000 0000000000000111112457888999999999999999999999999743
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=281.28 Aligned_cols=228 Identities=22% Similarity=0.298 Sum_probs=182.7
Q ss_pred CeEEEEEeecccC------hhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHH
Q 024027 1 MEVAVKVFNLQCG------RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQ 74 (273)
Q Consensus 1 ~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (273)
+.||||+++.... ...+.+.+|+.+++.++||||+++++++.+....++||||+++++|.+++... ..+++..
T Consensus 31 ~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~ 109 (283)
T 3bhy_A 31 KEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEK-ESLTEDE 109 (283)
T ss_dssp CEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHH
T ss_pred CeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhc-CCCCHHH
Confidence 4799999976531 13577999999999999999999999999999999999999999999999654 3689999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCC----ceEEeecccccccccCCCcceeecccccCCCCCCccc
Q 024027 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNL----VAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYG 150 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~----~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 150 (273)
++.++.|++.||.||| +.|++|+||+|+||+++.++ .++|+|||.+....... ......+++.|+|||.+
T Consensus 110 ~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~ 183 (283)
T 3bhy_A 110 ATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNIFGTPEFVAPEIV 183 (283)
T ss_dssp HHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-----------CCCGGGCCHHHH
T ss_pred HHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecccceeccCCC---cccccCCCcCccCccee
Confidence 9999999999999999 99999999999999998877 89999999997653221 22345688999999999
Q ss_pred CCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHH
Q 024027 151 REGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLA 230 (273)
Q Consensus 151 ~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 230 (273)
.+..++.++||||||+++++|++|..||........ ....... ...........++..+.+|+
T Consensus 184 ~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~----------------~~~~~~~~~~~~~~~~~~li 246 (283)
T 3bhy_A 184 NYEPLGLEADMWSIGVITYILLSGASPFLGETKQET-LTNISAV----------------NYDFDEEYFSNTSELAKDFI 246 (283)
T ss_dssp TTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHTT----------------CCCCCHHHHTTCCHHHHHHH
T ss_pred cCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH-HHHhHhc----------------ccCCcchhcccCCHHHHHHH
Confidence 988899999999999999999999999876332211 1111000 01111122345677899999
Q ss_pred hhcCCCCccCCCCHHHHHHHHH
Q 024027 231 MACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 231 ~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
.+||..||.+|||+.++++|-.
T Consensus 247 ~~~l~~dp~~Rps~~~~l~h~~ 268 (283)
T 3bhy_A 247 RRLLVKDPKRRMTIAQSLEHSW 268 (283)
T ss_dssp HTTSCSSGGGSCCHHHHHHCHH
T ss_pred HHHccCCHhHCcCHHHHHhCHH
Confidence 9999999999999999999743
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=294.41 Aligned_cols=241 Identities=17% Similarity=0.181 Sum_probs=185.6
Q ss_pred eEEEEEeecccCh-----------hhhhHHHHHHHHhcCCCccceeeeeeeec----CCceeEEEeccCCCCHHHhhhcC
Q 024027 2 EVAVKVFNLQCGR-----------AFKSFDVECEMMKSIRHRNLIKVISSCSN----EEFKALVLEYMPHGSLEKYLYSS 66 (273)
Q Consensus 2 ~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~ 66 (273)
.||||++...... ....+.+|+..++.++||||+++++++.. ....++||||+ +++|.+++...
T Consensus 67 ~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~ 145 (345)
T 2v62_A 67 RHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN 145 (345)
T ss_dssp CEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG
T ss_pred eEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhc
Confidence 6899999765322 12346678889999999999999999887 77899999999 88999999765
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCC--ceEEeecccccccccCCCc-----ceeeccc
Q 024027 67 NCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNL--VAYLSDFGIAKLLIGEDQS-----MTQTQTL 139 (273)
Q Consensus 67 ~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~--~~kl~Df~~~~~~~~~~~~-----~~~~~~~ 139 (273)
+ .+++..++.++.|++.||.||| +.|++|+||||+||+++.++ .+||+|||++..+...... .......
T Consensus 146 ~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~ 221 (345)
T 2v62_A 146 G-TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHN 221 (345)
T ss_dssp G-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSC
T ss_pred C-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccC
Confidence 4 7999999999999999999999 99999999999999998877 9999999999766332211 1113446
Q ss_pred ccCCCCCCcccCCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhh
Q 024027 140 ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAK 219 (273)
Q Consensus 140 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (273)
|++.|+|||++.+..++.++|||||||++|+|++|..||.................... ..... ......
T Consensus 222 gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~---------~~~~~~ 291 (345)
T 2v62_A 222 GTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDE-LPQSV---------LKWAPS 291 (345)
T ss_dssp SCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHT-TTHHH---------HHHSCT
T ss_pred CCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhccc-ccHHH---------Hhhccc
Confidence 89999999999988899999999999999999999999965333322222111111000 00000 000001
Q ss_pred hhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHHHHHHh
Q 024027 220 EQCVSFVFNLAMACTVESPEQRINAKEIVTKLLKIRDS 257 (273)
Q Consensus 220 ~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~ 257 (273)
..++.++.+++.+||..||++|||++++++.|+.+...
T Consensus 292 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 329 (345)
T 2v62_A 292 GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIP 329 (345)
T ss_dssp TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCC
T ss_pred cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCc
Confidence 25677899999999999999999999999999876543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=291.85 Aligned_cols=217 Identities=24% Similarity=0.301 Sum_probs=181.2
Q ss_pred eEEEEEeecccC--------hhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCC-CHHHhhhcCCCCCCH
Q 024027 2 EVAVKVFNLQCG--------RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHG-SLEKYLYSSNCILDI 72 (273)
Q Consensus 2 ~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~ 72 (273)
.||||+++.... .....+.+|+.+++.++||||+++++++.+.+..++||||+.+| +|.+++.... .+++
T Consensus 51 ~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~-~l~~ 129 (335)
T 3dls_A 51 EVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP-RLDE 129 (335)
T ss_dssp EEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCC-CCCH
T ss_pred EEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcC-CCCH
Confidence 699999976531 24457888999999999999999999999999999999998666 9999996543 6999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC
Q 024027 73 FQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE 152 (273)
Q Consensus 73 ~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 152 (273)
..++.++.|++.||.||| +.|++|+||||+||+++.++.+||+|||++....... ......|++.|+|||++.+
T Consensus 130 ~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~ 203 (335)
T 3dls_A 130 PLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK---LFYTFCGTIEYCAPEVLMG 203 (335)
T ss_dssp HHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTC---CBCEECSCGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecccceECCCCC---ceeccCCCccccChhhhcC
Confidence 999999999999999999 9999999999999999999999999999998653322 2234568999999999988
Q ss_pred CCc-CCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHh
Q 024027 153 GRV-STNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAM 231 (273)
Q Consensus 153 ~~~-~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 231 (273)
..+ +.++||||||+++|+|++|..||....... .. ....+..++.++.+|+.
T Consensus 204 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------~~--------------------~~~~~~~~~~~l~~li~ 256 (335)
T 3dls_A 204 NPYRGPELEMWSLGVTLYTLVFEENPFCELEETV-------EA--------------------AIHPPYLVSKELMSLVS 256 (335)
T ss_dssp CCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT-------TT--------------------CCCCSSCCCHHHHHHHH
T ss_pred CCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH-------hh--------------------ccCCCcccCHHHHHHHH
Confidence 776 789999999999999999999986521110 00 00013335677999999
Q ss_pred hcCCCCccCCCCHHHHHHHHH
Q 024027 232 ACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 232 ~~l~~dp~~Rps~~~~l~~l~ 252 (273)
+||..||++|||+.++++|-+
T Consensus 257 ~~L~~dP~~Rps~~ell~hp~ 277 (335)
T 3dls_A 257 GLLQPVPERRTTLEKLVTDPW 277 (335)
T ss_dssp HHTCSSGGGSCCHHHHHHCTT
T ss_pred HHccCChhhCcCHHHHhcCcc
Confidence 999999999999999999854
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=300.48 Aligned_cols=231 Identities=19% Similarity=0.234 Sum_probs=185.5
Q ss_pred eEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 2 EVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 2 ~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
.||||+++... ......+.+|..++..++||||++++++|.++..+++||||++||+|.+++......+++..++.+
T Consensus 101 ~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~ 180 (437)
T 4aw2_A 101 VFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFY 180 (437)
T ss_dssp EEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHH
T ss_pred EEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHH
Confidence 69999997532 233455899999999999999999999999999999999999999999999876667999999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccC-----CC
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR-----EG 153 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~ 153 (273)
+.|++.||.||| +.|++||||||+||+++.++.+||+|||++....... .......+||+.|+|||++. ..
T Consensus 181 ~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~ 256 (437)
T 4aw2_A 181 LAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAVGTPDYISPEILQAMEGGKG 256 (437)
T ss_dssp HHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-CEECCSCCSCGGGCCHHHHHHHHTSCC
T ss_pred HHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC-CcccccccCCcCeeChHHHhhcccCCC
Confidence 999999999999 9999999999999999999999999999997653222 22233467999999999986 45
Q ss_pred CcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhc
Q 024027 154 RVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMAC 233 (273)
Q Consensus 154 ~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 233 (273)
.++.++|+|||||++|+|++|..||......+. ...+..... ....+ .....++.++.+||.+|
T Consensus 257 ~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~-~~~i~~~~~-----------~~~~p----~~~~~~s~~~~dLi~~l 320 (437)
T 4aw2_A 257 RYGPECDWWSLGVCMYEMLYGETPFYAESLVET-YGKIMNHKE-----------RFQFP----TQVTDVSENAKDLIRRL 320 (437)
T ss_dssp EECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHTHHH-----------HCCCC----SSCCCSCHHHHHHHHTT
T ss_pred CCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH-HHhhhhccc-----------cccCC----cccccCCHHHHHHHHHH
Confidence 689999999999999999999999976332221 111111000 00000 00133677899999999
Q ss_pred CCCCccC--CCCHHHHHHHHH
Q 024027 234 TVESPEQ--RINAKEIVTKLL 252 (273)
Q Consensus 234 l~~dp~~--Rps~~~~l~~l~ 252 (273)
|..+|++ ||+++++++|-+
T Consensus 321 L~~~~~r~~r~~~~eil~Hpf 341 (437)
T 4aw2_A 321 ICSREHRLGQNGIEDFKKHPF 341 (437)
T ss_dssp SSCGGGCTTTTTTHHHHTSGG
T ss_pred hcccccccCCCCHHHHhCCCc
Confidence 9999888 999999998754
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=304.15 Aligned_cols=227 Identities=23% Similarity=0.306 Sum_probs=185.7
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||||++.... ......+.+|+.+++.++||||+++++++.+.+..++||||+.+++|.+++... ..+++..++.
T Consensus 52 ~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~ 130 (484)
T 3nyv_A 52 QECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR-KRFSEVDAAR 130 (484)
T ss_dssp CEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTC-SCCBHHHHHH
T ss_pred CEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHH
Confidence 479999997542 345678999999999999999999999999999999999999999999999654 4699999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceee---CCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLL---DDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGR 154 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~---~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 154 (273)
++.|++.||.||| +.|++||||||+||++ +.++.+||+|||++..+.... ......|++.|+|||++.+ .
T Consensus 131 i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~ 203 (484)
T 3nyv_A 131 IIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVLHG-T 203 (484)
T ss_dssp HHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC---SHHHHTTGGGTCCHHHHHT-C
T ss_pred HHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc---ccccCCCCccccCceeecC-C
Confidence 9999999999999 9999999999999999 567899999999997653222 2334578999999999876 6
Q ss_pred cCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcC
Q 024027 155 VSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACT 234 (273)
Q Consensus 155 ~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 234 (273)
++.++||||+||++|+|++|.+||......+. ....... ......+....++.++.+|+.+||
T Consensus 204 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~----------------~~~~~~~~~~~~s~~~~~li~~~L 266 (484)
T 3nyv_A 204 YDEKCDVWSTGVILYILLSGCPPFNGANEYDI-LKKVEKG----------------KYTFELPQWKKVSESAKDLIRKML 266 (484)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHC----------------CCCCCSGGGGGSCHHHHHHHHHHT
T ss_pred CCCcceeHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHcC----------------CCCCCCcccccCCHHHHHHHHHHC
Confidence 89999999999999999999999976432211 1111110 001111223457788999999999
Q ss_pred CCCccCCCCHHHHHHHHH
Q 024027 235 VESPEQRINAKEIVTKLL 252 (273)
Q Consensus 235 ~~dp~~Rps~~~~l~~l~ 252 (273)
..||.+|||+.++++|-+
T Consensus 267 ~~dp~~R~s~~e~l~h~~ 284 (484)
T 3nyv_A 267 TYVPSMRISARDALDHEW 284 (484)
T ss_dssp CSSGGGSCCHHHHHTSHH
T ss_pred CCChhHCcCHHHHhhChh
Confidence 999999999999999866
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=294.44 Aligned_cols=242 Identities=13% Similarity=0.129 Sum_probs=188.6
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCcccee---------------eeeeeec-CCceeEEEeccCCCCHHHhhh
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIK---------------VISSCSN-EEFKALVLEYMPHGSLEKYLY 64 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~---------------~~~~~~~-~~~~~lv~e~~~~~~L~~~l~ 64 (273)
+.||||+++.. ..+.+|+++++.++||||++ +++++.. +...++||||+ +++|.+++.
T Consensus 76 ~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~ 149 (352)
T 2jii_A 76 QKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALD 149 (352)
T ss_dssp -CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHH
T ss_pred ceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHH
Confidence 36999999744 57889999999999999998 5566654 67889999999 889999997
Q ss_pred cC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCC--ceEEeecccccccccCCCcc-----eee
Q 024027 65 SS-NCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNL--VAYLSDFGIAKLLIGEDQSM-----TQT 136 (273)
Q Consensus 65 ~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~--~~kl~Df~~~~~~~~~~~~~-----~~~ 136 (273)
.. ...+++..++.++.|++.||.||| +.|++|+||||+||+++.++ .++|+|||++..+....... ...
T Consensus 150 ~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~ 226 (352)
T 2jii_A 150 VSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRS 226 (352)
T ss_dssp HSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSC
T ss_pred hCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccc
Confidence 65 356999999999999999999999 99999999999999999988 99999999997664322111 123
Q ss_pred cccccCCCCCCcccCCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhh
Q 024027 137 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHF 216 (273)
Q Consensus 137 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (273)
...+++.|+|||.+.+..++.++||||||+++|+|++|..||.................... .. ......
T Consensus 227 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~---------~~~~~~ 296 (352)
T 2jii_A 227 PHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDK-PG---------PFVGPC 296 (352)
T ss_dssp TTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHS-CC---------CEECTT
T ss_pred cccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCC-hh---------hhhhhc
Confidence 34789999999999988899999999999999999999999987543322222111110000 00 000000
Q ss_pred hhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHHHHHHhhhhh
Q 024027 217 VAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLLKIRDSLLRN 261 (273)
Q Consensus 217 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~ 261 (273)
.....++.++.+|+.+||..||++|||++++++.|+++.+++...
T Consensus 297 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 341 (352)
T 2jii_A 297 GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVS 341 (352)
T ss_dssp SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence 001235677999999999999999999999999999999887644
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=306.52 Aligned_cols=231 Identities=28% Similarity=0.437 Sum_probs=183.0
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcC-CCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~ 80 (273)
+||||+++... ...+.+.+|+++++.++||||+++++++.+ ...++||||+++|+|.+++... +..+++..++.++.
T Consensus 210 ~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~ 287 (452)
T 1fmk_A 210 RVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 287 (452)
T ss_dssp EEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHH
T ss_pred eEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHH
Confidence 69999998653 345789999999999999999999999876 6789999999999999999643 34589999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
|++.||.||| +.|++||||||+||+++.++.+||+|||++....... ........++..|+|||.+.+..++.++|
T Consensus 288 qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sD 363 (452)
T 1fmk_A 288 QIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSD 363 (452)
T ss_dssp HHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHH
T ss_pred HHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc-eecccCCcccccccCHhHHhcCCCCcccc
Confidence 9999999999 9999999999999999999999999999997653221 11122334677899999998888999999
Q ss_pred hHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCcc
Q 024027 161 VYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239 (273)
Q Consensus 161 iwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 239 (273)
|||||+++|+|++ |..||......+.. ..... . .....+..++..+.+|+.+||..||+
T Consensus 364 vwslG~~l~el~t~g~~P~~~~~~~~~~-~~i~~-------------~------~~~~~~~~~~~~l~~li~~cl~~dP~ 423 (452)
T 1fmk_A 364 VWSFGILLTELTTKGRVPYPGMVNREVL-DQVER-------------G------YRMPCPPECPESLHDLMCQCWRKEPE 423 (452)
T ss_dssp HHHHHHHHHHHHTTTCCSSTTCCHHHHH-HHHHT-------------T------CCCCCCTTSCHHHHHHHHHHTCSSGG
T ss_pred HHhHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHc-------------C------CCCCCCCCCCHHHHHHHHHHccCChh
Confidence 9999999999999 99998764332211 00000 0 01112456778899999999999999
Q ss_pred CCCCHHHHHHHHHHHHHhh
Q 024027 240 QRINAKEIVTKLLKIRDSL 258 (273)
Q Consensus 240 ~Rps~~~~l~~l~~~~~~~ 258 (273)
+|||++++++.|+++..+.
T Consensus 424 ~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 424 ERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp GSCCHHHHHHHHHTTTSCS
T ss_pred hCcCHHHHHHHHHHHhccC
Confidence 9999999999998776543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=300.15 Aligned_cols=247 Identities=19% Similarity=0.171 Sum_probs=174.8
Q ss_pred CeEEEEEeecc--cChhhhhHHHHHHHHhcCCCccceeeeeeeec-----CCceeEEEeccCCCCHHHhhhcCCCCCCHH
Q 024027 1 MEVAVKVFNLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSN-----EEFKALVLEYMPHGSLEKYLYSSNCILDIF 73 (273)
Q Consensus 1 ~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 73 (273)
+.||||++... +....+.+.+|+++|+.++||||+++++++.. ...+|+||||++ ++|.+++... ..+++.
T Consensus 79 ~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~l~~~ 156 (458)
T 3rp9_A 79 RVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTP-VYLTEL 156 (458)
T ss_dssp CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCCS-EEHHHHHHSS-CCCCHH
T ss_pred cEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEeccc-cchhhhcccC-CCCCHH
Confidence 47999999654 23456778999999999999999999999844 357899999995 5999999654 469999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCc---------------------
Q 024027 74 QRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQS--------------------- 132 (273)
Q Consensus 74 ~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~--------------------- 132 (273)
.++.++.||+.||.||| +.|++||||||+|||++.++.+||+|||++.........
T Consensus 157 ~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (458)
T 3rp9_A 157 HIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHT 233 (458)
T ss_dssp HHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC----------------
T ss_pred HHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCcccccccccccccc
Confidence 99999999999999999 999999999999999999999999999999866322110
Q ss_pred ----ceeecccccCCCCCCccc-CCCCcCCcchhHHHHHHHHHHHh-----------CCCCCcccccc------------
Q 024027 133 ----MTQTQTLATIGYMAPEYG-REGRVSTNGDVYSFGIMLMETFT-----------GKKPTYEFFNG------------ 184 (273)
Q Consensus 133 ----~~~~~~~~~~~~~aPE~~-~~~~~~~~~DiwslG~~l~~ll~-----------g~~pf~~~~~~------------ 184 (273)
......+||++|+|||++ .+..++.++|||||||++|+|++ |.++|.....-
T Consensus 234 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~ 313 (458)
T 3rp9_A 234 KNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDF 313 (458)
T ss_dssp -----------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC-----------------
T ss_pred ccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccc
Confidence 122345789999999976 45669999999999999999998 55555432210
Q ss_pred -------ccchhhhhhhccCccchh-----------hhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHH
Q 024027 185 -------EMTLKHWVNDWLPISTME-----------VVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKE 246 (273)
Q Consensus 185 -------~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 246 (273)
...+..+........... .................+.++.++.+||.+||..||++|||++|
T Consensus 314 ~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e 393 (458)
T 3rp9_A 314 KFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINE 393 (458)
T ss_dssp ---CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred cccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHH
Confidence 000000000000000000 00000000000011112345788999999999999999999999
Q ss_pred HHHHHH
Q 024027 247 IVTKLL 252 (273)
Q Consensus 247 ~l~~l~ 252 (273)
+++|=+
T Consensus 394 ~L~Hp~ 399 (458)
T 3rp9_A 394 CLAHPF 399 (458)
T ss_dssp HHHSGG
T ss_pred HhcCHh
Confidence 999854
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=284.81 Aligned_cols=226 Identities=21% Similarity=0.332 Sum_probs=182.7
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeec----------------CCceeEEEeccCCCCHHHhhh
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSN----------------EEFKALVLEYMPHGSLEKYLY 64 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~~~~~L~~~l~ 64 (273)
+.||||+++... ..+.+|+++++.++||||+++++++.. ....++||||+++++|.+++.
T Consensus 37 ~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 112 (284)
T 2a19_B 37 KTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE 112 (284)
T ss_dssp CEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHH
T ss_pred eEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHh
Confidence 479999997553 467899999999999999999998854 455899999999999999996
Q ss_pred cC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCC
Q 024027 65 SS-NCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIG 143 (273)
Q Consensus 65 ~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~ 143 (273)
.. ...+++..++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++....... ......+++.
T Consensus 113 ~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~ 186 (284)
T 2a19_B 113 KRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG---KRTRSKGTLR 186 (284)
T ss_dssp HGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCCS---CCCCCCSCCT
T ss_pred hccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCCEEECcchhheeccccc---cccccCCccc
Confidence 54 346899999999999999999999 9999999999999999999999999999987653322 2234568999
Q ss_pred CCCCcccCCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhH
Q 024027 144 YMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCV 223 (273)
Q Consensus 144 ~~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (273)
|+|||.+.+..++.++||||||+++|+|++|..||..... ..... .. ...+..++
T Consensus 187 y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~~~-------------~~---------~~~~~~~~ 241 (284)
T 2a19_B 187 YMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK---FFTDL-------------RD---------GIISDIFD 241 (284)
T ss_dssp TSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH---HHHHH-------------HT---------TCCCTTSC
T ss_pred ccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH---HHHHh-------------hc---------ccccccCC
Confidence 9999999888899999999999999999999988643110 00000 00 00123456
Q ss_pred HHHHHHHhhcCCCCccCCCCHHHHHHHHHHHHHhhhhh
Q 024027 224 SFVFNLAMACTVESPEQRINAKEIVTKLLKIRDSLLRN 261 (273)
Q Consensus 224 ~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~ 261 (273)
.++.+++.+||..||.+|||+.+++++|+.+.++..++
T Consensus 242 ~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~ 279 (284)
T 2a19_B 242 KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKN 279 (284)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-----
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCcc
Confidence 67899999999999999999999999999998776654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=285.15 Aligned_cols=227 Identities=30% Similarity=0.426 Sum_probs=178.2
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeec-CCceeEEEeccCCCCHHHhhhcCCC-CCCHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSN-EEFKALVLEYMPHGSLEKYLYSSNC-ILDIFQRLNI 78 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~ 78 (273)
++||||+++... ..+.+.+|+++++.++||||+++++++.+ .+..++||||+++++|.+++..... .+++..++.+
T Consensus 45 ~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 122 (278)
T 1byg_A 45 NKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 122 (278)
T ss_dssp EEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHH
T ss_pred CEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHH
Confidence 369999997542 45779999999999999999999998654 4578999999999999999965432 3789999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCc
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTN 158 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 158 (273)
+.|++.||.||| +.|++|+||||+||+++.++.++|+|||++...... .....+++.|+|||.+.+..++.+
T Consensus 123 ~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~ 194 (278)
T 1byg_A 123 SLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTK 194 (278)
T ss_dssp HHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCCCHH
T ss_pred HHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeecccccccccc-----ccCCCccccccCHHHhCCCCCCch
Confidence 999999999999 999999999999999999999999999998754221 223356788999999988889999
Q ss_pred chhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 159 GDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 159 ~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
+||||||+++|+|++ |..||......+. ....... .....+..++..+.+++.+||..|
T Consensus 195 ~Di~slG~il~~l~t~g~~p~~~~~~~~~-~~~~~~~-------------------~~~~~~~~~~~~l~~li~~~l~~~ 254 (278)
T 1byg_A 195 SDVWSFGILLWEIYSFGRVPYPRIPLKDV-VPRVEKG-------------------YKMDAPDGCPPAVYEVMKNCWHLD 254 (278)
T ss_dssp HHHHHHHHHHHHHHTTSCCSCTTSCGGGH-HHHHTTT-------------------CCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred hcHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHhcC-------------------CCCCCcccCCHHHHHHHHHHhcCC
Confidence 999999999999998 9999875432211 1110000 001113456778999999999999
Q ss_pred ccCCCCHHHHHHHHHHHHHh
Q 024027 238 PEQRINAKEIVTKLLKIRDS 257 (273)
Q Consensus 238 p~~Rps~~~~l~~l~~~~~~ 257 (273)
|.+|||+.++++.|++++..
T Consensus 255 p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 255 AAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp GGGSCCHHHHHHHHHHHHHH
T ss_pred hhhCCCHHHHHHHHHHHHhh
Confidence 99999999999999998764
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=282.82 Aligned_cols=222 Identities=23% Similarity=0.275 Sum_probs=183.9
Q ss_pred eEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 2 EVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 2 ~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
.||||++.... ......+.+|+++++.++||||+++++++.+.+..++||||+++++|.+++...+ .+++..++.+
T Consensus 41 ~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~ 119 (284)
T 2vgo_A 41 IMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG-RFDEQRSATF 119 (284)
T ss_dssp EEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS-SCCHHHHHHH
T ss_pred EEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHH
Confidence 69999997542 2335678999999999999999999999999999999999999999999997553 5899999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCc
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTN 158 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 158 (273)
+.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++...... ......+++.|+|||.+.+..++.+
T Consensus 120 ~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~ 192 (284)
T 2vgo_A 120 MEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL----RRRTMCGTLDYLPPEMIEGKTHDEK 192 (284)
T ss_dssp HHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS----CBCCCCSCGGGCCHHHHTTCCBCTT
T ss_pred HHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCccc----ccccccCCCCcCCHHHhccCCCCcc
Confidence 999999999999 999999999999999999999999999998654221 2234568899999999998889999
Q ss_pred chhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc
Q 024027 159 GDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238 (273)
Q Consensus 159 ~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 238 (273)
+||||||+++|+|++|..||........ ....... ....+..++.++.+|+.+||..||
T Consensus 193 ~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~--------------------~~~~~~~~~~~~~~li~~~l~~~p 251 (284)
T 2vgo_A 193 VDLWCAGVLCYEFLVGMPPFDSPSHTET-HRRIVNV--------------------DLKFPPFLSDGSKDLISKLLRYHP 251 (284)
T ss_dssp HHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHTT--------------------CCCCCTTSCHHHHHHHHHHSCSSG
T ss_pred cchhhHHHHHHHHHHCCCCCCCCCHhHH-HHHHhcc--------------------ccCCCCcCCHHHHHHHHHHhhcCH
Confidence 9999999999999999999875332211 1111000 001134466779999999999999
Q ss_pred cCCCCHHHHHHHHH
Q 024027 239 EQRINAKEIVTKLL 252 (273)
Q Consensus 239 ~~Rps~~~~l~~l~ 252 (273)
.+|||++++++|-+
T Consensus 252 ~~Rps~~~ll~h~~ 265 (284)
T 2vgo_A 252 PQRLPLKGVMEHPW 265 (284)
T ss_dssp GGSCCHHHHHTCHH
T ss_pred hhCCCHHHHhhCHH
Confidence 99999999999855
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=305.20 Aligned_cols=228 Identities=22% Similarity=0.269 Sum_probs=185.9
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC-CCCCHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~ 76 (273)
+.||||+++... ......+.+|+++|+.++||||+++++++.+...+++||||++||+|.+++...+ ..+++..++
T Consensus 210 ~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~ 289 (576)
T 2acx_A 210 KMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAV 289 (576)
T ss_dssp CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHH
T ss_pred CEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHH
Confidence 479999997542 3345668899999999999999999999999999999999999999999997553 349999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcC
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVS 156 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 156 (273)
.++.||+.||.||| +.|++||||||+||+++.++.+||+|||++..+.... .....+||+.|+|||++.+..++
T Consensus 290 ~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~ 363 (576)
T 2acx_A 290 FYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYT 363 (576)
T ss_dssp HHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC---CEECCCSCGGGCCHHHHTTCEES
T ss_pred HHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceecccCc---cccccCCCccccCHHHHcCCCCC
Confidence 99999999999999 9999999999999999999999999999998653221 23345799999999999988899
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++|+|||||++|+|++|..||.......... ..... +... ....+..++.++.+|+.+||..
T Consensus 364 ~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~-~i~~~---------i~~~-------~~~~p~~~s~~~~dLI~~lL~~ 426 (576)
T 2acx_A 364 FSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE-EVERL---------VKEV-------PEEYSERFSPQARSLCSQLLCK 426 (576)
T ss_dssp SHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH-HHHHH---------HHHC-------CCCCCTTSCHHHHHHHHHHTCS
T ss_pred ccchHHHHHHHHHHHHhCCCCCcccccchhHH-HHHHH---------hhcc-------cccCCccCCHHHHHHHHHhccC
Confidence 99999999999999999999997643321111 00000 0000 0011345677899999999999
Q ss_pred CccCCC-----CHHHHHHHH
Q 024027 237 SPEQRI-----NAKEIVTKL 251 (273)
Q Consensus 237 dp~~Rp-----s~~~~l~~l 251 (273)
||.+|| +++++++|-
T Consensus 427 dP~~R~g~~~~sa~eil~Hp 446 (576)
T 2acx_A 427 DPAERLGCRGGSAREVKEHP 446 (576)
T ss_dssp SGGGSTTCSSSHHHHHHTSG
T ss_pred CHHHcCCCCCCCHHHHHhCh
Confidence 999999 789999874
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=302.47 Aligned_cols=227 Identities=22% Similarity=0.310 Sum_probs=182.4
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
+.||||+++... ......+.+|+.+++.++||||++++++|.+....++||||+++|+|.+++... ..+++..++.+
T Consensus 63 ~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i 141 (494)
T 3lij_A 63 VERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR-MKFNEVDAAVI 141 (494)
T ss_dssp CEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHH
T ss_pred cEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHH
Confidence 369999997553 344677899999999999999999999999999999999999999999988654 36899999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCC---CCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCc
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDD---NLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRV 155 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~---~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~ 155 (273)
+.|++.||.||| +.|++||||||+||+++. ++.+||+|||++..+.... .....+|++.|+|||++. ..+
T Consensus 142 ~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~ 214 (494)
T 3lij_A 142 IKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYYIAPEVLR-KKY 214 (494)
T ss_dssp HHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB---CBCCCCSCTTTCCHHHHT-TCB
T ss_pred HHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc---cccccCCCcCeeCHHHHc-ccC
Confidence 999999999999 999999999999999976 4459999999997663322 233457999999999886 468
Q ss_pred CCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCC
Q 024027 156 STNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTV 235 (273)
Q Consensus 156 ~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 235 (273)
+.++||||+||++|+|++|..||......+. ........ ..........++.++.+|+.+||.
T Consensus 215 ~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~----------------~~~~~~~~~~~s~~~~~li~~~L~ 277 (494)
T 3lij_A 215 DEKCDVWSIGVILFILLAGYPPFGGQTDQEI-LRKVEKGK----------------YTFDSPEWKNVSEGAKDLIKQMLQ 277 (494)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHTC----------------CCCCSGGGTTSCHHHHHHHHHHTC
T ss_pred CCchhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCC----------------CCCCchhcccCCHHHHHHHHHHCC
Confidence 9999999999999999999999976433211 11111100 001111134567789999999999
Q ss_pred CCccCCCCHHHHHHHHH
Q 024027 236 ESPEQRINAKEIVTKLL 252 (273)
Q Consensus 236 ~dp~~Rps~~~~l~~l~ 252 (273)
.||.+|||+.++++|-+
T Consensus 278 ~dp~~R~s~~e~l~hp~ 294 (494)
T 3lij_A 278 FDSQRRISAQQALEHPW 294 (494)
T ss_dssp SSTTTSCCHHHHHTCHH
T ss_pred CChhhCccHHHHhcCcc
Confidence 99999999999999854
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=303.29 Aligned_cols=229 Identities=22% Similarity=0.264 Sum_probs=185.1
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcC---CCCCCHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS---NCILDIFQ 74 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~ 74 (273)
+.||||+++... ......+..|+++++.++||||+++++++.+...+++||||++||+|.+++... ...+++..
T Consensus 211 ~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~ 290 (543)
T 3c4z_A 211 KLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPR 290 (543)
T ss_dssp CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHH
T ss_pred cEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHH
Confidence 479999997542 234567889999999999999999999999999999999999999999998654 34699999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCC
Q 024027 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGR 154 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 154 (273)
++.++.||+.||.||| +.|++||||||+||+++.++.+||+|||++..+.... ......+||+.|+|||++.+..
T Consensus 291 ~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~ 365 (543)
T 3c4z_A 291 AIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ--TKTKGYAGTPGFMAPELLLGEE 365 (543)
T ss_dssp HHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC--CCBCCCCSCTTTSCHHHHTTCC
T ss_pred HHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCC--cccccccCCccccChhhhcCCC
Confidence 9999999999999999 9999999999999999999999999999998653222 1223457999999999999989
Q ss_pred cCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcC
Q 024027 155 VSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACT 234 (273)
Q Consensus 155 ~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 234 (273)
++.++|+|||||++|+|++|..||......... ........ . . ....+..++.++.+|+.+||
T Consensus 366 ~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~-~~~~~~i~---------~---~----~~~~p~~~s~~~~~li~~lL 428 (543)
T 3c4z_A 366 YDFSVDYFALGVTLYEMIAARGPFRARGEKVEN-KELKQRVL---------E---Q----AVTYPDKFSPASKDFCEALL 428 (543)
T ss_dssp BCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH-HHHHHHHH---------H---C----CCCCCTTSCHHHHHHHHHHS
T ss_pred CChHHhcCcchHHHHHHHhCCCCCCCCccchhH-HHHHHHHh---------h---c----ccCCCcccCHHHHHHHHHhc
Confidence 999999999999999999999999764322111 11111000 0 0 00113456788999999999
Q ss_pred CCCccCCCCH-----HHHHHHH
Q 024027 235 VESPEQRINA-----KEIVTKL 251 (273)
Q Consensus 235 ~~dp~~Rps~-----~~~l~~l 251 (273)
..||.+||++ +++++|-
T Consensus 429 ~~dP~~R~~~~~~~a~ei~~Hp 450 (543)
T 3c4z_A 429 QKDPEKRLGFRDGSCDGLRTHP 450 (543)
T ss_dssp CSSGGGSCCCBTTBSHHHHTSG
T ss_pred cCCHhHCCCCcccCHHHHHcCc
Confidence 9999999964 7777653
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=297.44 Aligned_cols=231 Identities=23% Similarity=0.273 Sum_probs=183.6
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||||+++... ......+.+|..++..++||||++++++|.++..+++||||++||+|.+++.+.+..+++..++.
T Consensus 87 ~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~ 166 (412)
T 2vd5_A 87 QVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARF 166 (412)
T ss_dssp CEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHH
T ss_pred CEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHH
Confidence 479999997532 23456689999999999999999999999999999999999999999999977655799999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccC------
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR------ 151 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~------ 151 (273)
++.|++.||.||| +.|++||||||+||+++.++.+||+|||++........ ......+||+.|+|||++.
T Consensus 167 ~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~ 242 (412)
T 2vd5_A 167 YLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGP 242 (412)
T ss_dssp HHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCT
T ss_pred HHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechhheeccCCCc-cccceeccccCcCCHHHHhhcccCc
Confidence 9999999999999 99999999999999999999999999999976533221 1223457999999999986
Q ss_pred -CCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHH
Q 024027 152 -EGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLA 230 (273)
Q Consensus 152 -~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 230 (273)
...++.++|+|||||++|+|++|..||......+. ...+.... ..... ...+..++.++.+||
T Consensus 243 ~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-~~~i~~~~-----------~~~~~----p~~~~~~s~~~~dli 306 (412)
T 2vd5_A 243 GTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET-YGKIVHYK-----------EHLSL----PLVDEGVPEEARDFI 306 (412)
T ss_dssp TCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHTHH-----------HHCCC----C----CCCHHHHHHH
T ss_pred CCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH-HHHHHhcc-----------cCcCC----CccccCCCHHHHHHH
Confidence 35689999999999999999999999976432211 11111100 00000 001245778899999
Q ss_pred hhcCCCCccCC---CCHHHHHHHHH
Q 024027 231 MACTVESPEQR---INAKEIVTKLL 252 (273)
Q Consensus 231 ~~~l~~dp~~R---ps~~~~l~~l~ 252 (273)
.+||. +|.+| |+++++++|=.
T Consensus 307 ~~lL~-~p~~Rlgr~~~~ei~~Hpf 330 (412)
T 2vd5_A 307 QRLLC-PPETRLGRGGAGDFRTHPF 330 (412)
T ss_dssp HTTSS-CGGGCTTTTTHHHHHTSGG
T ss_pred HHHcC-ChhhcCCCCCHHHHhcCCC
Confidence 99999 99998 58999988743
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=290.30 Aligned_cols=242 Identities=21% Similarity=0.224 Sum_probs=175.6
Q ss_pred eEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 2 EVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 2 ~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
.||||+++... ......+.+|+++++.++||||+++++++.++...++||||+++ +|.+++.... .+++..++.++
T Consensus 61 ~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~-~~~~~~~~~i~ 138 (329)
T 3gbz_A 61 TVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNP-DVSMRVIKSFL 138 (329)
T ss_dssp EEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHCT-TCCHHHHHHHH
T ss_pred eEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCCC-CHHHHHhhcC-CCCHHHHHHHH
Confidence 69999997553 23356678999999999999999999999999999999999975 9999997654 59999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceee-----CCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCC-
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLL-----DDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG- 153 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~-----~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~- 153 (273)
.|++.||.||| +.|++|+||||+||++ +.++.+||+|||++...... ........+++.|+|||++.+.
T Consensus 139 ~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~ 213 (329)
T 3gbz_A 139 YQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP--IRQFTHEIITLWYRPPEILLGSR 213 (329)
T ss_dssp HHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTCC
T ss_pred HHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc--ccccCCCcCCccccCHHHhcCCC
Confidence 99999999999 9999999999999999 45556999999999765322 1223345679999999998875
Q ss_pred CcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccch--hhhh--------hhccccchhhhhhhhhhH
Q 024027 154 RVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTM--EVVD--------ANLLSQEDIHFVAKEQCV 223 (273)
Q Consensus 154 ~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~--------~~~~~~~~~~~~~~~~~~ 223 (273)
.++.++|||||||++|+|++|..||......+... ............ .... .............+..++
T Consensus 214 ~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (329)
T 3gbz_A 214 HYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLF-KIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLD 292 (329)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-HHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSC
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHH-HHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccC
Confidence 48999999999999999999999997643322211 111111100000 0000 000011112222344467
Q ss_pred HHHHHHHhhcCCCCccCCCCHHHHHHHH
Q 024027 224 SFVFNLAMACTVESPEQRINAKEIVTKL 251 (273)
Q Consensus 224 ~~l~~li~~~l~~dp~~Rps~~~~l~~l 251 (273)
.++.+|+.+||..||++|||+.++++|-
T Consensus 293 ~~~~~li~~~L~~dP~~R~t~~e~l~hp 320 (329)
T 3gbz_A 293 DEGLDLLTAMLEMDPVKRISAKNALEHP 320 (329)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhCCc
Confidence 8899999999999999999999999863
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=284.91 Aligned_cols=244 Identities=21% Similarity=0.248 Sum_probs=183.0
Q ss_pred CeEEEEEeeccc-----ChhhhhHHHHHHHHhcC---CCccceeeeeeeecCC-----ceeEEEeccCCCCHHHhhhcCC
Q 024027 1 MEVAVKVFNLQC-----GRAFKSFDVECEMMKSI---RHRNLIKVISSCSNEE-----FKALVLEYMPHGSLEKYLYSSN 67 (273)
Q Consensus 1 ~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~ 67 (273)
+.||||+++... ......+.+|+.+++.+ +||||+++++++.... ..++||||+++ +|.+++....
T Consensus 35 ~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~ 113 (308)
T 3g33_A 35 HFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAP 113 (308)
T ss_dssp CEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCCC-BHHHHHHTCC
T ss_pred cEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhhc-CHHHHHhhcc
Confidence 479999997542 12235677888888777 4999999999997755 57899999975 9999997654
Q ss_pred C-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCC
Q 024027 68 C-ILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMA 146 (273)
Q Consensus 68 ~-~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~a 146 (273)
. .+++..++.++.|++.||.||| +.|++|+||||+||+++.++.+||+|||++...... .......+++.|+|
T Consensus 114 ~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~a 187 (308)
T 3g33_A 114 PPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALTPVVVTLWYRA 187 (308)
T ss_dssp TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEECSCSCTTTSTTC---CCSGGGGCCCSSCC
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEeeCccccccCCC---cccCCccccccccC
Confidence 3 3899999999999999999999 999999999999999999999999999999765322 22344678999999
Q ss_pred CcccCCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhh------hhc-cccchhhhhhh
Q 024027 147 PEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVD------ANL-LSQEDIHFVAK 219 (273)
Q Consensus 147 PE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~-~~~~~~~~~~~ 219 (273)
||++.+..++.++|||||||++|+|++|..||........ .................. ... ...........
T Consensus 188 PE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (308)
T 3g33_A 188 PEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ-LGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVV 266 (308)
T ss_dssp HHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHS
T ss_pred chHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhC
Confidence 9999988999999999999999999999999976433322 222211111100000000 000 00011112223
Q ss_pred hhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 220 EQCVSFVFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 220 ~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
..++.++.+|+.+||..||++|||+.++++|-+
T Consensus 267 ~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~ 299 (308)
T 3g33_A 267 PEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299 (308)
T ss_dssp CSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTT
T ss_pred ccccHHHHHHHHHHhcCCCccCCCHHHHhcCcc
Confidence 457788999999999999999999999998743
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=295.67 Aligned_cols=228 Identities=23% Similarity=0.281 Sum_probs=173.5
Q ss_pred CeEEEEEeeccc--------ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCH
Q 024027 1 MEVAVKVFNLQC--------GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDI 72 (273)
Q Consensus 1 ~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 72 (273)
+.||||++.... ......+.+|+.+|+.++||||+++++++..+ ..++||||+++++|.+++... ..+++
T Consensus 161 ~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~-~~~~~ 238 (419)
T 3i6u_A 161 KKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGN-KRLKE 238 (419)
T ss_dssp CEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS-EEEEEEECCTTCBGGGGTSSS-CCCCH
T ss_pred cEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC-ceEEEEEcCCCCcHHHHHhcc-CCCCH
Confidence 479999997542 12334688999999999999999999998654 578999999999999998654 46999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCC---ceEEeecccccccccCCCcceeecccccCCCCCCcc
Q 024027 73 FQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNL---VAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEY 149 (273)
Q Consensus 73 ~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~---~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~ 149 (273)
..++.++.|++.||.||| +.|++|+||||+||+++.++ .+||+|||++..... .......+|++.|+|||+
T Consensus 239 ~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~ 312 (419)
T 3i6u_A 239 ATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---TSLMRTLCGTPTYLAPEV 312 (419)
T ss_dssp HHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC--------------CTTCCTTT
T ss_pred HHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEeecccceecCC---CccccccCCCCCccCcee
Confidence 999999999999999999 99999999999999997544 599999999986532 222334678999999999
Q ss_pred cCC---CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHH
Q 024027 150 GRE---GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFV 226 (273)
Q Consensus 150 ~~~---~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 226 (273)
+.+ ..++.++|||||||++|+|++|..||.................. .........++.++
T Consensus 313 ~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~----------------~~~~~~~~~~~~~~ 376 (419)
T 3i6u_A 313 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY----------------NFIPEVWAEVSEKA 376 (419)
T ss_dssp TC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCC----------------CCCHHHHTTSCHHH
T ss_pred eecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCC----------------CCCchhhcccCHHH
Confidence 864 45788999999999999999999999764333222221111100 01111234567789
Q ss_pred HHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 227 FNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 227 ~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
.+|+.+||..||++|||++++++|-+
T Consensus 377 ~~li~~~L~~dP~~Rps~~e~l~hp~ 402 (419)
T 3i6u_A 377 LDLVKKLLVVDPKARFTTEEALRHPW 402 (419)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred HHHHHHHccCChhHCcCHHHHhCCcc
Confidence 99999999999999999999999754
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=291.83 Aligned_cols=239 Identities=23% Similarity=0.239 Sum_probs=181.9
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCC------ceeEEEeccCCCCHHHhhhcCCCCCCH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEE------FKALVLEYMPHGSLEKYLYSSNCILDI 72 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~ 72 (273)
+.||||++.... ....+.+.+|+++++.++||||+++++++.... .+++||||+ +++|.+++... .+++
T Consensus 51 ~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~l~~ 127 (367)
T 1cm8_A 51 AKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE--KLGE 127 (367)
T ss_dssp CEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHHC--CCCH
T ss_pred CEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhcC--CCCH
Confidence 479999996542 334567889999999999999999999997763 459999999 77999999763 5899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC
Q 024027 73 FQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE 152 (273)
Q Consensus 73 ~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 152 (273)
..+..++.|++.||.||| +.|++||||||+||+++.++.+||+|||++..... .....++++.|+|||++.+
T Consensus 128 ~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~ 199 (367)
T 1cm8_A 128 DRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS-----EMTGYVVTRWYRAPEVILN 199 (367)
T ss_dssp HHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS-----SCCSSCSCGGGCCTHHHHT
T ss_pred HHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeeccccccc-----ccCcCcCCCCcCCHHHHhC
Confidence 999999999999999999 99999999999999999999999999999986522 1234578999999999877
Q ss_pred -CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCcc--chh---------hhhhhccccchhhhhhhh
Q 024027 153 -GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPIS--TME---------VVDANLLSQEDIHFVAKE 220 (273)
Q Consensus 153 -~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~---------~~~~~~~~~~~~~~~~~~ 220 (273)
..++.++||||+||++++|++|+.||....... ....+........ ... ..................
T Consensus 200 ~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (367)
T 1cm8_A 200 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILT 278 (367)
T ss_dssp TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCT
T ss_pred CCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCC
Confidence 678999999999999999999999997643221 1222211111110 000 000000000000111224
Q ss_pred hhHHHHHHHHhhcCCCCccCCCCHHHHHHHH
Q 024027 221 QCVSFVFNLAMACTVESPEQRINAKEIVTKL 251 (273)
Q Consensus 221 ~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l 251 (273)
.++.++.+|+.+||..||.+|||+.++++|-
T Consensus 279 ~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp 309 (367)
T 1cm8_A 279 NASPLAVNLLEKMLVLDAEQRVTAGEALAHP 309 (367)
T ss_dssp TCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred CCCHHHHHHHHHHccCChhHCCCHHHHhcCh
Confidence 5678899999999999999999999999973
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=291.76 Aligned_cols=222 Identities=24% Similarity=0.329 Sum_probs=181.3
Q ss_pred eEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 2 EVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 2 ~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
.||||+++... ....+.+.+|+++++.++||||+++++++.+++..++||||++| +|.+++......+++..++.+
T Consensus 81 ~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~g-~l~~~l~~~~~~l~~~~~~~i 159 (348)
T 1u5q_A 81 VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAV 159 (348)
T ss_dssp EEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHHTSCCCHHHHHHH
T ss_pred EEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCCC-CHHHHHHHhcCCCCHHHHHHH
Confidence 69999997543 23456788999999999999999999999999999999999974 898988766667999999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccC---CCCc
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR---EGRV 155 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~ 155 (273)
+.|++.||.||| +.|++|+||||+||+++.++.+||+|||++..... .....|++.|+|||++. +..+
T Consensus 160 ~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~ 230 (348)
T 1u5q_A 160 THGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQY 230 (348)
T ss_dssp HHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------BCCCCSCGGGCCHHHHHTTSSCCB
T ss_pred HHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC------CCcccCCcceeCHhhhccccCCCC
Confidence 999999999999 99999999999999999999999999999976522 22356899999999874 4568
Q ss_pred CCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCC
Q 024027 156 STNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTV 235 (273)
Q Consensus 156 ~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 235 (273)
+.++|||||||++|+|++|..||......... ........+ ...+..++..+.+|+.+||.
T Consensus 231 ~~~~DiwslG~il~ell~g~~p~~~~~~~~~~-~~~~~~~~~------------------~~~~~~~~~~l~~li~~~l~ 291 (348)
T 1u5q_A 231 DGKVDVWSLGITCIELAERKPPLFNMNAMSAL-YHIAQNESP------------------ALQSGHWSEYFRNFVDSCLQ 291 (348)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-HHHHHSCCC------------------CCCCTTSCHHHHHHHHHHTC
T ss_pred CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHhcCCC------------------CCCCCCCCHHHHHHHHHHcc
Confidence 99999999999999999999998654322111 111110000 00123456779999999999
Q ss_pred CCccCCCCHHHHHHHHH
Q 024027 236 ESPEQRINAKEIVTKLL 252 (273)
Q Consensus 236 ~dp~~Rps~~~~l~~l~ 252 (273)
.||++|||+.++++|.+
T Consensus 292 ~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 292 KIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp SSGGGSCCHHHHTTCHH
T ss_pred cChhhCcCHHHHhhChh
Confidence 99999999999998765
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=280.33 Aligned_cols=224 Identities=24% Similarity=0.357 Sum_probs=180.2
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeec----CCceeEEEeccCCCCHHHhhhcCCCCCCHHH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSN----EEFKALVLEYMPHGSLEKYLYSSNCILDIFQ 74 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (273)
+.||+|++.... ....+.+.+|+.+++.++||||+++++++.. ...+++||||+++++|.+++... ..+++..
T Consensus 52 ~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~ 130 (290)
T 1t4h_A 52 VEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKV 130 (290)
T ss_dssp CEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHH-SSCCHHH
T ss_pred eEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHc-cCCCHHH
Confidence 368999997553 4456778999999999999999999998865 45689999999999999999654 3589999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCC--eEeccCCCCceeeC-CCCceEEeecccccccccCCCcceeecccccCCCCCCcccC
Q 024027 75 RLNIMIDVASALEYLHFGCSAP--VIHCDLKPDNVLLD-DNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR 151 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~~--i~h~di~p~nil~~-~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 151 (273)
++.++.|++.||.||| +.| ++|+||||+||+++ .++.++|+|||++..... .......+++.|+|||.+.
T Consensus 131 ~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~----~~~~~~~~t~~y~aPE~~~ 203 (290)
T 1t4h_A 131 LRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGTPEFMAPEMYE 203 (290)
T ss_dssp HHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT----TSBEESCSSCCCCCGGGGG
T ss_pred HHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc----cccccccCCcCcCCHHHHh
Confidence 9999999999999999 888 99999999999998 789999999999975422 1223456899999999886
Q ss_pred CCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHh
Q 024027 152 EGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAM 231 (273)
Q Consensus 152 ~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 231 (273)
+ .++.++||||||+++|+|++|..||.................. ....+...+.++.+|+.
T Consensus 204 ~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~l~~li~ 264 (290)
T 1t4h_A 204 E-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK------------------PASFDKVAIPEVKEIIE 264 (290)
T ss_dssp T-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC------------------CGGGGGCCCHHHHHHHH
T ss_pred c-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC------------------ccccCCCCCHHHHHHHH
Confidence 4 5899999999999999999999999764333222221111100 01113344567999999
Q ss_pred hcCCCCccCCCCHHHHHHHH
Q 024027 232 ACTVESPEQRINAKEIVTKL 251 (273)
Q Consensus 232 ~~l~~dp~~Rps~~~~l~~l 251 (273)
+||..||.+|||+.++++|-
T Consensus 265 ~~l~~dp~~Rps~~ell~h~ 284 (290)
T 1t4h_A 265 GCIRQNKDERYSIKDLLNHA 284 (290)
T ss_dssp HHSCSSGGGSCCHHHHHTSG
T ss_pred HHccCChhhCCCHHHHhhCc
Confidence 99999999999999999863
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=285.81 Aligned_cols=227 Identities=26% Similarity=0.307 Sum_probs=186.3
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
+.||||+++... ....+.+|+.+++.++||||+++++++......++||||+++++|.+++......+++..++.++.
T Consensus 55 ~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~ 132 (314)
T 3com_A 55 QIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQ 132 (314)
T ss_dssp CEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHH
T ss_pred CEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHH
Confidence 479999997543 456789999999999999999999999999999999999999999999975556799999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
|++.||.||| +.|++|+||+|+||+++.++.++|+|||.+....... .......+++.|+|||.+.+..++.++|
T Consensus 133 ~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~D 207 (314)
T 3com_A 133 STLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM--AKRNTVIGTPFWMAPEVIQEIGYNCVAD 207 (314)
T ss_dssp HHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB--SCBCCCCSCGGGCCHHHHSSSCBCTTHH
T ss_pred HHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc--cccCccCCCCCccChhhcCCCCCCcccc
Confidence 9999999999 9999999999999999999999999999997653221 1223456889999999999888999999
Q ss_pred hHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccC
Q 024027 161 VYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQ 240 (273)
Q Consensus 161 iwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 240 (273)
|||||+++|+|++|..||.......... .. ... .......+..++.++.+|+.+||..||.+
T Consensus 208 i~slG~il~~l~~g~~p~~~~~~~~~~~-~~-~~~----------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 269 (314)
T 3com_A 208 IWSLGITAIEMAEGKPPYADIHPMRAIF-MI-PTN----------------PPPTFRKPELWSDNFTDFVKQCLVKSPEQ 269 (314)
T ss_dssp HHHHHHHHHHHHHSSCTTTTSCHHHHHH-HH-HHS----------------CCCCCSSGGGSCHHHHHHHHHHTCSCTTT
T ss_pred HHHHHHHHHHHHhCCCCCCCCChHHHHH-HH-hcC----------------CCcccCCcccCCHHHHHHHHHHccCChhh
Confidence 9999999999999999987533211110 00 000 00001113445677999999999999999
Q ss_pred CCCHHHHHHHHH
Q 024027 241 RINAKEIVTKLL 252 (273)
Q Consensus 241 Rps~~~~l~~l~ 252 (273)
|||+.++++|-.
T Consensus 270 Rpt~~~ll~~~~ 281 (314)
T 3com_A 270 RATATQLLQHPF 281 (314)
T ss_dssp SCCHHHHTTSHH
T ss_pred CcCHHHHHhCHH
Confidence 999999998754
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=288.51 Aligned_cols=226 Identities=15% Similarity=0.130 Sum_probs=186.7
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCC---CccceeeeeeeecCCceeEEEeccCCCCHHHhhhc----CCCCCCHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIR---HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS----SNCILDIF 73 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~ 73 (273)
+.||||+++.. ....+..|+++++.++ |+||+++++++..++..++||||+++|+|.+++.. ....+++.
T Consensus 96 ~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~ 172 (365)
T 3e7e_A 96 QKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQG 172 (365)
T ss_dssp CCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHH
T ss_pred cEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHH
Confidence 47999999754 3457888888888886 99999999999999999999999999999999964 34569999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCC-----------CCceEEeecccccccccCCCcceeecccccC
Q 024027 74 QRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDD-----------NLVAYLSDFGIAKLLIGEDQSMTQTQTLATI 142 (273)
Q Consensus 74 ~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~-----------~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~ 142 (273)
.++.++.|++.||.||| +.|++||||||+||+++. ++.+||+|||++..+............+||+
T Consensus 173 ~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~ 249 (365)
T 3e7e_A 173 LVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETS 249 (365)
T ss_dssp HHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTT
T ss_pred HHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCC
Confidence 99999999999999999 999999999999999998 8999999999997664434444455667999
Q ss_pred CCCCCcccCCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhh
Q 024027 143 GYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQC 222 (273)
Q Consensus 143 ~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (273)
.|+|||++.+..++.++|||||||++|+|++|+.||.....+....... .. ....
T Consensus 250 ~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~------------~~-------------~~~~ 304 (365)
T 3e7e_A 250 GFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGL------------FR-------------RLPH 304 (365)
T ss_dssp SCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEEECSC------------CT-------------TCSS
T ss_pred CCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCceeechh------------cc-------------ccCc
Confidence 9999999999899999999999999999999999986543332111000 00 0123
Q ss_pred HHHHHHHHhhcCCCCccCCC-CHHHHHHHHHHHHHh
Q 024027 223 VSFVFNLAMACTVESPEQRI-NAKEIVTKLLKIRDS 257 (273)
Q Consensus 223 ~~~l~~li~~~l~~dp~~Rp-s~~~~l~~l~~~~~~ 257 (273)
+..+.+++.+||..+|.+|+ +++++.+.|+++..+
T Consensus 305 ~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 305 LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 45578899999999999995 788888888887765
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=292.74 Aligned_cols=228 Identities=22% Similarity=0.378 Sum_probs=176.2
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCC--ccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRH--RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (273)
+.||||+++... ......+.+|+.+++.++| +||+++++++.++...++|||+. +++|.+++.... .+++..+.
T Consensus 34 ~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~ 111 (343)
T 3dbq_A 34 QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKK-SIDPWERK 111 (343)
T ss_dssp CEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHSC-CCCHHHHH
T ss_pred CEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeCC-CCCHHHHHHhcC-CCCHHHHH
Confidence 469999997553 3445778999999999976 99999999999999999999955 679999997653 68999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC----
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE---- 152 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---- 152 (273)
.++.|++.||.||| +.|++||||||+||+++ ++.+||+|||++..+.............|++.|+|||++.+
T Consensus 112 ~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 187 (343)
T 3dbq_A 112 SYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 187 (343)
T ss_dssp HHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC--
T ss_pred HHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhcccc
Confidence 99999999999999 99999999999999997 67899999999987644333333345679999999999854
Q ss_pred -------CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHH
Q 024027 153 -------GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSF 225 (273)
Q Consensus 153 -------~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (273)
..++.++|||||||++|+|++|..||................ ......+...+.+
T Consensus 188 ~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~ 249 (343)
T 3dbq_A 188 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP------------------NHEIEFPDIPEKD 249 (343)
T ss_dssp ---------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT------------------TSCCCCCCCSCHH
T ss_pred ccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcC------------------CcccCCcccCCHH
Confidence 567889999999999999999999997543322111111110 0001113334567
Q ss_pred HHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 226 VFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 226 l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
+.+|+.+||..||.+|||+.++++|-+
T Consensus 250 l~~li~~~L~~dp~~Rpt~~e~l~hp~ 276 (343)
T 3dbq_A 250 LQDVLKCCLKRDPKQRISIPELLAHPY 276 (343)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence 899999999999999999999999866
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=281.93 Aligned_cols=241 Identities=20% Similarity=0.213 Sum_probs=188.3
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeee-ecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSC-SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
+.||||++.... ....+.+|+.+++.++|++++..+..+ ......++||||+ +++|.+++......+++..++.++
T Consensus 35 ~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~ 111 (296)
T 4hgt_A 35 EEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLA 111 (296)
T ss_dssp EEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHH
T ss_pred ceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHH
Confidence 379999976543 335789999999999888877776655 6677889999999 889999998666679999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceee---CCCCceEEeecccccccccCCCc-----ceeecccccCCCCCCcccC
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLL---DDNLVAYLSDFGIAKLLIGEDQS-----MTQTQTLATIGYMAPEYGR 151 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~---~~~~~~kl~Df~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~ 151 (273)
.|++.||.||| +.|++|+||||+||++ +.++.+||+|||++......... .......+++.|+|||.+.
T Consensus 112 ~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 188 (296)
T 4hgt_A 112 DQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 188 (296)
T ss_dssp HHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHT
T ss_pred HHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhc
Confidence 99999999999 9999999999999999 78899999999999876433221 1223456899999999999
Q ss_pred CCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHh
Q 024027 152 EGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAM 231 (273)
Q Consensus 152 ~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 231 (273)
+..++.++|||||||++|+|++|..||............. ....... ..........++.++.+|+.
T Consensus 189 ~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~----------~~~~~~~---~~~~~~~~~~~~~~l~~li~ 255 (296)
T 4hgt_A 189 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE----------RISEKKM---STPIEVLCKGYPSEFATYLN 255 (296)
T ss_dssp TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHH----------HHHHHHH---HSCHHHHTTTSCHHHHHHHH
T ss_pred CCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhh----------hhhcccc---cchhhhhhccCCHHHHHHHH
Confidence 9899999999999999999999999997643332111100 0000000 00011112445778999999
Q ss_pred hcCCCCccCCCCHHHHHHHHHHHHHhhhh
Q 024027 232 ACTVESPEQRINAKEIVTKLLKIRDSLLR 260 (273)
Q Consensus 232 ~~l~~dp~~Rps~~~~l~~l~~~~~~~~~ 260 (273)
+||..||++|||++++++.|+++.++...
T Consensus 256 ~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~ 284 (296)
T 4hgt_A 256 FCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp HHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred HHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence 99999999999999999999999987654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=287.67 Aligned_cols=227 Identities=21% Similarity=0.276 Sum_probs=179.5
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
+.||+|++........+.+.+|+++++.++||||+++++++.+++..++||||+++++|.+++......+++..++.++.
T Consensus 45 ~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 124 (302)
T 2j7t_A 45 ALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCR 124 (302)
T ss_dssp CEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHH
T ss_pred cEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHH
Confidence 46999999877666778899999999999999999999999999999999999999999999876666799999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCccc-----CCCCc
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYG-----REGRV 155 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~-----~~~~~ 155 (273)
|++.||.||| +.|++|+||+|+||+++.++.++|+|||++...... ........+++.|+|||.+ .+..+
T Consensus 125 ~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 199 (302)
T 2j7t_A 125 QMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--LQKRDSFIGTPYWMAPEVVMCETMKDTPY 199 (302)
T ss_dssp HHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--HHC-----CCGGGCCHHHHHHHHTTSTTT
T ss_pred HHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc--ccccccccCChhhcCCeeeccccCCCCCC
Confidence 9999999999 999999999999999999999999999987543111 1112334688999999987 35668
Q ss_pred CCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCC
Q 024027 156 STNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTV 235 (273)
Q Consensus 156 ~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 235 (273)
+.++||||||+++|+|++|..||......... ........ .....+..++.++.+|+.+||.
T Consensus 200 ~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~-----------------~~~~~~~~~~~~l~~li~~~l~ 261 (302)
T 2j7t_A 200 DYKADIWSLGITLIEMAQIEPPHHELNPMRVL-LKIAKSDP-----------------PTLLTPSKWSVEFRDFLKIALD 261 (302)
T ss_dssp TTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-HHHHHSCC-----------------CCCSSGGGSCHHHHHHHHHHSC
T ss_pred chhhhHHHHHHHHHHHhcCCCCCccCCHHHHH-HHHhccCC-----------------cccCCccccCHHHHHHHHHHcc
Confidence 89999999999999999999998764322111 11111000 0011244567779999999999
Q ss_pred CCccCCCCHHHHHHH
Q 024027 236 ESPEQRINAKEIVTK 250 (273)
Q Consensus 236 ~dp~~Rps~~~~l~~ 250 (273)
.||.+|||+.++++|
T Consensus 262 ~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 262 KNPETRPSAAQLLEH 276 (302)
T ss_dssp SCTTTSCCHHHHTTS
T ss_pred cChhhCCCHHHHhcC
Confidence 999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=291.89 Aligned_cols=245 Identities=22% Similarity=0.232 Sum_probs=184.0
Q ss_pred CeEEEEEeecccC-----hhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHH
Q 024027 1 MEVAVKVFNLQCG-----RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQR 75 (273)
Q Consensus 1 ~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (273)
+.||||+++.... ...+.+.+|+++++.++||||+++++++.+.+..++||||+++ +|.+++......+++..+
T Consensus 36 ~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~ 114 (346)
T 1ua2_A 36 QIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHI 114 (346)
T ss_dssp SEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTTCCSSCCSSHH
T ss_pred cEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHhcCcCCCHHHH
Confidence 4699999975421 1245788999999999999999999999999999999999986 999999877777999999
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCC-C
Q 024027 76 LNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG-R 154 (273)
Q Consensus 76 ~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~ 154 (273)
+.++.|++.||.||| +.|++|+||||+||+++.++.+||+|||++..+.... .......+++.|+|||++.+. .
T Consensus 115 ~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~ 189 (346)
T 1ua2_A 115 KAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGARM 189 (346)
T ss_dssp HHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSC
T ss_pred HHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc--ccCCcccccccccCchHhhCCCC
Confidence 999999999999999 9999999999999999999999999999998653222 223345789999999998764 4
Q ss_pred cCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhcc------c--cchhhhhhhhhhHHHH
Q 024027 155 VSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLL------S--QEDIHFVAKEQCVSFV 226 (273)
Q Consensus 155 ~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~--~~~~~~~~~~~~~~~l 226 (273)
++.++|||||||++|+|++|.+||......+ ..................+.... . ...........++.++
T Consensus 190 ~~~~~DiwslG~il~ell~g~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (346)
T 1ua2_A 190 YGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDL 268 (346)
T ss_dssp CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHH
T ss_pred CCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHH
Confidence 8899999999999999999999987643322 22222221111100000000000 0 0000111124567889
Q ss_pred HHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 227 FNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 227 ~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
.+|+.+||..||.+|||+.++++|-+
T Consensus 269 ~~li~~~L~~dP~~Rpt~~ell~h~~ 294 (346)
T 1ua2_A 269 LDLIQGLFLFNPCARITATQALKMKY 294 (346)
T ss_dssp HHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred HHHHHHHhccChhhCCCHHHHhcChh
Confidence 99999999999999999999998754
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=288.27 Aligned_cols=229 Identities=20% Similarity=0.239 Sum_probs=182.7
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcC-CCCCCHHHHH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~ 76 (273)
+.||||+++... ......+.+|+.+++.+ +||||+++++++.+.+..++||||+++++|.+++... ...+++..++
T Consensus 55 ~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~ 134 (327)
T 3lm5_A 55 QEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVI 134 (327)
T ss_dssp CEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHH
T ss_pred CEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHH
Confidence 479999997543 33467889999999999 5799999999999999999999999999999998643 3569999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCC---CCceEEeecccccccccCCCcceeecccccCCCCCCcccCCC
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDD---NLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG 153 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~---~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 153 (273)
.++.|++.||.||| +.|++|+||||+||+++. ++.++|+|||++....... ......+++.|+|||++.+.
T Consensus 135 ~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~ 208 (327)
T 3lm5_A 135 RLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYD 208 (327)
T ss_dssp HHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTC
T ss_pred HHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCcc---ccccccCCcCccCCeeecCC
Confidence 99999999999999 999999999999999987 7899999999998653221 22345689999999999988
Q ss_pred CcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhc
Q 024027 154 RVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMAC 233 (273)
Q Consensus 154 ~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 233 (273)
.++.++||||||+++|+|++|..||......+.... .... ...........++..+.+|+.+|
T Consensus 209 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-i~~~----------------~~~~~~~~~~~~~~~~~~li~~~ 271 (327)
T 3lm5_A 209 PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN-ISQV----------------NVDYSEETFSSVSQLATDFIQSL 271 (327)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-HHHT----------------CCCCCTTTTTTSCHHHHHHHHHH
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHH-HHhc----------------ccccCchhhcccCHHHHHHHHHH
Confidence 999999999999999999999999966433221111 1100 00011111345677799999999
Q ss_pred CCCCccCCCCHHHHHHHHH
Q 024027 234 TVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 234 l~~dp~~Rps~~~~l~~l~ 252 (273)
|..||.+|||++++++|-+
T Consensus 272 L~~dP~~Rpt~~~ll~h~~ 290 (327)
T 3lm5_A 272 LVKNPEKRPTAEICLSHSW 290 (327)
T ss_dssp SCSSGGGSCCHHHHTTCGG
T ss_pred cCCChhhCcCHHHHhCCHh
Confidence 9999999999999998754
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=283.36 Aligned_cols=225 Identities=26% Similarity=0.334 Sum_probs=176.6
Q ss_pred CeEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcC---CCCCCHHHHH
Q 024027 1 MEVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS---NCILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~ 76 (273)
+.||+|++.... ....+.+.+|+++++.++||||+++++++.+....++||||+++++|.+++... +..+++..++
T Consensus 48 ~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 127 (285)
T 3is5_A 48 LERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVA 127 (285)
T ss_dssp CEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHH
T ss_pred ceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHH
Confidence 379999997653 345678999999999999999999999999999999999999999999998532 3569999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccCCCCceee---CCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCC
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLL---DDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG 153 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~---~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 153 (273)
.++.|++.||.||| +.|++|+||||+||++ +.++.++|+|||++..+... .......+++.|+|||.+. .
T Consensus 128 ~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~-~ 200 (285)
T 3is5_A 128 ELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD---EHSTNAAGTALYMAPEVFK-R 200 (285)
T ss_dssp HHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-------------CTTGGGCCHHHHT-T
T ss_pred HHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc---ccCcCcccccCcCChHHhc-c
Confidence 99999999999999 9999999999999999 45678999999999765322 2233456899999999885 4
Q ss_pred CcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhc
Q 024027 154 RVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMAC 233 (273)
Q Consensus 154 ~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 233 (273)
.++.++||||||+++|+|++|..||................ . .........+.++.+|+.+|
T Consensus 201 ~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-----------------~-~~~~~~~~~~~~~~~li~~~ 262 (285)
T 3is5_A 201 DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKE-----------------P-NYAVECRPLTPQAVDLLKQM 262 (285)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----------------C-CCCC--CCCCHHHHHHHHHH
T ss_pred CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCC-----------------c-ccccccCcCCHHHHHHHHHH
Confidence 68899999999999999999999997643222111100000 0 00000122456789999999
Q ss_pred CCCCccCCCCHHHHHHH
Q 024027 234 TVESPEQRINAKEIVTK 250 (273)
Q Consensus 234 l~~dp~~Rps~~~~l~~ 250 (273)
|..||++|||+.++++|
T Consensus 263 L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 263 LTKDPERRPSAAQVLHH 279 (285)
T ss_dssp TCSCTTTSCCHHHHHTS
T ss_pred ccCChhhCcCHHHHhcC
Confidence 99999999999999976
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=289.99 Aligned_cols=238 Identities=24% Similarity=0.255 Sum_probs=180.8
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCC-----CccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC-CCCCHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIR-----HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQ 74 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~ 74 (273)
+.||||+++.. ......+..|+.+++.+. ||||+++++++......++||||+ +++|.+++.... ..+++..
T Consensus 61 ~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~ 138 (360)
T 3llt_A 61 KYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIED 138 (360)
T ss_dssp CEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHH
T ss_pred eEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHH
Confidence 46999999743 345567888999999986 999999999999999999999999 889999997654 3589999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCC-------------------------CCceEEeecccccccccC
Q 024027 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDD-------------------------NLVAYLSDFGIAKLLIGE 129 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~-------------------------~~~~kl~Df~~~~~~~~~ 129 (273)
++.++.|++.||.||| +.|++|+||||+||+++. ++.+||+|||++.....
T Consensus 139 ~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~- 214 (360)
T 3llt_A 139 IKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD- 214 (360)
T ss_dssp HHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-
T ss_pred HHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCC-
Confidence 9999999999999999 999999999999999975 78999999999976422
Q ss_pred CCcceeecccccCCCCCCcccCCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhcc
Q 024027 130 DQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLL 209 (273)
Q Consensus 130 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (273)
......|++.|+|||++.+..++.++|||||||++|+|++|..||......+ ..........+ ...........
T Consensus 215 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~-~p~~~~~~~~~ 288 (360)
T 3llt_A 215 ----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHME-HLAMMESIIQP-IPKNMLYEATK 288 (360)
T ss_dssp ----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHTCC-CCHHHHHHHTT
T ss_pred ----CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHH-HHHHHHHhcCC-CCHHHHhhhhh
Confidence 2234568999999999999999999999999999999999999997643221 11111111100 00000000000
Q ss_pred cc-------c--------------------hhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHH
Q 024027 210 SQ-------E--------------------DIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 210 ~~-------~--------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
.. . ..........+..+.+|+.+||..||++|||+.++++|
T Consensus 289 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 289 TNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp SGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00 0 00000112233668899999999999999999999976
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=285.95 Aligned_cols=238 Identities=19% Similarity=0.255 Sum_probs=182.3
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCC-Cccceeeeeeeec--CCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIR-HRNLIKVISSCSN--EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||||+++.. ..+.+.+|+.+++.++ ||||+++++++.+ ....++||||+++++|.++++ .+++..++.
T Consensus 62 ~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~ 134 (330)
T 3nsz_A 62 EKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRF 134 (330)
T ss_dssp CEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGG----GCCHHHHHH
T ss_pred cEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHH----hCCHHHHHH
Confidence 47999999743 3467899999999996 9999999999987 667899999999999999985 388999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCC-ceEEeecccccccccCCCcceeecccccCCCCCCcccCC-CCc
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNL-VAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE-GRV 155 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~-~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~ 155 (273)
++.|++.||.||| +.|++|+||||+||+++.++ .++|+|||++....... ......++..|+|||.+.+ ..+
T Consensus 135 ~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~ 208 (330)
T 3nsz_A 135 YMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMY 208 (330)
T ss_dssp HHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC---CCCSCCSCGGGCCHHHHTTCCCC
T ss_pred HHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC---ccccccccccccChhhhcCCCcC
Confidence 9999999999999 99999999999999999766 89999999997653322 2334568889999999877 568
Q ss_pred CCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccc-----------------cchhhhhh
Q 024027 156 STNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLS-----------------QEDIHFVA 218 (273)
Q Consensus 156 ~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~ 218 (273)
+.++|||||||++|+|++|..||................................ ........
T Consensus 209 ~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (330)
T 3nsz_A 209 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSEN 288 (330)
T ss_dssp CTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTT
T ss_pred CchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccc
Confidence 9999999999999999999999965433322222222211111111111110000 00011112
Q ss_pred hhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHH
Q 024027 219 KEQCVSFVFNLAMACTVESPEQRINAKEIVTKL 251 (273)
Q Consensus 219 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l 251 (273)
+..++.++.+|+.+||..||++|||++++++|-
T Consensus 289 ~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp 321 (330)
T 3nsz_A 289 QHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 321 (330)
T ss_dssp GGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSG
T ss_pred cccCCHHHHHHHHHHhcCCcccCCCHHHHhcCc
Confidence 334678899999999999999999999999873
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=313.41 Aligned_cols=233 Identities=25% Similarity=0.380 Sum_probs=186.8
Q ss_pred eEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 2 EVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 2 ~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
.||||+++... ....+.+.+|+++++.++||||+++++++..+ ..++||||+++|+|.+++... ..+++..++.++
T Consensus 398 ~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~ 475 (635)
T 4fl3_A 398 TVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELV 475 (635)
T ss_dssp EEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHH
T ss_pred EEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CEEEEEEccCCCCHHHHHhhC-CCCCHHHHHHHH
Confidence 69999998653 33467899999999999999999999999754 578999999999999999654 468999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCc-ceeecccccCCCCCCcccCCCCcCCc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQS-MTQTQTLATIGYMAPEYGREGRVSTN 158 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~ 158 (273)
.||+.||.||| +.|++||||||+||+++.++.+||+|||++..+...... .......+++.|+|||++.+..++.+
T Consensus 476 ~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~ 552 (635)
T 4fl3_A 476 HQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK 552 (635)
T ss_dssp HHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHH
T ss_pred HHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcH
Confidence 99999999999 999999999999999999999999999999866432221 12223346788999999988889999
Q ss_pred chhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 159 GDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 159 ~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
+|||||||++|+|++ |..||......+.. .... .. .....+..++.++.+|+.+||..|
T Consensus 553 sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~--~~i~------------~~------~~~~~p~~~~~~l~~li~~cl~~d 612 (635)
T 4fl3_A 553 SDVWSFGVLMWEAFSYGQKPYRGMKGSEVT--AMLE------------KG------ERMGCPAGCPREMYDLMNLCWTYD 612 (635)
T ss_dssp HHHHHHHHHHHHHHTTTCCSSTTCCHHHHH--HHHH------------TT------CCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCCCHHHHH--HHHH------------cC------CCCCCCCCCCHHHHHHHHHHcCCC
Confidence 999999999999998 99999764332211 0000 00 011124567788999999999999
Q ss_pred ccCCCCHHHHHHHHHHHHHhhh
Q 024027 238 PEQRINAKEIVTKLLKIRDSLL 259 (273)
Q Consensus 238 p~~Rps~~~~l~~l~~~~~~~~ 259 (273)
|++|||+.++++.|+++..++.
T Consensus 613 P~~RPs~~~l~~~L~~~~~~l~ 634 (635)
T 4fl3_A 613 VENRPGFAAVELRLRNYYYDVV 634 (635)
T ss_dssp TTTSCCHHHHHHHHHHHHHHHC
T ss_pred HhHCcCHHHHHHHHHHHHHHhc
Confidence 9999999999999999987753
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=282.69 Aligned_cols=225 Identities=20% Similarity=0.252 Sum_probs=185.5
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++||||+++++|.+++.... .+++..++.
T Consensus 41 ~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~ 119 (294)
T 2rku_A 41 EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK-ALTEPEARY 119 (294)
T ss_dssp CEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHC-SCCHHHHHH
T ss_pred ceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHH
Confidence 368999997552 3456778899999999999999999999999999999999999999999986543 689999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||.+....... .......+++.|+|||.+.+..++.
T Consensus 120 i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~ 194 (294)
T 2rku_A 120 YLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGHSF 194 (294)
T ss_dssp HHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT--CCBCCCCSCCSSCCHHHHTTSCBCT
T ss_pred HHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccCc--cccccccCCCCcCCcchhccCCCCc
Confidence 9999999999999 9999999999999999999999999999997653222 2233456899999999999888999
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
++||||||+++++|++|..||......+.. ...... ....+..++..+.+++.+||..|
T Consensus 195 ~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~--------------------~~~~~~~~~~~~~~li~~~l~~~ 253 (294)
T 2rku_A 195 EVDVWSIGCIMYTLLVGKPPFETSCLKETY-LRIKKN--------------------EYSIPKHINPVAASLIQKMLQTD 253 (294)
T ss_dssp HHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-HHHHTT--------------------CCCCCTTSCHHHHHHHHHHTCSS
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHhhc--------------------cCCCccccCHHHHHHHHHHcccC
Confidence 999999999999999999998653322111 000000 00113345677999999999999
Q ss_pred ccCCCCHHHHHHHHH
Q 024027 238 PEQRINAKEIVTKLL 252 (273)
Q Consensus 238 p~~Rps~~~~l~~l~ 252 (273)
|++|||++++++|-.
T Consensus 254 p~~Rps~~~ll~~~~ 268 (294)
T 2rku_A 254 PTARPTINELLNDEF 268 (294)
T ss_dssp GGGSCCGGGGGGSHH
T ss_pred hhhCcCHHHHhhChh
Confidence 999999999999865
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=289.56 Aligned_cols=245 Identities=22% Similarity=0.284 Sum_probs=182.0
Q ss_pred CeEEEEEeecccC--hhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 1 MEVAVKVFNLQCG--RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 1 ~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
+.||||++..... ...+.+.+|+++++.++||||+++++++.+.+..++||||+++++|.+++... ..+++..++.+
T Consensus 51 ~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~ 129 (331)
T 4aaa_A 51 RIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFP-NGLDYQVVQKY 129 (331)
T ss_dssp CEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHST-TCCCHHHHHHH
T ss_pred ceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhc-cCCCHHHHHHH
Confidence 4799999975532 33556789999999999999999999999999999999999998888876544 46999999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCC-CcCC
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG-RVST 157 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~ 157 (273)
+.|++.||.||| +.|++|+||||+||+++.++.++|+|||++....... .......+++.|+|||.+.+. .++.
T Consensus 130 ~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~ 204 (331)
T 4aaa_A 130 LFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EVYDDEVATRWYRAPELLVGDVKYGK 204 (331)
T ss_dssp HHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC--------------CCCCCTTCCHHHHTTCTTCCT
T ss_pred HHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc--cccCCCcCCccccCcccccCCCCcch
Confidence 999999999999 9999999999999999999999999999997653221 223345689999999998775 6899
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCc--cchhhhhh---------hccccchhhhhhhhhhHHHH
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPI--STMEVVDA---------NLLSQEDIHFVAKEQCVSFV 226 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~---------~~~~~~~~~~~~~~~~~~~l 226 (273)
++|||||||++|+|++|..||......+.... ........ ........ .............+.++.++
T Consensus 205 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 283 (331)
T 4aaa_A 205 AVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYH-IMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVV 283 (331)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-HHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHH-HHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHH
Confidence 99999999999999999999976443322111 11110000 00000000 00000111112234567889
Q ss_pred HHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 227 FNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 227 ~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
.+|+.+||..||.+|||+.++++|-+
T Consensus 284 ~~li~~~L~~dP~~Rpt~~ell~hp~ 309 (331)
T 4aaa_A 284 IDLAKKCLHIDPDKRPFCAELLHHDF 309 (331)
T ss_dssp HHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred HHHHHHHhccCcccCCCHHHHhcCch
Confidence 99999999999999999999999865
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=284.24 Aligned_cols=226 Identities=25% Similarity=0.340 Sum_probs=186.7
Q ss_pred CeEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 1 MEVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 1 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
+.||||+++... ....+.+.+|+.+++.++||||+++++++.++...++||||+++++|.+++.. ..+++..++.++
T Consensus 48 ~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~ 125 (303)
T 3a7i_A 48 KVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATIL 125 (303)
T ss_dssp CEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTT--SCCCHHHHHHHH
T ss_pred cEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHH
Confidence 479999997653 44567899999999999999999999999999999999999999999999965 358999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 159 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 159 (273)
.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++....... .......+++.|+|||.+.+..++.++
T Consensus 126 ~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~ 200 (303)
T 3a7i_A 126 REILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKA 200 (303)
T ss_dssp HHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB--CCBCCCCSCGGGCCHHHHTTCCBCTHH
T ss_pred HHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCccc--cccCccCCCcCccCHHHHhcCCCCchh
Confidence 99999999999 9999999999999999999999999999997653322 122345688999999999988899999
Q ss_pred hhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCcc
Q 024027 160 DVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239 (273)
Q Consensus 160 DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 239 (273)
||||||+++|+|++|..||.......... . ... .. ....+..++..+.+|+.+||..||.
T Consensus 201 Di~slG~il~~l~~g~~p~~~~~~~~~~~-~-~~~------------~~------~~~~~~~~~~~l~~li~~~l~~dp~ 260 (303)
T 3a7i_A 201 DIWSLGITAIELARGEPPHSELHPMKVLF-L-IPK------------NN------PPTLEGNYSKPLKEFVEACLNKEPS 260 (303)
T ss_dssp HHHHHHHHHHHHHHSSCTTTTSCHHHHHH-H-HHH------------SC------CCCCCSSCCHHHHHHHHHHCCSSGG
T ss_pred hhHHHHHHHHHHccCCCCCCCcCHHHHHH-H-hhc------------CC------CCCCccccCHHHHHHHHHHcCCChh
Confidence 99999999999999999986532211110 0 000 00 0011234567799999999999999
Q ss_pred CCCCHHHHHHHHHH
Q 024027 240 QRINAKEIVTKLLK 253 (273)
Q Consensus 240 ~Rps~~~~l~~l~~ 253 (273)
+|||+.++++|..-
T Consensus 261 ~Rps~~~ll~~~~~ 274 (303)
T 3a7i_A 261 FRPTAKELLKHKFI 274 (303)
T ss_dssp GSCCHHHHTTCHHH
T ss_pred hCcCHHHHhhChhh
Confidence 99999999998764
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=279.86 Aligned_cols=240 Identities=20% Similarity=0.211 Sum_probs=189.7
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeee-ecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSC-SNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
+.||||++.... ....+.+|+.+++.++|++++..+..+ ......++||||+ +++|.+++......+++..++.++
T Consensus 35 ~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~ 111 (296)
T 3uzp_A 35 EEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLA 111 (296)
T ss_dssp EEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHH
T ss_pred cEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHH
Confidence 379999987553 235789999999999888877766655 5667789999999 889999998666679999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeC---CCCceEEeecccccccccCCCcc-----eeecccccCCCCCCcccC
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLD---DNLVAYLSDFGIAKLLIGEDQSM-----TQTQTLATIGYMAPEYGR 151 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~---~~~~~kl~Df~~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~ 151 (273)
.|++.||.||| +.|++|+||||+||+++ .++.+||+|||++.......... ......+++.|+|||.+.
T Consensus 112 ~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 188 (296)
T 3uzp_A 112 DQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 188 (296)
T ss_dssp HHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHT
T ss_pred HHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhc
Confidence 99999999999 99999999999999994 78899999999998764332211 123456899999999999
Q ss_pred CCCcCCcchhHHHHHHHHHHHhCCCCCcccccccc--chhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHH
Q 024027 152 EGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEM--TLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNL 229 (273)
Q Consensus 152 ~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 229 (273)
+..++.++||||||+++|+|++|..||........ ......... . ..........++.++.+|
T Consensus 189 ~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------~---~~~~~~~~~~~~~~l~~l 253 (296)
T 3uzp_A 189 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK------------M---STPIEVLCKGYPSEFATY 253 (296)
T ss_dssp TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH------------H---HSCHHHHTTTSCHHHHHH
T ss_pred CCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccc------------c---CCchHHHHhhCCHHHHHH
Confidence 98899999999999999999999999976433221 111111000 0 000111124567889999
Q ss_pred HhhcCCCCccCCCCHHHHHHHHHHHHHhhhhh
Q 024027 230 AMACTVESPEQRINAKEIVTKLLKIRDSLLRN 261 (273)
Q Consensus 230 i~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~ 261 (273)
+.+||..||.+|||+.++++.|+++.++....
T Consensus 254 i~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 285 (296)
T 3uzp_A 254 LNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp HHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence 99999999999999999999999998876543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=282.93 Aligned_cols=227 Identities=26% Similarity=0.376 Sum_probs=181.0
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC--CCCCHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN--CILDIFQRLNI 78 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~ 78 (273)
+.||||+++.......+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|.+++.... ..+++..++.+
T Consensus 48 ~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 127 (295)
T 2clq_A 48 VRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFY 127 (295)
T ss_dssp CEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHH
T ss_pred eEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHH
Confidence 4799999987766667889999999999999999999999999999999999999999999997653 24678899999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCC-CCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCC--c
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDD-NLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGR--V 155 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~-~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~ 155 (273)
+.|++.||.||| +.|++|+||+|+||+++. ++.++|+|||.+....... .......+++.|+|||++.+.. +
T Consensus 128 ~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~ 202 (295)
T 2clq_A 128 TKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN--PCTETFTGTLQYMAPEIIDKGPRGY 202 (295)
T ss_dssp HHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------CCCCCCGGGCCHHHHHHGGGGC
T ss_pred HHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC--CcccccCCCccccChhhhcCCCCCC
Confidence 999999999999 999999999999999987 8999999999997653221 1223456889999999987643 7
Q ss_pred CCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCC
Q 024027 156 STNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTV 235 (273)
Q Consensus 156 ~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 235 (273)
+.++||||||+++|+|++|..||................ ......+..++.++.+|+.+||.
T Consensus 203 ~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~li~~~l~ 264 (295)
T 2clq_A 203 GKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF------------------KVHPEIPESMSAEAKAFILKCFE 264 (295)
T ss_dssp SHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHH------------------CCCCCCCTTSCHHHHHHHHHTTC
T ss_pred CcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccc------------------cccccccccCCHHHHHHHHHHcc
Confidence 899999999999999999999997543322111110000 00011134567789999999999
Q ss_pred CCccCCCCHHHHHHH
Q 024027 236 ESPEQRINAKEIVTK 250 (273)
Q Consensus 236 ~dp~~Rps~~~~l~~ 250 (273)
.||++|||+.++++|
T Consensus 265 ~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 265 PDPDKRACANDLLVD 279 (295)
T ss_dssp SSTTTSCCHHHHHTS
T ss_pred CChhhCCCHHHHhcC
Confidence 999999999999876
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=287.38 Aligned_cols=234 Identities=22% Similarity=0.238 Sum_probs=170.6
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCC-Cccceeeeeee--------ecCCceeEEEeccCCCCHHHhhhc--CCCC
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIR-HRNLIKVISSC--------SNEEFKALVLEYMPHGSLEKYLYS--SNCI 69 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~--------~~~~~~~lv~e~~~~~~L~~~l~~--~~~~ 69 (273)
+.||||++........+.+.+|+.+++.+. ||||+++++++ .....++++|||++ |+|.+++.. ....
T Consensus 54 ~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~ 132 (337)
T 3ll6_A 54 REYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGP 132 (337)
T ss_dssp CEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCS
T ss_pred cEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCC
Confidence 479999997766666778999999999995 99999999998 34456899999996 599998864 3456
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCCC--eEeccCCCCceeeCCCCceEEeecccccccccCCCcc----------eeec
Q 024027 70 LDIFQRLNIMIDVASALEYLHFGCSAP--VIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSM----------TQTQ 137 (273)
Q Consensus 70 ~~~~~~~~~~~ql~~~l~~lh~~~~~~--i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~----------~~~~ 137 (273)
+++..++.++.|++.||.||| +.| ++|+||||+||+++.++.+||+|||++.......... ....
T Consensus 133 ~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (337)
T 3ll6_A 133 LSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT 209 (337)
T ss_dssp CCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-----------------
T ss_pred CCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhcc
Confidence 999999999999999999999 888 9999999999999999999999999998764322211 1113
Q ss_pred ccccCCCCCCccc---CCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchh
Q 024027 138 TLATIGYMAPEYG---REGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDI 214 (273)
Q Consensus 138 ~~~~~~~~aPE~~---~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (273)
..+++.|+|||++ .+..++.++||||||+++|+|++|..||.......... .. .
T Consensus 210 ~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~-----~~------------------~ 266 (337)
T 3ll6_A 210 RNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN-----GK------------------Y 266 (337)
T ss_dssp --------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------------------------------C
T ss_pred ccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhc-----Cc------------------c
Confidence 4588999999998 45668899999999999999999999986532211100 00 0
Q ss_pred hhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHHHHHHhhhhh
Q 024027 215 HFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLLKIRDSLLRN 261 (273)
Q Consensus 215 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~ 261 (273)
....+...+..+.+|+.+||..||.+|||+.+++++|+.+......+
T Consensus 267 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~ 313 (337)
T 3ll6_A 267 SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVN 313 (337)
T ss_dssp CCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCC
T ss_pred cCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCC
Confidence 00112233445889999999999999999999999999998765433
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=284.75 Aligned_cols=245 Identities=22% Similarity=0.331 Sum_probs=187.5
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhc--CCCccceeeeeeeecCC----ceeEEEeccCCCCHHHhhhcCCCCCCHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKS--IRHRNLIKVISSCSNEE----FKALVLEYMPHGSLEKYLYSSNCILDIFQ 74 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (273)
++||||+++.. ....+.+|.+++.. ++||||+++++++.... ..++||||+++|+|.+++... .+++..
T Consensus 66 ~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~ 140 (342)
T 1b6c_B 66 EEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEG 140 (342)
T ss_dssp EEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC--CBCHHH
T ss_pred ccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhcc--CccHHH
Confidence 37999999644 34667889999887 68999999999998876 789999999999999999764 489999
Q ss_pred HHHHHHHHHHHHHHHhcCC-----CCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcc--eeecccccCCCCCC
Q 024027 75 RLNIMIDVASALEYLHFGC-----SAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSM--TQTQTLATIGYMAP 147 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~-----~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~--~~~~~~~~~~~~aP 147 (273)
++.++.|++.||.|||... +.|++|+||||+||+++.++.++|+|||++.......... ......+++.|+||
T Consensus 141 ~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aP 220 (342)
T 1b6c_B 141 MIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220 (342)
T ss_dssp HHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCH
T ss_pred HHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCH
Confidence 9999999999999999211 3689999999999999999999999999997664333211 22345689999999
Q ss_pred cccCCC------CcCCcchhHHHHHHHHHHHhC----------CCCCccccccccchhhhhhhccCccchhhhhhhcccc
Q 024027 148 EYGREG------RVSTNGDVYSFGIMLMETFTG----------KKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQ 211 (273)
Q Consensus 148 E~~~~~------~~~~~~DiwslG~~l~~ll~g----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (273)
|.+.+. .++.++||||||+++|+|++| ..||........................ .
T Consensus 221 E~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------~ 292 (342)
T 1b6c_B 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRP--------N 292 (342)
T ss_dssp HHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCC--------C
T ss_pred hhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCC--------C
Confidence 998765 234789999999999999999 6777665443333222222111100000 0
Q ss_pred chhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHHHHHHhhh
Q 024027 212 EDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLLKIRDSLL 259 (273)
Q Consensus 212 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 259 (273)
.. .......++..+.+|+.+||..||++|||+.+++++|+.+.++..
T Consensus 293 ~~-~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~ 339 (342)
T 1b6c_B 293 IP-NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 339 (342)
T ss_dssp CC-GGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC
T ss_pred Cc-ccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhc
Confidence 00 001134567789999999999999999999999999999987643
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=288.29 Aligned_cols=225 Identities=20% Similarity=0.247 Sum_probs=185.6
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|.+++... ..+++..++.
T Consensus 67 ~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~ 145 (335)
T 2owb_A 67 EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR-KALTEPEARY 145 (335)
T ss_dssp CEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHH-CSCCHHHHHH
T ss_pred CEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhcc-CCCCHHHHHH
Confidence 368999997542 345677899999999999999999999999999999999999999999998654 3689999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++....... .......+++.|+|||.+.+..++.
T Consensus 146 i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ 220 (335)
T 2owb_A 146 YLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGHSF 220 (335)
T ss_dssp HHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT--CCBCCCCSCCSSCCHHHHHTSCBCT
T ss_pred HHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc--ccccccCCCccccCHHHhccCCCCc
Confidence 9999999999999 9999999999999999999999999999998653222 2233456899999999999888999
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
++||||||+++|+|++|..||......+.. ...... ....+..++.++.+|+.+||..|
T Consensus 221 ~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~--------------------~~~~~~~~~~~~~~li~~~l~~d 279 (335)
T 2owb_A 221 EVDVWSIGCIMYTLLVGKPPFETSCLKETY-LRIKKN--------------------EYSIPKHINPVAASLIQKMLQTD 279 (335)
T ss_dssp HHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-HHHHHT--------------------CCCCCTTSCHHHHHHHHHHTCSS
T ss_pred hhhHHHHHHHHHHHHHCcCCCCCCCHHHHH-HHHhcC--------------------CCCCCccCCHHHHHHHHHHccCC
Confidence 999999999999999999998653322111 000000 00113345677999999999999
Q ss_pred ccCCCCHHHHHHHHH
Q 024027 238 PEQRINAKEIVTKLL 252 (273)
Q Consensus 238 p~~Rps~~~~l~~l~ 252 (273)
|++|||+.++++|-.
T Consensus 280 p~~Rps~~ell~~~~ 294 (335)
T 2owb_A 280 PTARPTINELLNDEF 294 (335)
T ss_dssp GGGSCCGGGGGGSHH
T ss_pred hhHCcCHHHHhcCcc
Confidence 999999999999755
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=284.11 Aligned_cols=233 Identities=27% Similarity=0.381 Sum_probs=183.3
Q ss_pred eEEEEEeecc---cChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 2 EVAVKVFNLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 2 ~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
.||||+++.. .....+.+.+|+++++.++||||+++++++..+. .++|+||+++++|.+++......+++..++.+
T Consensus 48 ~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 126 (291)
T 1u46_A 48 SVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY 126 (291)
T ss_dssp EEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHH
T ss_pred EEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHH
Confidence 5899999754 2455678999999999999999999999998765 88999999999999999776667999999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcc-eeecccccCCCCCCcccCCCCcCC
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSM-TQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
+.|++.||.||| +.|++|+||||+||+++.++.++|+|||++.......... ......++..|+|||.+.+..++.
T Consensus 127 ~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 203 (291)
T 1u46_A 127 AVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSH 203 (291)
T ss_dssp HHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEH
T ss_pred HHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCc
Confidence 999999999999 9999999999999999999999999999998764332211 123345677899999998888999
Q ss_pred cchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 158 NGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
++||||||+++|+|++ |..||........ ........ .....+..++.++.+++.+||..
T Consensus 204 ~~Di~slG~il~~l~~~g~~p~~~~~~~~~-~~~~~~~~------------------~~~~~~~~~~~~l~~li~~~l~~ 264 (291)
T 1u46_A 204 ASDTWMFGVTLWEMFTYGQEPWIGLNGSQI-LHKIDKEG------------------ERLPRPEDCPQDIYNVMVQCWAH 264 (291)
T ss_dssp HHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-HHHHHTSC------------------CCCCCCTTCCHHHHHHHHHHTCS
T ss_pred hhhHHHHHHHHHHHHhCCCCCcccCCHHHH-HHHHHccC------------------CCCCCCcCcCHHHHHHHHHHccC
Confidence 9999999999999999 9999876432211 11110000 00111345677899999999999
Q ss_pred CccCCCCHHHHHHHHHHHHHh
Q 024027 237 SPEQRINAKEIVTKLLKIRDS 257 (273)
Q Consensus 237 dp~~Rps~~~~l~~l~~~~~~ 257 (273)
||.+|||+.+++++|+++...
T Consensus 265 ~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 265 KPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp SGGGSCCHHHHHHHHHHHC--
T ss_pred CcccCcCHHHHHHHHHHhCcc
Confidence 999999999999999987654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=293.07 Aligned_cols=218 Identities=27% Similarity=0.319 Sum_probs=169.9
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHH-HhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEM-MKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (273)
+.||||+++... ......+..|..+ ++.++||||+++++++.+.+.+|+||||++||+|.+++...+ .+++..++
T Consensus 64 ~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~ 142 (373)
T 2r5t_A 64 VFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER-CFLEPRAR 142 (373)
T ss_dssp CEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHH
T ss_pred CEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHH
Confidence 368999997653 2334556677776 467899999999999999999999999999999999997543 68999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcC
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVS 156 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 156 (273)
.++.|++.||.||| +.|++||||||+||+++.++.+||+|||++...... .......+||+.|+|||++.+..++
T Consensus 143 ~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~ 217 (373)
T 2r5t_A 143 FYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NSTTSTFCGTPEYLAPEVLHKQPYD 217 (373)
T ss_dssp HHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC--CCCCCSBSCCCCCCCHHHHTTCCCC
T ss_pred HHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccccC--CCccccccCCccccCHHHhCCCCCC
Confidence 99999999999999 999999999999999999999999999999754221 2233456799999999999998999
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++|+|||||++|+|++|..||......+. ...+... ....+..++.++.+|+.+||..
T Consensus 218 ~~~DiwslG~il~ell~G~~Pf~~~~~~~~-~~~i~~~--------------------~~~~~~~~~~~~~~li~~lL~~ 276 (373)
T 2r5t_A 218 RTVDWWCLGAVLYEMLYGLPPFYSRNTAEM-YDNILNK--------------------PLQLKPNITNSARHLLEGLLQK 276 (373)
T ss_dssp THHHHHHHHHHHHHHHHSSCTTCCSBHHHH-HHHHHHS--------------------CCCCCSSSCHHHHHHHHHHTCS
T ss_pred chhhhHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHhc--------------------ccCCCCCCCHHHHHHHHHHccc
Confidence 999999999999999999999975332211 1111110 0011345677799999999999
Q ss_pred CccCCCCHH
Q 024027 237 SPEQRINAK 245 (273)
Q Consensus 237 dp~~Rps~~ 245 (273)
||.+||++.
T Consensus 277 dp~~R~~~~ 285 (373)
T 2r5t_A 277 DRTKRLGAK 285 (373)
T ss_dssp SGGGSTTTT
T ss_pred CHHhCCCCC
Confidence 999999974
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=294.49 Aligned_cols=228 Identities=22% Similarity=0.367 Sum_probs=177.3
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCC--CccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIR--HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (273)
+.||||+++... ......+.+|+.+++.++ ||||+++++++..+..+++|||+ .+++|.+++.... .+++..++
T Consensus 81 ~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E~-~~~~L~~~l~~~~-~~~~~~~~ 158 (390)
T 2zmd_A 81 QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK-SIDPWERK 158 (390)
T ss_dssp CEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEEC-CSEEHHHHHHHCS-SCCHHHHH
T ss_pred CEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEec-CCCCHHHHHHhcC-CCCHHHHH
Confidence 469999997543 345678999999999995 59999999999999999999995 5779999997654 68999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC----
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE---- 152 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---- 152 (273)
.++.|++.||.||| +.|++||||||+||+++ ++.+||+|||++..+............+|++.|+|||++.+
T Consensus 159 ~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 234 (390)
T 2zmd_A 159 SYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234 (390)
T ss_dssp HHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC---
T ss_pred HHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhcccc
Confidence 99999999999999 99999999999999996 58999999999987643332223345679999999998865
Q ss_pred -------CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHH
Q 024027 153 -------GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSF 225 (273)
Q Consensus 153 -------~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (273)
..++.++|||||||++|+|++|..||................. .....+...+.+
T Consensus 235 ~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~ 296 (390)
T 2zmd_A 235 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN------------------HEIEFPDIPEKD 296 (390)
T ss_dssp ---------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTT------------------SCCCCCCCSCHH
T ss_pred ccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcc------------------ccCCCCccchHH
Confidence 3588899999999999999999999975433211111111100 000112234567
Q ss_pred HHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 226 VFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 226 l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
+.+|+.+||..||.+|||+.++++|-+
T Consensus 297 ~~~li~~~L~~dP~~Rps~~ell~hp~ 323 (390)
T 2zmd_A 297 LQDVLKCCLKRDPKQRISIPELLAHPY 323 (390)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HHHHHHHHcccChhhCCCHHHHhhCcC
Confidence 999999999999999999999998865
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=300.63 Aligned_cols=227 Identities=23% Similarity=0.327 Sum_probs=183.9
Q ss_pred CeEEEEEeecccC-------------hhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC
Q 024027 1 MEVAVKVFNLQCG-------------RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN 67 (273)
Q Consensus 1 ~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 67 (273)
+.||||+++.... ...+.+.+|+.+++.++||||+++++++.++...++||||+++|+|.+++...
T Consensus 62 ~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~- 140 (504)
T 3q5i_A 62 SEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR- 140 (504)
T ss_dssp CEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-
T ss_pred cEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHc-
Confidence 4799999975421 33567899999999999999999999999999999999999999999998654
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCC---ceEEeecccccccccCCCcceeecccccCCC
Q 024027 68 CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNL---VAYLSDFGIAKLLIGEDQSMTQTQTLATIGY 144 (273)
Q Consensus 68 ~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~---~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~ 144 (273)
..+++..++.++.|++.||.||| +.|++||||||+||+++.++ .+||+|||++..+... .......|++.|
T Consensus 141 ~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y 214 (504)
T 3q5i_A 141 HKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD---YKLRDRLGTAYY 214 (504)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTT---SCBCCCCSCTTT
T ss_pred CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCC---CccccccCCcCC
Confidence 36999999999999999999999 99999999999999998765 6999999999866332 223445799999
Q ss_pred CCCcccCCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHH
Q 024027 145 MAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVS 224 (273)
Q Consensus 145 ~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (273)
+|||++. ..++.++||||+||++|+|++|..||......+. ...... ............++.
T Consensus 215 ~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~----------------~~~~~~~~~~~~~s~ 276 (504)
T 3q5i_A 215 IAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI-IKKVEK----------------GKYYFDFNDWKNISD 276 (504)
T ss_dssp CCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHH----------------CCCCCCHHHHTTSCH
T ss_pred CCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHc----------------CCCCCCccccCCCCH
Confidence 9999986 4689999999999999999999999976432211 111110 011111222355778
Q ss_pred HHHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 225 FVFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 225 ~l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
++.+|+.+||.+||.+|||+.++++|-+
T Consensus 277 ~~~~li~~~L~~dp~~R~t~~e~l~h~~ 304 (504)
T 3q5i_A 277 EAKELIKLMLTYDYNKRCTAEEALNSRW 304 (504)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HHHHHHHHHcCCChhHCCCHHHHhcCHh
Confidence 8999999999999999999999999865
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=283.04 Aligned_cols=221 Identities=19% Similarity=0.133 Sum_probs=174.6
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||||++.... ......+..|+..+..+ +||||++++++|.+.+..++||||+ +++|.+++...+..+++..++.
T Consensus 83 ~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~ 161 (311)
T 3p1a_A 83 RLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWG 161 (311)
T ss_dssp CEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHH
T ss_pred eEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHH
Confidence 479999986542 23344455566666555 8999999999999999999999999 5699999987777799999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
++.|++.||.||| +.|++|+||||+||+++.++.+||+|||++...... .......|++.|+|||++.+ .++.
T Consensus 162 i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~ 234 (311)
T 3p1a_A 162 YLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA---GAGEVQEGDPRYMAPELLQG-SYGT 234 (311)
T ss_dssp HHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---------CCCCCGGGCCGGGGGT-CCST
T ss_pred HHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecccC---CCCcccCCCccccCHhHhcC-CCCc
Confidence 9999999999999 999999999999999999999999999998765322 22334568999999999876 7899
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
++|||||||++|+|++|..||..... ....... ......+..++.++.+|+.+||..|
T Consensus 235 ~~DiwslG~il~el~~g~~~~~~~~~----~~~~~~~------------------~~~~~~~~~~~~~l~~li~~~L~~d 292 (311)
T 3p1a_A 235 AADVFSLGLTILEVACNMELPHGGEG----WQQLRQG------------------YLPPEFTAGLSSELRSVLVMMLEPD 292 (311)
T ss_dssp HHHHHHHHHHHHHHHHTCCCCSSHHH----HHHHTTT------------------CCCHHHHTTSCHHHHHHHHHHSCSS
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCccH----HHHHhcc------------------CCCcccccCCCHHHHHHHHHHcCCC
Confidence 99999999999999999776543111 1111110 0111224557788999999999999
Q ss_pred ccCCCCHHHHHHHH
Q 024027 238 PEQRINAKEIVTKL 251 (273)
Q Consensus 238 p~~Rps~~~~l~~l 251 (273)
|++|||+.++++|-
T Consensus 293 P~~Rpt~~ell~hp 306 (311)
T 3p1a_A 293 PKLRATAEALLALP 306 (311)
T ss_dssp TTTSCCHHHHHTSG
T ss_pred hhhCcCHHHHHhCc
Confidence 99999999999863
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=289.27 Aligned_cols=227 Identities=26% Similarity=0.391 Sum_probs=182.0
Q ss_pred CeEEEEEeecccC--------hhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCC
Q 024027 1 MEVAVKVFNLQCG--------RAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILD 71 (273)
Q Consensus 1 ~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 71 (273)
+.||||+++.... ...+.+.+|+.+++.+ +||||+++++++...+..++||||++|++|.+++... ..++
T Consensus 120 ~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~ 198 (365)
T 2y7j_A 120 HEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK-VALS 198 (365)
T ss_dssp CEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHH-SSCC
T ss_pred cEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhc-CCCC
Confidence 4799999975531 1245688999999999 7999999999999999999999999999999999654 3699
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccC
Q 024027 72 IFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR 151 (273)
Q Consensus 72 ~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 151 (273)
+..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++..+.... ......|++.|+|||++.
T Consensus 199 ~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~ 272 (365)
T 2y7j_A 199 EKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILK 272 (365)
T ss_dssp HHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEEecCcccccCCCc---ccccCCCCCCccChhhcc
Confidence 9999999999999999999 9999999999999999999999999999987653322 223467899999999875
Q ss_pred C------CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHH
Q 024027 152 E------GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSF 225 (273)
Q Consensus 152 ~------~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (273)
+ ..++.++|||||||++|+|++|..||....... ........ ...........++.+
T Consensus 273 ~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-~~~~i~~~----------------~~~~~~~~~~~~~~~ 335 (365)
T 2y7j_A 273 CSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL-MLRMIMEG----------------QYQFSSPEWDDRSST 335 (365)
T ss_dssp HTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHT----------------CCCCCHHHHSSSCHH
T ss_pred ccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhC----------------CCCCCCcccccCCHH
Confidence 3 358899999999999999999999986532211 11111110 000111123456777
Q ss_pred HHHHHhhcCCCCccCCCCHHHHHHHH
Q 024027 226 VFNLAMACTVESPEQRINAKEIVTKL 251 (273)
Q Consensus 226 l~~li~~~l~~dp~~Rps~~~~l~~l 251 (273)
+.+|+.+||..||++|||+.++++|-
T Consensus 336 ~~~li~~~L~~dP~~Rps~~ell~hp 361 (365)
T 2y7j_A 336 VKDLISRLLQVDPEARLTAEQALQHP 361 (365)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred HHHHHHHHcCCChhHCcCHHHHhcCc
Confidence 99999999999999999999999863
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=288.59 Aligned_cols=242 Identities=19% Similarity=0.264 Sum_probs=184.5
Q ss_pred CeEEEEEeecccChh-----------------hhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHh-
Q 024027 1 MEVAVKVFNLQCGRA-----------------FKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKY- 62 (273)
Q Consensus 1 ~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~- 62 (273)
+.||||++....... ...+.+|+.+++.++||||+++++++.+++..++||||+++++|.++
T Consensus 55 ~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 134 (348)
T 2pml_X 55 KFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFD 134 (348)
T ss_dssp EEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEES
T ss_pred ceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHH
Confidence 379999997552111 17899999999999999999999999999999999999999999998
Q ss_pred -----hhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEeccCCCCceeeCCCCceEEeecccccccccCCCccee
Q 024027 63 -----LYSS-NCILDIFQRLNIMIDVASALEYLHFGCS-APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQ 135 (273)
Q Consensus 63 -----l~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~-~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~ 135 (273)
+... ...+++..++.++.|++.||.||| + .|++|+||+|+||+++.++.++|+|||.+...... ..
T Consensus 135 ~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~ 207 (348)
T 2pml_X 135 EYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KI 207 (348)
T ss_dssp SSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEEECTTSCEEECCCTTCEECBTT----EE
T ss_pred HHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEEEcCCCcEEEeccccccccccc----cc
Confidence 6442 456999999999999999999999 8 99999999999999999999999999999865322 33
Q ss_pred ecccccCCCCCCcccCCC-CcCC-cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccch
Q 024027 136 TQTLATIGYMAPEYGREG-RVST-NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQED 213 (273)
Q Consensus 136 ~~~~~~~~~~aPE~~~~~-~~~~-~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (273)
....+++.|+|||.+.+. .++. ++||||||+++|+|++|..||........................ ..........
T Consensus 208 ~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~-~~~~~~~~~~ 286 (348)
T 2pml_X 208 KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDR-NHFLYPLTNK 286 (348)
T ss_dssp CSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSS-SSSTTTTCC-
T ss_pred cCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCCccch-hhhhcccccc
Confidence 455689999999999877 5666 999999999999999999999765442222222221111100000 0000000000
Q ss_pred hhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHH
Q 024027 214 IHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 214 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
........++.++.+|+.+||..||.+|||+.++++|
T Consensus 287 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 287 KSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp -------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0111125577889999999999999999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=291.87 Aligned_cols=242 Identities=20% Similarity=0.290 Sum_probs=185.3
Q ss_pred CeEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 1 MEVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 1 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
+.||+|+++... ......+.+|+.+++.++||||+++++++.+++..++||||+++++|.+++...+ .+++..+..++
T Consensus 59 ~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~ 137 (360)
T 3eqc_A 59 LVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVS 137 (360)
T ss_dssp CEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHH
T ss_pred cEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcC-CCCHHHHHHHH
Confidence 469999998653 3456779999999999999999999999999999999999999999999996543 58999999999
Q ss_pred HHHHHHHHHHhcCCCC-CeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCc
Q 024027 80 IDVASALEYLHFGCSA-PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTN 158 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~-~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 158 (273)
.|++.||.||| +. |++|+||||+||+++.++.++|+|||++...... ......+++.|+|||++.+..++.+
T Consensus 138 ~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~ 210 (360)
T 3eqc_A 138 IAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQ 210 (360)
T ss_dssp HHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----C----CCCCTTCCHHHHTTCCCSHH
T ss_pred HHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc----cccCCCCCCCeECHHHHcCCCCCch
Confidence 99999999999 75 9999999999999999999999999998654221 2234578999999999999899999
Q ss_pred chhHHHHHHHHHHHhCCCCCccccccccchhhhhhh-------------------------ccCccchhhhhhhccccch
Q 024027 159 GDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVND-------------------------WLPISTMEVVDANLLSQED 213 (273)
Q Consensus 159 ~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~~~~ 213 (273)
+|||||||++|+|++|..||................ .......+..+..... .
T Consensus 211 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 288 (360)
T 3eqc_A 211 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNE--P 288 (360)
T ss_dssp HHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------------CCCHHHHHHHHHHS--C
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhcc--C
Confidence 999999999999999999997643322111000000 0000000000000000 0
Q ss_pred hhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 214 IHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 214 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
........++.++.+|+.+||..||++|||++++++|-+
T Consensus 289 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 327 (360)
T 3eqc_A 289 PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 327 (360)
T ss_dssp CCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred CCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence 000112335778999999999999999999999999876
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=287.41 Aligned_cols=239 Identities=21% Similarity=0.203 Sum_probs=173.8
Q ss_pred eEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCC------ceeEEEeccCCCCHHHhhhcCCCCCCHH
Q 024027 2 EVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEE------FKALVLEYMPHGSLEKYLYSSNCILDIF 73 (273)
Q Consensus 2 ~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 73 (273)
.||||+++... ......+.+|+.+++.++||||+++++++.... ..++||||+++ +|.+++.. .+++.
T Consensus 52 ~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~ 127 (371)
T 2xrw_A 52 NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQM---ELDHE 127 (371)
T ss_dssp EEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSE-EHHHHHHS---CCCHH
T ss_pred eEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCCC-CHHHHHhh---ccCHH
Confidence 69999997542 344567889999999999999999999997665 67999999976 89888853 48899
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCC
Q 024027 74 QRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG 153 (273)
Q Consensus 74 ~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 153 (273)
.+..++.|++.||.||| +.|++|+||||+||+++.++.+||+|||++...... .......+++.|+|||++.+.
T Consensus 128 ~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~ 201 (371)
T 2xrw_A 128 RMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGM 201 (371)
T ss_dssp HHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC-------------------CTTCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeecccccccc---cccCCceecCCccCHHHhcCC
Confidence 99999999999999999 999999999999999999999999999999765221 122345789999999999988
Q ss_pred CcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhh-----------hhhc----------c--c
Q 024027 154 RVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVV-----------DANL----------L--S 210 (273)
Q Consensus 154 ~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~----------~--~ 210 (273)
.++.++|||||||++|+|++|..||....... ............ ..+.. .... . .
T Consensus 202 ~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (371)
T 2xrw_A 202 GYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQLGTP-CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDV 279 (371)
T ss_dssp CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHC-CCCC-CHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGG
T ss_pred CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCC-CHHHHHHhhhHHHHHHhhCccccccchhhhcccc
Confidence 89999999999999999999999997643321 111111111000 00000 0000 0 0
Q ss_pred cchhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 211 QEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 211 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
..+.........+.++.+|+.+||..||++|||++++++|-+
T Consensus 280 ~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 321 (371)
T 2xrw_A 280 LFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 321 (371)
T ss_dssp GSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred cCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcc
Confidence 000011112345778999999999999999999999999865
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=284.78 Aligned_cols=247 Identities=19% Similarity=0.231 Sum_probs=183.2
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeec--------CCceeEEEeccCCCCHHHhhhcCCCCC
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSN--------EEFKALVLEYMPHGSLEKYLYSSNCIL 70 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~~~ 70 (273)
+.||||++.... ......+.+|+++++.++||||+++++++.. .+..++||||+++ +|.+.+......+
T Consensus 43 ~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~ 121 (351)
T 3mi9_A 43 QKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKF 121 (351)
T ss_dssp CEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHCTTSCC
T ss_pred CEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhhccCCC
Confidence 479999996553 2335578899999999999999999999877 3468999999976 8888887776779
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCC--cceeecccccCCCCCCc
Q 024027 71 DIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQ--SMTQTQTLATIGYMAPE 148 (273)
Q Consensus 71 ~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~--~~~~~~~~~~~~~~aPE 148 (273)
++..++.++.|++.||.||| +.|++|+||||+||+++.++.+||+|||++..+..... ........+++.|+|||
T Consensus 122 ~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE 198 (351)
T 3mi9_A 122 TLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 198 (351)
T ss_dssp CHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHH
T ss_pred CHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCch
Confidence 99999999999999999999 99999999999999999999999999999976642221 22234456899999999
Q ss_pred ccCC-CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhc--cCccchhhhh------hhccc----cchhh
Q 024027 149 YGRE-GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDW--LPISTMEVVD------ANLLS----QEDIH 215 (273)
Q Consensus 149 ~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~------~~~~~----~~~~~ 215 (273)
++.+ ..++.++|||||||++|+|++|..||........ ........ .......... ..... .....
T Consensus 199 ~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (351)
T 3mi9_A 199 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ-LALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKD 277 (351)
T ss_dssp HHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHH
T ss_pred hhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCChhhccccccchhhcccccccccccCHHH
Confidence 8876 4589999999999999999999999976433221 11111110 0000000000 00000 00001
Q ss_pred hhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 216 FVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 216 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
.......+.++.+|+.+||..||++|||++++++|-+
T Consensus 278 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 314 (351)
T 3mi9_A 278 RLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 314 (351)
T ss_dssp HHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCC
Confidence 1111223567999999999999999999999999854
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=296.89 Aligned_cols=215 Identities=16% Similarity=0.159 Sum_probs=167.8
Q ss_pred CeEEEEEeecc---cChhhhhHHHHHHH---HhcCCCccceeee-------eeeecCC-----------------ceeEE
Q 024027 1 MEVAVKVFNLQ---CGRAFKSFDVECEM---MKSIRHRNLIKVI-------SSCSNEE-----------------FKALV 50 (273)
Q Consensus 1 ~~vavK~~~~~---~~~~~~~~~~E~~~---l~~l~h~~i~~~~-------~~~~~~~-----------------~~~lv 50 (273)
++||||+++.. .....+.+.+|+.+ ++.++||||++++ +++.+++ ..++|
T Consensus 99 ~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv 178 (377)
T 3byv_A 99 ESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFL 178 (377)
T ss_dssp CEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEE
T ss_pred cEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEE
Confidence 47999999743 34566789999954 5555899999998 5555543 37899
Q ss_pred EeccCCCCHHHhhhcCCC------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeeccccc
Q 024027 51 LEYMPHGSLEKYLYSSNC------ILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 124 (273)
Q Consensus 51 ~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~ 124 (273)
|||+ +|+|.+++...+. .+++..++.++.|++.||.||| +.|++||||||+||+++.++.+||+|||++.
T Consensus 179 ~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DFG~a~ 254 (377)
T 3byv_A 179 YPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 254 (377)
T ss_dssp EECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCGGGCE
T ss_pred Eecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEechhhe
Confidence 9999 5699999975421 2335888899999999999999 9999999999999999999999999999997
Q ss_pred ccccCCCcceeecccccCCCCCCcccCCC-----------CcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhh
Q 024027 125 LLIGEDQSMTQTQTLATIGYMAPEYGREG-----------RVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVN 193 (273)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----------~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~ 193 (273)
.. ........| +.|+|||++.+. .++.++|||||||++|+|++|..||........... ..
T Consensus 255 ~~-----~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~-~~- 326 (377)
T 3byv_A 255 RD-----GARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEW-IF- 326 (377)
T ss_dssp ET-----TCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGG-GG-
T ss_pred ec-----CCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhh-hh-
Confidence 53 112334567 999999999877 789999999999999999999999865332221100 00
Q ss_pred hccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHH
Q 024027 194 DWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
.....++.++.+|+.+||..||++|||+.++++|
T Consensus 327 -----------------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 327 -----------------------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp -----------------------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred -----------------------hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 0013456779999999999999999999999985
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=285.87 Aligned_cols=237 Identities=24% Similarity=0.323 Sum_probs=170.9
Q ss_pred CeEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhc-------CCCCCCH
Q 024027 1 MEVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS-------SNCILDI 72 (273)
Q Consensus 1 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-------~~~~~~~ 72 (273)
+.||||++.... ......+.+|+.+++.++||||+++++++..++..++||||+++++|.+++.. ....+++
T Consensus 41 ~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 120 (303)
T 2vwi_A 41 EKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDE 120 (303)
T ss_dssp CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCH
T ss_pred cEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCH
Confidence 479999997543 34567788999999999999999999999999999999999999999999863 3446899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCC---cceeecccccCCCCCCcc
Q 024027 73 FQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQ---SMTQTQTLATIGYMAPEY 149 (273)
Q Consensus 73 ~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~---~~~~~~~~~~~~~~aPE~ 149 (273)
..++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++........ ........+++.|+|||.
T Consensus 121 ~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 197 (303)
T 2vwi_A 121 STIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV 197 (303)
T ss_dssp HHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHH
T ss_pred HHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHH
Confidence 999999999999999999 99999999999999999999999999999876533221 112234568999999999
Q ss_pred cCC-CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHH
Q 024027 150 GRE-GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFN 228 (273)
Q Consensus 150 ~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 228 (273)
+.+ ..++.++||||||+++|+|++|..||................. . ... ...........++.++.+
T Consensus 198 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~-~~~---------~~~~~~~~~~~~~~~~~~ 266 (303)
T 2vwi_A 198 MEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP-P-SLE---------TGVQDKEMLKKYGKSFRK 266 (303)
T ss_dssp HHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSC-C-CTT---------C-----CCCCCCCHHHHH
T ss_pred hccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCC-C-ccc---------cccccchhhhhhhHHHHH
Confidence 865 4689999999999999999999999976543322211111100 0 000 000001112345677999
Q ss_pred HHhhcCCCCccCCCCHHHHHHHH
Q 024027 229 LAMACTVESPEQRINAKEIVTKL 251 (273)
Q Consensus 229 li~~~l~~dp~~Rps~~~~l~~l 251 (273)
|+.+||..||.+|||+.++++|-
T Consensus 267 li~~~l~~dp~~Rps~~~ll~h~ 289 (303)
T 2vwi_A 267 MISLCLQKDPEKRPTAAELLRHK 289 (303)
T ss_dssp HHHHHCCSSGGGSCCHHHHHTST
T ss_pred HHHHHccCChhhCcCHHHHhhCh
Confidence 99999999999999999999863
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=277.98 Aligned_cols=224 Identities=26% Similarity=0.353 Sum_probs=175.6
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||||+++... ......+.+|+.+++.++||||+++++++.+++..++||||+++++|.+++.... .+++..++.
T Consensus 37 ~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~ 115 (276)
T 2h6d_A 37 HKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG-RVEEMEARR 115 (276)
T ss_dssp CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC-SCCHHHHHH
T ss_pred ceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhccC-CCCHHHHHH
Confidence 479999997542 3345678999999999999999999999999999999999999999999996543 589999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCc-C
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRV-S 156 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~ 156 (273)
++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++...... .......+++.|+|||.+.+..+ +
T Consensus 116 ~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~ 189 (276)
T 2h6d_A 116 LFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---EFLRTSCGSPNYAAPEVISGRLYAG 189 (276)
T ss_dssp HHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----------------CCTGGGTTSCCCH
T ss_pred HHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCC---cceecccCCccccCHHHHcCCCCCC
Confidence 9999999999999 999999999999999999999999999998765322 12234568899999999987765 6
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++|+||||+++++|++|..||........ ...... .. ...+..++.++.+++.+||..
T Consensus 190 ~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~-------------~~-------~~~~~~~~~~l~~li~~~l~~ 248 (276)
T 2h6d_A 190 PEVDIWSCGVILYALLCGTLPFDDEHVPTL-FKKIRG-------------GV-------FYIPEYLNRSVATLLMHMLQV 248 (276)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHH-------------CC-------CCCCTTSCHHHHHHHHHHTCS
T ss_pred ccchHHHHHHHHHHHHhCCCCCCCCcHHHH-HHHhhc-------------Cc-------ccCchhcCHHHHHHHHHHccC
Confidence 899999999999999999999865322110 100000 00 011334567799999999999
Q ss_pred CccCCCCHHHHHHHHH
Q 024027 237 SPEQRINAKEIVTKLL 252 (273)
Q Consensus 237 dp~~Rps~~~~l~~l~ 252 (273)
||.+|||+.++++|-+
T Consensus 249 ~p~~Rps~~~~l~h~~ 264 (276)
T 2h6d_A 249 DPLKRATIKDIREHEW 264 (276)
T ss_dssp SGGGSCCHHHHHHSHH
T ss_pred ChhhCCCHHHHHhChh
Confidence 9999999999999854
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=287.17 Aligned_cols=244 Identities=20% Similarity=0.203 Sum_probs=177.0
Q ss_pred CeEEEEEeecccCh-----------hhhhHHHHHHHHhcCCCccceeeeeeeec-----CCceeEEEeccCCCCHHHhhh
Q 024027 1 MEVAVKVFNLQCGR-----------AFKSFDVECEMMKSIRHRNLIKVISSCSN-----EEFKALVLEYMPHGSLEKYLY 64 (273)
Q Consensus 1 ~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~ 64 (273)
++||||++...... ..+.+.+|+++++.++||||+++++++.. ...+++||||+++ +|.+++.
T Consensus 47 ~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~ 125 (362)
T 3pg1_A 47 IPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIH 125 (362)
T ss_dssp CEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCSE-EHHHHHH
T ss_pred CeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCCC-CHHHHHH
Confidence 47999999654221 23678999999999999999999999843 4468999999975 9999998
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCC
Q 024027 65 SSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGY 144 (273)
Q Consensus 65 ~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~ 144 (273)
.....+++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++...... .......+++.|
T Consensus 126 ~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y 199 (362)
T 3pg1_A 126 DQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTAD---ANKTHYVTHRWY 199 (362)
T ss_dssp CTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCTTC------------------CGGG
T ss_pred hcccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEEcCCCCEEEEecCcccccccc---cccceeccccee
Confidence 77777999999999999999999999 999999999999999999999999999999754221 223345688899
Q ss_pred CCCcccCC-CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhh-----------hhhhcc-cc
Q 024027 145 MAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEV-----------VDANLL-SQ 211 (273)
Q Consensus 145 ~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~-~~ 211 (273)
+|||++.+ ..++.++|||||||++|+|++|..||......+ ................. ...... ..
T Consensus 200 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (362)
T 3pg1_A 200 RAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN-QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVP 278 (362)
T ss_dssp CCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCC
T ss_pred cCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCC
Confidence 99998876 668999999999999999999999997643222 11111111111111100 000000 00
Q ss_pred chhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 212 EDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 212 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
..........++..+.+|+.+||..||.+|||+.++++|-+
T Consensus 279 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 319 (362)
T 3pg1_A 279 ARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPY 319 (362)
T ss_dssp CCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred hhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCch
Confidence 11112223456778999999999999999999999998743
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=289.57 Aligned_cols=240 Identities=21% Similarity=0.207 Sum_probs=169.3
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecC------CceeEEEeccCCCCHHHhhhcCCCCCCH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNE------EFKALVLEYMPHGSLEKYLYSSNCILDI 72 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 72 (273)
+.||||++.... ......+.+|+++++.++||||+++++++... ...++|+|++ +++|.+++.. ..+++
T Consensus 55 ~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~ 131 (367)
T 2fst_X 55 LRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTD 131 (367)
T ss_dssp EEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC-------CCCCH
T ss_pred CEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhc--CCCCH
Confidence 379999997542 34566788999999999999999999998654 5679999999 6799999865 35999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC
Q 024027 73 FQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE 152 (273)
Q Consensus 73 ~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 152 (273)
..+..++.|++.||.||| +.|++||||||+||+++.++.+||+|||++..... ......+++.|+|||++.+
T Consensus 132 ~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~ 203 (367)
T 2fst_X 132 DHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD-----EMTGYVATRWYRAPEIMLN 203 (367)
T ss_dssp HHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC--------------------CCCTTCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeeccccccccc-----cCCCcCcCcCccChHHHcC
Confidence 999999999999999999 99999999999999999999999999999976422 2234578999999999877
Q ss_pred -CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccc-----------hhhhhhhccccchhhhhhhh
Q 024027 153 -GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPIST-----------MEVVDANLLSQEDIHFVAKE 220 (273)
Q Consensus 153 -~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~ 220 (273)
..++.++|||||||++|+|++|..||....... ....+......+.. ....................
T Consensus 204 ~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (367)
T 2fst_X 204 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 282 (367)
T ss_dssp CCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTT
T ss_pred CcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCC
Confidence 678999999999999999999999997643321 12222211111100 00000000000001111123
Q ss_pred hhHHHHHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 221 QCVSFVFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 221 ~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
.++.++.+|+.+||..||.+|||+.++++|-.
T Consensus 283 ~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~ 314 (367)
T 2fst_X 283 GANPLAVDLLEKMLVLDSDKRITAAQALAHAY 314 (367)
T ss_dssp TCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred CCCHHHHHHHHHhCCCCcccCcCHHHHhcChh
Confidence 46778999999999999999999999998843
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=284.47 Aligned_cols=227 Identities=22% Similarity=0.264 Sum_probs=180.8
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeee--cCCceeEEEeccCCCCHHHhhhcC---CCCCCHH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCS--NEEFKALVLEYMPHGSLEKYLYSS---NCILDIF 73 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~ 73 (273)
+.||+|+++... ....+.+.+|+++++.++||||+++++++. .....++||||+++++|.+++... ...+++.
T Consensus 32 ~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 111 (279)
T 2w5a_A 32 KILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111 (279)
T ss_dssp CEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHH
T ss_pred cEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHH
Confidence 469999997553 345677999999999999999999999874 467889999999999999999643 3358999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCC-----eEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCc
Q 024027 74 QRLNIMIDVASALEYLHFGCSAP-----VIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPE 148 (273)
Q Consensus 74 ~~~~~~~ql~~~l~~lh~~~~~~-----i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE 148 (273)
.++.++.|++.||.||| +.| ++|+||+|+||+++.++.++|+|||.+....... .......+++.|+|||
T Consensus 112 ~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE 186 (279)
T 2w5a_A 112 FVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT--SFAKTFVGTPYYMSPE 186 (279)
T ss_dssp HHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---C--HHHHHHHSCCTTCCHH
T ss_pred HHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeecccc--ccccccCCCccccChH
Confidence 99999999999999999 888 9999999999999999999999999987653211 1123456899999999
Q ss_pred ccCCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHH
Q 024027 149 YGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFN 228 (273)
Q Consensus 149 ~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 228 (273)
.+.+..++.++||||||+++|+|++|..||........ ........ . ...+..++.++.+
T Consensus 187 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~i~~~~-------------~------~~~~~~~~~~l~~ 246 (279)
T 2w5a_A 187 QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL-AGKIREGK-------------F------RRIPYRYSDELNE 246 (279)
T ss_dssp HHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHTC-------------C------CCCCTTSCHHHHH
T ss_pred HhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHH-HHHHhhcc-------------c------ccCCcccCHHHHH
Confidence 99888899999999999999999999999876432111 11110000 0 0113356778999
Q ss_pred HHhhcCCCCccCCCCHHHHHHHHH
Q 024027 229 LAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 229 li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
++.+||..||.+|||+.+++++++
T Consensus 247 li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 247 IITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred HHHHHcCCCcccCCCHHHHHhChh
Confidence 999999999999999999998765
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=307.47 Aligned_cols=224 Identities=21% Similarity=0.239 Sum_probs=185.2
Q ss_pred CeEEEEEeecc---cChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHH
Q 024027 1 MEVAVKVFNLQ---CGRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (273)
+.||||+++.. .....+.+..|..++..+ +||+|+++++++.+...+|+||||++||+|.+++...+ .+++..++
T Consensus 367 ~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~-~~~~~~~~ 445 (674)
T 3pfq_A 367 ELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-RFKEPHAV 445 (674)
T ss_dssp CEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHH
T ss_pred cEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcC-CCCHHHHH
Confidence 36999999854 234566788999999988 79999999999999999999999999999999997654 69999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcC
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVS 156 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 156 (273)
.++.||+.||.||| +.||+||||||+|||++.++.+||+|||++...... .......+||+.|+|||++.+..++
T Consensus 446 ~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~--~~~~~~~~GT~~Y~APE~l~~~~~~ 520 (674)
T 3pfq_A 446 FYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD--GVTTKTFCGTPDYIAPEIIAYQPYG 520 (674)
T ss_dssp HHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT--TCCBCCCCSCSSSCCHHHHTCCCBS
T ss_pred HHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeeccccC--CcccccccCCCcccCHhhhcCCCCC
Confidence 99999999999999 999999999999999999999999999999754222 2233456799999999999999999
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++|+||||+++|+|++|..||......+ ....+.... ...+..++.++.+||.+||..
T Consensus 521 ~~~DvwSlGvilyelltG~~Pf~~~~~~~-~~~~i~~~~--------------------~~~p~~~s~~~~~li~~lL~~ 579 (674)
T 3pfq_A 521 KSVDWWAFGVLLYEMLAGQAPFEGEDEDE-LFQSIMEHN--------------------VAYPKSMSKEAVAICKGLMTK 579 (674)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHSSC--------------------CCCCTTSCHHHHHHHHHHSCS
T ss_pred ccceEechHHHHHHHHcCCCCCCCCCHHH-HHHHHHhCC--------------------CCCCccCCHHHHHHHHHHccC
Confidence 99999999999999999999997643221 111111100 011345678899999999999
Q ss_pred CccCCCCH-----HHHHHHH
Q 024027 237 SPEQRINA-----KEIVTKL 251 (273)
Q Consensus 237 dp~~Rps~-----~~~l~~l 251 (273)
||++||++ ++|++|-
T Consensus 580 dP~~R~~~~~~~~~ei~~h~ 599 (674)
T 3pfq_A 580 HPGKRLGCGPEGERDIKEHA 599 (674)
T ss_dssp SSTTCTTCSTTHHHHHHSSG
T ss_pred CHHHCCCCCCCcHHHHhcCc
Confidence 99999997 7777653
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=288.96 Aligned_cols=230 Identities=24% Similarity=0.310 Sum_probs=183.1
Q ss_pred CeEEEEEeeccc----ChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHH
Q 024027 1 MEVAVKVFNLQC----GRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQR 75 (273)
Q Consensus 1 ~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (273)
+.||||+++... ....+.+.+|+++++.+ +||||+++++++..+...++||||+++++|.+++.... .+++..+
T Consensus 83 ~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~ 161 (355)
T 1vzo_A 83 KLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-RFTEHEV 161 (355)
T ss_dssp CEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHS-CCCHHHH
T ss_pred eEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHcC-CCCHHHH
Confidence 479999997542 23456788899999999 79999999999999999999999999999999996543 6899999
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCC--
Q 024027 76 LNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG-- 153 (273)
Q Consensus 76 ~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-- 153 (273)
+.++.|++.||.||| +.|++|+||||+||+++.++.+||+|||++..+.... .......+|++.|+|||++.+.
T Consensus 162 ~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~ 237 (355)
T 1vzo_A 162 QIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDS 237 (355)
T ss_dssp HHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC-
T ss_pred HHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccCC-CCcccCcccCcCccChhhhcCCCC
Confidence 999999999999999 9999999999999999999999999999997653221 1223345789999999998863
Q ss_pred CcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhc
Q 024027 154 RVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMAC 233 (273)
Q Consensus 154 ~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 233 (273)
.++.++|||||||++|+|++|..||......... ..+.... ... ....+..++..+.+|+.+|
T Consensus 238 ~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~~------------~~~----~~~~~~~~~~~~~~li~~~ 300 (355)
T 1vzo_A 238 GHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ-AEISRRI------------LKS----EPPYPQEMSALAKDLIQRL 300 (355)
T ss_dssp --CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH-HHHHHHH------------HHC----CCCCCTTSCHHHHHHHHHH
T ss_pred CCCchhhHHHHHHHHHHHHHCCCCCccCCccchH-HHHHHHH------------hcc----CCCCCcccCHHHHHHHHHH
Confidence 4789999999999999999999999753332211 1111100 000 0111345667799999999
Q ss_pred CCCCccCCC-----CHHHHHHHHH
Q 024027 234 TVESPEQRI-----NAKEIVTKLL 252 (273)
Q Consensus 234 l~~dp~~Rp-----s~~~~l~~l~ 252 (273)
|..||.+|| |++++++|..
T Consensus 301 L~~dP~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 301 LMKDPKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp TCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred hhhCHHHhcCCCCCCHHHHHcCcc
Confidence 999999999 9999999875
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=279.05 Aligned_cols=227 Identities=24% Similarity=0.338 Sum_probs=181.7
Q ss_pred CeEEEEEeeccc---------ChhhhhHHHHHHHHhcCC-CccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCC
Q 024027 1 MEVAVKVFNLQC---------GRAFKSFDVECEMMKSIR-HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCIL 70 (273)
Q Consensus 1 ~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 70 (273)
+.||||+++... ....+.+.+|+++++.+. ||||+++++++.++...++||||+++++|.+++... ..+
T Consensus 43 ~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~ 121 (298)
T 1phk_A 43 KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTL 121 (298)
T ss_dssp EEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSC
T ss_pred ceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhcc-CCC
Confidence 369999997542 123566889999999995 999999999999999999999999999999999654 368
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCccc
Q 024027 71 DIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYG 150 (273)
Q Consensus 71 ~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 150 (273)
++..++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||.+....... ......+++.|+|||++
T Consensus 122 ~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~ 195 (298)
T 1phk_A 122 SEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEII 195 (298)
T ss_dssp CHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHH
T ss_pred CHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEecccchhhcCCCc---ccccccCCccccCHHHh
Confidence 99999999999999999999 9999999999999999999999999999997653222 22345688999999987
Q ss_pred C------CCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHH
Q 024027 151 R------EGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVS 224 (273)
Q Consensus 151 ~------~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (273)
. ...++.++||||||+++++|++|..||....... ......... ..........++.
T Consensus 196 ~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~----------------~~~~~~~~~~~~~ 258 (298)
T 1phk_A 196 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-MLRMIMSGN----------------YQFGSPEWDDYSD 258 (298)
T ss_dssp HHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTC----------------CCCCTTTGGGSCH
T ss_pred ccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH-HHHHHhcCC----------------cccCcccccccCH
Confidence 4 4568899999999999999999999986532211 111111100 0001111245677
Q ss_pred HHHHHHhhcCCCCccCCCCHHHHHHHH
Q 024027 225 FVFNLAMACTVESPEQRINAKEIVTKL 251 (273)
Q Consensus 225 ~l~~li~~~l~~dp~~Rps~~~~l~~l 251 (273)
++.+|+.+||..||.+|||+.++++|-
T Consensus 259 ~l~~li~~~l~~dp~~Rps~~~ll~h~ 285 (298)
T 1phk_A 259 TVKDLVSRFLVVQPQKRYTAEEALAHP 285 (298)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred HHHHHHHHHccCCcccCCCHHHHHhCh
Confidence 899999999999999999999999763
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=281.22 Aligned_cols=225 Identities=24% Similarity=0.292 Sum_probs=175.9
Q ss_pred eEEEEEeeccc--------ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHH
Q 024027 2 EVAVKVFNLQC--------GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIF 73 (273)
Q Consensus 2 ~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 73 (273)
.||||+++... ......+.+|+++++.++||||+++++++..+. .++||||+++++|.+++... ..+++.
T Consensus 37 ~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~-~~~~~~ 114 (322)
T 2ycf_A 37 KVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGN-KRLKEA 114 (322)
T ss_dssp EEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHSTT-CCCCHH
T ss_pred EEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhcc-CCCCHH
Confidence 69999996432 123456889999999999999999999997665 89999999999999998654 469999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCc---eEEeecccccccccCCCcceeecccccCCCCCCccc
Q 024027 74 QRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLV---AYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYG 150 (273)
Q Consensus 74 ~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~---~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 150 (273)
.++.++.|++.||.||| +.|++|+||||+||+++.++. +||+|||++..... ........+++.|+|||++
T Consensus 115 ~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~gt~~y~aPE~~ 188 (322)
T 2ycf_A 115 TCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---TSLMRTLCGTPTYLAPEVL 188 (322)
T ss_dssp HHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCC---CHHHHHHHSCCTTCCHHHH
T ss_pred HHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccCccceeccc---ccccccccCCcCccCchhh
Confidence 99999999999999999 999999999999999987654 99999999976522 1122345689999999986
Q ss_pred C---CCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHH
Q 024027 151 R---EGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVF 227 (273)
Q Consensus 151 ~---~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 227 (273)
. ...++.++|||||||++|+|++|..||................. ..........++.++.
T Consensus 189 ~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~ 252 (322)
T 2ycf_A 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK----------------YNFIPEVWAEVSEKAL 252 (322)
T ss_dssp HHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTC----------------CCCCHHHHTTSCHHHH
T ss_pred ccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCc----------------cccCchhhhhcCHHHH
Confidence 3 45689999999999999999999999976443322221111110 0001112345677899
Q ss_pred HHHhhcCCCCccCCCCHHHHHHH
Q 024027 228 NLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 228 ~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
+|+.+||..||++|||+.++++|
T Consensus 253 ~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 253 DLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHcccCHhhCCCHHHHhhC
Confidence 99999999999999999999975
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=286.17 Aligned_cols=244 Identities=21% Similarity=0.197 Sum_probs=183.0
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecC-----CceeEEEeccCCCCHHHhhhcCCCCCCHHHH
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNE-----EFKALVLEYMPHGSLEKYLYSSNCILDIFQR 75 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (273)
.||||+++... ......+.+|+++++.++||||+++++++... ...++||||+++ +|.+++... .+++..+
T Consensus 54 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~-~L~~~l~~~--~~~~~~~ 130 (364)
T 3qyz_A 54 RVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQ--HLSNDHI 130 (364)
T ss_dssp EEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCSE-EHHHHHHHC--CCCHHHH
T ss_pred EEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccCc-CHHHHHHhC--CCCHHHH
Confidence 69999997543 33457789999999999999999999998665 468999999975 999999764 4899999
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCc-ceeecccccCCCCCCcccCC-C
Q 024027 76 LNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQS-MTQTQTLATIGYMAPEYGRE-G 153 (273)
Q Consensus 76 ~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~-~ 153 (273)
+.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++......... .......|++.|+|||++.+ .
T Consensus 131 ~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 207 (364)
T 3qyz_A 131 CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207 (364)
T ss_dssp HHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBC
T ss_pred HHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCC
Confidence 999999999999999 999999999999999999999999999999865432221 11234578999999998654 4
Q ss_pred CcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhh-----------hhhhccccchhhhhhhhhh
Q 024027 154 RVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEV-----------VDANLLSQEDIHFVAKEQC 222 (273)
Q Consensus 154 ~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~ 222 (273)
.++.++|||||||++|+|++|..||......+. ................ ..................+
T Consensus 208 ~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (364)
T 3qyz_A 208 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ-LNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNA 286 (364)
T ss_dssp SCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH-HHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTS
T ss_pred CCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH-HHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCC
Confidence 589999999999999999999999976433322 2222111111111000 0000000000011122456
Q ss_pred HHHHHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 223 VSFVFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 223 ~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
+.++.+|+.+||..||.+|||+.++++|-+
T Consensus 287 ~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 316 (364)
T 3qyz_A 287 DSKALDLLDKMLTFNPHKRIEVEQALAHPY 316 (364)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence 778999999999999999999999998754
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=307.83 Aligned_cols=231 Identities=28% Similarity=0.435 Sum_probs=186.3
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcC-CCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~ 80 (273)
.||||+++... ...+.|.+|+++|+.++||||+++++++.+ ...++||||+++|+|.+++... +..+++..++.++.
T Consensus 293 ~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~ 370 (535)
T 2h8h_A 293 RVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 370 (535)
T ss_dssp EEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHH
T ss_pred eEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHH
Confidence 69999998653 345789999999999999999999999876 6789999999999999999643 34589999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
|++.||.||| +.|++||||||+|||++.++.+||+|||++....... ........++..|+|||.+.+..++.++|
T Consensus 371 qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sD 446 (535)
T 2h8h_A 371 QIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSD 446 (535)
T ss_dssp HHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHH
T ss_pred HHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-eecccCCcCcccccCHHHhccCCCCchhh
Confidence 9999999999 9999999999999999999999999999997653211 11112234567899999998888999999
Q ss_pred hHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCcc
Q 024027 161 VYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239 (273)
Q Consensus 161 iwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 239 (273)
|||||+++|+|++ |..||......+.. .... .. .....+..++.++.+||.+||..||+
T Consensus 447 vwSlGv~l~el~t~g~~P~~~~~~~~~~-~~i~-------------~~------~~~~~~~~~~~~l~~li~~cl~~dP~ 506 (535)
T 2h8h_A 447 VWSFGILLTELTTKGRVPYPGMVNREVL-DQVE-------------RG------YRMPCPPECPESLHDLMCQCWRKEPE 506 (535)
T ss_dssp HHHHHHHHHHHTTTTCCSSTTCCHHHHH-HHHH-------------TT------CCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHH-------------cC------CCCCCCCCCCHHHHHHHHHHcCCChh
Confidence 9999999999999 99998764332111 0000 00 01112446778899999999999999
Q ss_pred CCCCHHHHHHHHHHHHHhh
Q 024027 240 QRINAKEIVTKLLKIRDSL 258 (273)
Q Consensus 240 ~Rps~~~~l~~l~~~~~~~ 258 (273)
+|||+++|++.|+.+..+.
T Consensus 507 ~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 507 ERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp GSCCHHHHHHHHHTSSCCC
T ss_pred HCcCHHHHHHHHHHHhhcc
Confidence 9999999999998765443
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=287.30 Aligned_cols=238 Identities=23% Similarity=0.287 Sum_probs=178.9
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeec-------------------------------------
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSN------------------------------------- 43 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------------------------------------- 43 (273)
+.||||++..+. ....+|+++++.++||||++++++|..
T Consensus 33 ~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 108 (383)
T 3eb0_A 33 KRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPS 108 (383)
T ss_dssp CEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC------------------------------------
T ss_pred CEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCC
Confidence 479999997542 334579999999999999999999843
Q ss_pred -CCceeEEEeccCCCCHHHhhh---cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeC-CCCceEEe
Q 024027 44 -EEFKALVLEYMPHGSLEKYLY---SSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLD-DNLVAYLS 118 (273)
Q Consensus 44 -~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~-~~~~~kl~ 118 (273)
....++||||+++ +|.+.+. ..+..+++..++.++.|++.||.||| +.|++||||||+||+++ .++.+||+
T Consensus 109 ~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~gi~H~Dikp~Nil~~~~~~~~kl~ 184 (383)
T 3eb0_A 109 QNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLC 184 (383)
T ss_dssp -CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEEETTTTEEEEC
T ss_pred CceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCcCccCccCHHHEEEcCCCCcEEEE
Confidence 3348899999985 8877764 34557999999999999999999999 99999999999999997 68899999
Q ss_pred ecccccccccCCCcceeecccccCCCCCCcccCCC-CcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccC
Q 024027 119 DFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLP 197 (273)
Q Consensus 119 Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 197 (273)
|||++..+.... ......+++.|+|||++.+. .++.++||||+||++|+|++|..||......+ ...........
T Consensus 185 Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~g~ 260 (383)
T 3eb0_A 185 DFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSID-QLVRIIQIMGT 260 (383)
T ss_dssp CCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCC
T ss_pred ECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCC
Confidence 999998653322 22345689999999988765 48999999999999999999999997643322 22222221111
Q ss_pred ccchhhhhh---------hccccchhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHH
Q 024027 198 ISTMEVVDA---------NLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 198 ~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
+........ ............+..++.++.+|+.+||..||.+|||+.++++|
T Consensus 261 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 261 PTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAH 322 (383)
T ss_dssp CCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111111000 00011112223345578889999999999999999999999976
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=278.11 Aligned_cols=220 Identities=15% Similarity=0.192 Sum_probs=177.5
Q ss_pred CeEEEEEeecc--cChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcC---CCCCCHHH
Q 024027 1 MEVAVKVFNLQ--CGRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS---NCILDIFQ 74 (273)
Q Consensus 1 ~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~ 74 (273)
+.||||+++.. .......+.+|+..+..+ +||||+++++++.+++..++||||+++++|.+++... ...+++..
T Consensus 37 ~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 116 (289)
T 1x8b_A 37 CIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAE 116 (289)
T ss_dssp CEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHH
T ss_pred ceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHH
Confidence 47999999864 244567788999999999 9999999999999999999999999999999999653 24589999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCC-------------------CceEEeecccccccccCCCccee
Q 024027 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDN-------------------LVAYLSDFGIAKLLIGEDQSMTQ 135 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~-------------------~~~kl~Df~~~~~~~~~~~~~~~ 135 (273)
++.++.|++.||.||| +.|++|+||||+||+++.+ ..++|+|||.+......
T Consensus 117 ~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------ 187 (289)
T 1x8b_A 117 LKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP------ 187 (289)
T ss_dssp HHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCS------
T ss_pred HHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCc------
Confidence 9999999999999999 9999999999999999844 47999999998865321
Q ss_pred ecccccCCCCCCcccCCC-CcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchh
Q 024027 136 TQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDI 214 (273)
Q Consensus 136 ~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (273)
....+++.|+|||.+.+. .++.++||||||++++++++|.+|+.... ......... .
T Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----~~~~~~~~~-------------~----- 245 (289)
T 1x8b_A 188 QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD----QWHEIRQGR-------------L----- 245 (289)
T ss_dssp CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH----HHHHHHTTC-------------C-----
T ss_pred cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh----HHHHHHcCC-------------C-----
Confidence 223588999999998765 56789999999999999999988764321 111111100 0
Q ss_pred hhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 215 HFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 215 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
...+..++.++.+|+.+||..||++|||+.++++|-+
T Consensus 246 -~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~ 282 (289)
T 1x8b_A 246 -PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSV 282 (289)
T ss_dssp -CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTT
T ss_pred -CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChH
Confidence 0113456778999999999999999999999998743
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=291.65 Aligned_cols=231 Identities=12% Similarity=0.084 Sum_probs=163.5
Q ss_pred CeEEEEEeecccC---hhhhhHHHHHHHHhcC--CCccceeee-------eeeecC-----------------CceeEEE
Q 024027 1 MEVAVKVFNLQCG---RAFKSFDVECEMMKSI--RHRNLIKVI-------SSCSNE-----------------EFKALVL 51 (273)
Q Consensus 1 ~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~h~~i~~~~-------~~~~~~-----------------~~~~lv~ 51 (273)
++||||+++.... ...+.+.+|+.+++.+ +||||++++ +++..+ ..+++||
T Consensus 88 ~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~ 167 (371)
T 3q60_A 88 EDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLM 167 (371)
T ss_dssp EEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEE
T ss_pred ceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEe
Confidence 3699999987532 3456677885444444 699988755 444332 3379999
Q ss_pred eccCCCCHHHhhhcCCCCCCHHHH------HHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccc
Q 024027 52 EYMPHGSLEKYLYSSNCILDIFQR------LNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL 125 (273)
Q Consensus 52 e~~~~~~L~~~l~~~~~~~~~~~~------~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~ 125 (273)
||++ ++|.+++...+..+....+ ..++.|++.||+||| +.|++||||||+||+++.++.+||+|||++..
T Consensus 168 e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~ 243 (371)
T 3q60_A 168 PAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWK 243 (371)
T ss_dssp CCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGGGEEECTTSCEEECCGGGEEE
T ss_pred cCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCccCcCCHHHEEECCCCCEEEEecceeee
Confidence 9998 6999999765444555555 677799999999999 99999999999999999999999999999986
Q ss_pred cccCCCcceeecccccCCCCCCcccCC--CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhh
Q 024027 126 LIGEDQSMTQTQTLATIGYMAPEYGRE--GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEV 203 (273)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (273)
.. .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.............. .
T Consensus 244 ~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~------~---- 308 (371)
T 3q60_A 244 VG-----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRP------S---- 308 (371)
T ss_dssp TT-----CEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBC------C----
T ss_pred cC-----CCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhh------h----
Confidence 52 12224567799999999987 6789999999999999999999999976533221100000 0
Q ss_pred hhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 204 VDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
................++.++.+|+.+||..||++|||+.++++|-+
T Consensus 309 --~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 355 (371)
T 3q60_A 309 --LRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPE 355 (371)
T ss_dssp --TTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHH
T ss_pred --hhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHH
Confidence 00000111111123456788999999999999999999999998643
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=278.26 Aligned_cols=227 Identities=21% Similarity=0.293 Sum_probs=179.3
Q ss_pred CeEEEEEeeccc----ChhhhhHHHHHHHHhcCCCccceeeeeee--ecCCceeEEEeccCCCCHHHhhhc-CCCCCCHH
Q 024027 1 MEVAVKVFNLQC----GRAFKSFDVECEMMKSIRHRNLIKVISSC--SNEEFKALVLEYMPHGSLEKYLYS-SNCILDIF 73 (273)
Q Consensus 1 ~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~ 73 (273)
+.||||+++... ......+.+|+++++.++||||+++++++ .+....++||||++++ |.+++.. ....+++.
T Consensus 31 ~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~ 109 (305)
T 2wtk_C 31 CRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVC 109 (305)
T ss_dssp CEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHH
T ss_pred cEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHH
Confidence 479999997542 34567899999999999999999999998 4556889999999875 7777754 34469999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCC
Q 024027 74 QRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG 153 (273)
Q Consensus 74 ~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 153 (273)
.++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||.+................+++.|+|||++.+.
T Consensus 110 ~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 186 (305)
T 2wtk_C 110 QAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGL 186 (305)
T ss_dssp HHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCC
T ss_pred HHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCc
Confidence 99999999999999999 999999999999999999999999999999876433333334455689999999998764
Q ss_pred C--cCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHh
Q 024027 154 R--VSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAM 231 (273)
Q Consensus 154 ~--~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 231 (273)
. ++.++||||||+++|+|++|..||........ ...... . ....+..++..+.+|+.
T Consensus 187 ~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~i~~-------------~-------~~~~~~~~~~~l~~li~ 245 (305)
T 2wtk_C 187 DTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL-FENIGK-------------G-------SYAIPGDCGPPLSDLLK 245 (305)
T ss_dssp SCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHH-------------C-------CCCCCSSSCHHHHHHHH
T ss_pred ccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH-HHHHhc-------------C-------CCCCCCccCHHHHHHHH
Confidence 4 47899999999999999999999875321110 000000 0 00113456677999999
Q ss_pred hcCCCCccCCCCHHHHHHHHH
Q 024027 232 ACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 232 ~~l~~dp~~Rps~~~~l~~l~ 252 (273)
+||..||.+|||+.++++|-+
T Consensus 246 ~~l~~dp~~Rps~~~ll~~~~ 266 (305)
T 2wtk_C 246 GMLEYEPAKRFSIRQIRQHSW 266 (305)
T ss_dssp HHTCSSTTTSCCHHHHHHSHH
T ss_pred HHccCChhhCCCHHHHhcCcc
Confidence 999999999999999999865
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=289.16 Aligned_cols=246 Identities=19% Similarity=0.179 Sum_probs=171.5
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeee--cCCceeEEEeccCCCCHHHhhhcC--------CCCC
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS--NEEFKALVLEYMPHGSLEKYLYSS--------NCIL 70 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~ 70 (273)
+.||||+++... ....+.+|+.+|+.++||||+++++++. .....++||||+++ +|.+++... ...+
T Consensus 49 ~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l 125 (405)
T 3rgf_A 49 KDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQL 125 (405)
T ss_dssp CCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSE-EHHHHHHHHHHHC-------C
T ss_pred eEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCC
Confidence 369999997543 2357889999999999999999999994 47789999999975 888887522 2248
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceee----CCCCceEEeecccccccccCCC-cceeecccccCCCC
Q 024027 71 DIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLL----DDNLVAYLSDFGIAKLLIGEDQ-SMTQTQTLATIGYM 145 (273)
Q Consensus 71 ~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~----~~~~~~kl~Df~~~~~~~~~~~-~~~~~~~~~~~~~~ 145 (273)
++..++.++.|++.||.||| +.|++||||||+||++ +.++.+||+|||++..+..... .......+||+.|+
T Consensus 126 ~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~ 202 (405)
T 3rgf_A 126 PRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 202 (405)
T ss_dssp CHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTC
T ss_pred CHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCccc
Confidence 99999999999999999999 9999999999999999 6778999999999987643211 12234467899999
Q ss_pred CCcccCCC-CcCCcchhHHHHHHHHHHHhCCCCCccccccc--------cchhhhhhhccCccchhhhhhhcc-------
Q 024027 146 APEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTYEFFNGE--------MTLKHWVNDWLPISTMEVVDANLL------- 209 (273)
Q Consensus 146 aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~------- 209 (273)
|||++.+. .++.++|||||||++|+|++|..||....... ..+..+..................
T Consensus 203 aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 282 (405)
T 3rgf_A 203 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLM 282 (405)
T ss_dssp CHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHH
T ss_pred CchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhh
Confidence 99998874 48999999999999999999999997543321 111111111111000000000000
Q ss_pred --------ccch---hhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 210 --------SQED---IHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 210 --------~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
.... .........+.++.+||.+||..||.+|||++++++|-+
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~ 336 (405)
T 3rgf_A 283 KDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY 336 (405)
T ss_dssp HHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred hhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChh
Confidence 0000 000001112567899999999999999999999999866
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=277.37 Aligned_cols=229 Identities=21% Similarity=0.256 Sum_probs=173.7
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeec-------------CCceeEEEeccCCCCHHHhhhcCC
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSN-------------EEFKALVLEYMPHGSLEKYLYSSN 67 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-------------~~~~~lv~e~~~~~~L~~~l~~~~ 67 (273)
+.||||+++.. ....+.+.+|+.+++.++||||+++++++.+ ....++||||+++++|.+++...+
T Consensus 32 ~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 110 (303)
T 1zy4_A 32 RYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN 110 (303)
T ss_dssp CEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSC
T ss_pred eEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccc
Confidence 47999999754 4456789999999999999999999998754 457899999999999999998777
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCC------------ccee
Q 024027 68 CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQ------------SMTQ 135 (273)
Q Consensus 68 ~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~------------~~~~ 135 (273)
..+++..++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 111 ~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (303)
T 1zy4_A 111 LNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187 (303)
T ss_dssp GGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------
T ss_pred cccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhcccccccccccccc
Confidence 67889999999999999999999 99999999999999999999999999999876532110 1122
Q ss_pred ecccccCCCCCCcccCCC-CcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchh
Q 024027 136 TQTLATIGYMAPEYGREG-RVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDI 214 (273)
Q Consensus 136 ~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (273)
....+++.|+|||.+.+. .++.++||||||+++|+|++ ||................ ....
T Consensus 188 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~----------------~~~~ 248 (303)
T 1zy4_A 188 TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSV----------------SIEF 248 (303)
T ss_dssp ------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHST----------------TCCC
T ss_pred ccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhcccc----------------cccc
Confidence 345688999999998765 68999999999999999998 543221111111111000 0000
Q ss_pred hhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 215 HFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 215 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
....+...+..+.+|+.+||..||.+|||+.++++|-+
T Consensus 249 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (303)
T 1zy4_A 249 PPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGW 286 (303)
T ss_dssp CTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSC
T ss_pred CccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCC
Confidence 11113445667899999999999999999999998743
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=285.03 Aligned_cols=239 Identities=20% Similarity=0.191 Sum_probs=178.6
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCce------eEEEeccCCCCHHHhhhcCCCCCCH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFK------ALVLEYMPHGSLEKYLYSSNCILDI 72 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~------~lv~e~~~~~~L~~~l~~~~~~~~~ 72 (273)
+.||||+++... ......+.+|+.+++.++||||+++++++...+.. ++||||+++ +|.+++.. .+++
T Consensus 68 ~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~ 143 (371)
T 4exu_A 68 EKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGM---EFSE 143 (371)
T ss_dssp EEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCCE-EHHHHTTS---CCCH
T ss_pred CEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEccccc-cHHHHhhc---CCCH
Confidence 379999997642 33467788999999999999999999999887655 999999974 99888743 4899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC
Q 024027 73 FQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE 152 (273)
Q Consensus 73 ~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 152 (273)
..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++..... ......+++.|+|||++.+
T Consensus 144 ~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~ 215 (371)
T 4exu_A 144 EKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA-----EMTGYVVTRWYRAPEVILS 215 (371)
T ss_dssp HHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC-------------CTTCCCTTSCHHHHSC
T ss_pred HHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCccccccc-----CcCCcccCccccCHHHhcC
Confidence 999999999999999999 99999999999999999999999999999975422 2234568999999999877
Q ss_pred -CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCcc-----------chhhhhhhccccchhhhhhhh
Q 024027 153 -GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPIS-----------TMEVVDANLLSQEDIHFVAKE 220 (273)
Q Consensus 153 -~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~ 220 (273)
..++.++|||||||++|+|++|..||......+. ............ .....................
T Consensus 216 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (371)
T 4exu_A 216 WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-LTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFP 294 (371)
T ss_dssp CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHST
T ss_pred CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhcc
Confidence 6789999999999999999999999976432221 111111100000 000000000001111112234
Q ss_pred hhHHHHHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 221 QCVSFVFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 221 ~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
.++.++.+|+.+||..||.+|||+.++++|-+
T Consensus 295 ~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 326 (371)
T 4exu_A 295 RASPQAADLLEKMLELDVDKRLTAAQALTHPF 326 (371)
T ss_dssp TSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred ccChHHHHHHHHHCCCChhhcCCHHHHhcCcc
Confidence 56788999999999999999999999998854
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=278.87 Aligned_cols=245 Identities=21% Similarity=0.255 Sum_probs=182.2
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeee--------------cCCceeEEEeccCCCCHHHhhhcC
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCS--------------NEEFKALVLEYMPHGSLEKYLYSS 66 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--------------~~~~~~lv~e~~~~~~L~~~l~~~ 66 (273)
+.||||++...+....+.+.+|+++++.++||||+++++++. +....++||||+++ +|.+++..
T Consensus 37 ~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~- 114 (320)
T 2i6l_A 37 KRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQ- 114 (320)
T ss_dssp EEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCSE-EHHHHHTT-
T ss_pred eEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccCC-CHHHHhhc-
Confidence 379999998776667788999999999999999999999874 34678999999974 99999964
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeC-CCCceEEeecccccccccCCC-cceeecccccCCC
Q 024027 67 NCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLD-DNLVAYLSDFGIAKLLIGEDQ-SMTQTQTLATIGY 144 (273)
Q Consensus 67 ~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~-~~~~~kl~Df~~~~~~~~~~~-~~~~~~~~~~~~~ 144 (273)
..+++..++.++.|++.||.||| +.|++|+||||+||+++ .++.+||+|||++........ ........++..|
T Consensus 115 -~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y 190 (320)
T 2i6l_A 115 -GPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWY 190 (320)
T ss_dssp -CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTT
T ss_pred -CCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccc
Confidence 35899999999999999999999 99999999999999997 567999999999986532211 1122344678899
Q ss_pred CCCcccCC-CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhh----------hhhhccccch
Q 024027 145 MAPEYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEV----------VDANLLSQED 213 (273)
Q Consensus 145 ~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~ 213 (273)
+|||.+.+ ..++.++||||||+++|+|++|..||......+ ................. ..........
T Consensus 191 ~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (320)
T 2i6l_A 191 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE-QMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHK 269 (320)
T ss_dssp CCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCC
T ss_pred cCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCC
Confidence 99998765 568999999999999999999999997643321 11111111111100000 0000000001
Q ss_pred hhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 214 IHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 214 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
........++.++.+|+.+||..||.+|||++++++|-+
T Consensus 270 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 308 (320)
T 2i6l_A 270 PLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPY 308 (320)
T ss_dssp CHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHH
T ss_pred ChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcc
Confidence 111223457888999999999999999999999998754
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=277.53 Aligned_cols=227 Identities=22% Similarity=0.260 Sum_probs=168.4
Q ss_pred CeEEEEEeecccC--hhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhc---CCCCCCHHHH
Q 024027 1 MEVAVKVFNLQCG--RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS---SNCILDIFQR 75 (273)
Q Consensus 1 ~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~ 75 (273)
+.||||+++.... ...+.+.++...++.++||||+++++++.+++..++||||+++ +|.+++.. .+..+++..+
T Consensus 33 ~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~ 111 (290)
T 3fme_A 33 QIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDIL 111 (290)
T ss_dssp EEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHH
T ss_pred eEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHH
Confidence 3699999976532 2233445556668888999999999999999999999999975 98887753 4557999999
Q ss_pred HHHHHHHHHHHHHHhcCCCC-CeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCccc----
Q 024027 76 LNIMIDVASALEYLHFGCSA-PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYG---- 150 (273)
Q Consensus 76 ~~~~~ql~~~l~~lh~~~~~-~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~---- 150 (273)
+.++.|++.||.||| +. |++|+||||+||+++.++.++|+|||++...... .......+++.|+|||.+
T Consensus 112 ~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~ 185 (290)
T 3fme_A 112 GKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD---VAKDIDAGCKPYMAPERINPEL 185 (290)
T ss_dssp HHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC------------------CCCCCCSCHHHHSCCT
T ss_pred HHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCccccccc---ccccccCCCccccChhhcChhh
Confidence 999999999999999 87 9999999999999999999999999999765322 222334689999999996
Q ss_pred CCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHH
Q 024027 151 REGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLA 230 (273)
Q Consensus 151 ~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 230 (273)
.+..++.++||||||+++|+|++|..||................... ......++.++.+|+
T Consensus 186 ~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~li 247 (290)
T 3fme_A 186 NQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSP------------------QLPADKFSAEFVDFT 247 (290)
T ss_dssp TC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCC------------------CCCTTTSCHHHHHHH
T ss_pred cCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCC------------------CcccccCCHHHHHHH
Confidence 45568899999999999999999999997543332222221111100 001234567799999
Q ss_pred hhcCCCCccCCCCHHHHHHHHH
Q 024027 231 MACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 231 ~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
.+||..||++|||+.++++|-+
T Consensus 248 ~~~l~~~p~~Rpt~~e~l~hp~ 269 (290)
T 3fme_A 248 SQCLKKNSKERPTYPELMQHPF 269 (290)
T ss_dssp HHHTCSSGGGSCCHHHHTTSHH
T ss_pred HHHhhcChhhCcCHHHHHhCcc
Confidence 9999999999999999999765
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=280.51 Aligned_cols=227 Identities=22% Similarity=0.298 Sum_probs=175.0
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcC-CCccceeeeeeeec------CCceeEEEeccCCCCHHHhhhcCC-CCCCH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSI-RHRNLIKVISSCSN------EEFKALVLEYMPHGSLEKYLYSSN-CILDI 72 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~ 72 (273)
+.||||++... ......+.+|+.+++.+ +||||+++++++.. ....++||||+++++|.+++.... ..+++
T Consensus 50 ~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 128 (326)
T 2x7f_A 50 QLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE 128 (326)
T ss_dssp CEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCH
T ss_pred CeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCH
Confidence 47999999755 33457899999999999 89999999999976 467899999999999999997643 46899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccC-
Q 024027 73 FQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR- 151 (273)
Q Consensus 73 ~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~- 151 (273)
..++.++.|++.||.||| +.|++|+||+|+||+++.++.++|+|||++....... .......+++.|+|||++.
T Consensus 129 ~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~ 203 (326)
T 2x7f_A 129 EWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIAC 203 (326)
T ss_dssp HHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCTTTC---------------CCGGGCCHHHHC-
T ss_pred HHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEEEeeCcCceecCcCc--cccccccCCccccChhhhcc
Confidence 999999999999999999 9999999999999999999999999999987653211 1223456899999999986
Q ss_pred ----CCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHH
Q 024027 152 ----EGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVF 227 (273)
Q Consensus 152 ----~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 227 (273)
+..++.++|||||||++|+|++|..||.......... ..... .. ....+..++..+.
T Consensus 204 ~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~-~~-----------------~~~~~~~~~~~l~ 264 (326)
T 2x7f_A 204 DENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-LIPRN-PA-----------------PRLKSKKWSKKFQ 264 (326)
T ss_dssp -------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-HHHHS-CC-----------------CCCSCSCSCHHHH
T ss_pred ccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH-HhhcC-cc-----------------ccCCccccCHHHH
Confidence 4568899999999999999999999986533221110 00000 00 0001234567799
Q ss_pred HHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 228 NLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 228 ~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
+|+.+||..||.+|||+.++++|-.
T Consensus 265 ~li~~~l~~dp~~Rps~~~ll~hp~ 289 (326)
T 2x7f_A 265 SFIESCLVKNHSQRPATEQLMKHPF 289 (326)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHTSHH
T ss_pred HHHHHHhccChhhCCCHHHHhhChH
Confidence 9999999999999999999999743
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=288.04 Aligned_cols=240 Identities=22% Similarity=0.207 Sum_probs=179.6
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCC--------Cccceeeeeeee----cCCceeEEEeccCCCCHHHhhhcC-C
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIR--------HRNLIKVISSCS----NEEFKALVLEYMPHGSLEKYLYSS-N 67 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~~i~~~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~-~ 67 (273)
+.||||+++.. ....+.+.+|+.+++.++ |+||+++++++. .....++||||+. ++|.+++... .
T Consensus 63 ~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~ 140 (397)
T 1wak_A 63 KFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLG-HHLLKWIIKSNY 140 (397)
T ss_dssp EEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCCC-CBHHHHHHHTTT
T ss_pred eEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEeccC-ccHHHHHHhccc
Confidence 36999999754 345677889999999985 888999999987 5668999999995 5776666544 3
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEeccCCCCceeeCCCC---------------------------------
Q 024027 68 CILDIFQRLNIMIDVASALEYLHFGCSA-PVIHCDLKPDNVLLDDNL--------------------------------- 113 (273)
Q Consensus 68 ~~~~~~~~~~~~~ql~~~l~~lh~~~~~-~i~h~di~p~nil~~~~~--------------------------------- 113 (273)
..+++..++.++.|++.||.||| +. |++||||||+||+++.++
T Consensus 141 ~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (397)
T 1wak_A 141 QGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATA 217 (397)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------C
T ss_pred CCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCccc
Confidence 56999999999999999999999 88 999999999999999775
Q ss_pred ----------------ceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcchhHHHHHHHHHHHhCCCC
Q 024027 114 ----------------VAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 177 (273)
Q Consensus 114 ----------------~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~p 177 (273)
.++|+|||++..... ......+|+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 218 ~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 292 (397)
T 1wak_A 218 GNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----HFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYL 292 (397)
T ss_dssp CTTSCCTTSGGGGGGCCEEECCGGGCEETTB-----CSCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ccccccccccccccccceEeccccccccccc-----cCccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCC
Confidence 799999999976532 12345689999999999998899999999999999999999999
Q ss_pred Cccccccccch-----hhhhhhccCccchhhhhhhccc-----------------c------chhhhhhhhhhHHHHHHH
Q 024027 178 TYEFFNGEMTL-----KHWVNDWLPISTMEVVDANLLS-----------------Q------EDIHFVAKEQCVSFVFNL 229 (273)
Q Consensus 178 f~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~-----------------~------~~~~~~~~~~~~~~l~~l 229 (273)
|.......... ......... ............ . .......+...+.++.+|
T Consensus 293 f~~~~~~~~~~~~~~~~~~~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 371 (397)
T 1wak_A 293 FEPHSGEEYTRDEDHIALIIELLGK-VPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDF 371 (397)
T ss_dssp CCCCCCSSSCHHHHHHHHHHHHHCS-CCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHH
T ss_pred CCCCcccccCchHHHHHHHHHhcCC-CChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHH
Confidence 97654432211 111110000 000000000000 0 000011235567789999
Q ss_pred HhhcCCCCccCCCCHHHHHHHH
Q 024027 230 AMACTVESPEQRINAKEIVTKL 251 (273)
Q Consensus 230 i~~~l~~dp~~Rps~~~~l~~l 251 (273)
+.+||..||++|||+.++++|-
T Consensus 372 i~~~L~~dP~~Rpt~~e~l~hp 393 (397)
T 1wak_A 372 LLPMLELIPEKRATAAECLRHP 393 (397)
T ss_dssp HGGGGCSSGGGSCCHHHHHTSG
T ss_pred HHHHhccChhhcCCHHHHhhCc
Confidence 9999999999999999999863
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=273.58 Aligned_cols=227 Identities=23% Similarity=0.308 Sum_probs=181.5
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
+.||||+++... ......+.+|+++++.++||||+++++++.+....++|+||+++++|.+++.... .+++..++.+
T Consensus 48 ~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i 126 (287)
T 2wei_A 48 QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARI 126 (287)
T ss_dssp CEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS-SCCHHHHHHH
T ss_pred cEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhcC-CCCHHHHHHH
Confidence 479999997543 3456789999999999999999999999999999999999999999999886543 5899999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCC---CceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCc
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDN---LVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRV 155 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~---~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~ 155 (273)
+.|++.||.||| +.|++|+||+|+||+++.+ +.++|+|||++....... ......+++.|+|||.+.+ .+
T Consensus 127 ~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~ 199 (287)
T 2wei_A 127 IKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TY 199 (287)
T ss_dssp HHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS---SCSCHHHHHTTCCHHHHTT-CC
T ss_pred HHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC---ccccccCcccccChHHhcC-CC
Confidence 999999999999 9999999999999999754 479999999987653222 1233457889999998875 48
Q ss_pred CCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCC
Q 024027 156 STNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTV 235 (273)
Q Consensus 156 ~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 235 (273)
+.++||||||+++++|++|..||........ ........ ..........++.++.+++.+||.
T Consensus 200 ~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~----------------~~~~~~~~~~~~~~~~~li~~~l~ 262 (287)
T 2wei_A 200 DEKCDVWSAGVILYILLSGTPPFYGKNEYDI-LKRVETGK----------------YAFDLPQWRTISDDAKDLIRKMLT 262 (287)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCC----------------CCCCSGGGTTSCHHHHHHHHHHTC
T ss_pred CCchhhHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHcCC----------------CCCCchhhhhcCHHHHHHHHHHcc
Confidence 9999999999999999999999876332211 11111100 000111124567789999999999
Q ss_pred CCccCCCCHHHHHHHHH
Q 024027 236 ESPEQRINAKEIVTKLL 252 (273)
Q Consensus 236 ~dp~~Rps~~~~l~~l~ 252 (273)
.||.+|||+.++++|-.
T Consensus 263 ~dp~~Rps~~ell~hp~ 279 (287)
T 2wei_A 263 FHPSLRITATQCLEHPW 279 (287)
T ss_dssp SSGGGSCCHHHHHHSHH
T ss_pred cChhhCcCHHHHhcCHH
Confidence 99999999999999743
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=290.41 Aligned_cols=239 Identities=19% Similarity=0.225 Sum_probs=181.7
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcC------CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC-CCCCHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSI------RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQ 74 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~ 74 (273)
.||||+++.. ......+.+|+.+++.+ .|+||+++++++......++||||+. ++|.+++.... ..+++..
T Consensus 124 ~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~ 201 (429)
T 3kvw_A 124 HVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPL 201 (429)
T ss_dssp EEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHH
T ss_pred EEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHH
Confidence 6999999754 34456788888888877 57799999999999999999999996 59999987654 3589999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCc--eEEeecccccccccCCCcceeecccccCCCCCCcccCC
Q 024027 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLV--AYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE 152 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~--~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 152 (273)
++.++.|++.||.||| +.|++||||||+||+++.++. +||+|||++..... ......+++.|+|||++.+
T Consensus 202 ~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~ 273 (429)
T 3kvw_A 202 VRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ-----RVYTYIQSRFYRAPEVILG 273 (429)
T ss_dssp HHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTC-----CCCSSCSCGGGCCHHHHHT
T ss_pred HHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecccceecCC-----cccccCCCCCccChHHHhC
Confidence 9999999999999999 999999999999999998887 99999999975421 2234578999999999999
Q ss_pred CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhh-------------------------
Q 024027 153 GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDAN------------------------- 207 (273)
Q Consensus 153 ~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------------- 207 (273)
..++.++|||||||++|+|++|.+||......+. ........... .....+..
T Consensus 274 ~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~-l~~i~~~~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (429)
T 3kvw_A 274 ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQ-LACMIELLGMP-SQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGS 351 (429)
T ss_dssp BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCC-CHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--
T ss_pred CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCC-CHHHHHhhhhhhhccCCCCCccccccccccccc
Confidence 8999999999999999999999999976443221 11111110000 00000000
Q ss_pred ---------------ccccchhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 208 ---------------LLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 208 ---------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
...........+...+.++.+|+.+||++||++|||++++++|-+
T Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw 411 (429)
T 3kvw_A 352 VVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPW 411 (429)
T ss_dssp CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTT
T ss_pred ccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChh
Confidence 000000111112234677999999999999999999999999865
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=304.41 Aligned_cols=231 Identities=23% Similarity=0.361 Sum_probs=185.8
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
.||||+++... ....+.+.+|+.+++.++||||+++++++.+ +..++||||+++|+|.+++...+..+++..++.++.
T Consensus 420 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~ 498 (656)
T 2j0j_A 420 AVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAY 498 (656)
T ss_dssp EEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHH
T ss_pred EEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHH
Confidence 48999987543 3445779999999999999999999999854 568999999999999999987766799999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
|++.||.||| +.|++||||||+||+++.++.+||+|||++........ .......+++.|+|||.+.+..++.++|
T Consensus 499 qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~D 574 (656)
T 2j0j_A 499 QLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASD 574 (656)
T ss_dssp HHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHH
T ss_pred HHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhh
Confidence 9999999999 99999999999999999999999999999986532221 1222345677899999998888999999
Q ss_pred hHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCcc
Q 024027 161 VYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239 (273)
Q Consensus 161 iwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 239 (273)
|||||+++|+|++ |..||......+.. ...... .....+..++..+.+|+.+||..||.
T Consensus 575 iwSlG~il~ellt~g~~Pf~~~~~~~~~-~~i~~~-------------------~~~~~~~~~~~~l~~li~~~l~~dP~ 634 (656)
T 2j0j_A 575 VWMFGVCMWEILMHGVKPFQGVKNNDVI-GRIENG-------------------ERLPMPPNCPPTLYSLMTKCWAYDPS 634 (656)
T ss_dssp HHHHHHHHHHHHTTSCCTTTTCCHHHHH-HHHHHT-------------------CCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred HHHHHHHHHHHHHcCCCCCCCCCHHHHH-HHHHcC-------------------CCCCCCccccHHHHHHHHHHcCCChh
Confidence 9999999999997 99998764332211 111000 00111445677899999999999999
Q ss_pred CCCCHHHHHHHHHHHHHh
Q 024027 240 QRINAKEIVTKLLKIRDS 257 (273)
Q Consensus 240 ~Rps~~~~l~~l~~~~~~ 257 (273)
+|||+.++++.|+++.++
T Consensus 635 ~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 635 RRPRFTELKAQLSTILEE 652 (656)
T ss_dssp GSCCHHHHHHHHHHHHHH
T ss_pred HCcCHHHHHHHHHHHHHH
Confidence 999999999999998765
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=279.66 Aligned_cols=237 Identities=19% Similarity=0.224 Sum_probs=180.8
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCc------cceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC-CCCCHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHR------NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQ 74 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~ 74 (273)
.||||+++.. ....+.+.+|+++++.++|+ +++++++++.+.+..++||||+ +++|.+++...+ ..+++..
T Consensus 42 ~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~ 119 (339)
T 1z57_A 42 HVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDH 119 (339)
T ss_dssp EEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHH
T ss_pred EEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHH
Confidence 6999999754 34567788999999988665 4999999999999999999999 779999997654 3588999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCC-------------------CCceEEeecccccccccCCCccee
Q 024027 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDD-------------------NLVAYLSDFGIAKLLIGEDQSMTQ 135 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~-------------------~~~~kl~Df~~~~~~~~~~~~~~~ 135 (273)
++.++.|++.||.||| +.|++|+||||+||+++. ++.++|+|||++..... ..
T Consensus 120 ~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~ 191 (339)
T 1z57_A 120 IRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE-----HH 191 (339)
T ss_dssp HHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTS-----CC
T ss_pred HHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCcc-----cc
Confidence 9999999999999999 999999999999999987 66899999999976422 22
Q ss_pred ecccccCCCCCCcccCCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhh--------
Q 024027 136 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDAN-------- 207 (273)
Q Consensus 136 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 207 (273)
....+++.|+|||++.+..++.++|||||||++|+|++|..||......+. ......... ..........
T Consensus 192 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~-~~p~~~~~~~~~~~~~~~ 269 (339)
T 1z57_A 192 STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH-LAMMERILG-PLPKHMIQKTRKRKYFHH 269 (339)
T ss_dssp CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH-HHHHHHHHC-SCCHHHHHHCSCGGGEET
T ss_pred ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhC-CCCHHHHhhccchhHHhh
Confidence 345689999999999988999999999999999999999999976433221 111111100 0000000000
Q ss_pred -----------------ccccchhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHH
Q 024027 208 -----------------LLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 208 -----------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
...........+...+.++.+|+.+||..||.+|||+.++++|
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 270 DRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKH 329 (339)
T ss_dssp TEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcC
Confidence 0000000011123457789999999999999999999999987
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=282.63 Aligned_cols=244 Identities=22% Similarity=0.183 Sum_probs=180.3
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecC-----CceeEEEeccCCCCHHHhhhcCCCCCCHHHH
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNE-----EFKALVLEYMPHGSLEKYLYSSNCILDIFQR 75 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (273)
.||||+++... ......+.+|+++++.++||||+++++++... ...++||||+++ +|.+++... .+++..+
T Consensus 38 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~--~~~~~~~ 114 (353)
T 2b9h_A 38 IVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQ--MLSDDHI 114 (353)
T ss_dssp EEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCSE-EHHHHHHHC--CCCHHHH
T ss_pred EEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccCc-cHHHHHhhc--CCCHHHH
Confidence 69999997543 34456788999999999999999999987654 678999999975 999998764 5899999
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcc--------eeecccccCCCCCC
Q 024027 76 LNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSM--------TQTQTLATIGYMAP 147 (273)
Q Consensus 76 ~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~--------~~~~~~~~~~~~aP 147 (273)
+.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++.......... ......|++.|+||
T Consensus 115 ~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 191 (353)
T 2b9h_A 115 QYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAP 191 (353)
T ss_dssp HHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCH
T ss_pred HHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCC
Confidence 999999999999999 9999999999999999999999999999998664221111 11234679999999
Q ss_pred cccCC-CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCcc------------chhhhhhhccccchh
Q 024027 148 EYGRE-GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPIS------------TMEVVDANLLSQEDI 214 (273)
Q Consensus 148 E~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~ 214 (273)
|++.+ ..++.++|||||||++|+|++|..||........ ............ ..+............
T Consensus 192 E~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (353)
T 2b9h_A 192 EVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ-LLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAP 270 (353)
T ss_dssp HHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCC
T ss_pred eeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcc
Confidence 98754 6789999999999999999999999976432211 111111000000 000000000000001
Q ss_pred hhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 215 HFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 215 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
.......++.++.+|+.+||..||++|||+.++++|-+
T Consensus 271 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 308 (353)
T 2b9h_A 271 LEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPY 308 (353)
T ss_dssp HHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred hhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcc
Confidence 11223467788999999999999999999999998754
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=283.36 Aligned_cols=235 Identities=19% Similarity=0.257 Sum_probs=180.6
Q ss_pred eEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 2 EVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 2 ~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
.||+|+++... ....+.+.+|+.+++.++||||+++++++.++...++||||+++++|.+++...+..+++..++.++
T Consensus 57 ~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~ 136 (319)
T 2y4i_B 57 EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIA 136 (319)
T ss_dssp SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHH
T ss_pred eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHH
Confidence 58999997542 3445678899999999999999999999999999999999999999999998776679999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCC---cceeecccccCCCCCCcccCC----
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQ---SMTQTQTLATIGYMAPEYGRE---- 152 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~---~~~~~~~~~~~~~~aPE~~~~---- 152 (273)
.|++.||.||| +.|++|+||||+||+++ ++.++|+|||++........ ........|++.|+|||.+.+
T Consensus 137 ~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 212 (319)
T 2y4i_B 137 QEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212 (319)
T ss_dssp HHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC
T ss_pred HHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhcccc
Confidence 99999999999 99999999999999998 67999999999865422111 112233458889999998864
Q ss_pred -----CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHH
Q 024027 153 -----GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVF 227 (273)
Q Consensus 153 -----~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 227 (273)
..++.++||||||+++|+|++|..||......... ....... .. ...+..++.++.
T Consensus 213 ~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~~-~~-----------------~~~~~~~~~~l~ 273 (319)
T 2y4i_B 213 TEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII-WQMGTGM-KP-----------------NLSQIGMGKEIS 273 (319)
T ss_dssp --CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH-HHHHTTC-CC-----------------CCCCSSCCTTHH
T ss_pred ccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHhccCC-CC-----------------CCCcCCCCHHHH
Confidence 34688999999999999999999998754322111 1110000 00 000123456689
Q ss_pred HHHhhcCCCCccCCCCHHHHHHHHHHHHHhhh
Q 024027 228 NLAMACTVESPEQRINAKEIVTKLLKIRDSLL 259 (273)
Q Consensus 228 ~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 259 (273)
+|+.+||..||.+|||+.++++.|+++.+...
T Consensus 274 ~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~ 305 (319)
T 2y4i_B 274 DILLFCWAFEQEERPTFTKLMDMLEKLPKRNR 305 (319)
T ss_dssp HHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred HHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence 99999999999999999999999999887643
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=289.29 Aligned_cols=225 Identities=22% Similarity=0.329 Sum_probs=170.0
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
++||||++... ....+.+|+++|+.+ +||||+++++++.+....++||||+++ +|.+++...........++.++
T Consensus 49 ~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~g-~L~~~l~~~~~~~~~~~~~~i~ 124 (432)
T 3p23_A 49 RDVAVKRILPE---CFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAA-TLQEYVEQKDFAHLGLEPITLL 124 (432)
T ss_dssp SEEEEEEECTT---TEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHSSSCCCCSSCHHHHH
T ss_pred eEEEEEEECHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCCC-CHHHHHHhcCCCccchhHHHHH
Confidence 47999999643 234577899999999 799999999999999999999999965 9999998766556666778999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCC-----CCceEEeecccccccccCCC-cceeecccccCCCCCCcccCC-
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDD-----NLVAYLSDFGIAKLLIGEDQ-SMTQTQTLATIGYMAPEYGRE- 152 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~-----~~~~kl~Df~~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~- 152 (273)
.|++.||.||| +.|++||||||+||+++. ...++|+|||++........ ........||+.|+|||++.+
T Consensus 125 ~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 201 (432)
T 3p23_A 125 QQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSED 201 (432)
T ss_dssp HHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC
T ss_pred HHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcc
Confidence 99999999999 999999999999999953 23578999999986643221 122344578999999999874
Q ss_pred --CCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHH
Q 024027 153 --GRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNL 229 (273)
Q Consensus 153 --~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 229 (273)
..++.++|||||||++|+|++ |..||......... ...... . ..........+..+.+|
T Consensus 202 ~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~--~~~~~~-~---------------~~~~~~~~~~~~~~~~l 263 (432)
T 3p23_A 202 CKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN--ILLGAC-S---------------LDCLHPEKHEDVIAREL 263 (432)
T ss_dssp ---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH--HHTTCC-C---------------CTTSCTTCHHHHHHHHH
T ss_pred cccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH--HHhccC-C---------------ccccCccccccHHHHHH
Confidence 457889999999999999999 99998543221110 000000 0 00000122345668999
Q ss_pred HhhcCCCCccCCCCHHHHHHH
Q 024027 230 AMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 230 i~~~l~~dp~~Rps~~~~l~~ 250 (273)
+.+||..||.+|||+.++++|
T Consensus 264 i~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 264 IEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp HHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhCCHhhCCCHHHHHhC
Confidence 999999999999999999965
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=287.11 Aligned_cols=240 Identities=22% Similarity=0.255 Sum_probs=176.5
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeec------CCceeEEEeccCCCCHHHhhh---cCCCCCC
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSN------EEFKALVLEYMPHGSLEKYLY---SSNCILD 71 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~---~~~~~~~ 71 (273)
+.||||++.... ..+.+|+++++.++||||++++++|.. ...+++||||+++ +|.+.+. .....++
T Consensus 80 ~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~ 154 (420)
T 1j1b_A 80 ELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLP 154 (420)
T ss_dssp CEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCC
T ss_pred cEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCC
Confidence 479999996542 334579999999999999999998843 2346799999976 7766654 3455799
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCC-CceEEeecccccccccCCCcceeecccccCCCCCCccc
Q 024027 72 IFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDN-LVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYG 150 (273)
Q Consensus 72 ~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~-~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 150 (273)
+..++.++.|++.||.||| +.|++||||||+||+++.+ +.+||+|||++..+.... ......+++.|+|||++
T Consensus 155 ~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~ 228 (420)
T 1j1b_A 155 VIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE---PNVSYICSRYYRAPELI 228 (420)
T ss_dssp HHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC---CCCSCCSCTTSCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhhhcccCC---CceeeeeCCCcCCHHHH
Confidence 9999999999999999999 9999999999999999954 678999999998653222 22345789999999998
Q ss_pred CCC-CcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhh---------ccccchhhhhhhh
Q 024027 151 REG-RVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDAN---------LLSQEDIHFVAKE 220 (273)
Q Consensus 151 ~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~ 220 (273)
.+. .++.++|||||||++|+|++|+.||...... ..+..+................ ...........+.
T Consensus 229 ~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~-~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 307 (420)
T 1j1b_A 229 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP 307 (420)
T ss_dssp TTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCT
T ss_pred cCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCC
Confidence 765 6899999999999999999999999764322 2222222211111111000000 0000111111234
Q ss_pred hhHHHHHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 221 QCVSFVFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 221 ~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
.++.++.+|+.+||..||.+|||+.++++|-+
T Consensus 308 ~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~ 339 (420)
T 1j1b_A 308 RTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339 (420)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred CCCHHHHHHHHHhccCChhHCCCHHHHhCCHh
Confidence 56788999999999999999999999998754
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=287.11 Aligned_cols=240 Identities=18% Similarity=0.182 Sum_probs=189.2
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCC-ccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRH-RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
+.||||+++.... ...+..|+++++.++| +++..+..++......++||||+ +++|.+++......+++..++.++
T Consensus 33 ~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~ 109 (483)
T 3sv0_A 33 EEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 109 (483)
T ss_dssp CEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHH
T ss_pred cEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHH
Confidence 4799999875532 3568999999999976 55666666667788889999999 889999998666679999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceee---CCCCceEEeecccccccccCCCcc-----eeecccccCCCCCCcccC
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLL---DDNLVAYLSDFGIAKLLIGEDQSM-----TQTQTLATIGYMAPEYGR 151 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~---~~~~~~kl~Df~~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~ 151 (273)
.||+.||.||| +.|++|+||||+|||+ +.++.+||+|||++..+....... ......|+..|+|||.+.
T Consensus 110 ~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~ 186 (483)
T 3sv0_A 110 DQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHL 186 (483)
T ss_dssp HHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT
T ss_pred HHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhc
Confidence 99999999999 9999999999999999 588899999999998764332211 122557899999999999
Q ss_pred CCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHh
Q 024027 152 EGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAM 231 (273)
Q Consensus 152 ~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 231 (273)
+..++.++|||||||++|+|++|..||............ ... .... ...........++.++.+|+.
T Consensus 187 ~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~--~~i--------~~~~---~~~~~~~l~~~~p~~l~~li~ 253 (483)
T 3sv0_A 187 GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY--EKI--------SEKK---VATSIEALCRGYPTEFASYFH 253 (483)
T ss_dssp TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHH--HHH--------HHHH---HHSCHHHHHTTSCHHHHHHHH
T ss_pred CCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHH--HHH--------hhcc---ccccHHHHhcCCcHHHHHHHH
Confidence 999999999999999999999999999764443211110 000 0000 001111223456788999999
Q ss_pred hcCCCCccCCCCHHHHHHHHHHHHHhhh
Q 024027 232 ACTVESPEQRINAKEIVTKLLKIRDSLL 259 (273)
Q Consensus 232 ~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 259 (273)
+||..||.+||++.+|++.|+.+.....
T Consensus 254 ~cl~~dP~~RPs~~el~~~L~~l~~~~~ 281 (483)
T 3sv0_A 254 YCRSLRFDDKPDYSYLKRLFRDLFIREG 281 (483)
T ss_dssp HHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHhcCChhhCcCHHHHHHHHHHHHHHcC
Confidence 9999999999999999999999987654
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=275.60 Aligned_cols=242 Identities=23% Similarity=0.260 Sum_probs=181.5
Q ss_pred eEEEEEeeccc--ChhhhhHHHHHHHHhcC---CCccceeeeeeee-----cCCceeEEEeccCCCCHHHhhhcCC-CCC
Q 024027 2 EVAVKVFNLQC--GRAFKSFDVECEMMKSI---RHRNLIKVISSCS-----NEEFKALVLEYMPHGSLEKYLYSSN-CIL 70 (273)
Q Consensus 2 ~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~-~~~ 70 (273)
.||||+++... ......+.+|+.+++.+ +||||+++++++. .....++||||+++ +|.+++.... ..+
T Consensus 39 ~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~ 117 (326)
T 1blx_A 39 FVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGV 117 (326)
T ss_dssp EEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSC-BHHHHHHHSCTTCS
T ss_pred EEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCCC-CHHHHHHhcccCCC
Confidence 69999997543 22345677888888776 8999999999987 56778999999975 9999997543 348
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCccc
Q 024027 71 DIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYG 150 (273)
Q Consensus 71 ~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 150 (273)
++..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++...... .......+++.|+|||.+
T Consensus 118 ~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~ 191 (326)
T 1blx_A 118 PTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVL 191 (326)
T ss_dssp CHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHH
T ss_pred CHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEecCcccccccCC---CCccccccccceeCHHHH
Confidence 99999999999999999999 999999999999999999999999999999765321 122345689999999999
Q ss_pred CCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhh------hh-ccccchhhhhhhhhhH
Q 024027 151 REGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVD------AN-LLSQEDIHFVAKEQCV 223 (273)
Q Consensus 151 ~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~-~~~~~~~~~~~~~~~~ 223 (273)
.+..++.++||||||+++|+|++|..||........ .................. .. ..............++
T Consensus 192 ~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (326)
T 1blx_A 192 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDID 270 (326)
T ss_dssp TTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCC
T ss_pred hcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCC
Confidence 988899999999999999999999999976433221 111111111000000000 00 0000001111234567
Q ss_pred HHHHHHHhhcCCCCccCCCCHHHHHHHH
Q 024027 224 SFVFNLAMACTVESPEQRINAKEIVTKL 251 (273)
Q Consensus 224 ~~l~~li~~~l~~dp~~Rps~~~~l~~l 251 (273)
.++.+|+.+||..||.+|||+.++++|-
T Consensus 271 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp 298 (326)
T 1blx_A 271 ELGKDLLLKCLTFNPAKRISAYSALSHP 298 (326)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence 8899999999999999999999999763
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=279.50 Aligned_cols=239 Identities=20% Similarity=0.187 Sum_probs=177.1
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCc------eeEEEeccCCCCHHHhhhcCCCCCCH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEF------KALVLEYMPHGSLEKYLYSSNCILDI 72 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~------~~lv~e~~~~~~L~~~l~~~~~~~~~ 72 (273)
+.||||++.... ......+.+|+.+++.++||||+++++++..... .++||||+++ +|.+++.. .+++
T Consensus 50 ~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~ 125 (353)
T 3coi_A 50 EKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGL---KFSE 125 (353)
T ss_dssp EEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCSE-EGGGTTTS---CCCH
T ss_pred CEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEeccccC-CHHHHhcC---CCCH
Confidence 379999997542 2345678899999999999999999999987654 4999999975 99888743 4899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC
Q 024027 73 FQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE 152 (273)
Q Consensus 73 ~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 152 (273)
..++.++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++..... ......+++.|+|||.+.+
T Consensus 126 ~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~-----~~~~~~~t~~y~aPE~~~~ 197 (353)
T 3coi_A 126 EKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA-----EMTGYVVTRWYRAPEVILS 197 (353)
T ss_dssp HHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-------------CCSBCCSCHHHHSC
T ss_pred HHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccccCCCC-----CccccccCcCcCCHHHHhC
Confidence 999999999999999999 99999999999999999999999999999975422 1234568999999998876
Q ss_pred -CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCc--cc---------hhhhhhhccccchhhhhhhh
Q 024027 153 -GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPI--ST---------MEVVDANLLSQEDIHFVAKE 220 (273)
Q Consensus 153 -~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--~~---------~~~~~~~~~~~~~~~~~~~~ 220 (273)
..++.++||||||+++|+|++|..||......+ ............ .. ....................
T Consensus 198 ~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (353)
T 3coi_A 198 WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFP 276 (353)
T ss_dssp CSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH-HHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCT
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcC
Confidence 678999999999999999999999997643221 111111110000 00 00000000000000011124
Q ss_pred hhHHHHHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 221 QCVSFVFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 221 ~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
.++.++.+|+.+||..||.+|||+.++++|-+
T Consensus 277 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 308 (353)
T 3coi_A 277 RASPQAADLLEKMLELDVDKRLTAAQALTHPF 308 (353)
T ss_dssp TSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred CcCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 56788999999999999999999999998754
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=285.99 Aligned_cols=227 Identities=24% Similarity=0.365 Sum_probs=168.2
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCC------CCHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCI------LDIF 73 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------~~~~ 73 (273)
++||||++... ....+.+|+.+++.+ +||||+++++++.+++..++||||++ |+|.+++...... ..+.
T Consensus 40 ~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~ 115 (434)
T 2rio_A 40 RPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEY 115 (434)
T ss_dssp SEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------C
T ss_pred eEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccch
Confidence 47999999754 235678999999876 89999999999999999999999996 5999999755421 1233
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCC-------------CceEEeecccccccccCCCcc--eeecc
Q 024027 74 QRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDN-------------LVAYLSDFGIAKLLIGEDQSM--TQTQT 138 (273)
Q Consensus 74 ~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~-------------~~~kl~Df~~~~~~~~~~~~~--~~~~~ 138 (273)
.++.++.|++.||.||| +.|++||||||+||+++.+ +.+||+|||++..+....... .....
T Consensus 116 ~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~ 192 (434)
T 2rio_A 116 NPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192 (434)
T ss_dssp CHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC------------
T ss_pred hHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCC
Confidence 45789999999999999 9999999999999999754 489999999998764322211 12345
Q ss_pred cccCCCCCCcccCC-------CCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccc
Q 024027 139 LATIGYMAPEYGRE-------GRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLS 210 (273)
Q Consensus 139 ~~~~~~~aPE~~~~-------~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (273)
.|++.|+|||++.+ ..++.++|||||||++|+|++ |..||....... .........
T Consensus 193 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---~~i~~~~~~------------- 256 (434)
T 2rio_A 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE---SNIIRGIFS------------- 256 (434)
T ss_dssp --CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH---HHHHHTCCC-------------
T ss_pred CCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH---HHHhcCCCC-------------
Confidence 79999999999865 568999999999999999999 999986533221 111111100
Q ss_pred cchhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHH
Q 024027 211 QEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 211 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
...........++.++.+|+.+||..||.+|||+.++++|
T Consensus 257 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 257 LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 0000111134567889999999999999999999999975
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=283.05 Aligned_cols=238 Identities=24% Similarity=0.287 Sum_probs=174.8
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCC------ceeEEEeccCCCCHHHhhh---cCCCCCCH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEE------FKALVLEYMPHGSLEKYLY---SSNCILDI 72 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~---~~~~~~~~ 72 (273)
.||+|++.... ....+|+++++.++||||++++++|...+ .+++||||+++ ++...+. .....+++
T Consensus 66 ~~aikk~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~ 140 (394)
T 4e7w_A 66 EVAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPM 140 (394)
T ss_dssp EEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCH
T ss_pred eEEEEEEecCc----chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCH
Confidence 48888886442 23347999999999999999999985433 37899999987 5544432 23456999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeC-CCCceEEeecccccccccCCCcceeecccccCCCCCCcccC
Q 024027 73 FQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLD-DNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR 151 (273)
Q Consensus 73 ~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~-~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 151 (273)
..++.++.|++.||.||| +.|++||||||+||+++ .++.+||+|||++..+.... ......+++.|+|||++.
T Consensus 141 ~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~ 214 (394)
T 4e7w_A 141 LLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE---PNVSYICSRYYRAPELIF 214 (394)
T ss_dssp HHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC---CCCSSCSCGGGCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC---CCcccccCcCccCHHHHc
Confidence 999999999999999999 99999999999999998 79999999999998653222 223456899999999887
Q ss_pred CC-CcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhh--h-------ccccchhhhhhhhh
Q 024027 152 EG-RVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDA--N-------LLSQEDIHFVAKEQ 221 (273)
Q Consensus 152 ~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~-------~~~~~~~~~~~~~~ 221 (273)
+. .++.++||||+||++|+|++|..||......+ ....+......+........ . ...........+..
T Consensus 215 ~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (394)
T 4e7w_A 215 GATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID-QLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPR 293 (394)
T ss_dssp TCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTT
T ss_pred CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhcccc
Confidence 65 58999999999999999999999997643322 22222221111111000000 0 00111112222345
Q ss_pred hHHHHHHHHhhcCCCCccCCCCHHHHHHHH
Q 024027 222 CVSFVFNLAMACTVESPEQRINAKEIVTKL 251 (273)
Q Consensus 222 ~~~~l~~li~~~l~~dp~~Rps~~~~l~~l 251 (273)
++.++.+|+.+||..||.+|||+.++++|-
T Consensus 294 ~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 323 (394)
T 4e7w_A 294 TPPDAIDLISRLLEYTPSARLTAIEALCHP 323 (394)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred CCHHHHHHHHHHhCCChhhCCCHHHHhcCh
Confidence 778899999999999999999999999873
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=275.64 Aligned_cols=228 Identities=22% Similarity=0.370 Sum_probs=175.2
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCC--CccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIR--HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (273)
+.||||+++... ......+.+|+++++.++ |+||+++++++..++..++|||+ .+++|.+++.... .+++..++
T Consensus 53 ~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~~-~~~~~~~~ 130 (313)
T 3cek_A 53 QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK-SIDPWERK 130 (313)
T ss_dssp CEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHHCS-SCCHHHHH
T ss_pred cEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEec-CCCcHHHHHHhcC-CCCHHHHH
Confidence 469999997543 345678899999999996 59999999999999999999995 4779999997654 68999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC----
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE---- 152 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---- 152 (273)
.++.|++.||.||| +.|++|+||||+||+++ ++.+||+|||++..+.............+++.|+|||.+.+
T Consensus 131 ~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 206 (313)
T 3cek_A 131 SYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 206 (313)
T ss_dssp HHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC--
T ss_pred HHHHHHHHHHHHHH---HCCceecCCCcccEEEE-CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccc
Confidence 99999999999999 99999999999999996 48999999999987643333223344568999999999865
Q ss_pred -------CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHH
Q 024027 153 -------GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSF 225 (273)
Q Consensus 153 -------~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (273)
..++.++||||||+++|+|++|..||................. .....+...+.+
T Consensus 207 ~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~ 268 (313)
T 3cek_A 207 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN------------------HEIEFPDIPEKD 268 (313)
T ss_dssp --------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTT------------------SCCCCCCCSCHH
T ss_pred cccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcc------------------cccCCcccchHH
Confidence 3578899999999999999999999975433222111111100 000112334567
Q ss_pred HHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 226 VFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 226 l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
+.+|+.+||..||.+|||+.++++|-+
T Consensus 269 l~~li~~~l~~dp~~Rps~~ell~h~~ 295 (313)
T 3cek_A 269 LQDVLKCCLKRDPKQRISIPELLAHPY 295 (313)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HHHHHHHHccCCcccCcCHHHHhcCcc
Confidence 999999999999999999999999865
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=276.70 Aligned_cols=228 Identities=19% Similarity=0.241 Sum_probs=154.6
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeec----CCceeEEEeccCCCCHHHhhhcCC-CCCCHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSN----EEFKALVLEYMPHGSLEKYLYSSN-CILDIFQR 75 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~ 75 (273)
+.||||++... . ....+....++.+.||||+++++++.. ....++||||+++|+|.+++.... ..+++..+
T Consensus 55 ~~vavK~~~~~-~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~ 130 (336)
T 3fhr_A 55 QKCALKLLYDS-P---KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREA 130 (336)
T ss_dssp CEEEEEEEESS-H---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHH
T ss_pred CEEEEEEecCc-H---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHH
Confidence 47999999654 1 122223334566799999999999876 455899999999999999997654 36999999
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCC---CCceEEeecccccccccCCCcceeecccccCCCCCCcccCC
Q 024027 76 LNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDD---NLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE 152 (273)
Q Consensus 76 ~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~---~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 152 (273)
+.++.|++.||.||| +.|++|+||||+||+++. ++.++|+|||++..... .......+++.|+|||++.+
T Consensus 131 ~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~~~t~~y~aPE~~~~ 203 (336)
T 3fhr_A 131 AEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ----NALQTPCYTPYYVAPEVLGP 203 (336)
T ss_dssp HHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--------------------------
T ss_pred HHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccceeccc----cccccCCCCcCccChhhhCC
Confidence 999999999999999 999999999999999976 45599999999976522 12234567999999999988
Q ss_pred CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhh
Q 024027 153 GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMA 232 (273)
Q Consensus 153 ~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 232 (273)
..++.++||||||+++|+|++|..||............... . ..............++.++.+|+.+
T Consensus 204 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~----------~---~~~~~~~~~~~~~~~~~~~~~li~~ 270 (336)
T 3fhr_A 204 EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRR----------I---RLGQYGFPNPEWSEVSEDAKQLIRL 270 (336)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------------------CCCTTTSTTCCHHHHHHHHH
T ss_pred CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHh----------h---hccccccCchhhccCCHHHHHHHHH
Confidence 88999999999999999999999999764332211000000 0 0000001111124567789999999
Q ss_pred cCCCCccCCCCHHHHHHHHH
Q 024027 233 CTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 233 ~l~~dp~~Rps~~~~l~~l~ 252 (273)
||..||.+|||+.++++|-+
T Consensus 271 ~L~~dP~~Rpt~~ell~hp~ 290 (336)
T 3fhr_A 271 LLKTDPTERLTITQFMNHPW 290 (336)
T ss_dssp HSCSSGGGSCCHHHHHHSHH
T ss_pred HCCCChhHCcCHHHHhcCcc
Confidence 99999999999999999876
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=274.05 Aligned_cols=228 Identities=21% Similarity=0.242 Sum_probs=169.4
Q ss_pred CeEEEEEeecccC--hhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 1 MEVAVKVFNLQCG--RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 1 ~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
+.||||+++.... ...+.+.++..+++.++||||+++++++.++...++||||+ ++.+..+.......+++..++.+
T Consensus 51 ~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~ 129 (318)
T 2dyl_A 51 HVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKM 129 (318)
T ss_dssp CEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHH
T ss_pred eEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHH
Confidence 4799999986532 22334455556788889999999999999999999999999 55777766554567999999999
Q ss_pred HHHHHHHHHHHhcCCCC-CeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccC-----C
Q 024027 79 MIDVASALEYLHFGCSA-PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR-----E 152 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~-~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~ 152 (273)
+.|++.||.||| +. |++|+||+|+||+++.++.++|+|||++....... ......+++.|+|||.+. .
T Consensus 130 ~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~ 203 (318)
T 2dyl_A 130 TVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK---AKDRSAGCAAYMAPERIDPPDPTK 203 (318)
T ss_dssp HHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----------------CCTTCCHHHHC------
T ss_pred HHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc---cccccCCCccccChhhcccccccc
Confidence 999999999999 85 99999999999999999999999999987653221 223456899999999984 4
Q ss_pred CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhh
Q 024027 153 GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMA 232 (273)
Q Consensus 153 ~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 232 (273)
..++.++||||||+++|+|++|..||................... .......++.++.+|+.+
T Consensus 204 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~l~~li~~ 266 (318)
T 2dyl_A 204 PDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPP-----------------LLPGHMGFSGDFQSFVKD 266 (318)
T ss_dssp --CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCC-----------------CCCSSSCCCHHHHHHHHH
T ss_pred cCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCC-----------------CCCccCCCCHHHHHHHHH
Confidence 557899999999999999999999997643322222221111100 000122456779999999
Q ss_pred cCCCCccCCCCHHHHHHHHH
Q 024027 233 CTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 233 ~l~~dp~~Rps~~~~l~~l~ 252 (273)
||..||.+|||+.++++|-.
T Consensus 267 ~l~~dp~~Rps~~~ll~h~~ 286 (318)
T 2dyl_A 267 CLTKDHRKRPKYNKLLEHSF 286 (318)
T ss_dssp HTCSCTTTSCCHHHHTTSHH
T ss_pred HccCChhHCcCHHHHhhCHH
Confidence 99999999999999998754
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=276.87 Aligned_cols=239 Identities=21% Similarity=0.236 Sum_probs=179.1
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCcc------ceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC-CCCCHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRN------LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQ 74 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~------i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~ 74 (273)
.||||+++.. ......+.+|+.+++.++|++ ++.+++++...+..++||||+ ++++.+++.... ..+++..
T Consensus 47 ~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~ 124 (355)
T 2eu9_A 47 QVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPH 124 (355)
T ss_dssp EEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHH
T ss_pred EEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHH
Confidence 6999999754 345677889999999997665 899999999999999999999 557777775543 4699999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceee-------------------CCCCceEEeecccccccccCCCccee
Q 024027 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLL-------------------DDNLVAYLSDFGIAKLLIGEDQSMTQ 135 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~-------------------~~~~~~kl~Df~~~~~~~~~~~~~~~ 135 (273)
++.++.|++.||.||| +.|++|+||||+||++ +.++.+||+|||++..... ..
T Consensus 125 ~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~ 196 (355)
T 2eu9_A 125 VRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE-----HH 196 (355)
T ss_dssp HHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTS-----CC
T ss_pred HHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCccccccc-----cc
Confidence 9999999999999999 9999999999999999 5678999999999976422 22
Q ss_pred ecccccCCCCCCcccCCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhc-------
Q 024027 136 TQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANL------- 208 (273)
Q Consensus 136 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 208 (273)
....+++.|+|||++.+..++.++|||||||++|+|++|..||......+. ........ ............
T Consensus 197 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~~~~~~-~~~p~~~~~~~~~~~~~~~ 274 (355)
T 2eu9_A 197 TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH-LVMMEKIL-GPIPSHMIHRTRKQKYFYK 274 (355)
T ss_dssp CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHH-CCCCHHHHHHCSCGGGEET
T ss_pred cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHc-CCCcHHHhhhccchhhhcc
Confidence 345689999999999988999999999999999999999999976433221 11111110 000000000000
Q ss_pred ------------------cccchhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 209 ------------------LSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 209 ------------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
..............+.++.+|+.+||..||++|||+.++++|-+
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~ 336 (355)
T 2eu9_A 275 GGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPF 336 (355)
T ss_dssp TEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGG
T ss_pred cccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 00000000112234667999999999999999999999998743
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=275.63 Aligned_cols=230 Identities=23% Similarity=0.273 Sum_probs=160.5
Q ss_pred CeEEEEEeeccc-ChhhhhHHHHHH-HHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhc----CCCCCCHHH
Q 024027 1 MEVAVKVFNLQC-GRAFKSFDVECE-MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS----SNCILDIFQ 74 (273)
Q Consensus 1 ~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~ 74 (273)
+.||||+++... ......+..|+. +++.++||||+++++++.+++..++||||+++ +|.+++.. ....+++..
T Consensus 48 ~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~ 126 (327)
T 3aln_A 48 QIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEI 126 (327)
T ss_dssp EEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHH
T ss_pred CEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHH
Confidence 369999998653 334455666666 67778999999999999999999999999976 88888752 245689999
Q ss_pred HHHHHHHHHHHHHHHhcCCCC-CeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCccc---
Q 024027 75 RLNIMIDVASALEYLHFGCSA-PVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYG--- 150 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~-~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~--- 150 (273)
+..++.|++.||.||| +. |++|+||||+||+++.++.+||+|||++....... ......+++.|+|||.+
T Consensus 127 ~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~ 200 (327)
T 3aln_A 127 LGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPS 200 (327)
T ss_dssp HHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC----------------------------
T ss_pred HHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceeccccc---ccccCCCCccccCceeeccc
Confidence 9999999999999999 88 99999999999999999999999999997653221 22334689999999998
Q ss_pred -CCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHH
Q 024027 151 -REGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNL 229 (273)
Q Consensus 151 -~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 229 (273)
.+..++.++||||||+++|+|++|..||.................. ..........++.++.+|
T Consensus 201 ~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~l~~l 265 (327)
T 3aln_A 201 ASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDP---------------PQLSNSEEREFSPSFINF 265 (327)
T ss_dssp -----CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCC---------------CCCCCCSSCCCCHHHHHH
T ss_pred cCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCC---------------CCCCCcccccCCHHHHHH
Confidence 4556899999999999999999999999764322111111111000 000001123466779999
Q ss_pred HhhcCCCCccCCCCHHHHHHHHH
Q 024027 230 AMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 230 i~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
+.+||..||.+|||+.++++|-+
T Consensus 266 i~~~l~~dp~~Rps~~ell~hp~ 288 (327)
T 3aln_A 266 VNLCLTKDESKRPKYKELLKHPF 288 (327)
T ss_dssp HHHHTCSSGGGSCCHHHHTTSHH
T ss_pred HHHHhhCChhhCcCHHHHHhChH
Confidence 99999999999999999999755
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=274.17 Aligned_cols=245 Identities=20% Similarity=0.210 Sum_probs=177.3
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCc-------eeEEEeccCCCCHHHhhh---cCCCCC
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEF-------KALVLEYMPHGSLEKYLY---SSNCIL 70 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-------~~lv~e~~~~~~L~~~l~---~~~~~~ 70 (273)
+.||||++... ........++++.++.++||||++++++|...+. .++||||+++ +|.+.+. .....+
T Consensus 49 ~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~ 126 (360)
T 3e3p_A 49 MSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAP 126 (360)
T ss_dssp CEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCC
T ss_pred CEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCC
Confidence 47999999654 3444567788888999999999999999865433 7899999987 6655443 244568
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCC-CCceEEeecccccccccCCCcceeecccccCCCCCCcc
Q 024027 71 DIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDD-NLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEY 149 (273)
Q Consensus 71 ~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~-~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~ 149 (273)
++..++.++.|++.||.|||.. +.|++|+||||+||+++. ++.+||+|||++..+.... ......+++.|+|||+
T Consensus 127 ~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~ 202 (360)
T 3e3p_A 127 PPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE---PNVAYICSRYYRAPEL 202 (360)
T ss_dssp CHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTS---CCCSTTSCGGGCCHHH
T ss_pred CHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCC---CcccccCCcceeCHHH
Confidence 9999999999999999999922 579999999999999996 8999999999998653322 2234568999999998
Q ss_pred cCCCC-cCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccc--hhhhh----------hhccccchhhh
Q 024027 150 GREGR-VSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPIST--MEVVD----------ANLLSQEDIHF 216 (273)
Q Consensus 150 ~~~~~-~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~----------~~~~~~~~~~~ 216 (273)
+.+.. ++.++|||||||++|+|++|..||....... .............. ..... ...........
T Consensus 203 ~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (360)
T 3e3p_A 203 IFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG-QLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFS 281 (360)
T ss_dssp HTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTT
T ss_pred HcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH-HHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccc
Confidence 86654 8999999999999999999999997643322 12222111111000 00000 00000000011
Q ss_pred hhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 217 VAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 217 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
......+.++.+|+.+||..||.+|||+.++++|-+
T Consensus 282 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 317 (360)
T 3e3p_A 282 DHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPY 317 (360)
T ss_dssp TCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGG
T ss_pred hhhccccHHHHHHHHHHhccCccccCCHHHHhcCcc
Confidence 112236788999999999999999999999998754
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=281.05 Aligned_cols=241 Identities=15% Similarity=0.197 Sum_probs=177.9
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCC-----------CccceeeeeeeecCC----ceeEEEeccCCCCHHHhhhc
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIR-----------HRNLIKVISSCSNEE----FKALVLEYMPHGSLEKYLYS 65 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~ 65 (273)
+.||||+++.. ......+.+|+.+++.++ |+||+++++++...+ ..++|||++ +++|.+++..
T Consensus 45 ~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~ 122 (373)
T 1q8y_A 45 THVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKK 122 (373)
T ss_dssp EEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHH
T ss_pred cEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHH
Confidence 37999999744 345577889999999885 899999999987654 789999999 7799999976
Q ss_pred C-CCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEeccCCCCceeeC------CCCceEEeecccccccccCCCcceeec
Q 024027 66 S-NCILDIFQRLNIMIDVASALEYLHFGCSA-PVIHCDLKPDNVLLD------DNLVAYLSDFGIAKLLIGEDQSMTQTQ 137 (273)
Q Consensus 66 ~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~-~i~h~di~p~nil~~------~~~~~kl~Df~~~~~~~~~~~~~~~~~ 137 (273)
. ...+++..++.++.|++.||.||| +. |++|+||||+||+++ ..+.+||+|||++..... ....
T Consensus 123 ~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~ 194 (373)
T 1q8y_A 123 YEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE-----HYTN 194 (373)
T ss_dssp TTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB-----CCCS
T ss_pred hhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCC-----CCCC
Confidence 4 345999999999999999999999 87 999999999999994 445899999999976532 1233
Q ss_pred ccccCCCCCCcccCCCCcCCcchhHHHHHHHHHHHhCCCCCcccccccc-----chhhhhhhccCccchhhhhhh-----
Q 024027 138 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEM-----TLKHWVNDWLPISTMEVVDAN----- 207 (273)
Q Consensus 138 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~----- 207 (273)
..+++.|+|||++.+..++.++|||||||++|+|++|..||........ ............. .......
T Consensus 195 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p-~~~~~~~~~~~~ 273 (373)
T 1q8y_A 195 SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELP-SYLLRNGKYTRT 273 (373)
T ss_dssp CCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCC-HHHHHHCTTHHH
T ss_pred CCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCC-HHHHhccchhhh
Confidence 4689999999999988899999999999999999999999976432211 1111111100000 0000000
Q ss_pred --------------ccc----cchhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 208 --------------LLS----QEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 208 --------------~~~----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
... ........+..++.++.+||.+||..||.+|||+.++++|-+
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 336 (373)
T 1q8y_A 274 FFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPW 336 (373)
T ss_dssp HBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGG
T ss_pred hcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChh
Confidence 000 000011123567888999999999999999999999999754
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=275.78 Aligned_cols=173 Identities=23% Similarity=0.278 Sum_probs=146.7
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCC-Cc-----cceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC-CCCCHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIR-HR-----NLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQ 74 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~ 74 (273)
.||||+++.. ......+..|+.+++.++ |+ +|+++++++......++||||+++ +|.+++.... ..+++..
T Consensus 81 ~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~ 158 (382)
T 2vx3_A 81 WVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNL 158 (382)
T ss_dssp EEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHH
T ss_pred EEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHH
Confidence 6999999754 344567888999988874 44 499999999999999999999965 9999997654 4589999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeC--CCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC
Q 024027 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLD--DNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE 152 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~--~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 152 (273)
++.++.|++.||.|||.. +.|++||||||+||+++ .++.+||+|||++..... ......+++.|+|||++.+
T Consensus 159 ~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~ 232 (382)
T 2vx3_A 159 TRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ-----RIYQYIQSRFYRSPEVLLG 232 (382)
T ss_dssp HHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTC-----CCCSSCSCGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCceeccc-----ccccccCCccccChHHHcC
Confidence 999999999999999921 36899999999999995 477899999999986522 1234568999999999999
Q ss_pred CCcCCcchhHHHHHHHHHHHhCCCCCcccc
Q 024027 153 GRVSTNGDVYSFGIMLMETFTGKKPTYEFF 182 (273)
Q Consensus 153 ~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 182 (273)
..++.++|||||||++|+|++|..||....
T Consensus 233 ~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 233 MPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 899999999999999999999999998643
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=289.21 Aligned_cols=242 Identities=23% Similarity=0.272 Sum_probs=177.7
Q ss_pred CeEEEEEeecc-cChhhhhHHHHHHHHhcCCCccceeeeeeeec------CCceeEEEeccCCCCHHHhhhcCC--CCCC
Q 024027 1 MEVAVKVFNLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCSN------EEFKALVLEYMPHGSLEKYLYSSN--CILD 71 (273)
Q Consensus 1 ~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~--~~~~ 71 (273)
+.||||+++.. .....+.+.+|+++++.++||||+++++++.. .+..++||||++||+|.+++.... ..++
T Consensus 40 ~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~ls 119 (676)
T 3qa8_A 40 EQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLK 119 (676)
T ss_dssp CCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCC
T ss_pred cEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCC
Confidence 46999999755 34456779999999999999999999998765 677899999999999999997643 2588
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCc---eEEeecccccccccCCCcceeecccccCCCCCCc
Q 024027 72 IFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLV---AYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPE 148 (273)
Q Consensus 72 ~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~---~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE 148 (273)
+..++.++.|++.||.||| +.|++|+||+|+||+++.++. ++|+|||.+....... ......+++.|+|||
T Consensus 120 e~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~---~~~~~~gt~~Y~APE 193 (676)
T 3qa8_A 120 EGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVGTLQYLAPE 193 (676)
T ss_dssp SSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCC---CCCCCCSCCTTCSSC
T ss_pred HHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEccccccccccccc---ccccccCCcccCChH
Confidence 8999999999999999999 999999999999999986654 9999999998653222 223457899999999
Q ss_pred ccCCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCc-cchhhhhhh--ccccchhhhhhhhhhHHH
Q 024027 149 YGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPI-STMEVVDAN--LLSQEDIHFVAKEQCVSF 225 (273)
Q Consensus 149 ~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 225 (273)
.+.+..++.++||||||+++|++++|..||.................... ......... .....+........++..
T Consensus 194 ~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~ 273 (676)
T 3qa8_A 194 LLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGK 273 (676)
T ss_dssp SSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHH
T ss_pred HhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHH
Confidence 99999999999999999999999999999865321110000000000000 000000000 000001111123457888
Q ss_pred HHHHHhhcCCCCccCCCCHHHHH
Q 024027 226 VFNLAMACTVESPEQRINAKEIV 248 (273)
Q Consensus 226 l~~li~~~l~~dp~~Rps~~~~l 248 (273)
+.+|+.+||..||++|||+.+++
T Consensus 274 L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 274 LERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp HHHHHHHHSCSSCC---CCTTCC
T ss_pred HHHHHHHHccCCHhhCcCHHHHh
Confidence 99999999999999999999854
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=274.50 Aligned_cols=217 Identities=22% Similarity=0.250 Sum_probs=177.5
Q ss_pred CeEEEEEeecccC------hhhhhHHHHHHHHhcCC--CccceeeeeeeecCCceeEEEeccCC-CCHHHhhhcCCCCCC
Q 024027 1 MEVAVKVFNLQCG------RAFKSFDVECEMMKSIR--HRNLIKVISSCSNEEFKALVLEYMPH-GSLEKYLYSSNCILD 71 (273)
Q Consensus 1 ~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~ 71 (273)
++||||+++.... .....+.+|+.+++.++ |+||+++++++..++..++|+|++.+ ++|.+++... ..++
T Consensus 69 ~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~-~~l~ 147 (320)
T 3a99_A 69 LPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQ 147 (320)
T ss_dssp EEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHH-CSCC
T ss_pred cEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhcc-CCCC
Confidence 3799999976532 13356788999999995 69999999999999999999999975 8999999654 3689
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeC-CCCceEEeecccccccccCCCcceeecccccCCCCCCccc
Q 024027 72 IFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLD-DNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYG 150 (273)
Q Consensus 72 ~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~-~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 150 (273)
+..++.++.|++.||.||| +.|++|+||||+||+++ .++.+||+|||++...... ......+++.|+|||++
T Consensus 148 ~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~ 220 (320)
T 3a99_A 148 EELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWI 220 (320)
T ss_dssp HHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEeeCccccccccc----cccCCCCCccCCChHHh
Confidence 9999999999999999999 99999999999999998 7889999999999865321 22335689999999998
Q ss_pred CCCCc-CCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHH
Q 024027 151 REGRV-STNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNL 229 (273)
Q Consensus 151 ~~~~~-~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 229 (273)
.+..+ +.++||||||+++|+|++|..||..... ..... ...+..++.++.+|
T Consensus 221 ~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-------~~~~~--------------------~~~~~~~~~~~~~l 273 (320)
T 3a99_A 221 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------IIRGQ--------------------VFFRQRVSSECQHL 273 (320)
T ss_dssp HHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------HHHCC--------------------CCCSSCCCHHHHHH
T ss_pred ccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-------hhccc--------------------ccccccCCHHHHHH
Confidence 76665 6889999999999999999999864211 00000 00123456779999
Q ss_pred HhhcCCCCccCCCCHHHHHHHHH
Q 024027 230 AMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 230 i~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
+.+||..||++|||+.++++|-+
T Consensus 274 i~~~l~~dp~~Rps~~~ll~hp~ 296 (320)
T 3a99_A 274 IRWCLALRPSDRPTFEEIQNHPW 296 (320)
T ss_dssp HHHHTCSSGGGSCCHHHHHTSGG
T ss_pred HHHHccCChhhCcCHHHHhcCHh
Confidence 99999999999999999998643
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=272.59 Aligned_cols=217 Identities=24% Similarity=0.296 Sum_probs=172.3
Q ss_pred CeEEEEEeecccC------hhhhhHHHHHHHHhcC----CCccceeeeeeeecCCceeEEEec-cCCCCHHHhhhcCCCC
Q 024027 1 MEVAVKVFNLQCG------RAFKSFDVECEMMKSI----RHRNLIKVISSCSNEEFKALVLEY-MPHGSLEKYLYSSNCI 69 (273)
Q Consensus 1 ~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~h~~i~~~~~~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~ 69 (273)
+.||||+++.... .....+.+|+.+++.+ +||||+++++++...+..++|+|+ +.+++|.+++.... .
T Consensus 57 ~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-~ 135 (312)
T 2iwi_A 57 LQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG-P 135 (312)
T ss_dssp CEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHC-S
T ss_pred eEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcC-C
Confidence 4799999975532 2345567899999998 899999999999999999999999 78899999997643 5
Q ss_pred CCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeC-CCCceEEeecccccccccCCCcceeecccccCCCCCCc
Q 024027 70 LDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLD-DNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPE 148 (273)
Q Consensus 70 ~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~-~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE 148 (273)
+++..++.++.|++.||.||| +.|++|+||+|+||+++ .++.++|+|||++...... ......++..|+|||
T Consensus 136 ~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE 208 (312)
T 2iwi_A 136 LGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE----PYTDFDGTRVYSPPE 208 (312)
T ss_dssp CCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEEECCCSSCEECCSS----CBCCCCSCTTTSCHH
T ss_pred CCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEEEEEcchhhhcccC----cccccCCcccccCce
Confidence 899999999999999999999 99999999999999998 8899999999999865332 223456899999999
Q ss_pred ccCCCCc-CCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHH
Q 024027 149 YGREGRV-STNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVF 227 (273)
Q Consensus 149 ~~~~~~~-~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 227 (273)
++.+..+ +.++||||||+++|+|++|..||..... .... ....+..++.++.
T Consensus 209 ~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~--------------------~~~~~~~~~~~~~ 261 (312)
T 2iwi_A 209 WISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-------ILEA--------------------ELHFPAHVSPDCC 261 (312)
T ss_dssp HHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------HHHT--------------------CCCCCTTSCHHHH
T ss_pred eeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-------Hhhh--------------------ccCCcccCCHHHH
Confidence 8876665 4589999999999999999999864211 0000 0011344667799
Q ss_pred HHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 228 NLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 228 ~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
+|+.+||..||++|||+.++++|-+
T Consensus 262 ~li~~~l~~~p~~Rps~~e~l~~~~ 286 (312)
T 2iwi_A 262 ALIRRCLAPKPSSRPSLEEILLDPW 286 (312)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHSTT
T ss_pred HHHHHHccCChhhCcCHHHHhcChh
Confidence 9999999999999999999998643
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=259.87 Aligned_cols=207 Identities=20% Similarity=0.289 Sum_probs=162.5
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHH-hcCCCccceeeeeeeec----CCceeEEEeccCCCCHHHhhhcCC-CCCCHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMM-KSIRHRNLIKVISSCSN----EEFKALVLEYMPHGSLEKYLYSSN-CILDIFQ 74 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~ 74 (273)
+.||||+++.. ..+.+|+.++ +..+||||+++++++.. ....++||||+++++|.+++.... ..+++..
T Consensus 44 ~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 118 (299)
T 3m2w_A 44 EKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE 118 (299)
T ss_dssp CEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHH
T ss_pred cEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHH
Confidence 47999999643 5677899988 55699999999999876 678899999999999999997653 3699999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCC---CCceEEeecccccccccCCCcceeecccccCCCCCCcccC
Q 024027 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDD---NLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR 151 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~---~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 151 (273)
++.++.|++.||.||| +.|++|+||||+||+++. ++.++|+|||++....
T Consensus 119 ~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~------------------------ 171 (299)
T 3m2w_A 119 ASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT------------------------ 171 (299)
T ss_dssp HHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT------------------------
T ss_pred HHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc------------------------
Confidence 9999999999999999 999999999999999997 7899999999986431
Q ss_pred CCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHh
Q 024027 152 EGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAM 231 (273)
Q Consensus 152 ~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 231 (273)
+..++.++|||||||++|+|++|..||............ .. ................++.++.+|+.
T Consensus 172 ~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~-~~------------~~~~~~~~~~~~~~~~~~~~~~~li~ 238 (299)
T 3m2w_A 172 GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-KT------------RIRMGQYEFPNPEWSEVSEEVKMLIR 238 (299)
T ss_dssp TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCS-CC------------SSCTTCCSSCHHHHTTSCHHHHHHHH
T ss_pred cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH-HH------------HHhhccccCCchhcccCCHHHHHHHH
Confidence 245678999999999999999999999653322110000 00 00000111111223457788999999
Q ss_pred hcCCCCccCCCCHHHHHHHHH
Q 024027 232 ACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 232 ~~l~~dp~~Rps~~~~l~~l~ 252 (273)
+||..||.+|||+.++++|-+
T Consensus 239 ~~l~~dP~~Rps~~e~l~hp~ 259 (299)
T 3m2w_A 239 NLLKTEPTQRMTITEFMNHPW 259 (299)
T ss_dssp HHTCSSTTTSCCHHHHHTSHH
T ss_pred HHcccChhhCCCHHHHhcChh
Confidence 999999999999999999866
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=256.23 Aligned_cols=208 Identities=14% Similarity=0.059 Sum_probs=164.4
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
++||||+++... ....+.+.+|+.++..++||||+++++++.+++..++||||++|++|.++++.. .....+..
T Consensus 57 ~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~ 133 (286)
T 3uqc_A 57 RQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIR 133 (286)
T ss_dssp EEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTTC---CCHHHHHH
T ss_pred ceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhcC---CChHHHHH
Confidence 379999997653 234577999999999999999999999999999999999999999999999542 35567889
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
++.|++.||.||| +.|++|+||||+||+++.++.++|++++ |++ .++.
T Consensus 134 i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~----------------------~~~-------~~~~ 181 (286)
T 3uqc_A 134 AMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA----------------------TMP-------DANP 181 (286)
T ss_dssp HHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC----------------------CCT-------TCCH
T ss_pred HHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc----------------------ccC-------CCCc
Confidence 9999999999999 9999999999999999999999998433 222 3688
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
++|||||||++|+|++|+.||................ .............++.++.+|+.+||..|
T Consensus 182 ~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~l~~li~~~l~~d 247 (286)
T 3uqc_A 182 QDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDT--------------AGQPIEPADIDRDIPFQISAVAARSVQGD 247 (286)
T ss_dssp HHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCT--------------TSCBCCHHHHCTTSCHHHHHHHHHHHCTT
T ss_pred hhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHh--------------ccCCCChhhcccCCCHHHHHHHHHHcccC
Confidence 9999999999999999999998644332110000000 00001111223457788999999999999
Q ss_pred ccCCCCHHHHHHHHHHHHHhh
Q 024027 238 PEQRINAKEIVTKLLKIRDSL 258 (273)
Q Consensus 238 p~~Rps~~~~l~~l~~~~~~~ 258 (273)
|++| |+.++++.|+++...-
T Consensus 248 P~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 248 GGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp SSCC-CHHHHHHHHHHHHC--
T ss_pred CccC-CHHHHHHHHHHHhccC
Confidence 9999 9999999999887543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=285.58 Aligned_cols=217 Identities=20% Similarity=0.261 Sum_probs=173.2
Q ss_pred CeEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCc-----eeEEEeccCCCCHHHhhhcCCCCCCHHH
Q 024027 1 MEVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEF-----KALVLEYMPHGSLEKYLYSSNCILDIFQ 74 (273)
Q Consensus 1 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (273)
++||||++.... ......+.+|+++++.++||||+++++++...+. .|+||||++|++|.+++.. .+++..
T Consensus 107 ~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~ 183 (681)
T 2pzi_A 107 RPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAE 183 (681)
T ss_dssp EEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C---CCCHHH
T ss_pred cEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC---CCCHHH
Confidence 369999987543 3456678999999999999999999999987665 7999999999999988754 589999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCC
Q 024027 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGR 154 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 154 (273)
++.++.|++.||.||| +.|++|+||||+||+++.+ .+||+|||++...... ....||+.|+|||++.+.
T Consensus 184 ~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~- 252 (681)
T 2pzi_A 184 AIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTG- 252 (681)
T ss_dssp HHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC------SCCCCCTTTSCTTHHHHC-
T ss_pred HHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchhcccC------CccCCCccccCHHHHcCC-
Confidence 9999999999999999 9999999999999999975 8999999999765321 345689999999988654
Q ss_pred cCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcC
Q 024027 155 VSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACT 234 (273)
Q Consensus 155 ~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 234 (273)
++.++|||||||++++|++|..||........ . ........+..+.+|+.+||
T Consensus 253 ~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~---------~------------------~~~~~~~~~~~l~~li~~~l 305 (681)
T 2pzi_A 253 PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL---------P------------------EDDPVLKTYDSYGRLLRRAI 305 (681)
T ss_dssp SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC---------C------------------TTCHHHHHCHHHHHHHHHHT
T ss_pred CCCceehhhhHHHHHHHHhCCCCCcccccccc---------c------------------ccccccccCHHHHHHHhhhc
Confidence 48899999999999999999888754211100 0 00002234466899999999
Q ss_pred CCCccCCC-CHHHHHHHHHHHHHhh
Q 024027 235 VESPEQRI-NAKEIVTKLLKIRDSL 258 (273)
Q Consensus 235 ~~dp~~Rp-s~~~~l~~l~~~~~~~ 258 (273)
..||.+|| +++++.+.|..+..+.
T Consensus 306 ~~dP~~R~~~~~~l~~~l~~~~~~~ 330 (681)
T 2pzi_A 306 DPDPRQRFTTAEEMSAQLTGVLREV 330 (681)
T ss_dssp CSSGGGSCSSHHHHHHHHHHHHHHH
T ss_pred cCChhhCCCHHHHHHHHHHHHHHHh
Confidence 99999999 5677777777776554
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=265.88 Aligned_cols=223 Identities=17% Similarity=0.163 Sum_probs=164.9
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCC-ccceeee---------e------------eeec-----CCceeEE
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRH-RNLIKVI---------S------------SCSN-----EEFKALV 50 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~~i~~~~---------~------------~~~~-----~~~~~lv 50 (273)
++||||+++... ....+.+.+|+.+++.++| +|...+. + ++.. ....+++
T Consensus 104 ~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (413)
T 3dzo_A 104 ESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFL 183 (413)
T ss_dssp CEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC---------------CCSEEEE
T ss_pred CceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCCCccccccceEEE
Confidence 479999998442 2346789999999999976 3221111 1 1111 1245678
Q ss_pred EeccCCCCHHHhhh------cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeeccccc
Q 024027 51 LEYMPHGSLEKYLY------SSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 124 (273)
Q Consensus 51 ~e~~~~~~L~~~l~------~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~ 124 (273)
|+.+ +++|.+++. ..+..+++..++.++.|++.||.||| +.|++||||||+||+++.++.+||+|||++.
T Consensus 184 ~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~ 259 (413)
T 3dzo_A 184 YPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259 (413)
T ss_dssp EECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCGGGCE
T ss_pred eehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcccceEEEecCCeEEEEecccee
Confidence 8877 569999984 33445788899999999999999999 9999999999999999999999999999987
Q ss_pred ccccCCCcceeecccccCCCCCCccc----------CCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhh
Q 024027 125 LLIGEDQSMTQTQTLATIGYMAPEYG----------REGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVND 194 (273)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~aPE~~----------~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~ 194 (273)
.... .....+| +.|+|||++ .+..++.++|||||||++|+|++|+.||............
T Consensus 260 ~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~---- 329 (413)
T 3dzo_A 260 RDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWI---- 329 (413)
T ss_dssp ETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGG----
T ss_pred ecCC-----ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHH----
Confidence 5421 1344567 999999998 5556888999999999999999999999754322110000
Q ss_pred ccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHH--HHHHHHhh
Q 024027 195 WLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTK--LLKIRDSL 258 (273)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~--l~~~~~~~ 258 (273)
......++.++.+|+.+||..||++|||+.+++++ +..+.+.+
T Consensus 330 ---------------------~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~~~~ 374 (413)
T 3dzo_A 330 ---------------------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTEL 374 (413)
T ss_dssp ---------------------GSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHHH
T ss_pred ---------------------HhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHHHHH
Confidence 00012455779999999999999999999999876 55554443
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-37 Score=256.18 Aligned_cols=220 Identities=15% Similarity=0.112 Sum_probs=163.8
Q ss_pred CeEEEEEeeccc--------ChhhhhHHHHHHHHhcCC--------------------------Cccceeeeeeeec---
Q 024027 1 MEVAVKVFNLQC--------GRAFKSFDVECEMMKSIR--------------------------HRNLIKVISSCSN--- 43 (273)
Q Consensus 1 ~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~--------------------------h~~i~~~~~~~~~--- 43 (273)
+.||||+++... ....+.+.+|+.+++.++ ||||++++++|.+
T Consensus 44 ~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~ 123 (336)
T 2vuw_A 44 TPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKG 123 (336)
T ss_dssp EEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTC
T ss_pred ceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhcc
Confidence 379999998652 223477889999998886 5666666666654
Q ss_pred ----------CCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCC
Q 024027 44 ----------EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNL 113 (273)
Q Consensus 44 ----------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~ 113 (273)
....++||||+++|++.+.+.+ ..+++..++.++.|++.||.|||+ +.|++||||||+|||++.++
T Consensus 124 ~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~--~~~ivHrDlKp~NILl~~~~ 199 (336)
T 2vuw_A 124 SANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVLLKKTS 199 (336)
T ss_dssp CSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHHHHHH--HHCCBCSCCCGGGEEEEECS
T ss_pred ccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH--hCCEeECCCCHHHEEEeccC
Confidence 7889999999999977676644 358999999999999999999993 47999999999999999876
Q ss_pred --------------------ceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcchhHHHHHH-HHHHH
Q 024027 114 --------------------VAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIM-LMETF 172 (273)
Q Consensus 114 --------------------~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~-l~~ll 172 (273)
.+||+|||++..... ...+||+.|+|||++.+.. +.++||||+|++ .++++
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~ 271 (336)
T 2vuw_A 200 LKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRW 271 (336)
T ss_dssp CSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCT
T ss_pred CcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccChhhhcCCC-ccceehhhhhCCCCcccc
Confidence 899999999986532 2347899999999998766 889999998777 77788
Q ss_pred hCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHH-HH
Q 024027 173 TGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIV-TK 250 (273)
Q Consensus 173 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l-~~ 250 (273)
.|..||............... ............+..++.++.+||.+||++| |+.+++ +|
T Consensus 272 ~g~~p~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 272 GEYHPYSNVLWLHYLTDKMLK-------------QMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp TSCCTHHHHHHHHHHHHHHHH-------------TCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred cccCCCcchhhhhHHHHhhhh-------------hhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcC
Confidence 899997431100000000000 0000111111235568889999999999987 999998 65
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-34 Score=252.51 Aligned_cols=166 Identities=20% Similarity=0.141 Sum_probs=125.5
Q ss_pred eEEEEEeeccc----------ChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCC
Q 024027 2 EVAVKVFNLQC----------GRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCIL 70 (273)
Q Consensus 2 ~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 70 (273)
.||+|++..+. ....++|.+|+++|+++ +|+||+++++++++++..||||||++|++|.++|...+ ++
T Consensus 261 ~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~-~l 339 (569)
T 4azs_A 261 DYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGE-EI 339 (569)
T ss_dssp SEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTC-CC
T ss_pred eeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCC-CC
Confidence 58999997541 23457799999999999 79999999999999999999999999999999997654 56
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCccc
Q 024027 71 DIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYG 150 (273)
Q Consensus 71 ~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 150 (273)
+.. .++.||+.||.|+| ++||+||||||+|||++.++.+||+|||++...... .......+||+.|+|||++
T Consensus 340 ~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~--~~~~~t~vGTp~YmAPE~l 411 (569)
T 4azs_A 340 DRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD--CSWPTNLVQSFFVFVNELF 411 (569)
T ss_dssp CHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----CCSHHHHHHHHHHHHHHC
T ss_pred CHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCC--CccccCceechhhccHHHh
Confidence 654 47899999999999 999999999999999999999999999999765322 2233456899999999998
Q ss_pred CCCCcCCcchhHHHHHHHHHHHhCCCC
Q 024027 151 REGRVSTNGDVYSFGIMLMETFTGKKP 177 (273)
Q Consensus 151 ~~~~~~~~~DiwslG~~l~~ll~g~~p 177 (273)
.+ .+..++|+||+|++++.+.++..+
T Consensus 412 ~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 412 AE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ------------------CCCCTTHHH
T ss_pred CC-CCCCcccccccccchhhhccccch
Confidence 75 466789999999998877665544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=7.3e-26 Score=200.41 Aligned_cols=164 Identities=16% Similarity=0.172 Sum_probs=133.2
Q ss_pred CeEEEEEeecccC--------hhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCH
Q 024027 1 MEVAVKVFNLQCG--------RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDI 72 (273)
Q Consensus 1 ~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 72 (273)
++||+|+...... ...+.+.+|+++++.++||||+++..++......++||||++|++|.+++..
T Consensus 360 ~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~------- 432 (540)
T 3en9_A 360 FDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED------- 432 (540)
T ss_dssp CEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT-------
T ss_pred CeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH-------
Confidence 3688888643321 1245589999999999999999766666677788999999999999999965
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcc-----eeecccccCCCCCC
Q 024027 73 FQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSM-----TQTQTLATIGYMAP 147 (273)
Q Consensus 73 ~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~-----~~~~~~~~~~~~aP 147 (273)
+..++.|++.||.||| +.|++||||||+||+++. .+||+|||++.......... ......||+.|+||
T Consensus 433 --~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~AP 505 (540)
T 3en9_A 433 --NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFD 505 (540)
T ss_dssp --CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHH
T ss_pred --HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCH
Confidence 5689999999999999 999999999999999998 99999999998763221111 12355789999999
Q ss_pred cccCC--CCcCCcchhHHHHHHHHHHHhCCCCC
Q 024027 148 EYGRE--GRVSTNGDVYSFGIMLMETFTGKKPT 178 (273)
Q Consensus 148 E~~~~--~~~~~~~DiwslG~~l~~ll~g~~pf 178 (273)
|++.. ..|+...|+|+..+-..+-+.++.+|
T Consensus 506 Ev~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 506 EIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred HHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 99976 56888899999998888877766665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=3.6e-21 Score=156.95 Aligned_cols=109 Identities=17% Similarity=0.177 Sum_probs=89.2
Q ss_pred CeEEEEEeecccC------------------hhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHh
Q 024027 1 MEVAVKVFNLQCG------------------RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKY 62 (273)
Q Consensus 1 ~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 62 (273)
++||||+++.... .....+.+|+++++.++ | +++.+++.. +..++||||++|++|.+
T Consensus 115 ~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~- 189 (282)
T 1zar_A 115 GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR- 189 (282)
T ss_dssp EEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-
T ss_pred CEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-
Confidence 3799999974321 13566899999999999 5 677775544 56799999999999988
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccc
Q 024027 63 LYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL 125 (273)
Q Consensus 63 l~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~ 125 (273)
+.. .....++.|++.||.||| +.|++|+||||+||+++ ++.++|+|||++..
T Consensus 190 l~~-------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~-~~~vkl~DFG~a~~ 241 (282)
T 1zar_A 190 VRV-------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE 241 (282)
T ss_dssp CCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-TTEEEECCCTTCEE
T ss_pred cch-------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-CCcEEEEECCCCeE
Confidence 522 124579999999999999 99999999999999999 99999999999863
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=7.2e-17 Score=129.89 Aligned_cols=97 Identities=21% Similarity=0.257 Sum_probs=76.4
Q ss_pred hHHHHHHHHhcCCCccc--eeeeeeeecCCceeEEEeccCC-C----CHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHh
Q 024027 18 SFDVECEMMKSIRHRNL--IKVISSCSNEEFKALVLEYMPH-G----SLEKYLYSSNCILDIFQRLNIMIDVASALEYLH 90 (273)
Q Consensus 18 ~~~~E~~~l~~l~h~~i--~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~~~~~~~~ql~~~l~~lh 90 (273)
.+.+|+.+|+.+.|+++ ..+++. ...++||||+.+ | +|.++... .++..+..++.|++.+|.+||
T Consensus 116 ~~~~E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH 187 (258)
T 1zth_A 116 WTEKEFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLY 187 (258)
T ss_dssp HHHHHHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHH
Confidence 57899999999987764 333332 356899999942 3 67766532 224457889999999999999
Q ss_pred cCCCCCeEeccCCCCceeeCCCCceEEeeccccccc
Q 024027 91 FGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLL 126 (273)
Q Consensus 91 ~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~ 126 (273)
. +.|++||||||+|||++. .++|+|||++...
T Consensus 188 ~--~~givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 188 Q--EAELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp H--TSCEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred H--HCCEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 5 579999999999999998 9999999999753
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.49 E-value=1.4e-14 Score=121.61 Aligned_cols=69 Identities=13% Similarity=0.170 Sum_probs=57.7
Q ss_pred eeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCC----------ceE
Q 024027 47 KALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNL----------VAY 116 (273)
Q Consensus 47 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~----------~~k 116 (273)
.+|||||++|++|.++... ..+..++.|++.+|.+|| ..|++||||||.|||++.++ .+.
T Consensus 186 ~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~ 255 (397)
T 4gyi_A 186 HTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLA---KHGLIHGDFNEFNILIREEKDAEDPSSITLTPI 255 (397)
T ss_dssp TEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEEEECSSCTTSEEEEEE
T ss_pred ceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeCCCCcccccccccceE
Confidence 3799999999888765422 134678899999999999 99999999999999998766 389
Q ss_pred Eeecccccc
Q 024027 117 LSDFGIAKL 125 (273)
Q Consensus 117 l~Df~~~~~ 125 (273)
|+||+.+..
T Consensus 256 iID~~Q~V~ 264 (397)
T 4gyi_A 256 IIXFPQMVS 264 (397)
T ss_dssp ECCCTTCEE
T ss_pred EEEeCCccc
Confidence 999998764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=2.4e-12 Score=103.52 Aligned_cols=118 Identities=15% Similarity=0.104 Sum_probs=91.8
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCC-CccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIR-HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
+++++|+...........+.+|+.+++.+. +..+.++++++.+.+..++||||++|.+|.+.+.. ......++
T Consensus 38 ~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~------~~~~~~~~ 111 (263)
T 3tm0_A 38 ENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED------EQSPEKII 111 (263)
T ss_dssp CEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCCT------TTCHHHHH
T ss_pred CcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccCC------cccHHHHH
Confidence 368999987532234467999999999984 67788999999988899999999999999876421 11234678
Q ss_pred HHHHHHHHHHhcC--------------------------------------------------------CCCCeEeccCC
Q 024027 80 IDVASALEYLHFG--------------------------------------------------------CSAPVIHCDLK 103 (273)
Q Consensus 80 ~ql~~~l~~lh~~--------------------------------------------------------~~~~i~h~di~ 103 (273)
.++..++..||.. ....++|||++
T Consensus 112 ~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~ 191 (263)
T 3tm0_A 112 ELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLG 191 (263)
T ss_dssp HHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCC
T ss_pred HHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCC
Confidence 8899999999930 00458999999
Q ss_pred CCceeeCCCCceEEeeccccc
Q 024027 104 PDNVLLDDNLVAYLSDFGIAK 124 (273)
Q Consensus 104 p~nil~~~~~~~kl~Df~~~~ 124 (273)
|.||+++.+..+.|+||+.+.
T Consensus 192 ~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 192 DSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTSEEEETTEEEEECCCTTCE
T ss_pred cCcEEEECCcEEEEEEchhcc
Confidence 999999876667799999875
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.18 E-value=6.9e-11 Score=94.66 Aligned_cols=111 Identities=18% Similarity=0.112 Sum_probs=82.7
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCcc--ceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRN--LIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
+++||+.... ....+..|+.+++.+.+.+ +.+++++...++..++||||++|.+|. ... .+ ...++
T Consensus 46 ~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~~----~~---~~~~~ 113 (264)
T 1nd4_A 46 VLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SSH----LA---PAEKV 113 (264)
T ss_dssp CEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TSC----CC---HHHHH
T ss_pred eEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cCc----CC---HhHHH
Confidence 5889987543 3367889999999985434 556888888888899999999998884 211 12 23567
Q ss_pred HHHHHHHHHHhcCC-------------------------------------------------------CCCeEeccCCC
Q 024027 80 IDVASALEYLHFGC-------------------------------------------------------SAPVIHCDLKP 104 (273)
Q Consensus 80 ~ql~~~l~~lh~~~-------------------------------------------------------~~~i~h~di~p 104 (273)
.++...+..||... ..+++|||++|
T Consensus 114 ~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~ 193 (264)
T 1nd4_A 114 SIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACL 193 (264)
T ss_dssp HHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCG
T ss_pred HHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCC
Confidence 77778888888211 01299999999
Q ss_pred CceeeCCCCceEEeeccccc
Q 024027 105 DNVLLDDNLVAYLSDFGIAK 124 (273)
Q Consensus 105 ~nil~~~~~~~kl~Df~~~~ 124 (273)
.||+++.++.+.|+||+.+.
T Consensus 194 ~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 194 PNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp GGEEEETTEEEEECCCTTCE
T ss_pred CcEEEECCcEEEEEcchhcc
Confidence 99999877667799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.04 E-value=8.1e-10 Score=92.87 Aligned_cols=121 Identities=14% Similarity=0.183 Sum_probs=89.1
Q ss_pred eEEEEEee--ccc-ChhhhhHHHHHHHHhcCC--CccceeeeeeeecC---CceeEEEeccCCCCHHHhhhcCCCCCCHH
Q 024027 2 EVAVKVFN--LQC-GRAFKSFDVECEMMKSIR--HRNLIKVISSCSNE---EFKALVLEYMPHGSLEKYLYSSNCILDIF 73 (273)
Q Consensus 2 ~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 73 (273)
++++|+.. ... ......+.+|+.+++.+. +..+.+++.++.+. +..++||||++|..+.+.. ...++..
T Consensus 63 ~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~---~~~l~~~ 139 (359)
T 3dxp_A 63 TYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS---LPGMSPA 139 (359)
T ss_dssp EEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT---CTTCCHH
T ss_pred eEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCc---cccCCHH
Confidence 57778775 332 123467889999999996 45688889888776 4588999999997775421 1236777
Q ss_pred HHHHHHHHHHHHHHHHhcCC-------------------------------------------------------CCCeE
Q 024027 74 QRLNIMIDVASALEYLHFGC-------------------------------------------------------SAPVI 98 (273)
Q Consensus 74 ~~~~~~~ql~~~l~~lh~~~-------------------------------------------------------~~~i~ 98 (273)
....++.+++.+|..||... ..+++
T Consensus 140 ~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lv 219 (359)
T 3dxp_A 140 ERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIV 219 (359)
T ss_dssp HHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEE
T ss_pred HHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEE
Confidence 88889999999999999310 14699
Q ss_pred eccCCCCceeeCCCC--ceEEeecccccc
Q 024027 99 HCDLKPDNVLLDDNL--VAYLSDFGIAKL 125 (273)
Q Consensus 99 h~di~p~nil~~~~~--~~kl~Df~~~~~ 125 (273)
|||++|.||+++.++ .+.++||+.+..
T Consensus 220 HgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 220 HGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred eCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 999999999998765 368999998763
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.89 E-value=1.9e-09 Score=88.47 Aligned_cols=167 Identities=19% Similarity=0.175 Sum_probs=103.7
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcC-CCcc--ceeeeeeeecCC---ceeEEEeccCCCCHHHhhhcCCCCCCHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSI-RHRN--LIKVISSCSNEE---FKALVLEYMPHGSLEKYLYSSNCILDIFQR 75 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~--i~~~~~~~~~~~---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (273)
.++||+.... .....+.+|+.+|+.+ .+.. +.+++....... ..++||++++|.++.+... ..++....
T Consensus 42 ~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~---~~l~~~~~ 116 (304)
T 3sg8_A 42 DFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL---NNLPKQSQ 116 (304)
T ss_dssp SEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHH---HTSCHHHH
T ss_pred EEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCcccc---ccCCHHHH
Confidence 5788886432 3456789999999888 3332 344555443333 3478999999988765332 12556666
Q ss_pred HHHHHHHHHHHHHHhcC-------------------------------------------------------CCCCeEec
Q 024027 76 LNIMIDVASALEYLHFG-------------------------------------------------------CSAPVIHC 100 (273)
Q Consensus 76 ~~~~~ql~~~l~~lh~~-------------------------------------------------------~~~~i~h~ 100 (273)
..++.+++..+..||.. ....++||
T Consensus 117 ~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~Hg 196 (304)
T 3sg8_A 117 NQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHN 196 (304)
T ss_dssp HHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECS
T ss_pred HHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeC
Confidence 67777777777777720 01357999
Q ss_pred cCCCCceeeCC--CCceEEeecccccccccCCCcceeecccccCCC---CCCcccCC--------------CCcCCcchh
Q 024027 101 DLKPDNVLLDD--NLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGY---MAPEYGRE--------------GRVSTNGDV 161 (273)
Q Consensus 101 di~p~nil~~~--~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~---~aPE~~~~--------------~~~~~~~Di 161 (273)
|++|.||+++. +..+.++||+.+..-... . ........ ..|+.... .....-.+.
T Consensus 197 D~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~---~---Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~ 270 (304)
T 3sg8_A 197 DFSSDHILFDTEKNTICGIIDFGDAAISDPD---N---DFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKY 270 (304)
T ss_dssp CCCGGGEEEETTTTEEEEECCCTTCEEECTT---H---HHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHH
T ss_pred CCCcccEEEeCCCCCEEEEEeCCCCccCChH---H---HHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHH
Confidence 99999999997 567889999987642110 0 00000001 12221100 001122589
Q ss_pred HHHHHHHHHHHhCCCCCc
Q 024027 162 YSFGIMLMETFTGKKPTY 179 (273)
Q Consensus 162 wslG~~l~~ll~g~~pf~ 179 (273)
|++|.+++.+.+|..+|.
T Consensus 271 ~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 271 WSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHHHHHHHTTCHHHH
T ss_pred HHHHHHHHHHHcCCHHHH
Confidence 999999999999988754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.58 E-value=2e-07 Score=74.99 Aligned_cols=115 Identities=18% Similarity=0.074 Sum_probs=81.7
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCC-CccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIR-HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
.++||+-... ....+.+|...|+.+. +-.+.++++++.+++..++|||+++|.++.+...... .....+..
T Consensus 52 ~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~~-----~~~~~~~~ 123 (272)
T 4gkh_A 52 ELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYP-----DSGENIVD 123 (272)
T ss_dssp CEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHCG-----GGHHHHHH
T ss_pred EEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCCH-----HHHHHHHH
Confidence 4677876533 4467889999999884 4447788899999999999999999988876553211 12233445
Q ss_pred HHHHHHHHHhcC-------------------------------------------------------CCCCeEeccCCCC
Q 024027 81 DVASALEYLHFG-------------------------------------------------------CSAPVIHCDLKPD 105 (273)
Q Consensus 81 ql~~~l~~lh~~-------------------------------------------------------~~~~i~h~di~p~ 105 (273)
++...|..||.. ....++|||+.+.
T Consensus 124 ~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~ 203 (272)
T 4gkh_A 124 ALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLD 203 (272)
T ss_dssp HHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTT
T ss_pred HHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCC
Confidence 555555555510 0113789999999
Q ss_pred ceeeCCCCceEEeeccccc
Q 024027 106 NVLLDDNLVAYLSDFGIAK 124 (273)
Q Consensus 106 nil~~~~~~~kl~Df~~~~ 124 (273)
||+++.++.+-|+||+.+.
T Consensus 204 Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 204 NLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp SEEEETTEEEEECCCTTCE
T ss_pred eEEEECCeEEEEEECcccc
Confidence 9999988777899999875
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.42 E-value=1.4e-06 Score=71.40 Aligned_cols=119 Identities=14% Similarity=0.128 Sum_probs=75.6
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCc---cceeeeeeee-cCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHR---NLIKVISSCS-NEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
.++||+... ......+.+|..+|+.+.+. .+.+++.+.. ..+..++|||+++|.++.+..-. .++......
T Consensus 41 ~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~~---~l~~~~~~~ 115 (306)
T 3tdw_A 41 DWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGMA---VLPDDAKDR 115 (306)
T ss_dssp TEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHHT---TSCHHHHHH
T ss_pred EEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhhh---hCCHHHHHH
Confidence 567887532 23456789999999999642 3556666663 45667899999999887653111 122333333
Q ss_pred HHHHHHHHHHHHhcC---------------------------------------------------------CCCCeEec
Q 024027 78 IMIDVASALEYLHFG---------------------------------------------------------CSAPVIHC 100 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~---------------------------------------------------------~~~~i~h~ 100 (273)
++.++...|..||.. ....++|+
T Consensus 116 ~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~Hg 195 (306)
T 3tdw_A 116 LALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHG 195 (306)
T ss_dssp HHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECS
T ss_pred HHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeC
Confidence 333333333333310 13467999
Q ss_pred cCCCCceeeCC---CCc-eEEeecccccc
Q 024027 101 DLKPDNVLLDD---NLV-AYLSDFGIAKL 125 (273)
Q Consensus 101 di~p~nil~~~---~~~-~kl~Df~~~~~ 125 (273)
|+.|.||+++. ++. +.|+||+.+..
T Consensus 196 D~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 196 DLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp CCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred CCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 99999999987 344 58999998753
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.35 E-value=4.5e-06 Score=63.81 Aligned_cols=144 Identities=11% Similarity=-0.007 Sum_probs=97.4
Q ss_pred CCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceee
Q 024027 57 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQT 136 (273)
Q Consensus 57 ~~L~~~l~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~ 136 (273)
.+|.+.|+..+.++++.++|.++.|-+.+|..+-. ...-...=+.|..|++..+|.|-+.+ ..+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc------------
Confidence 48999999888899999999999999999888731 11112334557888898888888763 1110
Q ss_pred cccccCCCCCCcccCCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhh
Q 024027 137 QTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHF 216 (273)
Q Consensus 137 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (273)
.....+.|||... ...+.+.=|||||+++|.-+-...|-..
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~e------------------------------------ 138 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKENE------------------------------------ 138 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTTE------------------------------------
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCccc------------------------------------
Confidence 1122367888763 3456778899999999999976555111
Q ss_pred hhhhhhHHHHHHHHhhcCCC-------------------------CccCCCCHHHHHHHHHHHHH
Q 024027 217 VAKEQCVSFVFNLAMACTVE-------------------------SPEQRINAKEIVTKLLKIRD 256 (273)
Q Consensus 217 ~~~~~~~~~l~~li~~~l~~-------------------------dp~~Rps~~~~l~~l~~~~~ 256 (273)
+...++.|..||..|..- .+..|+++++|++.-..-.+
T Consensus 139 --E~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~hl~ 201 (229)
T 2yle_A 139 --ERELSPPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAAHLP 201 (229)
T ss_dssp --EECCCHHHHHHHHHHTTCCC--------------------CCSCCCCCCSHHHHHHHHHTTSS
T ss_pred --chhhCHHHHHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHHHHHhhcc
Confidence 344556678888888755 34688999999987776554
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.24 E-value=2.2e-06 Score=71.64 Aligned_cols=59 Identities=8% Similarity=0.014 Sum_probs=40.5
Q ss_pred eEEEEEeeccc---ChhhhhHHHHHHHHhcCC-C--ccceeeeeeeecC---CceeEEEeccCCCCHH
Q 024027 2 EVAVKVFNLQC---GRAFKSFDVECEMMKSIR-H--RNLIKVISSCSNE---EFKALVLEYMPHGSLE 60 (273)
Q Consensus 2 ~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~~i~~~~~~~~~~---~~~~lv~e~~~~~~L~ 60 (273)
++++|+..... ......+.+|+.+++.+. + -.+.+++.++.+. +..++||||++|..+.
T Consensus 54 ~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 54 KLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp EEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCCC
T ss_pred eEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCChh
Confidence 46777764332 112357889999999884 2 3577788877665 4568999999986654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.79 E-value=8.3e-05 Score=61.48 Aligned_cols=31 Identities=26% Similarity=0.362 Sum_probs=28.2
Q ss_pred CCCeEeccCCCCceeeCCCCceEEeeccccc
Q 024027 94 SAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 124 (273)
Q Consensus 94 ~~~i~h~di~p~nil~~~~~~~kl~Df~~~~ 124 (273)
..+++|||+.+.||+++.++.+.++||+.+.
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 5789999999999999888899999999774
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00026 Score=57.56 Aligned_cols=31 Identities=23% Similarity=0.419 Sum_probs=25.6
Q ss_pred CCCeEeccCCCCceeeCCCCceEEeecccccc
Q 024027 94 SAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL 125 (273)
Q Consensus 94 ~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~ 125 (273)
...++|+|+.+.||+ ..++.+.++||..+..
T Consensus 172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 446899999999999 5566789999998753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00056 Score=57.88 Aligned_cols=30 Identities=20% Similarity=0.296 Sum_probs=25.9
Q ss_pred CCCeEeccCCCCceeeCCCCceEEeeccccc
Q 024027 94 SAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 124 (273)
Q Consensus 94 ~~~i~h~di~p~nil~~~~~~~kl~Df~~~~ 124 (273)
...++|||+.|.||+++.+ .++++||..+.
T Consensus 226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~ 255 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAF 255 (397)
T ss_dssp CCEEECSCCSGGGEEECSS-CEEECCCTTCE
T ss_pred CCceeeCCCCcCcEEEeCC-CeEEEeCcccc
Confidence 5689999999999999875 48899998765
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00095 Score=55.00 Aligned_cols=32 Identities=28% Similarity=0.293 Sum_probs=27.7
Q ss_pred CCCeEeccCCCCceeeCCC----CceEEeecccccc
Q 024027 94 SAPVIHCDLKPDNVLLDDN----LVAYLSDFGIAKL 125 (273)
Q Consensus 94 ~~~i~h~di~p~nil~~~~----~~~kl~Df~~~~~ 125 (273)
...++|||+.+.||+++.+ +.+.++||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 5689999999999999874 6889999998764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00099 Score=54.47 Aligned_cols=55 Identities=18% Similarity=0.148 Sum_probs=43.7
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCC---CccceeeeeeeecCCceeEEEeccCCCCH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIR---HRNLIKVISSCSNEEFKALVLEYMPHGSL 59 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 59 (273)
+++||+.... ....+..|...|+.+. ...+.+++.+....+..++||||++|..+
T Consensus 61 ~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 61 TVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred eEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 6788887533 3567889999999883 46788888888888889999999998764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.27 E-value=0.00075 Score=56.76 Aligned_cols=119 Identities=14% Similarity=0.158 Sum_probs=72.2
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCC-CccceeeeeeeecCCceeEEEeccCCCCHHHh--------------h---
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIR-HRNLIKVISSCSNEEFKALVLEYMPHGSLEKY--------------L--- 63 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~--------------l--- 63 (273)
+|++|+.... ........+|..+++.+. +.-..++++.+.+ .+|+||++|.+|..- +
T Consensus 84 ~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~L 158 (379)
T 3feg_A 84 EVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQF 158 (379)
T ss_dssp EEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHH
T ss_pred eEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHH
Confidence 5778876322 223456678999998884 3334566776654 299999988554311 0
Q ss_pred hcC----CCCCC--HHHHHHHHHHHHHH-------------------HHH----Hh-cCCCCCeEeccCCCCceeeCCC-
Q 024027 64 YSS----NCILD--IFQRLNIMIDVASA-------------------LEY----LH-FGCSAPVIHCDLKPDNVLLDDN- 112 (273)
Q Consensus 64 ~~~----~~~~~--~~~~~~~~~ql~~~-------------------l~~----lh-~~~~~~i~h~di~p~nil~~~~- 112 (273)
+.. +.... +..+..|+.++-.. +.. |. ......++|+|+.+.||+++.+
T Consensus 159 H~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~ 238 (379)
T 3feg_A 159 HGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEP 238 (379)
T ss_dssp HTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC
T ss_pred hCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCC
Confidence 111 11122 34555565544221 222 22 1113479999999999999876
Q ss_pred ---CceEEeecccccc
Q 024027 113 ---LVAYLSDFGIAKL 125 (273)
Q Consensus 113 ---~~~kl~Df~~~~~ 125 (273)
+.+.++||..+..
T Consensus 239 ~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 239 ENADSLMLVDFEYSSY 254 (379)
T ss_dssp ---CCEEECCCTTCEE
T ss_pred CccCcEEEEecccCCc
Confidence 7899999998863
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0016 Score=54.48 Aligned_cols=30 Identities=23% Similarity=0.352 Sum_probs=25.0
Q ss_pred CCCeEeccCCCCceeeCCCCceEEeeccccc
Q 024027 94 SAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 124 (273)
Q Consensus 94 ~~~i~h~di~p~nil~~~~~~~kl~Df~~~~ 124 (273)
..+++|+|+.+.||+++.++ +.++||+.+.
T Consensus 211 ~~~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 211 TIVFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp CEEEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred CeEEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 35699999999999998654 8999998875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0079 Score=49.24 Aligned_cols=29 Identities=21% Similarity=0.304 Sum_probs=25.3
Q ss_pred CCCeEeccCCCCceeeCCCCceEEeeccccc
Q 024027 94 SAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 124 (273)
Q Consensus 94 ~~~i~h~di~p~nil~~~~~~~kl~Df~~~~ 124 (273)
...++|||+++.||+++ + .+.++||+.+.
T Consensus 194 ~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 194 TVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp CCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred CeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 45789999999999999 4 89999998775
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.80 E-value=0.0019 Score=55.27 Aligned_cols=52 Identities=19% Similarity=0.229 Sum_probs=32.9
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCcc-ceeeeeeeecCCceeEEEeccCCCCH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRN-LIKVISSCSNEEFKALVLEYMPHGSL 59 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~~~L 59 (273)
.|++|+..... ....+..|+.+++.+...+ ..++++.+.+ .+|+||++|.++
T Consensus 107 ~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G~~l 159 (429)
T 1nw1_A 107 KVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL 159 (429)
T ss_dssp EEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred eEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCCccc
Confidence 57888874321 1145557999998884333 3567776543 389999987443
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.16 E-value=0.016 Score=46.51 Aligned_cols=55 Identities=13% Similarity=0.047 Sum_probs=36.5
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCC---ccceeeeeeeecCCceeEEEeccCCCCH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRH---RNLIKVISSCSNEEFKALVLEYMPHGSL 59 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~~i~~~~~~~~~~~~~~lv~e~~~~~~L 59 (273)
++|+||+...........+..|+..|+.+.. -.+.+++++. .-++||||++++..
T Consensus 40 ~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 40 TPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDERPP 97 (288)
T ss_dssp CEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCCCC
T ss_pred CEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecccCC
Confidence 4789998765544444568899999998842 2344455432 24689999977553
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.68 E-value=0.025 Score=48.15 Aligned_cols=31 Identities=23% Similarity=0.333 Sum_probs=26.9
Q ss_pred CCCeEeccCCCCceeeCCCCceEEeecccccc
Q 024027 94 SAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL 125 (273)
Q Consensus 94 ~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~ 125 (273)
...++|+|+.+.||+ +.++.+.++||..+..
T Consensus 261 ~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 261 SLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp CEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 346899999999999 7788999999998863
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=95.49 E-value=0.015 Score=49.46 Aligned_cols=31 Identities=19% Similarity=0.305 Sum_probs=27.9
Q ss_pred CCCeEeccCCCCceeeCCCCceEEeecccccc
Q 024027 94 SAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL 125 (273)
Q Consensus 94 ~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~ 125 (273)
...++|||+.|.||+++.++ +.++||+.+..
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 78899999999999998776 99999998764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=93.55 E-value=0.022 Score=46.42 Aligned_cols=31 Identities=42% Similarity=0.443 Sum_probs=26.7
Q ss_pred CCCeEeccCCCCceeeCCCCceEEeeccccc
Q 024027 94 SAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 124 (273)
Q Consensus 94 ~~~i~h~di~p~nil~~~~~~~kl~Df~~~~ 124 (273)
..+++|+|+.+.||+++.++.+.++||+.+.
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 3579999999999999987667899998775
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=93.06 E-value=0.1 Score=44.99 Aligned_cols=53 Identities=11% Similarity=0.188 Sum_probs=33.3
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccc-eeeeeeeecCCceeEEEeccCCCCH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNL-IKVISSCSNEEFKALVLEYMPHGSL 59 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~L 59 (273)
.+++|+..... ...-.-.+|+.+++.+...++ .++++.+. + .+|+||++|.+|
T Consensus 135 ~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~-~---G~v~e~I~G~~l 188 (458)
T 2qg7_A 135 KYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT-N---GRIEEFMDGYAL 188 (458)
T ss_dssp EEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET-T---EEEEECCCSEEC
T ss_pred eEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC-C---eEEEEeeCCccC
Confidence 57788774332 222233689999999864444 56777663 2 359999987444
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=92.79 E-value=0.44 Score=36.30 Aligned_cols=122 Identities=11% Similarity=0.203 Sum_probs=81.2
Q ss_pred CCccceeeeeeeecCCceeEEEeccC-CCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCcee
Q 024027 30 RHRNLIKVISSCSNEEFKALVLEYMP-HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVL 108 (273)
Q Consensus 30 ~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil 108 (273)
.||+.+.. .+-.+++.+.+.++.-+ +.++.. ++ ..+....++++..|+....+++ .-+|--+.|+|++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik----~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P~NL~ 111 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK----SFTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAPDELF 111 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG----GSCHHHHHHHHHHGGGGGGGGG-----SSEECCCSGGGEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH----hcCHHHHHHHHHHHHHHHHHhc-----CceEEEEecceEE
Confidence 58888877 45555555555555543 222222 32 3678888999999988876555 3578899999999
Q ss_pred eCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcchhHHHHHHHHHHHhCCCCCcccccccc
Q 024027 109 LDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEM 186 (273)
Q Consensus 109 ~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~ 186 (273)
++.++.+++.-.|....+ +|. ..+...-.-.+=|++..++.++..|....++..
T Consensus 112 f~~~~~p~i~~RGik~~l-------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~l~~G~l 165 (215)
T 4ann_A 112 FTRDGLPIAKTRGLQNVV-------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFDALVEGNL 165 (215)
T ss_dssp ECTTSCEEESCCEETTTB-------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHHHHHSCG
T ss_pred EcCCCCEEEEEccCccCC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHHHHcChH
Confidence 999999999866654322 221 112222344677889999999998876555543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=91.53 E-value=0.058 Score=44.44 Aligned_cols=32 Identities=25% Similarity=0.422 Sum_probs=27.8
Q ss_pred CCCeEeccCCCCceeeCCCCceEEeecccccc
Q 024027 94 SAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKL 125 (273)
Q Consensus 94 ~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~ 125 (273)
...++|||+.+.||+++.++.+.++||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 35799999999999999888899999987653
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=90.83 E-value=1.2 Score=34.06 Aligned_cols=116 Identities=12% Similarity=0.110 Sum_probs=76.3
Q ss_pred CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHHHHHHHH-HHhcCCCCCeEeccCCCCcee
Q 024027 30 RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALE-YLHFGCSAPVIHCDLKPDNVL 108 (273)
Q Consensus 30 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ql~~~l~-~lh~~~~~~i~h~di~p~nil 108 (273)
.||++ -..+-.+++.+.+.++.-+++.-+..++ ..+....++++..++.... +++ .-+|--+.|+|++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~----~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL~ 116 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR----KTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENLM 116 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH----TSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH----hcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceEE
Confidence 57777 3334466666666666653333333442 3678888989988888766 444 4678899999999
Q ss_pred eCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcchhHHHHHHHHHHHhCCCCCcc
Q 024027 109 LDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYE 180 (273)
Q Consensus 109 ~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~ 180 (273)
++.++.+++.-.|.-..+ +|.- .+...=.-.+=|++..++.++..|..
T Consensus 117 f~~~~~p~i~hRGi~~~l-------------------pP~e-----~~ee~fl~qyKali~all~~K~~Fe~ 164 (219)
T 4ano_A 117 FNRALEPFFLHVGVKESL-------------------PPDE-----WDDERLLREVKATVLALTEGEYRFDE 164 (219)
T ss_dssp ECTTCCEEESCCEETTTB-------------------SSCS-----CCHHHHHHHHHHHHHHHTTCSSCHHH
T ss_pred EeCCCcEEEEEcCCcccC-------------------CCCC-----CCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 999999999876654322 2211 11122234667888888888887654
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.07 E-value=0.14 Score=43.16 Aligned_cols=30 Identities=27% Similarity=0.373 Sum_probs=25.5
Q ss_pred CeEeccCCCCceee------CCCCceEEeecccccc
Q 024027 96 PVIHCDLKPDNVLL------DDNLVAYLSDFGIAKL 125 (273)
Q Consensus 96 ~i~h~di~p~nil~------~~~~~~kl~Df~~~~~ 125 (273)
.+||+|+.+.||++ +.+..+.++||.++..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 47899999999999 4567899999998863
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 273 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-60 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-50 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-50 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-50 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-50 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-48 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-48 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-48 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-47 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-47 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-47 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 9e-47 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-46 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-46 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-46 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-45 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-45 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-45 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-45 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 8e-45 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-44 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-44 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-44 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-44 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-43 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-43 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-43 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-42 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-42 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-42 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-42 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-40 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-40 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-39 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-39 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-36 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-36 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-35 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-34 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-33 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-32 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-31 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-31 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-31 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-31 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-31 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-31 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-30 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-30 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-29 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-29 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-28 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-27 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-27 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-26 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-25 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-25 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-24 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-23 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-22 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-21 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-20 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-10 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 2e-60
Identities = 61/262 (23%), Positives = 113/262 (43%), Gaps = 24/262 (9%)
Query: 2 EVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
+VAVK+ N+ + ++F E +++ RH N++ + + A+V ++ SL
Sbjct: 32 DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSL 90
Query: 60 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSD 119
+L+ ++ + ++I A ++YLH +IH DLK +N+ L ++L + D
Sbjct: 91 YHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGD 147
Query: 120 FGIAKLLIGEDQSMTQTQTLATIGYMAPEY---GREGRVSTNGDVYSFGIMLMETFTGKK 176
FG+A + S Q +I +MAPE + S DVY+FGI+L E TG+
Sbjct: 148 FGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQL 207
Query: 177 PTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236
P N + + +L +V + C + L C +
Sbjct: 208 PYSNINNRDQIIFMVGRGYLSPDLSKV---------------RSNCPKAMKRLMAECLKK 252
Query: 237 SPEQRINAKEIVTKLLKIRDSL 258
++R +I+ + + SL
Sbjct: 253 KRDERPLFPQILASIELLARSL 274
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 1e-50
Identities = 62/251 (24%), Positives = 112/251 (44%), Gaps = 26/251 (10%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 61
+VAVK Q + +F E +MK ++H+ L+++ + + E ++ EYM +GSL
Sbjct: 39 KVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVD 96
Query: 62 YLYSSNCI-LDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDF 120
+L + + I L I + L++ +A + ++ IH DL+ N+L+ D L ++DF
Sbjct: 97 FLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADF 153
Query: 121 GIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYE 180
G+A+L I +++ + I + APE G + DV+SFGI+L E T + Y
Sbjct: 154 GLARL-IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP 212
Query: 181 FFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQ 240
+++ + V + C ++ L C E PE
Sbjct: 213 GMTNPEVIQNLERGYRM-------------------VRPDNCPEELYQLMRLCWKERPED 253
Query: 241 RINAKEIVTKL 251
R + + L
Sbjct: 254 RPTFDYLRSVL 264
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 2e-50
Identities = 56/266 (21%), Positives = 104/266 (39%), Gaps = 25/266 (9%)
Query: 1 MEVAVKVFNLQCGRAF-KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
++VA+KV +A + E ++M + + ++++I C E LV+E G L
Sbjct: 37 IDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPL 95
Query: 60 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSD 119
K+L + + ++ V+ ++YL +H DL NVLL + A +SD
Sbjct: 96 HKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISD 152
Query: 120 FGIAKLLIGEDQSMTQTQTLA-TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPT 178
FG++K L +D T + + APE + S+ DV+S+G+ + E + +
Sbjct: 153 FGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 212
Query: 179 YEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238
Y+ G + +C ++ L C +
Sbjct: 213 YKKMKGPEVMAFIEQGKRM-------------------ECPPECPPELYALMSDCWIYKW 253
Query: 239 EQRINAKEIVTKLLKIRDSLLRNVGG 264
E R + + ++ SL V G
Sbjct: 254 EDRPDFLTVEQRMRACYYSLASKVEG 279
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 4e-50
Identities = 64/256 (25%), Positives = 111/256 (43%), Gaps = 24/256 (9%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 61
+VA+K + + F E E+M + H L+++ C + LV E+M HG L
Sbjct: 31 KVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD 89
Query: 62 YLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFG 121
YL + + L + +DV + YL A VIH DL N L+ +N V +SDFG
Sbjct: 90 YLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRDLAARNCLVGENQVIKVSDFG 146
Query: 122 IAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEF 181
+ + ++ + + + T + + +PE R S+ DV+SFG+++ E F+ K YE
Sbjct: 147 MTRFVLDDQYTSSTG-TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 205
Query: 182 FNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQR 241
+ ++ + + L S V+ + C E PE R
Sbjct: 206 RSNSEVVEDISTGF------RLYKPRLASTH-------------VYQIMNHCWKERPEDR 246
Query: 242 INAKEIVTKLLKIRDS 257
++ +L +I +S
Sbjct: 247 PAFSRLLRQLAEIAES 262
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 4e-50
Identities = 57/253 (22%), Positives = 115/253 (45%), Gaps = 24/253 (9%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 61
+VA+K+ + + F E ++M ++ H L+++ C+ + ++ EYM +G L
Sbjct: 30 DVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN 88
Query: 62 YLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFG 121
YL Q L + DV A+EYL +H DL N L++D V +SDFG
Sbjct: 89 YLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFG 145
Query: 122 IAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEF 181
+++ ++ +D+ + + + + PE + S+ D+++FG+++ E ++ K YE
Sbjct: 146 LSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 204
Query: 182 FNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQR 241
F T +H +L S++ V+ + +C E ++R
Sbjct: 205 FTNSETAEHIAQGLRL------YRPHLASEK-------------VYTIMYSCWHEKADER 245
Query: 242 INAKEIVTKLLKI 254
K +++ +L +
Sbjct: 246 PTFKILLSNILDV 258
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 2e-48
Identities = 69/256 (26%), Positives = 108/256 (42%), Gaps = 31/256 (12%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFK-ALVLEYMPHGSLE 60
+VAVK ++F E +M +RH NL++++ E+ +V EYM GSL
Sbjct: 32 KVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 89
Query: 61 KYLYSSNC-ILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSD 119
YL S +L L +DV A+EYL +H DL NVL+ ++ VA +SD
Sbjct: 90 DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSD 146
Query: 120 FGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTY 179
FG+ K S TQ + + APE RE + ST DV+SFGI+L E ++ + Y
Sbjct: 147 FGLTKEA-----SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 201
Query: 180 EFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239
+ + + A + C V+ + C
Sbjct: 202 PRIPLKDVVPRVEKGYKM-------------------DAPDGCPPAVYEVMKNCWHLDAA 242
Query: 240 QRINAKEIVTKLLKIR 255
R + ++ +L I+
Sbjct: 243 MRPSFLQLREQLEHIK 258
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 2e-48
Identities = 56/274 (20%), Positives = 104/274 (37%), Gaps = 21/274 (7%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKA----LVLEYMPHG 57
EVAVK+F+ + R++ + E +RH N++ I++ + + LV +Y HG
Sbjct: 28 EVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHG 86
Query: 58 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGC-----SAPVIHCDLKPDNVLLDDN 112
SL YL + + + + + AS L +LH + H DLK N+L+ N
Sbjct: 87 SLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 144
Query: 113 LVAYLSDFGIAKLLIGEDQSMT--QTQTLATIGYMAPEY------GREGRVSTNGDVYSF 164
++D G+A ++ + T YMAPE + D+Y+
Sbjct: 145 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM 204
Query: 165 GIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTM-EVVDANLLSQEDIHFVAKEQCV 223
G++ E + ++ V + M +VV L + + +
Sbjct: 205 GLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEAL 264
Query: 224 SFVFNLAMACTVESPEQRINAKEIVTKLLKIRDS 257
+ + C + R+ A I L ++
Sbjct: 265 RVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 160 bits (405), Expect = 2e-48
Identities = 58/263 (22%), Positives = 111/263 (42%), Gaps = 30/263 (11%)
Query: 3 VAVKVFNLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 61
VA+K + + F E +M H N+I + + ++ E+M +GSL+
Sbjct: 57 VAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS 116
Query: 62 YLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFG 121
+L ++ + Q + ++ +A+ ++YL +H DL N+L++ NLV +SDFG
Sbjct: 117 FLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFG 173
Query: 122 IAKLLIGEDQSMTQTQTL---ATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPT 178
+++ L + T T L I + APE + + ++ DV+S+GI++ E + +
Sbjct: 174 LSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 233
Query: 179 YEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238
Y + + D+ M+ A + L + C +
Sbjct: 234 YWDMTNQDVINAIEQDYRLPPPMDCPSA-------------------LHQLMLDCWQKDR 274
Query: 239 EQRINAKEIVTKLLKIRDSLLRN 261
R +IV L D ++RN
Sbjct: 275 NHRPKFGQIVNTL----DKMIRN 293
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 4e-47
Identities = 50/251 (19%), Positives = 96/251 (38%), Gaps = 28/251 (11%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 61
A KV + + + + VE +++ S H N++K++ + E +++E+ G+++
Sbjct: 39 LAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDA 98
Query: 62 YLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFG 121
+ L Q + AL YLH +IH DLK N+L + L+DFG
Sbjct: 99 VMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFG 155
Query: 122 IAKLLIGEDQSMTQTQTLATIGYMAPEY-----GREGRVSTNGDVYSFGIMLMETFTGKK 176
++ Q T +MAPE ++ DV+S GI L+E +
Sbjct: 156 VSAKNTRTIQRRDSFI--GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP 213
Query: 177 PTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236
P +E + LK ++ ++ +N + C +
Sbjct: 214 PHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFK------------------DFLKKCLEK 255
Query: 237 SPEQRINAKEI 247
+ + R ++
Sbjct: 256 NVDARWTTSQL 266
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 4e-47
Identities = 54/275 (19%), Positives = 101/275 (36%), Gaps = 45/275 (16%)
Query: 1 MEVAVKVFNLQCGRAF-KSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGS 58
++VAVK+ + + ++ E +MM + H N++ ++ +C+ L+ EY +G
Sbjct: 68 IQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGD 127
Query: 59 LEKYLYSSN----------------------CILDIFQRLNIMIDVASALEYLHFGCSAP 96
L YL S +L L VA +E+L
Sbjct: 128 LLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKS 184
Query: 97 VIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVS 156
+H DL NVL+ V + DFG+A+ ++ + + + + +MAPE EG +
Sbjct: 185 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT 244
Query: 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHF 216
DV+S+GI+L E F+ Y + + Q
Sbjct: 245 IKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLI------------------QNGFKM 286
Query: 217 VAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKL 251
++ + +C +R + + + L
Sbjct: 287 DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 4e-47
Identities = 51/270 (18%), Positives = 106/270 (39%), Gaps = 31/270 (11%)
Query: 2 EVAVKVFNLQCGRAFKS-FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 60
+A K+ +L+ A ++ E +++ ++ + ++ ++ +E+M GSL+
Sbjct: 33 VMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD 92
Query: 61 KYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDF 120
+ L + + + I V L YL ++H D+KP N+L++ L DF
Sbjct: 93 QVLKKAGR-IPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDF 149
Query: 121 GIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYE 180
G++ L SM + T YM+PE + S D++S G+ L+E G+ P
Sbjct: 150 GVSGQL---IDSMANSFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205
Query: 181 FFNGEMTLKH------WVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFN------ 228
E+ L + P + + +A + + ++ N
Sbjct: 206 PDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKL 265
Query: 229 -----------LAMACTVESPEQRINAKEI 247
C +++P +R + K++
Sbjct: 266 PSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 9e-47
Identities = 54/248 (21%), Positives = 97/248 (39%), Gaps = 24/248 (9%)
Query: 2 EVAVKVFNL-QCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 60
VAVK+ ++ + ++ E + K + H N++K + L LEY G L
Sbjct: 32 AVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 91
Query: 61 KYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDF 120
+ + + + + + YLH + H D+KP+N+LLD+ +SDF
Sbjct: 92 DRIEP-DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDF 147
Query: 121 GIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG-DVYSFGIMLMETFTGKKPTY 179
G+A + ++ + T+ Y+APE + DV+S GI+L G+ P
Sbjct: 148 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 207
Query: 180 EFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239
+ + W ++ + +D+ L L VE+P
Sbjct: 208 QPSDSCQEYSDWKEKKTYLNPWKKIDSAPL------------------ALLHKILVENPS 249
Query: 240 QRINAKEI 247
RI +I
Sbjct: 250 ARITIPDI 257
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 1e-46
Identities = 62/251 (24%), Positives = 108/251 (43%), Gaps = 26/251 (10%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 61
VA+K + ++F E ++MK +RH L+++ + S E +V EYM GSL
Sbjct: 43 RVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLD 100
Query: 62 YLYSSNCILDIF-QRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDF 120
+L Q +++ +AS + Y+ +H DL+ N+L+ +NLV ++DF
Sbjct: 101 FLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADF 157
Query: 121 GIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYE 180
G+A+L I +++ + I + APE GR + DV+SFGI+L E T + Y
Sbjct: 158 GLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 216
Query: 181 FFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQ 240
L + E ++ + +L C + PE+
Sbjct: 217 GMVNREVLDQVERGYRMPCPPECPES-------------------LHDLMCQCWRKEPEE 257
Query: 241 RINAKEIVTKL 251
R + + L
Sbjct: 258 RPTFEYLQAFL 268
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 5e-46
Identities = 57/264 (21%), Positives = 104/264 (39%), Gaps = 26/264 (9%)
Query: 1 MEVAVKVFNLQCGRAF-KSFDVECEMMKSIRHRNLIKVISSCSNEEFKA-LVLEYMPHGS 58
+ AVK N F E +MK H N++ ++ C E +VL YM HG
Sbjct: 56 IHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGD 115
Query: 59 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLS 118
L ++ + + + + VA + F S +H DL N +LD+ ++
Sbjct: 116 LRNFIRNETHNPTVKDLIGFGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVA 172
Query: 119 DFGIAKLLIGED--QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKK 176
DFG+A+ + ++ +T + +MA E + + +T DV+SFG++L E T
Sbjct: 173 DFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 232
Query: 177 PTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236
P Y N + + + E C ++ + + C
Sbjct: 233 PPYPDVNTFDITVYLLQGRRLLQP-------------------EYCPDPLYEVMLKCWHP 273
Query: 237 SPEQRINAKEIVTKLLKIRDSLLR 260
E R + E+V+++ I + +
Sbjct: 274 KAEMRPSFSELVSRISAIFSTFIG 297
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 6e-46
Identities = 58/255 (22%), Positives = 106/255 (41%), Gaps = 32/255 (12%)
Query: 1 MEVAVKVFNLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSC----SNEEFKALVLEYM 54
+EVA + + F E EM+K ++H N+++ S ++ LV E M
Sbjct: 35 VEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 94
Query: 55 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDD-NL 113
G+L+ YL ++ I + + L++LH + P+IH DLK DN+ +
Sbjct: 95 TSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTG 152
Query: 114 VAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 173
+ D G+A L S + + T +MAPE E + + DVY+FG+ ++E T
Sbjct: 153 SVKIGDLGLATLK---RASFAKA-VIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMAT 207
Query: 174 GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMAC 233
+ P E N + + P S +V + + C
Sbjct: 208 SEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK------------------EIIEGC 249
Query: 234 TVESPEQRINAKEIV 248
++ ++R + K+++
Sbjct: 250 IRQNKDERYSIKDLL 264
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 153 bits (386), Expect = 2e-45
Identities = 59/277 (21%), Positives = 106/277 (38%), Gaps = 46/277 (16%)
Query: 2 EVAVKVFNLQCGRAF-KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 60
VAVK+ + F E +M + N++K++ C+ + L+ EYM +G L
Sbjct: 45 MVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLN 104
Query: 61 KYLYSSNC-----------------------ILDIFQRLNIMIDVASALEYLHFGCSAPV 97
++L S + L ++L I VA+ + YL
Sbjct: 105 EFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKF 161
Query: 98 IHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVST 157
+H DL N L+ +N+V ++DFG+++ + D I +M PE R +T
Sbjct: 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTT 221
Query: 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFV 217
DV+++G++L E F+ Y E + + + +
Sbjct: 222 ESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNIL-------------------A 262
Query: 218 AKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLLKI 254
E C ++NL C + P R + I L ++
Sbjct: 263 CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 2e-45
Identities = 53/256 (20%), Positives = 88/256 (34%), Gaps = 31/256 (12%)
Query: 2 EVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKAL--VLEYMPHG 57
+ K + + E +++ ++H N+++ + L V+EY G
Sbjct: 31 ILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGG 90
Query: 58 SLEKYLYS---SNCILDIFQRLNIMIDVASALEYLH--FGCSAPVIHCDLKPDNVLLDDN 112
L + LD L +M + AL+ H V+H DLKP NV LD
Sbjct: 91 DLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK 150
Query: 113 LVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETF 172
L DFG+A++L D S + T YM+PE + D++S G +L E
Sbjct: 151 QNVKLGDFGLARIL-NHDTSFAKAFV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELC 208
Query: 173 TGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMA 232
P F E+ K + I + + +
Sbjct: 209 ALMPPFTAFSQKELAGKIREGKFRRIP--------------------YRYSDELNEIITR 248
Query: 233 CTVESPEQRINAKEIV 248
R + +EI+
Sbjct: 249 MLNLKDYHRPSVEEIL 264
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 3e-45
Identities = 59/259 (22%), Positives = 117/259 (45%), Gaps = 24/259 (9%)
Query: 1 MEVAVKVFNLQCG-RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
+ VA+K + F E +M H N+I++ S + ++ EYM +G+L
Sbjct: 37 VPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGAL 96
Query: 60 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSD 119
+K+L + + Q + ++ +A+ ++YL + +H DL N+L++ NLV +SD
Sbjct: 97 DKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSD 153
Query: 120 FGIAKLLI-GEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPT 178
FG++++L + + T + I + APE + ++ DV+SFGI++ E T +
Sbjct: 154 FGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 213
Query: 179 YEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238
Y + +K + + + M+ A ++ L M C +
Sbjct: 214 YWELSNHEVMKAINDGFRLPTPMDCPSA-------------------IYQLMMQCWQQER 254
Query: 239 EQRINAKEIVTKLLKIRDS 257
+R +IV+ L K+ +
Sbjct: 255 ARRPKFADIVSILDKLIRA 273
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 151 bits (383), Expect = 4e-45
Identities = 64/255 (25%), Positives = 106/255 (41%), Gaps = 25/255 (9%)
Query: 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 60
+ VAVK + F E +MK I+H NL++++ C+ E ++ E+M +G+L
Sbjct: 43 LTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 101
Query: 61 KYLYSSN-CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSD 119
YL N + L + ++SA+EYL IH DL N L+ +N + ++D
Sbjct: 102 DYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVAD 158
Query: 120 FGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTY 179
FG+++L+ G D I + APE + S DV++FG++L E T Y
Sbjct: 159 FGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 217
Query: 180 EFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239
+ + ++D E C V+ L AC +P
Sbjct: 218 PGIDLSQVYELL-------------------EKDYRMERPEGCPEKVYELMRACWQWNPS 258
Query: 240 QRINAKEIVTKLLKI 254
R + EI +
Sbjct: 259 DRPSFAEIHQAFETM 273
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 8e-45
Identities = 53/253 (20%), Positives = 95/253 (37%), Gaps = 27/253 (10%)
Query: 2 EVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
VAVK+ + E +M+ + + ++++I C E + LV+E G L
Sbjct: 36 TVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPL 94
Query: 60 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSD 119
KYL + + + ++ V+ ++YL + +H DL NVLL A +SD
Sbjct: 95 NKYLQQNRH-VKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISD 150
Query: 120 FGIAKLLIGEDQSMTQTQTLA-TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPT 178
FG++K L ++ + + APE + S+ DV+SFG+++ E F+ +
Sbjct: 151 FGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 210
Query: 179 YEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238
Y G C +++L C
Sbjct: 211 YRGMKGSEVTAMLEKGERM-------------------GCPAGCPREMYDLMNLCWTYDV 251
Query: 239 EQRINAKEIVTKL 251
E R + +L
Sbjct: 252 ENRPGFAAVELRL 264
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 1e-44
Identities = 54/273 (19%), Positives = 103/273 (37%), Gaps = 40/273 (14%)
Query: 1 MEVAVKVFNLQCGRAF-KSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGS 58
M VAVK+ ++ E +++ + H N++ ++ +C+ ++ EY +G
Sbjct: 54 MTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGD 113
Query: 59 LEKYLYSS-----------------NCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCD 101
L +L LD+ L+ VA + +L S IH D
Sbjct: 114 LLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRD 170
Query: 102 LKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 161
L N+LL + + DFG+A+ + + + + + +MAPE + DV
Sbjct: 171 LAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDV 230
Query: 162 YSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQ 221
+S+GI L E F+ Y + + +E ++ E
Sbjct: 231 WSYGIFLWELFSLGSSPYPGMPVDSKFYKMI------------------KEGFRMLSPEH 272
Query: 222 CVSFVFNLAMACTVESPEQRINAKEIVTKLLKI 254
+ ++++ C P +R K+IV + K
Sbjct: 273 APAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 1e-44
Identities = 65/259 (25%), Positives = 93/259 (35%), Gaps = 26/259 (10%)
Query: 1 MEVAVKVFN---LQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHG 57
+ VAVK L A F E M S+ HRNLI++ K +V E P G
Sbjct: 37 VSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLG 95
Query: 58 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYL 117
SL L + + VA + YL S IH DL N+LL + +
Sbjct: 96 SLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKI 152
Query: 118 SDFGIAKLLI-GEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKK 176
DFG+ + L +D + Q + APE + S D + FG+ L E FT +
Sbjct: 153 GDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ 212
Query: 177 PTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236
+ NG L E E C ++N+ + C
Sbjct: 213 EPWIGLNGSQILHKIDK------------------EGERLPRPEDCPQDIYNVMVQCWAH 254
Query: 237 SPEQRINAKEIVTKLLKIR 255
PE R + LL+ +
Sbjct: 255 KPEDRPTFVALRDFLLEAQ 273
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 149 bits (378), Expect = 3e-44
Identities = 54/253 (21%), Positives = 91/253 (35%), Gaps = 35/253 (13%)
Query: 2 EVAVKVFNL---QCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGS 58
VA+K + Q ++ E ++ +RH N I+ E LV+EY +
Sbjct: 42 VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSA 101
Query: 59 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLS 118
+ L + + L YLH S +IH D+K N+LL + + L
Sbjct: 102 SDLLEVHKKP-LQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLG 157
Query: 119 DFGIAKLLIGEDQSMTQTQTLATIGYMAPEY---GREGRVSTNGDVYSFGIMLMETFTGK 175
DFG A ++ + T +MAPE EG+ DV+S GI +E K
Sbjct: 158 DFGSASIM------APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 211
Query: 176 KPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTV 235
P + N+ + + S+ +FV C
Sbjct: 212 PPLFNMNAMSALYHIAQNESPALQSGHW------SEYFRNFVDS-------------CLQ 252
Query: 236 ESPEQRINAKEIV 248
+ P+ R ++ ++
Sbjct: 253 KIPQDRPTSEVLL 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 6e-44
Identities = 54/250 (21%), Positives = 102/250 (40%), Gaps = 32/250 (12%)
Query: 2 EVAVKVFN---LQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGS 58
+A+KV L+ E E+ +RH N++++ + L+LEY P G+
Sbjct: 33 ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT 92
Query: 59 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLS 118
+ + L + D + + ++A+AL Y H S VIH D+KP+N+LL ++
Sbjct: 93 VYRELQKLSK-FDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIA 148
Query: 119 DFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPT 178
DFG + ++ T+ Y+ PE D++S G++ E GK P
Sbjct: 149 DFGWSVHAPSSRRTTLCG----TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP- 203
Query: 179 YEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238
F + + IS +E + +++ +++ +P
Sbjct: 204 ---FEANTYQETYKR----ISRVEFTFPDFVTEGARDLISR-------------LLKHNP 243
Query: 239 EQRINAKEIV 248
QR +E++
Sbjct: 244 SQRPMLREVL 253
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 1e-43
Identities = 65/246 (26%), Positives = 103/246 (41%), Gaps = 25/246 (10%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 61
EVA++ NLQ + E +M+ ++ N++ + S + +V+EY+ GSL
Sbjct: 47 EVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD 106
Query: 62 YLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFG 121
+ + D Q + + ALE+LH S VIH D+K DN+LL + L+DFG
Sbjct: 107 VVTETCM--DEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFG 161
Query: 122 IAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEF 181
+ E + T +MAPE D++S GIM +E G+ P Y
Sbjct: 162 FCAQITPEQSKRSTMVG--TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP-YLN 218
Query: 182 FNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQR 241
N L + P E+ + LS F+ + C E+R
Sbjct: 219 ENPLRALYLIATNGTP----ELQNPEKLSAIFRDFLNR-------------CLDMDVEKR 261
Query: 242 INAKEI 247
+AKE+
Sbjct: 262 GSAKEL 267
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 3e-43
Identities = 51/255 (20%), Positives = 97/255 (38%), Gaps = 24/255 (9%)
Query: 1 MEVAVKVFNL-QCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
+ VA+K +A K E +M S+ + ++ +++ C + L+ + MP G L
Sbjct: 39 IPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCL 97
Query: 60 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSD 119
Y+ + LN + +A + YL ++H DL NVL+ ++D
Sbjct: 98 LDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITD 154
Query: 120 FGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTY 179
FG+AKLL E++ I +MA E + DV+S+G+ + E T Y
Sbjct: 155 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 214
Query: 180 EFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239
+ ++ C V+ + + C + +
Sbjct: 215 DGIPASEISSIL-------------------EKGERLPQPPICTIDVYMIMVKCWMIDAD 255
Query: 240 QRINAKEIVTKLLKI 254
R +E++ + K+
Sbjct: 256 SRPKFRELIIEFSKM 270
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 147 bits (373), Expect = 4e-43
Identities = 45/248 (18%), Positives = 88/248 (35%), Gaps = 25/248 (10%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 61
A K ++ E + M +RH L+ + + ++ ++ E+M G L +
Sbjct: 53 NFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFE 112
Query: 62 YLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLL--DDNLVAYLSD 119
+ + + + + M V L ++H +H DLKP+N++ + L D
Sbjct: 113 KVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLID 169
Query: 120 FGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTY 179
FG+ L + T T + APE V D++S G++ +G P
Sbjct: 170 FGLTAHLDPKQSVKVTTGTA---EFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG 226
Query: 180 EFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239
+ E DW + + +S++ F+ K + P
Sbjct: 227 GENDDETLRNVKSCDWNMDDSAF----SGISEDGKDFIRK-------------LLLADPN 269
Query: 240 QRINAKEI 247
R+ +
Sbjct: 270 TRMTIHQA 277
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 1e-42
Identities = 57/271 (21%), Positives = 102/271 (37%), Gaps = 28/271 (10%)
Query: 2 EVAVKVFN---LQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGS 58
E A+K+ + E ++M + H +K+ + ++E L Y +G
Sbjct: 35 EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 94
Query: 59 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLS 118
L KY+ D ++ SALEYLH +IH DLKP+N+LL++++ ++
Sbjct: 95 LLKYIRKIGS-FDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQIT 150
Query: 119 DFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPT 178
DFG AK+L E + + T Y++PE E + D+++ G ++ + G P
Sbjct: 151 DFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP- 209
Query: 179 YEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238
F + I +E + V K V
Sbjct: 210 ---FRAGNEYLIFQK----IIKLEYDFPEKFFPKARDLVEK-------------LLVLDA 249
Query: 239 EQRINAKEIVTKLLKIRDSLLRNVGGRRIRQ 269
+R+ +E+ +V + Q
Sbjct: 250 TKRLGCEEMEGYGPLKAHPFFESVTWENLHQ 280
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 3e-42
Identities = 55/271 (20%), Positives = 110/271 (40%), Gaps = 32/271 (11%)
Query: 2 EVAVKVFNLQCG-RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 60
VA+K N R F E +MK ++++++ S + +++E M G L+
Sbjct: 52 RVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLK 111
Query: 61 KYLY---------SSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDD 111
YL + + + + ++A + YL + +H DL N ++ +
Sbjct: 112 SYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAE 168
Query: 112 NLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMET 171
+ + DFG+ + + D + L + +M+PE ++G +T DV+SFG++L E
Sbjct: 169 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 228
Query: 172 FTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAM 231
T + Y+ + E L+ + L + C +F L
Sbjct: 229 ATLAEQPYQGLSNEQVLRFVMEGGLLD-------------------KPDNCPDMLFELMR 269
Query: 232 ACTVESPEQRINAKEIVTKLLKIRDSLLRNV 262
C +P+ R + EI++ + + + R V
Sbjct: 270 MCWQYNPKMRPSFLEIISSIKEEMEPGFREV 300
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 4e-42
Identities = 63/279 (22%), Positives = 114/279 (40%), Gaps = 42/279 (15%)
Query: 1 MEVAVKVFNLQCGR-AFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGS 58
M+ A+K + + F E E++ + H N+I ++ +C + + L +EY PHG+
Sbjct: 38 MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGN 97
Query: 59 LEKYLYSSNCI---------------LDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLK 103
L +L S + L Q L+ DVA ++YL IH DL
Sbjct: 98 LLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLA 154
Query: 104 PDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYS 163
N+L+ +N VA ++DFG+++ G++ + +T + +MA E +TN DV+S
Sbjct: 155 ARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWS 211
Query: 164 FGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCV 223
+G++L E + Y + + C
Sbjct: 212 YGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL-------------------EKPLNCD 252
Query: 224 SFVFNLAMACTVESPEQRINAKEIVTKLLKIRDSLLRNV 262
V++L C E P +R + +I+ L ++ + V
Sbjct: 253 DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV 291
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 144 bits (365), Expect = 7e-42
Identities = 45/248 (18%), Positives = 89/248 (35%), Gaps = 25/248 (10%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 61
K N + E +M + H LI + + ++ L+LE++ G L
Sbjct: 56 VFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFD 115
Query: 62 YLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLD--DNLVAYLSD 119
+ + + + + +N M L+++H ++H D+KP+N++ + + D
Sbjct: 116 RIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIID 172
Query: 120 FGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTY 179
FG+A L + T AT + APE V D+++ G++ +G P
Sbjct: 173 FGLATKL---NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFA 229
Query: 180 EFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239
+ E DW + +S E F+ + P
Sbjct: 230 GEDDLETLQNVKRCDWEFDEDA----FSSVSPEAKDFIKN-------------LLQKEPR 272
Query: 240 QRINAKEI 247
+R+ +
Sbjct: 273 KRLTVHDA 280
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 139 bits (352), Expect = 1e-40
Identities = 63/264 (23%), Positives = 109/264 (41%), Gaps = 30/264 (11%)
Query: 2 EVAVKVFNLQCGR---AFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKA----LVLEYM 54
+VAVKV R + F E + ++ H ++ V + E +V+EY+
Sbjct: 34 DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 93
Query: 55 PHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLV 114
+L +++ + + + ++ D AL + +IH D+KP N+++
Sbjct: 94 DGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFS---HQNGIIHRDVKPANIMISATNA 149
Query: 115 AYLSDFGIAKLLIGEDQSMTQTQTLA-TIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 173
+ DFGIA+ + S+TQT + T Y++PE R V DVYS G +L E T
Sbjct: 150 VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 209
Query: 174 GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMAC 233
G+ P + +H D +P S LS + V K
Sbjct: 210 GEPPFTGDSPVSVAYQHVREDPIPPSA----RHEGLSADLDAVVLK-------------A 252
Query: 234 TVESPEQRI-NAKEIVTKLLKIRD 256
++PE R A E+ L+++ +
Sbjct: 253 LAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 4e-40
Identities = 51/257 (19%), Positives = 96/257 (37%), Gaps = 25/257 (9%)
Query: 1 MEVAVKVFNLQCGRAFKS-FDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
+ VA+K + + F E M+ H +++K+I + E +++E G L
Sbjct: 36 LAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGEL 94
Query: 60 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSD 119
+L LD+ + +++AL YL S +H D+ NVL+ N L D
Sbjct: 95 RSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGD 151
Query: 120 FGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTY 179
FG+++ + + ++ I +MAPE R ++ DV+ FG+ + E +
Sbjct: 152 FGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 210
Query: 180 EFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239
+ + N C +++L C P
Sbjct: 211 QGVKNNDVIGRIENGERLP-------------------MPPNCPPTLYSLMTKCWAYDPS 251
Query: 240 QRINAKEIVTKLLKIRD 256
+R E+ +L I +
Sbjct: 252 RRPRFTELKAQLSTILE 268
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 2e-39
Identities = 66/271 (24%), Positives = 109/271 (40%), Gaps = 39/271 (14%)
Query: 1 MEVAVKVFNLQCG-RAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGS 58
+VAVK+ + E EMMK I +H+N+I ++ +C+ + +++EY G+
Sbjct: 46 TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 105
Query: 59 LEKYL---------------YSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLK 103
L +YL ++ L ++ VA +EYL S IH DL
Sbjct: 106 LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLA 162
Query: 104 PDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYS 163
NVL+ ++ V ++DFG+A+ + D T + +MAPE + + DV+S
Sbjct: 163 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 222
Query: 164 FGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCV 223
FG++L E FT Y E K C
Sbjct: 223 FGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRM-------------------DKPSNCT 263
Query: 224 SFVFNLAMACTVESPEQRINAKEIVTKLLKI 254
+ ++ + C P QR K++V L +I
Sbjct: 264 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 4e-39
Identities = 52/277 (18%), Positives = 112/277 (40%), Gaps = 32/277 (11%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 61
K ++ G E ++ RHRN++ + S + E ++ E++ + +
Sbjct: 32 TYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFE 90
Query: 62 YLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLD--DNLVAYLSD 119
+ +S L+ + ++ + V AL++LH S + H D++P+N++ + + +
Sbjct: 91 RINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIE 147
Query: 120 FGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTY 179
FG A+ L D Y APE + VST D++S G ++ +G P +
Sbjct: 148 FGQARQLKPGDNFRLLFT---APEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP-F 203
Query: 180 EFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239
+ +++ +N + +S E + FV + V+ +
Sbjct: 204 LAETNQQIIENIMNAEYTFDEEAFKE---ISIEAMDFVDR-------------LLVKERK 247
Query: 240 QRINAKEIVT------KLLKIRDSLLRNVGGRRIRQS 270
R+ A E + K+ ++ ++R + RR +
Sbjct: 248 SRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHT 284
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (326), Expect = 1e-36
Identities = 54/274 (19%), Positives = 99/274 (36%), Gaps = 39/274 (14%)
Query: 2 EVAVKVFNLQCGRA-FKSFDVECEMMKSIRHRNLIKVISSCSNEEFKAL--VLEYMPHGS 58
VAVK+ + ++ E +++ I H + + + L ++E+ G+
Sbjct: 45 TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 104
Query: 59 LEKYLYSSNC---------------ILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLK 103
L YL S L + + VA +E+L S IH DL
Sbjct: 105 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLA 161
Query: 104 PDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYS 163
N+LL + V + DFG+A+ + + + + + +MAPE + + DV+S
Sbjct: 162 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 221
Query: 164 FGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCV 223
FG++L E F+ Y + + +E A +
Sbjct: 222 FGVLLWEIFSLGASPYPGVKIDEEFCRRL------------------KEGTRMRAPDYTT 263
Query: 224 SFVFNLAMACTVESPEQRINAKEIVTKLLKIRDS 257
++ + C P QR E+V L + +
Sbjct: 264 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 127 bits (321), Expect = 9e-36
Identities = 43/247 (17%), Positives = 87/247 (35%), Gaps = 22/247 (8%)
Query: 2 EVAVKVFNLQCGRAF-KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 60
VA+K + S + E ++ I+H N++ + + L+++ + G L
Sbjct: 36 LVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELF 95
Query: 61 KYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDF 120
+ ++ V A++YLH LD++ +SDF
Sbjct: 96 DRIVEKGF-YTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDF 154
Query: 121 GIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYE 180
G++K+ ED + T GY+APE + S D +S G++ G P
Sbjct: 155 GLSKM---EDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP--- 208
Query: 181 FFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQ 240
F E + ++ + L ++ + + + + PE+
Sbjct: 209 -FYDE-------------NDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEK 254
Query: 241 RINAKEI 247
R ++
Sbjct: 255 RFTCEQA 261
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 124 bits (313), Expect = 7e-35
Identities = 59/262 (22%), Positives = 103/262 (39%), Gaps = 40/262 (15%)
Query: 2 EVAVKVFNLQCGRAFKSFDV---------ECEMMKSIR-HRNLIKVISSCSNEEFKALVL 51
E AVK+ ++ G +F + +V E ++++ + H N+I++ + F LV
Sbjct: 30 EYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVF 89
Query: 52 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDD 111
+ M G L YL + L + IM + + LH ++H DLKP+N+LLDD
Sbjct: 90 DLMKKGELFDYL-TEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDD 145
Query: 112 NLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG------DVYSFG 165
++ L+DFG + L D + T Y+APE + D++S G
Sbjct: 146 DMNIKLTDFGFSCQL---DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTG 202
Query: 166 IMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSF 225
+++ G P F M ++ + +
Sbjct: 203 VIMYTLLAGSPP----FWHR-------------KQMLMLRMIMSGNYQFGSPEWDDYSDT 245
Query: 226 VFNLAMACTVESPEQRINAKEI 247
V +L V P++R A+E
Sbjct: 246 VKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 6e-34
Identities = 52/251 (20%), Positives = 96/251 (38%), Gaps = 31/251 (12%)
Query: 2 EVAVKVFN---LQCGRAFKSFDVECE-MMKSIRHRNLIKVISSCSNEEFKALVLEYMPHG 57
A+K + + VE + + H L + + +E V+EY+ G
Sbjct: 29 FFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGG 88
Query: 58 SLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYL 117
L ++ S + D+ + ++ L++L S +++ DLK DN+LLD + +
Sbjct: 89 DLMYHIQSCHK-FDLSRATFYAAEIILGLQFL---HSKGIVYRDLKLDNILLDKDGHIKI 144
Query: 118 SDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKP 177
+DFG+ K + D T Y+APE + + + D +SFG++L E G+ P
Sbjct: 145 ADFGMCKENMLGDAKTNTFC--GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 202
Query: 178 TYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237
+ + E D L +E + K V
Sbjct: 203 -FHGQDEEELFHSIRMDNPFYP-------RWLEKEAKDLLVK-------------LFVRE 241
Query: 238 PEQRINAKEIV 248
PE+R+ + +
Sbjct: 242 PEKRLGVRGDI 252
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 2e-33
Identities = 46/254 (18%), Positives = 97/254 (38%), Gaps = 31/254 (12%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSC----SNEEFKALVLEYMPHG 57
+ A+K+ C +A + ++ ++ + ++++++ + + +V+E + G
Sbjct: 39 KFALKMLQ-DCPKARREVEL---HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGG 94
Query: 58 SLEKYLYS-SNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLD---DNL 113
L + + + IM + A++YLH S + H D+KP+N+L N
Sbjct: 95 ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNA 151
Query: 114 VAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 173
+ L+DFG AK + T T Y+APE + + D++S G+++
Sbjct: 152 ILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 208
Query: 174 GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMAC 233
G P Y ++ + + + +S+E +
Sbjct: 209 GYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN-------------L 255
Query: 234 TVESPEQRINAKEI 247
P QR+ E
Sbjct: 256 LKTEPTQRMTITEF 269
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 118 bits (297), Expect = 3e-32
Identities = 55/255 (21%), Positives = 103/255 (40%), Gaps = 33/255 (12%)
Query: 2 EVAVKVFN---LQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGS 58
A+KV + + + + E M+ + H +I++ + + + ++++Y+ G
Sbjct: 31 YYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIE-GG 89
Query: 59 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLS 118
L + +V ALEYLH S +I+ DLKP+N+LLD N ++
Sbjct: 90 ELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKIT 146
Query: 119 DFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPT 178
DFG AK + ++ T Y+APE + + D +SFGI++ E G P
Sbjct: 147 DFGFAKYVPDVTYTLCG-----TPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP- 200
Query: 179 YEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238
F T+K + I E+ +++ +++
Sbjct: 201 ---FYDSNTMKTYEK----ILNAELRFPPFFNEDVKDLLSR-------------LITRDL 240
Query: 239 EQRINAKEIVTKLLK 253
QR+ + T+ +K
Sbjct: 241 SQRLGNLQNGTEDVK 255
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 116 bits (290), Expect = 2e-31
Identities = 49/261 (18%), Positives = 84/261 (32%), Gaps = 26/261 (9%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 61
EVA+K+ ++ +E ++ K ++ I I C E +++ + SLE
Sbjct: 34 EVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLED 91
Query: 62 YLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVL---LDDNLVAYLS 118
+ + L + + S +EY+H S IH D+KPDN L + Y+
Sbjct: 92 LFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYII 148
Query: 119 DFGIAKLLIGED-----QSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 173
DFG+AK T Y + S D+ S G +LM
Sbjct: 149 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNL 208
Query: 174 GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMAC 233
G P K+ +ST V E ++ C
Sbjct: 209 GSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNF-------------C 255
Query: 234 TVESPEQRINAKEIVTKLLKI 254
+ + + + +
Sbjct: 256 RSLRFDDKPDYSYLRQLFRNL 276
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 2e-31
Identities = 49/256 (19%), Positives = 96/256 (37%), Gaps = 34/256 (13%)
Query: 2 EVAVKVFNL------QCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMP 55
+ A K + G + + + E ++K I+H N+I + N+ L+LE +
Sbjct: 37 QYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVA 96
Query: 56 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDN--- 112
G L + + L + + + + + YLH S + H DLKP+N++L D
Sbjct: 97 GGELFDF-LAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVP 152
Query: 113 -LVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMET 171
+ DFG+A + D T ++APE + D++S G++
Sbjct: 153 KPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 209
Query: 172 FTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAM 231
+G P + + TL + + S F+ +
Sbjct: 210 LSGASP-FLGDTKQETLANVSAVNYEFEDEYFSN---TSALAKDFIRR------------ 253
Query: 232 ACTVESPEQRINAKEI 247
V+ P++R+ ++
Sbjct: 254 -LLVKDPKKRMTIQDS 268
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 4e-31
Identities = 55/260 (21%), Positives = 100/260 (38%), Gaps = 21/260 (8%)
Query: 2 EVAVKVFNLQC-----GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPH 56
VA+K L ++ E ++++ + H N+I ++ + ++ +LV ++M
Sbjct: 25 IVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET 84
Query: 57 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAY 116
+ ++ +L M+ LEYLH ++H DLKP+N+LLD+N V
Sbjct: 85 DLE-VIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLK 140
Query: 117 LSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRV-STNGDVYSFGIMLMETFTGK 175
L+DFG+AK + T + T Y APE R+ D+++ G +L E
Sbjct: 141 LADFGLAKSF--GSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 198
Query: 176 KPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVF-------- 227
+ L + + D L + +F
Sbjct: 199 PF-LPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLL 257
Query: 228 NLAMACTVESPEQRINAKEI 247
+L + +P RI A +
Sbjct: 258 DLIQGLFLFNPCARITATQA 277
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 4e-31
Identities = 52/261 (19%), Positives = 98/261 (37%), Gaps = 18/261 (6%)
Query: 2 EVAVKVFNLQCGRAF-KSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLE 60
VA+K + + + + E +++ RH N+I + + + Y+ +
Sbjct: 35 RVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMG 94
Query: 61 KYLYS--SNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLS 118
LY L + + L+Y+H SA V+H DLKP N+LL+ +
Sbjct: 95 ADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKIC 151
Query: 119 DFGIAKLLI-GEDQSMTQTQTLATIGYMAPEYGREGRVSTN-GDVYSFGIMLMETFTGKK 176
DFG+A++ D + T+ +AT Y APE + T D++S G +L E + +
Sbjct: 152 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 211
Query: 177 PTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSF----------V 226
+ P NL ++ + + + V +
Sbjct: 212 IFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 271
Query: 227 FNLAMACTVESPEQRINAKEI 247
+L +P +RI ++
Sbjct: 272 LDLLDKMLTFNPHKRIEVEQA 292
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 5e-31
Identities = 55/263 (20%), Positives = 102/263 (38%), Gaps = 24/263 (9%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECE-----MMKSIRHRNLIKVISSCSNEEFKA-----LVL 51
VA+K +Q G E +++ H N++++ C+ LV
Sbjct: 35 FVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVF 94
Query: 52 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDD 111
E++ + ++M + L++LH S V+H DLKP N+L+
Sbjct: 95 EHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTS 151
Query: 112 NLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMET 171
+ L+DFG+A++ M T + T+ Y APE + +T D++S G + E
Sbjct: 152 SGQIKLADFGLARIY---SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 208
Query: 172 FTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFV----- 226
F K + + L ++ + L ++ H + + FV
Sbjct: 209 FRRKPL-FRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDE 267
Query: 227 --FNLAMACTVESPEQRINAKEI 247
+L + C +P +RI+A
Sbjct: 268 LGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 114 bits (286), Expect = 7e-31
Identities = 48/256 (18%), Positives = 99/256 (38%), Gaps = 15/256 (5%)
Query: 2 EVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
A+K L+ + E ++K ++H N++K+ ++ LV E++ L
Sbjct: 28 TFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL-DQDL 86
Query: 60 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSD 119
+K L L+ + ++ + + + Y H V+H DLKP N+L++ ++D
Sbjct: 87 KKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIAD 143
Query: 120 FGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTY 179
FG+A+ G + + + ST D++S G + E G
Sbjct: 144 FGLARAF-GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFP 202
Query: 180 EFFNGEMTLKHW-------VNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVF-NLAM 231
+ ++ + +W ++ + D N E + + + + + +L
Sbjct: 203 GVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLS 262
Query: 232 ACTVESPEQRINAKEI 247
P QRI AK+
Sbjct: 263 KMLKLDPNQRITAKQA 278
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 2e-30
Identities = 52/257 (20%), Positives = 95/257 (36%), Gaps = 16/257 (6%)
Query: 2 EVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
VA+K L + E ++K + H N++K++ E LV E++
Sbjct: 29 VVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLK 88
Query: 60 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSD 119
+ S+ + + + + + L + S V+H DLKP N+L++ L+D
Sbjct: 89 KFMDASALTGIPLPLIKSYLFQLLQGLAFC---HSHRVLHRDLKPQNLLINTEGAIKLAD 145
Query: 120 FGIAKLLIGEDQSMTQTQTLATIGYMAPE-YGREGRVSTNGDVYSFGIMLMETFTGKKPT 178
FG+A+ ++ T T+ Y APE ST D++S G + E T +
Sbjct: 146 FGLARAFGVPVRTYTHEVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 203
Query: 179 YEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVF--------NLA 230
+ + + P + ++ + Q S V +L
Sbjct: 204 PGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLL 263
Query: 231 MACTVESPEQRINAKEI 247
P +RI+AK
Sbjct: 264 SQMLHYDPNKRISAKAA 280
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 114 bits (287), Expect = 2e-30
Identities = 40/214 (18%), Positives = 83/214 (38%), Gaps = 15/214 (7%)
Query: 2 EVAVKVFNL------QCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMP 55
A+K + Q + + ++ + ++ + + + + +L+ M
Sbjct: 31 MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 90
Query: 56 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVA 115
G L +L + ++ LE++H + V++ DLKP N+LLD++
Sbjct: 91 GGDLHYHLSQHGVFSEA-DMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHV 146
Query: 116 YLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGR-VSTNGDVYSFGIMLMETFTG 174
+SD G+A ++ T GYMAPE ++G ++ D +S G ML + G
Sbjct: 147 RISDLGLACDF----SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 202
Query: 175 KKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANL 208
P + + + + + + L
Sbjct: 203 HSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 236
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 1e-29
Identities = 57/265 (21%), Positives = 105/265 (39%), Gaps = 30/265 (11%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSC------SNEEFKALVLEYMP 55
VA+K + + E ++M+ + H N++++ +E + LVL+Y+P
Sbjct: 47 LVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP 102
Query: 56 HGSLE--KYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLD-DN 112
++ + L + M + +L Y+H S + H D+KP N+LLD D
Sbjct: 103 ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDT 159
Query: 113 LVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAP-EYGREGRVSTNGDVYSFGIMLMET 171
V L DFG AK L+ + +++ + + Y AP +++ DV+S G +L E
Sbjct: 160 AVLKLCDFGSAKQLVRGEPNVS---YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAEL 216
Query: 172 FTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVF---- 227
G+ + +G L + + ++ + N E K + VF
Sbjct: 217 LLGQPI-FPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRT 275
Query: 228 -----NLAMACTVESPEQRINAKEI 247
L +P R+ E
Sbjct: 276 PPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 2e-29
Identities = 50/257 (19%), Positives = 84/257 (32%), Gaps = 44/257 (17%)
Query: 1 MEVAVKVFNLQCGRAF------KSFDVECEMMKSIR--HRNLIKVISSCSNEEFKALVLE 52
+ VA+K + +E ++K + +I+++ + L+LE
Sbjct: 30 LPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE 89
Query: 53 YMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLD-D 111
+ L + V A+ + + V+H D+K +N+L+D +
Sbjct: 90 RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC---HNCGVLHRDIKDENILIDLN 146
Query: 112 NLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG-DVYSFGIMLME 170
L DFG LL + T T Y PE+ R R V+S GI+L +
Sbjct: 147 RGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYD 202
Query: 171 TFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLA 230
G P F + I +V +S E H +
Sbjct: 203 MVCGDIP----FEHDE----------EIIRGQVFFRQRVSSECQHLIRW----------- 237
Query: 231 MACTVESPEQRINAKEI 247
C P R +EI
Sbjct: 238 --CLALRPSDRPTFEEI 252
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 1e-28
Identities = 49/258 (18%), Positives = 102/258 (39%), Gaps = 18/258 (6%)
Query: 2 EVAVKVFNLQCG--RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSL 59
VA+K L S E ++K ++H+N++++ +++ LV E+
Sbjct: 29 IVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLK 88
Query: 60 EKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSD 119
+ + + + D + + + L + H V+H DLKP N+L++ N L++
Sbjct: 89 KYFDSCNGDL-DPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLAN 144
Query: 120 FGIAKLLIGEDQSMTQTQTLATIGYMAPE-YGREGRVSTNGDVYSFGIMLMETFTGKKPT 178
FG+A+ + + + T+ Y P+ ST+ D++S G + E +P
Sbjct: 145 FGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
Query: 179 YEFFNGEMTLKHWVN--------DWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVF-NL 229
+ + + LK W ++ + + V ++ +L
Sbjct: 203 FPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDL 262
Query: 230 AMACTVESPEQRINAKEI 247
+P QRI+A+E
Sbjct: 263 LQNLLKCNPVQRISAEEA 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (264), Expect = 3e-27
Identities = 52/248 (20%), Positives = 97/248 (39%), Gaps = 30/248 (12%)
Query: 2 EVAVKVFNLQCGRA---FKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGS 58
A+K+ + A E ++++ RH L + + + V+EY G
Sbjct: 32 YYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 91
Query: 59 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLS 118
L +L S + + ++ SALEYLH S V++ D+K +N++LD + ++
Sbjct: 92 LFFHL-SRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKIT 147
Query: 119 DFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPT 178
DFG+ K I + +M T Y+APE + D + G+++ E G+ P
Sbjct: 148 DFGLCKEGISDGATM--KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP- 204
Query: 179 YEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238
+ + E + + + + LS E +A + P
Sbjct: 205 FYNQDHERLFELILMEEIRFP-------RTLSPEAKSLLAG-------------LLKKDP 244
Query: 239 EQRINAKE 246
+QR+
Sbjct: 245 KQRLGGGP 252
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 104 bits (261), Expect = 3e-27
Identities = 34/269 (12%), Positives = 72/269 (26%), Gaps = 32/269 (11%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEK 61
+VA+K + E K + I + E +++ + SLE
Sbjct: 32 QVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLED 89
Query: 62 YLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLV-----AY 116
L + + + ++ +H +++ D+KPDN L+ Y
Sbjct: 90 LLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIY 146
Query: 117 LSDFGIAKLLIGEDQS-----MTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMET 171
+ DFG+ K + T YM+ S D+ + G + M
Sbjct: 147 VVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYF 206
Query: 172 FTGK--KPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNL 229
G + + + E+ +
Sbjct: 207 LRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA---------------GFPEEFYKY 251
Query: 230 AMACTVESPEQRINAKEIVTKLLKIRDSL 258
+ + + + K+ + L
Sbjct: 252 MHYARNLAFDATPDYDYLQGLFSKVLERL 280
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (256), Expect = 2e-26
Identities = 47/270 (17%), Positives = 97/270 (35%), Gaps = 28/270 (10%)
Query: 2 EVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKA--------LVL 51
+VA+K ++ + E ++++ ++H N++ +I C + LV
Sbjct: 37 KVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVF 96
Query: 52 EYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDD 111
++ H + + +M + L L++ ++H D+K NVL+
Sbjct: 97 DFCEHDLAGLLSNVLVK-FTLSEIKRVMQML---LNGLYYIHRNKILHRDMKAANVLITR 152
Query: 112 NLVAYLSDFGIAKLLIGEDQSMTQTQT--LATIGYMAPEYGREGR-VSTNGDVYSFGIML 168
+ V L+DFG+A+ S T + T+ Y PE R D++ G ++
Sbjct: 153 DGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIM 212
Query: 169 METFTGKKPTY-----------EFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFV 217
E +T G +T + W N ++ ++ +
Sbjct: 213 AEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRL 272
Query: 218 AKEQCVSFVFNLAMACTVESPEQRINAKEI 247
+ +L V P QRI++ +
Sbjct: 273 KAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 101 bits (251), Expect = 2e-25
Identities = 40/200 (20%), Positives = 81/200 (40%), Gaps = 13/200 (6%)
Query: 2 EVAVKVFN---LQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGS 58
A+K+ + + + + E +++++ L+K+ S + +V+EY+ G
Sbjct: 68 HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE 127
Query: 59 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLS 118
+ +L + EYLH S +I+ DLKP+N+L+D ++
Sbjct: 128 MFSHLRRIGR-FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVT 183
Query: 119 DFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPT 178
DFG AK + G ++ T +APE + D ++ G+++ E G P
Sbjct: 184 DFGFAKRVKGRTWTLCG-----TPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP- 237
Query: 179 YEFFNGEMTLKHWVNDWLPI 198
+ + V+ +
Sbjct: 238 FFADQPIQIYEKIVSGKVRF 257
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 2e-25
Identities = 53/250 (21%), Positives = 96/250 (38%), Gaps = 29/250 (11%)
Query: 2 EVAVKVFN----LQCGRAFKSFDVECEMMKSIRHR-NLIKVISSCSNEEFKALVLEYMPH 56
A+KV +Q + + E ++++ IR L+ + + E L+L+Y+
Sbjct: 54 LYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYING 113
Query: 57 GSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAY 116
G L +L F + I V + L +I+ D+K +N+LLD N
Sbjct: 114 GELFTHLSQRER----FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVV 169
Query: 117 LSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG--DVYSFGIMLMETFTG 174
L+DFG++K + ++ TI YMAP+ R G + D +S G+++ E TG
Sbjct: 170 LTDFGLSKEFVADETERAYDFC-GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 228
Query: 175 KKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACT 234
P F + I E +S + +
Sbjct: 229 ASP----FTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQR-------------LL 271
Query: 235 VESPEQRINA 244
++ P++R+
Sbjct: 272 MKDPKKRLGC 281
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.6 bits (242), Expect = 3e-24
Identities = 52/264 (19%), Positives = 99/264 (37%), Gaps = 28/264 (10%)
Query: 2 EVAVKVFN--LQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKA------LVLEY 53
+VA+K Q K E ++K +RH N+I ++ + +E LV+ +
Sbjct: 45 KVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPF 104
Query: 54 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNL 113
M G+ L L + ++ + L Y+H +A +IH DLKP N+ ++++
Sbjct: 105 M--GTDLGKLMKHEK-LGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDC 158
Query: 114 VAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 173
+ DFG+A+ + S + R + D++S G ++ E T
Sbjct: 159 ELKILDFGLAR----QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMIT 214
Query: 174 GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSF-------- 225
GK + + + P + + ++ + + + + F
Sbjct: 215 GKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNAS 274
Query: 226 --VFNLAMACTVESPEQRINAKEI 247
NL V EQR+ A E
Sbjct: 275 PLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 94.5 bits (234), Expect = 4e-23
Identities = 46/268 (17%), Positives = 100/268 (37%), Gaps = 35/268 (13%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIR-HRNLIKVISSCSNEEFK--ALVLEYMPHGS 58
+V VK+ + K E ++++++R N+I + + + ALV E++ +
Sbjct: 62 KVVVKILKPVKKKKIKR---EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD 118
Query: 59 LEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLD-DNLVAYL 117
++ + L + M ++ AL+Y H S ++H D+KP NV++D ++ L
Sbjct: 119 FKQLYQT----LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRL 171
Query: 118 SDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGR-VSTNGDVYSFGIMLMETFTGKK 176
D+G+A+ +A+ + PE + + + D++S G ML K+
Sbjct: 172 IDWGLAEFY---HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 228
Query: 177 PTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLS-----------------QEDIHFVAK 219
P + + L + +D + + +H +
Sbjct: 229 PFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQ 288
Query: 220 EQCVSFVFNLAMACTVESPEQRINAKEI 247
+ + R+ A+E
Sbjct: 289 HLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.9 bits (227), Expect = 4e-22
Identities = 48/262 (18%), Positives = 96/262 (36%), Gaps = 24/262 (9%)
Query: 2 EVAVKVFN--LQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNE----EFKALVLEYMP 55
VAVK + Q K E ++K ++H N+I ++ + EF + L
Sbjct: 45 RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 104
Query: 56 HGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVA 115
G+ + L ++ + L+Y+H SA +IH DLKP N+ ++++
Sbjct: 105 MGADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCEL 160
Query: 116 YLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGK 175
+ DFG+A+ E T + D++S G ++ E TG+
Sbjct: 161 KILDFGLARHTDDEMTGYVAT----RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
Query: 176 KPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSF---------- 225
+ + P + + ++ ++ I + + ++F
Sbjct: 217 TLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPL 276
Query: 226 VFNLAMACTVESPEQRINAKEI 247
+L V ++RI A +
Sbjct: 277 AVDLLEKMLVLDSDKRITAAQA 298
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 89.3 bits (220), Expect = 4e-21
Identities = 47/289 (16%), Positives = 94/289 (32%), Gaps = 46/289 (15%)
Query: 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFK-------------- 47
VA+K+ ++ + E ++++ + + K S +N K
Sbjct: 40 HVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVH 98
Query: 48 -ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDN 106
+V E + L + + + I + L+Y+H C +IH D+KP+N
Sbjct: 99 VVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPEN 156
Query: 107 VLLD-DNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFG 165
VL++ + L IA L T ++ T Y +PE D++S
Sbjct: 157 VLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTA 216
Query: 166 IMLMETFTGKKP---------------------------TYEFFNGEMTLKHWVNDWLPI 198
++ E TG +Y NG+ T + + L
Sbjct: 217 CLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLR 276
Query: 199 STMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEI 247
+ ++ L + + + + P +R +A +
Sbjct: 277 NISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.7 bits (216), Expect = 1e-20
Identities = 53/275 (19%), Positives = 100/275 (36%), Gaps = 39/275 (14%)
Query: 2 EVAVKVFN--LQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFK------ALVLEY 53
VA+K + Q K E +MK + H+N+I +++ + ++ LV+E
Sbjct: 44 NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 103
Query: 54 MPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNL 113
M + D + ++ + +++LH SA +IH DLKP N+++ +
Sbjct: 104 MDANLCQVIQMEL----DHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDC 156
Query: 114 VAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT 173
+ DFG+A+ S T + T Y APE N D++S G ++ E
Sbjct: 157 TLKILDFGLART---AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 213
Query: 174 GKKPTYEFFNGEM---------------------TLKHWVNDWLPISTMEVVDANLLSQE 212
K + T++++V + + + S
Sbjct: 214 HKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLF 273
Query: 213 DIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEI 247
+ S +L V P +RI+ +
Sbjct: 274 PADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 56.3 bits (135), Expect = 2e-10
Identities = 22/183 (12%), Positives = 56/183 (30%), Gaps = 31/183 (16%)
Query: 2 EVAVKVFNL----------QCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEF----K 47
E VK + + F V R L K+ + +
Sbjct: 26 ECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEGN 85
Query: 48 ALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNV 107
A+++E + + + ++ + + + ++H DL NV
Sbjct: 86 AVLMELIDAKE--------LYRVRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNV 134
Query: 108 LLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDVYSFGIM 167
L+ + + ++ DF + + + + + + + R R D+ S
Sbjct: 135 LVSEEGI-WIIDFPQS---VEVGEEGWREILERDVRNIITYFSRTYRTEK--DINSAIDR 188
Query: 168 LME 170
+++
Sbjct: 189 ILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 273 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.77 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.59 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.08 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.53 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.01 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.95 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.97 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-54 Score=349.61 Aligned_cols=239 Identities=26% Similarity=0.382 Sum_probs=190.6
Q ss_pred eEEEEEeecc--cChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 2 EVAVKVFNLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 2 ~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
.||||+++.. +....+.|.+|++++++++||||+++++++.+ ..+++|||||++|+|.+++...+..+++..+..++
T Consensus 32 ~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~ 110 (276)
T d1uwha_ 32 DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 110 (276)
T ss_dssp EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHH
T ss_pred EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHH
Confidence 6999999754 35567889999999999999999999998754 56899999999999999998777779999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCC---CcC
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG---RVS 156 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~ 156 (273)
.|++.||+||| ++|++||||||+|||++.++.+||+|||++................||+.|+|||++.+. .++
T Consensus 111 ~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~ 187 (276)
T d1uwha_ 111 RQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187 (276)
T ss_dssp HHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCC
T ss_pred HHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCC
Confidence 99999999999 999999999999999999999999999999876443333344556789999999998643 478
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++|||||||++|+|++|+.||...................+. ....+..+++++.+|+.+||..
T Consensus 188 ~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~---------------~~~~~~~~~~~l~~li~~cl~~ 252 (276)
T d1uwha_ 188 FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD---------------LSKVRSNCPKAMKRLMAECLKK 252 (276)
T ss_dssp HHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCC---------------GGGSCTTCCHHHHHHHHHHTCS
T ss_pred chhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCc---------------chhccccchHHHHHHHHHHcCC
Confidence 9999999999999999999999764433222221111111111 1112456778899999999999
Q ss_pred CccCCCCHHHHHHHHHHHHHhhh
Q 024027 237 SPEQRINAKEIVTKLLKIRDSLL 259 (273)
Q Consensus 237 dp~~Rps~~~~l~~l~~~~~~~~ 259 (273)
||.+|||+++++++|+.+.+++.
T Consensus 253 dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 253 KRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp SGGGSCCHHHHHHHHHHHHHTCC
T ss_pred CHhHCcCHHHHHHHHHHHHHcCC
Confidence 99999999999999999987754
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-54 Score=348.12 Aligned_cols=229 Identities=23% Similarity=0.314 Sum_probs=187.3
Q ss_pred CeEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 1 MEVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 1 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
+.||||+++... ....+.+.+|+++++.++||||+++++++.+++..++|||||+||+|.+++... ..+++..++.++
T Consensus 31 ~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~i~ 109 (271)
T d1nvra_ 31 EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFF 109 (271)
T ss_dssp CEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTT-TBCCHHHHHHHH
T ss_pred CEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhcC-CCCCHHHHHHHH
Confidence 479999997553 345677999999999999999999999999999999999999999999999654 479999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCc-CCc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRV-STN 158 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~ 158 (273)
.|++.||.||| ++|++||||||+|||++.++.+||+|||++..+............+||+.|+|||++.+..+ +.+
T Consensus 110 ~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~ 186 (271)
T d1nvra_ 110 HQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 186 (271)
T ss_dssp HHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHH
T ss_pred HHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCc
Confidence 99999999999 99999999999999999999999999999987654443334455689999999999988775 678
Q ss_pred chhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc
Q 024027 159 GDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238 (273)
Q Consensus 159 ~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 238 (273)
+||||+||++|+|++|+.||.................. .......++.++.+|+.+||..||
T Consensus 187 ~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~------------------~~~~~~~~s~~~~~li~~~L~~dP 248 (271)
T d1nvra_ 187 VDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT------------------YLNPWKKIDSAPLALLHKILVENP 248 (271)
T ss_dssp HHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT------------------TSTTGGGSCHHHHHHHHHHSCSST
T ss_pred eeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC------------------CCCccccCCHHHHHHHHHHcCCCh
Confidence 99999999999999999999764443322222211110 011134567789999999999999
Q ss_pred cCCCCHHHHHHHH
Q 024027 239 EQRINAKEIVTKL 251 (273)
Q Consensus 239 ~~Rps~~~~l~~l 251 (273)
++|||++++++|=
T Consensus 249 ~~R~t~~eil~hp 261 (271)
T d1nvra_ 249 SARITIPDIKKDR 261 (271)
T ss_dssp TTSCCHHHHTTCT
T ss_pred hHCcCHHHHhcCH
Confidence 9999999998863
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=347.28 Aligned_cols=226 Identities=26% Similarity=0.311 Sum_probs=190.1
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
+.||||+++.......+.+.+|+++++.++||||++++++|.++..+++|||||+||+|.+++.+. .+++..++.++.
T Consensus 46 ~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~~--~l~~~~~~~i~~ 123 (293)
T d1yhwa1 46 QEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCR 123 (293)
T ss_dssp CEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHH
T ss_pred CEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhcc--CCCHHHHHHHHH
Confidence 479999998776666778999999999999999999999999999999999999999999988654 499999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
|++.||.||| ++|++||||||+|||++.++.+||+|||++..+.... ......+||+.|+|||++.+..++.++|
T Consensus 124 qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~D 198 (293)
T d1yhwa1 124 ECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVD 198 (293)
T ss_dssp HHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--CCBCCCCSCGGGCCHHHHSSSCBCTHHH
T ss_pred HHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeecccc--ccccccccCCCccChhhhcCCCCCchhc
Confidence 9999999999 9999999999999999999999999999998763322 2334567999999999999999999999
Q ss_pred hHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccC
Q 024027 161 VYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQ 240 (273)
Q Consensus 161 iwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 240 (273)
|||+||++|+|++|..||........... ..... ......+..++.++.+|+.+||..||.+
T Consensus 199 iwSlGvilyemltG~~Pf~~~~~~~~~~~-~~~~~-----------------~~~~~~~~~~s~~~~~li~~~L~~dP~~ 260 (293)
T d1yhwa1 199 IWSLGIMAIEMIEGEPPYLNENPLRALYL-IATNG-----------------TPELQNPEKLSAIFRDFLNRCLDMDVEK 260 (293)
T ss_dssp HHHHHHHHHHHHHSSCTTTTSCHHHHHHH-HHHHC-----------------SCCCSSGGGSCHHHHHHHHHHTCSSTTT
T ss_pred eehHhHHHHHHhhCCCCCCCCCHHHHHHH-HHhCC-----------------CCCCCCcccCCHHHHHHHHHHccCChhH
Confidence 99999999999999999975332221111 11100 0011124567788999999999999999
Q ss_pred CCCHHHHHHHH
Q 024027 241 RINAKEIVTKL 251 (273)
Q Consensus 241 Rps~~~~l~~l 251 (273)
|||++|+++|=
T Consensus 261 R~s~~eil~Hp 271 (293)
T d1yhwa1 261 RGSAKELLQHQ 271 (293)
T ss_dssp SCCHHHHTTCG
T ss_pred CcCHHHHhcCH
Confidence 99999999873
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-53 Score=347.61 Aligned_cols=227 Identities=21% Similarity=0.273 Sum_probs=189.2
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
+.||||+++..+....+.+.+|+++|+.++||||+++++++.+++.+++|||||++|+|.+++.+....+++..+..++.
T Consensus 38 ~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~ 117 (288)
T d2jfla1 38 VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCK 117 (288)
T ss_dssp CEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHH
T ss_pred eEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHH
Confidence 36999999877777788999999999999999999999999999999999999999999999876666799999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccC-----CCCc
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR-----EGRV 155 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~ 155 (273)
|++.||.||| ++||+||||||+|||++.++.+||+|||++....... .......||+.|+|||++. +..+
T Consensus 118 qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~y 192 (288)
T d2jfla1 118 QTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPY 192 (288)
T ss_dssp HHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--HHHTCCCSCCTTCCHHHHTTCSTTTSST
T ss_pred HHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCCc--ccccccccccccCCHHHHhhcccCCCCC
Confidence 9999999999 9999999999999999999999999999987542211 1223457999999999874 3457
Q ss_pred CCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCC
Q 024027 156 STNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTV 235 (273)
Q Consensus 156 ~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 235 (273)
+.++|||||||++|+|++|..||......+.. ........ .....+..++.++.+||.+||+
T Consensus 193 ~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~-~~i~~~~~-----------------~~~~~~~~~s~~~~~li~~~L~ 254 (288)
T d2jfla1 193 DYKADVWSLGITLIEMAEIEPPHHELNPMRVL-LKIAKSEP-----------------PTLAQPSRWSSNFKDFLKKCLE 254 (288)
T ss_dssp TTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH-HHHHHSCC-----------------CCCSSGGGSCHHHHHHHHHHSC
T ss_pred ChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHH-HHHHcCCC-----------------CCCCccccCCHHHHHHHHHHcc
Confidence 89999999999999999999999764433221 11111100 0111245677889999999999
Q ss_pred CCccCCCCHHHHHHH
Q 024027 236 ESPEQRINAKEIVTK 250 (273)
Q Consensus 236 ~dp~~Rps~~~~l~~ 250 (273)
.||++|||++|+++|
T Consensus 255 ~dp~~R~t~~ell~h 269 (288)
T d2jfla1 255 KNVDARWTTSQLLQH 269 (288)
T ss_dssp SSTTTSCCHHHHTTS
T ss_pred CChhHCcCHHHHhcC
Confidence 999999999999986
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-53 Score=341.93 Aligned_cols=223 Identities=25% Similarity=0.318 Sum_probs=187.1
Q ss_pred CeEEEEEeecc---cChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||||+++.. .......+.+|+++++.++||||+++++++.+++..++|||||++|+|.+++...+ .+++..++.
T Consensus 32 ~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~~-~l~e~~~~~ 110 (263)
T d2j4za1 32 FILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTAT 110 (263)
T ss_dssp CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHH
T ss_pred cEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhcC-CCCHHHHHH
Confidence 47999999743 23456778999999999999999999999999999999999999999999997544 699999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
++.|++.||.||| ++|++||||||+||+++.++.+||+|||++..... .......||+.|+|||++.+..++.
T Consensus 111 i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~----~~~~~~~Gt~~Y~APE~~~~~~~~~ 183 (263)
T d2j4za1 111 YITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS----SRRTTLCGTLDYLPPEMIEGRMHDE 183 (263)
T ss_dssp HHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC----CCCEETTEEGGGCCHHHHTTCCCCT
T ss_pred HHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCC----CcccccCCCCcccCHHHHcCCCCCc
Confidence 9999999999999 99999999999999999999999999999976522 2234567999999999999999999
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
++|||||||++|+|++|+.||......+ ........ ....+..+++++.+|+.+||+.|
T Consensus 184 ~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~~--------------------~~~~p~~~s~~~~~li~~~L~~d 242 (263)
T d2j4za1 184 KVDLWSLGVLCYEFLVGKPPFEANTYQE-TYKRISRV--------------------EFTFPDFVTEGARDLISRLLKHN 242 (263)
T ss_dssp THHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTT--------------------CCCCCTTSCHHHHHHHHHHTCSS
T ss_pred hhhhhhHhHHHHHHhcCCCCCCCCCHHH-HHHHHHcC--------------------CCCCCccCCHHHHHHHHHHccCC
Confidence 9999999999999999999996532221 11111110 01113457788999999999999
Q ss_pred ccCCCCHHHHHHHHH
Q 024027 238 PEQRINAKEIVTKLL 252 (273)
Q Consensus 238 p~~Rps~~~~l~~l~ 252 (273)
|++|||++++++|=+
T Consensus 243 p~~R~t~~eil~hp~ 257 (263)
T d2j4za1 243 PSQRPMLREVLEHPW 257 (263)
T ss_dssp GGGSCCHHHHHTCHH
T ss_pred HhHCcCHHHHHcCcC
Confidence 999999999998743
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-53 Score=339.78 Aligned_cols=231 Identities=27% Similarity=0.453 Sum_probs=182.4
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~q 81 (273)
.||||+++.+ ....++|.+|+++++.++||||++++|+|.+++..++||||+++|+|.+++......+++..++.++.|
T Consensus 31 ~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~q 109 (263)
T d1sm2a_ 31 KVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 109 (263)
T ss_dssp EEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHH
T ss_pred EEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHH
Confidence 6999999755 344578999999999999999999999999999999999999999999999877778999999999999
Q ss_pred HHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcchh
Q 024027 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 161 (273)
Q Consensus 82 l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di 161 (273)
++.||.||| +.+++||||||+||+++.++.+||+|||++........ .......||+.|+|||++.+..++.++||
T Consensus 110 ia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DV 185 (263)
T d1sm2a_ 110 VCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDV 185 (263)
T ss_dssp HHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC-------------------CTTSCCHHHHTTCCCCHHHHH
T ss_pred HHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCc-eeecceecCcccCChHHhcCCCCCchhhh
Confidence 999999999 99999999999999999999999999999986633222 22234568999999999999999999999
Q ss_pred HHHHHHHHHHHhC-CCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccC
Q 024027 162 YSFGIMLMETFTG-KKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQ 240 (273)
Q Consensus 162 wslG~~l~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 240 (273)
|||||++|||+++ .+||... ............ .....+..++.++.+|+.+||..||++
T Consensus 186 wS~Gvil~el~t~~~~~~~~~-~~~~~~~~i~~~-------------------~~~~~p~~~~~~l~~li~~cl~~~p~~ 245 (263)
T d1sm2a_ 186 WSFGVLMWEVFSEGKIPYENR-SNSEVVEDISTG-------------------FRLYKPRLASTHVYQIMNHCWKERPED 245 (263)
T ss_dssp HHHHHHHHHHHTTSCCTTCSC-CHHHHHHHHHHT-------------------CCCCCCTTSCHHHHHHHHHHTCSSGGG
T ss_pred cchHHHHHHHHHCCCCCCCCC-CHHHHHHHHHhc-------------------CCCCCccccCHHHHHHHHHHccCCHhH
Confidence 9999999999995 5554432 221111111111 011114456778999999999999999
Q ss_pred CCCHHHHHHHHHHHHHh
Q 024027 241 RINAKEIVTKLLKIRDS 257 (273)
Q Consensus 241 Rps~~~~l~~l~~~~~~ 257 (273)
|||+++++++|+++.++
T Consensus 246 Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 246 RPAFSRLLRQLAEIAES 262 (263)
T ss_dssp SCCHHHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHHHhC
Confidence 99999999999998764
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-53 Score=346.34 Aligned_cols=244 Identities=22% Similarity=0.313 Sum_probs=195.3
Q ss_pred CeEEEEEeecc---cChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||||+++.. +....+.+.+|+++++.++||||++++++|.++..+++|||||+||+|.+++...+ .+++..++.
T Consensus 34 ~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~-~l~e~~~~~ 112 (288)
T d1uu3a_ 34 REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRF 112 (288)
T ss_dssp CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS-SCCHHHHHH
T ss_pred CEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhccC-CCCHHHHHH
Confidence 47999999754 23455779999999999999999999999999999999999999999999986554 699999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
++.|++.||.||| +.|++||||||+||+++.++.+||+|||++..+............+||+.|+|||++.+..++.
T Consensus 113 ~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~ 189 (288)
T d1uu3a_ 113 YTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK 189 (288)
T ss_dssp HHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCH
T ss_pred HHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCc
Confidence 9999999999999 9999999999999999999999999999998765444433444567999999999999999999
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
++||||+||++|+|++|..||....... ........ . ...+..++.++.+||.+||+.|
T Consensus 190 ~~DiwSlGvilyell~g~~Pf~~~~~~~-~~~~i~~~----------------~----~~~p~~~s~~~~~li~~~L~~d 248 (288)
T d1uu3a_ 190 SSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKIIKL----------------E----YDFPEKFFPKARDLVEKLLVLD 248 (288)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHTT----------------C----CCCCTTCCHHHHHHHHTTSCSS
T ss_pred ccceehhhHHHHHHhhCCCCCCCcCHHH-HHHHHHcC----------------C----CCCCccCCHHHHHHHHHHccCC
Confidence 9999999999999999999997632221 11111110 0 0113456778999999999999
Q ss_pred ccCCCCHHHHHHHHHHHHHhhhhhcccccccc
Q 024027 238 PEQRINAKEIVTKLLKIRDSLLRNVGGRRIRQ 269 (273)
Q Consensus 238 p~~Rps~~~~l~~l~~~~~~~~~~~~~~~~~~ 269 (273)
|++|||++|++++-+-..-.+..++++...++
T Consensus 249 P~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~ 280 (288)
T d1uu3a_ 249 ATKRLGCEEMEGYGPLKAHPFFESVTWENLHQ 280 (288)
T ss_dssp GGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGG
T ss_pred HhHCcCHHHHcCCHHHHcCCccCCCCHHHhhc
Confidence 99999999998876532224667777666554
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=341.86 Aligned_cols=240 Identities=23% Similarity=0.373 Sum_probs=198.7
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
+||||+++... ....+.|.+|+++|++++||||++++|++.++ .+++||||+++|+|.+++...+..+++..++.++.
T Consensus 38 ~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~ 116 (285)
T d1u59a_ 38 DVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLH 116 (285)
T ss_dssp EEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHH
T ss_pred EEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHH
Confidence 69999997553 44577899999999999999999999999764 57899999999999999877777799999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCc-ceeecccccCCCCCCcccCCCCcCCcc
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQS-MTQTQTLATIGYMAPEYGREGRVSTNG 159 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~ 159 (273)
|++.||.||| ++|++||||||+||+++.++.+||+|||++..+...... .......||+.|+|||++.+..++.++
T Consensus 117 qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ks 193 (285)
T d1u59a_ 117 QVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRS 193 (285)
T ss_dssp HHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHH
T ss_pred HHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccc
Confidence 9999999999 999999999999999999999999999999876443322 122344678899999999888999999
Q ss_pred hhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc
Q 024027 160 DVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238 (273)
Q Consensus 160 DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 238 (273)
|||||||++|||++ |..||......+. ....... .....+..++.++.+|+.+||..||
T Consensus 194 DVwS~Gv~l~E~lt~G~~Pf~~~~~~~~-~~~i~~~-------------------~~~~~p~~~~~~l~~li~~cl~~~p 253 (285)
T d1u59a_ 194 DVWSYGVTMWEALSYGQKPYKKMKGPEV-MAFIEQG-------------------KRMECPPECPPELYALMSDCWIYKW 253 (285)
T ss_dssp HHHHHHHHHHHHHTTSCCTTTTCCTHHH-HHHHHTT-------------------CCCCCCTTCCHHHHHHHHHTTCSSG
T ss_pred hhhcchHHHHHHHhCCCCCCCCCCHHHH-HHHHHcC-------------------CCCCCCCcCCHHHHHHHHHHcCCCH
Confidence 99999999999998 9999976433221 1111100 0112245678889999999999999
Q ss_pred cCCCCHHHHHHHHHHHHHhhhhhcccc
Q 024027 239 EQRINAKEIVTKLLKIRDSLLRNVGGR 265 (273)
Q Consensus 239 ~~Rps~~~~l~~l~~~~~~~~~~~~~~ 265 (273)
++|||+.++++.|+....++.....+.
T Consensus 254 ~~RPs~~~i~~~L~~~~~~~~~~~~~~ 280 (285)
T d1u59a_ 254 EDRPDFLTVEQRMRACYYSLASKVEGH 280 (285)
T ss_dssp GGSCCHHHHHHHHHHHHHHHHTTCSSC
T ss_pred hHCcCHHHHHHHHHHHHHHhhhccchh
Confidence 999999999999999888877666554
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-52 Score=343.87 Aligned_cols=233 Identities=24% Similarity=0.436 Sum_probs=184.0
Q ss_pred eEEEEEeecc-cChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
.||||++... +....+.|.+|+++|++++||||++++|++.+++.+++|||||++|+|.+++......+++..+..++.
T Consensus 56 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~ 135 (299)
T d1jpaa_ 56 FVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLR 135 (299)
T ss_dssp EEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHH
T ss_pred EEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHH
Confidence 4899998754 344567899999999999999999999999999999999999999999999987777899999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcce---eecccccCCCCCCcccCCCCcCC
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMT---QTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
|++.||.||| +.|++||||||+|||++.++.+||+|||++..+........ .....+|+.|+|||.+.+..++.
T Consensus 136 qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 212 (299)
T d1jpaa_ 136 GIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTS 212 (299)
T ss_dssp HHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCH
T ss_pred HHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCc
Confidence 9999999999 99999999999999999999999999999987643322211 12235788999999999889999
Q ss_pred cchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 158 NGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
++|||||||++|||++ |..||......+. ....... .....+..++.++.+|+.+||..
T Consensus 213 ~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~-~~~i~~~-------------------~~~~~~~~~~~~l~~li~~cl~~ 272 (299)
T d1jpaa_ 213 ASDVWSYGIVMWEVMSYGERPYWDMTNQDV-INAIEQD-------------------YRLPPPMDCPSALHQLMLDCWQK 272 (299)
T ss_dssp HHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-HHHHHTT-------------------CCCCCCTTCCHHHHHHHHHHTCS
T ss_pred ccccccchHHHHHHHhCCCCCCCCCCHHHH-HHHHHcC-------------------CCCCCCccchHHHHHHHHHHcCC
Confidence 9999999999999998 8999876433211 1111000 01112456778899999999999
Q ss_pred CccCCCCHHHHHHHHHHHHHh
Q 024027 237 SPEQRINAKEIVTKLLKIRDS 257 (273)
Q Consensus 237 dp~~Rps~~~~l~~l~~~~~~ 257 (273)
||.+|||+.++++.|+++.++
T Consensus 273 ~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 273 DRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp STTTSCCHHHHHHHHHHHHHS
T ss_pred CHhHCcCHHHHHHHHHHHhcC
Confidence 999999999999999988764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=332.71 Aligned_cols=223 Identities=24% Similarity=0.366 Sum_probs=181.2
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeec----CCceeEEEeccCCCCHHHhhhcCCCCCCHHH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSN----EEFKALVLEYMPHGSLEKYLYSSNCILDIFQ 74 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (273)
+.||+|+++... ....+.+.+|+++|++++||||++++++|.+ +..+++||||+++|+|.+++.+.. .+++..
T Consensus 35 ~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~-~~~~~~ 113 (270)
T d1t4ha_ 35 VEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKV 113 (270)
T ss_dssp CEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHS-SCCHHH
T ss_pred eEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhccc-cccHHH
Confidence 479999997552 3456779999999999999999999999865 456899999999999999996543 699999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCC--eEeccCCCCceeeC-CCCceEEeecccccccccCCCcceeecccccCCCCCCcccC
Q 024027 75 RLNIMIDVASALEYLHFGCSAP--VIHCDLKPDNVLLD-DNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR 151 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~~--i~h~di~p~nil~~-~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 151 (273)
++.++.|++.||.||| +++ ++||||||+|||++ .++.+||+|||++..... ......+||+.|+|||++.
T Consensus 114 ~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~----~~~~~~~GT~~Y~aPE~~~ 186 (270)
T d1t4ha_ 114 LRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGTPEFMAPEMYE 186 (270)
T ss_dssp HHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT----TSBEESCSSCCCCCGGGGG
T ss_pred HHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC----CccCCcccCccccCHHHhC
Confidence 9999999999999999 888 99999999999996 578999999999975422 2234567999999999986
Q ss_pred CCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHh
Q 024027 152 EGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAM 231 (273)
Q Consensus 152 ~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 231 (273)
+ .++.++|||||||++|+|++|+.||.................. ....+..+++++.+|+.
T Consensus 187 ~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~------------------~~~~~~~~~~~~~~li~ 247 (270)
T d1t4ha_ 187 E-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK------------------PASFDKVAIPEVKEIIE 247 (270)
T ss_dssp T-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC------------------CGGGGGCCCHHHHHHHH
T ss_pred C-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCC------------------CcccCccCCHHHHHHHH
Confidence 5 5999999999999999999999999754333222222111110 01113445677999999
Q ss_pred hcCCCCccCCCCHHHHHHH
Q 024027 232 ACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 232 ~~l~~dp~~Rps~~~~l~~ 250 (273)
+||..||++|||++|+++|
T Consensus 248 ~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 248 GCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp HHSCSSGGGSCCHHHHHTS
T ss_pred HHccCCHhHCcCHHHHhCC
Confidence 9999999999999999986
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.6e-52 Score=346.14 Aligned_cols=227 Identities=19% Similarity=0.228 Sum_probs=190.1
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
+.||||+++.......+.+.+|+++|+.++||||+++++++.+++.+++|||||+||+|.+++......+++..++.++.
T Consensus 52 ~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~ 131 (350)
T d1koaa2 52 NNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR 131 (350)
T ss_dssp EEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHH
T ss_pred CEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHH
Confidence 37999999876666678899999999999999999999999999999999999999999999976666799999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeC--CCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCc
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLD--DNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTN 158 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~--~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 158 (273)
||+.||.||| ++|++||||||+|||++ .++.+||+|||++..+... .......||+.|+|||++.+..++.+
T Consensus 132 qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~---~~~~~~~gT~~Y~aPEv~~~~~~~~~ 205 (350)
T d1koaa2 132 QVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK---QSVKVTTGTAEFAAPEVAEGKPVGYY 205 (350)
T ss_dssp HHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT---SCEEEECSCTTTCCHHHHHTCCBCHH
T ss_pred HHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheecccc---cccceecCcccccCHHHHcCCCCChh
Confidence 9999999999 99999999999999996 4678999999999876322 23345678999999999999999999
Q ss_pred chhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc
Q 024027 159 GDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238 (273)
Q Consensus 159 ~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 238 (273)
+|||||||++|+|++|..||......+ .+..+.... ..........++.++.+||.+||..||
T Consensus 206 ~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~~~----------------~~~~~~~~~~~s~~~~~li~~~L~~dP 268 (350)
T d1koaa2 206 TDMWSVGVLSYILLSGLSPFGGENDDE-TLRNVKSCD----------------WNMDDSAFSGISEDGKDFIRKLLLADP 268 (350)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTC----------------CCSCCGGGGGCCHHHHHHHHHHCCSSG
T ss_pred HhhhhhhHHHHHHHhCCCCCCCCCHHH-HHHHHHhCC----------------CCCCcccccCCCHHHHHHHHHHccCCh
Confidence 999999999999999999997543221 111111110 011111234577889999999999999
Q ss_pred cCCCCHHHHHHH
Q 024027 239 EQRINAKEIVTK 250 (273)
Q Consensus 239 ~~Rps~~~~l~~ 250 (273)
++|||++++++|
T Consensus 269 ~~R~t~~eil~h 280 (350)
T d1koaa2 269 NTRMTIHQALEH 280 (350)
T ss_dssp GGSCCHHHHHHS
T ss_pred hHCcCHHHHhcC
Confidence 999999999987
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=8.7e-52 Score=345.69 Aligned_cols=227 Identities=19% Similarity=0.245 Sum_probs=190.5
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
+.||||+++.........+.+|+++|+.++||||++++++|.+++.+++|||||+||+|.+++...+..+++..++.++.
T Consensus 55 ~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~ 134 (352)
T d1koba_ 55 RVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR 134 (352)
T ss_dssp CEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHH
T ss_pred CEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHH
Confidence 47999999876656677889999999999999999999999999999999999999999999877777799999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeC--CCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCc
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLD--DNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTN 158 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~--~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 158 (273)
||+.||.||| +.|++||||||+|||++ .++.+||+|||++..+... .......|++.|+|||++.+..++.+
T Consensus 135 qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~ 208 (352)
T d1koba_ 135 QACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD---EIVKVTTATAEFAAPEIVDREPVGFY 208 (352)
T ss_dssp HHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT---SCEEEECSSGGGCCHHHHTTCCBCHH
T ss_pred HHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCC---CceeeccCcccccCHHHHcCCCCCCc
Confidence 9999999999 99999999999999997 6789999999999876332 22345678999999999999999999
Q ss_pred chhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCc
Q 024027 159 GDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESP 238 (273)
Q Consensus 159 ~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 238 (273)
+|||||||++|+|++|..||......+. +...... ...........++.++.+||.+||.+||
T Consensus 209 ~DiwSlGvilyelltG~~Pf~~~~~~~~-~~~i~~~----------------~~~~~~~~~~~~s~~~~~li~~~L~~dp 271 (352)
T d1koba_ 209 TDMWAIGVLGYVLLSGLSPFAGEDDLET-LQNVKRC----------------DWEFDEDAFSSVSPEAKDFIKNLLQKEP 271 (352)
T ss_dssp HHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHHHHC----------------CCCCCSSTTTTSCHHHHHHHHTTSCSSG
T ss_pred cchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhC----------------CCCCCcccccCCCHHHHHHHHHHccCCh
Confidence 9999999999999999999975332221 1111111 0011111234577889999999999999
Q ss_pred cCCCCHHHHHHH
Q 024027 239 EQRINAKEIVTK 250 (273)
Q Consensus 239 ~~Rps~~~~l~~ 250 (273)
.+|||++|+++|
T Consensus 272 ~~R~s~~eil~H 283 (352)
T d1koba_ 272 RKRLTVHDALEH 283 (352)
T ss_dssp GGSCCHHHHHTS
T ss_pred hHCcCHHHHhcC
Confidence 999999999986
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.2e-52 Score=340.36 Aligned_cols=226 Identities=19% Similarity=0.305 Sum_probs=171.1
Q ss_pred CeEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 1 MEVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 1 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
+.||||++.... ......+.+|+++|+.++||||+++++++.+++.+++|||||+||+|.+++... ..+++..+..++
T Consensus 35 ~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~-~~l~e~~~~~~~ 113 (307)
T d1a06a_ 35 KLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK-GFYTERDASRLI 113 (307)
T ss_dssp CEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTC-SCCCHHHHHHHH
T ss_pred CEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhcc-cCCCHHHHHHHH
Confidence 479999997553 334466889999999999999999999999999999999999999999999654 469999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeC---CCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcC
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLD---DNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVS 156 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~---~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 156 (273)
.|++.||.||| +.|++||||||+||+++ .++.+||+|||++...... ......+||+.|+|||++.+..++
T Consensus 114 ~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~---~~~~~~~GT~~y~APE~~~~~~~~ 187 (307)
T d1a06a_ 114 FQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG---SVLSTACGTPGYVAPEVLAQKPYS 187 (307)
T ss_dssp HHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC---------------------CTTSCHHHHTTCCCC
T ss_pred HHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEccCC---CeeeeeeeCccccCcHHHcCCCCC
Confidence 99999999999 99999999999999995 5789999999999765222 223446799999999999999999
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++||||+||++|+|++|..||......+. ...+... ........+..+++++.+|+.+||.+
T Consensus 188 ~~~DiwSlGvilyell~g~~Pf~~~~~~~~-~~~i~~~----------------~~~~~~~~~~~~s~~~~~li~~~L~~ 250 (307)
T d1a06a_ 188 KAVDCWSIGVIAYILLCGYPPFYDENDAKL-FEQILKA----------------EYEFDSPYWDDISDSAKDFIRHLMEK 250 (307)
T ss_dssp THHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHTT----------------CCCCCTTTTTTSCHHHHHHHHHHSCS
T ss_pred cHHHhhhhhHHHHHHHhCCCCCCCCCHHHH-HHHHhcc----------------CCCCCCccccCCCHHHHHHHHHHccC
Confidence 999999999999999999999976332221 1111111 11111122346778899999999999
Q ss_pred CccCCCCHHHHHHH
Q 024027 237 SPEQRINAKEIVTK 250 (273)
Q Consensus 237 dp~~Rps~~~~l~~ 250 (273)
||++|||++|+++|
T Consensus 251 dP~~R~s~~eil~h 264 (307)
T d1a06a_ 251 DPEKRFTCEQALQH 264 (307)
T ss_dssp SGGGSCCHHHHHHS
T ss_pred CHhHCcCHHHHhcC
Confidence 99999999999997
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-52 Score=345.79 Aligned_cols=241 Identities=20% Similarity=0.268 Sum_probs=185.5
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
.||||+++... ......+.+|+.+|+.++||||++++++|.++..+++||||++||+|.+++.+.+ .+++..++.++.
T Consensus 33 ~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~-~l~~~~~~~~~~ 111 (322)
T d1s9ja_ 33 VMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSI 111 (322)
T ss_dssp EEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHH
T ss_pred EEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcC-CCCHHHHHHHHH
Confidence 69999998653 4456778999999999999999999999999999999999999999999997554 699999999999
Q ss_pred HHHHHHHHHhcCCC-CCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcc
Q 024027 81 DVASALEYLHFGCS-APVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 159 (273)
Q Consensus 81 ql~~~l~~lh~~~~-~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 159 (273)
|++.||.||| + +||+||||||+|||++.++.+||+|||++..+... .....+||+.|+|||++.+..++.++
T Consensus 112 qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~ 184 (322)
T d1s9ja_ 112 AVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQS 184 (322)
T ss_dssp HHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----TC---CCSSCCCCHHHHHCSCCCTTH
T ss_pred HHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC----ccccccCCccccCchHHcCCCCCcHH
Confidence 9999999999 7 49999999999999999999999999999865321 22346899999999999999999999
Q ss_pred hhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCc-------------------------cchhhhhhhccccchh
Q 024027 160 DVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPI-------------------------STMEVVDANLLSQEDI 214 (273)
Q Consensus 160 DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~ 214 (273)
||||+||++|+|++|+.||......+............. ...+..........
T Consensus 185 DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 262 (322)
T d1s9ja_ 185 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPP-- 262 (322)
T ss_dssp HHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCC--
T ss_pred HHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCC--
Confidence 999999999999999999976443322111111000000 00000000000000
Q ss_pred hhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 215 HFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 215 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
........+.++.+|+.+||..||++|||++|+++|=.
T Consensus 263 ~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf 300 (322)
T d1s9ja_ 263 PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 300 (322)
T ss_dssp CCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred ccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHh
Confidence 00001235678999999999999999999999999833
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-52 Score=332.82 Aligned_cols=227 Identities=25% Similarity=0.460 Sum_probs=191.3
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~q 81 (273)
+||||+++.+ ....++|.+|++++++++||||++++|+|.+++.+++||||+++|+|.+++......+++..++.++.|
T Consensus 30 ~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~q 108 (258)
T d1k2pa_ 30 DVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKD 108 (258)
T ss_dssp EEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHH
T ss_pred EEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHH
Confidence 7999999865 334578999999999999999999999999999999999999999999998777777999999999999
Q ss_pred HHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcchh
Q 024027 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGDV 161 (273)
Q Consensus 82 l~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di 161 (273)
++.||.||| +.|++||||||+||+++.++.+||+|||++........ .......+|+.|+|||.+.+..++.++||
T Consensus 109 i~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~ksDi 184 (258)
T d1k2pa_ 109 VCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDI 184 (258)
T ss_dssp HHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-CCCCCSCCCGGGCCHHHHHHCCCCHHHHH
T ss_pred HHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCCc-eeecccCCCCCcCCcHHhcCCCCCcceee
Confidence 999999999 99999999999999999999999999999976543222 22334568899999999998999999999
Q ss_pred HHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccC
Q 024027 162 YSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQ 240 (273)
Q Consensus 162 wslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 240 (273)
|||||++|+|++ |+.||......+. ....... .....|..++.++.+|+.+||..||++
T Consensus 185 wS~G~~l~el~t~g~~Pf~~~~~~~~-~~~i~~~-------------------~~~~~p~~~~~~l~~li~~cl~~dP~~ 244 (258)
T d1k2pa_ 185 WAFGVLMWEIYSLGKMPYERFTNSET-AEHIAQG-------------------LRLYRPHLASEKVYTIMYSCWHEKADE 244 (258)
T ss_dssp HHHHHHHHHHHTTSCCTTTTSCHHHH-HHHHHTT-------------------CCCCCCTTCCHHHHHHHHHTTCSSGGG
T ss_pred cccchhhHhHHhcCCCCCCCCCHHHH-HHHHHhC-------------------CCCCCcccccHHHHHHHHHHccCCHhH
Confidence 999999999998 8999976543322 1111110 011124456778999999999999999
Q ss_pred CCCHHHHHHHHHH
Q 024027 241 RINAKEIVTKLLK 253 (273)
Q Consensus 241 Rps~~~~l~~l~~ 253 (273)
|||+++++++|.+
T Consensus 245 RPt~~eil~~L~d 257 (258)
T d1k2pa_ 245 RPTFKILLSNILD 257 (258)
T ss_dssp SCCHHHHHHHHHC
T ss_pred CcCHHHHHHHhhC
Confidence 9999999999864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-52 Score=338.12 Aligned_cols=225 Identities=21% Similarity=0.270 Sum_probs=173.3
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeec--CCceeEEEeccCCCCHHHhhhc---CCCCCCHH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSN--EEFKALVLEYMPHGSLEKYLYS---SNCILDIF 73 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~ 73 (273)
+.||||+++... ....+.+.+|++++++++||||+++++++.+ ++.+++|||||++|+|.+++.+ .+..+++.
T Consensus 30 ~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~ 109 (269)
T d2java1 30 KILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 109 (269)
T ss_dssp CEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHH
T ss_pred CEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHH
Confidence 479999997653 3446678999999999999999999999865 4568999999999999999863 24569999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCC-----eEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCc
Q 024027 74 QRLNIMIDVASALEYLHFGCSAP-----VIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPE 148 (273)
Q Consensus 74 ~~~~~~~ql~~~l~~lh~~~~~~-----i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE 148 (273)
.++.++.|++.||.||| +.| |+||||||+|||++.++.+||+|||++..+... .......+||+.|+|||
T Consensus 110 ~~~~i~~qi~~al~ylH---~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~--~~~~~~~~gt~~Y~APE 184 (269)
T d2java1 110 FVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFAKAFVGTPYYMSPE 184 (269)
T ss_dssp HHHHHHHHHHHHHHHHH---HHCC---------CCGGGEEECTTSCEEECCHHHHHHC-------------CCCSCCCHH
T ss_pred HHHHHHHHHHHHHHHHH---HhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccC--CCccccCCCCcccCCHH
Confidence 99999999999999999 654 999999999999999999999999999876322 22234567899999999
Q ss_pred ccCCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHH
Q 024027 149 YGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFN 228 (273)
Q Consensus 149 ~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 228 (273)
++.+..++.++|||||||++|+|++|..||......+. ....... .. ...+..+++++.+
T Consensus 185 ~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~-~~~i~~~-------------~~------~~~~~~~s~~l~~ 244 (269)
T d2java1 185 QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL-AGKIREG-------------KF------RRIPYRYSDELNE 244 (269)
T ss_dssp HHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHT-------------CC------CCCCTTSCHHHHH
T ss_pred HHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHH-HHHHHcC-------------CC------CCCCcccCHHHHH
Confidence 99999999999999999999999999999975432211 1111110 00 0113456778999
Q ss_pred HHhhcCCCCccCCCCHHHHHHH
Q 024027 229 LAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 229 li~~~l~~dp~~Rps~~~~l~~ 250 (273)
|+.+||..||++|||++|+++|
T Consensus 245 li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 245 IITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHcCCChhHCcCHHHHHhC
Confidence 9999999999999999999876
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-52 Score=336.39 Aligned_cols=233 Identities=24% Similarity=0.369 Sum_probs=188.0
Q ss_pred eEEEEEeecc--cChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 2 EVAVKVFNLQ--CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 2 ~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
.||||+++.. +....+.|.+|+++|++++||||++++++|.++ ..++||||+++|+|.+++.... .+++..++.++
T Consensus 36 ~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~g~L~~~l~~~~-~l~~~~~~~i~ 113 (277)
T d1xbba_ 36 TVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELV 113 (277)
T ss_dssp EEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHHHCT-TCCHHHHHHHH
T ss_pred EEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCCCcHHHHHhhcc-CCCHHHHHHHH
Confidence 6999999754 344567899999999999999999999999755 5789999999999999997554 69999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcc-eeecccccCCCCCCcccCCCCcCCc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSM-TQTQTLATIGYMAPEYGREGRVSTN 158 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~ 158 (273)
.|++.||.||| +.|++||||||+||+++.++.+||+|||++..+....... ......||+.|+|||.+.+..++.+
T Consensus 114 ~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~ 190 (277)
T d1xbba_ 114 HQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK 190 (277)
T ss_dssp HHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHH
T ss_pred HHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCch
Confidence 99999999999 9999999999999999999999999999998764333222 2234568899999999998899999
Q ss_pred chhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 159 GDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 159 ~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
+|||||||++|+|++ |..||......+. ...... . .....+..++.++.+|+.+||..|
T Consensus 191 sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~-~~~i~~-------------~------~~~~~p~~~~~~~~~li~~cl~~d 250 (277)
T d1xbba_ 191 SDVWSFGVLMWEAFSYGQKPYRGMKGSEV-TAMLEK-------------G------ERMGCPAGCPREMYDLMNLCWTYD 250 (277)
T ss_dssp HHHHHHHHHHHHHHTTTCCSSTTCCHHHH-HHHHHT-------------T------CCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred hhhccchhhhhHHhhCCCCCCCCCCHHHH-HHHHHc-------------C------CCCCCCcccCHHHHHHHHHHcCCC
Confidence 999999999999997 8999976433211 111100 0 011124567888999999999999
Q ss_pred ccCCCCHHHHHHHHHHHHHhhh
Q 024027 238 PEQRINAKEIVTKLLKIRDSLL 259 (273)
Q Consensus 238 p~~Rps~~~~l~~l~~~~~~~~ 259 (273)
|++|||++++++.|+....+..
T Consensus 251 p~~RPs~~~i~~~L~~~~~~~~ 272 (277)
T d1xbba_ 251 VENRPGFAAVELRLRNYYYDVV 272 (277)
T ss_dssp TTTSCCHHHHHHHHHHHHHHHH
T ss_pred HhHCcCHHHHHHHhhCHHhhcC
Confidence 9999999999999988766543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=341.93 Aligned_cols=229 Identities=24% Similarity=0.363 Sum_probs=188.9
Q ss_pred eEEEEEeecc-cChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC------------
Q 024027 2 EVAVKVFNLQ-CGRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN------------ 67 (273)
Q Consensus 2 ~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------ 67 (273)
.||||++... +......+.+|+.+++++ +||||+++++++.+++.+++|||||++|+|.+++....
T Consensus 69 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~ 148 (325)
T d1rjba_ 69 QVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 148 (325)
T ss_dssp EEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------
T ss_pred EEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhcc
Confidence 5899999654 345567899999999998 89999999999999999999999999999999996543
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeec
Q 024027 68 ----------CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQ 137 (273)
Q Consensus 68 ----------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~ 137 (273)
..+++..++.++.|++.||+||| ++||+||||||+||+++.++.+||+|||++..............
T Consensus 149 ~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~ 225 (325)
T d1rjba_ 149 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGN 225 (325)
T ss_dssp ------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETT
T ss_pred ccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeecc
Confidence 24888999999999999999999 99999999999999999999999999999987655444444455
Q ss_pred ccccCCCCCCcccCCCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhh
Q 024027 138 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHF 216 (273)
Q Consensus 138 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (273)
..||+.|+|||++.+..++.++|||||||++|+|++ |..||.......... ...... ...
T Consensus 226 ~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~-~~~~~~------------------~~~ 286 (325)
T d1rjba_ 226 ARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY-KLIQNG------------------FKM 286 (325)
T ss_dssp EEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH-HHHHTT------------------CCC
T ss_pred ccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHH-HHHhcC------------------CCC
Confidence 678999999999998999999999999999999997 899997644432221 111110 011
Q ss_pred hhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 217 VAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 217 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
..+..++.++.+|+.+||..||++|||+++|+++|.
T Consensus 287 ~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 287 DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 124567788999999999999999999999999986
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-51 Score=336.48 Aligned_cols=231 Identities=26% Similarity=0.409 Sum_probs=190.2
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhc-CCCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYS-SNCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~ 80 (273)
.||||+++.+ ....+.|.+|+++|++++||||++++++|.++..+++|||||++|+|.+++.. ....+++..++.++.
T Consensus 44 ~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~ 122 (287)
T d1opja_ 44 TVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 122 (287)
T ss_dssp EEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHH
T ss_pred EEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHH
Confidence 6999999755 44567899999999999999999999999999999999999999999999864 345689999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
|++.||.||| ++|++||||||+|||++.++.+||+|||++....... ........+++.|+|||++.+..++.++|
T Consensus 123 qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~k~D 198 (287)
T d1opja_ 123 QISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSD 198 (287)
T ss_dssp HHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS-SEEETTEEECGGGCCHHHHHHCCCSHHHH
T ss_pred HHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCCCC-ceeeccccccccccChHHHcCCCCCchhh
Confidence 9999999999 9999999999999999999999999999998654322 22233445788999999999899999999
Q ss_pred hHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccC
Q 024027 161 VYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQ 240 (273)
Q Consensus 161 iwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 240 (273)
||||||++|+|++|..||............ ... . .....+..++.++.+|+.+||..||++
T Consensus 199 iwS~Gv~l~ell~~~~p~~~~~~~~~~~~~-i~~------------~------~~~~~~~~~~~~l~~li~~cl~~dP~~ 259 (287)
T d1opja_ 199 VWAFGVLLWEIATYGMSPYPGIDLSQVYEL-LEK------------D------YRMERPEGCPEKVYELMRACWQWNPSD 259 (287)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCHHHHHHH-HHT------------T------CCCCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred hhhHHHHHHHHHhCCCCCCCcchHHHHHHH-Hhc------------C------CCCCCCccchHHHHHHHHHHcCCCHhH
Confidence 999999999999977765442222111111 110 0 011124567788999999999999999
Q ss_pred CCCHHHHHHHHHHHHH
Q 024027 241 RINAKEIVTKLLKIRD 256 (273)
Q Consensus 241 Rps~~~~l~~l~~~~~ 256 (273)
|||++++++.|+.+.+
T Consensus 260 Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 260 RPSFAEIHQAFETMFQ 275 (287)
T ss_dssp SCCHHHHHHHHHHTTS
T ss_pred CcCHHHHHHHHHHHHH
Confidence 9999999999987754
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=330.62 Aligned_cols=227 Identities=21% Similarity=0.300 Sum_probs=186.5
Q ss_pred CeEEEEEeeccc------ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHH
Q 024027 1 MEVAVKVFNLQC------GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQ 74 (273)
Q Consensus 1 ~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (273)
+.||||+++... ....+.+.+|+++|+.++||||++++++|.+++.+++|||||+||+|.+++...+ .+++..
T Consensus 36 ~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~-~l~~~~ 114 (293)
T d1jksa_ 36 LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEE 114 (293)
T ss_dssp CEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS-SCCHHH
T ss_pred CEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhcccc-ccchhH
Confidence 479999997542 1235779999999999999999999999999999999999999999999996544 699999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCC----ceEEeecccccccccCCCcceeecccccCCCCCCccc
Q 024027 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNL----VAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYG 150 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~----~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 150 (273)
++.++.|++.||+||| +.|++||||||+||+++.++ .+|++|||++....... ......+++.|+|||++
T Consensus 115 ~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~---~~~~~~~t~~y~APE~~ 188 (293)
T d1jksa_ 115 ATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIV 188 (293)
T ss_dssp HHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSC---BCSCCCCCGGGCCHHHH
T ss_pred HHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhhhhhcCCCc---cccccCCCCcccCHHHH
Confidence 9999999999999999 99999999999999998766 59999999998763222 23345689999999999
Q ss_pred CCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHH
Q 024027 151 REGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLA 230 (273)
Q Consensus 151 ~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 230 (273)
.+..++.++||||+||++|+|++|..||......+. ....... ........+..++.++.+||
T Consensus 189 ~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-~~~i~~~----------------~~~~~~~~~~~~s~~~~~li 251 (293)
T d1jksa_ 189 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-LANVSAV----------------NYEFEDEYFSNTSALAKDFI 251 (293)
T ss_dssp TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHTT----------------CCCCCHHHHTTSCHHHHHHH
T ss_pred cCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH-HHHHHhc----------------CCCCCchhcCCCCHHHHHHH
Confidence 998999999999999999999999999976332211 1111110 11111222456778899999
Q ss_pred hhcCCCCccCCCCHHHHHHHH
Q 024027 231 MACTVESPEQRINAKEIVTKL 251 (273)
Q Consensus 231 ~~~l~~dp~~Rps~~~~l~~l 251 (273)
.+||..||++|||++++++|=
T Consensus 252 ~~~L~~dP~~R~s~~eil~hp 272 (293)
T d1jksa_ 252 RRLLVKDPKKRMTIQDSLQHP 272 (293)
T ss_dssp HTTSCSSGGGSCCHHHHHHST
T ss_pred HHHccCChhHCcCHHHHhcCc
Confidence 999999999999999999863
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=328.59 Aligned_cols=231 Identities=26% Similarity=0.429 Sum_probs=186.3
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC-CCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~ 80 (273)
+||||+++.. ....+.|.+|++++++++||||++++|++.+ +..++||||+++|+|.+++.... ..+++..++.++.
T Consensus 39 ~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~ 116 (272)
T d1qpca_ 39 KVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 116 (272)
T ss_dssp EEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHH
T ss_pred EEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHH
Confidence 6999999765 3455789999999999999999999998865 56789999999999999875433 3589999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
|++.||.||| +.|++||||||+||+++.++.+||+|||++..+.... ........+++.|+|||++.+..++.++|
T Consensus 117 qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~~sD 192 (272)
T d1qpca_ 117 QIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSD 192 (272)
T ss_dssp HHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EECCTTCCCCTTTSCHHHHHHCEECHHHH
T ss_pred HHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCCc-cccccccCCcccccChHHHhCCCCCchhh
Confidence 9999999999 9999999999999999999999999999998763322 22233456889999999998888999999
Q ss_pred hHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccC
Q 024027 161 VYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQ 240 (273)
Q Consensus 161 iwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 240 (273)
||||||++|+|++|..|+................ .....+..++.++.+|+.+||..||++
T Consensus 193 vwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~-------------------~~~~~p~~~~~~l~~li~~cl~~~P~~ 253 (272)
T d1qpca_ 193 VWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-------------------YRMVRPDNCPEELYQLMRLCWKERPED 253 (272)
T ss_dssp HHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-------------------CCCCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred hhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-------------------CCCCCcccChHHHHHHHHHHcCCCHhH
Confidence 9999999999999665544322222111111110 011124567788999999999999999
Q ss_pred CCCHHHHHHHHHHHHHh
Q 024027 241 RINAKEIVTKLLKIRDS 257 (273)
Q Consensus 241 Rps~~~~l~~l~~~~~~ 257 (273)
|||++++++.|+++..+
T Consensus 254 Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 254 RPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp SCCHHHHHHHHHHHHHH
T ss_pred CcCHHHHHHHhhhhhhc
Confidence 99999999999987653
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-50 Score=335.09 Aligned_cols=223 Identities=22% Similarity=0.299 Sum_probs=187.5
Q ss_pred CeEEEEEeecc---cChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||||+++.. .....+.+.+|+.+|+.++||||++++++|.++..+|+|||||+||+|.+++.+.+ .+++..++.
T Consensus 31 ~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~~-~~~e~~~~~ 109 (337)
T d1o6la_ 31 RYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARF 109 (337)
T ss_dssp CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHH
T ss_pred CEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhccc-CCcHHHHHH
Confidence 47999999754 23456778899999999999999999999999999999999999999999997654 689999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
++.|++.||.||| ++|++||||||+|||++.+|.+||+|||++....... ......+||+.|+|||++.+..++.
T Consensus 110 ~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~--~~~~~~~GT~~Y~aPE~~~~~~y~~ 184 (337)
T d1o6la_ 110 YGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGR 184 (337)
T ss_dssp HHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCT
T ss_pred HHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccCC--cccccceeCHHHhhhhhccCCCCCh
Confidence 9999999999999 9999999999999999999999999999998653222 2334568999999999999999999
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
++|+||+||++|+|++|.+||......+. ....... ....|..++.++.+||.+||++|
T Consensus 185 ~~DiwSlGvilyeml~G~~pf~~~~~~~~-~~~i~~~--------------------~~~~p~~~s~~~~dli~~~L~~d 243 (337)
T d1o6la_ 185 AVDWWGLGVVMYEMMCGRLPFYNQDHERL-FELILME--------------------EIRFPRTLSPEAKSLLAGLLKKD 243 (337)
T ss_dssp THHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHC--------------------CCCCCTTSCHHHHHHHHHHTCSS
T ss_pred hhcccchhhHHHHHHHCCCCCCCcCHHHH-HHHHhcC--------------------CCCCCccCCHHHHHHHHhhccCC
Confidence 99999999999999999999976433221 1111100 01114557788999999999999
Q ss_pred ccCCCC-----HHHHHHH
Q 024027 238 PEQRIN-----AKEIVTK 250 (273)
Q Consensus 238 p~~Rps-----~~~~l~~ 250 (273)
|.+||+ ++++++|
T Consensus 244 P~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 244 PKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp TTTSTTCSTTTHHHHHTS
T ss_pred chhhcccccccHHHHHcC
Confidence 999995 8999987
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-50 Score=327.37 Aligned_cols=234 Identities=25% Similarity=0.419 Sum_probs=185.7
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
+||||+++... ......|.+|++++++++||||++++|++.+....++||||+.++++.+++......+++..+..++.
T Consensus 38 ~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~ 117 (283)
T d1mqba_ 38 PVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR 117 (283)
T ss_dssp EEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHH
T ss_pred EEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHH
Confidence 69999997553 34456799999999999999999999999999999999999999999999887777899999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCC-cceeecccccCCCCCCcccCCCCcCCcc
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQ-SMTQTQTLATIGYMAPEYGREGRVSTNG 159 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 159 (273)
|++.||.||| +.+++||||||+|||++.++.+||+|||++..+..... ........||+.|+|||.+.+..++.++
T Consensus 118 ~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~s 194 (283)
T d1mqba_ 118 GIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSAS 194 (283)
T ss_dssp HHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHH
T ss_pred HHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcc
Confidence 9999999999 99999999999999999999999999999987643322 2223344678999999999999999999
Q ss_pred hhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCcc
Q 024027 160 DVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239 (273)
Q Consensus 160 DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 239 (273)
|||||||++|||++|..|+................ .....+..++.++.+|+.+||..||+
T Consensus 195 DI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~-------------------~~~~~~~~~~~~l~~li~~cl~~~p~ 255 (283)
T d1mqba_ 195 DVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-------------------FRLPTPMDCPSAIYQLMMQCWQQERA 255 (283)
T ss_dssp HHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-------------------CCCCCCTTCBHHHHHHHHHHTCSSTT
T ss_pred cccccHHHHHHHHhCCCCccccCCHHHHHHHHhcc-------------------CCCCCchhhHHHHHHHHHHHCcCCHh
Confidence 99999999999999666654332222211111110 11112445777899999999999999
Q ss_pred CCCCHHHHHHHHHHHHHh
Q 024027 240 QRINAKEIVTKLLKIRDS 257 (273)
Q Consensus 240 ~Rps~~~~l~~l~~~~~~ 257 (273)
+|||+.+|++.|+.+.+.
T Consensus 256 ~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 256 RRPKFADIVSILDKLIRA 273 (283)
T ss_dssp TSCCHHHHHHHHHHHHHS
T ss_pred HCcCHHHHHHHHHHHhhC
Confidence 999999999999988763
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-50 Score=333.41 Aligned_cols=220 Identities=23% Similarity=0.312 Sum_probs=180.5
Q ss_pred eEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 2 EVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 2 ~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
.||||+++... ....+.+.+|++++++++||||+++++++.+++.+++|||||++|+|..++... ..+++..++.+
T Consensus 42 ~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~-~~l~e~~~~~i 120 (309)
T d1u5ra_ 42 VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAV 120 (309)
T ss_dssp EEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHT-SCCCHHHHHHH
T ss_pred EEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHhC-CCCCHHHHHHH
Confidence 69999997553 234567899999999999999999999999999999999999998887766544 46999999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC---CCc
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE---GRV 155 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~ 155 (273)
+.||+.||.||| ++|++||||||+|||++.++.+||+|||++..... .....||+.|+|||++.+ ..+
T Consensus 121 ~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y 191 (309)
T d1u5ra_ 121 THGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQY 191 (309)
T ss_dssp HHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------BCCCCSCGGGCCHHHHTTTTSCCB
T ss_pred HHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCC------CCccccCccccCHHHHhccCCCCc
Confidence 999999999999 99999999999999999999999999999976422 234579999999999864 358
Q ss_pred CCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCC
Q 024027 156 STNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTV 235 (273)
Q Consensus 156 ~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 235 (273)
+.++|||||||++|+|++|..||......+. ......... ....+..++.++.+|+.+||+
T Consensus 192 ~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~-~~~i~~~~~------------------~~~~~~~~s~~~~~li~~~L~ 252 (309)
T d1u5ra_ 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNES------------------PALQSGHWSEYFRNFVDSCLQ 252 (309)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHSCC------------------CCCSCTTSCHHHHHHHHHHTC
T ss_pred CchhhhhhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHhCCC------------------CCCCCCCCCHHHHHHHHHHCc
Confidence 9999999999999999999999875332211 111111000 001123467789999999999
Q ss_pred CCccCCCCHHHHHHH
Q 024027 236 ESPEQRINAKEIVTK 250 (273)
Q Consensus 236 ~dp~~Rps~~~~l~~ 250 (273)
.||.+|||++++++|
T Consensus 253 ~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 253 KIPQDRPTSEVLLKH 267 (309)
T ss_dssp SSGGGSCCHHHHTTC
T ss_pred CChhHCcCHHHHHhC
Confidence 999999999999885
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-50 Score=331.63 Aligned_cols=234 Identities=23% Similarity=0.347 Sum_probs=189.6
Q ss_pred eEEEEEeecc-cChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
+||||+++.. +....+.|.+|++++++++||||++++|+|.++ ..++++|++.+|+|.+++......+++..++.++.
T Consensus 40 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~ 118 (317)
T d1xkka_ 40 PVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 118 (317)
T ss_dssp EEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHH
T ss_pred EEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEeccCCcccccccccccCCCHHHHHHHHH
Confidence 6899998754 345677899999999999999999999999865 56788899999999999988877899999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
|++.||.||| ++|++||||||+||+++.++.+||+|||++..+.............||+.|+|||.+.+..++.++|
T Consensus 119 qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sD 195 (317)
T d1xkka_ 119 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSD 195 (317)
T ss_dssp HHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHH
T ss_pred HHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhh
Confidence 9999999999 9999999999999999999999999999998775444444444556899999999999889999999
Q ss_pred hHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCcc
Q 024027 161 VYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239 (273)
Q Consensus 161 iwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 239 (273)
||||||++|+|++ |.+||......+. ...... . .....+..++.++.+|+.+||..||.
T Consensus 196 vwS~Gvil~el~t~g~~p~~~~~~~~~--~~~i~~------------~------~~~~~p~~~~~~~~~li~~cl~~dP~ 255 (317)
T d1xkka_ 196 VWSYGVTVWELMTFGSKPYDGIPASEI--SSILEK------------G------ERLPQPPICTIDVYMIMVKCWMIDAD 255 (317)
T ss_dssp HHHHHHHHHHHHTTSCCTTTTSCGGGH--HHHHHH------------T------CCCCCCTTBCHHHHHHHHHHTCSSGG
T ss_pred hhhHHHHHHHHHHCCCCCCCCCCHHHH--HHHHHc------------C------CCCCCCcccCHHHHHHHHHhCCCChh
Confidence 9999999999998 7888865433221 111110 0 01112456778899999999999999
Q ss_pred CCCCHHHHHHHHHHHHHhhh
Q 024027 240 QRINAKEIVTKLLKIRDSLL 259 (273)
Q Consensus 240 ~Rps~~~~l~~l~~~~~~~~ 259 (273)
+|||+.+++++|..+.++..
T Consensus 256 ~RPs~~eil~~l~~~~~~~~ 275 (317)
T d1xkka_ 256 SRPKFRELIIEFSKMARDPQ 275 (317)
T ss_dssp GSCCHHHHHHHHHHHHHSHH
T ss_pred hCcCHHHHHHHHHHHHhChH
Confidence 99999999999999876543
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-50 Score=326.47 Aligned_cols=231 Identities=24% Similarity=0.368 Sum_probs=181.6
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
.||||+++... ....+.+.+|+++++.++||||+++++++. ++.+++||||+++|+|.+++......+++..++.++.
T Consensus 37 ~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~ 115 (273)
T d1mp8a_ 37 AVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 115 (273)
T ss_dssp EEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHH
T ss_pred EEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHH
Confidence 48899986543 344677999999999999999999999996 4678999999999999999887777899999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
|++.||.||| +.|++||||||+||+++.++.+||+|||++..+..... .......+|+.|+|||.+.+..++.++|
T Consensus 116 qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~D 191 (273)
T d1mp8a_ 116 QLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASD 191 (273)
T ss_dssp HHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCCCSHHHH
T ss_pred HHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccCCcc-eeccceecCcccchhhHhccCCCCCccc
Confidence 9999999999 99999999999999999999999999999986533222 2233456789999999999889999999
Q ss_pred hHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCcc
Q 024027 161 VYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239 (273)
Q Consensus 161 iwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 239 (273)
||||||++|+|++ |.+||......+. ........ ....+..++.++.+|+.+||..||.
T Consensus 192 iwSlGvil~e~lt~g~~P~~~~~~~~~-~~~i~~~~-------------------~~~~~~~~~~~~~~li~~cl~~dp~ 251 (273)
T d1mp8a_ 192 VWMFGVCMWEILMHGVKPFQGVKNNDV-IGRIENGE-------------------RLPMPPNCPPTLYSLMTKCWAYDPS 251 (273)
T ss_dssp HHHHHHHHHHHHTTSCCTTTTCCGGGH-HHHHHTTC-------------------CCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred cccchHHHHHHHhcCCCCCCCCCHHHH-HHHHHcCC-------------------CCCCCCCCCHHHHHHHHHHcCCCHh
Confidence 9999999999998 8999876443321 11111100 0112456788899999999999999
Q ss_pred CCCCHHHHHHHHHHHHHh
Q 024027 240 QRINAKEIVTKLLKIRDS 257 (273)
Q Consensus 240 ~Rps~~~~l~~l~~~~~~ 257 (273)
+|||+++|+++|+.+.++
T Consensus 252 ~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 252 RRPRFTELKAQLSTILEE 269 (273)
T ss_dssp GSCCHHHHHHHHHHHHHH
T ss_pred HCcCHHHHHHHHHHHHHH
Confidence 999999999999998765
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-50 Score=330.13 Aligned_cols=227 Identities=20% Similarity=0.290 Sum_probs=188.2
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMID 81 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~q 81 (273)
.||||+++.. ......+.+|+++|+.++||||++++++|.+++.+|+|||||+||+|.+++...+..+++..++.++.|
T Consensus 32 ~~AiK~i~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~q 110 (321)
T d1tkia_ 32 TYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQ 110 (321)
T ss_dssp EEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHH
T ss_pred EEEEEEEcCC-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHH
Confidence 6999999765 334567889999999999999999999999999999999999999999999877667999999999999
Q ss_pred HHHHHHHHhcCCCCCeEeccCCCCceeeCC--CCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcc
Q 024027 82 VASALEYLHFGCSAPVIHCDLKPDNVLLDD--NLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNG 159 (273)
Q Consensus 82 l~~~l~~lh~~~~~~i~h~di~p~nil~~~--~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~ 159 (273)
|+.||.||| +.|++||||||+||+++. ...++|+|||++..... ........+++.|+|||...+..++.++
T Consensus 111 i~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~---~~~~~~~~~t~~y~ape~~~~~~~~~~~ 184 (321)
T d1tkia_ 111 VCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP---GDNFRLLFTAPEYYAPEVHQHDVVSTAT 184 (321)
T ss_dssp HHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT---TCEEEEEESCGGGSCHHHHTTCEECHHH
T ss_pred HHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhcccc---CCcccccccccccccchhccCCCCCchh
Confidence 999999999 999999999999999985 45899999999986532 2233456789999999999999999999
Q ss_pred hhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCcc
Q 024027 160 DVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPE 239 (273)
Q Consensus 160 DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 239 (273)
||||+||++|+|++|..||......+. ...+... ...........++.++.+|+.+||..||.
T Consensus 185 DiWSlGvily~ll~G~~Pf~~~~~~~~-~~~i~~~----------------~~~~~~~~~~~~s~~~~~li~~~L~~dp~ 247 (321)
T d1tkia_ 185 DMWSLGTLVYVLLSGINPFLAETNQQI-IENIMNA----------------EYTFDEEAFKEISIEAMDFVDRLLVKERK 247 (321)
T ss_dssp HHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHHT----------------CCCCCHHHHTTSCHHHHHHHHTTSCSSGG
T ss_pred hcccHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhC----------------CCCCChhhccCCCHHHHHHHHHHccCChh
Confidence 999999999999999999976432211 1111111 11111222345778899999999999999
Q ss_pred CCCCHHHHHHHHH
Q 024027 240 QRINAKEIVTKLL 252 (273)
Q Consensus 240 ~Rps~~~~l~~l~ 252 (273)
+|||++|+++|=+
T Consensus 248 ~R~s~~eil~hp~ 260 (321)
T d1tkia_ 248 SRMTASEALQHPW 260 (321)
T ss_dssp GSCCHHHHHHSHH
T ss_pred HCcCHHHHhcCHh
Confidence 9999999999743
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.4e-49 Score=328.04 Aligned_cols=220 Identities=25% Similarity=0.308 Sum_probs=185.2
Q ss_pred CeEEEEEeecc---cChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||||+++.. .....+.+.+|+.+++.++||||+++++++.+++.+++|||||+||+|..++.... .+++..++.
T Consensus 30 ~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~~-~~~~~~~~~ 108 (316)
T d1fota_ 30 RYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ-RFPNPVAKF 108 (316)
T ss_dssp CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTS-SCCHHHHHH
T ss_pred CEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCccccccccccc-cccccHHHH
Confidence 47999999754 23456778999999999999999999999999999999999999999999986554 688999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
++.||+.||.||| ++|++||||||+|||++.++.+||+|||++..... .....+||+.|+|||++.+..++.
T Consensus 109 ~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~-----~~~~~~Gt~~Y~APE~l~~~~y~~ 180 (316)
T d1fota_ 109 YAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIAPEVVSTKPYNK 180 (316)
T ss_dssp HHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-----CBCCCCSCTTTCCHHHHTTCCBCT
T ss_pred HHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEecc-----ccccccCcccccCHHHHcCCCCCc
Confidence 9999999999999 99999999999999999999999999999987532 223467999999999999999999
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
++|||||||++|+|++|..||......+. ....... ....+..++.++.+++.+||..|
T Consensus 181 ~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~i~~~--------------------~~~~p~~~s~~~~~li~~~L~~d 239 (316)
T d1fota_ 181 SIDWWSFGILIYEMLAGYTPFYDSNTMKT-YEKILNA--------------------ELRFPPFFNEDVKDLLSRLITRD 239 (316)
T ss_dssp THHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHHC--------------------CCCCCTTSCHHHHHHHHHHTCSC
T ss_pred hhhccccchhHHHHHhCCCCCCCcCHHHH-HHHHHcC--------------------CCCCCCCCCHHHHHHHHHHhhhC
Confidence 99999999999999999999976332211 1111100 01113456778999999999999
Q ss_pred ccCCC-----CHHHHHHH
Q 024027 238 PEQRI-----NAKEIVTK 250 (273)
Q Consensus 238 p~~Rp-----s~~~~l~~ 250 (273)
|.+|+ |++++++|
T Consensus 240 p~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 240 LSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp TTTCTTSSTTTTHHHHTS
T ss_pred HHhccccchhhHHHHHcC
Confidence 99996 99999987
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.8e-49 Score=322.49 Aligned_cols=234 Identities=23% Similarity=0.371 Sum_probs=181.4
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHhcCCCccceeeeeeeecCC----ceeEEEeccCCCCHHHhhhcCCCCCCHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEE----FKALVLEYMPHGSLEKYLYSSNCILDIF 73 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 73 (273)
+.||||+++... ......+.+|+++++.++||||+++++++..+. .+|+||||++|++|.+++...+ .+++.
T Consensus 33 ~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~-~l~~~ 111 (277)
T d1o6ya_ 33 RDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPK 111 (277)
T ss_dssp EEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHC-SCCHH
T ss_pred CEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcccC-CCCHH
Confidence 379999997543 334567899999999999999999999987643 4789999999999999986554 69999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCC-cceeecccccCCCCCCcccCC
Q 024027 74 QRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQ-SMTQTQTLATIGYMAPEYGRE 152 (273)
Q Consensus 74 ~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~ 152 (273)
.++.++.|++.||.||| +.|++||||||+||+++.++.++++|||.+........ .......+||+.|+|||++.+
T Consensus 112 ~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~ 188 (277)
T d1o6ya_ 112 RAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 188 (277)
T ss_dssp HHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcC
Confidence 99999999999999999 99999999999999999999999999998875533222 223345679999999999999
Q ss_pred CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhh
Q 024027 153 GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMA 232 (273)
Q Consensus 153 ~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 232 (273)
..++.++|||||||++|+|++|..||......+........ ...........++.++.+|+.+
T Consensus 189 ~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~s~~l~~li~~ 251 (277)
T d1o6ya_ 189 DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE-----------------DPIPPSARHEGLSADLDAVVLK 251 (277)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC-----------------CCCCGGGTSSSCCHHHHHHHHH
T ss_pred CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhc-----------------CCCCCchhccCCCHHHHHHHHH
Confidence 89999999999999999999999999764332221111111 0011111234577889999999
Q ss_pred cCCCCccCCC-CHHHHHHHHHHHH
Q 024027 233 CTVESPEQRI-NAKEIVTKLLKIR 255 (273)
Q Consensus 233 ~l~~dp~~Rp-s~~~~l~~l~~~~ 255 (273)
||++||.+|| |++++++.|.+++
T Consensus 252 ~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 252 ALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp HTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HccCCHhHCHhHHHHHHHHHHHHh
Confidence 9999999999 8999999888765
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.7e-49 Score=320.39 Aligned_cols=226 Identities=24% Similarity=0.339 Sum_probs=183.8
Q ss_pred CeEEEEEeecccC---------hhhhhHHHHHHHHhcCC-CccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCC
Q 024027 1 MEVAVKVFNLQCG---------RAFKSFDVECEMMKSIR-HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCIL 70 (273)
Q Consensus 1 ~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 70 (273)
+.||||+++.... ...+.+.+|+.++++++ ||||+++++++.+++..+|||||+++|+|.+++...+ .+
T Consensus 29 ~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~-~l 107 (277)
T d1phka_ 29 KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-TL 107 (277)
T ss_dssp EEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-SC
T ss_pred CEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhcC-CC
Confidence 3699999975531 12346889999999996 9999999999999999999999999999999997644 69
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCccc
Q 024027 71 DIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYG 150 (273)
Q Consensus 71 ~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 150 (273)
++..++.++.||+.||.||| ++|++||||||+||+++.++.+||+|||++..+... .......||+.|.|||.+
T Consensus 108 ~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~~PE~~ 181 (277)
T d1phka_ 108 SEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG---EKLREVCGTPSYLAPEII 181 (277)
T ss_dssp CHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT---CCBCCCCSCGGGCCHHHH
T ss_pred CHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchheeEccCC---CceeeeeccCCCCCHHHh
Confidence 99999999999999999999 999999999999999999999999999999876322 223446789999999987
Q ss_pred CC------CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHH
Q 024027 151 RE------GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVS 224 (273)
Q Consensus 151 ~~------~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (273)
.+ ..++.++||||+||++|+|++|+.||....... ......... ..........+++
T Consensus 182 ~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-~~~~i~~~~----------------~~~~~~~~~~~s~ 244 (277)
T d1phka_ 182 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-MLRMIMSGN----------------YQFGSPEWDDYSD 244 (277)
T ss_dssp HHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTC----------------CCCCTTTGGGSCH
T ss_pred hccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-HHHHHHhCC----------------CCCCCcccccCCH
Confidence 53 347889999999999999999999997643222 111111110 0011112446788
Q ss_pred HHHHHHhhcCCCCccCCCCHHHHHHH
Q 024027 225 FVFNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 225 ~l~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
++.+|+.+||++||++|||++++++|
T Consensus 245 ~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 245 TVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHHccCChhHCcCHHHHHcC
Confidence 89999999999999999999999886
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-50 Score=321.19 Aligned_cols=226 Identities=30% Similarity=0.433 Sum_probs=178.5
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeec-CCceeEEEeccCCCCHHHhhhcCC-CCCCHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSN-EEFKALVLEYMPHGSLEKYLYSSN-CILDIFQRLNI 78 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~ 78 (273)
++||||+++.+ ...+.+.+|++++++++||||++++|+|.+ +..+++||||+++|+|.+++...+ ..+++..++.+
T Consensus 31 ~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i 108 (262)
T d1byga_ 31 NKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 108 (262)
T ss_dssp EEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHH
T ss_pred eEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHH
Confidence 37999999654 345789999999999999999999998854 566899999999999999996543 34899999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCc
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTN 158 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~ 158 (273)
+.||+.||.||| +.+++||||||+||+++.++.+|++|||++..... ......++..|+|||.+.+..++.+
T Consensus 109 ~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~-----~~~~~~~~~~y~aPE~l~~~~~t~~ 180 (262)
T d1byga_ 109 SLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----TQDTGKLPVKWTAPEALREKKFSTK 180 (262)
T ss_dssp HHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCCCHH
T ss_pred HHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCC-----CCccccccccCCChHHHhCCCCChH
Confidence 999999999999 99999999999999999999999999999976422 2234467889999999988899999
Q ss_pred chhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 159 GDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 159 ~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
+|||||||++|||++ |.+||......+. ...... ......+..++.++.+|+.+||..|
T Consensus 181 sDIwSfG~il~el~t~~~~p~~~~~~~~~-~~~i~~-------------------~~~~~~~~~~~~~~~~li~~cl~~d 240 (262)
T d1byga_ 181 SDVWSFGILLWEIYSFGRVPYPRIPLKDV-VPRVEK-------------------GYKMDAPDGCPPAVYEVMKNCWHLD 240 (262)
T ss_dssp HHHHHHHHHHHHHHTTSCCSCTTSCGGGH-HHHHTT-------------------TCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred HHHHhHHHHHHHHHHCCCCCCCCCCHHHH-HHHHHc-------------------CCCCCCCccCCHHHHHHHHHHcccC
Confidence 999999999999998 7888765433221 111110 0111224556778999999999999
Q ss_pred ccCCCCHHHHHHHHHHHHH
Q 024027 238 PEQRINAKEIVTKLLKIRD 256 (273)
Q Consensus 238 p~~Rps~~~~l~~l~~~~~ 256 (273)
|++|||+.+++++|+.++.
T Consensus 241 P~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 241 AAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp GGGSCCHHHHHHHHHHHHH
T ss_pred HhHCcCHHHHHHHHHHHHh
Confidence 9999999999999998865
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-49 Score=327.64 Aligned_cols=227 Identities=21% Similarity=0.277 Sum_probs=180.3
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhc-CCCccceeeeeeeec----CCceeEEEeccCCCCHHHhhhcCC-CCCCHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKS-IRHRNLIKVISSCSN----EEFKALVLEYMPHGSLEKYLYSSN-CILDIFQ 74 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~ 74 (273)
+.||||+++.. ..+.+|+.++.+ .+||||++++++|.+ +..+|+|||||+||+|.+++...+ ..+++..
T Consensus 38 ~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~ 112 (335)
T d2ozaa1 38 EKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE 112 (335)
T ss_dssp CEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHH
T ss_pred CEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHH
Confidence 47999999643 567889998765 489999999999875 467899999999999999997643 4699999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCC---CCceEEeecccccccccCCCcceeecccccCCCCCCcccC
Q 024027 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDD---NLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR 151 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~---~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 151 (273)
++.++.|++.||+||| +.|++||||||+||+++. .+.+||+|||++....... .....+||+.|+|||++.
T Consensus 113 ~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~ 186 (335)
T d2ozaa1 113 ASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLG 186 (335)
T ss_dssp HHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC---CCCCCSCCCSSCCCCCCC
T ss_pred HHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccccccccceeeeccCCC---ccccccCCcccCCcHHHc
Confidence 9999999999999999 999999999999999985 5579999999998653322 234567999999999999
Q ss_pred CCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHh
Q 024027 152 EGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAM 231 (273)
Q Consensus 152 ~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 231 (273)
+..++.++|||||||++|+|++|+.||........... ..... ..............++.++.+||.
T Consensus 187 ~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~-~~~~i------------~~~~~~~~~~~~~~~s~~~~~li~ 253 (335)
T d2ozaa1 187 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-MKTRI------------RMGQYEFPNPEWSEVSEEVKMLIR 253 (335)
T ss_dssp GGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------CC------------CSCSSSCCTTHHHHSCHHHHHHHH
T ss_pred CCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH-HHHHH------------hcCCCCCCCcccccCCHHHHHHHH
Confidence 99999999999999999999999999976433221111 00000 000111111224567888999999
Q ss_pred hcCCCCccCCCCHHHHHHHH
Q 024027 232 ACTVESPEQRINAKEIVTKL 251 (273)
Q Consensus 232 ~~l~~dp~~Rps~~~~l~~l 251 (273)
+||+.||++|||+.++++|=
T Consensus 254 ~~L~~dP~~R~s~~eil~hp 273 (335)
T d2ozaa1 254 NLLKTEPTQRMTITEFMNHP 273 (335)
T ss_dssp HHSCSSTTTSCCHHHHHHSH
T ss_pred HHccCChhHCcCHHHHHcCH
Confidence 99999999999999999973
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=325.63 Aligned_cols=234 Identities=24% Similarity=0.368 Sum_probs=180.6
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcC-CCccceeeeeeeec-CCceeEEEeccCCCCHHHhhhcCC-----------
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSI-RHRNLIKVISSCSN-EEFKALVLEYMPHGSLEKYLYSSN----------- 67 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~----------- 67 (273)
.||||+++... ....+.+..|..++.++ +|+||+.+++++.. +..+++|||||++|+|.+++....
T Consensus 45 ~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~ 124 (299)
T d1ywna1 45 TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 124 (299)
T ss_dssp EEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC------
T ss_pred EEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchh
Confidence 69999997553 34566788888888877 79999999998765 456899999999999999996432
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCC
Q 024027 68 ----CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIG 143 (273)
Q Consensus 68 ----~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~ 143 (273)
..+++..++.++.|++.||.||| ++|++||||||+|||++.++.+||+|||++................||+.
T Consensus 125 ~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~ 201 (299)
T d1ywna1 125 DLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 201 (299)
T ss_dssp -----CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGG
T ss_pred hhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCcc
Confidence 34889999999999999999999 99999999999999999999999999999987654444444445678999
Q ss_pred CCCCcccCCCCcCCcchhHHHHHHHHHHHhC-CCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhh
Q 024027 144 YMAPEYGREGRVSTNGDVYSFGIMLMETFTG-KKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQC 222 (273)
Q Consensus 144 ~~aPE~~~~~~~~~~~DiwslG~~l~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (273)
|+|||++.+..++.++|||||||++|+|++| .+||................. ....+..+
T Consensus 202 y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~ 262 (299)
T d1ywna1 202 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT-------------------RMRAPDYT 262 (299)
T ss_dssp GCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTC-------------------CCCCCTTC
T ss_pred ccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC-------------------CCCCCccC
Confidence 9999999999999999999999999999986 557765433322111111110 11124556
Q ss_pred HHHHHHHHhhcCCCCccCCCCHHHHHHHHHHHHHh
Q 024027 223 VSFVFNLAMACTVESPEQRINAKEIVTKLLKIRDS 257 (273)
Q Consensus 223 ~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~ 257 (273)
++++.+|+.+||..||++|||++++++||+++.++
T Consensus 263 ~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 263 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 77899999999999999999999999999998753
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-50 Score=323.31 Aligned_cols=230 Identities=27% Similarity=0.376 Sum_probs=183.7
Q ss_pred eEEEEEeecc---cChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 2 EVAVKVFNLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 2 ~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
+||||+++.. +....+.|.+|+++|+.++||||++++|++.++ ..++||||+++|++.+++......+++..++.+
T Consensus 38 ~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~ 116 (273)
T d1u46a_ 38 SVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY 116 (273)
T ss_dssp EEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHH
T ss_pred EEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chheeeeeecCcchhhhhhcccCCCCHHHHHHH
Confidence 6899999754 244567899999999999999999999999764 678999999999999998777667999999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcc-eeecccccCCCCCCcccCCCCcCC
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSM-TQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
+.|++.||.||| ++|++||||||+||+++.++.+||+|||++..+....... ......++..|+|||.+.+..++.
T Consensus 117 ~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 193 (273)
T d1u46a_ 117 AVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSH 193 (273)
T ss_dssp HHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEH
T ss_pred HHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCc
Confidence 999999999999 9999999999999999999999999999998764433322 223445788999999999989999
Q ss_pred cchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 158 NGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
++||||||+++|||++ |..||......+.. ...... ......+..++.++.+|+.+||..
T Consensus 194 ~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~-~~i~~~------------------~~~~~~~~~~~~~l~~li~~cl~~ 254 (273)
T d1u46a_ 194 ASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL-HKIDKE------------------GERLPRPEDCPQDIYNVMVQCWAH 254 (273)
T ss_dssp HHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-HHHHTS------------------CCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred chhhhhhHHHHHHHHhCCCCCCCCcCHHHHH-HHHHhC------------------CCCCCCcccccHHHHHHHHHHcCC
Confidence 9999999999999997 89998764333221 111111 011112456677899999999999
Q ss_pred CccCCCCHHHHHHHHHHH
Q 024027 237 SPEQRINAKEIVTKLLKI 254 (273)
Q Consensus 237 dp~~Rps~~~~l~~l~~~ 254 (273)
||++|||+++|++.|.+.
T Consensus 255 dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 255 KPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp SGGGSCCHHHHHHHHHHH
T ss_pred ChhHCcCHHHHHHHHHhc
Confidence 999999999999888764
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=320.67 Aligned_cols=238 Identities=24% Similarity=0.390 Sum_probs=193.7
Q ss_pred eEEEEEeecc-cChhhhhHHHHHHHHhcCCCccceeeeeeeec-CCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 2 EVAVKVFNLQ-CGRAFKSFDVECEMMKSIRHRNLIKVISSCSN-EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 2 ~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
.||||+++.. +....+.|.+|++++++++||||++++|++.+ ++..++|||||++|+|.+++.......++..++.++
T Consensus 57 ~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~ 136 (311)
T d1r0pa_ 57 HCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 136 (311)
T ss_dssp EEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHH
T ss_pred EEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccccccchHHHHHHHH
Confidence 5899999743 45567889999999999999999999999765 568899999999999999998777778899999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCc--ceeecccccCCCCCCcccCCCCcCC
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQS--MTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
.|++.||.||| +.+++||||||+|||++.++.+||+|||++......... .......|++.|+|||.+.+..++.
T Consensus 137 ~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 213 (311)
T d1r0pa_ 137 LQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT 213 (311)
T ss_dssp HHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCH
T ss_pred HHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCC
Confidence 99999999999 999999999999999999999999999999876433221 1223346889999999998889999
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
++||||||+++|||++|..||................. ....+..++.++.+|+.+||..|
T Consensus 214 ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~-------------------~~~~p~~~~~~l~~li~~cl~~d 274 (311)
T d1r0pa_ 214 KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-------------------RLLQPEYCPDPLYEVMLKCWHPK 274 (311)
T ss_dssp HHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTC-------------------CCCCCTTCCHHHHHHHHHHTCSS
T ss_pred hhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-------------------CCCCcccCcHHHHHHHHHHcCCC
Confidence 99999999999999998888765433322222111111 01113456778999999999999
Q ss_pred ccCCCCHHHHHHHHHHHHHhhhhh
Q 024027 238 PEQRINAKEIVTKLLKIRDSLLRN 261 (273)
Q Consensus 238 p~~Rps~~~~l~~l~~~~~~~~~~ 261 (273)
|++|||+.||+++|+.+.+++..+
T Consensus 275 P~~RPs~~ei~~~L~~i~~~~~~~ 298 (311)
T d1r0pa_ 275 AEMRPSFSELVSRISAIFSTFIGE 298 (311)
T ss_dssp GGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred HhHCcCHHHHHHHHHHHHHhhhhh
Confidence 999999999999999998875544
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.8e-49 Score=328.02 Aligned_cols=220 Identities=20% Similarity=0.225 Sum_probs=185.0
Q ss_pred CeEEEEEeecc---cChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQ---CGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||||+++.. .....+.+.+|+++|+.++||||+++++++.+....++||||+.+|+|..++...+ .+++..++.
T Consensus 67 ~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~-~l~e~~~~~ 145 (350)
T d1rdqe_ 67 NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARF 145 (350)
T ss_dssp CEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHC-CCCHHHHHH
T ss_pred CEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccccchhhhHhhcC-CCCHHHHHH
Confidence 47999999754 23456678999999999999999999999999999999999999999999996554 699999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVST 157 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 157 (273)
++.||+.||.||| ++|++||||||+|||++.++.+||+|||++..+... .....||+.|+|||++.+..++.
T Consensus 146 i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~ 217 (350)
T d1rdqe_ 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNK 217 (350)
T ss_dssp HHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCT
T ss_pred HHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-----cccccCccccCCHHHHcCCCCCc
Confidence 9999999999999 999999999999999999999999999999876322 23457999999999999999999
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCC
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVES 237 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 237 (273)
++|||||||++|+|++|..||....... ........ ....+..++.++.+|+.+||..|
T Consensus 218 ~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~i~~~--------------------~~~~p~~~s~~~~~li~~~L~~d 276 (350)
T d1rdqe_ 218 AVDWWALGVLIYEMAAGYPPFFADQPIQ-IYEKIVSG--------------------KVRFPSHFSSDLKDLLRNLLQVD 276 (350)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHC--------------------CCCCCTTCCHHHHHHHHHHSCSC
T ss_pred cccccchhHHHHHHHhCCCCCCCcCHHH-HHHHHhcC--------------------CCCCCccCCHHHHHHHHHHhhhC
Confidence 9999999999999999999997532211 11111110 00113456778999999999999
Q ss_pred ccCCC-----CHHHHHHH
Q 024027 238 PEQRI-----NAKEIVTK 250 (273)
Q Consensus 238 p~~Rp-----s~~~~l~~ 250 (273)
|.+|+ |++++++|
T Consensus 277 P~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 277 LTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp TTTCTTSSTTTTHHHHTS
T ss_pred HHhccccccccHHHHHcC
Confidence 99995 99999986
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-49 Score=324.08 Aligned_cols=243 Identities=22% Similarity=0.206 Sum_probs=180.6
Q ss_pred CeEEEEEeecccC-----hhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHH
Q 024027 1 MEVAVKVFNLQCG-----RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQR 75 (273)
Q Consensus 1 ~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (273)
+.||||+++.... ...+.+.+|+++++.++||||+++++++.+++.+++||||+.++++..+. ..+..+++..+
T Consensus 24 ~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~-~~~~~l~~~~~ 102 (299)
T d1ua2a_ 24 QIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIK-DNSLVLTPSHI 102 (299)
T ss_dssp SEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHT-TCCSSCCSSHH
T ss_pred cEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhh-hcccCCCHHHH
Confidence 4799999975421 22456889999999999999999999999999999999999887666555 45557999999
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCC-C
Q 024027 76 LNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG-R 154 (273)
Q Consensus 76 ~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~ 154 (273)
..++.||+.||.||| ++|++||||||+||+++.++.+||+|||.+....... ......+||+.|+|||++.+. .
T Consensus 103 ~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~ 177 (299)
T d1ua2a_ 103 KAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGARM 177 (299)
T ss_dssp HHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSC
T ss_pred HHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCc--ccccceecChhhccHHHHccCCC
Confidence 999999999999999 9999999999999999999999999999997653322 223345789999999988654 5
Q ss_pred cCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhc-------cc-cchhhhhhhhhhHHHH
Q 024027 155 VSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANL-------LS-QEDIHFVAKEQCVSFV 226 (273)
Q Consensus 155 ~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~-~~~~~~~~~~~~~~~l 226 (273)
++.++||||+||++|+|++|.+||......+ .+..+.+............... .. ............+.++
T Consensus 178 ~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 256 (299)
T d1ua2a_ 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDL 256 (299)
T ss_dssp CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHH
T ss_pred CChhhhhhhcchHHHHHHhCcCCCCCCCHHH-HHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHH
Confidence 7999999999999999999999997643322 1222221111110000000000 00 0000111123467789
Q ss_pred HHHHhhcCCCCccCCCCHHHHHHH
Q 024027 227 FNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 227 ~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
.+|+.+||+.||++|||++|+++|
T Consensus 257 ~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 257 LDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp HHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHccCChhhCcCHHHHhCC
Confidence 999999999999999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.3e-49 Score=322.33 Aligned_cols=231 Identities=26% Similarity=0.419 Sum_probs=188.6
Q ss_pred eEEEEEeecccC-hhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC-------------
Q 024027 2 EVAVKVFNLQCG-RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN------------- 67 (273)
Q Consensus 2 ~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------- 67 (273)
.||||+++.... ...+.|.+|++++++++||||++++++|.+....+++|||+++|+|.+++....
T Consensus 45 ~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~ 124 (301)
T d1lufa_ 45 MVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124 (301)
T ss_dssp EEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC------------
T ss_pred EEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccc
Confidence 699999976543 346779999999999999999999999999999999999999999999985432
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeec
Q 024027 68 ----------CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQ 137 (273)
Q Consensus 68 ----------~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~ 137 (273)
..+++..++.++.|++.||+||| +.+++||||||+||+++.++.+||+|||++..+...........
T Consensus 125 ~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~ 201 (301)
T d1lufa_ 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGN 201 (301)
T ss_dssp ----------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----
T ss_pred hhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCC
Confidence 24888999999999999999999 99999999999999999999999999999986644444344445
Q ss_pred ccccCCCCCCcccCCCCcCCcchhHHHHHHHHHHHhCC-CCCccccccccchhhhhhhccCccchhhhhhhccccchhhh
Q 024027 138 TLATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGK-KPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHF 216 (273)
Q Consensus 138 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (273)
..+++.|+|||.+.+..++.++|||||||++|+|++|. +||......+. ........ ..
T Consensus 202 ~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~-~~~v~~~~-------------------~~ 261 (301)
T d1lufa_ 202 DAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV-IYYVRDGN-------------------IL 261 (301)
T ss_dssp CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-HHHHHTTC-------------------CC
T ss_pred CCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHH-HHHHHcCC-------------------CC
Confidence 67889999999999999999999999999999999986 56655322221 11111100 01
Q ss_pred hhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHHHHH
Q 024027 217 VAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLLKIR 255 (273)
Q Consensus 217 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 255 (273)
..+..++.++.+|+.+||..||++|||+.+|++.|+++.
T Consensus 262 ~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 262 ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 124567778999999999999999999999999999874
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-49 Score=321.70 Aligned_cols=232 Identities=29% Similarity=0.446 Sum_probs=192.9
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC------------
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN------------ 67 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------ 67 (273)
.||||+++.+. ......+.+|+..+.++ +||||++++++|.+++..++||||+++|+|.+++....
T Consensus 47 ~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~ 126 (299)
T d1fgka_ 47 KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 126 (299)
T ss_dssp EEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC----------
T ss_pred EEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCcccccccccc
Confidence 59999998664 34567888999999888 79999999999999999999999999999999996443
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCC
Q 024027 68 ---CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGY 144 (273)
Q Consensus 68 ---~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~ 144 (273)
..+++..++.++.|++.||.||| +.+++||||||+|||++.++.+||+|||++................+++.|
T Consensus 127 ~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 203 (299)
T d1fgka_ 127 NPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKW 203 (299)
T ss_dssp --CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGG
T ss_pred CccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhh
Confidence 34899999999999999999999 999999999999999999999999999999877555444444556788999
Q ss_pred CCCcccCCCCcCCcchhHHHHHHHHHHHh-CCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhH
Q 024027 145 MAPEYGREGRVSTNGDVYSFGIMLMETFT-GKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCV 223 (273)
Q Consensus 145 ~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (273)
+|||.+.+..++.++||||||+++|+|++ |.+||....... ... .... . .....+..++
T Consensus 204 ~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~-~~~-~i~~------------~------~~~~~p~~~~ 263 (299)
T d1fgka_ 204 MAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-LFK-LLKE------------G------HRMDKPSNCT 263 (299)
T ss_dssp SCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-HHH-HHHT------------T------CCCCCCSSCC
T ss_pred hhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH-HHH-HHHc------------C------CCCCCCccch
Confidence 99999998999999999999999999998 788876533221 111 1110 0 0111244567
Q ss_pred HHHHHHHhhcCCCCccCCCCHHHHHHHHHHHHH
Q 024027 224 SFVFNLAMACTVESPEQRINAKEIVTKLLKIRD 256 (273)
Q Consensus 224 ~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 256 (273)
.++.+|+.+||..||.+|||+.+|++.|+++..
T Consensus 264 ~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 264 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 789999999999999999999999999988753
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-49 Score=319.88 Aligned_cols=232 Identities=27% Similarity=0.412 Sum_probs=182.5
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcC-CCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS-NCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~ 80 (273)
+||||+++.. ....+.|.+|+.++++++||||++++|++.+ +..++||||+++|+|..++... ...+++..++.++.
T Consensus 43 ~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~ 120 (285)
T d1fmka3 43 RVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 120 (285)
T ss_dssp EEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHH
T ss_pred EEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHH
Confidence 6999999755 3445789999999999999999999999865 5678999999999999888643 34589999999999
Q ss_pred HHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcCCcch
Q 024027 81 DVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVSTNGD 160 (273)
Q Consensus 81 ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 160 (273)
||+.||+||| +.|++||||||+||+++.++.+||+|||++..+.... ........+++.|+|||.+....++.++|
T Consensus 121 ~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksD 196 (285)
T d1fmka3 121 QIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSD 196 (285)
T ss_dssp HHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHH
T ss_pred HHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCC-ceeeccccccccccChHHHhCCCCCcHHh
Confidence 9999999999 9999999999999999999999999999997653222 22334456899999999999999999999
Q ss_pred hHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCCCccC
Q 024027 161 VYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVESPEQ 240 (273)
Q Consensus 161 iwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 240 (273)
||||||++|+|++|..||................ .....+..++.++.+|+.+||+.||++
T Consensus 197 I~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~-------------------~~~~~~~~~~~~l~~li~~cl~~dP~~ 257 (285)
T d1fmka3 197 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-------------------YRMPCPPECPESLHDLMCQCWRKEPEE 257 (285)
T ss_dssp HHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-------------------CCCCCCTTSCHHHHHHHHHHTCSSGGG
T ss_pred hhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-------------------CCCCCCcccCHHHHHHHHHHcccCHhH
Confidence 9999999999999766655433322222221111 011124567788999999999999999
Q ss_pred CCCHHHHHHHHHHHHHhh
Q 024027 241 RINAKEIVTKLLKIRDSL 258 (273)
Q Consensus 241 Rps~~~~l~~l~~~~~~~ 258 (273)
|||+++|++.|+++..+.
T Consensus 258 Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 258 RPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp SCCHHHHHHHHHTTTSCS
T ss_pred CcCHHHHHHHHhhhhcCC
Confidence 999999998888766543
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-48 Score=317.95 Aligned_cols=236 Identities=26% Similarity=0.407 Sum_probs=187.8
Q ss_pred eEEEEEeecc-cChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcC-------------
Q 024027 2 EVAVKVFNLQ-CGRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS------------- 66 (273)
Q Consensus 2 ~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------------- 66 (273)
.||||.++.. +....+.+.+|+++|+++ +||||++++++|.+++.+++||||+++|+|.++++..
T Consensus 39 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~ 118 (309)
T d1fvra_ 39 DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 118 (309)
T ss_dssp EEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHT
T ss_pred EEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccc
Confidence 5889998644 345677899999999999 7999999999999999999999999999999999654
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCC
Q 024027 67 --NCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGY 144 (273)
Q Consensus 67 --~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~ 144 (273)
...+++..+..++.|++.||.||| +.+++||||||+|||++.++.+||+|||++..... ........+|..|
T Consensus 119 ~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~---~~~~~~~~gt~~y 192 (309)
T d1fvra_ 119 STASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV---YVKKTMGRLPVRW 192 (309)
T ss_dssp TBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEESSCE---ECCC----CCTTT
T ss_pred cccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCceEEccccccccccc---cccccceecCCcc
Confidence 246899999999999999999999 99999999999999999999999999999975422 1222345689999
Q ss_pred CCCcccCCCCcCCcchhHHHHHHHHHHHhCCC-CCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhH
Q 024027 145 MAPEYGREGRVSTNGDVYSFGIMLMETFTGKK-PTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCV 223 (273)
Q Consensus 145 ~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (273)
+|||.+.+..++.++|||||||++|+|++|.. ||......+ ........ .....+..++
T Consensus 193 ~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~-~~~~i~~~-------------------~~~~~~~~~~ 252 (309)
T d1fvra_ 193 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-LYEKLPQG-------------------YRLEKPLNCD 252 (309)
T ss_dssp CCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHHGGGT-------------------CCCCCCTTBC
T ss_pred cchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH-HHHHHHhc-------------------CCCCCCccCC
Confidence 99999998899999999999999999999764 565432211 11111110 0111245577
Q ss_pred HHHHHHHhhcCCCCccCCCCHHHHHHHHHHHHHhhhhhcc
Q 024027 224 SFVFNLAMACTVESPEQRINAKEIVTKLLKIRDSLLRNVG 263 (273)
Q Consensus 224 ~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~~~ 263 (273)
.++.+|+.+||+.||++|||+++|+++|+++.++.....+
T Consensus 253 ~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~~~~ 292 (309)
T d1fvra_ 253 DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVN 292 (309)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSBC
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCcCCCC
Confidence 8899999999999999999999999999999876554443
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-48 Score=317.80 Aligned_cols=243 Identities=22% Similarity=0.222 Sum_probs=181.7
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhh-hcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYL-YSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l-~~~~~~~~~~~~~~ 77 (273)
+.||||+++... ......+.+|+++|++++||||++++++|.++..+|+||||+.+ ++.+++ ......+++..++.
T Consensus 28 ~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~ 106 (298)
T d1gz8a_ 28 EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKS 106 (298)
T ss_dssp CEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTTCCCHHHHHH
T ss_pred CEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC-chhhhhhhhcccCCCHHHHHH
Confidence 479999997553 23467889999999999999999999999999999999999976 554544 45556799999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCC-cC
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGR-VS 156 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~ 156 (273)
++.|++.||.||| +.||+||||||+||+++.++.+||+|||.+...... ........|++.|+|||.+.... ++
T Consensus 107 ~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~--~~~~~~~~gt~~y~apE~~~~~~~~~ 181 (298)
T d1gz8a_ 107 YLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYTHEVVTLWYRAPEILLGCKYYS 181 (298)
T ss_dssp HHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC--SBCTTCCBCCCTTCCHHHHTTCSSCC
T ss_pred HHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCC--cccceeecccceeeehhhhccccCCC
Confidence 9999999999999 999999999999999999999999999999765322 22334457999999999876655 58
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCcc--chhhhhh------hc-cccchhhhhhhhhhHHHHH
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPIS--TMEVVDA------NL-LSQEDIHFVAKEQCVSFVF 227 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~------~~-~~~~~~~~~~~~~~~~~l~ 227 (273)
.++||||+||++|+|++|+.||......+. ............ ....... .. .............++.++.
T Consensus 182 ~~~DiwSlGvily~m~~G~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 260 (298)
T d1gz8a_ 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQ-LFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGR 260 (298)
T ss_dssp THHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHH
T ss_pred ccccccccchhhhHHhhCCCCCCCCCHHHH-HHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHH
Confidence 899999999999999999999976433221 111111111100 0000000 00 0000111112235678899
Q ss_pred HHHhhcCCCCccCCCCHHHHHHH
Q 024027 228 NLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 228 ~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
+|+.+||++||++|||++|+++|
T Consensus 261 dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 261 SLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHccCChhHCcCHHHHhCC
Confidence 99999999999999999999987
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=315.17 Aligned_cols=252 Identities=21% Similarity=0.251 Sum_probs=180.5
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeecCC----ceeEEEeccCCCCHHHhhhcCCCCCCHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSNEE----FKALVLEYMPHGSLEKYLYSSNCILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (273)
+.||||+++... ......+.|+..++.++||||+++++++.+++ .+++||||+++|+|.+++++. .+++..++
T Consensus 27 ~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~--~l~~~~~~ 103 (303)
T d1vjya_ 27 EEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMI 103 (303)
T ss_dssp EEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHH
T ss_pred EEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcC--CCCHHHHH
Confidence 379999997542 22222334555556789999999999997653 578999999999999999765 48999999
Q ss_pred HHHHHHHHHHHHHhcC-----CCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCc--ceeecccccCCCCCCcc
Q 024027 77 NIMIDVASALEYLHFG-----CSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQS--MTQTQTLATIGYMAPEY 149 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~-----~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~ 149 (273)
.++.|++.||.|+|.. ...||+||||||+|||++.++.+||+|||++......... .......||+.|+|||+
T Consensus 104 ~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 183 (303)
T d1vjya_ 104 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183 (303)
T ss_dssp HHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHH
T ss_pred HHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhh
Confidence 9999999999999921 0259999999999999999999999999999876443322 12345679999999999
Q ss_pred cCCCC------cCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhh---ccccchhhhhhhh
Q 024027 150 GREGR------VSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDAN---LLSQEDIHFVAKE 220 (273)
Q Consensus 150 ~~~~~------~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 220 (273)
+.+.. ++.++|||||||++|+|++|..||................. .......... .............
T Consensus 184 ~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~p~~~~~~~~~ 261 (303)
T d1vjya_ 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD--PSVEEMRKVVCEQKLRPNIPNRWQSC 261 (303)
T ss_dssp HTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS--CCHHHHHHHHTTSCCCCCCCGGGGGC
T ss_pred ccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc--chHHHHHHHHhccccCCCCCcccCCh
Confidence 87543 57789999999999999999988765333322211111100 0000000000 0000001111233
Q ss_pred hhHHHHHHHHhhcCCCCccCCCCHHHHHHHHHHHHHh
Q 024027 221 QCVSFVFNLAMACTVESPEQRINAKEIVTKLLKIRDS 257 (273)
Q Consensus 221 ~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~ 257 (273)
.+..++.+|+.+||..||++|||+.+|+++|+++.++
T Consensus 262 ~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 262 EALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 4567799999999999999999999999999988754
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=322.66 Aligned_cols=223 Identities=23% Similarity=0.287 Sum_probs=182.5
Q ss_pred CeEEEEEeeccc---ChhhhhHHHHHHHHh-cCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDVECEMMK-SIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRL 76 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 76 (273)
+.||||+++.+. ....+.+..|..++. .++||||+++++++.++...|+||||+++|+|.+++.... .+++..++
T Consensus 28 ~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~~-~~~e~~~~ 106 (320)
T d1xjda_ 28 QFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRAT 106 (320)
T ss_dssp EEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHH
T ss_pred CEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhccC-CCCHHHHH
Confidence 369999997542 344566777777765 6899999999999999999999999999999999996544 68999999
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCCcC
Q 024027 77 NIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGRVS 156 (273)
Q Consensus 77 ~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~ 156 (273)
.++.||+.||.||| ++|++||||||+|||++.++.+||+|||++...... ........||+.|+|||++.+..++
T Consensus 107 ~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~ 181 (320)
T d1xjda_ 107 FYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG--DAKTNTFCGTPDYIAPEILLGQKYN 181 (320)
T ss_dssp HHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--TCCBCCCCSCGGGCCHHHHTTCCBC
T ss_pred HHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhcccc--cccccccCCCCCcCCHHHHcCCCCC
Confidence 99999999999999 999999999999999999999999999999865322 2233446799999999999999999
Q ss_pred CcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhcCCC
Q 024027 157 TNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMACTVE 236 (273)
Q Consensus 157 ~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 236 (273)
.++||||+||++|+|++|+.||.+..... ........ . ...+..++.++.+|+.+||..
T Consensus 182 ~~~DiwSlGvilyemltG~~PF~~~~~~~-~~~~i~~~----------------~----~~~p~~~s~~~~dli~~~L~~ 240 (320)
T d1xjda_ 182 HSVDWWSFGVLLYEMLIGQSPFHGQDEEE-LFHSIRMD----------------N----PFYPRWLEKEAKDLLVKLFVR 240 (320)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHC----------------C----CCCCTTSCHHHHHHHHHHSCS
T ss_pred chhhhhhhhHHHHHHHhCCCCCCCCCHHH-HHHHHHcC----------------C----CCCCccCCHHHHHHHHHhccc
Confidence 99999999999999999999997533221 11111100 0 011345678899999999999
Q ss_pred CccCCCCHH-HHHHH
Q 024027 237 SPEQRINAK-EIVTK 250 (273)
Q Consensus 237 dp~~Rps~~-~~l~~ 250 (273)
||.+|||+. ++++|
T Consensus 241 dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 241 EPEKRLGVRGDIRQH 255 (320)
T ss_dssp SGGGSBTTBSCGGGS
T ss_pred CCCCCcCHHHHHHhC
Confidence 999999995 78764
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.2e-48 Score=324.28 Aligned_cols=225 Identities=19% Similarity=0.206 Sum_probs=179.6
Q ss_pred CeEEEEEeeccc---ChhhhhHHH---HHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHH
Q 024027 1 MEVAVKVFNLQC---GRAFKSFDV---ECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQ 74 (273)
Q Consensus 1 ~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 74 (273)
+.||||++.... ......+.+ |+++++.++||||++++++|.+++.+|+|||||+||+|.+++.+.. .+++..
T Consensus 30 ~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~-~~~e~~ 108 (364)
T d1omwa3 30 KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-VFSEAD 108 (364)
T ss_dssp CEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHC-SCCHHH
T ss_pred CEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhcc-cccHHH
Confidence 479999996432 112223333 4777788899999999999999999999999999999999996654 689999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC-C
Q 024027 75 RLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE-G 153 (273)
Q Consensus 75 ~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~ 153 (273)
++.++.||+.||.||| +.|++||||||+|||++.++.+||+|||++..+... .....+||+.|+|||++.. .
T Consensus 109 ~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~----~~~~~~GT~~y~APE~~~~~~ 181 (364)
T d1omwa3 109 MRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKGV 181 (364)
T ss_dssp HHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS----CCCSCCSCGGGCCHHHHSTTC
T ss_pred HHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecCCC----cccccccccccchhHHhhcCC
Confidence 9999999999999999 999999999999999999999999999999865322 2334579999999999864 5
Q ss_pred CcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhc
Q 024027 154 RVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMAC 233 (273)
Q Consensus 154 ~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 233 (273)
.++.++|||||||++|+|++|..||......... ........ .....+..++.++.+||.+|
T Consensus 182 ~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~--~~~~~~~~----------------~~~~~~~~~s~~~~~li~~~ 243 (364)
T d1omwa3 182 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRMTLT----------------MAVELPDSFSPELRSLLEGL 243 (364)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH--HHHHHSSS----------------CCCCCCSSSCHHHHHHHHHH
T ss_pred CCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHhccc----------------CCCCCCCCCCHHHHHHHHHH
Confidence 6899999999999999999999999764333211 11100000 00111345778899999999
Q ss_pred CCCCccCCCC-----HHHHHHHH
Q 024027 234 TVESPEQRIN-----AKEIVTKL 251 (273)
Q Consensus 234 l~~dp~~Rps-----~~~~l~~l 251 (273)
|..||++||| ++++++|=
T Consensus 244 L~~dP~~R~t~~~~~a~eil~Hp 266 (364)
T d1omwa3 244 LQRDVNRRLGCLGRGAQEVKESP 266 (364)
T ss_dssp TCSSTTTSTTTSSSTHHHHHTSG
T ss_pred cccCHHHhCCCcccCHHHHHcCc
Confidence 9999999999 79998873
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-48 Score=319.05 Aligned_cols=234 Identities=22% Similarity=0.354 Sum_probs=192.4
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcC-CCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCC------------
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSI-RHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSN------------ 67 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------ 67 (273)
.||||+++... ......+.+|+.+++.+ +||||+++++++.++...++|||||++|+|.+++....
T Consensus 55 ~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~ 134 (311)
T d1t46a_ 55 TVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134 (311)
T ss_dssp EEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC---------
T ss_pred EEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhcccccccccccccc
Confidence 69999998653 34566789999999999 69999999999999999999999999999999986542
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccC
Q 024027 68 -----CILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATI 142 (273)
Q Consensus 68 -----~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~ 142 (273)
..+++..+..++.|++.||+||| ++|++||||||+||+++.++.++++|||.+...............++|+
T Consensus 135 ~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~ 211 (311)
T d1t46a_ 135 MEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPV 211 (311)
T ss_dssp -----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECG
T ss_pred ccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccccccccccccCcccccccchheeccCCCcceEeeecccCh
Confidence 25889999999999999999999 9999999999999999999999999999998775544444445667899
Q ss_pred CCCCCcccCCCCcCCcchhHHHHHHHHHHHhC-CCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhh
Q 024027 143 GYMAPEYGREGRVSTNGDVYSFGIMLMETFTG-KKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQ 221 (273)
Q Consensus 143 ~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (273)
.|+|||.+.+..++.++|||||||++|+|+++ .+||... .............. ....+..
T Consensus 212 ~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~-~~~~~~~~~i~~~~------------------~~~~~~~ 272 (311)
T d1t46a_ 212 KWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM-PVDSKFYKMIKEGF------------------RMLSPEH 272 (311)
T ss_dssp GGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-CSSHHHHHHHHHTC------------------CCCCCTT
T ss_pred HHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC-CHHHHHHHHHhcCC------------------CCCCccc
Confidence 99999999988999999999999999999994 5555443 22222222221111 1111345
Q ss_pred hHHHHHHHHhhcCCCCccCCCCHHHHHHHHHHHHHh
Q 024027 222 CVSFVFNLAMACTVESPEQRINAKEIVTKLLKIRDS 257 (273)
Q Consensus 222 ~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~ 257 (273)
++.++.+||.+||..||.+|||++++++.|++...+
T Consensus 273 ~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 273 APAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 677899999999999999999999999999887665
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=315.16 Aligned_cols=236 Identities=23% Similarity=0.383 Sum_probs=191.8
Q ss_pred eEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcC---------CCCCC
Q 024027 2 EVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSS---------NCILD 71 (273)
Q Consensus 2 ~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------~~~~~ 71 (273)
.||||+++... ......|.+|++++++++||||+++++++..+...++||||+++|+|.+++... ...++
T Consensus 52 ~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~ 131 (308)
T d1p4oa_ 52 RVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 131 (308)
T ss_dssp EEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCC
T ss_pred EEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCC
Confidence 69999997543 345567899999999999999999999999999999999999999999998532 13478
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccC
Q 024027 72 IFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR 151 (273)
Q Consensus 72 ~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 151 (273)
+..+..++.|++.||.||| +.+++||||||+|||++.++.+||+|||++..+.............+++.|+|||.+.
T Consensus 132 ~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~ 208 (308)
T d1p4oa_ 132 LSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK 208 (308)
T ss_dssp HHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHc
Confidence 8999999999999999999 9999999999999999999999999999998765444433344456899999999999
Q ss_pred CCCcCCcchhHHHHHHHHHHHhCC-CCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHH
Q 024027 152 EGRVSTNGDVYSFGIMLMETFTGK-KPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLA 230 (273)
Q Consensus 152 ~~~~~~~~DiwslG~~l~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 230 (273)
+..++.++||||||+++|+|++|. .||......+ ........ .....+..++..+.+|+
T Consensus 209 ~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~-~~~~i~~~-------------------~~~~~p~~~~~~l~~li 268 (308)
T d1p4oa_ 209 DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-VLRFVMEG-------------------GLLDKPDNCPDMLFELM 268 (308)
T ss_dssp HCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH-HHHHHHTT-------------------CCCCCCTTCCHHHHHHH
T ss_pred cCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHhC-------------------CCCCCcccchHHHHHHH
Confidence 899999999999999999999985 6665432221 11111110 01112445677899999
Q ss_pred hhcCCCCccCCCCHHHHHHHHHHHHHhhhh
Q 024027 231 MACTVESPEQRINAKEIVTKLLKIRDSLLR 260 (273)
Q Consensus 231 ~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~ 260 (273)
.+||..||.+|||+++|+++|++..+...+
T Consensus 269 ~~cl~~~P~~RPs~~~il~~L~~~~~~~~~ 298 (308)
T d1p4oa_ 269 RMCWQYNPKMRPSFLEIISSIKEEMEPGFR 298 (308)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHGGGSCTTHH
T ss_pred HHHcCCChhHCcCHHHHHHHHHHhcCCCCc
Confidence 999999999999999999999877654433
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-47 Score=312.30 Aligned_cols=242 Identities=22% Similarity=0.229 Sum_probs=182.8
Q ss_pred eEEEEEeeccc--ChhhhhHHHHHHHHhcC---CCccceeeeeeeec-----CCceeEEEeccCCCCHHHhhhcCCCCCC
Q 024027 2 EVAVKVFNLQC--GRAFKSFDVECEMMKSI---RHRNLIKVISSCSN-----EEFKALVLEYMPHGSLEKYLYSSNCILD 71 (273)
Q Consensus 2 ~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 71 (273)
.||||+++... ......+.+|+.+++.+ +||||++++++|.. ....+++||+++++++..........++
T Consensus 35 ~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~ 114 (305)
T d1blxa_ 35 FVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVP 114 (305)
T ss_dssp EEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSC
T ss_pred EEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCC
Confidence 58999997553 23345677888887766 79999999999853 4578999999998777666666666799
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccC
Q 024027 72 IFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR 151 (273)
Q Consensus 72 ~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 151 (273)
+..++.++.|++.||+||| ++|++||||||+|||++.++.+||+|||.+..... ........||+.|+|||++.
T Consensus 115 ~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~---~~~~~~~~gT~~Y~APE~~~ 188 (305)
T d1blxa_ 115 TETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAPEVLL 188 (305)
T ss_dssp HHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCG---GGGGCCCCCCCTTCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecchhhhhhhcc---cccCCCcccChhhcCcchhc
Confidence 9999999999999999999 99999999999999999999999999999875422 22334567999999999999
Q ss_pred CCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhh-------hhhccccchhhhhhhhhhHH
Q 024027 152 EGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVV-------DANLLSQEDIHFVAKEQCVS 224 (273)
Q Consensus 152 ~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~ 224 (273)
+..++.++||||+||++|+|++|..||......+ .+................ .................+++
T Consensus 189 ~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 267 (305)
T d1blxa_ 189 QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDE 267 (305)
T ss_dssp TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCH
T ss_pred CCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH-HHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCH
Confidence 9999999999999999999999999997643322 222222111111000000 00000011111122345678
Q ss_pred HHHHHHhhcCCCCccCCCCHHHHHHH
Q 024027 225 FVFNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 225 ~l~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
++.+|+.+||.+||++|||++|+++|
T Consensus 268 ~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 268 LGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 89999999999999999999999987
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.7e-46 Score=306.38 Aligned_cols=243 Identities=20% Similarity=0.207 Sum_probs=181.0
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
+.||||+++... ....+.+.+|+++|+.++||||++++++|.+++..++++|++.++.+..+. .....+++..+..+
T Consensus 27 ~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~-~~~~~l~~~~~~~i 105 (286)
T d1ob3a_ 27 ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD-VCEGGLESVTAKSF 105 (286)
T ss_dssp CEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHH-TSTTCCCHHHHHHH
T ss_pred CEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHH-hhcCCcchhhhHHH
Confidence 479999997553 334678999999999999999999999999999999999999876555554 44567999999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCC-CcCC
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG-RVST 157 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~ 157 (273)
+.|++.||.||| +.||+||||||+||+++.++.+|++|||.+...... ........+++.|.|||.+.+. .++.
T Consensus 106 ~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~~~~~~~~~y~~pE~~~~~~~~~~ 180 (286)
T d1ob3a_ 106 LLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VRKYTHEIVTLWYRAPDVLMGSKKYST 180 (286)
T ss_dssp HHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCT
T ss_pred HHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccC--ccccceecccchhhhHHHHhCCCCCCc
Confidence 999999999999 999999999999999999999999999999865322 2223445688999999988754 4689
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhh--------hhh-ccccchhhhhhhhhhHHHHHH
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVV--------DAN-LLSQEDIHFVAKEQCVSFVFN 228 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~-~~~~~~~~~~~~~~~~~~l~~ 228 (273)
++||||+||++|+|++|+.||......+. ................. ... ..............++.++.+
T Consensus 181 ~~DiwslGv~l~el~~G~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 259 (286)
T d1ob3a_ 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGID 259 (286)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHH
T ss_pred ceeehhcCcHHHHHHHCCCCCCCCCHHHH-HHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHH
Confidence 99999999999999999999976433222 11111111110000000 000 000011111223456778999
Q ss_pred HHhhcCCCCccCCCCHHHHHHH
Q 024027 229 LAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 229 li~~~l~~dp~~Rps~~~~l~~ 250 (273)
|+.+||++||++|||++|+++|
T Consensus 260 li~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 260 LLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999976
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=310.13 Aligned_cols=216 Identities=22% Similarity=0.242 Sum_probs=176.1
Q ss_pred CeEEEEEeecccC------hhhhhHHHHHHHHhcCC--CccceeeeeeeecCCceeEEEeccCC-CCHHHhhhcCCCCCC
Q 024027 1 MEVAVKVFNLQCG------RAFKSFDVECEMMKSIR--HRNLIKVISSCSNEEFKALVLEYMPH-GSLEKYLYSSNCILD 71 (273)
Q Consensus 1 ~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~ 71 (273)
++||||+++.... .....+.+|+.++++++ ||||+++++++.+++..++||||+.+ +++.+++... ..++
T Consensus 30 ~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~-~~l~ 108 (273)
T d1xwsa_ 30 LPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQ 108 (273)
T ss_dssp CEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHH-CSCC
T ss_pred CEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhcc-CCCC
Confidence 4799999975421 12345778999999986 89999999999999999999999975 6788888654 3699
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCC-CCceEEeecccccccccCCCcceeecccccCCCCCCccc
Q 024027 72 IFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDD-NLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYG 150 (273)
Q Consensus 72 ~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~-~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 150 (273)
+..++.++.|++.||.||| +.|++||||||+||+++. ++.+||+|||++..... .......||+.|+|||++
T Consensus 109 e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~----~~~~~~~GT~~y~aPE~~ 181 (273)
T d1xwsa_ 109 EELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD----TVYTDFDGTRVYSPPEWI 181 (273)
T ss_dssp HHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCS----SCBCCCCSCGGGSCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccccceeccc----ccccccccCCCcCCHHHH
Confidence 9999999999999999999 999999999999999985 57999999999976422 223446799999999998
Q ss_pred CCCCc-CCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHH
Q 024027 151 REGRV-STNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNL 229 (273)
Q Consensus 151 ~~~~~-~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 229 (273)
.+..+ +.++||||+||++|+|++|..||..... ..... ...+..++.++.+|
T Consensus 182 ~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------i~~~~--------------------~~~~~~~s~~~~~l 234 (273)
T d1xwsa_ 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------IIRGQ--------------------VFFRQRVSSECQHL 234 (273)
T ss_dssp HHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------HHHCC--------------------CCCSSCCCHHHHHH
T ss_pred cCCCCCCcccccccceeeehhHhhCCCCCCCchH-------Hhhcc--------------------cCCCCCCCHHHHHH
Confidence 77665 6779999999999999999999865210 00000 00133467789999
Q ss_pred HhhcCCCCccCCCCHHHHHHHH
Q 024027 230 AMACTVESPEQRINAKEIVTKL 251 (273)
Q Consensus 230 i~~~l~~dp~~Rps~~~~l~~l 251 (273)
+.+||..||++|||++|+++|=
T Consensus 235 i~~~L~~dp~~R~s~~eil~hp 256 (273)
T d1xwsa_ 235 IRWCLALRPSDRPTFEEIQNHP 256 (273)
T ss_dssp HHHHTCSSGGGSCCHHHHHTSG
T ss_pred HHHHccCCHhHCcCHHHHhcCH
Confidence 9999999999999999999873
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-45 Score=306.33 Aligned_cols=238 Identities=24% Similarity=0.251 Sum_probs=180.5
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCC------ceeEEEeccCCCCHHHhhhcCCCCCCH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEE------FKALVLEYMPHGSLEKYLYSSNCILDI 72 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~ 72 (273)
+.||||+++... ....+.+.+|+++|+.++||||++++++|...+ .+++||||+ +.+|..+++.. .+++
T Consensus 44 ~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~--~l~~ 120 (346)
T d1cm8a_ 44 AKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE--KLGE 120 (346)
T ss_dssp CEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHHC--CCCH
T ss_pred CEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHHhc--cccH
Confidence 479999997542 344667889999999999999999999997654 569999999 55888887654 4999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC
Q 024027 73 FQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE 152 (273)
Q Consensus 73 ~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 152 (273)
..++.++.|++.||.||| ++||+||||||+|||++.++.+|++|||++..... ......+++.|+|||++.+
T Consensus 121 ~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~ 192 (346)
T d1cm8a_ 121 DRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS-----EMTGYVVTRWYRAPEVILN 192 (346)
T ss_dssp HHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS-----SCCSSCSCGGGCCTHHHHT
T ss_pred HHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccceeccCC-----ccccccccccccCHHHHcC
Confidence 999999999999999999 99999999999999999999999999999986522 2234678999999998876
Q ss_pred C-CcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccc--hh--------hhhhhccc-cchhhhhhhh
Q 024027 153 G-RVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPIST--ME--------VVDANLLS-QEDIHFVAKE 220 (273)
Q Consensus 153 ~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~--------~~~~~~~~-~~~~~~~~~~ 220 (273)
. .++.++||||+||++|+|++|.+||........ +............ .. ........ ..........
T Consensus 193 ~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (346)
T d1cm8a_ 193 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ-LKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILT 271 (346)
T ss_dssp TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCT
T ss_pred CCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH-HHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhcc
Confidence 4 578999999999999999999999976433221 1111111111000 00 00000000 0001111224
Q ss_pred hhHHHHHHHHhhcCCCCccCCCCHHHHHHH
Q 024027 221 QCVSFVFNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 221 ~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
.+++++.+||.+||..||.+|||++|+++|
T Consensus 272 ~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 272 NASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp TCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 567789999999999999999999999998
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-45 Score=304.18 Aligned_cols=244 Identities=20% Similarity=0.170 Sum_probs=180.0
Q ss_pred CeEEEEEeeccc-ChhhhhHHHHHHHHhcCCCccceeeeeeeecCC----ceeEEEeccCCCCHHHhhhcCCCCCCHHHH
Q 024027 1 MEVAVKVFNLQC-GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEE----FKALVLEYMPHGSLEKYLYSSNCILDIFQR 75 (273)
Q Consensus 1 ~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (273)
+.||||+++... ....+.+.+|+++|+.++||||+++++++..+. ..+++++++.+|+|.+++... .+++..+
T Consensus 34 ~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~~--~l~~~~i 111 (345)
T d1pmea_ 34 VRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHI 111 (345)
T ss_dssp SEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHHC--CCCHHHH
T ss_pred cEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhcC--CCCHHHH
Confidence 469999997543 345667899999999999999999999987653 224445556688999999765 4899999
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCc-ceeecccccCCCCCCcccCC-C
Q 024027 76 LNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQS-MTQTQTLATIGYMAPEYGRE-G 153 (273)
Q Consensus 76 ~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~-~ 153 (273)
+.++.|++.||.||| ++||+||||||+|||++.++.+||+|||++......... ......+|++.|+|||++.. .
T Consensus 112 ~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~ 188 (345)
T d1pmea_ 112 CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 188 (345)
T ss_dssp HHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBC
T ss_pred HHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCC
Confidence 999999999999999 999999999999999999999999999999766433221 22345678999999999854 4
Q ss_pred CcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchh-----------hhhhhccccchhhhhhhhhh
Q 024027 154 RVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTME-----------VVDANLLSQEDIHFVAKEQC 222 (273)
Q Consensus 154 ~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~ 222 (273)
.++.++||||+||++|+|++|..||......+..... ........... ...................+
T Consensus 189 ~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (345)
T d1pmea_ 189 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI-LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNA 267 (345)
T ss_dssp SCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-HHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTS
T ss_pred CCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHH-hhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCC
Confidence 5789999999999999999999999764332221111 11111100000 00000000000111123356
Q ss_pred HHHHHHHHhhcCCCCccCCCCHHHHHHH
Q 024027 223 VSFVFNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 223 ~~~l~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
+.++.+|+.+||+.||.+|||++++++|
T Consensus 268 s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 268 DSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 6789999999999999999999999987
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-45 Score=297.50 Aligned_cols=244 Identities=20% Similarity=0.201 Sum_probs=187.3
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNI 78 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 78 (273)
+.||||+++... ......+.+|+.+|+.++||||++++++|.+....+++++++.++++..++.. ...+++..++.+
T Consensus 28 ~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~-~~~~~~~~~~~~ 106 (292)
T d1unla_ 28 EIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC-NGDLDPEIVKSF 106 (292)
T ss_dssp CEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHT-TTCCCHHHHHHH
T ss_pred cEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeecccccccccccc-ccccchhHHHHH
Confidence 469999997553 34567899999999999999999999999999999999999999888887754 447899999999
Q ss_pred HHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCCC-cCC
Q 024027 79 MIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREGR-VST 157 (273)
Q Consensus 79 ~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~ 157 (273)
+.|++.||+||| ++||+||||||+||+++.++.+||+|||.+....... .......+++.|.|||++.+.. ++.
T Consensus 107 ~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~ 181 (292)
T d1unla_ 107 LFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYST 181 (292)
T ss_dssp HHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC--SCCCSCCSCGGGCCHHHHTTCSCCCT
T ss_pred HHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCC--ccceeeccccchhhhhHhccCCCCCc
Confidence 999999999999 9999999999999999999999999999998763322 2233445778899999887665 689
Q ss_pred cchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhh---------ccccchhhhhhhhhhHHHHHH
Q 024027 158 NGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDAN---------LLSQEDIHFVAKEQCVSFVFN 228 (273)
Q Consensus 158 ~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~l~~ 228 (273)
++||||+||++|+|++|..||....+........................ ...............+..+.+
T Consensus 182 ~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 261 (292)
T d1unla_ 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRD 261 (292)
T ss_dssp HHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHH
T ss_pred hhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHH
Confidence 99999999999999999999765444333333322221111110000000 000111112223456778999
Q ss_pred HHhhcCCCCccCCCCHHHHHHH
Q 024027 229 LAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 229 li~~~l~~dp~~Rps~~~~l~~ 250 (273)
|+.+||++||++|||++|+++|
T Consensus 262 ll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 262 LLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp HHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-44 Score=297.45 Aligned_cols=247 Identities=19% Similarity=0.214 Sum_probs=177.1
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeec--------CCceeEEEeccCCCCHHHhhhcCCCCC
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSN--------EEFKALVLEYMPHGSLEKYLYSSNCIL 70 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~~~ 70 (273)
+.||||+++... ......+.+|+++|+.++||||+++++++.. +...++||||+.++.+ .........+
T Consensus 36 ~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~-~~~~~~~~~~ 114 (318)
T d3blha1 36 QKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA-GLLSNVLVKF 114 (318)
T ss_dssp CEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHH-HHHTCTTCCC
T ss_pred CEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCcc-chhhhccccc
Confidence 479999986542 3456778899999999999999999998855 3568999999987555 4444556679
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCC--cceeecccccCCCCCCc
Q 024027 71 DIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQ--SMTQTQTLATIGYMAPE 148 (273)
Q Consensus 71 ~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~--~~~~~~~~~~~~~~aPE 148 (273)
++..++.++.|++.||.||| +.|++||||||+||+++.++.+|++|||++..+..... .......+||+.|+|||
T Consensus 115 ~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE 191 (318)
T d3blha1 115 TLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191 (318)
T ss_dssp CHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHH
T ss_pred ccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHH
Confidence 99999999999999999999 99999999999999999999999999999976643222 12223456899999999
Q ss_pred ccCCC-CcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCc--cc---------hhhhhhhcc-ccchhh
Q 024027 149 YGREG-RVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPI--ST---------MEVVDANLL-SQEDIH 215 (273)
Q Consensus 149 ~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--~~---------~~~~~~~~~-~~~~~~ 215 (273)
++.+. .++.++||||+||++|+|++|+.||........ ........... .. ......... ......
T Consensus 192 ~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (318)
T d3blha1 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ-LALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKD 270 (318)
T ss_dssp HHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHH
T ss_pred HHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHH-HHHHHHhcCCCChhhccccchhhhhhhhcccccccccchh
Confidence 98765 589999999999999999999999975332221 11111111000 00 000000000 000111
Q ss_pred hhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHHH
Q 024027 216 FVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKLL 252 (273)
Q Consensus 216 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 252 (273)
.......+.++.+||.+||++||++|||++|+++|=+
T Consensus 271 ~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpf 307 (318)
T d3blha1 271 RLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 307 (318)
T ss_dssp HHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred hhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChh
Confidence 1112334667899999999999999999999998743
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-45 Score=304.57 Aligned_cols=239 Identities=22% Similarity=0.244 Sum_probs=174.3
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccceeeeeeeec------CCceeEEEeccCCCCHHHhh--hcCCCCCCH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLIKVISSCSN------EEFKALVLEYMPHGSLEKYL--YSSNCILDI 72 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l--~~~~~~~~~ 72 (273)
+.||||+++.+. ..+.+|+++|+.++||||++++++|.. ..++++|||||+++.+..+. ......+++
T Consensus 46 ~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~ 121 (350)
T d1q5ka_ 46 ELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 121 (350)
T ss_dssp CEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCH
T ss_pred CEEEEEEECccc----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCH
Confidence 479999997553 234579999999999999999999843 34578999999875333332 234556999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCC-ceEEeecccccccccCCCcceeecccccCCCCCCcccC
Q 024027 73 FQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNL-VAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGR 151 (273)
Q Consensus 73 ~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~-~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 151 (273)
..++.++.|++.||+||| ++||+||||||+|||++.++ .+||+|||++..+.... ......|++.|+|||.+.
T Consensus 122 ~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~ 195 (350)
T d1q5ka_ 122 IYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE---PNVSYICSRYYRAPELIF 195 (350)
T ss_dssp HHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS---CCCSCCSCTTSCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhccCCc---ccccccccccccChHHhh
Confidence 999999999999999999 99999999999999999765 89999999998653322 233467899999999876
Q ss_pred C-CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhh-------h--ccccchhhhhhhhh
Q 024027 152 E-GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDA-------N--LLSQEDIHFVAKEQ 221 (273)
Q Consensus 152 ~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~--~~~~~~~~~~~~~~ 221 (273)
+ ..++.++||||+||++|+|++|..||......+. +.................. . ..............
T Consensus 196 ~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~-l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (350)
T d1q5ka_ 196 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ-LVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPR 274 (350)
T ss_dssp TCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH-HHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTT
T ss_pred cccCCCcceeecccceEEEehhhCCCCCCCCCHHHH-HHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccC
Confidence 5 5689999999999999999999999976443221 1111111111000000000 0 00000111112334
Q ss_pred hHHHHHHHHhhcCCCCccCCCCHHHHHHH
Q 024027 222 CVSFVFNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 222 ~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
.++++.+|+.+||.+||++|||+.|+++|
T Consensus 275 ~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 275 TPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 67789999999999999999999999987
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-45 Score=301.77 Aligned_cols=228 Identities=24% Similarity=0.299 Sum_probs=182.4
Q ss_pred CeEEEEEeecc----cChhhhhHHHHHHHHhcCCC-ccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHH
Q 024027 1 MEVAVKVFNLQ----CGRAFKSFDVECEMMKSIRH-RNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQR 75 (273)
Q Consensus 1 ~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 75 (273)
+.||||+++.. +....+.+.+|++++++++| |||+++++++.+....+++|||+.+|+|.+++...+ .+++..+
T Consensus 53 ~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~-~~~e~~~ 131 (322)
T d1vzoa_ 53 KLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-RFTEHEV 131 (322)
T ss_dssp CEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHS-CCCHHHH
T ss_pred cEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhcc-cccHHHH
Confidence 36999999643 23346778899999999965 899999999999999999999999999999996554 5788999
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCC--
Q 024027 76 LNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG-- 153 (273)
Q Consensus 76 ~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-- 153 (273)
..++.|++.||.||| +.|++||||||+||+++.++.++|+|||++..+..... .......|++.|+|||.+.+.
T Consensus 132 ~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~ 207 (322)
T d1vzoa_ 132 QIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDS 207 (322)
T ss_dssp HHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC-
T ss_pred HHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhhhccccc-ccccccccccccchhHHhhcCCc
Confidence 999999999999999 99999999999999999999999999999976533222 223456789999999988754
Q ss_pred CcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHhhc
Q 024027 154 RVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAMAC 233 (273)
Q Consensus 154 ~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 233 (273)
.++.++|||||||++|+|++|..||........... ....... .....+..++.++.+|+.+|
T Consensus 208 ~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~-i~~~~~~----------------~~~~~~~~~s~~~~~li~~~ 270 (322)
T d1vzoa_ 208 GHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE-ISRRILK----------------SEPPYPQEMSALAKDLIQRL 270 (322)
T ss_dssp --CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH-HHHHHHH----------------CCCCCCTTSCHHHHHHHHHH
T ss_pred CCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHhccc----------------CCCCCcccCCHHHHHHHHHH
Confidence 468899999999999999999999976544332211 1111000 00111345788899999999
Q ss_pred CCCCccCCCC-----HHHHHHH
Q 024027 234 TVESPEQRIN-----AKEIVTK 250 (273)
Q Consensus 234 l~~dp~~Rps-----~~~~l~~ 250 (273)
|.+||++||| ++|+++|
T Consensus 271 l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 271 LMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp TCSSGGGSTTSSTTTHHHHHTS
T ss_pred cccCHHHcCCCCcccHHHHHcC
Confidence 9999999994 8999876
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.4e-44 Score=298.98 Aligned_cols=237 Identities=19% Similarity=0.245 Sum_probs=178.0
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCC-Cccceeeeeeeec--CCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIR-HRNLIKVISSCSN--EEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLN 77 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 77 (273)
+.||||+++.. ..+.+.+|+++|+.++ ||||++++++|.. ...+++||||+++++|..+. ..+++..++.
T Consensus 61 ~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~----~~l~e~~i~~ 133 (328)
T d3bqca1 61 EKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRF 133 (328)
T ss_dssp EEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT----TSCCHHHHHH
T ss_pred CEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh----cCCCHHHHHH
Confidence 36999999744 3467889999999995 9999999999874 45689999999999997764 3589999999
Q ss_pred HHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCC-CceEEeecccccccccCCCcceeecccccCCCCCCcccCCC-Cc
Q 024027 78 IMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDN-LVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG-RV 155 (273)
Q Consensus 78 ~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~-~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~ 155 (273)
++.||+.||.||| ++||+||||||+|||++.+ +.++|+|||++....... ......+|+.|+|||.+.+. .+
T Consensus 134 i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~ 207 (328)
T d3bqca1 134 YMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMY 207 (328)
T ss_dssp HHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC---CCCSCCSCGGGCCHHHHTTCCCC
T ss_pred HHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCCC---cccccccCccccCcccccCCCCC
Confidence 9999999999999 9999999999999999865 469999999998653322 23445789999999998765 47
Q ss_pred CCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhh---------------h--hccccchhhhhh
Q 024027 156 STNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVD---------------A--NLLSQEDIHFVA 218 (273)
Q Consensus 156 ~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~--~~~~~~~~~~~~ 218 (273)
+.++||||+||+++++++|..||........................... . ............
T Consensus 208 ~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (328)
T d3bqca1 208 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSEN 287 (328)
T ss_dssp CTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTT
T ss_pred CcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccc
Confidence 99999999999999999999999764433222211111110000000000 0 000001111122
Q ss_pred hhhhHHHHHHHHhhcCCCCccCCCCHHHHHHH
Q 024027 219 KEQCVSFVFNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 219 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
...++.++.+||.+||.+||++|||++|+++|
T Consensus 288 ~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 288 QHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp GGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 34577889999999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-44 Score=300.40 Aligned_cols=240 Identities=22% Similarity=0.184 Sum_probs=173.8
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeec------CCceeEEEeccCCCCHHHhhhcCCCCCCH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSN------EEFKALVLEYMPHGSLEKYLYSSNCILDI 72 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 72 (273)
+.||||+++... ......+.+|+.++++++||||++++++|.. ..++|+||||+.+ ++.+.+. ..+++
T Consensus 43 ~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~-~l~~~~~---~~~~~ 118 (355)
T d2b1pa1 43 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ---MELDH 118 (355)
T ss_dssp EEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHT---SCCCH
T ss_pred CEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccch-HHHHhhh---cCCCH
Confidence 379999997553 3445678899999999999999999999854 4678999999977 5555553 24899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCC
Q 024027 73 FQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGRE 152 (273)
Q Consensus 73 ~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 152 (273)
..++.++.|++.||.||| +.|++||||||+||+++.++.++++|||++..... ........+|+.|+|||++.+
T Consensus 119 ~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~---~~~~~~~~~t~~y~aPE~l~~ 192 (355)
T d2b1pa1 119 ERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILG 192 (355)
T ss_dssp HHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC------------------CCTTCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhcccc---ccccccccccccccChhhhcC
Confidence 999999999999999999 99999999999999999999999999999875422 223345578999999999999
Q ss_pred CCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccC----------------------ccchhhhhhhccc
Q 024027 153 GRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLP----------------------ISTMEVVDANLLS 210 (273)
Q Consensus 153 ~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~ 210 (273)
..++.++||||+||++++|++|+.||....... ........... .............
T Consensus 193 ~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (355)
T d2b1pa1 193 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDS 271 (355)
T ss_dssp CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGG
T ss_pred CCCCCCcccccccchHHHHhhCCCCCCCCCHHH-HHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccc
Confidence 999999999999999999999999997543221 11111110000 0000000000000
Q ss_pred cchhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHHH
Q 024027 211 QEDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTKL 251 (273)
Q Consensus 211 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l 251 (273)
............+.++.+|+.+||.+||++|||++|+|+|=
T Consensus 272 ~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hp 312 (355)
T d2b1pa1 272 LFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 312 (355)
T ss_dssp GSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred cccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCc
Confidence 11112223455788899999999999999999999999883
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-43 Score=289.46 Aligned_cols=238 Identities=19% Similarity=0.184 Sum_probs=182.2
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCCCccce-eeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIRHRNLI-KVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
+.||||+++... ....+..|+++++.++|++++ .+.+++.+....++||||++ +++.+.+......+++..+..++
T Consensus 33 ~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~-~~l~~~~~~~~~~~~~~~~~~~~ 109 (299)
T d1ckia_ 33 EEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG-PSLEDLFNFCSRKFSLKTVLLLA 109 (299)
T ss_dssp EEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTCCCHHHHHHHH
T ss_pred CEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC-CchhhhhhhccCCCcHHHHHHHH
Confidence 379999987553 235688999999999766655 45556677888899999994 58888887777789999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCC---CCceEEeecccccccccCCCc-----ceeecccccCCCCCCcccC
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDD---NLVAYLSDFGIAKLLIGEDQS-----MTQTQTLATIGYMAPEYGR 151 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~---~~~~kl~Df~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~ 151 (273)
.|++.||+||| ++|++||||||+||+++. +..++++|||++..+...... .......||+.|+|||.+.
T Consensus 110 ~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 186 (299)
T d1ckia_ 110 DQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186 (299)
T ss_dssp HHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHT
T ss_pred HHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHh
Confidence 99999999999 999999999999999864 557999999999876433221 1223457999999999999
Q ss_pred CCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHHHh
Q 024027 152 EGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNLAM 231 (273)
Q Consensus 152 ~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 231 (273)
+..++.++|||||||++|+|++|..||................ ... ...........++.++.+|+.
T Consensus 187 ~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~----------~~~---~~~~~~~~~~~~p~~~~~li~ 253 (299)
T d1ckia_ 187 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS----------EKK---MSTPIEVLCKGYPSEFATYLN 253 (299)
T ss_dssp TBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHH----------HHH---HHSCHHHHTTTSCHHHHHHHH
T ss_pred CCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhh----------ccc---CCCChhHhccCCCHHHHHHHH
Confidence 9999999999999999999999999997754433222111000 000 000011123467788999999
Q ss_pred hcCCCCccCCCCHHHHHHHHHHHHHh
Q 024027 232 ACTVESPEQRINAKEIVTKLLKIRDS 257 (273)
Q Consensus 232 ~~l~~dp~~Rps~~~~l~~l~~~~~~ 257 (273)
+||..||.+||+++++.+.|+.+..+
T Consensus 254 ~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 254 FCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp HHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHccCChhHCcCHHHHHHHHHHHHHH
Confidence 99999999999999998888877654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7.1e-43 Score=285.37 Aligned_cols=240 Identities=15% Similarity=0.122 Sum_probs=190.6
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCC-CccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHH
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIR-HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIM 79 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 79 (273)
+.||||+++... ....+.+|++.++.++ |+|++.+++++......++||||+ +++|.+++...+..++...+..++
T Consensus 31 ~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~ 107 (293)
T d1csna_ 31 QQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAA 107 (293)
T ss_dssp EEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHH
T ss_pred CEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhhccchhhHHHHHHH
Confidence 379999986543 3356889999999996 599999999999999999999999 679999998877789999999999
Q ss_pred HHHHHHHHHHhcCCCCCeEeccCCCCceeeCC-----CCceEEeecccccccccCCCc-----ceeecccccCCCCCCcc
Q 024027 80 IDVASALEYLHFGCSAPVIHCDLKPDNVLLDD-----NLVAYLSDFGIAKLLIGEDQS-----MTQTQTLATIGYMAPEY 149 (273)
Q Consensus 80 ~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~-----~~~~kl~Df~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~ 149 (273)
.|++.||.||| +.|++||||||+||+++. ++.++|+|||++..+...... ......+||+.|+|||.
T Consensus 108 ~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~ 184 (293)
T d1csna_ 108 KQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184 (293)
T ss_dssp HHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHH
T ss_pred HHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHH
Confidence 99999999999 999999999999999964 578999999999876433221 12234579999999999
Q ss_pred cCCCCcCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccchhhhhhhccccchhhhhhhhhhHHHHHHH
Q 024027 150 GREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPISTMEVVDANLLSQEDIHFVAKEQCVSFVFNL 229 (273)
Q Consensus 150 ~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 229 (273)
+.+..++.++||||||+++|+|++|..||.............. ..... ...........++.++.++
T Consensus 185 ~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~----------i~~~~---~~~~~~~l~~~~p~~l~~i 251 (293)
T d1csna_ 185 HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER----------IGEKK---QSTPLRELCAGFPEEFYKY 251 (293)
T ss_dssp HTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH----------HHHHH---HHSCHHHHTTTSCHHHHHH
T ss_pred hcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHH----------HHhcc---CCCChHHhcCCCCHHHHHH
Confidence 9999999999999999999999999999976444322111100 00000 0000111134567889999
Q ss_pred HhhcCCCCccCCCCHHHHHHHHHHHHHhhh
Q 024027 230 AMACTVESPEQRINAKEIVTKLLKIRDSLL 259 (273)
Q Consensus 230 i~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 259 (273)
+..|+..+|.+||+.+.+.+.|+++.++..
T Consensus 252 i~~~~~~~~~~rP~y~~l~~~l~~~~~~~~ 281 (293)
T d1csna_ 252 MHYARNLAFDATPDYDYLQGLFSKVLERLN 281 (293)
T ss_dssp HHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence 999999999999999999988888876554
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=296.67 Aligned_cols=239 Identities=20% Similarity=0.181 Sum_probs=174.6
Q ss_pred CeEEEEEeeccc--ChhhhhHHHHHHHHhcCCCccceeeeeeeecC-----CceeEEEeccCCCCHHHhhhcCCCCCCHH
Q 024027 1 MEVAVKVFNLQC--GRAFKSFDVECEMMKSIRHRNLIKVISSCSNE-----EFKALVLEYMPHGSLEKYLYSSNCILDIF 73 (273)
Q Consensus 1 ~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 73 (273)
+.||||+++... ....+.+.+|+++|+.++||||+++++++... ...+++++++.+|+|.+++... .+++.
T Consensus 44 ~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~~--~l~e~ 121 (348)
T d2gfsa1 44 LRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDD 121 (348)
T ss_dssp EEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTTC--CCCHH
T ss_pred CEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhcccc--cccHH
Confidence 369999997553 33456788999999999999999999998643 3446667777899999999654 59999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccCCCCCCcccCCC
Q 024027 74 QRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATIGYMAPEYGREG 153 (273)
Q Consensus 74 ~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 153 (273)
.++.++.||+.||+||| ++|++||||||+||+++.++.++++|||.+.... .......|++.|+|||...+.
T Consensus 122 ~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~-----~~~~~~~g~~~y~apE~~~~~ 193 (348)
T d2gfsa1 122 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATRWYRAPEIMLNW 193 (348)
T ss_dssp HHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----CCT-----GGGSSSCHHHHTSCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhcccC-----cccccccccccccCchhhcCC
Confidence 99999999999999999 9999999999999999999999999999987542 223345688899999987665
Q ss_pred C-cCCcchhHHHHHHHHHHHhCCCCCccccccccchhhhhhhccCccc-----------hhhhhhhccccchhhhhhhhh
Q 024027 154 R-VSTNGDVYSFGIMLMETFTGKKPTYEFFNGEMTLKHWVNDWLPIST-----------MEVVDANLLSQEDIHFVAKEQ 221 (273)
Q Consensus 154 ~-~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~ 221 (273)
. ++.++||||+||++|+|++|..||......... ............ .....................
T Consensus 194 ~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (348)
T d2gfsa1 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL-KLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 272 (348)
T ss_dssp SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTT
T ss_pred ccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHH-HHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCC
Confidence 4 689999999999999999999999754322211 111111110000 000000000000011111245
Q ss_pred hHHHHHHHHhhcCCCCccCCCCHHHHHHH
Q 024027 222 CVSFVFNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 222 ~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
++.++.+||.+||..||++|||++|+++|
T Consensus 273 ~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 273 ANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 67789999999999999999999999997
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.1e-38 Score=266.50 Aligned_cols=240 Identities=16% Similarity=0.166 Sum_probs=166.4
Q ss_pred CeEEEEEeecccChhhhhHHHHHHHHhcCC-----------CccceeeeeeeecC--CceeEEEeccCCCCH-HH-hhhc
Q 024027 1 MEVAVKVFNLQCGRAFKSFDVECEMMKSIR-----------HRNLIKVISSCSNE--EFKALVLEYMPHGSL-EK-YLYS 65 (273)
Q Consensus 1 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L-~~-~l~~ 65 (273)
+.||||+++.+ ....+.+.+|+++++.++ |+||+++++++... ...+++++++..+.. .. ....
T Consensus 39 ~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 117 (362)
T d1q8ya_ 39 THVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKY 117 (362)
T ss_dssp EEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHT
T ss_pred CEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeecccccccccccccc
Confidence 36999999755 334567888999988774 57899999988653 445566666544332 22 2234
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEeccCCCCceeeCCCC------ceEEeecccccccccCCCcceeecc
Q 024027 66 SNCILDIFQRLNIMIDVASALEYLHFGCS-APVIHCDLKPDNVLLDDNL------VAYLSDFGIAKLLIGEDQSMTQTQT 138 (273)
Q Consensus 66 ~~~~~~~~~~~~~~~ql~~~l~~lh~~~~-~~i~h~di~p~nil~~~~~------~~kl~Df~~~~~~~~~~~~~~~~~~ 138 (273)
....+++..+..++.|++.||.||| + .||+||||||+|||++.++ .++++|||.+.... ......
T Consensus 118 ~~~~~~~~~i~~i~~qil~al~~lh---~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~-----~~~~~~ 189 (362)
T d1q8ya_ 118 EHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD-----EHYTNS 189 (362)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETT-----BCCCSC
T ss_pred cccCCcHHHHHHHHHHHHHHHHHHh---hhcCcccccCChhHeeeeccCcccccceeeEeecccccccc-----cccccc
Confidence 4456899999999999999999999 6 8999999999999997654 48999999987542 223456
Q ss_pred cccCCCCCCcccCCCCcCCcchhHHHHHHHHHHHhCCCCCcccccccc-----chhhhhhhccCccchhhhhh-------
Q 024027 139 LATIGYMAPEYGREGRVSTNGDVYSFGIMLMETFTGKKPTYEFFNGEM-----TLKHWVNDWLPISTMEVVDA------- 206 (273)
Q Consensus 139 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~------- 206 (273)
++++.|+|||++.+..++.++||||+||++++|++|+.||........ ........... ........
T Consensus 190 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~-~~~~~~~~~~~~~~~ 268 (362)
T d1q8ya_ 190 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGE-LPSYLLRNGKYTRTF 268 (362)
T ss_dssp CSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCS-CCHHHHHHCTTHHHH
T ss_pred cccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCC-CCHHHhhcccccccc
Confidence 789999999999998999999999999999999999999975332111 11111110000 00000000
Q ss_pred --------h--cccc------chhhhhhhhhhHHHHHHHHhhcCCCCccCCCCHHHHHHH
Q 024027 207 --------N--LLSQ------EDIHFVAKEQCVSFVFNLAMACTVESPEQRINAKEIVTK 250 (273)
Q Consensus 207 --------~--~~~~------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 250 (273)
. .... ...........+.++.+|+.+||++||.+|||++|+|+|
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 269 FNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 328 (362)
T ss_dssp BCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred cccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 0000 001111234567889999999999999999999999987
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.77 E-value=5.2e-20 Score=139.81 Aligned_cols=146 Identities=16% Similarity=0.124 Sum_probs=98.9
Q ss_pred CeEEEEEeecccC------------------hhhhhHHHHHHHHhcCCCccceeeeeeeecCCceeEEEeccCCCCHHHh
Q 024027 1 MEVAVKVFNLQCG------------------RAFKSFDVECEMMKSIRHRNLIKVISSCSNEEFKALVLEYMPHGSLEKY 62 (273)
Q Consensus 1 ~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 62 (273)
++||||+++.+.. .....+..|...+.++.|.+++..+++.. .+++|||+++..+.+
T Consensus 25 ~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~~----~~lvme~~~~~~~~~- 99 (191)
T d1zara2 25 GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEG----NAVLMELIDAKELYR- 99 (191)
T ss_dssp EEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEET----TEEEEECCCCEEGGG-
T ss_pred CEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEecC----CEEEEEeeccccccc-
Confidence 3799999764211 11234556889999999999998887542 379999998855533
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccCCCCceeeCCCCceEEeecccccccccCCCcceeecccccC
Q 024027 63 LYSSNCILDIFQRLNIMIDVASALEYLHFGCSAPVIHCDLKPDNVLLDDNLVAYLSDFGIAKLLIGEDQSMTQTQTLATI 142 (273)
Q Consensus 63 l~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~kl~Df~~~~~~~~~~~~~~~~~~~~~~ 142 (273)
++...+..++.|++.++.||| ..|++||||||+|||++.+ .++|+|||.+...............+...
T Consensus 100 -------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~~~~l~rd~~~~ 168 (191)
T d1zara2 100 -------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWREILERDVRNI 168 (191)
T ss_dssp -------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEECCCTTCEETTSTTHHHHHHHHHHHH
T ss_pred -------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEEECCCcccCCCCCcHHHHHHHHHHH
Confidence 233446789999999999999 9999999999999999965 58899999987642111100000000000
Q ss_pred CCCCCcccCCCCcCCcchhHHHHHH
Q 024027 143 GYMAPEYGREGRVSTNGDVYSFGIM 167 (273)
Q Consensus 143 ~~~aPE~~~~~~~~~~~DiwslG~~ 167 (273)
.+ +....|+.++|+||+.--
T Consensus 169 ----~~-~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 169 ----IT-YFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp ----HH-HHHHHHCCCCCHHHHHHH
T ss_pred ----HH-HHcCCCCCcccHHHHHHH
Confidence 01 113457889999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.59 E-value=7.9e-08 Score=74.98 Aligned_cols=117 Identities=15% Similarity=0.123 Sum_probs=80.3
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCC-CccceeeeeeeecCCceeEEEeccCCCCHHHhhhcCCCCCCHHHHHHHHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIR-HRNLIKVISSCSNEEFKALVLEYMPHGSLEKYLYSSNCILDIFQRLNIMI 80 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 80 (273)
.++||+...........+.+|...++.+. +-.+.+++.+..+++..++||++++|.++.+..... .. ...++.
T Consensus 39 ~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~---~~---~~~~~~ 112 (263)
T d1j7la_ 39 NLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE---QS---PEKIIE 112 (263)
T ss_dssp EEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC---SC---HHHHHH
T ss_pred eEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc---cc---HHHHHH
Confidence 57788876555555667889999998874 444677888888888999999999998876544211 11 112233
Q ss_pred HHHHHHHHHhcC--------------------------------------------------------CCCCeEeccCCC
Q 024027 81 DVASALEYLHFG--------------------------------------------------------CSAPVIHCDLKP 104 (273)
Q Consensus 81 ql~~~l~~lh~~--------------------------------------------------------~~~~i~h~di~p 104 (273)
++...+..||.. ....++|+|+.|
T Consensus 113 ~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~ 192 (263)
T d1j7la_ 113 LYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGD 192 (263)
T ss_dssp HHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCT
T ss_pred HHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccC
Confidence 333344444410 012378999999
Q ss_pred CceeeCCCCceEEeeccccc
Q 024027 105 DNVLLDDNLVAYLSDFGIAK 124 (273)
Q Consensus 105 ~nil~~~~~~~kl~Df~~~~ 124 (273)
.||+++.++.+.|+||+.+.
T Consensus 193 ~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 193 SNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TSEEEETTEEEEECCCTTCE
T ss_pred cceeecCCceEEEeechhcc
Confidence 99999987777899999875
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.08 E-value=4.9e-06 Score=64.13 Aligned_cols=56 Identities=16% Similarity=0.074 Sum_probs=40.7
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCC--CccceeeeeeeecCCceeEEEeccCCCCHH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIR--HRNLIKVISSCSNEEFKALVLEYMPHGSLE 60 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 60 (273)
.+++|..... ....+..|...++.+. .-.+.+++.+..+++..++||++++|.++.
T Consensus 37 ~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 37 VLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred EEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 3677775433 3456888999888773 334667788888888899999999886653
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.53 E-value=0.00034 Score=57.18 Aligned_cols=30 Identities=20% Similarity=0.286 Sum_probs=25.7
Q ss_pred CCCeEeccCCCCceeeCCCCceEEeeccccc
Q 024027 94 SAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 124 (273)
Q Consensus 94 ~~~i~h~di~p~nil~~~~~~~kl~Df~~~~ 124 (273)
...++|||+.|.|||++.+. ++++||..+.
T Consensus 222 ~~~LiHGDl~~gNIlv~~~~-~~vID~E~a~ 251 (392)
T d2pula1 222 AETLIHGDLHTGSIFASEHE-TKVIDPEFAF 251 (392)
T ss_dssp CCEEECSCCCGGGEEECSSC-EEECCCTTCE
T ss_pred CcceeccCCcCCceeEcCCc-eEEechhhcc
Confidence 34699999999999998764 8999998875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.01 E-value=0.0006 Score=55.73 Aligned_cols=52 Identities=17% Similarity=0.213 Sum_probs=33.9
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCC-CccceeeeeeeecCCceeEEEeccCCCCH
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIR-HRNLIKVISSCSNEEFKALVLEYMPHGSL 59 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 59 (273)
.|++++.- . ........+|..+++.+. +.-..++++++.. .+|+||++|.++
T Consensus 76 ~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 76 KVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL 128 (395)
T ss_dssp EEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred cEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence 35566654 2 223345678999999884 4334577777753 589999987544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.95 E-value=0.0032 Score=49.77 Aligned_cols=120 Identities=13% Similarity=0.143 Sum_probs=68.0
Q ss_pred eEEEEEeecccChhhhhHHHHHHHHhcCCCcc--ceeeee-----eeecCCceeEEEeccCCCCHH-----Hh------h
Q 024027 2 EVAVKVFNLQCGRAFKSFDVECEMMKSIRHRN--LIKVIS-----SCSNEEFKALVLEYMPHGSLE-----KY------L 63 (273)
Q Consensus 2 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~--i~~~~~-----~~~~~~~~~lv~e~~~~~~L~-----~~------l 63 (273)
+|++|+.+.+ ..+.+++..|...+..|...+ ++..+. .+...+..+.++++++|..+. .+ +
T Consensus 48 ~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~~~~~~~lG~~L 126 (325)
T d1zyla1 48 RFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYL 126 (325)
T ss_dssp CEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHH
T ss_pred EEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCCHHHHHHHHHHH
Confidence 6899998644 345577888999988873222 222221 234456678899999773321 11 0
Q ss_pred ---h----cC----CCCCCH----------------------HHHHHHHHHHHHHHHHHh-cCCCCCeEeccCCCCceee
Q 024027 64 ---Y----SS----NCILDI----------------------FQRLNIMIDVASALEYLH-FGCSAPVIHCDLKPDNVLL 109 (273)
Q Consensus 64 ---~----~~----~~~~~~----------------------~~~~~~~~ql~~~l~~lh-~~~~~~i~h~di~p~nil~ 109 (273)
. .. ....+. ......+.++...+...- .....+++|||+.+.||++
T Consensus 127 A~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~liHgDlh~~NvL~ 206 (325)
T d1zyla1 127 GRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILW 206 (325)
T ss_dssp HHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEE
T ss_pred HHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceeecCCCCcccEEE
Confidence 0 00 011111 112233344444443332 2224578999999999999
Q ss_pred CCCCceEEeeccccc
Q 024027 110 DDNLVAYLSDFGIAK 124 (273)
Q Consensus 110 ~~~~~~kl~Df~~~~ 124 (273)
+.+ ..++||+-+.
T Consensus 207 ~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 207 RDG--PMFVDLDDAR 219 (325)
T ss_dssp SSS--EEECCCTTCC
T ss_pred eCC--ceEEechhcc
Confidence 743 4578999876
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.97 E-value=0.0034 Score=49.26 Aligned_cols=31 Identities=42% Similarity=0.443 Sum_probs=28.0
Q ss_pred CCCeEeccCCCCceeeCCCCceEEeeccccc
Q 024027 94 SAPVIHCDLKPDNVLLDDNLVAYLSDFGIAK 124 (273)
Q Consensus 94 ~~~i~h~di~p~nil~~~~~~~kl~Df~~~~ 124 (273)
..|++|+|+.++|++++.+...-++||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 4689999999999999988888899999886
|